drugbank_id,drug_name,drug_type,groups,smiles,inchikey,molecular_weight,target_uniprot,target_id,target_name,target_organism,actions,known_action
DB00006,Bivalirudin,small molecule,approved;investigational,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O,OIRCOABEOLEUMC-GEJPAHFPSA-N,2180.2853,P00734,BE0000048,Prothrombin,Humans,inhibitor,yes
DB00014,Goserelin,small molecule,approved,CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NNC(N)=O,BLCLNMBMMGCOAS-URPVMXJPSA-N,1269.4105,P22888,BE0000134,Lutropin-choriogonadotropic hormone receptor,Humans,agonist,yes
DB00014,Goserelin,small molecule,approved,CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NNC(N)=O,BLCLNMBMMGCOAS-URPVMXJPSA-N,1269.4105,P01148,BE0010526,Progonadoliberin-1,Humans,activator,yes
DB00014,Goserelin,small molecule,approved,CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NNC(N)=O,BLCLNMBMMGCOAS-URPVMXJPSA-N,1269.4105,P30968,BE0000203,Gonadotropin-releasing hormone receptor,Humans,agonist,yes
DB00027,Gramicidin D,small molecule,approved,CC(C)C[C@@H](NC(=O)CNC(=O)[C@@H](NC=O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCCO,NDAYQJDHGXTBJL-MWWSRJDJSA-N,1811.253,P0AC13,BE0000803,Dihydropteroate synthase,Escherichia coli (strain K12),binder,yes
DB00035,Desmopressin,small molecule,approved,NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O,NFLWUMRGJYTJIN-PNIOQBSNSA-N,1069.22,P30559,BE0000844,Oxytocin receptor,Humans,agonist,yes
DB00035,Desmopressin,small molecule,approved,NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O,NFLWUMRGJYTJIN-PNIOQBSNSA-N,1069.22,P30518,BE0000293,Vasopressin V2 receptor,Humans,agonist,yes
DB00035,Desmopressin,small molecule,approved,NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O,NFLWUMRGJYTJIN-PNIOQBSNSA-N,1069.22,P37288,BE0000165,Vasopressin V1a receptor,Humans,agonist,yes
DB00035,Desmopressin,small molecule,approved,NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O,NFLWUMRGJYTJIN-PNIOQBSNSA-N,1069.22,P47901,BE0000773,Vasopressin V1b receptor,Humans,agonist,yes
DB00050,Cetrorelix,small molecule,approved;investigational,CC(C)C[C@H](NC(=O)[C@@H](CCCNC(N)=O)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1=CN=CC=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC2=CC=CC=C2C=C1)NC(C)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,SBNPWPIBESPSIF-MHWMIDJBSA-N,1431.038,P30968,BE0000203,Gonadotropin-releasing hormone receptor,Humans,antagonist,yes
DB00080,Daptomycin,small molecule,approved;investigational,CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H]1[C@@H](C)OC(=O)[C@H](CC(=O)C2=CC=CC=C2N)NC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN)NC(=O)CNC1=O)[C@H](C)CC(O)=O,DOAKLVKFURWEDJ-QCMAZARJSA-N,1620.693,P0AC13,BE0000803,Dihydropteroate synthase,Escherichia coli (strain K12),binder,yes
DB00080,Daptomycin,small molecule,approved;investigational,CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H]1[C@@H](C)OC(=O)[C@H](CC(=O)C2=CC=CC=C2N)NC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN)NC(=O)CNC1=O)[C@H](C)CC(O)=O,DOAKLVKFURWEDJ-QCMAZARJSA-N,1620.693,,BE0010021,Cytoplasmic membrane,Bacteria,incorporation into and destabilization,yes
DB00091,Cyclosporine,small molecule,approved;investigational;vet_approved,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,PMATZTZNYRCHOR-CGLBZJNRSA-N,1202.635,P49069,BE0000379,Guided entry of tail-anchored proteins factor CAMLG,Humans,binder,yes
DB00091,Cyclosporine,small molecule,approved;investigational;vet_approved,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,PMATZTZNYRCHOR-CGLBZJNRSA-N,1202.635,Q08209,BE0004238,Protein phosphatase 3 catalytic subunit alpha,Humans,inhibitor,yes
DB00091,Cyclosporine,small molecule,approved;investigational;vet_approved,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,PMATZTZNYRCHOR-CGLBZJNRSA-N,1202.635,Q96LZ3,BE0002143,Calcineurin subunit B type 2,Humans,inhibitor,yes
DB00091,Cyclosporine,small molecule,approved;investigational;vet_approved,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,PMATZTZNYRCHOR-CGLBZJNRSA-N,1202.635,P62937,BE0001014,Peptidyl-prolyl cis-trans isomerase A,Humans,inhibitor;binder,yes
DB00091,Cyclosporine,small molecule,approved;investigational;vet_approved,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,PMATZTZNYRCHOR-CGLBZJNRSA-N,1202.635,P30405,BE0001399,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",Humans,binder,yes
DB00106,Abarelix,small molecule,approved;investigational;withdrawn,CC(C)C[C@H](NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](CC1=CC=C(O)C=C1)N(C)C(=O)[C@H](CO)NC(=O)[C@@H](CC1=CN=CC=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC2=C(C=CC=C2)C=C1)NC(C)=O)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,AIWRTTMUVOZGPW-HSPKUQOVSA-N,1416.09,P30968,BE0000203,Gonadotropin-releasing hormone receptor,Humans,antagonist,yes
DB00114,Pyridoxal phosphate,small molecule,approved;investigational;nutraceutical,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O,NGVDGCNFYWLIFO-UHFFFAOYSA-N,247.1419,P80404,BE0000253,"4-aminobutyrate aminotransferase, mitochondrial",Humans,inhibitor,yes
DB00114,Pyridoxal phosphate,small molecule,approved;investigational;nutraceutical,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O,NGVDGCNFYWLIFO-UHFFFAOYSA-N,247.1419,P00734,BE0000048,Prothrombin,Humans,inhibitor,yes
DB00115,Cyanocobalamin,small molecule,approved;nutraceutical,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,RMRCNWBMXRMIRW-WZHZPDAFSA-L,1355.3652,Q99707,BE0000734,Methionine synthase,Humans,cofactor,yes
DB00115,Cyanocobalamin,small molecule,approved;nutraceutical,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,RMRCNWBMXRMIRW-WZHZPDAFSA-L,1355.3652,P22033,BE0000777,"Methylmalonyl-CoA mutase, mitochondrial",Humans,cofactor,yes
DB00120,Phenylalanine,small molecule,approved;investigational;nutraceutical,N[C@@H](CC1=CC=CC=C1)C(O)=O,COLNVLDHVKWLRT-QMMMGPOBSA-N,165.1891,P07101,BE0000614,Tyrosine 3-monooxygenase,Humans,binder,yes
DB00126,Ascorbic acid,small molecule,approved;nutraceutical,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,176.1241,Q9UGH3,BE0009869,Solute carrier family 23 member 2,Humans,modulator,yes
DB00126,Ascorbic acid,small molecule,approved;nutraceutical,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,176.1241,Q9UHI7,BE0000168,Solute carrier family 23 member 1,Humans,modulator,yes
DB00127,Spermine,small molecule,experimental;nutraceutical,NCCCNCCCCNCCCN,PFNFFQXMRSDOHW-UHFFFAOYSA-N,202.3402,P52788,BE0000964,Spermine synthase,Humans,ligand,yes
DB00127,Spermine,small molecule,experimental;nutraceutical,NCCCNCCCCNCCCN,PFNFFQXMRSDOHW-UHFFFAOYSA-N,202.3402,P22748,BE0000535,Carbonic anhydrase 4,Humans,inhibitor,yes
DB00127,Spermine,small molecule,experimental;nutraceutical,NCCCNCCCCNCCCN,PFNFFQXMRSDOHW-UHFFFAOYSA-N,202.3402,Q05586,BE0000365,"Glutamate receptor ionotropic, NMDA 1",Humans,inhibitor,yes
DB00127,Spermine,small molecule,experimental;nutraceutical,NCCCNCCCCNCCCN,PFNFFQXMRSDOHW-UHFFFAOYSA-N,202.3402,Q16790,BE0002437,Carbonic anhydrase 9,Humans,inhibitor,yes
DB00127,Spermine,small molecule,experimental;nutraceutical,NCCCNCCCCNCCCN,PFNFFQXMRSDOHW-UHFFFAOYSA-N,202.3402,P23280,BE0003628,Carbonic anhydrase 6,Humans,inhibitor,yes
DB00127,Spermine,small molecule,experimental;nutraceutical,NCCCNCCCCNCCCN,PFNFFQXMRSDOHW-UHFFFAOYSA-N,202.3402,Q9ULX7,BE0003634,Carbonic anhydrase 14,Humans,inhibitor,yes
DB00127,Spermine,small molecule,experimental;nutraceutical,NCCCNCCCCNCCCN,PFNFFQXMRSDOHW-UHFFFAOYSA-N,202.3402,Q12879,BE0000760,"Glutamate receptor ionotropic, NMDA 2A",Humans,inhibitor,yes
DB00127,Spermine,small molecule,experimental;nutraceutical,NCCCNCCCCNCCCN,PFNFFQXMRSDOHW-UHFFFAOYSA-N,202.3402,Q9NWM0,BE0000566,Spermine oxidase,Humans,ligand,yes
DB00127,Spermine,small molecule,experimental;nutraceutical,NCCCNCCCCNCCCN,PFNFFQXMRSDOHW-UHFFFAOYSA-N,202.3402,,BE0004796,DNA,Humans,binder,yes
DB00128,Aspartic acid,small molecule,approved;nutraceutical,N[C@@H](CC(O)=O)C(O)=O,CKLJMWTZIZZHCS-REOHCLBHSA-N,133.1027,Q12879,BE0000760,"Glutamate receptor ionotropic, NMDA 2A",Humans,agonist,yes
DB00128,Aspartic acid,small molecule,approved;nutraceutical,N[C@@H](CC(O)=O)C(O)=O,CKLJMWTZIZZHCS-REOHCLBHSA-N,133.1027,Q13224,BE0000417,"Glutamate receptor ionotropic, NMDA 2B",Humans,agonist,yes
DB00128,Aspartic acid,small molecule,approved;nutraceutical,N[C@@H](CC(O)=O)C(O)=O,CKLJMWTZIZZHCS-REOHCLBHSA-N,133.1027,Q05586,BE0000365,"Glutamate receptor ionotropic, NMDA 1",Humans,agonist,yes
DB00131,Adenosine phosphate,small molecule,approved;investigational;nutraceutical;withdrawn,NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1,UDMBCSSLTHHNCD-KQYNXXCUSA-N,347.2212,Q13131,BE0004907,5'-AMP-activated protein kinase,Humans,activator,yes
DB00132,alpha-Linolenic acid,small molecule,approved;investigational;nutraceutical,CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O,DTOSIQBPPRVQHS-PDBXOOCHSA-N,278.4296,O14842,BE0000688,Free fatty acid receptor 1,Humans,agonist,yes
DB00132,alpha-Linolenic acid,small molecule,approved;investigational;nutraceutical,CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O,DTOSIQBPPRVQHS-PDBXOOCHSA-N,278.4296,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB00132,alpha-Linolenic acid,small molecule,approved;investigational;nutraceutical,CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O,DTOSIQBPPRVQHS-PDBXOOCHSA-N,278.4296,O60427,BE0000888,Acyl-CoA (8-3)-desaturase,Humans,ligand,yes
DB00132,alpha-Linolenic acid,small molecule,approved;investigational;nutraceutical,CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O,DTOSIQBPPRVQHS-PDBXOOCHSA-N,278.4296,O95864,BE0002246,Acyl-CoA 6-desaturase,Humans,ligand,yes
DB00132,alpha-Linolenic acid,small molecule,approved;investigational;nutraceutical,CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O,DTOSIQBPPRVQHS-PDBXOOCHSA-N,278.4296,Q8NER1,BE0001023,Transient receptor potential cation channel subfamily V member 1,Humans,inhibitor,yes
DB00135,Tyrosine,small molecule,approved;investigational;nutraceutical,N[C@@H](CC1=CC=C(O)C=C1)C(O)=O,OUYCCCASQSFEME-QMMMGPOBSA-N,181.1885,P07101,BE0000614,Tyrosine 3-monooxygenase,Humans,binder,yes
DB00136,Calcitriol,small molecule,approved;nutraceutical,C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C,GMRQFYUYWCNGIN-NKMMMXOESA-N,416.6365,P11473,BE0000779,Vitamin D3 receptor,Humans,agonist,yes
DB00140,Riboflavin,small molecule,approved;investigational;nutraceutical;vet_approved,CC1=C(C)C=C2N(C[C@H](O)[C@H](O)[C@H](O)CO)C3=NC(=O)NC(=O)C3=NC2=C1,AUNGANRZJHBGPY-SCRDCRAPSA-N,376.3639,Q969G6,BE0000370,Riboflavin kinase,Humans,ligand,yes
DB00140,Riboflavin,small molecule,approved;investigational;nutraceutical;vet_approved,CC1=C(C)C=C2N(C[C@H](O)[C@H](O)[C@H](O)CO)C3=NC(=O)NC(=O)C3=NC2=C1,AUNGANRZJHBGPY-SCRDCRAPSA-N,376.3639,P0AFU8,BE0003327,Riboflavin synthase,Escherichia coli (strain K12),other,yes
DB00140,Riboflavin,small molecule,approved;investigational;nutraceutical;vet_approved,CC1=C(C)C=C2N(C[C@H](O)[C@H](O)[C@H](O)CO)C3=NC(=O)NC(=O)C3=NC2=C1,AUNGANRZJHBGPY-SCRDCRAPSA-N,376.3639,P30043,BE0000595,Flavin reductase (NADPH),Humans,product of,yes
DB00146,Calcifediol,small molecule,approved;nutraceutical,C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C,JWUBBDSIWDLEOM-DTOXIADCSA-N,400.6371,P11473,BE0000779,Vitamin D3 receptor,Humans,agonist,yes
DB00147,Pyridoxal,small molecule,experimental;nutraceutical,CC1=NC=C(CO)C(C=O)=C1O,RADKZDMFGJYCBB-UHFFFAOYSA-N,167.162,O00764,BE0000042,Pyridoxal kinase,Humans,,yes
DB00148,Creatine,small molecule,approved;investigational;nutraceutical,CN(CC(O)=O)C(N)=N,CVSVTCORWBXHQV-UHFFFAOYSA-N,131.1332,P06732,BE0000714,Creatine kinase M-type,Humans,ligand,yes
DB00148,Creatine,small molecule,approved;investigational;nutraceutical,CN(CC(O)=O)C(N)=N,CVSVTCORWBXHQV-UHFFFAOYSA-N,131.1332,P12532,BE0000171,"Creatine kinase U-type, mitochondrial",Humans,ligand,yes
DB00148,Creatine,small molecule,approved;investigational;nutraceutical,CN(CC(O)=O)C(N)=N,CVSVTCORWBXHQV-UHFFFAOYSA-N,131.1332,P12277,BE0000082,Creatine kinase B-type,Humans,ligand,yes
DB00148,Creatine,small molecule,approved;investigational;nutraceutical,CN(CC(O)=O)C(N)=N,CVSVTCORWBXHQV-UHFFFAOYSA-N,131.1332,P17540,BE0000410,"Creatine kinase S-type, mitochondrial",Humans,ligand,yes
DB00148,Creatine,small molecule,approved;investigational;nutraceutical,CN(CC(O)=O)C(N)=N,CVSVTCORWBXHQV-UHFFFAOYSA-N,131.1332,P48029,BE0000375,Sodium- and chloride-dependent creatine transporter 1,Humans,,yes
DB00148,Creatine,small molecule,approved;investigational;nutraceutical,CN(CC(O)=O)C(N)=N,CVSVTCORWBXHQV-UHFFFAOYSA-N,131.1332,Q14353,BE0000567,Guanidinoacetate N-methyltransferase,Humans,product of,yes
DB00150,Tryptophan,small molecule,approved;nutraceutical;withdrawn,N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O,QIVBCDIJIAJPQS-VIFPVBQESA-N,204.2252,P14902,BE0000693,"Indoleamine 2,3-dioxygenase 1",Humans,binder,yes
DB00152,Thiamine,small molecule,approved;investigational;nutraceutical;vet_approved,CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N,JZRWCGZRTZMZEH-UHFFFAOYSA-N,265.355,Q9H3S4,BE0000157,Thiamine pyrophosphokinase 1,Humans,substrate,yes
DB00152,Thiamine,small molecule,approved;investigational;nutraceutical;vet_approved,CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N,JZRWCGZRTZMZEH-UHFFFAOYSA-N,265.355,P0AFG8,BE0002003,Pyruvate dehydrogenase E1 component,Escherichia coli (strain K12),cofactor,yes
DB00153,Ergocalciferol,small molecule,approved;nutraceutical,CC(C)[C@@H](C)\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C,MECHNRXZTMCUDQ-RKHKHRCZSA-N,396.6484,P11473,BE0000779,Vitamin D3 receptor,Humans,agonist,yes
DB00154,Dihomo-gamma-linolenic acid,small molecule,investigational;nutraceutical,CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O,HOBAELRKJCKHQD-QNEBEIHSSA-N,306.4828,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,,yes
DB00154,Dihomo-gamma-linolenic acid,small molecule,investigational;nutraceutical,CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O,HOBAELRKJCKHQD-QNEBEIHSSA-N,306.4828,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB00157,NADH,small molecule,approved;nutraceutical,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O,BOPGDPNILDQYTO-NNYOXOHSSA-N,665.441,P03897,BE0000196,NADH-ubiquinone oxidoreductase chain 3,Humans,binder,yes
DB00158,Folic acid,small molecule,approved;nutraceutical;vet_approved,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1,OVBPIULPVIDEAO-LBPRGKRZSA-N,441.3975,Q96NT5,BE0001048,Proton-coupled folate transporter,Humans,modulator,yes
DB00158,Folic acid,small molecule,approved;nutraceutical;vet_approved,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1,OVBPIULPVIDEAO-LBPRGKRZSA-N,441.3975,P41440,BE0004711,Reduced folate transporter,Humans,modulator,yes
DB00159,Icosapent,small molecule,approved;nutraceutical,CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O,JAZBEHYOTPTENJ-JLNKQSITSA-N,302.451,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB00159,Icosapent,small molecule,approved;nutraceutical,CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O,JAZBEHYOTPTENJ-JLNKQSITSA-N,302.451,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB00159,Icosapent,small molecule,approved;nutraceutical,CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O,JAZBEHYOTPTENJ-JLNKQSITSA-N,302.451,P37231,BE0000215,Peroxisome proliferator-activated receptor gamma,Humans,agonist;regulator,yes
DB00159,Icosapent,small molecule,approved;nutraceutical,CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O,JAZBEHYOTPTENJ-JLNKQSITSA-N,302.451,Q03181,BE0001007,Peroxisome proliferator-activated receptor delta,Humans,agonist,yes
DB00159,Icosapent,small molecule,approved;nutraceutical,CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O,JAZBEHYOTPTENJ-JLNKQSITSA-N,302.451,O14842,BE0000688,Free fatty acid receptor 1,Humans,agonist,yes
DB00159,Icosapent,small molecule,approved;nutraceutical,CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O,JAZBEHYOTPTENJ-JLNKQSITSA-N,302.451,P32418,BE0000986,Sodium/calcium exchanger 1,Humans,inhibitor,yes
DB00159,Icosapent,small molecule,approved;nutraceutical,CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O,JAZBEHYOTPTENJ-JLNKQSITSA-N,302.451,O15540,BE0001821,"Fatty acid-binding protein, brain",Humans,agonist,yes
DB00162,Vitamin A,small molecule,approved;nutraceutical;vet_approved,C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C,FPIPGXGPPPQFEQ-OVSJKPMPSA-N,286.4516,P48443,BE0000707,Retinoic acid receptor RXR-gamma,Humans,binder,yes
DB00165,Pyridoxine,small molecule,approved;investigational;nutraceutical;vet_approved,CC1=C(O)C(CO)=C(CO)C=N1,LXNHXLLTXMVWPM-UHFFFAOYSA-N,169.1778,P20711,BE0002151,Aromatic-L-amino-acid decarboxylase,Humans,cofactor,yes
DB00165,Pyridoxine,small molecule,approved;investigational;nutraceutical;vet_approved,CC1=C(O)C(CO)=C(CO)C=N1,LXNHXLLTXMVWPM-UHFFFAOYSA-N,169.1778,O00764,BE0000042,Pyridoxal kinase,Humans,ligand,yes
DB00169,Cholecalciferol,small molecule,approved;nutraceutical,CC(C)CCC[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C,QYSXJUFSXHHAJI-YRZJJWOYSA-N,384.6377,P11473,BE0000779,Vitamin D3 receptor,Humans,agonist,yes
DB00170,Menadione,small molecule,approved;nutraceutical,CC1=CC(=O)C2=CC=CC=C2C1=O,MJVAVZPDRWSRRC-UHFFFAOYSA-N,172.18,Q06278,BE0003539,Aldehyde oxidase,Humans,inhibitor,yes
DB00170,Menadione,small molecule,approved;nutraceutical,CC1=CC(=O)C2=CC=CC=C2C1=O,MJVAVZPDRWSRRC-UHFFFAOYSA-N,172.18,P38435,BE0000403,Vitamin K-dependent gamma-carboxylase,Humans,cofactor,yes
DB00170,Menadione,small molecule,approved;nutraceutical,CC1=CC(=O)C2=CC=CC=C2C1=O,MJVAVZPDRWSRRC-UHFFFAOYSA-N,172.18,Q9BQB6,BE0000713,Vitamin K epoxide reductase complex subunit 1,Humans,cofactor,yes
DB00170,Menadione,small molecule,approved;nutraceutical,CC1=CC(=O)C2=CC=CC=C2C1=O,MJVAVZPDRWSRRC-UHFFFAOYSA-N,172.18,Q8N0U8,BE0002329,Vitamin K epoxide reductase complex subunit 1-like protein 1,Humans,cofactor,yes
DB00171,ATP,small molecule,investigational;nutraceutical,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O,ZKHQWZAMYRWXGA-KQYNXXCUSA-N,507.181,P00519,BE0000014,Tyrosine-protein kinase ABL1,Humans,inhibitor,yes
DB00174,Asparagine,small molecule,approved;investigational;nutraceutical,N[C@@H](CC(N)=O)C(O)=O,DCXYFEDJOCDNAF-REOHCLBHSA-N,132.1179,Q9H2H9,BE0009976,Sodium-coupled neutral amino acid transporters,Humans,inhibitor,yes
DB00175,Pravastatin,small molecule,approved,[H][C@]12[C@H](C[C@H](O)C=C1C=C[C@H](C)[C@@H]2CC[C@@H](O)C[C@@H](O)CC(O)=O)OC(=O)[C@@H](C)CC,TUZYXOIXSAXUGO-PZAWKZKUSA-N,424.5277,P04035,BE0000574,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Humans,inhibitor,yes
DB00176,Fluvoxamine,small molecule,approved;investigational,COCCCC\C(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F,CJOFXWAVKWHTFT-XSFVSMFZSA-N,318.34,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB00177,Valsartan,small molecule,approved;investigational,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,ACWBQPMHZXGDFX-QFIPXVFZSA-N,435.5188,P30556,BE0000062,Type-1 angiotensin II receptor,Humans,antagonist,yes
DB00178,Ramipril,small molecule,approved,[H][C@@]12CCC[C@]1([H])N([C@@H](C2)C(O)=O)C(=O)[C@H](C)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC,HDACQVRGBOVJII-JBDAPHQKSA-N,416.5106,P12821,BE0000221,Angiotensin-converting enzyme,Humans,inhibitor,yes
DB00179,Masoprocol,small molecule,approved;investigational,C[C@@H](CC1=CC(O)=C(O)C=C1)[C@H](C)CC1=CC(O)=C(O)C=C1,HCZKYJDFEPMADG-TXEJJXNPSA-N,302.3649,P09917,BE0000248,Polyunsaturated fatty acid 5-lipoxygenase,Humans,inhibitor,yes
DB00179,Masoprocol,small molecule,approved;investigational,C[C@@H](CC1=CC(O)=C(O)C=C1)[C@H](C)CC1=CC(O)=C(O)C=C1,HCZKYJDFEPMADG-TXEJJXNPSA-N,302.3649,P04626,BE0000511,Receptor tyrosine-protein kinase erbB-2,Humans,modulator,yes
DB00179,Masoprocol,small molecule,approved;investigational,C[C@@H](CC1=CC(O)=C(O)C=C1)[C@H](C)CC1=CC(O)=C(O)C=C1,HCZKYJDFEPMADG-TXEJJXNPSA-N,302.3649,Q96QT4,BE0004624,Transient receptor potential cation channel subfamily M member 7,Humans,inhibitor,yes
DB00180,Flunisolide,small molecule,approved;investigational,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,XSFJVAJPIHIPKU-XWCQMRHXSA-N,434.4977,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB00181,Baclofen,small molecule,approved,NCC(CC(O)=O)C1=CC=C(Cl)C=C1,KPYSYYIEGFHWSV-UHFFFAOYSA-N,213.661,O75899,BE0002340,Gamma-aminobutyric acid type B receptor subunit 2,Humans,agonist,yes
DB00182,Amphetamine,small molecule,approved;illicit;investigational,CC(N)CC1=CC=CC=C1,KWTSXDURSIMDCE-UHFFFAOYSA-N,135.2062,Q05940,BE0000118,Synaptic vesicular amine transporter,Humans,inhibitor,yes
DB00182,Amphetamine,small molecule,approved;illicit;investigational,CC(N)CC1=CC=CC=C1,KWTSXDURSIMDCE-UHFFFAOYSA-N,135.2062,Q01959,BE0000647,Sodium-dependent dopamine transporter,Humans,negative modulator,yes
DB00182,Amphetamine,small molecule,approved;illicit;investigational,CC(N)CC1=CC=CC=C1,KWTSXDURSIMDCE-UHFFFAOYSA-N,135.2062,Q16568,BE0000867,Cocaine- and amphetamine-regulated transcript protein,Humans,agonist,yes
DB00182,Amphetamine,small molecule,approved;illicit;investigational,CC(N)CC1=CC=CC=C1,KWTSXDURSIMDCE-UHFFFAOYSA-N,135.2062,Q96RJ0,BE0001044,Trace amine-associated receptor 1,Humans,agonist,yes
DB00182,Amphetamine,small molecule,approved;illicit;investigational,CC(N)CC1=CC=CC=C1,KWTSXDURSIMDCE-UHFFFAOYSA-N,135.2062,P21397,BE0004909,Monoamine oxidase,Humans,inhibitor,yes
DB00183,Pentagastrin,small molecule,approved,CSCC[C@H](NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)CCNC(=O)OC(C)(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(N)=O,NEYNJQRKHLUJRU-DZUOILHNSA-N,767.9,P32239,BE0001158,Gastrin/cholecystokinin type B receptor,Humans,agonist,yes
DB00184,Nicotine,small molecule,approved,CN1CCC[C@H]1C1=CN=CC=C1,SNICXCGAKADSCV-JTQLQIEISA-N,162.2316,P43681,BE0000849,Neuronal acetylcholine receptor subunit alpha-4,Humans,agonist,yes
DB00184,Nicotine,small molecule,approved,CN1CCC[C@H]1C1=CN=CC=C1,SNICXCGAKADSCV-JTQLQIEISA-N,162.2316,P36544,BE0002341,Neuronal acetylcholine receptor subunit alpha-7,Humans,agonist,yes
DB00184,Nicotine,small molecule,approved,CN1CCC[C@H]1C1=CN=CC=C1,SNICXCGAKADSCV-JTQLQIEISA-N,162.2316,P17787,BE0000850,Neuronal acetylcholine receptor subunit beta-2,Humans,agonist,yes
DB00185,Cevimeline,small molecule,approved,CC1O[C@@]2(CS1)CN1CCC2CC1,WUTYZMFRCNBCHQ-LHIURRSHSA-N,199.313,P20309,BE0000045,Muscarinic acetylcholine receptor M3,Humans,agonist,yes
DB00185,Cevimeline,small molecule,approved,CC1O[C@@]2(CS1)CN1CCC2CC1,WUTYZMFRCNBCHQ-LHIURRSHSA-N,199.313,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,agonist,yes
DB00186,Lorazepam,small molecule,approved,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2,DIWRORZWFLOCLC-UHFFFAOYSA-N,321.158,P30536,BE0000736,Translocator protein,Humans,modulator,yes
DB00186,Lorazepam,small molecule,approved,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2,DIWRORZWFLOCLC-UHFFFAOYSA-N,321.158,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB00186,Lorazepam,small molecule,approved,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2,DIWRORZWFLOCLC-UHFFFAOYSA-N,321.158,P14867,BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,Humans,ligand,yes
DB00187,Esmolol,small molecule,approved;withdrawn,COC(=O)CCC1=CC=C(OCC(O)CNC(C)C)C=C1,AQNDDEOPVVGCPG-UHFFFAOYSA-N,295.374,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,antagonist,yes
DB00188,Bortezomib,small molecule,approved;investigational,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,GXJABQQUPOEUTA-RDJZCZTQSA-N,384.237,P28074,BE0002348,Proteasome subunit beta type-5,Humans,inhibitor,yes
DB00188,Bortezomib,small molecule,approved;investigational,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,GXJABQQUPOEUTA-RDJZCZTQSA-N,384.237,P07477,BE0001739,Serine protease 1,Humans,inhibitor,yes
DB00188,Bortezomib,small molecule,approved;investigational,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,GXJABQQUPOEUTA-RDJZCZTQSA-N,384.237,P20618,BE0002347,Proteasome subunit beta type-1,Humans,inhibitor,yes
DB00189,Ethchlorvynol,small molecule,approved;illicit;withdrawn,CCC(O)(\C=C\Cl)C#C,ZEHYJZXQEQOSON-AATRIKPKSA-N,144.6,P47870,BE0002346,Gamma-aminobutyric acid receptor subunit beta-2,Humans,antagonist,yes
DB00189,Ethchlorvynol,small molecule,approved;illicit;withdrawn,CCC(O)(\C=C\Cl)C#C,ZEHYJZXQEQOSON-AATRIKPKSA-N,144.6,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,antagonist,yes
DB00189,Ethchlorvynol,small molecule,approved;illicit;withdrawn,CCC(O)(\C=C\Cl)C#C,ZEHYJZXQEQOSON-AATRIKPKSA-N,144.6,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB00190,Carbidopa,small molecule,approved,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,TZFNLOMSOLWIDK-JTQLQIEISA-N,226.2292,P20711,BE0002151,Aromatic-L-amino-acid decarboxylase,Humans,inhibitor,yes
DB00191,Phentermine,small molecule,approved;illicit,CC(C)(N)CC1=CC=CC=C1,DHHVAGZRUROJKS-UHFFFAOYSA-N,149.2328,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,inhibitor,yes
DB00191,Phentermine,small molecule,approved;illicit,CC(C)(N)CC1=CC=CC=C1,DHHVAGZRUROJKS-UHFFFAOYSA-N,149.2328,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB00191,Phentermine,small molecule,approved;illicit,CC(C)(N)CC1=CC=CC=C1,DHHVAGZRUROJKS-UHFFFAOYSA-N,149.2328,Q01959,BE0000647,Sodium-dependent dopamine transporter,Humans,inhibitor,yes
DB00191,Phentermine,small molecule,approved;illicit,CC(C)(N)CC1=CC=CC=C1,DHHVAGZRUROJKS-UHFFFAOYSA-N,149.2328,P21397,BE0002198,Amine oxidase [flavin-containing] A,Humans,antagonist,yes
DB00191,Phentermine,small molecule,approved;illicit,CC(C)(N)CC1=CC=CC=C1,DHHVAGZRUROJKS-UHFFFAOYSA-N,149.2328,P27338,BE0002196,Amine oxidase [flavin-containing] B,Humans,antagonist,yes
DB00191,Phentermine,small molecule,approved;illicit,CC(C)(N)CC1=CC=CC=C1,DHHVAGZRUROJKS-UHFFFAOYSA-N,149.2328,P01303,BE0003476,Pro-neuropeptide Y,Humans,inhibitor,yes
DB00192,Indecainide,small molecule,approved,CC(C)NCCCC1(C(N)=O)C2=CC=CC=C2C2=CC=CC=C12,UCEWGESNIULAGX-UHFFFAOYSA-N,308.4174,Q14524,BE0000197,Sodium channel protein type 5 subunit alpha,Humans,inhibitor,yes
DB00193,Tramadol,small molecule,approved;investigational,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,TVYLLZQTGLZFBW-UHFFFAOYSA-N,263.381,P35372,BE0000770,Mu-type opioid receptor,Humans,agonist,yes
DB00193,Tramadol,small molecule,approved;investigational,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,TVYLLZQTGLZFBW-UHFFFAOYSA-N,263.381,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,inhibitor,yes
DB00193,Tramadol,small molecule,approved;investigational,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,TVYLLZQTGLZFBW-UHFFFAOYSA-N,263.381,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB00193,Tramadol,small molecule,approved;investigational,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,TVYLLZQTGLZFBW-UHFFFAOYSA-N,263.381,Q99250,BE0002081,Sodium channel protein type 2 subunit alpha,Humans,inhibitor,yes
DB00193,Tramadol,small molecule,approved;investigational,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,TVYLLZQTGLZFBW-UHFFFAOYSA-N,263.381,Q05586,BE0004956,NMDA receptor,Humans,inhibitor,yes
DB00193,Tramadol,small molecule,approved;investigational,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,TVYLLZQTGLZFBW-UHFFFAOYSA-N,263.381,P30542,BE0000013,Adenosine receptor A1,Humans,agonist,yes
DB00193,Tramadol,small molecule,approved;investigational,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,TVYLLZQTGLZFBW-UHFFFAOYSA-N,263.381,P08913,BE0004864,Alpha-2 adrenergic receptors,Humans,inducer,yes
DB00194,Vidarabine,small molecule,approved;investigational,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,OIRDTQYFTABQOQ-UHTZMRCNSA-N,267.2413,P29275,BE0000241,Adenosine receptor A2b,Humans,modulator,yes
DB00194,Vidarabine,small molecule,approved;investigational,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,OIRDTQYFTABQOQ-UHTZMRCNSA-N,267.2413,P04293,BE0000308,DNA polymerase catalytic subunit,HHV-1,inhibitor,yes
DB00194,Vidarabine,small molecule,approved;investigational,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,OIRDTQYFTABQOQ-UHTZMRCNSA-N,267.2413,P09250,BE0004499,Thymidine kinase,,inducer,yes
DB00194,Vidarabine,small molecule,approved;investigational,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,OIRDTQYFTABQOQ-UHTZMRCNSA-N,267.2413,Q9QNF7,BE0000458,Thymidine kinase,HHV-1,inducer,yes
DB00195,Betaxolol,small molecule,approved;investigational,CC(C)NCC(O)COC1=CC=C(CCOCC2CC2)C=C1,NWIUTZDMDHAVTP-UHFFFAOYSA-N,307.4278,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,antagonist,yes
DB00196,Fluconazole,small molecule,approved;investigational,OC(CN1C=NC=N1)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,RFHAOTPXVQNOHP-UHFFFAOYSA-N,306.2708,P10613,BE0000233,Lanosterol 14-alpha demethylase,Yeast,inhibitor,yes
DB00197,Troglitazone,small molecule,approved;investigational;withdrawn,CC1=C(C)C2=C(CCC(C)(COC3=CC=C(CC4SC(=O)NC4=O)C=C3)O2)C(C)=C1O,GXPHKUHSUJUWKP-UHFFFAOYSA-N,441.54,P37231,BE0000215,Peroxisome proliferator-activated receptor gamma,Humans,agonist;regulator,yes
DB00198,Oseltamivir,small molecule,approved,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,VSZGPKBBMSAYNT-RRFJBIMHSA-N,312.4045,P11485,BE0000584,Neuraminidase,Influenza A virus (strain A/Chile/1/1983 H1N1),inhibitor,yes
DB00199,Erythromycin,small molecule,approved;investigational;vet_approved,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,ULGZDMOVFRHVEP-RWJQBGPGSA-N,733.9268,,BE0004800,23S ribosomal RNA,Enteric bacteria and other eubacteria,inhibitor,yes
DB00200,Hydroxocobalamin,small molecule,approved,[N+]1=2[Co-3]345([N+]6=C7[C@H]([C@@](CC(=O)N)(C)[C@@]6([C@@]6(N3C(=C(C)C3=[N+]4C(C(C)(C)[C@@H]3CCC(=O)N)=CC3=[N+]5C(=C7C)[C@@](CC(=O)N)([C@@H]3CCC(=O)N)C)[C@@](C)([C@H]6CC(=O)N)CCC(NC[C@@H](C)OP(=O)(O[C@@H]3[C@H](O[C@H](N(C4=CC(=C(C=C14)C)C)C=2)[C@@H]3O)CO)[O-])=O)[H])C)CCC(=O)N)O[H],YOZNUFWCRFCGIH-WZHZPDAFSA-K,1346.3551,Q99707,BE0000734,Methionine synthase,Humans,cofactor,yes
DB00200,Hydroxocobalamin,small molecule,approved,[N+]1=2[Co-3]345([N+]6=C7[C@H]([C@@](CC(=O)N)(C)[C@@]6([C@@]6(N3C(=C(C)C3=[N+]4C(C(C)(C)[C@@H]3CCC(=O)N)=CC3=[N+]5C(=C7C)[C@@](CC(=O)N)([C@@H]3CCC(=O)N)C)[C@@](C)([C@H]6CC(=O)N)CCC(NC[C@@H](C)OP(=O)(O[C@@H]3[C@H](O[C@H](N(C4=CC(=C(C=C14)C)C)C=2)[C@@H]3O)CO)[O-])=O)[H])C)CCC(=O)N)O[H],YOZNUFWCRFCGIH-WZHZPDAFSA-K,1346.3551,P22033,BE0000777,"Methylmalonyl-CoA mutase, mitochondrial",Humans,cofactor,yes
DB00201,Caffeine,small molecule,approved,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,RYYVLZVUVIJVGH-UHFFFAOYSA-N,194.1906,P30542,BE0000013,Adenosine receptor A1,Humans,antagonist,yes
DB00201,Caffeine,small molecule,approved,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,RYYVLZVUVIJVGH-UHFFFAOYSA-N,194.1906,P21589,BE0001096,5'-nucleotidase,Humans,inhibitor,yes
DB00201,Caffeine,small molecule,approved,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,RYYVLZVUVIJVGH-UHFFFAOYSA-N,194.1906,P29274,BE0000924,Adenosine receptor A2a,Humans,antagonist,yes
DB00201,Caffeine,small molecule,approved,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,RYYVLZVUVIJVGH-UHFFFAOYSA-N,194.1906,P29275,BE0000241,Adenosine receptor A2b,Humans,antagonist,yes
DB00201,Caffeine,small molecule,approved,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,RYYVLZVUVIJVGH-UHFFFAOYSA-N,194.1906,P0DMS8,BE0000354,Adenosine receptor A3,Humans,antagonist,yes
DB00201,Caffeine,small molecule,approved,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,RYYVLZVUVIJVGH-UHFFFAOYSA-N,194.1906,Q08499,BE0009789,Phosphodiesterase enzymes,Humans,inhibitor,yes
DB00202,Succinylcholine,small molecule,approved,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,AXOIZCJOOAYSMI-UHFFFAOYSA-N,290.399,Q9GZZ6,BE0009927,Neuronal Acetylcholine (nACh) Receptor Subunits,Humans,agonist,yes
DB00203,Sildenafil,small molecule,approved;investigational,CCCC1=NN(C)C2=C1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(C)CC1,BNRNXUUZRGQAQC-UHFFFAOYSA-N,474.576,P05155,BE0002458,Plasma protease C1 inhibitor,Humans,modulator,yes
DB00203,Sildenafil,small molecule,approved;investigational,CCCC1=NN(C)C2=C1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(C)CC1,BNRNXUUZRGQAQC-UHFFFAOYSA-N,474.576,O76074,BE0000182,"cGMP-specific 3',5'-cyclic phosphodiesterase",Humans,inhibitor,yes
DB00204,Dofetilide,small molecule,approved;investigational,CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1,IXTMWRCNAAVVAI-UHFFFAOYSA-N,441.565,Q12809,BE0000090,Voltage-gated inwardly rectifying potassium channel KCNH2,Humans,inhibitor,yes
DB00204,Dofetilide,small molecule,approved;investigational,CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1,IXTMWRCNAAVVAI-UHFFFAOYSA-N,441.565,O95069,BE0000210,Potassium channel subfamily K member 2,Humans,inhibitor,yes
DB00204,Dofetilide,small molecule,approved;investigational,CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1,IXTMWRCNAAVVAI-UHFFFAOYSA-N,441.565,Q14500,BE0001131,ATP-sensitive inward rectifier potassium channel 12,Humans,inhibitor,yes
DB00205,Pyrimethamine,small molecule,approved;investigational;vet_approved,CCC1=C(C(N)=NC(N)=N1)C1=CC=C(Cl)C=C1,WKSAUQYGYAYLPV-UHFFFAOYSA-N,248.711,P00374,BE0000330,Dihydrofolate reductase,Humans,inhibitor,yes
DB00205,Pyrimethamine,small molecule,approved;investigational;vet_approved,CCC1=C(C(N)=NC(N)=N1)C1=CC=C(Cl)C=C1,WKSAUQYGYAYLPV-UHFFFAOYSA-N,248.711,P15328,BE0003405,Folate receptor alpha,Humans,modulator,yes
DB00205,Pyrimethamine,small molecule,approved;investigational;vet_approved,CCC1=C(C(N)=NC(N)=N1)C1=CC=C(Cl)C=C1,WKSAUQYGYAYLPV-UHFFFAOYSA-N,248.711,P13922,BE0000563,Bifunctional dihydrofolate reductase-thymidylate synthase,Plasmodium falciparum (isolate K1 / Thailand),inhibitor,yes
DB00206,Reserpine,small molecule,approved;investigational;withdrawn,[H][C@]12C[C@@H](OC(=O)C3=CC(OC)=C(OC)C(OC)=C3)[C@H](OC)[C@@H](C(=O)OC)[C@@]1([H])C[C@@]1([H])N(CCC3=C1NC1=C3C=CC(OC)=C1)C2,QEVHRUUCFGRFIF-MDEJGZGSSA-N,608.6787,Q05940,BE0000118,Synaptic vesicular amine transporter,Humans,inhibitor,yes
DB00207,Azithromycin,small molecule,approved,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,MQTOSJVFKKJCRP-BICOPXKESA-N,748.9845,,BE0004800,23S ribosomal RNA,Enteric bacteria and other eubacteria,inhibitor,yes
DB00208,Ticlopidine,small molecule,approved,ClC1=CC=CC=C1CN1CCC2=C(C1)C=CS2,PHWBOXQYWZNQIN-UHFFFAOYSA-N,263.786,P25105,BE0005561,Platelet-activating factor receptor,Humans,modulator,yes
DB00208,Ticlopidine,small molecule,approved,ClC1=CC=CC=C1CN1CCC2=C(C1)C=CS2,PHWBOXQYWZNQIN-UHFFFAOYSA-N,263.786,Q9H244,BE0000110,P2Y purinoceptor 12,Humans,antagonist,yes
DB00209,Trospium,small molecule,approved,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)[N+]21CCCC1,OYYDSUSKLWTMMQ-JKHIJQBDSA-N,392.518,P08912,BE0000247,Muscarinic acetylcholine receptor M5,Humans,antagonist,yes
DB00210,Adapalene,small molecule,approved,COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2,LZCDAPDGXCYOEH-UHFFFAOYSA-N,412.5201,P10826,BE0000206,Retinoic acid receptor beta,Humans,agonist,yes
DB00210,Adapalene,small molecule,approved,COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2,LZCDAPDGXCYOEH-UHFFFAOYSA-N,412.5201,P13631,BE0000144,Retinoic acid receptor gamma,Humans,agonist,yes
DB00210,Adapalene,small molecule,approved,COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2,LZCDAPDGXCYOEH-UHFFFAOYSA-N,412.5201,P28702,BE0000078,Retinoic acid receptor RXR-beta,Humans,agonist,yes
DB00210,Adapalene,small molecule,approved,COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2,LZCDAPDGXCYOEH-UHFFFAOYSA-N,412.5201,P48443,BE0000707,Retinoic acid receptor RXR-gamma,Humans,agonist,yes
DB00210,Adapalene,small molecule,approved,COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2,LZCDAPDGXCYOEH-UHFFFAOYSA-N,412.5201,P19793,BE0000412,Retinoic acid receptor RXR-alpha,Humans,agonist,yes
DB00210,Adapalene,small molecule,approved,COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2,LZCDAPDGXCYOEH-UHFFFAOYSA-N,412.5201,P05412,BE0001040,Transcription factor Jun,Humans,antagonist,yes
DB00210,Adapalene,small molecule,approved,COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2,LZCDAPDGXCYOEH-UHFFFAOYSA-N,412.5201,O60603,BE0001164,Toll-like receptor 2,Humans,antagonist,yes
DB00211,Midodrine,small molecule,approved,COC1=CC(C(O)CNC(=O)CN)=C(OC)C=C1,PTKSEFOSCHHMPD-UHFFFAOYSA-N,254.2823,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,agonist,yes
DB00211,Midodrine,small molecule,approved,COC1=CC(C(O)CNC(=O)CN)=C(OC)C=C1,PTKSEFOSCHHMPD-UHFFFAOYSA-N,254.2823,P35368,BE0000575,Alpha-1B adrenergic receptor,Humans,agonist,yes
DB00212,Remikiren,small molecule,experimental,CC(C)(C)S(=O)(=O)C[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC1CCCCC1)[C@@H](O)[C@@H](O)C1CC1,UXIGZRQVLGFTOU-VQXQMPIVSA-N,630.838,P00797,BE0000270,Renin,Humans,inhibitor,yes
DB00213,Pantoprazole,small molecule,approved,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1,IQPSEEYGBUAQFF-UHFFFAOYSA-N,383.37,P20648,BE0000349,Potassium-transporting ATPase alpha chain 1,Humans,inhibitor,yes
DB00213,Pantoprazole,small molecule,approved,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1,IQPSEEYGBUAQFF-UHFFFAOYSA-N,383.37,P51164,BE0000619,Potassium-transporting ATPase subunit beta,Humans,modulator,yes
DB00214,Torasemide,small molecule,approved,CC(C)NC(=O)NS(=O)(=O)C1=C(NC2=CC=CC(C)=C2)C=CN=C1,NGBFQHCMQULJNZ-UHFFFAOYSA-N,348.42,P55011,BE0000281,Solute carrier family 12 member 2,Humans,inhibitor,yes
DB00214,Torasemide,small molecule,approved,CC(C)NC(=O)NS(=O)(=O)C1=C(NC2=CC=CC(C)=C2)C=CN=C1,NGBFQHCMQULJNZ-UHFFFAOYSA-N,348.42,Q13621,BE0000502,Solute carrier family 12 member 1,Humans,inhibitor,yes
DB00215,Citalopram,small molecule,approved,CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1,WSEQXVZVJXJVFP-UHFFFAOYSA-N,324.3919,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB00216,Eletriptan,small molecule,approved;investigational,CN1CCC[C@@H]1CC1=CNC2=C1C=C(CCS(=O)(=O)C1=CC=CC=C1)C=C2,PWVXXGRKLHYWKM-LJQANCHMSA-N,382.519,P28221,BE0000659,5-hydroxytryptamine receptor 1D,Humans,agonist,yes
DB00216,Eletriptan,small molecule,approved;investigational,CN1CCC[C@@H]1CC1=CNC2=C1C=C(CCS(=O)(=O)C1=CC=CC=C1)C=C2,PWVXXGRKLHYWKM-LJQANCHMSA-N,382.519,P28222,BE0000797,5-hydroxytryptamine receptor 1B,Humans,agonist,yes
DB00216,Eletriptan,small molecule,approved;investigational,CN1CCC[C@@H]1CC1=CNC2=C1C=C(CCS(=O)(=O)C1=CC=CC=C1)C=C2,PWVXXGRKLHYWKM-LJQANCHMSA-N,382.519,P30939,BE0000460,5-hydroxytryptamine receptor 1F,Humans,agonist,yes
DB00217,Bethanidine,small molecule,approved,CN\C(NCC1=CC=CC=C1)=N/C,NIVZHWNOUVJHKV-UHFFFAOYSA-N,177.2462,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,antagonist,yes
DB00217,Bethanidine,small molecule,approved,CN\C(NCC1=CC=CC=C1)=N/C,NIVZHWNOUVJHKV-UHFFFAOYSA-N,177.2462,P48048,BE0000644,ATP-sensitive inward rectifier potassium channel 1,Humans,inhibitor,yes
DB00217,Bethanidine,small molecule,approved,CN\C(NCC1=CC=CC=C1)=N/C,NIVZHWNOUVJHKV-UHFFFAOYSA-N,177.2462,P08913,BE0004864,Alpha-2 adrenergic receptors,Humans,agonist,yes
DB00218,Moxifloxacin,small molecule,approved;investigational,[H][C@]12CN(C[C@@]1([H])NCCC2)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1OC)C(O)=O,FABPRXSRWADJSP-MEDUHNTESA-N,401.4314,P20831,BE0008385,DNA gyrase subunit A,Staphylococcus aureus,modulator,yes
DB00218,Moxifloxacin,small molecule,approved;investigational,[H][C@]12CN(C[C@@]1([H])NCCC2)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1OC)C(O)=O,FABPRXSRWADJSP-MEDUHNTESA-N,401.4314,P0A0K8,BE0002388,DNA gyrase subunit B,Staphylococcus aureus,modulator,yes
DB00218,Moxifloxacin,small molecule,approved;investigational,[H][C@]12CN(C[C@@]1([H])NCCC2)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1OC)C(O)=O,FABPRXSRWADJSP-MEDUHNTESA-N,401.4314,P43700,BE0000366,DNA gyrase subunit A,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd),inhibitor,yes
DB00218,Moxifloxacin,small molecule,approved;investigational,[H][C@]12CN(C[C@@]1([H])NCCC2)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1OC)C(O)=O,FABPRXSRWADJSP-MEDUHNTESA-N,401.4314,P43702,BE0000429,DNA topoisomerase 4 subunit A,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd),inhibitor,yes
DB00219,Oxyphenonium,small molecule,approved,CC[N+](C)(CC)CCOC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1,GFRUPHOKLBPHTQ-UHFFFAOYSA-N,348.4996,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,antagonist,yes
DB00220,Nelfinavir,small molecule,approved,[H][C@@]12CCCC[C@]1([H])CN(C[C@@H](O)[C@H](CSC1=CC=CC=C1)NC(=O)C1=C(C)C(O)=CC=C1)[C@@H](C2)C(=O)NC(C)(C)C,QAGYKUNXZHXKMR-HKWSIXNMSA-N,567.782,O90777,BE0000664,HIV-1 protease,Human Immunodeficiency Virus,inhibitor,yes
DB00221,Isoetharine,small molecule,approved,CCC(NC(C)C)C(O)C1=CC(O)=C(O)C=C1,HUYWAWARQUIQLE-UHFFFAOYSA-N,239.3107,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,agonist,yes
DB00222,Glimepiride,small molecule,approved,CCC1=C(C)CN(C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]2CC[C@H](C)CC2)C1=O,WIGIZIANZCJQQY-RUCARUNLSA-N,490.62,O60706,BE0000469,ATP-binding cassette sub-family C member 9,Humans,blocker,yes
DB00222,Glimepiride,small molecule,approved,CCC1=C(C)CN(C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]2CC[C@H](C)CC2)C1=O,WIGIZIANZCJQQY-RUCARUNLSA-N,490.62,Q14654,BE0000708,ATP-sensitive inward rectifier potassium channel 11,Humans,inhibitor,yes
DB00222,Glimepiride,small molecule,approved,CCC1=C(C)CN(C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]2CC[C@H](C)CC2)C1=O,WIGIZIANZCJQQY-RUCARUNLSA-N,490.62,P48048,BE0000644,ATP-sensitive inward rectifier potassium channel 1,Humans,inhibitor,yes
DB00222,Glimepiride,small molecule,approved,CCC1=C(C)CN(C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]2CC[C@H](C)CC2)C1=O,WIGIZIANZCJQQY-RUCARUNLSA-N,490.62,Q09428,BE0000207,ATP-binding cassette sub-family C member 8,Humans,inducer,yes
DB00223,Diflorasone,small molecule,approved,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,WXURHACBFYSXBI-XHIJKXOTSA-N,410.4515,P04054,BE0003997,Phospholipase A2,Humans,inhibitor,yes
DB00223,Diflorasone,small molecule,approved,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,WXURHACBFYSXBI-XHIJKXOTSA-N,410.4515,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB00224,Indinavir,small molecule,approved,CC(C)(C)NC(=O)[C@@H]1CN(CC2=CN=CC=C2)CCN1C[C@@H](O)C[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]1[C@H](O)CC2=CC=CC=C12,CBVCZFGXHXORBI-PXQQMZJSSA-N,613.7895,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB00224,Indinavir,small molecule,approved,CC(C)(C)NC(=O)[C@@H]1CN(CC2=CN=CC=C2)CCN1C[C@@H](O)C[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]1[C@H](O)CC2=CC=CC=C12,CBVCZFGXHXORBI-PXQQMZJSSA-N,613.7895,Q72874,BE0004854,Pol polyprotein,Human immunodeficiency virus 1,inhibitor,yes
DB00226,Guanadrel,small molecule,approved,NC(N)=NCC1COC2(CCCCC2)O1,HPBNRIOWIXYZFK-UHFFFAOYSA-N,213.2768,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,partial agonist,yes
DB00227,Lovastatin,small molecule,approved;investigational,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)[C@@H](C)CC,PCZOHLXUXFIOCF-BXMDZJJMSA-N,404.5396,P04035,BE0000574,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Humans,inhibitor,yes
DB00228,Enflurane,small molecule,approved;investigational;vet_approved,FC(F)OC(F)(F)C(F)Cl,JPGQOUSTVILISH-UHFFFAOYSA-N,184.492,P14867,BE0004797,GABA(A) Receptor,Humans,potentiator,yes
DB00228,Enflurane,small molecule,approved;investigational;vet_approved,FC(F)OC(F)(F)C(F)Cl,JPGQOUSTVILISH-UHFFFAOYSA-N,184.492,Q06432,BE0004902,Voltage-dependent calcium channel,Humans,inhibitor;activator,yes
DB00228,Enflurane,small molecule,approved;investigational;vet_approved,FC(F)OC(F)(F)C(F)Cl,JPGQOUSTVILISH-UHFFFAOYSA-N,184.492,P23415,BE0000433,Glycine receptor subunit alpha-1,Humans,potentiator,yes
DB00229,Cefotiam,small molecule,approved;investigational,[H][C@]12SCC(CSC3=NN=NN3CCN(C)C)=C(N1C(=O)[C@H]2NC(=O)CC1=CSC(N)=N1)C(O)=O,QYQDKDWGWDOFFU-IUODEOHRSA-N,525.628,P0AD68,BE0002393,Peptidoglycan synthase FtsI,Escherichia coli (strain K12),binder,yes
DB00229,Cefotiam,small molecule,approved;investigational,[H][C@]12SCC(CSC3=NN=NN3CCN(C)C)=C(N1C(=O)[C@H]2NC(=O)CC1=CSC(N)=N1)C(O)=O,QYQDKDWGWDOFFU-IUODEOHRSA-N,525.628,Q8XJ01,BE0000576,Penicillin-binding protein 1A,Clostridium perfringens (strain 13 / Type A),inducer,yes
DB00230,Pregabalin,small molecule,approved;investigational,CC(C)C[C@H](CN)CC(O)=O,AYXYPKUFHZROOJ-ZETCQYMHSA-N,159.2261,P54289,BE0000691,Voltage-dependent calcium channel subunit alpha-2/delta-1,Humans,modulator,yes
DB00231,Temazepam,small molecule,approved;investigational,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1,SEQDDYPDSLOBDC-UHFFFAOYSA-N,300.74,P30536,BE0000736,Translocator protein,Humans,modulator,yes
DB00231,Temazepam,small molecule,approved;investigational,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1,SEQDDYPDSLOBDC-UHFFFAOYSA-N,300.74,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB00232,Methyclothiazide,small molecule,withdrawn,CN1C(CCl)NC2=CC(Cl)=C(C=C2S1(=O)=O)S(N)(=O)=O,CESYKOGBSMNBPD-UHFFFAOYSA-N,360.237,Q13621,BE0000502,Solute carrier family 12 member 1,Humans,inhibitor,yes
DB00233,Aminosalicylic acid,small molecule,approved,NC1=CC(O)=C(C=C1)C(O)=O,WUBBRNOQWQTFEX-UHFFFAOYSA-N,153.1354,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,modulator,yes
DB00233,Aminosalicylic acid,small molecule,approved,NC1=CC(O)=C(C=C1)C(O)=O,WUBBRNOQWQTFEX-UHFFFAOYSA-N,153.1354,P00374,BE0000330,Dihydrofolate reductase,Humans,modulator,yes
DB00234,Reboxetine,small molecule,approved;experimental,[H][C@@]1(CNCCO1)[C@H](OC1=CC=CC=C1OCC)C1=CC=CC=C1,CBQGYUDMJHNJBX-RTBURBONSA-N,313.397,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,inhibitor,yes
DB00235,Milrinone,small molecule,approved,CC1=C(C=C(C#N)C(=O)N1)C1=CC=NC=C1,PZRHRDRVRGEVNW-UHFFFAOYSA-N,211.2194,Q14432,BE0000436,"cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A",Humans,inhibitor,yes
DB00236,Pipobroman,small molecule,approved,BrCCC(=O)N1CCN(CC1)C(=O)CCBr,NJBFOOCLYDNZJN-UHFFFAOYSA-N,356.054,,BE0004796,DNA,Humans,cross-linking/alkylation,yes
DB00237,Butabarbital,small molecule,approved;illicit,CCC(C)C1(CC)C(=O)NC(=O)NC1=O,ZRIHAIZYIMGOAB-UHFFFAOYSA-N,212.2456,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB00237,Butabarbital,small molecule,approved;illicit,CCC(C)C1(CC)C(=O)NC(=O)NC1=O,ZRIHAIZYIMGOAB-UHFFFAOYSA-N,212.2456,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,antagonist,yes
DB00238,Nevirapine,small molecule,approved,CC1=C2NC(=O)C3=C(N=CC=C3)N(C3CC3)C2=NC=C1,NQDJXKOVJZTUJA-UHFFFAOYSA-N,266.2979,P03366,BE0002050,Gag-Pol polyprotein,,modulator,yes
DB00238,Nevirapine,small molecule,approved,CC1=C2NC(=O)C3=C(N=CC=C3)N(C3CC3)C2=NC=C1,NQDJXKOVJZTUJA-UHFFFAOYSA-N,266.2979,Q72547,BE0004136,Reverse transcriptase/RNaseH,Human immunodeficiency virus 1,inhibitor,yes
DB00239,Oxiconazole,small molecule,approved,ClC1=CC(Cl)=C(CO\N=C(/CN2C=CN=C2)C2=CC=C(Cl)C=C2Cl)C=C1,QRJJEGAJXVEBNE-HKOYGPOVSA-N,429.12,P10613,BE0000233,Lanosterol 14-alpha demethylase,Yeast,inhibitor,yes
DB00239,Oxiconazole,small molecule,approved,ClC1=CC(Cl)=C(CO\N=C(/CN2C=CN=C2)C2=CC=C(Cl)C=C2Cl)C=C1,QRJJEGAJXVEBNE-HKOYGPOVSA-N,429.12,Q04782,BE0004668,Lanosterol synthase,Yeast,inhibitor,yes
DB00240,Alclometasone,small molecule,approved,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])[C@H](Cl)CC2=CC(=O)C=C[C@]12C,FJXOGVLKCZQRDN-PHCHRAKRSA-N,408.916,P08185,BE0000209,Corticosteroid-binding globulin,Humans,binder,yes
DB00240,Alclometasone,small molecule,approved,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])[C@H](Cl)CC2=CC(=O)C=C[C@]12C,FJXOGVLKCZQRDN-PHCHRAKRSA-N,408.916,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB00241,Butalbital,small molecule,approved;illicit,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,UZVHFVZFNXBMQJ-UHFFFAOYSA-N,224.2563,P47869,BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,Humans,potentiator,yes
DB00241,Butalbital,small molecule,approved;illicit,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,UZVHFVZFNXBMQJ-UHFFFAOYSA-N,224.2563,P34903,BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,Humans,potentiator,yes
DB00241,Butalbital,small molecule,approved;illicit,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,UZVHFVZFNXBMQJ-UHFFFAOYSA-N,224.2563,P48169,BE0000478,Gamma-aminobutyric acid receptor subunit alpha-4,Humans,potentiator,yes
DB00241,Butalbital,small molecule,approved;illicit,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,UZVHFVZFNXBMQJ-UHFFFAOYSA-N,224.2563,P31644,BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,Humans,potentiator,yes
DB00241,Butalbital,small molecule,approved;illicit,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,UZVHFVZFNXBMQJ-UHFFFAOYSA-N,224.2563,Q16445,BE0000764,Gamma-aminobutyric acid receptor subunit alpha-6,Humans,potentiator,yes
DB00241,Butalbital,small molecule,approved;illicit,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,UZVHFVZFNXBMQJ-UHFFFAOYSA-N,224.2563,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB00241,Butalbital,small molecule,approved;illicit,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,UZVHFVZFNXBMQJ-UHFFFAOYSA-N,224.2563,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,potentiator,yes
DB00242,Cladribine,small molecule,approved;investigational,NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC(Cl)=N1,PTOAARAWEBMLNO-KVQBGUIXSA-N,285.687,P23921,BE0000325,Ribonucleoside-diphosphate reductase large subunit,Humans,inhibitor,yes
DB00242,Cladribine,small molecule,approved;investigational,NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC(Cl)=N1,PTOAARAWEBMLNO-KVQBGUIXSA-N,285.687,P00813,BE0002214,Adenosine deaminase,Humans,inhibitor,yes
DB00242,Cladribine,small molecule,approved;investigational,NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC(Cl)=N1,PTOAARAWEBMLNO-KVQBGUIXSA-N,285.687,P31350,BE0002450,Ribonucleoside-diphosphate reductase subunit M2,Humans,inhibitor,yes
DB00242,Cladribine,small molecule,approved;investigational,NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC(Cl)=N1,PTOAARAWEBMLNO-KVQBGUIXSA-N,285.687,Q7LG56,BE0003613,Ribonucleoside-diphosphate reductase subunit M2 B,Humans,inhibitor,yes
DB00242,Cladribine,small molecule,approved;investigational,NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC(Cl)=N1,PTOAARAWEBMLNO-KVQBGUIXSA-N,285.687,P09884,BE0000546,DNA polymerase alpha catalytic subunit,Humans,inhibitor,yes
DB00242,Cladribine,small molecule,approved;investigational,NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC(Cl)=N1,PTOAARAWEBMLNO-KVQBGUIXSA-N,285.687,Q07864,BE0003614,DNA polymerase epsilon catalytic subunit A,Humans,inhibitor,yes
DB00242,Cladribine,small molecule,approved;investigational,NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC(Cl)=N1,PTOAARAWEBMLNO-KVQBGUIXSA-N,285.687,P56282,BE0003615,DNA polymerase epsilon subunit 2,Humans,inhibitor,yes
DB00242,Cladribine,small molecule,approved;investigational,NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC(Cl)=N1,PTOAARAWEBMLNO-KVQBGUIXSA-N,285.687,Q9NRF9,BE0003617,DNA polymerase epsilon subunit 3,Humans,inhibitor,yes
DB00242,Cladribine,small molecule,approved;investigational,NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC(Cl)=N1,PTOAARAWEBMLNO-KVQBGUIXSA-N,285.687,Q9NR33,BE0003616,DNA polymerase epsilon subunit 4,Humans,inhibitor,yes
DB00242,Cladribine,small molecule,approved;investigational,NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC(Cl)=N1,PTOAARAWEBMLNO-KVQBGUIXSA-N,285.687,P00491,BE0000250,Purine nucleoside phosphorylase,Humans,inducer,yes
DB00243,Ranolazine,small molecule,approved;investigational,COC1=CC=CC=C1OCC(O)CN1CCN(CC(=O)NC2=C(C)C=CC=C2C)CC1,XKLMZUWKNUAPSZ-UHFFFAOYSA-N,427.5365,P00747,BE0000211,Plasminogen,Humans,modulator,yes
DB00244,Mesalazine,small molecule,approved,NC1=CC(C(O)=O)=C(O)C=C1,KBOPZPXVLCULAV-UHFFFAOYSA-N,153.1354,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB00244,Mesalazine,small molecule,approved,NC1=CC(C(O)=O)=C(O)C=C1,KBOPZPXVLCULAV-UHFFFAOYSA-N,153.1354,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB00244,Mesalazine,small molecule,approved,NC1=CC(C(O)=O)=C(O)C=C1,KBOPZPXVLCULAV-UHFFFAOYSA-N,153.1354,P09917,BE0000248,Polyunsaturated fatty acid 5-lipoxygenase,Humans,inhibitor,yes
DB00244,Mesalazine,small molecule,approved,NC1=CC(C(O)=O)=C(O)C=C1,KBOPZPXVLCULAV-UHFFFAOYSA-N,153.1354,P37231,BE0000215,Peroxisome proliferator-activated receptor gamma,Humans,agonist,yes
DB00245,Benzatropine,small molecule,approved,[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C,GIJXKZJWITVLHI-PMOLBWCYSA-N,307.4293,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,antagonist,yes
DB00245,Benzatropine,small molecule,approved,[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C,GIJXKZJWITVLHI-PMOLBWCYSA-N,307.4293,Q01959,BE0000647,Sodium-dependent dopamine transporter,Humans,inhibitor,yes
DB00246,Ziprasidone,small molecule,approved,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,MVWVFYHBGMAFLY-UHFFFAOYSA-N,412.936,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB00246,Ziprasidone,small molecule,approved,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,MVWVFYHBGMAFLY-UHFFFAOYSA-N,412.936,P36544,BE0002341,Neuronal acetylcholine receptor subunit alpha-7,Humans,binder,yes
DB00246,Ziprasidone,small molecule,approved,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,MVWVFYHBGMAFLY-UHFFFAOYSA-N,412.936,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB00246,Ziprasidone,small molecule,approved,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,MVWVFYHBGMAFLY-UHFFFAOYSA-N,412.936,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,agonist,yes
DB00246,Ziprasidone,small molecule,approved,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,MVWVFYHBGMAFLY-UHFFFAOYSA-N,412.936,P28221,BE0000659,5-hydroxytryptamine receptor 1D,Humans,antagonist,yes
DB00246,Ziprasidone,small molecule,approved,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,MVWVFYHBGMAFLY-UHFFFAOYSA-N,412.936,P28335,BE0000533,5-hydroxytryptamine receptor 2C,Humans,antagonist,yes
DB00247,Methysergide,small molecule,approved,[H][C@@]12CC3=CN(C)C4=C3C(=CC=C4)C1=C[C@H](CN2C)C(=O)NC(CC)CO,KPJZHOPZRAFDTN-NQUBZZJWSA-N,353.458,P41595,BE0000393,5-hydroxytryptamine receptor 2B,Humans,antagonist,yes
DB00247,Methysergide,small molecule,approved,[H][C@@]12CC3=CN(C)C4=C3C(=CC=C4)C1=C[C@H](CN2C)C(=O)NC(CC)CO,KPJZHOPZRAFDTN-NQUBZZJWSA-N,353.458,P28335,BE0000533,5-hydroxytryptamine receptor 2C,Humans,antagonist,yes
DB00247,Methysergide,small molecule,approved,[H][C@@]12CC3=CN(C)C4=C3C(=CC=C4)C1=C[C@H](CN2C)C(=O)NC(CC)CO,KPJZHOPZRAFDTN-NQUBZZJWSA-N,353.458,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB00247,Methysergide,small molecule,approved,[H][C@@]12CC3=CN(C)C4=C3C(=CC=C4)C1=C[C@H](CN2C)C(=O)NC(CC)CO,KPJZHOPZRAFDTN-NQUBZZJWSA-N,353.458,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,agonist,yes
DB00247,Methysergide,small molecule,approved,[H][C@@]12CC3=CN(C)C4=C3C(=CC=C4)C1=C[C@H](CN2C)C(=O)NC(CC)CO,KPJZHOPZRAFDTN-NQUBZZJWSA-N,353.458,P34969,BE0000650,5-hydroxytryptamine receptor 7,Humans,antagonist,yes
DB00248,Cabergoline,small molecule,approved,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,KORNTPPJEAJQIU-KJXAQDMKSA-N,451.6043,P14416,BE0000756,D(2) dopamine receptor,Humans,agonist,yes
DB00249,Idoxuridine,small molecule,approved;investigational,OC[C@H]1O[C@H](C[C@@H]1O)N1C=C(I)C(=O)NC1=O,XQFRJNBWHJMXHO-RRKCRQDMSA-N,354.0985,,BE0004796,DNA,Humans,other,yes
DB00250,Dapsone,small molecule,approved;investigational,NC1=CC=C(C=C1)S(=O)(=O)C1=CC=C(N)C=C1,MQJKPEGWNLWLTK-UHFFFAOYSA-N,248.301,P0C0X2,BE0002087,Inactive dihydropteroate synthase 2,Mycobacterium leprae (strain TN),inhibitor,yes
DB00250,Dapsone,small molecule,approved;investigational,NC1=CC=C(C=C1)S(=O)(=O)C1=CC=C(N)C=C1,MQJKPEGWNLWLTK-UHFFFAOYSA-N,248.301,P0C0X1,BE0002086,Dihydropteroate synthase,Mycobacterium leprae (strain TN),inhibitor,yes
DB00251,Terconazole,small molecule,approved,CC(C)N1CCN(CC1)C1=CC=C(OC[C@@H]2CO[C@](CN3C=NC=N3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1,BLSQLHNBWJLIBQ-ZEQKJWHPSA-N,532.47,P10613,BE0000233,Lanosterol 14-alpha demethylase,Yeast,antagonist,yes
DB00252,Phenytoin,small molecule,approved;vet_approved,O=C1NC(=O)C(N1)(C1=CC=CC=C1)C1=CC=CC=C1,CXOFVDLJLONNDW-UHFFFAOYSA-N,252.268,Q14524,BE0000197,Sodium channel protein type 5 subunit alpha,Humans,inhibitor,yes
DB00252,Phenytoin,small molecule,approved;vet_approved,O=C1NC(=O)C(N1)(C1=CC=CC=C1)C1=CC=CC=C1,CXOFVDLJLONNDW-UHFFFAOYSA-N,252.268,P35498,BE0000141,Sodium channel protein type 1 subunit alpha,Humans,inhibitor,yes
DB00252,Phenytoin,small molecule,approved;vet_approved,O=C1NC(=O)C(N1)(C1=CC=CC=C1)C1=CC=CC=C1,CXOFVDLJLONNDW-UHFFFAOYSA-N,252.268,Q12809,BE0000090,Voltage-gated inwardly rectifying potassium channel KCNH2,Humans,inhibitor,yes
DB00252,Phenytoin,small molecule,approved;vet_approved,O=C1NC(=O)C(N1)(C1=CC=CC=C1)C1=CC=CC=C1,CXOFVDLJLONNDW-UHFFFAOYSA-N,252.268,Q13936,BE0008715,Voltage-dependent L-type calcium channel,Humans,inhibitor,yes
DB00252,Phenytoin,small molecule,approved;vet_approved,O=C1NC(=O)C(N1)(C1=CC=CC=C1)C1=CC=CC=C1,CXOFVDLJLONNDW-UHFFFAOYSA-N,252.268,Q99250,BE0002081,Sodium channel protein type 2 subunit alpha,Humans,inhibitor,yes
DB00252,Phenytoin,small molecule,approved;vet_approved,O=C1NC(=O)C(N1)(C1=CC=CC=C1)C1=CC=CC=C1,CXOFVDLJLONNDW-UHFFFAOYSA-N,252.268,Q9UQD0,BE0002084,Sodium channel protein type 8 subunit alpha,Humans,inhibitor,yes
DB00253,Medrysone,small molecule,approved,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)CC[C@]12C,GZENKSODFLBBHQ-ILSZZQPISA-N,344.4877,P11474,BE0003722,Steroid hormone receptor ERR1,Humans,modulator,yes
DB00253,Medrysone,small molecule,approved,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)CC[C@]12C,GZENKSODFLBBHQ-ILSZZQPISA-N,344.4877,O95718,BE0005001,Steroid hormone receptor ERR2,Humans,modulator,yes
DB00253,Medrysone,small molecule,approved,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)CC[C@]12C,GZENKSODFLBBHQ-ILSZZQPISA-N,344.4877,P62508,BE0002088,Estrogen-related receptor gamma,Humans,modulator,yes
DB00253,Medrysone,small molecule,approved,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)CC[C@]12C,GZENKSODFLBBHQ-ILSZZQPISA-N,344.4877,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB00254,Doxycycline,small molecule,approved;investigational;vet_approved,[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])[C@H]2O,JBIWCJUYHHGXTC-AKNGSSGZSA-N,444.4346,,BE0009998,30S ribosomal protein,,inhibitor,yes
DB00255,Diethylstilbestrol,small molecule,approved;investigational;withdrawn,CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1,RGLYKWWBQGJZGM-ISLYRVAYSA-N,268.356,Q92731,BE0000792,Estrogen receptor beta,Humans,agonist,yes
DB00255,Diethylstilbestrol,small molecule,approved;investigational;withdrawn,CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1,RGLYKWWBQGJZGM-ISLYRVAYSA-N,268.356,P03372,BE0000123,Estrogen receptor,Humans,agonist,yes
DB00255,Diethylstilbestrol,small molecule,approved;investigational;withdrawn,CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1,RGLYKWWBQGJZGM-ISLYRVAYSA-N,268.356,P62508,BE0002088,Estrogen-related receptor gamma,Humans,agonist,yes
DB00256,Lymecycline,small molecule,approved;investigational,[H][C@@]12C[C@@]3([H])C(C(=O)C4=C(O)C=CC=C4[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(=O)NCNCCCC[C@H](N)C(O)=O)=C(O)[C@H]2N(C)C,AHEVKYYGXVEWNO-UEPZRUIBSA-N,602.6328,P0A7V8,BE0000019,30S ribosomal protein S4,Escherichia coli (strain K12),inhibitor,yes
DB00257,Clotrimazole,small molecule,approved;vet_approved,ClC1=CC=CC=C1C(N1C=CN=C1)(C1=CC=CC=C1)C1=CC=CC=C1,VNFPBHJOKIVQEB-UHFFFAOYSA-N,344.837,P25025,BE0010516,C-X-C chemokine receptor type 2,Humans,modulator,yes
DB00257,Clotrimazole,small molecule,approved;vet_approved,ClC1=CC=CC=C1C(N1C=CN=C1)(C1=CC=CC=C1)C1=CC=CC=C1,VNFPBHJOKIVQEB-UHFFFAOYSA-N,344.837,P10613,BE0000233,Lanosterol 14-alpha demethylase,Yeast,antagonist;inhibitor,yes
DB00257,Clotrimazole,small molecule,approved;vet_approved,ClC1=CC=CC=C1C(N1C=CN=C1)(C1=CC=CC=C1)C1=CC=CC=C1,VNFPBHJOKIVQEB-UHFFFAOYSA-N,344.837,O15554,BE0000415,Intermediate conductance calcium-activated potassium channel protein 4,Humans,inhibitor,yes
DB00257,Clotrimazole,small molecule,approved;vet_approved,ClC1=CC=CC=C1C(N1C=CN=C1)(C1=CC=CC=C1)C1=CC=CC=C1,VNFPBHJOKIVQEB-UHFFFAOYSA-N,344.837,,BE0004803,Ergosterol,Candida albicans,inhibitor,yes
DB00258,Calcium acetate,small molecule,approved;investigational,[Ca++].CC([O-])=O.CC([O-])=O,VSGNNIFQASZAOI-UHFFFAOYSA-L,158.166,,BE0004815,Phosphate,Humans,binder,yes
DB00259,Sulfanilamide,small molecule,approved,NC1=CC=C(C=C1)S(N)(=O)=O,FDDDEECHVMSUSB-UHFFFAOYSA-N,172.205,P0AC13,BE0000803,Dihydropteroate synthase,Escherichia coli (strain K12),inhibitor,yes
DB00261,Anagrelide,small molecule,approved,ClC1=CC=C2N=C3NC(=O)CN3CC2=C1Cl,OTBXOEAOVRKTNQ-UHFFFAOYSA-N,256.088,Q14432,BE0000436,"cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A",Humans,inhibitor,yes
DB00262,Carmustine,small molecule,approved;investigational,ClCCNC(=O)N(CCCl)N=O,DLGOEMSEDOSKAD-UHFFFAOYSA-N,214.05,P00390,BE0000648,"Glutathione reductase, mitochondrial",Humans,inhibitor,yes
DB00263,Sulfisoxazole,small molecule,approved;vet_approved,CC1=NOC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1C,NHUHCSRWZMLRLA-UHFFFAOYSA-N,267.304,P0AC13,BE0000803,Dihydropteroate synthase,Escherichia coli (strain K12),inhibitor,yes
DB00264,Metoprolol,small molecule,approved;investigational,COCCC1=CC=C(OCC(O)CNC(C)C)C=C1,IUBSYMUCCVWXPE-UHFFFAOYSA-N,267.3639,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,antagonist,yes
DB00265,Crotamiton,small molecule,approved,CCN(C(=O)C=CC)C1=CC=CC=C1C,DNTGGZPQPQTDQF-XBXARRHUSA-N,203.2802,Q9HBA0,BE0009159,Transient receptor potential cation channel subfamily V member 4,Humans,inhibitor,yes
DB00266,Dicoumarol,small molecule,approved,OC1=C(CC2=C(O)C3=C(OC2=O)C=CC=C3)C(=O)OC2=C1C=CC=C2,DOBMPNYZJYQDGZ-UHFFFAOYSA-N,336.295,Q9BQB6,BE0000713,Vitamin K epoxide reductase complex subunit 1,Humans,inhibitor,yes
DB00267,Cefmenoxime,small molecule,approved,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,HJJDBAOLQAWBMH-YCRCPZNHSA-N,511.558,P0AD68,BE0002393,Peptidoglycan synthase FtsI,Escherichia coli (strain K12),inhibitor,yes
DB00267,Cefmenoxime,small molecule,approved,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,HJJDBAOLQAWBMH-YCRCPZNHSA-N,511.558,Q8XJ01,BE0000576,Penicillin-binding protein 1A,Clostridium perfringens (strain 13 / Type A),inhibitor,yes
DB00268,Ropinirole,small molecule,approved;investigational,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,UHSKFQJFRQCDBE-UHFFFAOYSA-N,260.3746,P35462,BE0000581,D(3) dopamine receptor,Humans,agonist,yes
DB00268,Ropinirole,small molecule,approved;investigational,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,UHSKFQJFRQCDBE-UHFFFAOYSA-N,260.3746,P14416,BE0000756,D(2) dopamine receptor,Humans,agonist,yes
DB00269,Chlorotrianisene,small molecule,investigational;withdrawn,COC1=CC=C(C=C1)C(Cl)=C(C1=CC=C(OC)C=C1)C1=CC=C(OC)C=C1,BFPSDSIWYFKGBC-UHFFFAOYSA-N,380.864,P03372,BE0000123,Estrogen receptor,Humans,agonist,yes
DB00270,Isradipine,small molecule,approved;investigational,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC2=NON=C12)C(=O)OC(C)C,HMJIYCCIJYRONP-UHFFFAOYSA-N,371.3871,Q13936,BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,Humans,inhibitor,yes
DB00270,Isradipine,small molecule,approved;investigational,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC2=NON=C12)C(=O)OC(C)C,HMJIYCCIJYRONP-UHFFFAOYSA-N,371.3871,P54289,BE0000691,Voltage-dependent calcium channel subunit alpha-2/delta-1,Humans,inhibitor,yes
DB00270,Isradipine,small molecule,approved;investigational,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC2=NON=C12)C(=O)OC(C)C,HMJIYCCIJYRONP-UHFFFAOYSA-N,371.3871,Q08289,BE0002354,Voltage-dependent L-type calcium channel subunit beta-2,Humans,inhibitor,yes
DB00270,Isradipine,small molecule,approved;investigational,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC2=NON=C12)C(=O)OC(C)C,HMJIYCCIJYRONP-UHFFFAOYSA-N,371.3871,O95180,BE0000864,Voltage-dependent T-type calcium channel subunit alpha-1H,Humans,inhibitor,yes
DB00270,Isradipine,small molecule,approved;investigational,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC2=NON=C12)C(=O)OC(C)C,HMJIYCCIJYRONP-UHFFFAOYSA-N,371.3871,Q9NY47,BE0002396,Voltage-dependent calcium channel subunit alpha-2/delta-2,Humans,inhibitor,yes
DB00270,Isradipine,small molecule,approved;investigational,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC2=NON=C12)C(=O)OC(C)C,HMJIYCCIJYRONP-UHFFFAOYSA-N,371.3871,Q01668,BE0002359,Voltage-dependent L-type calcium channel subunit alpha-1D,Humans,inhibitor,yes
DB00270,Isradipine,small molecule,approved;investigational,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC2=NON=C12)C(=O)OC(C)C,HMJIYCCIJYRONP-UHFFFAOYSA-N,371.3871,Q13698,BE0002355,Voltage-dependent L-type calcium channel subunit alpha-1S,Humans,inhibitor,yes
DB00273,Topiramate,small molecule,approved,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2,KJADKKWYZYXHBB-XBWDGYHZSA-N,339.362,P39086,BE0000346,"Glutamate receptor ionotropic, kainate 1",Humans,antagonist,yes
DB00273,Topiramate,small molecule,approved,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2,KJADKKWYZYXHBB-XBWDGYHZSA-N,339.362,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,agonist,yes
DB00273,Topiramate,small molecule,approved,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2,KJADKKWYZYXHBB-XBWDGYHZSA-N,339.362,P35498,BE0009738,Voltage-gated sodium channel alpha subunit,Humans,inhibitor,yes
DB00273,Topiramate,small molecule,approved,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2,KJADKKWYZYXHBB-XBWDGYHZSA-N,339.362,P39086,BE0009793,Kainate receptors,Humans,antagonist,yes
DB00273,Topiramate,small molecule,approved,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2,KJADKKWYZYXHBB-XBWDGYHZSA-N,339.362,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB00273,Topiramate,small molecule,approved,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2,KJADKKWYZYXHBB-XBWDGYHZSA-N,339.362,P22748,BE0000535,Carbonic anhydrase 4,Humans,inhibitor,yes
DB00273,Topiramate,small molecule,approved,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2,KJADKKWYZYXHBB-XBWDGYHZSA-N,339.362,Q13936,BE0009739,Voltage gated L-type calcium channel,Humans,antagonist,yes
DB00274,Cefmetazole,small molecule,approved;investigational,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@]2(NC(=O)CSCC#N)OC)C(O)=O,SNBUBQHDYVFSQF-HIFRSBDPSA-N,471.534,C1KC03,BE0003577,Penicillin binding protein 2a,Staphylococcus aureus,inhibitor,yes
DB00274,Cefmetazole,small molecule,approved;investigational,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@]2(NC(=O)CSCC#N)OC)C(O)=O,SNBUBQHDYVFSQF-HIFRSBDPSA-N,471.534,P02918,BE0000588,Penicillin-binding protein 1A,Escherichia coli (strain K12),inhibitor,yes
DB00274,Cefmetazole,small molecule,approved;investigational,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@]2(NC(=O)CSCC#N)OC)C(O)=O,SNBUBQHDYVFSQF-HIFRSBDPSA-N,471.534,P02919,BE0000488,Penicillin-binding protein 1B,Escherichia coli (strain K12),inhibitor,yes
DB00274,Cefmetazole,small molecule,approved;investigational,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@]2(NC(=O)CSCC#N)OC)C(O)=O,SNBUBQHDYVFSQF-HIFRSBDPSA-N,471.534,P0AD68,BE0002393,Peptidoglycan synthase FtsI,Escherichia coli (strain K12),inhibitor,yes
DB00274,Cefmetazole,small molecule,approved;investigational,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@]2(NC(=O)CSCC#N)OC)C(O)=O,SNBUBQHDYVFSQF-HIFRSBDPSA-N,471.534,P0AEB2,BE0002063,D-alanyl-D-alanine carboxypeptidase DacA,Escherichia coli (strain K12),inhibitor,yes
DB00274,Cefmetazole,small molecule,approved;investigational,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@]2(NC(=O)CSCC#N)OC)C(O)=O,SNBUBQHDYVFSQF-HIFRSBDPSA-N,471.534,P08506,BE0003685,D-alanyl-D-alanine carboxypeptidase DacC,Escherichia coli (strain K12),inhibitor,yes
DB00275,Olmesartan,small molecule,approved;investigational,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,VTRAEEWXHOVJFV-UHFFFAOYSA-N,446.5016,P30556,BE0000062,Type-1 angiotensin II receptor,Humans,antagonist,yes
DB00276,Amsacrine,small molecule,approved;investigational,COC1=C(NC2=C3C=CC=CC3=NC3=CC=CC=C23)C=CC(NS(C)(=O)=O)=C1,XCPGHVQEEXUHNC-UHFFFAOYSA-N,393.459,,BE0004796,DNA,Humans,intercalation,yes
DB00276,Amsacrine,small molecule,approved;investigational,COC1=C(NC2=C3C=CC=CC3=NC3=CC=CC=C23)C=CC(NS(C)(=O)=O)=C1,XCPGHVQEEXUHNC-UHFFFAOYSA-N,393.459,Q02880,BE0002425,DNA topoisomerase 2-beta,Humans,inhibitor,yes
DB00276,Amsacrine,small molecule,approved;investigational,COC1=C(NC2=C3C=CC=CC3=NC3=CC=CC=C23)C=CC(NS(C)(=O)=O)=C1,XCPGHVQEEXUHNC-UHFFFAOYSA-N,393.459,P11388,BE0000742,DNA topoisomerase 2-alpha,Humans,inhibitor,yes
DB00277,Theophylline,small molecule,approved,CN1C2=C(NC=N2)C(=O)N(C)C1=O,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,180.164,P30542,BE0000013,Adenosine receptor A1,Humans,antagonist,yes
DB00277,Theophylline,small molecule,approved,CN1C2=C(NC=N2)C(=O)N(C)C1=O,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,180.164,P21589,BE0001096,5'-nucleotidase,Humans,inhibitor,yes
DB00277,Theophylline,small molecule,approved,CN1C2=C(NC=N2)C(=O)N(C)C1=O,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,180.164,P29274,BE0000924,Adenosine receptor A2a,Humans,antagonist,yes
DB00277,Theophylline,small molecule,approved,CN1C2=C(NC=N2)C(=O)N(C)C1=O,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,180.164,P29275,BE0000241,Adenosine receptor A2b,Humans,antagonist,yes
DB00277,Theophylline,small molecule,approved,CN1C2=C(NC=N2)C(=O)N(C)C1=O,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,180.164,Q07343,BE0000487,"3',5'-cyclic-AMP phosphodiesterase 4B",Humans,inhibitor,yes
DB00277,Theophylline,small molecule,approved,CN1C2=C(NC=N2)C(=O)N(C)C1=O,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,180.164,O76074,BE0000182,"cGMP-specific 3',5'-cyclic phosphodiesterase",Humans,inhibitor,yes
DB00277,Theophylline,small molecule,approved,CN1C2=C(NC=N2)C(=O)N(C)C1=O,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,180.164,P27815,BE0001133,"3',5'-cyclic-AMP phosphodiesterase 4A",Humans,inhibitor,yes
DB00277,Theophylline,small molecule,approved,CN1C2=C(NC=N2)C(=O)N(C)C1=O,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,180.164,Q14432,BE0000436,"cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A",Humans,inhibitor,yes
DB00277,Theophylline,small molecule,approved,CN1C2=C(NC=N2)C(=O)N(C)C1=O,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,180.164,Q92769,BE0002366,Histone deacetylase 2,Humans,activator,yes
DB00278,Argatroban,small molecule,approved;investigational,C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)C1=CC=CC2=C1NCC(C)C2,KXNPVXPOPUZYGB-IOVMHBDKSA-N,508.64,P00734,BE0000048,Prothrombin,Humans,inhibitor,yes
DB00279,Liothyronine,small molecule,approved;vet_approved,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(O)=O,AUYYCJSJGJYCDS-LBPRGKRZSA-N,650.9735,P10827,BE0000687,Thyroid hormone receptor alpha,Humans,agonist,yes
DB00279,Liothyronine,small molecule,approved;vet_approved,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(O)=O,AUYYCJSJGJYCDS-LBPRGKRZSA-N,650.9735,P10828,BE0000315,Thyroid hormone receptor beta,Humans,agonist,yes
DB00280,Disopyramide,small molecule,approved,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C,UVTNFZQICZKOEM-UHFFFAOYSA-N,339.4745,Q14524,BE0000197,Sodium channel protein type 5 subunit alpha,Humans,inhibitor,yes
DB00281,Lidocaine,small molecule,approved;vet_approved,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,NNJVILVZKWQKPM-UHFFFAOYSA-N,234.3373,Q9UI33,BE0000192,Sodium channel protein type 11 subunit alpha,Humans,blocker,yes
DB00281,Lidocaine,small molecule,approved;vet_approved,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,NNJVILVZKWQKPM-UHFFFAOYSA-N,234.3373,Q9Y5Y9,BE0000177,Sodium channel protein type 10 subunit alpha,Humans,inhibitor,yes
DB00281,Lidocaine,small molecule,approved;vet_approved,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,NNJVILVZKWQKPM-UHFFFAOYSA-N,234.3373,Q15858,BE0001143,Sodium channel protein type 9 subunit alpha,Humans,inhibitor,yes
DB00281,Lidocaine,small molecule,approved;vet_approved,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,NNJVILVZKWQKPM-UHFFFAOYSA-N,234.3373,Q14524,BE0000197,Sodium channel protein type 5 subunit alpha,Humans,inhibitor,yes
DB00282,Pamidronic acid,small molecule,approved,NCCC(O)(P(O)(O)=O)P(O)(O)=O,WRUUGTRCQOWXEG-UHFFFAOYSA-N,235.0695,P14324,BE0000776,Farnesyl pyrophosphate synthase,Humans,inhibitor,yes
DB00282,Pamidronic acid,small molecule,approved,NCCC(O)(P(O)(O)=O)P(O)(O)=O,WRUUGTRCQOWXEG-UHFFFAOYSA-N,235.0695,,BE0004801,Hydroxylapatite,Humans,antagonist,yes
DB00283,Clemastine,small molecule,approved;investigational,CN1CCC[C@@H]1CCO[C@](C)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,YNNUSGIPVFPVBX-NHCUHLMSSA-N,343.89,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB00284,Acarbose,small molecule,approved;investigational,[H]C(=O)[C@H](O)[C@@H](O)[C@]([H])(O[C@@]1([H])O[C@H](CO)[C@@]([H])(O[C@H]2O[C@H](C)[C@@H](N[C@@]3([H])C=C(CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)CO,CEMXHAPUFJOOSV-XGWNLRGSSA-N,645.608,O43451,BE0000837,Maltase-glucoamylase,Humans,inhibitor,yes
DB00284,Acarbose,small molecule,approved;investigational,[H]C(=O)[C@H](O)[C@@H](O)[C@]([H])(O[C@@]1([H])O[C@H](CO)[C@@]([H])(O[C@H]2O[C@H](C)[C@@H](N[C@@]3([H])C=C(CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)CO,CEMXHAPUFJOOSV-XGWNLRGSSA-N,645.608,P14410,BE0001176,"Sucrase-isomaltase, intestinal",Humans,inhibitor,yes
DB00284,Acarbose,small molecule,approved;investigational,[H]C(=O)[C@H](O)[C@@H](O)[C@]([H])(O[C@@]1([H])O[C@H](CO)[C@@]([H])(O[C@H]2O[C@H](C)[C@@H](N[C@@]3([H])C=C(CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)CO,CEMXHAPUFJOOSV-XGWNLRGSSA-N,645.608,P04746,BE0002639,Pancreatic alpha-amylase,Humans,inhibitor,yes
DB00285,Venlafaxine,small molecule,approved,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,PNVNVHUZROJLTJ-UHFFFAOYSA-N,277.4018,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB00285,Venlafaxine,small molecule,approved,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,PNVNVHUZROJLTJ-UHFFFAOYSA-N,277.4018,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,inhibitor,yes
DB00287,Travoprost,small molecule,approved,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC1=CC=CC(=C1)C(F)(F)F,MKPLKVHSHYCHOC-AHTXBMBWSA-N,500.5477,P43088,BE0000610,Prostaglandin F2-alpha receptor,Humans,agonist,yes
DB00288,Amcinonide,small molecule,approved,[H][C@@]12C[C@H]3OC4(CCCC4)O[C@@]3(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,ILKJAFIWWBXGDU-MOGDOJJUSA-N,502.5717,P11474,BE0003722,Steroid hormone receptor ERR1,Humans,modulator,yes
DB00288,Amcinonide,small molecule,approved,[H][C@@]12C[C@H]3OC4(CCCC4)O[C@@]3(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,ILKJAFIWWBXGDU-MOGDOJJUSA-N,502.5717,O95718,BE0005001,Steroid hormone receptor ERR2,Humans,modulator,yes
DB00288,Amcinonide,small molecule,approved,[H][C@@]12C[C@H]3OC4(CCCC4)O[C@@]3(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,ILKJAFIWWBXGDU-MOGDOJJUSA-N,502.5717,P62508,BE0002088,Estrogen-related receptor gamma,Humans,modulator,yes
DB00288,Amcinonide,small molecule,approved,[H][C@@]12C[C@H]3OC4(CCCC4)O[C@@]3(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,ILKJAFIWWBXGDU-MOGDOJJUSA-N,502.5717,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB00289,Atomoxetine,small molecule,approved,CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1,VHGCDTVCOLNTBX-QGZVFWFLSA-N,255.3547,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,inhibitor,yes
DB00290,Bleomycin,small molecule,approved;investigational,[H][C@](C)(NC(=O)[C@@]([H])(NC(=O)C1=NC(=NC(N)=C1C)[C@H](CC(N)=O)NC[C@H](N)C(N)=O)[C@@]([H])(OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(OC(N)=O)C1O)C1=CNC=N1)[C@@H](O)[C@H](C)C(=O)N[C@]([H])(C(=O)NCCC1=NC(=CS1)C1=NC(=CS1)C(=O)NCCC[S+](C)C)[C@@]([H])(C)O,OYVAGSVQBOHSSS-WXFSZRTFSA-O,1415.552,,BE0004796,DNA,Humans,cleavage,yes
DB00291,Chlorambucil,small molecule,approved,OC(=O)CCCC1=CC=C(C=C1)N(CCCl)CCCl,JCKYGMPEJWAADB-UHFFFAOYSA-N,304.212,,BE0004796,DNA,Humans,cross-linking/alkylation,yes
DB00292,Etomidate,small molecule,approved,CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1,NPUKDXXFDDZOKR-LLVKDONJSA-N,244.289,Q99928,BE0003594,Gamma-aminobutyric acid receptor subunit gamma-3,Humans,modulator,yes
DB00292,Etomidate,small molecule,approved,CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1,NPUKDXXFDDZOKR-LLVKDONJSA-N,244.289,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,agonist,yes
DB00292,Etomidate,small molecule,approved,CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1,NPUKDXXFDDZOKR-LLVKDONJSA-N,244.289,P18089,BE0000572,Alpha-2B adrenergic receptor,Humans,agonist,yes
DB00292,Etomidate,small molecule,approved,CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1,NPUKDXXFDDZOKR-LLVKDONJSA-N,244.289,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB00293,Raltitrexed,small molecule,approved;investigational,CN(CC1=CC2=C(NC(C)=NC2=O)C=C1)C1=CC=C(S1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,IVTVGDXNLFLDRM-HNNXBMFYSA-N,458.488,P12461,BE0000021,Thymidylate synthase,Yeast,inhibitor,yes
DB00293,Raltitrexed,small molecule,approved;investigational,CN(CC1=CC2=C(NC(C)=NC2=O)C=C1)C1=CC=C(S1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,IVTVGDXNLFLDRM-HNNXBMFYSA-N,458.488,P04818,BE0000324,Thymidylate synthase,Humans,inhibitor,yes
DB00294,Etonogestrel,small molecule,approved;investigational,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC(=C)[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],GCKFUYQCUCGESZ-BPIQYHPVSA-N,324.4565,P06401,BE0000557,Progesterone receptor,Humans,agonist,yes
DB00295,Morphine,small molecule,approved;investigational,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,BQJCRHHNABKAKU-KBQPJGBKSA-N,285.3377,P35372,BE0000770,Mu-type opioid receptor,Humans,agonist;regulator,yes
DB00295,Morphine,small molecule,approved;investigational,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,BQJCRHHNABKAKU-KBQPJGBKSA-N,285.3377,P41145,BE0000632,Kappa-type opioid receptor,Humans,agonist,yes
DB00295,Morphine,small molecule,approved;investigational,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,BQJCRHHNABKAKU-KBQPJGBKSA-N,285.3377,P41143,BE0000420,Delta-type opioid receptor,Humans,agonist,yes
DB00296,Ropivacaine,small molecule,approved,CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C,ZKMNUMMKYBVTFN-HNNXBMFYSA-N,274.4011,Q9Y5Y9,BE0000177,Sodium channel protein type 10 subunit alpha,Humans,inhibitor,yes
DB00297,Bupivacaine,small molecule,approved;investigational,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,LEBVLXFERQHONN-UHFFFAOYSA-N,288.4277,Q9Y5Y9,BE0000177,Sodium channel protein type 10 subunit alpha,Humans,inhibitor,yes
DB00298,Dapiprazole,small molecule,approved,CC1=CC=CC=C1N1CCN(CCC2=NN=C3CCCCN23)CC1,RFWZESUMWJKKRN-UHFFFAOYSA-N,325.4512,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB00298,Dapiprazole,small molecule,approved,CC1=CC=CC=C1N1CCN(CCC2=NN=C3CCCCN23)CC1,RFWZESUMWJKKRN-UHFFFAOYSA-N,325.4512,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,antagonist,yes
DB00298,Dapiprazole,small molecule,approved,CC1=CC=CC=C1N1CCN(CCC2=NN=C3CCCCN23)CC1,RFWZESUMWJKKRN-UHFFFAOYSA-N,325.4512,P25100,BE0000715,Alpha-1D adrenergic receptor,Humans,antagonist,yes
DB00298,Dapiprazole,small molecule,approved,CC1=CC=CC=C1N1CCN(CCC2=NN=C3CCCCN23)CC1,RFWZESUMWJKKRN-UHFFFAOYSA-N,325.4512,P35368,BE0000575,Alpha-1B adrenergic receptor,Humans,antagonist,yes
DB00299,Penciclovir,small molecule,approved,NC1=NC(=O)C2=C(N1)N(CCC(CO)CO)C=N2,JNTOCHDNEULJHD-UHFFFAOYSA-N,253.2578,P04183,BE0001260,"Thymidine kinase, cytosolic",Humans,inhibitor,yes
DB00299,Penciclovir,small molecule,approved,NC1=NC(=O)C2=C(N1)N(CCC(CO)CO)C=N2,JNTOCHDNEULJHD-UHFFFAOYSA-N,253.2578,P04293,BE0000308,DNA polymerase catalytic subunit,HHV-1,inhibitor,yes
DB00299,Penciclovir,small molecule,approved,NC1=NC(=O)C2=C(N1)N(CCC(CO)CO)C=N2,JNTOCHDNEULJHD-UHFFFAOYSA-N,253.2578,P06478,BE0000514,Thymidine kinase,,inducer,yes
DB00300,Tenofovir disoproxil,small molecule,approved;investigational,[H][C@@](C)(CN1C=NC2=C(N)N=CN=C12)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C,JFVZFKDSXNQEJW-CQSZACIVSA-N,519.448,P03366,BE0002050,Gag-Pol polyprotein,,modulator,yes
DB00300,Tenofovir disoproxil,small molecule,approved;investigational,[H][C@@](C)(CN1C=NC2=C(N)N=CN=C12)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C,JFVZFKDSXNQEJW-CQSZACIVSA-N,519.448,Q72547,BE0004136,Reverse transcriptase/RNaseH,Human immunodeficiency virus 1,inhibitor,yes
DB00301,Flucloxacillin,small molecule,approved;investigational,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=C(Cl)C=CC=C1F)C(O)=O,UIOFUWFRIANQPC-JKIFEVAISA-N,453.872,Q8XJ01,BE0000576,Penicillin-binding protein 1A,Clostridium perfringens (strain 13 / Type A),inhibitor,yes
DB00302,Tranexamic acid,small molecule,approved,NC[C@H]1CC[C@@H](CC1)C(O)=O,GYDJEQRTZSCIOI-LJGSYFOKSA-N,157.2102,P00747,BE0000211,Plasminogen,Humans,inhibitor,yes
DB00303,Ertapenem,small molecule,approved;investigational,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,JUZNIMUFDBIJCM-ANEDZVCMSA-N,475.515,P02918,BE0000588,Penicillin-binding protein 1A,Escherichia coli (strain K12),inhibitor,yes
DB00303,Ertapenem,small molecule,approved;investigational,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,JUZNIMUFDBIJCM-ANEDZVCMSA-N,475.515,P02919,BE0000488,Penicillin-binding protein 1B,Escherichia coli (strain K12),inhibitor,yes
DB00303,Ertapenem,small molecule,approved;investigational,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,JUZNIMUFDBIJCM-ANEDZVCMSA-N,475.515,P44469,BE0000103,Penicillin-binding protein 2,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd),inhibitor,yes
DB00303,Ertapenem,small molecule,approved;investigational,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,JUZNIMUFDBIJCM-ANEDZVCMSA-N,475.515,P0AD65,BE0003579,Penicillin-binding protein 2,Escherichia coli (strain K12),inhibitor,yes
DB00303,Ertapenem,small molecule,approved;investigational,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,JUZNIMUFDBIJCM-ANEDZVCMSA-N,475.515,P45059,BE0000001,Peptidoglycan synthase FtsI,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd),inhibitor,yes
DB00303,Ertapenem,small molecule,approved;investigational,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,JUZNIMUFDBIJCM-ANEDZVCMSA-N,475.515,P0AD68,BE0002393,Peptidoglycan synthase FtsI,Escherichia coli (strain K12),inhibitor,yes
DB00303,Ertapenem,small molecule,approved;investigational,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,JUZNIMUFDBIJCM-ANEDZVCMSA-N,475.515,P24228,BE0000744,D-alanyl-D-alanine carboxypeptidase DacB,Escherichia coli (strain K12),inhibitor,yes
DB00303,Ertapenem,small molecule,approved;investigational,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,JUZNIMUFDBIJCM-ANEDZVCMSA-N,475.515,P08506,BE0003685,D-alanyl-D-alanine carboxypeptidase DacC,Escherichia coli (strain K12),inhibitor,yes
DB00304,Desogestrel,small molecule,approved,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC(=C)[C@]1([H])[C@@]3([H])CCCC=C3CC[C@@]21[H],RPLCPCMSCLEKRS-BPIQYHPVSA-N,310.473,P06401,BE0000557,Progesterone receptor,Humans,agonist,yes
DB00304,Desogestrel,small molecule,approved,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC(=C)[C@]1([H])[C@@]3([H])CCCC=C3CC[C@@]21[H],RPLCPCMSCLEKRS-BPIQYHPVSA-N,310.473,P03372,BE0000123,Estrogen receptor,Humans,agonist,yes
DB00305,Mitomycin,small molecule,approved,[H][C@]12CN3C4=C([C@@H](COC(N)=O)[C@@]3(OC)[C@@]1([H])N2)C(=O)C(N)=C(C)C4=O,NWIBSHFKIJFRCO-WUDYKRTCSA-N,334.3272,,BE0004796,DNA,Humans,cross-linking/alkylation,yes
DB00306,Talbutal,small molecule,approved;illicit,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,BJVVMKUXKQHWJK-UHFFFAOYSA-N,224.2563,P47869,BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,Humans,potentiator,yes
DB00306,Talbutal,small molecule,approved;illicit,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,BJVVMKUXKQHWJK-UHFFFAOYSA-N,224.2563,Q99928,BE0003594,Gamma-aminobutyric acid receptor subunit gamma-3,Humans,modulator,yes
DB00306,Talbutal,small molecule,approved;illicit,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,BJVVMKUXKQHWJK-UHFFFAOYSA-N,224.2563,P34903,BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,Humans,potentiator,yes
DB00306,Talbutal,small molecule,approved;illicit,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,BJVVMKUXKQHWJK-UHFFFAOYSA-N,224.2563,P48169,BE0000478,Gamma-aminobutyric acid receptor subunit alpha-4,Humans,potentiator,yes
DB00306,Talbutal,small molecule,approved;illicit,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,BJVVMKUXKQHWJK-UHFFFAOYSA-N,224.2563,P31644,BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,Humans,potentiator,yes
DB00306,Talbutal,small molecule,approved;illicit,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,BJVVMKUXKQHWJK-UHFFFAOYSA-N,224.2563,Q16445,BE0000764,Gamma-aminobutyric acid receptor subunit alpha-6,Humans,potentiator,yes
DB00306,Talbutal,small molecule,approved;illicit,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,BJVVMKUXKQHWJK-UHFFFAOYSA-N,224.2563,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB00306,Talbutal,small molecule,approved;illicit,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,BJVVMKUXKQHWJK-UHFFFAOYSA-N,224.2563,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,potentiator,yes
DB00307,Bexarotene,small molecule,approved;investigational,CC1=CC2=C(C=C1C(=C)C1=CC=C(C=C1)C(O)=O)C(C)(C)CCC2(C)C,NAVMQTYZDKMPEU-UHFFFAOYSA-N,348.4779,P19793,BE0000412,Retinoic acid receptor RXR-alpha,Humans,agonist,yes
DB00307,Bexarotene,small molecule,approved;investigational,CC1=CC2=C(C=C1C(=C)C1=CC=C(C=C1)C(O)=O)C(C)(C)CCC2(C)C,NAVMQTYZDKMPEU-UHFFFAOYSA-N,348.4779,P28702,BE0000078,Retinoic acid receptor RXR-beta,Humans,agonist,yes
DB00307,Bexarotene,small molecule,approved;investigational,CC1=CC2=C(C=C1C(=C)C1=CC=C(C=C1)C(O)=O)C(C)(C)CCC2(C)C,NAVMQTYZDKMPEU-UHFFFAOYSA-N,348.4779,P48443,BE0000707,Retinoic acid receptor RXR-gamma,Humans,agonist,yes
DB00308,Ibutilide,small molecule,approved,CCCCCCCN(CC)CCCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,ALOBUEHUHMBRLE-UHFFFAOYSA-N,384.576,Q13936,BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,Humans,activator,yes
DB00308,Ibutilide,small molecule,approved,CCCCCCCN(CC)CCCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,ALOBUEHUHMBRLE-UHFFFAOYSA-N,384.576,Q02641,BE0000303,Voltage-dependent L-type calcium channel subunit beta-1,Humans,activator,yes
DB00308,Ibutilide,small molecule,approved,CCCCCCCN(CC)CCCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,ALOBUEHUHMBRLE-UHFFFAOYSA-N,384.576,Q12809,BE0000090,Voltage-gated inwardly rectifying potassium channel KCNH2,Humans,inhibitor,yes
DB00309,Vindesine,small molecule,approved;investigational,[H][C@@]12N3CC[C@@]11C4=CC(=C(OC)C=C4N(C)[C@@]1([H])[C@](O)([C@H](O)[C@]2(CC)C=CC3)C(N)=O)[C@]1(C[C@@]2([H])CN(C[C@](O)(CC)C2)CCC2=C1NC1=C2C=CC=C1)C(=O)OC,HHJUWIANJFBDHT-ZVTSDNJWSA-N,753.941,Q9H4B7,BE0000026,Tubulin beta-1 chain,Humans,inhibitor,yes
DB00310,Chlorthalidone,small molecule,approved,NS(=O)(=O)C1=C(Cl)C=CC(=C1)C1(O)NC(=O)C2=CC=CC=C12,JIVPVXMEBJLZRO-UHFFFAOYSA-N,338.766,P00915,BE0000267,Carbonic anhydrase 1,Humans,inhibitor,yes
DB00310,Chlorthalidone,small molecule,approved,NS(=O)(=O)C1=C(Cl)C=CC(=C1)C1(O)NC(=O)C2=CC=CC=C12,JIVPVXMEBJLZRO-UHFFFAOYSA-N,338.766,Q13621,BE0000502,Solute carrier family 12 member 1,Humans,inhibitor,yes
DB00311,Ethoxzolamide,small molecule,withdrawn,CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O,OUZWUKMCLIBBOG-UHFFFAOYSA-N,258.317,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB00311,Ethoxzolamide,small molecule,withdrawn,CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O,OUZWUKMCLIBBOG-UHFFFAOYSA-N,258.317,P22748,BE0000535,Carbonic anhydrase 4,Humans,inhibitor,yes
DB00311,Ethoxzolamide,small molecule,withdrawn,CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O,OUZWUKMCLIBBOG-UHFFFAOYSA-N,258.317,P43166,BE0003629,Carbonic anhydrase 7,Humans,inhibitor,yes
DB00311,Ethoxzolamide,small molecule,withdrawn,CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O,OUZWUKMCLIBBOG-UHFFFAOYSA-N,258.317,P00915,BE0000267,Carbonic anhydrase 1,Humans,inhibitor,yes
DB00312,Pentobarbital,small molecule,approved;investigational;vet_approved,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,226.2722,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,potentiator,yes
DB00312,Pentobarbital,small molecule,approved;investigational;vet_approved,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,226.2722,P47869,BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,Humans,potentiator,yes
DB00312,Pentobarbital,small molecule,approved;investigational;vet_approved,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,226.2722,P34903,BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,Humans,potentiator,yes
DB00312,Pentobarbital,small molecule,approved;investigational;vet_approved,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,226.2722,P48169,BE0000478,Gamma-aminobutyric acid receptor subunit alpha-4,Humans,potentiator,yes
DB00312,Pentobarbital,small molecule,approved;investigational;vet_approved,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,226.2722,P31644,BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,Humans,potentiator,yes
DB00312,Pentobarbital,small molecule,approved;investigational;vet_approved,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,226.2722,Q16445,BE0000764,Gamma-aminobutyric acid receptor subunit alpha-6,Humans,potentiator,yes
DB00312,Pentobarbital,small molecule,approved;investigational;vet_approved,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,226.2722,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB00313,Valproic acid,small molecule,approved;investigational,CCCC(CCC)C(O)=O,NIJJYAXOARWZEE-UHFFFAOYSA-N,144.2114,P80404,BE0000253,"4-aminobutyrate aminotransferase, mitochondrial",Humans,inhibitor,yes
DB00313,Valproic acid,small molecule,approved;investigational,CCCC(CCC)C(O)=O,NIJJYAXOARWZEE-UHFFFAOYSA-N,144.2114,P49840,BE0009446,Glycogen synthase kinase-3 alpha,Humans,inhibitor,yes
DB00313,Valproic acid,small molecule,approved;investigational,CCCC(CCC)C(O)=O,NIJJYAXOARWZEE-UHFFFAOYSA-N,144.2114,Q9UKV0,BE0000881,Histone deacetylase 9,Humans,inhibitor,yes
DB00314,Capreomycin,small molecule,approved,[H][C@@]1(CCN=C(N)N1)[C@]1([H])NC(=O)\C(NC(=O)[C@H](CNC(=O)C[C@@H](N)CCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)CNC1=O)=C/NC(N)=O.[H][C@@]1(CCN=C(N)N1)[C@]1([H])NC(=O)\C(NC(=O)[C@H](CNC(=O)C[C@@H](N)CCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CNC1=O)=C/NC(N)=O,VCOPTHOUUNAYKQ-WBTCAYNUSA-N,1321.4123,P9WJ63,BE0009727,16S/23S rRNA (cytidine-2'-O)-methyltransferase TlyA,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),inhibitor,yes
DB00315,Zolmitriptan,small molecule,approved;investigational,CN(C)CCC1=CNC2=CC=C(C[C@H]3COC(=O)N3)C=C12,ULSDMUVEXKOYBU-ZDUSSCGKSA-N,287.3568,P28222,BE0000797,5-hydroxytryptamine receptor 1B,Humans,agonist,yes
DB00315,Zolmitriptan,small molecule,approved;investigational,CN(C)CCC1=CNC2=CC=C(C[C@H]3COC(=O)N3)C=C12,ULSDMUVEXKOYBU-ZDUSSCGKSA-N,287.3568,P28221,BE0000659,5-hydroxytryptamine receptor 1D,Humans,agonist,yes
DB00315,Zolmitriptan,small molecule,approved;investigational,CN(C)CCC1=CNC2=CC=C(C[C@H]3COC(=O)N3)C=C12,ULSDMUVEXKOYBU-ZDUSSCGKSA-N,287.3568,P30939,BE0000460,5-hydroxytryptamine receptor 1F,Humans,agonist,yes
DB00316,Acetaminophen,small molecule,approved,CC(=O)NC1=CC=C(O)C=C1,RZVAJINKPMORJF-UHFFFAOYSA-N,151.1626,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB00316,Acetaminophen,small molecule,approved,CC(=O)NC1=CC=C(O)C=C1,RZVAJINKPMORJF-UHFFFAOYSA-N,151.1626,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB00316,Acetaminophen,small molecule,approved,CC(=O)NC1=CC=C(O)C=C1,RZVAJINKPMORJF-UHFFFAOYSA-N,151.1626,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,inhibitor,yes
DB00316,Acetaminophen,small molecule,approved,CC(=O)NC1=CC=C(O)C=C1,RZVAJINKPMORJF-UHFFFAOYSA-N,151.1626,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB00317,Gefitinib,small molecule,approved;investigational,COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1,XGALLCVXEZPNRQ-UHFFFAOYSA-N,446.902,P00533,BE0000767,Epidermal growth factor receptor,Humans,antagonist,yes
DB00318,Codeine,small molecule,approved;illicit,[H][C@]12C=C[C@H](O)[C@@H]3OC4=C5C(C[C@H]1N(C)CC[C@@]235)=CC=C4OC,OROGSEYTTFOCAN-DNJOTXNNSA-N,299.3642,P35372,BE0000770,Mu-type opioid receptor,Humans,agonist;regulator,yes
DB00318,Codeine,small molecule,approved;illicit,[H][C@]12C=C[C@H](O)[C@@H]3OC4=C5C(C[C@H]1N(C)CC[C@@]235)=CC=C4OC,OROGSEYTTFOCAN-DNJOTXNNSA-N,299.3642,P41145,BE0000632,Kappa-type opioid receptor,Humans,agonist,yes
DB00318,Codeine,small molecule,approved;illicit,[H][C@]12C=C[C@H](O)[C@@H]3OC4=C5C(C[C@H]1N(C)CC[C@@]235)=CC=C4OC,OROGSEYTTFOCAN-DNJOTXNNSA-N,299.3642,P41143,BE0000420,Delta-type opioid receptor,Humans,agonist,yes
DB00319,Piperacillin,small molecule,approved,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](NC(=O)N1CCN(CC)C(=O)C1=O)C1=CC=CC=C1)C(O)=O,IVBHGBMCVLDMKU-GXNBUGAJSA-N,517.555,Q75Y35,BE0004643,Penicillin-binding protein 3,Streptococcus pneumoniae,inhibitor,yes
DB00319,Piperacillin,small molecule,approved,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](NC(=O)N1CCN(CC)C(=O)C1=O)C1=CC=CC=C1)C(O)=O,IVBHGBMCVLDMKU-GXNBUGAJSA-N,517.555,P0A3M6,BE0003624,Penicillin-binding protein 2B,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB00319,Piperacillin,small molecule,approved,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](NC(=O)N1CCN(CC)C(=O)C1=O)C1=CC=CC=C1)C(O)=O,IVBHGBMCVLDMKU-GXNBUGAJSA-N,517.555,Q8DNB6,BE0004644,Penicillin-binding protein 2a,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB00319,Piperacillin,small molecule,approved,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](NC(=O)N1CCN(CC)C(=O)C1=O)C1=CC=CC=C1)C(O)=O,IVBHGBMCVLDMKU-GXNBUGAJSA-N,517.555,Q7CRA4,BE0004335,Penicillin-binding protein 1b,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB00320,Dihydroergotamine,small molecule,approved;investigational,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O,LUZRJRNZXALNLM-JGRZULCMSA-N,583.6774,P28222,BE0000797,5-hydroxytryptamine receptor 1B,Humans,agonist,yes
DB00320,Dihydroergotamine,small molecule,approved;investigational,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O,LUZRJRNZXALNLM-JGRZULCMSA-N,583.6774,P28221,BE0000659,5-hydroxytryptamine receptor 1D,Humans,agonist,yes
DB00320,Dihydroergotamine,small molecule,approved;investigational,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O,LUZRJRNZXALNLM-JGRZULCMSA-N,583.6774,P30939,BE0000460,5-hydroxytryptamine receptor 1F,Humans,agonist,yes
DB00320,Dihydroergotamine,small molecule,approved;investigational,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O,LUZRJRNZXALNLM-JGRZULCMSA-N,583.6774,P14416,BE0000756,D(2) dopamine receptor,Humans,agonist,yes
DB00321,Amitriptyline,small molecule,approved,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,KRMDCWKBEZIMAB-UHFFFAOYSA-N,277.4033,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,inhibitor,yes
DB00321,Amitriptyline,small molecule,approved,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,KRMDCWKBEZIMAB-UHFFFAOYSA-N,277.4033,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB00321,Amitriptyline,small molecule,approved,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,KRMDCWKBEZIMAB-UHFFFAOYSA-N,277.4033,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB00322,Floxuridine,small molecule,approved,OC[C@H]1O[C@H](C[C@@H]1O)N1C=C(F)C(=O)NC1=O,ODKNJVUHOIMIIZ-RRKCRQDMSA-N,246.1924,P12461,BE0000021,Thymidylate synthase,Yeast,inhibitor,yes
DB00322,Floxuridine,small molecule,approved,OC[C@H]1O[C@H](C[C@@H]1O)N1C=C(F)C(=O)NC1=O,ODKNJVUHOIMIIZ-RRKCRQDMSA-N,246.1924,P04818,BE0000324,Thymidylate synthase,Humans,inhibitor,yes
DB00323,Tolcapone,small molecule,approved;withdrawn,CC1=CC=C(C=C1)C(=O)C1=CC(=C(O)C(O)=C1)[N+]([O-])=O,MIQPIUSUKVNLNT-UHFFFAOYSA-N,273.2408,P21964,BE0002089,Catechol O-methyltransferase,Humans,inhibitor,yes
DB00324,Fluorometholone,small molecule,approved;investigational,[H][C@@]12CC[C@](O)(C(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,FAOZLTXFLGPHNG-KNAQIMQKSA-N,376.4617,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB00325,Nitroprusside,small molecule,approved;investigational,O=N[Fe--](C#N)(C#N)(C#N)(C#N)C#N,ASPOIVQEUUCDQT-UHFFFAOYSA-N,215.938,Q02108,BE0010061,Guanylate cyclase soluble subunit alpha-1,Humans,modulator,yes
DB00325,Nitroprusside,small molecule,approved;investigational,O=N[Fe--](C#N)(C#N)(C#N)(C#N)C#N,ASPOIVQEUUCDQT-UHFFFAOYSA-N,215.938,Q02153,BE0010029,Guanylate cyclase soluble subunit beta-1,Humans,modulator,yes
DB00325,Nitroprusside,small molecule,approved;investigational,O=N[Fe--](C#N)(C#N)(C#N)(C#N)C#N,ASPOIVQEUUCDQT-UHFFFAOYSA-N,215.938,P16066,BE0000556,Atrial natriuretic peptide receptor 1,Humans,agonist,yes
DB00327,Hydromorphone,small molecule,approved;illicit,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])CCC2=O,WVLOADHCBXTIJK-YNHQPCIGSA-N,285.3377,P35372,BE0000770,Mu-type opioid receptor,Humans,agonist,yes
DB00327,Hydromorphone,small molecule,approved;illicit,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])CCC2=O,WVLOADHCBXTIJK-YNHQPCIGSA-N,285.3377,P41143,BE0000420,Delta-type opioid receptor,Humans,partial agonist,yes
DB00327,Hydromorphone,small molecule,approved;illicit,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])CCC2=O,WVLOADHCBXTIJK-YNHQPCIGSA-N,285.3377,P41145,BE0000632,Kappa-type opioid receptor,Humans,agonist,yes
DB00328,Indomethacin,small molecule,approved;investigational,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O,CGIGDMFJXJATDK-UHFFFAOYSA-N,357.788,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB00328,Indomethacin,small molecule,approved;investigational,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O,CGIGDMFJXJATDK-UHFFFAOYSA-N,357.788,P14555,BE0001640,"Phospholipase A2, membrane associated",Humans,inhibitor,yes
DB00328,Indomethacin,small molecule,approved;investigational,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O,CGIGDMFJXJATDK-UHFFFAOYSA-N,357.788,P23219,BE0010085,Human Cyclooxygenases,Humans,inhibitor,yes
DB00330,Ethambutol,small molecule,approved,CC[C@@H](CO)NCCN[C@@H](CC)CO,AEUTYOVWOVBAKS-UWVGGRQHSA-N,204.3098,P9WNL5,BE0000591,Probable arabinosyltransferase C,Mycobacterium tuberculosis,inhibitor,yes
DB00330,Ethambutol,small molecule,approved,CC[C@@H](CO)NCCN[C@@H](CC)CO,AEUTYOVWOVBAKS-UWVGGRQHSA-N,204.3098,P9WNL7,BE0000122,Probable arabinosyltransferase B,Mycobacterium tuberculosis,inhibitor,yes
DB00330,Ethambutol,small molecule,approved,CC[C@@H](CO)NCCN[C@@H](CC)CO,AEUTYOVWOVBAKS-UWVGGRQHSA-N,204.3098,P9WNL9,BE0000034,Probable arabinosyltransferase A,Mycobacterium tuberculosis,inhibitor,yes
DB00331,Metformin,small molecule,approved,CN(C)C(=N)NC(N)=N,XZWYZXLIPXDOLR-UHFFFAOYSA-N,129.1636,Q96FL8,BE0003657,Multidrug and toxin extrusion protein 1,Humans,modulator,yes
DB00331,Metformin,small molecule,approved,CN(C)C(=N)NC(N)=N,XZWYZXLIPXDOLR-UHFFFAOYSA-N,129.1636,O00763,BE0000702,Acetyl-CoA carboxylase 2,Humans,activator,yes
DB00331,Metformin,small molecule,approved,CN(C)C(=N)NC(N)=N,XZWYZXLIPXDOLR-UHFFFAOYSA-N,129.1636,Q16134,BE0003887,"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial",Humans,inhibitor,yes
DB00331,Metformin,small molecule,approved,CN(C)C(=N)NC(N)=N,XZWYZXLIPXDOLR-UHFFFAOYSA-N,129.1636,Q9Y478,BE0000254,5'-AMP-activated protein kinase subunit beta-1,Humans,inducer;activator,yes
DB00332,Ipratropium,small molecule,approved;experimental,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(CO)C1=CC=CC=C1)[N+]2(C)C(C)C,OEXHQOGQTVQTAT-BHIXFJMTSA-N,332.463,P20309,BE0000045,Muscarinic acetylcholine receptor M3,Humans,antagonist,yes
DB00332,Ipratropium,small molecule,approved;experimental,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(CO)C1=CC=CC=C1)[N+]2(C)C(C)C,OEXHQOGQTVQTAT-BHIXFJMTSA-N,332.463,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,antagonist,yes
DB00332,Ipratropium,small molecule,approved;experimental,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(CO)C1=CC=CC=C1)[N+]2(C)C(C)C,OEXHQOGQTVQTAT-BHIXFJMTSA-N,332.463,P08172,BE0000560,Muscarinic acetylcholine receptor M2,Humans,antagonist,yes
DB00333,Methadone,small molecule,approved,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,USSIQXCVUWKGNF-UHFFFAOYSA-N,309.4452,P35372,BE0000770,Mu-type opioid receptor,Humans,agonist,yes
DB00333,Methadone,small molecule,approved,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,USSIQXCVUWKGNF-UHFFFAOYSA-N,309.4452,Q05586,BE0004956,NMDA receptor,Humans,antagonist,yes
DB00333,Methadone,small molecule,approved,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,USSIQXCVUWKGNF-UHFFFAOYSA-N,309.4452,P41143,BE0000420,Delta-type opioid receptor,Humans,agonist,yes
DB00333,Methadone,small molecule,approved,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,USSIQXCVUWKGNF-UHFFFAOYSA-N,309.4452,P36544,BE0002341,Neuronal acetylcholine receptor subunit alpha-7,Humans,agonist,yes
DB00334,Olanzapine,small molecule,approved;investigational,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,KVWDHTXUZHCGIO-UHFFFAOYSA-N,312.432,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB00334,Olanzapine,small molecule,approved;investigational,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,KVWDHTXUZHCGIO-UHFFFAOYSA-N,312.432,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB00335,Atenolol,small molecule,approved,CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1,METKIMKYRPQLGS-UHFFFAOYSA-N,266.3361,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,antagonist,yes
DB00336,Nitrofural,small molecule,approved;investigational;vet_approved;withdrawn,NC(=O)N\N=C\C1=CC=C(O1)[N+]([O-])=O,IAIWVQXQOWNYOU-FPYGCLRLSA-N,198.1362,P06715,BE0000298,Glutathione reductase,Escherichia coli (strain K12),inhibitor,yes
DB00337,Pimecrolimus,small molecule,approved;investigational,[H][C@]1(CC[C@H](Cl)[C@@H](C1)OC)\C=C(/C)[C@@]1([H])OC(=O)[C@]2([H])CCCCN2C(=O)C(=O)[C@]2(O)O[C@@]([H])([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC)C(=O)C[C@H](O)[C@H]1C)OC,KASDHRXLYQOAKZ-XDSKOBMDSA-N,810.46,Q08209,BE0004238,Protein phosphatase 3 catalytic subunit alpha,Humans,inhibitor,yes
DB00337,Pimecrolimus,small molecule,approved;investigational,[H][C@]1(CC[C@H](Cl)[C@@H](C1)OC)\C=C(/C)[C@@]1([H])OC(=O)[C@]2([H])CCCCN2C(=O)C(=O)[C@]2(O)O[C@@]([H])([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC)C(=O)C[C@H](O)[C@H]1C)OC,KASDHRXLYQOAKZ-XDSKOBMDSA-N,810.46,P42345,BE0002386,Serine/threonine-protein kinase mTOR,Humans,potentiator,yes
DB00338,Omeprazole,small molecule,approved;investigational;vet_approved,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,SUBDBMMJDZJVOS-UHFFFAOYSA-N,345.416,P20648,BE0000349,Potassium-transporting ATPase alpha chain 1,Humans,inhibitor,yes
DB00338,Omeprazole,small molecule,approved;investigational;vet_approved,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,SUBDBMMJDZJVOS-UHFFFAOYSA-N,345.416,P51164,BE0000619,Potassium-transporting ATPase subunit beta,Humans,modulator,yes
DB00339,Pyrazinamide,small molecule,approved;investigational,NC(=O)C1=NC=CN=C1,IPEHBUMCGVEMRF-UHFFFAOYSA-N,123.1127,P95029,BE0009744,Probable fatty acid synthase Fas (Fatty acid synthetase),Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),inhibitor,yes
DB00339,Pyrazinamide,small molecule,approved;investigational,NC(=O)C1=NC=CN=C1,IPEHBUMCGVEMRF-UHFFFAOYSA-N,123.1127,P9WGR1,BE0000332,Enoyl-[acyl-carrier-protein] reductase [NADH],Mycobacterium tuberculosis,inhibitor,yes
DB00340,Metixene,small molecule,approved,CN1CCCC(CC2C3=CC=CC=C3SC3=CC=CC=C23)C1,MJFJKKXQDNNUJF-UHFFFAOYSA-N,309.468,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,modulator,yes
DB00340,Metixene,small molecule,approved,CN1CCCC(CC2C3=CC=CC=C3SC3=CC=CC=C23)C1,MJFJKKXQDNNUJF-UHFFFAOYSA-N,309.468,P11229,BE0004890,Muscarinic acetylcholine receptor,Humans,antagonist,yes
DB00341,Cetirizine,small molecule,approved,OC(=O)COCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,ZKLPARSLTMPFCP-UHFFFAOYSA-N,388.888,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB00342,Terfenadine,small molecule,approved;withdrawn,CC(C)(C)C1=CC=C(C=C1)C(O)CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1,GUGOEEXESWIERI-UHFFFAOYSA-N,471.6734,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB00343,Diltiazem,small molecule,approved;investigational,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,HSUGRBWQSSZJOP-RTWAWAEBSA-N,414.518,Q13936,BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,Humans,blocker,yes
DB00343,Diltiazem,small molecule,approved;investigational,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,HSUGRBWQSSZJOP-RTWAWAEBSA-N,414.518,P54289,BE0000691,Voltage-dependent calcium channel subunit alpha-2/delta-1,Humans,blocker,yes
DB00343,Diltiazem,small molecule,approved;investigational,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,HSUGRBWQSSZJOP-RTWAWAEBSA-N,414.518,Q06432,BE0000679,Voltage-dependent calcium channel gamma-1 subunit,Humans,blocker,yes
DB00344,Protriptyline,small molecule,approved,CNCCCC1C2=CC=CC=C2C=CC2=CC=CC=C12,BWPIARFWQZKAIA-UHFFFAOYSA-N,263.3767,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,inhibitor,yes
DB00344,Protriptyline,small molecule,approved,CNCCCC1C2=CC=CC=C2C=CC2=CC=CC=C12,BWPIARFWQZKAIA-UHFFFAOYSA-N,263.3767,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB00345,Aminohippuric acid,small molecule,approved;investigational,NC1=CC=C(C=C1)C(=O)NCC(O)=O,HSMNQINEKMPTIC-UHFFFAOYSA-N,194.1873,Q8TCC7,BE0003645,Organic anion transporter 3,Humans,inhibitor,yes
DB00346,Alfuzosin,small molecule,approved;investigational,COC1=CC2=C(C=C1OC)C(N)=NC(=N2)N(C)CCCNC(=O)C1CCCO1,WNMJYKCGWZFFKR-UHFFFAOYSA-N,389.4488,P35348,BE0004863,Alpha-1 adrenergic receptors,Humans,antagonist,yes
DB00346,Alfuzosin,small molecule,approved;investigational,COC1=CC2=C(C=C1OC)C(N)=NC(=N2)N(C)CCCNC(=O)C1CCCO1,WNMJYKCGWZFFKR-UHFFFAOYSA-N,389.4488,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,antagonist,yes
DB00346,Alfuzosin,small molecule,approved;investigational,COC1=CC2=C(C=C1OC)C(N)=NC(=N2)N(C)CCCNC(=O)C1CCCO1,WNMJYKCGWZFFKR-UHFFFAOYSA-N,389.4488,P35368,BE0000575,Alpha-1B adrenergic receptor,Humans,antagonist,yes
DB00346,Alfuzosin,small molecule,approved;investigational,COC1=CC2=C(C=C1OC)C(N)=NC(=N2)N(C)CCCNC(=O)C1CCCO1,WNMJYKCGWZFFKR-UHFFFAOYSA-N,389.4488,P25100,BE0000715,Alpha-1D adrenergic receptor,Humans,antagonist,yes
DB00347,Trimethadione,small molecule,approved,CN1C(=O)OC(C)(C)C1=O,IRYJRGCIQBGHIV-UHFFFAOYSA-N,143.1406,O43497,BE0000483,Voltage-dependent T-type calcium channel subunit alpha-1G,Humans,inhibitor,yes
DB00348,Nitisinone,small molecule,approved;investigational,[O-][N+](=O)C1=C(C=CC(=C1)C(F)(F)F)C(=O)C1C(=O)CCCC1=O,OUBCNLGXQFSTLU-UHFFFAOYSA-N,329.2281,P32754,BE0000455,4-hydroxyphenylpyruvate dioxygenase,Humans,inhibitor,yes
DB00349,Clobazam,small molecule,approved;illicit,CN1C2=C(C=C(Cl)C=C2)N(C2=CC=CC=C2)C(=O)CC1=O,CXOXHMZGEKVPMT-UHFFFAOYSA-N,300.74,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB00349,Clobazam,small molecule,approved;illicit,CN1C2=C(C=C(Cl)C=C2)N(C2=CC=CC=C2)C(=O)CC1=O,CXOXHMZGEKVPMT-UHFFFAOYSA-N,300.74,Q99928,BE0003594,Gamma-aminobutyric acid receptor subunit gamma-3,Humans,modulator,yes
DB00349,Clobazam,small molecule,approved;illicit,CN1C2=C(C=C(Cl)C=C2)N(C2=CC=CC=C2)C(=O)CC1=O,CXOXHMZGEKVPMT-UHFFFAOYSA-N,300.74,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,antagonist,yes
DB00349,Clobazam,small molecule,approved;illicit,CN1C2=C(C=C(Cl)C=C2)N(C2=CC=CC=C2)C(=O)CC1=O,CXOXHMZGEKVPMT-UHFFFAOYSA-N,300.74,P14867,BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,Humans,ligand,yes
DB00350,Minoxidil,small molecule,approved;investigational,NC1=CC(=NC(N)=[N+]1[O-])N1CCCCC1,ZFMITUMMTDLWHR-UHFFFAOYSA-N,209.2483,P48048,BE0000644,ATP-sensitive inward rectifier potassium channel 1,Humans,inducer,yes
DB00351,Megestrol acetate,small molecule,approved;investigational;vet_approved,[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C=C(C)C2=CC(=O)CC[C@]12C,RQZAXGRLVPAYTJ-GQFGMJRRSA-N,384.516,P06401,BE0000557,Progesterone receptor,Humans,agonist,yes
DB00352,Tioguanine,small molecule,approved,NC1=NC(=S)C2=C(N1)N=CN2,WYWHKKSPHMUBEB-UHFFFAOYSA-N,167.192,,BE0004796,DNA,Humans,intercalation,yes
DB00353,Methylergometrine,small molecule,approved,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO,UNBRKDKAWYKMIV-QWQRMKEZSA-N,339.4314,P21728,BE0000020,D(1A) dopamine receptor,Humans,antagonist,yes
DB00354,Buclizine,small molecule,approved,CC(C)(C)C1=CC=C(CN2CCN(CC2)C(C2=CC=CC=C2)C2=CC=C(Cl)C=C2)C=C1,MOYGZHXDRJNJEP-UHFFFAOYSA-N,433.028,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB00354,Buclizine,small molecule,approved,CC(C)(C)C1=CC=C(CN2CCN(CC2)C(C2=CC=CC=C2)C2=CC=C(Cl)C=C2)C=C1,MOYGZHXDRJNJEP-UHFFFAOYSA-N,433.028,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,antagonist,yes
DB00355,Aztreonam,small molecule,approved,C[C@H]1[C@H](NC(=O)C(=N/OC(C)(C)C(=O)O)\C2=CSC([NH3+])=N2)C(=O)N1S([O-])(=O)=O,WZPBZJONDBGPKJ-VEHQQRBSSA-N,435.433,P42971,BE0000790,Penicillin-binding protein 3,Bacillus subtilis (strain 168),inhibitor,yes
DB00355,Aztreonam,small molecule,approved,C[C@H]1[C@H](NC(=O)C(=N/OC(C)(C)C(=O)O)\C2=CSC([NH3+])=N2)C(=O)N1S([O-])(=O)=O,WZPBZJONDBGPKJ-VEHQQRBSSA-N,435.433,P0AD68,BE0002393,Peptidoglycan synthase FtsI,Escherichia coli (strain K12),binder,yes
DB00355,Aztreonam,small molecule,approved,C[C@H]1[C@H](NC(=O)C(=N/OC(C)(C)C(=O)O)\C2=CSC([NH3+])=N2)C(=O)N1S([O-])(=O)=O,WZPBZJONDBGPKJ-VEHQQRBSSA-N,435.433,P05193,BE0001444,Beta-lactamase,Citrobacter freundii,potentiator,yes
DB00356,Chlorzoxazone,small molecule,approved,ClC1=CC2=C(OC(=O)N2)C=C1,TZFWDZFKRBELIQ-UHFFFAOYSA-N,169.565,Q12791,BE0000553,Calcium-activated potassium channel subunit alpha-1,Humans,inhibitor,yes
DB00357,Aminoglutethimide,small molecule,approved;investigational,CCC1(CCC(=O)NC1=O)C1=CC=C(N)C=C1,ROBVIMPUHSLWNV-UHFFFAOYSA-N,232.2783,P05108,BE0003537,"Cholesterol side-chain cleavage enzyme, mitochondrial",Humans,inhibitor,yes
DB00357,Aminoglutethimide,small molecule,approved;investigational,CCC1(CCC(=O)NC1=O)C1=CC=C(N)C=C1,ROBVIMPUHSLWNV-UHFFFAOYSA-N,232.2783,P11511,BE0002090,Aromatase,Humans,inhibitor,yes
DB00358,Mefloquine,small molecule,approved;investigational,OC(C1CCCCN1)C1=CC(=NC2=C1C=CC=C2C(F)(F)F)C(F)(F)F,XEEQGYMUWCZPDN-UHFFFAOYSA-N,378.3122,,BE0004805,Fe(II)-protoporphyrin IX,Plasmodium falciparum,binder,yes
DB00358,Mefloquine,small molecule,approved;investigational,OC(C1CCCCN1)C1=CC(=NC2=C1C=CC=C2C(F)(F)F)C(F)(F)F,XEEQGYMUWCZPDN-UHFFFAOYSA-N,378.3122,,BE0009993,80S ribosomal subunit,Plasmodium falciparum,binder,yes
DB00359,Sulfadiazine,small molecule,approved;investigational;vet_approved,NC1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=N1,SEEPANYCNGTZFQ-UHFFFAOYSA-N,250.277,Q27738,BE0002360,Dihydropteroate synthetase,Plasmodium falciparum,inhibitor,yes
DB00359,Sulfadiazine,small molecule,approved;investigational;vet_approved,NC1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=N1,SEEPANYCNGTZFQ-UHFFFAOYSA-N,250.277,P0AC13,BE0000803,Dihydropteroate synthase,Escherichia coli (strain K12),inhibitor,yes
DB00360,Sapropterin,small molecule,approved;investigational,[H][C@@]1(CNC2=C(N1)C(=O)NC(N)=N2)[C@@H](O)[C@H](C)O,FNKQXYHWGSIFBK-RPDRRWSUSA-N,241.2471,P00439,BE0000753,Phenylalanine-4-hydroxylase,Humans,cofactor,yes
DB00360,Sapropterin,small molecule,approved;investigational,[H][C@@]1(CNC2=C(N1)C(=O)NC(N)=N2)[C@@H](O)[C@H](C)O,FNKQXYHWGSIFBK-RPDRRWSUSA-N,241.2471,P29474,BE0000263,Nitric oxide synthase 3,Humans,cofactor,yes
DB00360,Sapropterin,small molecule,approved;investigational,[H][C@@]1(CNC2=C(N1)C(=O)NC(N)=N2)[C@@H](O)[C@H](C)O,FNKQXYHWGSIFBK-RPDRRWSUSA-N,241.2471,P07101,BE0000614,Tyrosine 3-monooxygenase,Humans,cofactor,yes
DB00360,Sapropterin,small molecule,approved;investigational,[H][C@@]1(CNC2=C(N1)C(=O)NC(N)=N2)[C@@H](O)[C@H](C)O,FNKQXYHWGSIFBK-RPDRRWSUSA-N,241.2471,P17752,BE0000121,Tryptophan 5-hydroxylase 1,Humans,cofactor,yes
DB00361,Vinorelbine,small molecule,approved;investigational,[H][C@@]12N(C)C3=CC(OC)=C(C=C3[C@@]11CCN3CC=C[C@](CC)([C@@]13[H])[C@@]([H])(OC(C)=O)[C@]2(O)C(=O)OC)[C@]1(C[C@@]2([H])CN(CC(CC)=C2)CC2=C1NC1=CC=CC=C21)C(=O)OC,GBABOYUKABKIAF-IELIFDKJSA-N,778.947,P07437,BE0000143,Tubulin beta chain,Humans,antagonist;inhibitor,yes
DB00363,Clozapine,small molecule,approved,CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12,QZUDBNBUXVUHMW-UHFFFAOYSA-N,326.823,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB00363,Clozapine,small molecule,approved,CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12,QZUDBNBUXVUHMW-UHFFFAOYSA-N,326.823,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB00364,Sucralfate,small molecule,approved,O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@](COS(=O)(=O)O[Al](O)O)(O[C@H]2O[C@H](COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@H]2OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O,IPLJAZDIICJQEL-JTJNLBSYSA-A,1558.67,P0DJD9,BE0009737,Pepsin A-5,Humans,inhibitor,yes
DB00364,Sucralfate,small molecule,approved,O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@](COS(=O)(=O)O[Al](O)O)(O[C@H]2O[C@H](COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@H]2OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O,IPLJAZDIICJQEL-JTJNLBSYSA-A,1558.67,P09038,BE0001015,Fibroblast growth factor 2,Humans,agonist;inducer,yes
DB00364,Sucralfate,small molecule,approved,O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@](COS(=O)(=O)O[Al](O)O)(O[C@H]2O[C@H](COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@H]2OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O,IPLJAZDIICJQEL-JTJNLBSYSA-A,1558.67,P01133,BE0000953,Pro-epidermal growth factor,Humans,inducer,yes
DB00365,Grepafloxacin,small molecule,approved;investigational;withdrawn,CC1CN(CCN1)C1=C(F)C(C)=C2C(=O)C(=CN(C3CC3)C2=C1)C(O)=O,AIJTTZAVMXIJGM-UHFFFAOYSA-N,359.3947,P43700,BE0000366,DNA gyrase subunit A,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd),inhibitor,yes
DB00365,Grepafloxacin,small molecule,approved;investigational;withdrawn,CC1CN(CCN1)C1=C(F)C(C)=C2C(=O)C(=CN(C3CC3)C2=C1)C(O)=O,AIJTTZAVMXIJGM-UHFFFAOYSA-N,359.3947,P0A0K8,BE0002388,DNA gyrase subunit B,Staphylococcus aureus,modulator,yes
DB00365,Grepafloxacin,small molecule,approved;investigational;withdrawn,CC1CN(CCN1)C1=C(F)C(C)=C2C(=O)C(=CN(C3CC3)C2=C1)C(O)=O,AIJTTZAVMXIJGM-UHFFFAOYSA-N,359.3947,P20831,BE0008385,DNA gyrase subunit A,Staphylococcus aureus,modulator,yes
DB00365,Grepafloxacin,small molecule,approved;investigational;withdrawn,CC1CN(CCN1)C1=C(F)C(C)=C2C(=O)C(=CN(C3CC3)C2=C1)C(O)=O,AIJTTZAVMXIJGM-UHFFFAOYSA-N,359.3947,P43702,BE0000429,DNA topoisomerase 4 subunit A,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd),inhibitor,yes
DB00366,Doxylamine,small molecule,approved;vet_approved,CN(C)CCOC(C)(C1=CC=CC=C1)C1=CC=CC=N1,HCFDWZZGGLSKEP-UHFFFAOYSA-N,270.3694,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB00367,Levonorgestrel,small molecule,approved;investigational,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],WWYNJERNGUHSAO-XUDSTZEESA-N,312.4458,P06401,BE0000557,Progesterone receptor,Humans,modulator,yes
DB00367,Levonorgestrel,small molecule,approved;investigational,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],WWYNJERNGUHSAO-XUDSTZEESA-N,312.4458,P18405,BE0000539,3-oxo-5-alpha-steroid 4-dehydrogenase 1,Humans,inhibitor,yes
DB00368,Norepinephrine,small molecule,approved,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,169.1778,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,agonist,yes
DB00368,Norepinephrine,small molecule,approved,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,169.1778,P35368,BE0000575,Alpha-1B adrenergic receptor,Humans,agonist,yes
DB00368,Norepinephrine,small molecule,approved,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,169.1778,P25100,BE0000715,Alpha-1D adrenergic receptor,Humans,agonist,yes
DB00368,Norepinephrine,small molecule,approved,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,169.1778,P08913,BE0000289,Alpha-2A adrenergic receptor,Humans,agonist,yes
DB00368,Norepinephrine,small molecule,approved,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,169.1778,P18089,BE0000572,Alpha-2B adrenergic receptor,Humans,agonist,yes
DB00368,Norepinephrine,small molecule,approved,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,169.1778,P18825,BE0000342,Alpha-2C adrenergic receptor,Humans,agonist,yes
DB00368,Norepinephrine,small molecule,approved,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,169.1778,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,agonist,yes
DB00368,Norepinephrine,small molecule,approved,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,169.1778,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,agonist,yes
DB00368,Norepinephrine,small molecule,approved,NC[C@H](O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,169.1778,P13945,BE0001012,Beta-3 adrenergic receptor,Humans,agonist,yes
DB00369,Cidofovir,small molecule,approved,NC1=NC(=O)N(C[C@@H](CO)OCP(O)(O)=O)C=C1,VWFCHDSQECPREK-LURJTMIESA-N,279.187,P04293,BE0000308,DNA polymerase catalytic subunit,HHV-1,modulator,yes
DB00369,Cidofovir,small molecule,approved,NC1=NC(=O)N(C[C@@H](CO)OCP(O)(O)=O)C=C1,VWFCHDSQECPREK-LURJTMIESA-N,279.187,P08546,BE0000343,DNA polymerase catalytic subunit,HHV-5,inhibitor,yes
DB00370,Mirtazapine,small molecule,approved,CN1CCN2C(C1)C1=CC=CC=C1CC1=C2N=CC=C1,RONZAEMNMFQXRA-UHFFFAOYSA-N,265.3529,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB00370,Mirtazapine,small molecule,approved,CN1CCN2C(C1)C1=CC=CC=C1CC1=C2N=CC=C1,RONZAEMNMFQXRA-UHFFFAOYSA-N,265.3529,Q9UE69,BE0005582,5HT3 serotonin receptor,Humans,antagonist,yes
DB00370,Mirtazapine,small molecule,approved,CN1CCN2C(C1)C1=CC=CC=C1CC1=C2N=CC=C1,RONZAEMNMFQXRA-UHFFFAOYSA-N,265.3529,P08913,BE0000289,Alpha-2A adrenergic receptor,Humans,antagonist,yes
DB00370,Mirtazapine,small molecule,approved,CN1CCN2C(C1)C1=CC=CC=C1CC1=C2N=CC=C1,RONZAEMNMFQXRA-UHFFFAOYSA-N,265.3529,P28335,BE0000533,5-hydroxytryptamine receptor 2C,Humans,antagonist,yes
DB00371,Meprobamate,small molecule,approved;illicit,CCCC(C)(COC(N)=O)COC(N)=O,NPPQSCRMBWNHMW-UHFFFAOYSA-N,218.2502,Q9HBH1,BE0002201,"Peptide deformylase, mitochondrial",Humans,inhibitor,yes
DB00371,Meprobamate,small molecule,approved;illicit,CCCC(C)(COC(N)=O)COC(N)=O,NPPQSCRMBWNHMW-UHFFFAOYSA-N,218.2502,Q02156,BE0003431,Protein kinase C epsilon type,Humans,stimulator,yes
DB00371,Meprobamate,small molecule,approved;illicit,CCCC(C)(COC(N)=O)COC(N)=O,NPPQSCRMBWNHMW-UHFFFAOYSA-N,218.2502,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB00371,Meprobamate,small molecule,approved;illicit,CCCC(C)(COC(N)=O)COC(N)=O,NPPQSCRMBWNHMW-UHFFFAOYSA-N,218.2502,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,agonist,yes
DB00371,Meprobamate,small molecule,approved;illicit,CCCC(C)(COC(N)=O)COC(N)=O,NPPQSCRMBWNHMW-UHFFFAOYSA-N,218.2502,P47869,BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,Humans,agonist,yes
DB00371,Meprobamate,small molecule,approved;illicit,CCCC(C)(COC(N)=O)COC(N)=O,NPPQSCRMBWNHMW-UHFFFAOYSA-N,218.2502,P34903,BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,Humans,agonist,yes
DB00371,Meprobamate,small molecule,approved;illicit,CCCC(C)(COC(N)=O)COC(N)=O,NPPQSCRMBWNHMW-UHFFFAOYSA-N,218.2502,P48169,BE0000478,Gamma-aminobutyric acid receptor subunit alpha-4,Humans,agonist,yes
DB00371,Meprobamate,small molecule,approved;illicit,CCCC(C)(COC(N)=O)COC(N)=O,NPPQSCRMBWNHMW-UHFFFAOYSA-N,218.2502,P31644,BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,Humans,agonist,yes
DB00371,Meprobamate,small molecule,approved;illicit,CCCC(C)(COC(N)=O)COC(N)=O,NPPQSCRMBWNHMW-UHFFFAOYSA-N,218.2502,Q16445,BE0000764,Gamma-aminobutyric acid receptor subunit alpha-6,Humans,agonist,yes
DB00372,Thiethylperazine,small molecule,approved;withdrawn,CCSC1=CC2=C(SC3=CC=CC=C3N2CCCN2CCN(C)CC2)C=C1,XCTYLCDETUVOIP-UHFFFAOYSA-N,399.616,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB00373,Timolol,small molecule,approved,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,BLJRIMJGRPQVNF-JTQLQIEISA-N,316.42,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,antagonist,yes
DB00373,Timolol,small molecule,approved,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,BLJRIMJGRPQVNF-JTQLQIEISA-N,316.42,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,antagonist,yes
DB00374,Treprostinil,small molecule,approved;investigational,[H][C@]12C[C@@H](O)[C@H](CC[C@@H](O)CCCCC)[C@@]1([H])CC1=C(C2)C(OCC(O)=O)=CC=C1,PAJMKGZZBBTTOY-ZFORQUDYSA-N,390.5131,P43119,BE0000475,Prostacyclin receptor,Humans,agonist,yes
DB00374,Treprostinil,small molecule,approved;investigational,[H][C@]12C[C@@H](O)[C@H](CC[C@@H](O)CCCCC)[C@@]1([H])CC1=C(C2)C(OCC(O)=O)=CC=C1,PAJMKGZZBBTTOY-ZFORQUDYSA-N,390.5131,P43116,BE0000368,Prostaglandin E2 receptor EP2 subtype,Humans,agonist,yes
DB00374,Treprostinil,small molecule,approved;investigational,[H][C@]12C[C@@H](O)[C@H](CC[C@@H](O)CCCCC)[C@@]1([H])CC1=C(C2)C(OCC(O)=O)=CC=C1,PAJMKGZZBBTTOY-ZFORQUDYSA-N,390.5131,Q13258,BE0000296,Prostaglandin D2 receptor,Humans,agonist,yes
DB00374,Treprostinil,small molecule,approved;investigational,[H][C@]12C[C@@H](O)[C@H](CC[C@@H](O)CCCCC)[C@@]1([H])CC1=C(C2)C(OCC(O)=O)=CC=C1,PAJMKGZZBBTTOY-ZFORQUDYSA-N,390.5131,Q03181,BE0001007,Peroxisome proliferator-activated receptor delta,Humans,agonist,yes
DB00376,Trihexyphenidyl,small molecule,approved,OC(CCN1CCCCC1)(C1CCCCC1)C1=CC=CC=C1,HWHLPVGTWGOCJO-UHFFFAOYSA-N,301.4662,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,antagonist,yes
DB00376,Trihexyphenidyl,small molecule,approved,OC(CCN1CCCCC1)(C1CCCCC1)C1=CC=CC=C1,HWHLPVGTWGOCJO-UHFFFAOYSA-N,301.4662,P13945,BE0001012,Beta-3 adrenergic receptor,Humans,agonist,yes
DB00377,Palonosetron,small molecule,approved;investigational,[H][C@]12CCCC3=C1C(=CC=C3)C(=O)N(C2)[C@@H]1CN2CCC1CC2,CPZBLNMUGSZIPR-NVXWUHKLSA-N,296.414,P46098,BE0000311,5-hydroxytryptamine receptor 3A,Humans,antagonist,yes
DB00378,Dydrogesterone,small molecule,approved;investigational;withdrawn,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@]1([H])[C@@]2([H])C=CC2=CC(=O)CC[C@@]12C,JGMOKGBVKVMRFX-HQZYFCCVSA-N,312.4458,P06401,BE0000557,Progesterone receptor,Humans,agonist,yes
DB00379,Mexiletine,small molecule,approved;investigational,CC(N)COC1=C(C)C=CC=C1C,VLPIATFUUWWMKC-UHFFFAOYSA-N,179.2588,Q14524,BE0000197,Sodium channel protein type 5 subunit alpha,Humans,inhibitor,yes
DB00380,Dexrazoxane,small molecule,approved;withdrawn,C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1,BMKDZUISNHGIBY-ZETCQYMHSA-N,268.2691,P11388,BE0000742,DNA topoisomerase 2-alpha,Humans,inhibitor,yes
DB00380,Dexrazoxane,small molecule,approved;withdrawn,C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1,BMKDZUISNHGIBY-ZETCQYMHSA-N,268.2691,Q02880,BE0002425,DNA topoisomerase 2-beta,Humans,inhibitor,yes
DB00381,Amlodipine,small molecule,approved,CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=CC=CC=C1Cl)C(=O)OC,HTIQEAQVCYTUBX-UHFFFAOYSA-N,408.876,Q13936,BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,Humans,inhibitor,yes
DB00381,Amlodipine,small molecule,approved,CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=CC=CC=C1Cl)C(=O)OC,HTIQEAQVCYTUBX-UHFFFAOYSA-N,408.876,P54289,BE0000691,Voltage-dependent calcium channel subunit alpha-2/delta-1,Humans,blocker,yes
DB00381,Amlodipine,small molecule,approved,CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=CC=CC=C1Cl)C(=O)OC,HTIQEAQVCYTUBX-UHFFFAOYSA-N,408.876,Q9P0X4,BE0000012,Voltage-dependent T-type calcium channel subunit alpha-1I,Humans,inhibitor,yes
DB00382,Tacrine,small molecule,approved;investigational;withdrawn,NC1=C2CCCCC2=NC2=CC=CC=C12,YLJREFDVOIBQDA-UHFFFAOYSA-N,198.2637,P06276,BE0002180,Cholinesterase,Humans,inhibitor,yes
DB00382,Tacrine,small molecule,approved;investigational;withdrawn,NC1=C2CCCCC2=NC2=CC=CC=C12,YLJREFDVOIBQDA-UHFFFAOYSA-N,198.2637,P22303,BE0000426,Acetylcholinesterase,Humans,inhibitor,yes
DB00383,Oxyphencyclimine,small molecule,approved,CN1CCCN=C1COC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1,DUDKAZCAISNGQN-UHFFFAOYSA-N,344.4479,P08912,BE0000247,Muscarinic acetylcholine receptor M5,Humans,binder,yes
DB00383,Oxyphencyclimine,small molecule,approved,CN1CCCN=C1COC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1,DUDKAZCAISNGQN-UHFFFAOYSA-N,344.4479,P20309,BE0000045,Muscarinic acetylcholine receptor M3,Humans,antagonist,yes
DB00383,Oxyphencyclimine,small molecule,approved,CN1CCCN=C1COC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1,DUDKAZCAISNGQN-UHFFFAOYSA-N,344.4479,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,antagonist,yes
DB00383,Oxyphencyclimine,small molecule,approved,CN1CCCN=C1COC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1,DUDKAZCAISNGQN-UHFFFAOYSA-N,344.4479,P08172,BE0000560,Muscarinic acetylcholine receptor M2,Humans,antagonist,yes
DB00384,Triamterene,small molecule,approved,NC1=NC(N)=C2N=C(C(N)=NC2=N1)C1=CC=CC=C1,FNYLWPVRPXGIIP-UHFFFAOYSA-N,253.2626,P51170,BE0000497,Amiloride-sensitive sodium channel subunit gamma,Humans,inhibitor,yes
DB00384,Triamterene,small molecule,approved,NC1=NC(N)=C2N=C(C(N)=NC2=N1)C1=CC=CC=C1,FNYLWPVRPXGIIP-UHFFFAOYSA-N,253.2626,P37088,BE0000190,Amiloride-sensitive sodium channel subunit alpha,Humans,inhibitor,yes
DB00384,Triamterene,small molecule,approved,NC1=NC(N)=C2N=C(C(N)=NC2=N1)C1=CC=CC=C1,FNYLWPVRPXGIIP-UHFFFAOYSA-N,253.2626,P51168,BE0000024,Amiloride-sensitive sodium channel subunit beta,Humans,inhibitor,yes
DB00385,Valrubicin,small molecule,approved,[H][C@@]1(C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(=O)COC(=O)CCCC)O[C@H]1C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O1,ZOCKGBMQLCSHFP-KQRAQHLDSA-N,723.651,,BE0004796,DNA,Humans,intercalation,yes
DB00385,Valrubicin,small molecule,approved,[H][C@@]1(C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(=O)COC(=O)CCCC)O[C@H]1C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O1,ZOCKGBMQLCSHFP-KQRAQHLDSA-N,723.651,Q02880,BE0002425,DNA topoisomerase 2-beta,Humans,inhibitor,yes
DB00385,Valrubicin,small molecule,approved,[H][C@@]1(C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(=O)COC(=O)CCCC)O[C@H]1C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O1,ZOCKGBMQLCSHFP-KQRAQHLDSA-N,723.651,P11388,BE0000742,DNA topoisomerase 2-alpha,Humans,inhibitor,yes
DB00387,Procyclidine,small molecule,approved,OC(CCN1CCCC1)(C1CCCCC1)C1=CC=CC=C1,WYDUSKDSKCASEF-UHFFFAOYSA-N,287.4397,P20309,BE0000045,Muscarinic acetylcholine receptor M3,Humans,antagonist,yes
DB00387,Procyclidine,small molecule,approved,OC(CCN1CCCC1)(C1CCCCC1)C1=CC=CC=C1,WYDUSKDSKCASEF-UHFFFAOYSA-N,287.4397,P08912,BE0000247,Muscarinic acetylcholine receptor M5,Humans,antagonist,yes
DB00387,Procyclidine,small molecule,approved,OC(CCN1CCCC1)(C1CCCCC1)C1=CC=CC=C1,WYDUSKDSKCASEF-UHFFFAOYSA-N,287.4397,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,antagonist,yes
DB00387,Procyclidine,small molecule,approved,OC(CCN1CCCC1)(C1CCCCC1)C1=CC=CC=C1,WYDUSKDSKCASEF-UHFFFAOYSA-N,287.4397,P08172,BE0000560,Muscarinic acetylcholine receptor M2,Humans,antagonist,yes
DB00387,Procyclidine,small molecule,approved,OC(CCN1CCCC1)(C1CCCCC1)C1=CC=CC=C1,WYDUSKDSKCASEF-UHFFFAOYSA-N,287.4397,P08173,BE0000405,Muscarinic acetylcholine receptor M4,Humans,antagonist,yes
DB00388,Phenylephrine,small molecule,approved,CNC[C@H](O)C1=CC(O)=CC=C1,SONNWYBIRXJNDC-VIFPVBQESA-N,167.205,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,agonist,yes
DB00388,Phenylephrine,small molecule,approved,CNC[C@H](O)C1=CC(O)=CC=C1,SONNWYBIRXJNDC-VIFPVBQESA-N,167.205,P14416,BE0000756,D(2) dopamine receptor,Humans,agonist,yes
DB00388,Phenylephrine,small molecule,approved,CNC[C@H](O)C1=CC(O)=CC=C1,SONNWYBIRXJNDC-VIFPVBQESA-N,167.205,P35368,BE0000575,Alpha-1B adrenergic receptor,Humans,agonist,yes
DB00388,Phenylephrine,small molecule,approved,CNC[C@H](O)C1=CC(O)=CC=C1,SONNWYBIRXJNDC-VIFPVBQESA-N,167.205,P25100,BE0000715,Alpha-1D adrenergic receptor,Humans,agonist,yes
DB00389,Carbimazole,small molecule,approved;investigational,CCOC(=O)N1C=CN(C)C1=S,CFOYWRHIYXMDOT-UHFFFAOYSA-N,186.232,P07202,BE0000507,Thyroid peroxidase,Humans,inhibitor,yes
DB00390,Digoxin,small molecule,approved,[H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1,LTMHDMANZUZIPE-PUGKRICDSA-N,780.9385,P50993,BE0005034,Sodium/potassium-transporting ATPase subunit alpha-2,Humans,inhibitor,yes
DB00390,Digoxin,small molecule,approved,[H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1,LTMHDMANZUZIPE-PUGKRICDSA-N,780.9385,P13637,BE0005047,Sodium/potassium-transporting ATPase subunit alpha-3,Humans,inhibitor,yes
DB00390,Digoxin,small molecule,approved,[H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1,LTMHDMANZUZIPE-PUGKRICDSA-N,780.9385,P05026,BE0004994,Sodium/potassium-transporting ATPase subunit beta-1,Humans,inhibitor,yes
DB00390,Digoxin,small molecule,approved,[H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1,LTMHDMANZUZIPE-PUGKRICDSA-N,780.9385,P14415,BE0005018,Sodium/potassium-transporting ATPase subunit beta-2,Humans,inhibitor,yes
DB00390,Digoxin,small molecule,approved,[H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1,LTMHDMANZUZIPE-PUGKRICDSA-N,780.9385,P54709,BE0005026,Sodium/potassium-transporting ATPase subunit beta-3,Humans,inhibitor,yes
DB00390,Digoxin,small molecule,approved,[H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1,LTMHDMANZUZIPE-PUGKRICDSA-N,780.9385,Q6ZQN7,BE0003653,Solute carrier organic anion transporter family member 4C1,Humans,modulator,yes
DB00390,Digoxin,small molecule,approved,[H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1,LTMHDMANZUZIPE-PUGKRICDSA-N,780.9385,P05023,BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,Humans,inhibitor,yes
DB00391,Sulpiride,small molecule,approved;investigational,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,BGRJTUBHPOOWDU-UHFFFAOYSA-N,341.426,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB00392,Profenamine,small molecule,approved,CCN(CC)C(C)CN1C2=CC=CC=C2SC2=CC=CC=C12,CDOZDBSBBXSXLB-UHFFFAOYSA-N,312.472,P35367,BE0000442,Histamine H1 receptor,Humans,modulator,yes
DB00392,Profenamine,small molecule,approved,CCN(CC)C(C)CN1C2=CC=CC=C2SC2=CC=CC=C12,CDOZDBSBBXSXLB-UHFFFAOYSA-N,312.472,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,antagonist,yes
DB00392,Profenamine,small molecule,approved,CCN(CC)C(C)CN1C2=CC=CC=C2SC2=CC=CC=C12,CDOZDBSBBXSXLB-UHFFFAOYSA-N,312.472,Q8TCU5,BE0000641,"Glutamate receptor ionotropic, NMDA 3A",Humans,antagonist,yes
DB00393,Nimodipine,small molecule,approved;investigational,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C,UIAGMCDKSXEBJQ-UHFFFAOYSA-N,418.4403,Q13936,BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,Humans,inhibitor,yes
DB00393,Nimodipine,small molecule,approved;investigational,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C,UIAGMCDKSXEBJQ-UHFFFAOYSA-N,418.4403,Q01668,BE0002359,Voltage-dependent L-type calcium channel subunit alpha-1D,Humans,inhibitor,yes
DB00393,Nimodipine,small molecule,approved;investigational,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C,UIAGMCDKSXEBJQ-UHFFFAOYSA-N,418.4403,O60840,BE0002357,Voltage-dependent L-type calcium channel subunit alpha-1F,Humans,inhibitor,yes
DB00393,Nimodipine,small molecule,approved;investigational,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C,UIAGMCDKSXEBJQ-UHFFFAOYSA-N,418.4403,Q13698,BE0002355,Voltage-dependent L-type calcium channel subunit alpha-1S,Humans,inhibitor,yes
DB00393,Nimodipine,small molecule,approved;investigational,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C,UIAGMCDKSXEBJQ-UHFFFAOYSA-N,418.4403,Q02641,BE0000303,Voltage-dependent L-type calcium channel subunit beta-1,Humans,inhibitor,yes
DB00393,Nimodipine,small molecule,approved;investigational,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C,UIAGMCDKSXEBJQ-UHFFFAOYSA-N,418.4403,Q08289,BE0002354,Voltage-dependent L-type calcium channel subunit beta-2,Humans,inhibitor,yes
DB00393,Nimodipine,small molecule,approved;investigational,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C,UIAGMCDKSXEBJQ-UHFFFAOYSA-N,418.4403,P54284,BE0002358,Voltage-dependent L-type calcium channel subunit beta-3,Humans,inhibitor,yes
DB00393,Nimodipine,small molecule,approved;investigational,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C,UIAGMCDKSXEBJQ-UHFFFAOYSA-N,418.4403,O00305,BE0002356,Voltage-dependent L-type calcium channel subunit beta-4,Humans,inhibitor,yes
DB00394,Beclomethasone dipropionate,small molecule,approved;investigational,[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,KUVIULQEHSCUHY-XYWKZLDCSA-N,521.042,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB00395,Carisoprodol,small molecule,approved,CCCC(C)(COC(N)=O)COC(=O)NC(C)C,OFZCIYFFPZCNJE-UHFFFAOYSA-N,260.33,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,activator;modulator,yes
DB00395,Carisoprodol,small molecule,approved,CCCC(C)(COC(N)=O)COC(=O)NC(C)C,OFZCIYFFPZCNJE-UHFFFAOYSA-N,260.33,P47870,BE0002346,Gamma-aminobutyric acid receptor subunit beta-2,Humans,modulator,yes
DB00395,Carisoprodol,small molecule,approved,CCCC(C)(COC(N)=O)COC(=O)NC(C)C,OFZCIYFFPZCNJE-UHFFFAOYSA-N,260.33,P18507,BE0003592,Gamma-aminobutyric acid receptor subunit gamma-2,Humans,modulator,yes
DB00395,Carisoprodol,small molecule,approved,CCCC(C)(COC(N)=O)COC(=O)NC(C)C,OFZCIYFFPZCNJE-UHFFFAOYSA-N,260.33,P31644,BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,Humans,modulator,yes
DB00395,Carisoprodol,small molecule,approved,CCCC(C)(COC(N)=O)COC(=O)NC(C)C,OFZCIYFFPZCNJE-UHFFFAOYSA-N,260.33,P34903,BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,Humans,modulator,yes
DB00396,Progesterone,small molecule,approved;vet_approved,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,RJKFOVLPORLFTN-LEKSSAKUSA-N,314.4617,P06401,BE0000557,Progesterone receptor,Humans,agonist,yes
DB00396,Progesterone,small molecule,approved;vet_approved,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,RJKFOVLPORLFTN-LEKSSAKUSA-N,314.4617,P08235,BE0000668,Mineralocorticoid receptor,Humans,antagonist;agonist,yes
DB00398,Sorafenib,small molecule,approved;investigational,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,464.825,P15056,BE0000634,Serine/threonine-protein kinase B-raf,Humans,inhibitor,yes
DB00398,Sorafenib,small molecule,approved;investigational,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,464.825,P00533,BE0000767,Epidermal growth factor receptor,Humans,inhibitor,yes
DB00398,Sorafenib,small molecule,approved;investigational,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,464.825,P04049,BE0000036,RAF proto-oncogene serine/threonine-protein kinase,Humans,inhibitor,yes
DB00398,Sorafenib,small molecule,approved;investigational,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,464.825,P35916,BE0000023,Vascular endothelial growth factor receptor 3,Humans,inhibitor,yes
DB00398,Sorafenib,small molecule,approved;investigational,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,464.825,P35968,BE0000369,Vascular endothelial growth factor receptor 2,Humans,inhibitor,yes
DB00398,Sorafenib,small molecule,approved;investigational,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,464.825,P17948,BE0000029,Vascular endothelial growth factor receptor 1,Humans,inhibitor,yes
DB00398,Sorafenib,small molecule,approved;investigational,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,464.825,P36888,BE0000147,Receptor-type tyrosine-protein kinase FLT3,Humans,inhibitor,yes
DB00398,Sorafenib,small molecule,approved;investigational,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,464.825,P09619,BE0000205,Platelet-derived growth factor receptor beta,Humans,inhibitor,yes
DB00398,Sorafenib,small molecule,approved;investigational,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,464.825,P10721,BE0000453,Mast/stem cell growth factor receptor Kit,Humans,antagonist,yes
DB00398,Sorafenib,small molecule,approved;investigational,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,464.825,P11362,BE0002131,Fibroblast growth factor receptor 1,Humans,inhibitor,yes
DB00398,Sorafenib,small molecule,approved;investigational,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,464.825,P07949,BE0002411,Proto-oncogene tyrosine-protein kinase receptor Ret,Humans,inhibitor,yes
DB00399,Zoledronic acid,small molecule,approved,OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O,XRASPMIURGNCCH-UHFFFAOYSA-N,272.0896,O95749,BE0003570,Geranylgeranyl pyrophosphate synthase,Humans,inhibitor,yes
DB00399,Zoledronic acid,small molecule,approved,OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O,XRASPMIURGNCCH-UHFFFAOYSA-N,272.0896,,BE0004801,Hydroxylapatite,Humans,antagonist;binder,yes
DB00399,Zoledronic acid,small molecule,approved,OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O,XRASPMIURGNCCH-UHFFFAOYSA-N,272.0896,P14324,BE0000776,Farnesyl pyrophosphate synthase,Humans,inhibitor,yes
DB00400,Griseofulvin,small molecule,approved;investigational;vet_approved,COC1=CC(OC)=C(Cl)C2=C1C(=O)[C@]1(O2)[C@H](C)CC(=O)C=C1OC,DDUHZTYCFQRHIY-RBHXEPJQSA-N,352.766,Q5UBX3,BE0010210,Tubulin beta chain,Trichophyton rubrum,inhibitor,yes
DB00401,Nisoldipine,small molecule,approved,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OCC(C)C,VKQFCGNPDRICFG-UHFFFAOYSA-N,388.4144,Q13936,BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,Humans,inhibitor,yes
DB00401,Nisoldipine,small molecule,approved,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OCC(C)C,VKQFCGNPDRICFG-UHFFFAOYSA-N,388.4144,P54289,BE0000691,Voltage-dependent calcium channel subunit alpha-2/delta-1,Humans,inhibitor,yes
DB00401,Nisoldipine,small molecule,approved,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OCC(C)C,VKQFCGNPDRICFG-UHFFFAOYSA-N,388.4144,Q08289,BE0002354,Voltage-dependent L-type calcium channel subunit beta-2,Humans,inhibitor,yes
DB00401,Nisoldipine,small molecule,approved,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OCC(C)C,VKQFCGNPDRICFG-UHFFFAOYSA-N,388.4144,Q01668,BE0002359,Voltage-dependent L-type calcium channel subunit alpha-1D,Humans,inhibitor,yes
DB00401,Nisoldipine,small molecule,approved,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OCC(C)C,VKQFCGNPDRICFG-UHFFFAOYSA-N,388.4144,Q13698,BE0002355,Voltage-dependent L-type calcium channel subunit alpha-1S,Humans,inhibitor,yes
DB00402,Eszopiclone,small molecule,approved;investigational,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1,GBBSUAFBMRNDJC-INIZCTEOSA-N,388.808,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,potentiator,yes
DB00402,Eszopiclone,small molecule,approved;investigational,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1,GBBSUAFBMRNDJC-INIZCTEOSA-N,388.808,P30536,BE0000736,Translocator protein,Humans,agonist,yes
DB00402,Eszopiclone,small molecule,approved;investigational,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1,GBBSUAFBMRNDJC-INIZCTEOSA-N,388.808,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB00403,Ceruletide,small molecule,approved,[H][C@](NC(=O)[C@H](CC1=CC=C(OS(O)(=O)=O)C=C1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCC(=O)N1)([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(N)=O,YRALAIOMGQZKOW-HYAOXDFASA-N,1352.405,P32238,BE0000402,Cholecystokinin receptor type A,Humans,inducer,yes
DB00403,Ceruletide,small molecule,approved,[H][C@](NC(=O)[C@H](CC1=CC=C(OS(O)(=O)=O)C=C1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCC(=O)N1)([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(N)=O,YRALAIOMGQZKOW-HYAOXDFASA-N,1352.405,P32239,BE0001158,Gastrin/cholecystokinin type B receptor,Humans,agonist,yes
DB00404,Alprazolam,small molecule,approved;illicit;investigational,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12,VREFGVBLTWBCJP-UHFFFAOYSA-N,308.765,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB00404,Alprazolam,small molecule,approved;illicit;investigational,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12,VREFGVBLTWBCJP-UHFFFAOYSA-N,308.765,P30536,BE0000736,Translocator protein,Humans,agonist,yes
DB00404,Alprazolam,small molecule,approved;illicit;investigational,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12,VREFGVBLTWBCJP-UHFFFAOYSA-N,308.765,P14867,BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,Humans,ligand,yes
DB00405,Dexbrompheniramine,small molecule,approved,CN(C)CC[C@@H](C1=CC=C(Br)C=C1)C1=CC=CC=N1,ZDIGNSYAACHWNL-HNNXBMFYSA-N,319.239,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB00406,Gentian violet cation,small molecule,approved,CN(C)C1=CC=C(C=C1)C(C1=CC=C(C=C1)N(C)C)=C1C=CC(C=C1)=[N+](C)C,LGLFFNDHMLKUMI-UHFFFAOYSA-N,372.5258,,BE0004796,DNA,Humans,intercalation,yes
DB00408,Loxapine,small molecule,approved,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,XJGVXQDUIWGIRW-UHFFFAOYSA-N,327.808,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB00408,Loxapine,small molecule,approved,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,XJGVXQDUIWGIRW-UHFFFAOYSA-N,327.808,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB00409,Remoxipride,small molecule,approved;withdrawn,CCN1CCC[C@H]1CNC(=O)C1=C(OC)C=CC(Br)=C1OC,GUJRSXAPGDDABA-NSHDSACASA-N,371.269,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB00410,Mupirocin,small molecule,approved;investigational;vet_approved,C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@H]1CO[C@@H](C\C(C)=C\C(=O)OCCCCCCCCC(O)=O)[C@H](O)[C@@H]1O,MINDHVHHQZYEEK-HBBNESRFSA-N,500.6222,P41972,BE0000804,Isoleucine--tRNA ligase,Staphylococcus aureus,inhibitor,yes
DB00411,Carbamoylcholine,small molecule,approved,C[N+](C)(C)CCOC(N)=O,VPJXQGSRWJZDOB-UHFFFAOYSA-O,147.1955,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,agonist,yes
DB00411,Carbamoylcholine,small molecule,approved,C[N+](C)(C)CCOC(N)=O,VPJXQGSRWJZDOB-UHFFFAOYSA-O,147.1955,P08172,BE0000560,Muscarinic acetylcholine receptor M2,Humans,agonist,yes
DB00411,Carbamoylcholine,small molecule,approved,C[N+](C)(C)CCOC(N)=O,VPJXQGSRWJZDOB-UHFFFAOYSA-O,147.1955,Q15822,BE0000738,Neuronal acetylcholine receptor subunit alpha-2,Humans,agonist,yes
DB00412,Rosiglitazone,small molecule,approved;investigational,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1,YASAKCUCGLMORW-UHFFFAOYSA-N,357.427,P37231,BE0000215,Peroxisome proliferator-activated receptor gamma,Humans,agonist,yes
DB00413,Pramipexole,small molecule,approved;investigational,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,FASDKYOPVNHBLU-ZETCQYMHSA-N,211.327,P35462,BE0000581,D(3) dopamine receptor,Humans,agonist,yes
DB00413,Pramipexole,small molecule,approved;investigational,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,FASDKYOPVNHBLU-ZETCQYMHSA-N,211.327,P14416,BE0000756,D(2) dopamine receptor,Humans,agonist,yes
DB00413,Pramipexole,small molecule,approved;investigational,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,FASDKYOPVNHBLU-ZETCQYMHSA-N,211.327,P21917,BE0000389,D(4) dopamine receptor,Humans,agonist,yes
DB00414,Acetohexamide,small molecule,approved;investigational;withdrawn,CC(=O)C1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1,VGZSUPCWNCWDAN-UHFFFAOYSA-N,324.395,P48048,BE0000644,ATP-sensitive inward rectifier potassium channel 1,Humans,inhibitor,yes
DB00414,Acetohexamide,small molecule,approved;investigational;withdrawn,CC(=O)C1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1,VGZSUPCWNCWDAN-UHFFFAOYSA-N,324.395,Q09428,BE0000207,ATP-binding cassette sub-family C member 8,Humans,modulator,yes
DB00415,Ampicillin,small molecule,approved;vet_approved,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O,AVKUERGKIZMTKX-NJBDSQKTSA-N,349.405,Q8DNB6,BE0004644,Penicillin-binding protein 2a,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB00415,Ampicillin,small molecule,approved;vet_approved,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O,AVKUERGKIZMTKX-NJBDSQKTSA-N,349.405,Q7CRA4,BE0004335,Penicillin-binding protein 1b,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB00415,Ampicillin,small molecule,approved;vet_approved,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O,AVKUERGKIZMTKX-NJBDSQKTSA-N,349.405,Q75Y35,BE0004643,Penicillin-binding protein 3,Streptococcus pneumoniae,inhibitor,yes
DB00415,Ampicillin,small molecule,approved;vet_approved,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O,AVKUERGKIZMTKX-NJBDSQKTSA-N,349.405,Q8DR59,BE0004290,Penicillin-binding protein 1A,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB00415,Ampicillin,small molecule,approved;vet_approved,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O,AVKUERGKIZMTKX-NJBDSQKTSA-N,349.405,P0A3M6,BE0003624,Penicillin-binding protein 2B,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB00416,Metocurine iodide,small molecule,approved;withdrawn,[I-].[I-].[H][C@@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC(OC6=C(OC)C=C(CC[N+]1(C)C)C2=C6)=C(OC)C=C5)=CC(OC)=C4OC)C=C3,DIGFQJFCDPKEPF-OIUSMDOTSA-L,906.6279,P43681,BE0000849,Neuronal acetylcholine receptor subunit alpha-4,Humans,modulator,yes
DB00416,Metocurine iodide,small molecule,approved;withdrawn,[I-].[I-].[H][C@@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC(OC6=C(OC)C=C(CC[N+]1(C)C)C2=C6)=C(OC)C=C5)=CC(OC)=C4OC)C=C3,DIGFQJFCDPKEPF-OIUSMDOTSA-L,906.6279,P17787,BE0000850,Neuronal acetylcholine receptor subunit beta-2,Humans,modulator,yes
DB00416,Metocurine iodide,small molecule,approved;withdrawn,[I-].[I-].[H][C@@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC(OC6=C(OC)C=C(CC[N+]1(C)C)C2=C6)=C(OC)C=C5)=CC(OC)=C4OC)C=C3,DIGFQJFCDPKEPF-OIUSMDOTSA-L,906.6279,Q15822,BE0000738,Neuronal acetylcholine receptor subunit alpha-2,Humans,antagonist,yes
DB00417,Phenoxymethylpenicillin,small molecule,approved;vet_approved,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)COC1=CC=CC=C1)C(O)=O,BPLBGHOLXOTWMN-MBNYWOFBSA-N,350.39,Q53707,BE0003618,MecA PBP2' (penicillin binding protein 2'),Staphylococcus aureus,inhibitor,yes
DB00417,Phenoxymethylpenicillin,small molecule,approved;vet_approved,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)COC1=CC=CC=C1)C(O)=O,BPLBGHOLXOTWMN-MBNYWOFBSA-N,350.39,Q8XJ01,BE0000576,Penicillin-binding protein 1A,Clostridium perfringens (strain 13 / Type A),inhibitor,yes
DB00418,Secobarbital,small molecule,approved;vet_approved,CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,KQPKPCNLIDLUMF-UHFFFAOYSA-N,238.2829,P47869,BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,Humans,potentiator,yes
DB00418,Secobarbital,small molecule,approved;vet_approved,CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,KQPKPCNLIDLUMF-UHFFFAOYSA-N,238.2829,P34903,BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,Humans,potentiator,yes
DB00418,Secobarbital,small molecule,approved;vet_approved,CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,KQPKPCNLIDLUMF-UHFFFAOYSA-N,238.2829,P48169,BE0000478,Gamma-aminobutyric acid receptor subunit alpha-4,Humans,potentiator,yes
DB00418,Secobarbital,small molecule,approved;vet_approved,CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,KQPKPCNLIDLUMF-UHFFFAOYSA-N,238.2829,P31644,BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,Humans,potentiator,yes
DB00418,Secobarbital,small molecule,approved;vet_approved,CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,KQPKPCNLIDLUMF-UHFFFAOYSA-N,238.2829,Q16445,BE0000764,Gamma-aminobutyric acid receptor subunit alpha-6,Humans,potentiator,yes
DB00418,Secobarbital,small molecule,approved;vet_approved,CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,KQPKPCNLIDLUMF-UHFFFAOYSA-N,238.2829,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,potentiator,yes
DB00419,Miglustat,small molecule,approved,CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,UQRORFVVSGFNRO-UTINFBMNSA-N,219.278,Q16739,BE0000477,Ceramide glucosyltransferase,Humans,inhibitor,yes
DB00420,Promazine,small molecule,approved;vet_approved,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12,ZGUGWUXLJSTTMA-UHFFFAOYSA-N,284.419,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB00420,Promazine,small molecule,approved;vet_approved,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12,ZGUGWUXLJSTTMA-UHFFFAOYSA-N,284.419,P08912,BE0000247,Muscarinic acetylcholine receptor M5,Humans,binder,yes
DB00421,Spironolactone,small molecule,approved,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O,LXMSZDCAJNLERA-ZHYRCANASA-N,416.573,P08235,BE0000668,Mineralocorticoid receptor,Humans,antagonist,yes
DB00422,Methylphenidate,small molecule,approved;investigational,COC(=O)C(C1CCCCN1)C1=CC=CC=C1,DUGOZIWVEXMGBE-UHFFFAOYSA-N,233.3062,Q01959,BE0000647,Sodium-dependent dopamine transporter,Humans,inhibitor,yes
DB00424,Hyoscyamine,small molecule,approved,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,RKUNBYITZUJHSG-FXUDXRNXSA-N,289.3694,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,antagonist,yes
DB00424,Hyoscyamine,small molecule,approved,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,RKUNBYITZUJHSG-FXUDXRNXSA-N,289.3694,P08912,BE0000247,Muscarinic acetylcholine receptor M5,Humans,antagonist,yes
DB00424,Hyoscyamine,small molecule,approved,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,RKUNBYITZUJHSG-FXUDXRNXSA-N,289.3694,P08172,BE0000560,Muscarinic acetylcholine receptor M2,Humans,antagonist,yes
DB00425,Zolpidem,small molecule,approved,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,ZAFYATHCZYHLPB-UHFFFAOYSA-N,307.3895,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,agonist,yes
DB00425,Zolpidem,small molecule,approved,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,ZAFYATHCZYHLPB-UHFFFAOYSA-N,307.3895,Q99928,BE0003594,Gamma-aminobutyric acid receptor subunit gamma-3,Humans,allosteric modulator,yes
DB00426,Famciclovir,small molecule,approved;investigational,CC(=O)OCC(CCN1C=NC2=CN=C(N)N=C12)COC(C)=O,GGXKWVWZWMLJEH-UHFFFAOYSA-N,321.3318,P04293,BE0000308,DNA polymerase catalytic subunit,HHV-1,inhibitor,yes
DB00427,Triprolidine,small molecule,approved,CC1=CC=C(C=C1)C(=C/CN1CCCC1)\C1=CC=CC=N1,CBEQULMOCCWAQT-WOJGMQOQSA-N,278.3914,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB00428,Streptozocin,small molecule,approved;investigational,CN(N=O)C(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO,AGRCPNMCOXLKFO-BDVNFPICSA-N,265.222,Q89ZI2,BE0004258,O-GlcNAcase BT_4395,Bacteroides thetaiotaomicron (strain ATCC 29148 / DSM 2079 / NCTC 10582 / E50 / VPI-5482),antagonist,yes
DB00428,Streptozocin,small molecule,approved;investigational,CN(N=O)C(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO,AGRCPNMCOXLKFO-BDVNFPICSA-N,265.222,,BE0004796,DNA,Humans,cross-linking/alkylation,yes
DB00429,Carboprost tromethamine,small molecule,approved,NC(CO)(CO)CO.CCCCC[C@](C)(O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O,UMMADZJLZAPZAW-XOWPVRJPSA-N,489.65,P34995,BE0000064,Prostaglandin E2 receptor EP1 subtype,Humans,agonist,yes
DB00429,Carboprost tromethamine,small molecule,approved,NC(CO)(CO)CO.CCCCC[C@](C)(O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O,UMMADZJLZAPZAW-XOWPVRJPSA-N,489.65,P43088,BE0000610,Prostaglandin F2-alpha receptor,Humans,modulator,yes
DB00430,Cefpiramide,small molecule,approved,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](NC(=O)C1=C(O)C=C(C)N=C1)C1=CC=C(O)C=C1)C(O)=O,PWAUCHMQEXVFJR-PMAPCBKXSA-N,612.637,P0AD68,BE0002393,Peptidoglycan synthase FtsI,Escherichia coli (strain K12),inhibitor,yes
DB00430,Cefpiramide,small molecule,approved,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](NC(=O)C1=C(O)C=C(C)N=C1)C1=CC=C(O)C=C1)C(O)=O,PWAUCHMQEXVFJR-PMAPCBKXSA-N,612.637,P02919,BE0000488,Penicillin-binding protein 1B,Escherichia coli (strain K12),inhibitor,yes
DB00430,Cefpiramide,small molecule,approved,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](NC(=O)C1=C(O)C=C(C)N=C1)C1=CC=C(O)C=C1)C(O)=O,PWAUCHMQEXVFJR-PMAPCBKXSA-N,612.637,Q07806,BE0003686,Penicillin-binding protein 1A,Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228),inhibitor,yes
DB00430,Cefpiramide,small molecule,approved,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](NC(=O)C1=C(O)C=C(C)N=C1)C1=CC=C(O)C=C1)C(O)=O,PWAUCHMQEXVFJR-PMAPCBKXSA-N,612.637,Q9X6W0,BE0003687,Penicillin-binding protein 1B,Pseudomonas aeruginosa,inhibitor,yes
DB00430,Cefpiramide,small molecule,approved,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](NC(=O)C1=C(O)C=C(C)N=C1)C1=CC=C(O)C=C1)C(O)=O,PWAUCHMQEXVFJR-PMAPCBKXSA-N,612.637,P08506,BE0003685,D-alanyl-D-alanine carboxypeptidase DacC,Escherichia coli (strain K12),inhibitor,yes
DB00430,Cefpiramide,small molecule,approved,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](NC(=O)C1=C(O)C=C(C)N=C1)C1=CC=C(O)C=C1)C(O)=O,PWAUCHMQEXVFJR-PMAPCBKXSA-N,612.637,P02918,BE0000588,Penicillin-binding protein 1A,Escherichia coli (strain K12),inhibitor,yes
DB00431,Lindane,small molecule,approved;withdrawn,Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl,JLYXXMFPNIAWKQ-GNIYUCBRSA-N,290.83,P18505,BE0002344,Gamma-aminobutyric acid receptor subunit beta-1,Humans,antagonist,yes
DB00432,Trifluridine,small molecule,approved;investigational,OC[C@H]1O[C@H](C[C@@H]1O)N1C=C(C(=O)NC1=O)C(F)(F)F,VSQQQLOSPVPRAZ-RRKCRQDMSA-N,296.1999,P12461,BE0000021,Thymidylate synthase,Yeast,inhibitor,yes
DB00432,Trifluridine,small molecule,approved;investigational,OC[C@H]1O[C@H](C[C@@H]1O)N1C=C(C(=O)NC1=O)C(F)(F)F,VSQQQLOSPVPRAZ-RRKCRQDMSA-N,296.1999,P04818,BE0000324,Thymidylate synthase,Humans,inhibitor,yes
DB00433,Prochlorperazine,small molecule,approved;vet_approved,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,WIKYUJGCLQQFNW-UHFFFAOYSA-N,373.943,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB00434,Cyproheptadine,small molecule,approved,CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=CC=CC=C12,JJCFRYNCJDLXIK-UHFFFAOYSA-N,287.3981,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB00434,Cyproheptadine,small molecule,approved,CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=CC=CC=C12,JJCFRYNCJDLXIK-UHFFFAOYSA-N,287.3981,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB00434,Cyproheptadine,small molecule,approved,CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=CC=CC=C12,JJCFRYNCJDLXIK-UHFFFAOYSA-N,287.3981,P28335,BE0000533,5-hydroxytryptamine receptor 2C,Humans,antagonist,yes
DB00436,Bendroflumethiazide,small molecule,approved,NS(=O)(=O)C1=CC2=C(NC(CC3=CC=CC=C3)NS2(=O)=O)C=C1C(F)(F)F,HDWIHXWEUNVBIY-UHFFFAOYSA-N,421.415,P55017,BE0000419,Solute carrier family 12 member 3,Humans,inhibitor,yes
DB00436,Bendroflumethiazide,small molecule,approved,NS(=O)(=O)C1=CC2=C(NC(CC3=CC=CC=C3)NS2(=O)=O)C=C1C(F)(F)F,HDWIHXWEUNVBIY-UHFFFAOYSA-N,421.415,Q13621,BE0000502,Solute carrier family 12 member 1,Humans,blocker,yes
DB00436,Bendroflumethiazide,small molecule,approved,NS(=O)(=O)C1=CC2=C(NC(CC3=CC=CC=C3)NS2(=O)=O)C=C1C(F)(F)F,HDWIHXWEUNVBIY-UHFFFAOYSA-N,421.415,Q12791,BE0000553,Calcium-activated potassium channel subunit alpha-1,Humans,inducer,yes
DB00437,Allopurinol,small molecule,approved,OC1=NC=NC2=C1C=NN2,OFCNXPDARWKPPY-UHFFFAOYSA-N,136.1115,P47989,BE0002204,Xanthine dehydrogenase/oxidase,Humans,inhibitor,yes
DB00438,Ceftazidime,small molecule,approved,[O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1,ORFOPKXBNMVMKC-DWVKKRMSSA-N,546.576,P0AD68,BE0002393,Peptidoglycan synthase FtsI,Escherichia coli (strain K12),inhibitor,yes
DB00438,Ceftazidime,small molecule,approved,[O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1,ORFOPKXBNMVMKC-DWVKKRMSSA-N,546.576,P02918,BE0000588,Penicillin-binding protein 1A,Escherichia coli (strain K12),inhibitor,yes
DB00438,Ceftazidime,small molecule,approved,[O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1,ORFOPKXBNMVMKC-DWVKKRMSSA-N,546.576,P02919,BE0000488,Penicillin-binding protein 1B,Escherichia coli (strain K12),inhibitor,yes
DB00438,Ceftazidime,small molecule,approved,[O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1,ORFOPKXBNMVMKC-DWVKKRMSSA-N,546.576,P0AD65,BE0003579,Penicillin-binding protein 2,Escherichia coli (strain K12),inhibitor,yes
DB00439,Cerivastatin,small molecule,approved;withdrawn,COCC1=C(C2=CC=C(F)C=C2)C(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)=C(C(C)C)N=C1C(C)C,SEERZIQQUAZTOL-ANMDKAQQSA-N,459.5503,P04035,BE0000574,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Humans,inhibitor,yes
DB00440,Trimethoprim,small molecule,approved;vet_approved,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,IEDVJHCEMCRBQM-UHFFFAOYSA-N,290.3177,P00374,BE0000330,Dihydrofolate reductase,Humans,modulator,yes
DB00440,Trimethoprim,small molecule,approved;vet_approved,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,IEDVJHCEMCRBQM-UHFFFAOYSA-N,290.3177,P0ABQ4,BE0002010,Dihydrofolate reductase,Escherichia coli (strain K12),inhibitor,yes
DB00441,Gemcitabine,small molecule,approved,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F,SDUQYLNIPVEERB-QPPQHZFASA-N,263.1981,,BE0004796,DNA,Humans,cross-linking/alkylation,yes
DB00441,Gemcitabine,small molecule,approved,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F,SDUQYLNIPVEERB-QPPQHZFASA-N,263.1981,P31350,BE0002450,Ribonucleoside-diphosphate reductase subunit M2,Humans,modulator,yes
DB00441,Gemcitabine,small molecule,approved,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F,SDUQYLNIPVEERB-QPPQHZFASA-N,263.1981,P23921,BE0000325,Ribonucleoside-diphosphate reductase large subunit,Humans,inhibitor,yes
DB00442,Entecavir,small molecule,approved;investigational,NC1=NC(=O)C2=C(N1)N(C=N2)[C@H]1C[C@H](O)[C@@H](CO)C1=C,QDGZDCVAUDNJFG-FXQIFTODSA-N,277.2792,,BE0004796,DNA,Humans,other,yes
DB00443,Betamethasone,small molecule,approved;vet_approved,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,UREBDLICKHMUKA-DVTGEIKXSA-N,392.4611,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB00444,Teniposide,small molecule,approved,[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(O)C(OC)=C1)C1=C(C=C3OCOC3=C1)[C@H]2O[C@]1([H])O[C@]2([H])CO[C@H](O[C@@]2([H])[C@H](O)[C@H]1O)C1=CC=CS1,NRUKOCRGYNPUPR-QBPJDGROSA-N,656.654,P11388,BE0000742,DNA topoisomerase 2-alpha,Humans,inhibitor,yes
DB00444,Teniposide,small molecule,approved,[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(O)C(OC)=C1)C1=C(C=C3OCOC3=C1)[C@H]2O[C@]1([H])O[C@]2([H])CO[C@H](O[C@@]2([H])[C@H](O)[C@H]1O)C1=CC=CS1,NRUKOCRGYNPUPR-QBPJDGROSA-N,656.654,Q02880,BE0002425,DNA topoisomerase 2-beta,Humans,modulator,yes
DB00445,Epirubicin,small molecule,approved,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O,AOJJSUZBOXZQNB-VTZDEGQISA-N,543.5193,Q02880,BE0002425,DNA topoisomerase 2-beta,Humans,modulator,yes
DB00446,Chloramphenicol,small molecule,approved;vet_approved;withdrawn,OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C(C=C1)[N+]([O-])=O,WIIZWVCIJKGZOK-RKDXNWHRSA-N,323.129,P0ADY7,BE0004650,50S ribosomal protein L16,Escherichia coli (strain K12),inhibitor,yes
DB00447,Loracarbef,small molecule,approved;investigational;withdrawn,N[C@@H](C(=O)N[C@H]1[C@H]2CCC(Cl)=C(N2C1=O)C(O)=O)C1=CC=CC=C1,JAPHQRWPEGVNBT-UTUOFQBUSA-N,349.769,Q75Y35,BE0004643,Penicillin-binding protein 3,Streptococcus pneumoniae,inhibitor,yes
DB00447,Loracarbef,small molecule,approved;investigational;withdrawn,N[C@@H](C(=O)N[C@H]1[C@H]2CCC(Cl)=C(N2C1=O)C(O)=O)C1=CC=CC=C1,JAPHQRWPEGVNBT-UTUOFQBUSA-N,349.769,Q8XJ01,BE0000576,Penicillin-binding protein 1A,Clostridium perfringens (strain 13 / Type A),inhibitor,yes
DB00448,Lansoprazole,small molecule,approved;investigational,CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1,MJIHNNLFOKEZEW-UHFFFAOYSA-N,369.361,P20648,BE0000349,Potassium-transporting ATPase alpha chain 1,Humans,inhibitor,yes
DB00449,Dipivefrin,small molecule,approved,CNCC(O)C1=CC(OC(=O)C(C)(C)C)=C(OC(=O)C(C)(C)C)C=C1,OCUJLLGVOUDECM-UHFFFAOYSA-N,351.4373,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,antagonist,yes
DB00449,Dipivefrin,small molecule,approved,CNCC(O)C1=CC(OC(=O)C(C)(C)C)=C(OC(=O)C(C)(C)C)C=C1,OCUJLLGVOUDECM-UHFFFAOYSA-N,351.4373,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,agonist,yes
DB00449,Dipivefrin,small molecule,approved,CNCC(O)C1=CC(OC(=O)C(C)(C)C)=C(OC(=O)C(C)(C)C)C=C1,OCUJLLGVOUDECM-UHFFFAOYSA-N,351.4373,P08913,BE0000289,Alpha-2A adrenergic receptor,Humans,agonist,yes
DB00449,Dipivefrin,small molecule,approved,CNCC(O)C1=CC(OC(=O)C(C)(C)C)=C(OC(=O)C(C)(C)C)C=C1,OCUJLLGVOUDECM-UHFFFAOYSA-N,351.4373,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,agonist,yes
DB00449,Dipivefrin,small molecule,approved,CNCC(O)C1=CC(OC(=O)C(C)(C)C)=C(OC(=O)C(C)(C)C)C=C1,OCUJLLGVOUDECM-UHFFFAOYSA-N,351.4373,P06276,BE0002180,Cholinesterase,Humans,substrate,yes
DB00450,Droperidol,small molecule,approved;vet_approved,FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=CC=CC=C12,RMEDXOLNCUSCGS-UHFFFAOYSA-N,379.4274,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,antagonist,yes
DB00450,Droperidol,small molecule,approved;vet_approved,FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=CC=CC=C12,RMEDXOLNCUSCGS-UHFFFAOYSA-N,379.4274,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB00451,Levothyroxine,small molecule,approved,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O,XUIIKFGFIJCVMT-LBPRGKRZSA-N,776.87,P06756,BE0003576,Integrin alpha-V,Humans,binder,yes
DB00451,Levothyroxine,small molecule,approved,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O,XUIIKFGFIJCVMT-LBPRGKRZSA-N,776.87,P05106,BE0001155,Integrin beta-3,Humans,binder,yes
DB00451,Levothyroxine,small molecule,approved,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O,XUIIKFGFIJCVMT-LBPRGKRZSA-N,776.87,P10827,BE0000687,Thyroid hormone receptor alpha,Humans,agonist,yes
DB00451,Levothyroxine,small molecule,approved,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O,XUIIKFGFIJCVMT-LBPRGKRZSA-N,776.87,P10828,BE0000315,Thyroid hormone receptor beta,Humans,agonist,yes
DB00452,Framycetin,small molecule,approved,NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O,PGBHMTALBVVCIT-VCIWKGPPSA-N,614.6437,,BE0004799,16S ribosomal RNA,Enteric bacteria and other eubacteria,inhibitor,yes
DB00452,Framycetin,small molecule,approved,NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O,PGBHMTALBVVCIT-VCIWKGPPSA-N,614.6437,P0A7S3,BE0000279,30S ribosomal protein S12,Escherichia coli (strain K12),inhibitor,yes
DB00453,Clomocycline,small molecule,experimental,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(=O)NCO)=C(O)[C@H]2N(C)C)C(=O)C1=C(C(Cl)=CC=C1O)[C@@]3(C)O,GJGDLRSSCNAKGL-KMVLDZISSA-N,508.906,P0A7V8,BE0000019,30S ribosomal protein S4,Escherichia coli (strain K12),inhibitor,yes
DB00454,Meperidine,small molecule,approved,CCOC(=O)C1(CCN(C)CC1)C1=CC=CC=C1,XADCESSVHJOZHK-UHFFFAOYSA-N,247.3327,P41145,BE0000632,Kappa-type opioid receptor,Humans,agonist,yes
DB00455,Loratadine,small molecule,approved;investigational,CCOC(=O)N1CCC(CC1)=C1C2=C(CCC3=C1N=CC=C3)C=C(Cl)C=C2,JCCNYMKQOSZNPW-UHFFFAOYSA-N,382.883,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB00456,Cefalotin,small molecule,approved;investigational;vet_approved,[H][C@@]1(NC(=O)CC2=CC=CS2)C(=O)N2C(C(O)=O)=C(COC(C)=O)CS[C@]12[H],XIURVHNZVLADCM-IUODEOHRSA-N,396.438,P15555,BE0001349,D-alanyl-D-alanine carboxypeptidase,Streptomyces sp. (strain R61),inhibitor,yes
DB00456,Cefalotin,small molecule,approved;investigational;vet_approved,[H][C@@]1(NC(=O)CC2=CC=CS2)C(=O)N2C(C(O)=O)=C(COC(C)=O)CS[C@]12[H],XIURVHNZVLADCM-IUODEOHRSA-N,396.438,Q8DR59,BE0004290,Penicillin-binding protein 1A,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB00456,Cefalotin,small molecule,approved;investigational;vet_approved,[H][C@@]1(NC(=O)CC2=CC=CS2)C(=O)N2C(C(O)=O)=C(COC(C)=O)CS[C@]12[H],XIURVHNZVLADCM-IUODEOHRSA-N,396.438,Q7CRA4,BE0004335,Penicillin-binding protein 1b,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB00456,Cefalotin,small molecule,approved;investigational;vet_approved,[H][C@@]1(NC(=O)CC2=CC=CS2)C(=O)N2C(C(O)=O)=C(COC(C)=O)CS[C@]12[H],XIURVHNZVLADCM-IUODEOHRSA-N,396.438,Q75Y35,BE0004643,Penicillin-binding protein 3,Streptococcus pneumoniae,inhibitor,yes
DB00456,Cefalotin,small molecule,approved;investigational;vet_approved,[H][C@@]1(NC(=O)CC2=CC=CS2)C(=O)N2C(C(O)=O)=C(COC(C)=O)CS[C@]12[H],XIURVHNZVLADCM-IUODEOHRSA-N,396.438,Q8DNB6,BE0004644,Penicillin-binding protein 2a,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB00456,Cefalotin,small molecule,approved;investigational;vet_approved,[H][C@@]1(NC(=O)CC2=CC=CS2)C(=O)N2C(C(O)=O)=C(COC(C)=O)CS[C@]12[H],XIURVHNZVLADCM-IUODEOHRSA-N,396.438,P0A3M6,BE0003624,Penicillin-binding protein 2B,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB00456,Cefalotin,small molecule,approved;investigational;vet_approved,[H][C@@]1(NC(=O)CC2=CC=CS2)C(=O)N2C(C(O)=O)=C(COC(C)=O)CS[C@]12[H],XIURVHNZVLADCM-IUODEOHRSA-N,396.438,Q8XJ01,BE0000576,Penicillin-binding protein 1A,Clostridium perfringens (strain 13 / Type A),inhibitor,yes
DB00456,Cefalotin,small molecule,approved;investigational;vet_approved,[H][C@@]1(NC(=O)CC2=CC=CS2)C(=O)N2C(C(O)=O)=C(COC(C)=O)CS[C@]12[H],XIURVHNZVLADCM-IUODEOHRSA-N,396.438,P00811,BE0001358,Beta-lactamase,Escherichia coli (strain K12),potentiator,yes
DB00457,Prazosin,small molecule,approved,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1,IENZQIKPVFGBNW-UHFFFAOYSA-N,383.4011,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,antagonist,yes
DB00457,Prazosin,small molecule,approved,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1,IENZQIKPVFGBNW-UHFFFAOYSA-N,383.4011,P35368,BE0000575,Alpha-1B adrenergic receptor,Humans,antagonist,yes
DB00457,Prazosin,small molecule,approved,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1,IENZQIKPVFGBNW-UHFFFAOYSA-N,383.4011,P25100,BE0000715,Alpha-1D adrenergic receptor,Humans,antagonist,yes
DB00458,Imipramine,small molecule,approved,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,BCGWQEUPMDMJNV-UHFFFAOYSA-N,280.4073,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,inhibitor,yes
DB00458,Imipramine,small molecule,approved,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,BCGWQEUPMDMJNV-UHFFFAOYSA-N,280.4073,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB00459,Acitretin,small molecule,approved,COC1=C(C)C(C)=C(\C=C\C(\C)=C\C=C\C(\C)=C\C(O)=O)C(C)=C1,IHUNBGSDBOWDMA-AQFIFDHZSA-N,326.4293,P19793,BE0000412,Retinoic acid receptor RXR-alpha,Humans,agonist,yes
DB00459,Acitretin,small molecule,approved,COC1=C(C)C(C)=C(\C=C\C(\C)=C\C=C\C(\C)=C\C(O)=O)C(C)=C1,IHUNBGSDBOWDMA-AQFIFDHZSA-N,326.4293,P40763,BE0003462,Signal transducer and activator of transcription 3,Humans,inhibitor,yes
DB00459,Acitretin,small molecule,approved,COC1=C(C)C(C)=C(\C=C\C(\C)=C\C=C\C(\C)=C\C(O)=O)C(C)=C1,IHUNBGSDBOWDMA-AQFIFDHZSA-N,326.4293,P10276,BE0000663,Retinoic acid receptor alpha,Humans,agonist,yes
DB00459,Acitretin,small molecule,approved,COC1=C(C)C(C)=C(\C=C\C(\C)=C\C=C\C(\C)=C\C(O)=O)C(C)=C1,IHUNBGSDBOWDMA-AQFIFDHZSA-N,326.4293,P10826,BE0000206,Retinoic acid receptor beta,Humans,agonist,yes
DB00459,Acitretin,small molecule,approved,COC1=C(C)C(C)=C(\C=C\C(\C)=C\C=C\C(\C)=C\C(O)=O)C(C)=C1,IHUNBGSDBOWDMA-AQFIFDHZSA-N,326.4293,P13631,BE0000144,Retinoic acid receptor gamma,Humans,agonist,yes
DB00459,Acitretin,small molecule,approved,COC1=C(C)C(C)=C(\C=C\C(\C)=C\C=C\C(\C)=C\C(O)=O)C(C)=C1,IHUNBGSDBOWDMA-AQFIFDHZSA-N,326.4293,P48443,BE0000707,Retinoic acid receptor RXR-gamma,Humans,agonist,yes
DB00459,Acitretin,small molecule,approved,COC1=C(C)C(C)=C(\C=C\C(\C)=C\C=C\C(\C)=C\C(O)=O)C(C)=C1,IHUNBGSDBOWDMA-AQFIFDHZSA-N,326.4293,P28702,BE0000078,Retinoic acid receptor RXR-beta,Humans,agonist,yes
DB00461,Nabumetone,small molecule,approved,COC1=CC2=C(C=C1)C=C(CCC(C)=O)C=C2,BLXXJMDCKKHMKV-UHFFFAOYSA-N,228.2863,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB00462,Methscopolamine bromide,small molecule,approved,[Br-].[H][C@@]12O[C@]1([H])[C@H]1C[C@H](C[C@@H]2[N+]1(C)C)OC(=O)[C@H](CO)C1=CC=CC=C1,CXYRUNPLKGGUJF-RAFJPFSSSA-M,398.297,P08172,BE0000560,Muscarinic acetylcholine receptor M2,Humans,antagonist,yes
DB00462,Methscopolamine bromide,small molecule,approved,[Br-].[H][C@@]12O[C@]1([H])[C@H]1C[C@H](C[C@@H]2[N+]1(C)C)OC(=O)[C@H](CO)C1=CC=CC=C1,CXYRUNPLKGGUJF-RAFJPFSSSA-M,398.297,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,antagonist,yes
DB00463,Metharbital,small molecule,withdrawn,CCC1(CC)C(=O)NC(=O)N(C)C1=O,FWJKNZONDWOGMI-UHFFFAOYSA-N,198.2191,P47869,BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,Humans,potentiator,yes
DB00463,Metharbital,small molecule,withdrawn,CCC1(CC)C(=O)NC(=O)N(C)C1=O,FWJKNZONDWOGMI-UHFFFAOYSA-N,198.2191,Q99928,BE0003594,Gamma-aminobutyric acid receptor subunit gamma-3,Humans,modulator,yes
DB00463,Metharbital,small molecule,withdrawn,CCC1(CC)C(=O)NC(=O)N(C)C1=O,FWJKNZONDWOGMI-UHFFFAOYSA-N,198.2191,P34903,BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,Humans,potentiator,yes
DB00463,Metharbital,small molecule,withdrawn,CCC1(CC)C(=O)NC(=O)N(C)C1=O,FWJKNZONDWOGMI-UHFFFAOYSA-N,198.2191,P48169,BE0000478,Gamma-aminobutyric acid receptor subunit alpha-4,Humans,potentiator,yes
DB00463,Metharbital,small molecule,withdrawn,CCC1(CC)C(=O)NC(=O)N(C)C1=O,FWJKNZONDWOGMI-UHFFFAOYSA-N,198.2191,P31644,BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,Humans,potentiator,yes
DB00463,Metharbital,small molecule,withdrawn,CCC1(CC)C(=O)NC(=O)N(C)C1=O,FWJKNZONDWOGMI-UHFFFAOYSA-N,198.2191,Q16445,BE0000764,Gamma-aminobutyric acid receptor subunit alpha-6,Humans,potentiator,yes
DB00463,Metharbital,small molecule,withdrawn,CCC1(CC)C(=O)NC(=O)N(C)C1=O,FWJKNZONDWOGMI-UHFFFAOYSA-N,198.2191,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB00463,Metharbital,small molecule,withdrawn,CCC1(CC)C(=O)NC(=O)N(C)C1=O,FWJKNZONDWOGMI-UHFFFAOYSA-N,198.2191,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,potentiator,yes
DB00464,Sodium tetradecyl sulfate,small molecule,approved;investigational,[Na+].CCCCC(CC)CCC(CC(C)C)OS([O-])(=O)=O,FVEFRICMTUKAML-UHFFFAOYSA-M,316.43,P07225,BE0000943,Vitamin K-dependent protein S,Humans,inhibitor,yes
DB00464,Sodium tetradecyl sulfate,small molecule,approved;investigational,[Na+].CCCCC(CC)CCC(CC(C)C)OS([O-])(=O)=O,FVEFRICMTUKAML-UHFFFAOYSA-M,316.43,P04070,BE0000380,Vitamin K-dependent protein C,Humans,inhibitor,yes
DB00465,Ketorolac,small molecule,approved,OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1,OZWKMVRBQXNZKK-UHFFFAOYSA-N,255.2686,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB00465,Ketorolac,small molecule,approved,OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1,OZWKMVRBQXNZKK-UHFFFAOYSA-N,255.2686,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB00466,Picrotoxin,small molecule,experimental,[H][C@@]12OC(=O)[C@@]34OC3C[C@@](O)(C3[C@@H](C1OC3=O)C(C)=C)[C@@]24C.[H][C@@]12C[C@@]3(O)C4[C@@H](C(OC4=O)[C@@]4([H])OC(=O)[C@]1(O2)[C@@]34C)C(C)(C)O,VJKUPQSHOVKBCO-ZTYBEOBUSA-N,602.5832,P24046,BE0000129,Gamma-aminobutyric acid receptor subunit rho-1,Humans,antagonist,yes
DB00466,Picrotoxin,small molecule,experimental,[H][C@@]12OC(=O)[C@@]34OC3C[C@@](O)(C3[C@@H](C1OC3=O)C(C)=C)[C@@]24C.[H][C@@]12C[C@@]3(O)C4[C@@H](C(OC4=O)[C@@]4([H])OC(=O)[C@]1(O2)[C@@]34C)C(C)(C)O,VJKUPQSHOVKBCO-ZTYBEOBUSA-N,602.5832,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,antagonist,yes
DB00467,Enoxacin,small molecule,approved;investigational,CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(N=C12)N1CCNCC1,IDYZIJYBMGIQMJ-UHFFFAOYSA-N,320.3189,Q02880,BE0002425,DNA topoisomerase 2-beta,Humans,inhibitor,yes
DB00467,Enoxacin,small molecule,approved;investigational,CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(N=C12)N1CCNCC1,IDYZIJYBMGIQMJ-UHFFFAOYSA-N,320.3189,P43700,BE0000366,DNA gyrase subunit A,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd),inhibitor,yes
DB00467,Enoxacin,small molecule,approved;investigational,CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(N=C12)N1CCNCC1,IDYZIJYBMGIQMJ-UHFFFAOYSA-N,320.3189,P43702,BE0000429,DNA topoisomerase 4 subunit A,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd),inhibitor,yes
DB00467,Enoxacin,small molecule,approved;investigational,CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(N=C12)N1CCNCC1,IDYZIJYBMGIQMJ-UHFFFAOYSA-N,320.3189,P11388,BE0000742,DNA topoisomerase 2-alpha,Humans,inhibitor,yes
DB00468,Quinine,small molecule,approved,[H][C@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@H](O)C1=CC=NC2=CC=C(OC)C=C12,LOUPRKONTZGTKE-WZBLMQSHSA-N,324.4168,,BE0004805,Fe(II)-protoporphyrin IX,Plasmodium falciparum,antagonist,yes
DB00469,Tenoxicam,small molecule,approved,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C2=C(C=CS2)S1(=O)=O,LZNWYQJJBLGYLT-UHFFFAOYSA-N,337.37,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB00470,Dronabinol,small molecule,approved;illicit,[H][C@@]12C=C(C)CC[C@@]1([H])C(C)(C)OC1=C2C(O)=CC(CCCCC)=C1,CYQFCXCEBYINGO-IAGOWNOFSA-N,314.4617,P21554,BE0000061,Cannabinoid receptor 1,Humans,agonist,yes
DB00470,Dronabinol,small molecule,approved;illicit,[H][C@@]12C=C(C)CC[C@@]1([H])C(C)(C)OC1=C2C(O)=CC(CCCCC)=C1,CYQFCXCEBYINGO-IAGOWNOFSA-N,314.4617,P34972,BE0000095,Cannabinoid receptor 2,Humans,agonist,yes
DB00471,Montelukast,small molecule,approved,OC(=O)CC1(CC1)CS[C@H](CCC1=CC=CC=C1C(O)(C)C)C1=CC=CC(\C=C\C2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,UCHDWCPVSPXUMX-TZIWLTJVSA-N,586.183,Q9Y271,BE0000705,Cysteinyl leukotriene receptor 1,Humans,antagonist,yes
DB00472,Fluoxetine,small molecule,approved;vet_approved,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,309.3261,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB00473,Hexylcaine,small molecule,approved;withdrawn,CC(CNC1CCCCC1)OC(=O)C1=CC=CC=C1,DKLKMKYDWHYZTD-UHFFFAOYSA-N,261.3593,Q14524,BE0000197,Sodium channel protein type 5 subunit alpha,Humans,inhibitor,yes
DB00474,Methohexital,small molecule,approved,CCC#CC(C)C1(CC=C)C(=O)NC(=O)N(C)C1=O,NZXKDOXHBHYTKP-UHFFFAOYSA-N,262.3043,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,antagonist,yes
DB00475,Chlordiazepoxide,small molecule,approved;illicit;investigational,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1,ANTSCNMPPGJYLG-UHFFFAOYSA-N,299.755,P30536,BE0000736,Translocator protein,Humans,modulator,yes
DB00475,Chlordiazepoxide,small molecule,approved;illicit;investigational,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1,ANTSCNMPPGJYLG-UHFFFAOYSA-N,299.755,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB00475,Chlordiazepoxide,small molecule,approved;illicit;investigational,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1,ANTSCNMPPGJYLG-UHFFFAOYSA-N,299.755,P14867,BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,Humans,ligand,yes
DB00476,Duloxetine,small molecule,approved,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,ZEUITGRIYCTCEM-KRWDZBQOSA-N,297.415,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB00476,Duloxetine,small molecule,approved,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,ZEUITGRIYCTCEM-KRWDZBQOSA-N,297.415,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,inhibitor,yes
DB00477,Chlorpromazine,small molecule,approved;investigational;vet_approved,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,ZPEIMTDSQAKGNT-UHFFFAOYSA-N,318.864,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB00477,Chlorpromazine,small molecule,approved;investigational;vet_approved,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,ZPEIMTDSQAKGNT-UHFFFAOYSA-N,318.864,P21728,BE0000020,D(1A) dopamine receptor,Humans,antagonist,yes
DB00477,Chlorpromazine,small molecule,approved;investigational;vet_approved,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,ZPEIMTDSQAKGNT-UHFFFAOYSA-N,318.864,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,antagonist,yes
DB00477,Chlorpromazine,small molecule,approved;investigational;vet_approved,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,ZPEIMTDSQAKGNT-UHFFFAOYSA-N,318.864,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB00477,Chlorpromazine,small molecule,approved;investigational;vet_approved,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,ZPEIMTDSQAKGNT-UHFFFAOYSA-N,318.864,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,antagonist,yes
DB00477,Chlorpromazine,small molecule,approved;investigational;vet_approved,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,ZPEIMTDSQAKGNT-UHFFFAOYSA-N,318.864,P35368,BE0000575,Alpha-1B adrenergic receptor,Humans,antagonist,yes
DB00477,Chlorpromazine,small molecule,approved;investigational;vet_approved,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,ZPEIMTDSQAKGNT-UHFFFAOYSA-N,318.864,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB00479,Amikacin,small molecule,approved;investigational;vet_approved,NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O,LKCWBDHBTVXHDL-RMDFUYIESA-N,585.6025,P0A7S3,BE0000279,30S ribosomal protein S12,Escherichia coli (strain K12),inhibitor,yes
DB00480,Lenalidomide,small molecule,approved,NC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O,GOTYRUGSSMKFNF-UHFFFAOYSA-N,259.2606,P01375,BE0000704,Tumor necrosis factor,Humans,inhibitor,yes
DB00480,Lenalidomide,small molecule,approved,NC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O,GOTYRUGSSMKFNF-UHFFFAOYSA-N,259.2606,Q96SW2,BE0004755,Protein cereblon,Humans,inhibitor,yes
DB00480,Lenalidomide,small molecule,approved,NC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O,GOTYRUGSSMKFNF-UHFFFAOYSA-N,259.2606,O14788,BE0003517,Tumor necrosis factor ligand superfamily member 11,Humans,inhibitor,yes
DB00481,Raloxifene,small molecule,approved;investigational,OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2,GZUITABIAKMVPG-UHFFFAOYSA-N,473.583,P03372,BE0000123,Estrogen receptor,Humans,agonist,yes
DB00481,Raloxifene,small molecule,approved;investigational,OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2,GZUITABIAKMVPG-UHFFFAOYSA-N,473.583,Q92731,BE0000792,Estrogen receptor beta,Humans,agonist,yes
DB00482,Celecoxib,small molecule,approved;investigational,CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F,RZEKVGVHFLEQIL-UHFFFAOYSA-N,381.372,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB00482,Celecoxib,small molecule,approved;investigational,CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F,RZEKVGVHFLEQIL-UHFFFAOYSA-N,381.372,P40763,BE0003462,Signal transducer and activator of transcription 3,Humans,inhibitor,yes
DB00482,Celecoxib,small molecule,approved;investigational,CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F,RZEKVGVHFLEQIL-UHFFFAOYSA-N,381.372,Q99519,BE0000914,Sialidase-1,Humans,inhibitor,yes
DB00483,Gallamine triethiodide,small molecule,approved,[I-].[I-].[I-].CC[N+](CC)(CC)CCOC1=CC=CC(OCC[N+](CC)(CC)CC)=C1OCC[N+](CC)(CC)CC,REEUVFCVXKWOFE-UHFFFAOYSA-K,891.5291,P08172,BE0000560,Muscarinic acetylcholine receptor M2,Humans,antagonist,yes
DB00483,Gallamine triethiodide,small molecule,approved,[I-].[I-].[I-].CC[N+](CC)(CC)CCOC1=CC=CC(OCC[N+](CC)(CC)CC)=C1OCC[N+](CC)(CC)CC,REEUVFCVXKWOFE-UHFFFAOYSA-K,891.5291,P22303,BE0000426,Acetylcholinesterase,Humans,inhibitor,yes
DB00484,Brimonidine,small molecule,approved,BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12,XYLJNLCSTIOKRM-UHFFFAOYSA-N,292.135,P08913,BE0000289,Alpha-2A adrenergic receptor,Humans,agonist,yes
DB00484,Brimonidine,small molecule,approved,BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12,XYLJNLCSTIOKRM-UHFFFAOYSA-N,292.135,P18089,BE0000572,Alpha-2B adrenergic receptor,Humans,agonist,yes
DB00484,Brimonidine,small molecule,approved,BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12,XYLJNLCSTIOKRM-UHFFFAOYSA-N,292.135,P18825,BE0000342,Alpha-2C adrenergic receptor,Humans,agonist,yes
DB00485,Dicloxacillin,small molecule,approved;investigational;vet_approved,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=C(Cl)C=CC=C1Cl)C(O)=O,YFAGHNZHGGCZAX-JKIFEVAISA-N,470.326,A0A0E1R3H3,BE0009126,Penicillin-binding protein 3,Listeria monocytogenes serotype 4b str. LL195,inhibitor,yes
DB00485,Dicloxacillin,small molecule,approved;investigational;vet_approved,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=C(Cl)C=CC=C1Cl)C(O)=O,YFAGHNZHGGCZAX-JKIFEVAISA-N,470.326,Q7CRA4,BE0004335,Penicillin-binding protein 1b,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB00485,Dicloxacillin,small molecule,approved;investigational;vet_approved,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=C(Cl)C=CC=C1Cl)C(O)=O,YFAGHNZHGGCZAX-JKIFEVAISA-N,470.326,Q8DNB6,BE0004644,Penicillin-binding protein 2a,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB00485,Dicloxacillin,small molecule,approved;investigational;vet_approved,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=C(Cl)C=CC=C1Cl)C(O)=O,YFAGHNZHGGCZAX-JKIFEVAISA-N,470.326,Q75Y35,BE0004643,Penicillin-binding protein 3,Streptococcus pneumoniae,inhibitor,yes
DB00485,Dicloxacillin,small molecule,approved;investigational;vet_approved,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=C(Cl)C=CC=C1Cl)C(O)=O,YFAGHNZHGGCZAX-JKIFEVAISA-N,470.326,Q8DR59,BE0004290,Penicillin-binding protein 1A,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB00485,Dicloxacillin,small molecule,approved;investigational;vet_approved,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=C(Cl)C=CC=C1Cl)C(O)=O,YFAGHNZHGGCZAX-JKIFEVAISA-N,470.326,P0A3M6,BE0003624,Penicillin-binding protein 2B,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB00486,Nabilone,small molecule,approved;investigational,[H][C@@]12CC(=O)CC[C@@]1([H])C(C)(C)OC1=CC(=CC(O)=C21)C(C)(C)CCCCCC,GECBBEABIDMGGL-RTBURBONSA-N,372.5408,P34972,BE0000095,Cannabinoid receptor 2,Humans,partial agonist,yes
DB00486,Nabilone,small molecule,approved;investigational,[H][C@@]12CC(=O)CC[C@@]1([H])C(C)(C)OC1=CC(=CC(O)=C21)C(C)(C)CCCCCC,GECBBEABIDMGGL-RTBURBONSA-N,372.5408,P21554,BE0000061,Cannabinoid receptor 1,Humans,partial agonist,yes
DB00487,Pefloxacin,small molecule,approved,CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(C=C12)N1CCN(C)CC1,FHFYDNQZQSQIAI-UHFFFAOYSA-N,333.3574,Q02880,BE0002425,DNA topoisomerase 2-beta,Humans,inhibitor,yes
DB00487,Pefloxacin,small molecule,approved,CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(C=C12)N1CCN(C)CC1,FHFYDNQZQSQIAI-UHFFFAOYSA-N,333.3574,P43702,BE0000429,DNA topoisomerase 4 subunit A,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd),inhibitor,yes
DB00487,Pefloxacin,small molecule,approved,CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(C=C12)N1CCN(C)CC1,FHFYDNQZQSQIAI-UHFFFAOYSA-N,333.3574,P43700,BE0000366,DNA gyrase subunit A,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd),inhibitor,yes
DB00487,Pefloxacin,small molecule,approved,CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(C=C12)N1CCN(C)CC1,FHFYDNQZQSQIAI-UHFFFAOYSA-N,333.3574,P11388,BE0000742,DNA topoisomerase 2-alpha,Humans,inhibitor,yes
DB00489,Sotalol,small molecule,approved,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,ZBMZVLHSJCTVON-UHFFFAOYSA-N,272.364,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,antagonist,yes
DB00489,Sotalol,small molecule,approved,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,ZBMZVLHSJCTVON-UHFFFAOYSA-N,272.364,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,antagonist,yes
DB00489,Sotalol,small molecule,approved,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,ZBMZVLHSJCTVON-UHFFFAOYSA-N,272.364,Q12809,BE0000090,Voltage-gated inwardly rectifying potassium channel KCNH2,Humans,inhibitor,yes
DB00490,Buspirone,small molecule,approved;investigational,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,QWCRAEMEVRGPNT-UHFFFAOYSA-N,385.5031,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,partial agonist,yes
DB00490,Buspirone,small molecule,approved;investigational,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,QWCRAEMEVRGPNT-UHFFFAOYSA-N,385.5031,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB00491,Miglitol,small molecule,approved,OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,IBAQFPQHRJAVAV-ULAWRXDQSA-N,207.2243,P10253,BE0000876,Lysosomal alpha-glucosidase,Humans,antagonist,yes
DB00491,Miglitol,small molecule,approved,OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,IBAQFPQHRJAVAV-ULAWRXDQSA-N,207.2243,Q14697,BE0004698,Neutral alpha-glucosidase AB,Humans,antagonist,yes
DB00491,Miglitol,small molecule,approved,OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,IBAQFPQHRJAVAV-ULAWRXDQSA-N,207.2243,Q8TET4,BE0004699,Neutral alpha-glucosidase C,Humans,antagonist,yes
DB00491,Miglitol,small molecule,approved,OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,IBAQFPQHRJAVAV-ULAWRXDQSA-N,207.2243,O43451,BE0000837,Maltase-glucoamylase,Humans,antagonist;inhibitor,yes
DB00492,Fosinopril,small molecule,approved,CCC(=O)O[C@@H](OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N1C[C@@H](C[C@H]1C(O)=O)C1CCCCC1)C(C)C,BIDNLKIUORFRQP-FLODCBCLSA-N,563.672,P12821,BE0000221,Angiotensin-converting enzyme,Humans,inhibitor,yes
DB00493,Cefotaxime,small molecule,approved,[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,GPRBEKHLDVQUJE-QSWIMTSFSA-N,455.465,Q7CRA4,BE0004335,Penicillin-binding protein 1b,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB00493,Cefotaxime,small molecule,approved,[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,GPRBEKHLDVQUJE-QSWIMTSFSA-N,455.465,Q8DNB6,BE0004644,Penicillin-binding protein 2a,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB00493,Cefotaxime,small molecule,approved,[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,GPRBEKHLDVQUJE-QSWIMTSFSA-N,455.465,P42971,BE0000790,Penicillin-binding protein 3,Bacillus subtilis (strain 168),inhibitor,yes
DB00493,Cefotaxime,small molecule,approved,[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,GPRBEKHLDVQUJE-QSWIMTSFSA-N,455.465,Q8DR59,BE0004290,Penicillin-binding protein 1A,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB00493,Cefotaxime,small molecule,approved,[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,GPRBEKHLDVQUJE-QSWIMTSFSA-N,455.465,P0A3M6,BE0003624,Penicillin-binding protein 2B,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB00494,Entacapone,small molecule,approved;investigational,CCN(CC)C(=O)C(=C\C1=CC(=C(O)C(O)=C1)[N+]([O-])=O)\C#N,JRURYQJSLYLRLN-BJMVGYQFSA-N,305.286,P21964,BE0002089,Catechol O-methyltransferase,Humans,inhibitor,yes
DB00495,Zidovudine,small molecule,approved,CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O,HBOMLICNUCNMMY-XLPZGREQSA-N,267.2413,P36888,BE0000147,Receptor-type tyrosine-protein kinase FLT3,Humans,binder,yes
DB00495,Zidovudine,small molecule,approved,CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O,HBOMLICNUCNMMY-XLPZGREQSA-N,267.2413,Q72547,BE0004136,Reverse transcriptase/RNaseH,Human immunodeficiency virus 1,inhibitor,yes
DB00495,Zidovudine,small molecule,approved,CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O,HBOMLICNUCNMMY-XLPZGREQSA-N,267.2413,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB00496,Darifenacin,small molecule,approved;investigational,NC(=O)C([C@@H]1CCN(CCC2=CC3=C(OCC3)C=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1,HXGBXQDTNZMWGS-RUZDIDTESA-N,426.55,P20309,BE0000045,Muscarinic acetylcholine receptor M3,Humans,antagonist,yes
DB00497,Oxycodone,small molecule,approved;illicit;investigational,COC1=C2O[C@H]3C(=O)CC[C@@]4(O)[C@H]5CC(C=C1)=C2[C@@]34CCN5C,BRUQQQPBMZOVGD-XFKAJCMBSA-N,315.3636,P35372,BE0000770,Mu-type opioid receptor,Humans,agonist,yes
DB00497,Oxycodone,small molecule,approved;illicit;investigational,COC1=C2O[C@H]3C(=O)CC[C@@]4(O)[C@H]5CC(C=C1)=C2[C@@]34CCN5C,BRUQQQPBMZOVGD-XFKAJCMBSA-N,315.3636,P41145,BE0000632,Kappa-type opioid receptor,Humans,agonist,yes
DB00497,Oxycodone,small molecule,approved;illicit;investigational,COC1=C2O[C@H]3C(=O)CC[C@@]4(O)[C@H]5CC(C=C1)=C2[C@@]34CCN5C,BRUQQQPBMZOVGD-XFKAJCMBSA-N,315.3636,P41143,BE0000420,Delta-type opioid receptor,Humans,agonist,yes
DB00498,Phenindione,small molecule,approved;investigational,O=C1C(C(=O)C2=CC=CC=C12)C1=CC=CC=C1,NFBAXHOPROOJAW-UHFFFAOYSA-N,222.2387,Q9BQB6,BE0000713,Vitamin K epoxide reductase complex subunit 1,Humans,inhibitor,yes
DB00499,Flutamide,small molecule,approved;investigational,CC(C)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F,MKXKFYHWDHIYRV-UHFFFAOYSA-N,276.2118,P10275,BE0000132,Androgen receptor,Humans,antagonist,yes
DB00500,Tolmetin,small molecule,approved,CN1C(CC(O)=O)=CC=C1C(=O)C1=CC=C(C)C=C1,UPSPUYADGBWSHF-UHFFFAOYSA-N,257.2845,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB00501,Cimetidine,small molecule,approved;investigational,CN\C(NCCSCC1=C(C)NC=N1)=N\C#N,AQIXAKUUQRKLND-UHFFFAOYSA-N,252.339,P25021,BE0000112,Histamine H2 receptor,Humans,antagonist,yes
DB00502,Haloperidol,small molecule,approved,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,LNEPOXFFQSENCJ-UHFFFAOYSA-N,375.864,P28335,BE0000533,5-hydroxytryptamine receptor 2C,Humans,antagonist,yes
DB00502,Haloperidol,small molecule,approved,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,LNEPOXFFQSENCJ-UHFFFAOYSA-N,375.864,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB00503,Ritonavir,small molecule,approved;investigational,CC(C)[C@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC1=CC=CC=C1)NC(=O)OCC1=CN=CS1)CC1=CC=CC=C1,NCDNCNXCDXHOMX-XGKFQTDJSA-N,720.944,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB00503,Ritonavir,small molecule,approved;investigational,CC(C)[C@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC1=CC=CC=C1)NC(=O)OCC1=CN=CS1)CC1=CC=CC=C1,NCDNCNXCDXHOMX-XGKFQTDJSA-N,720.944,Q72874,BE0004854,Pol polyprotein,Human immunodeficiency virus 1,inhibitor,yes
DB00504,Levallorphan,small molecule,approved,[H][C@@]12CCCC[C@@]11CCN(CC=C)[C@@H]2CC2=C1C=C(O)C=C2,OZYUPQUCAUTOBP-QXAKKESOSA-N,283.4079,Q15822,BE0000738,Neuronal acetylcholine receptor subunit alpha-2,Humans,antagonist,yes
DB00504,Levallorphan,small molecule,approved,[H][C@@]12CCCC[C@@]11CCN(CC=C)[C@@H]2CC2=C1C=C(O)C=C2,OZYUPQUCAUTOBP-QXAKKESOSA-N,283.4079,P35372,BE0000770,Mu-type opioid receptor,Humans,partial agonist,yes
DB00505,Tridihexethyl,small molecule,withdrawn,CC[N+](CC)(CC)CCC(O)(C1CCCCC1)C1=CC=CC=C1,NPRHVSBSZMAEIN-UHFFFAOYSA-N,318.5166,P08912,BE0000247,Muscarinic acetylcholine receptor M5,Humans,binder,yes
DB00505,Tridihexethyl,small molecule,withdrawn,CC[N+](CC)(CC)CCC(O)(C1CCCCC1)C1=CC=CC=C1,NPRHVSBSZMAEIN-UHFFFAOYSA-N,318.5166,P20309,BE0000045,Muscarinic acetylcholine receptor M3,Humans,antagonist,yes
DB00505,Tridihexethyl,small molecule,withdrawn,CC[N+](CC)(CC)CCC(O)(C1CCCCC1)C1=CC=CC=C1,NPRHVSBSZMAEIN-UHFFFAOYSA-N,318.5166,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,antagonist,yes
DB00505,Tridihexethyl,small molecule,withdrawn,CC[N+](CC)(CC)CCC(O)(C1CCCCC1)C1=CC=CC=C1,NPRHVSBSZMAEIN-UHFFFAOYSA-N,318.5166,P08172,BE0000560,Muscarinic acetylcholine receptor M2,Humans,antagonist,yes
DB00507,Nitazoxanide,small molecule,approved;investigational;vet_approved,CC(=O)OC1=CC=CC=C1C(=O)NC1=NC=C(S1)[N+]([O-])=O,YQNQNVDNTFHQSW-UHFFFAOYSA-N,307.282,P94692,BE0002674,Pyruvate synthase,Desulfovibrio africanus,antagonist;inhibitor,yes
DB00508,Triflupromazine,small molecule,approved;vet_approved,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F,XSCGXQMFQXDFCW-UHFFFAOYSA-N,352.417,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB00508,Triflupromazine,small molecule,approved;vet_approved,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F,XSCGXQMFQXDFCW-UHFFFAOYSA-N,352.417,P21728,BE0000020,D(1A) dopamine receptor,Humans,antagonist,yes
DB00508,Triflupromazine,small molecule,approved;vet_approved,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F,XSCGXQMFQXDFCW-UHFFFAOYSA-N,352.417,P41595,BE0000393,5-hydroxytryptamine receptor 2B,Humans,antagonist,yes
DB00508,Triflupromazine,small molecule,approved;vet_approved,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F,XSCGXQMFQXDFCW-UHFFFAOYSA-N,352.417,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,antagonist,yes
DB00508,Triflupromazine,small molecule,approved;vet_approved,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F,XSCGXQMFQXDFCW-UHFFFAOYSA-N,352.417,P08172,BE0000560,Muscarinic acetylcholine receptor M2,Humans,antagonist,yes
DB00509,Dextrothyroxine,small molecule,approved;investigational,N[C@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O,XUIIKFGFIJCVMT-GFCCVEGCSA-N,776.87,P10827,BE0000687,Thyroid hormone receptor alpha,Humans,agonist,yes
DB00509,Dextrothyroxine,small molecule,approved;investigational,N[C@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O,XUIIKFGFIJCVMT-GFCCVEGCSA-N,776.87,P10828,BE0000315,Thyroid hormone receptor beta,Humans,agonist,yes
DB00511,Acetyldigitoxin,small molecule,approved,[H][C@@]1(CC[C@]2(O)[C@]3([H])CC[C@]4([H])C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](OC(C)=O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)C1=CC(=O)OC1,HPMZBILYSWLILX-UMDUKNJSSA-N,806.9757,P05023,BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,Humans,inhibitor,yes
DB00512,Vancomycin,small molecule,approved,CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(N)[C@H](O)[C@H](C)O4)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]1C3=CC(=C(O)C=C3)C3=C(O)C=C(O)C=C3[C@H](NC(=O)[C@@H](NC1=O)[C@H](O)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2,MYPYJXKWCTUITO-LYRMYLQWSA-N,1449.254,,BE0004826,D-Ala-D-Ala moiety of NAM/NAG peptide subunits of peptidoglycan,Gram-positive Bacteria,ligand,yes
DB00513,Aminocaproic acid,small molecule,approved;investigational,NCCCCCC(O)=O,SLXKOJJOQWFEFD-UHFFFAOYSA-N,131.1729,P00747,BE0000211,Plasminogen,Humans,inhibitor,yes
DB00513,Aminocaproic acid,small molecule,approved;investigational,NCCCCCC(O)=O,SLXKOJJOQWFEFD-UHFFFAOYSA-N,131.1729,P00750,BE0001088,Tissue-type plasminogen activator,Humans,antagonist,yes
DB00514,Dextromethorphan,small molecule,approved,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,MKXZASYAUGDDCJ-NJAFHUGGSA-N,271.404,Q99720,BE0000156,Sigma non-opioid intracellular receptor 1,Humans,agonist,yes
DB00514,Dextromethorphan,small molecule,approved,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,MKXZASYAUGDDCJ-NJAFHUGGSA-N,271.404,P11511,BE0002090,Aromatase,Humans,inhibitor,yes
DB00514,Dextromethorphan,small molecule,approved,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,MKXZASYAUGDDCJ-NJAFHUGGSA-N,271.404,Q8TCU5,BE0000641,"Glutamate receptor ionotropic, NMDA 3A",Humans,antagonist,yes
DB00515,Cisplatin,small molecule,approved,[H][N]([H])([H])[Pt](Cl)(Cl)[N]([H])([H])[H],LXZZYRPGZAFOLE-UHFFFAOYSA-L,300.05,,BE0004796,DNA,Humans,cross-linking/alkylation,yes
DB00517,Anisotropine methylbromide,small molecule,approved,[Br-].CCCC(CCC)C(=O)O[C@H]1CC2CCC(C1)[N+]2(C)C,QSFKGMJOKUZAJM-UHFFFAOYSA-M,362.345,P08912,BE0000247,Muscarinic acetylcholine receptor M5,Humans,binder,yes
DB00517,Anisotropine methylbromide,small molecule,approved,[Br-].CCCC(CCC)C(=O)O[C@H]1CC2CCC(C1)[N+]2(C)C,QSFKGMJOKUZAJM-UHFFFAOYSA-M,362.345,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,antagonist,yes
DB00517,Anisotropine methylbromide,small molecule,approved,[Br-].CCCC(CCC)C(=O)O[C@H]1CC2CCC(C1)[N+]2(C)C,QSFKGMJOKUZAJM-UHFFFAOYSA-M,362.345,P08172,BE0000560,Muscarinic acetylcholine receptor M2,Humans,antagonist,yes
DB00517,Anisotropine methylbromide,small molecule,approved,[Br-].CCCC(CCC)C(=O)O[C@H]1CC2CCC(C1)[N+]2(C)C,QSFKGMJOKUZAJM-UHFFFAOYSA-M,362.345,P20309,BE0000045,Muscarinic acetylcholine receptor M3,Humans,antagonist,yes
DB00518,Albendazole,small molecule,approved;vet_approved,CCCSC1=CC2=C(C=C1)N=C(NC(=O)OC)N2,HXHWSAZORRCQMX-UHFFFAOYSA-N,265.331,F1L7U3,BE0004789,Tubulin beta-2 chain,Pig roundworm,inhibitor,yes
DB00519,Trandolapril,small molecule,approved,[H][C@@]12C[C@H](N(C(=O)[C@H](C)N[C@@H](CCC3=CC=CC=C3)C(=O)OCC)[C@@]1([H])CCCC2)C(O)=O,VXFJYXUZANRPDJ-WTNASJBWSA-N,430.5372,P12821,BE0000221,Angiotensin-converting enzyme,Humans,inhibitor,yes
DB00520,Caspofungin,small molecule,approved,[H][C@@]12C[C@@H](O)CN1C(=O)[C@@H](NC(=O)[C@]([H])(C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]1[C@@H](O)CCN1C(=O)[C@@H](NC(=O)[C@@H](NC2=O)[C@H](O)[C@@H](O)C1=CC=C(O)C=C1)[C@H](O)CCN)NC(=O)CCCCCCCC[C@@H](C)C[C@@H](C)CC)[C@@H](C)O,JYIKNQVWKBUSNH-WVDDFWQHSA-N,1093.331,A2QLK4,BE0004669,"1,3-beta-glucan synthase component FKS1",Aspergillus niger (strain CBS 513.88 / FGSC A1513),inhibitor,yes
DB00520,Caspofungin,small molecule,approved,[H][C@@]12C[C@@H](O)CN1C(=O)[C@@H](NC(=O)[C@]([H])(C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]1[C@@H](O)CCN1C(=O)[C@@H](NC(=O)[C@@H](NC2=O)[C@H](O)[C@@H](O)C1=CC=C(O)C=C1)[C@H](O)CCN)NC(=O)CCCCCCCC[C@@H](C)C[C@@H](C)CC)[C@@H](C)O,JYIKNQVWKBUSNH-WVDDFWQHSA-N,1093.331,P40989,BE0010066,"1,3-beta-glucan synthase component GSC2",Baker's yeast,modulator,yes
DB00521,Carteolol,small molecule,approved,CC(C)(C)NCC(O)COC1=CC=CC2=C1CCC(=O)N2,LWAFSWPYPHEXKX-UHFFFAOYSA-N,292.3734,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,antagonist,yes
DB00521,Carteolol,small molecule,approved,CC(C)(C)NCC(O)COC1=CC=CC2=C1CCC(=O)N2,LWAFSWPYPHEXKX-UHFFFAOYSA-N,292.3734,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,antagonist;partial agonist,yes
DB00522,Bentiromide,small molecule,investigational;withdrawn,OC(=O)C1=CC=C(NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)C2=CC=CC=C2)C=C1,SPPTWHFVYKCNNK-FQEVSTJZSA-N,404.4153,P05981,BE0002128,Serine protease hepsin,Humans,ligand,yes
DB00523,Alitretinoin,small molecule,approved;investigational,C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O,SHGAZHPCJJPHSC-ZVCIMWCZSA-N,300.4351,P10276,BE0000663,Retinoic acid receptor alpha,Humans,agonist,yes
DB00523,Alitretinoin,small molecule,approved;investigational,C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O,SHGAZHPCJJPHSC-ZVCIMWCZSA-N,300.4351,P19793,BE0000412,Retinoic acid receptor RXR-alpha,Humans,agonist,yes
DB00523,Alitretinoin,small molecule,approved;investigational,C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O,SHGAZHPCJJPHSC-ZVCIMWCZSA-N,300.4351,P10826,BE0000206,Retinoic acid receptor beta,Humans,agonist,yes
DB00523,Alitretinoin,small molecule,approved;investigational,C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O,SHGAZHPCJJPHSC-ZVCIMWCZSA-N,300.4351,P28702,BE0000078,Retinoic acid receptor RXR-beta,Humans,agonist,yes
DB00523,Alitretinoin,small molecule,approved;investigational,C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O,SHGAZHPCJJPHSC-ZVCIMWCZSA-N,300.4351,P13631,BE0000144,Retinoic acid receptor gamma,Humans,agonist,yes
DB00523,Alitretinoin,small molecule,approved;investigational,C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O,SHGAZHPCJJPHSC-ZVCIMWCZSA-N,300.4351,P48443,BE0000707,Retinoic acid receptor RXR-gamma,Humans,agonist,yes
DB00524,Metolazone,small molecule,approved,CC1NC2=CC(Cl)=C(C=C2C(=O)N1C1=CC=CC=C1C)S(N)(=O)=O,AQCHWTWZEMGIFD-UHFFFAOYSA-N,365.835,P55017,BE0000419,Solute carrier family 12 member 3,Humans,inhibitor,yes
DB00525,Tolnaftate,small molecule,approved;investigational;vet_approved,CN(C(=S)OC1=CC2=CC=CC=C2C=C1)C1=CC=CC(C)=C1,FUSNMLFNXJSCDI-UHFFFAOYSA-N,307.409,Q92206,BE0004670,Squalene monooxygenase,Yeast,inhibitor,yes
DB00525,Tolnaftate,small molecule,approved;investigational;vet_approved,CN(C(=S)OC1=CC2=CC=CC=C2C=C1)C1=CC=CC(C)=C1,FUSNMLFNXJSCDI-UHFFFAOYSA-N,307.409,Q14534,BE0000577,Squalene monooxygenase,Humans,inhibitor,yes
DB00526,Oxaliplatin,small molecule,approved;investigational,[H][N]1([H])[C@@H]2CCCC[C@H]2[N]([H])([H])[Pt]11OC(=O)C(=O)O1,ZROHGHOFXNOHSO-BNTLRKBRSA-L,397.294,,BE0004796,DNA,Humans,adduct;cross-linking/alkylation,yes
DB00527,Cinchocaine,small molecule,approved;vet_approved,CCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC,PUFQVTATUTYEAL-UHFFFAOYSA-N,343.4632,Q14524,BE0000197,Sodium channel protein type 5 subunit alpha,Humans,inhibitor,yes
DB00527,Cinchocaine,small molecule,approved;vet_approved,CCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC,PUFQVTATUTYEAL-UHFFFAOYSA-N,343.4632,Q9Y5Y9,BE0000177,Sodium channel protein type 10 subunit alpha,Humans,inhibitor,yes
DB00528,Lercanidipine,small molecule,approved;investigational,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C1=CC=CC=C1)C1=CC=CC=C1,ZDXUKAKRHYTAKV-UHFFFAOYSA-N,611.7272,Q06432,BE0000679,Voltage-dependent calcium channel gamma-1 subunit,Humans,inhibitor,yes
DB00528,Lercanidipine,small molecule,approved;investigational,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C1=CC=CC=C1)C1=CC=CC=C1,ZDXUKAKRHYTAKV-UHFFFAOYSA-N,611.7272,P54289,BE0000691,Voltage-dependent calcium channel subunit alpha-2/delta-1,Humans,blocker,yes
DB00529,Foscarnet,small molecule,approved,OC(=O)P(O)(O)=O,ZJAOAACCNHFJAH-UHFFFAOYSA-N,126.0053,P04293,BE0000308,DNA polymerase catalytic subunit,HHV-1,inhibitor,yes
DB00529,Foscarnet,small molecule,approved,OC(=O)P(O)(O)=O,ZJAOAACCNHFJAH-UHFFFAOYSA-N,126.0053,P08546,BE0000343,DNA polymerase catalytic subunit,HHV-5,inhibitor,yes
DB00530,Erlotinib,small molecule,approved;investigational,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,AAKJLRGGTJKAMG-UHFFFAOYSA-N,393.4357,O75469,BE0000956,Nuclear receptor subfamily 1 group I member 2,Humans,agonist,yes
DB00530,Erlotinib,small molecule,approved;investigational,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,AAKJLRGGTJKAMG-UHFFFAOYSA-N,393.4357,P00533,BE0000767,Epidermal growth factor receptor,Humans,antagonist,yes
DB00531,Cyclophosphamide,small molecule,approved;investigational,ClCCN(CCCl)P1(=O)NCCCO1,CMSMOCZEIVJLDB-UHFFFAOYSA-N,261.086,,BE0004796,DNA,Humans,cross-linking/alkylation,yes
DB00532,Mephenytoin,small molecule,approved;investigational;withdrawn,CCC1(NC(=O)N(C)C1=O)C1=CC=CC=C1,GMHKMTDVRCWUDX-UHFFFAOYSA-N,218.2518,Q14524,BE0000197,Sodium channel protein type 5 subunit alpha,Humans,inhibitor,yes
DB00533,Rofecoxib,small molecule,approved;investigational;withdrawn,CS(=O)(=O)C1=CC=C(C=C1)C1=C(C(=O)OC1)C1=CC=CC=C1,RZJQGNCSTQAWON-UHFFFAOYSA-N,314.356,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB00534,Chlormerodrin,small molecule,approved;withdrawn,COC(CNC(N)=O)C[Hg]Cl,BJFGVYCULWBXKF-UHFFFAOYSA-M,367.2,Q13621,BE0000502,Solute carrier family 12 member 1,Humans,inducer,yes
DB00535,Cefdinir,small molecule,approved,[H][C@]12SCC(C=C)=C(N1C(=O)[C@H]2NC(=O)C(=N/O)\C1=CSC(N)=N1)C(O)=O,RTXOFQZKPXMALH-GHXIOONMSA-N,395.414,P08149,BE0003621,Penicillin-binding protein 2,Neisseria gonorrhoeae,inhibitor,yes
DB00535,Cefdinir,small molecule,approved,[H][C@]12SCC(C=C)=C(N1C(=O)[C@H]2NC(=O)C(=N/O)\C1=CSC(N)=N1)C(O)=O,RTXOFQZKPXMALH-GHXIOONMSA-N,395.414,Q60FT7,BE0003622,PBP3,Haemophilus influenzae,inhibitor,yes
DB00537,Ciprofloxacin,small molecule,approved;investigational,OC(=O)C1=CN(C2CC2)C2=CC(N3CCNCC3)=C(F)C=C2C1=O,MYSWGUAQZAJSOK-UHFFFAOYSA-N,331.3415,P43702,BE0000429,DNA topoisomerase 4 subunit A,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd),inhibitor,yes
DB00537,Ciprofloxacin,small molecule,approved;investigational,OC(=O)C1=CN(C2CC2)C2=CC(N3CCNCC3)=C(F)C=C2C1=O,MYSWGUAQZAJSOK-UHFFFAOYSA-N,331.3415,P0A0K8,BE0002388,DNA gyrase subunit B,Staphylococcus aureus,modulator,yes
DB00537,Ciprofloxacin,small molecule,approved;investigational,OC(=O)C1=CN(C2CC2)C2=CC(N3CCNCC3)=C(F)C=C2C1=O,MYSWGUAQZAJSOK-UHFFFAOYSA-N,331.3415,P12461,BE0000021,Thymidylate synthase,Yeast,inhibitor,yes
DB00537,Ciprofloxacin,small molecule,approved;investigational,OC(=O)C1=CN(C2CC2)C2=CC(N3CCNCC3)=C(F)C=C2C1=O,MYSWGUAQZAJSOK-UHFFFAOYSA-N,331.3415,P43700,BE0000366,DNA gyrase subunit A,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd),inhibitor,yes
DB00537,Ciprofloxacin,small molecule,approved;investigational,OC(=O)C1=CN(C2CC2)C2=CC(N3CCNCC3)=C(F)C=C2C1=O,MYSWGUAQZAJSOK-UHFFFAOYSA-N,331.3415,P20831,BE0008385,DNA gyrase subunit A,Staphylococcus aureus,modulator,yes
DB00539,Toremifene,small molecule,approved;investigational,CN(C)CCOC1=CC=C(C=C1)C(=C(\CCCl)C1=CC=CC=C1)\C1=CC=CC=C1,XFCLJVABOIYOMF-QPLCGJKRSA-N,405.96,P03372,BE0000123,Estrogen receptor,Humans,modulator,yes
DB00540,Nortriptyline,small molecule,approved,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,263.3767,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,inhibitor,yes
DB00540,Nortriptyline,small molecule,approved,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,263.3767,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB00540,Nortriptyline,small molecule,approved,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,263.3767,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB00541,Vincristine,small molecule,approved;investigational,[H][C@@]12N3CC[C@@]11C4=C(C=C(OC)C(=C4)[C@]4(C[C@H]5C[N@](C[C@](O)(CC)C5)CCC5=C4NC4=CC=CC=C54)C(=O)OC)N(C=O)[C@@]1([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)C=CC3)C(=O)OC,OGWKCGZFUXNPDA-CFWMRBGOSA-N,824.972,P07437,BE0000143,Tubulin beta chain,Humans,inhibitor,yes
DB00542,Benazepril,small molecule,approved;investigational,[H][C@@]1(CCC2=CC=CC=C2N(CC(O)=O)C1=O)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC,XPCFTKFZXHTYIP-PMACEKPBSA-N,424.4895,P12821,BE0000221,Angiotensin-converting enzyme,Humans,inhibitor,yes
DB00543,Amoxapine,small molecule,approved,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1,QWGDMFLQWFTERH-UHFFFAOYSA-N,313.781,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB00543,Amoxapine,small molecule,approved,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1,QWGDMFLQWFTERH-UHFFFAOYSA-N,313.781,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,inhibitor,yes
DB00544,Fluorouracil,small molecule,approved,FC1=CNC(=O)NC1=O,GHASVSINZRGABV-UHFFFAOYSA-N,130.0772,Q12882,BE0000960,Dihydropyrimidine dehydrogenase [NADP(+)],Humans,inhibitor,yes
DB00544,Fluorouracil,small molecule,approved,FC1=CNC(=O)NC1=O,GHASVSINZRGABV-UHFFFAOYSA-N,130.0772,P12461,BE0000021,Thymidylate synthase,Yeast,inhibitor,yes
DB00544,Fluorouracil,small molecule,approved,FC1=CNC(=O)NC1=O,GHASVSINZRGABV-UHFFFAOYSA-N,130.0772,,BE0004796,DNA,Humans,incorporation into and destabilization,yes
DB00544,Fluorouracil,small molecule,approved,FC1=CNC(=O)NC1=O,GHASVSINZRGABV-UHFFFAOYSA-N,130.0772,,BE0004810,RNA,Humans,incorporation into and destabilization,yes
DB00545,Pyridostigmine,small molecule,approved;investigational,CN(C)C(=O)OC1=C[N+](C)=CC=C1,RVOLLAQWKVFTGE-UHFFFAOYSA-N,181.2117,P00742,BE0000216,Coagulation factor X,Humans,inhibitor,yes
DB00545,Pyridostigmine,small molecule,approved;investigational,CN(C)C(=O)OC1=C[N+](C)=CC=C1,RVOLLAQWKVFTGE-UHFFFAOYSA-N,181.2117,P06276,BE0002180,Cholinesterase,Humans,inhibitor,yes
DB00545,Pyridostigmine,small molecule,approved;investigational,CN(C)C(=O)OC1=C[N+](C)=CC=C1,RVOLLAQWKVFTGE-UHFFFAOYSA-N,181.2117,P22303,BE0000426,Acetylcholinesterase,Humans,inhibitor,yes
DB00546,Adinazolam,small molecule,experimental,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12,GJSLOMWRLALDCT-UHFFFAOYSA-N,351.833,P30536,BE0000736,Translocator protein,Humans,agonist,yes
DB00546,Adinazolam,small molecule,experimental,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12,GJSLOMWRLALDCT-UHFFFAOYSA-N,351.833,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB00546,Adinazolam,small molecule,experimental,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12,GJSLOMWRLALDCT-UHFFFAOYSA-N,351.833,P14867,BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,Humans,ligand,yes
DB00547,Desoximetasone,small molecule,approved,[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,VWVSBHGCDBMOOT-IIEHVVJPSA-N,376.4617,P62508,BE0002088,Estrogen-related receptor gamma,Humans,modulator,yes
DB00547,Desoximetasone,small molecule,approved,[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,VWVSBHGCDBMOOT-IIEHVVJPSA-N,376.4617,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB00547,Desoximetasone,small molecule,approved,[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,VWVSBHGCDBMOOT-IIEHVVJPSA-N,376.4617,O95718,BE0005001,Steroid hormone receptor ERR2,Humans,modulator,yes
DB00547,Desoximetasone,small molecule,approved,[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,VWVSBHGCDBMOOT-IIEHVVJPSA-N,376.4617,P11474,BE0003722,Steroid hormone receptor ERR1,Humans,modulator,yes
DB00548,Azelaic acid,small molecule,approved,OC(=O)CCCCCCCC(O)=O,BDJRBEYXGGNYIS-UHFFFAOYSA-N,188.2209,P66010,BE0000474,Thioredoxin reductase,Staphylococcus aureus (strain Mu50 / ATCC 700699),inhibitor,yes
DB00548,Azelaic acid,small molecule,approved,OC(=O)CCCCCCCC(O)=O,BDJRBEYXGGNYIS-UHFFFAOYSA-N,188.2209,Q9H8P0,BE0009587,Polyprenal reductase,Humans,inhibitor,yes
DB00548,Azelaic acid,small molecule,approved,OC(=O)CCCCCCCC(O)=O,BDJRBEYXGGNYIS-UHFFFAOYSA-N,188.2209,P18405,BE0000539,3-oxo-5-alpha-steroid 4-dehydrogenase 1,Humans,inhibitor,yes
DB00548,Azelaic acid,small molecule,approved,OC(=O)CCCCCCCC(O)=O,BDJRBEYXGGNYIS-UHFFFAOYSA-N,188.2209,P51857,BE0003610,Aldo-keto reductase family 1 member D1,Humans,inhibitor,yes
DB00548,Azelaic acid,small molecule,approved,OC(=O)CCCCCCCC(O)=O,BDJRBEYXGGNYIS-UHFFFAOYSA-N,188.2209,P31213,BE0000585,3-oxo-5-alpha-steroid 4-dehydrogenase 2,Humans,inhibitor,yes
DB00548,Azelaic acid,small molecule,approved,OC(=O)CCCCCCCC(O)=O,BDJRBEYXGGNYIS-UHFFFAOYSA-N,188.2209,P14679,BE0000252,Tyrosinase,Humans,inhibitor,yes
DB00548,Azelaic acid,small molecule,approved,OC(=O)CCCCCCCC(O)=O,BDJRBEYXGGNYIS-UHFFFAOYSA-N,188.2209,P00582,BE0000498,DNA polymerase I,Escherichia coli (strain K12),inhibitor,yes
DB00549,Zafirlukast,small molecule,approved;investigational,COC1=CC(=CC=C1CC1=CN(C)C2=C1C=C(NC(=O)OC1CCCC1)C=C2)C(=O)NS(=O)(=O)C1=CC=CC=C1C,YEEZWCHGZNKEEK-UHFFFAOYSA-N,575.675,Q9Y271,BE0000705,Cysteinyl leukotriene receptor 1,Humans,antagonist,yes
DB00550,Propylthiouracil,small molecule,approved;investigational,CCCC1=CC(=O)NC(=S)N1,KNAHARQHSZJURB-UHFFFAOYSA-N,170.232,P49895,BE0009854,Type I iodothyronine deiodinase,Humans,inhibitor,yes
DB00550,Propylthiouracil,small molecule,approved;investigational,CCCC1=CC(=O)NC(=S)N1,KNAHARQHSZJURB-UHFFFAOYSA-N,170.232,P07202,BE0000507,Thyroid peroxidase,Humans,inhibitor,yes
DB00552,Pentostatin,small molecule,approved;investigational,OC[C@H]1O[C@H](C[C@@H]1O)N1C=NC2=C1N=CNC[C@H]2O,FPVKHBSQESCIEP-JQCXWYLXSA-N,268.2691,P00813,BE0002214,Adenosine deaminase,Humans,inhibitor,yes
DB00553,Methoxsalen,small molecule,approved,COC1=C2OC(=O)C=CC2=CC2=C1OC=C2,QXKHYNVANLEOEG-UHFFFAOYSA-N,216.192,,BE0004796,DNA,Humans,intercalation,yes
DB00553,Methoxsalen,small molecule,approved,COC1=C2OC(=O)C=CC2=CC2=C1OC=C2,QXKHYNVANLEOEG-UHFFFAOYSA-N,216.192,P11509,BE0003336,Cytochrome P450 2A6,Humans,binder,yes
DB00554,Piroxicam,small molecule,approved;investigational,CN1C(C(=O)NC2=NC=CC=C2)=C(O)C2=C(C=CC=C2)S1(=O)=O,QYSPLQLAKJAUJT-UHFFFAOYSA-N,331.346,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB00555,Lamotrigine,small molecule,approved;investigational,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1,PYZRQGJRPPTADH-UHFFFAOYSA-N,256.091,Q15878,BE0009609,Voltage-dependent R-type calcium channel subunit alpha-1E,Humans,inhibitor,yes
DB00555,Lamotrigine,small molecule,approved;investigational,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1,PYZRQGJRPPTADH-UHFFFAOYSA-N,256.091,Q9UI33,BE0000192,Sodium channel protein type 11 subunit alpha,Humans,blocker,yes
DB00555,Lamotrigine,small molecule,approved;investigational,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1,PYZRQGJRPPTADH-UHFFFAOYSA-N,256.091,P35498,BE0009738,Voltage-gated sodium channel alpha subunit,Humans,inhibitor,yes
DB00557,Hydroxyzine,small molecule,approved,OCCOCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,ZQDWXGKKHFNSQK-UHFFFAOYSA-N,374.904,P35367,BE0000442,Histamine H1 receptor,Humans,inverse agonist,yes
DB00558,Zanamivir,small molecule,approved;investigational,[H][C@]1(OC(=C[C@H](N=C(N)N)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO,ARAIBEBZBOPLMB-UFGQHTETSA-N,332.3098,P06818,BE0000057,Neuraminidase,Influenza A virus (strain A/Bangkok/1/1979 H3N2),inhibitor,yes
DB00558,Zanamivir,small molecule,approved;investigational,[H][C@]1(OC(=C[C@H](N=C(N)N)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO,ARAIBEBZBOPLMB-UFGQHTETSA-N,332.3098,P27907,BE0003527,Neuraminidase,Influenza B virus (strain B/Beijing/1/1987),inhibitor,yes
DB00559,Bosentan,small molecule,approved;investigational,COC1=CC=CC=C1OC1=C(NS(=O)(=O)C2=CC=C(C=C2)C(C)(C)C)N=C(N=C1OCCO)C1=NC=CC=N1,GJPICJJJRGTNOD-UHFFFAOYSA-N,551.614,P24530,BE0000043,Endothelin receptor type B,Humans,antagonist,yes
DB00559,Bosentan,small molecule,approved;investigational,COC1=CC=CC=C1OC1=C(NS(=O)(=O)C2=CC=C(C=C2)C(C)(C)C)N=C(N=C1OCCO)C1=NC=CC=N1,GJPICJJJRGTNOD-UHFFFAOYSA-N,551.614,P25101,BE0000521,Endothelin-1 receptor,Humans,antagonist,yes
DB00560,Tigecycline,small molecule,approved,[H][C@@]12CC3=C(C(O)=C(NC(=O)CNC(C)(C)C)C=C3N(C)C)C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2,FPZLLRFZJZRHSY-HJYUBDRYSA-N,585.6487,,BE0004799,16S ribosomal RNA,Enteric bacteria and other eubacteria,binder,yes
DB00560,Tigecycline,small molecule,approved,[H][C@@]12CC3=C(C(O)=C(NC(=O)CNC(C)(C)C)C=C3N(C)C)C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2,FPZLLRFZJZRHSY-HJYUBDRYSA-N,585.6487,P0A7X3,BE0000127,30S ribosomal protein S9,Escherichia coli (strain K12),binder,yes
DB00560,Tigecycline,small molecule,approved,[H][C@@]12CC3=C(C(O)=C(NC(=O)CNC(C)(C)C)C=C3N(C)C)C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2,FPZLLRFZJZRHSY-HJYUBDRYSA-N,585.6487,P0A7S3,BE0000279,30S ribosomal protein S12,Escherichia coli (strain K12),binder,yes
DB00560,Tigecycline,small molecule,approved,[H][C@@]12CC3=C(C(O)=C(NC(=O)CNC(C)(C)C)C=C3N(C)C)C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2,FPZLLRFZJZRHSY-HJYUBDRYSA-N,585.6487,P0A7S9,BE0003709,30S ribosomal protein S13,Escherichia coli (strain K12),binder,yes
DB00560,Tigecycline,small molecule,approved,[H][C@@]12CC3=C(C(O)=C(NC(=O)CNC(C)(C)C)C=C3N(C)C)C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2,FPZLLRFZJZRHSY-HJYUBDRYSA-N,585.6487,P0AG59,BE0003708,30S ribosomal protein S14,Escherichia coli (strain K12),binder,yes
DB00560,Tigecycline,small molecule,approved,[H][C@@]12CC3=C(C(O)=C(NC(=O)CNC(C)(C)C)C=C3N(C)C)C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2,FPZLLRFZJZRHSY-HJYUBDRYSA-N,585.6487,P0A7U3,BE0003710,30S ribosomal protein S19,Escherichia coli (strain K12),binder,yes
DB00561,Doxapram,small molecule,approved;vet_approved,CCN1CC(CCN2CCOCC2)C(C1=O)(C1=CC=CC=C1)C1=CC=CC=C1,XFDJYSQDBULQSI-UHFFFAOYSA-N,378.5072,O14649,BE0003582,Potassium channel subfamily K member 3,Humans,inhibitor,yes
DB00561,Doxapram,small molecule,approved;vet_approved,CCN1CC(CCN2CCOCC2)C(C1=O)(C1=CC=CC=C1)C1=CC=CC=C1,XFDJYSQDBULQSI-UHFFFAOYSA-N,378.5072,Q9NPC2,BE0003583,Potassium channel subfamily K member 9,Humans,inhibitor,yes
DB00562,Benzthiazide,small molecule,approved,NS(=O)(=O)C1=CC2=C(C=C1Cl)N=C(CSCC1=CC=CC=C1)NS2(=O)=O,NDTSRXAMMQDVSW-UHFFFAOYSA-N,431.937,P55017,BE0000419,Solute carrier family 12 member 3,Humans,inhibitor,yes
DB00562,Benzthiazide,small molecule,approved,NS(=O)(=O)C1=CC2=C(C=C1Cl)N=C(CSCC1=CC=CC=C1)NS2(=O)=O,NDTSRXAMMQDVSW-UHFFFAOYSA-N,431.937,P00915,BE0009965,Carbonic anhydrase,Humans,inhibitor,yes
DB00562,Benzthiazide,small molecule,approved,NS(=O)(=O)C1=CC2=C(C=C1Cl)N=C(CSCC1=CC=CC=C1)NS2(=O)=O,NDTSRXAMMQDVSW-UHFFFAOYSA-N,431.937,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB00563,Methotrexate,small molecule,approved,CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,FBOZXECLQNJBKD-ZDUSSCGKSA-N,454.4393,P04818,BE0000324,Thymidylate synthase,Humans,inhibitor,yes
DB00563,Methotrexate,small molecule,approved,CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,FBOZXECLQNJBKD-ZDUSSCGKSA-N,454.4393,P41440,BE0004711,Reduced folate transporter,Humans,modulator,yes
DB00563,Methotrexate,small molecule,approved,CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,FBOZXECLQNJBKD-ZDUSSCGKSA-N,454.4393,Q96NT5,BE0001048,Proton-coupled folate transporter,Humans,modulator,yes
DB00563,Methotrexate,small molecule,approved,CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,FBOZXECLQNJBKD-ZDUSSCGKSA-N,454.4393,P31939,BE0001240,Bifunctional purine biosynthesis protein ATIC,Humans,inhibitor,yes
DB00563,Methotrexate,small molecule,approved,CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,FBOZXECLQNJBKD-ZDUSSCGKSA-N,454.4393,P00374,BE0000330,Dihydrofolate reductase,Humans,inhibitor,yes
DB00564,Carbamazepine,small molecule,approved;investigational,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,FFGPTBGBLSHEPO-UHFFFAOYSA-N,236.2686,P35498,BE0009738,Voltage-gated sodium channel alpha subunit,Humans,inhibitor,yes
DB00565,Cisatracurium,small molecule,approved;investigational,COC1=CC2=C(C=C1OC)[C@@H](CC1=CC(OC)=C(OC)C=C1)[N@@+](C)(CCC(=O)OCCCCCOC(=O)CC[N@@+]1(C)CCC3=C(C=C(OC)C(OC)=C3)[C@H]1CC1=CC(OC)=C(OC)C=C1)CC2,YXSLJKQTIDHPOT-LJCJQEJUSA-N,929.16,Q15822,BE0000738,Neuronal acetylcholine receptor subunit alpha-2,Humans,antagonist,yes
DB00565,Cisatracurium,small molecule,approved;investigational,COC1=CC2=C(C=C1OC)[C@@H](CC1=CC(OC)=C(OC)C=C1)[N@@+](C)(CCC(=O)OCCCCCOC(=O)CC[N@@+]1(C)CCC3=C(C=C(OC)C(OC)=C3)[C@H]1CC1=CC(OC)=C(OC)C=C1)CC2,YXSLJKQTIDHPOT-LJCJQEJUSA-N,929.16,Q9GZZ6,BE0009927,Neuronal Acetylcholine (nACh) Receptor Subunits,Humans,antagonist,yes
DB00566,Succimer,small molecule,approved,OC(=O)[C@@H](S)[C@@H](S)C(O)=O,ACTRVOBWPAIOHC-XIXRPRMCSA-N,182.21,,BE0004808,Lead,Humans,chelator,yes
DB00566,Succimer,small molecule,approved,OC(=O)[C@@H](S)[C@@H](S)C(O)=O,ACTRVOBWPAIOHC-XIXRPRMCSA-N,182.21,,BE0004814,Mercury,Humans,chelator,yes
DB00566,Succimer,small molecule,approved,OC(=O)[C@@H](S)[C@@H](S)C(O)=O,ACTRVOBWPAIOHC-XIXRPRMCSA-N,182.21,,BE0004802,Cadmium,Humans,chelator,yes
DB00566,Succimer,small molecule,approved,OC(=O)[C@@H](S)[C@@H](S)C(O)=O,ACTRVOBWPAIOHC-XIXRPRMCSA-N,182.21,,BE0004813,Arsenic,Humans,chelator,yes
DB00567,Cephalexin,small molecule,approved;investigational;vet_approved,[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,347.389,Q75Y35,BE0004643,Penicillin-binding protein 3,Streptococcus pneumoniae,inhibitor,yes
DB00567,Cephalexin,small molecule,approved;investigational;vet_approved,[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,347.389,Q8DNB6,BE0004644,Penicillin-binding protein 2a,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB00567,Cephalexin,small molecule,approved;investigational;vet_approved,[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,347.389,Q7CRA4,BE0004335,Penicillin-binding protein 1b,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB00567,Cephalexin,small molecule,approved;investigational;vet_approved,[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,347.389,P0A3M6,BE0003624,Penicillin-binding protein 2B,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB00567,Cephalexin,small molecule,approved;investigational;vet_approved,[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,347.389,Q8DR59,BE0004290,Penicillin-binding protein 1A,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB00568,Cinnarizine,small molecule,approved;investigational,C(\C=C\C1=CC=CC=C1)N1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1,DERZBLKQOCDDDZ-JLHYYAGUSA-N,368.524,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB00568,Cinnarizine,small molecule,approved;investigational,C(\C=C\C1=CC=CC=C1)N1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1,DERZBLKQOCDDDZ-JLHYYAGUSA-N,368.524,Q13936,BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,Humans,inhibitor,yes
DB00568,Cinnarizine,small molecule,approved;investigational,C(\C=C\C1=CC=CC=C1)N1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1,DERZBLKQOCDDDZ-JLHYYAGUSA-N,368.524,Q01668,BE0002359,Voltage-dependent L-type calcium channel subunit alpha-1D,Humans,inhibitor,yes
DB00568,Cinnarizine,small molecule,approved;investigational,C(\C=C\C1=CC=CC=C1)N1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1,DERZBLKQOCDDDZ-JLHYYAGUSA-N,368.524,O60840,BE0002357,Voltage-dependent L-type calcium channel subunit alpha-1F,Humans,inhibitor,yes
DB00568,Cinnarizine,small molecule,approved;investigational,C(\C=C\C1=CC=CC=C1)N1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1,DERZBLKQOCDDDZ-JLHYYAGUSA-N,368.524,Q13698,BE0002355,Voltage-dependent L-type calcium channel subunit alpha-1S,Humans,inhibitor,yes
DB00568,Cinnarizine,small molecule,approved;investigational,C(\C=C\C1=CC=CC=C1)N1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1,DERZBLKQOCDDDZ-JLHYYAGUSA-N,368.524,O43497,BE0000483,Voltage-dependent T-type calcium channel subunit alpha-1G,Humans,inhibitor,yes
DB00568,Cinnarizine,small molecule,approved;investigational,C(\C=C\C1=CC=CC=C1)N1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1,DERZBLKQOCDDDZ-JLHYYAGUSA-N,368.524,O95180,BE0000864,Voltage-dependent T-type calcium channel subunit alpha-1H,Humans,inhibitor,yes
DB00568,Cinnarizine,small molecule,approved;investigational,C(\C=C\C1=CC=CC=C1)N1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1,DERZBLKQOCDDDZ-JLHYYAGUSA-N,368.524,Q9P0X4,BE0000012,Voltage-dependent T-type calcium channel subunit alpha-1I,Humans,inhibitor,yes
DB00569,Fondaparinux,small molecule,approved;investigational,CO[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]2O[C@H]([C@@H](O[C@H]3O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]4O[C@@H]([C@@H](O[C@H]5O[C@H](COS(O)(=O)=O)[C@@H](O)[C@H](O)[C@H]5NS(O)(=O)=O)[C@H](O)[C@H]4O)C(O)=O)[C@H](OS(O)(=O)=O)[C@H]3NS(O)(=O)=O)[C@H](O)[C@H]2OS(O)(=O)=O)C(O)=O)[C@H](O)[C@H]1NS(O)(=O)=O,KANJSNBRCNMZMV-ABRZTLGGSA-N,1508.263,P00742,BE0000216,Coagulation factor X,Humans,inhibitor,yes
DB00569,Fondaparinux,small molecule,approved;investigational,CO[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]2O[C@H]([C@@H](O[C@H]3O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]4O[C@@H]([C@@H](O[C@H]5O[C@H](COS(O)(=O)=O)[C@@H](O)[C@H](O)[C@H]5NS(O)(=O)=O)[C@H](O)[C@H]4O)C(O)=O)[C@H](OS(O)(=O)=O)[C@H]3NS(O)(=O)=O)[C@H](O)[C@H]2OS(O)(=O)=O)C(O)=O)[C@H](O)[C@H]1NS(O)(=O)=O,KANJSNBRCNMZMV-ABRZTLGGSA-N,1508.263,P01008,BE0000280,Antithrombin-III,Humans,potentiator,yes
DB00570,Vinblastine,small molecule,approved,[H][C@@]12N(C)C3=CC(OC)=C(C=C3[C@@]11CCN3CC=C[C@@](CC)([C@@H](OC(C)=O)[C@]2(O)C(=O)OC)[C@@]13[H])[C@]1(C[C@@]2([H])CN(C[C@](O)(CC)C2)CCC2=C1NC1=C2C=CC=C1)C(=O)OC,JXLYSJRDGCGARV-CFWMRBGOSA-N,810.9741,Q13885,BE0003400,Tubulin beta-2A chain,Humans,inhibitor,yes
DB00570,Vinblastine,small molecule,approved,[H][C@@]12N(C)C3=CC(OC)=C(C=C3[C@@]11CCN3CC=C[C@@](CC)([C@@H](OC(C)=O)[C@]2(O)C(=O)OC)[C@@]13[H])[C@]1(C[C@@]2([H])CN(C[C@](O)(CC)C2)CCC2=C1NC1=C2C=CC=C1)C(=O)OC,JXLYSJRDGCGARV-CFWMRBGOSA-N,810.9741,Q71U36,BE0001340,Tubulin alpha-1A chain,Humans,binder,yes
DB00570,Vinblastine,small molecule,approved,[H][C@@]12N(C)C3=CC(OC)=C(C=C3[C@@]11CCN3CC=C[C@@](CC)([C@@H](OC(C)=O)[C@]2(O)C(=O)OC)[C@@]13[H])[C@]1(C[C@@]2([H])CN(C[C@](O)(CC)C2)CCC2=C1NC1=C2C=CC=C1)C(=O)OC,JXLYSJRDGCGARV-CFWMRBGOSA-N,810.9741,P07437,BE0000143,Tubulin beta chain,Humans,binder,yes
DB00570,Vinblastine,small molecule,approved,[H][C@@]12N(C)C3=CC(OC)=C(C=C3[C@@]11CCN3CC=C[C@@](CC)([C@@H](OC(C)=O)[C@]2(O)C(=O)OC)[C@@]13[H])[C@]1(C[C@@]2([H])CN(C[C@](O)(CC)C2)CCC2=C1NC1=C2C=CC=C1)C(=O)OC,JXLYSJRDGCGARV-CFWMRBGOSA-N,810.9741,Q9UJT1,BE0003711,Tubulin delta chain,Humans,binder,yes
DB00570,Vinblastine,small molecule,approved,[H][C@@]12N(C)C3=CC(OC)=C(C=C3[C@@]11CCN3CC=C[C@@](CC)([C@@H](OC(C)=O)[C@]2(O)C(=O)OC)[C@@]13[H])[C@]1(C[C@@]2([H])CN(C[C@](O)(CC)C2)CCC2=C1NC1=C2C=CC=C1)C(=O)OC,JXLYSJRDGCGARV-CFWMRBGOSA-N,810.9741,P23258,BE0003713,Tubulin gamma-1 chain,Humans,binder,yes
DB00570,Vinblastine,small molecule,approved,[H][C@@]12N(C)C3=CC(OC)=C(C=C3[C@@]11CCN3CC=C[C@@](CC)([C@@H](OC(C)=O)[C@]2(O)C(=O)OC)[C@@]13[H])[C@]1(C[C@@]2([H])CN(C[C@](O)(CC)C2)CCC2=C1NC1=C2C=CC=C1)C(=O)OC,JXLYSJRDGCGARV-CFWMRBGOSA-N,810.9741,Q9UJT0,BE0003712,Tubulin epsilon chain,Humans,binder,yes
DB00571,Propranolol,small molecule,approved;investigational,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,AQHHHDLHHXJYJD-UHFFFAOYSA-N,259.3434,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,antagonist,yes
DB00572,Atropine,small molecule,approved;vet_approved,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1,RKUNBYITZUJHSG-SPUOUPEWSA-N,289.3694,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,antagonist,yes
DB00572,Atropine,small molecule,approved;vet_approved,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1,RKUNBYITZUJHSG-SPUOUPEWSA-N,289.3694,P08172,BE0000560,Muscarinic acetylcholine receptor M2,Humans,antagonist,yes
DB00572,Atropine,small molecule,approved;vet_approved,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1,RKUNBYITZUJHSG-SPUOUPEWSA-N,289.3694,P20309,BE0000045,Muscarinic acetylcholine receptor M3,Humans,antagonist,yes
DB00572,Atropine,small molecule,approved;vet_approved,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1,RKUNBYITZUJHSG-SPUOUPEWSA-N,289.3694,P08173,BE0000405,Muscarinic acetylcholine receptor M4,Humans,antagonist,yes
DB00572,Atropine,small molecule,approved;vet_approved,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1,RKUNBYITZUJHSG-SPUOUPEWSA-N,289.3694,P08912,BE0000247,Muscarinic acetylcholine receptor M5,Humans,antagonist,yes
DB00573,Fenoprofen,small molecule,approved,CC(C(O)=O)C1=CC(OC2=CC=CC=C2)=CC=C1,RDJGLLICXDHJDY-UHFFFAOYSA-N,242.2699,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB00573,Fenoprofen,small molecule,approved,CC(C(O)=O)C1=CC(OC2=CC=CC=C2)=CC=C1,RDJGLLICXDHJDY-UHFFFAOYSA-N,242.2699,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB00574,Fenfluramine,small molecule,approved;illicit;investigational;withdrawn,CCNC(C)CC1=CC=CC(=C1)C(F)(F)F,DBGIVFWFUFKIQN-UHFFFAOYSA-N,231.2573,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,substrate;inhibitor,yes
DB00574,Fenfluramine,small molecule,approved;illicit;investigational;withdrawn,CCNC(C)CC1=CC=CC(=C1)C(F)(F)F,DBGIVFWFUFKIQN-UHFFFAOYSA-N,231.2573,P28221,BE0000659,5-hydroxytryptamine receptor 1D,Humans,agonist,yes
DB00574,Fenfluramine,small molecule,approved;illicit;investigational;withdrawn,CCNC(C)CC1=CC=CC(=C1)C(F)(F)F,DBGIVFWFUFKIQN-UHFFFAOYSA-N,231.2573,P28335,BE0000533,5-hydroxytryptamine receptor 2C,Humans,agonist,yes
DB00574,Fenfluramine,small molecule,approved;illicit;investigational;withdrawn,CCNC(C)CC1=CC=CC(=C1)C(F)(F)F,DBGIVFWFUFKIQN-UHFFFAOYSA-N,231.2573,Q99720,BE0000156,Sigma non-opioid intracellular receptor 1,Humans,antagonist,yes
DB00575,Clonidine,small molecule,approved,ClC1=CC=CC(Cl)=C1NC1=NCCN1,GJSURZIOUXUGAL-UHFFFAOYSA-N,230.094,Q16853,BE0001002,Amine oxidase [copper-containing] 3,Humans,inhibitor,yes
DB00575,Clonidine,small molecule,approved,ClC1=CC=CC(Cl)=C1NC1=NCCN1,GJSURZIOUXUGAL-UHFFFAOYSA-N,230.094,P18089,BE0000572,Alpha-2B adrenergic receptor,Humans,agonist,yes
DB00575,Clonidine,small molecule,approved,ClC1=CC=CC(Cl)=C1NC1=NCCN1,GJSURZIOUXUGAL-UHFFFAOYSA-N,230.094,P18825,BE0000342,Alpha-2C adrenergic receptor,Humans,agonist,yes
DB00575,Clonidine,small molecule,approved,ClC1=CC=CC(Cl)=C1NC1=NCCN1,GJSURZIOUXUGAL-UHFFFAOYSA-N,230.094,P08913,BE0000289,Alpha-2A adrenergic receptor,Humans,agonist,yes
DB00576,Sulfamethizole,small molecule,approved;investigational;vet_approved,CC1=NN=C(NS(=O)(=O)C2=CC=C(N)C=C2)S1,VACCAVUAMIDAGB-UHFFFAOYSA-N,270.331,P0AC13,BE0000803,Dihydropteroate synthase,Escherichia coli (strain K12),inhibitor,yes
DB00577,Valaciclovir,small molecule,approved;investigational,CC(C)[C@H](N)C(=O)OCCOCN1C=NC2=C1NC(N)=NC2=O,HDOVUKNUBWVHOX-QMMMGPOBSA-N,324.3357,Q9QNF7,BE0000458,Thymidine kinase,HHV-1,substrate,yes
DB00577,Valaciclovir,small molecule,approved;investigational,CC(C)[C@H](N)C(=O)OCCOCN1C=NC2=C1NC(N)=NC2=O,HDOVUKNUBWVHOX-QMMMGPOBSA-N,324.3357,P04293,BE0000308,DNA polymerase catalytic subunit,HHV-1,inhibitor,yes
DB00578,Carbenicillin,small molecule,approved;investigational,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C(C(O)=O)C1=CC=CC=C1)C(O)=O,FPPNZSSZRUTDAP-UWFZAAFLSA-N,378.4,P0AEB2,BE0004840,Penicillin-binding protein,Gram positive and gram negative bacteria,inhibitor,yes
DB00579,Mazindol,small molecule,approved;investigational,OC1(N2CCN=C2C2=CC=CC=C12)C1=CC=C(Cl)C=C1,ZPXSCAKFGYXMGA-UHFFFAOYSA-N,284.74,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,inhibitor,yes
DB00579,Mazindol,small molecule,approved;investigational,OC1(N2CCN=C2C2=CC=CC=C12)C1=CC=C(Cl)C=C1,ZPXSCAKFGYXMGA-UHFFFAOYSA-N,284.74,Q01959,BE0000647,Sodium-dependent dopamine transporter,Humans,inhibitor,yes
DB00579,Mazindol,small molecule,approved;investigational,OC1(N2CCN=C2C2=CC=CC=C12)C1=CC=C(Cl)C=C1,ZPXSCAKFGYXMGA-UHFFFAOYSA-N,284.74,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB00580,Valdecoxib,small molecule,approved;investigational;withdrawn,CC1=C(C(=NO1)C1=CC=CC=C1)C1=CC=C(C=C1)S(N)(=O)=O,LNPDTQAFDNKSHK-UHFFFAOYSA-N,314.359,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB00581,Lactulose,small molecule,approved,OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O,JCQLYHFGKNRPGE-FCVZTGTOSA-N,342.2965,P06864,BE0000116,Evolved beta-galactosidase subunit alpha,Escherichia coli (strain K12),other,yes
DB00582,Voriconazole,small molecule,approved,C[C@@H](C1=NC=NC=C1F)[C@](O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,BCEHBSKCWLPMDN-MGPLVRAMSA-N,349.3105,P10613,BE0000233,Lanosterol 14-alpha demethylase,Yeast,antagonist;inhibitor,yes
DB00583,Levocarnitine,small molecule,approved;investigational,C[N+](C)(C)C[C@H](O)CC([O-])=O,PHIQHXFUZVPYII-ZCFIWIBFSA-N,161.1989,Q92523,BE0017721,"Carnitine O-palmitoyltransferase 1, muscle isoform",Humans,activator,yes
DB00584,Enalapril,small molecule,approved;vet_approved,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O,GBXSMTUPTTWBMN-XIRDDKMYSA-N,376.4467,P12821,BE0000221,Angiotensin-converting enzyme,Humans,inhibitor,yes
DB00585,Nizatidine,small molecule,approved,CNC(NCCSCC1=CSC(CN(C)C)=N1)=C[N+]([O-])=O,SGXXNSQHWDMGGP-UHFFFAOYSA-N,331.45,P25021,BE0000112,Histamine H2 receptor,Humans,antagonist,yes
DB00586,Diclofenac,small molecule,approved;vet_approved,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,DCOPUUMXTXDBNB-UHFFFAOYSA-N,296.149,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB00586,Diclofenac,small molecule,approved;vet_approved,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,DCOPUUMXTXDBNB-UHFFFAOYSA-N,296.149,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB00587,Cinalukast,small molecule,experimental,CCC(CC)(CC(=O)NC1=CC(\C=C\C2=NC(=CS2)C2CCC2)=CC=C1)C(O)=O,BZMKNPGKXJAIDV-VAWYXSNFSA-N,412.545,Q9Y271,BE0000705,Cysteinyl leukotriene receptor 1,Humans,antagonist,yes
DB00588,Fluticasone propionate,small molecule,approved,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,WMWTYOKRWGGJOA-CENSZEJFSA-N,500.571,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB00589,Lisuride,small molecule,approved;investigational,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC,BKRGVLQUQGGVSM-KBXCAEBGSA-N,338.4466,P14416,BE0000756,D(2) dopamine receptor,Humans,agonist,yes
DB00589,Lisuride,small molecule,approved;investigational,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC,BKRGVLQUQGGVSM-KBXCAEBGSA-N,338.4466,P35462,BE0000581,D(3) dopamine receptor,Humans,agonist,yes
DB00589,Lisuride,small molecule,approved;investigational,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC,BKRGVLQUQGGVSM-KBXCAEBGSA-N,338.4466,P21917,BE0000389,D(4) dopamine receptor,Humans,agonist,yes
DB00589,Lisuride,small molecule,approved;investigational,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC,BKRGVLQUQGGVSM-KBXCAEBGSA-N,338.4466,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,agonist,yes
DB00589,Lisuride,small molecule,approved;investigational,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC,BKRGVLQUQGGVSM-KBXCAEBGSA-N,338.4466,P28335,BE0000533,5-hydroxytryptamine receptor 2C,Humans,agonist,yes
DB00590,Doxazosin,small molecule,approved,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1COC2=CC=CC=C2O1,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,451.4751,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,antagonist,yes
DB00590,Doxazosin,small molecule,approved,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1COC2=CC=CC=C2O1,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,451.4751,P25100,BE0000715,Alpha-1D adrenergic receptor,Humans,antagonist,yes
DB00591,Fluocinolone acetonide,small molecule,approved;investigational;vet_approved,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,FEBLZLNTKCEFIT-VSXGLTOVSA-N,452.4882,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB00591,Fluocinolone acetonide,small molecule,approved;investigational;vet_approved,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,FEBLZLNTKCEFIT-VSXGLTOVSA-N,452.4882,P04083,BE0000422,Annexin A1,Humans,inducer,yes
DB00591,Fluocinolone acetonide,small molecule,approved;investigational;vet_approved,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,FEBLZLNTKCEFIT-VSXGLTOVSA-N,452.4882,P07355,BE0001170,Annexin A2,Humans,inducer,yes
DB00591,Fluocinolone acetonide,small molecule,approved;investigational;vet_approved,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,FEBLZLNTKCEFIT-VSXGLTOVSA-N,452.4882,P12429,BE0003201,Annexin A3,Humans,inducer,yes
DB00591,Fluocinolone acetonide,small molecule,approved;investigational;vet_approved,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,FEBLZLNTKCEFIT-VSXGLTOVSA-N,452.4882,P09525,BE0008969,Annexin A4,Humans,inducer,yes
DB00591,Fluocinolone acetonide,small molecule,approved;investigational;vet_approved,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,FEBLZLNTKCEFIT-VSXGLTOVSA-N,452.4882,P08758,BE0004149,Annexin A5,Humans,inducer,yes
DB00593,Ethosuximide,small molecule,approved,CCC1(C)CC(=O)NC1=O,HAPOVYFOVVWLRS-UHFFFAOYSA-N,141.1677,O43497,BE0000483,Voltage-dependent T-type calcium channel subunit alpha-1G,Humans,inhibitor,yes
DB00594,Amiloride,small molecule,approved,NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N,XSDQTOBWRPYKKA-UHFFFAOYSA-N,229.627,P37088,BE0000190,Amiloride-sensitive sodium channel subunit alpha,Humans,inhibitor,yes
DB00594,Amiloride,small molecule,approved,NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N,XSDQTOBWRPYKKA-UHFFFAOYSA-N,229.627,P51168,BE0000024,Amiloride-sensitive sodium channel subunit beta,Humans,inhibitor,yes
DB00594,Amiloride,small molecule,approved,NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N,XSDQTOBWRPYKKA-UHFFFAOYSA-N,229.627,P51170,BE0000497,Amiloride-sensitive sodium channel subunit gamma,Humans,inhibitor,yes
DB00594,Amiloride,small molecule,approved,NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N,XSDQTOBWRPYKKA-UHFFFAOYSA-N,229.627,P51172,BE0000495,Amiloride-sensitive sodium channel subunit delta,Humans,inhibitor,yes
DB00595,Oxytetracycline,small molecule,approved;investigational;vet_approved,[H][C@@]12[C@@H](O)[C@@]3([H])C(C(=O)C4=C(C=CC=C4O)[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C,IWVCMVBTMGNXQD-PXOLEDIWSA-N,460.434,P0A7X3,BE0000127,30S ribosomal protein S9,Escherichia coli (strain K12),inhibitor,yes
DB00595,Oxytetracycline,small molecule,approved;investigational;vet_approved,[H][C@@]12[C@@H](O)[C@@]3([H])C(C(=O)C4=C(C=CC=C4O)[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C,IWVCMVBTMGNXQD-PXOLEDIWSA-N,460.434,P0A7V8,BE0000019,30S ribosomal protein S4,Escherichia coli (strain K12),inhibitor,yes
DB00596,Ulobetasol,small molecule,approved,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,LEHFPXVYPMWYQD-XHIJKXOTSA-N,428.9,P11474,BE0003722,Steroid hormone receptor ERR1,Humans,modulator,yes
DB00596,Ulobetasol,small molecule,approved,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,LEHFPXVYPMWYQD-XHIJKXOTSA-N,428.9,O95718,BE0005001,Steroid hormone receptor ERR2,Humans,modulator,yes
DB00596,Ulobetasol,small molecule,approved,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,LEHFPXVYPMWYQD-XHIJKXOTSA-N,428.9,P62508,BE0002088,Estrogen-related receptor gamma,Humans,modulator,yes
DB00596,Ulobetasol,small molecule,approved,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,LEHFPXVYPMWYQD-XHIJKXOTSA-N,428.9,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB00598,Labetalol,small molecule,approved,CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1,SGUAFYQXFOLMHL-UHFFFAOYSA-N,328.4055,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,antagonist,yes
DB00598,Labetalol,small molecule,approved,CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1,SGUAFYQXFOLMHL-UHFFFAOYSA-N,328.4055,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,antagonist,yes
DB00598,Labetalol,small molecule,approved,CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1,SGUAFYQXFOLMHL-UHFFFAOYSA-N,328.4055,P35348,BE0004863,Alpha-1 adrenergic receptors,Humans,antagonist,yes
DB00599,Thiopental,small molecule,approved;vet_approved,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O,IUJDSEJGGMCXSG-UHFFFAOYSA-N,242.338,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,potentiator,yes
DB00599,Thiopental,small molecule,approved;vet_approved,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O,IUJDSEJGGMCXSG-UHFFFAOYSA-N,242.338,P47869,BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,Humans,potentiator,yes
DB00599,Thiopental,small molecule,approved;vet_approved,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O,IUJDSEJGGMCXSG-UHFFFAOYSA-N,242.338,P34903,BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,Humans,potentiator,yes
DB00599,Thiopental,small molecule,approved;vet_approved,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O,IUJDSEJGGMCXSG-UHFFFAOYSA-N,242.338,P48169,BE0000478,Gamma-aminobutyric acid receptor subunit alpha-4,Humans,potentiator,yes
DB00599,Thiopental,small molecule,approved;vet_approved,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O,IUJDSEJGGMCXSG-UHFFFAOYSA-N,242.338,P31644,BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,Humans,potentiator,yes
DB00599,Thiopental,small molecule,approved;vet_approved,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O,IUJDSEJGGMCXSG-UHFFFAOYSA-N,242.338,Q16445,BE0000764,Gamma-aminobutyric acid receptor subunit alpha-6,Humans,potentiator,yes
DB00600,Monobenzone,small molecule,approved,OC1=CC=C(OCC2=CC=CC=C2)C=C1,VYQNWZOUAUKGHI-UHFFFAOYSA-N,200.2332,P14679,BE0000252,Tyrosinase,Humans,inhibitor,yes
DB00601,Linezolid,small molecule,approved;investigational,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1,TYZROVQLWOKYKF-ZDUSSCGKSA-N,337.3461,,BE0004800,23S ribosomal RNA,Enteric bacteria and other eubacteria,inhibitor,yes
DB00602,Ivermectin,small molecule,approved;investigational;vet_approved,[H][C@@]12OC\C3=C/C=C/[C@H](C)[C@H](O[C@H]4C[C@H](OC)[C@@H](O[C@H]5C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)\C(C)=C\C[C@]4([H])C[C@@]([H])(C[C@]5(CC[C@H](C)[C@]([H])(O5)C(C)C)O4)OC(=O)[C@]([H])(C=C(C)[C@H]1O)[C@@]23O.[H][C@@]12OC\C3=C/C=C/[C@H](C)[C@H](O[C@H]4C[C@H](OC)[C@@H](O[C@H]5C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)\C(C)=C\C[C@]4([H])C[C@@]([H])(C[C@]5(CC[C@H](C)[C@]([H])(O5)[C@@H](C)CC)O4)OC(=O)[C@]([H])(C=C(C)[C@H]1O)[C@@]23O,SPBDXSGPUHCETR-JFUDTMANSA-N,1736.185,Q17328,BE0027480,Glutamate-gated chloride channel subunit beta,Caenorhabditis elegans,binder,yes
DB00602,Ivermectin,small molecule,approved;investigational;vet_approved,[H][C@@]12OC\C3=C/C=C/[C@H](C)[C@H](O[C@H]4C[C@H](OC)[C@@H](O[C@H]5C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)\C(C)=C\C[C@]4([H])C[C@@]([H])(C[C@]5(CC[C@H](C)[C@]([H])(O5)C(C)C)O4)OC(=O)[C@]([H])(C=C(C)[C@H]1O)[C@@]23O.[H][C@@]12OC\C3=C/C=C/[C@H](C)[C@H](O[C@H]4C[C@H](OC)[C@@H](O[C@H]5C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)\C(C)=C\C[C@]4([H])C[C@@]([H])(C[C@]5(CC[C@H](C)[C@]([H])(O5)[C@@H](C)CC)O4)OC(=O)[C@]([H])(C=C(C)[C@H]1O)[C@@]23O,SPBDXSGPUHCETR-JFUDTMANSA-N,1736.185,G5EBR3,BE0027481,Glutamate-gated chloride channel alpha,Caenorhabditis elegans,binder,yes
DB00603,Medroxyprogesterone acetate,small molecule,approved;investigational,[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)CC[C@]12C,PSGAAPLEWMOORI-PEINSRQWSA-N,386.5244,P06401,BE0000557,Progesterone receptor,Humans,agonist,yes
DB00603,Medroxyprogesterone acetate,small molecule,approved;investigational,[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)CC[C@]12C,PSGAAPLEWMOORI-PEINSRQWSA-N,386.5244,P03372,BE0000123,Estrogen receptor,Humans,agonist,yes
DB00604,Cisapride,small molecule,approved;investigational;withdrawn,CO[C@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C1=CC(Cl)=C(N)C=C1OC,DCSUBABJRXZOMT-IRLDBZIGSA-N,465.945,Q13639,BE0000084,5-hydroxytryptamine receptor 4,Humans,agonist,yes
DB00604,Cisapride,small molecule,approved;investigational;withdrawn,CO[C@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C1=CC(Cl)=C(N)C=C1OC,DCSUBABJRXZOMT-IRLDBZIGSA-N,465.945,P46098,BE0000311,5-hydroxytryptamine receptor 3A,Humans,agonist,yes
DB00604,Cisapride,small molecule,approved;investigational;withdrawn,CO[C@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C1=CC(Cl)=C(N)C=C1OC,DCSUBABJRXZOMT-IRLDBZIGSA-N,465.945,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,agonist,yes
DB00605,Sulindac,small molecule,approved;investigational,CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(C=C1)S(C)=O,MLKXDPUZXIRXEP-MFOYZWKCSA-N,356.411,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB00605,Sulindac,small molecule,approved;investigational,CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(C=C1)S(C)=O,MLKXDPUZXIRXEP-MFOYZWKCSA-N,356.411,P15121,BE0000747,Aldo-keto reductase family 1 member B1,Humans,inhibitor,yes
DB00606,Cyclothiazide,small molecule,approved,NS(=O)(=O)C1=C(Cl)C=C2NC(NS(=O)(=O)C2=C1)C1CC2CC1C=C2,BOCUKUHCLICSIY-UHFFFAOYSA-N,389.878,P54710,BE0000229,Sodium/potassium-transporting ATPase subunit gamma,Humans,inhibitor,yes
DB00606,Cyclothiazide,small molecule,approved,NS(=O)(=O)C1=C(Cl)C=C2NC(NS(=O)(=O)C2=C1)C1CC2CC1C=C2,BOCUKUHCLICSIY-UHFFFAOYSA-N,389.878,P00915,BE0009965,Carbonic anhydrase,Humans,inhibitor,yes
DB00606,Cyclothiazide,small molecule,approved,NS(=O)(=O)C1=C(Cl)C=C2NC(NS(=O)(=O)C2=C1)C1CC2CC1C=C2,BOCUKUHCLICSIY-UHFFFAOYSA-N,389.878,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB00607,Nafcillin,small molecule,approved;investigational,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(OCC)C=CC2=CC=CC=C12)C(O)=O,GPXLMGHLHQJAGZ-JTDSTZFVSA-N,414.475,Q7CRA4,BE0004335,Penicillin-binding protein 1b,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB00607,Nafcillin,small molecule,approved;investigational,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(OCC)C=CC2=CC=CC=C12)C(O)=O,GPXLMGHLHQJAGZ-JTDSTZFVSA-N,414.475,P0A3M6,BE0003624,Penicillin-binding protein 2B,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB00607,Nafcillin,small molecule,approved;investigational,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(OCC)C=CC2=CC=CC=C12)C(O)=O,GPXLMGHLHQJAGZ-JTDSTZFVSA-N,414.475,Q8DNB6,BE0004644,Penicillin-binding protein 2a,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB00607,Nafcillin,small molecule,approved;investigational,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(OCC)C=CC2=CC=CC=C12)C(O)=O,GPXLMGHLHQJAGZ-JTDSTZFVSA-N,414.475,Q75Y35,BE0004643,Penicillin-binding protein 3,Streptococcus pneumoniae,inhibitor,yes
DB00607,Nafcillin,small molecule,approved;investigational,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(OCC)C=CC2=CC=CC=C12)C(O)=O,GPXLMGHLHQJAGZ-JTDSTZFVSA-N,414.475,Q8DR59,BE0004290,Penicillin-binding protein 1A,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB00608,Chloroquine,small molecule,approved;investigational;vet_approved,CCN(CC)CCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12,WHTVZRBIWZFKQO-UHFFFAOYSA-N,319.872,Q16570,BE0015068,Atypical chemokine receptor 1,Humans,modulator,yes
DB00609,Ethionamide,small molecule,approved,CCC1=NC=CC(=C1)C(N)=S,AEOCXXJPGCBFJA-UHFFFAOYSA-N,166.243,P9WGR1,BE0000332,Enoyl-[acyl-carrier-protein] reductase [NADH],Mycobacterium tuberculosis,inhibitor,yes
DB00609,Ethionamide,small molecule,approved,CCC1=NC=CC(=C1)C(N)=S,AEOCXXJPGCBFJA-UHFFFAOYSA-N,166.243,Q16236,BE0010121,Nuclear factor erythroid 2-related factor 2,Humans,inhibitor,yes
DB00610,Metaraminol,small molecule,approved;investigational,C[C@H](N)[C@H](O)C1=CC(O)=CC=C1,WXFIGDLSSYIKKV-RCOVLWMOSA-N,167.205,P14416,BE0000756,D(2) dopamine receptor,Humans,agonist,yes
DB00610,Metaraminol,small molecule,approved;investigational,C[C@H](N)[C@H](O)C1=CC(O)=CC=C1,WXFIGDLSSYIKKV-RCOVLWMOSA-N,167.205,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,agonist,yes
DB00611,Butorphanol,small molecule,approved;illicit;vet_approved,[H][C@@]12CC3=C(C=C(O)C=C3)[C@]3(CCCC[C@@]13O)CCN2CC1CCC1,IFKLAQQSCNILHL-QHAWAJNXSA-N,327.4605,P41145,BE0000632,Kappa-type opioid receptor,Humans,agonist,yes
DB00611,Butorphanol,small molecule,approved;illicit;vet_approved,[H][C@@]12CC3=C(C=C(O)C=C3)[C@]3(CCCC[C@@]13O)CCN2CC1CCC1,IFKLAQQSCNILHL-QHAWAJNXSA-N,327.4605,P41143,BE0000420,Delta-type opioid receptor,Humans,agonist,yes
DB00611,Butorphanol,small molecule,approved;illicit;vet_approved,[H][C@@]12CC3=C(C=C(O)C=C3)[C@]3(CCCC[C@@]13O)CCN2CC1CCC1,IFKLAQQSCNILHL-QHAWAJNXSA-N,327.4605,P35372,BE0000770,Mu-type opioid receptor,Humans,antagonist,yes
DB00612,Bisoprolol,small molecule,approved,CC(C)NCC(O)COC1=CC=C(COCCOC(C)C)C=C1,VHYCDWMUTMEGQY-UHFFFAOYSA-N,325.443,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,antagonist,yes
DB00613,Amodiaquine,small molecule,approved;investigational,CCN(CC)CC1=C(O)C=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=C1,OVCDSSHSILBFBN-UHFFFAOYSA-N,355.861,,BE0004805,Fe(II)-protoporphyrin IX,Plasmodium falciparum,binder,yes
DB00613,Amodiaquine,small molecule,approved;investigational,CCN(CC)CC1=C(O)C=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=C1,OVCDSSHSILBFBN-UHFFFAOYSA-N,355.861,P50135,BE0002436,Histamine N-methyltransferase,Humans,inhibitor,yes
DB00614,Furazolidone,small molecule,experimental;vet_approved,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CCOC1=O,PLHJDBGFXBMTGZ-WEVVVXLNSA-N,225.16,,BE0004796,DNA,Humans,cross-linking/alkylation,yes
DB00615,Rifabutin,small molecule,approved;investigational,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(C(O)=C3C)C(=O)C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)=C1NC3(CCN(CC3)CC(C)C)N=C21,ATEBXHFBFRCZMA-VXTBVIBXSA-N,847.0047,P0A7Z4,BE0000461,DNA-directed RNA polymerase subunit alpha,Escherichia coli (strain K12),inhibitor,yes
DB00615,Rifabutin,small molecule,approved;investigational,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(C(O)=C3C)C(=O)C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)=C1NC3(CCN(CC3)CC(C)C)N=C21,ATEBXHFBFRCZMA-VXTBVIBXSA-N,847.0047,P0A8V2,BE0000257,DNA-directed RNA polymerase subunit beta,Escherichia coli (strain K12),inhibitor,yes
DB00615,Rifabutin,small molecule,approved;investigational,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(C(O)=C3C)C(=O)C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)=C1NC3(CCN(CC3)CC(C)C)N=C21,ATEBXHFBFRCZMA-VXTBVIBXSA-N,847.0047,P0A8T7,BE0003707,DNA-directed RNA polymerase subunit beta',Escherichia coli (strain K12),inhibitor,yes
DB00616,Candoxatril,small molecule,experimental,COCCOC[C@H](CC1(CCCC1)C(=O)N[C@H]1CC[C@H](CC1)C(O)=O)C(=O)OC1=CC2=C(CCC2)C=C1,ZTWZVMIYIIVABD-OEMFJLHTSA-N,515.6383,P08473,BE0000266,Neprilysin,Humans,inhibitor,yes
DB00617,Paramethadione,small molecule,approved,CCC1(C)OC(=O)N(C)C1=O,VQASKUSHBVDKGU-UHFFFAOYSA-N,157.1671,O43497,BE0000483,Voltage-dependent T-type calcium channel subunit alpha-1G,Humans,blocker,yes
DB00617,Paramethadione,small molecule,approved,CCC1(C)OC(=O)N(C)C1=O,VQASKUSHBVDKGU-UHFFFAOYSA-N,157.1671,Q9P0X4,BE0000012,Voltage-dependent T-type calcium channel subunit alpha-1I,Humans,inhibitor,yes
DB00618,Demeclocycline,small molecule,approved,[H][C@]12C[C@@]3([H])[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C(=O)C1=C([C@H]2O)C(Cl)=CC=C1O,FMTDIUIBLCQGJB-SEYHBJAFSA-N,464.853,,BE0009998,30S ribosomal protein,,inhibitor,yes
DB00619,Imatinib,small molecule,approved,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1,KTUFNOKKBVMGRW-UHFFFAOYSA-N,493.6027,P11274,BE0004743,Breakpoint cluster region protein,Humans,inhibitor,yes
DB00619,Imatinib,small molecule,approved,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1,KTUFNOKKBVMGRW-UHFFFAOYSA-N,493.6027,P10721,BE0000453,Mast/stem cell growth factor receptor Kit,Humans,antagonist,yes
DB00619,Imatinib,small molecule,approved,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1,KTUFNOKKBVMGRW-UHFFFAOYSA-N,493.6027,P07949,BE0002411,Proto-oncogene tyrosine-protein kinase receptor Ret,Humans,inhibitor,yes
DB00619,Imatinib,small molecule,approved,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1,KTUFNOKKBVMGRW-UHFFFAOYSA-N,493.6027,P16234,BE0000852,Platelet-derived growth factor receptor alpha,Humans,antagonist,yes
DB00619,Imatinib,small molecule,approved,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1,KTUFNOKKBVMGRW-UHFFFAOYSA-N,493.6027,P00519,BE0000014,Tyrosine-protein kinase ABL1,Humans,inhibitor,yes
DB00619,Imatinib,small molecule,approved,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1,KTUFNOKKBVMGRW-UHFFFAOYSA-N,493.6027,P09619,BE0000205,Platelet-derived growth factor receptor beta,Humans,antagonist,yes
DB00620,Triamcinolone,small molecule,approved;vet_approved,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,GFNANZIMVAIWHM-OBYCQNJPSA-N,394.4339,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB00621,Oxandrolone,small molecule,approved;investigational,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)OC[C@]12C,QSLJIVKCVHQPLV-PEMPUTJUSA-N,306.4397,P10275,BE0000132,Androgen receptor,Humans,agonist,yes
DB00622,Nicardipine,small molecule,approved;investigational,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1,ZBBHBTPTTSWHBA-UHFFFAOYSA-N,479.525,Q13936,BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,Humans,inhibitor,yes
DB00622,Nicardipine,small molecule,approved;investigational,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1,ZBBHBTPTTSWHBA-UHFFFAOYSA-N,479.525,Q08289,BE0002354,Voltage-dependent L-type calcium channel subunit beta-2,Humans,inhibitor,yes
DB00622,Nicardipine,small molecule,approved;investigational,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1,ZBBHBTPTTSWHBA-UHFFFAOYSA-N,479.525,P54289,BE0000691,Voltage-dependent calcium channel subunit alpha-2/delta-1,Humans,inhibitor,yes
DB00622,Nicardipine,small molecule,approved;investigational,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1,ZBBHBTPTTSWHBA-UHFFFAOYSA-N,479.525,Q01668,BE0002359,Voltage-dependent L-type calcium channel subunit alpha-1D,Humans,inhibitor,yes
DB00623,Fluphenazine,small molecule,approved,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,PLDUPXSUYLZYBN-UHFFFAOYSA-N,437.522,P28222,BE0000797,5-hydroxytryptamine receptor 1B,Humans,modulator,yes
DB00623,Fluphenazine,small molecule,approved,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,PLDUPXSUYLZYBN-UHFFFAOYSA-N,437.522,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB00623,Fluphenazine,small molecule,approved,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,PLDUPXSUYLZYBN-UHFFFAOYSA-N,437.522,P21728,BE0000020,D(1A) dopamine receptor,Humans,antagonist,yes
DB00624,Testosterone,small molecule,approved;investigational,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,288.4244,P10275,BE0000132,Androgen receptor,Humans,agonist,yes
DB00625,Efavirenz,small molecule,approved;investigational,FC(F)(F)[C@]1(OC(=O)NC2=C1C=C(Cl)C=C2)C#CC1CC1,XPOQHMRABVBWPR-ZDUSSCGKSA-N,315.675,P03366,BE0002050,Gag-Pol polyprotein,,modulator,yes
DB00625,Efavirenz,small molecule,approved;investigational,FC(F)(F)[C@]1(OC(=O)NC2=C1C=C(Cl)C=C2)C#CC1CC1,XPOQHMRABVBWPR-ZDUSSCGKSA-N,315.675,Q72547,BE0004136,Reverse transcriptase/RNaseH,Human immunodeficiency virus 1,inhibitor,yes
DB00626,Bacitracin,small molecule,approved;vet_approved,CC[C@H](C)[C@H](N)C1=N[C@@H](CS1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H]1CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(O)=O)NC(=O)[C@H](CC2=CNC=N2)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@@H](CCCN)NC1=O)[C@@H](C)CC,CLKOFPXJLQSYAH-ABRJDSQDSA-N,1422.693,,BE0004829,C55-isoprenyl pyrophosphate,Gram positive and gram negative bacteria,antagonist,yes
DB00626,Bacitracin,small molecule,approved;vet_approved,CC[C@H](C)[C@H](N)C1=N[C@@H](CS1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H]1CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(O)=O)NC(=O)[C@H](CC2=CNC=N2)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@@H](CCCN)NC1=O)[C@@H](C)CC,CLKOFPXJLQSYAH-ABRJDSQDSA-N,1422.693,P14735,BE0001183,Insulin-degrading enzyme,Humans,inhibitor,yes
DB00627,Niacin,small molecule,approved;investigational;nutraceutical,OC(=O)C1=CN=CC=C1,PVNIIMVLHYAWGP-UHFFFAOYSA-N,123.1094,P49019,BE0000836,Hydroxycarboxylic acid receptor 3,Humans,agonist,yes
DB00627,Niacin,small molecule,approved;investigational;nutraceutical,OC(=O)C1=CN=CC=C1,PVNIIMVLHYAWGP-UHFFFAOYSA-N,123.1094,Q96PD7,BE0008719,Diacylglycerol O-acyltransferase 2,Humans,inhibitor,yes
DB00627,Niacin,small molecule,approved;investigational;nutraceutical,OC(=O)C1=CN=CC=C1,PVNIIMVLHYAWGP-UHFFFAOYSA-N,123.1094,Q8TDS4,BE0000635,Hydroxycarboxylic acid receptor 2,Humans,agonist,yes
DB00627,Niacin,small molecule,approved;investigational;nutraceutical,OC(=O)C1=CN=CC=C1,PVNIIMVLHYAWGP-UHFFFAOYSA-N,123.1094,Q15274,BE0000526,Nicotinate-nucleotide pyrophosphorylase [carboxylating],Humans,binder,yes
DB00627,Niacin,small molecule,approved;investigational;nutraceutical,OC(=O)C1=CN=CC=C1,PVNIIMVLHYAWGP-UHFFFAOYSA-N,123.1094,P40261,BE0000783,Nicotinamide N-methyltransferase,Humans,binder,yes
DB00628,Clorazepic acid,small molecule,approved;illicit,OC(=O)C1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2,XDDJGVMJFWAHJX-UHFFFAOYSA-N,314.723,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB00628,Clorazepic acid,small molecule,approved;illicit,OC(=O)C1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2,XDDJGVMJFWAHJX-UHFFFAOYSA-N,314.723,P30536,BE0000736,Translocator protein,Humans,modulator,yes
DB00628,Clorazepic acid,small molecule,approved;illicit,OC(=O)C1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2,XDDJGVMJFWAHJX-UHFFFAOYSA-N,314.723,P14867,BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,Humans,ligand,yes
DB00629,Guanabenz,small molecule,approved;investigational,NC(N)=NN=CC1=C(Cl)C=CC=C1Cl,WDZVGELJXXEGPV-YIXHJXPBSA-N,231.082,P08913,BE0000289,Alpha-2A adrenergic receptor,Humans,agonist,yes
DB00630,Alendronic acid,small molecule,approved,NCCCC(O)(P(O)(O)=O)P(O)(O)=O,OGSPWJRAVKPPFI-UHFFFAOYSA-N,249.096,P14324,BE0000776,Farnesyl pyrophosphate synthase,Humans,inhibitor,yes
DB00630,Alendronic acid,small molecule,approved,NCCCC(O)(P(O)(O)=O)P(O)(O)=O,OGSPWJRAVKPPFI-UHFFFAOYSA-N,249.096,,BE0004801,Hydroxylapatite,Humans,antagonist,yes
DB00631,Clofarabine,small molecule,approved;investigational,[H][C@]1(F)[C@H](O)[C@@H](CO)O[C@H]1N1C=NC2=C(N)N=C(Cl)N=C12,WDDPHFBMKLOVOX-AYQXTPAHSA-N,303.677,Q7LG56,BE0003613,Ribonucleoside-diphosphate reductase subunit M2 B,Humans,inhibitor,yes
DB00631,Clofarabine,small molecule,approved;investigational,[H][C@]1(F)[C@H](O)[C@@H](CO)O[C@H]1N1C=NC2=C(N)N=C(Cl)N=C12,WDDPHFBMKLOVOX-AYQXTPAHSA-N,303.677,P31350,BE0002450,Ribonucleoside-diphosphate reductase subunit M2,Humans,inhibitor,yes
DB00631,Clofarabine,small molecule,approved;investigational,[H][C@]1(F)[C@H](O)[C@@H](CO)O[C@H]1N1C=NC2=C(N)N=C(Cl)N=C12,WDDPHFBMKLOVOX-AYQXTPAHSA-N,303.677,P09884,BE0000546,DNA polymerase alpha catalytic subunit,Humans,inhibitor,yes
DB00631,Clofarabine,small molecule,approved;investigational,[H][C@]1(F)[C@H](O)[C@@H](CO)O[C@H]1N1C=NC2=C(N)N=C(Cl)N=C12,WDDPHFBMKLOVOX-AYQXTPAHSA-N,303.677,P23921,BE0000325,Ribonucleoside-diphosphate reductase large subunit,Humans,inhibitor,yes
DB00632,Docosanol,small molecule,approved;investigational,CCCCCCCCCCCCCCCCCCCCCCO,NOPFSRXAKWQILS-UHFFFAOYSA-N,326.6,P03200,BE0000594,Envelope glycoprotein GP350,HHV-4,intercalation,yes
DB00633,Dexmedetomidine,small molecule,approved;vet_approved,C[C@H](C1=CNC=N1)C1=C(C)C(C)=CC=C1,CUHVIMMYOGQXCV-NSHDSACASA-N,200.2795,P08913,BE0000289,Alpha-2A adrenergic receptor,Humans,agonist,yes
DB00634,Sulfacetamide,small molecule,approved,CC(=O)NS(=O)(=O)C1=CC=C(N)C=C1,SKIVFJLNDNKQPD-UHFFFAOYSA-N,214.242,P0AC13,BE0000803,Dihydropteroate synthase,Escherichia coli (strain K12),inhibitor,yes
DB00634,Sulfacetamide,small molecule,approved,CC(=O)NS(=O)(=O)C1=CC=C(N)C=C1,SKIVFJLNDNKQPD-UHFFFAOYSA-N,214.242,P0C002,BE0004657,Dihydropteroate synthase type-1,Escherichia coli,inhibitor,yes
DB00634,Sulfacetamide,small molecule,approved,CC(=O)NS(=O)(=O)C1=CC=C(N)C=C1,SKIVFJLNDNKQPD-UHFFFAOYSA-N,214.242,P53848,BE0004658,Folic acid synthesis protein FOL1,Baker's yeast,inhibitor,yes
DB00635,Prednisone,small molecule,approved;vet_approved,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,XOFYZVNMUHMLCC-ZPOLXVRWSA-N,358.4281,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB00636,Clofibrate,small molecule,approved;investigational,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1,KNHUKKLJHYUCFP-UHFFFAOYSA-N,242.699,Q07869,BE0000071,Peroxisome proliferator-activated receptor alpha,Humans,agonist,yes
DB00636,Clofibrate,small molecule,approved;investigational,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1,KNHUKKLJHYUCFP-UHFFFAOYSA-N,242.699,P06858,BE0000239,Lipoprotein lipase,Humans,activator,yes
DB00637,Astemizole,small molecule,approved;withdrawn,COC1=CC=C(CCN2CCC(CC2)NC2=NC3=CC=CC=C3N2CC2=CC=C(F)C=C2)C=C1,GXDALQBWZGODGZ-UHFFFAOYSA-N,458.5703,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB00639,Butoconazole,small molecule,approved,ClC1=CC=C(CCC(CN2C=CN=C2)SC2=C(Cl)C=CC=C2Cl)C=C1,SWLMUYACZKCSHZ-UHFFFAOYSA-N,411.776,,BE0004803,Ergosterol,Candida albicans,other,yes
DB00639,Butoconazole,small molecule,approved,ClC1=CC=C(CCC(CN2C=CN=C2)SC2=C(Cl)C=CC=C2Cl)C=C1,SWLMUYACZKCSHZ-UHFFFAOYSA-N,411.776,P10613,BE0000233,Lanosterol 14-alpha demethylase,Yeast,inhibitor,yes
DB00640,Adenosine,small molecule,approved;investigational,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1,OIRDTQYFTABQOQ-KQYNXXCUSA-N,267.2413,P30542,BE0000013,Adenosine receptor A1,Humans,agonist,yes
DB00640,Adenosine,small molecule,approved;investigational,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1,OIRDTQYFTABQOQ-KQYNXXCUSA-N,267.2413,P29274,BE0000924,Adenosine receptor A2a,Humans,agonist,yes
DB00640,Adenosine,small molecule,approved;investigational,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1,OIRDTQYFTABQOQ-KQYNXXCUSA-N,267.2413,P29275,BE0000241,Adenosine receptor A2b,Humans,agonist,yes
DB00640,Adenosine,small molecule,approved;investigational,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1,OIRDTQYFTABQOQ-KQYNXXCUSA-N,267.2413,P0DMS8,BE0000354,Adenosine receptor A3,Humans,agonist,yes
DB00641,Simvastatin,small molecule,approved,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)C(C)(C)CC,RYMZZMVNJRMUDD-HGQWONQESA-N,418.5662,P04035,BE0000574,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Humans,inhibitor,yes
DB00642,Pemetrexed,small molecule,approved;investigational,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1,WBXPDJSOTKVWSJ-ZDUSSCGKSA-N,427.4106,P04818,BE0000324,Thymidylate synthase,Humans,inhibitor,yes
DB00642,Pemetrexed,small molecule,approved;investigational,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1,WBXPDJSOTKVWSJ-ZDUSSCGKSA-N,427.4106,P12461,BE0000021,Thymidylate synthase,Yeast,inhibitor,yes
DB00642,Pemetrexed,small molecule,approved;investigational,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1,WBXPDJSOTKVWSJ-ZDUSSCGKSA-N,427.4106,P31939,BE0001240,Bifunctional purine biosynthesis protein ATIC,Humans,inhibitor,yes
DB00642,Pemetrexed,small molecule,approved;investigational,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1,WBXPDJSOTKVWSJ-ZDUSSCGKSA-N,427.4106,P00374,BE0000330,Dihydrofolate reductase,Humans,inhibitor,yes
DB00642,Pemetrexed,small molecule,approved;investigational,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1,WBXPDJSOTKVWSJ-ZDUSSCGKSA-N,427.4106,P22102,BE0000882,Trifunctional purine biosynthetic protein adenosine-3,Humans,inhibitor,yes
DB00643,Mebendazole,small molecule,approved;vet_approved,COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C1=CC=CC=C1,OPXLLQIJSORQAM-UHFFFAOYSA-N,295.2927,Q71U36,BE0001340,Tubulin alpha-1A chain,Humans,inhibitor,yes
DB00643,Mebendazole,small molecule,approved;vet_approved,COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C1=CC=CC=C1,OPXLLQIJSORQAM-UHFFFAOYSA-N,295.2927,P68371,BE0001367,Tubulin beta-4B chain,Humans,inhibitor,yes
DB00645,Dyclonine,small molecule,approved,CCCCOC1=CC=C(C=C1)C(=O)CCN1CCCCC1,BZEWSEKUUPWQDQ-UHFFFAOYSA-N,289.4125,Q9Y5Y9,BE0000177,Sodium channel protein type 10 subunit alpha,Humans,inhibitor,yes
DB00645,Dyclonine,small molecule,approved,CCCCOC1=CC=C(C=C1)C(=O)CCN1CCCCC1,BZEWSEKUUPWQDQ-UHFFFAOYSA-N,289.4125,Q14524,BE0000197,Sodium channel protein type 5 subunit alpha,Humans,blocker,yes
DB00646,Nystatin,small molecule,approved;vet_approved,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,VQOXZBDYSJBXMA-NQTDYLQESA-N,926.107,,BE0004803,Ergosterol,Candida albicans,binder,yes
DB00647,Dextropropoxyphene,small molecule,approved;illicit;investigational;withdrawn,CCC(=O)O[C@@](CC1=CC=CC=C1)([C@H](C)CN(C)C)C1=CC=CC=C1,XLMALTXPSGQGBX-GCJKJVERSA-N,339.4712,P35372,BE0000770,Mu-type opioid receptor,Humans,agonist,yes
DB00647,Dextropropoxyphene,small molecule,approved;illicit;investigational;withdrawn,CCC(=O)O[C@@](CC1=CC=CC=C1)([C@H](C)CN(C)C)C1=CC=CC=C1,XLMALTXPSGQGBX-GCJKJVERSA-N,339.4712,P41143,BE0000420,Delta-type opioid receptor,Humans,agonist,yes
DB00647,Dextropropoxyphene,small molecule,approved;illicit;investigational;withdrawn,CCC(=O)O[C@@](CC1=CC=CC=C1)([C@H](C)CN(C)C)C1=CC=CC=C1,XLMALTXPSGQGBX-GCJKJVERSA-N,339.4712,P41145,BE0000632,Kappa-type opioid receptor,Humans,antagonist,yes
DB00648,Mitotane,small molecule,approved,ClC(Cl)C(C1=CC=C(Cl)C=C1)C1=CC=CC=C1Cl,JWBOIMRXGHLCPP-UHFFFAOYSA-N,320.041,P15538,BE0000731,"Cytochrome P450 11B1, mitochondrial",Humans,inducer,yes
DB00648,Mitotane,small molecule,approved,ClC(Cl)C(C1=CC=C(Cl)C=C1)C1=CC=CC=C1Cl,JWBOIMRXGHLCPP-UHFFFAOYSA-N,320.041,P03372,BE0000123,Estrogen receptor,Humans,binder,yes
DB00649,Stavudine,small molecule,approved;investigational,CC1=CN([C@@H]2O[C@H](CO)C=C2)C(=O)NC1=O,XNKLLVCARDGLGL-JGVFFNPUSA-N,224.2133,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB00649,Stavudine,small molecule,approved;investigational,CC1=CN([C@@H]2O[C@H](CO)C=C2)C(=O)NC1=O,XNKLLVCARDGLGL-JGVFFNPUSA-N,224.2133,Q72547,BE0004136,Reverse transcriptase/RNaseH,Human immunodeficiency virus 1,inhibitor,yes
DB00650,Leucovorin,small molecule,approved,[H]C(=O)N1C(CNC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNC2=C1C(=O)NC(N)=N2,VVIAGPKUTFNRDU-ABLWVSNPSA-N,473.446,Q96NT5,BE0001048,Proton-coupled folate transporter,Humans,modulator,yes
DB00650,Leucovorin,small molecule,approved,[H]C(=O)N1C(CNC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNC2=C1C(=O)NC(N)=N2,VVIAGPKUTFNRDU-ABLWVSNPSA-N,473.446,P00374,BE0000330,Dihydrofolate reductase,Humans,modulator,yes
DB00651,Dyphylline,small molecule,approved,CN1C2=C(N(CC(O)CO)C=N2)C(=O)N(C)C1=O,KSCFJBIXMNOVSH-UHFFFAOYSA-N,254.2426,Q07343,BE0000487,"3',5'-cyclic-AMP phosphodiesterase 4B",Humans,inhibitor,yes
DB00651,Dyphylline,small molecule,approved,CN1C2=C(N(CC(O)CO)C=N2)C(=O)N(C)C1=O,KSCFJBIXMNOVSH-UHFFFAOYSA-N,254.2426,P21589,BE0001096,5'-nucleotidase,Humans,inhibitor,yes
DB00651,Dyphylline,small molecule,approved,CN1C2=C(N(CC(O)CO)C=N2)C(=O)N(C)C1=O,KSCFJBIXMNOVSH-UHFFFAOYSA-N,254.2426,P27815,BE0001133,"3',5'-cyclic-AMP phosphodiesterase 4A",Humans,inhibitor,yes
DB00651,Dyphylline,small molecule,approved,CN1C2=C(N(CC(O)CO)C=N2)C(=O)N(C)C1=O,KSCFJBIXMNOVSH-UHFFFAOYSA-N,254.2426,Q08493,BE0002353,"3',5'-cyclic-AMP phosphodiesterase 4C",Humans,inhibitor,yes
DB00651,Dyphylline,small molecule,approved,CN1C2=C(N(CC(O)CO)C=N2)C(=O)N(C)C1=O,KSCFJBIXMNOVSH-UHFFFAOYSA-N,254.2426,Q08499,BE0001287,"3',5'-cyclic-AMP phosphodiesterase 4D",Humans,inhibitor,yes
DB00651,Dyphylline,small molecule,approved,CN1C2=C(N(CC(O)CO)C=N2)C(=O)N(C)C1=O,KSCFJBIXMNOVSH-UHFFFAOYSA-N,254.2426,P30542,BE0000013,Adenosine receptor A1,Humans,antagonist,yes
DB00651,Dyphylline,small molecule,approved,CN1C2=C(N(CC(O)CO)C=N2)C(=O)N(C)C1=O,KSCFJBIXMNOVSH-UHFFFAOYSA-N,254.2426,P29274,BE0000924,Adenosine receptor A2a,Humans,antagonist,yes
DB00652,Pentazocine,small molecule,approved;vet_approved,CC1C2CC3=C(C=C(O)C=C3)C1(C)CCN2CC=C(C)C,VOKSWYLNZZRQPF-UHFFFAOYSA-N,285.431,Q99720,BE0000156,Sigma non-opioid intracellular receptor 1,Humans,agonist,yes
DB00652,Pentazocine,small molecule,approved;vet_approved,CC1C2CC3=C(C=C(O)C=C3)C1(C)CCN2CC=C(C)C,VOKSWYLNZZRQPF-UHFFFAOYSA-N,285.431,P35372,BE0000770,Mu-type opioid receptor,Humans,antagonist,yes
DB00652,Pentazocine,small molecule,approved;vet_approved,CC1C2CC3=C(C=C(O)C=C3)C1(C)CCN2CC=C(C)C,VOKSWYLNZZRQPF-UHFFFAOYSA-N,285.431,P41145,BE0000632,Kappa-type opioid receptor,Humans,agonist,yes
DB00654,Latanoprost,small molecule,approved;investigational,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1,GGXICVAJURFBLW-CEYXHVGTSA-N,432.5928,P43088,BE0000610,Prostaglandin F2-alpha receptor,Humans,agonist,yes
DB00655,Estrone,small molecule,approved,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,DNXHEGUUPJUMQT-CBZIJGRNSA-N,270.3661,P03372,BE0000123,Estrogen receptor,Humans,agonist,yes
DB00656,Trazodone,small molecule,approved;investigational,ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1,PHLBKPHSAVXXEF-UHFFFAOYSA-N,371.864,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB00656,Trazodone,small molecule,approved;investigational,ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1,PHLBKPHSAVXXEF-UHFFFAOYSA-N,371.864,P28335,BE0000533,5-hydroxytryptamine receptor 2C,Humans,agonist,yes
DB00656,Trazodone,small molecule,approved;investigational,ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1,PHLBKPHSAVXXEF-UHFFFAOYSA-N,371.864,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB00656,Trazodone,small molecule,approved;investigational,ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1,PHLBKPHSAVXXEF-UHFFFAOYSA-N,371.864,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,antagonist;partial agonist,yes
DB00657,Mecamylamine,small molecule,approved;investigational,CNC1(C)C2CCC(C2)C1(C)C,IMYZQPCYWPFTAG-UHFFFAOYSA-N,167.2911,Q15822,BE0000738,Neuronal acetylcholine receptor subunit alpha-2,Humans,antagonist,yes
DB00658,Sevelamer,small molecule,approved,NCC=C.ClCC1CO1,ZNSIZMQNQCNRBW-UHFFFAOYSA-N,149.619,,BE0004815,Phosphate,Humans,binder,yes
DB00659,Acamprosate,small molecule,approved;investigational,CC(=O)NCCCS(O)(=O)=O,AFCGFAGUEYAMAO-UHFFFAOYSA-N,181.21,Q05586,BE0004852,Glutamate (NMDA) receptor,Humans,antagonist,yes
DB00659,Acamprosate,small molecule,approved;investigational,CC(=O)NCCCS(O)(=O)=O,AFCGFAGUEYAMAO-UHFFFAOYSA-N,181.21,P41594,BE0001192,Metabotropic glutamate receptor 5,Humans,antagonist,yes
DB00659,Acamprosate,small molecule,approved;investigational,CC(=O)NCCCS(O)(=O)=O,AFCGFAGUEYAMAO-UHFFFAOYSA-N,181.21,Q9UBS5,BE0000217,Gamma-aminobutyric acid type B receptor subunit 1,Humans,inhibitor,yes
DB00661,Verapamil,small molecule,approved,COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1,SGTNSNPWRIOYBX-UHFFFAOYSA-N,454.6016,Q13936,BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,Humans,inhibitor,yes
DB00662,Trimethobenzamide,small molecule,approved;investigational,COC1=CC(=CC(OC)=C1OC)C(=O)NCC1=CC=C(OCCN(C)C)C=C1,FEZBIKUBAYAZIU-UHFFFAOYSA-N,388.4574,P14416,BE0000756,D(2) dopamine receptor,Humans,inhibitor,yes
DB00663,Flumethasone,small molecule,approved;vet_approved,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,WXURHACBFYSXBI-GQKYHHCASA-N,410.458,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB00663,Flumethasone,small molecule,approved;vet_approved,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,WXURHACBFYSXBI-GQKYHHCASA-N,410.458,O95718,BE0005001,Steroid hormone receptor ERR2,Humans,modulator,yes
DB00663,Flumethasone,small molecule,approved;vet_approved,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,WXURHACBFYSXBI-GQKYHHCASA-N,410.458,P62508,BE0002088,Estrogen-related receptor gamma,Humans,modulator,yes
DB00663,Flumethasone,small molecule,approved;vet_approved,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,WXURHACBFYSXBI-GQKYHHCASA-N,410.458,P11474,BE0003722,Steroid hormone receptor ERR1,Humans,modulator,yes
DB00664,Sulfametopyrazine,small molecule,approved;withdrawn,COC1=NC=CN=C1NS(=O)(=O)C1=CC=C(N)C=C1,KXRZBTAEDBELFD-UHFFFAOYSA-N,280.303,Q27738,BE0002360,Dihydropteroate synthetase,Plasmodium falciparum,inhibitor,yes
DB00664,Sulfametopyrazine,small molecule,approved;withdrawn,COC1=NC=CN=C1NS(=O)(=O)C1=CC=C(N)C=C1,KXRZBTAEDBELFD-UHFFFAOYSA-N,280.303,P0AC13,BE0000803,Dihydropteroate synthase,Escherichia coli (strain K12),inhibitor,yes
DB00665,Nilutamide,small molecule,approved;investigational,CC1(C)NC(=O)N(C1=O)C1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F,XWXYUMMDTVBTOU-UHFFFAOYSA-N,317.2207,P10275,BE0000132,Androgen receptor,Humans,antagonist,yes
DB00666,Nafarelin,small molecule,approved,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC2=C(C=CC=C2)C=C1)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O,RWHUEXWOYVBUCI-ITQXDASVSA-N,1322.496,P30968,BE0000203,Gonadotropin-releasing hormone receptor,Humans,agonist,yes
DB00666,Nafarelin,small molecule,approved,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC2=C(C=CC=C2)C=C1)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O,RWHUEXWOYVBUCI-ITQXDASVSA-N,1322.496,Q96P88,BE0000472,Putative gonadotropin-releasing hormone II receptor,Humans,agonist,yes
DB00668,Epinephrine,small molecule,approved;vet_approved,CNC[C@H](O)C1=CC(O)=C(O)C=C1,UCTWMZQNUQWSLP-VIFPVBQESA-N,183.2044,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,agonist,yes
DB00668,Epinephrine,small molecule,approved;vet_approved,CNC[C@H](O)C1=CC(O)=C(O)C=C1,UCTWMZQNUQWSLP-VIFPVBQESA-N,183.2044,P35368,BE0000575,Alpha-1B adrenergic receptor,Humans,agonist,yes
DB00668,Epinephrine,small molecule,approved;vet_approved,CNC[C@H](O)C1=CC(O)=C(O)C=C1,UCTWMZQNUQWSLP-VIFPVBQESA-N,183.2044,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,agonist,yes
DB00668,Epinephrine,small molecule,approved;vet_approved,CNC[C@H](O)C1=CC(O)=C(O)C=C1,UCTWMZQNUQWSLP-VIFPVBQESA-N,183.2044,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,agonist,yes
DB00668,Epinephrine,small molecule,approved;vet_approved,CNC[C@H](O)C1=CC(O)=C(O)C=C1,UCTWMZQNUQWSLP-VIFPVBQESA-N,183.2044,P08913,BE0000289,Alpha-2A adrenergic receptor,Humans,agonist,yes
DB00668,Epinephrine,small molecule,approved;vet_approved,CNC[C@H](O)C1=CC(O)=C(O)C=C1,UCTWMZQNUQWSLP-VIFPVBQESA-N,183.2044,P18089,BE0000572,Alpha-2B adrenergic receptor,Humans,agonist,yes
DB00669,Sumatriptan,small molecule,approved;investigational,CNS(=O)(=O)CC1=CC=C2NC=C(CCN(C)C)C2=C1,KQKPFRSPSRPDEB-UHFFFAOYSA-N,295.4,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,agonist,yes
DB00669,Sumatriptan,small molecule,approved;investigational,CNS(=O)(=O)CC1=CC=C2NC=C(CCN(C)C)C2=C1,KQKPFRSPSRPDEB-UHFFFAOYSA-N,295.4,P28221,BE0000659,5-hydroxytryptamine receptor 1D,Humans,agonist,yes
DB00669,Sumatriptan,small molecule,approved;investigational,CNS(=O)(=O)CC1=CC=C2NC=C(CCN(C)C)C2=C1,KQKPFRSPSRPDEB-UHFFFAOYSA-N,295.4,P28222,BE0000797,5-hydroxytryptamine receptor 1B,Humans,agonist,yes
DB00669,Sumatriptan,small molecule,approved;investigational,CNS(=O)(=O)CC1=CC=C2NC=C(CCN(C)C)C2=C1,KQKPFRSPSRPDEB-UHFFFAOYSA-N,295.4,P30939,BE0000460,5-hydroxytryptamine receptor 1F,Humans,agonist,yes
DB00670,Pirenzepine,small molecule,approved,CN1CCN(CC(=O)N2C3=CC=CC=C3C(=O)NC3=C2N=CC=C3)CC1,RMHMFHUVIITRHF-UHFFFAOYSA-N,351.4023,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,antagonist,yes
DB00671,Cefixime,small molecule,approved;investigational,[H][C@]12SCC(C=C)=C(N1C(=O)[C@H]2NC(=O)C(=N/OCC(O)=O)\C1=CSC(N)=N1)C(O)=O,OKBVVJOGVLARMR-QSWIMTSFSA-N,453.45,P0AEB2,BE0004840,Penicillin-binding protein,Gram positive and gram negative bacteria,inhibitor,yes
DB00672,Chlorpropamide,small molecule,approved;investigational,CCCNC(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1,RKWGIWYCVPQPMF-UHFFFAOYSA-N,276.74,Q09428,BE0000207,ATP-binding cassette sub-family C member 8,Humans,inhibitor,yes
DB00672,Chlorpropamide,small molecule,approved;investigational,CCCNC(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1,RKWGIWYCVPQPMF-UHFFFAOYSA-N,276.74,P78508,BE0009591,ATP-sensitive inward rectifier potassium channel 10,Humans,blocker,yes
DB00673,Aprepitant,small molecule,approved;investigational,C[C@@H](O[C@H]1OCCN(CC2=NNC(=O)N2)[C@H]1C1=CC=C(F)C=C1)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F,ATALOFNDEOCMKK-OITMNORJSA-N,534.4267,P25103,BE0000384,Substance-P receptor,Humans,antagonist,yes
DB00674,Galantamine,small molecule,approved,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3,ASUTZQLVASHGKV-JDFRZJQESA-N,287.3535,P22303,BE0000426,Acetylcholinesterase,Humans,inhibitor,yes
DB00674,Galantamine,small molecule,approved,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3,ASUTZQLVASHGKV-JDFRZJQESA-N,287.3535,P36544,BE0002341,Neuronal acetylcholine receptor subunit alpha-7,Humans,allosteric modulator,yes
DB00675,Tamoxifen,small molecule,approved,CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,NKANXQFJJICGDU-QPLCGJKRSA-N,371.5146,P03372,BE0000123,Estrogen receptor,Humans,antagonist;agonist,yes
DB00675,Tamoxifen,small molecule,approved,CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,NKANXQFJJICGDU-QPLCGJKRSA-N,371.5146,Q92731,BE0000792,Estrogen receptor beta,Humans,antagonist;agonist,yes
DB00675,Tamoxifen,small molecule,approved,CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,NKANXQFJJICGDU-QPLCGJKRSA-N,371.5146,P17252,BE0004895,Protein kinase C,Humans,inhibitor,yes
DB00675,Tamoxifen,small molecule,approved,CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,NKANXQFJJICGDU-QPLCGJKRSA-N,371.5146,P04278,BE0000685,Sex hormone-binding globulin,Humans,inducer,yes
DB00676,Benzyl benzoate,small molecule,approved,O=C(OCC1=CC=CC=C1)C1=CC=CC=C1,SESFRYSPDFLNCH-UHFFFAOYSA-N,212.2439,Q05469,BE0014016,Hormone-sensitive lipase,Humans,modulator,yes
DB00677,Isoflurophate,small molecule,approved;investigational;withdrawn,CC(C)OP(F)(=O)OC(C)C,MUCZHBLJLSDCSD-UHFFFAOYSA-N,184.1457,P22303,BE0000426,Acetylcholinesterase,Humans,inhibitor,yes
DB00677,Isoflurophate,small molecule,approved;investigational;withdrawn,CC(C)OP(F)(=O)OC(C)C,MUCZHBLJLSDCSD-UHFFFAOYSA-N,184.1457,P06276,BE0002180,Cholinesterase,Humans,inhibitor,yes
DB00678,Losartan,small molecule,approved,CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1,PSIFNNKUMBGKDQ-UHFFFAOYSA-N,422.911,P19235,BE0000654,Erythropoietin receptor,Humans,stimulator,yes
DB00678,Losartan,small molecule,approved,CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1,PSIFNNKUMBGKDQ-UHFFFAOYSA-N,422.911,P30556,BE0000062,Type-1 angiotensin II receptor,Humans,antagonist,yes
DB00679,Thioridazine,small molecule,approved;withdrawn,CSC1=CC2=C(SC3=CC=CC=C3N2CCC2CCCCN2C)C=C1,KLBQZWRITKRQQV-UHFFFAOYSA-N,370.575,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB00679,Thioridazine,small molecule,approved;withdrawn,CSC1=CC2=C(SC3=CC=CC=C3N2CCC2CCCCN2C)C=C1,KLBQZWRITKRQQV-UHFFFAOYSA-N,370.575,P21728,BE0000020,D(1A) dopamine receptor,Humans,antagonist,yes
DB00679,Thioridazine,small molecule,approved;withdrawn,CSC1=CC2=C(SC3=CC=CC=C3N2CCC2CCCCN2C)C=C1,KLBQZWRITKRQQV-UHFFFAOYSA-N,370.575,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,antagonist,yes
DB00679,Thioridazine,small molecule,approved;withdrawn,CSC1=CC2=C(SC3=CC=CC=C3N2CCC2CCCCN2C)C=C1,KLBQZWRITKRQQV-UHFFFAOYSA-N,370.575,P35368,BE0000575,Alpha-1B adrenergic receptor,Humans,antagonist,yes
DB00679,Thioridazine,small molecule,approved;withdrawn,CSC1=CC2=C(SC3=CC=CC=C3N2CCC2CCCCN2C)C=C1,KLBQZWRITKRQQV-UHFFFAOYSA-N,370.575,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB00680,Moricizine,small molecule,approved;investigational;withdrawn,CCOC(=O)NC1=CC2=C(SC3=CC=CC=C3N2C(=O)CCN2CCOCC2)C=C1,FUBVWMNBEHXPSU-UHFFFAOYSA-N,427.517,Q14524,BE0000197,Sodium channel protein type 5 subunit alpha,Humans,inhibitor,yes
DB00681,Amphotericin B,small molecule,approved;investigational,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,APKFDSVGJQXUKY-INPOYWNPSA-N,924.079,,BE0004803,Ergosterol,Candida albicans,binder,yes
DB00682,Warfarin,small molecule,approved,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=C(OC1=O)C=CC=C2,PJVWKTKQMONHTI-UHFFFAOYSA-N,308.3279,Q9BQB6,BE0000713,Vitamin K epoxide reductase complex subunit 1,Humans,inhibitor,yes
DB00683,Midazolam,small molecule,approved;illicit,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,DDLIGBOFAVUZHB-UHFFFAOYSA-N,325.767,P30536,BE0000736,Translocator protein,Humans,modulator,yes
DB00683,Midazolam,small molecule,approved;illicit,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,DDLIGBOFAVUZHB-UHFFFAOYSA-N,325.767,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB00683,Midazolam,small molecule,approved;illicit,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,DDLIGBOFAVUZHB-UHFFFAOYSA-N,325.767,P14867,BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,Humans,ligand,yes
DB00684,Tobramycin,small molecule,approved;investigational,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,NLVFBUXFDBBNBW-PBSUHMDJSA-N,467.5145,,BE0004799,16S ribosomal RNA,Enteric bacteria and other eubacteria,inhibitor,yes
DB00684,Tobramycin,small molecule,approved;investigational,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,NLVFBUXFDBBNBW-PBSUHMDJSA-N,467.5145,,BE0004800,23S ribosomal RNA,Enteric bacteria and other eubacteria,inhibitor,yes
DB00684,Tobramycin,small molecule,approved;investigational,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,NLVFBUXFDBBNBW-PBSUHMDJSA-N,467.5145,,BE0004833,Bacterial outer membrane,Bacteria,incorporation into and destabilization,yes
DB00684,Tobramycin,small molecule,approved;investigational,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,NLVFBUXFDBBNBW-PBSUHMDJSA-N,467.5145,,BE0010021,Cytoplasmic membrane,Bacteria,incorporation into and destabilization,yes
DB00685,Trovafloxacin,small molecule,approved;investigational;withdrawn,[H][C@@]12CN(C[C@]1([H])[C@H]2N)C1=NC2=C(C=C1F)C(=O)C(=CN2C1=C(F)C=C(F)C=C1)C(O)=O,WVPSKSLAZQPAKQ-CDMJZVDBSA-N,416.36,P43700,BE0000366,DNA gyrase subunit A,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd),inhibitor,yes
DB00685,Trovafloxacin,small molecule,approved;investigational;withdrawn,[H][C@@]12CN(C[C@]1([H])[C@H]2N)C1=NC2=C(C=C1F)C(=O)C(=CN2C1=C(F)C=C(F)C=C1)C(O)=O,WVPSKSLAZQPAKQ-CDMJZVDBSA-N,416.36,P0A0K8,BE0002388,DNA gyrase subunit B,Staphylococcus aureus,modulator,yes
DB00685,Trovafloxacin,small molecule,approved;investigational;withdrawn,[H][C@@]12CN(C[C@]1([H])[C@H]2N)C1=NC2=C(C=C1F)C(=O)C(=CN2C1=C(F)C=C(F)C=C1)C(O)=O,WVPSKSLAZQPAKQ-CDMJZVDBSA-N,416.36,P20831,BE0008385,DNA gyrase subunit A,Staphylococcus aureus,modulator,yes
DB00685,Trovafloxacin,small molecule,approved;investigational;withdrawn,[H][C@@]12CN(C[C@]1([H])[C@H]2N)C1=NC2=C(C=C1F)C(=O)C(=CN2C1=C(F)C=C(F)C=C1)C(O)=O,WVPSKSLAZQPAKQ-CDMJZVDBSA-N,416.36,P43702,BE0000429,DNA topoisomerase 4 subunit A,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd),inhibitor,yes
DB00686,Pentosan polysulfate,small molecule,approved,O[C@@H]1CO[C@@H](O[C@@H]2CO[C@@H](O)[C@H](OS(O)(=O)=O)[C@H]2OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O,FCCNSUIJIOOXEZ-SJYYZXOBSA-N,602.497,P09038,BE0001015,Fibroblast growth factor 2,Humans,antagonist,yes
DB00686,Pentosan polysulfate,small molecule,approved,O[C@@H]1CO[C@@H](O[C@@H]2CO[C@@H](O)[C@H](OS(O)(=O)=O)[C@H]2OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O,FCCNSUIJIOOXEZ-SJYYZXOBSA-N,602.497,P05230,BE0000689,Fibroblast growth factor 1,Humans,antagonist,yes
DB00687,Fludrocortisone,small molecule,approved;investigational,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C,AAXVEMMRQDVLJB-BULBTXNYSA-N,380.4504,P10275,BE0000132,Androgen receptor,Humans,inhibitor,yes
DB00687,Fludrocortisone,small molecule,approved;investigational,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C,AAXVEMMRQDVLJB-BULBTXNYSA-N,380.4504,P08235,BE0000668,Mineralocorticoid receptor,Humans,agonist,yes
DB00688,Mycophenolate mofetil,small molecule,approved;investigational,COC1=C(C\C=C(/C)CCC(=O)OCCN2CCOCC2)C(O)=C2C(=O)OCC2=C1C,RTGDFNSFWBGLEC-SYZQJQIISA-N,433.4947,P43116,BE0000368,Prostaglandin E2 receptor EP2 subtype,Humans,modulator,yes
DB00688,Mycophenolate mofetil,small molecule,approved;investigational,COC1=C(C\C=C(/C)CCC(=O)OCCN2CCOCC2)C(O)=C2C(=O)OCC2=C1C,RTGDFNSFWBGLEC-SYZQJQIISA-N,433.4947,P20839,BE0000761,Inosine-5'-monophosphate dehydrogenase 1,Humans,inhibitor;inducer,yes
DB00688,Mycophenolate mofetil,small molecule,approved;investigational,COC1=C(C\C=C(/C)CCC(=O)OCCN2CCOCC2)C(O)=C2C(=O)OCC2=C1C,RTGDFNSFWBGLEC-SYZQJQIISA-N,433.4947,P12268,BE0000722,Inosine-5'-monophosphate dehydrogenase 2,Humans,inhibitor,yes
DB00689,Cephaloglycin,small molecule,approved,[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O,FUBBGQLTSCSAON-PBFPGSCMSA-N,405.425,P02919,BE0000488,Penicillin-binding protein 1B,Escherichia coli (strain K12),antagonist,yes
DB00690,Flurazepam,small molecule,approved;illicit;investigational,CCN(CC)CCN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F,SAADBVWGJQAEFS-UHFFFAOYSA-N,387.878,P30536,BE0000736,Translocator protein,Humans,modulator,yes
DB00690,Flurazepam,small molecule,approved;illicit;investigational,CCN(CC)CCN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F,SAADBVWGJQAEFS-UHFFFAOYSA-N,387.878,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB00690,Flurazepam,small molecule,approved;illicit;investigational,CCN(CC)CCN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F,SAADBVWGJQAEFS-UHFFFAOYSA-N,387.878,P14867,BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,Humans,ligand,yes
DB00691,Moexipril,small molecule,approved,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC(OC)=C(OC)C=C2C[C@H]1C(O)=O,UWWDHYUMIORJTA-HSQYWUDLSA-N,498.5681,P12821,BE0000221,Angiotensin-converting enzyme,Humans,inhibitor,yes
DB00692,Phentolamine,small molecule,approved,CC1=CC=C(C=C1)N(CC1=NCCN1)C1=CC(O)=CC=C1,MRBDMNSDAVCSSF-UHFFFAOYSA-N,281.3523,P35348,BE0004863,Alpha-1 adrenergic receptors,Humans,antagonist,yes
DB00692,Phentolamine,small molecule,approved,CC1=CC=C(C=C1)N(CC1=NCCN1)C1=CC(O)=CC=C1,MRBDMNSDAVCSSF-UHFFFAOYSA-N,281.3523,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB00693,Fluorescein,small molecule,approved,OC1=CC=C2C(OC3=CC(O)=CC=C3C22OC(=O)C3=C2C=CC=C3)=C1,GNBHRKFJIUUOQI-UHFFFAOYSA-N,332.3063,Q8TCC7,BE0003645,Organic anion transporter 3,Humans,inhibitor,yes
DB00694,Daunorubicin,small molecule,approved,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(C)=O)C(O)=C1C2=O,STQGQHZAVUOBTE-VGBVRHCVSA-N,527.5199,,BE0004796,DNA,Humans,intercalation,yes
DB00694,Daunorubicin,small molecule,approved,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(C)=O)C(O)=C1C2=O,STQGQHZAVUOBTE-VGBVRHCVSA-N,527.5199,P11388,BE0000742,DNA topoisomerase 2-alpha,Humans,inhibitor,yes
DB00694,Daunorubicin,small molecule,approved,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(C)=O)C(O)=C1C2=O,STQGQHZAVUOBTE-VGBVRHCVSA-N,527.5199,Q02880,BE0002425,DNA topoisomerase 2-beta,Humans,inhibitor,yes
DB00695,Furosemide,small molecule,approved;vet_approved,NS(=O)(=O)C1=C(Cl)C=C(NCC2=CC=CO2)C(=C1)C(O)=O,ZZUFCTLCJUWOSV-UHFFFAOYSA-N,330.744,Q13621,BE0000502,Solute carrier family 12 member 1,Humans,inhibitor,yes
DB00696,Ergotamine,small molecule,approved,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O,XCGSFFUVFURLIX-VFGNJEKYSA-N,581.6615,P28221,BE0000659,5-hydroxytryptamine receptor 1D,Humans,agonist,yes
DB00696,Ergotamine,small molecule,approved,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O,XCGSFFUVFURLIX-VFGNJEKYSA-N,581.6615,P28222,BE0000797,5-hydroxytryptamine receptor 1B,Humans,agonist,yes
DB00696,Ergotamine,small molecule,approved,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O,XCGSFFUVFURLIX-VFGNJEKYSA-N,581.6615,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,agonist,yes
DB00696,Ergotamine,small molecule,approved,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O,XCGSFFUVFURLIX-VFGNJEKYSA-N,581.6615,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,partial agonist,yes
DB00696,Ergotamine,small molecule,approved,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O,XCGSFFUVFURLIX-VFGNJEKYSA-N,581.6615,P35368,BE0000575,Alpha-1B adrenergic receptor,Humans,partial agonist,yes
DB00696,Ergotamine,small molecule,approved,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O,XCGSFFUVFURLIX-VFGNJEKYSA-N,581.6615,P25100,BE0000715,Alpha-1D adrenergic receptor,Humans,partial agonist,yes
DB00697,Tizanidine,small molecule,approved;investigational,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1,XFYDIVBRZNQMJC-UHFFFAOYSA-N,253.711,P35348,BE0004863,Alpha-1 adrenergic receptors,Humans,agonist,yes
DB00697,Tizanidine,small molecule,approved;investigational,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1,XFYDIVBRZNQMJC-UHFFFAOYSA-N,253.711,P08913,BE0004864,Alpha-2 adrenergic receptors,Humans,agonist,yes
DB00698,Nitrofurantoin,small molecule,approved;vet_approved,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,NXFQHRVNIOXGAQ-YCRREMRBSA-N,238.159,P52647,BE0002361,Probable pyruvate-flavodoxin oxidoreductase,Escherichia coli (strain K12),potentiator,yes
DB00698,Nitrofurantoin,small molecule,approved;vet_approved,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,NXFQHRVNIOXGAQ-YCRREMRBSA-N,238.159,P17117,BE0000621,Oxygen-insensitive NADPH nitroreductase,Escherichia coli (strain K12),potentiator,yes
DB00699,Nicergoline,small molecule,approved;investigational,[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)[C@]1(C[C@@H](COC(=O)C1=CN=CC(Br)=C1)CN2C)OC,YSEXMKHXIOCEJA-FVFQAYNVSA-N,484.386,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,antagonist,yes
DB00700,Eplerenone,small molecule,approved,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)C[C@H]1O[C@@]11[C@@]2([H])[C@@H](CC2=CC(=O)CC[C@]12C)C(=O)OC,JUKPWJGBANNWMW-VWBFHTRKSA-N,414.4914,P08235,BE0000668,Mineralocorticoid receptor,Humans,antagonist,yes
DB00701,Amprenavir,small molecule,approved;investigational,CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)C1=CC=C(N)C=C1,YMARZQAQMVYCKC-OEMFJLHTSA-N,505.627,Q72874,BE0004854,Pol polyprotein,Human immunodeficiency virus 1,inhibitor,yes
DB00701,Amprenavir,small molecule,approved;investigational,CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)C1=CC=C(N)C=C1,YMARZQAQMVYCKC-OEMFJLHTSA-N,505.627,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB00703,Methazolamide,small molecule,approved,CN1N=C(S\C1=N\C(C)=O)S(N)(=O)=O,FLOSMHQXBMRNHR-QPJJXVBHSA-N,236.26,P00915,BE0000267,Carbonic anhydrase 1,Humans,inhibitor,yes
DB00703,Methazolamide,small molecule,approved,CN1N=C(S\C1=N\C(C)=O)S(N)(=O)=O,FLOSMHQXBMRNHR-QPJJXVBHSA-N,236.26,P22748,BE0000535,Carbonic anhydrase 4,Humans,inhibitor,yes
DB00703,Methazolamide,small molecule,approved,CN1N=C(S\C1=N\C(C)=O)S(N)(=O)=O,FLOSMHQXBMRNHR-QPJJXVBHSA-N,236.26,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB00703,Methazolamide,small molecule,approved,CN1N=C(S\C1=N\C(C)=O)S(N)(=O)=O,FLOSMHQXBMRNHR-QPJJXVBHSA-N,236.26,P43166,BE0003629,Carbonic anhydrase 7,Humans,inhibitor,yes
DB00704,Naltrexone,small molecule,approved;investigational;vet_approved,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,DQCKKXVULJGBQN-XFWGSAIBSA-N,341.4009,P35372,BE0000770,Mu-type opioid receptor,Humans,antagonist,yes
DB00704,Naltrexone,small molecule,approved;investigational;vet_approved,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,DQCKKXVULJGBQN-XFWGSAIBSA-N,341.4009,P41145,BE0000632,Kappa-type opioid receptor,Humans,antagonist,yes
DB00704,Naltrexone,small molecule,approved;investigational;vet_approved,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,DQCKKXVULJGBQN-XFWGSAIBSA-N,341.4009,P41143,BE0000420,Delta-type opioid receptor,Humans,antagonist,yes
DB00705,Delavirdine,small molecule,approved,CC(C)NC1=C(N=CC=C1)N1CCN(CC1)C(=O)C1=CC2=C(N1)C=CC(NS(C)(=O)=O)=C2,WHBIGIKBNXZKFE-UHFFFAOYSA-N,456.561,P03366,BE0002050,Gag-Pol polyprotein,,modulator,yes
DB00705,Delavirdine,small molecule,approved,CC(C)NC1=C(N=CC=C1)N1CCN(CC1)C(=O)C1=CC2=C(N1)C=CC(NS(C)(=O)=O)=C2,WHBIGIKBNXZKFE-UHFFFAOYSA-N,456.561,Q72547,BE0004136,Reverse transcriptase/RNaseH,Human immunodeficiency virus 1,inhibitor,yes
DB00706,Tamsulosin,small molecule,approved;investigational,CCOC1=CC=CC=C1OCCN[C@H](C)CC1=CC(=C(OC)C=C1)S(N)(=O)=O,DRHKJLXJIQTDTD-OAHLLOKOSA-N,408.512,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,antagonist,yes
DB00708,Sufentanil,small molecule,approved;investigational,CCC(=O)N(C1=CC=CC=C1)C1(COC)CCN(CCC2=CC=CS2)CC1,GGCSSNBKKAUURC-UHFFFAOYSA-N,386.551,P35372,BE0000770,Mu-type opioid receptor,Humans,agonist,yes
DB00709,Lamivudine,small molecule,approved;investigational,NC1=NC(=O)N(C=C1)[C@@H]1CS[C@H](CO)O1,JTEGQNOMFQHVDC-NKWVEPMBSA-N,229.256,P03366,BE0002050,Gag-Pol polyprotein,,modulator,yes
DB00709,Lamivudine,small molecule,approved;investigational,NC1=NC(=O)N(C=C1)[C@@H]1CS[C@H](CO)O1,JTEGQNOMFQHVDC-NKWVEPMBSA-N,229.256,Q72547,BE0004136,Reverse transcriptase/RNaseH,Human immunodeficiency virus 1,inhibitor,yes
DB00709,Lamivudine,small molecule,approved;investigational,NC1=NC(=O)N(C=C1)[C@@H]1CS[C@H](CO)O1,JTEGQNOMFQHVDC-NKWVEPMBSA-N,229.256,,BE0004796,DNA,Humans,binder,yes
DB00709,Lamivudine,small molecule,approved;investigational,NC1=NC(=O)N(C=C1)[C@@H]1CS[C@H](CO)O1,JTEGQNOMFQHVDC-NKWVEPMBSA-N,229.256,Q05486,BE0000555,Protein P,HBV-F,inhibitor,yes
DB00710,Ibandronate,small molecule,approved;investigational,CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O,MPBVHIBUJCELCL-UHFFFAOYSA-N,319.2289,,BE0004801,Hydroxylapatite,Humans,antagonist,yes
DB00710,Ibandronate,small molecule,approved;investigational,CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O,MPBVHIBUJCELCL-UHFFFAOYSA-N,319.2289,O95749,BE0003570,Geranylgeranyl pyrophosphate synthase,Humans,inhibitor,yes
DB00710,Ibandronate,small molecule,approved;investigational,CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O,MPBVHIBUJCELCL-UHFFFAOYSA-N,319.2289,P14324,BE0000776,Farnesyl pyrophosphate synthase,Humans,inhibitor,yes
DB00711,Diethylcarbamazine,small molecule,approved;investigational;vet_approved,CCN(CC)C(=O)N1CCN(C)CC1,RCKMWOKWVGPNJF-UHFFFAOYSA-N,199.2932,P09917,BE0000248,Polyunsaturated fatty acid 5-lipoxygenase,Humans,inhibitor,yes
DB00712,Flurbiprofen,small molecule,approved;investigational,CC(C(O)=O)C1=CC(F)=C(C=C1)C1=CC=CC=C1,SYTBZMRGLBWNTM-UHFFFAOYSA-N,244.2609,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB00713,Oxacillin,small molecule,approved;investigational,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=CC=CC=C1)C(O)=O,UWYHMGVUTGAWSP-JKIFEVAISA-N,401.436,Q75Y35,BE0004643,Penicillin-binding protein 3,Streptococcus pneumoniae,inhibitor,yes
DB00713,Oxacillin,small molecule,approved;investigational,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=CC=CC=C1)C(O)=O,UWYHMGVUTGAWSP-JKIFEVAISA-N,401.436,Q8DNB6,BE0004644,Penicillin-binding protein 2a,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB00713,Oxacillin,small molecule,approved;investigational,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=CC=CC=C1)C(O)=O,UWYHMGVUTGAWSP-JKIFEVAISA-N,401.436,Q8DR59,BE0004290,Penicillin-binding protein 1A,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB00713,Oxacillin,small molecule,approved;investigational,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=CC=CC=C1)C(O)=O,UWYHMGVUTGAWSP-JKIFEVAISA-N,401.436,P0A3M6,BE0003624,Penicillin-binding protein 2B,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB00713,Oxacillin,small molecule,approved;investigational,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=CC=CC=C1)C(O)=O,UWYHMGVUTGAWSP-JKIFEVAISA-N,401.436,Q7CRA4,BE0004335,Penicillin-binding protein 1b,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB00713,Oxacillin,small molecule,approved;investigational,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=CC=CC=C1)C(O)=O,UWYHMGVUTGAWSP-JKIFEVAISA-N,401.436,Q8XJ01,BE0000576,Penicillin-binding protein 1A,Clostridium perfringens (strain 13 / Type A),inhibitor,yes
DB00714,Apomorphine,small molecule,approved;investigational,[H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23,VMWNQDUVQKEIOC-CYBMUJFWSA-N,267.3224,P21917,BE0000389,D(4) dopamine receptor,Humans,agonist,yes
DB00714,Apomorphine,small molecule,approved;investigational,[H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23,VMWNQDUVQKEIOC-CYBMUJFWSA-N,267.3224,P14416,BE0000756,D(2) dopamine receptor,Humans,agonist,yes
DB00714,Apomorphine,small molecule,approved;investigational,[H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23,VMWNQDUVQKEIOC-CYBMUJFWSA-N,267.3224,P35462,BE0000581,D(3) dopamine receptor,Humans,agonist,yes
DB00715,Paroxetine,small molecule,approved;investigational,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,AHOUBRCZNHFOSL-YOEHRIQHSA-N,329.3654,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB00716,Nedocromil,small molecule,approved;investigational,CCCC1=C2N(CC)C(=CC(=O)C2=CC2=C1OC(=CC2=O)C(O)=O)C(O)=O,RQTOOFIXOKYGAN-UHFFFAOYSA-N,371.3408,Q9Y271,BE0000705,Cysteinyl leukotriene receptor 1,Humans,antagonist,yes
DB00716,Nedocromil,small molecule,approved;investigational,CCCC1=C2N(CC)C(=CC(=O)C2=CC2=C1OC(=CC2=O)C(O)=O)C(O)=O,RQTOOFIXOKYGAN-UHFFFAOYSA-N,371.3408,Q9NS75,BE0000099,Cysteinyl leukotriene receptor 2,Humans,antagonist,yes
DB00717,Norethisterone,small molecule,approved,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],VIKNJXKGJWUCNN-XGXHKTLJSA-N,298.4192,P06401,BE0000557,Progesterone receptor,Humans,agonist,yes
DB00718,Adefovir dipivoxil,small molecule,approved;investigational,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N)N=CN=C12)OCOC(=O)C(C)(C)C,WOZSCQDILHKSGG-UHFFFAOYSA-N,501.4705,P24024,BE0000312,Protein P,HBV-D,other,yes
DB00719,Azatadine,small molecule,approved,CN1CCC(CC1)=C1C2=CC=CC=C2CCC2=C1N=CC=C2,SEBMTIQKRHYNIT-UHFFFAOYSA-N,290.4021,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB00720,Clodronic acid,small molecule,approved;investigational;vet_approved,OP(O)(=O)C(Cl)(Cl)P(O)(O)=O,ACSIXWWBWUQEHA-UHFFFAOYSA-N,244.892,,BE0004801,Hydroxylapatite,Humans,antagonist,yes
DB00720,Clodronic acid,small molecule,approved;investigational;vet_approved,OP(O)(=O)C(Cl)(Cl)P(O)(O)=O,ACSIXWWBWUQEHA-UHFFFAOYSA-N,244.892,P12235,BE0000599,ADP/ATP translocase 1,Humans,inhibitor,yes
DB00720,Clodronic acid,small molecule,approved;investigational;vet_approved,OP(O)(=O)C(Cl)(Cl)P(O)(O)=O,ACSIXWWBWUQEHA-UHFFFAOYSA-N,244.892,P05141,BE0000709,ADP/ATP translocase 2,Humans,inhibitor,yes
DB00720,Clodronic acid,small molecule,approved;investigational;vet_approved,OP(O)(=O)C(Cl)(Cl)P(O)(O)=O,ACSIXWWBWUQEHA-UHFFFAOYSA-N,244.892,P12236,BE0000624,ADP/ATP translocase 3,Humans,inhibitor,yes
DB00721,Procaine,small molecule,approved;investigational;vet_approved,CCN(CC)CCOC(=O)C1=CC=C(N)C=C1,MFDFERRIHVXMIY-UHFFFAOYSA-N,236.3101,Q9Y5Y9,BE0000177,Sodium channel protein type 10 subunit alpha,Humans,inhibitor,yes
DB00721,Procaine,small molecule,approved;investigational;vet_approved,CCN(CC)CCOC(=O)C1=CC=C(N)C=C1,MFDFERRIHVXMIY-UHFFFAOYSA-N,236.3101,Q8TCU5,BE0000641,"Glutamate receptor ionotropic, NMDA 3A",Humans,antagonist,yes
DB00721,Procaine,small molecule,approved;investigational;vet_approved,CCN(CC)CCOC(=O)C1=CC=C(N)C=C1,MFDFERRIHVXMIY-UHFFFAOYSA-N,236.3101,P46098,BE0000311,5-hydroxytryptamine receptor 3A,Humans,antagonist,yes
DB00721,Procaine,small molecule,approved;investigational;vet_approved,CCN(CC)CCOC(=O)C1=CC=C(N)C=C1,MFDFERRIHVXMIY-UHFFFAOYSA-N,236.3101,Q01959,BE0000647,Sodium-dependent dopamine transporter,Humans,inhibitor,yes
DB00722,Lisinopril,small molecule,approved;investigational,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,RLAWWYSOJDYHDC-BZSNNMDCSA-N,405.4879,P12821,BE0000221,Angiotensin-converting enzyme,Humans,inhibitor,yes
DB00723,Methoxamine,small molecule,approved;investigational,COC1=CC(C(O)C(C)N)=C(OC)C=C1,WJAJPNHVVFWKKL-UHFFFAOYSA-N,211.2576,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,agonist,yes
DB00724,Imiquimod,small molecule,approved;investigational,CC(C)CN1C=NC2=C1C1=C(C=CC=C1)N=C2N,DOUYETYNHWVLEO-UHFFFAOYSA-N,240.3036,Q9NYK1,BE0000155,Toll-like receptor 7,Humans,agonist,yes
DB00725,Homatropine methylbromide,small molecule,approved,[Br-].C[N+]1(C)C2CCC1CC(C2)OC(=O)C(O)C1=CC=CC=C1,FUFVKLQESJNNAN-UHFFFAOYSA-M,370.281,P08172,BE0000560,Muscarinic acetylcholine receptor M2,Humans,antagonist,yes
DB00725,Homatropine methylbromide,small molecule,approved,[Br-].C[N+]1(C)C2CCC1CC(C2)OC(=O)C(O)C1=CC=CC=C1,FUFVKLQESJNNAN-UHFFFAOYSA-M,370.281,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,antagonist,yes
DB00725,Homatropine methylbromide,small molecule,approved,[Br-].C[N+]1(C)C2CCC1CC(C2)OC(=O)C(O)C1=CC=CC=C1,FUFVKLQESJNNAN-UHFFFAOYSA-M,370.281,P08173,BE0000405,Muscarinic acetylcholine receptor M4,Humans,antagonist,yes
DB00725,Homatropine methylbromide,small molecule,approved,[Br-].C[N+]1(C)C2CCC1CC(C2)OC(=O)C(O)C1=CC=CC=C1,FUFVKLQESJNNAN-UHFFFAOYSA-M,370.281,P08912,BE0000247,Muscarinic acetylcholine receptor M5,Humans,antagonist,yes
DB00725,Homatropine methylbromide,small molecule,approved,[Br-].C[N+]1(C)C2CCC1CC(C2)OC(=O)C(O)C1=CC=CC=C1,FUFVKLQESJNNAN-UHFFFAOYSA-M,370.281,P20309,BE0000045,Muscarinic acetylcholine receptor M3,Humans,antagonist,yes
DB00726,Trimipramine,small molecule,approved,CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C12,ZSCDBOWYZJWBIY-UHFFFAOYSA-N,294.4338,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB00726,Trimipramine,small molecule,approved,CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C12,ZSCDBOWYZJWBIY-UHFFFAOYSA-N,294.4338,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,inhibitor,yes
DB00727,Nitroglycerin,small molecule,approved;investigational,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,SNIOPGDIGTZGOP-UHFFFAOYSA-N,227.0865,P00533,BE0000767,Epidermal growth factor receptor,Humans,activator,yes
DB00727,Nitroglycerin,small molecule,approved;investigational,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,SNIOPGDIGTZGOP-UHFFFAOYSA-N,227.0865,Q02108,BE0010061,Guanylate cyclase soluble subunit alpha-1,Humans,modulator,yes
DB00727,Nitroglycerin,small molecule,approved;investigational,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,SNIOPGDIGTZGOP-UHFFFAOYSA-N,227.0865,Q02153,BE0010029,Guanylate cyclase soluble subunit beta-1,Humans,modulator,yes
DB00728,Rocuronium,small molecule,approved,[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](O)[C@H](C[C@]12C)N1CCOCC1)[N+]1(CC=C)CCCC1,YXRDKMPIGHSVRX-OOJCLDBCSA-N,529.7742,Q15822,BE0000738,Neuronal acetylcholine receptor subunit alpha-2,Humans,antagonist,yes
DB00728,Rocuronium,small molecule,approved,[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](O)[C@H](C[C@]12C)N1CCOCC1)[N+]1(CC=C)CCCC1,YXRDKMPIGHSVRX-OOJCLDBCSA-N,529.7742,P08172,BE0000560,Muscarinic acetylcholine receptor M2,Humans,antagonist,yes
DB00730,Thiabendazole,small molecule,approved;vet_approved,N1C2=CC=CC=C2N=C1C1=CSC=N1,WJCNZQLZVWNLKY-UHFFFAOYSA-N,201.248,P00363,BE0000548,Fumarate reductase flavoprotein subunit,Escherichia coli (strain K12),inhibitor,yes
DB00731,Nateglinide,small molecule,approved;investigational,CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](CC1=CC=CC=C1)C(O)=O,OELFLUMRDSZNSF-BRWVUGGUSA-N,317.429,Q09428,BE0000207,ATP-binding cassette sub-family C member 8,Humans,inhibitor,yes
DB00732,Atracurium besylate,small molecule,approved,[O-]S(=O)(=O)C1=CC=CC=C1.[O-]S(=O)(=O)C1=CC=CC=C1.COC1=CC2=C(C=C1OC)C(CC1=CC(OC)=C(OC)C=C1)[N+](C)(CCC(=O)OCCCCCOC(=O)CC[N+]1(C)CCC3=C(C=C(OC)C(OC)=C3)C1CC1=CC(OC)=C(OC)C=C1)CC2,XXZSQOVSEBAPGS-UHFFFAOYSA-L,1243.49,Q15822,BE0000738,Neuronal acetylcholine receptor subunit alpha-2,Humans,antagonist,yes
DB00733,Pralidoxime,small molecule,approved;vet_approved,C[N+]1=C(\C=N\O)C=CC=C1,JBKPUQTUERUYQE-UHFFFAOYSA-O,137.1592,P22303,BE0000426,Acetylcholinesterase,Humans,activator,yes
DB00733,Pralidoxime,small molecule,approved;vet_approved,C[N+]1=C(\C=N\O)C=CC=C1,JBKPUQTUERUYQE-UHFFFAOYSA-O,137.1592,P06276,BE0002180,Cholinesterase,Humans,activator,yes
DB00734,Risperidone,small molecule,approved;investigational,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,RAPZEAPATHNIPO-UHFFFAOYSA-N,410.4845,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB00734,Risperidone,small molecule,approved;investigational,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,RAPZEAPATHNIPO-UHFFFAOYSA-N,410.4845,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB00735,Naftifine,small molecule,approved,CN(CC=CC1=CC=CC=C1)CC1=CC=CC2=CC=CC=C12,OZGNYLLQHRPOBR-DHZHZOJOSA-N,287.3981,Q14534,BE0000577,Squalene monooxygenase,Humans,inhibitor,yes
DB00736,Esomeprazole,small molecule,approved;investigational,COC1=CC2=C(NC(=N2)[S@@](=O)CC2=NC=C(C)C(OC)=C2C)C=C1,SUBDBMMJDZJVOS-DEOSSOPVSA-N,345.416,P20648,BE0000349,Potassium-transporting ATPase alpha chain 1,Humans,inhibitor,yes
DB00736,Esomeprazole,small molecule,approved;investigational,COC1=CC2=C(NC(=N2)[S@@](=O)CC2=NC=C(C)C(OC)=C2C)C=C1,SUBDBMMJDZJVOS-DEOSSOPVSA-N,345.416,P51164,BE0000619,Potassium-transporting ATPase subunit beta,Humans,modulator,yes
DB00737,Meclizine,small molecule,approved,CC1=CC(CN2CCN(CC2)C(C2=CC=CC=C2)C2=CC=C(Cl)C=C2)=CC=C1,OCJYIGYOJCODJL-UHFFFAOYSA-N,390.948,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB00738,Pentamidine,small molecule,approved;investigational,NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1,XDRYMKDFEDOLFX-UHFFFAOYSA-N,340.4195,Q15661,BE0003736,Tryptase alpha/beta-1,Humans,inhibitor,yes
DB00739,Hetacillin,small molecule,approved;vet_approved;withdrawn,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2N1C(=O)[C@H](NC1(C)C)C1=CC=CC=C1)C(O)=O,DXVUYOAEDJXBPY-NFFDBFGFSA-N,389.469,Q8DNB6,BE0004644,Penicillin-binding protein 2a,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB00739,Hetacillin,small molecule,approved;vet_approved;withdrawn,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2N1C(=O)[C@H](NC1(C)C)C1=CC=CC=C1)C(O)=O,DXVUYOAEDJXBPY-NFFDBFGFSA-N,389.469,Q7CRA4,BE0004335,Penicillin-binding protein 1b,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB00739,Hetacillin,small molecule,approved;vet_approved;withdrawn,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2N1C(=O)[C@H](NC1(C)C)C1=CC=CC=C1)C(O)=O,DXVUYOAEDJXBPY-NFFDBFGFSA-N,389.469,Q75Y35,BE0004643,Penicillin-binding protein 3,Streptococcus pneumoniae,inhibitor,yes
DB00739,Hetacillin,small molecule,approved;vet_approved;withdrawn,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2N1C(=O)[C@H](NC1(C)C)C1=CC=CC=C1)C(O)=O,DXVUYOAEDJXBPY-NFFDBFGFSA-N,389.469,Q8DR59,BE0004290,Penicillin-binding protein 1A,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB00739,Hetacillin,small molecule,approved;vet_approved;withdrawn,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2N1C(=O)[C@H](NC1(C)C)C1=CC=CC=C1)C(O)=O,DXVUYOAEDJXBPY-NFFDBFGFSA-N,389.469,P0A3M6,BE0003624,Penicillin-binding protein 2B,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB00740,Riluzole,small molecule,approved;investigational,NC1=NC2=C(S1)C=C(OC(F)(F)F)C=C2,FTALBRSUTCGOEG-UHFFFAOYSA-N,234.198,Q14524,BE0000197,Sodium channel protein type 5 subunit alpha,Humans,inhibitor,yes
DB00740,Riluzole,small molecule,approved;investigational,NC1=NC2=C(S1)C=C(OC(F)(F)F)C=C2,FTALBRSUTCGOEG-UHFFFAOYSA-N,234.198,Q9UI33,BE0000192,Sodium channel protein type 11 subunit alpha,Humans,blocker,yes
DB00740,Riluzole,small molecule,approved;investigational,NC1=NC2=C(S1)C=C(OC(F)(F)F)C=C2,FTALBRSUTCGOEG-UHFFFAOYSA-N,234.198,Q9UPY5,BE0000030,Cystine/glutamate transporter,Humans,inducer,yes
DB00741,Hydrocortisone,small molecule,approved;vet_approved,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,JYGXADMDTFJGBT-VWUMJDOOSA-N,362.4599,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB00741,Hydrocortisone,small molecule,approved;vet_approved,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,JYGXADMDTFJGBT-VWUMJDOOSA-N,362.4599,P04083,BE0000422,Annexin A1,Humans,agonist,yes
DB00743,Gadobenic acid,small molecule,approved;investigational,[Gd+3].OC(=O)CN(CCN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O)C(COCC1=CC=CC=C1)C(O)=O,MXZROTBGJUUXID-UHFFFAOYSA-K,667.73,P02768,BE0000530,Albumin,Humans,binder,yes
DB00744,Zileuton,small molecule,approved;investigational;withdrawn,CC(N(O)C(N)=O)C1=CC2=CC=CC=C2S1,MWLSOWXNZPKENC-UHFFFAOYSA-N,236.29,P09917,BE0000248,Polyunsaturated fatty acid 5-lipoxygenase,Humans,inhibitor,yes
DB00745,Modafinil,small molecule,approved;investigational,NC(=O)CS(=O)C(C1=CC=CC=C1)C1=CC=CC=C1,YFGHCGITMMYXAQ-UHFFFAOYSA-N,273.35,Q01959,BE0000647,Sodium-dependent dopamine transporter,Humans,inhibitor,yes
DB00746,Deferoxamine,small molecule,approved;investigational,CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN,UBQYURCVBFRUQT-UHFFFAOYSA-N,560.684,,BE0004807,Iron,Humans,chelator,yes
DB00746,Deferoxamine,small molecule,approved;investigational,CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN,UBQYURCVBFRUQT-UHFFFAOYSA-N,560.684,,BE0004818,Aluminum,Humans,chelator,yes
DB00747,Scopolamine,small molecule,approved;investigational,CN1[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1,STECJAGHUSJQJN-FWXGHANASA-N,303.3529,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,antagonist,yes
DB00747,Scopolamine,small molecule,approved;investigational,CN1[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1,STECJAGHUSJQJN-FWXGHANASA-N,303.3529,P08172,BE0000560,Muscarinic acetylcholine receptor M2,Humans,antagonist,yes
DB00747,Scopolamine,small molecule,approved;investigational,CN1[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1,STECJAGHUSJQJN-FWXGHANASA-N,303.3529,P20309,BE0000045,Muscarinic acetylcholine receptor M3,Humans,antagonist,yes
DB00747,Scopolamine,small molecule,approved;investigational,CN1[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1,STECJAGHUSJQJN-FWXGHANASA-N,303.3529,P08173,BE0000405,Muscarinic acetylcholine receptor M4,Humans,antagonist,yes
DB00747,Scopolamine,small molecule,approved;investigational,CN1[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1,STECJAGHUSJQJN-FWXGHANASA-N,303.3529,P08912,BE0000247,Muscarinic acetylcholine receptor M5,Humans,antagonist,yes
DB00748,Carbinoxamine,small molecule,approved,CN(C)CCOC(C1=CC=C(Cl)C=C1)C1=CC=CC=N1,OJFSXZCBGQGRNV-UHFFFAOYSA-N,290.788,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB00749,Etodolac,small molecule,approved;investigational;vet_approved,CCC1=C2NC3=C(CCOC3(CC)CC(O)=O)C2=CC=C1,NNYBQONXHNTVIJ-UHFFFAOYSA-N,287.3535,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB00750,Prilocaine,small molecule,approved,CCCNC(C)C(=O)NC1=CC=CC=C1C,MVFGUOIZUNYYSO-UHFFFAOYSA-N,220.3107,Q14524,BE0000197,Sodium channel protein type 5 subunit alpha,Humans,inhibitor,yes
DB00751,Epinastine,small molecule,approved;investigational,NC1=NCC2N1C1=CC=CC=C1CC1=CC=CC=C21,WHWZLSFABNNENI-UHFFFAOYSA-N,249.3104,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB00751,Epinastine,small molecule,approved;investigational,NC1=NCC2N1C1=CC=CC=C1CC1=CC=CC=C21,WHWZLSFABNNENI-UHFFFAOYSA-N,249.3104,P25021,BE0000112,Histamine H2 receptor,Humans,antagonist,yes
DB00752,Tranylcypromine,small molecule,approved;investigational,NC1CC1C1=CC=CC=C1,AELCINSCMGFISI-UHFFFAOYSA-N,133.194,P27338,BE0002196,Amine oxidase [flavin-containing] B,Humans,inhibitor,yes
DB00752,Tranylcypromine,small molecule,approved;investigational,NC1CC1C1=CC=CC=C1,AELCINSCMGFISI-UHFFFAOYSA-N,133.194,P21397,BE0002198,Amine oxidase [flavin-containing] A,Humans,inhibitor,yes
DB00753,Isoflurane,small molecule,approved;vet_approved,FC(F)OC(Cl)C(F)(F)F,PIWKPBJCKXDKJR-UHFFFAOYSA-N,184.492,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,agonist,yes
DB00753,Isoflurane,small molecule,approved;vet_approved,FC(F)OC(Cl)C(F)(F)F,PIWKPBJCKXDKJR-UHFFFAOYSA-N,184.492,P98194,BE0000218,Calcium-transporting ATPase type 2C member 1,Humans,inhibitor,yes
DB00753,Isoflurane,small molecule,approved;vet_approved,FC(F)OC(Cl)C(F)(F)F,PIWKPBJCKXDKJR-UHFFFAOYSA-N,184.492,P23415,BE0000433,Glycine receptor subunit alpha-1,Humans,agonist,yes
DB00753,Isoflurane,small molecule,approved;vet_approved,FC(F)OC(Cl)C(F)(F)F,PIWKPBJCKXDKJR-UHFFFAOYSA-N,184.492,P42261,BE0000640,Glutamate receptor 1,Humans,antagonist,yes
DB00753,Isoflurane,small molecule,approved;vet_approved,FC(F)OC(Cl)C(F)(F)F,PIWKPBJCKXDKJR-UHFFFAOYSA-N,184.492,Q09470,BE0000781,Potassium voltage-gated channel subfamily A member 1,Humans,inducer,yes
DB00753,Isoflurane,small molecule,approved;vet_approved,FC(F)OC(Cl)C(F)(F)F,PIWKPBJCKXDKJR-UHFFFAOYSA-N,184.492,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB00754,Ethotoin,small molecule,approved,CCN1C(=O)NC(C1=O)C1=CC=CC=C1,SZQIFWWUIBRPBZ-UHFFFAOYSA-N,204.2252,Q14524,BE0000197,Sodium channel protein type 5 subunit alpha,Humans,inhibitor,yes
DB00755,Tretinoin,small molecule,approved;investigational;nutraceutical,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O,SHGAZHPCJJPHSC-YCNIQYBTSA-N,300.442,P10276,BE0000663,Retinoic acid receptor alpha,Humans,agonist,yes
DB00755,Tretinoin,small molecule,approved;investigational;nutraceutical,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O,SHGAZHPCJJPHSC-YCNIQYBTSA-N,300.442,P10826,BE0000206,Retinoic acid receptor beta,Humans,agonist,yes
DB00755,Tretinoin,small molecule,approved;investigational;nutraceutical,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O,SHGAZHPCJJPHSC-YCNIQYBTSA-N,300.442,P13631,BE0000144,Retinoic acid receptor gamma,Humans,agonist,yes
DB00755,Tretinoin,small molecule,approved;investigational;nutraceutical,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O,SHGAZHPCJJPHSC-YCNIQYBTSA-N,300.442,P28702,BE0000078,Retinoic acid receptor RXR-beta,Humans,agonist,yes
DB00755,Tretinoin,small molecule,approved;investigational;nutraceutical,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O,SHGAZHPCJJPHSC-YCNIQYBTSA-N,300.442,P48443,BE0000707,Retinoic acid receptor RXR-gamma,Humans,agonist,yes
DB00756,Hexachlorophene,small molecule,approved;withdrawn,OC1=C(CC2=C(O)C(Cl)=CC(Cl)=C2Cl)C(Cl)=C(Cl)C=C1Cl,ACGUYXCXAPNIKK-UHFFFAOYSA-N,406.904,P06149,BE0000114,D-lactate dehydrogenase,Escherichia coli (strain K12),inhibitor,yes
DB00756,Hexachlorophene,small molecule,approved;withdrawn,OC1=C(CC2=C(O)C(Cl)=CC(Cl)=C2Cl)C(Cl)=C(Cl)C=C1Cl,ACGUYXCXAPNIKK-UHFFFAOYSA-N,406.904,O14521,BE0002252,"Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial",Humans,inhibitor,yes
DB00757,Dolasetron,small molecule,approved;investigational,[H][C@@]1(C[C@@]2([H])C[C@]3([H])C[C@@]([H])(C1)N2CC3=O)OC(=O)C1=CNC2=C1C=CC=C2,UKTAZPQNNNJVKR-KJGYPYNMSA-N,324.38,P46098,BE0000311,5-hydroxytryptamine receptor 3A,Humans,antagonist,yes
DB00758,Clopidogrel,small molecule,approved,[H][C@@](N1CCC2=C(C1)C=CS2)(C(=O)OC)C1=CC=CC=C1Cl,GKTWGGQPFAXNFI-HNNXBMFYSA-N,321.822,Q9H244,BE0000110,P2Y purinoceptor 12,Humans,antagonist,yes
DB00759,Tetracycline,small molecule,approved;vet_approved;withdrawn,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC=C1[C@@]3(C)O,OFVLGDICTFRJMM-WESIUVDSSA-N,444.4346,P02359,BE0004653,30S ribosomal protein S7,Escherichia coli (strain K12),inhibitor,yes
DB00759,Tetracycline,small molecule,approved;vet_approved;withdrawn,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC=C1[C@@]3(C)O,OFVLGDICTFRJMM-WESIUVDSSA-N,444.4346,P0AG59,BE0003708,30S ribosomal protein S14,Escherichia coli (strain K12),inhibitor,yes
DB00759,Tetracycline,small molecule,approved;vet_approved;withdrawn,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC=C1[C@@]3(C)O,OFVLGDICTFRJMM-WESIUVDSSA-N,444.4346,P0A7V3,BE0004651,30S ribosomal protein S3,Escherichia coli (strain K12),inhibitor,yes
DB00759,Tetracycline,small molecule,approved;vet_approved;withdrawn,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC=C1[C@@]3(C)O,OFVLGDICTFRJMM-WESIUVDSSA-N,444.4346,P0A7W7,BE0004652,30S ribosomal protein S8,Escherichia coli (strain K12),inhibitor,yes
DB00759,Tetracycline,small molecule,approved;vet_approved;withdrawn,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC=C1[C@@]3(C)O,OFVLGDICTFRJMM-WESIUVDSSA-N,444.4346,P0A7U3,BE0003710,30S ribosomal protein S19,Escherichia coli (strain K12),inhibitor,yes
DB00759,Tetracycline,small molecule,approved;vet_approved;withdrawn,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC=C1[C@@]3(C)O,OFVLGDICTFRJMM-WESIUVDSSA-N,444.4346,,BE0004799,16S ribosomal RNA,Enteric bacteria and other eubacteria,inhibitor,yes
DB00760,Meropenem,small molecule,approved;investigational,[H][C@]1([C@@H](C)O)C(=O)N2C(C(O)=O)=C(S[C@@H]3CN[C@@H](C3)C(=O)N(C)C)[C@H](C)[C@]12[H],DMJNNHOOLUXYBV-PQTSNVLCSA-N,383.463,P24228,BE0000744,D-alanyl-D-alanine carboxypeptidase DacB,Escherichia coli (strain K12),inhibitor,yes
DB00762,Irinotecan,small molecule,approved;investigational,CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12,UWKQSNNFCGGAFS-XIFFEERXSA-N,586.678,Q969P6,BE0000091,"DNA topoisomerase I, mitochondrial",Humans,inhibitor,yes
DB00762,Irinotecan,small molecule,approved;investigational,CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12,UWKQSNNFCGGAFS-XIFFEERXSA-N,586.678,P11387,BE0000971,DNA topoisomerase 1,Humans,inhibitor,yes
DB00764,Mometasone,small molecule,experimental,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,QLIIKPVHVRXHRI-CXSFZGCWSA-N,427.361,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB00765,Metyrosine,small molecule,approved,C[C@](N)(CC1=CC=C(O)C=C1)C(O)=O,NHTGHBARYWONDQ-JTQLQIEISA-N,195.2151,P07101,BE0000614,Tyrosine 3-monooxygenase,Humans,binder,yes
DB00766,Clavulanic acid,small molecule,approved;vet_approved,[H][C@@]12CC(=O)N1[C@@H](C(O)=O)\C(O2)=C\CO,HZZVJAQRINQKSD-PBFISZAISA-N,199.1608,,BE0009711,Bacterial beta-lactamase enzymes,,inhibitor,yes
DB00766,Clavulanic acid,small molecule,approved;vet_approved,[H][C@@]12CC(=O)N1[C@@H](C(O)=O)\C(O2)=C\CO,HZZVJAQRINQKSD-PBFISZAISA-N,199.1608,P00807,BE0000302,Beta-lactamase,Staphylococcus aureus,inhibitor,yes
DB00767,Benzquinamide,small molecule,withdrawn,CCN(CC)C(=O)C1CN2CCC3=CC(OC)=C(OC)C=C3C2CC1OC(C)=O,JSZILQVIPPROJI-UHFFFAOYSA-N,404.4999,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB00767,Benzquinamide,small molecule,withdrawn,CCN(CC)C(=O)C1CN2CCC3=CC(OC)=C(OC)C=C3C2CC1OC(C)=O,JSZILQVIPPROJI-UHFFFAOYSA-N,404.4999,P08173,BE0000405,Muscarinic acetylcholine receptor M4,Humans,antagonist,yes
DB00767,Benzquinamide,small molecule,withdrawn,CCN(CC)C(=O)C1CN2CCC3=CC(OC)=C(OC)C=C3C2CC1OC(C)=O,JSZILQVIPPROJI-UHFFFAOYSA-N,404.4999,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,antagonist,yes
DB00767,Benzquinamide,small molecule,withdrawn,CCN(CC)C(=O)C1CN2CCC3=CC(OC)=C(OC)C=C3C2CC1OC(C)=O,JSZILQVIPPROJI-UHFFFAOYSA-N,404.4999,P08912,BE0000247,Muscarinic acetylcholine receptor M5,Humans,antagonist,yes
DB00767,Benzquinamide,small molecule,withdrawn,CCN(CC)C(=O)C1CN2CCC3=CC(OC)=C(OC)C=C3C2CC1OC(C)=O,JSZILQVIPPROJI-UHFFFAOYSA-N,404.4999,P08172,BE0000560,Muscarinic acetylcholine receptor M2,Humans,antagonist,yes
DB00767,Benzquinamide,small molecule,withdrawn,CCN(CC)C(=O)C1CN2CCC3=CC(OC)=C(OC)C=C3C2CC1OC(C)=O,JSZILQVIPPROJI-UHFFFAOYSA-N,404.4999,P20309,BE0000045,Muscarinic acetylcholine receptor M3,Humans,antagonist,yes
DB00768,Olopatadine,small molecule,approved,CN(C)CC\C=C1\C2=CC=CC=C2COC2=C1C=C(CC(O)=O)C=C2,JBIMVDZLSHOPLA-LSCVHKIXSA-N,337.4122,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB00769,Hydrocortamate,small molecule,approved,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CN(CC)CC)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,FWFVLWGEFDIZMJ-FOMYWIRZSA-N,475.6175,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB00770,Alprostadil,small molecule,approved;investigational,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O,GMVPRGQOIOIIMI-DWKJAMRDSA-N,354.487,P21731,BE0000759,Thromboxane A2 receptor,Humans,modulator,yes
DB00770,Alprostadil,small molecule,approved;investigational,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O,GMVPRGQOIOIIMI-DWKJAMRDSA-N,354.487,P34995,BE0000064,Prostaglandin E2 receptor EP1 subtype,Humans,agonist,yes
DB00770,Alprostadil,small molecule,approved;investigational,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O,GMVPRGQOIOIIMI-DWKJAMRDSA-N,354.487,P43116,BE0000368,Prostaglandin E2 receptor EP2 subtype,Humans,agonist,yes
DB00770,Alprostadil,small molecule,approved;investigational,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O,GMVPRGQOIOIIMI-DWKJAMRDSA-N,354.487,P43115,BE0002375,Prostaglandin E2 receptor EP3 subtype,Humans,agonist,yes
DB00770,Alprostadil,small molecule,approved;investigational,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O,GMVPRGQOIOIIMI-DWKJAMRDSA-N,354.487,P35408,BE0003522,Prostaglandin E2 receptor EP4 subtype,Humans,agonist,yes
DB00771,Clidinium,small molecule,approved,C[N@@+]12CC[C@@H](CC1)C(C2)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1,HOOSGZJRQIVJSZ-NNBUQUNQSA-N,352.4467,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,antagonist,yes
DB00772,Malathion,small molecule,approved;investigational,CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC,JXSJBGJIGXNWCI-UHFFFAOYSA-N,330.358,P06276,BE0002180,Cholinesterase,Humans,inhibitor,yes
DB00772,Malathion,small molecule,approved;investigational,CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC,JXSJBGJIGXNWCI-UHFFFAOYSA-N,330.358,P22303,BE0000426,Acetylcholinesterase,Humans,inhibitor,yes
DB00773,Etoposide,small molecule,approved,[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(O)C(OC)=C1)C1=CC3=C(OCO3)C=C1[C@H]2O[C@@H]1O[C@]2([H])CO[C@@H](C)O[C@@]2([H])[C@H](O)[C@H]1O,VJJPUSNTGOMMGY-MRVIYFEKSA-N,588.5566,P11388,BE0000742,DNA topoisomerase 2-alpha,Humans,inhibitor,yes
DB00774,Hydroflumethiazide,small molecule,approved;investigational;withdrawn,NS(=O)(=O)C1=CC2=C(NCNS2(=O)=O)C=C1C(F)(F)F,DMDGGSIALPNSEE-UHFFFAOYSA-N,331.292,Q13621,BE0000502,Solute carrier family 12 member 1,Humans,inhibitor,yes
DB00775,Tirofiban,small molecule,approved,CCCCS(=O)(=O)N[C@@H](CC1=CC=C(OCCCCC2CCNCC2)C=C1)C(O)=O,COKMIXFXJJXBQG-NRFANRHFSA-N,440.597,P08514,BE0000439,Integrin alpha-IIb,Humans,antagonist,yes
DB00775,Tirofiban,small molecule,approved,CCCCS(=O)(=O)N[C@@H](CC1=CC=C(OCCCCC2CCNCC2)C=C1)C(O)=O,COKMIXFXJJXBQG-NRFANRHFSA-N,440.597,P05106,BE0001155,Integrin beta-3,Humans,antagonist,yes
DB00776,Oxcarbazepine,small molecule,approved,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,CTRLABGOLIVAIY-UHFFFAOYSA-N,252.268,Q9UI33,BE0000192,Sodium channel protein type 11 subunit alpha,Humans,blocker,yes
DB00777,Propiomazine,small molecule,approved,CCC(=O)C1=CC2=C(SC3=CC=CC=C3N2CC(C)N(C)C)C=C1,UVOIBTBFPOZKGP-UHFFFAOYSA-N,340.482,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB00778,Roxithromycin,small molecule,approved;investigational;withdrawn,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=NOCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O,RXZBMPWDPOLZGW-XMRMVWPWSA-N,837.0465,P0A7J6,BE0000743,50S ribosomal protein L10,Shigella flexneri,inhibitor,yes
DB00779,Nalidixic acid,small molecule,approved;investigational,CCN1C=C(C(O)=O)C(=O)C2=C1N=C(C)C=C2,MHWLWQUZZRMNGJ-UHFFFAOYSA-N,232.2353,,BE0004796,DNA,Humans,other,yes
DB00779,Nalidixic acid,small molecule,approved;investigational,CCN1C=C(C(O)=O)C(=O)C2=C1N=C(C)C=C2,MHWLWQUZZRMNGJ-UHFFFAOYSA-N,232.2353,Q02880,BE0002425,DNA topoisomerase 2-beta,Humans,inhibitor,yes
DB00779,Nalidixic acid,small molecule,approved;investigational,CCN1C=C(C(O)=O)C(=O)C2=C1N=C(C)C=C2,MHWLWQUZZRMNGJ-UHFFFAOYSA-N,232.2353,P11388,BE0000742,DNA topoisomerase 2-alpha,Humans,inhibitor,yes
DB00780,Phenelzine,small molecule,approved,NNCCC1=CC=CC=C1,RMUCZJUITONUFY-UHFFFAOYSA-N,136.1943,P21397,BE0002198,Amine oxidase [flavin-containing] A,Humans,antagonist,yes
DB00780,Phenelzine,small molecule,approved,NNCCC1=CC=CC=C1,RMUCZJUITONUFY-UHFFFAOYSA-N,136.1943,P27338,BE0002196,Amine oxidase [flavin-containing] B,Humans,antagonist,yes
DB00782,Propantheline,small molecule,approved,CC(C)[N+](C)(CCOC(=O)C1C2=CC=CC=C2OC2=CC=CC=C12)C(C)C,VVWYOYDLCMFIEM-UHFFFAOYSA-N,368.4892,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,antagonist,yes
DB00783,Estradiol,small molecule,approved;investigational;vet_approved,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,VOXZDWNPVJITMN-ZBRFXRBCSA-N,272.382,P03372,BE0000123,Estrogen receptor,Humans,agonist,yes
DB00783,Estradiol,small molecule,approved;investigational;vet_approved,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,VOXZDWNPVJITMN-ZBRFXRBCSA-N,272.382,Q92731,BE0000792,Estrogen receptor beta,Humans,agonist,yes
DB00784,Mefenamic acid,small molecule,approved,CC1=C(C)C(NC2=CC=CC=C2C(O)=O)=CC=C1,HYYBABOKPJLUIN-UHFFFAOYSA-N,241.2851,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB00786,Marimastat,small molecule,investigational,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C,OCSMOTCMPXTDND-OUAUKWLOSA-N,331.4079,P03956,BE0000920,Interstitial collagenase,Humans,inhibitor,yes
DB00786,Marimastat,small molecule,investigational,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C,OCSMOTCMPXTDND-OUAUKWLOSA-N,331.4079,P08253,BE0000642,72 kDa type IV collagenase,Humans,inhibitor,yes
DB00786,Marimastat,small molecule,investigational,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C,OCSMOTCMPXTDND-OUAUKWLOSA-N,331.4079,P08254,BE0001116,Stromelysin-1,Humans,antagonist,yes
DB00786,Marimastat,small molecule,investigational,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C,OCSMOTCMPXTDND-OUAUKWLOSA-N,331.4079,P09237,BE0003690,Matrilysin,Humans,antagonist,yes
DB00786,Marimastat,small molecule,investigational,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C,OCSMOTCMPXTDND-OUAUKWLOSA-N,331.4079,P22894,BE0001182,Neutrophil collagenase,Humans,inhibitor,yes
DB00786,Marimastat,small molecule,investigational,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C,OCSMOTCMPXTDND-OUAUKWLOSA-N,331.4079,P14780,BE0000058,Matrix metalloproteinase-9,Humans,inhibitor,yes
DB00786,Marimastat,small molecule,investigational,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C,OCSMOTCMPXTDND-OUAUKWLOSA-N,331.4079,P09238,BE0003689,Stromelysin-2,Humans,antagonist,yes
DB00786,Marimastat,small molecule,investigational,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C,OCSMOTCMPXTDND-OUAUKWLOSA-N,331.4079,P24347,BE0003691,Stromelysin-3,Humans,antagonist,yes
DB00786,Marimastat,small molecule,investigational,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C,OCSMOTCMPXTDND-OUAUKWLOSA-N,331.4079,P39900,BE0001198,Macrophage metalloelastase,Humans,inhibitor,yes
DB00786,Marimastat,small molecule,investigational,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C,OCSMOTCMPXTDND-OUAUKWLOSA-N,331.4079,P45452,BE0000966,Collagenase 3,Humans,inhibitor,yes
DB00786,Marimastat,small molecule,investigational,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C,OCSMOTCMPXTDND-OUAUKWLOSA-N,331.4079,P50281,BE0003692,Matrix metalloproteinase-14,Humans,inhibitor,yes
DB00786,Marimastat,small molecule,investigational,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C,OCSMOTCMPXTDND-OUAUKWLOSA-N,331.4079,P51511,BE0003693,Matrix metalloproteinase-15,Humans,inhibitor,yes
DB00786,Marimastat,small molecule,investigational,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C,OCSMOTCMPXTDND-OUAUKWLOSA-N,331.4079,P51512,BE0001637,Matrix metalloproteinase-16,Humans,inhibitor,yes
DB00786,Marimastat,small molecule,investigational,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C,OCSMOTCMPXTDND-OUAUKWLOSA-N,331.4079,Q9ULZ9,BE0003694,Matrix metalloproteinase-17,Humans,inhibitor,yes
DB00786,Marimastat,small molecule,investigational,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C,OCSMOTCMPXTDND-OUAUKWLOSA-N,331.4079,Q99542,BE0003695,Matrix metalloproteinase-19,Humans,inhibitor,yes
DB00786,Marimastat,small molecule,investigational,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C,OCSMOTCMPXTDND-OUAUKWLOSA-N,331.4079,O60882,BE0003696,Matrix metalloproteinase-20,Humans,inhibitor,yes
DB00786,Marimastat,small molecule,investigational,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C,OCSMOTCMPXTDND-OUAUKWLOSA-N,331.4079,Q8N119,BE0003697,Matrix metalloproteinase-21,Humans,inhibitor,yes
DB00786,Marimastat,small molecule,investigational,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C,OCSMOTCMPXTDND-OUAUKWLOSA-N,331.4079,O75900,BE0003698,Matrix metalloproteinase-23,Humans,inhibitor,yes
DB00786,Marimastat,small molecule,investigational,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C,OCSMOTCMPXTDND-OUAUKWLOSA-N,331.4079,Q9Y5R2,BE0003699,Matrix metalloproteinase-24,Humans,inhibitor,yes
DB00786,Marimastat,small molecule,investigational,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C,OCSMOTCMPXTDND-OUAUKWLOSA-N,331.4079,Q9NPA2,BE0009742,Matrix metalloproteinase-25,Humans,inhibitor,yes
DB00786,Marimastat,small molecule,investigational,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C,OCSMOTCMPXTDND-OUAUKWLOSA-N,331.4079,Q9NRE1,BE0003701,Matrix metalloproteinase-26,Humans,inhibitor,yes
DB00786,Marimastat,small molecule,investigational,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C,OCSMOTCMPXTDND-OUAUKWLOSA-N,331.4079,Q9H306,BE0003702,Matrix metalloproteinase-27,Humans,inhibitor,yes
DB00786,Marimastat,small molecule,investigational,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C,OCSMOTCMPXTDND-OUAUKWLOSA-N,331.4079,Q9H239,BE0003703,Matrix metalloproteinase-28,Humans,inhibitor,yes
DB00787,Acyclovir,small molecule,approved,NC1=NC(=O)C2=C(N1)N(COCCO)C=N2,MKUXAQIIEYXACX-UHFFFAOYSA-N,225.2046,P04293,BE0000308,DNA polymerase catalytic subunit,HHV-1,inhibitor,yes
DB00787,Acyclovir,small molecule,approved,NC1=NC(=O)C2=C(N1)N(COCCO)C=N2,MKUXAQIIEYXACX-UHFFFAOYSA-N,225.2046,P09252,BE0000633,DNA polymerase catalytic subunit,HHV-3,inhibitor,yes
DB00788,Naproxen,small molecule,approved;vet_approved,COC1=CC2=C(C=C1)C=C(C=C2)[C@H](C)C(O)=O,CMWTZPSULFXXJA-VIFPVBQESA-N,230.2592,P16233,BE0000683,Pancreatic triacylglycerol lipase,Humans,inhibitor,yes
DB00788,Naproxen,small molecule,approved;vet_approved,COC1=CC2=C(C=C1)C=C(C=C2)[C@H](C)C(O)=O,CMWTZPSULFXXJA-VIFPVBQESA-N,230.2592,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB00788,Naproxen,small molecule,approved;vet_approved,COC1=CC2=C(C=C1)C=C(C=C2)[C@H](C)C(O)=O,CMWTZPSULFXXJA-VIFPVBQESA-N,230.2592,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB00790,Perindopril,small molecule,approved,[H][C@]12C[C@H](N(C(=O)[C@H](C)N[C@@H](CCC)C(=O)OCC)[C@@]1([H])CCCC2)C(O)=O,IPVQLZZIHOAWMC-QXKUPLGCSA-N,368.4678,P12821,BE0000221,Angiotensin-converting enzyme,Humans,inhibitor,yes
DB00792,Tripelennamine,small molecule,approved;vet_approved,CN(C)CCN(CC1=CC=CC=C1)C1=CC=CC=N1,UFLGIAIHIAPJJC-UHFFFAOYSA-N,255.358,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB00794,Primidone,small molecule,approved;vet_approved,CCC1(C(=O)NCNC1=O)C1=CC=CC=C1,DQMZLTXERSFNPB-UHFFFAOYSA-N,218.2518,P47869,BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,Humans,potentiator,yes
DB00794,Primidone,small molecule,approved;vet_approved,CCC1(C(=O)NCNC1=O)C1=CC=CC=C1,DQMZLTXERSFNPB-UHFFFAOYSA-N,218.2518,P34903,BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,Humans,potentiator,yes
DB00794,Primidone,small molecule,approved;vet_approved,CCC1(C(=O)NCNC1=O)C1=CC=CC=C1,DQMZLTXERSFNPB-UHFFFAOYSA-N,218.2518,P48169,BE0000478,Gamma-aminobutyric acid receptor subunit alpha-4,Humans,potentiator,yes
DB00794,Primidone,small molecule,approved;vet_approved,CCC1(C(=O)NCNC1=O)C1=CC=CC=C1,DQMZLTXERSFNPB-UHFFFAOYSA-N,218.2518,P31644,BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,Humans,potentiator,yes
DB00794,Primidone,small molecule,approved;vet_approved,CCC1(C(=O)NCNC1=O)C1=CC=CC=C1,DQMZLTXERSFNPB-UHFFFAOYSA-N,218.2518,Q16445,BE0000764,Gamma-aminobutyric acid receptor subunit alpha-6,Humans,potentiator,yes
DB00794,Primidone,small molecule,approved;vet_approved,CCC1(C(=O)NCNC1=O)C1=CC=CC=C1,DQMZLTXERSFNPB-UHFFFAOYSA-N,218.2518,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB00794,Primidone,small molecule,approved;vet_approved,CCC1(C(=O)NCNC1=O)C1=CC=CC=C1,DQMZLTXERSFNPB-UHFFFAOYSA-N,218.2518,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,potentiator,yes
DB00795,Sulfasalazine,small molecule,approved,OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=C1,NCEXYHBECQHGNR-QZQOTICOSA-N,398.393,Q9UNQ0,BE0001067,Broad substrate specificity ATP-binding cassette transporter ABCG2,Humans,inhibitor,yes
DB00795,Sulfasalazine,small molecule,approved,OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=C1,NCEXYHBECQHGNR-QZQOTICOSA-N,398.393,Q01201,BE0013795,Transcription factor RelB,Humans,activator,yes
DB00795,Sulfasalazine,small molecule,approved,OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=C1,NCEXYHBECQHGNR-QZQOTICOSA-N,398.393,Q04206,BE0005551,Transcription factor p65,Humans,activator,yes
DB00795,Sulfasalazine,small molecule,approved,OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=C1,NCEXYHBECQHGNR-QZQOTICOSA-N,398.393,Q04864,BE0010782,Proto-oncogene c-Rel,Humans,activator,yes
DB00795,Sulfasalazine,small molecule,approved,OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=C1,NCEXYHBECQHGNR-QZQOTICOSA-N,398.393,P09917,BE0000248,Polyunsaturated fatty acid 5-lipoxygenase,Humans,inhibitor,yes
DB00795,Sulfasalazine,small molecule,approved,OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=C1,NCEXYHBECQHGNR-QZQOTICOSA-N,398.393,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB00795,Sulfasalazine,small molecule,approved,OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=C1,NCEXYHBECQHGNR-QZQOTICOSA-N,398.393,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB00795,Sulfasalazine,small molecule,approved,OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=C1,NCEXYHBECQHGNR-QZQOTICOSA-N,398.393,P24752,BE0000069,"Acetyl-CoA acetyltransferase, mitochondrial",Humans,inhibitor,yes
DB00795,Sulfasalazine,small molecule,approved,OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=C1,NCEXYHBECQHGNR-QZQOTICOSA-N,398.393,P04054,BE0003997,Phospholipase A2,Humans,antagonist,yes
DB00795,Sulfasalazine,small molecule,approved,OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=C1,NCEXYHBECQHGNR-QZQOTICOSA-N,398.393,O14920,BE0001154,Inhibitor of nuclear factor kappa-B kinase subunit beta,Humans,inhibitor,yes
DB00796,Candesartan cilexetil,small molecule,approved,CCOC1=NC2=C(N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NN=NN1)C(=CC=C2)C(=O)OC(C)OC(=O)OC1CCCCC1,GHOSNRCGJFBJIB-UHFFFAOYSA-N,610.671,P30556,BE0000062,Type-1 angiotensin II receptor,Humans,antagonist,yes
DB00797,Tolazoline,small molecule,approved;vet_approved,C(C1=NCCN1)C1=CC=CC=C1,JIVZKJJQOZQXQB-UHFFFAOYSA-N,160.2157,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,antagonist,yes
DB00797,Tolazoline,small molecule,approved;vet_approved,C(C1=NCCN1)C1=CC=CC=C1,JIVZKJJQOZQXQB-UHFFFAOYSA-N,160.2157,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB00798,Gentamicin,small molecule,approved;vet_approved,[H][C@@]1(CN)CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1.[H][C@]1(CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1)C(C)N.[H][C@]1(CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1)C(C)NC,NPEFREDMMVQEPL-RWPARATISA-N,1390.728,P0A7S3,BE0000279,30S ribosomal protein S12,Escherichia coli (strain K12),binder,yes
DB00798,Gentamicin,small molecule,approved;vet_approved,[H][C@@]1(CN)CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1.[H][C@]1(CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1)C(C)N.[H][C@]1(CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1)C(C)NC,NPEFREDMMVQEPL-RWPARATISA-N,1390.728,,BE0004799,16S ribosomal RNA,Enteric bacteria and other eubacteria,binder,yes
DB00798,Gentamicin,small molecule,approved;vet_approved,[H][C@@]1(CN)CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1.[H][C@]1(CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1)C(C)N.[H][C@]1(CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1)C(C)NC,NPEFREDMMVQEPL-RWPARATISA-N,1390.728,,BE0004800,23S ribosomal RNA,Enteric bacteria and other eubacteria,inhibitor,yes
DB00798,Gentamicin,small molecule,approved;vet_approved,[H][C@@]1(CN)CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1.[H][C@]1(CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1)C(C)N.[H][C@]1(CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1)C(C)NC,NPEFREDMMVQEPL-RWPARATISA-N,1390.728,,BE0004833,Bacterial outer membrane,Bacteria,incorporation into and destabilization,yes
DB00798,Gentamicin,small molecule,approved;vet_approved,[H][C@@]1(CN)CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1.[H][C@]1(CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1)C(C)N.[H][C@]1(CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1)C(C)NC,NPEFREDMMVQEPL-RWPARATISA-N,1390.728,,BE0010021,Cytoplasmic membrane,Bacteria,incorporation into and destabilization,yes
DB00799,Tazarotene,small molecule,approved;investigational,CCOC(=O)C1=CN=C(C=C1)C#CC1=CC2=C(SCCC2(C)C)C=C1,OGQICQVSFDPSEI-UHFFFAOYSA-N,351.462,P10276,BE0000663,Retinoic acid receptor alpha,Humans,agonist,yes
DB00799,Tazarotene,small molecule,approved;investigational,CCOC(=O)C1=CN=C(C=C1)C#CC1=CC2=C(SCCC2(C)C)C=C1,OGQICQVSFDPSEI-UHFFFAOYSA-N,351.462,P28702,BE0000078,Retinoic acid receptor RXR-beta,Humans,agonist,yes
DB00799,Tazarotene,small molecule,approved;investigational,CCOC(=O)C1=CN=C(C=C1)C#CC1=CC2=C(SCCC2(C)C)C=C1,OGQICQVSFDPSEI-UHFFFAOYSA-N,351.462,P13631,BE0000144,Retinoic acid receptor gamma,Humans,agonist,yes
DB00799,Tazarotene,small molecule,approved;investigational,CCOC(=O)C1=CN=C(C=C1)C#CC1=CC2=C(SCCC2(C)C)C=C1,OGQICQVSFDPSEI-UHFFFAOYSA-N,351.462,P10826,BE0000206,Retinoic acid receptor beta,Humans,agonist,yes
DB00800,Fenoldopam,small molecule,approved,OC1=CC=C(C=C1)C1CNCCC2=C(Cl)C(O)=C(O)C=C12,TVURRHSHRRELCG-UHFFFAOYSA-N,305.756,P21918,BE0000145,D(1B) dopamine receptor,Humans,agonist,yes
DB00800,Fenoldopam,small molecule,approved,OC1=CC=C(C=C1)C1CNCCC2=C(Cl)C(O)=C(O)C=C12,TVURRHSHRRELCG-UHFFFAOYSA-N,305.756,P21728,BE0000020,D(1A) dopamine receptor,Humans,agonist,yes
DB00801,Halazepam,small molecule,approved;illicit;withdrawn,FC(F)(F)CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,WYCLKVQLVUQKNZ-UHFFFAOYSA-N,352.738,P30536,BE0000736,Translocator protein,Humans,modulator,yes
DB00801,Halazepam,small molecule,approved;illicit;withdrawn,FC(F)(F)CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,WYCLKVQLVUQKNZ-UHFFFAOYSA-N,352.738,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB00802,Alfentanil,small molecule,approved;illicit,CCN1N=NN(CCN2CCC(COC)(CC2)N(C(=O)CC)C2=CC=CC=C2)C1=O,IDBPHNDTYPBSNI-UHFFFAOYSA-N,416.5172,P35372,BE0000770,Mu-type opioid receptor,Humans,agonist,yes
DB00804,Dicyclomine,small molecule,approved,CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1,CURUTKGFNZGFSE-UHFFFAOYSA-N,309.4867,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,antagonist,yes
DB00805,Minaprine,small molecule,approved,CC1=CC(=NN=C1NCCN1CCOCC1)C1=CC=CC=C1,LDMWSLGGVTVJPG-UHFFFAOYSA-N,298.3828,P21397,BE0002198,Amine oxidase [flavin-containing] A,Humans,inhibitor,yes
DB00805,Minaprine,small molecule,approved,CC1=CC(=NN=C1NCCN1CCOCC1)C1=CC=CC=C1,LDMWSLGGVTVJPG-UHFFFAOYSA-N,298.3828,P41595,BE0000393,5-hydroxytryptamine receptor 2B,Humans,antagonist,yes
DB00805,Minaprine,small molecule,approved,CC1=CC(=NN=C1NCCN1CCOCC1)C1=CC=CC=C1,LDMWSLGGVTVJPG-UHFFFAOYSA-N,298.3828,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB00805,Minaprine,small molecule,approved,CC1=CC(=NN=C1NCCN1CCOCC1)C1=CC=CC=C1,LDMWSLGGVTVJPG-UHFFFAOYSA-N,298.3828,P28335,BE0000533,5-hydroxytryptamine receptor 2C,Humans,antagonist,yes
DB00805,Minaprine,small molecule,approved,CC1=CC(=NN=C1NCCN1CCOCC1)C1=CC=CC=C1,LDMWSLGGVTVJPG-UHFFFAOYSA-N,298.3828,P22303,BE0000426,Acetylcholinesterase,Humans,inhibitor,yes
DB00806,Pentoxifylline,small molecule,approved;investigational,CN1C=NC2=C1C(=O)N(CCCCC(C)=O)C(=O)N2C,BYPFEZZEUUWMEJ-UHFFFAOYSA-N,278.307,P29274,BE0000924,Adenosine receptor A2a,Humans,agonist,yes
DB00806,Pentoxifylline,small molecule,approved;investigational,CN1C=NC2=C1C(=O)N(CCCCC(C)=O)C(=O)N2C,BYPFEZZEUUWMEJ-UHFFFAOYSA-N,278.307,,BE0009788,Phosphodiesterase enzymes,Humans,inhibitor,yes
DB00806,Pentoxifylline,small molecule,approved;investigational,CN1C=NC2=C1C(=O)N(CCCCC(C)=O)C(=O)N2C,BYPFEZZEUUWMEJ-UHFFFAOYSA-N,278.307,P21589,BE0001096,5'-nucleotidase,Humans,inhibitor,yes
DB00807,Proparacaine,small molecule,approved;vet_approved,CCCOC1=C(N)C=C(C=C1)C(=O)OCCN(CC)CC,KCLANYCVBBTKTO-UHFFFAOYSA-N,294.3892,Q9Y5Y9,BE0000177,Sodium channel protein type 10 subunit alpha,Humans,inhibitor,yes
DB00808,Indapamide,small molecule,approved,CC1CC2=CC=CC=C2N1NC(=O)C1=CC(=C(Cl)C=C1)S(N)(=O)=O,NDDAHWYSQHTHNT-UHFFFAOYSA-N,365.835,P55017,BE0000419,Solute carrier family 12 member 3,Humans,inhibitor,yes
DB00808,Indapamide,small molecule,approved,CC1CC2=CC=CC=C2N1NC(=O)C1=CC(=C(Cl)C=C1)S(N)(=O)=O,NDDAHWYSQHTHNT-UHFFFAOYSA-N,365.835,P51787,BE0000672,Potassium voltage-gated channel subfamily KQT member 1,Humans,blocker,yes
DB00809,Tropicamide,small molecule,approved;investigational,CCN(CC1=CC=NC=C1)C(=O)C(CO)C1=CC=CC=C1,BGDKAVGWHJFAGW-UHFFFAOYSA-N,284.3529,P08173,BE0000405,Muscarinic acetylcholine receptor M4,Humans,antagonist,yes
DB00809,Tropicamide,small molecule,approved;investigational,CCN(CC1=CC=NC=C1)C(=O)C(CO)C1=CC=CC=C1,BGDKAVGWHJFAGW-UHFFFAOYSA-N,284.3529,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,antagonist,yes
DB00809,Tropicamide,small molecule,approved;investigational,CCN(CC1=CC=NC=C1)C(=O)C(CO)C1=CC=CC=C1,BGDKAVGWHJFAGW-UHFFFAOYSA-N,284.3529,P08172,BE0000560,Muscarinic acetylcholine receptor M2,Humans,antagonist,yes
DB00810,Biperiden,small molecule,approved;investigational,OC(CCN1CCCCC1)(C1CC2CC1C=C2)C1=CC=CC=C1,YSXKPIUOCJLQIE-UHFFFAOYSA-N,311.4611,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,antagonist,yes
DB00811,Ribavirin,small molecule,approved,NC(=O)C1=NN(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,IWUCXVSUMQZMFG-AFCXAGJDSA-N,244.2047,P20839,BE0000761,Inosine-5'-monophosphate dehydrogenase 1,Humans,inhibitor,yes
DB00811,Ribavirin,small molecule,approved,NC(=O)C1=NN(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,IWUCXVSUMQZMFG-AFCXAGJDSA-N,244.2047,P26676,BE0000681,RNA-directed RNA polymerase L,HPIV-2,antagonist,yes
DB00811,Ribavirin,small molecule,approved,NC(=O)C1=NN(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,IWUCXVSUMQZMFG-AFCXAGJDSA-N,244.2047,P12823,BE0001261,Genome polyprotein,DENV-2,inhibitor,yes
DB00812,Phenylbutazone,small molecule,approved;vet_approved,CCCCC1C(=O)N(N(C1=O)C1=CC=CC=C1)C1=CC=CC=C1,VYMDGNCVAMGZFE-UHFFFAOYSA-N,308.3743,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB00812,Phenylbutazone,small molecule,approved;vet_approved,CCCCC1C(=O)N(N(C1=O)C1=CC=CC=C1)C1=CC=CC=C1,VYMDGNCVAMGZFE-UHFFFAOYSA-N,308.3743,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB00812,Phenylbutazone,small molecule,approved;vet_approved,CCCCC1C(=O)N(N(C1=O)C1=CC=CC=C1)C1=CC=CC=C1,VYMDGNCVAMGZFE-UHFFFAOYSA-N,308.3743,Q16647,BE0000117,Prostacyclin synthase,Humans,inhibitor,yes
DB00813,Fentanyl,small molecule,approved;illicit;investigational;vet_approved,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,PJMPHNIQZUBGLI-UHFFFAOYSA-N,336.4705,P35372,BE0000770,Mu-type opioid receptor,Humans,agonist,yes
DB00813,Fentanyl,small molecule,approved;illicit;investigational;vet_approved,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,PJMPHNIQZUBGLI-UHFFFAOYSA-N,336.4705,P41143,BE0000420,Delta-type opioid receptor,Humans,agonist,yes
DB00814,Meloxicam,small molecule,approved;vet_approved,CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C2=C(C=CC=C2)S1(=O)=O,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,351.401,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB00815,Sodium lauryl sulfate,small molecule,experimental,[Na+].CCCCCCCCCCCCOS([O-])(=O)=O,DBMJMQXJHONAFJ-UHFFFAOYSA-M,288.379,P02768,BE0000530,Albumin,Humans,binder,yes
DB00816,Orciprenaline,small molecule,approved,CC(C)NCC(O)C1=CC(O)=CC(O)=C1,LMOINURANNBYCM-UHFFFAOYSA-N,211.2576,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,agonist,yes
DB00817,Rosoxacin,small molecule,approved;investigational,CCN1C=C(C(O)=O)C(=O)C2=C1C=C(C=C2)C1=CC=NC=C1,XBPZXDSZHPDXQU-UHFFFAOYSA-N,294.3047,P11388,BE0000742,DNA topoisomerase 2-alpha,Humans,inhibitor,yes
DB00817,Rosoxacin,small molecule,approved;investigational,CCN1C=C(C(O)=O)C(=O)C2=C1C=C(C=C2)C1=CC=NC=C1,XBPZXDSZHPDXQU-UHFFFAOYSA-N,294.3047,Q02880,BE0002425,DNA topoisomerase 2-beta,Humans,inhibitor,yes
DB00817,Rosoxacin,small molecule,approved;investigational,CCN1C=C(C(O)=O)C(=O)C2=C1C=C(C=C2)C1=CC=NC=C1,XBPZXDSZHPDXQU-UHFFFAOYSA-N,294.3047,P0AES6,BE0000799,DNA gyrase subunit B,Escherichia coli (strain K12),inhibitor,yes
DB00817,Rosoxacin,small molecule,approved;investigational,CCN1C=C(C(O)=O)C(=O)C2=C1C=C(C=C2)C1=CC=NC=C1,XBPZXDSZHPDXQU-UHFFFAOYSA-N,294.3047,P0AFI2,BE0000798,DNA topoisomerase 4 subunit A,Escherichia coli (strain K12),inhibitor,yes
DB00818,Propofol,small molecule,approved;investigational;vet_approved,CC(C)C1=CC=CC(C(C)C)=C1O,OLBCVFGFOZPWHH-UHFFFAOYSA-N,178.2707,P47870,BE0002346,Gamma-aminobutyric acid receptor subunit beta-2,Humans,potentiator,yes
DB00818,Propofol,small molecule,approved;investigational;vet_approved,CC(C)C1=CC=CC(C(C)C)=C1O,OLBCVFGFOZPWHH-UHFFFAOYSA-N,178.2707,P28472,BE0002345,Gamma-aminobutyric acid receptor subunit beta-3,Humans,potentiator,yes
DB00818,Propofol,small molecule,approved;investigational;vet_approved,CC(C)C1=CC=CC(C(C)C)=C1O,OLBCVFGFOZPWHH-UHFFFAOYSA-N,178.2707,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB00819,Acetazolamide,small molecule,approved;vet_approved,CC(=O)NC1=NN=C(S1)S(N)(=O)=O,BZKPWHYZMXOIDC-UHFFFAOYSA-N,222.245,P00915,BE0000267,Carbonic anhydrase 1,Humans,inhibitor,yes
DB00819,Acetazolamide,small molecule,approved;vet_approved,CC(=O)NC1=NN=C(S1)S(N)(=O)=O,BZKPWHYZMXOIDC-UHFFFAOYSA-N,222.245,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB00819,Acetazolamide,small molecule,approved;vet_approved,CC(=O)NC1=NN=C(S1)S(N)(=O)=O,BZKPWHYZMXOIDC-UHFFFAOYSA-N,222.245,P22748,BE0000535,Carbonic anhydrase 4,Humans,inhibitor,yes
DB00819,Acetazolamide,small molecule,approved;vet_approved,CC(=O)NC1=NN=C(S1)S(N)(=O)=O,BZKPWHYZMXOIDC-UHFFFAOYSA-N,222.245,O43570,BE0001653,Carbonic anhydrase 12,Humans,inhibitor,yes
DB00819,Acetazolamide,small molecule,approved;vet_approved,CC(=O)NC1=NN=C(S1)S(N)(=O)=O,BZKPWHYZMXOIDC-UHFFFAOYSA-N,222.245,Q9ULX7,BE0003634,Carbonic anhydrase 14,Humans,inhibitor,yes
DB00819,Acetazolamide,small molecule,approved;vet_approved,CC(=O)NC1=NN=C(S1)S(N)(=O)=O,BZKPWHYZMXOIDC-UHFFFAOYSA-N,222.245,P07451,BE0003625,Carbonic anhydrase 3,Humans,inhibitor,yes
DB00819,Acetazolamide,small molecule,approved;vet_approved,CC(=O)NC1=NN=C(S1)S(N)(=O)=O,BZKPWHYZMXOIDC-UHFFFAOYSA-N,222.245,P43166,BE0003629,Carbonic anhydrase 7,Humans,inhibitor,yes
DB00820,Tadalafil,small molecule,approved;investigational,[H][C@]12CC3=C(NC4=CC=CC=C34)[C@H](N1C(=O)CN(C)C2=O)C1=CC2=C(OCO2)C=C1,WOXKDUGGOYFFRN-IIBYNOLFSA-N,389.404,O76074,BE0000182,"cGMP-specific 3',5'-cyclic phosphodiesterase",Humans,inhibitor,yes
DB00821,Carprofen,small molecule,approved;vet_approved;withdrawn,CC(C(O)=O)C1=CC2=C(C=C1)C1=C(N2)C=CC(Cl)=C1,PUXBGTOOZJQSKH-UHFFFAOYSA-N,273.714,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB00822,Disulfiram,small molecule,approved,CCN(CC)C(=S)SSC(=S)N(CC)CC,AUZONCFQVSMFAP-UHFFFAOYSA-N,296.539,P09172,BE0000138,Dopamine beta-hydroxylase,Humans,inhibitor,yes
DB00822,Disulfiram,small molecule,approved,CCN(CC)C(=S)SSC(=S)N(CC)CC,AUZONCFQVSMFAP-UHFFFAOYSA-N,296.539,P51648,BE0000600,Aldehyde dehydrogenase family 3 member A2,Humans,inhibitor,yes
DB00822,Disulfiram,small molecule,approved,CCN(CC)C(=S)SSC(=S)N(CC)CC,AUZONCFQVSMFAP-UHFFFAOYSA-N,296.539,P05091,BE0000133,"Aldehyde dehydrogenase, mitochondrial",Humans,inhibitor,yes
DB00823,Ethynodiol diacetate,small molecule,approved,[H][C@@]12CC[C@@](OC(C)=O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CC[C@H](OC(C)=O)C=C3CC[C@@]21[H],ONKUMRGIYFNPJW-KIEAKMPYSA-N,384.5085,P06401,BE0000557,Progesterone receptor,Humans,agonist,yes
DB00823,Ethynodiol diacetate,small molecule,approved,[H][C@@]12CC[C@@](OC(C)=O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CC[C@H](OC(C)=O)C=C3CC[C@@]21[H],ONKUMRGIYFNPJW-KIEAKMPYSA-N,384.5085,P03372,BE0000123,Estrogen receptor,Humans,agonist,yes
DB00824,Enprofylline,small molecule,approved;experimental,CCCN1C2=C(NC=N2)C(=O)NC1=O,SIQPXVQCUCHWDI-UHFFFAOYSA-N,194.1906,Q07343,BE0000487,"3',5'-cyclic-AMP phosphodiesterase 4B",Humans,inhibitor,yes
DB00824,Enprofylline,small molecule,approved;experimental,CCCN1C2=C(NC=N2)C(=O)NC1=O,SIQPXVQCUCHWDI-UHFFFAOYSA-N,194.1906,P21589,BE0001096,5'-nucleotidase,Humans,inhibitor,yes
DB00824,Enprofylline,small molecule,approved;experimental,CCCN1C2=C(NC=N2)C(=O)NC1=O,SIQPXVQCUCHWDI-UHFFFAOYSA-N,194.1906,P29275,BE0000241,Adenosine receptor A2b,Humans,antagonist,yes
DB00824,Enprofylline,small molecule,approved;experimental,CCCN1C2=C(NC=N2)C(=O)NC1=O,SIQPXVQCUCHWDI-UHFFFAOYSA-N,194.1906,P27815,BE0001133,"3',5'-cyclic-AMP phosphodiesterase 4A",Humans,inhibitor,yes
DB00825,Levomenthol,small molecule,approved,CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O,NOOLISFMXDJSKH-KXUCPTDWSA-N,156.2652,Q7Z2W7,BE0001186,Transient receptor potential cation channel subfamily M member 8,Humans,inducer,yes
DB00825,Levomenthol,small molecule,approved,CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O,NOOLISFMXDJSKH-KXUCPTDWSA-N,156.2652,O75762,BE0001122,Transient receptor potential cation channel subfamily A member 1,Humans,inducer,yes
DB00825,Levomenthol,small molecule,approved,CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O,NOOLISFMXDJSKH-KXUCPTDWSA-N,156.2652,Q8NET8,BE0003416,Transient receptor potential cation channel subfamily V member 3,Humans,inducer,yes
DB00825,Levomenthol,small molecule,approved,CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O,NOOLISFMXDJSKH-KXUCPTDWSA-N,156.2652,Q13936,BE0008715,Voltage-dependent L-type calcium channel,Humans,antagonist,yes
DB00826,Natamycin,small molecule,approved,[H][C@@]12C[C@H](O)C[C@]3(O)C[C@H](O)[C@@H](C(O)=O)[C@]([H])(C[C@@H](O[C@]4([H])O[C@H](C)[C@@H](O)[C@H](N)[C@@H]4O)\C=C\C=C\C=C\C=C\C[C@@H](C)OC(=O)\C=C\[C@@]1([H])O2)O3,NCXMLFZGDNKEPB-FFPOYIOWSA-N,665.733,,BE0004803,Ergosterol,Candida albicans,binder,yes
DB00827,Cinoxacin,small molecule,approved;investigational;withdrawn,CCN1N=C(C(O)=O)C(=O)C2=CC3=C(OCO3)C=C12,VDUWPHTZYNWKRN-UHFFFAOYSA-N,262.2182,P43700,BE0000366,DNA gyrase subunit A,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd),inhibitor,yes
DB00827,Cinoxacin,small molecule,approved;investigational;withdrawn,CCN1N=C(C(O)=O)C(=O)C2=CC3=C(OCO3)C=C12,VDUWPHTZYNWKRN-UHFFFAOYSA-N,262.2182,Q02880,BE0002425,DNA topoisomerase 2-beta,Humans,inhibitor,yes
DB00827,Cinoxacin,small molecule,approved;investigational;withdrawn,CCN1N=C(C(O)=O)C(=O)C2=CC3=C(OCO3)C=C12,VDUWPHTZYNWKRN-UHFFFAOYSA-N,262.2182,P11388,BE0000742,DNA topoisomerase 2-alpha,Humans,inhibitor,yes
DB00828,Fosfomycin,small molecule,approved,C[C@@H]1O[C@@H]1P(O)(O)=O,YMDXZJFXQJVXBF-STHAYSLISA-N,138.059,P0A749,BE0000468,UDP-N-acetylglucosamine 1-carboxyvinyltransferase,Escherichia coli (strain K12),inhibitor,yes
DB00829,Diazepam,small molecule,approved;illicit;investigational;vet_approved,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,AAOVKJBEBIDNHE-UHFFFAOYSA-N,284.74,P30536,BE0000736,Translocator protein,Humans,agonist,yes
DB00829,Diazepam,small molecule,approved;illicit;investigational;vet_approved,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,AAOVKJBEBIDNHE-UHFFFAOYSA-N,284.74,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB00829,Diazepam,small molecule,approved;illicit;investigational;vet_approved,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,AAOVKJBEBIDNHE-UHFFFAOYSA-N,284.74,P14867,BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,Humans,ligand,yes
DB00830,Phenmetrazine,small molecule,approved;illicit,CC1NCCOC1C1=CC=CC=C1,OOBHFESNSZDWIU-UHFFFAOYSA-N,177.2429,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,inhibitor,yes
DB00830,Phenmetrazine,small molecule,approved;illicit,CC1NCCOC1C1=CC=CC=C1,OOBHFESNSZDWIU-UHFFFAOYSA-N,177.2429,Q01959,BE0000647,Sodium-dependent dopamine transporter,Humans,inhibitor,yes
DB00831,Trifluoperazine,small molecule,approved;investigational,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,ZEWQUBUPAILYHI-UHFFFAOYSA-N,407.496,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB00831,Trifluoperazine,small molecule,approved;investigational,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,ZEWQUBUPAILYHI-UHFFFAOYSA-N,407.496,P0DP23,BE0012563,Calmodulin-1,Humans,inhibitor,yes
DB00831,Trifluoperazine,small molecule,approved;investigational,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,ZEWQUBUPAILYHI-UHFFFAOYSA-N,407.496,P0DP25,BE0008706,Calmodulin-3,Humans,inhibitor,yes
DB00831,Trifluoperazine,small molecule,approved;investigational,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,ZEWQUBUPAILYHI-UHFFFAOYSA-N,407.496,P0DP24,BE0008705,Calmodulin-2,Humans,inhibitor,yes
DB00831,Trifluoperazine,small molecule,approved;investigational,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,ZEWQUBUPAILYHI-UHFFFAOYSA-N,407.496,Q9NYX4,BE0000666,Neuron-specific vesicular protein calcyon,Humans,antagonist,yes
DB00831,Trifluoperazine,small molecule,approved;investigational,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,ZEWQUBUPAILYHI-UHFFFAOYSA-N,407.496,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,antagonist,yes
DB00833,Cefaclor,small molecule,approved,[H][C@]12SCC(Cl)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O,QYIYFLOTGYLRGG-GPCCPHFNSA-N,367.807,Q75Y35,BE0004643,Penicillin-binding protein 3,Streptococcus pneumoniae,inhibitor,yes
DB00833,Cefaclor,small molecule,approved,[H][C@]12SCC(Cl)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O,QYIYFLOTGYLRGG-GPCCPHFNSA-N,367.807,Q8XJ01,BE0000576,Penicillin-binding protein 1A,Clostridium perfringens (strain 13 / Type A),inhibitor,yes
DB00834,Mifepristone,small molecule,approved;investigational,[H][C@@]12CC[C@@](O)(C#CC)[C@@]1(C)C[C@H](C1=CC=C(C=C1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@]21[H],VKHAHZOOUSRJNA-GCNJZUOMSA-N,429.5937,P06401,BE0000557,Progesterone receptor,Humans,antagonist,yes
DB00834,Mifepristone,small molecule,approved;investigational,[H][C@@]12CC[C@@](O)(C#CC)[C@@]1(C)C[C@H](C1=CC=C(C=C1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@]21[H],VKHAHZOOUSRJNA-GCNJZUOMSA-N,429.5937,P04150,BE0000794,Glucocorticoid receptor,Humans,antagonist,yes
DB00835,Brompheniramine,small molecule,approved,CN(C)CCC(C1=CC=C(Br)C=C1)C1=CC=CC=N1,ZDIGNSYAACHWNL-UHFFFAOYSA-N,319.239,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB00836,Loperamide,small molecule,approved,CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1,RDOIQAHITMMDAJ-UHFFFAOYSA-N,477.038,P35372,BE0000770,Mu-type opioid receptor,Humans,agonist,yes
DB00837,Progabide,small molecule,experimental,OC(=N)CCCN=C(C1=CC=C(Cl)C=C1)C1=C(O)C=CC(F)=C1,IBALRBWGSVJPAP-UHFFFAOYSA-N,334.78,O75899,BE0002340,Gamma-aminobutyric acid type B receptor subunit 2,Humans,agonist,yes
DB00837,Progabide,small molecule,experimental,OC(=N)CCCN=C(C1=CC=C(Cl)C=C1)C1=C(O)C=CC(F)=C1,IBALRBWGSVJPAP-UHFFFAOYSA-N,334.78,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,agonist,yes
DB00837,Progabide,small molecule,experimental,OC(=N)CCCN=C(C1=CC=C(Cl)C=C1)C1=C(O)C=CC(F)=C1,IBALRBWGSVJPAP-UHFFFAOYSA-N,334.78,Q9UBS5,BE0000217,Gamma-aminobutyric acid type B receptor subunit 1,Humans,agonist,yes
DB00838,Clocortolone,small molecule,approved,[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,YMTMADLUXIRMGX-RFPWEZLHSA-N,410.907,P04054,BE0003997,Phospholipase A2,Humans,inducer,yes
DB00838,Clocortolone,small molecule,approved,[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,YMTMADLUXIRMGX-RFPWEZLHSA-N,410.907,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB00839,Tolazamide,small molecule,approved;investigational,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN1CCCCCC1,OUDSBRTVNLOZBN-UHFFFAOYSA-N,311.4,Q09428,BE0008670,"Sulfonylurea receptor 1, Kir6.2",Humans,blocker,yes
DB00839,Tolazamide,small molecule,approved;investigational,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN1CCCCCC1,OUDSBRTVNLOZBN-UHFFFAOYSA-N,311.4,P78508,BE0009591,ATP-sensitive inward rectifier potassium channel 10,Humans,blocker,yes
DB00841,Dobutamine,small molecule,approved,CC(CCC1=CC=C(O)C=C1)NCCC1=CC(O)=C(O)C=C1,JRWZLRBJNMZMFE-UHFFFAOYSA-N,301.3801,P35348,BE0004863,Alpha-1 adrenergic receptors,Humans,agonist,yes
DB00841,Dobutamine,small molecule,approved,CC(CCC1=CC=C(O)C=C1)NCCC1=CC(O)=C(O)C=C1,JRWZLRBJNMZMFE-UHFFFAOYSA-N,301.3801,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,agonist,yes
DB00842,Oxazepam,small molecule,approved,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2,ADIMAYPTOBDMTL-UHFFFAOYSA-N,286.713,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB00842,Oxazepam,small molecule,approved,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2,ADIMAYPTOBDMTL-UHFFFAOYSA-N,286.713,P30536,BE0000736,Translocator protein,Humans,agonist,yes
DB00842,Oxazepam,small molecule,approved,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2,ADIMAYPTOBDMTL-UHFFFAOYSA-N,286.713,P14867,BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,Humans,ligand,yes
DB00843,Donepezil,small molecule,approved,COC1=C(OC)C=C2C(=O)C(CC3CCN(CC4=CC=CC=C4)CC3)CC2=C1,ADEBPBSSDYVVLD-UHFFFAOYSA-N,379.492,P22303,BE0000426,Acetylcholinesterase,Humans,inhibitor,yes
DB00844,Nalbuphine,small molecule,approved,O[C@H]1CC[C@@]2(O)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC2CCC2)[C@H]1O5,NETZHAKZCGBWSS-CEDHKZHLSA-N,357.4434,P41145,BE0000632,Kappa-type opioid receptor,Humans,agonist,yes
DB00844,Nalbuphine,small molecule,approved,O[C@H]1CC[C@@]2(O)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC2CCC2)[C@H]1O5,NETZHAKZCGBWSS-CEDHKZHLSA-N,357.4434,P35372,BE0000770,Mu-type opioid receptor,Humans,antagonist,yes
DB00844,Nalbuphine,small molecule,approved,O[C@H]1CC[C@@]2(O)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC2CCC2)[C@H]1O5,NETZHAKZCGBWSS-CEDHKZHLSA-N,357.4434,P41143,BE0000420,Delta-type opioid receptor,Humans,antagonist,yes
DB00846,Flurandrenolide,small molecule,approved,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO,POPFMWWJOGLOIF-XWCQMRHXSA-N,436.5136,P11474,BE0003722,Steroid hormone receptor ERR1,Humans,modulator,yes
DB00846,Flurandrenolide,small molecule,approved,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO,POPFMWWJOGLOIF-XWCQMRHXSA-N,436.5136,O95718,BE0005001,Steroid hormone receptor ERR2,Humans,modulator,yes
DB00846,Flurandrenolide,small molecule,approved,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO,POPFMWWJOGLOIF-XWCQMRHXSA-N,436.5136,P62508,BE0002088,Estrogen-related receptor gamma,Humans,modulator,yes
DB00846,Flurandrenolide,small molecule,approved,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO,POPFMWWJOGLOIF-XWCQMRHXSA-N,436.5136,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB00848,Levamisole,small molecule,approved;investigational;vet_approved;withdrawn,C1CN2C[C@@H](N=C2S1)C1=CC=CC=C1,HLFSDGLLUJUHTE-SNVBAGLBSA-N,204.291,P32297,BE0003585,Neuronal acetylcholine receptor subunit alpha-3,Humans,agonist,yes
DB00848,Levamisole,small molecule,approved;investigational;vet_approved;withdrawn,C1CN2C[C@@H](N=C2S1)C1=CC=CC=C1,HLFSDGLLUJUHTE-SNVBAGLBSA-N,204.291,P05186,BE0003546,"Alkaline phosphatase, tissue-nonspecific isozyme",Humans,inhibitor,yes
DB00849,Methylphenobarbital,small molecule,approved,CCC1(C(=O)NC(=O)N(C)C1=O)C1=CC=CC=C1,ALARQZQTBTVLJV-UHFFFAOYSA-N,246.2619,P47869,BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,Humans,potentiator,yes
DB00849,Methylphenobarbital,small molecule,approved,CCC1(C(=O)NC(=O)N(C)C1=O)C1=CC=CC=C1,ALARQZQTBTVLJV-UHFFFAOYSA-N,246.2619,P34903,BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,Humans,potentiator,yes
DB00849,Methylphenobarbital,small molecule,approved,CCC1(C(=O)NC(=O)N(C)C1=O)C1=CC=CC=C1,ALARQZQTBTVLJV-UHFFFAOYSA-N,246.2619,P48169,BE0000478,Gamma-aminobutyric acid receptor subunit alpha-4,Humans,potentiator,yes
DB00849,Methylphenobarbital,small molecule,approved,CCC1(C(=O)NC(=O)N(C)C1=O)C1=CC=CC=C1,ALARQZQTBTVLJV-UHFFFAOYSA-N,246.2619,P31644,BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,Humans,potentiator,yes
DB00849,Methylphenobarbital,small molecule,approved,CCC1(C(=O)NC(=O)N(C)C1=O)C1=CC=CC=C1,ALARQZQTBTVLJV-UHFFFAOYSA-N,246.2619,Q16445,BE0000764,Gamma-aminobutyric acid receptor subunit alpha-6,Humans,potentiator,yes
DB00849,Methylphenobarbital,small molecule,approved,CCC1(C(=O)NC(=O)N(C)C1=O)C1=CC=CC=C1,ALARQZQTBTVLJV-UHFFFAOYSA-N,246.2619,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,potentiator,yes
DB00850,Perphenazine,small molecule,approved,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,RGCVKNLCSQQDEP-UHFFFAOYSA-N,403.969,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB00850,Perphenazine,small molecule,approved,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,RGCVKNLCSQQDEP-UHFFFAOYSA-N,403.969,P21728,BE0000020,D(1A) dopamine receptor,Humans,antagonist,yes
DB00851,Dacarbazine,small molecule,approved;investigational,CN(C)\N=N\C1=C(N=CN1)C(N)=O,FDKXTQMXEQVLRF-ZHACJKMWSA-N,182.187,,BE0004796,DNA,Humans,cross-linking/alkylation,yes
DB00852,Pseudoephedrine,small molecule,approved,CN[C@@H](C)[C@@H](O)C1=CC=CC=C1,KWGRBVOPPLSCSI-WCBMZHEXSA-N,165.2322,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,inhibitor,yes
DB00852,Pseudoephedrine,small molecule,approved,CN[C@@H](C)[C@@H](O)C1=CC=CC=C1,KWGRBVOPPLSCSI-WCBMZHEXSA-N,165.2322,P14416,BE0000756,D(2) dopamine receptor,Humans,stimulator,yes
DB00852,Pseudoephedrine,small molecule,approved,CN[C@@H](C)[C@@H](O)C1=CC=CC=C1,KWGRBVOPPLSCSI-WCBMZHEXSA-N,165.2322,Q01959,BE0000647,Sodium-dependent dopamine transporter,Humans,inhibitor,yes
DB00852,Pseudoephedrine,small molecule,approved,CN[C@@H](C)[C@@H](O)C1=CC=CC=C1,KWGRBVOPPLSCSI-WCBMZHEXSA-N,165.2322,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,agonist,yes
DB00852,Pseudoephedrine,small molecule,approved,CN[C@@H](C)[C@@H](O)C1=CC=CC=C1,KWGRBVOPPLSCSI-WCBMZHEXSA-N,165.2322,P08913,BE0000289,Alpha-2A adrenergic receptor,Humans,agonist,yes
DB00852,Pseudoephedrine,small molecule,approved,CN[C@@H](C)[C@@H](O)C1=CC=CC=C1,KWGRBVOPPLSCSI-WCBMZHEXSA-N,165.2322,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB00853,Temozolomide,small molecule,approved;investigational,CN1N=NC2=C(N=CN2C1=O)C(N)=O,BPEGJWRSRHCHSN-UHFFFAOYSA-N,194.1508,,BE0004796,DNA,Humans,cross-linking/alkylation,yes
DB00854,Levorphanol,small molecule,approved,[H][C@@]12CCCC[C@@]11CCN(C)[C@@H]2CC2=C1C=C(O)C=C2,JAQUASYNZVUNQP-USXIJHARSA-N,257.3706,P35372,BE0000770,Mu-type opioid receptor,Humans,agonist,yes
DB00855,Aminolevulinic acid,small molecule,approved,NCC(=O)CCC(O)=O,ZGXJTSGNIOSYLO-UHFFFAOYSA-N,131.1299,P50336,BE0013344,Protoporphyrinogen oxidase,Humans,modulator,yes
DB00855,Aminolevulinic acid,small molecule,approved,NCC(=O)CCC(O)=O,ZGXJTSGNIOSYLO-UHFFFAOYSA-N,131.1299,P13716,BE0000050,Delta-aminolevulinic acid dehydratase,Humans,inducer,yes
DB00857,Terbinafine,small molecule,approved;investigational;vet_approved,CN(C\C=C\C#CC(C)(C)C)CC1=CC=CC2=CC=CC=C12,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,291.4299,Q92206,BE0004670,Squalene monooxygenase,Yeast,inhibitor,yes
DB00858,Drostanolone,small molecule,illicit,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)[C@H](C)C[C@]12C,IKXILDNPCZPPRV-RFMGOVQKSA-N,304.4669,P10275,BE0000132,Androgen receptor,Humans,agonist,yes
DB00859,Penicillamine,small molecule,approved,[H][C@](N)(C(O)=O)C(C)(C)S,VVNCNSJFMMFHPL-VKHMYHEASA-N,149.211,,BE0004825,Copper,Humans,chelator,yes
DB00860,Prednisolone,small molecule,approved;vet_approved,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,OIGNJSKKLXVSLS-VWUMJDOOSA-N,360.444,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB00861,Diflunisal,small molecule,approved;investigational,OC(=O)C1=C(O)C=CC(=C1)C1=C(F)C=C(F)C=C1,HUPFGZXOMWLGNK-UHFFFAOYSA-N,250.1976,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB00862,Vardenafil,small molecule,approved,CCCC1=NC(C)=C2N1NC(=NC2=O)C1=C(OCC)C=CC(=C1)S(=O)(=O)N1CCN(CC)CC1,SECKRCOLJRRGGV-UHFFFAOYSA-N,488.603,O76074,BE0000182,"cGMP-specific 3',5'-cyclic phosphodiesterase",Humans,inhibitor,yes
DB00863,Ranitidine,small molecule,approved;withdrawn,CNC(NCCSCC1=CC=C(CN(C)C)O1)=C[N+]([O-])=O,VMXUWOKSQNHOCA-UHFFFAOYSA-N,314.4,P25021,BE0000112,Histamine H2 receptor,Humans,antagonist,yes
DB00864,Tacrolimus,small molecule,approved;investigational,CO[C@@H]1C[C@@H](CC[C@H]1O)\C=C(/C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]1C)OC,QJJXYPPXXYFBGM-LFZNUXCKSA-N,804.0182,Q08209,BE0004238,Protein phosphatase 3 catalytic subunit alpha,Humans,inhibitor,yes
DB00864,Tacrolimus,small molecule,approved;investigational,CO[C@@H]1C[C@@H](CC[C@H]1O)\C=C(/C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]1C)OC,QJJXYPPXXYFBGM-LFZNUXCKSA-N,804.0182,P62942,BE0000695,Peptidyl-prolyl cis-trans isomerase FKBP1A,Humans,inhibitor,yes
DB00865,Benzphetamine,small molecule,approved;illicit,C[C@@H](CC1=CC=CC=C1)N(C)CC1=CC=CC=C1,YXKTVDFXDRQTKV-HNNXBMFYSA-N,239.3553,Q05940,BE0000118,Synaptic vesicular amine transporter,Humans,inducer,yes
DB00865,Benzphetamine,small molecule,approved;illicit,C[C@@H](CC1=CC=CC=C1)N(C)CC1=CC=CC=C1,YXKTVDFXDRQTKV-HNNXBMFYSA-N,239.3553,P08913,BE0000289,Alpha-2A adrenergic receptor,Humans,agonist,yes
DB00865,Benzphetamine,small molecule,approved;illicit,C[C@@H](CC1=CC=CC=C1)N(C)CC1=CC=CC=C1,YXKTVDFXDRQTKV-HNNXBMFYSA-N,239.3553,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,agonist,yes
DB00866,Alprenolol,small molecule,experimental;withdrawn,CC(C)NCC(O)COC1=CC=CC=C1CC=C,PAZJSJFMUHDSTF-UHFFFAOYSA-N,249.3486,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,antagonist,yes
DB00866,Alprenolol,small molecule,experimental;withdrawn,CC(C)NCC(O)COC1=CC=CC=C1CC=C,PAZJSJFMUHDSTF-UHFFFAOYSA-N,249.3486,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,antagonist,yes
DB00866,Alprenolol,small molecule,experimental;withdrawn,CC(C)NCC(O)COC1=CC=CC=C1CC=C,PAZJSJFMUHDSTF-UHFFFAOYSA-N,249.3486,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,antagonist,yes
DB00867,Ritodrine,small molecule,approved;investigational,C[C@@H](NCCC1=CC=C(O)C=C1)[C@@H](O)C1=CC=C(O)C=C1,IOVGROKTTNBUGK-SJKOYZFVSA-N,287.359,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,agonist,yes
DB00867,Ritodrine,small molecule,approved;investigational,C[C@@H](NCCC1=CC=C(O)C=C1)[C@@H](O)C1=CC=C(O)C=C1,IOVGROKTTNBUGK-SJKOYZFVSA-N,287.359,P08588,BE0004872,Beta adrenergic receptor,Humans,agonist;downregulator,yes
DB00867,Ritodrine,small molecule,approved;investigational,C[C@@H](NCCC1=CC=C(O)C=C1)[C@@H](O)C1=CC=C(O)C=C1,IOVGROKTTNBUGK-SJKOYZFVSA-N,287.359,P48048,BE0004905,ATP-sensitive potassium channel,Humans,activator,yes
DB00867,Ritodrine,small molecule,approved;investigational,C[C@@H](NCCC1=CC=C(O)C=C1)[C@@H](O)C1=CC=C(O)C=C1,IOVGROKTTNBUGK-SJKOYZFVSA-N,287.359,Q12791,BE0004906,Calcium-activated potassium channel,Humans,activator,yes
DB00869,Dorzolamide,small molecule,approved,CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,IAVUPMFITXYVAF-XPUUQOCRSA-N,324.44,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB00869,Dorzolamide,small molecule,approved,CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,IAVUPMFITXYVAF-XPUUQOCRSA-N,324.44,P22748,BE0000535,Carbonic anhydrase 4,Humans,inhibitor,yes
DB00869,Dorzolamide,small molecule,approved,CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,IAVUPMFITXYVAF-XPUUQOCRSA-N,324.44,P00915,BE0000267,Carbonic anhydrase 1,Humans,inhibitor,yes
DB00870,Suprofen,small molecule,approved;withdrawn,CC(C(O)=O)C1=CC=C(C=C1)C(=O)C1=CC=CS1,MDKGKXOCJGEUJW-UHFFFAOYSA-N,260.308,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB00870,Suprofen,small molecule,approved;withdrawn,CC(C(O)=O)C1=CC=C(C=C1)C(=O)C1=CC=CS1,MDKGKXOCJGEUJW-UHFFFAOYSA-N,260.308,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB00871,Terbutaline,small molecule,approved,CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1,XWTYSIMOBUGWOL-UHFFFAOYSA-N,225.2842,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,agonist,yes
DB00872,Conivaptan,small molecule,approved;investigational,CC1=NC2=C(CCN(C(=O)C3=CC=C(NC(=O)C4=CC=CC=C4C4=CC=CC=C4)C=C3)C3=CC=CC=C23)N1,IKENVDNFQMCRTR-UHFFFAOYSA-N,498.5744,P37288,BE0000165,Vasopressin V1a receptor,Humans,antagonist,yes
DB00872,Conivaptan,small molecule,approved;investigational,CC1=NC2=C(CCN(C(=O)C3=CC=C(NC(=O)C4=CC=CC=C4C4=CC=CC=C4)C=C3)C3=CC=CC=C23)N1,IKENVDNFQMCRTR-UHFFFAOYSA-N,498.5744,P30518,BE0000293,Vasopressin V2 receptor,Humans,antagonist,yes
DB14596,Loteprednol etabonate,small molecule,approved,[H][C@@]12CC[C@](OC(=O)OCC)(C(=O)OCCl)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,DMKSVUSAATWOCU-HROMYWEYSA-N,466.96,P11474,BE0003722,Steroid hormone receptor ERR1,Humans,modulator,yes
DB14596,Loteprednol etabonate,small molecule,approved,[H][C@@]12CC[C@](OC(=O)OCC)(C(=O)OCCl)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,DMKSVUSAATWOCU-HROMYWEYSA-N,466.96,O95718,BE0005001,Steroid hormone receptor ERR2,Humans,modulator,yes
DB14596,Loteprednol etabonate,small molecule,approved,[H][C@@]12CC[C@](OC(=O)OCC)(C(=O)OCCl)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,DMKSVUSAATWOCU-HROMYWEYSA-N,466.96,P62508,BE0002088,Estrogen-related receptor gamma,Humans,modulator,yes
DB14596,Loteprednol etabonate,small molecule,approved,[H][C@@]12CC[C@](OC(=O)OCC)(C(=O)OCCl)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,DMKSVUSAATWOCU-HROMYWEYSA-N,466.96,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB00875,Flupentixol,small molecule,approved;investigational;withdrawn,[H]\C(CCN1CCN(CCO)CC1)=C1/C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F,NJMYODHXAKYRHW-DVZOWYKESA-N,434.52,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB00875,Flupentixol,small molecule,approved;investigational;withdrawn,[H]\C(CCN1CCN(CCO)CC1)=C1/C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F,NJMYODHXAKYRHW-DVZOWYKESA-N,434.52,P21728,BE0000020,D(1A) dopamine receptor,Humans,antagonist,yes
DB00875,Flupentixol,small molecule,approved;investigational;withdrawn,[H]\C(CCN1CCN(CCO)CC1)=C1/C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F,NJMYODHXAKYRHW-DVZOWYKESA-N,434.52,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB00876,Eprosartan,small molecule,approved,CCCCC1=NC=C(\C=C(/CC2=CC=CS2)C(O)=O)N1CC1=CC=C(C=C1)C(O)=O,OROAFUQRIXKEMV-LDADJPATSA-N,424.513,P30556,BE0000062,Type-1 angiotensin II receptor,Humans,antagonist,yes
DB00877,Sirolimus,small molecule,approved;investigational,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](O)[C@@H](C1)OC,QFJCIRLUMZQUOT-HPLJOQBZSA-N,914.187,P42345,BE0002386,Serine/threonine-protein kinase mTOR,Humans,inhibitor,yes
DB00878,Chlorhexidine,small molecule,approved;vet_approved;withdrawn,ClC1=CC=C(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC2=CC=C(Cl)C=C2)C=C1,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,505.447,,BE0004833,Bacterial outer membrane,Bacteria,incorporation into and destabilization,yes
DB00879,Emtricitabine,small molecule,approved;investigational,NC1=NC(=O)N(C=C1F)[C@@H]1CS[C@H](CO)O1,XQSPYNMVSIKCOC-NTSWFWBYSA-N,247.247,Q72547,BE0004136,Reverse transcriptase/RNaseH,Human immunodeficiency virus 1,inhibitor,yes
DB00879,Emtricitabine,small molecule,approved;investigational,NC1=NC(=O)N(C=C1F)[C@@H]1CS[C@H](CO)O1,XQSPYNMVSIKCOC-NTSWFWBYSA-N,247.247,P03366,BE0002050,Gag-Pol polyprotein,,modulator,yes
DB00880,Chlorothiazide,small molecule,approved;vet_approved,NS(=O)(=O)C1=C(Cl)C=C2NC=NS(=O)(=O)C2=C1,JBMKAUGHUNFTOL-UHFFFAOYSA-N,295.723,P55017,BE0000419,Solute carrier family 12 member 3,Humans,inhibitor,yes
DB00880,Chlorothiazide,small molecule,approved;vet_approved,NS(=O)(=O)C1=C(Cl)C=C2NC=NS(=O)(=O)C2=C1,JBMKAUGHUNFTOL-UHFFFAOYSA-N,295.723,P00915,BE0000267,Carbonic anhydrase 1,Humans,inhibitor,yes
DB00880,Chlorothiazide,small molecule,approved;vet_approved,NS(=O)(=O)C1=C(Cl)C=C2NC=NS(=O)(=O)C2=C1,JBMKAUGHUNFTOL-UHFFFAOYSA-N,295.723,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB00881,Quinapril,small molecule,approved;investigational,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC=CC=C2C[C@H]1C(O)=O,JSDRRTOADPPCHY-HSQYWUDLSA-N,438.5161,P12821,BE0000221,Angiotensin-converting enzyme,Humans,inhibitor,yes
DB00882,Clomifene,small molecule,approved;investigational,CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1,GKIRPKYJQBWNGO-UHFFFAOYSA-N,405.96,P03372,BE0000123,Estrogen receptor,Humans,antagonist;agonist,yes
DB00883,Isosorbide dinitrate,small molecule,approved;investigational,[H][C@]12OC[C@H](O[N+]([O-])=O)[C@@]1([H])OC[C@H]2O[N+]([O-])=O,MOYKHGMNXAOIAT-JGWLITMVSA-N,236.1363,P16066,BE0000556,Atrial natriuretic peptide receptor 1,Humans,agonist,yes
DB00884,Risedronic acid,small molecule,approved;investigational,OC(CC1=CN=CC=C1)(P(O)(O)=O)P(O)(O)=O,IIDJRNMFWXDHID-UHFFFAOYSA-N,283.1123,,BE0004801,Hydroxylapatite,Humans,antagonist,yes
DB00884,Risedronic acid,small molecule,approved;investigational,OC(CC1=CN=CC=C1)(P(O)(O)=O)P(O)(O)=O,IIDJRNMFWXDHID-UHFFFAOYSA-N,283.1123,P14324,BE0000776,Farnesyl pyrophosphate synthase,Humans,inhibitor,yes
DB00885,Pemirolast,small molecule,approved;investigational,CC1=CC=CN2C(=O)C(=CN=C12)C1=NNN=N1,HIANJWSAHKJQTH-UHFFFAOYSA-N,228.2101,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB00886,Omapatrilat,small molecule,investigational,[H][C@]12CCC[C@H](N1C(=O)[C@H](CCS2)NC(=O)[C@@H](S)CC1=CC=CC=C1)C(O)=O,LVRLSYPNFFBYCZ-VGWMRTNUSA-N,408.53,P08473,BE0000266,Neprilysin,Humans,modulator,yes
DB00886,Omapatrilat,small molecule,investigational,[H][C@]12CCC[C@H](N1C(=O)[C@H](CCS2)NC(=O)[C@@H](S)CC1=CC=CC=C1)C(O)=O,LVRLSYPNFFBYCZ-VGWMRTNUSA-N,408.53,P12821,BE0000221,Angiotensin-converting enzyme,Humans,modulator,yes
DB00887,Bumetanide,small molecule,approved,CCCCNC1=C(OC2=CC=CC=C2)C(=CC(=C1)C(O)=O)S(N)(=O)=O,MAEIEVLCKWDQJH-UHFFFAOYSA-N,364.416,Q13621,BE0000502,Solute carrier family 12 member 1,Humans,inhibitor,yes
DB00887,Bumetanide,small molecule,approved,CCCCNC1=C(OC2=CC=CC=C2)C(=CC(=C1)C(O)=O)S(N)(=O)=O,MAEIEVLCKWDQJH-UHFFFAOYSA-N,364.416,P55011,BE0000281,Solute carrier family 12 member 2,Humans,inhibitor,yes
DB00887,Bumetanide,small molecule,approved,CCCCNC1=C(OC2=CC=CC=C2)C(=CC(=C1)C(O)=O)S(N)(=O)=O,MAEIEVLCKWDQJH-UHFFFAOYSA-N,364.416,Q9UP95,BE0000601,Solute carrier family 12 member 4,Humans,inhibitor,yes
DB00887,Bumetanide,small molecule,approved,CCCCNC1=C(OC2=CC=CC=C2)C(=CC(=C1)C(O)=O)S(N)(=O)=O,MAEIEVLCKWDQJH-UHFFFAOYSA-N,364.416,Q9H2X9,BE0000047,Solute carrier family 12 member 5,Humans,inhibitor,yes
DB00888,Mechlorethamine,small molecule,approved;investigational,CN(CCCl)CCCl,HAWPXGHAZFHHAD-UHFFFAOYSA-N,156.054,,BE0004796,DNA,Humans,intercalation,yes
DB00889,Granisetron,small molecule,approved;investigational,CN1N=C(C(=O)N[C@@H]2C[C@@H]3CCC[C@H](C2)N3C)C2=C1C=CC=C2,MFWNKCLOYSRHCJ-BTTYYORXSA-N,312.417,P46098,BE0000311,5-hydroxytryptamine receptor 3A,Humans,antagonist,yes
DB00890,Dienestrol,small molecule,approved;investigational,[H]\C(C)=C(/C(=C(\[H])C)/C1=CC=C(O)C=C1)\C1=CC=C(O)C=C1,NFDFQCUYFHCNBW-SCGPFSFSSA-N,266.34,P03372,BE0000123,Estrogen receptor,Humans,agonist,yes
DB00891,Sulfapyridine,small molecule,approved,NC1=CC=C(C=C1)S(=O)(=O)NC1=CC=CC=N1,GECHUMIMRBOMGK-UHFFFAOYSA-N,249.289,P0AC13,BE0000803,Dihydropteroate synthase,Escherichia coli (strain K12),inhibitor,yes
DB00892,Oxybuprocaine,small molecule,approved;investigational,CCCCOC1=CC(=CC=C1N)C(=O)OCCN(CC)CC,CMHHMUWAYWTMGS-UHFFFAOYSA-N,308.4158,Q9Y5Y9,BE0000177,Sodium channel protein type 10 subunit alpha,Humans,inhibitor,yes
DB00894,Testolactone,small molecule,approved;investigational,[H][C@@]12CCC3=CC(=O)C=C[C@]3(C)[C@@]1([H])CC[C@]1(C)OC(=O)CC[C@@]21[H],BPEWUONYVDABNZ-DZBHQSCQSA-N,300.3921,P11511,BE0002090,Aromatase,Humans,inhibitor,yes
DB00896,Rimexolone,small molecule,approved,[H][C@@]12C[C@@H](C)[C@](C)(C(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,QTTRZHGPGKRAFB-OOKHYKNYSA-N,370.533,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB00896,Rimexolone,small molecule,approved,[H][C@@]12C[C@@H](C)[C@](C)(C(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,QTTRZHGPGKRAFB-OOKHYKNYSA-N,370.533,P11474,BE0003722,Steroid hormone receptor ERR1,Humans,modulator,yes
DB00897,Triazolam,small molecule,approved;investigational,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,JOFWLTCLBGQGBO-UHFFFAOYSA-N,343.21,P30536,BE0000736,Translocator protein,Humans,modulator,yes
DB00897,Triazolam,small molecule,approved;investigational,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,JOFWLTCLBGQGBO-UHFFFAOYSA-N,343.21,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB00897,Triazolam,small molecule,approved;investigational,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,JOFWLTCLBGQGBO-UHFFFAOYSA-N,343.21,P14867,BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,Humans,ligand,yes
DB00899,Remifentanil,small molecule,approved,CCC(=O)N(C1=CC=CC=C1)C1(CCN(CCC(=O)OC)CC1)C(=O)OC,ZTVQQQVZCWLTDF-UHFFFAOYSA-N,376.4467,P35372,BE0000770,Mu-type opioid receptor,Humans,agonist,yes
DB00900,Didanosine,small molecule,approved,OC[C@@H]1CC[C@@H](O1)N1C=NC2=C1NC=NC2=O,BXZVVICBKDXVGW-NKWVEPMBSA-N,236.2273,Q72547,BE0004136,Reverse transcriptase/RNaseH,Human immunodeficiency virus 1,inhibitor,yes
DB00900,Didanosine,small molecule,approved,OC[C@@H]1CC[C@@H](O1)N1C=NC2=C1NC=NC2=O,BXZVVICBKDXVGW-NKWVEPMBSA-N,236.2273,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB00901,Bitolterol,small molecule,withdrawn,CC1=CC=C(C=C1)C(=O)OC1=C(OC(=O)C2=CC=C(C)C=C2)C=C(C=C1)C(O)CNC(C)(C)C,FZGVEKPRDOIXJY-UHFFFAOYSA-N,461.5494,P13945,BE0001012,Beta-3 adrenergic receptor,Humans,modulator,yes
DB00901,Bitolterol,small molecule,withdrawn,CC1=CC=C(C=C1)C(=O)OC1=C(OC(=O)C2=CC=C(C)C=C2)C=C(C=C1)C(O)CNC(C)(C)C,FZGVEKPRDOIXJY-UHFFFAOYSA-N,461.5494,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,,yes
DB00902,Methdilazine,small molecule,approved,CN1CCC(CN2C3=CC=CC=C3SC3=CC=CC=C23)C1,HTMIBDQKFHUPSX-UHFFFAOYSA-N,296.43,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB00903,Etacrynic acid,small molecule,approved;investigational,CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1,AVOLMBLBETYQHX-UHFFFAOYSA-N,303.138,Q13621,BE0000502,Solute carrier family 12 member 1,Humans,inhibitor,yes
DB00903,Etacrynic acid,small molecule,approved;investigational,CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1,AVOLMBLBETYQHX-UHFFFAOYSA-N,303.138,P05023,BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,Humans,inhibitor,yes
DB00904,Ondansetron,small molecule,approved;withdrawn,CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2,FELGMEQIXOGIFQ-UHFFFAOYSA-N,293.363,P46098,BE0000311,5-hydroxytryptamine receptor 3A,Humans,antagonist,yes
DB00905,Bimatoprost,small molecule,approved;investigational,CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC1=CC=CC=C1,AQOKCDNYWBIDND-FTOWTWDKSA-N,415.5656,P43088,BE0000610,Prostaglandin F2-alpha receptor,Humans,agonist,yes
DB00905,Bimatoprost,small molecule,approved;investigational,CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC1=CC=CC=C1,AQOKCDNYWBIDND-FTOWTWDKSA-N,415.5656,P34995,BE0000064,Prostaglandin E2 receptor EP1 subtype,Humans,agonist,yes
DB00905,Bimatoprost,small molecule,approved;investigational,CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC1=CC=CC=C1,AQOKCDNYWBIDND-FTOWTWDKSA-N,415.5656,P43115,BE0002375,Prostaglandin E2 receptor EP3 subtype,Humans,agonist,yes
DB00906,Tiagabine,small molecule,approved;investigational,CC1=C(SC=C1)C(=CCCN1CCC[C@H](C1)C(O)=O)C1=C(C)C=CS1,PBJUNZJWGZTSKL-MRXNPFEDSA-N,375.548,P30531,BE0000249,Sodium- and chloride-dependent GABA transporter 1,Humans,inhibitor,yes
DB00907,Cocaine,small molecule,approved;illicit,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,ZPUCINDJVBIVPJ-LJISPDSOSA-N,303.3529,Q01959,BE0000647,Sodium-dependent dopamine transporter,Humans,inhibitor,yes
DB00907,Cocaine,small molecule,approved;illicit,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,ZPUCINDJVBIVPJ-LJISPDSOSA-N,303.3529,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,inhibitor,yes
DB00907,Cocaine,small molecule,approved;illicit,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,ZPUCINDJVBIVPJ-LJISPDSOSA-N,303.3529,P35498,BE0004901,Sodium channel protein,Humans,inhibitor,yes
DB00907,Cocaine,small molecule,approved;illicit,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,ZPUCINDJVBIVPJ-LJISPDSOSA-N,303.3529,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB00908,Quinidine,small molecule,approved;investigational,[H][C@@]12CCN(C[C@@H]1C=C)[C@]([H])(C2)[C@@H](O)C1=C2C=C(OC)C=CC2=NC=C1,LOUPRKONTZGTKE-LHHVKLHASA-N,324.4168,Q14524,BE0000197,Sodium channel protein type 5 subunit alpha,Humans,inhibitor,yes
DB00909,Zonisamide,small molecule,approved;investigational,NS(=O)(=O)CC1=NOC2=CC=CC=C12,UBQNRHZMVUUOMG-UHFFFAOYSA-N,212.226,P35498,BE0000141,Sodium channel protein type 1 subunit alpha,Humans,inhibitor,yes
DB00909,Zonisamide,small molecule,approved;investigational,NS(=O)(=O)CC1=NOC2=CC=CC=C12,UBQNRHZMVUUOMG-UHFFFAOYSA-N,212.226,Q99250,BE0002081,Sodium channel protein type 2 subunit alpha,Humans,inhibitor,yes
DB00909,Zonisamide,small molecule,approved;investigational,NS(=O)(=O)CC1=NOC2=CC=CC=C12,UBQNRHZMVUUOMG-UHFFFAOYSA-N,212.226,Q9NY46,BE0002082,Sodium channel protein type 3 subunit alpha,Humans,inhibitor,yes
DB00909,Zonisamide,small molecule,approved;investigational,NS(=O)(=O)CC1=NOC2=CC=CC=C12,UBQNRHZMVUUOMG-UHFFFAOYSA-N,212.226,P35499,BE0002083,Sodium channel protein type 4 subunit alpha,Humans,inhibitor,yes
DB00909,Zonisamide,small molecule,approved;investigational,NS(=O)(=O)CC1=NOC2=CC=CC=C12,UBQNRHZMVUUOMG-UHFFFAOYSA-N,212.226,Q14524,BE0000197,Sodium channel protein type 5 subunit alpha,Humans,inhibitor,yes
DB00909,Zonisamide,small molecule,approved;investigational,NS(=O)(=O)CC1=NOC2=CC=CC=C12,UBQNRHZMVUUOMG-UHFFFAOYSA-N,212.226,Q15858,BE0001143,Sodium channel protein type 9 subunit alpha,Humans,inhibitor,yes
DB00909,Zonisamide,small molecule,approved;investigational,NS(=O)(=O)CC1=NOC2=CC=CC=C12,UBQNRHZMVUUOMG-UHFFFAOYSA-N,212.226,Q9UI33,BE0000192,Sodium channel protein type 11 subunit alpha,Humans,inhibitor,yes
DB00909,Zonisamide,small molecule,approved;investigational,NS(=O)(=O)CC1=NOC2=CC=CC=C12,UBQNRHZMVUUOMG-UHFFFAOYSA-N,212.226,Q07699,BE0003635,Sodium channel regulatory subunit beta-1,Humans,inhibitor,yes
DB00909,Zonisamide,small molecule,approved;investigational,NS(=O)(=O)CC1=NOC2=CC=CC=C12,UBQNRHZMVUUOMG-UHFFFAOYSA-N,212.226,O60939,BE0003636,Sodium channel regulatory subunit beta-2,Humans,inhibitor,yes
DB00909,Zonisamide,small molecule,approved;investigational,NS(=O)(=O)CC1=NOC2=CC=CC=C12,UBQNRHZMVUUOMG-UHFFFAOYSA-N,212.226,Q9NY72,BE0003637,Sodium channel regulatory subunit beta-3,Humans,inhibitor,yes
DB00909,Zonisamide,small molecule,approved;investigational,NS(=O)(=O)CC1=NOC2=CC=CC=C12,UBQNRHZMVUUOMG-UHFFFAOYSA-N,212.226,Q8IWT1,BE0003638,Sodium channel regulatory subunit beta-4,Humans,inhibitor,yes
DB00909,Zonisamide,small molecule,approved;investigational,NS(=O)(=O)CC1=NOC2=CC=CC=C12,UBQNRHZMVUUOMG-UHFFFAOYSA-N,212.226,O43497,BE0000483,Voltage-dependent T-type calcium channel subunit alpha-1G,Humans,inhibitor,yes
DB00909,Zonisamide,small molecule,approved;investigational,NS(=O)(=O)CC1=NOC2=CC=CC=C12,UBQNRHZMVUUOMG-UHFFFAOYSA-N,212.226,O95180,BE0000864,Voltage-dependent T-type calcium channel subunit alpha-1H,Humans,inhibitor,yes
DB00909,Zonisamide,small molecule,approved;investigational,NS(=O)(=O)CC1=NOC2=CC=CC=C12,UBQNRHZMVUUOMG-UHFFFAOYSA-N,212.226,Q9P0X4,BE0000012,Voltage-dependent T-type calcium channel subunit alpha-1I,Humans,inhibitor,yes
DB00910,Paricalcitol,small molecule,approved;investigational,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1C[C@@H](O)C[C@H](O)C1)[C@H](C)\C=C\[C@H](C)C(C)(C)O,BPKAHTKRCLCHEA-UBFJEZKGSA-N,416.6365,P11473,BE0000779,Vitamin D3 receptor,Humans,agonist,yes
DB00911,Tinidazole,small molecule,approved;investigational,CCS(=O)(=O)CCN1C(C)=NC=C1[N+]([O-])=O,HJLSLZFTEKNLFI-UHFFFAOYSA-N,247.272,,BE0004796,DNA,Humans,binder,yes
DB00912,Repaglinide,small molecule,approved;investigational,CCOC1=C(C=CC(CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N2CCCCC2)=C1)C(O)=O,FAEKWTJYAYMJKF-QHCPKHFHSA-N,452.5857,O60706,BE0000469,ATP-binding cassette sub-family C member 9,Humans,blocker,yes
DB00912,Repaglinide,small molecule,approved;investigational,CCOC1=C(C=CC(CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N2CCCCC2)=C1)C(O)=O,FAEKWTJYAYMJKF-QHCPKHFHSA-N,452.5857,Q09428,BE0000207,ATP-binding cassette sub-family C member 8,Humans,inhibitor,yes
DB00912,Repaglinide,small molecule,approved;investigational,CCOC1=C(C=CC(CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N2CCCCC2)=C1)C(O)=O,FAEKWTJYAYMJKF-QHCPKHFHSA-N,452.5857,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB00913,Anileridine,small molecule,approved;illicit,CCOC(=O)C1(CCN(CCC2=CC=C(N)C=C2)CC1)C1=CC=CC=C1,LKYQLAWMNBFNJT-UHFFFAOYSA-N,352.4699,P35372,BE0000770,Mu-type opioid receptor,Humans,agonist,yes
DB00914,Phenformin,small molecule,approved;investigational;withdrawn,NC(=N)NC(=N)NCCC1=CC=CC=C1,ICFJFFQQTFMIBG-UHFFFAOYSA-N,205.2596,Q13131,BE0000677,5'-AMP-activated protein kinase catalytic subunit alpha-1,Humans,activator,yes
DB00914,Phenformin,small molecule,approved;investigational;withdrawn,NC(=N)NC(=N)NCCC1=CC=CC=C1,ICFJFFQQTFMIBG-UHFFFAOYSA-N,205.2596,P54619,BE0009988,5'-AMP-activated protein kinase subunit gamma-1,Humans,activator,yes
DB00914,Phenformin,small molecule,approved;investigational;withdrawn,NC(=N)NC(=N)NCCC1=CC=CC=C1,ICFJFFQQTFMIBG-UHFFFAOYSA-N,205.2596,Q9Y478,BE0000254,5'-AMP-activated protein kinase subunit beta-1,Humans,activator,yes
DB00915,Amantadine,small molecule,approved,NC12CC3CC(CC(C3)C1)C2,DKNWSYNQZKUICI-UHFFFAOYSA-N,151.2487,P21430,BE0000630,Matrix protein 2,Influenza A virus (strain A/Ann Arbor/6/1960 H2N2),inhibitor,yes
DB00915,Amantadine,small molecule,approved,NC12CC3CC(CC(C3)C1)C2,DKNWSYNQZKUICI-UHFFFAOYSA-N,151.2487,Q8TCU5,BE0000641,"Glutamate receptor ionotropic, NMDA 3A",Humans,antagonist,yes
DB00915,Amantadine,small molecule,approved,NC12CC3CC(CC(C3)C1)C2,DKNWSYNQZKUICI-UHFFFAOYSA-N,151.2487,P14416,BE0000756,D(2) dopamine receptor,Humans,agonist,yes
DB00916,Metronidazole,small molecule,approved,CC1=NC=C(N1CCO)[N+]([O-])=O,VAOCPAMSLUNLGC-UHFFFAOYSA-N,171.154,O25608,BE0004435,Oxygen-insensitive NADPH nitroreductase,Helicobacter pylori (strain ATCC 700392 / 26695),potentiator,yes
DB00917,Dinoprostone,small molecule,approved,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O,XEYBRNLFEZDVAW-ARSRFYASSA-N,352.4651,P43088,BE0000610,Prostaglandin F2-alpha receptor,Humans,antagonist,yes
DB00917,Dinoprostone,small molecule,approved,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O,XEYBRNLFEZDVAW-ARSRFYASSA-N,352.4651,P43116,BE0000368,Prostaglandin E2 receptor EP2 subtype,Humans,agonist,yes
DB00917,Dinoprostone,small molecule,approved,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O,XEYBRNLFEZDVAW-ARSRFYASSA-N,352.4651,P34995,BE0000064,Prostaglandin E2 receptor EP1 subtype,Humans,agonist,yes
DB00917,Dinoprostone,small molecule,approved,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O,XEYBRNLFEZDVAW-ARSRFYASSA-N,352.4651,P43115,BE0002375,Prostaglandin E2 receptor EP3 subtype,Humans,agonist,yes
DB00917,Dinoprostone,small molecule,approved,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O,XEYBRNLFEZDVAW-ARSRFYASSA-N,352.4651,P35408,BE0003522,Prostaglandin E2 receptor EP4 subtype,Humans,agonist,yes
DB00918,Almotriptan,small molecule,approved;investigational,CN(C)CCC1=CNC2=C1C=C(CS(=O)(=O)N1CCCC1)C=C2,WKEMJKQOLOHJLZ-UHFFFAOYSA-N,335.464,P28221,BE0000659,5-hydroxytryptamine receptor 1D,Humans,agonist,yes
DB00919,Spectinomycin,small molecule,approved;investigational;vet_approved,[H][C@@]12O[C@H](C)CC(=O)[C@]1(O)O[C@]1([H])[C@@H](NC)[C@@H](O)[C@@H](NC)[C@H](O)[C@@]1([H])O2,UNFWWIHTNXNPBV-WXKVUWSESA-N,332.3496,P0A7S3,BE0000279,30S ribosomal protein S12,Escherichia coli (strain K12),inhibitor,yes
DB00920,Ketotifen,small molecule,approved,CN1CCC(CC1)=C1C2=C(SC=C2)C(=O)CC2=CC=CC=C12,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,309.425,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB00921,Buprenorphine,small molecule,approved;illicit;investigational;vet_approved,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,RMRJXGBAOAMLHD-IHFGGWKQSA-N,467.6401,P41145,BE0000632,Kappa-type opioid receptor,Humans,antagonist,yes
DB00921,Buprenorphine,small molecule,approved;illicit;investigational;vet_approved,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,RMRJXGBAOAMLHD-IHFGGWKQSA-N,467.6401,P35372,BE0000770,Mu-type opioid receptor,Humans,partial agonist,yes
DB00922,Levosimendan,small molecule,approved;investigational,C[C@@H]1CC(=O)NN=C1C1=CC=C(NN=C(C#N)C#N)C=C1,WHXMKTBCFHIYNQ-SECBINFHSA-N,280.2847,P63316,BE0001024,"Troponin C, slow skeletal and cardiac muscles",Humans,potentiator,yes
DB00922,Levosimendan,small molecule,approved;investigational,C[C@@H]1CC(=O)NN=C1C1=CC=C(NN=C(C#N)C#N)C=C1,WHXMKTBCFHIYNQ-SECBINFHSA-N,280.2847,Q14654,BE0000708,ATP-sensitive inward rectifier potassium channel 11,Humans,inducer,yes
DB00922,Levosimendan,small molecule,approved;investigational,C[C@@H]1CC(=O)NN=C1C1=CC=C(NN=C(C#N)C#N)C=C1,WHXMKTBCFHIYNQ-SECBINFHSA-N,280.2847,Q15842,BE0002441,ATP-sensitive inward rectifier potassium channel 8,Humans,inducer,yes
DB00923,Ceforanide,small molecule,approved,[H][C@]12SCC(CSC3=NN=NN3CC(O)=O)=C(N1C(=O)[C@H]2NC(=O)CC1=CC=CC=C1CN)C(O)=O,SLAYUXIURFNXPG-CRAIPNDOSA-N,519.554,Q70KI2,BE0003688,Penicillin-binding protein 2,Bacteroides fragilis,inhibitor,yes
DB00924,Cyclobenzaprine,small molecule,approved,CN(C)CCC=C1C2=CC=CC=C2C=CC2=CC=CC=C12,JURKNVYFZMSNLP-UHFFFAOYSA-N,275.3874,P18825,BE0000342,Alpha-2C adrenergic receptor,Humans,antagonist,yes
DB00924,Cyclobenzaprine,small molecule,approved,CN(C)CCC=C1C2=CC=CC=C2C=CC2=CC=CC=C12,JURKNVYFZMSNLP-UHFFFAOYSA-N,275.3874,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB00925,Phenoxybenzamine,small molecule,approved,CC(COC1=CC=CC=C1)N(CCCl)CC1=CC=CC=C1,QZVCTJOXCFMACW-UHFFFAOYSA-N,303.826,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB00925,Phenoxybenzamine,small molecule,approved,CC(COC1=CC=CC=C1)N(CCCl)CC1=CC=CC=C1,QZVCTJOXCFMACW-UHFFFAOYSA-N,303.826,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,antagonist,yes
DB00925,Phenoxybenzamine,small molecule,approved,CC(COC1=CC=CC=C1)N(CCCl)CC1=CC=CC=C1,QZVCTJOXCFMACW-UHFFFAOYSA-N,303.826,P08913,BE0000289,Alpha-2A adrenergic receptor,Humans,antagonist,yes
DB00926,Etretinate,small molecule,withdrawn,CCOC(=O)C=C(C)C=CC=C(C)C=CC1=C(C)C(C)=C(OC)C=C1C,HQMNCQVAMBCHCO-DJRRULDNSA-N,354.4825,P10276,BE0000663,Retinoic acid receptor alpha,Humans,agonist,yes
DB00926,Etretinate,small molecule,withdrawn,CCOC(=O)C=C(C)C=CC=C(C)C=CC1=C(C)C(C)=C(OC)C=C1C,HQMNCQVAMBCHCO-DJRRULDNSA-N,354.4825,P19793,BE0000412,Retinoic acid receptor RXR-alpha,Humans,agonist,yes
DB00926,Etretinate,small molecule,withdrawn,CCOC(=O)C=C(C)C=CC=C(C)C=CC1=C(C)C(C)=C(OC)C=C1C,HQMNCQVAMBCHCO-DJRRULDNSA-N,354.4825,P10826,BE0000206,Retinoic acid receptor beta,Humans,agonist,yes
DB00926,Etretinate,small molecule,withdrawn,CCOC(=O)C=C(C)C=CC=C(C)C=CC1=C(C)C(C)=C(OC)C=C1C,HQMNCQVAMBCHCO-DJRRULDNSA-N,354.4825,P48443,BE0000707,Retinoic acid receptor RXR-gamma,Humans,agonist,yes
DB00926,Etretinate,small molecule,withdrawn,CCOC(=O)C=C(C)C=CC=C(C)C=CC1=C(C)C(C)=C(OC)C=C1C,HQMNCQVAMBCHCO-DJRRULDNSA-N,354.4825,P28702,BE0000078,Retinoic acid receptor RXR-beta,Humans,agonist,yes
DB00926,Etretinate,small molecule,withdrawn,CCOC(=O)C=C(C)C=CC=C(C)C=CC1=C(C)C(C)=C(OC)C=C1C,HQMNCQVAMBCHCO-DJRRULDNSA-N,354.4825,P13631,BE0000144,Retinoic acid receptor gamma,Humans,agonist,yes
DB00927,Famotidine,small molecule,approved,NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1,XUFQPHANEAPEMJ-UHFFFAOYSA-N,337.445,P25021,BE0000112,Histamine H2 receptor,Humans,antagonist,yes
DB00928,Azacitidine,small molecule,approved;investigational,NC1=NC(=O)N(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,NMUSYJAQQFHJEW-KVTDHHQDSA-N,244.2047,P26358,BE0000892,DNA (cytosine-5)-methyltransferase 1,Humans,inhibitor,yes
DB00928,Azacitidine,small molecule,approved;investigational,NC1=NC(=O)N(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,NMUSYJAQQFHJEW-KVTDHHQDSA-N,244.2047,,BE0004810,RNA,Humans,other,yes
DB00928,Azacitidine,small molecule,approved;investigational,NC1=NC(=O)N(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,NMUSYJAQQFHJEW-KVTDHHQDSA-N,244.2047,,BE0004796,DNA,Humans,other,yes
DB00929,Misoprostol,small molecule,approved,CCCCC(C)(O)C\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC,OJLOPKGSLYJEMD-URPKTTJQSA-N,382.5341,P43119,BE0000475,Prostacyclin receptor,Humans,antagonist,yes
DB00929,Misoprostol,small molecule,approved,CCCCC(C)(O)C\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC,OJLOPKGSLYJEMD-URPKTTJQSA-N,382.5341,P43115,BE0002375,Prostaglandin E2 receptor EP3 subtype,Humans,agonist,yes
DB00929,Misoprostol,small molecule,approved,CCCCC(C)(O)C\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC,OJLOPKGSLYJEMD-URPKTTJQSA-N,382.5341,P43116,BE0000368,Prostaglandin E2 receptor EP2 subtype,Humans,agonist,yes
DB00929,Misoprostol,small molecule,approved,CCCCC(C)(O)C\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC,OJLOPKGSLYJEMD-URPKTTJQSA-N,382.5341,P34995,BE0000064,Prostaglandin E2 receptor EP1 subtype,Humans,agonist,yes
DB00931,Metacycline,small molecule,approved;investigational,[H][C@@]12[C@@H](O)[C@]3([H])C(=C)C4=C(C(O)=CC=C4)C(=O)C3=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C,MHIGBKBJSQVXNH-IWVLMIASSA-N,442.424,,BE0004799,16S ribosomal RNA,Enteric bacteria and other eubacteria,inhibitor,yes
DB00932,Tipranavir,small molecule,approved;investigational,[H][C@@](CC)(C1=CC(NS(=O)(=O)C2=NC=C(C=C2)C(F)(F)F)=CC=C1)C1=C(O)C[C@@](CCC)(CCC2=CC=CC=C2)OC1=O,SUJUHGSWHZTSEU-FYBSXPHGSA-N,602.664,P03366,BE0002050,Gag-Pol polyprotein,,modulator,yes
DB00932,Tipranavir,small molecule,approved;investigational,[H][C@@](CC)(C1=CC(NS(=O)(=O)C2=NC=C(C=C2)C(F)(F)F)=CC=C1)C1=C(O)C[C@@](CCC)(CCC2=CC=CC=C2)OC1=O,SUJUHGSWHZTSEU-FYBSXPHGSA-N,602.664,Q72874,BE0004854,Pol polyprotein,Human immunodeficiency virus 1,inhibitor,yes
DB00933,Mesoridazine,small molecule,approved;investigational,CN1CCCCC1CCN1C2=C(SC3=C1C=C(C=C3)S(C)=O)C=CC=C2,SLVMESMUVMCQIY-UHFFFAOYSA-N,386.574,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB00933,Mesoridazine,small molecule,approved;investigational,CN1CCCCC1CCN1C2=C(SC3=C1C=C(C=C3)S(C)=O)C=CC=C2,SLVMESMUVMCQIY-UHFFFAOYSA-N,386.574,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB00934,Maprotiline,small molecule,approved;investigational,CNCCCC12CCC(C3=CC=CC=C13)C1=CC=CC=C21,QSLMDECMDJKHMQ-UHFFFAOYSA-N,277.4033,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,inhibitor,yes
DB00935,Oxymetazoline,small molecule,approved;investigational,CC1=CC(=C(O)C(C)=C1CC1=NCCN1)C(C)(C)C,WYWIFABBXFUGLM-UHFFFAOYSA-N,260.3746,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,partial agonist,yes
DB00935,Oxymetazoline,small molecule,approved;investigational,CC1=CC(=C(O)C(C)=C1CC1=NCCN1)C(C)(C)C,WYWIFABBXFUGLM-UHFFFAOYSA-N,260.3746,P08913,BE0000289,Alpha-2A adrenergic receptor,Humans,agonist;partial agonist,yes
DB00935,Oxymetazoline,small molecule,approved;investigational,CC1=CC(=C(O)C(C)=C1CC1=NCCN1)C(C)(C)C,WYWIFABBXFUGLM-UHFFFAOYSA-N,260.3746,P18089,BE0000572,Alpha-2B adrenergic receptor,Humans,agonist,yes
DB00936,Salicylic acid,small molecule,approved;investigational;vet_approved,OC(=O)C1=CC=CC=C1O,YGSDEFSMJLZEOE-UHFFFAOYSA-N,138.1207,P23280,BE0003628,Carbonic anhydrase 6,Humans,inhibitor,yes
DB00936,Salicylic acid,small molecule,approved;investigational;vet_approved,OC(=O)C1=CC=CC=C1O,YGSDEFSMJLZEOE-UHFFFAOYSA-N,138.1207,O43570,BE0001653,Carbonic anhydrase 12,Humans,inhibitor,yes
DB00936,Salicylic acid,small molecule,approved;investigational;vet_approved,OC(=O)C1=CC=CC=C1O,YGSDEFSMJLZEOE-UHFFFAOYSA-N,138.1207,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB00936,Salicylic acid,small molecule,approved;investigational;vet_approved,OC(=O)C1=CC=CC=C1O,YGSDEFSMJLZEOE-UHFFFAOYSA-N,138.1207,P22748,BE0000535,Carbonic anhydrase 4,Humans,inhibitor,yes
DB00936,Salicylic acid,small molecule,approved;investigational;vet_approved,OC(=O)C1=CC=CC=C1O,YGSDEFSMJLZEOE-UHFFFAOYSA-N,138.1207,P00915,BE0000267,Carbonic anhydrase 1,Humans,inhibitor,yes
DB00936,Salicylic acid,small molecule,approved;investigational;vet_approved,OC(=O)C1=CC=CC=C1O,YGSDEFSMJLZEOE-UHFFFAOYSA-N,138.1207,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB00936,Salicylic acid,small molecule,approved;investigational;vet_approved,OC(=O)C1=CC=CC=C1O,YGSDEFSMJLZEOE-UHFFFAOYSA-N,138.1207,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB00937,Diethylpropion,small molecule,approved;illicit,CCN(CC)C(C)C(=O)C1=CC=CC=C1,XXEPPPIWZFICOJ-UHFFFAOYSA-N,205.2961,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,inhibitor,yes
DB00937,Diethylpropion,small molecule,approved;illicit,CCN(CC)C(C)C(=O)C1=CC=CC=C1,XXEPPPIWZFICOJ-UHFFFAOYSA-N,205.2961,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB00937,Diethylpropion,small molecule,approved;illicit,CCN(CC)C(C)C(=O)C1=CC=CC=C1,XXEPPPIWZFICOJ-UHFFFAOYSA-N,205.2961,Q01959,BE0000647,Sodium-dependent dopamine transporter,Humans,inhibitor,yes
DB00938,Salmeterol,small molecule,approved,OCC1=C(O)C=CC(=C1)C(O)CNCCCCCCOCCCCC1=CC=CC=C1,GIIZNNXWQWCKIB-UHFFFAOYSA-N,415.5656,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,agonist,yes
DB00939,Meclofenamic acid,small molecule,approved;vet_approved,CC1=C(Cl)C(NC2=CC=CC=C2C(O)=O)=C(Cl)C=C1,SBDNJUWAMKYJOX-UHFFFAOYSA-N,296.149,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB00939,Meclofenamic acid,small molecule,approved;vet_approved,CC1=C(Cl)C(NC2=CC=CC=C2C(O)=O)=C(Cl)C=C1,SBDNJUWAMKYJOX-UHFFFAOYSA-N,296.149,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB00939,Meclofenamic acid,small molecule,approved;vet_approved,CC1=C(Cl)C(NC2=CC=CC=C2C(O)=O)=C(Cl)C=C1,SBDNJUWAMKYJOX-UHFFFAOYSA-N,296.149,P09917,BE0000248,Polyunsaturated fatty acid 5-lipoxygenase,Humans,inhibitor,yes
DB00940,Methantheline,small molecule,approved;investigational,CC[N+](C)(CC)CCOC(=O)C1C2=CC=CC=C2OC2=CC=CC=C12,GZHFODJQISUKAY-UHFFFAOYSA-N,340.436,P25021,BE0000112,Histamine H2 receptor,Humans,antagonist,yes
DB00940,Methantheline,small molecule,approved;investigational,CC[N+](C)(CC)CCOC(=O)C1C2=CC=CC=C2OC2=CC=CC=C12,GZHFODJQISUKAY-UHFFFAOYSA-N,340.436,P08912,BE0000247,Muscarinic acetylcholine receptor M5,Humans,antagonist,yes
DB00941,Hexafluronium,small molecule,approved,C[N+](C)(CCCCCC[N+](C)(C)C1C2=C(C=CC=C2)C2=C1C=CC=C2)C1C2=C(C=CC=C2)C2=C1C=CC=C2,HDZAQYPYABGTCL-UHFFFAOYSA-N,502.745,P06276,BE0002180,Cholinesterase,Humans,inhibitor,yes
DB00942,Cycrimine,small molecule,approved,OC(CCN1CCCCC1)(C1CCCC1)C1=CC=CC=C1,SWRUZBWLEWHWRI-UHFFFAOYSA-N,287.4397,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,antagonist,yes
DB00943,Zalcitabine,small molecule,approved;investigational,NC1=NC(=O)N(C=C1)[C@H]1CC[C@@H](CO)O1,WREGKURFCTUGRC-POYBYMJQSA-N,211.2178,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB00943,Zalcitabine,small molecule,approved;investigational,NC1=NC(=O)N(C=C1)[C@H]1CC[C@@H](CO)O1,WREGKURFCTUGRC-POYBYMJQSA-N,211.2178,Q72547,BE0004136,Reverse transcriptase/RNaseH,Human immunodeficiency virus 1,inhibitor,yes
DB00944,Demecarium,small molecule,approved,CN(CCCCCCCCCCN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C,RWZVPVOZTJJMNU-UHFFFAOYSA-N,556.7797,P22303,BE0000426,Acetylcholinesterase,Humans,inhibitor,yes
DB00945,Acetylsalicylic acid,small molecule,approved;vet_approved,CC(=O)OC1=CC=CC=C1C(O)=O,BSYNRYMUTXBXSQ-UHFFFAOYSA-N,180.1574,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB00945,Acetylsalicylic acid,small molecule,approved;vet_approved,CC(=O)OC1=CC=CC=C1C(O)=O,BSYNRYMUTXBXSQ-UHFFFAOYSA-N,180.1574,P04035,BE0000574,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Humans,inhibitor,yes
DB00945,Acetylsalicylic acid,small molecule,approved;vet_approved,CC(=O)OC1=CC=CC=C1C(O)=O,BSYNRYMUTXBXSQ-UHFFFAOYSA-N,180.1574,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB00946,Phenprocoumon,small molecule,approved;investigational,CCC(C1=CC=CC=C1)C1=C(O)C2=C(OC1=O)C=CC=C2,DQDAYGNAKTZFIW-UHFFFAOYSA-N,280.3178,Q9BQB6,BE0000713,Vitamin K epoxide reductase complex subunit 1,Humans,inhibitor,yes
DB00947,Fulvestrant,small molecule,approved;investigational,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@@]21[H],VWUXBMIQPBEWFH-WCCTWKNTSA-N,606.78,P03372,BE0000123,Estrogen receptor,Humans,antagonist,yes
DB00948,Mezlocillin,small molecule,approved;investigational,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](NC(=O)N1CCN(C1=O)S(C)(=O)=O)C1=CC=CC=C1)C(O)=O,YPBATNHYBCGSSN-VWPFQQQWSA-N,539.582,Q8XJ01,BE0000576,Penicillin-binding protein 1A,Clostridium perfringens (strain 13 / Type A),inhibitor,yes
DB00948,Mezlocillin,small molecule,approved;investigational,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](NC(=O)N1CCN(C1=O)S(C)(=O)=O)C1=CC=CC=C1)C(O)=O,YPBATNHYBCGSSN-VWPFQQQWSA-N,539.582,P0AD68,BE0002393,Peptidoglycan synthase FtsI,Escherichia coli (strain K12),binder,yes
DB00948,Mezlocillin,small molecule,approved;investigational,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](NC(=O)N1CCN(C1=O)S(C)(=O)=O)C1=CC=CC=C1)C(O)=O,YPBATNHYBCGSSN-VWPFQQQWSA-N,539.582,Q75Y35,BE0004643,Penicillin-binding protein 3,Streptococcus pneumoniae,inhibitor,yes
DB00949,Felbamate,small molecule,approved,NC(=O)OCC(COC(N)=O)C1=CC=CC=C1,WKGXYQFOCVYPAC-UHFFFAOYSA-N,238.2399,Q13224,BE0000417,"Glutamate receptor ionotropic, NMDA 2B",Humans,antagonist,yes
DB00949,Felbamate,small molecule,approved,NC(=O)OCC(COC(N)=O)C1=CC=CC=C1,WKGXYQFOCVYPAC-UHFFFAOYSA-N,238.2399,Q12879,BE0000760,"Glutamate receptor ionotropic, NMDA 2A",Humans,antagonist,yes
DB00950,Fexofenadine,small molecule,approved;investigational,CC(C)(C(O)=O)C1=CC=C(C=C1)C(O)CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1,RWTNPBWLLIMQHL-UHFFFAOYSA-N,501.6564,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB00951,Isoniazid,small molecule,approved;investigational,NNC(=O)C1=CC=NC=C1,QRXWMOHMRWLFEY-UHFFFAOYSA-N,137.1393,P9WGR1,BE0000332,Enoyl-[acyl-carrier-protein] reductase [NADH],Mycobacterium tuberculosis,adduct,yes
DB00952,Naratriptan,small molecule,approved;investigational,CNS(=O)(=O)CCC1=CC2=C(NC=C2C2CCN(C)CC2)C=C1,AMKVXSZCKVJAGH-UHFFFAOYSA-N,335.464,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,agonist,yes
DB00952,Naratriptan,small molecule,approved;investigational,CNS(=O)(=O)CCC1=CC2=C(NC=C2C2CCN(C)CC2)C=C1,AMKVXSZCKVJAGH-UHFFFAOYSA-N,335.464,P28221,BE0000659,5-hydroxytryptamine receptor 1D,Humans,agonist,yes
DB00952,Naratriptan,small molecule,approved;investigational,CNS(=O)(=O)CCC1=CC2=C(NC=C2C2CCN(C)CC2)C=C1,AMKVXSZCKVJAGH-UHFFFAOYSA-N,335.464,P28222,BE0000797,5-hydroxytryptamine receptor 1B,Humans,agonist,yes
DB00952,Naratriptan,small molecule,approved;investigational,CNS(=O)(=O)CCC1=CC2=C(NC=C2C2CCN(C)CC2)C=C1,AMKVXSZCKVJAGH-UHFFFAOYSA-N,335.464,P30939,BE0000460,5-hydroxytryptamine receptor 1F,Humans,agonist,yes
DB00953,Rizatriptan,small molecule,approved,CN(C)CCC1=CNC2=C1C=C(CN1C=NC=N1)C=C2,ULFRLSNUDGIQQP-UHFFFAOYSA-N,269.3449,P28222,BE0000797,5-hydroxytryptamine receptor 1B,Humans,agonist,yes
DB00953,Rizatriptan,small molecule,approved,CN(C)CCC1=CNC2=C1C=C(CN1C=NC=N1)C=C2,ULFRLSNUDGIQQP-UHFFFAOYSA-N,269.3449,P28221,BE0000659,5-hydroxytryptamine receptor 1D,Humans,agonist,yes
DB00954,Dirithromycin,small molecule,experimental,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)[C@@H]2N[C@@H](COCCOC)O[C@H]([C@H]2C)[C@]1(C)O,WLOHNSSYAXHWNR-DWIOZXRMSA-N,835.086,,BE0004800,23S ribosomal RNA,Enteric bacteria and other eubacteria,inhibitor,yes
DB00955,Netilmicin,small molecule,approved;investigational,CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O,CIDUJQMULVCIBT-MQDUPKMGSA-N,475.587,P0A7S3,BE0000279,30S ribosomal protein S12,Escherichia coli (strain K12),inhibitor,yes
DB00955,Netilmicin,small molecule,approved;investigational,CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O,CIDUJQMULVCIBT-MQDUPKMGSA-N,475.587,,BE0004799,16S ribosomal RNA,Enteric bacteria and other eubacteria,inhibitor,yes
DB00956,Hydrocodone,small molecule,approved;illicit;investigational,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])CCC2=O,LLPOLZWFYMWNKH-CMKMFDCUSA-N,299.3642,P35372,BE0000770,Mu-type opioid receptor,Humans,agonist,yes
DB00956,Hydrocodone,small molecule,approved;illicit;investigational,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])CCC2=O,LLPOLZWFYMWNKH-CMKMFDCUSA-N,299.3642,P41143,BE0000420,Delta-type opioid receptor,Humans,agonist,yes
DB00957,Norgestimate,small molecule,approved;investigational,[H][C@@]12CC[C@@](OC(C)=O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CC\C(C=C3CC[C@@]21[H])=N/O,KIQQMECNKUGGKA-NMYWJIRASA-N,369.4971,P06401,BE0000557,Progesterone receptor,Humans,agonist,yes
DB00957,Norgestimate,small molecule,approved;investigational,[H][C@@]12CC[C@@](OC(C)=O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CC\C(C=C3CC[C@@]21[H])=N/O,KIQQMECNKUGGKA-NMYWJIRASA-N,369.4971,P03372,BE0000123,Estrogen receptor,Humans,agonist,yes
DB00958,Carboplatin,small molecule,approved,[H][N]([H])([H])[Pt]1(OC(=O)C2(CCC2)C(=O)O1)[N]([H])([H])[H],OLESAACUTLOWQZ-UHFFFAOYSA-L,371.254,,BE0004796,DNA,Humans,cross-linking/alkylation,yes
DB00959,Methylprednisolone,small molecule,approved;vet_approved,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,VHRSUDSXCMQTMA-PJHHCJLFSA-N,374.4706,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB00960,Pindolol,small molecule,approved;investigational,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,JZQKKSLKJUAGIC-UHFFFAOYSA-N,248.3208,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,partial agonist,yes
DB00960,Pindolol,small molecule,approved;investigational,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,JZQKKSLKJUAGIC-UHFFFAOYSA-N,248.3208,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,partial agonist,yes
DB00961,Mepivacaine,small molecule,approved;vet_approved,CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,INWLQCZOYSRPNW-UHFFFAOYSA-N,246.348,Q9Y5Y9,BE0000177,Sodium channel protein type 10 subunit alpha,Humans,inhibitor,yes
DB00962,Zaleplon,small molecule,approved;illicit;investigational,CCN(C(C)=O)C1=CC=CC(=C1)C1=CC=NC2=C(C=NN12)C#N,HUNXMJYCHXQEGX-UHFFFAOYSA-N,305.3339,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,potentiator,yes
DB00963,Bromfenac,small molecule,approved;withdrawn,NC1=C(CC(O)=O)C=CC=C1C(=O)C1=CC=C(Br)C=C1,ZBPLOVFIXSTCRZ-UHFFFAOYSA-N,334.165,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB00963,Bromfenac,small molecule,approved;withdrawn,NC1=C(CC(O)=O)C=CC=C1C(=O)C1=CC=C(Br)C=C1,ZBPLOVFIXSTCRZ-UHFFFAOYSA-N,334.165,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB00964,Apraclonidine,small molecule,approved,NC1=CC(Cl)=C(NC2=NCCN2)C(Cl)=C1,IEJXVRYNEISIKR-UHFFFAOYSA-N,245.109,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,agonist,yes
DB00964,Apraclonidine,small molecule,approved,NC1=CC(Cl)=C(NC2=NCCN2)C(Cl)=C1,IEJXVRYNEISIKR-UHFFFAOYSA-N,245.109,P08913,BE0000289,Alpha-2A adrenergic receptor,Humans,agonist,yes
DB00966,Telmisartan,small molecule,approved;investigational,CCCC1=NC2=C(C=C(C=C2C)C2=NC3=CC=CC=C3N2C)N1CC1=CC=C(C=C1)C1=CC=CC=C1C(O)=O,RMMXLENWKUUMAY-UHFFFAOYSA-N,514.6169,P37231,BE0000215,Peroxisome proliferator-activated receptor gamma,Humans,partial agonist,yes
DB00966,Telmisartan,small molecule,approved;investigational,CCCC1=NC2=C(C=C(C=C2C)C2=NC3=CC=CC=C3N2C)N1CC1=CC=C(C=C1)C1=CC=CC=C1C(O)=O,RMMXLENWKUUMAY-UHFFFAOYSA-N,514.6169,P30556,BE0000062,Type-1 angiotensin II receptor,Humans,antagonist,yes
DB00967,Desloratadine,small molecule,approved;investigational,ClC1=CC2=C(C=C1)C(=C1CCNCC1)C1=C(CC2)C=CC=N1,JAUOIFJMECXRGI-UHFFFAOYSA-N,310.821,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB00968,Methyldopa,small molecule,approved,C[C@](N)(CC1=CC=C(O)C(O)=C1)C(O)=O,CJCSPKMFHVPWAR-JTQLQIEISA-N,211.2145,P14416,BE0000756,D(2) dopamine receptor,Humans,agonist,yes
DB00968,Methyldopa,small molecule,approved,C[C@](N)(CC1=CC=C(O)C(O)=C1)C(O)=O,CJCSPKMFHVPWAR-JTQLQIEISA-N,211.2145,P20711,BE0002151,Aromatic-L-amino-acid decarboxylase,Humans,inhibitor,yes
DB00968,Methyldopa,small molecule,approved,C[C@](N)(CC1=CC=C(O)C(O)=C1)C(O)=O,CJCSPKMFHVPWAR-JTQLQIEISA-N,211.2145,P08913,BE0000289,Alpha-2A adrenergic receptor,Humans,agonist,yes
DB00969,Alosetron,small molecule,approved;withdrawn,CN1C2=C(C3=CC=CC=C13)C(=O)N(CC1=C(C)NC=N1)CC2,JSWZEAMFRNKZNL-UHFFFAOYSA-N,294.351,P46098,BE0000311,5-hydroxytryptamine receptor 3A,Humans,antagonist,yes
DB00970,Dactinomycin,small molecule,approved;investigational,[H][C@@]12CCCN1C(=O)[C@H](NC(=O)[C@@H](NC(=O)C1=C3N=C4C(OC3=C(C)C=C1)=C(C)C(=O)C(N)=C4C(=O)N[C@H]1[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@]3([H])CCCN3C(=O)[C@H](NC1=O)C(C)C)[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C2=O)C(C)C,RJURFGZVJUQBHK-IIXSONLDSA-N,1255.417,,BE0004796,DNA,Humans,adduct,yes
DB00972,Azelastine,small molecule,approved,CN1CCCC(CC1)N1N=C(CC2=CC=C(Cl)C=C2)C2=CC=CC=C2C1=O,MBUVEWMHONZEQD-UHFFFAOYSA-N,381.898,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB00973,Ezetimibe,small molecule,approved,[H][C@]1(CC[C@H](O)C2=CC=C(F)C=C2)C(=O)N(C2=CC=C(F)C=C2)[C@]1([H])C1=CC=C(O)C=C1,OLNTVTPDXPETLC-XPWALMASSA-N,409.4252,Q9UHC9,BE0000802,NPC1-like intracellular cholesterol transporter 1,Humans,inhibitor,yes
DB00973,Ezetimibe,small molecule,approved,[H][C@]1(CC[C@H](O)C2=CC=C(F)C=C2)C(=O)N(C2=CC=C(F)C=C2)[C@]1([H])C1=CC=C(O)C=C1,OLNTVTPDXPETLC-XPWALMASSA-N,409.4252,P35610,BE0000105,Sterol O-acyltransferase 1,Humans,inhibitor,yes
DB00974,Edetic acid,small molecule,approved;vet_approved,OC(=O)CN(CCN(CC(O)=O)CC(O)=O)CC(O)=O,KCXVZYZYPLLWCC-UHFFFAOYSA-N,292.2426,,BE0004808,Lead,Humans,chelator,yes
DB00975,Dipyridamole,small molecule,approved,OCCN(CCO)C1=NC2=C(N=C(N=C2N2CCCCC2)N(CCO)CCO)C(=N1)N1CCCCC1,IZEKFCXSFNUWAM-UHFFFAOYSA-N,504.6256,Q9Y233,BE0000631,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",Humans,inhibitor,yes
DB00975,Dipyridamole,small molecule,approved,OCCN(CCO)C1=NC2=C(N=C(N=C2N2CCCCC2)N(CCO)CCO)C(=N1)N1CCCCC1,IZEKFCXSFNUWAM-UHFFFAOYSA-N,504.6256,O76074,BE0000182,"cGMP-specific 3',5'-cyclic phosphodiesterase",Humans,inhibitor,yes
DB00975,Dipyridamole,small molecule,approved,OCCN(CCO)C1=NC2=C(N=C(N=C2N2CCCCC2)N(CCO)CCO)C(=N1)N1CCCCC1,IZEKFCXSFNUWAM-UHFFFAOYSA-N,504.6256,P27815,BE0001133,"3',5'-cyclic-AMP phosphodiesterase 4A",Humans,inhibitor,yes
DB00975,Dipyridamole,small molecule,approved,OCCN(CCO)C1=NC2=C(N=C(N=C2N2CCCCC2)N(CCO)CCO)C(=N1)N1CCCCC1,IZEKFCXSFNUWAM-UHFFFAOYSA-N,504.6256,P00813,BE0002214,Adenosine deaminase,Humans,inhibitor,yes
DB00976,Telithromycin,small molecule,approved,[H][C@@]12[C@@H](C)C(=O)[C@H](C)C[C@@](C)(OC)[C@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@H](C)C(=O)[C@@H](C)C(=O)O[C@H](CC)[C@@]1(C)OC(=O)N2CCCCN1C=NC(=C1)C1=CC=CN=C1,LJVAJPDWBABPEJ-PNUFFHFMSA-N,812.018,,BE0004800,23S ribosomal RNA,Enteric bacteria and other eubacteria,inhibitor,yes
DB00977,Ethinylestradiol,small molecule,approved,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,BFPYWIDHMRZLRN-SLHNCBLASA-N,296.4034,P03372,BE0000123,Estrogen receptor,Humans,agonist,yes
DB00978,Lomefloxacin,small molecule,approved;investigational,CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(N3CCNC(C)C3)C(F)=C12,ZEKZLJVOYLTDKK-UHFFFAOYSA-N,351.3479,P43700,BE0000366,DNA gyrase subunit A,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd),inhibitor,yes
DB00978,Lomefloxacin,small molecule,approved;investigational,CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(N3CCNC(C)C3)C(F)=C12,ZEKZLJVOYLTDKK-UHFFFAOYSA-N,351.3479,Q02880,BE0002425,DNA topoisomerase 2-beta,Humans,inhibitor,yes
DB00978,Lomefloxacin,small molecule,approved;investigational,CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(N3CCNC(C)C3)C(F)=C12,ZEKZLJVOYLTDKK-UHFFFAOYSA-N,351.3479,P43702,BE0000429,DNA topoisomerase 4 subunit A,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd),inhibitor,yes
DB00978,Lomefloxacin,small molecule,approved;investigational,CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(N3CCNC(C)C3)C(F)=C12,ZEKZLJVOYLTDKK-UHFFFAOYSA-N,351.3479,P11388,BE0000742,DNA topoisomerase 2-alpha,Humans,inhibitor,yes
DB00979,Cyclopentolate,small molecule,approved,CN(C)CCOC(=O)C(C1=CC=CC=C1)C1(O)CCCC1,SKYSRIRYMSLOIN-UHFFFAOYSA-N,291.3853,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,antagonist,yes
DB00979,Cyclopentolate,small molecule,approved,CN(C)CCOC(=O)C(C1=CC=CC=C1)C1(O)CCCC1,SKYSRIRYMSLOIN-UHFFFAOYSA-N,291.3853,P08912,BE0000247,Muscarinic acetylcholine receptor M5,Humans,antagonist,yes
DB00980,Ramelteon,small molecule,approved;investigational,CCC(=O)NCC[C@@H]1CCC2=C1C1=C(OCC1)C=C2,YLXDSYKOBKBWJQ-LBPRGKRZSA-N,259.3434,P49286,BE0000327,Melatonin receptor type 1B,Humans,multitarget,yes
DB00980,Ramelteon,small molecule,approved;investigational,CCC(=O)NCC[C@@H]1CCC2=C1C1=C(OCC1)C=C2,YLXDSYKOBKBWJQ-LBPRGKRZSA-N,259.3434,P48039,BE0000515,Melatonin receptor type 1A,Humans,multitarget,yes
DB00981,Physostigmine,small molecule,approved;investigational,[H][C@]12N(C)CC[C@@]1(C)C1=C(C=CC(OC(=O)NC)=C1)N2C,PIJVFDBKTWXHHD-HIFRSBDPSA-N,275.3461,P22303,BE0000426,Acetylcholinesterase,Humans,inhibitor,yes
DB00983,Formoterol,small molecule,approved;investigational,COC1=CC=C(CC(C)NCC(O)C2=CC(NC=O)=C(O)C=C2)C=C1,BPZSYCZIITTYBL-UHFFFAOYSA-N,344.4049,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,agonist,yes
DB00984,Nandrolone phenpropionate,small molecule,approved;illicit;investigational,[H][C@@]12CC[C@H](OC(=O)CCC3=CC=CC=C3)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],UBWXUGDQUBIEIZ-QNTYDACNSA-N,406.5571,P10275,BE0000132,Androgen receptor,Humans,agonist,yes
DB00985,Dimenhydrinate,small molecule,approved,CN1C2=C(N=C(Cl)N2)C(=O)N(C)C1=O.CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1,NFLLKCVHYJRNRH-UHFFFAOYSA-N,469.97,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB00986,Glycopyrronium,small molecule,approved;investigational;vet_approved,C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1,ANGKOCUUWGHLCE-UHFFFAOYSA-N,318.4305,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,antagonist,yes
DB00986,Glycopyrronium,small molecule,approved;investigational;vet_approved,C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1,ANGKOCUUWGHLCE-UHFFFAOYSA-N,318.4305,P20309,BE0000045,Muscarinic acetylcholine receptor M3,Humans,antagonist,yes
DB00986,Glycopyrronium,small molecule,approved;investigational;vet_approved,C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1,ANGKOCUUWGHLCE-UHFFFAOYSA-N,318.4305,P08172,BE0000560,Muscarinic acetylcholine receptor M2,Humans,antagonist,yes
DB00986,Glycopyrronium,small molecule,approved;investigational;vet_approved,C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1,ANGKOCUUWGHLCE-UHFFFAOYSA-N,318.4305,P08173,BE0000405,Muscarinic acetylcholine receptor M4,Humans,antagonist,yes
DB00987,Cytarabine,small molecule,approved;investigational,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,UHDGCWIWMRVCDJ-CCXZUQQUSA-N,243.2166,P06746,BE0000113,DNA polymerase beta,Humans,inhibitor,yes
DB00987,Cytarabine,small molecule,approved;investigational,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,UHDGCWIWMRVCDJ-CCXZUQQUSA-N,243.2166,P04293,BE0000308,DNA polymerase catalytic subunit,HHV-1,inhibitor,yes
DB00987,Cytarabine,small molecule,approved;investigational,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,UHDGCWIWMRVCDJ-CCXZUQQUSA-N,243.2166,,BE0004796,DNA,Humans,cross-linking/alkylation,yes
DB00988,Dopamine,small molecule,approved,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,153.1784,P14416,BE0000756,D(2) dopamine receptor,Humans,agonist,yes
DB00988,Dopamine,small molecule,approved,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,153.1784,P21728,BE0000020,D(1A) dopamine receptor,Humans,agonist,yes
DB00988,Dopamine,small molecule,approved,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,153.1784,P21918,BE0000145,D(1B) dopamine receptor,Humans,agonist,yes
DB00988,Dopamine,small molecule,approved,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,153.1784,P35462,BE0000581,D(3) dopamine receptor,Humans,agonist,yes
DB00988,Dopamine,small molecule,approved,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,153.1784,P21917,BE0000389,D(4) dopamine receptor,Humans,agonist,yes
DB00988,Dopamine,small molecule,approved,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,153.1784,Q01959,BE0000647,Sodium-dependent dopamine transporter,Humans,inducer,yes
DB00988,Dopamine,small molecule,approved,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,153.1784,P09172,BE0000138,Dopamine beta-hydroxylase,Humans,ligand,yes
DB00989,Rivastigmine,small molecule,approved;investigational,CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C,XSVMFMHYUFZWBK-NSHDSACASA-N,250.3367,P22303,BE0000426,Acetylcholinesterase,Humans,inhibitor,yes
DB00989,Rivastigmine,small molecule,approved;investigational,CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C,XSVMFMHYUFZWBK-NSHDSACASA-N,250.3367,P06276,BE0002180,Cholinesterase,Humans,inhibitor,yes
DB00990,Exemestane,small molecule,approved;investigational,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC(=C)C2=CC(=O)C=C[C@]12C,BFYIZQONLCFLEV-DAELLWKTSA-N,296.4034,P11511,BE0002090,Aromatase,Humans,inhibitor,yes
DB00991,Oxaprozin,small molecule,approved,OC(=O)CCC1=NC(=C(O1)C1=CC=CC=C1)C1=CC=CC=C1,OFPXSFXSNFPTHF-UHFFFAOYSA-N,293.3166,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB00991,Oxaprozin,small molecule,approved,OC(=O)CCC1=NC(=C(O1)C1=CC=CC=C1)C1=CC=CC=C1,OFPXSFXSNFPTHF-UHFFFAOYSA-N,293.3166,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB00992,Methyl aminolevulinate,small molecule,approved;investigational,COC(=O)CCC(=O)CN,YUUAYBAIHCDHHD-UHFFFAOYSA-N,145.1564,P22830,BE0001033,"Ferrochelatase, mitochondrial",Humans,activator,yes
DB00993,Azathioprine,small molecule,approved,CN1C=NC(=C1SC1=NC=NC2=C1NC=N2)[N+]([O-])=O,LMEKQMALGUDUQG-UHFFFAOYSA-N,277.263,Q06203,BE0000374,Amidophosphoribosyltransferase,Humans,inhibitor,yes
DB00995,Auranofin,small molecule,approved;investigational,CCP(CC)(CC)=[Au]S[C@@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O,AUJRCFUBUPVWSZ-XTZHGVARSA-M,678.484,P11474,BE0003722,Steroid hormone receptor ERR1,Humans,modulator,yes
DB00995,Auranofin,small molecule,approved;investigational,CCP(CC)(CC)=[Au]S[C@@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O,AUJRCFUBUPVWSZ-XTZHGVARSA-M,678.484,O95718,BE0005001,Steroid hormone receptor ERR2,Humans,modulator,yes
DB00995,Auranofin,small molecule,approved;investigational,CCP(CC)(CC)=[Au]S[C@@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O,AUJRCFUBUPVWSZ-XTZHGVARSA-M,678.484,P62508,BE0002088,Estrogen-related receptor gamma,Humans,modulator,yes
DB00995,Auranofin,small molecule,approved;investigational,CCP(CC)(CC)=[Au]S[C@@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O,AUJRCFUBUPVWSZ-XTZHGVARSA-M,678.484,P30044,BE0000907,"Peroxiredoxin-5, mitochondrial",Humans,inhibitor,yes
DB00995,Auranofin,small molecule,approved;investigational,CCP(CC)(CC)=[Au]S[C@@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O,AUJRCFUBUPVWSZ-XTZHGVARSA-M,678.484,O14920,BE0001154,Inhibitor of nuclear factor kappa-B kinase subunit beta,Humans,inhibitor,yes
DB00996,Gabapentin,small molecule,approved;investigational,NCC1(CC(O)=O)CCCCC1,UGJMXCAKCUNAIE-UHFFFAOYSA-N,171.2368,P54289,BE0000691,Voltage-dependent calcium channel subunit alpha-2/delta-1,Humans,inhibitor,yes
DB00996,Gabapentin,small molecule,approved;investigational,NCC1(CC(O)=O)CCCCC1,UGJMXCAKCUNAIE-UHFFFAOYSA-N,171.2368,O75899,BE0002340,Gamma-aminobutyric acid type B receptor subunit 2,Humans,antagonist,yes
DB00996,Gabapentin,small molecule,approved;investigational,NCC1(CC(O)=O)CCCCC1,UGJMXCAKCUNAIE-UHFFFAOYSA-N,171.2368,Q9UBS5,BE0000217,Gamma-aminobutyric acid type B receptor subunit 1,Humans,antagonist,yes
DB00997,Doxorubicin,small molecule,approved;investigational,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O,AOJJSUZBOXZQNB-TZSSRYMLSA-N,543.5193,P11388,BE0000742,DNA topoisomerase 2-alpha,Humans,inhibitor,yes
DB00997,Doxorubicin,small molecule,approved;investigational,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O,AOJJSUZBOXZQNB-TZSSRYMLSA-N,543.5193,,BE0004796,DNA,Humans,intercalation,yes
DB00997,Doxorubicin,small molecule,approved;investigational,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O,AOJJSUZBOXZQNB-TZSSRYMLSA-N,543.5193,P11387,BE0000971,DNA topoisomerase 1,Humans,inhibitor,yes
DB00997,Doxorubicin,small molecule,approved;investigational,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O,AOJJSUZBOXZQNB-TZSSRYMLSA-N,543.5193,Q02880,BE0002425,DNA topoisomerase 2-beta,Humans,inhibitor,yes
DB00998,Frovatriptan,small molecule,approved;investigational,CN[C@@H]1CCC2=C(C1)C1=C(N2)C=CC(=C1)C(N)=O,XPSQPHWEGNHMSK-SECBINFHSA-N,243.3043,P28221,BE0000659,5-hydroxytryptamine receptor 1D,Humans,agonist,yes
DB00998,Frovatriptan,small molecule,approved;investigational,CN[C@@H]1CCC2=C(C1)C1=C(N2)C=CC(=C1)C(N)=O,XPSQPHWEGNHMSK-SECBINFHSA-N,243.3043,P28222,BE0000797,5-hydroxytryptamine receptor 1B,Humans,agonist,yes
DB00999,Hydrochlorothiazide,small molecule,approved;vet_approved,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1,JZUFKLXOESDKRF-UHFFFAOYSA-N,297.739,P55017,BE0000419,Solute carrier family 12 member 3,Humans,inhibitor,yes
DB00999,Hydrochlorothiazide,small molecule,approved;vet_approved,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1,JZUFKLXOESDKRF-UHFFFAOYSA-N,297.739,P12821,BE0000221,Angiotensin-converting enzyme,Humans,modulator,yes
DB00999,Hydrochlorothiazide,small molecule,approved;vet_approved,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1,JZUFKLXOESDKRF-UHFFFAOYSA-N,297.739,Q12791,BE0000553,Calcium-activated potassium channel subunit alpha-1,Humans,inhibitor,yes
DB01000,Cyclacillin,small molecule,approved,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1(N)CCCCC1)C(O)=O,HGBLNBBNRORJKI-WCABBAIRSA-N,341.426,Q8DR59,BE0004290,Penicillin-binding protein 1A,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB01000,Cyclacillin,small molecule,approved,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1(N)CCCCC1)C(O)=O,HGBLNBBNRORJKI-WCABBAIRSA-N,341.426,Q75Y35,BE0004643,Penicillin-binding protein 3,Streptococcus pneumoniae,inhibitor,yes
DB01000,Cyclacillin,small molecule,approved,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1(N)CCCCC1)C(O)=O,HGBLNBBNRORJKI-WCABBAIRSA-N,341.426,C1KC03,BE0003577,Penicillin binding protein 2a,Staphylococcus aureus,inhibitor,yes
DB01000,Cyclacillin,small molecule,approved,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1(N)CCCCC1)C(O)=O,HGBLNBBNRORJKI-WCABBAIRSA-N,341.426,P0AEB2,BE0004840,Penicillin-binding protein,Gram positive and gram negative bacteria,inhibitor,yes
DB01001,Albuterol,small molecule,approved;vet_approved,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,NDAUXUAQIAJITI-UHFFFAOYSA-N,239.3107,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,agonist,yes
DB01002,Levobupivacaine,small molecule,approved;investigational,CCCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C,LEBVLXFERQHONN-INIZCTEOSA-N,288.4277,Q9Y5Y9,BE0000177,Sodium channel protein type 10 subunit alpha,Humans,inhibitor,yes
DB01003,Cromoglicic acid,small molecule,approved,OC(COC1=CC=CC2=C1C(=O)C=C(O2)C(O)=O)COC1=CC=CC2=C1C(=O)C=C(O2)C(O)=O,IMZMKUWMOSJXDT-UHFFFAOYSA-N,468.3665,P07900,BE0001120,Heat shock protein HSP 90-alpha,Humans,inhibitor,yes
DB01004,Ganciclovir,small molecule,approved;investigational,NC1=NC2=C(N=CN2COC(CO)CO)C(=O)N1,IRSCQMHQWWYFCW-UHFFFAOYSA-N,255.2306,P04293,BE0000308,DNA polymerase catalytic subunit,HHV-1,inhibitor,yes
DB01004,Ganciclovir,small molecule,approved;investigational,NC1=NC2=C(N=CN2COC(CO)CO)C(=O)N1,IRSCQMHQWWYFCW-UHFFFAOYSA-N,255.2306,,BE0004796,DNA,Humans,incorporation into and destabilization,yes
DB01004,Ganciclovir,small molecule,approved;investigational,NC1=NC2=C(N=CN2COC(CO)CO)C(=O)N1,IRSCQMHQWWYFCW-UHFFFAOYSA-N,255.2306,Q9QNF7,BE0000458,Thymidine kinase,HHV-1,substrate,yes
DB01006,Letrozole,small molecule,approved;investigational,N#CC1=CC=C(C=C1)C(N1C=NC=N1)C1=CC=C(C=C1)C#N,HPJKCIUCZWXJDR-UHFFFAOYSA-N,285.3027,P11511,BE0002090,Aromatase,Humans,antagonist,yes
DB01007,Tioconazole,small molecule,approved,ClC1=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=CS1,QXHHHPZILQDDPS-UHFFFAOYSA-N,387.711,P10613,BE0000233,Lanosterol 14-alpha demethylase,Yeast,antagonist,yes
DB01008,Busulfan,small molecule,approved;investigational,CS(=O)(=O)OCCCCOS(C)(=O)=O,COVZYZSDYWQREU-UHFFFAOYSA-N,246.302,,BE0004796,DNA,Humans,cross-linking/alkylation,yes
DB01009,Ketoprofen,small molecule,approved;vet_approved,CC(C(O)=O)C1=CC(=CC=C1)C(=O)C1=CC=CC=C1,DKYWVDODHFEZIM-UHFFFAOYSA-N,254.2806,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB01010,Edrophonium,small molecule,approved,CC[N+](C)(C)C1=CC(O)=CC=C1,VWLHWLSRQJQWRG-UHFFFAOYSA-O,166.2401,P06276,BE0002180,Cholinesterase,Humans,inhibitor,yes
DB01010,Edrophonium,small molecule,approved,CC[N+](C)(C)C1=CC(O)=CC=C1,VWLHWLSRQJQWRG-UHFFFAOYSA-O,166.2401,P22303,BE0000426,Acetylcholinesterase,Humans,inhibitor,yes
DB01011,Metyrapone,small molecule,approved;investigational,CC(C)(C(=O)C1=CN=CC=C1)C1=CC=CN=C1,FJLBFSROUSIWMA-UHFFFAOYSA-N,226.2738,P15538,BE0000731,"Cytochrome P450 11B1, mitochondrial",Humans,inhibitor,yes
DB01012,Cinacalcet,small molecule,approved,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12,VDHAWDNDOKGFTD-MRXNPFEDSA-N,357.412,P41180,BE0000509,Extracellular calcium-sensing receptor,Humans,agonist,yes
DB01013,Clobetasol propionate,small molecule,approved,[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,CBGUOGMQLZIXBE-XGQKBEPLSA-N,466.97,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB01014,Balsalazide,small molecule,approved;investigational,OC(=O)CCNC(=O)C1=CC=C(C=C1)\N=N\C1=CC=C(O)C(=C1)C(O)=O,IPOKCKJONYRRHP-FMQUCBEESA-N,357.3175,P37231,BE0000215,Peroxisome proliferator-activated receptor gamma,Humans,agonist,yes
DB01014,Balsalazide,small molecule,approved;investigational,OC(=O)CCNC(=O)C1=CC=C(C=C1)\N=N\C1=CC=C(O)C(=C1)C(O)=O,IPOKCKJONYRRHP-FMQUCBEESA-N,357.3175,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB01014,Balsalazide,small molecule,approved;investigational,OC(=O)CCNC(=O)C1=CC=C(C=C1)\N=N\C1=CC=C(O)C(=C1)C(O)=O,IPOKCKJONYRRHP-FMQUCBEESA-N,357.3175,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB01014,Balsalazide,small molecule,approved;investigational,OC(=O)CCNC(=O)C1=CC=C(C=C1)\N=N\C1=CC=C(O)C(=C1)C(O)=O,IPOKCKJONYRRHP-FMQUCBEESA-N,357.3175,P09917,BE0000248,Polyunsaturated fatty acid 5-lipoxygenase,Humans,inhibitor,yes
DB01015,Sulfamethoxazole,small molecule,approved,CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NO1,JLKIGFTWXXRPMT-UHFFFAOYSA-N,253.278,P0AC13,BE0000803,Dihydropteroate synthase,Escherichia coli (strain K12),antagonist,yes
DB01016,Glyburide,small molecule,approved,COC1=C(C=C(Cl)C=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,494.004,Q09428,BE0000207,ATP-binding cassette sub-family C member 8,Humans,modulator,yes
DB01016,Glyburide,small molecule,approved,COC1=C(C=C(Cl)C=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,494.004,Q09428,BE0008670,"Sulfonylurea receptor 1, Kir6.2",Humans,blocker,yes
DB01017,Minocycline,small molecule,approved;investigational,[H][C@@]12CC3=C(C(O)=CC=C3N(C)C)C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2,DYKFCLLONBREIL-KVUCHLLUSA-N,457.4764,P0A7X3,BE0000127,30S ribosomal protein S9,Escherichia coli (strain K12),inhibitor,yes
DB01017,Minocycline,small molecule,approved;investigational,[H][C@@]12CC3=C(C(O)=CC=C3N(C)C)C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2,DYKFCLLONBREIL-KVUCHLLUSA-N,457.4764,P0A7V8,BE0000019,30S ribosomal protein S4,Escherichia coli (strain K12),inhibitor,yes
DB01018,Guanfacine,small molecule,approved;investigational,NC(=N)NC(=O)CC1=C(Cl)C=CC=C1Cl,INJOMKTZOLKMBF-UHFFFAOYSA-N,246.093,P08913,BE0000289,Alpha-2A adrenergic receptor,Humans,agonist,yes
DB01019,Bethanechol,small molecule,approved,CC(C[N+](C)(C)C)OC(N)=O,NZUPCNDJBJXXRF-UHFFFAOYSA-O,161.2221,P20309,BE0000045,Muscarinic acetylcholine receptor M3,Humans,agonist,yes
DB01019,Bethanechol,small molecule,approved,CC(C[N+](C)(C)C)OC(N)=O,NZUPCNDJBJXXRF-UHFFFAOYSA-O,161.2221,P08912,BE0000247,Muscarinic acetylcholine receptor M5,Humans,agonist,yes
DB01020,Isosorbide mononitrate,small molecule,approved,[H][C@]12OC[C@@H](O[N+]([O-])=O)[C@@]1([H])OC[C@@H]2O,YWXYYJSYQOXTPL-SLPGGIOYSA-N,191.1388,P33402,BE0003578,Guanylate cyclase soluble subunit alpha-2,Humans,activator,yes
DB01021,Trichlormethiazide,small molecule,approved;vet_approved,NS(=O)(=O)C1=C(Cl)C=C2NC(NS(=O)(=O)C2=C1)C(Cl)Cl,LMJSLTNSBFUCMU-UHFFFAOYSA-N,380.656,P55017,BE0000419,Solute carrier family 12 member 3,Humans,inhibitor,yes
DB01021,Trichlormethiazide,small molecule,approved;vet_approved,NS(=O)(=O)C1=C(Cl)C=C2NC(NS(=O)(=O)C2=C1)C(Cl)Cl,LMJSLTNSBFUCMU-UHFFFAOYSA-N,380.656,Q13621,BE0000502,Solute carrier family 12 member 1,Humans,blocker,yes
DB01021,Trichlormethiazide,small molecule,approved;vet_approved,NS(=O)(=O)C1=C(Cl)C=C2NC(NS(=O)(=O)C2=C1)C(Cl)Cl,LMJSLTNSBFUCMU-UHFFFAOYSA-N,380.656,P05023,BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,Humans,inhibitor,yes
DB01022,Phylloquinone,small molecule,approved;investigational,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC\C(C)=C\CC1=C(C)C(=O)C2=C(C=CC=C2)C1=O,MBWXNTAXLNYFJB-NKFFZRIASA-N,450.6957,P38435,BE0000403,Vitamin K-dependent gamma-carboxylase,Humans,substrate;inducer;cofactor,yes
DB01023,Felodipine,small molecule,approved;investigational,CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(Cl)C(Cl)=CC=C1)C(=O)OC,RZTAMFZIAATZDJ-UHFFFAOYSA-N,384.254,Q13936,BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,Humans,inhibitor,yes
DB01023,Felodipine,small molecule,approved;investigational,CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(Cl)C(Cl)=CC=C1)C(=O)OC,RZTAMFZIAATZDJ-UHFFFAOYSA-N,384.254,P54289,BE0000691,Voltage-dependent calcium channel subunit alpha-2/delta-1,Humans,inhibitor,yes
DB01023,Felodipine,small molecule,approved;investigational,CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(Cl)C(Cl)=CC=C1)C(=O)OC,RZTAMFZIAATZDJ-UHFFFAOYSA-N,384.254,Q08289,BE0002354,Voltage-dependent L-type calcium channel subunit beta-2,Humans,inhibitor,yes
DB01023,Felodipine,small molecule,approved;investigational,CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(Cl)C(Cl)=CC=C1)C(=O)OC,RZTAMFZIAATZDJ-UHFFFAOYSA-N,384.254,Q01668,BE0002359,Voltage-dependent L-type calcium channel subunit alpha-1D,Humans,inhibitor,yes
DB01023,Felodipine,small molecule,approved;investigational,CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(Cl)C(Cl)=CC=C1)C(=O)OC,RZTAMFZIAATZDJ-UHFFFAOYSA-N,384.254,Q13698,BE0002355,Voltage-dependent L-type calcium channel subunit alpha-1S,Humans,inhibitor,yes
DB01024,Mycophenolic acid,small molecule,approved;investigational,COC1=C(C\C=C(/C)CCC(O)=O)C(O)=C2C(=O)OCC2=C1C,HPNSFSBZBAHARI-RUDMXATFSA-N,320.3371,P12268,BE0000722,Inosine-5'-monophosphate dehydrogenase 2,Humans,inhibitor,yes
DB01024,Mycophenolic acid,small molecule,approved;investigational,COC1=C(C\C=C(/C)CCC(O)=O)C(O)=C2C(=O)OCC2=C1C,HPNSFSBZBAHARI-RUDMXATFSA-N,320.3371,P20839,BE0000761,Inosine-5'-monophosphate dehydrogenase 1,Humans,inhibitor,yes
DB01025,Amlexanox,small molecule,approved;investigational;withdrawn,CC(C)C1=CC2=C(OC3=NC(N)=C(C=C3C2=O)C(O)=O)C=C1,SGRYPYWGNKJSDL-UHFFFAOYSA-N,298.2934,P07900,BE0001120,Heat shock protein HSP 90-alpha,Humans,inhibitor,yes
DB01026,Ketoconazole,small molecule,approved;investigational,CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=CC=C(Cl)C=C2Cl)C=C1,XMAYWYJOQHXEEK-UHFFFAOYSA-N,531.431,P10613,BE0000233,Lanosterol 14-alpha demethylase,Yeast,inhibitor,yes
DB01026,Ketoconazole,small molecule,approved;investigational,CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=CC=C(Cl)C=C2Cl)C=C1,XMAYWYJOQHXEEK-UHFFFAOYSA-N,531.431,P50859,BE0000690,Lanosterol 14-alpha demethylase,,inhibitor,yes
DB01026,Ketoconazole,small molecule,approved;investigational,CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=CC=C(Cl)C=C2Cl)C=C1,XMAYWYJOQHXEEK-UHFFFAOYSA-N,531.431,P05093,BE0000344,"Steroid 17-alpha-hydroxylase/17,20 lyase",Humans,inhibitor,yes
DB01028,Methoxyflurane,small molecule,approved;investigational;vet_approved;withdrawn,COC(F)(F)C(Cl)Cl,RFKMCNOHBTXSMU-UHFFFAOYSA-N,164.966,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,agonist,yes
DB01028,Methoxyflurane,small molecule,approved;investigational;vet_approved;withdrawn,COC(F)(F)C(Cl)Cl,RFKMCNOHBTXSMU-UHFFFAOYSA-N,164.966,P42261,BE0000640,Glutamate receptor 1,Humans,antagonist,yes
DB01028,Methoxyflurane,small molecule,approved;investigational;vet_approved;withdrawn,COC(F)(F)C(Cl)Cl,RFKMCNOHBTXSMU-UHFFFAOYSA-N,164.966,P23415,BE0000433,Glycine receptor subunit alpha-1,Humans,agonist,yes
DB01028,Methoxyflurane,small molecule,approved;investigational;vet_approved;withdrawn,COC(F)(F)C(Cl)Cl,RFKMCNOHBTXSMU-UHFFFAOYSA-N,164.966,Q09470,BE0000781,Potassium voltage-gated channel subfamily A member 1,Humans,inducer,yes
DB01028,Methoxyflurane,small molecule,approved;investigational;vet_approved;withdrawn,COC(F)(F)C(Cl)Cl,RFKMCNOHBTXSMU-UHFFFAOYSA-N,164.966,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB01029,Irbesartan,small molecule,approved;investigational,CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1,YOSHYTLCDANDAN-UHFFFAOYSA-N,428.5294,P30556,BE0000062,Type-1 angiotensin II receptor,Humans,antagonist,yes
DB01030,Topotecan,small molecule,approved;investigational,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(C=CC(O)=C4CN(C)C)N=C13)C2=O,UCFGDBYHRUNTLO-QHCPKHFHSA-N,421.4458,P11387,BE0000971,DNA topoisomerase 1,Humans,inhibitor,yes
DB01030,Topotecan,small molecule,approved;investigational,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(C=CC(O)=C4CN(C)C)N=C13)C2=O,UCFGDBYHRUNTLO-QHCPKHFHSA-N,421.4458,,BE0004796,DNA,Humans,intercalation,yes
DB01031,Ethinamate,small molecule,approved;illicit;withdrawn,NC(=O)OC1(CCCCC1)C#C,GXRZIMHKGDIBEW-UHFFFAOYSA-N,167.205,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB01031,Ethinamate,small molecule,approved;illicit;withdrawn,NC(=O)OC1(CCCCC1)C#C,GXRZIMHKGDIBEW-UHFFFAOYSA-N,167.205,P00915,BE0000267,Carbonic anhydrase 1,Humans,inhibitor,yes
DB01032,Probenecid,small molecule,approved;investigational,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O,DBABZHXKTCFAPX-UHFFFAOYSA-N,285.359,Q4U2R8,BE0001066,Solute carrier family 22 member 6,Humans,inhibitor,yes
DB01032,Probenecid,small molecule,approved;investigational,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O,DBABZHXKTCFAPX-UHFFFAOYSA-N,285.359,Q9NSA0,BE0000879,Solute carrier family 22 member 11,Humans,inhibitor,yes
DB01032,Probenecid,small molecule,approved;investigational,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O,DBABZHXKTCFAPX-UHFFFAOYSA-N,285.359,Q8TCC7,BE0003645,Organic anion transporter 3,Humans,inhibitor,yes
DB01033,Mercaptopurine,small molecule,approved,S=C1N=CNC2=C1NC=N2,GLVAUDGFNGKCSF-UHFFFAOYSA-N,152.177,P00492,BE0000077,Hypoxanthine-guanine phosphoribosyltransferase,Humans,inhibitor,yes
DB01033,Mercaptopurine,small molecule,approved,S=C1N=CNC2=C1NC=N2,GLVAUDGFNGKCSF-UHFFFAOYSA-N,152.177,P20839,BE0000761,Inosine-5'-monophosphate dehydrogenase 1,Humans,inhibitor,yes
DB01034,Cerulenin,small molecule,experimental,[H][C@]1(O[C@]1([H])C(=O)CC\C=C\C\C=C\C)C(N)=O,GVEZIHKRYBHEFX-NQQPLRFYSA-N,223.272,P0A953,BE0000801,3-oxoacyl-[acyl-carrier-protein] synthase 1,Escherichia coli (strain K12),inhibitor,yes
DB01034,Cerulenin,small molecule,experimental,[H][C@]1(O[C@]1([H])C(=O)CC\C=C\C\C=C\C)C(N)=O,GVEZIHKRYBHEFX-NQQPLRFYSA-N,223.272,P0AAI5,BE0000800,3-oxoacyl-[acyl-carrier-protein] synthase 2,Escherichia coli (strain K12),inhibitor,yes
DB01034,Cerulenin,small molecule,experimental,[H][C@]1(O[C@]1([H])C(=O)CC\C=C\C\C=C\C)C(N)=O,GVEZIHKRYBHEFX-NQQPLRFYSA-N,223.272,P0A6R0,BE0000558,3-oxoacyl-[acyl-carrier-protein] synthase 3,Escherichia coli (strain K12),inhibitor,yes
DB01034,Cerulenin,small molecule,experimental,[H][C@]1(O[C@]1([H])C(=O)CC\C=C\C\C=C\C)C(N)=O,GVEZIHKRYBHEFX-NQQPLRFYSA-N,223.272,P49327,BE0000959,Fatty acid synthase,Humans,inhibitor,yes
DB01035,Procainamide,small molecule,approved,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,REQCZEXYDRLIBE-UHFFFAOYSA-N,235.3253,Q12809,BE0000090,Voltage-gated inwardly rectifying potassium channel KCNH2,Humans,inhibitor,yes
DB01035,Procainamide,small molecule,approved,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,REQCZEXYDRLIBE-UHFFFAOYSA-N,235.3253,Q14524,BE0000197,Sodium channel protein type 5 subunit alpha,Humans,inhibitor,yes
DB01036,Tolterodine,small molecule,approved;investigational,CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(O)C=CC(C)=C1)C(C)C,OOGJQPCLVADCPB-HXUWFJFHSA-N,325.4876,P20309,BE0000045,Muscarinic acetylcholine receptor M3,Humans,antagonist,yes
DB01036,Tolterodine,small molecule,approved;investigational,CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(O)C=CC(C)=C1)C(C)C,OOGJQPCLVADCPB-HXUWFJFHSA-N,325.4876,P08172,BE0000560,Muscarinic acetylcholine receptor M2,Humans,antagonist,yes
DB01036,Tolterodine,small molecule,approved;investigational,CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(O)C=CC(C)=C1)C(C)C,OOGJQPCLVADCPB-HXUWFJFHSA-N,325.4876,P08912,BE0000247,Muscarinic acetylcholine receptor M5,Humans,antagonist,yes
DB01036,Tolterodine,small molecule,approved;investigational,CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(O)C=CC(C)=C1)C(C)C,OOGJQPCLVADCPB-HXUWFJFHSA-N,325.4876,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,antagonist,yes
DB01036,Tolterodine,small molecule,approved;investigational,CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(O)C=CC(C)=C1)C(C)C,OOGJQPCLVADCPB-HXUWFJFHSA-N,325.4876,P08173,BE0000405,Muscarinic acetylcholine receptor M4,Humans,antagonist,yes
DB01037,Selegiline,small molecule,approved;investigational;vet_approved,C[C@H](CC1=CC=CC=C1)N(C)CC#C,MEZLKOACVSPNER-GFCCVEGCSA-N,187.286,P27338,BE0002196,Amine oxidase [flavin-containing] B,Humans,inhibitor,yes
DB01037,Selegiline,small molecule,approved;investigational;vet_approved,C[C@H](CC1=CC=CC=C1)N(C)CC#C,MEZLKOACVSPNER-GFCCVEGCSA-N,187.286,P25103,BE0000384,Substance-P receptor,Humans,antagonist,yes
DB01038,Carphenazine,small molecule,withdrawn,CCC(=O)C1=CC=C2SC3=C(C=CC=C3)N(CCCN3CCN(CCO)CC3)C2=C1,XZSMZRXAEFNJCU-UHFFFAOYSA-N,425.59,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB01038,Carphenazine,small molecule,withdrawn,CCC(=O)C1=CC=C2SC3=C(C=CC=C3)N(CCCN3CCN(CCO)CC3)C2=C1,XZSMZRXAEFNJCU-UHFFFAOYSA-N,425.59,P21728,BE0000020,D(1A) dopamine receptor,Humans,antagonist,yes
DB01038,Carphenazine,small molecule,withdrawn,CCC(=O)C1=CC=C2SC3=C(C=CC=C3)N(CCCN3CCN(CCO)CC3)C2=C1,XZSMZRXAEFNJCU-UHFFFAOYSA-N,425.59,P21918,BE0000145,D(1B) dopamine receptor,Humans,antagonist,yes
DB01039,Fenofibrate,small molecule,approved,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1,YMTINGFKWWXKFG-UHFFFAOYSA-N,360.831,Q07869,BE0000071,Peroxisome proliferator-activated receptor alpha,Humans,agonist,yes
DB01041,Thalidomide,small molecule,approved;investigational;withdrawn,O=C1N(C2CCC(=O)NC2=O)C(=O)C2=CC=CC=C12,UEJJHQNACJXSKW-UHFFFAOYSA-N,258.2295,P01375,BE0000704,Tumor necrosis factor,Humans,inhibitor,yes
DB01041,Thalidomide,small molecule,approved;investigational;withdrawn,O=C1N(C2CCC(=O)NC2=O)C(=O)C2=CC=CC=C12,UEJJHQNACJXSKW-UHFFFAOYSA-N,258.2295,Q96SW2,BE0004755,Protein cereblon,Humans,inhibitor,yes
DB01041,Thalidomide,small molecule,approved;investigational;withdrawn,O=C1N(C2CCC(=O)NC2=O)C(=O)C2=CC=CC=C12,UEJJHQNACJXSKW-UHFFFAOYSA-N,258.2295,,BE0004796,DNA,Humans,intercalation,yes
DB01041,Thalidomide,small molecule,approved;investigational;withdrawn,O=C1N(C2CCC(=O)NC2=O)C(=O)C2=CC=CC=C12,UEJJHQNACJXSKW-UHFFFAOYSA-N,258.2295,P02763,BE0004879,alpha1-acid glycoprotein,Humans,binder,yes
DB01042,Melphalan,small molecule,approved,N[C@@H](CC1=CC=C(C=C1)N(CCCl)CCCl)C(O)=O,SGDBTWWWUNNDEQ-LBPRGKRZSA-N,305.2,,BE0004796,DNA,Humans,cross-linking/alkylation,yes
DB01043,Memantine,small molecule,approved;investigational,CC12CC3CC(C)(C1)CC(N)(C3)C2,BUGYDGFZZOZRHP-UHFFFAOYSA-N,179.3018,Q05586,BE0004852,Glutamate (NMDA) receptor,Humans,antagonist,yes
DB01044,Gatifloxacin,small molecule,approved;investigational;withdrawn,COC1=C2N(C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNC(C)C1)C1CC1,XUBOMFCQGDBHNK-UHFFFAOYSA-N,375.3941,P72524,BE0003724,DNA gyrase subunit A,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4),inhibitor,yes
DB01044,Gatifloxacin,small molecule,approved;investigational;withdrawn,COC1=C2N(C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNC(C)C1)C1CC1,XUBOMFCQGDBHNK-UHFFFAOYSA-N,375.3941,P0A0K8,BE0002388,DNA gyrase subunit B,Staphylococcus aureus,modulator,yes
DB01044,Gatifloxacin,small molecule,approved;investigational;withdrawn,COC1=C2N(C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNC(C)C1)C1CC1,XUBOMFCQGDBHNK-UHFFFAOYSA-N,375.3941,P20831,BE0008385,DNA gyrase subunit A,Staphylococcus aureus,modulator,yes
DB01044,Gatifloxacin,small molecule,approved;investigational;withdrawn,COC1=C2N(C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNC(C)C1)C1CC1,XUBOMFCQGDBHNK-UHFFFAOYSA-N,375.3941,P0A4L9,BE0003725,DNA gyrase subunit B,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4),inhibitor,yes
DB01044,Gatifloxacin,small molecule,approved;investigational;withdrawn,COC1=C2N(C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNC(C)C1)C1CC1,XUBOMFCQGDBHNK-UHFFFAOYSA-N,375.3941,P72525,BE0003726,DNA topoisomerase 4 subunit A,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4),inhibitor,yes
DB01044,Gatifloxacin,small molecule,approved;investigational;withdrawn,COC1=C2N(C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNC(C)C1)C1CC1,XUBOMFCQGDBHNK-UHFFFAOYSA-N,375.3941,Q59961,BE0003727,DNA topoisomerase 4 subunit B,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4),inhibitor,yes
DB01045,Rifampin,small molecule,approved,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(O)C(\C=N\N4CCN(C)CC4)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C2C(O)=C3C,JQXXHWHPUNPDRT-WLSIYKJHSA-N,822.9402,P9WGY9,BE0010989,DNA-directed RNA polymerase subunit beta,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),inhibitor,yes
DB01046,Lubiprostone,small molecule,approved;investigational,[H][C@@]12CC(=O)[C@H](CCCCCCC(O)=O)[C@@]1([H])CC[C@@](O)(O2)C(F)(F)CCCC,WGFOBBZOWHGYQH-MXHNKVEKSA-N,390.468,P51788,BE0000765,Chloride channel protein 2,Humans,inducer,yes
DB01047,Fluocinonide,small molecule,approved;investigational,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)COC(C)=O,WJOHZNCJWYWUJD-IUGZLZTKSA-N,494.5249,P11474,BE0003722,Steroid hormone receptor ERR1,Humans,modulator,yes
DB01047,Fluocinonide,small molecule,approved;investigational,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)COC(C)=O,WJOHZNCJWYWUJD-IUGZLZTKSA-N,494.5249,O95718,BE0005001,Steroid hormone receptor ERR2,Humans,modulator,yes
DB01047,Fluocinonide,small molecule,approved;investigational,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)COC(C)=O,WJOHZNCJWYWUJD-IUGZLZTKSA-N,494.5249,P62508,BE0002088,Estrogen-related receptor gamma,Humans,modulator,yes
DB01047,Fluocinonide,small molecule,approved;investigational,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)COC(C)=O,WJOHZNCJWYWUJD-IUGZLZTKSA-N,494.5249,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB01048,Abacavir,small molecule,approved;investigational,NC1=NC2=C(N=CN2[C@@H]2C[C@H](CO)C=C2)C(NC2CC2)=N1,MCGSCOLBFJQGHM-SCZZXKLOSA-N,286.3323,Q72547,BE0004136,Reverse transcriptase/RNaseH,Human immunodeficiency virus 1,inhibitor,yes
DB01048,Abacavir,small molecule,approved;investigational,NC1=NC2=C(N=CN2[C@@H]2C[C@H](CO)C=C2)C(NC2CC2)=N1,MCGSCOLBFJQGHM-SCZZXKLOSA-N,286.3323,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB01050,Ibuprofen,small molecule,approved,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,HEFNNWSXXWATRW-UHFFFAOYSA-N,206.2808,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB01050,Ibuprofen,small molecule,approved,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,HEFNNWSXXWATRW-UHFFFAOYSA-N,206.2808,P25025,BE0010516,C-X-C chemokine receptor type 2,Humans,inhibitor,yes
DB01050,Ibuprofen,small molecule,approved,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,HEFNNWSXXWATRW-UHFFFAOYSA-N,206.2808,P10145,BE0000961,Interleukin-8,Humans,inhibitor,yes
DB01050,Ibuprofen,small molecule,approved,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,HEFNNWSXXWATRW-UHFFFAOYSA-N,206.2808,P25024,BE0003552,C-X-C chemokine receptor type 1,Humans,inhibitor,yes
DB01050,Ibuprofen,small molecule,approved,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,HEFNNWSXXWATRW-UHFFFAOYSA-N,206.2808,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB01051,Novobiocin,small molecule,approved;investigational;vet_approved;withdrawn,CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2=C(C)C3=C(C=C2)C(O)=C(NC(=O)C2=CC=C(O)C(CC=C(C)C)=C2)C(=O)O3)OC1(C)C,YJQPYGGHQPGBLI-KGSXXDOSSA-N,612.6243,P11388,BE0000742,DNA topoisomerase 2-alpha,Humans,inhibitor,yes
DB01051,Novobiocin,small molecule,approved;investigational;vet_approved;withdrawn,CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2=C(C)C3=C(C=C2)C(O)=C(NC(=O)C2=CC=C(O)C(CC=C(C)C)=C2)C(=O)O3)OC1(C)C,YJQPYGGHQPGBLI-KGSXXDOSSA-N,612.6243,Q02880,BE0002425,DNA topoisomerase 2-beta,Humans,inhibitor,yes
DB01051,Novobiocin,small molecule,approved;investigational;vet_approved;withdrawn,CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2=C(C)C3=C(C=C2)C(O)=C(NC(=O)C2=CC=C(O)C(CC=C(C)C)=C2)C(=O)O3)OC1(C)C,YJQPYGGHQPGBLI-KGSXXDOSSA-N,612.6243,P0A0K8,BE0002388,DNA gyrase subunit B,Staphylococcus aureus,inhibitor,yes
DB01053,Benzylpenicillin,small molecule,approved;vet_approved,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)CC1=CC=CC=C1)C(O)=O,JGSARLDLIJGVTE-MBNYWOFBSA-N,334.39,P0AD68,BE0002393,Peptidoglycan synthase FtsI,Escherichia coli (strain K12),binder,yes
DB01053,Benzylpenicillin,small molecule,approved;vet_approved,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)CC1=CC=CC=C1)C(O)=O,JGSARLDLIJGVTE-MBNYWOFBSA-N,334.39,P02918,BE0000588,Penicillin-binding protein 1A,Escherichia coli (strain K12),binder,yes
DB01053,Benzylpenicillin,small molecule,approved;vet_approved,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)CC1=CC=CC=C1)C(O)=O,JGSARLDLIJGVTE-MBNYWOFBSA-N,334.39,P02919,BE0000488,Penicillin-binding protein 1B,Escherichia coli (strain K12),binder,yes
DB01053,Benzylpenicillin,small molecule,approved;vet_approved,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)CC1=CC=CC=C1)C(O)=O,JGSARLDLIJGVTE-MBNYWOFBSA-N,334.39,P76577,BE0003723,Penicillin-binding protein 1C,Escherichia coli (strain K12),binder,yes
DB01054,Nitrendipine,small molecule,approved;investigational,CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC,PVHUJELLJLJGLN-UHFFFAOYSA-N,360.3612,Q13936,BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,Humans,inhibitor,yes
DB01054,Nitrendipine,small molecule,approved;investigational,CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC,PVHUJELLJLJGLN-UHFFFAOYSA-N,360.3612,P54289,BE0000691,Voltage-dependent calcium channel subunit alpha-2/delta-1,Humans,inhibitor,yes
DB01054,Nitrendipine,small molecule,approved;investigational,CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC,PVHUJELLJLJGLN-UHFFFAOYSA-N,360.3612,Q08289,BE0002354,Voltage-dependent L-type calcium channel subunit beta-2,Humans,inhibitor,yes
DB01054,Nitrendipine,small molecule,approved;investigational,CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC,PVHUJELLJLJGLN-UHFFFAOYSA-N,360.3612,Q01668,BE0002359,Voltage-dependent L-type calcium channel subunit alpha-1D,Humans,inhibitor,yes
DB01054,Nitrendipine,small molecule,approved;investigational,CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC,PVHUJELLJLJGLN-UHFFFAOYSA-N,360.3612,Q13698,BE0002355,Voltage-dependent L-type calcium channel subunit alpha-1S,Humans,inhibitor,yes
DB01055,Mimosine,small molecule,experimental,N[C@@H](CN1C=CC(=O)C(O)=C1)C(O)=O,WZNJWVWKTVETCG-YFKPBYRVSA-N,198.176,P34896,BE0000331,"Serine hydroxymethyltransferase, cytosolic",Humans,inhibitor,yes
DB01055,Mimosine,small molecule,experimental,N[C@@H](CN1C=CC(=O)C(O)=C1)C(O)=O,WZNJWVWKTVETCG-YFKPBYRVSA-N,198.176,P13500,BE0001047,C-C motif chemokine 2,Humans,inhibitor,yes
DB01056,Tocainide,small molecule,approved,CC(N)C(=O)NC1=C(C)C=CC=C1C,BUJAGSGYPOAWEI-UHFFFAOYSA-N,192.2575,Q14524,BE0000197,Sodium channel protein type 5 subunit alpha,Humans,inhibitor,yes
DB01057,Echothiophate,small molecule,approved,CCOP(=O)(OCC)SCC[N+](C)(C)C,BJOLKYGKSZKIGU-UHFFFAOYSA-N,256.323,P06276,BE0002180,Cholinesterase,Humans,inhibitor,yes
DB01057,Echothiophate,small molecule,approved,CCOP(=O)(OCC)SCC[N+](C)(C)C,BJOLKYGKSZKIGU-UHFFFAOYSA-N,256.323,P22303,BE0000426,Acetylcholinesterase,Humans,modulator,yes
DB01058,Praziquantel,small molecule,approved;investigational;vet_approved,O=C(C1CCCCC1)N1CC2N(CCC3=CC=CC=C23)C(=O)C1,FSVJFNAIGNNGKK-UHFFFAOYSA-N,312.4061,O60760,BE0001167,Hematopoietic prostaglandin D synthase,Humans,inhibitor,yes
DB01059,Norfloxacin,small molecule,approved,CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(C=C12)N1CCNCC1,OGJPXUAPXNRGGI-UHFFFAOYSA-N,319.3308,P43700,BE0000366,DNA gyrase subunit A,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd),inhibitor,yes
DB01059,Norfloxacin,small molecule,approved,CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(C=C12)N1CCNCC1,OGJPXUAPXNRGGI-UHFFFAOYSA-N,319.3308,P0A0K8,BE0002388,DNA gyrase subunit B,Staphylococcus aureus,modulator,yes
DB01059,Norfloxacin,small molecule,approved,CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(C=C12)N1CCNCC1,OGJPXUAPXNRGGI-UHFFFAOYSA-N,319.3308,P43702,BE0000429,DNA topoisomerase 4 subunit A,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd),inhibitor,yes
DB01060,Amoxicillin,small molecule,approved;vet_approved,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=C(O)C=C1)C(O)=O,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,365.404,Q8L103,BE0009851,Penicillin binding protein,Helicobacter pylori,inhibitor,yes
DB01061,Azlocillin,small molecule,approved,[H][C@](NC(=O)N1CCNC1=O)(C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@]12[H])C1=CC=CC=C1,JTWOMNBEOCYFNV-NFFDBFGFSA-N,461.492,Q8XJ01,BE0000576,Penicillin-binding protein 1A,Clostridium perfringens (strain 13 / Type A),inhibitor,yes
DB01062,Oxybutynin,small molecule,approved;investigational,CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1,XIQVNETUBQGFHX-UHFFFAOYSA-N,357.4864,P20309,BE0000045,Muscarinic acetylcholine receptor M3,Humans,antagonist,yes
DB01062,Oxybutynin,small molecule,approved;investigational,CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1,XIQVNETUBQGFHX-UHFFFAOYSA-N,357.4864,P08172,BE0000560,Muscarinic acetylcholine receptor M2,Humans,antagonist,yes
DB01062,Oxybutynin,small molecule,approved;investigational,CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1,XIQVNETUBQGFHX-UHFFFAOYSA-N,357.4864,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,antagonist,yes
DB01063,Acetophenazine,small molecule,approved,CC(=O)C1=CC=C2SC3=C(C=CC=C3)N(CCCN3CCN(CCO)CC3)C2=C1,WNTYBHLDCKXEOT-UHFFFAOYSA-N,411.56,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB01064,Isoprenaline,small molecule,approved;investigational,CC(C)NCC(O)C1=CC(O)=C(O)C=C1,JWZZKOKVBUJMES-UHFFFAOYSA-N,211.2576,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,agonist,yes
DB01064,Isoprenaline,small molecule,approved;investigational,CC(C)NCC(O)C1=CC(O)=C(O)C=C1,JWZZKOKVBUJMES-UHFFFAOYSA-N,211.2576,P29460,BE0000981,Interleukin-12 subunit beta,Humans,modulator,yes
DB01064,Isoprenaline,small molecule,approved;investigational,CC(C)NCC(O)C1=CC(O)=C(O)C=C1,JWZZKOKVBUJMES-UHFFFAOYSA-N,211.2576,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,agonist;binder,yes
DB01064,Isoprenaline,small molecule,approved;investigational,CC(C)NCC(O)C1=CC(O)=C(O)C=C1,JWZZKOKVBUJMES-UHFFFAOYSA-N,211.2576,P13945,BE0001012,Beta-3 adrenergic receptor,Humans,agonist,yes
DB01065,Melatonin,small molecule,approved;nutraceutical;vet_approved,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,DRLFMBDRBRZALE-UHFFFAOYSA-N,232.2783,P48039,BE0000515,Melatonin receptor type 1A,Humans,agonist,yes
DB01065,Melatonin,small molecule,approved;nutraceutical;vet_approved,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,DRLFMBDRBRZALE-UHFFFAOYSA-N,232.2783,P49286,BE0000327,Melatonin receptor type 1B,Humans,agonist,yes
DB01065,Melatonin,small molecule,approved;nutraceutical;vet_approved,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,DRLFMBDRBRZALE-UHFFFAOYSA-N,232.2783,P16083,BE0000220,Ribosyldihydronicotinamide dehydrogenase [quinone],Humans,inhibitor,yes
DB01066,Cefditoren,small molecule,approved;investigational,[H][C@]12SCC(\C=C/C3=C(C)N=CS3)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,KMIPKYQIOVAHOP-YLGJWRNMSA-N,506.578,P0A3M6,BE0003624,Penicillin-binding protein 2B,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB01066,Cefditoren,small molecule,approved;investigational,[H][C@]12SCC(\C=C/C3=C(C)N=CS3)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,KMIPKYQIOVAHOP-YLGJWRNMSA-N,506.578,Q8XJ01,BE0000576,Penicillin-binding protein 1A,Clostridium perfringens (strain 13 / Type A),inhibitor,yes
DB01067,Glipizide,small molecule,approved;investigational,CC1=NC=C(N=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,445.535,Q09428,BE0000207,ATP-binding cassette sub-family C member 8,Humans,inhibitor,yes
DB01067,Glipizide,small molecule,approved;investigational,CC1=NC=C(N=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,445.535,P78508,BE0009591,ATP-sensitive inward rectifier potassium channel 10,Humans,blocker,yes
DB01068,Clonazepam,small molecule,approved;illicit,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2Cl)C=C1,DGBIGWXXNGSACT-UHFFFAOYSA-N,315.711,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB01068,Clonazepam,small molecule,approved;illicit,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2Cl)C=C1,DGBIGWXXNGSACT-UHFFFAOYSA-N,315.711,P14867,BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,Humans,ligand,yes
DB01069,Promethazine,small molecule,approved;investigational,CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C,PWWVAXIEGOYWEE-UHFFFAOYSA-N,284.419,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB01070,Dihydrotachysterol,small molecule,approved,CC(C)[C@@H](C)\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1/C[C@@H](O)CC[C@@H]1C,ILYCWAKSDCYMBB-OPCMSESCSA-N,398.6642,P11473,BE0000779,Vitamin D3 receptor,Humans,agonist,yes
DB01071,Mequitazine,small molecule,experimental,C(C1CN2CCC1CC2)N1C2=CC=CC=C2SC2=CC=CC=C12,HOKDBMAJZXIPGC-UHFFFAOYSA-N,322.467,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB01072,Atazanavir,small molecule,approved;investigational,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,AXRYRYVKAWYZBR-GASGPIRDSA-N,704.8555,Q72874,BE0004854,Pol polyprotein,Human immunodeficiency virus 1,inhibitor,yes
DB01072,Atazanavir,small molecule,approved;investigational,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,AXRYRYVKAWYZBR-GASGPIRDSA-N,704.8555,P03366,BE0002050,Gag-Pol polyprotein,,modulator,yes
DB01073,Fludarabine,small molecule,approved,NC1=NC(F)=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,HBUBKKRHXORPQB-FJFJXFQQSA-N,285.235,,BE0004796,DNA,Humans,incorporation into and destabilization,yes
DB01073,Fludarabine,small molecule,approved,NC1=NC(F)=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,HBUBKKRHXORPQB-FJFJXFQQSA-N,285.235,P00813,BE0002214,Adenosine deaminase,Humans,inhibitor,yes
DB01073,Fludarabine,small molecule,approved,NC1=NC(F)=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,HBUBKKRHXORPQB-FJFJXFQQSA-N,285.235,P27707,BE0002804,Deoxycytidine kinase,Humans,agonist,yes
DB01073,Fludarabine,small molecule,approved,NC1=NC(F)=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,HBUBKKRHXORPQB-FJFJXFQQSA-N,285.235,P09884,BE0000546,DNA polymerase alpha catalytic subunit,Humans,inhibitor,yes
DB01073,Fludarabine,small molecule,approved,NC1=NC(F)=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,HBUBKKRHXORPQB-FJFJXFQQSA-N,285.235,P23921,BE0000325,Ribonucleoside-diphosphate reductase large subunit,Humans,inhibitor,yes
DB01074,Perhexiline,small molecule,approved;investigational,C(C(C1CCCCC1)C1CCCCC1)C1CCCCN1,CYXKNKQEMFBLER-UHFFFAOYSA-N,277.4879,P50416,BE0000406,"Carnitine O-palmitoyltransferase 1, liver isoform",Humans,inhibitor,yes
DB01074,Perhexiline,small molecule,approved;investigational,C(C(C1CCCCC1)C1CCCCC1)C1CCCCN1,CYXKNKQEMFBLER-UHFFFAOYSA-N,277.4879,Q92523,BE0017721,"Carnitine O-palmitoyltransferase 1, muscle isoform",Humans,inhibitor,yes
DB01074,Perhexiline,small molecule,approved;investigational,C(C(C1CCCCC1)C1CCCCC1)C1CCCCN1,CYXKNKQEMFBLER-UHFFFAOYSA-N,277.4879,P23786,BE0000179,"Carnitine O-palmitoyltransferase 2, mitochondrial",Humans,inhibitor,yes
DB01075,Diphenhydramine,small molecule,approved;investigational,CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1,ZZVUWRFHKOJYTH-UHFFFAOYSA-N,255.3547,P50135,BE0002436,Histamine N-methyltransferase,Humans,inhibitor,yes
DB01075,Diphenhydramine,small molecule,approved;investigational,CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1,ZZVUWRFHKOJYTH-UHFFFAOYSA-N,255.3547,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB01076,Atorvastatin,small molecule,approved,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C1=CC=C(F)C=C1)C1=CC=CC=C1,XUKUURHRXDUEBC-KAYWLYCHSA-N,558.6398,P04035,BE0000574,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Humans,inhibitor,yes
DB01077,Etidronic acid,small molecule,approved,CC(O)(P(O)(O)=O)P(O)(O)=O,DBVJJBKOTRCVKF-UHFFFAOYSA-N,206.0282,,BE0004801,Hydroxylapatite,Humans,antagonist,yes
DB01077,Etidronic acid,small molecule,approved,CC(O)(P(O)(O)=O)P(O)(O)=O,DBVJJBKOTRCVKF-UHFFFAOYSA-N,206.0282,Q13332,BE0003567,Receptor-type tyrosine-protein phosphatase S,Humans,inhibitor,yes
DB01078,Deslanoside,small molecule,approved,C[C@H]1O[C@H](C[C@H](O)[C@@H]1O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@H](CC[C@@H]3[C@@H]2C[C@@H](O)[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1,OBATZBGFDSVCJD-LALPQLPRSA-N,943.0791,P05023,BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,Humans,inhibitor,yes
DB01079,Tegaserod,small molecule,approved;investigational;withdrawn,CCCCCNC(=N)N\N=C\C1=CNC2=C1C=C(OC)C=C2,IKBKZGMPCYNSLU-RGVLZGJSSA-N,301.394,Q13639,BE0000084,5-hydroxytryptamine receptor 4,Humans,antagonist;partial agonist,yes
DB01080,Vigabatrin,small molecule,approved,NC(CCC(O)=O)C=C,PJDFLNIOAUIZSL-UHFFFAOYSA-N,129.157,P80404,BE0000253,"4-aminobutyrate aminotransferase, mitochondrial",Humans,inhibitor,yes
DB01081,Diphenoxylate,small molecule,approved;illicit,CCOC(=O)C1(CCN(CCC(C#N)(C2=CC=CC=C2)C2=CC=CC=C2)CC1)C1=CC=CC=C1,HYPPXZBJBPSRLK-UHFFFAOYSA-N,452.5873,P35372,BE0000770,Mu-type opioid receptor,Humans,agonist,yes
DB01082,Streptomycin,small molecule,approved;vet_approved,CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](NC(N)=N)[C@@H](O)[C@@H]2NC(N)=N)O[C@@H](C)[C@]1(O)C=O,UCSJYZPVAKXKNQ-HZYVHMACSA-N,581.5741,,BE0004799,16S ribosomal RNA,Enteric bacteria and other eubacteria,inhibitor,yes
DB01082,Streptomycin,small molecule,approved;vet_approved,CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](NC(N)=N)[C@@H](O)[C@@H]2NC(N)=N)O[C@@H](C)[C@]1(O)C=O,UCSJYZPVAKXKNQ-HZYVHMACSA-N,581.5741,,BE0004800,23S ribosomal RNA,Enteric bacteria and other eubacteria,inhibitor,yes
DB01082,Streptomycin,small molecule,approved;vet_approved,CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](NC(N)=N)[C@@H](O)[C@@H]2NC(N)=N)O[C@@H](C)[C@]1(O)C=O,UCSJYZPVAKXKNQ-HZYVHMACSA-N,581.5741,P0A7S3,BE0000279,30S ribosomal protein S12,Escherichia coli (strain K12),inhibitor,yes
DB01082,Streptomycin,small molecule,approved;vet_approved,CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](NC(N)=N)[C@@H](O)[C@@H]2NC(N)=N)O[C@@H](C)[C@]1(O)C=O,UCSJYZPVAKXKNQ-HZYVHMACSA-N,581.5741,,BE0010021,Cytoplasmic membrane,Bacteria,incorporation into and destabilization,yes
DB01082,Streptomycin,small molecule,approved;vet_approved,CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](NC(N)=N)[C@@H](O)[C@@H]2NC(N)=N)O[C@@H](C)[C@]1(O)C=O,UCSJYZPVAKXKNQ-HZYVHMACSA-N,581.5741,,BE0004833,Bacterial outer membrane,Bacteria,incorporation into and destabilization,yes
DB01083,Orlistat,small molecule,approved;investigational,CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O,AHLBNYSZXLDEJQ-FWEHEUNISA-N,495.7348,P16233,BE0000683,Pancreatic triacylglycerol lipase,Humans,inhibitor,yes
DB01083,Orlistat,small molecule,approved;investigational,CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O,AHLBNYSZXLDEJQ-FWEHEUNISA-N,495.7348,P21554,BE0000061,Cannabinoid receptor 1,Humans,inhibitor,yes
DB01083,Orlistat,small molecule,approved;investigational,CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O,AHLBNYSZXLDEJQ-FWEHEUNISA-N,495.7348,P07098,BE0003620,Gastric triacylglycerol lipase,Humans,inhibitor,yes
DB01084,Emedastine,small molecule,approved,CCOCCN1C(=NC2=CC=CC=C12)N1CCCN(C)CC1,KBUZBQVCBVDWKX-UHFFFAOYSA-N,302.4145,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB01085,Pilocarpine,small molecule,approved;investigational,CC[C@H]1[C@@H](CC2=CN=CN2C)COC1=O,QCHFTSOMWOSFHM-WPRPVWTQSA-N,208.2569,P20309,BE0000045,Muscarinic acetylcholine receptor M3,Humans,agonist,yes
DB01085,Pilocarpine,small molecule,approved;investigational,CC[C@H]1[C@@H](CC2=CN=CN2C)COC1=O,QCHFTSOMWOSFHM-WPRPVWTQSA-N,208.2569,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,agonist,yes
DB01085,Pilocarpine,small molecule,approved;investigational,CC[C@H]1[C@@H](CC2=CN=CN2C)COC1=O,QCHFTSOMWOSFHM-WPRPVWTQSA-N,208.2569,P08172,BE0000560,Muscarinic acetylcholine receptor M2,Humans,agonist,yes
DB01085,Pilocarpine,small molecule,approved;investigational,CC[C@H]1[C@@H](CC2=CN=CN2C)COC1=O,QCHFTSOMWOSFHM-WPRPVWTQSA-N,208.2569,P08912,BE0000247,Muscarinic acetylcholine receptor M5,Humans,agonist,yes
DB01086,Benzocaine,small molecule,approved;investigational,CCOC(=O)C1=CC=C(N)C=C1,BLFLLBZGZJTVJG-UHFFFAOYSA-N,165.1891,Q9Y5Y9,BE0000177,Sodium channel protein type 10 subunit alpha,Humans,inhibitor,yes
DB01087,Primaquine,small molecule,approved,COC1=CC(NC(C)CCCN)=C2N=CC=CC2=C1,INDBQLZJXZLFIT-UHFFFAOYSA-N,259.3467,,BE0004805,Fe(II)-protoporphyrin IX,Plasmodium falciparum,antagonist,yes
DB01088,Iloprost,small molecule,approved;investigational,[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)C(C)CC#CC)[C@@]1([H])C\C(C2)=C\CCCC(O)=O,HIFJCPQKFCZDDL-ACWOEMLNSA-N,360.494,P43119,BE0000475,Prostacyclin receptor,Humans,agonist,yes
DB01088,Iloprost,small molecule,approved;investigational,[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)C(C)CC#CC)[C@@]1([H])C\C(C2)=C\CCCC(O)=O,HIFJCPQKFCZDDL-ACWOEMLNSA-N,360.494,P43116,BE0000368,Prostaglandin E2 receptor EP2 subtype,Humans,agonist,yes
DB01088,Iloprost,small molecule,approved;investigational,[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)C(C)CC#CC)[C@@]1([H])C\C(C2)=C\CCCC(O)=O,HIFJCPQKFCZDDL-ACWOEMLNSA-N,360.494,P34995,BE0000064,Prostaglandin E2 receptor EP1 subtype,Humans,agonist,yes
DB01089,Deserpidine,small molecule,approved,[H][C@]12C[C@@H](OC(=O)C3=CC(OC)=C(OC)C(OC)=C3)[C@H](OC)[C@@H](C(=O)OC)[C@@]1([H])C[C@@]1([H])N(CCC3=C1NC1=CC=CC=C31)C2,CVBMAZKKCSYWQR-WCGOZPBSSA-N,578.6527,Q05940,BE0000118,Synaptic vesicular amine transporter,Humans,inhibitor,yes
DB01089,Deserpidine,small molecule,approved,[H][C@]12C[C@@H](OC(=O)C3=CC(OC)=C(OC)C(OC)=C3)[C@H](OC)[C@@H](C(=O)OC)[C@@]1([H])C[C@@]1([H])N(CCC3=C1NC1=CC=CC=C31)C2,CVBMAZKKCSYWQR-WCGOZPBSSA-N,578.6527,P12821,BE0000221,Angiotensin-converting enzyme,Humans,inhibitor,yes
DB01090,Pentolinium,small molecule,approved,C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1,XSBSKEQEUFOSDD-UHFFFAOYSA-N,240.428,P43681,BE0000849,Neuronal acetylcholine receptor subunit alpha-4,Humans,antagonist,yes
DB01090,Pentolinium,small molecule,approved,C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1,XSBSKEQEUFOSDD-UHFFFAOYSA-N,240.428,P32297,BE0003585,Neuronal acetylcholine receptor subunit alpha-3,Humans,antagonist,yes
DB01090,Pentolinium,small molecule,approved,C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1,XSBSKEQEUFOSDD-UHFFFAOYSA-N,240.428,P30926,BE0003584,Neuronal acetylcholine receptor subunit beta-4,Humans,antagonist,yes
DB01090,Pentolinium,small molecule,approved,C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1,XSBSKEQEUFOSDD-UHFFFAOYSA-N,240.428,Q9GZZ6,BE0000411,Neuronal acetylcholine receptor subunit alpha-10,Humans,antagonist,yes
DB01091,Butenafine,small molecule,approved,CN(CC1=CC=C(C=C1)C(C)(C)C)CC1=CC=CC2=CC=CC=C12,ABJKWBDEJIDSJZ-UHFFFAOYSA-N,317.4672,Q14534,BE0000577,Squalene monooxygenase,Humans,inhibitor,yes
DB01091,Butenafine,small molecule,approved,CN(CC1=CC=C(C=C1)C(C)(C)C)CC1=CC=CC2=CC=CC=C12,ABJKWBDEJIDSJZ-UHFFFAOYSA-N,317.4672,Q92206,BE0004670,Squalene monooxygenase,Yeast,modulator,yes
DB01092,Ouabain,small molecule,approved,[H][C@@]12CC[C@]3(O)C[C@H](C[C@@H](O)[C@]3(CO)[C@@]1([H])[C@H](O)C[C@]1(C)[C@H](CC[C@]21O)C1=CC(=O)OC1)O[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O,LPMXVESGRSUGHW-HBYQJFLCSA-N,584.6525,P05023,BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,Humans,inhibitor,yes
DB01094,Hesperetin,small molecule,experimental,COC1=C(O)C=C(C=C1)[C@@H]1CC(=O)C2=C(O)C=C(O)C=C2O1,AIONOLUJZLIMTK-AWEZNQCLSA-N,302.2788,O75907,BE0012021,Diacylglycerol O-acyltransferase 1,Humans,inhibitor,yes
DB01094,Hesperetin,small molecule,experimental,COC1=C(O)C=C(C=C1)[C@@H]1CC(=O)C2=C(O)C=C(O)C=C2O1,AIONOLUJZLIMTK-AWEZNQCLSA-N,302.2788,P55157,BE0000232,Microsomal triglyceride transfer protein large subunit,Humans,antagonist,yes
DB01094,Hesperetin,small molecule,experimental,COC1=C(O)C=C(C=C1)[C@@H]1CC(=O)C2=C(O)C=C(O)C=C2O1,AIONOLUJZLIMTK-AWEZNQCLSA-N,302.2788,P35610,BE0000105,Sterol O-acyltransferase 1,Humans,inhibitor,yes
DB01095,Fluvastatin,small molecule,approved,CC(C)N1C(\C=C\C(O)CC(O)CC(O)=O)=C(C2=CC=CC=C12)C1=CC=C(F)C=C1,FJLGEFLZQAZZCD-VAWYXSNFSA-N,411.473,P04035,BE0000574,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Humans,inhibitor,yes
DB01097,Leflunomide,small molecule,approved;investigational,CC1=C(C=NO1)C(=O)NC1=CC=C(C=C1)C(F)(F)F,VHOGYURTWQBHIL-UHFFFAOYSA-N,270.2073,Q02127,BE0000382,"Dihydroorotate dehydrogenase (quinone), mitochondrial",Humans,inhibitor,yes
DB01097,Leflunomide,small molecule,approved;investigational,CC1=C(C=NO1)C(=O)NC1=CC=C(C=C1)C(F)(F)F,VHOGYURTWQBHIL-UHFFFAOYSA-N,270.2073,Q08210,BE0000612,"Dihydroorotate dehydrogenase (quinone), mitochondrial",Plasmodium falciparum (isolate 3D7),inhibitor,yes
DB01098,Rosuvastatin,small molecule,approved,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(=O)O)N(C)S(C)(=O)=O,BPRHUIZQVSMCRT-VEUZHWNKSA-N,481.538,P04035,BE0000574,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Humans,inhibitor,yes
DB01099,Flucytosine,small molecule,approved;investigational,NC1=C(F)C=NC(=O)N1,XRECTZIEBJDKEO-UHFFFAOYSA-N,129.0925,,BE0004796,DNA,Humans,cross-linking/alkylation,yes
DB01099,Flucytosine,small molecule,approved;investigational,NC1=C(F)C=NC(=O)N1,XRECTZIEBJDKEO-UHFFFAOYSA-N,129.0925,P12461,BE0000021,Thymidylate synthase,Yeast,inhibitor,yes
DB01100,Pimozide,small molecule,approved,FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=CC=CC=C12)C1=CC=C(F)C=C1,YVUQSNJEYSNKRX-UHFFFAOYSA-N,461.5462,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB01100,Pimozide,small molecule,approved,FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=CC=CC=C12)C1=CC=C(F)C=C1,YVUQSNJEYSNKRX-UHFFFAOYSA-N,461.5462,P35462,BE0000581,D(3) dopamine receptor,Humans,antagonist,yes
DB01100,Pimozide,small molecule,approved,FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=CC=CC=C12)C1=CC=C(F)C=C1,YVUQSNJEYSNKRX-UHFFFAOYSA-N,461.5462,Q12809,BE0000090,Voltage-gated inwardly rectifying potassium channel KCNH2,Humans,inhibitor,yes
DB01101,Capecitabine,small molecule,approved;investigational,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O,GAGWJHPBXLXJQN-UORFTKCHSA-N,359.3501,P12461,BE0000021,Thymidylate synthase,Yeast,inhibitor,yes
DB01101,Capecitabine,small molecule,approved;investigational,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O,GAGWJHPBXLXJQN-UORFTKCHSA-N,359.3501,,BE0004796,DNA,Humans,incorporation into and destabilization;inhibition of synthesis,yes
DB01101,Capecitabine,small molecule,approved;investigational,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O,GAGWJHPBXLXJQN-UORFTKCHSA-N,359.3501,,BE0004810,RNA,Humans,incorporation into and destabilization,yes
DB01101,Capecitabine,small molecule,approved;investigational,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O,GAGWJHPBXLXJQN-UORFTKCHSA-N,359.3501,P04818,BE0000324,Thymidylate synthase,Humans,inhibitor,yes
DB01102,Arbutamine,small molecule,approved,O[C@@H](CNCCCCC1=CC=C(O)C=C1)C1=CC(O)=C(O)C=C1,IIRWWTKISYTTBL-SFHVURJKSA-N,317.3795,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,agonist,yes
DB01103,Quinacrine,small molecule,investigational,CCN(CC)CCCC(C)NC1=C2C=C(OC)C=CC2=NC2=C1C=CC(Cl)=C2,GPKJTRJOBQGKQK-UHFFFAOYSA-N,399.957,,BE0004796,DNA,Humans,intercalation,yes
DB01103,Quinacrine,small molecule,investigational,CCN(CC)CCCC(C)NC1=C2C=C(OC)C=CC2=NC2=C1C=CC(Cl)=C2,GPKJTRJOBQGKQK-UHFFFAOYSA-N,399.957,P04054,BE0003997,Phospholipase A2,Humans,inhibitor,yes
DB01103,Quinacrine,small molecule,investigational,CCN(CC)CCCC(C)NC1=C2C=C(OC)C=CC2=NC2=C1C=CC(Cl)=C2,GPKJTRJOBQGKQK-UHFFFAOYSA-N,399.957,O60733,BE0001077,85/88 kDa calcium-independent phospholipase A2,Humans,inhibitor,yes
DB01103,Quinacrine,small molecule,investigational,CCN(CC)CCCC(C)NC1=C2C=C(OC)C=CC2=NC2=C1C=CC(Cl)=C2,GPKJTRJOBQGKQK-UHFFFAOYSA-N,399.957,P47712,BE0000657,Cytosolic phospholipase A2,Humans,inhibitor,yes
DB01103,Quinacrine,small molecule,investigational,CCN(CC)CCCC(C)NC1=C2C=C(OC)C=CC2=NC2=C1C=CC(Cl)=C2,GPKJTRJOBQGKQK-UHFFFAOYSA-N,399.957,Q15111,BE0001081,Inactive phospholipase C-like protein 1,Humans,inhibitor,yes
DB01104,Sertraline,small molecule,approved,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,VGKDLMBJGBXTGI-SJCJKPOMSA-N,306.23,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor;binder;downregulator,yes
DB01105,Sibutramine,small molecule,approved;illicit;investigational;withdrawn,CC(C)CC(N(C)C)C1(CCC1)C1=CC=C(Cl)C=C1,UNAANXDKBXWMLN-UHFFFAOYSA-N,279.848,Q01959,BE0000647,Sodium-dependent dopamine transporter,Humans,inhibitor,yes
DB01105,Sibutramine,small molecule,approved;illicit;investigational;withdrawn,CC(C)CC(N(C)C)C1(CCC1)C1=CC=C(Cl)C=C1,UNAANXDKBXWMLN-UHFFFAOYSA-N,279.848,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB01105,Sibutramine,small molecule,approved;illicit;investigational;withdrawn,CC(C)CC(N(C)C)C1(CCC1)C1=CC=C(Cl)C=C1,UNAANXDKBXWMLN-UHFFFAOYSA-N,279.848,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,inhibitor,yes
DB01106,Levocabastine,small molecule,approved;investigational,C[C@@H]1CN(CC[C@]1(C(O)=O)C1=CC=CC=C1)[C@H]1CC[C@](CC1)(C#N)C1=CC=C(F)C=C1,ZCGOMHNNNFPNMX-KYTRFIICSA-N,420.528,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB01106,Levocabastine,small molecule,approved;investigational,C[C@@H]1CN(CC[C@]1(C(O)=O)C1=CC=CC=C1)[C@H]1CC[C@](CC1)(C#N)C1=CC=C(F)C=C1,ZCGOMHNNNFPNMX-KYTRFIICSA-N,420.528,O95665,BE0000464,Neurotensin receptor type 2,Humans,partial antagonist,yes
DB01107,Methyprylon,small molecule,approved;illicit;withdrawn,CCC1(CC)C(=O)NCC(C)C1=O,SIDLZWOQUZRBRU-UHFFFAOYSA-N,183.2475,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB01107,Methyprylon,small molecule,approved;illicit;withdrawn,CCC1(CC)C(=O)NCC(C)C1=O,SIDLZWOQUZRBRU-UHFFFAOYSA-N,183.2475,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,agonist,yes
DB01108,Trilostane,small molecule,approved;investigational;vet_approved;withdrawn,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]23O[C@@H]2C(O)=C(C[C@]13C)C#N,KVJXBPDAXMEYOA-CXANFOAXSA-N,329.4333,P14060,BE0000051,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,Humans,inhibitor,yes
DB01108,Trilostane,small molecule,approved;investigational;vet_approved;withdrawn,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]23O[C@@H]2C(O)=C(C[C@]13C)C#N,KVJXBPDAXMEYOA-CXANFOAXSA-N,329.4333,P26439,BE0000059,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2,Humans,inhibitor,yes
DB01108,Trilostane,small molecule,approved;investigational;vet_approved;withdrawn,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]23O[C@@H]2C(O)=C(C[C@]13C)C#N,KVJXBPDAXMEYOA-CXANFOAXSA-N,329.4333,P03372,BE0000123,Estrogen receptor,Humans,allosteric modulator,yes
DB01108,Trilostane,small molecule,approved;investigational;vet_approved;withdrawn,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]23O[C@@H]2C(O)=C(C[C@]13C)C#N,KVJXBPDAXMEYOA-CXANFOAXSA-N,329.4333,Q92731,BE0000792,Estrogen receptor beta,Humans,allosteric modulator,yes
DB01110,Miconazole,small molecule,approved;investigational;vet_approved,ClC1=CC(Cl)=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1,BYBLEWFAAKGYCD-UHFFFAOYSA-N,416.129,P10613,BE0000233,Lanosterol 14-alpha demethylase,Yeast,inhibitor,yes
DB01111,Colistimethate,small molecule,approved;vet_approved,CCC(C)CCCCC(=O)NC(CCNCS([O-])(=O)=O)C(=O)NC(C(C)O)C(=O)NC(CCNCS([O-])(=O)=O)C(=O)NC1CCNC(=O)C(NC(=O)C(CCNCS([O-])(=O)=O)NC(=O)C(CCNCS([O-])(=O)=O)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCNCS([O-])(=O)=O)NC1=O)C(C)O,BSSIRFLGSWHWDE-UHFFFAOYSA-I,1634.87,P0AC13,BE0000803,Dihydropteroate synthase,Escherichia coli (strain K12),binder,yes
DB01111,Colistimethate,small molecule,approved;vet_approved,CCC(C)CCCCC(=O)NC(CCNCS([O-])(=O)=O)C(=O)NC(C(C)O)C(=O)NC(CCNCS([O-])(=O)=O)C(=O)NC1CCNC(=O)C(NC(=O)C(CCNCS([O-])(=O)=O)NC(=O)C(CCNCS([O-])(=O)=O)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCNCS([O-])(=O)=O)NC1=O)C(C)O,BSSIRFLGSWHWDE-UHFFFAOYSA-I,1634.87,,BE0004833,Bacterial outer membrane,Bacteria,incorporation into and destabilization,yes
DB01112,Cefuroxime,small molecule,approved,[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CC=CO1)C(O)=O,JFPVXVDWJQMJEE-IZRZKJBUSA-N,424.385,Q8XJ01,BE0000576,Penicillin-binding protein 1A,Clostridium perfringens (strain 13 / Type A),inhibitor,yes
DB01113,Papaverine,small molecule,approved;investigational,COC1=C(OC)C=C(CC2=NC=CC3=CC(OC)=C(OC)C=C23)C=C1,XQYZDYMELSJDRZ-UHFFFAOYSA-N,339.385,Q08499,BE0001287,"3',5'-cyclic-AMP phosphodiesterase 4D",Humans,inhibitor,yes
DB01113,Papaverine,small molecule,approved;investigational,COC1=C(OC)C=C(CC2=NC=CC3=CC(OC)=C(OC)C=C23)C=C1,XQYZDYMELSJDRZ-UHFFFAOYSA-N,339.385,O76074,BE0000182,"cGMP-specific 3',5'-cyclic phosphodiesterase",Humans,inhibitor,yes
DB01113,Papaverine,small molecule,approved;investigational,COC1=C(OC)C=C(CC2=NC=CC3=CC(OC)=C(OC)C=C23)C=C1,XQYZDYMELSJDRZ-UHFFFAOYSA-N,339.385,Q07343,BE0000487,"3',5'-cyclic-AMP phosphodiesterase 4B",Humans,inhibitor,yes
DB01114,Chlorpheniramine,small molecule,approved,CN(C)CCC(C1=CC=C(Cl)C=C1)C1=CC=CC=N1,SOYKEARSMXGVTM-UHFFFAOYSA-N,274.788,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB01115,Nifedipine,small molecule,approved,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OC,HYIMSNHJOBLJNT-UHFFFAOYSA-N,346.3346,Q13936,BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,Humans,inhibitor,yes
DB01115,Nifedipine,small molecule,approved,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OC,HYIMSNHJOBLJNT-UHFFFAOYSA-N,346.3346,Q01668,BE0002359,Voltage-dependent L-type calcium channel subunit alpha-1D,Humans,inhibitor,yes
DB01115,Nifedipine,small molecule,approved,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OC,HYIMSNHJOBLJNT-UHFFFAOYSA-N,346.3346,Q08289,BE0002354,Voltage-dependent L-type calcium channel subunit beta-2,Humans,inhibitor,yes
DB01116,Trimethaphan,small molecule,approved;investigational,O=C1N(CC2=CC=CC=C2)C2C[S+]3CCCC3C2N1CC1=CC=CC=C1,CHQOEHPMXSHGCL-UHFFFAOYSA-N,365.512,P43681,BE0000849,Neuronal acetylcholine receptor subunit alpha-4,Humans,antagonist,yes
DB01116,Trimethaphan,small molecule,approved;investigational,O=C1N(CC2=CC=CC=C2)C2C[S+]3CCCC3C2N1CC1=CC=CC=C1,CHQOEHPMXSHGCL-UHFFFAOYSA-N,365.512,Q9GZZ6,BE0000411,Neuronal acetylcholine receptor subunit alpha-10,Humans,antagonist,yes
DB01117,Atovaquone,small molecule,approved,OC1=C([C@H]2CC[C@@H](CC2)C2=CC=C(Cl)C=C2)C(=O)C2=CC=CC=C2C1=O,KUCQYCKVKVOKAY-CTYIDZIISA-N,366.837,Q02768,BE0004428,Cytochrome b,Plasmodium falciparum,inhibitor,yes
DB01117,Atovaquone,small molecule,approved,OC1=C([C@H]2CC[C@@H](CC2)C2=CC=C(Cl)C=C2)C(=O)C2=CC=CC=C2C1=O,KUCQYCKVKVOKAY-CTYIDZIISA-N,366.837,Q08210,BE0000612,"Dihydroorotate dehydrogenase (quinone), mitochondrial",Plasmodium falciparum (isolate 3D7),inhibitor,yes
DB01118,Amiodarone,small molecule,approved;investigational,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2,IYIKLHRQXLHMJQ-UHFFFAOYSA-N,645.3116,Q12809,BE0009629,HERG human cardiac K+ channel,Humans,inhibitor,yes
DB01118,Amiodarone,small molecule,approved;investigational,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2,IYIKLHRQXLHMJQ-UHFFFAOYSA-N,645.3116,P08588,BE0004872,Beta adrenergic receptor,Humans,inhibitor;downregulator,yes
DB01119,Diazoxide,small molecule,approved,CC1=NS(=O)(=O)C2=C(N1)C=CC(Cl)=C2,GDLBFKVLRPITMI-UHFFFAOYSA-N,230.671,Q14654,BE0000708,ATP-sensitive inward rectifier potassium channel 11,Humans,inducer,yes
DB01120,Gliclazide,small molecule,approved,[H][C@@]12CCC[C@]1([H])CN(C2)NC(=O)NS(=O)(=O)C1=CC=C(C)C=C1,BOVGTQGAOIONJV-BETUJISGSA-N,323.41,Q09428,BE0000207,ATP-binding cassette sub-family C member 8,Humans,binder,yes
DB01121,Phenacemide,small molecule,approved,NC(=O)NC(=O)CC1=CC=CC=C1,XPFRXWCVYUEORT-UHFFFAOYSA-N,178.1879,P35498,BE0000141,Sodium channel protein type 1 subunit alpha,Humans,inhibitor,yes
DB01122,Ambenonium,small molecule,approved,CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)CC1=CC=CC=C1Cl)CC1=CC=CC=C1Cl,OMHBPUNFVFNHJK-UHFFFAOYSA-P,537.565,P22303,BE0000426,Acetylcholinesterase,Humans,inhibitor,yes
DB01123,Proflavine,small molecule,approved,NC1=CC2=NC3=C(C=CC(N)=C3)C=C2C=C1,WDVSHHCDHLJJJR-UHFFFAOYSA-N,209.2465,,BE0004796,DNA,Humans,intercalation,yes
DB01124,Tolbutamide,small molecule,approved;investigational,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1,JLRGJRBPOGGCBT-UHFFFAOYSA-N,270.348,O60706,BE0000469,ATP-binding cassette sub-family C member 9,Humans,blocker,yes
DB01124,Tolbutamide,small molecule,approved;investigational,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1,JLRGJRBPOGGCBT-UHFFFAOYSA-N,270.348,Q09428,BE0000207,ATP-binding cassette sub-family C member 8,Humans,inhibitor,yes
DB01125,Anisindione,small molecule,approved,COC1=CC=C(C=C1)C1C(=O)C2=CC=CC=C2C1=O,XRCFXMGQEVUZFC-UHFFFAOYSA-N,252.2647,P38435,BE0000403,Vitamin K-dependent gamma-carboxylase,Humans,inhibitor,yes
DB01125,Anisindione,small molecule,approved,COC1=CC=C(C=C1)C1C(=O)C2=CC=CC=C2C1=O,XRCFXMGQEVUZFC-UHFFFAOYSA-N,252.2647,P00734,BE0000048,Prothrombin,Humans,modulator,yes
DB01126,Dutasteride,small molecule,approved;investigational,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])NC(=O)C=C[C@]4(C)[C@@]3([H])CC[C@]12C)C(=O)NC1=CC(=CC=C1C(F)(F)F)C(F)(F)F,JWJOTENAMICLJG-QWBYCMEYSA-N,528.5297,P18405,BE0000539,3-oxo-5-alpha-steroid 4-dehydrogenase 1,Humans,inhibitor,yes
DB01126,Dutasteride,small molecule,approved;investigational,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])NC(=O)C=C[C@]4(C)[C@@]3([H])CC[C@]12C)C(=O)NC1=CC(=CC=C1C(F)(F)F)C(F)(F)F,JWJOTENAMICLJG-QWBYCMEYSA-N,528.5297,Q9H8P0,BE0009587,Polyprenal reductase,Humans,inhibitor,yes
DB01126,Dutasteride,small molecule,approved;investigational,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])NC(=O)C=C[C@]4(C)[C@@]3([H])CC[C@]12C)C(=O)NC1=CC(=CC=C1C(F)(F)F)C(F)(F)F,JWJOTENAMICLJG-QWBYCMEYSA-N,528.5297,P31213,BE0000585,3-oxo-5-alpha-steroid 4-dehydrogenase 2,Humans,inhibitor,yes
DB01127,Econazole,small molecule,approved,ClC1=CC=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1,LEZWWPYKPKIXLL-UHFFFAOYSA-N,381.684,P10613,BE0000233,Lanosterol 14-alpha demethylase,Yeast,antagonist,yes
DB01128,Bicalutamide,small molecule,approved,CC(O)(CS(=O)(=O)C1=CC=C(F)C=C1)C(=O)NC1=CC(=C(C=C1)C#N)C(F)(F)F,LKJPYSCBVHEWIU-UHFFFAOYSA-N,430.373,P10275,BE0000132,Androgen receptor,Humans,antagonist,yes
DB01129,Rabeprazole,small molecule,approved;investigational,COCCCOC1=C(C)C(CS(=O)C2=NC3=CC=CC=C3N2)=NC=C1,YREYEVIYCVEVJK-UHFFFAOYSA-N,359.443,P20648,BE0000349,Potassium-transporting ATPase alpha chain 1,Humans,inhibitor,yes
DB01130,Prednicarbate,small molecule,approved;investigational,[H][C@@]12CC[C@](OC(=O)OCC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,FNPXMHRZILFCKX-KAJVQRHHSA-N,488.577,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB01130,Prednicarbate,small molecule,approved;investigational,[H][C@@]12CC[C@](OC(=O)OCC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,FNPXMHRZILFCKX-KAJVQRHHSA-N,488.577,O95718,BE0005001,Steroid hormone receptor ERR2,Humans,modulator,yes
DB01130,Prednicarbate,small molecule,approved;investigational,[H][C@@]12CC[C@](OC(=O)OCC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,FNPXMHRZILFCKX-KAJVQRHHSA-N,488.577,P62508,BE0002088,Estrogen-related receptor gamma,Humans,modulator,yes
DB01130,Prednicarbate,small molecule,approved;investigational,[H][C@@]12CC[C@](OC(=O)OCC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,FNPXMHRZILFCKX-KAJVQRHHSA-N,488.577,P11474,BE0003722,Steroid hormone receptor ERR1,Humans,modulator,yes
DB01131,Proguanil,small molecule,approved,CC(C)NC(=N)NC(=N)NC1=CC=C(Cl)C=C1,SSOLNOMRVKKSON-UHFFFAOYSA-N,253.731,P00374,BE0000330,Dihydrofolate reductase,Humans,inhibitor,yes
DB01131,Proguanil,small molecule,approved,CC(C)NC(=N)NC(=N)NC1=CC=C(Cl)C=C1,SSOLNOMRVKKSON-UHFFFAOYSA-N,253.731,Q9HBH1,BE0002201,"Peptide deformylase, mitochondrial",Humans,inhibitor,yes
DB01132,Pioglitazone,small molecule,approved;investigational,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,HYAFETHFCAUJAY-UHFFFAOYSA-N,356.439,P37231,BE0000215,Peroxisome proliferator-activated receptor gamma,Humans,agonist,yes
DB01133,Tiludronic acid,small molecule,approved;investigational;vet_approved,OP(O)(=O)C(SC1=CC=C(Cl)C=C1)P(O)(O)=O,DKJJVAGXPKPDRL-UHFFFAOYSA-N,318.608,,BE0004801,Hydroxylapatite,Humans,antagonist;binder,yes
DB01133,Tiludronic acid,small molecule,approved;investigational;vet_approved,OP(O)(=O)C(SC1=CC=C(Cl)C=C1)P(O)(O)=O,DKJJVAGXPKPDRL-UHFFFAOYSA-N,318.608,,BE0008669,Adenosine triphosphate (ATP),Humans,inhibitor,yes
DB01134,Desoxycorticosterone pivalate,small molecule,experimental;vet_approved,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(=O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(=O)COC(=O)C(C)(C)C,VVOIQBFMTVCINR-WWMZEODYSA-N,414.586,P08235,BE0000668,Mineralocorticoid receptor,Humans,agonist,yes
DB01135,Doxacurium,small molecule,approved,COC1=CC(CC2C3=C(OC)C(OC)=C(OC)C=C3CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCC3=CC(OC)=C(OC)C(OC)=C3C2CC2=CC(OC)=C(OC)C(OC)=C2)=CC(OC)=C1OC,GBLRQXKSCRCLBZ-UHFFFAOYSA-N,1035.2223,Q15822,BE0000738,Neuronal acetylcholine receptor subunit alpha-2,Humans,antagonist,yes
DB01136,Carvedilol,small molecule,approved;investigational,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,OGHNVEJMJSYVRP-UHFFFAOYSA-N,406.4742,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,antagonist,yes
DB01136,Carvedilol,small molecule,approved;investigational,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,OGHNVEJMJSYVRP-UHFFFAOYSA-N,406.4742,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,antagonist;potentiator,yes
DB01136,Carvedilol,small molecule,approved;investigational,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,OGHNVEJMJSYVRP-UHFFFAOYSA-N,406.4742,P35348,BE0004863,Alpha-1 adrenergic receptors,Humans,inhibitor,yes
DB01137,Levofloxacin,small molecule,approved;investigational,C[C@H]1COC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2N1CCN(C)CC1,GSDSWSVVBLHKDQ-JTQLQIEISA-N,361.3675,P43700,BE0000366,DNA gyrase subunit A,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd),inhibitor,yes
DB01137,Levofloxacin,small molecule,approved;investigational,C[C@H]1COC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2N1CCN(C)CC1,GSDSWSVVBLHKDQ-JTQLQIEISA-N,361.3675,P0A0K8,BE0002388,DNA gyrase subunit B,Staphylococcus aureus,modulator,yes
DB01137,Levofloxacin,small molecule,approved;investigational,C[C@H]1COC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2N1CCN(C)CC1,GSDSWSVVBLHKDQ-JTQLQIEISA-N,361.3675,P20831,BE0008385,DNA gyrase subunit A,Staphylococcus aureus,modulator,yes
DB01137,Levofloxacin,small molecule,approved;investigational,C[C@H]1COC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2N1CCN(C)CC1,GSDSWSVVBLHKDQ-JTQLQIEISA-N,361.3675,P43702,BE0000429,DNA topoisomerase 4 subunit A,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd),inhibitor,yes
DB01138,Sulfinpyrazone,small molecule,approved,O=C1C(CCS(=O)C2=CC=CC=C2)C(=O)N(N1C1=CC=CC=C1)C1=CC=CC=C1,MBGGBVCUIVRRBF-UHFFFAOYSA-N,404.482,Q96S37,BE0004782,Solute carrier family 22 member 12,Humans,inhibitor,yes
DB01138,Sulfinpyrazone,small molecule,approved,O=C1C(CCS(=O)C2=CC=CC=C2)C(=O)N(N1C1=CC=CC=C1)C1=CC=CC=C1,MBGGBVCUIVRRBF-UHFFFAOYSA-N,404.482,P33527,BE0000785,Multidrug resistance-associated protein 1,Humans,inhibitor,yes
DB01138,Sulfinpyrazone,small molecule,approved,O=C1C(CCS(=O)C2=CC=CC=C2)C(=O)N(N1C1=CC=CC=C1)C1=CC=CC=C1,MBGGBVCUIVRRBF-UHFFFAOYSA-N,404.482,Q92887,BE0001069,ATP-binding cassette sub-family C member 2,Humans,inhibitor,yes
DB01139,Cefapirin,small molecule,approved;vet_approved,[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)CSC1=CC=NC=C1)C(O)=O,UQLLWWBDSUHNEB-CZUORRHYSA-N,423.463,Q8XJ01,BE0000576,Penicillin-binding protein 1A,Clostridium perfringens (strain 13 / Type A),inhibitor,yes
DB01140,Cefadroxil,small molecule,approved;vet_approved;withdrawn,[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=C(O)C=C1)C(O)=O,BOEGTKLJZSQCCD-UEKVPHQBSA-N,363.388,Q75Y35,BE0004643,Penicillin-binding protein 3,Streptococcus pneumoniae,inhibitor,yes
DB01140,Cefadroxil,small molecule,approved;vet_approved;withdrawn,[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=C(O)C=C1)C(O)=O,BOEGTKLJZSQCCD-UEKVPHQBSA-N,363.388,Q8DR59,BE0004290,Penicillin-binding protein 1A,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB01140,Cefadroxil,small molecule,approved;vet_approved;withdrawn,[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=C(O)C=C1)C(O)=O,BOEGTKLJZSQCCD-UEKVPHQBSA-N,363.388,Q7CRA4,BE0004335,Penicillin-binding protein 1b,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB01140,Cefadroxil,small molecule,approved;vet_approved;withdrawn,[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=C(O)C=C1)C(O)=O,BOEGTKLJZSQCCD-UEKVPHQBSA-N,363.388,P0A3M6,BE0003624,Penicillin-binding protein 2B,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB01141,Micafungin,small molecule,approved;investigational,CCCCCOC1=CC=C(C=C1)C1=CC(=NO1)C1=CC=C(C=C1)C(=O)N[C@H]1C[C@@H](O)[C@@H](O)NC(=O)[C@@H]2[C@@H](O)[C@@H](C)CN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC1=O)[C@@H](C)O)[C@H](O)[C@@H](O)C1=CC(OS(O)(=O)=O)=C(O)C=C1)[C@H](O)CC(N)=O,PIEUQSKUWLMALL-YABMTYFHSA-N,1270.274,A2QLK4,BE0004669,"1,3-beta-glucan synthase component FKS1",Aspergillus niger (strain CBS 513.88 / FGSC A1513),inhibitor,yes
DB01141,Micafungin,small molecule,approved;investigational,CCCCCOC1=CC=C(C=C1)C1=CC(=NO1)C1=CC=C(C=C1)C(=O)N[C@H]1C[C@@H](O)[C@@H](O)NC(=O)[C@@H]2[C@@H](O)[C@@H](C)CN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC1=O)[C@@H](C)O)[C@H](O)[C@@H](O)C1=CC(OS(O)(=O)=O)=C(O)C=C1)[C@H](O)CC(N)=O,PIEUQSKUWLMALL-YABMTYFHSA-N,1270.274,P40989,BE0010066,"1,3-beta-glucan synthase component GSC2",Baker's yeast,modulator,yes
DB01142,Doxepin,small molecule,approved;investigational,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12,ODQWQRRAPPTVAG-UHFFFAOYSA-N,279.3761,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB01142,Doxepin,small molecule,approved;investigational,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12,ODQWQRRAPPTVAG-UHFFFAOYSA-N,279.3761,P25021,BE0000112,Histamine H2 receptor,Humans,antagonist,yes
DB01142,Doxepin,small molecule,approved;investigational,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12,ODQWQRRAPPTVAG-UHFFFAOYSA-N,279.3761,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,inhibitor,yes
DB01142,Doxepin,small molecule,approved;investigational,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12,ODQWQRRAPPTVAG-UHFFFAOYSA-N,279.3761,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB01143,Amifostine,small molecule,approved;investigational,NCCCNCCSP(O)(O)=O,JKOQGQFVAUAYPM-UHFFFAOYSA-N,214.223,P10696,BE0000896,"Alkaline phosphatase, germ cell type",Humans,inducer,yes
DB01144,Diclofenamide,small molecule,approved;investigational,NS(=O)(=O)C1=CC(=C(Cl)C(Cl)=C1)S(N)(=O)=O,GJQPMPFPNINLKP-UHFFFAOYSA-N,305.159,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB01144,Diclofenamide,small molecule,approved;investigational,NS(=O)(=O)C1=CC(=C(Cl)C(Cl)=C1)S(N)(=O)=O,GJQPMPFPNINLKP-UHFFFAOYSA-N,305.159,P00915,BE0000267,Carbonic anhydrase 1,Humans,inhibitor,yes
DB01144,Diclofenamide,small molecule,approved;investigational,NS(=O)(=O)C1=CC(=C(Cl)C(Cl)=C1)S(N)(=O)=O,GJQPMPFPNINLKP-UHFFFAOYSA-N,305.159,P22748,BE0000535,Carbonic anhydrase 4,Humans,inhibitor,yes
DB01144,Diclofenamide,small molecule,approved;investigational,NS(=O)(=O)C1=CC(=C(Cl)C(Cl)=C1)S(N)(=O)=O,GJQPMPFPNINLKP-UHFFFAOYSA-N,305.159,P43166,BE0003629,Carbonic anhydrase 7,Humans,inhibitor,yes
DB01145,Sulfoxone,small molecule,approved,OS(=O)CNC1=CC=C(C=C1)S(=O)(=O)C1=CC=C(NCS(O)=O)C=C1,NEDPPCHNEOMTJV-UHFFFAOYSA-N,404.482,Q27738,BE0002360,Dihydropteroate synthetase,Plasmodium falciparum,inhibitor,yes
DB01146,Diphenylpyraline,small molecule,approved;investigational,CN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1,OWQUZNMMYNAXSL-UHFFFAOYSA-N,281.392,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB01147,Cloxacillin,small molecule,approved;investigational;vet_approved,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=CC=CC=C1Cl)C(O)=O,LQOLIRLGBULYKD-JKIFEVAISA-N,435.881,P0AEB2,BE0002063,D-alanyl-D-alanine carboxypeptidase DacA,Escherichia coli (strain K12),inhibitor,yes
DB01147,Cloxacillin,small molecule,approved;investigational;vet_approved,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=CC=CC=C1Cl)C(O)=O,LQOLIRLGBULYKD-JKIFEVAISA-N,435.881,P59676,BE0001868,Penicillin-binding protein 2X,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB01147,Cloxacillin,small molecule,approved;investigational;vet_approved,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=CC=CC=C1Cl)C(O)=O,LQOLIRLGBULYKD-JKIFEVAISA-N,435.881,Q8DR59,BE0004290,Penicillin-binding protein 1A,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB01148,Flavoxate,small molecule,approved,CC1=C(OC2=C(C=CC=C2C(=O)OCCN2CCCCC2)C1=O)C1=CC=CC=C1,SPIUTQOUKAMGCX-UHFFFAOYSA-N,391.4596,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,antagonist,yes
DB01148,Flavoxate,small molecule,approved,CC1=C(OC2=C(C=CC=C2C(=O)OCCN2CCCCC2)C1=O)C1=CC=CC=C1,SPIUTQOUKAMGCX-UHFFFAOYSA-N,391.4596,P08912,BE0000247,Muscarinic acetylcholine receptor M5,Humans,antagonist,yes
DB01148,Flavoxate,small molecule,approved,CC1=C(OC2=C(C=CC=C2C(=O)OCCN2CCCCC2)C1=O)C1=CC=CC=C1,SPIUTQOUKAMGCX-UHFFFAOYSA-N,391.4596,P08172,BE0000560,Muscarinic acetylcholine receptor M2,Humans,antagonist,yes
DB01149,Nefazodone,small molecule,approved;withdrawn,CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1,VRBKIVRKKCLPHA-UHFFFAOYSA-N,470.007,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB01149,Nefazodone,small molecule,approved;withdrawn,CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1,VRBKIVRKKCLPHA-UHFFFAOYSA-N,470.007,P28335,BE0000533,5-hydroxytryptamine receptor 2C,Humans,antagonist,yes
DB01149,Nefazodone,small molecule,approved;withdrawn,CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1,VRBKIVRKKCLPHA-UHFFFAOYSA-N,470.007,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB01149,Nefazodone,small molecule,approved;withdrawn,CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1,VRBKIVRKKCLPHA-UHFFFAOYSA-N,470.007,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,antagonist,yes
DB01149,Nefazodone,small molecule,approved;withdrawn,CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1,VRBKIVRKKCLPHA-UHFFFAOYSA-N,470.007,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,inhibitor,yes
DB01150,Cefprozil,small molecule,approved,[H][C@]12SCC(C=CC)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](N)C1=CC=C(O)C=C1)C(O)=O,WDLWHQDACQUCJR-PBFPGSCMSA-N,389.426,Q04707,BE0003395,Penicillin-binding protein 1A,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4),inhibitor,yes
DB01150,Cefprozil,small molecule,approved,[H][C@]12SCC(C=CC)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](N)C1=CC=C(O)C=C1)C(O)=O,WDLWHQDACQUCJR-PBFPGSCMSA-N,389.426,P14677,BE0002392,Penicillin-binding protein 2x,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4),inhibitor,yes
DB01150,Cefprozil,small molecule,approved,[H][C@]12SCC(C=CC)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](N)C1=CC=C(O)C=C1)C(O)=O,WDLWHQDACQUCJR-PBFPGSCMSA-N,389.426,P0A3M5,BE0000142,Penicillin-binding protein 2B,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4),inhibitor,yes
DB01151,Desipramine,small molecule,approved;investigational,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,HCYAFALTSJYZDH-UHFFFAOYSA-N,266.3807,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,inhibitor,yes
DB01151,Desipramine,small molecule,approved;investigational,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,HCYAFALTSJYZDH-UHFFFAOYSA-N,266.3807,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB01151,Desipramine,small molecule,approved;investigational,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,HCYAFALTSJYZDH-UHFFFAOYSA-N,266.3807,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB01152,Candicidin,small molecule,approved;withdrawn,CC(CC(C)C1OC(=O)CC(=O)CCCC(=O)CC(O)CC(O)CC(O)CC(=O)CC(O)C(C(O)CC(OC2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\C1C)C(O)=O)C(O)CC(=O)C1=CC=C(N)C=C1,OPGSFDUODIJJGF-JBUZINEHSA-N,1109.317,,BE0004803,Ergosterol,Candida albicans,antagonist,yes
DB01153,Sertaconazole,small molecule,approved;investigational,ClC1=CC(Cl)=C(C=C1)C(CN1C=CN=C1)OCC1=CSC2=C1C=CC=C2Cl,JLGKQTAYUIMGRK-UHFFFAOYSA-N,437.77,P10613,BE0000233,Lanosterol 14-alpha demethylase,Yeast,inhibitor,yes
DB01154,Thiamylal,small molecule,approved;vet_approved,CCCC(C)C1(CC=C)C(=O)NC(=S)NC1=O,XLOMZPUITCYLMJ-UHFFFAOYSA-N,254.349,Q99928,BE0003594,Gamma-aminobutyric acid receptor subunit gamma-3,Humans,modulator,yes
DB01154,Thiamylal,small molecule,approved;vet_approved,CCCC(C)C1(CC=C)C(=O)NC(=S)NC1=O,XLOMZPUITCYLMJ-UHFFFAOYSA-N,254.349,Q15842,BE0002441,ATP-sensitive inward rectifier potassium channel 8,Humans,inhibitor,yes
DB01154,Thiamylal,small molecule,approved;vet_approved,CCCC(C)C1(CC=C)C(=O)NC(=S)NC1=O,XLOMZPUITCYLMJ-UHFFFAOYSA-N,254.349,Q14654,BE0000708,ATP-sensitive inward rectifier potassium channel 11,Humans,inhibitor,yes
DB01154,Thiamylal,small molecule,approved;vet_approved,CCCC(C)C1(CC=C)C(=O)NC(=S)NC1=O,XLOMZPUITCYLMJ-UHFFFAOYSA-N,254.349,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,agonist,yes
DB01155,Gemifloxacin,small molecule,approved;investigational,CO\N=C1/CN(CC1CN)C1=NC2=C(C=C1F)C(=O)C(=CN2C1CC1)C(O)=O,ZRCVYEYHRGVLOC-HYARGMPZSA-N,389.3809,P43700,BE0000366,DNA gyrase subunit A,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd),inhibitor,yes
DB01155,Gemifloxacin,small molecule,approved;investigational,CO\N=C1/CN(CC1CN)C1=NC2=C(C=C1F)C(=O)C(=CN2C1CC1)C(O)=O,ZRCVYEYHRGVLOC-HYARGMPZSA-N,389.3809,P0A0K8,BE0002388,DNA gyrase subunit B,Staphylococcus aureus,modulator,yes
DB01155,Gemifloxacin,small molecule,approved;investigational,CO\N=C1/CN(CC1CN)C1=NC2=C(C=C1F)C(=O)C(=CN2C1CC1)C(O)=O,ZRCVYEYHRGVLOC-HYARGMPZSA-N,389.3809,P20831,BE0008385,DNA gyrase subunit A,Staphylococcus aureus,modulator,yes
DB01155,Gemifloxacin,small molecule,approved;investigational,CO\N=C1/CN(CC1CN)C1=NC2=C(C=C1F)C(=O)C(=CN2C1CC1)C(O)=O,ZRCVYEYHRGVLOC-HYARGMPZSA-N,389.3809,P43702,BE0000429,DNA topoisomerase 4 subunit A,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd),inhibitor,yes
DB01156,Bupropion,small molecule,approved,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,SNPPWIUOZRMYNY-UHFFFAOYSA-N,239.741,Q01959,BE0000647,Sodium-dependent dopamine transporter,Humans,inhibitor,yes
DB01156,Bupropion,small molecule,approved,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,SNPPWIUOZRMYNY-UHFFFAOYSA-N,239.741,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB01156,Bupropion,small molecule,approved,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,SNPPWIUOZRMYNY-UHFFFAOYSA-N,239.741,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,inhibitor,yes
DB01157,Trimetrexate,small molecule,approved;investigational,COC1=CC(NCC2=C(C)C3=C(C=C2)N=C(N)N=C3N)=CC(OC)=C1OC,NOYPYLRCIDNJJB-UHFFFAOYSA-N,369.4176,Q9HBH1,BE0002201,"Peptide deformylase, mitochondrial",Humans,inhibitor,yes
DB01157,Trimetrexate,small molecule,approved;investigational,COC1=CC(NCC2=C(C)C3=C(C=C2)N=C(N)N=C3N)=CC(OC)=C1OC,NOYPYLRCIDNJJB-UHFFFAOYSA-N,369.4176,P00374,BE0000330,Dihydrofolate reductase,Humans,inhibitor,yes
DB01158,Bretylium,small molecule,approved,CC[N+](C)(C)CC1=CC=CC=C1Br,AAQOQKQBGPPFNS-UHFFFAOYSA-N,243.163,P05023,BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,Humans,inhibitor,yes
DB01158,Bretylium,small molecule,approved,CC[N+](C)(C)CC1=CC=CC=C1Br,AAQOQKQBGPPFNS-UHFFFAOYSA-N,243.163,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,antagonist,yes
DB01159,Halothane,small molecule,approved;vet_approved,[H]C(Cl)(Br)C(F)(F)F,BCQZXOMGPXTTIC-UHFFFAOYSA-N,197.382,O14649,BE0003582,Potassium channel subfamily K member 3,Humans,binder,yes
DB01159,Halothane,small molecule,approved;vet_approved,[H]C(Cl)(Br)C(F)(F)F,BCQZXOMGPXTTIC-UHFFFAOYSA-N,197.382,Q9NPC2,BE0003583,Potassium channel subfamily K member 9,Humans,binder,yes
DB01159,Halothane,small molecule,approved;vet_approved,[H]C(Cl)(Br)C(F)(F)F,BCQZXOMGPXTTIC-UHFFFAOYSA-N,197.382,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB01159,Halothane,small molecule,approved;vet_approved,[H]C(Cl)(Br)C(F)(F)F,BCQZXOMGPXTTIC-UHFFFAOYSA-N,197.382,P20020,BE0009972,Plasma membrane calcium-transporting ATPase,Humans,inhibitor,yes
DB01160,Dinoprost tromethamine,small molecule,approved;vet_approved,NC(CO)(CO)CO.CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O,IYGXEHDCSOYNKY-RZHHZEQLSA-N,475.616,P43088,BE0000610,Prostaglandin F2-alpha receptor,Humans,agonist,yes
DB01160,Dinoprost tromethamine,small molecule,approved;vet_approved,NC(CO)(CO)CO.CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O,IYGXEHDCSOYNKY-RZHHZEQLSA-N,475.616,P43119,BE0000475,Prostacyclin receptor,Humans,antagonist,yes
DB01161,Chloroprocaine,small molecule,approved;investigational,CCN(CC)CCOC(=O)C1=C(Cl)C=C(N)C=C1,VDANGULDQQJODZ-UHFFFAOYSA-N,270.755,P05023,BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,Humans,blocker,yes
DB01161,Chloroprocaine,small molecule,approved;investigational,CCN(CC)CCOC(=O)C1=C(Cl)C=C(N)C=C1,VDANGULDQQJODZ-UHFFFAOYSA-N,270.755,P35498,BE0009738,Voltage-gated sodium channel alpha subunit,Humans,inhibitor,yes
DB01162,Terazosin,small molecule,approved,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1CCCO1,VCKUSRYTPJJLNI-UHFFFAOYSA-N,387.4329,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,antagonist,yes
DB01162,Terazosin,small molecule,approved,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1CCCO1,VCKUSRYTPJJLNI-UHFFFAOYSA-N,387.4329,P35368,BE0000575,Alpha-1B adrenergic receptor,Humans,antagonist,yes
DB01162,Terazosin,small molecule,approved,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1CCCO1,VCKUSRYTPJJLNI-UHFFFAOYSA-N,387.4329,P25100,BE0000715,Alpha-1D adrenergic receptor,Humans,antagonist,yes
DB01162,Terazosin,small molecule,approved,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1CCCO1,VCKUSRYTPJJLNI-UHFFFAOYSA-N,387.4329,P01137,BE0000984,Transforming growth factor beta-1 proprotein,Humans,inducer,yes
DB01163,Amdinocillin,small molecule,investigational;withdrawn,[H]C(=N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@]12[H])N1CCCCCC1,BWWVAEOLVKTZFQ-ISVUSNJMSA-N,325.426,Q8DNB6,BE0004644,Penicillin-binding protein 2a,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB01163,Amdinocillin,small molecule,investigational;withdrawn,[H]C(=N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@]12[H])N1CCCCCC1,BWWVAEOLVKTZFQ-ISVUSNJMSA-N,325.426,P0AD65,BE0003579,Penicillin-binding protein 2,Escherichia coli (strain K12),inhibitor,yes
DB01163,Amdinocillin,small molecule,investigational;withdrawn,[H]C(=N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@]12[H])N1CCCCCC1,BWWVAEOLVKTZFQ-ISVUSNJMSA-N,325.426,Q75Y35,BE0004643,Penicillin-binding protein 3,Streptococcus pneumoniae,inhibitor,yes
DB01163,Amdinocillin,small molecule,investigational;withdrawn,[H]C(=N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@]12[H])N1CCCCCC1,BWWVAEOLVKTZFQ-ISVUSNJMSA-N,325.426,Q8DR59,BE0004290,Penicillin-binding protein 1A,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB01163,Amdinocillin,small molecule,investigational;withdrawn,[H]C(=N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@]12[H])N1CCCCCC1,BWWVAEOLVKTZFQ-ISVUSNJMSA-N,325.426,P0A3M6,BE0003624,Penicillin-binding protein 2B,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB01163,Amdinocillin,small molecule,investigational;withdrawn,[H]C(=N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@]12[H])N1CCCCCC1,BWWVAEOLVKTZFQ-ISVUSNJMSA-N,325.426,Q7CRA4,BE0004335,Penicillin-binding protein 1b,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB01165,Ofloxacin,small molecule,approved,CC1COC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2N1CCN(C)CC1,GSDSWSVVBLHKDQ-UHFFFAOYSA-N,361.3675,P43700,BE0000366,DNA gyrase subunit A,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd),inhibitor,yes
DB01165,Ofloxacin,small molecule,approved,CC1COC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2N1CCN(C)CC1,GSDSWSVVBLHKDQ-UHFFFAOYSA-N,361.3675,P0A0K8,BE0002388,DNA gyrase subunit B,Staphylococcus aureus,modulator,yes
DB01165,Ofloxacin,small molecule,approved,CC1COC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2N1CCN(C)CC1,GSDSWSVVBLHKDQ-UHFFFAOYSA-N,361.3675,P20831,BE0008385,DNA gyrase subunit A,Staphylococcus aureus,modulator,yes
DB01165,Ofloxacin,small molecule,approved,CC1COC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2N1CCN(C)CC1,GSDSWSVVBLHKDQ-UHFFFAOYSA-N,361.3675,P43702,BE0000429,DNA topoisomerase 4 subunit A,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd),inhibitor,yes
DB01166,Cilostazol,small molecule,approved;investigational,O=C1CCC2=C(N1)C=CC(OCCCCC1=NN=NN1C1CCCCC1)=C2,RRGUKTPIGVIEKM-UHFFFAOYSA-N,369.4607,Q14432,BE0000436,"cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A",Humans,inhibitor,yes
DB01167,Itraconazole,small molecule,approved;investigational,CCC(C)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@H]2CO[C@@](CN3C=NC=N3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1,VHVPQPYKVGDNFY-ZPGVKDDISA-N,705.633,P14263,BE0010965,Lanosterol 14-alpha demethylase,Candida tropicalis,inhibitor,yes
DB01167,Itraconazole,small molecule,approved;investigational,CCC(C)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@H]2CO[C@@](CN3C=NC=N3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1,VHVPQPYKVGDNFY-ZPGVKDDISA-N,705.633,P10613,BE0000233,Lanosterol 14-alpha demethylase,Yeast,modulator,yes
DB01168,Procarbazine,small molecule,approved;investigational,CNNCC1=CC=C(C=C1)C(=O)NC(C)C,CPTBDICYNRMXFX-UHFFFAOYSA-N,221.2988,P21397,BE0004909,Monoamine oxidase,Humans,inhibitor,yes
DB01168,Procarbazine,small molecule,approved;investigational,CNNCC1=CC=C(C=C1)C(=O)NC(C)C,CPTBDICYNRMXFX-UHFFFAOYSA-N,221.2988,,BE0004796,DNA,Humans,cross-linking/alkylation,yes
DB01170,Guanethidine,small molecule,approved,NC(N)=NCCN1CCCCCCC1,ACGDKVXYNVEAGU-UHFFFAOYSA-N,198.3085,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,inducer,yes
DB01171,Moclobemide,small molecule,approved;investigational,ClC1=CC=C(C=C1)C(=O)NCCN1CCOCC1,YHXISWVBGDMDLQ-UHFFFAOYSA-N,268.739,P21397,BE0002198,Amine oxidase [flavin-containing] A,Humans,antagonist;inhibitor,yes
DB01172,Kanamycin,small molecule,approved;investigational;vet_approved,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,SBUJHOSQTJFQJX-NOAMYHISSA-N,484.4986,P0A7S3,BE0000279,30S ribosomal protein S12,Escherichia coli (strain K12),inhibitor,yes
DB01172,Kanamycin,small molecule,approved;investigational;vet_approved,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,SBUJHOSQTJFQJX-NOAMYHISSA-N,484.4986,,BE0004799,16S ribosomal RNA,Enteric bacteria and other eubacteria,inhibitor,yes
DB01173,Orphenadrine,small molecule,approved,CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1C,QVYRGXJJSLMXQH-UHFFFAOYSA-N,269.3813,O15399,BE0000396,"Glutamate receptor ionotropic, NMDA 2D",Humans,antagonist,yes
DB01173,Orphenadrine,small molecule,approved,CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1C,QVYRGXJJSLMXQH-UHFFFAOYSA-N,269.3813,Q05586,BE0000365,"Glutamate receptor ionotropic, NMDA 1",Humans,antagonist,yes
DB01173,Orphenadrine,small molecule,approved,CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1C,QVYRGXJJSLMXQH-UHFFFAOYSA-N,269.3813,O60391,BE0000534,"Glutamate receptor ionotropic, NMDA 3B",Humans,antagonist,yes
DB01173,Orphenadrine,small molecule,approved,CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1C,QVYRGXJJSLMXQH-UHFFFAOYSA-N,269.3813,Q8TCU5,BE0000641,"Glutamate receptor ionotropic, NMDA 3A",Humans,antagonist,yes
DB01173,Orphenadrine,small molecule,approved,CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1C,QVYRGXJJSLMXQH-UHFFFAOYSA-N,269.3813,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB01173,Orphenadrine,small molecule,approved,CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1C,QVYRGXJJSLMXQH-UHFFFAOYSA-N,269.3813,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,inhibitor,yes
DB01174,Phenobarbital,small molecule,approved;investigational,CCC1(C(=O)NC(=O)NC1=O)C1=CC=CC=C1,DDBREPKUVSBGFI-UHFFFAOYSA-N,232.2353,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,potentiator,yes
DB01175,Escitalopram,small molecule,approved,CN(C)CCC[C@]1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1,WSEQXVZVJXJVFP-FQEVSTJZSA-N,324.3919,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB01176,Cyclizine,small molecule,approved,CN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1,UVKZSORBKUEBAZ-UHFFFAOYSA-N,266.3807,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB01177,Idarubicin,small molecule,approved,C[C@@H]1O[C@H](C[C@H](N)[C@@H]1O)O[C@H]1C[C@@](O)(CC2=C1C(O)=C1C(=O)C3=CC=CC=C3C(=O)C1=C2O)C(C)=O,XDXDZDZNSLXDNA-TZNDIEGXSA-N,497.4939,Q02880,BE0002425,DNA topoisomerase 2-beta,Humans,modulator,yes
DB01177,Idarubicin,small molecule,approved,C[C@@H]1O[C@H](C[C@H](N)[C@@H]1O)O[C@H]1C[C@@](O)(CC2=C1C(O)=C1C(=O)C3=CC=CC=C3C(=O)C1=C2O)C(C)=O,XDXDZDZNSLXDNA-TZNDIEGXSA-N,497.4939,,BE0004796,DNA,Humans,intercalation,yes
DB01177,Idarubicin,small molecule,approved,C[C@@H]1O[C@H](C[C@H](N)[C@@H]1O)O[C@H]1C[C@@](O)(CC2=C1C(O)=C1C(=O)C3=CC=CC=C3C(=O)C1=C2O)C(C)=O,XDXDZDZNSLXDNA-TZNDIEGXSA-N,497.4939,P11388,BE0000742,DNA topoisomerase 2-alpha,Humans,inhibitor,yes
DB01178,Chlormezanone,small molecule,approved;investigational;withdrawn,CN1C(C2=CC=C(Cl)C=C2)S(=O)(=O)CCC1=O,WEQAYVWKMWHEJO-UHFFFAOYSA-N,273.736,P30536,BE0000736,Translocator protein,Humans,agonist,yes
DB01179,Podofilox,small molecule,approved,[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(OC)C(OC)=C1)C1=CC3=C(OCO3)C=C1[C@@H]2O,YJGVMLPVUAXIQN-XVVDYKMHSA-N,414.4053,Q02880,BE0002425,DNA topoisomerase 2-beta,Humans,modulator,yes
DB01179,Podofilox,small molecule,approved,[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(OC)C(OC)=C1)C1=CC3=C(OCO3)C=C1[C@@H]2O,YJGVMLPVUAXIQN-XVVDYKMHSA-N,414.4053,P68366,BE0001391,Tubulin alpha-4A chain,Humans,inhibitor,yes
DB01179,Podofilox,small molecule,approved,[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(OC)C(OC)=C1)C1=CC3=C(OCO3)C=C1[C@@H]2O,YJGVMLPVUAXIQN-XVVDYKMHSA-N,414.4053,P07437,BE0000143,Tubulin beta chain,Humans,inhibitor,yes
DB01179,Podofilox,small molecule,approved,[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(OC)C(OC)=C1)C1=CC3=C(OCO3)C=C1[C@@H]2O,YJGVMLPVUAXIQN-XVVDYKMHSA-N,414.4053,P11388,BE0000742,DNA topoisomerase 2-alpha,Humans,inhibitor,yes
DB01180,Rescinnamine,small molecule,approved,[H][C@]12C[C@@H](OC(=O)C=CC3=CC(OC)=C(OC)C(OC)=C3)[C@H](OC)[C@@H](C(=O)OC)[C@@]1([H])C[C@@]1([H])N(CCC3=C1NC1=C3C=CC(OC)=C1)C2,SZLZWPPUNLXJEA-QEGASFHISA-N,634.716,P12821,BE0000221,Angiotensin-converting enzyme,Humans,inhibitor,yes
DB01182,Propafenone,small molecule,approved,CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1,JWHAUXFOSRPERK-UHFFFAOYSA-N,341.444,Q14524,BE0000197,Sodium channel protein type 5 subunit alpha,Humans,inhibitor,yes
DB01182,Propafenone,small molecule,approved,CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1,JWHAUXFOSRPERK-UHFFFAOYSA-N,341.444,Q12809,BE0000090,Voltage-gated inwardly rectifying potassium channel KCNH2,Humans,inhibitor,yes
DB01183,Naloxone,small molecule,approved;vet_approved,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,UZHSEJADLWPNLE-GRGSLBFTSA-N,327.3743,P35372,BE0000770,Mu-type opioid receptor,Humans,antagonist,yes
DB01183,Naloxone,small molecule,approved;vet_approved,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,UZHSEJADLWPNLE-GRGSLBFTSA-N,327.3743,P41143,BE0000420,Delta-type opioid receptor,Humans,antagonist,yes
DB01183,Naloxone,small molecule,approved;vet_approved,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O,UZHSEJADLWPNLE-GRGSLBFTSA-N,327.3743,P41145,BE0000632,Kappa-type opioid receptor,Humans,antagonist,yes
DB01184,Domperidone,small molecule,approved;investigational;vet_approved,ClC1=CC2=C(C=C1)N(C1CCN(CCCN3C(=O)NC4=CC=CC=C34)CC1)C(=O)N2,FGXWKSZFVQUSTL-UHFFFAOYSA-N,425.911,P35462,BE0000581,D(3) dopamine receptor,Humans,antagonist,yes
DB01184,Domperidone,small molecule,approved;investigational;vet_approved,ClC1=CC2=C(C=C1)N(C1CCN(CCCN3C(=O)NC4=CC=CC=C34)CC1)C(=O)N2,FGXWKSZFVQUSTL-UHFFFAOYSA-N,425.911,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB01185,Fluoxymesterone,small molecule,approved;illicit,[H][C@@]12CC[C@](C)(O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C,YLRFCQOZQXIBAB-RBZZARIASA-N,336.4409,P10275,BE0000132,Androgen receptor,Humans,agonist,yes
DB01185,Fluoxymesterone,small molecule,approved;illicit,[H][C@@]12CC[C@](C)(O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C,YLRFCQOZQXIBAB-RBZZARIASA-N,336.4409,P03372,BE0000123,Estrogen receptor,Humans,antagonist,yes
DB01186,Pergolide,small molecule,approved;investigational;vet_approved;withdrawn,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,YEHCICAEULNIGD-MZMPZRCHSA-N,314.488,P14416,BE0000756,D(2) dopamine receptor,Humans,agonist,yes
DB01186,Pergolide,small molecule,approved;investigational;vet_approved;withdrawn,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,YEHCICAEULNIGD-MZMPZRCHSA-N,314.488,P35462,BE0000581,D(3) dopamine receptor,Humans,agonist,yes
DB01186,Pergolide,small molecule,approved;investigational;vet_approved;withdrawn,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,YEHCICAEULNIGD-MZMPZRCHSA-N,314.488,P21917,BE0000389,D(4) dopamine receptor,Humans,agonist,yes
DB01186,Pergolide,small molecule,approved;investigational;vet_approved;withdrawn,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,YEHCICAEULNIGD-MZMPZRCHSA-N,314.488,P21918,BE0000145,D(1B) dopamine receptor,Humans,agonist,yes
DB01186,Pergolide,small molecule,approved;investigational;vet_approved;withdrawn,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC,YEHCICAEULNIGD-MZMPZRCHSA-N,314.488,P21728,BE0000020,D(1A) dopamine receptor,Humans,agonist,yes
DB01188,Ciclopirox,small molecule,approved;investigational,CC1=CC(=O)N(O)C(=C1)C1CCCCC1,SCKYRAXSEDYPSA-UHFFFAOYSA-N,207.2689,P05023,BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,Humans,binder,yes
DB01189,Desflurane,small molecule,approved,FC(F)OC(F)C(F)(F)F,DPYMFVXJLLWWEU-UHFFFAOYSA-N,168.0378,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB01189,Desflurane,small molecule,approved,FC(F)OC(F)C(F)(F)F,DPYMFVXJLLWWEU-UHFFFAOYSA-N,168.0378,P23415,BE0000433,Glycine receptor subunit alpha-1,Humans,agonist,yes
DB01189,Desflurane,small molecule,approved,FC(F)OC(F)C(F)(F)F,DPYMFVXJLLWWEU-UHFFFAOYSA-N,168.0378,P42261,BE0000640,Glutamate receptor 1,Humans,antagonist,yes
DB01189,Desflurane,small molecule,approved,FC(F)OC(F)C(F)(F)F,DPYMFVXJLLWWEU-UHFFFAOYSA-N,168.0378,Q09470,BE0000781,Potassium voltage-gated channel subfamily A member 1,Humans,inducer,yes
DB01189,Desflurane,small molecule,approved,FC(F)OC(F)C(F)(F)F,DPYMFVXJLLWWEU-UHFFFAOYSA-N,168.0378,P03886,BE0000503,NADH-ubiquinone oxidoreductase chain 1,Humans,inhibitor,yes
DB01189,Desflurane,small molecule,approved,FC(F)OC(F)C(F)(F)F,DPYMFVXJLLWWEU-UHFFFAOYSA-N,168.0378,P98194,BE0010002,Calcium transporting ATPases,Humans,inhibitor,yes
DB01190,Clindamycin,small molecule,approved;vet_approved,[H][C@@](NC(=O)[C@@H]1C[C@@H](CCC)CN1C)([C@H](C)Cl)[C@@]1([H])O[C@H](SC)[C@H](O)[C@@H](O)[C@H]1O,KDLRVYVGXIQJDK-AWPVFWJPSA-N,424.98,Q2G0P0,BE0009850,50S ribosomal protein L1,Staphylococcus aureus (strain NCTC 8325),inhibitor,yes
DB01191,Dexfenfluramine,small molecule,approved;illicit;investigational;withdrawn,CCN[C@@H](C)CC1=CC=CC(=C1)C(F)(F)F,DBGIVFWFUFKIQN-VIFPVBQESA-N,231.2573,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB01192,Oxymorphone,small molecule,approved;investigational;vet_approved,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,UQCNKQCJZOAFTQ-ISWURRPUSA-N,301.3371,P35372,BE0000770,Mu-type opioid receptor,Humans,agonist,yes
DB01193,Acebutolol,small molecule,approved;investigational,CCCC(=O)NC1=CC=C(OCC(O)CNC(C)C)C(=C1)C(C)=O,GOEMGAFJFRBGGG-UHFFFAOYSA-N,336.4259,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,partial agonist,yes
DB01194,Brinzolamide,small molecule,approved,CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,HCRKCZRJWPKOAR-JTQLQIEISA-N,383.507,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB01195,Flecainide,small molecule,approved;withdrawn,FC(F)(F)COC1=CC(C(=O)NCC2CCCCN2)=C(OCC(F)(F)F)C=C1,DJBNUMBKLMJRSA-UHFFFAOYSA-N,414.3427,P35499,BE0002083,Sodium channel protein type 4 subunit alpha,Humans,inhibitor,yes
DB01195,Flecainide,small molecule,approved;withdrawn,FC(F)(F)COC1=CC(C(=O)NCC2CCCCN2)=C(OCC(F)(F)F)C=C1,DJBNUMBKLMJRSA-UHFFFAOYSA-N,414.3427,Q14524,BE0000197,Sodium channel protein type 5 subunit alpha,Humans,inhibitor,yes
DB01196,Estramustine,small molecule,approved;investigational,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(OC(=O)N(CCCl)CCCl)C=C3CC[C@@]21[H],FRPJXPJMRWBBIH-RBRWEJTLSA-N,440.403,P03372,BE0000123,Estrogen receptor,Humans,agonist,yes
DB01196,Estramustine,small molecule,approved;investigational,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(OC(=O)N(CCCl)CCCl)C=C3CC[C@@]21[H],FRPJXPJMRWBBIH-RBRWEJTLSA-N,440.403,P11137,BE0001100,Microtubule-associated protein 2,Humans,antagonist,yes
DB01196,Estramustine,small molecule,approved;investigational,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(OC(=O)N(CCCl)CCCl)C=C3CC[C@@]21[H],FRPJXPJMRWBBIH-RBRWEJTLSA-N,440.403,P78559,BE0001169,Microtubule-associated protein 1A,Humans,antagonist,yes
DB01197,Captopril,small molecule,approved,C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O,FAKRSMQSSFJEIM-RQJHMYQMSA-N,217.285,P12821,BE0000221,Angiotensin-converting enzyme,Humans,inhibitor,yes
DB01198,Zopiclone,small molecule,approved,CN1CCN(CC1)C(=O)OC1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1,GBBSUAFBMRNDJC-UHFFFAOYSA-N,388.808,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,potentiator,yes
DB01198,Zopiclone,small molecule,approved,CN1CCN(CC1)C(=O)OC1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1,GBBSUAFBMRNDJC-UHFFFAOYSA-N,388.808,P47869,BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,Humans,potentiator,yes
DB01198,Zopiclone,small molecule,approved,CN1CCN(CC1)C(=O)OC1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1,GBBSUAFBMRNDJC-UHFFFAOYSA-N,388.808,P34903,BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,Humans,potentiator,yes
DB01198,Zopiclone,small molecule,approved,CN1CCN(CC1)C(=O)OC1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1,GBBSUAFBMRNDJC-UHFFFAOYSA-N,388.808,P31644,BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,Humans,potentiator,yes
DB01199,Tubocurarine,small molecule,approved,[H][C@@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC(OC6=C(OC)C=C(CCN1C)C2=C6)=C(O)C=C5)=CC(OC)=C4O)C=C3,JFJZZMVDLULRGK-URLMMPGGSA-O,609.7312,Q15822,BE0000738,Neuronal acetylcholine receptor subunit alpha-2,Humans,antagonist,yes
DB01199,Tubocurarine,small molecule,approved,[H][C@@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC(OC6=C(OC)C=C(CCN1C)C2=C6)=C(O)C=C5)=CC(OC)=C4O)C=C3,JFJZZMVDLULRGK-URLMMPGGSA-O,609.7312,P46098,BE0000311,5-hydroxytryptamine receptor 3A,Humans,antagonist,yes
DB01200,Bromocriptine,small molecule,approved;investigational;withdrawn,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C,OZVBMTJYIDMWIL-AYFBDAFISA-N,654.595,P14416,BE0000756,D(2) dopamine receptor,Humans,agonist,yes
DB01200,Bromocriptine,small molecule,approved;investigational;withdrawn,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C,OZVBMTJYIDMWIL-AYFBDAFISA-N,654.595,P35462,BE0000581,D(3) dopamine receptor,Humans,agonist,yes
DB01201,Rifapentine,small molecule,approved;investigational,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(C(O)=C3C)C(O)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(\C=N\N1CCN(CC1)C1CCCC1)=C2O,WDZCUPBHRAEYDL-GZAUEHORSA-N,877.0307,P9WGY7,BE0000186,DNA-directed RNA polymerase subunit beta',Mycobacterium tuberculosis,inhibitor,yes
DB01202,Levetiracetam,small molecule,approved,CC[C@H](N1CCCC1=O)C(N)=O,HPHUVLMMVZITSG-LURJTMIESA-N,170.212,P46098,BE0000311,5-hydroxytryptamine receptor 3A,Humans,antagonist,yes
DB01202,Levetiracetam,small molecule,approved,CC[C@H](N1CCCC1=O)C(N)=O,HPHUVLMMVZITSG-LURJTMIESA-N,170.212,Q00975,BE0002226,Voltage-dependent N-type calcium channel subunit alpha-1B,Humans,inhibitor,yes
DB01202,Levetiracetam,small molecule,approved,CC[C@H](N1CCCC1=O)C(N)=O,HPHUVLMMVZITSG-LURJTMIESA-N,170.212,Q7L0J3,BE0000993,Synaptic vesicle glycoprotein 2A,Humans,agonist,yes
DB01203,Nadolol,small molecule,approved,CC(C)(C)NCC(O)COC1=CC=CC2=C1C[C@H](O)[C@H](O)C2,VWPOSFSPZNDTMJ-UCWKZMIHSA-N,309.4006,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,antagonist,yes
DB01204,Mitoxantrone,small molecule,approved;investigational,OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C1=C(C(O)=CC=C1O)C2=O,KKZJGLLVHKMTCM-UHFFFAOYSA-N,444.4809,Q02880,BE0002425,DNA topoisomerase 2-beta,Humans,modulator,yes
DB01204,Mitoxantrone,small molecule,approved;investigational,OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C1=C(C(O)=CC=C1O)C2=O,KKZJGLLVHKMTCM-UHFFFAOYSA-N,444.4809,,BE0004796,DNA,Humans,intercalation,yes
DB01204,Mitoxantrone,small molecule,approved;investigational,OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C1=C(C(O)=CC=C1O)C2=O,KKZJGLLVHKMTCM-UHFFFAOYSA-N,444.4809,P11388,BE0000742,DNA topoisomerase 2-alpha,Humans,inhibitor,yes
DB01205,Flumazenil,small molecule,approved,CCOC(=O)C1=C2CN(C)C(=O)C3=C(C=CC(F)=C3)N2C=N1,OFBIFZUFASYYRE-UHFFFAOYSA-N,303.2884,P30536,BE0000736,Translocator protein,Humans,antagonist,yes
DB01205,Flumazenil,small molecule,approved,CCOC(=O)C1=C2CN(C)C(=O)C3=C(C=CC(F)=C3)N2C=N1,OFBIFZUFASYYRE-UHFFFAOYSA-N,303.2884,P18507,BE0003592,Gamma-aminobutyric acid receptor subunit gamma-2,Humans,antagonist,yes
DB01205,Flumazenil,small molecule,approved,CCOC(=O)C1=C2CN(C)C(=O)C3=C(C=CC(F)=C3)N2C=N1,OFBIFZUFASYYRE-UHFFFAOYSA-N,303.2884,P47869,BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,Humans,allosteric modulator,yes
DB01205,Flumazenil,small molecule,approved,CCOC(=O)C1=C2CN(C)C(=O)C3=C(C=CC(F)=C3)N2C=N1,OFBIFZUFASYYRE-UHFFFAOYSA-N,303.2884,Q99928,BE0003594,Gamma-aminobutyric acid receptor subunit gamma-3,Humans,allosteric modulator,yes
DB01205,Flumazenil,small molecule,approved,CCOC(=O)C1=C2CN(C)C(=O)C3=C(C=CC(F)=C3)N2C=N1,OFBIFZUFASYYRE-UHFFFAOYSA-N,303.2884,P34903,BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,Humans,allosteric modulator,yes
DB01205,Flumazenil,small molecule,approved,CCOC(=O)C1=C2CN(C)C(=O)C3=C(C=CC(F)=C3)N2C=N1,OFBIFZUFASYYRE-UHFFFAOYSA-N,303.2884,P31644,BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,Humans,antagonist,yes
DB01205,Flumazenil,small molecule,approved,CCOC(=O)C1=C2CN(C)C(=O)C3=C(C=CC(F)=C3)N2C=N1,OFBIFZUFASYYRE-UHFFFAOYSA-N,303.2884,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB01205,Flumazenil,small molecule,approved,CCOC(=O)C1=C2CN(C)C(=O)C3=C(C=CC(F)=C3)N2C=N1,OFBIFZUFASYYRE-UHFFFAOYSA-N,303.2884,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,antagonist,yes
DB01206,Lomustine,small molecule,approved;investigational,ClCCN(N=O)C(=O)NC1CCCCC1,GQYIWUVLTXOXAJ-UHFFFAOYSA-N,233.695,,BE0004796,DNA,Humans,cross-linking/alkylation,yes
DB01207,Ridogrel,small molecule,experimental,OC(=O)CCCCO\N=C(\C1=CN=CC=C1)C1=CC(=CC=C1)C(F)(F)F,GLLPUTYLZIKEGF-HAVVHWLPSA-N,366.3344,P24557,BE0001893,Thromboxane-A synthase,Humans,inhibitor,yes
DB01207,Ridogrel,small molecule,experimental,OC(=O)CCCCO\N=C(\C1=CN=CC=C1)C1=CC(=CC=C1)C(F)(F)F,GLLPUTYLZIKEGF-HAVVHWLPSA-N,366.3344,P21731,BE0000759,Thromboxane A2 receptor,Humans,antagonist,yes
DB01208,Sparfloxacin,small molecule,approved;investigational;withdrawn,C[C@H]1CN(C[C@@H](C)N1)C1=C(F)C(N)=C2C(=O)C(=CN(C3CC3)C2=C1F)C(O)=O,DZZWHBIBMUVIIW-DTORHVGOSA-N,392.3998,P20831,BE0008385,DNA gyrase subunit A,Staphylococcus aureus,modulator,yes
DB01208,Sparfloxacin,small molecule,approved;investigational;withdrawn,C[C@H]1CN(C[C@@H](C)N1)C1=C(F)C(N)=C2C(=O)C(=CN(C3CC3)C2=C1F)C(O)=O,DZZWHBIBMUVIIW-DTORHVGOSA-N,392.3998,P0A0K8,BE0002388,DNA gyrase subunit B,Staphylococcus aureus,modulator,yes
DB01208,Sparfloxacin,small molecule,approved;investigational;withdrawn,C[C@H]1CN(C[C@@H](C)N1)C1=C(F)C(N)=C2C(=O)C(=CN(C3CC3)C2=C1F)C(O)=O,DZZWHBIBMUVIIW-DTORHVGOSA-N,392.3998,P43700,BE0000366,DNA gyrase subunit A,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd),inhibitor,yes
DB01208,Sparfloxacin,small molecule,approved;investigational;withdrawn,C[C@H]1CN(C[C@@H](C)N1)C1=C(F)C(N)=C2C(=O)C(=CN(C3CC3)C2=C1F)C(O)=O,DZZWHBIBMUVIIW-DTORHVGOSA-N,392.3998,P43702,BE0000429,DNA topoisomerase 4 subunit A,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd),inhibitor,yes
DB01208,Sparfloxacin,small molecule,approved;investigational;withdrawn,C[C@H]1CN(C[C@@H](C)N1)C1=C(F)C(N)=C2C(=O)C(=CN(C3CC3)C2=C1F)C(O)=O,DZZWHBIBMUVIIW-DTORHVGOSA-N,392.3998,P11388,BE0000742,DNA topoisomerase 2-alpha,Humans,inhibitor,yes
DB01209,Dezocine,small molecule,approved;investigational,[H][C@@]12CC3=CC=C(O)C=C3[C@@](C)(CCCCC1)[C@H]2N,VTMVHDZWSFQSQP-VBNZEHGJSA-N,245.3599,P35372,BE0000770,Mu-type opioid receptor,Humans,agonist,yes
DB01209,Dezocine,small molecule,approved;investigational,[H][C@@]12CC3=CC=C(O)C=C3[C@@](C)(CCCCC1)[C@H]2N,VTMVHDZWSFQSQP-VBNZEHGJSA-N,245.3599,P41145,BE0000632,Kappa-type opioid receptor,Humans,antagonist,yes
DB01210,Levobunolol,small molecule,approved,CC(C)(C)NC[C@H](O)COC1=CC=CC2=C1CCCC2=O,IXHBTMCLRNMKHZ-LBPRGKRZSA-N,291.3853,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,antagonist,yes
DB01210,Levobunolol,small molecule,approved,CC(C)(C)NC[C@H](O)COC1=CC=CC2=C1CCCC2=O,IXHBTMCLRNMKHZ-LBPRGKRZSA-N,291.3853,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,antagonist,yes
DB01211,Clarithromycin,small molecule,approved,[H][C@@]1(C[C@@](C)(OC)[C@@H](O)[C@H](C)O1)O[C@H]1[C@H](C)[C@@H](O[C@]2([H])O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)OC(=O)[C@@H]1C)OC,AGOYDEPGAOXOCK-KCBOHYOISA-N,747.9534,P0A7J6,BE0000743,50S ribosomal protein L10,Shigella flexneri,inhibitor,yes
DB01212,Ceftriaxone,small molecule,approved,[H][C@]12SCC(CSC3=NC(=O)C(=O)NN3C)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,VAAUVRVFOQPIGI-SPQHTLEESA-N,554.58,P0A3M6,BE0003624,Penicillin-binding protein 2B,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB01214,Metipranolol,small molecule,approved,CC(C)NCC(O)COC1=C(C)C(C)=C(OC(C)=O)C(C)=C1,BQIPXWYNLPYNHW-UHFFFAOYSA-N,309.4006,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,antagonist,yes
DB01214,Metipranolol,small molecule,approved,CC(C)NCC(O)COC1=C(C)C(C)=C(OC(C)=O)C(C)=C1,BQIPXWYNLPYNHW-UHFFFAOYSA-N,309.4006,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,antagonist,yes
DB01215,Estazolam,small molecule,approved;illicit,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,CDCHDCWJMGXXRH-UHFFFAOYSA-N,294.738,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB01215,Estazolam,small molecule,approved;illicit,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,CDCHDCWJMGXXRH-UHFFFAOYSA-N,294.738,P30536,BE0000736,Translocator protein,Humans,agonist,yes
DB01215,Estazolam,small molecule,approved;illicit,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,CDCHDCWJMGXXRH-UHFFFAOYSA-N,294.738,P14867,BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,Humans,ligand,yes
DB01216,Finasteride,small molecule,approved,[H][C@@]12CC[C@H](C(=O)NC(C)(C)C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])NC(=O)C=C[C@]12C,DBEPLOCGEIEOCV-WSBQPABSSA-N,372.5441,P31213,BE0000585,3-oxo-5-alpha-steroid 4-dehydrogenase 2,Humans,inhibitor,yes
DB01216,Finasteride,small molecule,approved,[H][C@@]12CC[C@H](C(=O)NC(C)(C)C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])NC(=O)C=C[C@]12C,DBEPLOCGEIEOCV-WSBQPABSSA-N,372.5441,Q9H8P0,BE0009587,Polyprenal reductase,Humans,inhibitor,yes
DB01216,Finasteride,small molecule,approved,[H][C@@]12CC[C@H](C(=O)NC(C)(C)C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])NC(=O)C=C[C@]12C,DBEPLOCGEIEOCV-WSBQPABSSA-N,372.5441,P18405,BE0000539,3-oxo-5-alpha-steroid 4-dehydrogenase 1,Humans,inhibitor,yes
DB01217,Anastrozole,small molecule,approved;investigational,CC(C)(C#N)C1=CC(=CC(CN2C=NC=N2)=C1)C(C)(C)C#N,YBBLVLTVTVSKRW-UHFFFAOYSA-N,293.3663,P11511,BE0002090,Aromatase,Humans,inhibitor,yes
DB01218,Halofantrine,small molecule,approved,CCCCN(CCCC)CCC(O)C1=C2C=CC(=CC2=C2C=C(Cl)C=C(Cl)C2=C1)C(F)(F)F,FOHHNHSLJDZUGQ-UHFFFAOYSA-N,500.424,,BE0004805,Fe(II)-protoporphyrin IX,Plasmodium falciparum,antagonist,yes
DB01218,Halofantrine,small molecule,approved,CCCCN(CCCC)CCC(O)C1=C2C=CC(=CC2=C2C=C(Cl)C=C(Cl)C2=C1)C(F)(F)F,FOHHNHSLJDZUGQ-UHFFFAOYSA-N,500.424,P0DP23,BE0012563,Calmodulin-1,Humans,modulator,yes
DB01218,Halofantrine,small molecule,approved,CCCCN(CCCC)CCC(O)C1=C2C=CC(=CC2=C2C=C(Cl)C=C(Cl)C2=C1)C(F)(F)F,FOHHNHSLJDZUGQ-UHFFFAOYSA-N,500.424,P0DP25,BE0008706,Calmodulin-3,Humans,modulator,yes
DB01218,Halofantrine,small molecule,approved,CCCCN(CCCC)CCC(O)C1=C2C=CC(=CC2=C2C=C(Cl)C=C(Cl)C2=C1)C(F)(F)F,FOHHNHSLJDZUGQ-UHFFFAOYSA-N,500.424,P0DP24,BE0008705,Calmodulin-2,Humans,modulator,yes
DB01218,Halofantrine,small molecule,approved,CCCCN(CCCC)CCC(O)C1=C2C=CC(=CC2=C2C=C(Cl)C=C(Cl)C2=C1)C(F)(F)F,FOHHNHSLJDZUGQ-UHFFFAOYSA-N,500.424,Q12809,BE0000090,Voltage-gated inwardly rectifying potassium channel KCNH2,Humans,inhibitor,yes
DB01219,Dantrolene,small molecule,approved;investigational,[O-][N+](=O)C1=CC=C(C=C1)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,OZOMQRBLCMDCEG-VIZOYTHASA-N,314.257,P21817,BE0000739,Ryanodine receptor 1,Humans,antagonist,yes
DB01220,Rifaximin,small molecule,approved;investigational,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C)C(O)=C4C(O)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C1=C(N=C5C=C(C)C=CN15)C4=C3C2=O,NZCRJKRKKOLAOJ-XRCRFVBUSA-N,785.8785,P0A8V2,BE0000257,DNA-directed RNA polymerase subunit beta,Escherichia coli (strain K12),inhibitor,yes
DB01221,Ketamine,small molecule,approved;vet_approved,CNC1(CCCCC1=O)C1=CC=CC=C1Cl,YQEZLKZALYSWHR-UHFFFAOYSA-N,237.725,Q8TCU5,BE0000641,"Glutamate receptor ionotropic, NMDA 3A",Humans,antagonist,yes
DB01221,Ketamine,small molecule,approved;vet_approved,CNC1(CCCCC1=O)C1=CC=CC=C1Cl,YQEZLKZALYSWHR-UHFFFAOYSA-N,237.725,P46098,BE0000311,5-hydroxytryptamine receptor 3A,Humans,potentiator,yes
DB01221,Ketamine,small molecule,approved;vet_approved,CNC1(CCCCC1=O)C1=CC=CC=C1Cl,YQEZLKZALYSWHR-UHFFFAOYSA-N,237.725,P36544,BE0002341,Neuronal acetylcholine receptor subunit alpha-7,Humans,antagonist,yes
DB01221,Ketamine,small molecule,approved;vet_approved,CNC1(CCCCC1=O)C1=CC=CC=C1Cl,YQEZLKZALYSWHR-UHFFFAOYSA-N,237.725,P06276,BE0002180,Cholinesterase,Humans,inhibitor,yes
DB01221,Ketamine,small molecule,approved;vet_approved,CNC1(CCCCC1=O)C1=CC=CC=C1Cl,YQEZLKZALYSWHR-UHFFFAOYSA-N,237.725,P29475,BE0000067,Nitric oxide synthase 1,Humans,inhibitor,yes
DB01222,Budesonide,small molecule,approved,[H][C@@]12C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,VOVIALXJUBGFJZ-KWVAZRHASA-N,430.5339,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB01223,Aminophylline,small molecule,approved,NCCN.CN1C2=C(NC=N2)C(=O)N(C)C1=O.CN1C2=C(NC=N2)C(=O)N(C)C1=O,FQPFAHBPWDRTLU-UHFFFAOYSA-N,420.4264,Q14432,BE0000436,"cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A",Humans,inhibitor,yes
DB01223,Aminophylline,small molecule,approved,NCCN.CN1C2=C(NC=N2)C(=O)N(C)C1=O.CN1C2=C(NC=N2)C(=O)N(C)C1=O,FQPFAHBPWDRTLU-UHFFFAOYSA-N,420.4264,P30542,BE0000013,Adenosine receptor A1,Humans,antagonist,yes
DB01223,Aminophylline,small molecule,approved,NCCN.CN1C2=C(NC=N2)C(=O)N(C)C1=O.CN1C2=C(NC=N2)C(=O)N(C)C1=O,FQPFAHBPWDRTLU-UHFFFAOYSA-N,420.4264,P0DMS8,BE0000354,Adenosine receptor A3,Humans,antagonist,yes
DB01223,Aminophylline,small molecule,approved,NCCN.CN1C2=C(NC=N2)C(=O)N(C)C1=O.CN1C2=C(NC=N2)C(=O)N(C)C1=O,FQPFAHBPWDRTLU-UHFFFAOYSA-N,420.4264,Q92769,BE0002366,Histone deacetylase 2,Humans,activator,yes
DB01224,Quetiapine,small molecule,approved,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,URKOMYMAXPYINW-UHFFFAOYSA-N,383.507,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB01224,Quetiapine,small molecule,approved,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,URKOMYMAXPYINW-UHFFFAOYSA-N,383.507,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB01226,Mivacurium,small molecule,approved,COC1=CC(C[C@@H]2C3=CC(OC)=C(OC)C=C3CC[N+]2(C)CCCOC(=O)CC\C=C\CCC(=O)OCCC[N+]2(C)CCC3=CC(OC)=C(OC)C=C3[C@H]2CC2=CC(OC)=C(OC)C(OC)=C2)=CC(OC)=C1OC,ILVYCEVXHALBSC-OTBYEXOQSA-N,1029.2608,Q15822,BE0000738,Neuronal acetylcholine receptor subunit alpha-2,Humans,antagonist,yes
DB01227,Levacetylmethadol,small molecule,approved;investigational;withdrawn,CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,XBMIVRRWGCYBTQ-AVRDEDQJSA-N,353.4977,P35372,BE0000770,Mu-type opioid receptor,Humans,agonist,yes
DB01228,Encainide,small molecule,approved;investigational;withdrawn,COC1=CC=C(C=C1)C(=O)NC1=CC=CC=C1CCC1CCCCN1C,PJWPNDMDCLXCOM-UHFFFAOYSA-N,352.4699,Q14524,BE0000197,Sodium channel protein type 5 subunit alpha,Humans,inhibitor,yes
DB01229,Paclitaxel,small molecule,approved;vet_approved,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,RCINICONZNJXQF-MZXODVADSA-N,853.9061,Q9H4B7,BE0000026,Tubulin beta-1 chain,Humans,inhibitor,yes
DB01229,Paclitaxel,small molecule,approved;vet_approved,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,RCINICONZNJXQF-MZXODVADSA-N,853.9061,P10415,BE0000246,Apoptosis regulator Bcl-2,Humans,inhibitor,yes
DB01231,Diphenidol,small molecule,approved;investigational;withdrawn,OC(CCCN1CCCCC1)(C1=CC=CC=C1)C1=CC=CC=C1,OGAKLTJNUQRZJU-UHFFFAOYSA-N,309.4452,P08173,BE0000405,Muscarinic acetylcholine receptor M4,Humans,antagonist,yes
DB01231,Diphenidol,small molecule,approved;investigational;withdrawn,OC(CCCN1CCCCC1)(C1=CC=CC=C1)C1=CC=CC=C1,OGAKLTJNUQRZJU-UHFFFAOYSA-N,309.4452,P08172,BE0000560,Muscarinic acetylcholine receptor M2,Humans,antagonist,yes
DB01231,Diphenidol,small molecule,approved;investigational;withdrawn,OC(CCCN1CCCCC1)(C1=CC=CC=C1)C1=CC=CC=C1,OGAKLTJNUQRZJU-UHFFFAOYSA-N,309.4452,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,antagonist,yes
DB01231,Diphenidol,small molecule,approved;investigational;withdrawn,OC(CCCN1CCCCC1)(C1=CC=CC=C1)C1=CC=CC=C1,OGAKLTJNUQRZJU-UHFFFAOYSA-N,309.4452,P20309,BE0000045,Muscarinic acetylcholine receptor M3,Humans,antagonist,yes
DB01232,Saquinavir,small molecule,approved;investigational,[H][C@@]12CCCC[C@]1([H])CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(N)=O)NC(=O)C1=NC3=C(C=CC=C3)C=C1)[C@@H](C2)C(=O)NC(C)(C)C,QWAXKHKRTORLEM-UGJKXSETSA-N,670.8408,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB01232,Saquinavir,small molecule,approved;investigational,[H][C@@]12CCCC[C@]1([H])CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(N)=O)NC(=O)C1=NC3=C(C=CC=C3)C=C1)[C@@H](C2)C(=O)NC(C)(C)C,QWAXKHKRTORLEM-UGJKXSETSA-N,670.8408,Q72874,BE0004854,Pol polyprotein,Human immunodeficiency virus 1,inhibitor,yes
DB01233,Metoclopramide,small molecule,approved;investigational,CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC,TTWJBBZEZQICBI-UHFFFAOYSA-N,299.796,Q13639,BE0000084,5-hydroxytryptamine receptor 4,Humans,agonist,yes
DB01233,Metoclopramide,small molecule,approved;investigational,CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC,TTWJBBZEZQICBI-UHFFFAOYSA-N,299.796,P46098,BE0000311,5-hydroxytryptamine receptor 3A,Humans,antagonist,yes
DB01233,Metoclopramide,small molecule,approved;investigational,CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC,TTWJBBZEZQICBI-UHFFFAOYSA-N,299.796,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,agonist,yes
DB01233,Metoclopramide,small molecule,approved;investigational,CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC,TTWJBBZEZQICBI-UHFFFAOYSA-N,299.796,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB01234,Dexamethasone,small molecule,approved;investigational;vet_approved,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,UREBDLICKHMUKA-CXSFZGCWSA-N,392.4611,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB01235,Levodopa,small molecule,approved,N[C@@H](CC1=CC(O)=C(O)C=C1)C(O)=O,WTDRDQBEARUVNC-LURJTMIESA-N,197.1879,P21728,BE0000020,D(1A) dopamine receptor,Humans,agonist,yes
DB01235,Levodopa,small molecule,approved,N[C@@H](CC1=CC(O)=C(O)C=C1)C(O)=O,WTDRDQBEARUVNC-LURJTMIESA-N,197.1879,P21918,BE0000145,D(1B) dopamine receptor,Humans,agonist,yes
DB01235,Levodopa,small molecule,approved,N[C@@H](CC1=CC(O)=C(O)C=C1)C(O)=O,WTDRDQBEARUVNC-LURJTMIESA-N,197.1879,P14416,BE0000756,D(2) dopamine receptor,Humans,agonist,yes
DB01235,Levodopa,small molecule,approved,N[C@@H](CC1=CC(O)=C(O)C=C1)C(O)=O,WTDRDQBEARUVNC-LURJTMIESA-N,197.1879,P35462,BE0000581,D(3) dopamine receptor,Humans,agonist,yes
DB01235,Levodopa,small molecule,approved,N[C@@H](CC1=CC(O)=C(O)C=C1)C(O)=O,WTDRDQBEARUVNC-LURJTMIESA-N,197.1879,P21917,BE0000389,D(4) dopamine receptor,Humans,agonist,yes
DB01236,Sevoflurane,small molecule,approved;vet_approved,FCOC(C(F)(F)F)C(F)(F)F,DFEYYRMXOJXZRJ-UHFFFAOYSA-N,200.0548,P14867,BE0004797,GABA(A) Receptor,Humans,agonist,yes
DB01236,Sevoflurane,small molecule,approved;vet_approved,FCOC(C(F)(F)F)C(F)(F)F,DFEYYRMXOJXZRJ-UHFFFAOYSA-N,200.0548,P23415,BE0000433,Glycine receptor subunit alpha-1,Humans,agonist,yes
DB01236,Sevoflurane,small molecule,approved;vet_approved,FCOC(C(F)(F)F)C(F)(F)F,DFEYYRMXOJXZRJ-UHFFFAOYSA-N,200.0548,P42261,BE0000640,Glutamate receptor 1,Humans,antagonist,yes
DB01236,Sevoflurane,small molecule,approved;vet_approved,FCOC(C(F)(F)F)C(F)(F)F,DFEYYRMXOJXZRJ-UHFFFAOYSA-N,200.0548,P98194,BE0010002,Calcium transporting ATPases,Humans,inhibitor,yes
DB01236,Sevoflurane,small molecule,approved;vet_approved,FCOC(C(F)(F)F)C(F)(F)F,DFEYYRMXOJXZRJ-UHFFFAOYSA-N,200.0548,Q96ER9,BE0009966,Mitochondrial potassium channel,Humans,activator,yes
DB01237,Bromodiphenhydramine,small molecule,approved,CN(C)CCOC(C1=CC=CC=C1)C1=CC=C(Br)C=C1,NUNIWXHYABYXKF-UHFFFAOYSA-N,334.251,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB01238,Aripiprazole,small molecule,approved;investigational,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,CEUORZQYGODEFX-UHFFFAOYSA-N,448.385,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist;partial agonist,yes
DB01238,Aripiprazole,small molecule,approved;investigational,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,CEUORZQYGODEFX-UHFFFAOYSA-N,448.385,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB01239,Chlorprothixene,small molecule,approved;experimental;investigational;withdrawn,CN(C)CC\C=C1\C2=CC=CC=C2SC2=CC=C(Cl)C=C12,WSPOMRSOLSGNFJ-AUWJEWJLSA-N,315.86,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB01239,Chlorprothixene,small molecule,approved;experimental;investigational;withdrawn,CN(C)CC\C=C1\C2=CC=CC=C2SC2=CC=C(Cl)C=C12,WSPOMRSOLSGNFJ-AUWJEWJLSA-N,315.86,P21728,BE0000020,D(1A) dopamine receptor,Humans,antagonist,yes
DB01239,Chlorprothixene,small molecule,approved;experimental;investigational;withdrawn,CN(C)CC\C=C1\C2=CC=CC=C2SC2=CC=C(Cl)C=C12,WSPOMRSOLSGNFJ-AUWJEWJLSA-N,315.86,P35462,BE0000581,D(3) dopamine receptor,Humans,antagonist,yes
DB01239,Chlorprothixene,small molecule,approved;experimental;investigational;withdrawn,CN(C)CC\C=C1\C2=CC=CC=C2SC2=CC=C(Cl)C=C12,WSPOMRSOLSGNFJ-AUWJEWJLSA-N,315.86,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB01239,Chlorprothixene,small molecule,approved;experimental;investigational;withdrawn,CN(C)CC\C=C1\C2=CC=CC=C2SC2=CC=C(Cl)C=C12,WSPOMRSOLSGNFJ-AUWJEWJLSA-N,315.86,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB01239,Chlorprothixene,small molecule,approved;experimental;investigational;withdrawn,CN(C)CC\C=C1\C2=CC=CC=C2SC2=CC=C(Cl)C=C12,WSPOMRSOLSGNFJ-AUWJEWJLSA-N,315.86,P08908,BE0004862,Serotonin Receptors,Humans,inhibitor,yes
DB01240,Epoprostenol,small molecule,approved,[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)CCCCC)[C@@]1([H])C\C(O2)=C\CCCC(O)=O,KAQKFAOMNZTLHT-OZUDYXHBSA-N,352.4651,Q16647,BE0000117,Prostacyclin synthase,Humans,inducer,yes
DB01240,Epoprostenol,small molecule,approved,[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)CCCCC)[C@@]1([H])C\C(O2)=C\CCCC(O)=O,KAQKFAOMNZTLHT-OZUDYXHBSA-N,352.4651,Q9H244,BE0000110,P2Y purinoceptor 12,Humans,agonist,yes
DB01240,Epoprostenol,small molecule,approved,[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)CCCCC)[C@@]1([H])C\C(O2)=C\CCCC(O)=O,KAQKFAOMNZTLHT-OZUDYXHBSA-N,352.4651,P43119,BE0000475,Prostacyclin receptor,Humans,agonist,yes
DB01241,Gemfibrozil,small molecule,approved,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1,HEMJJKBWTPKOJG-UHFFFAOYSA-N,250.3334,Q07869,BE0000071,Peroxisome proliferator-activated receptor alpha,Humans,agonist,yes
DB01241,Gemfibrozil,small molecule,approved,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1,HEMJJKBWTPKOJG-UHFFFAOYSA-N,250.3334,P06858,BE0000239,Lipoprotein lipase,Humans,activator,yes
DB01242,Clomipramine,small molecule,approved;investigational;vet_approved,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,GDLIGKIOYRNHDA-UHFFFAOYSA-N,314.852,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB01242,Clomipramine,small molecule,approved;investigational;vet_approved,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,GDLIGKIOYRNHDA-UHFFFAOYSA-N,314.852,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB01242,Clomipramine,small molecule,approved;investigational;vet_approved,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,GDLIGKIOYRNHDA-UHFFFAOYSA-N,314.852,P41595,BE0000393,5-hydroxytryptamine receptor 2B,Humans,antagonist,yes
DB01242,Clomipramine,small molecule,approved;investigational;vet_approved,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,GDLIGKIOYRNHDA-UHFFFAOYSA-N,314.852,P28335,BE0000533,5-hydroxytryptamine receptor 2C,Humans,antagonist,yes
DB01243,Chloroxine,small molecule,approved,OC1=C(Cl)C=C(Cl)C2=C1N=CC=C2,WDFKMLRRRCGAKS-UHFFFAOYSA-N,214.048,P41145,BE0000632,Kappa-type opioid receptor,Humans,inhibitor,yes
DB01244,Bepridil,small molecule,approved;withdrawn,CC(C)COCC(CN(CC1=CC=CC=C1)C1=CC=CC=C1)N1CCCC1,UIEATEWHFDRYRU-UHFFFAOYSA-N,366.5396,O00555,BE0000356,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,Humans,inhibitor,yes
DB01244,Bepridil,small molecule,approved;withdrawn,CC(C)COCC(CN(CC1=CC=CC=C1)C1=CC=CC=C1)N1CCCC1,UIEATEWHFDRYRU-UHFFFAOYSA-N,366.5396,O95180,BE0000864,Voltage-dependent T-type calcium channel subunit alpha-1H,Humans,inhibitor,yes
DB01244,Bepridil,small molecule,approved;withdrawn,CC(C)COCC(CN(CC1=CC=CC=C1)C1=CC=CC=C1)N1CCCC1,UIEATEWHFDRYRU-UHFFFAOYSA-N,366.5396,Q9NY47,BE0002396,Voltage-dependent calcium channel subunit alpha-2/delta-2,Humans,inhibitor,yes
DB01245,Decamethonium,small molecule,approved,C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C,MTCUAOILFDZKCO-UHFFFAOYSA-N,258.4863,Q15822,BE0000738,Neuronal acetylcholine receptor subunit alpha-2,Humans,partial agonist,yes
DB01245,Decamethonium,small molecule,approved,C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C,MTCUAOILFDZKCO-UHFFFAOYSA-N,258.4863,P02708,BE0004661,Acetylcholine receptor subunit alpha,Humans,modulator,yes
DB01246,Alimemazine,small molecule,approved;vet_approved,CC(CN(C)C)CN1C2=CC=CC=C2SC2=CC=CC=C12,ZZHLYYDVIOPZBE-UHFFFAOYSA-N,298.446,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB01247,Isocarboxazid,small molecule,approved,CC1=CC(=NO1)C(=O)NNCC1=CC=CC=C1,XKFPYPQQHFEXRZ-UHFFFAOYSA-N,231.2505,P21397,BE0002198,Amine oxidase [flavin-containing] A,Humans,inhibitor,yes
DB01247,Isocarboxazid,small molecule,approved,CC1=CC(=NO1)C(=O)NNCC1=CC=CC=C1,XKFPYPQQHFEXRZ-UHFFFAOYSA-N,231.2505,P27338,BE0002196,Amine oxidase [flavin-containing] B,Humans,inhibitor,yes
DB01248,Docetaxel,small molecule,approved;investigational,[H][C@@]1(C[C@@]2(O)[C@@H](OC(=O)C3=CC=CC=C3)[C@]3([H])[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C(=C1C)C2(C)C)OC(C)=O)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1,ZDZOTLJHXYCWBA-VCVYQWHSSA-N,807.8792,Q9H4B7,BE0000026,Tubulin beta-1 chain,Humans,inhibitor,yes
DB01250,Olsalazine,small molecule,approved,OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(O)C(=C1)C(O)=O,QQBDLJCYGRGAKP-FOCLMDBBSA-N,302.239,P23219,BE0010085,Human Cyclooxygenases,Humans,inhibitor,yes
DB01250,Olsalazine,small molecule,approved,OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(O)C(=C1)C(O)=O,QQBDLJCYGRGAKP-FOCLMDBBSA-N,302.239,P51580,BE0000987,Thiopurine S-methyltransferase,Humans,inhibitor,yes
DB01251,Gliquidone,small molecule,approved;investigational,COC1=CC2=C(C=C1)C(C)(C)C(=O)N(CCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1)C2=O,LLJFMFZYVVLQKT-UHFFFAOYSA-N,527.632,Q09428,BE0000207,ATP-binding cassette sub-family C member 8,Humans,inhibitor,yes
DB01251,Gliquidone,small molecule,approved;investigational,COC1=CC2=C(C=C1)C(C)(C)C(=O)N(CCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1)C2=O,LLJFMFZYVVLQKT-UHFFFAOYSA-N,527.632,P78508,BE0009591,ATP-sensitive inward rectifier potassium channel 10,Humans,binder,yes
DB01251,Gliquidone,small molecule,approved;investigational,COC1=CC2=C(C=C1)C(C)(C)C(=O)N(CCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1)C2=O,LLJFMFZYVVLQKT-UHFFFAOYSA-N,527.632,Q15842,BE0002441,ATP-sensitive inward rectifier potassium channel 8,Humans,inhibitor,yes
DB01252,Mitiglinide,small molecule,investigational,[H][C@@](CC(=O)N1C[C@@]2([H])CCCC[C@@]2([H])C1)(CC1=CC=CC=C1)C(O)=O,WPGGHFDDFPHPOB-BBWFWOEESA-N,315.413,Q09428,BE0000207,ATP-binding cassette sub-family C member 8,Humans,inhibitor,yes
DB01252,Mitiglinide,small molecule,investigational,[H][C@@](CC(=O)N1C[C@@]2([H])CCCC[C@@]2([H])C1)(CC1=CC=CC=C1)C(O)=O,WPGGHFDDFPHPOB-BBWFWOEESA-N,315.413,P78508,BE0009591,ATP-sensitive inward rectifier potassium channel 10,Humans,blocker,yes
DB01253,Ergometrine,small molecule,approved,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](C)CO,WVVSZNPYNCNODU-XTQGRXLLSA-N,325.4048,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,agonist,yes
DB01253,Ergometrine,small molecule,approved,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](C)CO,WVVSZNPYNCNODU-XTQGRXLLSA-N,325.4048,P14416,BE0000756,D(2) dopamine receptor,Humans,agonist,yes
DB01254,Dasatinib,small molecule,approved;investigational,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,488.006,P00519,BE0000014,Tyrosine-protein kinase ABL1,Humans,inhibitor;multitarget,yes
DB01254,Dasatinib,small molecule,approved;investigational,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,488.006,P12931,BE0000838,Proto-oncogene tyrosine-protein kinase Src,Humans,inhibitor;multitarget,yes
DB01254,Dasatinib,small molecule,approved;investigational,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,488.006,P29317,BE0000841,Ephrin type-A receptor 2,Humans,antagonist,yes
DB01254,Dasatinib,small molecule,approved;investigational,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,488.006,P06239,BE0000842,Tyrosine-protein kinase Lck,Humans,inhibitor;multitarget,yes
DB01254,Dasatinib,small molecule,approved;investigational,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,488.006,P07947,BE0000840,Tyrosine-protein kinase Yes,Humans,inhibitor,yes
DB01254,Dasatinib,small molecule,approved;investigational,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,488.006,P10721,BE0000453,Mast/stem cell growth factor receptor Kit,Humans,antagonist,yes
DB01254,Dasatinib,small molecule,approved;investigational,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,488.006,P09619,BE0000205,Platelet-derived growth factor receptor beta,Humans,antagonist,yes
DB01254,Dasatinib,small molecule,approved;investigational,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,488.006,P06241,BE0000839,Tyrosine-protein kinase Fyn,Humans,inhibitor;multitarget,yes
DB01254,Dasatinib,small molecule,approved;investigational,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,488.006,P11274,BE0004743,Breakpoint cluster region protein,Humans,inhibitor,yes
DB01255,Lisdexamfetamine,small molecule,approved;investigational,C[C@@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CCCCN,VOBHXZCDAVEXEY-JSGCOSHPSA-N,263.3785,Q96RJ0,BE0001044,Trace amine-associated receptor 1,Humans,agonist,yes
DB01256,Retapamulin,small molecule,approved,[H][C@@]12C(=O)CC[C@]11CC[C@@H](C)[C@@]2(C)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]1C)OC(=O)CS[C@H]1C[C@@H]2CC[C@H](C1)N2C,STZYTFJPGGDRJD-NHUWBDDWSA-N,517.763,Q9A1X4,BE0000843,50S ribosomal protein L3,Streptococcus pyogenes serotype M1,inhibitor,yes
DB01259,Lapatinib,small molecule,approved;investigational,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,BCFGMOOMADDAQU-UHFFFAOYSA-N,581.058,P00533,BE0000767,Epidermal growth factor receptor,Humans,antagonist,yes
DB01259,Lapatinib,small molecule,approved;investigational,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,BCFGMOOMADDAQU-UHFFFAOYSA-N,581.058,O00418,BE0011325,Eukaryotic elongation factor 2 kinase,Humans,inhibitor,yes
DB01259,Lapatinib,small molecule,approved;investigational,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,BCFGMOOMADDAQU-UHFFFAOYSA-N,581.058,P04626,BE0000511,Receptor tyrosine-protein kinase erbB-2,Humans,antagonist,yes
DB01260,Desonide,small molecule,approved;investigational,[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,WBGKWQHBNHJJPZ-LECWWXJVSA-N,416.5073,P11474,BE0003722,Steroid hormone receptor ERR1,Humans,modulator,yes
DB01260,Desonide,small molecule,approved;investigational,[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,WBGKWQHBNHJJPZ-LECWWXJVSA-N,416.5073,O95718,BE0005001,Steroid hormone receptor ERR2,Humans,modulator,yes
DB01260,Desonide,small molecule,approved;investigational,[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,WBGKWQHBNHJJPZ-LECWWXJVSA-N,416.5073,P62508,BE0002088,Estrogen-related receptor gamma,Humans,modulator,yes
DB01260,Desonide,small molecule,approved;investigational,[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,WBGKWQHBNHJJPZ-LECWWXJVSA-N,416.5073,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB01261,Sitagliptin,small molecule,approved;investigational,N[C@@H](CC(=O)N1CCN2C(C1)=NN=C2C(F)(F)F)CC1=CC(F)=C(F)C=C1F,MFFMDFFZMYYVKS-SECBINFHSA-N,407.3136,P27487,BE0000854,Dipeptidyl peptidase 4,Humans,inhibitor,yes
DB01262,Decitabine,small molecule,approved;investigational,NC1=NC(=O)N(C=N1)[C@H]1C[C@H](O)[C@@H](CO)O1,XAUDJQYHKZQPEU-KVQBGUIXSA-N,228.2053,P26358,BE0000892,DNA (cytosine-5)-methyltransferase 1,Humans,inhibitor,yes
DB01263,Posaconazole,small molecule,approved;investigational;vet_approved,CC[C@@H]([C@H](C)O)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@@H]2CO[C@](CN3C=NC=N3)(C2)C2=C(F)C=C(F)C=C2)C=C1,RAGOYPUPXAKGKH-XAKZXMRKSA-N,700.7774,P10613,BE0000233,Lanosterol 14-alpha demethylase,Yeast,antagonist,yes
DB01264,Darunavir,small molecule,approved,[H][C@@]12CCO[C@]1([H])OC[C@@H]2OC(=O)N[C@@H](CC1=CC=CC=C1)[C@H](O)CN(CC(C)C)S(=O)(=O)C1=CC=C(N)C=C1,CJBJHOAVZSMMDJ-HEXNFIEUSA-N,547.664,Q72874,BE0004854,Pol polyprotein,Human immunodeficiency virus 1,inhibitor,yes
DB01264,Darunavir,small molecule,approved,[H][C@@]12CCO[C@]1([H])OC[C@@H]2OC(=O)N[C@@H](CC1=CC=CC=C1)[C@H](O)CN(CC(C)C)S(=O)(=O)C1=CC=C(N)C=C1,CJBJHOAVZSMMDJ-HEXNFIEUSA-N,547.664,P03366,BE0002050,Gag-Pol polyprotein,,modulator,yes
DB01265,Telbivudine,small molecule,approved;investigational,CC1=CN([C@@H]2C[C@@H](O)[C@H](CO)O2)C(=O)NC1=O,IQFYYKKMVGJFEH-CSMHCCOUSA-N,242.2286,,BE0004796,DNA,Humans,,yes
DB01265,Telbivudine,small molecule,approved;investigational,CC1=CN([C@@H]2C[C@@H](O)[C@H](CO)O2)C(=O)NC1=O,IQFYYKKMVGJFEH-CSMHCCOUSA-N,242.2286,Q05486,BE0000555,Protein P,HBV-F,,yes
DB01267,Paliperidone,small molecule,approved,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,PMXMIIMHBWHSKN-UHFFFAOYSA-N,426.4839,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB01267,Paliperidone,small molecule,approved,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,PMXMIIMHBWHSKN-UHFFFAOYSA-N,426.4839,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB01267,Paliperidone,small molecule,approved,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,PMXMIIMHBWHSKN-UHFFFAOYSA-N,426.4839,P21917,BE0000389,D(4) dopamine receptor,Humans,antagonist,yes
DB01267,Paliperidone,small molecule,approved,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,PMXMIIMHBWHSKN-UHFFFAOYSA-N,426.4839,P35462,BE0000581,D(3) dopamine receptor,Humans,antagonist,yes
DB01267,Paliperidone,small molecule,approved,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,PMXMIIMHBWHSKN-UHFFFAOYSA-N,426.4839,P28335,BE0000533,5-hydroxytryptamine receptor 2C,Humans,antagonist,yes
DB01268,Sunitinib,small molecule,approved;investigational,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,WINHZLLDWRZWRT-ATVHPVEESA-N,398.4738,P09619,BE0000205,Platelet-derived growth factor receptor beta,Humans,inhibitor,yes
DB01268,Sunitinib,small molecule,approved;investigational,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,WINHZLLDWRZWRT-ATVHPVEESA-N,398.4738,P17948,BE0000029,Vascular endothelial growth factor receptor 1,Humans,inhibitor,yes
DB01268,Sunitinib,small molecule,approved;investigational,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,WINHZLLDWRZWRT-ATVHPVEESA-N,398.4738,P10721,BE0000453,Mast/stem cell growth factor receptor Kit,Humans,inhibitor,yes
DB01268,Sunitinib,small molecule,approved;investigational,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,WINHZLLDWRZWRT-ATVHPVEESA-N,398.4738,P35968,BE0000369,Vascular endothelial growth factor receptor 2,Humans,inhibitor,yes
DB01268,Sunitinib,small molecule,approved;investigational,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,WINHZLLDWRZWRT-ATVHPVEESA-N,398.4738,P35916,BE0000023,Vascular endothelial growth factor receptor 3,Humans,inhibitor,yes
DB01268,Sunitinib,small molecule,approved;investigational,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,WINHZLLDWRZWRT-ATVHPVEESA-N,398.4738,P36888,BE0000147,Receptor-type tyrosine-protein kinase FLT3,Humans,inhibitor,yes
DB01268,Sunitinib,small molecule,approved;investigational,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,WINHZLLDWRZWRT-ATVHPVEESA-N,398.4738,P07333,BE0000853,Macrophage colony-stimulating factor 1 receptor,Humans,inhibitor,yes
DB01268,Sunitinib,small molecule,approved;investigational,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,WINHZLLDWRZWRT-ATVHPVEESA-N,398.4738,P16234,BE0000852,Platelet-derived growth factor receptor alpha,Humans,inhibitor,yes
DB01273,Varenicline,small molecule,approved;investigational,C1C2CNCC1C1=C2C=C2N=CC=NC2=C1,JQSHBVHOMNKWFT-UHFFFAOYSA-N,211.268,P43681,BE0000849,Neuronal acetylcholine receptor subunit alpha-4,Humans,partial agonist,yes
DB01274,Arformoterol,small molecule,approved;investigational,COC1=CC=C(C[C@@H](C)NC[C@H](O)C2=CC(NC=O)=C(O)C=C2)C=C1,BPZSYCZIITTYBL-YJYMSZOUSA-N,344.4049,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,agonist,yes
DB01275,Hydralazine,small molecule,approved,NNC1=NN=CC2=CC=CC=C12,RPTUSVTUFVMDQK-UHFFFAOYSA-N,160.1759,Q16853,BE0001002,Amine oxidase [copper-containing] 3,Humans,inhibitor,yes
DB01278,Pramlintide,small molecule,approved;investigational,[H]N[C@@H](CCCCN)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@]([H])(NC(=O)[C@H](C)NC(=O)[C@@]([H])(NC(=O)[C@H](CC(N)=O)NC1=O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@]([H])([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(N)=O,TZIRZGBAFTZREM-MKAGXXMWSA-N,3949.44,P43220,BE0000857,Glucagon-like peptide 1 receptor,Humans,agonist,yes
DB01278,Pramlintide,small molecule,approved;investigational,[H]N[C@@H](CCCCN)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@]([H])(NC(=O)[C@H](C)NC(=O)[C@@]([H])(NC(=O)[C@H](CC(N)=O)NC1=O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@]([H])([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(N)=O,TZIRZGBAFTZREM-MKAGXXMWSA-N,3949.44,P30988,BE0000431,Calcitonin receptor,Humans,agonist,yes
DB01278,Pramlintide,small molecule,approved;investigational,[H]N[C@@H](CCCCN)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@]([H])(NC(=O)[C@H](C)NC(=O)[C@@]([H])(NC(=O)[C@H](CC(N)=O)NC1=O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@]([H])([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(N)=O,TZIRZGBAFTZREM-MKAGXXMWSA-N,3949.44,O60894,BE0000859,Receptor activity-modifying protein 1,Humans,agonist,yes
DB01278,Pramlintide,small molecule,approved;investigational,[H]N[C@@H](CCCCN)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@]([H])(NC(=O)[C@H](C)NC(=O)[C@@]([H])(NC(=O)[C@H](CC(N)=O)NC1=O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@]([H])([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(N)=O,TZIRZGBAFTZREM-MKAGXXMWSA-N,3949.44,O60895,BE0000860,Receptor activity-modifying protein 2,Humans,agonist,yes
DB01278,Pramlintide,small molecule,approved;investigational,[H]N[C@@H](CCCCN)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@]([H])(NC(=O)[C@H](C)NC(=O)[C@@]([H])(NC(=O)[C@H](CC(N)=O)NC1=O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@]([H])([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(N)=O,TZIRZGBAFTZREM-MKAGXXMWSA-N,3949.44,O60896,BE0000861,Receptor activity-modifying protein 3,Humans,agonist,yes
DB01280,Nelarabine,small molecule,approved;investigational,COC1=NC(N)=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,IXOXBSCIXZEQEQ-UHTZMRCNSA-N,297.2673,,BE0004796,DNA,Humans,incorporation into and destabilization,yes
DB01280,Nelarabine,small molecule,approved;investigational,COC1=NC(N)=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,IXOXBSCIXZEQEQ-UHTZMRCNSA-N,297.2673,P09884,BE0000546,DNA polymerase alpha catalytic subunit,Humans,inhibitor,yes
DB01280,Nelarabine,small molecule,approved;investigational,COC1=NC(N)=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,IXOXBSCIXZEQEQ-UHTZMRCNSA-N,297.2673,P18858,BE0000199,DNA ligase 1,Humans,inhibitor,yes
DB01280,Nelarabine,small molecule,approved;investigational,COC1=NC(N)=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,IXOXBSCIXZEQEQ-UHTZMRCNSA-N,297.2673,P49642,BE0010216,DNA primase small subunit,Humans,inhibitor,yes
DB01280,Nelarabine,small molecule,approved;investigational,COC1=NC(N)=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,IXOXBSCIXZEQEQ-UHTZMRCNSA-N,297.2673,P23921,BE0000325,Ribonucleoside-diphosphate reductase large subunit,Humans,inhibitor,yes
DB01282,Carbetocin,small molecule,approved;investigational,[H][C@]1(NC(=O)[C@H](CC2=CC=C(OC)C=C2)NC(=O)CCCSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)[C@@H](C)CC,NSTRIRCPWQHTIA-DTRKZRJBSA-N,988.161,P30559,BE0000844,Oxytocin receptor,Humans,agonist,yes
DB01283,Lumiracoxib,small molecule,approved;investigational,CC1=CC=C(NC2=C(Cl)C=CC=C2F)C(CC(O)=O)=C1,KHPKQFYUPIUARC-UHFFFAOYSA-N,293.721,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB01283,Lumiracoxib,small molecule,approved;investigational,CC1=CC=C(NC2=C(Cl)C=CC=C2F)C(CC(O)=O)=C1,KHPKQFYUPIUARC-UHFFFAOYSA-N,293.721,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB01284,Tetracosactide,small molecule,approved,CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(O)=O,ZOEFCCMDUURGSE-SQKVDDBVSA-N,2933.49,Q01718,BE0000848,Adrenocorticotropic hormone receptor,Humans,agonist,yes
DB01288,Fenoterol,small molecule,approved;investigational,CC(CC1=CC=C(O)C=C1)NCC(O)C1=CC(O)=CC(O)=C1,LSLYOANBFKQKPT-UHFFFAOYSA-N,303.3529,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,agonist,yes
DB01289,Glisoxepide,small molecule,investigational,CC1=CC(=NO1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN1CCCCCC1,ZKUDBRCEOBOWLF-UHFFFAOYSA-N,449.524,P78508,BE0009591,ATP-sensitive inward rectifier potassium channel 10,Humans,blocker,yes
DB01289,Glisoxepide,small molecule,investigational,CC1=CC(=NO1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN1CCCCCC1,ZKUDBRCEOBOWLF-UHFFFAOYSA-N,449.524,Q15842,BE0002441,ATP-sensitive inward rectifier potassium channel 8,Humans,inhibitor,yes
DB01291,Pirbuterol,small molecule,approved,CC(C)(C)NCC(O)C1=NC(CO)=C(O)C=C1,VQDBNKDJNJQRDG-UHFFFAOYSA-N,240.2988,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,agonist,yes
DB01295,Bevantolol,small molecule,experimental,COC1=C(OC)C=C(CCNCC(O)COC2=CC=CC(C)=C2)C=C1,HXLAFSUPPDYFEO-UHFFFAOYSA-N,345.4327,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB01295,Bevantolol,small molecule,experimental,COC1=C(OC)C=C(CCNCC(O)COC2=CC=CC(C)=C2)C=C1,HXLAFSUPPDYFEO-UHFFFAOYSA-N,345.4327,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,antagonist,yes
DB01296,Glucosamine,small molecule,approved;investigational,N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O,MSWZFWKMSRAUBD-IVMDWMLBSA-N,179.1711,P01584,BE0001051,Interleukin-1 beta,Humans,inhibitor,yes
DB01297,Practolol,small molecule,approved,CC(C)NCC(O)COC1=CC=C(NC(C)=O)C=C1,DURULFYMVIFBIR-UHFFFAOYSA-N,266.3361,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,antagonist,yes
DB01298,Sulfacytine,small molecule,approved,CCN1C=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NC1=O,SIBQAECNSSQUOD-UHFFFAOYSA-N,294.33,P0AC13,BE0000803,Dihydropteroate synthase,Escherichia coli (strain K12),inhibitor,yes
DB01299,Sulfadoxine,small molecule,approved;investigational,COC1=NC=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1OC,PJSFRIWCGOHTNF-UHFFFAOYSA-N,310.329,Q27738,BE0002360,Dihydropteroate synthetase,Plasmodium falciparum,,yes
DB01299,Sulfadoxine,small molecule,approved;investigational,COC1=NC=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1OC,PJSFRIWCGOHTNF-UHFFFAOYSA-N,310.329,P27338,BE0002196,Amine oxidase [flavin-containing] B,Humans,inhibitor,yes
DB01299,Sulfadoxine,small molecule,approved;investigational,COC1=NC=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1OC,PJSFRIWCGOHTNF-UHFFFAOYSA-N,310.329,P0AC13,BE0000803,Dihydropteroate synthase,Escherichia coli (strain K12),binder,yes
DB01301,Rolitetracycline,small molecule,approved,[H][C@@]12C[C@@]3([H])C(C(=O)C4=C(O)C=CC=C4[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(=O)NCN1CCCC1)=C(O)[C@H]2N(C)C,HMEYVGGHISAPJR-IAHYZSEUSA-N,527.5662,P0A7X3,BE0000127,30S ribosomal protein S9,Escherichia coli (strain K12),inhibitor,yes
DB01301,Rolitetracycline,small molecule,approved,[H][C@@]12C[C@@]3([H])C(C(=O)C4=C(O)C=CC=C4[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(=O)NCN1CCCC1)=C(O)[C@H]2N(C)C,HMEYVGGHISAPJR-IAHYZSEUSA-N,527.5662,,BE0004799,16S ribosomal RNA,Enteric bacteria and other eubacteria,inhibitor,yes
DB01303,Oxtriphylline,small molecule,approved,C[N+](C)(C)CCO.CN1C2=C([N-]C=N2)C(=O)N(C)C1=O,RLANKEDHRWMNRO-UHFFFAOYSA-M,283.3268,Q14432,BE0000436,"cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A",Humans,inhibitor,yes
DB01303,Oxtriphylline,small molecule,approved,C[N+](C)(C)CCO.CN1C2=C([N-]C=N2)C(=O)N(C)C1=O,RLANKEDHRWMNRO-UHFFFAOYSA-M,283.3268,P27815,BE0001133,"3',5'-cyclic-AMP phosphodiesterase 4A",Humans,inhibitor,yes
DB01303,Oxtriphylline,small molecule,approved,C[N+](C)(C)CCO.CN1C2=C([N-]C=N2)C(=O)N(C)C1=O,RLANKEDHRWMNRO-UHFFFAOYSA-M,283.3268,P29274,BE0000924,Adenosine receptor A2a,Humans,antagonist,yes
DB01303,Oxtriphylline,small molecule,approved,C[N+](C)(C)CCO.CN1C2=C([N-]C=N2)C(=O)N(C)C1=O,RLANKEDHRWMNRO-UHFFFAOYSA-M,283.3268,P30542,BE0000013,Adenosine receptor A1,Humans,antagonist,yes
DB01303,Oxtriphylline,small molecule,approved,C[N+](C)(C)CCO.CN1C2=C([N-]C=N2)C(=O)N(C)C1=O,RLANKEDHRWMNRO-UHFFFAOYSA-M,283.3268,Q92769,BE0002366,Histone deacetylase 2,Humans,activator,yes
DB01319,Fosamprenavir,small molecule,approved,CC(C)CN(C[C@@H](OP(O)(O)=O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)C1=CC=C(N)C=C1,MLBVMOWEQCZNCC-OEMFJLHTSA-N,585.607,Q72874,BE0004854,Pol polyprotein,Human immunodeficiency virus 1,inhibitor,yes
DB01319,Fosamprenavir,small molecule,approved,CC(C)CN(C[C@@H](OP(O)(O)=O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)C1=CC=C(N)C=C1,MLBVMOWEQCZNCC-OEMFJLHTSA-N,585.607,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB01320,Fosphenytoin,small molecule,approved;investigational,OP(O)(=O)OCN1C(=O)NC(C1=O)(C1=CC=CC=C1)C1=CC=CC=C1,XWLUWCNOOVRFPX-UHFFFAOYSA-N,362.2739,Q14524,BE0000197,Sodium channel protein type 5 subunit alpha,Humans,inhibitor,yes
DB01321,Josamycin,small molecule,investigational,CO[C@H]1[C@@H](CC(=O)O[C@H](C)C\C=C\C=C\[C@H](O)[C@H](C)C[C@H](CC=O)[C@@H]1O[C@@H]1O[C@H](C)[C@@H](O[C@H]2C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O2)[C@@H]([C@H]1O)N(C)C)OC(C)=O,XJSFLOJWULLJQS-NGVXBBESSA-N,827.995,P44345,BE0003720,50S ribosomal protein L4,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd),inhibitor,yes
DB01324,Polythiazide,small molecule,approved,CN1C(CSCC(F)(F)F)NC2=CC(Cl)=C(C=C2S1(=O)=O)S(N)(=O)=O,CYLWJCABXYDINA-UHFFFAOYSA-N,439.882,P55017,BE0000419,Solute carrier family 12 member 3,Humans,inhibitor,yes
DB01325,Quinethazone,small molecule,approved,CCC1NC(=O)C2=CC(=C(Cl)C=C2N1)S(N)(=O)=O,AGMMTXLNIQSRCG-UHFFFAOYSA-N,289.739,Q13621,BE0000502,Solute carrier family 12 member 1,Humans,inhibitor,yes
DB01325,Quinethazone,small molecule,approved,CCC1NC(=O)C2=CC(=C(Cl)C=C2N1)S(N)(=O)=O,AGMMTXLNIQSRCG-UHFFFAOYSA-N,289.739,P55011,BE0000281,Solute carrier family 12 member 2,Humans,inhibitor,yes
DB01325,Quinethazone,small molecule,approved,CCC1NC(=O)C2=CC(=C(Cl)C=C2N1)S(N)(=O)=O,AGMMTXLNIQSRCG-UHFFFAOYSA-N,289.739,P55017,BE0000419,Solute carrier family 12 member 3,Humans,inhibitor,yes
DB01325,Quinethazone,small molecule,approved,CCC1NC(=O)C2=CC(=C(Cl)C=C2N1)S(N)(=O)=O,AGMMTXLNIQSRCG-UHFFFAOYSA-N,289.739,P00915,BE0000267,Carbonic anhydrase 1,Humans,inhibitor,yes
DB01325,Quinethazone,small molecule,approved,CCC1NC(=O)C2=CC(=C(Cl)C=C2N1)S(N)(=O)=O,AGMMTXLNIQSRCG-UHFFFAOYSA-N,289.739,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB01326,Cefamandole,small molecule,approved;experimental,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@H]2NC(=O)[C@H](O)C1=CC=CC=C1)C(O)=O,OLVCFLKTBJRLHI-AXAPSJFSSA-N,462.503,Q70KI2,BE0003688,Penicillin-binding protein 2,Bacteroides fragilis,inhibitor,yes
DB01327,Cefazolin,small molecule,approved,[H][C@]12SCC(CSC3=NN=C(C)S3)=C(N1C(=O)[C@H]2NC(=O)CN1C=NN=N1)C(O)=O,MLYYVTUWGNIJIB-BXKDBHETSA-N,454.507,P02918,BE0000588,Penicillin-binding protein 1A,Escherichia coli (strain K12),inhibitor,yes
DB01327,Cefazolin,small molecule,approved,[H][C@]12SCC(CSC3=NN=C(C)S3)=C(N1C(=O)[C@H]2NC(=O)CN1C=NN=N1)C(O)=O,MLYYVTUWGNIJIB-BXKDBHETSA-N,454.507,P02919,BE0000488,Penicillin-binding protein 1B,Escherichia coli (strain K12),inhibitor,yes
DB01327,Cefazolin,small molecule,approved,[H][C@]12SCC(CSC3=NN=C(C)S3)=C(N1C(=O)[C@H]2NC(=O)CN1C=NN=N1)C(O)=O,MLYYVTUWGNIJIB-BXKDBHETSA-N,454.507,P76577,BE0003723,Penicillin-binding protein 1C,Escherichia coli (strain K12),inhibitor,yes
DB01327,Cefazolin,small molecule,approved,[H][C@]12SCC(CSC3=NN=C(C)S3)=C(N1C(=O)[C@H]2NC(=O)CN1C=NN=N1)C(O)=O,MLYYVTUWGNIJIB-BXKDBHETSA-N,454.507,P0AD65,BE0003579,Penicillin-binding protein 2,Escherichia coli (strain K12),inhibitor,yes
DB01327,Cefazolin,small molecule,approved,[H][C@]12SCC(CSC3=NN=C(C)S3)=C(N1C(=O)[C@H]2NC(=O)CN1C=NN=N1)C(O)=O,MLYYVTUWGNIJIB-BXKDBHETSA-N,454.507,P0AD68,BE0002393,Peptidoglycan synthase FtsI,Escherichia coli (strain K12),inhibitor,yes
DB01328,Cefonicid,small molecule,approved;investigational,[H][C@]12SCC(CSC3=NN=NN3CS(O)(=O)=O)=C(N1C(=O)[C@H]2NC(=O)[C@H](O)C1=CC=CC=C1)C(O)=O,DYAIAHUQIPBDIP-AXAPSJFSSA-N,542.566,P02918,BE0000588,Penicillin-binding protein 1A,Escherichia coli (strain K12),inhibitor,yes
DB01328,Cefonicid,small molecule,approved;investigational,[H][C@]12SCC(CSC3=NN=NN3CS(O)(=O)=O)=C(N1C(=O)[C@H]2NC(=O)[C@H](O)C1=CC=CC=C1)C(O)=O,DYAIAHUQIPBDIP-AXAPSJFSSA-N,542.566,P0AD68,BE0002393,Peptidoglycan synthase FtsI,Escherichia coli (strain K12),inhibitor,yes
DB01328,Cefonicid,small molecule,approved;investigational,[H][C@]12SCC(CSC3=NN=NN3CS(O)(=O)=O)=C(N1C(=O)[C@H]2NC(=O)[C@H](O)C1=CC=CC=C1)C(O)=O,DYAIAHUQIPBDIP-AXAPSJFSSA-N,542.566,P02919,BE0000488,Penicillin-binding protein 1B,Escherichia coli (strain K12),inhibitor,yes
DB01328,Cefonicid,small molecule,approved;investigational,[H][C@]12SCC(CSC3=NN=NN3CS(O)(=O)=O)=C(N1C(=O)[C@H]2NC(=O)[C@H](O)C1=CC=CC=C1)C(O)=O,DYAIAHUQIPBDIP-AXAPSJFSSA-N,542.566,P24228,BE0000744,D-alanyl-D-alanine carboxypeptidase DacB,Escherichia coli (strain K12),inhibitor,yes
DB01328,Cefonicid,small molecule,approved;investigational,[H][C@]12SCC(CSC3=NN=NN3CS(O)(=O)=O)=C(N1C(=O)[C@H]2NC(=O)[C@H](O)C1=CC=CC=C1)C(O)=O,DYAIAHUQIPBDIP-AXAPSJFSSA-N,542.566,P0AD65,BE0003579,Penicillin-binding protein 2,Escherichia coli (strain K12),inhibitor,yes
DB01329,Cefoperazone,small molecule,approved;investigational,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](NC(=O)N1CCN(CC)C(=O)C1=O)C1=CC=C(O)C=C1)C(O)=O,GCFBRXLSHGKWDP-XCGNWRKASA-N,645.67,P0AD68,BE0002393,Peptidoglycan synthase FtsI,Escherichia coli (strain K12),inhibitor,yes
DB01329,Cefoperazone,small molecule,approved;investigational,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](NC(=O)N1CCN(CC)C(=O)C1=O)C1=CC=C(O)C=C1)C(O)=O,GCFBRXLSHGKWDP-XCGNWRKASA-N,645.67,P02919,BE0000488,Penicillin-binding protein 1B,Escherichia coli (strain K12),inhibitor,yes
DB01329,Cefoperazone,small molecule,approved;investigational,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](NC(=O)N1CCN(CC)C(=O)C1=O)C1=CC=C(O)C=C1)C(O)=O,GCFBRXLSHGKWDP-XCGNWRKASA-N,645.67,P0AD65,BE0003579,Penicillin-binding protein 2,Escherichia coli (strain K12),inhibitor,yes
DB01329,Cefoperazone,small molecule,approved;investigational,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](NC(=O)N1CCN(CC)C(=O)C1=O)C1=CC=C(O)C=C1)C(O)=O,GCFBRXLSHGKWDP-XCGNWRKASA-N,645.67,Q07806,BE0003686,Penicillin-binding protein 1A,Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228),inhibitor,yes
DB01329,Cefoperazone,small molecule,approved;investigational,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](NC(=O)N1CCN(CC)C(=O)C1=O)C1=CC=C(O)C=C1)C(O)=O,GCFBRXLSHGKWDP-XCGNWRKASA-N,645.67,Q9X6W0,BE0003687,Penicillin-binding protein 1B,Pseudomonas aeruginosa,inhibitor,yes
DB01329,Cefoperazone,small molecule,approved;investigational,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](NC(=O)N1CCN(CC)C(=O)C1=O)C1=CC=C(O)C=C1)C(O)=O,GCFBRXLSHGKWDP-XCGNWRKASA-N,645.67,P08506,BE0003685,D-alanyl-D-alanine carboxypeptidase DacC,Escherichia coli (strain K12),inhibitor,yes
DB01329,Cefoperazone,small molecule,approved;investigational,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](NC(=O)N1CCN(CC)C(=O)C1=O)C1=CC=C(O)C=C1)C(O)=O,GCFBRXLSHGKWDP-XCGNWRKASA-N,645.67,P02918,BE0000588,Penicillin-binding protein 1A,Escherichia coli (strain K12),inhibitor,yes
DB01329,Cefoperazone,small molecule,approved;investigational,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](NC(=O)N1CCN(CC)C(=O)C1=O)C1=CC=C(O)C=C1)C(O)=O,GCFBRXLSHGKWDP-XCGNWRKASA-N,645.67,P0AEB2,BE0002063,D-alanyl-D-alanine carboxypeptidase DacA,Escherichia coli (strain K12),inhibitor,yes
DB01329,Cefoperazone,small molecule,approved;investigational,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](NC(=O)N1CCN(CC)C(=O)C1=O)C1=CC=C(O)C=C1)C(O)=O,GCFBRXLSHGKWDP-XCGNWRKASA-N,645.67,P24228,BE0000744,D-alanyl-D-alanine carboxypeptidase DacB,Escherichia coli (strain K12),inhibitor,yes
DB01330,Cefotetan,small molecule,approved,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@]2(NC(=O)C1SC(S1)=C(C(N)=O)C(O)=O)OC)C(O)=O,SRZNHPXWXCNNDU-IXOPCIAXSA-N,575.619,Q75Y35,BE0004643,Penicillin-binding protein 3,Streptococcus pneumoniae,inhibitor,yes
DB01331,Cefoxitin,small molecule,approved,[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@]2(NC(=O)CC1=CC=CS1)OC)C(O)=O,WZOZEZRFJCJXNZ-ZBFHGGJFSA-N,427.452,P08506,BE0003685,D-alanyl-D-alanine carboxypeptidase DacC,Escherichia coli (strain K12),inhibitor,yes
DB01331,Cefoxitin,small molecule,approved,[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@]2(NC(=O)CC1=CC=CS1)OC)C(O)=O,WZOZEZRFJCJXNZ-ZBFHGGJFSA-N,427.452,P0AEB2,BE0002063,D-alanyl-D-alanine carboxypeptidase DacA,Escherichia coli (strain K12),inhibitor,yes
DB01331,Cefoxitin,small molecule,approved,[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@]2(NC(=O)CC1=CC=CS1)OC)C(O)=O,WZOZEZRFJCJXNZ-ZBFHGGJFSA-N,427.452,P0AFI5,BE0004430,D-alanyl-D-alanine endopeptidase,Escherichia coli (strain K12),inhibitor,yes
DB01331,Cefoxitin,small molecule,approved,[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@]2(NC(=O)CC1=CC=CS1)OC)C(O)=O,WZOZEZRFJCJXNZ-ZBFHGGJFSA-N,427.452,P24228,BE0000744,D-alanyl-D-alanine carboxypeptidase DacB,Escherichia coli (strain K12),inhibitor,yes
DB01331,Cefoxitin,small molecule,approved,[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@]2(NC(=O)CC1=CC=CS1)OC)C(O)=O,WZOZEZRFJCJXNZ-ZBFHGGJFSA-N,427.452,P02918,BE0000588,Penicillin-binding protein 1A,Escherichia coli (strain K12),inhibitor,yes
DB01331,Cefoxitin,small molecule,approved,[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@]2(NC(=O)CC1=CC=CS1)OC)C(O)=O,WZOZEZRFJCJXNZ-ZBFHGGJFSA-N,427.452,P02919,BE0000488,Penicillin-binding protein 1B,Escherichia coli (strain K12),inhibitor,yes
DB01331,Cefoxitin,small molecule,approved,[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@]2(NC(=O)CC1=CC=CS1)OC)C(O)=O,WZOZEZRFJCJXNZ-ZBFHGGJFSA-N,427.452,P0AD68,BE0002393,Peptidoglycan synthase FtsI,Escherichia coli (strain K12),inhibitor,yes
DB01331,Cefoxitin,small molecule,approved,[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@]2(NC(=O)CC1=CC=CS1)OC)C(O)=O,WZOZEZRFJCJXNZ-ZBFHGGJFSA-N,427.452,Q75Y35,BE0004643,Penicillin-binding protein 3,Streptococcus pneumoniae,inhibitor,yes
DB01331,Cefoxitin,small molecule,approved,[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@]2(NC(=O)CC1=CC=CS1)OC)C(O)=O,WZOZEZRFJCJXNZ-ZBFHGGJFSA-N,427.452,Q7CRA4,BE0004335,Penicillin-binding protein 1b,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB01331,Cefoxitin,small molecule,approved,[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@]2(NC(=O)CC1=CC=CS1)OC)C(O)=O,WZOZEZRFJCJXNZ-ZBFHGGJFSA-N,427.452,Q8DNB6,BE0004644,Penicillin-binding protein 2a,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB01331,Cefoxitin,small molecule,approved,[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@]2(NC(=O)CC1=CC=CS1)OC)C(O)=O,WZOZEZRFJCJXNZ-ZBFHGGJFSA-N,427.452,Q8DR59,BE0004290,Penicillin-binding protein 1A,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB01331,Cefoxitin,small molecule,approved,[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@]2(NC(=O)CC1=CC=CS1)OC)C(O)=O,WZOZEZRFJCJXNZ-ZBFHGGJFSA-N,427.452,P0A3M6,BE0003624,Penicillin-binding protein 2B,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB01332,Ceftizoxime,small molecule,approved;withdrawn,[H][C@]12SCC=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,NNULBSISHYWZJU-LLKWHZGFSA-N,383.403,P02918,BE0000588,Penicillin-binding protein 1A,Escherichia coli (strain K12),inhibitor,yes
DB01332,Ceftizoxime,small molecule,approved;withdrawn,[H][C@]12SCC=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,NNULBSISHYWZJU-LLKWHZGFSA-N,383.403,P02919,BE0000488,Penicillin-binding protein 1B,Escherichia coli (strain K12),inhibitor,yes
DB01333,Cefradine,small molecule,approved,[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CCC=CC1)C(O)=O,RDLPVSKMFDYCOR-UEKVPHQBSA-N,349.405,P02918,BE0000588,Penicillin-binding protein 1A,Escherichia coli (strain K12),inhibitor,yes
DB01336,Metocurine,small molecule,approved,[H][C@@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC(OC6=C(OC)C=C(CC[N+]1(C)C)C2=C6)=C(OC)C=C5)=CC(OC)=C4OC)C=C3,JFXBEKISTKFVAB-AJQTZOPKSA-N,652.8189,Q15822,BE0000738,Neuronal acetylcholine receptor subunit alpha-2,Humans,antagonist,yes
DB01337,Pancuronium,small molecule,approved,[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)[N+]1(C)CCCCC1)[N+]1(C)CCCCC1,GVEAYVLWDAFXET-XGHATYIMSA-N,572.8619,Q15822,BE0000738,Neuronal acetylcholine receptor subunit alpha-2,Humans,antagonist,yes
DB01338,Pipecuronium,small molecule,approved,[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)N1CC[N+](C)(C)CC1)N1CC[N+](C)(C)CC1,OWWLUIWOFHMHOQ-XGHATYIMSA-N,602.8912,Q15822,BE0000738,Neuronal acetylcholine receptor subunit alpha-2,Humans,antagonist,yes
DB01339,Vecuronium,small molecule,approved;investigational,[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)N1CCCCC1)[N+]1(C)CCCCC1,BGSZAXLLHYERSY-XQIGCQGXSA-N,557.8274,Q15822,BE0000738,Neuronal acetylcholine receptor subunit alpha-2,Humans,antagonist,yes
DB01340,Cilazapril,small molecule,approved,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]1CCCN2CCC[C@H](N2C1=O)C(O)=O,HHHKFGXWKKUNCY-FHWLQOOXSA-N,417.4986,P12821,BE0000221,Angiotensin-converting enzyme,Humans,inhibitor,yes
DB01342,Forasartan,small molecule,experimental,CCCCC1=NN(CC2=CN=C(C=C2)C2=CC=CC=C2C2=NNN=N2)C(CCCC)=N1,YONOBYIBNBCDSJ-UHFFFAOYSA-N,416.522,P30556,BE0000062,Type-1 angiotensin II receptor,Humans,antagonist,yes
DB01346,Quinidine barbiturate,small molecule,approved,CCC1(C(=O)NC(=O)NC1=O)C1=CC=CC=C1.COC1=CC2=C(C=CN=C2C=C1)C(O)C1CC2CCN1CC2C=C,YHRUERMOPBDCFD-UHFFFAOYSA-N,556.652,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,potentiator,yes
DB01346,Quinidine barbiturate,small molecule,approved,CCC1(C(=O)NC(=O)NC1=O)C1=CC=CC=C1.COC1=CC2=C(C=CN=C2C=C1)C(O)C1CC2CCN1CC2C=C,YHRUERMOPBDCFD-UHFFFAOYSA-N,556.652,P47869,BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,Humans,potentiator,yes
DB01346,Quinidine barbiturate,small molecule,approved,CCC1(C(=O)NC(=O)NC1=O)C1=CC=CC=C1.COC1=CC2=C(C=CN=C2C=C1)C(O)C1CC2CCN1CC2C=C,YHRUERMOPBDCFD-UHFFFAOYSA-N,556.652,Q14524,BE0000197,Sodium channel protein type 5 subunit alpha,Humans,inhibitor,yes
DB01347,Saprisartan,small molecule,experimental,CCC1=NC(C2CC2)=C(N1CC1=CC2=C(OC(=C2Br)C2=CC=CC=C2NS(=O)(=O)C(F)(F)F)C=C1)C(N)=O,DUEWVPTZCSAMNB-UHFFFAOYSA-N,611.431,P30556,BE0000062,Type-1 angiotensin II receptor,Humans,antagonist,yes
DB01348,Spirapril,small molecule,approved,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2(C[C@H]1C(O)=O)SCCS2,HRWCVUIFMSZDJS-SZMVWBNQSA-N,466.614,P12821,BE0000221,Angiotensin-converting enzyme,Humans,inhibitor,yes
DB01349,Tasosartan,small molecule,experimental,CC1=NC(C)=C2CCC(=O)N(CC3=CC=C(C=C3)C3=CC=CC=C3C3=NNN=N3)C2=N1,ADXGNEYLLLSOAR-UHFFFAOYSA-N,411.4591,P30556,BE0000062,Type-1 angiotensin II receptor,Humans,antagonist,yes
DB01351,Amobarbital,small molecule,approved;illicit,CCC1(CCC(C)C)C(=O)NC(=O)NC1=O,VIROVYVQCGLCII-UHFFFAOYSA-N,226.2722,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,potentiator,yes
DB01351,Amobarbital,small molecule,approved;illicit,CCC1(CCC(C)C)C(=O)NC(=O)NC1=O,VIROVYVQCGLCII-UHFFFAOYSA-N,226.2722,P47869,BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,Humans,potentiator,yes
DB01351,Amobarbital,small molecule,approved;illicit,CCC1(CCC(C)C)C(=O)NC(=O)NC1=O,VIROVYVQCGLCII-UHFFFAOYSA-N,226.2722,P34903,BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,Humans,potentiator,yes
DB01351,Amobarbital,small molecule,approved;illicit,CCC1(CCC(C)C)C(=O)NC(=O)NC1=O,VIROVYVQCGLCII-UHFFFAOYSA-N,226.2722,P48169,BE0000478,Gamma-aminobutyric acid receptor subunit alpha-4,Humans,potentiator,yes
DB01351,Amobarbital,small molecule,approved;illicit,CCC1(CCC(C)C)C(=O)NC(=O)NC1=O,VIROVYVQCGLCII-UHFFFAOYSA-N,226.2722,P31644,BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,Humans,potentiator,yes
DB01351,Amobarbital,small molecule,approved;illicit,CCC1(CCC(C)C)C(=O)NC(=O)NC1=O,VIROVYVQCGLCII-UHFFFAOYSA-N,226.2722,Q16445,BE0000764,Gamma-aminobutyric acid receptor subunit alpha-6,Humans,potentiator,yes
DB01352,Aprobarbital,small molecule,experimental;illicit,CC(C)C1(CC=C)C(=O)NC(=O)NC1=O,UORJNBVJVRLXMQ-UHFFFAOYSA-N,210.2298,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,potentiator,yes
DB01352,Aprobarbital,small molecule,experimental;illicit,CC(C)C1(CC=C)C(=O)NC(=O)NC1=O,UORJNBVJVRLXMQ-UHFFFAOYSA-N,210.2298,P47869,BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,Humans,potentiator,yes
DB01352,Aprobarbital,small molecule,experimental;illicit,CC(C)C1(CC=C)C(=O)NC(=O)NC1=O,UORJNBVJVRLXMQ-UHFFFAOYSA-N,210.2298,P34903,BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,Humans,potentiator,yes
DB01352,Aprobarbital,small molecule,experimental;illicit,CC(C)C1(CC=C)C(=O)NC(=O)NC1=O,UORJNBVJVRLXMQ-UHFFFAOYSA-N,210.2298,P48169,BE0000478,Gamma-aminobutyric acid receptor subunit alpha-4,Humans,potentiator,yes
DB01352,Aprobarbital,small molecule,experimental;illicit,CC(C)C1(CC=C)C(=O)NC(=O)NC1=O,UORJNBVJVRLXMQ-UHFFFAOYSA-N,210.2298,P31644,BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,Humans,potentiator,yes
DB01352,Aprobarbital,small molecule,experimental;illicit,CC(C)C1(CC=C)C(=O)NC(=O)NC1=O,UORJNBVJVRLXMQ-UHFFFAOYSA-N,210.2298,Q16445,BE0000764,Gamma-aminobutyric acid receptor subunit alpha-6,Humans,potentiator,yes
DB01353,Butobarbital,small molecule,approved;illicit,CCCCC1(CC)C(=O)NC(=O)NC1=O,STDBAQMTJLUMFW-UHFFFAOYSA-N,212.2456,P47869,BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,Humans,potentiator,yes
DB01353,Butobarbital,small molecule,approved;illicit,CCCCC1(CC)C(=O)NC(=O)NC1=O,STDBAQMTJLUMFW-UHFFFAOYSA-N,212.2456,P34903,BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,Humans,potentiator,yes
DB01353,Butobarbital,small molecule,approved;illicit,CCCCC1(CC)C(=O)NC(=O)NC1=O,STDBAQMTJLUMFW-UHFFFAOYSA-N,212.2456,P48169,BE0000478,Gamma-aminobutyric acid receptor subunit alpha-4,Humans,potentiator,yes
DB01353,Butobarbital,small molecule,approved;illicit,CCCCC1(CC)C(=O)NC(=O)NC1=O,STDBAQMTJLUMFW-UHFFFAOYSA-N,212.2456,P31644,BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,Humans,potentiator,yes
DB01353,Butobarbital,small molecule,approved;illicit,CCCCC1(CC)C(=O)NC(=O)NC1=O,STDBAQMTJLUMFW-UHFFFAOYSA-N,212.2456,Q16445,BE0000764,Gamma-aminobutyric acid receptor subunit alpha-6,Humans,potentiator,yes
DB01353,Butobarbital,small molecule,approved;illicit,CCCCC1(CC)C(=O)NC(=O)NC1=O,STDBAQMTJLUMFW-UHFFFAOYSA-N,212.2456,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,potentiator,yes
DB01354,Heptabarbital,small molecule,experimental,CCC1(C(=O)NC(=O)NC1=O)C1=CCCCCC1,PAZQYDJGLKSCSI-UHFFFAOYSA-N,250.2936,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,potentiator,yes
DB01354,Heptabarbital,small molecule,experimental,CCC1(C(=O)NC(=O)NC1=O)C1=CCCCCC1,PAZQYDJGLKSCSI-UHFFFAOYSA-N,250.2936,P47869,BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,Humans,potentiator,yes
DB01354,Heptabarbital,small molecule,experimental,CCC1(C(=O)NC(=O)NC1=O)C1=CCCCCC1,PAZQYDJGLKSCSI-UHFFFAOYSA-N,250.2936,P34903,BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,Humans,potentiator,yes
DB01354,Heptabarbital,small molecule,experimental,CCC1(C(=O)NC(=O)NC1=O)C1=CCCCCC1,PAZQYDJGLKSCSI-UHFFFAOYSA-N,250.2936,P48169,BE0000478,Gamma-aminobutyric acid receptor subunit alpha-4,Humans,potentiator,yes
DB01354,Heptabarbital,small molecule,experimental,CCC1(C(=O)NC(=O)NC1=O)C1=CCCCCC1,PAZQYDJGLKSCSI-UHFFFAOYSA-N,250.2936,P31644,BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,Humans,potentiator,yes
DB01354,Heptabarbital,small molecule,experimental,CCC1(C(=O)NC(=O)NC1=O)C1=CCCCCC1,PAZQYDJGLKSCSI-UHFFFAOYSA-N,250.2936,Q16445,BE0000764,Gamma-aminobutyric acid receptor subunit alpha-6,Humans,potentiator,yes
DB01355,Hexobarbital,small molecule,experimental,CN1C(=O)NC(=O)C(C)(C1=O)C1=CCCCC1,UYXAWHWODHRRMR-UHFFFAOYSA-N,236.267,P47869,BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,Humans,potentiator,yes
DB01355,Hexobarbital,small molecule,experimental,CN1C(=O)NC(=O)C(C)(C1=O)C1=CCCCC1,UYXAWHWODHRRMR-UHFFFAOYSA-N,236.267,P34903,BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,Humans,potentiator,yes
DB01355,Hexobarbital,small molecule,experimental,CN1C(=O)NC(=O)C(C)(C1=O)C1=CCCCC1,UYXAWHWODHRRMR-UHFFFAOYSA-N,236.267,P48169,BE0000478,Gamma-aminobutyric acid receptor subunit alpha-4,Humans,potentiator,yes
DB01355,Hexobarbital,small molecule,experimental,CN1C(=O)NC(=O)C(C)(C1=O)C1=CCCCC1,UYXAWHWODHRRMR-UHFFFAOYSA-N,236.267,P31644,BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,Humans,potentiator,yes
DB01355,Hexobarbital,small molecule,experimental,CN1C(=O)NC(=O)C(C)(C1=O)C1=CCCCC1,UYXAWHWODHRRMR-UHFFFAOYSA-N,236.267,Q16445,BE0000764,Gamma-aminobutyric acid receptor subunit alpha-6,Humans,potentiator,yes
DB01355,Hexobarbital,small molecule,experimental,CN1C(=O)NC(=O)C(C)(C1=O)C1=CCCCC1,UYXAWHWODHRRMR-UHFFFAOYSA-N,236.267,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,potentiator,yes
DB01357,Mestranol,small molecule,approved,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OC)C=C3,IMSSROKUHAOUJS-MJCUULBUSA-N,310.4299,P03372,BE0000123,Estrogen receptor,Humans,agonist,yes
DB01359,Penbutolol,small molecule,approved;investigational,CC(C)(C)NC[C@H](O)COC1=CC=CC=C1C1CCCC1,KQXKVJAGOJTNJS-HNNXBMFYSA-N,291.4284,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,antagonist;partial agonist,yes
DB01359,Penbutolol,small molecule,approved;investigational,CC(C)(C)NC[C@H](O)COC1=CC=CC=C1C1CCCC1,KQXKVJAGOJTNJS-HNNXBMFYSA-N,291.4284,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,antagonist;partial agonist,yes
DB01359,Penbutolol,small molecule,approved;investigational,CC(C)(C)NC[C@H](O)COC1=CC=CC=C1C1CCCC1,KQXKVJAGOJTNJS-HNNXBMFYSA-N,291.4284,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,antagonist,yes
DB01364,Ephedrine,small molecule,approved,CN[C@@H](C)[C@H](O)C1=CC=CC=C1,KWGRBVOPPLSCSI-WPRPVWTQSA-N,165.2322,P14416,BE0000756,D(2) dopamine receptor,Humans,agonist,yes
DB01364,Ephedrine,small molecule,approved,CN[C@@H](C)[C@H](O)C1=CC=CC=C1,KWGRBVOPPLSCSI-WPRPVWTQSA-N,165.2322,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,agonist,yes
DB01364,Ephedrine,small molecule,approved,CN[C@@H](C)[C@H](O)C1=CC=CC=C1,KWGRBVOPPLSCSI-WPRPVWTQSA-N,165.2322,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,agonist,yes
DB01364,Ephedrine,small molecule,approved,CN[C@@H](C)[C@H](O)C1=CC=CC=C1,KWGRBVOPPLSCSI-WPRPVWTQSA-N,165.2322,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,agonist,yes
DB01365,Mephentermine,small molecule,approved,CNC(C)(C)CC1=CC=CC=C1,RXQCGGRTAILOIN-UHFFFAOYSA-N,163.2594,P35348,BE0004888,Alpha adrenergic receptor,Humans,agonist,yes
DB01365,Mephentermine,small molecule,approved,CNC(C)(C)CC1=CC=CC=C1,RXQCGGRTAILOIN-UHFFFAOYSA-N,163.2594,P14416,BE0000756,D(2) dopamine receptor,Humans,agonist,yes
DB01366,Procaterol,small molecule,approved;investigational,CC[C@@H](NC(C)C)[C@@H](O)C1=CC=C(O)C2=C1C=CC(=O)N2,FKNXQNWAXFXVNW-WBMJQRKESA-N,290.363,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,agonist,yes
DB01367,Rasagiline,small molecule,approved,C#CCN[C@@H]1CCC2=CC=CC=C12,RUOKEQAAGRXIBM-GFCCVEGCSA-N,171.2383,P27338,BE0002196,Amine oxidase [flavin-containing] B,Humans,inhibitor,yes
DB01367,Rasagiline,small molecule,approved,C#CCN[C@@H]1CCC2=CC=CC=C12,RUOKEQAAGRXIBM-GFCCVEGCSA-N,171.2383,P10415,BE0000246,Apoptosis regulator Bcl-2,Humans,activator,yes
DB01369,Quinupristin,small molecule,approved,[H][C@@]12CCCN1C(=O)[C@@H](CC)NC(=O)[C@@H](NC(=O)C1=NC=CC=C1O)[C@@H](C)OC(=O)[C@@H](NC(=O)[C@]1([H])CC(=O)[C@]([H])(CS[C@@H]3CN4CCC3CC4)CN1C(=O)[C@H](CC1=CC=C(C=C1)N(C)C)N(C)C2=O)C1=CC=CC=C1,WTHRRGMBUAHGNI-LCYNINFDSA-N,1022.23,,BE0004800,23S ribosomal RNA,Enteric bacteria and other eubacteria,inhibitor,yes
DB01369,Quinupristin,small molecule,approved,[H][C@@]12CCCN1C(=O)[C@@H](CC)NC(=O)[C@@H](NC(=O)C1=NC=CC=C1O)[C@@H](C)OC(=O)[C@@H](NC(=O)[C@]1([H])CC(=O)[C@]([H])(CS[C@@H]3CN4CCC3CC4)CN1C(=O)[C@H](CC1=CC=C(C=C1)N(C)C)N(C)C2=O)C1=CC=CC=C1,WTHRRGMBUAHGNI-LCYNINFDSA-N,1022.23,P0A7J6,BE0000743,50S ribosomal protein L10,Shigella flexneri,inhibitor,yes
DB01369,Quinupristin,small molecule,approved,[H][C@@]12CCCN1C(=O)[C@@H](CC)NC(=O)[C@@H](NC(=O)C1=NC=CC=C1O)[C@@H](C)OC(=O)[C@@H](NC(=O)[C@]1([H])CC(=O)[C@]([H])(CS[C@@H]3CN4CCC3CC4)CN1C(=O)[C@H](CC1=CC=C(C=C1)N(C)C)N(C)C2=O)C1=CC=CC=C1,WTHRRGMBUAHGNI-LCYNINFDSA-N,1022.23,P61177,BE0002464,50S ribosomal protein L22,Escherichia coli O157:H7,inhibitor,yes
DB01380,Cortisone acetate,small molecule,approved;investigational,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,ITRJWOMZKQRYTA-RFZYENFJSA-N,402.4807,O95718,BE0005001,Steroid hormone receptor ERR2,Humans,modulator,yes
DB01380,Cortisone acetate,small molecule,approved;investigational,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,ITRJWOMZKQRYTA-RFZYENFJSA-N,402.4807,P62508,BE0002088,Estrogen-related receptor gamma,Humans,modulator,yes
DB01380,Cortisone acetate,small molecule,approved;investigational,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,ITRJWOMZKQRYTA-RFZYENFJSA-N,402.4807,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB01380,Cortisone acetate,small molecule,approved;investigational,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,ITRJWOMZKQRYTA-RFZYENFJSA-N,402.4807,P11474,BE0003722,Steroid hormone receptor ERR1,Humans,modulator,yes
DB01382,Glymidine,small molecule,approved;investigational,COCCOC1=CN=C(NS(=O)(=O)C2=CC=CC=C2)N=C1,QFWPJPIVLCBXFJ-UHFFFAOYSA-N,309.341,P78508,BE0009591,ATP-sensitive inward rectifier potassium channel 10,Humans,binder,yes
DB01384,Paramethasone,small molecule,experimental,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,MKPDWECBUAZOHP-AFYJWTTESA-N,392.4611,P08185,BE0000209,Corticosteroid-binding globulin,Humans,binder,yes
DB01384,Paramethasone,small molecule,experimental,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,MKPDWECBUAZOHP-AFYJWTTESA-N,392.4611,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB01388,Mibefradil,small molecule,investigational;withdrawn,COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=CC=CC=C3N2)CCC2=C(C=CC(F)=C2)[C@@H]1C(C)C,HBNPJJILLOYFJU-VMPREFPWSA-N,495.6287,O43497,BE0000483,Voltage-dependent T-type calcium channel subunit alpha-1G,Humans,inhibitor,yes
DB01388,Mibefradil,small molecule,investigational;withdrawn,COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=CC=CC=C3N2)CCC2=C(C=CC(F)=C2)[C@@H]1C(C)C,HBNPJJILLOYFJU-VMPREFPWSA-N,495.6287,O95180,BE0000864,Voltage-dependent T-type calcium channel subunit alpha-1H,Humans,inhibitor,yes
DB01388,Mibefradil,small molecule,investigational;withdrawn,COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=CC=CC=C3N2)CCC2=C(C=CC(F)=C2)[C@@H]1C(C)C,HBNPJJILLOYFJU-VMPREFPWSA-N,495.6287,Q13936,BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,Humans,inhibitor,yes
DB01388,Mibefradil,small molecule,investigational;withdrawn,COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=CC=CC=C3N2)CCC2=C(C=CC(F)=C2)[C@@H]1C(C)C,HBNPJJILLOYFJU-VMPREFPWSA-N,495.6287,Q01668,BE0002359,Voltage-dependent L-type calcium channel subunit alpha-1D,Humans,inhibitor,yes
DB01388,Mibefradil,small molecule,investigational;withdrawn,COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=CC=CC=C3N2)CCC2=C(C=CC(F)=C2)[C@@H]1C(C)C,HBNPJJILLOYFJU-VMPREFPWSA-N,495.6287,O60840,BE0002357,Voltage-dependent L-type calcium channel subunit alpha-1F,Humans,inhibitor,yes
DB01388,Mibefradil,small molecule,investigational;withdrawn,COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=CC=CC=C3N2)CCC2=C(C=CC(F)=C2)[C@@H]1C(C)C,HBNPJJILLOYFJU-VMPREFPWSA-N,495.6287,Q9P0X4,BE0000012,Voltage-dependent T-type calcium channel subunit alpha-1I,Humans,inhibitor,yes
DB01388,Mibefradil,small molecule,investigational;withdrawn,COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=CC=CC=C3N2)CCC2=C(C=CC(F)=C2)[C@@H]1C(C)C,HBNPJJILLOYFJU-VMPREFPWSA-N,495.6287,Q13698,BE0002355,Voltage-dependent L-type calcium channel subunit alpha-1S,Humans,inhibitor,yes
DB01388,Mibefradil,small molecule,investigational;withdrawn,COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=CC=CC=C3N2)CCC2=C(C=CC(F)=C2)[C@@H]1C(C)C,HBNPJJILLOYFJU-VMPREFPWSA-N,495.6287,Q02641,BE0000303,Voltage-dependent L-type calcium channel subunit beta-1,Humans,inhibitor,yes
DB01388,Mibefradil,small molecule,investigational;withdrawn,COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=CC=CC=C3N2)CCC2=C(C=CC(F)=C2)[C@@H]1C(C)C,HBNPJJILLOYFJU-VMPREFPWSA-N,495.6287,Q08289,BE0002354,Voltage-dependent L-type calcium channel subunit beta-2,Humans,inhibitor,yes
DB01388,Mibefradil,small molecule,investigational;withdrawn,COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=CC=CC=C3N2)CCC2=C(C=CC(F)=C2)[C@@H]1C(C)C,HBNPJJILLOYFJU-VMPREFPWSA-N,495.6287,P54284,BE0002358,Voltage-dependent L-type calcium channel subunit beta-3,Humans,inhibitor,yes
DB01388,Mibefradil,small molecule,investigational;withdrawn,COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=CC=CC=C3N2)CCC2=C(C=CC(F)=C2)[C@@H]1C(C)C,HBNPJJILLOYFJU-VMPREFPWSA-N,495.6287,O00305,BE0002356,Voltage-dependent L-type calcium channel subunit beta-4,Humans,inhibitor,yes
DB01392,Yohimbine,small molecule,approved;investigational;vet_approved,[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=CC=CC=C31)C2,BLGXFZZNTVWLAY-SCYLSFHTSA-N,354.4427,P08913,BE0000289,Alpha-2A adrenergic receptor,Humans,antagonist,yes
DB01392,Yohimbine,small molecule,approved;investigational;vet_approved,[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=CC=CC=C31)C2,BLGXFZZNTVWLAY-SCYLSFHTSA-N,354.4427,P18089,BE0000572,Alpha-2B adrenergic receptor,Humans,antagonist,yes
DB01392,Yohimbine,small molecule,approved;investigational;vet_approved,[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=CC=CC=C31)C2,BLGXFZZNTVWLAY-SCYLSFHTSA-N,354.4427,P18825,BE0000342,Alpha-2C adrenergic receptor,Humans,antagonist,yes
DB01393,Bezafibrate,small molecule,approved;investigational,CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O,IIBYAHWJQTYFKB-UHFFFAOYSA-N,361.819,Q03181,BE0001007,Peroxisome proliferator-activated receptor delta,Humans,agonist,yes
DB01393,Bezafibrate,small molecule,approved;investigational,CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O,IIBYAHWJQTYFKB-UHFFFAOYSA-N,361.819,P37231,BE0000215,Peroxisome proliferator-activated receptor gamma,Humans,agonist,yes
DB01393,Bezafibrate,small molecule,approved;investigational,CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O,IIBYAHWJQTYFKB-UHFFFAOYSA-N,361.819,Q07869,BE0000071,Peroxisome proliferator-activated receptor alpha,Humans,agonist,yes
DB01394,Colchicine,small molecule,approved,COC1=CC2=C(C(OC)=C1OC)C1=CC=C(OC)C(=O)C=C1[C@H](CC2)NC(C)=O,IAKHMKGGTNLKSZ-INIZCTEOSA-N,399.443,P07437,BE0000143,Tubulin beta chain,Humans,inhibitor;binder,yes
DB01395,Drospirenone,small molecule,approved,[H][C@@]12C[C@]1([H])[C@@]1([H])[C@]3([H])[C@]4([H])C[C@]4([H])[C@@]4(CCC(=O)O4)[C@@]3(C)CC[C@]1([H])[C@@]1(C)CCC(=O)C=C21,METQSPRSQINEEU-HXCATZOESA-N,366.4932,P08235,BE0000668,Mineralocorticoid receptor,Humans,antagonist,yes
DB01395,Drospirenone,small molecule,approved,[H][C@@]12C[C@]1([H])[C@@]1([H])[C@]3([H])[C@]4([H])C[C@]4([H])[C@@]4(CCC(=O)O4)[C@@]3(C)CC[C@]1([H])[C@@]1(C)CCC(=O)C=C21,METQSPRSQINEEU-HXCATZOESA-N,366.4932,P10275,BE0000132,Androgen receptor,Humans,antagonist,yes
DB01395,Drospirenone,small molecule,approved,[H][C@@]12C[C@]1([H])[C@@]1([H])[C@]3([H])[C@]4([H])C[C@]4([H])[C@@]4(CCC(=O)O4)[C@@]3(C)CC[C@]1([H])[C@@]1(C)CCC(=O)C=C21,METQSPRSQINEEU-HXCATZOESA-N,366.4932,P06401,BE0000557,Progesterone receptor,Humans,agonist,yes
DB01396,Digitoxin,small molecule,approved;investigational,[H][C@@]1(CC[C@]2(O)[C@]3([H])CC[C@]4([H])C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)C1=CC(=O)OC1,WDJUZGPOPHTGOT-XUDUSOBPSA-N,764.9391,P14415,BE0005018,Sodium/potassium-transporting ATPase subunit beta-2,Humans,inhibitor,yes
DB01396,Digitoxin,small molecule,approved;investigational,[H][C@@]1(CC[C@]2(O)[C@]3([H])CC[C@]4([H])C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)C1=CC(=O)OC1,WDJUZGPOPHTGOT-XUDUSOBPSA-N,764.9391,P54709,BE0005026,Sodium/potassium-transporting ATPase subunit beta-3,Humans,inhibitor,yes
DB01396,Digitoxin,small molecule,approved;investigational,[H][C@@]1(CC[C@]2(O)[C@]3([H])CC[C@]4([H])C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)C1=CC(=O)OC1,WDJUZGPOPHTGOT-XUDUSOBPSA-N,764.9391,P05023,BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,Humans,inhibitor,yes
DB01396,Digitoxin,small molecule,approved;investigational,[H][C@@]1(CC[C@]2(O)[C@]3([H])CC[C@]4([H])C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)C1=CC(=O)OC1,WDJUZGPOPHTGOT-XUDUSOBPSA-N,764.9391,P13637,BE0005047,Sodium/potassium-transporting ATPase subunit alpha-3,Humans,inhibitor,yes
DB01396,Digitoxin,small molecule,approved;investigational,[H][C@@]1(CC[C@]2(O)[C@]3([H])CC[C@]4([H])C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)C1=CC(=O)OC1,WDJUZGPOPHTGOT-XUDUSOBPSA-N,764.9391,P05026,BE0004994,Sodium/potassium-transporting ATPase subunit beta-1,Humans,inhibitor,yes
DB01396,Digitoxin,small molecule,approved;investigational,[H][C@@]1(CC[C@]2(O)[C@]3([H])CC[C@]4([H])C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)C1=CC(=O)OC1,WDJUZGPOPHTGOT-XUDUSOBPSA-N,764.9391,P50993,BE0005034,Sodium/potassium-transporting ATPase subunit alpha-2,Humans,inhibitor,yes
DB01397,Magnesium salicylate,small molecule,experimental,[Mg++].OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O,MQHWFIOJQSCFNM-UHFFFAOYSA-L,298.531,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB01397,Magnesium salicylate,small molecule,experimental,[Mg++].OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O,MQHWFIOJQSCFNM-UHFFFAOYSA-L,298.531,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB01399,Salsalate,small molecule,approved,OC(=O)C1=CC=CC=C1OC(=O)C1=CC=CC=C1O,WVYADZUPLLSGPU-UHFFFAOYSA-N,258.2262,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB01399,Salsalate,small molecule,approved,OC(=O)C1=CC=CC=C1OC(=O)C1=CC=CC=C1O,WVYADZUPLLSGPU-UHFFFAOYSA-N,258.2262,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB01400,Neostigmine,small molecule,approved;vet_approved,CN(C)C(=O)OC1=CC(=CC=C1)[N+](C)(C)C,ALWKGYPQUAPLQC-UHFFFAOYSA-N,223.2915,P22303,BE0000426,Acetylcholinesterase,Humans,inhibitor,yes
DB01401,Choline magnesium trisalicylate,small molecule,approved,[Mg++].C[N+](C)(C)CCO.OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O,FQCQGOZEWWPOKI-UHFFFAOYSA-K,539.814,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB01401,Choline magnesium trisalicylate,small molecule,approved,[Mg++].C[N+](C)(C)CCO.OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O,FQCQGOZEWWPOKI-UHFFFAOYSA-K,539.814,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB01403,Methotrimeprazine,small molecule,approved;investigational,COC1=CC2=C(SC3=C(C=CC=C3)N2C[C@H](C)CN(C)C)C=C1,VRQVVMDWGGWHTJ-CQSZACIVSA-N,328.472,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB01405,Temafloxacin,small molecule,withdrawn,CC1CN(CCN1)C1=C(F)C=C2C(=O)C(=CN(C2=C1)C1=C(F)C=C(F)C=C1)C(O)=O,QKDHBVNJCZBTMR-UHFFFAOYSA-N,417.3811,P20831,BE0008385,DNA gyrase subunit A,Staphylococcus aureus,modulator,yes
DB01405,Temafloxacin,small molecule,withdrawn,CC1CN(CCN1)C1=C(F)C=C2C(=O)C(=CN(C2=C1)C1=C(F)C=C(F)C=C1)C(O)=O,QKDHBVNJCZBTMR-UHFFFAOYSA-N,417.3811,P0A0K8,BE0002388,DNA gyrase subunit B,Staphylococcus aureus,modulator,yes
DB01405,Temafloxacin,small molecule,withdrawn,CC1CN(CCN1)C1=C(F)C=C2C(=O)C(=CN(C2=C1)C1=C(F)C=C(F)C=C1)C(O)=O,QKDHBVNJCZBTMR-UHFFFAOYSA-N,417.3811,P43700,BE0000366,DNA gyrase subunit A,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd),inhibitor,yes
DB01405,Temafloxacin,small molecule,withdrawn,CC1CN(CCN1)C1=C(F)C=C2C(=O)C(=CN(C2=C1)C1=C(F)C=C(F)C=C1)C(O)=O,QKDHBVNJCZBTMR-UHFFFAOYSA-N,417.3811,P43702,BE0000429,DNA topoisomerase 4 subunit A,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd),inhibitor,yes
DB01406,Danazol,small molecule,approved,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3,POZRVZJJTULAOH-LHZXLZLDSA-N,337.4553,P03372,BE0000123,Estrogen receptor,Humans,agonist,yes
DB01406,Danazol,small molecule,approved,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3,POZRVZJJTULAOH-LHZXLZLDSA-N,337.4553,P10275,BE0000132,Androgen receptor,Humans,agonist,yes
DB01406,Danazol,small molecule,approved,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3,POZRVZJJTULAOH-LHZXLZLDSA-N,337.4553,P06401,BE0000557,Progesterone receptor,Humans,agonist,yes
DB01406,Danazol,small molecule,approved,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3,POZRVZJJTULAOH-LHZXLZLDSA-N,337.4553,P30968,BE0000203,Gonadotropin-releasing hormone receptor,Humans,negative modulator,yes
DB01406,Danazol,small molecule,approved,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3,POZRVZJJTULAOH-LHZXLZLDSA-N,337.4553,Q96P88,BE0000472,Putative gonadotropin-releasing hormone II receptor,Humans,negative modulator,yes
DB01407,Clenbuterol,small molecule,approved;investigational;vet_approved,CC(C)(C)NCC(O)C1=CC(Cl)=C(N)C(Cl)=C1,STJMRWALKKWQGH-UHFFFAOYSA-N,277.19,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,agonist,yes
DB01408,Bambuterol,small molecule,investigational,CN(C)C(=O)OC1=CC(=CC(OC(=O)N(C)C)=C1)C(O)CNC(C)(C)C,ANZXOIAKUNOVQU-UHFFFAOYSA-N,367.44,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,agonist,yes
DB01409,Tiotropium,small molecule,approved,[H][C@]12O[C@@]1([H])[C@]1([H])C[C@@]([H])(C[C@@]2([H])[N+]1(C)C)OC(=O)C(O)(C1=CC=CS1)C1=CC=CS1,LERNTVKEWCAPOY-DZZGSBJMSA-N,392.512,P20309,BE0000045,Muscarinic acetylcholine receptor M3,Humans,antagonist,yes
DB01410,Ciclesonide,small molecule,approved;investigational,[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(O[C@@H](O2)C1CCCCC1)C(=O)COC(=O)C(C)C,LUKZNWIVRBCLON-GXOBDPJESA-N,540.697,P08185,BE0000209,Corticosteroid-binding globulin,Humans,binder,yes
DB01410,Ciclesonide,small molecule,approved;investigational,[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(O[C@@H](O2)C1CCCCC1)C(=O)COC(=O)C(C)C,LUKZNWIVRBCLON-GXOBDPJESA-N,540.697,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB01411,Pranlukast,small molecule,investigational,O=C(NC1=C2OC(=CC(=O)C2=CC=C1)C1=NNN=N1)C1=CC=C(OCCCCC2=CC=CC=C2)C=C1,NBQKINXMPLXUET-UHFFFAOYSA-N,481.512,Q9Y271,BE0000705,Cysteinyl leukotriene receptor 1,Humans,antagonist,yes
DB01412,Theobromine,small molecule,investigational,CN1C=NC2=C1C(=O)NC(=O)N2C,YAPQBXQYLJRXSA-UHFFFAOYSA-N,180.164,P30542,BE0000013,Adenosine receptor A1,Humans,antagonist,yes
DB01412,Theobromine,small molecule,investigational,CN1C=NC2=C1C(=O)NC(=O)N2C,YAPQBXQYLJRXSA-UHFFFAOYSA-N,180.164,P21589,BE0001096,5'-nucleotidase,Humans,inhibitor,yes
DB01412,Theobromine,small molecule,investigational,CN1C=NC2=C1C(=O)NC(=O)N2C,YAPQBXQYLJRXSA-UHFFFAOYSA-N,180.164,P29274,BE0000924,Adenosine receptor A2a,Humans,antagonist,yes
DB01413,Cefepime,small molecule,approved;investigational,CO\N=C(/C(=O)N[C@@H]1C(=O)N2[C@]1([H])SCC(C[N+]1(C)CCCC1)=C2C([O-])=O)C1=CSC(N)=N1,HVFLCNVBZFFHBT-ZKDACBOMSA-N,480.561,P02918,BE0000588,Penicillin-binding protein 1A,Escherichia coli (strain K12),inhibitor,yes
DB01413,Cefepime,small molecule,approved;investigational,CO\N=C(/C(=O)N[C@@H]1C(=O)N2[C@]1([H])SCC(C[N+]1(C)CCCC1)=C2C([O-])=O)C1=CSC(N)=N1,HVFLCNVBZFFHBT-ZKDACBOMSA-N,480.561,P02919,BE0000488,Penicillin-binding protein 1B,Escherichia coli (strain K12),inhibitor,yes
DB01413,Cefepime,small molecule,approved;investigational,CO\N=C(/C(=O)N[C@@H]1C(=O)N2[C@]1([H])SCC(C[N+]1(C)CCCC1)=C2C([O-])=O)C1=CSC(N)=N1,HVFLCNVBZFFHBT-ZKDACBOMSA-N,480.561,P0AD65,BE0003579,Penicillin-binding protein 2,Escherichia coli (strain K12),inhibitor,yes
DB01413,Cefepime,small molecule,approved;investigational,CO\N=C(/C(=O)N[C@@H]1C(=O)N2[C@]1([H])SCC(C[N+]1(C)CCCC1)=C2C([O-])=O)C1=CSC(N)=N1,HVFLCNVBZFFHBT-ZKDACBOMSA-N,480.561,P0AD68,BE0002393,Peptidoglycan synthase FtsI,Escherichia coli (strain K12),inhibitor,yes
DB01413,Cefepime,small molecule,approved;investigational,CO\N=C(/C(=O)N[C@@H]1C(=O)N2[C@]1([H])SCC(C[N+]1(C)CCCC1)=C2C([O-])=O)C1=CSC(N)=N1,HVFLCNVBZFFHBT-ZKDACBOMSA-N,480.561,Q9X6W0,BE0003687,Penicillin-binding protein 1B,Pseudomonas aeruginosa,inhibitor,yes
DB01413,Cefepime,small molecule,approved;investigational,CO\N=C(/C(=O)N[C@@H]1C(=O)N2[C@]1([H])SCC(C[N+]1(C)CCCC1)=C2C([O-])=O)C1=CSC(N)=N1,HVFLCNVBZFFHBT-ZKDACBOMSA-N,480.561,Q51504,BE0004647,Cell division protein,Pseudomonas aeruginosa,inhibitor,yes
DB01414,Cefacetrile,small molecule,experimental;vet_approved,[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)CC#N)C(O)=O,RRYMAQUWDLIUPV-BXKDBHETSA-N,339.324,P02918,BE0000588,Penicillin-binding protein 1A,Escherichia coli (strain K12),inhibitor,yes
DB01414,Cefacetrile,small molecule,experimental;vet_approved,[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)CC#N)C(O)=O,RRYMAQUWDLIUPV-BXKDBHETSA-N,339.324,P02919,BE0000488,Penicillin-binding protein 1B,Escherichia coli (strain K12),inhibitor,yes
DB01415,Ceftibuten,small molecule,approved;investigational,[H][C@]12SCC=C(N1C(=O)[C@H]2NC(=O)C(=C/CC(O)=O)\C1=CSC(N)=N1)C(O)=O,UNJFKXSSGBWRBZ-BJCIPQKHSA-N,410.425,P0AD68,BE0002393,Peptidoglycan synthase FtsI,Escherichia coli (strain K12),inhibitor,yes
DB01415,Ceftibuten,small molecule,approved;investigational,[H][C@]12SCC=C(N1C(=O)[C@H]2NC(=O)C(=C/CC(O)=O)\C1=CSC(N)=N1)C(O)=O,UNJFKXSSGBWRBZ-BJCIPQKHSA-N,410.425,P02918,BE0000588,Penicillin-binding protein 1A,Escherichia coli (strain K12),inhibitor,yes
DB01415,Ceftibuten,small molecule,approved;investigational,[H][C@]12SCC=C(N1C(=O)[C@H]2NC(=O)C(=C/CC(O)=O)\C1=CSC(N)=N1)C(O)=O,UNJFKXSSGBWRBZ-BJCIPQKHSA-N,410.425,P02919,BE0000488,Penicillin-binding protein 1B,Escherichia coli (strain K12),inhibitor,yes
DB01415,Ceftibuten,small molecule,approved;investigational,[H][C@]12SCC=C(N1C(=O)[C@H]2NC(=O)C(=C/CC(O)=O)\C1=CSC(N)=N1)C(O)=O,UNJFKXSSGBWRBZ-BJCIPQKHSA-N,410.425,P0AD65,BE0003579,Penicillin-binding protein 2,Escherichia coli (strain K12),inhibitor,yes
DB01416,Cefpodoxime,small molecule,approved;vet_approved,[H][C@]12SCC(COC)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,WYUSVOMTXWRGEK-HBWVYFAYSA-N,427.455,P0AD68,BE0002393,Peptidoglycan synthase FtsI,Escherichia coli (strain K12),inhibitor,yes
DB01418,Acenocoumarol,small molecule,approved;investigational,CC(=O)CC(C1=CC=C(C=C1)[N+]([O-])=O)C1=C(O)C2=CC=CC=C2OC1=O,VABCILAOYCMVPS-UHFFFAOYSA-N,353.3255,Q9BQB6,BE0000713,Vitamin K epoxide reductase complex subunit 1,Humans,inhibitor,yes
DB01420,Testosterone propionate,small molecule,approved;investigational;vet_approved;withdrawn,[H][C@@]12CC[C@H](OC(=O)CC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,PDMMFKSKQVNJMI-BLQWBTBKSA-N,344.4877,P10275,BE0000132,Androgen receptor,Humans,agonist,yes
DB01421,Paromomycin,small molecule,approved;investigational,NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O,UOZODPSAJZTQNH-LSWIJEOBSA-N,615.6285,Q5SHN7,BE0003676,30S ribosomal protein S10,Thermus thermophilus (strain HB8 / ATCC 27634 / DSM 579),inhibitor,yes
DB01421,Paromomycin,small molecule,approved;investigational,NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O,UOZODPSAJZTQNH-LSWIJEOBSA-N,615.6285,,BE0004799,16S ribosomal RNA,Enteric bacteria and other eubacteria,inhibitor,yes
DB01421,Paromomycin,small molecule,approved;investigational,NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O,UOZODPSAJZTQNH-LSWIJEOBSA-N,615.6285,P08865,BE0002402,Small ribosomal subunit protein uS2,Humans,inhibitor,yes
DB01421,Paromomycin,small molecule,approved;investigational,NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O,UOZODPSAJZTQNH-LSWIJEOBSA-N,615.6285,Q96L21,BE0003823,Ribosomal protein uL16-like,Humans,inhibitor,yes
DB01422,Nitroxoline,small molecule,experimental,OC1=C2N=CC=CC2=C(C=C1)[N+]([O-])=O,RJIWZDNTCBHXAL-UHFFFAOYSA-N,190.1555,P50579,BE0001534,Methionine aminopeptidase 2,Humans,inhibitor,yes
DB01425,Alizapride,small molecule,investigational,COC1=CC2=NNN=C2C=C1C(=O)NCC1CCCN1CC=C,KSEYRUGYKHXGFW-UHFFFAOYSA-N,315.3702,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB01426,Ajmaline,small molecule,approved;experimental,[H][C@]12C[C@]34[C@H](O)C1[C@@]1([H])C[C@]([H])(N2[C@H](O)[C@H]1CC)[C@]3([H])N(C)C1=CC=CC=C41,CJDRUOGAGYHKKD-HEFSZTOGSA-N,326.4326,Q14524,BE0000197,Sodium channel protein type 5 subunit alpha,Humans,inhibitor,yes
DB01427,Amrinone,small molecule,approved,NC1=CC(=CNC1=O)C1=CC=NC=C1,RNLQIBCLLYYYFJ-UHFFFAOYSA-N,187.198,P27815,BE0009963,"cAMP-specific 3',5'-cyclic phosphodiesterase 4 (PDE4)",Humans,inhibitor,yes
DB01427,Amrinone,small molecule,approved,NC1=CC(=CNC1=O)C1=CC=NC=C1,RNLQIBCLLYYYFJ-UHFFFAOYSA-N,187.198,Q14432,BE0000436,"cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A",Humans,inhibitor,yes
DB01428,Oxybenzone,small molecule,approved;investigational,COC1=CC(O)=C(C=C1)C(=O)C1=CC=CC=C1,DXGLGDHPHMLXJC-UHFFFAOYSA-N,228.2433,Q05469,BE0014016,Hormone-sensitive lipase,Humans,inhibitor,yes
DB01429,Aprindine,small molecule,experimental,CCN(CC)CCCN(C1CC2=CC=CC=C2C1)C1=CC=CC=C1,NZLBHDRPUJLHCE-UHFFFAOYSA-N,322.487,P0DP24,BE0008705,Calmodulin-2,Humans,inhibitor,yes
DB01429,Aprindine,small molecule,experimental,CCN(CC)CCCN(C1CC2=CC=CC=C2C1)C1=CC=CC=C1,NZLBHDRPUJLHCE-UHFFFAOYSA-N,322.487,P0DP23,BE0012563,Calmodulin-1,Humans,inhibitor,yes
DB01429,Aprindine,small molecule,experimental,CCN(CC)CCCN(C1CC2=CC=CC=C2C1)C1=CC=CC=C1,NZLBHDRPUJLHCE-UHFFFAOYSA-N,322.487,P0DP25,BE0008706,Calmodulin-3,Humans,inhibitor,yes
DB01429,Aprindine,small molecule,experimental,CCN(CC)CCCN(C1CC2=CC=CC=C2C1)C1=CC=CC=C1,NZLBHDRPUJLHCE-UHFFFAOYSA-N,322.487,Q14524,BE0000197,Sodium channel protein type 5 subunit alpha,Humans,inhibitor,yes
DB01430,Almitrine,small molecule,approved,FC1=CC=C(C=C1)C(N1CCN(CC1)C1=NC(NCC=C)=NC(NCC=C)=N1)C1=CC=C(F)C=C1,OBDOVFRMEYHSQB-UHFFFAOYSA-N,477.5522,P05023,BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,Humans,binder,yes
DB01431,Allylestrenol,small molecule,experimental,[H][C@@]12CC[C@@](O)(CC=C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCCC=C3CC[C@@]21[H],ATXHVCQZZJYMCF-XUDSTZEESA-N,300.4782,P06401,BE0000557,Progesterone receptor,Humans,agonist,yes
DB01431,Allylestrenol,small molecule,experimental,[H][C@@]12CC[C@@](O)(CC=C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCCC=C3CC[C@@]21[H],ATXHVCQZZJYMCF-XUDSTZEESA-N,300.4782,P48067,BE0000940,Sodium- and chloride-dependent glycine transporter 1,Humans,blocker,yes
DB01433,Methadyl acetate,small molecule,experimental;illicit,CCC(OC(C)=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,XBMIVRRWGCYBTQ-UHFFFAOYSA-N,353.4977,P35372,BE0000770,Mu-type opioid receptor,Humans,agonist,yes
DB01435,Antipyrine,small molecule,approved;investigational,CN1N(C(=O)C=C1C)C1=CC=CC=C1,VEQOALNAAJBPNY-UHFFFAOYSA-N,188.2258,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB01436,Alfacalcidol,small molecule,approved;nutraceutical,CC(C)CCC[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C,OFHCOWSQAMBJIW-AVJTYSNKSA-N,400.6371,P11473,BE0000779,Vitamin D3 receptor,Humans,agonist,yes
DB01437,Glutethimide,small molecule,approved;illicit,CCC1(CCC(=O)NC1=O)C1=CC=CC=C1,JMBQKKAJIKAWKF-UHFFFAOYSA-N,217.2637,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,agonist,yes
DB01437,Glutethimide,small molecule,approved;illicit,CCC1(CCC(=O)NC1=O)C1=CC=CC=C1,JMBQKKAJIKAWKF-UHFFFAOYSA-N,217.2637,P10635,BE0002363,Cytochrome P450 2D6,Humans,inducer,yes
DB01437,Glutethimide,small molecule,approved;illicit,CCC1(CCC(=O)NC1=O)C1=CC=CC=C1,JMBQKKAJIKAWKF-UHFFFAOYSA-N,217.2637,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB01438,Phenazopyridine,small molecule,approved,NC1=NC(N)=C(C=C1)\N=N\C1=CC=CC=C1,QPFYXYFORQJZEC-FOCLMDBBSA-N,213.2385,P35498,BE0000141,Sodium channel protein type 1 subunit alpha,Humans,inhibitor,yes
DB01439,3-Methylthiofentanyl,small molecule,experimental;illicit,CCC(=O)N(C1CCN(CCC2=CC=CS2)CC1C)C1=CC=CC=C1,SRARDYUHGVMEQI-UHFFFAOYSA-N,356.525,P41145,BE0000632,Kappa-type opioid receptor,Humans,agonist,yes
DB01439,3-Methylthiofentanyl,small molecule,experimental;illicit,CCC(=O)N(C1CCN(CCC2=CC=CS2)CC1C)C1=CC=CC=C1,SRARDYUHGVMEQI-UHFFFAOYSA-N,356.525,P35372,BE0000770,Mu-type opioid receptor,Humans,agonist,yes
DB01439,3-Methylthiofentanyl,small molecule,experimental;illicit,CCC(=O)N(C1CCN(CCC2=CC=CS2)CC1C)C1=CC=CC=C1,SRARDYUHGVMEQI-UHFFFAOYSA-N,356.525,P41143,BE0000420,Delta-type opioid receptor,Humans,agonist,yes
DB01442,MMDA,small molecule,experimental;illicit,COC1=CC(CC(C)N)=CC2=C1OCO2,YQYUWUKDEVZFDB-UHFFFAOYSA-N,209.2417,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,agonist,yes
DB01442,MMDA,small molecule,experimental;illicit,COC1=CC(CC(C)N)=CC2=C1OCO2,YQYUWUKDEVZFDB-UHFFFAOYSA-N,209.2417,Q01959,BE0000647,Sodium-dependent dopamine transporter,Humans,negative modulator,yes
DB01442,MMDA,small molecule,experimental;illicit,COC1=CC(CC(C)N)=CC2=C1OCO2,YQYUWUKDEVZFDB-UHFFFAOYSA-N,209.2417,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,negative modulator,yes
DB01442,MMDA,small molecule,experimental;illicit,COC1=CC(CC(C)N)=CC2=C1OCO2,YQYUWUKDEVZFDB-UHFFFAOYSA-N,209.2417,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,negative modulator,yes
DB01442,MMDA,small molecule,experimental;illicit,COC1=CC(CC(C)N)=CC2=C1OCO2,YQYUWUKDEVZFDB-UHFFFAOYSA-N,209.2417,Q05940,BE0000118,Synaptic vesicular amine transporter,Humans,inhibitor,yes
DB01442,MMDA,small molecule,experimental;illicit,COC1=CC(CC(C)N)=CC2=C1OCO2,YQYUWUKDEVZFDB-UHFFFAOYSA-N,209.2417,P54219,BE0004674,Chromaffin granule amine transporter,Humans,inhibitor,yes
DB01442,MMDA,small molecule,experimental;illicit,COC1=CC(CC(C)N)=CC2=C1OCO2,YQYUWUKDEVZFDB-UHFFFAOYSA-N,209.2417,P21397,BE0002198,Amine oxidase [flavin-containing] A,Humans,inhibitor,yes
DB01442,MMDA,small molecule,experimental;illicit,COC1=CC(CC(C)N)=CC2=C1OCO2,YQYUWUKDEVZFDB-UHFFFAOYSA-N,209.2417,P27338,BE0002196,Amine oxidase [flavin-containing] B,Humans,inhibitor,yes
DB01444,Dimethylthiambutene,small molecule,experimental;illicit,CC(C=C(C1=CC=CS1)C1=CC=CS1)N(C)C,CANBGVXYBPOLRR-UHFFFAOYSA-N,263.421,P35372,BE0000770,Mu-type opioid receptor,Humans,agonist,yes
DB01444,Dimethylthiambutene,small molecule,experimental;illicit,CC(C=C(C1=CC=CS1)C1=CC=CS1)N(C)C,CANBGVXYBPOLRR-UHFFFAOYSA-N,263.421,P41143,BE0000420,Delta-type opioid receptor,Humans,agonist,yes
DB01445,Bufotenine,small molecule,experimental;illicit,CN(C)CCC1=CNC2=C1C=C(O)C=C2,VTTONGPRPXSUTJ-UHFFFAOYSA-N,204.2682,P28221,BE0000659,5-hydroxytryptamine receptor 1D,Humans,antagonist,yes
DB01445,Bufotenine,small molecule,experimental;illicit,CN(C)CCC1=CNC2=C1C=C(O)C=C2,VTTONGPRPXSUTJ-UHFFFAOYSA-N,204.2682,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB01445,Bufotenine,small molecule,experimental;illicit,CN(C)CCC1=CNC2=C1C=C(O)C=C2,VTTONGPRPXSUTJ-UHFFFAOYSA-N,204.2682,P50406,BE0000945,5-hydroxytryptamine receptor 6,Humans,antagonist,yes
DB01445,Bufotenine,small molecule,experimental;illicit,CN(C)CCC1=CNC2=C1C=C(O)C=C2,VTTONGPRPXSUTJ-UHFFFAOYSA-N,204.2682,P34969,BE0000650,5-hydroxytryptamine receptor 7,Humans,agonist,yes
DB01445,Bufotenine,small molecule,experimental;illicit,CN(C)CCC1=CNC2=C1C=C(O)C=C2,VTTONGPRPXSUTJ-UHFFFAOYSA-N,204.2682,P47898,BE0004688,5-hydroxytryptamine receptor 5A,Humans,antagonist,yes
DB01452,Diamorphine,small molecule,approved;illicit;investigational,[H][C@@]12C=C[C@H](OC(C)=O)[C@@H]3OC4=C(OC(C)=O)C=CC5=C4[C@]13CCN(C)[C@@H]2C5,GVGLGOZIDCSQPN-PVHGPHFFSA-N,369.411,P35372,BE0000770,Mu-type opioid receptor,Humans,agonist,yes
DB01454,Midomafetamine,small molecule,experimental;illicit;investigational,CNC(C)CC1=CC2=C(OCO2)C=C1,SHXWCVYOXRDMCX-UHFFFAOYSA-N,193.2423,Q05940,BE0000118,Synaptic vesicular amine transporter,Humans,inhibitor,yes
DB01454,Midomafetamine,small molecule,experimental;illicit;investigational,CNC(C)CC1=CC2=C(OCO2)C=C1,SHXWCVYOXRDMCX-UHFFFAOYSA-N,193.2423,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,negative modulator,yes
DB01454,Midomafetamine,small molecule,experimental;illicit;investigational,CNC(C)CC1=CC2=C(OCO2)C=C1,SHXWCVYOXRDMCX-UHFFFAOYSA-N,193.2423,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,negative modulator,yes
DB01454,Midomafetamine,small molecule,experimental;illicit;investigational,CNC(C)CC1=CC2=C(OCO2)C=C1,SHXWCVYOXRDMCX-UHFFFAOYSA-N,193.2423,P28335,BE0000533,5-hydroxytryptamine receptor 2C,Humans,agonist,yes
DB01454,Midomafetamine,small molecule,experimental;illicit;investigational,CNC(C)CC1=CC2=C(OCO2)C=C1,SHXWCVYOXRDMCX-UHFFFAOYSA-N,193.2423,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,agonist,yes
DB01454,Midomafetamine,small molecule,experimental;illicit;investigational,CNC(C)CC1=CC2=C(OCO2)C=C1,SHXWCVYOXRDMCX-UHFFFAOYSA-N,193.2423,P41595,BE0000393,5-hydroxytryptamine receptor 2B,Humans,agonist,yes
DB01460,Diethyltryptamine,small molecule,experimental;illicit,CCN(CC)CCC1=CNC2=CC=CC=C12,LSSUMOWDTKZHHT-UHFFFAOYSA-N,216.322,P50406,BE0000945,5-hydroxytryptamine receptor 6,Humans,inhibitor,yes
DB01462,Etonitazene,small molecule,experimental;illicit,CCOC1=CC=C(CC2=NC3=C(C=CC(=C3)[N+]([O-])=O)N2CCN(CC)CC)C=C1,PXDBZSCGSQSKST-UHFFFAOYSA-N,396.4827,P41145,BE0000632,Kappa-type opioid receptor,Humans,inhibitor,yes
DB01462,Etonitazene,small molecule,experimental;illicit,CCOC1=CC=C(CC2=NC3=C(C=CC(=C3)[N+]([O-])=O)N2CCN(CC)CC)C=C1,PXDBZSCGSQSKST-UHFFFAOYSA-N,396.4827,P41143,BE0000420,Delta-type opioid receptor,Humans,inhibitor,yes
DB01462,Etonitazene,small molecule,experimental;illicit,CCOC1=CC=C(CC2=NC3=C(C=CC(=C3)[N+]([O-])=O)N2CCN(CC)CC)C=C1,PXDBZSCGSQSKST-UHFFFAOYSA-N,396.4827,P35372,BE0000770,Mu-type opioid receptor,Humans,inhibitor,yes
DB01463,Fencamfamin,small molecule,experimental;illicit;withdrawn,CCNC1C2CCC(C2)C1C1=CC=CC=C1,IKFBPFGUINLYQI-UHFFFAOYSA-N,215.3339,Q01959,BE0000647,Sodium-dependent dopamine transporter,Humans,inhibitor,yes
DB01463,Fencamfamin,small molecule,experimental;illicit;withdrawn,CCNC1C2CCC(C2)C1C1=CC=CC=C1,IKFBPFGUINLYQI-UHFFFAOYSA-N,215.3339,P14416,BE0000756,D(2) dopamine receptor,Humans,agonist,yes
DB01465,"2,5-Dimethoxyamphetamine",small molecule,experimental;illicit,COC1=CC(CC(C)N)=C(OC)C=C1,LATVFYDIBMDBSY-UHFFFAOYSA-N,195.2582,P28221,BE0000659,5-hydroxytryptamine receptor 1D,Humans,inhibitor,yes
DB01465,"2,5-Dimethoxyamphetamine",small molecule,experimental;illicit,COC1=CC(CC(C)N)=C(OC)C=C1,LATVFYDIBMDBSY-UHFFFAOYSA-N,195.2582,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,inhibitor,yes
DB01465,"2,5-Dimethoxyamphetamine",small molecule,experimental;illicit,COC1=CC(CC(C)N)=C(OC)C=C1,LATVFYDIBMDBSY-UHFFFAOYSA-N,195.2582,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,inhibitor,yes
DB01466,Ethylmorphine,small molecule,experimental;illicit,[H][C@@]12OC3=C(OCC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,OGDVEMNWJVYAJL-LEPYJNQMSA-N,313.3908,P35372,BE0000770,Mu-type opioid receptor,Humans,agonist,yes
DB01467,"2,5-Dimethoxy-4-ethylamphetamine",small molecule,experimental;illicit,CCC1=CC(OC)=C(CC(C)N)C=C1OC,HXJKWPGVENNMCC-UHFFFAOYSA-N,223.3113,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,inhibitor,yes
DB01472,4-Methoxyamphetamine,small molecule,experimental;illicit,COC1=CC=C(CC(C)N)C=C1,NEGYEDYHPHMHGK-UHFFFAOYSA-N,165.2322,Q01959,BE0000647,Sodium-dependent dopamine transporter,Humans,inhibitor,yes
DB01472,4-Methoxyamphetamine,small molecule,experimental;illicit,COC1=CC=C(CC(C)N)C=C1,NEGYEDYHPHMHGK-UHFFFAOYSA-N,165.2322,P25100,BE0000715,Alpha-1D adrenergic receptor,Humans,agonist,yes
DB01472,4-Methoxyamphetamine,small molecule,experimental;illicit,COC1=CC=C(CC(C)N)C=C1,NEGYEDYHPHMHGK-UHFFFAOYSA-N,165.2322,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB01472,4-Methoxyamphetamine,small molecule,experimental;illicit,COC1=CC=C(CC(C)N)C=C1,NEGYEDYHPHMHGK-UHFFFAOYSA-N,165.2322,Q05940,BE0000118,Synaptic vesicular amine transporter,Humans,inhibitor,yes
DB01472,4-Methoxyamphetamine,small molecule,experimental;illicit,COC1=CC=C(CC(C)N)C=C1,NEGYEDYHPHMHGK-UHFFFAOYSA-N,165.2322,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,agonist,yes
DB01472,4-Methoxyamphetamine,small molecule,experimental;illicit,COC1=CC=C(CC(C)N)C=C1,NEGYEDYHPHMHGK-UHFFFAOYSA-N,165.2322,P08913,BE0000289,Alpha-2A adrenergic receptor,Humans,agonist,yes
DB01472,4-Methoxyamphetamine,small molecule,experimental;illicit,COC1=CC=C(CC(C)N)C=C1,NEGYEDYHPHMHGK-UHFFFAOYSA-N,165.2322,P21397,BE0002198,Amine oxidase [flavin-containing] A,Humans,inhibitor,yes
DB01481,1-Testosterone,small molecule,experimental;illicit;investigational,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)C=C[C@]12C,OKJCFMUGMSVJBG-ABEVXSGRSA-N,288.4244,P10275,BE0000132,Androgen receptor,Humans,agonist,yes
DB01483,Barbital,small molecule,illicit,CCC1(CC)C(=O)NC(=O)NC1=O,FTOAOBMCPZCFFF-UHFFFAOYSA-N,184.1925,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,potentiator,yes
DB01483,Barbital,small molecule,illicit,CCC1(CC)C(=O)NC(=O)NC1=O,FTOAOBMCPZCFFF-UHFFFAOYSA-N,184.1925,P47869,BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,Humans,potentiator,yes
DB01483,Barbital,small molecule,illicit,CCC1(CC)C(=O)NC(=O)NC1=O,FTOAOBMCPZCFFF-UHFFFAOYSA-N,184.1925,P34903,BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,Humans,potentiator,yes
DB01483,Barbital,small molecule,illicit,CCC1(CC)C(=O)NC(=O)NC1=O,FTOAOBMCPZCFFF-UHFFFAOYSA-N,184.1925,P48169,BE0000478,Gamma-aminobutyric acid receptor subunit alpha-4,Humans,potentiator,yes
DB01483,Barbital,small molecule,illicit,CCC1(CC)C(=O)NC(=O)NC1=O,FTOAOBMCPZCFFF-UHFFFAOYSA-N,184.1925,P31644,BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,Humans,potentiator,yes
DB01483,Barbital,small molecule,illicit,CCC1(CC)C(=O)NC(=O)NC1=O,FTOAOBMCPZCFFF-UHFFFAOYSA-N,184.1925,Q16445,BE0000764,Gamma-aminobutyric acid receptor subunit alpha-6,Humans,potentiator,yes
DB01484,"4-Bromo-2,5-dimethoxyamphetamine",small molecule,experimental;illicit,COC1=CC(Br)=C(OC)C=C1CC(C)N,FXMWUTGUCAKGQL-UHFFFAOYSA-N,274.154,P28221,BE0000659,5-hydroxytryptamine receptor 1D,Humans,inhibitor,yes
DB01484,"4-Bromo-2,5-dimethoxyamphetamine",small molecule,experimental;illicit,COC1=CC(Br)=C(OC)C=C1CC(C)N,FXMWUTGUCAKGQL-UHFFFAOYSA-N,274.154,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,inhibitor,yes
DB01484,"4-Bromo-2,5-dimethoxyamphetamine",small molecule,experimental;illicit,COC1=CC(Br)=C(OC)C=C1CC(C)N,FXMWUTGUCAKGQL-UHFFFAOYSA-N,274.154,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,inhibitor,yes
DB01488,Dimethyltryptamine,small molecule,experimental;illicit,CN(C)CCC1=CNC2=CC=CC=C12,DMULVCHRPCFFGV-UHFFFAOYSA-N,188.2688,P50406,BE0000945,5-hydroxytryptamine receptor 6,Humans,inhibitor,yes
DB01488,Dimethyltryptamine,small molecule,experimental;illicit,CN(C)CCC1=CNC2=CC=CC=C12,DMULVCHRPCFFGV-UHFFFAOYSA-N,188.2688,Q99720,BE0000156,Sigma non-opioid intracellular receptor 1,Humans,inhibitor,yes
DB01488,Dimethyltryptamine,small molecule,experimental;illicit,CN(C)CCC1=CNC2=CC=CC=C12,DMULVCHRPCFFGV-UHFFFAOYSA-N,188.2688,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,inhibitor,yes
DB01489,Camazepam,small molecule,experimental;illicit,CN(C)C(=O)OC1N=C(C2=CC=CC=C2)C2=C(C=CC(Cl)=C2)N(C)C1=O,PXBVEXGRHZFEOF-UHFFFAOYSA-N,371.818,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB01489,Camazepam,small molecule,experimental;illicit,CN(C)C(=O)OC1N=C(C2=CC=CC=C2)C2=C(C=CC(Cl)=C2)N(C)C1=O,PXBVEXGRHZFEOF-UHFFFAOYSA-N,371.818,P14867,BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,Humans,ligand,yes
DB01493,Ethylestrenol,small molecule,withdrawn,[H][C@@]12CC[C@@](O)(CC)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCCC=C3CC[C@@]21[H],AOXRBFRFYPMWLR-XGXHKTLJSA-N,288.4675,P10275,BE0000132,Androgen receptor,Humans,modulator,yes
DB01496,"Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione",small molecule,experimental;illicit,FC(F)(F)C1=CC=CC=C1C1=CC=C(CC2C(=O)NC(=S)NC2=O)O1,DNZPLHRZXUJATK-UHFFFAOYSA-N,368.33,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,potentiator,yes
DB01496,"Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione",small molecule,experimental;illicit,FC(F)(F)C1=CC=CC=C1C1=CC=C(CC2C(=O)NC(=S)NC2=O)O1,DNZPLHRZXUJATK-UHFFFAOYSA-N,368.33,P47869,BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,Humans,potentiator,yes
DB01496,"Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione",small molecule,experimental;illicit,FC(F)(F)C1=CC=CC=C1C1=CC=C(CC2C(=O)NC(=S)NC2=O)O1,DNZPLHRZXUJATK-UHFFFAOYSA-N,368.33,P34903,BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,Humans,potentiator,yes
DB01496,"Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione",small molecule,experimental;illicit,FC(F)(F)C1=CC=CC=C1C1=CC=C(CC2C(=O)NC(=S)NC2=O)O1,DNZPLHRZXUJATK-UHFFFAOYSA-N,368.33,P48169,BE0000478,Gamma-aminobutyric acid receptor subunit alpha-4,Humans,potentiator,yes
DB01496,"Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione",small molecule,experimental;illicit,FC(F)(F)C1=CC=CC=C1C1=CC=C(CC2C(=O)NC(=S)NC2=O)O1,DNZPLHRZXUJATK-UHFFFAOYSA-N,368.33,P31644,BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,Humans,potentiator,yes
DB01496,"Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione",small molecule,experimental;illicit,FC(F)(F)C1=CC=CC=C1C1=CC=C(CC2C(=O)NC(=S)NC2=O)O1,DNZPLHRZXUJATK-UHFFFAOYSA-N,368.33,Q16445,BE0000764,Gamma-aminobutyric acid receptor subunit alpha-6,Humans,potentiator,yes
DB01496,"Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione",small molecule,experimental;illicit,FC(F)(F)C1=CC=CC=C1C1=CC=C(CC2C(=O)NC(=S)NC2=O)O1,DNZPLHRZXUJATK-UHFFFAOYSA-N,368.33,P36544,BE0002341,Neuronal acetylcholine receptor subunit alpha-7,Humans,antagonist,yes
DB01496,"Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione",small molecule,experimental;illicit,FC(F)(F)C1=CC=CC=C1C1=CC=C(CC2C(=O)NC(=S)NC2=O)O1,DNZPLHRZXUJATK-UHFFFAOYSA-N,368.33,P43681,BE0000849,Neuronal acetylcholine receptor subunit alpha-4,Humans,antagonist,yes
DB01497,Etorphine,small molecule,illicit;vet_approved,[H][C@]12CC3=C4C(OC5[C@@]4(CCN1C)[C@]21CC(C(C)(O)CCC)C5(OC)C=C1)=C(O)C=C3,CAHCBJPUTCKATP-HBDRVVKHSA-N,411.5338,P35372,BE0000770,Mu-type opioid receptor,Humans,agonist,yes
DB01497,Etorphine,small molecule,illicit;vet_approved,[H][C@]12CC3=C4C(OC5[C@@]4(CCN1C)[C@]21CC(C(C)(O)CCC)C5(OC)C=C1)=C(O)C=C3,CAHCBJPUTCKATP-HBDRVVKHSA-N,411.5338,P41143,BE0000420,Delta-type opioid receptor,Humans,agonist,yes
DB01497,Etorphine,small molecule,illicit;vet_approved,[H][C@]12CC3=C4C(OC5[C@@]4(CCN1C)[C@]21CC(C(C)(O)CCC)C5(OC)C=C1)=C(O)C=C3,CAHCBJPUTCKATP-HBDRVVKHSA-N,411.5338,P41145,BE0000632,Kappa-type opioid receptor,Humans,agonist,yes
DB01501,Difenoxin,small molecule,approved;illicit,OC(=O)C1(CCN(CCC(C#N)(C2=CC=CC=C2)C2=CC=CC=C2)CC1)C1=CC=CC=C1,UFIVBRCCIRTJTN-UHFFFAOYSA-N,424.5341,P35372,BE0000770,Mu-type opioid receptor,Humans,antagonist,yes
DB01509,Tenamfetamine,small molecule,experimental;illicit,CC(N)CC1=CC2=C(OCO2)C=C1,NGBBVGZWCFBOGO-UHFFFAOYSA-N,179.2157,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,inhibitor,yes
DB01509,Tenamfetamine,small molecule,experimental;illicit,CC(N)CC1=CC2=C(OCO2)C=C1,NGBBVGZWCFBOGO-UHFFFAOYSA-N,179.2157,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB01509,Tenamfetamine,small molecule,experimental;illicit,CC(N)CC1=CC2=C(OCO2)C=C1,NGBBVGZWCFBOGO-UHFFFAOYSA-N,179.2157,Q01959,BE0000647,Sodium-dependent dopamine transporter,Humans,inhibitor,yes
DB01511,Delorazepam,small molecule,experimental;illicit,ClC1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2Cl)C=C1,CHIFCDOIPRCHCF-UHFFFAOYSA-N,305.159,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB01511,Delorazepam,small molecule,experimental;illicit,ClC1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2Cl)C=C1,CHIFCDOIPRCHCF-UHFFFAOYSA-N,305.159,P14867,BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,Humans,ligand,yes
DB01520,Tenocyclidine,small molecule,experimental;illicit;investigational,C1CCN(CC1)C1(CCCCC1)C1=CC=CS1,JUZZEWSCNBCFRL-UHFFFAOYSA-N,249.415,Q8TCU5,BE0000641,"Glutamate receptor ionotropic, NMDA 3A",Humans,antagonist,yes
DB01520,Tenocyclidine,small molecule,experimental;illicit;investigational,C1CCN(CC1)C1(CCCCC1)C1=CC=CS1,JUZZEWSCNBCFRL-UHFFFAOYSA-N,249.415,O60391,BE0000534,"Glutamate receptor ionotropic, NMDA 3B",Humans,antagonist,yes
DB01520,Tenocyclidine,small molecule,experimental;illicit;investigational,C1CCN(CC1)C1(CCCCC1)C1=CC=CS1,JUZZEWSCNBCFRL-UHFFFAOYSA-N,249.415,Q12879,BE0000760,"Glutamate receptor ionotropic, NMDA 2A",Humans,antagonist,yes
DB01520,Tenocyclidine,small molecule,experimental;illicit;investigational,C1CCN(CC1)C1(CCCCC1)C1=CC=CS1,JUZZEWSCNBCFRL-UHFFFAOYSA-N,249.415,Q14957,BE0000454,"Glutamate receptor ionotropic, NMDA 2C",Humans,antagonist,yes
DB01520,Tenocyclidine,small molecule,experimental;illicit;investigational,C1CCN(CC1)C1(CCCCC1)C1=CC=CS1,JUZZEWSCNBCFRL-UHFFFAOYSA-N,249.415,Q13224,BE0000417,"Glutamate receptor ionotropic, NMDA 2B",Humans,antagonist,yes
DB01524,Androstenediol,small molecule,experimental;illicit,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C,QADHLRWLCPCEKT-LOVVWNRFSA-N,290.4403,P03372,BE0000123,Estrogen receptor,Humans,inhibitor,yes
DB01524,Androstenediol,small molecule,experimental;illicit,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C,QADHLRWLCPCEKT-LOVVWNRFSA-N,290.4403,Q92731,BE0000792,Estrogen receptor beta,Humans,inhibitor,yes
DB01528,"4-Methyl-2,5-dimethoxyamphetamine",small molecule,experimental;illicit,COC1=CC(CC(C)N)=C(OC)C=C1C,NTJQREUGJKIARY-UHFFFAOYSA-N,209.2848,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,inhibitor,yes
DB01535,Carfentanil,small molecule,illicit;investigational;vet_approved,CCC(=O)N(C1=CC=CC=C1)C1(CCN(CCC2=CC=CC=C2)CC1)C(=O)OC,YDSDEBIZUNNPOB-UHFFFAOYSA-N,394.5066,P35372,BE0000770,Mu-type opioid receptor,Humans,agonist,yes
DB01535,Carfentanil,small molecule,illicit;investigational;vet_approved,CCC(=O)N(C1=CC=CC=C1)C1(CCN(CCC2=CC=CC=C2)CC1)C(=O)OC,YDSDEBIZUNNPOB-UHFFFAOYSA-N,394.5066,P41143,BE0000420,Delta-type opioid receptor,Humans,agonist,yes
DB01535,Carfentanil,small molecule,illicit;investigational;vet_approved,CCC(=O)N(C1=CC=CC=C1)C1(CCN(CCC2=CC=CC=C2)CC1)C(=O)OC,YDSDEBIZUNNPOB-UHFFFAOYSA-N,394.5066,P41145,BE0000632,Kappa-type opioid receptor,Humans,agonist,yes
DB01536,Androstenedione,small molecule,experimental;illicit,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,AEMFNILZOJDQLW-QAGGRKNESA-N,286.4085,P11511,BE0002090,Aromatase,Humans,inhibitor,yes
DB01536,Androstenedione,small molecule,experimental;illicit,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,AEMFNILZOJDQLW-QAGGRKNESA-N,286.4085,P14061,BE0000194,17-beta-hydroxysteroid dehydrogenase type 1,Humans,inducer,yes
DB01536,Androstenedione,small molecule,experimental;illicit,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,AEMFNILZOJDQLW-QAGGRKNESA-N,286.4085,P14060,BE0000051,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,Humans,positive allosteric modulator,yes
DB01536,Androstenedione,small molecule,experimental;illicit,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,AEMFNILZOJDQLW-QAGGRKNESA-N,286.4085,P42330,BE0000592,Aldo-keto reductase family 1 member C3,Humans,substrate;inducer,yes
DB01537,"4-Bromo-2,5-dimethoxyphenethylamine",small molecule,experimental;illicit,COC1=CC(Br)=C(OC)C=C1CCN,YMHOBZXQZVXHBM-UHFFFAOYSA-N,260.128,P28335,BE0000533,5-hydroxytryptamine receptor 2C,Humans,partial agonist,yes
DB01541,Boldenone,small molecule,illicit;vet_approved,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,RSIHSRDYCUFFLA-DYKIIFRCSA-N,286.4085,P10275,BE0000132,Androgen receptor,Humans,agonist,yes
DB01544,Flunitrazepam,small molecule,approved;illicit,CN1C2=C(C=C(C=C2)[N+]([O-])=O)C(=NCC1=O)C1=CC=CC=C1F,PPTYJKAXVCCBDU-UHFFFAOYSA-N,313.2832,P30536,BE0000736,Translocator protein,Humans,agonist,yes
DB01544,Flunitrazepam,small molecule,approved;illicit,CN1C2=C(C=C(C=C2)[N+]([O-])=O)C(=NCC1=O)C1=CC=CC=C1F,PPTYJKAXVCCBDU-UHFFFAOYSA-N,313.2832,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB01544,Flunitrazepam,small molecule,approved;illicit,CN1C2=C(C=C(C=C2)[N+]([O-])=O)C(=NCC1=O)C1=CC=CC=C1F,PPTYJKAXVCCBDU-UHFFFAOYSA-N,313.2832,P14867,BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,Humans,ligand,yes
DB01545,Ethyl loflazepate,small molecule,experimental;illicit,CCOC(=O)C1N=C(C2=CC=CC=C2F)C2=C(NC1=O)C=CC(Cl)=C2,CUCHJCMWNFEYOM-UHFFFAOYSA-N,360.767,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB01545,Ethyl loflazepate,small molecule,experimental;illicit,CCOC(=O)C1N=C(C2=CC=CC=C2F)C2=C(NC1=O)C=CC(Cl)=C2,CUCHJCMWNFEYOM-UHFFFAOYSA-N,360.767,P14867,BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,Humans,ligand,yes
DB01548,Diprenorphine,small molecule,illicit;vet_approved,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]11CC[C@@]2(OC)[C@H](C1)C(C)(C)O,OIJXLIIMXHRJJH-KNLIIKEYSA-N,425.569,P35372,BE0000770,Mu-type opioid receptor,Humans,antagonist,yes
DB01548,Diprenorphine,small molecule,illicit;vet_approved,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]11CC[C@@]2(OC)[C@H](C1)C(C)(C)O,OIJXLIIMXHRJJH-KNLIIKEYSA-N,425.569,P41143,BE0000420,Delta-type opioid receptor,Humans,antagonist,yes
DB01548,Diprenorphine,small molecule,illicit;vet_approved,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]11CC[C@@]2(OC)[C@H](C1)C(C)(C)O,OIJXLIIMXHRJJH-KNLIIKEYSA-N,425.569,P41145,BE0000632,Kappa-type opioid receptor,Humans,antagonist,yes
DB01549,Rolicyclidine,small molecule,experimental;illicit,C1CCN(C1)C1(CCCCC1)C1=CC=CC=C1,FYOWWXMGDATDQY-UHFFFAOYSA-N,229.3605,Q8TCU5,BE0000641,"Glutamate receptor ionotropic, NMDA 3A",Humans,,yes
DB01549,Rolicyclidine,small molecule,experimental;illicit,C1CCN(C1)C1(CCCCC1)C1=CC=CC=C1,FYOWWXMGDATDQY-UHFFFAOYSA-N,229.3605,P14416,BE0000756,D(2) dopamine receptor,Humans,inhibitor,yes
DB01551,Dihydrocodeine,small molecule,approved;illicit,[H][C@@]12OC3=C4C(C[C@H]5N(C)CC[C@@]14[C@@]5([H])CC[C@@H]2O)=CC=C3OC,RBOXVHNMENFORY-DNJOTXNNSA-N,301.3801,P35372,BE0000770,Mu-type opioid receptor,Humans,antagonist,yes
DB01553,Cloxazolam,small molecule,experimental,ClC1=CC2=C(NC(=O)CN3CCOC23C2=CC=CC=C2Cl)C=C1,ZIXNZOBDFKSQTC-UHFFFAOYSA-N,349.211,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB01553,Cloxazolam,small molecule,experimental,ClC1=CC2=C(NC(=O)CN3CCOC23C2=CC=CC=C2Cl)C=C1,ZIXNZOBDFKSQTC-UHFFFAOYSA-N,349.211,P14867,BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,Humans,ligand,yes
DB01556,Chlorphentermine,small molecule,illicit;withdrawn,CC(C)(N)CC1=CC=C(Cl)C=C1,ZCKAMNXUHHNZLN-UHFFFAOYSA-N,183.678,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,modulator,yes
DB01558,Bromazepam,small molecule,approved;illicit;investigational,BrC1=CC2=C(NC(=O)CN=C2C2=CC=CC=N2)C=C1,VMIYHDSEFNYJSL-UHFFFAOYSA-N,316.153,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB01558,Bromazepam,small molecule,approved;illicit;investigational,BrC1=CC2=C(NC(=O)CN=C2C2=CC=CC=N2)C=C1,VMIYHDSEFNYJSL-UHFFFAOYSA-N,316.153,P14867,BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,Humans,ligand,yes
DB01559,Clotiazepam,small molecule,approved;illicit,CCC1=CC2=C(S1)N(C)C(=O)CN=C2C1=CC=CC=C1Cl,CHBRHODLKOZEPZ-UHFFFAOYSA-N,318.821,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB01559,Clotiazepam,small molecule,approved;illicit,CCC1=CC2=C(S1)N(C)C(=O)CN=C2C1=CC=CC=C1Cl,CHBRHODLKOZEPZ-UHFFFAOYSA-N,318.821,P30536,BE0000736,Translocator protein,Humans,agonist,yes
DB01559,Clotiazepam,small molecule,approved;illicit,CCC1=CC2=C(S1)N(C)C(=O)CN=C2C1=CC=CC=C1Cl,CHBRHODLKOZEPZ-UHFFFAOYSA-N,318.821,P14867,BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,Humans,ligand,yes
DB01561,Androstanedione,small molecule,experimental;illicit,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)CC[C@]12C,RAJWOBJTTGJROA-WZNAKSSCSA-N,288.4244,P14061,BE0000194,17-beta-hydroxysteroid dehydrogenase type 1,Humans,inhibitor,yes
DB01564,Calusterone,small molecule,experimental;illicit,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@H](C)CC2=CC(=O)CC[C@]12C,IVFYLRMMHVYGJH-PVPPCFLZSA-N,316.4776,P10275,BE0000132,Androgen receptor,Humans,inhibitor,yes
DB01565,Dihydromorphine,small molecule,experimental;illicit,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])CC[C@@H]2O,IJVCSMSMFSCRME-KBQPJGBKSA-N,287.3535,P35372,BE0000770,Mu-type opioid receptor,Humans,agonist,yes
DB01565,Dihydromorphine,small molecule,experimental;illicit,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])CC[C@@H]2O,IJVCSMSMFSCRME-KBQPJGBKSA-N,287.3535,P41145,BE0000632,Kappa-type opioid receptor,Humans,agonist,yes
DB01565,Dihydromorphine,small molecule,experimental;illicit,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])CC[C@@H]2O,IJVCSMSMFSCRME-KBQPJGBKSA-N,287.3535,P41143,BE0000420,Delta-type opioid receptor,Humans,agonist,yes
DB01567,Fludiazepam,small molecule,experimental;illicit,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F,ROYOYTLGDLIGBX-UHFFFAOYSA-N,302.731,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,potentiator,yes
DB01567,Fludiazepam,small molecule,experimental;illicit,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F,ROYOYTLGDLIGBX-UHFFFAOYSA-N,302.731,P30536,BE0000736,Translocator protein,Humans,agonist,yes
DB01567,Fludiazepam,small molecule,experimental;illicit,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F,ROYOYTLGDLIGBX-UHFFFAOYSA-N,302.731,P47869,BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,Humans,potentiator,yes
DB01567,Fludiazepam,small molecule,experimental;illicit,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F,ROYOYTLGDLIGBX-UHFFFAOYSA-N,302.731,P34903,BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,Humans,potentiator,yes
DB01567,Fludiazepam,small molecule,experimental;illicit,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F,ROYOYTLGDLIGBX-UHFFFAOYSA-N,302.731,P31644,BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,Humans,potentiator,yes
DB01567,Fludiazepam,small molecule,experimental;illicit,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F,ROYOYTLGDLIGBX-UHFFFAOYSA-N,302.731,Q8N1C3,BE0003593,Gamma-aminobutyric acid receptor subunit gamma-1,Humans,potentiator,yes
DB01567,Fludiazepam,small molecule,experimental;illicit,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F,ROYOYTLGDLIGBX-UHFFFAOYSA-N,302.731,P18507,BE0003592,Gamma-aminobutyric acid receptor subunit gamma-2,Humans,potentiator,yes
DB01567,Fludiazepam,small molecule,experimental;illicit,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F,ROYOYTLGDLIGBX-UHFFFAOYSA-N,302.731,Q99928,BE0003594,Gamma-aminobutyric acid receptor subunit gamma-3,Humans,potentiator,yes
DB01567,Fludiazepam,small molecule,experimental;illicit,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F,ROYOYTLGDLIGBX-UHFFFAOYSA-N,302.731,P18505,BE0002344,Gamma-aminobutyric acid receptor subunit beta-1,Humans,potentiator,yes
DB01567,Fludiazepam,small molecule,experimental;illicit,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F,ROYOYTLGDLIGBX-UHFFFAOYSA-N,302.731,P47870,BE0002346,Gamma-aminobutyric acid receptor subunit beta-2,Humans,potentiator,yes
DB01567,Fludiazepam,small molecule,experimental;illicit,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F,ROYOYTLGDLIGBX-UHFFFAOYSA-N,302.731,P28472,BE0002345,Gamma-aminobutyric acid receptor subunit beta-3,Humans,potentiator,yes
DB01567,Fludiazepam,small molecule,experimental;illicit,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F,ROYOYTLGDLIGBX-UHFFFAOYSA-N,302.731,O14764,BE0003599,Gamma-aminobutyric acid receptor subunit delta,Humans,potentiator,yes
DB01567,Fludiazepam,small molecule,experimental;illicit,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F,ROYOYTLGDLIGBX-UHFFFAOYSA-N,302.731,P78334,BE0003595,Gamma-aminobutyric acid receptor subunit epsilon,Humans,potentiator,yes
DB01567,Fludiazepam,small molecule,experimental;illicit,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F,ROYOYTLGDLIGBX-UHFFFAOYSA-N,302.731,O00591,BE0003596,Gamma-aminobutyric acid receptor subunit pi,Humans,potentiator,yes
DB01567,Fludiazepam,small molecule,experimental;illicit,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F,ROYOYTLGDLIGBX-UHFFFAOYSA-N,302.731,P24046,BE0000129,Gamma-aminobutyric acid receptor subunit rho-1,Humans,potentiator,yes
DB01567,Fludiazepam,small molecule,experimental;illicit,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F,ROYOYTLGDLIGBX-UHFFFAOYSA-N,302.731,P28476,BE0003598,Gamma-aminobutyric acid receptor subunit rho-2,Humans,potentiator,yes
DB01567,Fludiazepam,small molecule,experimental;illicit,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F,ROYOYTLGDLIGBX-UHFFFAOYSA-N,302.731,A8MPY1,BE0003619,Gamma-aminobutyric acid receptor subunit rho-3,Humans,potentiator,yes
DB01571,3-Methylfentanyl,small molecule,illicit,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1C)C1=CC=CC=C1,MLQRZXNZHAOCHQ-UHFFFAOYSA-N,350.4971,P35372,BE0000770,Mu-type opioid receptor,Humans,agonist,yes
DB01571,3-Methylfentanyl,small molecule,illicit,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1C)C1=CC=CC=C1,MLQRZXNZHAOCHQ-UHFFFAOYSA-N,350.4971,P41143,BE0000420,Delta-type opioid receptor,Humans,agonist,yes
DB01571,3-Methylfentanyl,small molecule,illicit,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1C)C1=CC=CC=C1,MLQRZXNZHAOCHQ-UHFFFAOYSA-N,350.4971,P41145,BE0000632,Kappa-type opioid receptor,Humans,agonist,yes
DB01576,Dextroamphetamine,small molecule,approved;illicit,C[C@H](N)CC1=CC=CC=C1,KWTSXDURSIMDCE-QMMMGPOBSA-N,135.2062,Q05940,BE0000118,Synaptic vesicular amine transporter,Humans,inducer,yes
DB01576,Dextroamphetamine,small molecule,approved;illicit,C[C@H](N)CC1=CC=CC=C1,KWTSXDURSIMDCE-QMMMGPOBSA-N,135.2062,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,negative modulator,yes
DB01576,Dextroamphetamine,small molecule,approved;illicit,C[C@H](N)CC1=CC=CC=C1,KWTSXDURSIMDCE-QMMMGPOBSA-N,135.2062,Q01959,BE0000647,Sodium-dependent dopamine transporter,Humans,negative modulator,yes
DB01577,Metamfetamine,small molecule,approved;illicit;withdrawn,CN[C@@H](C)CC1=CC=CC=C1,MYWUZJCMWCOHBA-VIFPVBQESA-N,149.2328,P14416,BE0000756,D(2) dopamine receptor,Humans,agonist,yes
DB01577,Metamfetamine,small molecule,approved;illicit;withdrawn,CN[C@@H](C)CC1=CC=CC=C1,MYWUZJCMWCOHBA-VIFPVBQESA-N,149.2328,P35368,BE0000575,Alpha-1B adrenergic receptor,Humans,antagonist,yes
DB01577,Metamfetamine,small molecule,approved;illicit;withdrawn,CN[C@@H](C)CC1=CC=CC=C1,MYWUZJCMWCOHBA-VIFPVBQESA-N,149.2328,Q01959,BE0000647,Sodium-dependent dopamine transporter,Humans,negative modulator,yes
DB01577,Metamfetamine,small molecule,approved;illicit;withdrawn,CN[C@@H](C)CC1=CC=CC=C1,MYWUZJCMWCOHBA-VIFPVBQESA-N,149.2328,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,negative modulator,yes
DB01577,Metamfetamine,small molecule,approved;illicit;withdrawn,CN[C@@H](C)CC1=CC=CC=C1,MYWUZJCMWCOHBA-VIFPVBQESA-N,149.2328,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,negative modulator,yes
DB01577,Metamfetamine,small molecule,approved;illicit;withdrawn,CN[C@@H](C)CC1=CC=CC=C1,MYWUZJCMWCOHBA-VIFPVBQESA-N,149.2328,Q05940,BE0000118,Synaptic vesicular amine transporter,Humans,inhibitor,yes
DB01577,Metamfetamine,small molecule,approved;illicit;withdrawn,CN[C@@H](C)CC1=CC=CC=C1,MYWUZJCMWCOHBA-VIFPVBQESA-N,149.2328,P54219,BE0004674,Chromaffin granule amine transporter,Humans,inhibitor,yes
DB01577,Metamfetamine,small molecule,approved;illicit;withdrawn,CN[C@@H](C)CC1=CC=CC=C1,MYWUZJCMWCOHBA-VIFPVBQESA-N,149.2328,Q96RJ0,BE0001044,Trace amine-associated receptor 1,Humans,agonist,yes
DB01577,Metamfetamine,small molecule,approved;illicit;withdrawn,CN[C@@H](C)CC1=CC=CC=C1,MYWUZJCMWCOHBA-VIFPVBQESA-N,149.2328,P08913,BE0000289,Alpha-2A adrenergic receptor,Humans,agonist,yes
DB01577,Metamfetamine,small molecule,approved;illicit;withdrawn,CN[C@@H](C)CC1=CC=CC=C1,MYWUZJCMWCOHBA-VIFPVBQESA-N,149.2328,P18089,BE0000572,Alpha-2B adrenergic receptor,Humans,agonist,yes
DB01577,Metamfetamine,small molecule,approved;illicit;withdrawn,CN[C@@H](C)CC1=CC=CC=C1,MYWUZJCMWCOHBA-VIFPVBQESA-N,149.2328,P18825,BE0000342,Alpha-2C adrenergic receptor,Humans,agonist,yes
DB01577,Metamfetamine,small molecule,approved;illicit;withdrawn,CN[C@@H](C)CC1=CC=CC=C1,MYWUZJCMWCOHBA-VIFPVBQESA-N,149.2328,P21397,BE0002198,Amine oxidase [flavin-containing] A,Humans,inhibitor,yes
DB01577,Metamfetamine,small molecule,approved;illicit;withdrawn,CN[C@@H](C)CC1=CC=CC=C1,MYWUZJCMWCOHBA-VIFPVBQESA-N,149.2328,P27338,BE0002196,Amine oxidase [flavin-containing] B,Humans,inhibitor,yes
DB01579,Phendimetrazine,small molecule,approved;illicit,C[C@H]1[C@@H](OCCN1C)C1=CC=CC=C1,MFOCDFTXLCYLKU-CMPLNLGQSA-N,191.274,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,agonist,yes
DB01579,Phendimetrazine,small molecule,approved;illicit,C[C@H]1[C@@H](OCCN1C)C1=CC=CC=C1,MFOCDFTXLCYLKU-CMPLNLGQSA-N,191.274,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,negative modulator,yes
DB01580,Oxprenolol,small molecule,approved,CC(C)NCC(O)COC1=CC=CC=C1OCC=C,CEMAWMOMDPGJMB-UHFFFAOYSA-N,265.348,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,antagonist,yes
DB01581,Sulfamerazine,small molecule,approved;vet_approved,CC1=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=NC=C1,QPPBRPIAZZHUNT-UHFFFAOYSA-N,264.304,P0AC13,BE0000803,Dihydropteroate synthase,Escherichia coli (strain K12),inhibitor,yes
DB01582,Sulfamethazine,small molecule,approved;investigational;vet_approved,CC1=CC(C)=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=N1,ASWVTGNCAZCNNR-UHFFFAOYSA-N,278.33,P0AC13,BE0000803,Dihydropteroate synthase,Escherichia coli (strain K12),inhibitor,yes
DB01583,Liotrix,small molecule,approved,[Na+].[Na+].N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C([O-])=O.N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C([O-])=O,LKYWLLWWYBVUPP-XOCLESOZSA-L,1471.8072,P10827,BE0000687,Thyroid hormone receptor alpha,Humans,agonist,yes
DB01583,Liotrix,small molecule,approved,[Na+].[Na+].N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C([O-])=O.N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C([O-])=O,LKYWLLWWYBVUPP-XOCLESOZSA-L,1471.8072,P10828,BE0000315,Thyroid hormone receptor beta,Humans,agonist,yes
DB01586,Ursodeoxycholic acid,small molecule,approved;investigational,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O,RUDATBOHQWOJDD-UZVSRGJWSA-N,392.572,P52895,BE0000622,Aldo-keto reductase family 1 member C2,Humans,inhibitor,yes
DB01586,Ursodeoxycholic acid,small molecule,approved;investigational,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O,RUDATBOHQWOJDD-UZVSRGJWSA-N,392.572,P53004,BE0000741,Biliverdin reductase A,Humans,activator,yes
DB01586,Ursodeoxycholic acid,small molecule,approved;investigational,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O,RUDATBOHQWOJDD-UZVSRGJWSA-N,392.572,Q9UGH3,BE0009869,Solute carrier family 23 member 2,Humans,activator,yes
DB01587,Ketazolam,small molecule,approved,CN1C2=C(C=C(Cl)C=C2)C2(OC(C)=CC(=O)N2CC1=O)C1=CC=CC=C1,PWAJCNITSBZRBL-UHFFFAOYSA-N,368.814,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB01587,Ketazolam,small molecule,approved,CN1C2=C(C=C(Cl)C=C2)C2(OC(C)=CC(=O)N2CC1=O)C1=CC=CC=C1,PWAJCNITSBZRBL-UHFFFAOYSA-N,368.814,P14867,BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,Humans,ligand,yes
DB01588,Prazepam,small molecule,approved;illicit,ClC1=CC2=C(C=C1)N(CC1CC1)C(=O)CN=C2C1=CC=CC=C1,MWQCHHACWWAQLJ-UHFFFAOYSA-N,324.804,P30536,BE0000736,Translocator protein,Humans,modulator,yes
DB01588,Prazepam,small molecule,approved;illicit,ClC1=CC2=C(C=C1)N(CC1CC1)C(=O)CN=C2C1=CC=CC=C1,MWQCHHACWWAQLJ-UHFFFAOYSA-N,324.804,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB01588,Prazepam,small molecule,approved;illicit,ClC1=CC2=C(C=C1)N(CC1CC1)C(=O)CN=C2C1=CC=CC=C1,MWQCHHACWWAQLJ-UHFFFAOYSA-N,324.804,P14867,BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,Humans,ligand,yes
DB01589,Quazepam,small molecule,approved;illicit,FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2,IKMPWMZBZSAONZ-UHFFFAOYSA-N,386.794,P30536,BE0000736,Translocator protein,Humans,modulator,yes
DB01589,Quazepam,small molecule,approved;illicit,FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2,IKMPWMZBZSAONZ-UHFFFAOYSA-N,386.794,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB01589,Quazepam,small molecule,approved;illicit,FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2,IKMPWMZBZSAONZ-UHFFFAOYSA-N,386.794,P14867,BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,Humans,ligand,yes
DB01590,Everolimus,small molecule,approved,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](OCCO)[C@@H](C1)OC,HKVAMNSJSFKALM-GKUWKFKPSA-N,958.24,P42345,BE0002386,Serine/threonine-protein kinase mTOR,Humans,inhibitor,yes
DB01591,Solifenacin,small molecule,approved,O=C(O[C@H]1CN2CCC1CC2)N1CCC2=CC=CC=C2[C@@H]1C1=CC=CC=C1,FBOUYBDGKBSUES-VXKWHMMOSA-N,362.473,P20309,BE0000045,Muscarinic acetylcholine receptor M3,Humans,antagonist,yes
DB01594,Cinolazepam,small molecule,experimental,OC1N=C(C2=CC=CC=C2F)C2=C(C=CC(Cl)=C2)N(CCC#N)C1=O,XAXMYHMKTCNRRZ-UHFFFAOYSA-N,357.766,P30536,BE0000736,Translocator protein,Humans,binder,yes
DB01594,Cinolazepam,small molecule,experimental,OC1N=C(C2=CC=CC=C2F)C2=C(C=CC(Cl)=C2)N(CCC#N)C1=O,XAXMYHMKTCNRRZ-UHFFFAOYSA-N,357.766,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB01594,Cinolazepam,small molecule,experimental,OC1N=C(C2=CC=CC=C2F)C2=C(C=CC(Cl)=C2)N(CCC#N)C1=O,XAXMYHMKTCNRRZ-UHFFFAOYSA-N,357.766,P14867,BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,Humans,ligand,yes
DB01595,Nitrazepam,small molecule,approved,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2)C=C1,KJONHKAYOJNZEC-UHFFFAOYSA-N,281.2661,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,antagonist,yes
DB01595,Nitrazepam,small molecule,approved,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2)C=C1,KJONHKAYOJNZEC-UHFFFAOYSA-N,281.2661,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB01595,Nitrazepam,small molecule,approved,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2)C=C1,KJONHKAYOJNZEC-UHFFFAOYSA-N,281.2661,P14867,BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,Humans,ligand,yes
DB01597,Cilastatin,small molecule,approved;investigational,CC1(C)C[C@@H]1C(=O)N\C(=C/CCCCSC[C@H](N)C(O)=O)C(O)=O,DHSUYTOATWAVLW-WFVMDLQDSA-N,358.453,P16444,BE0001148,Dipeptidase 1,Humans,inhibitor,yes
DB01598,Imipenem,small molecule,approved,[H][C@]12CC(SCC\N=C\N)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,ZSKVGTPCRGIANV-ZXFLCMHBSA-N,299.346,P0AD65,BE0003579,Penicillin-binding protein 2,Escherichia coli (strain K12),inhibitor,yes
DB01598,Imipenem,small molecule,approved,[H][C@]12CC(SCC\N=C\N)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,ZSKVGTPCRGIANV-ZXFLCMHBSA-N,299.346,P02919,BE0000488,Penicillin-binding protein 1B,Escherichia coli (strain K12),inhibitor,yes
DB01598,Imipenem,small molecule,approved,[H][C@]12CC(SCC\N=C\N)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,ZSKVGTPCRGIANV-ZXFLCMHBSA-N,299.346,P02918,BE0000588,Penicillin-binding protein 1A,Escherichia coli (strain K12),inhibitor,yes
DB01599,Probucol,small molecule,approved;investigational,CC(C)(SC1=CC(=C(O)C(=C1)C(C)(C)C)C(C)(C)C)SC1=CC(=C(O)C(=C1)C(C)(C)C)C(C)(C)C,FYPMFJGVHOHGLL-UHFFFAOYSA-N,516.842,O95477,BE0000119,Phospholipid-transporting ATPase ABCA1,Humans,inhibitor,yes
DB01600,Tiaprofenic acid,small molecule,approved,CC(C(O)=O)C1=CC=C(S1)C(=O)C1=CC=CC=C1,GUHPRPJDBZHYCJ-UHFFFAOYSA-N,260.308,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB01600,Tiaprofenic acid,small molecule,approved,CC(C(O)=O)C1=CC=C(S1)C(=O)C1=CC=CC=C1,GUHPRPJDBZHYCJ-UHFFFAOYSA-N,260.308,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB01601,Lopinavir,small molecule,approved,CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](CC1=CC=CC=C1)NC(=O)COC1=C(C)C=CC=C1C)CC1=CC=CC=C1,KJHKTHWMRKYKJE-SUGCFTRWSA-N,628.8008,Q72874,BE0004854,Pol polyprotein,Human immunodeficiency virus 1,inhibitor,yes
DB01602,Bacampicillin,small molecule,approved;investigational,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(=O)OC(C)OC(=O)OCC,PFOLLRNADZZWEX-FFGRCDKISA-N,465.52,P0AEB2,BE0004840,Penicillin-binding protein,Gram positive and gram negative bacteria,inhibitor,yes
DB01603,Meticillin,small molecule,approved;investigational,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(OC)C=CC=C1OC)C(O)=O,RJQXTJLFIWVMTO-TYNCELHUSA-N,380.415,Q53707,BE0003618,MecA PBP2' (penicillin binding protein 2'),Staphylococcus aureus,inhibitor,yes
DB01603,Meticillin,small molecule,approved;investigational,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(OC)C=CC=C1OC)C(O)=O,RJQXTJLFIWVMTO-TYNCELHUSA-N,380.415,Q8DNB6,BE0004644,Penicillin-binding protein 2a,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB01603,Meticillin,small molecule,approved;investigational,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(OC)C=CC=C1OC)C(O)=O,RJQXTJLFIWVMTO-TYNCELHUSA-N,380.415,Q7CRA4,BE0004335,Penicillin-binding protein 1b,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB01603,Meticillin,small molecule,approved;investigational,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(OC)C=CC=C1OC)C(O)=O,RJQXTJLFIWVMTO-TYNCELHUSA-N,380.415,P0A3M6,BE0003624,Penicillin-binding protein 2B,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB01603,Meticillin,small molecule,approved;investigational,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(OC)C=CC=C1OC)C(O)=O,RJQXTJLFIWVMTO-TYNCELHUSA-N,380.415,Q75Y35,BE0004643,Penicillin-binding protein 3,Streptococcus pneumoniae,inhibitor,yes
DB01603,Meticillin,small molecule,approved;investigational,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(OC)C=CC=C1OC)C(O)=O,RJQXTJLFIWVMTO-TYNCELHUSA-N,380.415,Q8DR59,BE0004290,Penicillin-binding protein 1A,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB01604,Pivampicillin,small molecule,approved,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(=O)OCOC(=O)C(C)(C)C,ZEMIJUDPLILVNQ-ZXFNITATSA-N,463.547,Q8XJ01,BE0000576,Penicillin-binding protein 1A,Clostridium perfringens (strain 13 / Type A),inhibitor,yes
DB01605,Pivmecillinam,small molecule,approved,[H]C(=N[C@@H]1C(=O)N2[C@@H](C(=O)OCOC(=O)C(C)(C)C)C(C)(C)S[C@]12[H])N1CCCCCC1,NPGNOVNWUSPMDP-HLLBOEOZSA-N,439.569,Q8XJ01,BE0000576,Penicillin-binding protein 1A,Clostridium perfringens (strain 13 / Type A),inhibitor,yes
DB01606,Tazobactam,small molecule,approved,[H][C@@]12CC(=O)N1[C@@H](C(O)=O)[C@](C)(CN1C=CN=N1)S2(=O)=O,LPQZKKCYTLCDGQ-WEDXCCLWSA-N,300.291,P00807,BE0000302,Beta-lactamase,Staphylococcus aureus,inhibitor,yes
DB01606,Tazobactam,small molecule,approved,[H][C@@]12CC(=O)N1[C@@H](C(O)=O)[C@](C)(CN1C=CN=N1)S2(=O)=O,LPQZKKCYTLCDGQ-WEDXCCLWSA-N,300.291,P62594,BE0001568,Beta-lactamase TEM,Salmonella typhi,inhibitor,yes
DB01606,Tazobactam,small molecule,approved,[H][C@@]12CC(=O)N1[C@@H](C(O)=O)[C@](C)(CN1C=CN=N1)S2(=O)=O,LPQZKKCYTLCDGQ-WEDXCCLWSA-N,300.291,P18251,BE0009681,Beta-lactamase Ohio-1,Enterobacter cloacae,inhibitor,yes
DB01606,Tazobactam,small molecule,approved,[H][C@@]12CC(=O)N1[C@@H](C(O)=O)[C@](C)(CN1C=CN=N1)S2(=O)=O,LPQZKKCYTLCDGQ-WEDXCCLWSA-N,300.291,P0AD63,BE0002015,Beta-lactamase SHV-1,Escherichia coli,inhibitor,yes
DB01607,Ticarcillin,small molecule,approved;investigational;vet_approved,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](C(O)=O)C1=CSC=C1)C(O)=O,OHKOGUYZJXTSFX-KZFFXBSXSA-N,384.427,C1KC03,BE0003577,Penicillin binding protein 2a,Staphylococcus aureus,inhibitor,yes
DB01608,Periciazine,small molecule,approved;investigational,OC1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C#N)CC1,LUALIOATIOESLM-UHFFFAOYSA-N,365.492,P21728,BE0000020,D(1A) dopamine receptor,Humans,antagonist,yes
DB01608,Periciazine,small molecule,approved;investigational,OC1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C#N)CC1,LUALIOATIOESLM-UHFFFAOYSA-N,365.492,P08913,BE0000289,Alpha-2A adrenergic receptor,Humans,antagonist,yes
DB01609,Deferasirox,small molecule,approved;investigational,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,BOFQWVMAQOTZIW-UHFFFAOYSA-N,373.3615,,BE0004807,Iron,Humans,chelator,yes
DB01610,Valganciclovir,small molecule,approved;investigational,CC(C)[C@H](N)C(=O)OCC(CO)OCN1C=NC2=C1NC(N)=NC2=O,WPVFJKSGQUFQAP-GKAPJAKFSA-N,354.3617,P04293,BE0000308,DNA polymerase catalytic subunit,HHV-1,inhibitor,yes
DB01610,Valganciclovir,small molecule,approved;investigational,CC(C)[C@H](N)C(=O)OCC(CO)OCN1C=NC2=C1NC(N)=NC2=O,WPVFJKSGQUFQAP-GKAPJAKFSA-N,354.3617,,BE0004796,DNA,Humans,adduct,yes
DB01611,Hydroxychloroquine,small molecule,approved,CCN(CCO)CCCC(C)NC1=C2C=CC(Cl)=CC2=NC=C1,XXSMGPRMXLTPCZ-UHFFFAOYSA-N,335.872,Q9NYK1,BE0000155,Toll-like receptor 7,Humans,antagonist,yes
DB01611,Hydroxychloroquine,small molecule,approved,CCN(CCO)CCCC(C)NC1=C2C=CC(Cl)=CC2=NC=C1,XXSMGPRMXLTPCZ-UHFFFAOYSA-N,335.872,Q9NR96,BE0001171,Toll-like receptor 9,Humans,antagonist,yes
DB01611,Hydroxychloroquine,small molecule,approved,CCN(CCO)CCCC(C)NC1=C2C=CC(Cl)=CC2=NC=C1,XXSMGPRMXLTPCZ-UHFFFAOYSA-N,335.872,,BE0004796,DNA,Humans,cross-linking/alkylation,yes
DB01613,Erythrityl tetranitrate,small molecule,approved;experimental;investigational,[O-][N+](=O)OC[C@@H](O[N+]([O-])=O)[C@H](CO[N+]([O-])=O)O[N+]([O-])=O,SNFOERUNNSHUGP-ZXZARUISSA-N,302.11,P16066,BE0000556,Atrial natriuretic peptide receptor 1,Humans,agonist,yes
DB01613,Erythrityl tetranitrate,small molecule,approved;experimental;investigational,[O-][N+](=O)OC[C@@H](O[N+]([O-])=O)[C@H](CO[N+]([O-])=O)O[N+]([O-])=O,SNFOERUNNSHUGP-ZXZARUISSA-N,302.11,P20594,BE0000997,Atrial natriuretic peptide receptor 2,Humans,agonist,yes
DB01614,Acepromazine,small molecule,experimental;vet_approved,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(C=C2)C(C)=O,NOSIYYJFMPDDSA-UHFFFAOYSA-N,326.456,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB01614,Acepromazine,small molecule,experimental;vet_approved,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(C=C2)C(C)=O,NOSIYYJFMPDDSA-UHFFFAOYSA-N,326.456,P21728,BE0000020,D(1A) dopamine receptor,Humans,antagonist,yes
DB01614,Acepromazine,small molecule,experimental;vet_approved,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(C=C2)C(C)=O,NOSIYYJFMPDDSA-UHFFFAOYSA-N,326.456,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB01614,Acepromazine,small molecule,experimental;vet_approved,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(C=C2)C(C)=O,NOSIYYJFMPDDSA-UHFFFAOYSA-N,326.456,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,antagonist,yes
DB01615,Aceprometazine,small molecule,experimental,CC(CN1C2=CC=CC=C2SC2=C1C=C(C=C2)C(C)=O)N(C)C,XLOQNFNTQIRSOX-UHFFFAOYSA-N,326.456,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB01616,Alverine,small molecule,approved;investigational,CCN(CCCC1=CC=CC=C1)CCCC1=CC=CC=C1,ZPFXAOWNKLFJDN-UHFFFAOYSA-N,281.4351,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,antagonist,yes
DB01618,Molindone,small molecule,approved,CCC1=C(C)NC2=C1C(=O)C(CN1CCOCC1)CC2,KLPWJLBORRMFGK-UHFFFAOYSA-N,276.374,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB01619,Phenindamine,small molecule,approved,CN1CCC2=C(C1)C(C1=CC=CC=C21)C1=CC=CC=C1,ISFHAYSTHMVOJR-UHFFFAOYSA-N,261.3609,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB01620,Pheniramine,small molecule,approved,CN(C)CCC(C1=CC=CC=C1)C1=CC=CC=N1,IJHNSHDBIRRJRN-UHFFFAOYSA-N,240.3434,Q9H3N8,BE0000146,Histamine H4 receptor,Humans,inverse agonist,yes
DB01620,Pheniramine,small molecule,approved,CN(C)CCC(C1=CC=CC=C1)C1=CC=CC=N1,IJHNSHDBIRRJRN-UHFFFAOYSA-N,240.3434,P35367,BE0000442,Histamine H1 receptor,Humans,inverse agonist,yes
DB01621,Pipotiazine,small molecule,approved;investigational,CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3N2CCCN2CCC(CCO)CC2)C=C1,JOMHSQGEWSNUKU-UHFFFAOYSA-N,475.667,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB01621,Pipotiazine,small molecule,approved;investigational,CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3N2CCCN2CCC(CCO)CC2)C=C1,JOMHSQGEWSNUKU-UHFFFAOYSA-N,475.667,P21728,BE0000020,D(1A) dopamine receptor,Humans,antagonist,yes
DB01621,Pipotiazine,small molecule,approved;investigational,CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3N2CCCN2CCC(CCO)CC2)C=C1,JOMHSQGEWSNUKU-UHFFFAOYSA-N,475.667,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB01621,Pipotiazine,small molecule,approved;investigational,CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3N2CCCN2CCC(CCO)CC2)C=C1,JOMHSQGEWSNUKU-UHFFFAOYSA-N,475.667,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,antagonist,yes
DB01622,Thioproperazine,small molecule,experimental,CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3N2CCCN2CCN(C)CC2)C=C1,VZYCZNZBPPHOFY-UHFFFAOYSA-N,446.629,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB01622,Thioproperazine,small molecule,experimental,CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3N2CCCN2CCN(C)CC2)C=C1,VZYCZNZBPPHOFY-UHFFFAOYSA-N,446.629,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,antagonist,yes
DB01622,Thioproperazine,small molecule,experimental,CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3N2CCCN2CCN(C)CC2)C=C1,VZYCZNZBPPHOFY-UHFFFAOYSA-N,446.629,P35368,BE0000575,Alpha-1B adrenergic receptor,Humans,antagonist,yes
DB01623,Thiothixene,small molecule,approved,CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1,GFBKORZTTCHDGY-UWVJOHFNSA-N,443.625,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB01623,Thiothixene,small molecule,approved,CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1,GFBKORZTTCHDGY-UWVJOHFNSA-N,443.625,P21728,BE0000020,D(1A) dopamine receptor,Humans,antagonist,yes
DB01624,Zuclopenthixol,small molecule,approved;investigational,OCCN1CCN(CC\C=C2\C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1,WFPIAZLQTJBIFN-DVZOWYKESA-N,400.965,P21728,BE0000020,D(1A) dopamine receptor,Humans,antagonist,yes
DB01624,Zuclopenthixol,small molecule,approved;investigational,OCCN1CCN(CC\C=C2\C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1,WFPIAZLQTJBIFN-DVZOWYKESA-N,400.965,P21918,BE0000145,D(1B) dopamine receptor,Humans,antagonist,yes
DB01624,Zuclopenthixol,small molecule,approved;investigational,OCCN1CCN(CC\C=C2\C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1,WFPIAZLQTJBIFN-DVZOWYKESA-N,400.965,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB01625,Isopropamide,small molecule,approved;vet_approved,CC(C)[N+](C)(CCC(C(N)=O)(C1=CC=CC=C1)C1=CC=CC=C1)C(C)C,JTPUMZTWMWIVPA-UHFFFAOYSA-O,353.5209,P20309,BE0000045,Muscarinic acetylcholine receptor M3,Humans,antagonist,yes
DB01626,Pargyline,small molecule,approved,CN(CC#C)CC1=CC=CC=C1,DPWPWRLQFGFJFI-UHFFFAOYSA-N,159.2276,P27338,BE0002196,Amine oxidase [flavin-containing] B,Humans,inhibitor,yes
DB01627,Lincomycin,small molecule,approved;vet_approved,[H][C@]1(C[C@@H](CCC)CN1C)C(=O)N[C@H]([C@@H](C)O)[C@H]1O[C@H](SC)[C@H](O)[C@@H](O)[C@H]1O,OJMMVQQUTAEWLP-KIDUDLJLSA-N,406.54,,BE0004800,23S ribosomal RNA,Enteric bacteria and other eubacteria,binder,yes
DB01628,Etoricoxib,small molecule,approved;investigational,CC1=NC=C(C=C1)C1=C(C=C(Cl)C=N1)C1=CC=C(C=C1)S(C)(=O)=O,MNJVRJDLRVPLFE-UHFFFAOYSA-N,358.842,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB01630,SC-74020,small molecule,experimental,CCCCCC1=CC=C(C=C1)C(=O)NC1=CC=C(C=C1)S(=O)(=O)N(CCN1CCOCC1)[C@H](C(C)C)C(=O)NO,YJNCFXPJICILOK-HHHXNRCGSA-N,574.732,P08253,BE0000642,72 kDa type IV collagenase,Humans,inhibitor,yes
DB01632,5-O-phosphono-alpha-D-ribofuranosyl diphosphate,small molecule,approved;experimental;investigational,O[C@H]1[C@@H](O)[C@@H](OP(O)(=O)OP(O)(O)=O)O[C@@H]1COP(O)(O)=O,PQGCEDQWHSBAJP-TXICZTDVSA-N,390.0696,P20035,BE0001516,Hypoxanthine-guanine-xanthine phosphoribosyltransferase,Plasmodium falciparum (isolate FCR-3 / Gambia),inhibitor,yes
DB01643,Thymidine monophosphate,small molecule,experimental,CC1=CN([C@H]2C[C@H](O)[C@@H](COP(O)(O)=O)O2)C(=O)NC1=O,GYOZYWVXFNDGLU-XLPZGREQSA-N,322.2085,P12461,BE0000021,Thymidylate synthase,Yeast,inhibitor,yes
DB01643,Thymidine monophosphate,small molecule,experimental,CC1=CN([C@H]2C[C@H](O)[C@@H](COP(O)(O)=O)O2)C(=O)NC1=O,GYOZYWVXFNDGLU-XLPZGREQSA-N,322.2085,P04183,BE0001260,"Thymidine kinase, cytosolic",Humans,inhibitor,yes
DB01644,"3,6-dihydroxy-xanthene-9-propionic acid",small molecule,experimental,OC(=O)CCC1C2=CC=C(O)C=C2OC2=C1C=CC(O)=C2,PFQGLFBMMPZYEU-UHFFFAOYSA-N,286.2794,P00390,BE0000648,"Glutathione reductase, mitochondrial",Humans,inhibitor,yes
DB01645,Genistein,small molecule,investigational,OC1=CC=C(C=C1)C1=COC2=C(C(O)=CC(O)=C2)C1=O,TZBJGXHYKVUXJN-UHFFFAOYSA-N,270.2369,Q92731,BE0000792,Estrogen receptor beta,Humans,modulator,yes
DB01647,Daxalipram,small molecule,experimental,CCCOC1=CC(=CC=C1OC)[C@]1(C)CNC(=O)O1,PCCPERGCFKIYIS-AWEZNQCLSA-N,265.305,Q08499,BE0001287,"3',5'-cyclic-AMP phosphodiesterase 4D",Humans,inhibitor,yes
DB01647,Daxalipram,small molecule,experimental,CCCOC1=CC(=CC=C1OC)[C@]1(C)CNC(=O)O1,PCCPERGCFKIYIS-AWEZNQCLSA-N,265.305,P27815,BE0001133,"3',5'-cyclic-AMP phosphodiesterase 4A",Humans,inhibitor,yes
DB01647,Daxalipram,small molecule,experimental,CCCOC1=CC(=CC=C1OC)[C@]1(C)CNC(=O)O1,PCCPERGCFKIYIS-AWEZNQCLSA-N,265.305,Q07343,BE0000487,"3',5'-cyclic-AMP phosphodiesterase 4B",Humans,inhibitor,yes
DB01650,trans-2-hydroxycinnamic acid,small molecule,experimental,OC(=O)\C=C\C1=CC=CC=C1O,PMOWTIHVNWZYFI-AATRIKPKSA-N,164.158,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB01650,trans-2-hydroxycinnamic acid,small molecule,experimental,OC(=O)\C=C\C1=CC=CC=C1O,PMOWTIHVNWZYFI-AATRIKPKSA-N,164.158,P00915,BE0000267,Carbonic anhydrase 1,Humans,inhibitor,yes
DB01656,Roflumilast,small molecule,approved,FC(F)OC1=C(OCC2CC2)C=C(C=C1)C(=O)NC1=C(Cl)C=NC=C1Cl,MNDBXUUTURYVHR-UHFFFAOYSA-N,403.207,P27815,BE0009963,"cAMP-specific 3',5'-cyclic phosphodiesterase 4 (PDE4)",Humans,inhibitor,yes
DB01667,8-azaguanine,small molecule,experimental,NC1=NC2=C(N=NN2)C(=O)N1,LPXQRXLUHJKZIE-UHFFFAOYSA-N,152.1142,P00491,BE0000250,Purine nucleoside phosphorylase,Humans,inhibitor,yes
DB01671,p-Hydroxymercuribenzoic acid,small molecule,experimental,O[Hg]C1=CC=C(C=C1)C(O)=O,WMHRYLDWLOGHSG-UHFFFAOYSA-M,338.71,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB01678,RU84687,small molecule,experimental,CC(=O)N[C@@H](CC1=CC=C(OP(O)(O)=O)C(C=O)=C1)C(=O)N[C@H]1CCCCN(CC2=CC=C(C=C2)C2=CC=CC=C2)C1=O,SAFPHFWYRLLBFO-NSOVKSMOSA-N,607.5907,P12931,BE0000838,Proto-oncogene tyrosine-protein kinase Src,Humans,inhibitor,yes
DB01683,Chymostatin,small molecule,experimental,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O)C1CCNC(=N)N1)C(=O)N[C@@H](CC1=CC=CC=C1)C=O,MRXDGVXSWIXTQL-HYHFHBMOSA-N,607.712,P23946,BE0001038,Chymase,Humans,inhibitor,yes
DB01684,1-Hydroxy-1-Thio-Glycerol,small molecule,experimental,OC[C@@H](O)CSO,DLQCXFUWHQZWJQ-GSVOUGTGSA-N,124.159,P48147,BE0002148,Prolyl endopeptidase,Humans,inhibitor,yes
DB01685,Topiroxostat,small molecule,experimental,N#CC1=NC=CC(=C1)C1=NNC(=N1)C1=CC=NC=C1,UBVZQGOVTLIHLH-UHFFFAOYSA-N,248.2428,P47989,BE0002204,Xanthine dehydrogenase/oxidase,Humans,inhibitor,yes
DB01686,"N,N-dimethylarginine",small molecule,experimental,N[C@@H](CCC\N=C(/N)N(C)C)C(O)=O,YDGMGEXADBMOMJ-LURJTMIESA-N,202.2541,P35228,BE0000005,"Nitric oxide synthase, inducible",Humans,inhibitor,yes
DB01686,"N,N-dimethylarginine",small molecule,experimental,N[C@@H](CCC\N=C(/N)N(C)C)C(O)=O,YDGMGEXADBMOMJ-LURJTMIESA-N,202.2541,P29474,BE0000263,Nitric oxide synthase 3,Humans,inhibitor,yes
DB01689,Inhibitor Idd 384,small molecule,experimental,CC1=CC=CC=C1CC(=O)NC1=CC(C)=C(C(C)=C1)S(=O)(=O)NCC(O)=O,CJKKMQCZOLCXAM-UHFFFAOYSA-N,390.453,P15121,BE0000747,Aldo-keto reductase family 1 member B1,Humans,inhibitor,yes
DB01691,Indole Naphthyridinone,small molecule,experimental,CN(CC1=CN(C)C2=CC=CC=C12)C(=O)\C=C\C1=CN=C2NC(=O)CCC2=C1,VAZMNDXVXVUKFY-JXMROGBWSA-N,374.4357,P9WGR1,BE0000332,Enoyl-[acyl-carrier-protein] reductase [NADH],Mycobacterium tuberculosis,inhibitor,yes
DB01698,Rutin,small molecule,approved;experimental;investigational,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](OC3=C(OC4=CC(O)=CC(O)=C4C3=O)C3=CC(O)=C(O)C=C3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,IKGXIBQEEMLURG-NVPNHPEKSA-N,610.5175,P42330,BE0000592,Aldo-keto reductase family 1 member C3,Humans,inhibitor,yes
DB01699,(4e)-4-Aminohex-4-Enoic Acid,small molecule,experimental,[H]\C(C)=C(/N)CCC(O)=O,KQFBUAIXCIGKAP-GORDUTHDSA-N,129.157,P80404,BE0000253,"4-aminobutyrate aminotransferase, mitochondrial",Humans,inhibitor,yes
DB01708,Prasterone,small molecule,approved;investigational;nutraceutical,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C,FMGSKLZLMKYGDP-USOAJAOKSA-N,288.4244,P11413,BE0001089,Glucose-6-phosphate 1-dehydrogenase,Humans,inhibitor,yes
DB01734,3-(Oxalyl-Amino)-Naphthalene-2-Carboxylic Acid,small molecule,experimental,OC(=O)C(=O)NC1=CC2=C(C=CC=C2)C=C1C(O)=O,DQBLKSRRWDWNKQ-UHFFFAOYSA-N,259.2143,P18031,BE0000623,Tyrosine-protein phosphatase non-receptor type 1,Humans,inhibitor,yes
DB01738,Phosphorylcolamine,small molecule,experimental,NCCOP(O)(O)=O,SUHOOTKUPISOBE-UHFFFAOYSA-N,141.063,P05771,BE0000872,Protein kinase C beta type,Humans,inhibitor,yes
DB01742,(3r)-1-Acetyl-3-Methylpiperidine,small molecule,experimental,C[C@@H]1CCCN(C1)C(C)=O,XKFPNHDGLSYZRC-SSDOTTSWSA-N,141.2108,P62937,BE0001014,Peptidyl-prolyl cis-trans isomerase A,Humans,inhibitor,yes
DB01744,Camphor,small molecule,approved;withdrawn,[H][C@@]12CC[C@@](C)(C(=O)C1)C2(C)C,DSSYKIVIOFKYAU-XCBNKYQSSA-N,152.2334,Q8NER1,BE0001023,Transient receptor potential cation channel subfamily V member 1,Humans,agonist;activator,yes
DB01744,Camphor,small molecule,approved;withdrawn,[H][C@@]12CC[C@@](C)(C(=O)C1)C2(C)C,DSSYKIVIOFKYAU-XCBNKYQSSA-N,152.2334,Q8NET8,BE0003416,Transient receptor potential cation channel subfamily V member 3,Humans,agonist;activator,yes
DB01744,Camphor,small molecule,approved;withdrawn,[H][C@@]12CC[C@@](C)(C(=O)C1)C2(C)C,DSSYKIVIOFKYAU-XCBNKYQSSA-N,152.2334,O75762,BE0001122,Transient receptor potential cation channel subfamily A member 1,Humans,inhibitor,yes
DB01744,Camphor,small molecule,approved;withdrawn,[H][C@@]12CC[C@@](C)(C(=O)C1)C2(C)C,DSSYKIVIOFKYAU-XCBNKYQSSA-N,152.2334,Q7Z2W7,BE0001186,Transient receptor potential cation channel subfamily M member 8,Humans,activator,yes
DB01748,N-Benzyl-4-Sulfamoyl-Benzamide,small molecule,experimental,NS(=O)(=O)C1=CC=C(C=C1)C(=O)NCC1=CC=CC=C1,CZKNSZUJCJHTTM-UHFFFAOYSA-N,290.338,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB01752,S-adenosyl-L-homocysteine,small molecule,experimental,N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12)C(O)=O,ZJUKTBDSGOFHSH-WFMPWKQPSA-N,384.411,Q9UBC3,BE0010009,DNA (cytosine-5)-methyltransferase 3B,Humans,inhibitor,yes
DB01752,S-adenosyl-L-homocysteine,small molecule,experimental,N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12)C(O)=O,ZJUKTBDSGOFHSH-WFMPWKQPSA-N,384.411,P50135,BE0002436,Histamine N-methyltransferase,Humans,inhibitor,yes
DB01758,3-Iodo-Tyrosine,small molecule,experimental,N[C@@H](CC1=CC=C(O)C(I)=C1)C(O)=O,UQTZMGFTRHFAAM-ZETCQYMHSA-N,307.0851,P07101,BE0000614,Tyrosine 3-monooxygenase,Humans,inhibitor,yes
DB01759,Kojic acid,small molecule,experimental,OCC1=CC(=O)C(O)=CO1,BEJNERDRQOWKJM-UHFFFAOYSA-N,142.1094,P14679,BE0000252,Tyrosinase,Humans,inhibitor,yes
DB01764,Dalfopristin,small molecule,approved,CCN(CC)CCS(=O)(=O)[C@@H]1CCN2[C@H]1C(=O)O[C@H](C(C)C)[C@H](C)\C=C\C(=O)NC\C=C\C(\C)=C\[C@@H](O)CC(=O)CC1=NC(=CO1)C2=O,SUYRLXYYZQTJHF-VMBLUXKRSA-N,690.85,P50870,BE0001238,Streptogramin A acetyltransferase,Enterococcus faecium,inhibitor,yes
DB01765,"(5-hydroxyindolo[1,2-a]quinazolin-7-yl)acetic acid",small molecule,experimental,OC(=O)CC1=C2NC(=O)C3=CC=CC=C3N2C2=C1C=CC=C2,INSBKYCYLCEBOD-UHFFFAOYSA-N,292.2888,P68400,BE0001209,Casein kinase II subunit alpha,Humans,inhibitor,yes
DB01766,Beta-(2-Naphthyl)-Alanine,small molecule,experimental,[H][C@](N)(CC1=CC=C2C=CC=CC2=C1)C(O)=O,JPZXHKDZASGCLU-LBPRGKRZSA-N,215.2478,Q13526,BE0003739,Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1,Humans,inhibitor,yes
DB01766,Beta-(2-Naphthyl)-Alanine,small molecule,experimental,[H][C@](N)(CC1=CC=C2C=CC=CC2=C1)C(O)=O,JPZXHKDZASGCLU-LBPRGKRZSA-N,215.2478,P00734,BE0000048,Prothrombin,Humans,inhibitor,yes
DB01767,Hemi-Babim,small molecule,experimental,NC(=N)C1=CC2=C(NC(CC3=NC4=C(N3)C=CC=C4)=N2)C=C1,KKJYVDXDZURHMA-UHFFFAOYSA-N,290.3226,P00734,BE0000048,Prothrombin,Humans,inhibitor,yes
DB01782,Pyrazolanthrone,small molecule,experimental,O=C1C2=CC=CC3=C2C(=NN3)C2=C1C=CC=C2,ACPOUJIDANTYHO-UHFFFAOYSA-N,220.2261,P45984,BE0003772,Mitogen-activated protein kinase 9,Humans,inhibitor,yes
DB01782,Pyrazolanthrone,small molecule,experimental,O=C1C2=CC=CC3=C2C(=NN3)C2=C1C=CC=C2,ACPOUJIDANTYHO-UHFFFAOYSA-N,220.2261,P45983,BE0003790,Mitogen-activated protein kinase 8,Humans,inhibitor,yes
DB01782,Pyrazolanthrone,small molecule,experimental,O=C1C2=CC=CC3=C2C(=NN3)C2=C1C=CC=C2,ACPOUJIDANTYHO-UHFFFAOYSA-N,220.2261,P33981,BE0003791,Dual specificity protein kinase TTK,Humans,inhibitor,yes
DB01782,Pyrazolanthrone,small molecule,experimental,O=C1C2=CC=CC3=C2C(=NN3)C2=C1C=CC=C2,ACPOUJIDANTYHO-UHFFFAOYSA-N,220.2261,P53779,BE0001097,Mitogen-activated protein kinase 10,Humans,inhibitor,yes
DB01784,4-Flourobenzenesulfonamide,small molecule,experimental,NS(=O)(=O)C1=CC=C(F)C=C1,LFLSATHZMYYIAQ-UHFFFAOYSA-N,175.181,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB01785,Dimethylallyl Diphosphate,small molecule,experimental,CC(C)=CCO[P@](O)(=O)OP(O)(O)=O,CBIDRCWHNCKSTO-UHFFFAOYSA-N,246.0921,P14324,BE0000776,Farnesyl pyrophosphate synthase,Humans,inhibitor,yes
DB01791,Piclamilast,small molecule,experimental,COC1=CC=C(C=C1OC1CCCC1)C(=O)NC1=C(Cl)C=NC=C1Cl,RRRUXBQSQLKHEL-UHFFFAOYSA-N,381.253,P27815,BE0001133,"3',5'-cyclic-AMP phosphodiesterase 4A",Humans,inhibitor,yes
DB01791,Piclamilast,small molecule,experimental,COC1=CC=C(C=C1OC1CCCC1)C(=O)NC1=C(Cl)C=NC=C1Cl,RRRUXBQSQLKHEL-UHFFFAOYSA-N,381.253,Q08499,BE0001287,"3',5'-cyclic-AMP phosphodiesterase 4D",Humans,inhibitor,yes
DB01791,Piclamilast,small molecule,experimental,COC1=CC=C(C=C1OC1CCCC1)C(=O)NC1=C(Cl)C=NC=C1Cl,RRRUXBQSQLKHEL-UHFFFAOYSA-N,381.253,Q07343,BE0000487,"3',5'-cyclic-AMP phosphodiesterase 4B",Humans,inhibitor,yes
DB01793,SB-409513,small molecule,experimental,OC(=O)C1=CC(NC2=C(C(=O)NC2=O)C2=CC(Cl)=CC=C2)=CC=C1Cl,ONVZFCHLOZUXRP-UHFFFAOYSA-N,377.178,P49841,BE0001065,Glycogen synthase kinase-3 beta,Humans,inhibitor,yes
DB01795,Phenylboronic acid,small molecule,experimental,OB(O)C1=CC=CC=C1,HXITXNWTGFUOAU-UHFFFAOYSA-N,121.93,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB01795,Phenylboronic acid,small molecule,experimental,OB(O)C1=CC=CC=C1,HXITXNWTGFUOAU-UHFFFAOYSA-N,121.93,P22748,BE0000535,Carbonic anhydrase 4,Humans,inhibitor,yes
DB01795,Phenylboronic acid,small molecule,experimental,OB(O)C1=CC=CC=C1,HXITXNWTGFUOAU-UHFFFAOYSA-N,121.93,P00915,BE0000267,Carbonic anhydrase 1,Humans,inhibitor,yes
DB01811,"3h-Indole-5,6-Diol",small molecule,experimental,OC1=C(O)C=C2C=CNC2=C1,SGNZYJXNUURYCH-UHFFFAOYSA-N,149.1467,P02788,BE0000994,Lactotransferrin,Humans,inhibitor,yes
DB01822,"(4R,5R)-1,2-dithiane-4,5-diol",small molecule,experimental,O[C@H]1CSSC[C@@H]1O,YPGMOWHXEQDBBV-IMJSIDKUSA-N,152.235,Q01201,BE0013795,Transcription factor RelB,Humans,inhibitor,yes
DB01822,"(4R,5R)-1,2-dithiane-4,5-diol",small molecule,experimental,O[C@H]1CSSC[C@@H]1O,YPGMOWHXEQDBBV-IMJSIDKUSA-N,152.235,P19838,BE0001086,Nuclear factor NF-kappa-B p105 subunit,Humans,inhibitor,yes
DB01822,"(4R,5R)-1,2-dithiane-4,5-diol",small molecule,experimental,O[C@H]1CSSC[C@@H]1O,YPGMOWHXEQDBBV-IMJSIDKUSA-N,152.235,Q00653,BE0002387,Nuclear factor NF-kappa-B p100 subunit,Humans,inhibitor,yes
DB01822,"(4R,5R)-1,2-dithiane-4,5-diol",small molecule,experimental,O[C@H]1CSSC[C@@H]1O,YPGMOWHXEQDBBV-IMJSIDKUSA-N,152.235,Q04206,BE0005551,Transcription factor p65,Humans,inhibitor,yes
DB01822,"(4R,5R)-1,2-dithiane-4,5-diol",small molecule,experimental,O[C@H]1CSSC[C@@H]1O,YPGMOWHXEQDBBV-IMJSIDKUSA-N,152.235,Q04864,BE0010782,Proto-oncogene c-Rel,Humans,inhibitor,yes
DB01827,"2,3,5,6-Tetrafluoro-4-Methoxy-Benzamide",small molecule,experimental,COC1=C(F)C(F)=C(C(N)=O)C(F)=C1F,JTXPTSGPUNTKSM-UHFFFAOYSA-N,223.1244,P17931,BE0001353,Galectin-3,Humans,inhibitor,yes
DB01830,AP-22408,small molecule,experimental,CC(=O)N[C@@H](CC1=CC=C(C(=C1)P(O)(O)=O)P(O)(O)=O)C(=O)N[C@H]1CCCCC2=CC(OCC3CCCCC3)=C(C=C12)C(N)=O,SPSGYTWOIGAABK-DQEYMECFSA-N,665.6082,P12931,BE0000838,Proto-oncogene tyrosine-protein kinase Src,Humans,inhibitor,yes
DB01833,Canavanine,small molecule,experimental,N[C@@H](CCONC(N)=N)C(O)=O,FSBIGDSBMBYOPN-VKHMYHEASA-N,176.1738,P29474,BE0000263,Nitric oxide synthase 3,Humans,inhibitor,yes
DB01835,4R-Fluoro-N6-ethanimidoyl-L-lysine,small molecule,experimental,[H]N([H])[C@@H](C[C@@H](F)CC\N=C(/C)N([H])[H])C(O)=O,LTCJJIZTKXNFGK-BQBZGAKWSA-N,205.233,P35228,BE0000005,"Nitric oxide synthase, inducible",Humans,inhibitor,yes
DB01837,O-acetyl-L-serine,small molecule,experimental,CC(=O)OC[C@H](N)C(O)=O,VZXPDPZARILFQX-BYPYZUCNSA-N,147.1293,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB01841,"4,6-Dideoxyglucose",small molecule,experimental,[H][C@@]1(C)C[C@]([H])(O)[C@@]([H])(O)[C@@]([H])(O)O1,BJBURJZEESAQPG-MOJAZDJTSA-N,148.1571,P10253,BE0000876,Lysosomal alpha-glucosidase,Humans,inhibitor,yes
DB01841,"4,6-Dideoxyglucose",small molecule,experimental,[H][C@@]1(C)C[C@]([H])(O)[C@@]([H])(O)[C@@]([H])(O)O1,BJBURJZEESAQPG-MOJAZDJTSA-N,148.1571,Q14697,BE0004698,Neutral alpha-glucosidase AB,Humans,inhibitor,yes
DB01841,"4,6-Dideoxyglucose",small molecule,experimental,[H][C@@]1(C)C[C@]([H])(O)[C@@]([H])(O)[C@@]([H])(O)O1,BJBURJZEESAQPG-MOJAZDJTSA-N,148.1571,Q8TET4,BE0004699,Neutral alpha-glucosidase C,Humans,inhibitor,yes
DB01852,Kaempherol,small molecule,experimental,OC1=CC=C(C=C1)C1=C(O)C(=O)C2=C(O1)C=C(O)C=C2O,IYRMWMYZSQPJKC-UHFFFAOYSA-N,286.2363,P09917,BE0000248,Polyunsaturated fatty acid 5-lipoxygenase,Humans,inhibitor,yes
DB01852,Kaempherol,small molecule,experimental,OC1=CC=C(C=C1)C1=C(O)C(=O)C2=C(O1)C=C(O)C=C2O,IYRMWMYZSQPJKC-UHFFFAOYSA-N,286.2363,P16050,BE0000309,Polyunsaturated fatty acid lipoxygenase ALOX15,Humans,inhibitor,yes
DB01852,Kaempherol,small molecule,experimental,OC1=CC=C(C=C1)C1=C(O)C(=O)C2=C(O1)C=C(O)C=C2O,IYRMWMYZSQPJKC-UHFFFAOYSA-N,286.2363,P15121,BE0000747,Aldo-keto reductase family 1 member B1,Humans,inhibitor,yes
DB01852,Kaempherol,small molecule,experimental,OC1=CC=C(C=C1)C1=C(O)C(=O)C2=C(O1)C=C(O)C=C2O,IYRMWMYZSQPJKC-UHFFFAOYSA-N,286.2363,Q04760,BE0000962,Lactoylglutathione lyase,Humans,inhibitor,yes
DB01852,Kaempherol,small molecule,experimental,OC1=CC=C(C=C1)C1=C(O)C(=O)C2=C(O1)C=C(O)C=C2O,IYRMWMYZSQPJKC-UHFFFAOYSA-N,286.2363,Q16678,BE0001111,Cytochrome P450 1B1,Humans,inhibitor,yes
DB01852,Kaempherol,small molecule,experimental,OC1=CC=C(C=C1)C1=C(O)C(=O)C2=C(O1)C=C(O)C=C2O,IYRMWMYZSQPJKC-UHFFFAOYSA-N,286.2363,P14061,BE0000194,17-beta-hydroxysteroid dehydrogenase type 1,Humans,inhibitor,yes
DB01852,Kaempherol,small molecule,experimental,OC1=CC=C(C=C1)C1=C(O)C(=O)C2=C(O1)C=C(O)C=C2O,IYRMWMYZSQPJKC-UHFFFAOYSA-N,286.2363,P10275,BE0000132,Androgen receptor,Humans,inhibitor,yes
DB01863,"Inositol 1,3,4,5-Tetrakisphosphate",small molecule,experimental,O[C@H]1[C@@H](OP(O)(O)=O)[C@H](O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H]1OP(O)(O)=O,CIPFCGZLFXVXBG-CNWJWELYSA-N,500.0755,P31749,BE0000428,RAC-alpha serine/threonine-protein kinase,Humans,inhibitor,yes
DB01863,"Inositol 1,3,4,5-Tetrakisphosphate",small molecule,experimental,O[C@H]1[C@@H](OP(O)(O)=O)[C@H](O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H]1OP(O)(O)=O,CIPFCGZLFXVXBG-CNWJWELYSA-N,500.0755,Q06187,BE0001284,Tyrosine-protein kinase BTK,Humans,inhibitor,yes
DB01866,RU79256,small molecule,experimental,[H][C@](C(O)=O)(C1=CC=CC=C1)S(O)(=O)=O,USNMCXDGQQVYSW-SSDOTTSWSA-N,216.211,P12931,BE0000838,Proto-oncogene tyrosine-protein kinase Src,Humans,inhibitor,yes
DB01880,"3,4-Dihydroxycinnamic Acid",small molecule,experimental;investigational,OC(=O)\C=C\C1=CC(O)=C(O)C=C1,QAIPRVGONGVQAS-DUXPYHPUSA-N,180.1574,P14174,BE0001855,Macrophage migration inhibitory factor,Humans,inhibitor,yes
DB01880,"3,4-Dihydroxycinnamic Acid",small molecule,experimental;investigational,OC(=O)\C=C\C1=CC(O)=C(O)C=C1,QAIPRVGONGVQAS-DUXPYHPUSA-N,180.1574,P09917,BE0000248,Polyunsaturated fatty acid 5-lipoxygenase,Humans,inhibitor,yes
DB01883,N-(Sulfanylacetyl)Tyrosylprolylmethioninamide,small molecule,experimental,[H][C@@](CCSC)(NC(=O)[C@]1([H])CCCN1C(=O)[C@]([H])(CC1=CC=C(O)C=C1)NC(=O)CS)C(N)=O,LNLWXWOYQHAKTD-ULQDDVLXSA-N,482.617,P15917,BE0001363,Lethal factor,Bacillus anthracis,inhibitor,yes
DB01884,2-Amino-3-Methyl-1-Pyrrolidin-1-Yl-Butan-1-One,small molecule,experimental,[H][C@](N)(C(C)C)C(=O)N1CCCC1,IHBAVXVTGLANPI-QMMMGPOBSA-N,170.252,P27487,BE0000854,Dipeptidyl peptidase 4,Humans,inhibitor,yes
DB01889,"16,17-Androstene-3-Ol",small molecule,experimental,[H][C@@]12CC=C[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@]([H])(O)CC[C@]12C,KRVXMNNRSSQZJP-PHFHYRSDSA-N,274.4409,Q14994,BE0003848,Nuclear receptor subfamily 1 group I member 3,Humans,antagonist,yes
DB01890,"N,N-Bis(3-(D-gluconamido)propyl)deoxycholamide",small molecule,experimental,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@]12C)[C@H](C)CCC(=O)N(CCCNC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO)CCCNC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,OJSUWTDDXLCUFR-HGZMBBKESA-N,862.056,Q07869,BE0000071,Peroxisome proliferator-activated receptor alpha,Humans,inhibitor,yes
DB01892,Hyperforin,small molecule,nutraceutical,CC(C)C(=O)[C@@]12C(O)=C(CC=C(C)C)C(=O)[C@@](CC=C(C)C)(C[C@H](CC=C(C)C)[C@@]1(C)CCC=C(C)C)C2=O,IWBJJCOKGLUQIZ-HQKKAZOISA-N,536.797,P09917,BE0000248,Polyunsaturated fatty acid 5-lipoxygenase,Humans,inhibitor,yes
DB01892,Hyperforin,small molecule,nutraceutical,CC(C)C(=O)[C@@]12C(O)=C(CC=C(C)C)C(=O)[C@@](CC=C(C)C)(C[C@H](CC=C(C)C)[C@@]1(C)CCC=C(C)C)C2=O,IWBJJCOKGLUQIZ-HQKKAZOISA-N,536.797,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB01893,N6-Benzyl Adenosine-5'-Diphosphate,small molecule,experimental,[H][C@]1(COP(O)(=O)OP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(NCC4=CC=CC=C4)N=CN=C23)[C@]([H])(O)[C@]1([H])O,MRHGMAGSDAQUFH-LSCFUAHRSA-N,517.3237,P12931,BE0000838,Proto-oncogene tyrosine-protein kinase Src,Humans,inhibitor,yes
DB01896,M-Aminophenylboronic Acid,small molecule,experimental,NC1=CC=CC(=C1)B(O)O,JMZFEHDNIAQMNB-UHFFFAOYSA-N,136.944,P00807,BE0000302,Beta-lactamase,Staphylococcus aureus,inhibitor,yes
DB01901,Sucrosofate,small molecule,experimental,OS(=O)(=O)OC[C@H]1O[C@@](COS(O)(=O)=O)(O[C@H]2O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]2OS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@@H]1OS(O)(=O)=O,WEPNHBQBLCNOBB-UGDNZRGBSA-N,982.802,P05230,BE0000689,Fibroblast growth factor 1,Humans,inhibitor,yes
DB01908,RU85493,small molecule,experimental,CC(=O)N[C@@H](CC1=CC=C(OCC(O)=O)C(=C1)P(O)(O)=O)C(=O)N[C@H]1CCCCN(CC2=CC=C(C=C2)C2=CC=CC=C2)C1=O,MWEWSHNGVWABKG-SVBPBHIXSA-N,637.6167,P12931,BE0000838,Proto-oncogene tyrosine-protein kinase Src,Humans,inhibitor,yes
DB01911,N-Methylmesoporphyrin,small molecule,experimental,CCC1=C(C)C2=CC3=C(CC)C(C)=C(C=C4N=C(C=C5N\C(=C/C1=N2)C(C)=C5CCC(O)=O)C(CCC(O)=O)=C4C)N3C,YNWHQWMCLCANDI-YIYRCNGCSA-N,580.7165,P22830,BE0001033,"Ferrochelatase, mitochondrial",Humans,inhibitor,yes
DB01915,S-Hydroxycysteine,small molecule,experimental,N[C@@H](CSO)C(O)=O,FXIRVRPOOYSARH-REOHCLBHSA-N,137.158,P18031,BE0000623,Tyrosine-protein phosphatase non-receptor type 1,Humans,inhibitor,yes
DB01915,S-Hydroxycysteine,small molecule,experimental,N[C@@H](CSO)C(O)=O,FXIRVRPOOYSARH-REOHCLBHSA-N,137.158,P30305,BE0001705,M-phase inducer phosphatase 2,Humans,inhibitor,yes
DB01915,S-Hydroxycysteine,small molecule,experimental,N[C@@H](CSO)C(O)=O,FXIRVRPOOYSARH-REOHCLBHSA-N,137.158,P12931,BE0000838,Proto-oncogene tyrosine-protein kinase Src,Humans,inhibitor,yes
DB01915,S-Hydroxycysteine,small molecule,experimental,N[C@@H](CSO)C(O)=O,FXIRVRPOOYSARH-REOHCLBHSA-N,137.158,P01024,BE0003455,Complement C3,Humans,inhibitor,yes
DB01927,Duroquinone,small molecule,experimental,CC1=C(C)C(=O)C(C)=C(C)C1=O,WAMKWBHYPYBEJY-UHFFFAOYSA-N,164.2011,P15559,BE0001184,NAD(P)H dehydrogenase [quinone] 1,Humans,inhibitor,yes
DB01929,"5-Chloryl-2,4,6-quinazolinetriamine",small molecule,experimental,NC1=C(C2=C(N)N=C(N)N=C2C=C1)[Cl](=O)=O,AOIWFGJNGXKHGL-UHFFFAOYSA-N,241.634,Q9HBH1,BE0002201,"Peptide deformylase, mitochondrial",Humans,inhibitor,yes
DB01931,"5,7-Dichlorokynurenic acid",small molecule,experimental,OC(=O)C1=CC(O)=C2C(Cl)=CC(Cl)=CC2=N1,BGKFPRIGXAVYNX-UHFFFAOYSA-N,258.058,Q05586,BE0000365,"Glutamate receptor ionotropic, NMDA 1",Humans,inhibitor,yes
DB01933,7-Hydroxystaurosporine,small molecule,experimental;investigational,[H][C@]12C[C@@H](NC)[C@@H](OC)[C@](C)(O1)N1C3=C(C=CC=C3)C3=C4[C@@H](O)NC(=O)C4=C4C5=C(C=CC=C5)N2C4=C13,PBCZSGKMGDDXIJ-HQCWYSJUSA-N,482.5304,O14757,BE0003382,Serine/threonine-protein kinase Chk1,Humans,inhibitor,yes
DB01941,LG-100268,small molecule,experimental,CC1=C(C=C2C(=C1)C(C)(C)CCC2(C)C)C1(CC1)C1=CC=C(C=N1)C(O)=O,SLXTWXQUEZSSTJ-UHFFFAOYSA-N,363.4926,P10276,BE0000663,Retinoic acid receptor alpha,Humans,agonist,yes
DB01947,RU78262,small molecule,experimental,OP(O)(=O)OC1=C(C=O)C=CC=C1,BYNSFVCWJXZPOW-UHFFFAOYSA-N,202.1012,P12931,BE0000838,Proto-oncogene tyrosine-protein kinase Src,Humans,inhibitor,yes
DB01950,AR-AO-14418,small molecule,experimental,COC1=CC=C(CNC(=O)NC2=NC=C(S2)[N+]([O-])=O)C=C1,YAEMHJKFIIIULI-UHFFFAOYSA-N,308.313,P49841,BE0001065,Glycogen synthase kinase-3 beta,Humans,inhibitor,yes
DB01951,Gpi-1046,small molecule,experimental,[H][C@]1(CCCN1C(=O)C(=O)C(C)(C)CC)C(=O)OCCCC1=CN=CC=C1,OQAHHWOPVDDWHD-INIZCTEOSA-N,360.4473,P62942,BE0000695,Peptidyl-prolyl cis-trans isomerase FKBP1A,Humans,inhibitor,yes
DB01953,Inhibitor of P38 Kinase,small molecule,experimental,C(CC1=CC=NC=C1)C1=CNC2=CC=CC=C12,UUEYCHLWAOBOHG-UHFFFAOYSA-N,222.2851,Q16539,BE0001019,Mitogen-activated protein kinase 14,Humans,inhibitor,yes
DB01954,Rolipram,small molecule,investigational,COC1=C(OC2CCCC2)C=C(C=C1)C1CNC(=O)C1,HJORMJIFDVBMOB-UHFFFAOYSA-N,275.348,O76074,BE0000182,"cGMP-specific 3',5'-cyclic phosphodiesterase",Humans,inhibitor,yes
DB01954,Rolipram,small molecule,investigational,COC1=C(OC2CCCC2)C=C(C=C1)C1CNC(=O)C1,HJORMJIFDVBMOB-UHFFFAOYSA-N,275.348,P27815,BE0001133,"3',5'-cyclic-AMP phosphodiesterase 4A",Humans,inhibitor,yes
DB01954,Rolipram,small molecule,investigational,COC1=C(OC2CCCC2)C=C(C=C1)C1CNC(=O)C1,HJORMJIFDVBMOB-UHFFFAOYSA-N,275.348,P27815,BE0009963,"cAMP-specific 3',5'-cyclic phosphodiesterase 4 (PDE4)",Humans,inhibitor,yes
DB01954,Rolipram,small molecule,investigational,COC1=C(OC2CCCC2)C=C(C=C1)C1CNC(=O)C1,HJORMJIFDVBMOB-UHFFFAOYSA-N,275.348,Q07343,BE0000487,"3',5'-cyclic-AMP phosphodiesterase 4B",Humans,inhibitor,yes
DB01954,Rolipram,small molecule,investigational,COC1=C(OC2CCCC2)C=C(C=C1)C1CNC(=O)C1,HJORMJIFDVBMOB-UHFFFAOYSA-N,275.348,Q08499,BE0001287,"3',5'-cyclic-AMP phosphodiesterase 4D",Humans,inhibitor,yes
DB01956,Taurine,small molecule,approved;nutraceutical,NCCS(O)(=O)=O,XOAAWQZATWQOTB-UHFFFAOYSA-N,125.147,Q13224,BE0000417,"Glutamate receptor ionotropic, NMDA 2B",Humans,inhibitor,yes
DB01956,Taurine,small molecule,approved;nutraceutical,NCCS(O)(=O)=O,XOAAWQZATWQOTB-UHFFFAOYSA-N,125.147,P48167,BE0000055,Glycine receptor subunit beta,Humans,agonist,yes
DB01956,Taurine,small molecule,approved;nutraceutical,NCCS(O)(=O)=O,XOAAWQZATWQOTB-UHFFFAOYSA-N,125.147,P23416,BE0000745,Glycine receptor subunit alpha-2,Humans,agonist,yes
DB01956,Taurine,small molecule,approved;nutraceutical,NCCS(O)(=O)=O,XOAAWQZATWQOTB-UHFFFAOYSA-N,125.147,O75311,BE0000414,Glycine receptor subunit alpha-3,Humans,agonist,yes
DB01956,Taurine,small molecule,approved;nutraceutical,NCCS(O)(=O)=O,XOAAWQZATWQOTB-UHFFFAOYSA-N,125.147,P14867,BE0004797,GABA(A) Receptor,Humans,agonist,yes
DB01956,Taurine,small molecule,approved;nutraceutical,NCCS(O)(=O)=O,XOAAWQZATWQOTB-UHFFFAOYSA-N,125.147,Q9UBS5,BE0000217,Gamma-aminobutyric acid type B receptor subunit 1,Humans,agonist,yes
DB01956,Taurine,small molecule,approved;nutraceutical,NCCS(O)(=O)=O,XOAAWQZATWQOTB-UHFFFAOYSA-N,125.147,P23415,BE0000433,Glycine receptor subunit alpha-1,Humans,agonist,yes
DB01962,Phosphonotyrosine,small molecule,experimental,N[C@@H](CC1=CC=C(OP(O)(O)=O)C=C1)C(O)=O,DCWXELXMIBXGTH-QMMMGPOBSA-N,261.1684,P12931,BE0000838,Proto-oncogene tyrosine-protein kinase Src,Humans,inhibitor,yes
DB01962,Phosphonotyrosine,small molecule,experimental,N[C@@H](CC1=CC=C(OP(O)(O)=O)C=C1)C(O)=O,DCWXELXMIBXGTH-QMMMGPOBSA-N,261.1684,P10721,BE0000453,Mast/stem cell growth factor receptor Kit,Humans,inhibitor,yes
DB01963,Phenylethane Boronic Acid,small molecule,experimental,OB(O)CCC1=CC=CC=C1,VPRUMANMDWQMNF-UHFFFAOYSA-N,149.983,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB01963,Phenylethane Boronic Acid,small molecule,experimental,OB(O)CCC1=CC=CC=C1,VPRUMANMDWQMNF-UHFFFAOYSA-N,149.983,P00915,BE0000267,Carbonic anhydrase 1,Humans,inhibitor,yes
DB01964,AL5424,small molecule,experimental,[H][C@]1(O)CN(C2=CC=C(OC)C=C2)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,ZWTSOJQGEWPWGO-NSHDSACASA-N,390.455,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB01972,Guanosine-5'-Monophosphate,small molecule,experimental,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1,RQFCJASXJCIDSX-UUOKFMHZSA-N,363.2206,P20035,BE0001516,Hypoxanthine-guanine-xanthine phosphoribosyltransferase,Plasmodium falciparum (isolate FCR-3 / Gambia),inhibitor,yes
DB01972,Guanosine-5'-Monophosphate,small molecule,experimental,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1,RQFCJASXJCIDSX-UUOKFMHZSA-N,363.2206,P04293,BE0000308,DNA polymerase catalytic subunit,HHV-1,inhibitor,yes
DB01972,Guanosine-5'-Monophosphate,small molecule,experimental,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1,RQFCJASXJCIDSX-UUOKFMHZSA-N,363.2206,P08546,BE0000343,DNA polymerase catalytic subunit,HHV-5,inhibitor,yes
DB01972,Guanosine-5'-Monophosphate,small molecule,experimental,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1,RQFCJASXJCIDSX-UUOKFMHZSA-N,363.2206,O76074,BE0000182,"cGMP-specific 3',5'-cyclic phosphodiesterase",Humans,inhibitor,yes
DB01972,Guanosine-5'-Monophosphate,small molecule,experimental,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1,RQFCJASXJCIDSX-UUOKFMHZSA-N,363.2206,P78352,BE0004524,Disks large homolog 4,Humans,inhibitor,yes
DB01973,O-Benzylsulfonyl-Serine,small molecule,experimental,N[C@@H](COS(=O)(=O)CC1=CC=CC=C1)C(O)=O,GCZVEKLTOLTWLM-VIFPVBQESA-N,259.279,P16753,BE0001331,Capsid scaffolding protein,HHV-5,inhibitor,yes
DB01977,6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine,small molecule,experimental,NC(=N)C1=CC=C2C=C(C=CC2=C1)C(=O)NC1=CC=CC=C1,AECPTICWHONWNW-UHFFFAOYSA-N,289.3312,P00749,BE0000895,Urokinase-type plasminogen activator,Humans,inhibitor,yes
DB01987,Cocarboxylase,small molecule,approved;experimental,CC1=C(CCO[P@](O)(=O)O[P@](O)([O-])=O)SC=[N+]1CC1=CN=C(C)N=C1N,AYEKOFBPNLCAJY-UHFFFAOYSA-N,424.306,,BE0004810,RNA,Humans,binder,yes
DB01992,Coenzyme A,small molecule,investigational;nutraceutical,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS,RGJOEKWQDUBAIZ-IBOSZNHHSA-N,767.534,P04035,BE0000574,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Humans,inhibitor,yes
DB01992,Coenzyme A,small molecule,investigational;nutraceutical,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS,RGJOEKWQDUBAIZ-IBOSZNHHSA-N,767.534,P43155,BE0000496,Carnitine O-acetyltransferase,Humans,inhibitor,yes
DB01997,3-Bromo-7-Nitroindazole,small molecule,experimental,BrC1=NNC2=C1C=CC=C2N(=O)=O,NFSTZPMYAZRZPC-UHFFFAOYSA-N,242.03,P29474,BE0000263,Nitric oxide synthase 3,Humans,inhibitor,yes
DB01997,3-Bromo-7-Nitroindazole,small molecule,experimental,BrC1=NNC2=C1C=CC=C2N(=O)=O,NFSTZPMYAZRZPC-UHFFFAOYSA-N,242.03,P29475,BE0000067,Nitric oxide synthase 1,Humans,inhibitor,yes
DB01997,3-Bromo-7-Nitroindazole,small molecule,experimental,BrC1=NNC2=C1C=CC=C2N(=O)=O,NFSTZPMYAZRZPC-UHFFFAOYSA-N,242.03,P35228,BE0000005,"Nitric oxide synthase, inducible",Humans,inhibitor,yes
DB02007,alpha-D-glucose 6-phosphate,small molecule,experimental,O[C@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O,NBSCHQHZLSJFNQ-DVKNGEFBSA-N,260.1358,P15121,BE0000747,Aldo-keto reductase family 1 member B1,Humans,inhibitor,yes
DB02007,alpha-D-glucose 6-phosphate,small molecule,experimental,O[C@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O,NBSCHQHZLSJFNQ-DVKNGEFBSA-N,260.1358,P11217,BE0000916,"Glycogen phosphorylase, muscle form",Humans,inhibitor,yes
DB02007,alpha-D-glucose 6-phosphate,small molecule,experimental,O[C@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O,NBSCHQHZLSJFNQ-DVKNGEFBSA-N,260.1358,P17169,BE0001423,Glutamine--fructose-6-phosphate aminotransferase [isomerizing],Escherichia coli (strain K12),inhibitor,yes
DB02009,L-756423,small molecule,experimental,CC(C)(C)NC(=O)[C@@H]1CN(CC2=CC3=C(O2)C=CC=C3)CCN1C[C@@H](O)C[C@@H](CC1=CC=CC=C1)C(=O)NC1[C@H](O)CC2=C1C=CC=C2,AOMZDQMIOCTPQP-CFSTZTOESA-N,652.836,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB02010,Staurosporine,small molecule,experimental,[H][C@]1(C[C@@]2([H])O[C@](C)(N3C4=CC=CC=C4C4=C5CNC(=O)C5=C5C6=CC=CC=C6N2C5=C34)[C@]1([H])OC)NC,HKSZLNNOFSGOKW-FYTWVXJKSA-N,466.531,O14920,BE0001154,Inhibitor of nuclear factor kappa-B kinase subunit beta,Humans,inhibitor,yes
DB02015,Dihydrofolic Acid,small molecule,experimental,NC1=NC2=C(N=C(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CN2)C(=O)N1,OZRNSSUDZOLUSN-LBPRGKRZSA-N,443.4133,Q9HBH1,BE0002201,"Peptide deformylase, mitochondrial",Humans,inhibitor,yes
DB02020,Alrestatin,small molecule,experimental,OC(=O)CN1C(=O)C2=CC=CC3=CC=CC(C1=O)=C23,GCUCIFQCGJIRNT-UHFFFAOYSA-N,255.2256,P15121,BE0000747,Aldo-keto reductase family 1 member B1,Humans,inhibitor,yes
DB02021,Fidarestat,small molecule,experimental,NC(=O)[C@@H]1C[C@]2(NC(=O)NC2=O)C2=C(O1)C=CC(F)=C2,WAAPEIZFCHNLKK-UFBFGSQYSA-N,279.2239,P15121,BE0000747,Aldo-keto reductase family 1 member B1,Humans,inhibitor,yes
DB02026,"Furo[2,3d]Pyrimidine Antifolate",small molecule,experimental,[H][C@@](CCC(O)=O)(NC(=O)C1=CC=C(C=C1)N(C)CC1=COC2=NC(N)=NC(N)=C12)C(O)=O,WXINNGCGSCFUCR-ZDUSSCGKSA-N,442.4253,Q9HBH1,BE0002201,"Peptide deformylase, mitochondrial",Humans,inhibitor,yes
DB02029,N-Cyclohexyl-N'-(4-Iodophenyl)Urea,small molecule,experimental,IC1=CC=C(NC(=O)NC2CCCCC2)C=C1,AQTBUVAFYDVTFD-UHFFFAOYSA-N,344.1914,P34913,BE0000950,Bifunctional epoxide hydrolase 2,Humans,inhibitor,yes
DB02034,Tridolgosir,small molecule,experimental,[H][C@@]1(O)CN2CCC[C@@]([H])(O)[C@]2([H])[C@]1([H])O,FXUAIOOAOAVCGD-WCTZXXKLSA-N,173.2096,Q16706,BE0003505,Alpha-mannosidase 2,Humans,inhibitor,yes
DB02044,N-[3-(aminomethyl)benzyl]acetamidine,small molecule,experimental,CC(=N)NCC1=CC(CN)=CC=C1,RODUKNYOEVZQPR-UHFFFAOYSA-N,177.2462,P35228,BE0000005,"Nitric oxide synthase, inducible",Humans,inhibitor,yes
DB02044,N-[3-(aminomethyl)benzyl]acetamidine,small molecule,experimental,CC(=N)NCC1=CC(CN)=CC=C1,RODUKNYOEVZQPR-UHFFFAOYSA-N,177.2462,P29474,BE0000263,Nitric oxide synthase 3,Humans,inhibitor,yes
DB02044,N-[3-(aminomethyl)benzyl]acetamidine,small molecule,experimental,CC(=N)NCC1=CC(CN)=CC=C1,RODUKNYOEVZQPR-UHFFFAOYSA-N,177.2462,P29475,BE0000067,Nitric oxide synthase 1,Humans,inhibitor,yes
DB02047,(+)-2-(4-biphenyl)propionic acid,small molecule,experimental,C[C@H](C(O)=O)C1=CC=C(C=C1)C1=CC=CC=C1,JALUUBQFLPUJMY-NSHDSACASA-N,226.2705,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB02056,Prostaglandin D2,small molecule,investigational,[H][C@](O)(CCCCC)\C=C\[C@@]1([H])C(=O)C[C@]([H])(O)[C@]1([H])C\C=C/CCCC(O)=O,BHMBVRSPMRCCGG-OUTUXVNYSA-N,352.4651,Q13258,BE0000296,Prostaglandin D2 receptor,Humans,agonist,yes
DB02056,Prostaglandin D2,small molecule,investigational,[H][C@](O)(CCCCC)\C=C\[C@@]1([H])C(=O)C[C@]([H])(O)[C@]1([H])C\C=C/CCCC(O)=O,BHMBVRSPMRCCGG-OUTUXVNYSA-N,352.4651,P43088,BE0000610,Prostaglandin F2-alpha receptor,Humans,agonist,yes
DB02056,Prostaglandin D2,small molecule,investigational,[H][C@](O)(CCCCC)\C=C\[C@@]1([H])C(=O)C[C@]([H])(O)[C@]1([H])C\C=C/CCCC(O)=O,BHMBVRSPMRCCGG-OUTUXVNYSA-N,352.4651,P34995,BE0000064,Prostaglandin E2 receptor EP1 subtype,Humans,agonist,yes
DB02056,Prostaglandin D2,small molecule,investigational,[H][C@](O)(CCCCC)\C=C\[C@@]1([H])C(=O)C[C@]([H])(O)[C@]1([H])C\C=C/CCCC(O)=O,BHMBVRSPMRCCGG-OUTUXVNYSA-N,352.4651,P43115,BE0002375,Prostaglandin E2 receptor EP3 subtype,Humans,agonist,yes
DB02056,Prostaglandin D2,small molecule,investigational,[H][C@](O)(CCCCC)\C=C\[C@@]1([H])C(=O)C[C@]([H])(O)[C@]1([H])C\C=C/CCCC(O)=O,BHMBVRSPMRCCGG-OUTUXVNYSA-N,352.4651,P43116,BE0000368,Prostaglandin E2 receptor EP2 subtype,Humans,agonist,yes
DB02056,Prostaglandin D2,small molecule,investigational,[H][C@](O)(CCCCC)\C=C\[C@@]1([H])C(=O)C[C@]([H])(O)[C@]1([H])C\C=C/CCCC(O)=O,BHMBVRSPMRCCGG-OUTUXVNYSA-N,352.4651,P35408,BE0003522,Prostaglandin E2 receptor EP4 subtype,Humans,agonist,yes
DB02056,Prostaglandin D2,small molecule,investigational,[H][C@](O)(CCCCC)\C=C\[C@@]1([H])C(=O)C[C@]([H])(O)[C@]1([H])C\C=C/CCCC(O)=O,BHMBVRSPMRCCGG-OUTUXVNYSA-N,352.4651,Q9Y5Y4,BE0003561,Prostaglandin D2 receptor 2,Humans,agonist,yes
DB02057,(S)-AMPA,small molecule,experimental,CC1=C(C[C@H](N)C(O)=O)C(O)=NO1,UUDAMDVQRQNNHZ-YFKPBYRVSA-N,186.1653,P42261,BE0000640,Glutamate receptor 1,Humans,inhibitor,yes
DB02069,N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide,small molecule,experimental,NS(=O)(=O)C1=CC=C(C=C1)C(=O)NCC1=CC=CC=C1F,ULYMHSXFSKOHGH-UHFFFAOYSA-N,308.328,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB02071,WAY-151693,small molecule,experimental,COC1=CC=C(C=C1)S(=O)(=O)N(CC1=CC=CN=C1)C1=C(C=CC=C1C)C(=O)NO,AINJYWXKBKRQSX-UHFFFAOYSA-N,427.474,P45452,BE0000966,Collagenase 3,Humans,inhibitor,yes
DB02073,Biliverdine IX Alpha,small molecule,experimental,CC1=C(C=C)\C(NC1=O)=C\C1=C(C)C(CCC(O)=O)=C(N1)\C=C1/N=C(/C=C2\NC(=O)C(C=C)=C2C)C(C)=C1CCC(O)=O,QBUVFDKTZJNUPP-BBROENKCSA-N,582.657,P09601,BE0000735,Heme oxygenase 1,Humans,inhibitor,yes
DB02076,6-phospho-D-gluconic acid,small molecule,experimental,O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O,BIRSGZKFKXLSJQ-SQOUGZDYSA-N,276.1352,P52209,BE0003559,"6-phosphogluconate dehydrogenase, decarboxylating",Humans,inhibitor,yes
DB02078,Triglyme,small molecule,experimental,COCCOCCOCCOC,YFNKIDBQEZZDLK-UHFFFAOYSA-N,178.2261,P06241,BE0000839,Tyrosine-protein kinase Fyn,Humans,inhibitor,yes
DB02087,"3,5-Difluorobenzenesulfonamide",small molecule,experimental,NS(=O)(=O)C1=CC(F)=CC(F)=C1,MKQPOVUFDWKPNO-UHFFFAOYSA-N,193.171,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB02091,"4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine",small molecule,experimental,CC1=NC(C)=C(S1)C1=NC(N)=NC=C1,CTFDMGIBHFQWKB-UHFFFAOYSA-N,206.267,P24941,BE0001072,Cyclin-dependent kinase 2,Humans,inhibitor,yes
DB02094,N-2-Thiophen-2-Yl-Acetamide Boronic Acid,small molecule,experimental,OB(O)CNC(=O)CC1=CC=CS1,VXAPSUDMBNWYNC-UHFFFAOYSA-N,199.035,P00807,BE0000302,Beta-lactamase,Staphylococcus aureus,inhibitor,yes
DB02095,Isatin,small molecule,experimental,O=C1NC2=CC=CC=C2C1=O,JXDYKVIHCLTXOP-UHFFFAOYSA-N,147.1308,P27338,BE0002196,Amine oxidase [flavin-containing] B,Humans,inhibitor,yes
DB02096,FR221647,small molecule,experimental,[H][C@](CO)(CCC1=CC=CC=C1)N1C=NC(=C1)C(N)=O,ZUYUIKKHHBEVHL-GFCCVEGCSA-N,259.3037,P00813,BE0002214,Adenosine deaminase,Humans,inhibitor,yes
DB02101,"(S,R)-fidarestat",small molecule,experimental,[H]N([H])C(=O)[C@@H]1C[C@@]2(N([H])C(=O)N([H])C2=O)C2=C(O1)C=CC(F)=C2,WAAPEIZFCHNLKK-QPUJVOFHSA-N,279.2239,P15121,BE0000747,Aldo-keto reductase family 1 member B1,Humans,inhibitor,yes
DB02102,Mozenavir,small molecule,experimental,NC1=CC(CN2[C@H](CC3=CC=CC=C3)[C@H](O)[C@@H](O)[C@@H](CC3=CC=CC=C3)N(CC3=CC(N)=CC=C3)C2=O)=CC=C1,KYRSNWPSSXSNEP-ZRTHHSRSSA-N,536.6639,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB02105,"3,5-Dinitrocatechol",small molecule,experimental,OC1=CC(=CC(=C1O)[N+]([O-])=O)[N+]([O-])=O,VDCDWNDTNSWDFJ-UHFFFAOYSA-N,200.1058,P21964,BE0002089,Catechol O-methyltransferase,Humans,inhibitor,yes
DB02114,Cumidine,small molecule,experimental,CC(C)C1=CC=C(N)C=C1,LRTFPLFDLJYEKT-UHFFFAOYSA-N,135.2062,Q9UNI1,BE0003758,Chymotrypsin-like elastase family member 1,Humans,inhibitor,yes
DB02115,Daidzin,small molecule,experimental,[H][C@]1(CO)O[C@@]([H])(OC2=CC=C3C(=O)C(=COC3=C2)C2=CC=C(O)C=C2)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O,KYQZWONCHDNPDP-QNDFHXLGSA-N,416.3781,P05091,BE0000133,"Aldehyde dehydrogenase, mitochondrial",Humans,inhibitor,yes
DB02116,Olomoucine,small molecule,experimental,CN1C=NC2=C1N=C(NCCO)N=C2NCC1=CC=CC=C1,GTVPOLSIJWJJNY-UHFFFAOYSA-N,298.343,P06493,BE0001082,Cyclin-dependent kinase 1,Humans,binder,yes
DB02116,Olomoucine,small molecule,experimental,CN1C=NC2=C1N=C(NCCO)N=C2NCC1=CC=CC=C1,GTVPOLSIJWJJNY-UHFFFAOYSA-N,298.343,P24941,BE0001072,Cyclin-dependent kinase 2,Humans,inhibitor,yes
DB02116,Olomoucine,small molecule,experimental,CN1C=NC2=C1N=C(NCCO)N=C2NCC1=CC=CC=C1,GTVPOLSIJWJJNY-UHFFFAOYSA-N,298.343,Q00535,BE0000890,Cyclin-dependent kinase 5,Humans,inhibitor,yes
DB02118,CP-271485,small molecule,experimental,[H][C@@]1(CN(CC2=CC=CC=C2)C(=O)CO1)C1=CC2=C(C=C1)N(C)S(=O)(=O)C2,CIUMOGWIMXNXSQ-GOSISDBHSA-N,372.438,P39900,BE0001198,Macrophage metalloelastase,Humans,inhibitor,yes
DB02122,4-iodo-acetamido phenylboronic acid,small molecule,experimental,OB(O)C1=CC=CC(NC(=O)CI)=C1,LMHXPDZPXBIIEX-UHFFFAOYSA-N,304.877,P00807,BE0000302,Beta-lactamase,Staphylococcus aureus,inhibitor,yes
DB02126,4-Carboxycinnamic Acid,small molecule,experimental,OC(=O)\C=C\C1=CC=C(C=C1)C(O)=O,HAEJSGLKJYIYTB-ZZXKWVIFSA-N,192.1681,P69905,BE0000130,Hemoglobin subunit alpha,Humans,inhibitor,yes
DB02132,Zenarestat,small molecule,experimental,OC(=O)CN1C(=O)N(CC2=C(F)C=C(Br)C=C2)C(=O)C2=C1C=C(Cl)C=C2,SXONDGSPUVNZLO-UHFFFAOYSA-N,441.636,P15121,BE0000747,Aldo-keto reductase family 1 member B1,Humans,inhibitor,yes
DB02134,Xanthine,small molecule,experimental,O=C1NC2=C(NC=N2)C(=O)N1,LRFVTYWOQMYALW-UHFFFAOYSA-N,152.1109,P29275,BE0000241,Adenosine receptor A2b,Humans,antagonist,yes
DB02153,3-sulfino-L-alanine,small molecule,experimental,N[C@@H](C[S@@](O)=O)C(O)=O,ADVPTQAUNPRNPO-REOHCLBHSA-N,153.157,P68826,BE0002535,Peptide deformylase,Staphylococcus aureus,inhibitor,yes
DB02153,3-sulfino-L-alanine,small molecule,experimental,N[C@@H](C[S@@](O)=O)C(O)=O,ADVPTQAUNPRNPO-REOHCLBHSA-N,153.157,P00390,BE0000648,"Glutathione reductase, mitochondrial",Humans,inhibitor,yes
DB02166,Propidium,small molecule,experimental,CC[N+](C)(CC)CCC[N+]1=C(C2=CC=CC=C2)C2=C(C=CC(N)=C2)C2=C1C=C(N)C=C2,ZDWVWKDAWBGPDN-UHFFFAOYSA-O,414.5857,P22303,BE0000426,Acetylcholinesterase,Humans,inhibitor,yes
DB02169,"9,10-Deepithio-9,10-Didehydroacanthifolicin",small molecule,experimental,[H]\C(=C(\[H])[C@@]1([H])CC[C@@]2(CC[C@@]3([H])O[C@@]([H])(C(=C)[C@@]([H])(O)[C@]3([H])O2)[C@@]([H])(O)C[C@]([H])(C)[C@@]2([H])O[C@@]3(CCCCO3)CC[C@@]2([H])C)O1)[C@@]([H])(C)[C@]1([H])CC(C)=C[C@@]2(O[C@]([H])(C[C@@](C)(O)C(O)=O)CC[C@@]2([H])O)O1,QNDVLZJODHBUFM-WFXQOWMNSA-N,805.0029,P28562,BE0013126,Dual specificity protein phosphatase 1,Humans,inhibitor,yes
DB02187,Equilin,small molecule,experimental,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC=C21)C=C(O)C=C3,WKRLQDKEXYKHJB-HFTRVMKXSA-N,268.3502,P14061,BE0000194,17-beta-hydroxysteroid dehydrogenase type 1,Humans,inhibitor,yes
DB02189,"2',3'-Dideoxyadenosine triphosphate",small molecule,experimental,NC1=C2N=CN([C@H]3CC[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O3)C2=NC=N1,OAKPWEUQDVLTCN-NKWVEPMBSA-N,475.1822,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB02198,2-Bromoacetyl Group,small molecule,experimental,OC(=O)CBr,KDPAWGWELVVRCH-UHFFFAOYSA-N,138.948,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB02207,7-Nitroindazole,small molecule,experimental,O=N(=O)C1=CC=CC2=CNN=C12,PQCAUHUKTBHUSA-UHFFFAOYSA-N,163.1335,P35228,BE0000005,"Nitric oxide synthase, inducible",Humans,inhibitor,yes
DB02207,7-Nitroindazole,small molecule,experimental,O=N(=O)C1=CC=CC2=CNN=C12,PQCAUHUKTBHUSA-UHFFFAOYSA-N,163.1335,P29474,BE0000263,Nitric oxide synthase 3,Humans,inhibitor,yes
DB02207,7-Nitroindazole,small molecule,experimental,O=N(=O)C1=CC=CC2=CNN=C12,PQCAUHUKTBHUSA-UHFFFAOYSA-N,163.1335,P29475,BE0000067,Nitric oxide synthase 1,Humans,inhibitor,yes
DB02209,Pyridoxine phosphate,small molecule,experimental,CC1=NC=C(COP(O)(O)=O)C(CO)=C1O,WHOMFKWHIQZTHY-UHFFFAOYSA-N,249.1577,P11926,BE0000404,Ornithine decarboxylase,Humans,inhibitor,yes
DB02211,(R)-N-methyl-N-2-propynyl-1-indanamine,small molecule,experimental,CN(CC#C)[C@@H]1CCC2=C1C=CC=C2,CSVGVHNFFZWQJU-CYBMUJFWSA-N,185.2649,P27338,BE0002196,Amine oxidase [flavin-containing] B,Humans,inhibitor,yes
DB02216,S-Methylcysteine,small molecule,experimental,CSC[C@H](N)C(O)=O,IDIDJDIHTAOVLG-VKHMYHEASA-N,135.185,P07339,BE0000941,Cathepsin D,Humans,inhibitor,yes
DB02216,S-Methylcysteine,small molecule,experimental,CSC[C@H](N)C(O)=O,IDIDJDIHTAOVLG-VKHMYHEASA-N,135.185,P16455,BE0001145,Methylated-DNA--protein-cysteine methyltransferase,Humans,inhibitor,yes
DB02220,AL7089A,small molecule,experimental,CN[C@H]1CN(C2=CC(OC)=CC=C2)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,RMOXCYSVWCHXII-LBPRGKRZSA-N,403.497,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB02223,LY231514 tetra glu,small molecule,experimental,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)NC(CCC(O)=O)C(O)=O)C(O)=O)C(O)=O)C(O)=O)N1,DICHBVJYDUDAIQ-QEGIFBSNSA-N,814.7526,P12461,BE0000021,Thymidylate synthase,Yeast,inhibitor,yes
DB02230,Immucillin-G,small molecule,experimental,NC1=NC2=C(NC=C2[C@@H]2N[C@H](CO)[C@@H](O)[C@H]2O)C(=O)N1,KBIDJCVAURJXFG-PVEDRDFWSA-N,281.2679,P00491,BE0000250,Purine nucleoside phosphorylase,Humans,inhibitor,yes
DB02235,L-methionine (R)-S-oxide,small molecule,experimental,C[S@@](=O)CC[C@H](N)C(O)=O,QEFRNWWLZKMPFJ-ZXPFJRLXSA-N,165.211,P12461,BE0000021,Thymidylate synthase,Yeast,inhibitor,yes
DB02235,L-methionine (R)-S-oxide,small molecule,experimental,C[S@@](=O)CC[C@H](N)C(O)=O,QEFRNWWLZKMPFJ-ZXPFJRLXSA-N,165.211,P05067,BE0003392,Amyloid-beta precursor protein,Humans,inhibitor,yes
DB02247,Hydrolyzed Cephalothin,small molecule,experimental,[H][C@@](NC(=O)CC1=CC=CS1)(C(O)=O)[C@@]1([H])NC(C(O)=O)=C(C)CS1,JRYZEMHNDUZNMI-RYUDHWBXSA-N,356.417,P00807,BE0000302,Beta-lactamase,Staphylococcus aureus,inhibitor,yes
DB02255,Ilomastat,small molecule,experimental,CNC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC(C)C)CC(=O)NO,NITYDPDXAAFEIT-DYVFJYSZSA-N,388.4607,P03956,BE0000920,Interstitial collagenase,Humans,inhibitor,yes
DB02255,Ilomastat,small molecule,experimental,CNC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC(C)C)CC(=O)NO,NITYDPDXAAFEIT-DYVFJYSZSA-N,388.4607,P50281,BE0003692,Matrix metalloproteinase-14,Humans,inhibitor,yes
DB02255,Ilomastat,small molecule,experimental,CNC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC(C)C)CC(=O)NO,NITYDPDXAAFEIT-DYVFJYSZSA-N,388.4607,P22894,BE0001182,Neutrophil collagenase,Humans,inhibitor,yes
DB02255,Ilomastat,small molecule,experimental,CNC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC(C)C)CC(=O)NO,NITYDPDXAAFEIT-DYVFJYSZSA-N,388.4607,P08253,BE0000642,72 kDa type IV collagenase,Humans,inhibitor,yes
DB02255,Ilomastat,small molecule,experimental,CNC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC(C)C)CC(=O)NO,NITYDPDXAAFEIT-DYVFJYSZSA-N,388.4607,P08254,BE0001116,Stromelysin-1,Humans,inhibitor,yes
DB02255,Ilomastat,small molecule,experimental,CNC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC(C)C)CC(=O)NO,NITYDPDXAAFEIT-DYVFJYSZSA-N,388.4607,P14780,BE0000058,Matrix metalloproteinase-9,Humans,inhibitor,yes
DB02255,Ilomastat,small molecule,experimental,CNC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC(C)C)CC(=O)NO,NITYDPDXAAFEIT-DYVFJYSZSA-N,388.4607,P39900,BE0001198,Macrophage metalloelastase,Humans,inhibitor,yes
DB02255,Ilomastat,small molecule,experimental,CNC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC(C)C)CC(=O)NO,NITYDPDXAAFEIT-DYVFJYSZSA-N,388.4607,P45452,BE0000966,Collagenase 3,Humans,inhibitor,yes
DB02255,Ilomastat,small molecule,experimental,CNC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC(C)C)CC(=O)NO,NITYDPDXAAFEIT-DYVFJYSZSA-N,388.4607,P15917,BE0001363,Lethal factor,Bacillus anthracis,inhibitor,yes
DB02256,2'-Deoxyuridine,small molecule,experimental,OC[C@H]1O[C@H](C[C@@H]1O)N1C=CC(=O)NC1=O,MXHRCPNRJAMMIM-SHYZEUOFSA-N,228.202,P04183,BE0001260,"Thymidine kinase, cytosolic",Humans,inhibitor,yes
DB02256,2'-Deoxyuridine,small molecule,experimental,OC[C@H]1O[C@H](C[C@@H]1O)N1C=CC(=O)NC1=O,MXHRCPNRJAMMIM-SHYZEUOFSA-N,228.202,P12461,BE0000021,Thymidylate synthase,Yeast,inhibitor,yes
DB02260,4-Oxosebacic Acid,small molecule,experimental,OC(=O)CCCCCC(=O)CCC(O)=O,XTQIBFVBYWIHIP-UHFFFAOYSA-N,216.231,P13716,BE0000050,Delta-aminolevulinic acid dehydratase,Humans,inhibitor,yes
DB02261,Platelet Activating Factor,small molecule,experimental,CCCCCCCCCCCCCCCCOC[C@H](CO[P@@]([O-])(=O)OCC[N+](C)(C)C)OC(C)=O,HVAUUPRFYPCOCA-AREMUKBSSA-N,523.6832,P25105,BE0005561,Platelet-activating factor receptor,Humans,agonist,yes
DB02262,Orotic acid,small molecule,investigational,OC(=O)C1=CC(=O)NC(=O)N1,PXQPEWDEAKTCGB-UHFFFAOYSA-N,156.0963,Q08210,BE0000612,"Dihydroorotate dehydrogenase (quinone), mitochondrial",Plasmodium falciparum (isolate 3D7),inhibitor,yes
DB02266,Flufenamic acid,small molecule,approved,OC(=O)C1=CC=CC=C1NC1=CC(=CC=C1)C(F)(F)F,LPEPZBJOKDYZAD-UHFFFAOYSA-N,281.2299,P10275,BE0000132,Androgen receptor,Humans,inhibitor,yes
DB02266,Flufenamic acid,small molecule,approved,OC(=O)C1=CC=CC=C1NC1=CC(=CC=C1)C(F)(F)F,LPEPZBJOKDYZAD-UHFFFAOYSA-N,281.2299,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB02266,Flufenamic acid,small molecule,approved,OC(=O)C1=CC=CC=C1NC1=CC(=CC=C1)C(F)(F)F,LPEPZBJOKDYZAD-UHFFFAOYSA-N,281.2299,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB02266,Flufenamic acid,small molecule,approved,OC(=O)C1=CC=CC=C1NC1=CC(=CC=C1)C(F)(F)F,LPEPZBJOKDYZAD-UHFFFAOYSA-N,281.2299,P42330,BE0000592,Aldo-keto reductase family 1 member C3,Humans,inhibitor,yes
DB02272,Porphobilinogen,small molecule,experimental,NCC1=C(CC(O)=O)C(CCC(O)=O)=CN1,QSHWIQZFGQKFMA-UHFFFAOYSA-N,226.2292,P13716,BE0000050,Delta-aminolevulinic acid dehydratase,Humans,inhibitor,yes
DB02282,5'-S-methyl-5'-thioadenosine,small molecule,experimental,CSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=CN=C2N,WUUGFSXJNOTRMR-IOSLPCCCSA-N,297.334,P0DMS8,BE0000354,Adenosine receptor A3,Humans,inhibitor,yes
DB02282,5'-S-methyl-5'-thioadenosine,small molecule,experimental,CSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=CN=C2N,WUUGFSXJNOTRMR-IOSLPCCCSA-N,297.334,P29274,BE0000924,Adenosine receptor A2a,Humans,inhibitor,yes
DB02282,5'-S-methyl-5'-thioadenosine,small molecule,experimental,CSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=CN=C2N,WUUGFSXJNOTRMR-IOSLPCCCSA-N,297.334,P29275,BE0000241,Adenosine receptor A2b,Humans,inhibitor,yes
DB02282,5'-S-methyl-5'-thioadenosine,small molecule,experimental,CSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=CN=C2N,WUUGFSXJNOTRMR-IOSLPCCCSA-N,297.334,P30542,BE0000013,Adenosine receptor A1,Humans,inhibitor,yes
DB02285,Protoporphyrin,small molecule,experimental,CC1=C(CCC(O)=O)/C2=C/C3=N/C(=C\C4=C(C)C(C=C)=C(N4)/C=C4\N=C(\C=C\1/N\2)C(C=C)=C4C)/C(C)=C3CCC(O)=O,KSFOVUSSGSKXFI-UJJXFSCMSA-N,562.6582,O60760,BE0001167,Hematopoietic prostaglandin D synthase,Humans,inhibitor,yes
DB02292,Irosustat,small molecule,investigational,NS(=O)(=O)OC1=CC=C2C3=C(CCCCC3)C(=O)OC2=C1,DSLPMJSGSBLWRE-UHFFFAOYSA-N,309.338,P08842,BE0001197,Steryl-sulfatase,Humans,inhibitor,yes
DB02297,2-Amino-6-Chloropyrazine,small molecule,experimental,NC1=CN=CC(Cl)=N1,JTPXVCKCLBROOJ-UHFFFAOYSA-N,129.548,P24941,BE0001072,Cyclin-dependent kinase 2,Humans,inhibitor,yes
DB02300,Calcipotriol,small molecule,approved,O[C@H](\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)C1CC1,LWQQLNNNIPYSNX-UROSTWAQSA-N,412.6047,P11473,BE0000779,Vitamin D3 receptor,Humans,antagonist,yes
DB02301,"5,10-Methylene-6-Hydrofolic Acid",small molecule,experimental,NC1=NC(=O)C2=C(N1)N=C[C@@H]1CN(CN21)C1=CC=C(C=C1)C(=O)N[C@H](CCC(O)=O)C(O)=O,BHJAPJNOACHPNI-CHWSQXEVSA-N,455.424,P12461,BE0000021,Thymidylate synthase,Yeast,inhibitor,yes
DB02303,"(5S)-5-Iododihydro-2,4(1H,3H)-pyrimidinedione",small molecule,experimental,[H]N1C[C@H](I)C(=O)N([H])C1=O,YGKCTZPSAOUUMT-REOHCLBHSA-N,239.9992,Q12882,BE0000960,Dihydropyrimidine dehydrogenase [NADP(+)],Humans,inhibitor,yes
DB02309,5-monophosphate-9-beta-D-ribofuranosyl xanthine,small molecule,experimental,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(O)=O)[N+]1=CNC2=C1NC(=O)NC2=O,XHDARDSMKMUDDI-UUOKFMHZSA-O,365.214,P20035,BE0001516,Hypoxanthine-guanine-xanthine phosphoribosyltransferase,Plasmodium falciparum (isolate FCR-3 / Gambia),inhibitor,yes
DB02310,"3,5,6,8-Tetramethyl-N-Methyl Phenanthrolinium",small molecule,experimental,CC1=CN=C2C(=C1)C(C)=C(C)C1=C2[N+](C)=CC(C)=C1,FQTUZNACZKILMC-UHFFFAOYSA-N,251.3462,P50579,BE0001534,Methionine aminopeptidase 2,Humans,inhibitor,yes
DB02311,Methyl Methylsulfinylmethyl Sulfide,small molecule,experimental,CSC[S@](C)=O,OTKFCIVOVKCFHR-LURJTMIESA-N,124.225,P62942,BE0000695,Peptidyl-prolyl cis-trans isomerase FKBP1A,Humans,inhibitor,yes
DB02315,Cyclic GMP,small molecule,experimental,NC1=NC2=C(N=CN2[C@@H]2O[C@@H]3COP(O)(=O)O[C@H]3[C@H]2O)C(=O)N1,ZOOGRGPOEVQQDX-UUOKFMHZSA-N,345.2053,O00408,BE0002085,"cGMP-dependent 3',5'-cyclic phosphodiesterase",Humans,inhibitor,yes
DB02320,N-beta-D-glucopyranosylacetamide,small molecule,experimental,[H]N([C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C(C)=O,IBONACLSSOLHFU-JAJWTYFOSA-N,221.2078,P11217,BE0000916,"Glycogen phosphorylase, muscle form",Humans,inhibitor,yes
DB02323,EM-1745,small molecule,experimental,[H][C@]1(CCCCCCCCC(=O)OC[C@@]2([H])O[C@@]([H])(N3C=NC4=C(N)N=CN=C34)[C@]([H])(O)[C@]2([H])O)C[C@@]2([H])[C@]3([H])CCC4=CC(O)=CC=C4[C@@]3([H])CC[C@]2(C)[C@@]1([H])O,CKSDYJASHNGOOS-KTXOUVACSA-N,677.8301,P14061,BE0000194,17-beta-hydroxysteroid dehydrogenase type 1,Humans,inhibitor,yes
DB02324,5-Iodo-2'-Deoxyuridine-5'-Monophosphate,small molecule,experimental,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])COP(O)(O)=O)N1C=C(I)C(=O)NC1=O,WXFYBFRZROJDLL-RRKCRQDMSA-N,434.0784,P04183,BE0001260,"Thymidine kinase, cytosolic",Humans,inhibitor,yes
DB02326,1-Hydroxyamine-2-Isobutylmalonic Acid,small molecule,experimental,CC(C)C[C@@H](C(O)=O)C(=O)NO,CINIOMOBGSHXRK-RXMQYKEDSA-N,175.1824,P22894,BE0001182,Neutrophil collagenase,Humans,inhibitor,yes
DB02329,Carbenoxolone,small molecule,experimental,[H][C@@]1(CC[C@@]2(C)[C@@]([H])(CC[C@]3(C)[C@]2([H])C(=O)C=C2[C@]4([H])C[C@](C)(CC[C@]4(C)CC[C@@]32C)C(O)=O)C1(C)C)OC(=O)CCC(O)=O,OBZHEBDUNPOCJG-WBXJDKIVSA-N,570.7566,P28845,BE0000329,11-beta-hydroxysteroid dehydrogenase 1,Humans,inhibitor,yes
DB02336,RU83876,small molecule,experimental,CC(=O)N[C@@H](CC1=CC(=C(C=C1)P(O)(O)=O)P(O)(O)=O)C(=O)N[C@H]1CCCCN(CC2=CC=C(C=C2)C2=CC=CC=C2)C1=O,WCMLXBUNHNAMNH-UIOOFZCWSA-N,643.5611,P12931,BE0000838,Proto-oncogene tyrosine-protein kinase Src,Humans,inhibitor,yes
DB02341,"Mdl 101,146",small molecule,experimental,CC(C)[C@@H](NC(=O)C1=CC=C(C=C1)C(=O)N1CCOCC1)C(=O)N1CCC[C@@H]1C(=O)N[C@H](C(C)C)C(=O)C(F)(F)C(F)(F)F,XQAMVCHQGHAELT-YPAWHYETSA-N,632.6193,P08246,BE0000394,Neutrophil elastase,Humans,inhibitor,yes
DB02341,"Mdl 101,146",small molecule,experimental,CC(C)[C@@H](NC(=O)C1=CC=C(C=C1)C(=O)N1CCOCC1)C(=O)N1CCC[C@@H]1C(=O)N[C@H](C(C)C)C(=O)C(F)(F)C(F)(F)F,XQAMVCHQGHAELT-YPAWHYETSA-N,632.6193,Q9UNI1,BE0003758,Chymotrypsin-like elastase family member 1,Humans,inhibitor,yes
DB02342,2-Methoxyestradiol,small molecule,investigational,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C(OC)=C3,CQOQDQWUFQDJMK-SSTWWWIQSA-N,302.4079,Q16665,BE0002374,Hypoxia-inducible factor 1-alpha,Humans,modulator,yes
DB02343,"3,6,9,12,15-Pentaoxaheptadecane",small molecule,experimental,CCOCCOCCOCCOCCOCC,HYDWALOBQJFOMS-UHFFFAOYSA-N,250.3318,P22303,BE0000426,Acetylcholinesterase,Humans,inhibitor,yes
DB02347,2-Amino-3-(5-Tert-Butyl-3-(Phosphonomethoxy)-4-Isoxazolyl)Propionic Acid,small molecule,experimental,CC(C)(C)C1=C(C[C@H](N)C(O)=O)C(OCP(O)(O)=O)=NO1,AGSOOCUNMTYPSE-ZETCQYMHSA-N,322.2515,P39086,BE0000346,"Glutamate receptor ionotropic, kainate 1",Humans,inhibitor,yes
DB02352,3-(Benzyloxy)Pyridin-2-Amine,small molecule,experimental,NC1=NC=CC=C1OCC1=CC=CC=C1,NMCBWICNRJLKKM-UHFFFAOYSA-N,200.2365,Q16539,BE0001019,Mitogen-activated protein kinase 14,Humans,inhibitor,yes
DB02352,3-(Benzyloxy)Pyridin-2-Amine,small molecule,experimental,NC1=NC=CC=C1OCC1=CC=CC=C1,NMCBWICNRJLKKM-UHFFFAOYSA-N,200.2365,P09960,BE0001680,Leukotriene A-4 hydrolase,Humans,inhibitor,yes
DB02360,Bis-Napthyl Beta-Ketophosphonic Acid,small molecule,experimental,[H][C@](C(=O)C1=CC2=CC=CC=C2C=C1)(C1=CC=CC2=CC=CC=C12)P(O)(O)=O,OFHMUASCSJJNNA-JOCHJYFZSA-N,376.3417,P08311,BE0001010,Cathepsin G,Humans,inhibitor,yes
DB02363,2'-Monophosphoadenosine-5'-Diphosphate,small molecule,experimental,[H][C@]1(COP(O)(=O)OP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O,YPTPYQSAVGGMFN-KQYNXXCUSA-N,507.181,Q9HBH1,BE0002201,"Peptide deformylase, mitochondrial",Humans,inhibitor,yes
DB02373,Adenosine monotungstate,small molecule,experimental,[H]N([H])C1=NC=NC2=C1N=CN2[C@]1([H])O[C@@]([H])(CO[W](O)(O)=O)[C@]([H])(O)[C@@]1([H])O,FJSJQPRHXPUMLC-LRDMJOKZSA-L,500.09,P49789,BE0001687,Bis(5'-adenosyl)-triphosphatase,Humans,inhibitor,yes
DB02375,Myricetin,small molecule,experimental,OC1=CC(O)=C2C(OC(=C(O)C2=O)C2=CC(O)=C(O)C(O)=C2)=C1,IKMDFBPHZNJCSN-UHFFFAOYSA-N,318.2351,P48736,BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",Humans,inhibitor,yes
DB02377,Guanine,small molecule,experimental,NC1=NC(=O)C2=C(N1)N=CN2,UYTPUPDQBNUYGX-UHFFFAOYSA-N,151.1261,P30793,BE0001055,GTP cyclohydrolase 1,Humans,inhibitor,yes
DB02379,Beta-D-Glucose,small molecule,experimental,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O,WQZGKKKJIJFFOK-VFUOTHLCSA-N,180.1559,Q14697,BE0004698,Neutral alpha-glucosidase AB,Humans,inhibitor,yes
DB02379,Beta-D-Glucose,small molecule,experimental,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O,WQZGKKKJIJFFOK-VFUOTHLCSA-N,180.1559,Q8TET4,BE0004699,Neutral alpha-glucosidase C,Humans,inhibitor,yes
DB02379,Beta-D-Glucose,small molecule,experimental,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O,WQZGKKKJIJFFOK-VFUOTHLCSA-N,180.1559,P35557,BE0001056,Hexokinase-4,Humans,inhibitor,yes
DB02379,Beta-D-Glucose,small molecule,experimental,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O,WQZGKKKJIJFFOK-VFUOTHLCSA-N,180.1559,P10253,BE0000876,Lysosomal alpha-glucosidase,Humans,inhibitor,yes
DB02379,Beta-D-Glucose,small molecule,experimental,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O,WQZGKKKJIJFFOK-VFUOTHLCSA-N,180.1559,P9WGR1,BE0000332,Enoyl-[acyl-carrier-protein] reductase [NADH],Mycobacterium tuberculosis,inhibitor,yes
DB02379,Beta-D-Glucose,small molecule,experimental,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O,WQZGKKKJIJFFOK-VFUOTHLCSA-N,180.1559,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB02379,Beta-D-Glucose,small molecule,experimental,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O,WQZGKKKJIJFFOK-VFUOTHLCSA-N,180.1559,P11217,BE0000916,"Glycogen phosphorylase, muscle form",Humans,inhibitor,yes
DB02379,Beta-D-Glucose,small molecule,experimental,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O,WQZGKKKJIJFFOK-VFUOTHLCSA-N,180.1559,P04746,BE0002639,Pancreatic alpha-amylase,Humans,inhibitor,yes
DB02381,nor-NOHA,small molecule,investigational,N[C@@H](CCNC(=N)NO)C(O)=O,KOBHCUDVWOTEKO-VKHMYHEASA-N,176.1738,P78540,BE0000758,"Arginase-2, mitochondrial",Humans,inhibitor,yes
DB02383,Tolrestat,small molecule,withdrawn,COC1=C(C2=CC=CC(C(=S)N(C)CC(O)=O)=C2C=C1)C(F)(F)F,LUBHDINQXIHVLS-UHFFFAOYSA-N,357.347,Q99720,BE0000156,Sigma non-opioid intracellular receptor 1,Humans,binder,yes
DB02383,Tolrestat,small molecule,withdrawn,COC1=C(C2=CC=CC(C(=S)N(C)CC(O)=O)=C2C=C1)C(F)(F)F,LUBHDINQXIHVLS-UHFFFAOYSA-N,357.347,P15121,BE0000747,Aldo-keto reductase family 1 member B1,Humans,inhibitor,yes
DB02400,ES-936,small molecule,experimental,COC1=CC(=O)C2=C(C(COC3=CC=C(C=C3)[N+]([O-])=O)=C(C)N2C)C1=O,IBLWSLZYYZHSRG-UHFFFAOYSA-N,356.3294,P15559,BE0001184,NAD(P)H dehydrogenase [quinone] 1,Humans,inhibitor,yes
DB02402,"5-(4-Methoxyphenoxy)-2,4-Quinazolinediamine",small molecule,experimental,COC1=CC=C(OC2=CC=CC3=NC(N)=NC(N)=C23)C=C1,CPZJZAIZIMCJRC-UHFFFAOYSA-N,282.2973,Q9HBH1,BE0002201,"Peptide deformylase, mitochondrial",Humans,inhibitor,yes
DB02404,1-Deoxy-1-Thio-Heptaethylene Glycol,small molecule,experimental,OCCOCCOCCOCCOCCOCCOCCS,ACMBXVJDKVNCGH-UHFFFAOYSA-N,342.449,P22303,BE0000426,Acetylcholinesterase,Humans,inhibitor,yes
DB02407,6-O-Cyclohexylmethyl Guanine,small molecule,experimental,NC1=NC(OCC2CCCCC2)=C2N=CNC2=N1,MWGXGTJJAOZBNW-UHFFFAOYSA-N,247.2963,P24941,BE0001072,Cyclin-dependent kinase 2,Humans,inhibitor,yes
DB02419,Ethyl Oxo(Piperidin-1-Yl)Acetate,small molecule,experimental,CCOC(=O)C(=O)N1CCCCC1,ASBDXHCMVYVJQQ-UHFFFAOYSA-N,185.2203,P62937,BE0001014,Peptidyl-prolyl cis-trans isomerase A,Humans,inhibitor,yes
DB02420,"[[4-(Aminomethyl)Phenyl]Amino]Oxo-Acetic Acid,",small molecule,experimental,NCC1=CC=C(NC(=O)C(O)=O)C=C1,RKILOCCSAVHHJT-UHFFFAOYSA-N,194.1873,P18031,BE0000623,Tyrosine-protein phosphatase non-receptor type 1,Humans,inhibitor,yes
DB02424,Geldanamycin,small molecule,experimental;investigational,CO[C@H]1C[C@H](C)CC2=C(OC)C(=O)C=C(NC(=O)\C(C)=C\C=C/[C@H](OC)[C@@H](OC(N)=O)\C(C)=C\[C@H](C)[C@H]1O)C2=O,QTQAWLPCGQOSGP-KSRBKZBZSA-N,560.6359,P07900,BE0001120,Heat shock protein HSP 90-alpha,Humans,inhibitor,yes
DB02431,Cytidine-5'-Triphosphate,small molecule,experimental,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O,PCDQPRRSZKQHHS-XVFCMESISA-N,483.1563,P51582,BE0009822,P2Y purinoceptor 4,Humans,agonist,yes
DB02432,RU90395,small molecule,experimental,COC(=O)C1=C(C=CC(C[C@H](NC(C)=O)C(=O)N[C@H]2CCCCN(CC3=CC=C(C=C3)C3=CC=CC=C3)C2=O)=C1)C(F)(C(O)=O)C(O)=O,RLLAUERCSKPFGD-VMPREFPWSA-N,661.6734,P12931,BE0000838,Proto-oncogene tyrosine-protein kinase Src,Humans,inhibitor,yes
DB02445,2-Deoxy-2-Amino Glucitol-6-Phosphate,small molecule,experimental,[H][C@](N)(CO)[C@@]([H])(O)[C@]([H])(O)[C@]([H])(O)COP(O)(O)=O,LBNVXZROMBUNNQ-SLPGGIOYSA-N,261.1669,P17169,BE0001423,Glutamine--fructose-6-phosphate aminotransferase [isomerizing],Escherichia coli (strain K12),inhibitor,yes
DB02446,Glutamine hydroxamate,small molecule,experimental,N[C@@H](CCC(=O)NO)C(O)=O,YVGZXTQJQNXIAU-VKHMYHEASA-N,162.1439,P17169,BE0001423,Glutamine--fructose-6-phosphate aminotransferase [isomerizing],Escherichia coli (strain K12),inhibitor,yes
DB02448,N-Tridecanoic Acid,small molecule,experimental,CCCCCCCCCCCCC(O)=O,SZHOJFHSIKHZHA-UHFFFAOYSA-N,214.3443,P04054,BE0003997,Phospholipase A2,Humans,inhibitor,yes
DB02448,N-Tridecanoic Acid,small molecule,experimental,CCCCCCCCCCCCC(O)=O,SZHOJFHSIKHZHA-UHFFFAOYSA-N,214.3443,P14555,BE0001640,"Phospholipase A2, membrane associated",Humans,inhibitor,yes
DB02451,B-nonylglucoside,small molecule,experimental,CCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,QFAPUKLCALRPLH-UXXRCYHCSA-N,306.3951,P16233,BE0000683,Pancreatic triacylglycerol lipase,Humans,inhibitor,yes
DB02452,Thymidine 5'-triphosphate,small molecule,experimental,CC1=CN([C@H]2C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O2)C(=O)NC1=O,NHVNXKFIZYSCEB-XLPZGREQSA-N,482.1683,P04293,BE0000308,DNA polymerase catalytic subunit,HHV-1,inhibitor,yes
DB02452,Thymidine 5'-triphosphate,small molecule,experimental,CC1=CN([C@H]2C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O2)C(=O)NC1=O,NHVNXKFIZYSCEB-XLPZGREQSA-N,482.1683,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB02452,Thymidine 5'-triphosphate,small molecule,experimental,CC1=CN([C@H]2C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O2)C(=O)NC1=O,NHVNXKFIZYSCEB-XLPZGREQSA-N,482.1683,P04183,BE0001260,"Thymidine kinase, cytosolic",Humans,inhibitor,yes
DB02462,Thiocoumarin,small molecule,experimental,CN(C)CCCOC1=CC(=O)SC2=CC=CC=C12,DIOZFKOOIBATNZ-UHFFFAOYSA-N,263.355,P35228,BE0000005,"Nitric oxide synthase, inducible",Humans,inhibitor,yes
DB02463,2-(2-Hydroxy-Phenyl)-1h-Indole-5-Carboxamidine,small molecule,experimental,NC(=[NH2+])C1=CC2=C(NC(=C2)C2=CC=CC=C2O)C=C1,JPGNPKIYCTXJPG-UHFFFAOYSA-O,252.2912,P00734,BE0000048,Prothrombin,Humans,inhibitor,yes
DB02463,2-(2-Hydroxy-Phenyl)-1h-Indole-5-Carboxamidine,small molecule,experimental,NC(=[NH2+])C1=CC2=C(NC(=C2)C2=CC=CC=C2O)C=C1,JPGNPKIYCTXJPG-UHFFFAOYSA-O,252.2912,P00747,BE0000211,Plasminogen,Humans,inhibitor,yes
DB02463,2-(2-Hydroxy-Phenyl)-1h-Indole-5-Carboxamidine,small molecule,experimental,NC(=[NH2+])C1=CC2=C(NC(=C2)C2=CC=CC=C2O)C=C1,JPGNPKIYCTXJPG-UHFFFAOYSA-O,252.2912,P00749,BE0000895,Urokinase-type plasminogen activator,Humans,inhibitor,yes
DB02463,2-(2-Hydroxy-Phenyl)-1h-Indole-5-Carboxamidine,small molecule,experimental,NC(=[NH2+])C1=CC2=C(NC(=C2)C2=CC=CC=C2O)C=C1,JPGNPKIYCTXJPG-UHFFFAOYSA-O,252.2912,P00750,BE0001088,Tissue-type plasminogen activator,Humans,inhibitor,yes
DB02463,2-(2-Hydroxy-Phenyl)-1h-Indole-5-Carboxamidine,small molecule,experimental,NC(=[NH2+])C1=CC2=C(NC(=C2)C2=CC=CC=C2O)C=C1,JPGNPKIYCTXJPG-UHFFFAOYSA-O,252.2912,P07477,BE0001739,Serine protease 1,Humans,inhibitor,yes
DB02471,Nojirimycine Tetrazole,small molecule,experimental,[H][C@]1(O)C2=NN=NN2[C@]([H])(CO)[C@@]([H])(O)[C@]1([H])O,UCJXQRFJERKPOZ-SQOUGZDYSA-N,202.168,P11217,BE0000916,"Glycogen phosphorylase, muscle form",Humans,inhibitor,yes
DB02482,Phosphonothreonine,small molecule,experimental,C[C@H](OP(O)(O)=O)[C@@H](N)C(O)=O,USRGIUJOYOXOQJ-STHAYSLISA-N,199.0991,O14965,BE0000991,Aurora kinase A,Humans,inhibitor,yes
DB02482,Phosphonothreonine,small molecule,experimental,C[C@H](OP(O)(O)=O)[C@@H](N)C(O)=O,USRGIUJOYOXOQJ-STHAYSLISA-N,199.0991,P50613,BE0001913,Cyclin-dependent kinase 7,Humans,inhibitor,yes
DB02482,Phosphonothreonine,small molecule,experimental,C[C@H](OP(O)(O)=O)[C@@H](N)C(O)=O,USRGIUJOYOXOQJ-STHAYSLISA-N,199.0991,Q04759,BE0001385,Protein kinase C theta type,Humans,inhibitor,yes
DB02482,Phosphonothreonine,small molecule,experimental,C[C@H](OP(O)(O)=O)[C@@H](N)C(O)=O,USRGIUJOYOXOQJ-STHAYSLISA-N,199.0991,P28482,BE0000923,Mitogen-activated protein kinase 1,Humans,inhibitor,yes
DB02482,Phosphonothreonine,small molecule,experimental,C[C@H](OP(O)(O)=O)[C@@H](N)C(O)=O,USRGIUJOYOXOQJ-STHAYSLISA-N,199.0991,P53778,BE0002790,Mitogen-activated protein kinase 12,Humans,inhibitor,yes
DB02493,Hydantocidin-5'-phosphate,small molecule,experimental,[H]N1C(=O)N([H])[C@@]2(O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]2O)C1=O,HVXIMXHBUJADCC-GTBMBKLPSA-N,298.144,Q9U8D3,BE0002700,Adenylosuccinate synthetase,Plasmodium falciparum,inhibitor,yes
DB02495,9-(4-hydroxybutyl)-N2-phenylguanine,small molecule,experimental,OCCCCN1C=NC2=C1N=C(NC1=CC=CC=C1)NC2=O,JHBXNPBKSPYOFT-UHFFFAOYSA-N,299.3278,P04183,BE0001260,"Thymidine kinase, cytosolic",Humans,inhibitor,yes
DB02498,Carba-nicotinamide-adenine-dinucleotide,small molecule,experimental,[H]N([H])C(=O)C1=C[N+](=CC=C1)[C@@H]1C[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N=CN=C23)N([H])[H])[C@@H](O)[C@H]1O,DGPLSUKWXXSBCU-VGXGLJSLSA-O,662.4602,P09874,BE0001717,Poly [ADP-ribose] polymerase 1,Humans,inhibitor,yes
DB02500,6-(Dihydroxy-Isobutyl)-Thymine,small molecule,experimental,CC1=C(CC(CO)CO)NC(=O)NC1=O,CLCPDSJUXHDRGX-UHFFFAOYSA-N,214.2185,P04183,BE0001260,"Thymidine kinase, cytosolic",Humans,inhibitor,yes
DB02503,4-(Carboxyvin-2-Yl)Phenylboronic Acid,small molecule,experimental,OB(O)C1=CC=C(\C=C\C(O)=O)C=C1,IEMLKNHGGSYOMP-ZZXKWVIFSA-N,191.976,P00807,BE0000302,Beta-lactamase,Staphylococcus aureus,inhibitor,yes
DB02505,N-(R-Carboxy-Ethyl)-Alpha-(S)-(2-Phenylethyl),small molecule,experimental,CCCCCC1=CC=C(C=C1)C(=O)N(CC1=CC=C(C=C1)C1=CC=C(CC(=O)OC)C=C1)C1CCN(CC2=NC=CN2)CC1,JJVQUUYZGJWBPW-UHFFFAOYSA-N,592.7703,P46925,BE0001694,Plasmepsin-2,Plasmodium falciparum,inhibitor,yes
DB02508,Isopentyl Pyrophosphate,small molecule,experimental,CC(C)CCO[P@](O)(=O)OP(O)(O)=O,IPFXNYPSBSIFOB-UHFFFAOYSA-N,248.108,P14324,BE0000776,Farnesyl pyrophosphate synthase,Humans,inhibitor,yes
DB02509,Farnesol,small molecule,experimental,CC(C)=CCC\C(C)=C/CC\C(C)=C/CO,CRDAMVZIKSXKFV-FBXUGWQNSA-N,222.3663,P27338,BE0002196,Amine oxidase [flavin-containing] B,Humans,inhibitor,yes
DB02518,N-Acetylalanine,small molecule,experimental,C[C@H](NC(C)=O)C(O)=O,KTHDTJVBEPMMGL-VKHMYHEASA-N,131.1299,P15121,BE0000747,Aldo-keto reductase family 1 member B1,Humans,inhibitor,yes
DB02526,CRA_10655,small molecule,experimental,NC(=[NH2+])C1=CC=C2NC(=NC2=C1)C1=CC=CC(OC2CCCC2)=C1[O-],WCFWDBPDMBXMTQ-UHFFFAOYSA-N,336.3877,P00749,BE0000895,Urokinase-type plasminogen activator,Humans,inhibitor,yes
DB02540,"10-formyl-5,8,10-trideazafolic acid",small molecule,experimental,[H]N([H])C1=NC(=O)C2=C(C=CC(C[C@H](C(O)=O)C3=CC=C(C=C3)C(=O)N([H])[C@@H](CCC(O)=O)C(O)=O)=C2)N1[H],DAOQLLQRJAXMGY-YOEHRIQHSA-N,482.4428,P22102,BE0000882,Trifunctional purine biosynthetic protein adenosine-3,Humans,inhibitor,yes
DB02545,Fexaramine,small molecule,experimental,COC(=O)\C=C\C1=CC(=CC=C1)N(CC1=CC=C(C=C1)C1=CC=C(C=C1)N(C)C)C(=O)C1CCCCC1,VLQTUNDJHLEFEQ-KGENOOAVSA-N,496.6398,Q96RI1,BE0001777,Bile acid receptor,Humans,inhibitor,yes
DB02546,Vorinostat,small molecule,approved;investigational,ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1,WAEXFXRVDQXREF-UHFFFAOYSA-N,264.3202,Q13547,BE0002365,Histone deacetylase 1,Humans,inhibitor,yes
DB02546,Vorinostat,small molecule,approved;investigational,ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1,WAEXFXRVDQXREF-UHFFFAOYSA-N,264.3202,Q92769,BE0002366,Histone deacetylase 2,Humans,inhibitor,yes
DB02546,Vorinostat,small molecule,approved;investigational,ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1,WAEXFXRVDQXREF-UHFFFAOYSA-N,264.3202,O15379,BE0002367,Histone deacetylase 3,Humans,inhibitor,yes
DB02546,Vorinostat,small molecule,approved;investigational,ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1,WAEXFXRVDQXREF-UHFFFAOYSA-N,264.3202,Q9UBN7,BE0002368,Histone deacetylase 6,Humans,inhibitor,yes
DB02552,Geranyl Diphosphate,small molecule,experimental,CC(C)=CCC\C(C)=C\CO[P@@](=O)(O)OP(=O)(O)O,GVVPGTZRZFNKDS-JXMROGBWSA-N,314.2091,P14324,BE0000776,Farnesyl pyrophosphate synthase,Humans,inhibitor,yes
DB02553,Glutathionylspermidine disulfide,small molecule,experimental,[H]N([H])CCCCN([H])CCCN([H])C(=O)CN([H])C(=O)[C@H](CSSC[C@H](N([H])C(=O)CC[C@@H](N([H])[H])C(O)=O)C(=O)N([H])CC(=O)N([H])CCCN([H])CCCCN([H])[H])N([H])C(=O)CC[C@@H](N([H])[H])C(O)=O,HCMZDPYSWPSKSP-XPGKHFPBSA-N,867.092,P00390,BE0000648,"Glutathione reductase, mitochondrial",Humans,inhibitor,yes
DB02555,SP4160,small molecule,experimental,CC(C)C[C@@H](N=C(N)N)C(=O)NCC(=O)N1CCC(CC1)C1=CC(=NN1C)C1=C(Cl)C(Cl)=C(OCC2=CC=C(NC(C)=O)C=C2)C=C1,VCXMTWSYQSVWRK-AREMUKBSSA-N,685.644,P60568,BE0001029,Interleukin-2,Humans,inhibitor,yes
DB02557,Phosphoramidon,small molecule,experimental,CC(C)C[C@H](NP(O)(=O)O[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(O)=O,ZPHBZEQOLSRPAK-XLCYBJAPSA-N,543.5039,P08473,BE0000266,Neprilysin,Humans,inhibitor,yes
DB02567,PD173955,small molecule,experimental,CSC1=CC=CC(NC2=NC=C3C=C(C(=O)N(C)C3=N2)C2=C(Cl)C=CC=C2Cl)=C1,VAARYSWULJUGST-UHFFFAOYSA-N,443.349,P16234,BE0000852,Platelet-derived growth factor receptor alpha,Humans,inhibitor,yes
DB02567,PD173955,small molecule,experimental,CSC1=CC=CC(NC2=NC=C3C=C(C(=O)N(C)C3=N2)C2=C(Cl)C=CC=C2Cl)=C1,VAARYSWULJUGST-UHFFFAOYSA-N,443.349,P06239,BE0000842,Tyrosine-protein kinase Lck,Humans,inhibitor,yes
DB02567,PD173955,small molecule,experimental,CSC1=CC=CC(NC2=NC=C3C=C(C(=O)N(C)C3=N2)C2=C(Cl)C=CC=C2Cl)=C1,VAARYSWULJUGST-UHFFFAOYSA-N,443.349,P12931,BE0000838,Proto-oncogene tyrosine-protein kinase Src,Humans,inhibitor,yes
DB02567,PD173955,small molecule,experimental,CSC1=CC=CC(NC2=NC=C3C=C(C(=O)N(C)C3=N2)C2=C(Cl)C=CC=C2Cl)=C1,VAARYSWULJUGST-UHFFFAOYSA-N,443.349,P11362,BE0002131,Fibroblast growth factor receptor 1,Humans,inhibitor,yes
DB02567,PD173955,small molecule,experimental,CSC1=CC=CC(NC2=NC=C3C=C(C(=O)N(C)C3=N2)C2=C(Cl)C=CC=C2Cl)=C1,VAARYSWULJUGST-UHFFFAOYSA-N,443.349,P09619,BE0000205,Platelet-derived growth factor receptor beta,Humans,inhibitor,yes
DB02568,Peldesine,small molecule,investigational,NC1=NC(=O)C2=C(N1)C(CC1=CN=CC=C1)=CN2,DOHVAKFYAHLCJP-UHFFFAOYSA-N,241.2486,P00491,BE0000250,Purine nucleoside phosphorylase,Humans,inhibitor,yes
DB02587,Colforsin,small molecule,experimental;investigational,[H][C@]1(O)CCC(C)(C)[C@]2([H])[C@]([H])(O)[C@]([H])(OC(C)=O)[C@@]3(C)O[C@](C)(CC(=O)[C@]3(O)[C@@]12C)C=C,OHCQJHSOBUTRHG-KGGHGJDLSA-N,410.5012,Q08828,BE0010179,Adenylate cyclase,Humans,activator,yes
DB02589,Se-Ethyl-Isoselenourea,small molecule,experimental,CC[Se]C(N)=N,FFKYNFXDBBLWGF-UHFFFAOYSA-N,151.07,P29474,BE0000263,Nitric oxide synthase 3,Humans,inhibitor,yes
DB02594,2'-Deoxycytidine,small molecule,experimental;investigational,NC1=NC(=O)N(C=C1)[C@H]1C[C@H](O)[C@@H](CO)O1,CKTSBUTUHBMZGZ-SHYZEUOFSA-N,227.2172,P04183,BE0001260,"Thymidine kinase, cytosolic",Humans,inhibitor,yes
DB02597,"[2(R,S)-2-Sulfanylheptanoyl]-Phe-Ala",small molecule,experimental,[H][C@@](C)(NC(=O)[C@]([H])(CC1=CC=CC=C1)NC(=O)[C@@]([H])(S)CCCCC)C(O)=O,GOIYKVXXGCPHQU-BPUTZDHNSA-N,380.502,P08473,BE0000266,Neprilysin,Humans,inhibitor,yes
DB02597,"[2(R,S)-2-Sulfanylheptanoyl]-Phe-Ala",small molecule,experimental,[H][C@@](C)(NC(=O)[C@]([H])(CC1=CC=CC=C1)NC(=O)[C@@]([H])(S)CCCCC)C(O)=O,GOIYKVXXGCPHQU-BPUTZDHNSA-N,380.502,P09874,BE0001717,Poly [ADP-ribose] polymerase 1,Humans,inhibitor,yes
DB02602,AL7182,small molecule,experimental,COC1=CC(=CC=C1)N1CCC2=C(SC(=C2)S(N)(=O)=O)S1(=O)=O,ICIXQGGQPKFQRL-UHFFFAOYSA-N,374.456,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB02603,1-Amino-6-Cyclohex-3-Enylmethyloxypurine,small molecule,experimental,NC1=NC(OCC2CCCCC2)=C2N=CNC2=C1,VPUIDVRYMVIXGO-UHFFFAOYSA-N,246.3082,P24941,BE0001072,Cyclin-dependent kinase 2,Humans,inhibitor,yes
DB02604,2-Deoxy-Glucose-6-Phosphate,small molecule,experimental,O[C@H]1C[C@@H](O)[C@H](O)[C@@H](COP(O)(O)=O)O1,UQJFZAAGZAYVKZ-KAZBKCHUSA-N,244.1364,P11217,BE0000916,"Glycogen phosphorylase, muscle form",Humans,inhibitor,yes
DB02613,Capric dimethyl amine oxide,small molecule,experimental,CCCCCCCCCC[N+](C)(C)[O-],ZRKZFNZPJKEWPC-UHFFFAOYSA-N,201.3489,Q08210,BE0000612,"Dihydroorotate dehydrogenase (quinone), mitochondrial",Plasmodium falciparum (isolate 3D7),inhibitor,yes
DB02616,FR117016,small molecule,experimental,NC(N)=NC1=NC(=CS1)C1=CC=C(CNC2=NC3=C(N2)C=CC=C3)S1,CKJGKHXCUDWFDC-UHFFFAOYSA-N,369.467,P00813,BE0002214,Adenosine deaminase,Humans,inhibitor,yes
DB02620,3-(4-{2-[2-(2-bromo-acetylamino)-ethyldisulfanyl]-ethylcarbamoyl}-cyclohexylcarbamoyl)-pyrazine-2-carboxylic acid,small molecule,experimental,CC(=O)NCCSSCCNC(=O)C1CCC(CC1)NC(=O)C1=NC=CN=C1C(O)=O,OMSKFAYIWROESZ-UHFFFAOYSA-N,469.58,P18031,BE0000623,Tyrosine-protein phosphatase non-receptor type 1,Humans,inhibitor,yes
DB02622,2-(Oxalyl-Amino)-Benzoic Acid,small molecule,experimental,OC(=O)C(=O)NC1=C(C=CC=C1)C(O)=O,QBYNNSFEMMNINN-UHFFFAOYSA-N,209.1556,P18031,BE0000623,Tyrosine-protein phosphatase non-receptor type 1,Humans,inhibitor,yes
DB02627,"4,4'-Biphenyldiboronic Acid",small molecule,experimental,OB(O)C1=CC=C(C=C1)C1=CC=C(C=C1)B(O)O,SLHKDOGTVUCXKX-UHFFFAOYSA-N,241.843,P00807,BE0000302,Beta-lactamase,Staphylococcus aureus,inhibitor,yes
DB02633,Cibacron Blue,small molecule,experimental,NC1=C(C=C(NC2=CC=C(NC3=NC(Cl)=NC(NC4=CC=CC=C4S(O)(=O)=O)=N3)C(=C2)S(O)(=O)=O)C2=C1C(=O)C1=CC=CC=C1C2=O)S(O)(=O)=O,YKCWQPZFAFZLBI-UHFFFAOYSA-N,774.157,O60760,BE0001167,Hematopoietic prostaglandin D synthase,Humans,inhibitor,yes
DB02642,[[N-(Benzyloxycarbonyl)Amino]Methyl]Phosphate,small molecule,experimental,OP(O)(=O)CNC(=O)OCC1=CC=CC=C1,WUNKRZNFNIYEPN-UHFFFAOYSA-N,245.169,P00807,BE0000302,Beta-lactamase,Staphylococcus aureus,inhibitor,yes
DB02647,N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide,small molecule,experimental,O=C(NC1=CC(=NN1)C1CC1)C1=CC=CC=C1,LUCORKWTQSQFFU-UHFFFAOYSA-N,227.2618,P24941,BE0001072,Cyclin-dependent kinase 2,Humans,inhibitor,yes
DB02655,D-Aspartic Acid,small molecule,experimental,N[C@H](CC(O)=O)C(O)=O,CKLJMWTZIZZHCS-UWTATZPHSA-N,133.1027,Q13224,BE0000417,"Glutamate receptor ionotropic, NMDA 2B",Humans,agonist,yes
DB02655,D-Aspartic Acid,small molecule,experimental,N[C@H](CC(O)=O)C(O)=O,CKLJMWTZIZZHCS-UWTATZPHSA-N,133.1027,Q12879,BE0000760,"Glutamate receptor ionotropic, NMDA 2A",Humans,agonist,yes
DB02655,D-Aspartic Acid,small molecule,experimental,N[C@H](CC(O)=O)C(O)=O,CKLJMWTZIZZHCS-UWTATZPHSA-N,133.1027,Q05586,BE0000365,"Glutamate receptor ionotropic, NMDA 1",Humans,agonist,yes
DB02656,LY-294002,small molecule,experimental,O=C1C=C(OC2=C1C=CC=C2C1=CC=CC=C1)N1CCOCC1,CZQHHVNHHHRRDU-UHFFFAOYSA-N,307.3432,P48736,BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",Humans,inhibitor,yes
DB02657,Glucosamine 6-Phosphate,small molecule,experimental,N[C@H]1[C@@H](O)O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O,XHMJOUIAFHJHBW-UKFBFLRUSA-N,259.151,P17169,BE0001423,Glutamine--fructose-6-phosphate aminotransferase [isomerizing],Escherichia coli (strain K12),inhibitor,yes
DB02659,Cholic Acid,small molecule,approved,[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)C[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C,BHQCQFFYRZLCQQ-OELDTZBJSA-N,408.5714,P04054,BE0003997,Phospholipase A2,Humans,inhibitor,yes
DB02659,Cholic Acid,small molecule,approved,[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)C[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C,BHQCQFFYRZLCQQ-OELDTZBJSA-N,408.5714,P22830,BE0001033,"Ferrochelatase, mitochondrial",Humans,inhibitor,yes
DB02659,Cholic Acid,small molecule,approved,[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)C[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C,BHQCQFFYRZLCQQ-OELDTZBJSA-N,408.5714,P23141,BE0002705,Liver carboxylesterase 1,Humans,inhibitor,yes
DB02660,Filaminast,small molecule,experimental,COC1=CC=C(C=C1OC1CCCC1)C(\C)=N\OC(N)=O,STTRYQAGHGJXJJ-LICLKQGHSA-N,292.3303,Q07343,BE0000487,"3',5'-cyclic-AMP phosphodiesterase 4B",Humans,inhibitor,yes
DB02662,Novo Nordisk a/S Compound,small molecule,experimental,OC(=O)C(=O)NC1=C(C=C(I)C=C1)C(O)=O,SHSWHSQPJKMCPN-UHFFFAOYSA-N,335.0521,P18031,BE0000623,Tyrosine-protein phosphatase non-receptor type 1,Humans,inhibitor,yes
DB02666,(C8-R)-hydantocidin 5'-phosphate,small molecule,experimental,[H]N1C(=O)N(CCC[C@@H](N(O)CO)C(O)=O)C(=O)[C@]11O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O,MAXSFYCTFIBEAR-OJMIUMIFSA-N,459.2998,Q9U8D3,BE0002700,Adenylosuccinate synthetase,Plasmodium falciparum,inhibitor,yes
DB02668,JE-2147,small molecule,experimental,CC1=CC=CC=C1CNC(=O)[C@H]1N(CSC1(C)C)C(=O)[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CC=CC(O)=C1C,CUFQBQOBLVLKRF-RZDMPUFOSA-N,575.718,P03366,BE0002050,Gag-Pol polyprotein,,modulator,yes
DB02669,RB106,small molecule,experimental,[H][C@](S)(CC1=CC=CC=C1)C(=O)NCC(=O)N1[C@@]([H])(CC[C@]1([H])C1=CC=CC=C1)C(O)=O,ZWDQTNWLXALTOV-QYZOEREBSA-N,412.502,P09874,BE0001717,Poly [ADP-ribose] polymerase 1,Humans,inhibitor,yes
DB02673,"(4aS,6R,8aS)-11-[8-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)octyl]-6-hydroxy-3-methoxy-5,6,9,10-tetrahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-11-ium",small molecule,experimental,COC1=CC=C2C=[N+](CCCCCCCCN3C(=O)C4=C(C=CC=C4)C3=O)CC[C@@]34C=C[C@H](O)C[C@@H]3OC1=C24,VLGAHTYYCHWLNI-BHRZLAGCSA-N,529.6466,P22303,BE0000426,Acetylcholinesterase,Humans,inhibitor,yes
DB02690,NU1025,small molecule,experimental,CC1=NC2=C(C=CC=C2O)C(=O)N1,YJDAOHJWLUNFLX-UHFFFAOYSA-N,176.172,P09874,BE0001717,Poly [ADP-ribose] polymerase 1,Humans,inhibitor,yes
DB02697,Hydroxyaminovaline,small molecule,experimental,CC(C)[C@@H](N)C(=O)NO,USSBBYRBOWZYSB-SCSAIBSYSA-N,132.161,P45452,BE0000966,Collagenase 3,Humans,inhibitor,yes
DB02697,Hydroxyaminovaline,small molecule,experimental,CC(C)[C@@H](N)C(=O)NO,USSBBYRBOWZYSB-SCSAIBSYSA-N,132.161,P08254,BE0001116,Stromelysin-1,Humans,inhibitor,yes
DB02701,Nicotinamide,small molecule,approved;investigational,NC(=O)C1=CC=CN=C1,DFPAKSUCGFBDDF-UHFFFAOYSA-N,122.1246,Q10588,BE0001241,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,Humans,product of,yes
DB02701,Nicotinamide,small molecule,approved;investigational,NC(=O)C1=CC=CN=C1,DFPAKSUCGFBDDF-UHFFFAOYSA-N,122.1246,P11439,BE0001869,Exotoxin A,Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228),product of,yes
DB02701,Nicotinamide,small molecule,approved;investigational,NC(=O)C1=CC=CN=C1,DFPAKSUCGFBDDF-UHFFFAOYSA-N,122.1246,P09874,BE0001717,Poly [ADP-ribose] polymerase 1,Humans,binder,yes
DB02703,Fusidic acid,small molecule,approved;investigational,[H][C@@]12C[C@@H](O)[C@@]3([H])[C@@]4(C)CC[C@@H](O)[C@@H](C)[C@]4([H])CC[C@]3(C)[C@@]1(C)C[C@H](OC(C)=O)\C2=C(\CCC=C(C)C)C(O)=O,IECPWNUMDGFDKC-MZJAQBGESA-N,516.7092,P13551,BE0001796,Elongation factor G,Thermus thermophilus,inhibitor,yes
DB02709,Resveratrol,small molecule,investigational,OC1=CC=C(\C=C\C2=CC(O)=CC(O)=C2)C=C1,LUKBXSAWLPMMSZ-OWOJBTEDSA-N,228.2433,Q96EB6,BE0002461,NAD-dependent protein deacetylase sirtuin-1,Humans,inhibitor,yes
DB02712,Sorbinil,small molecule,experimental;investigational,FC1=CC=C2OCC[C@]3(NC(=O)NC3=O)C2=C1,LXANPKRCLVQAOG-NSHDSACASA-N,236.1992,P15121,BE0000747,Aldo-keto reductase family 1 member B1,Humans,inhibitor,yes
DB02719,C-(1-hydrogyl-beta-D-glucopyranosyl) formamide,small molecule,experimental,[H]N([H])C(=O)[C@]1(O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,DTZYCNDAJQDPQC-UHKLXPPTSA-N,223.1806,P11217,BE0000916,"Glycogen phosphorylase, muscle form",Humans,inhibitor,yes
DB02720,alpha-D-glucopyranosyl-2-carboxylic acid amide,small molecule,experimental,[H]N([H])C(=O)[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,UKWLGCFJAVEFPE-DVKNGEFBSA-N,207.1812,P11217,BE0000916,"Glycogen phosphorylase, muscle form",Humans,inhibitor,yes
DB02727,2-butyl-1-hydroxyguanidine,small molecule,experimental,CCCC\N=C(/N)NO,ULDDTFAPYWLDGF-UHFFFAOYSA-N,131.1762,P29475,BE0000067,Nitric oxide synthase 1,Humans,inhibitor,yes
DB02733,Purvalanol,small molecule,experimental,[H][C@@](CO)(NC1=NC2=C(N=CN2C(C)C)C(NC2=CC=C(C(O)=O)C(Cl)=C2)=N1)C(C)C,ZKDXRFMOHZVXSG-HNNXBMFYSA-N,432.904,P06493,BE0001082,Cyclin-dependent kinase 1,Humans,binder,yes
DB02733,Purvalanol,small molecule,experimental,[H][C@@](CO)(NC1=NC2=C(N=CN2C(C)C)C(NC2=CC=C(C(O)=O)C(Cl)=C2)=N1)C(C)C,ZKDXRFMOHZVXSG-HNNXBMFYSA-N,432.904,P13945,BE0001012,Beta-3 adrenergic receptor,Humans,agonist,yes
DB02733,Purvalanol,small molecule,experimental,[H][C@@](CO)(NC1=NC2=C(N=CN2C(C)C)C(NC2=CC=C(C(O)=O)C(Cl)=C2)=N1)C(C)C,ZKDXRFMOHZVXSG-HNNXBMFYSA-N,432.904,Q00535,BE0000890,Cyclin-dependent kinase 5,Humans,inhibitor,yes
DB02733,Purvalanol,small molecule,experimental,[H][C@@](CO)(NC1=NC2=C(N=CN2C(C)C)C(NC2=CC=C(C(O)=O)C(Cl)=C2)=N1)C(C)C,ZKDXRFMOHZVXSG-HNNXBMFYSA-N,432.904,P24941,BE0001072,Cyclin-dependent kinase 2,Humans,inhibitor,yes
DB02741,CD564,small molecule,experimental,CC1(C)CCC(C)(C)C2=C1C=CC(=C2)C(=O)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O,RWYREGSYPCNZTL-UHFFFAOYSA-N,386.4828,P13631,BE0000144,Retinoic acid receptor gamma,Humans,inhibitor,yes
DB02745,Uridine,small molecule,experimental;investigational,OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(=O)NC1=O,DRTQHJPVMGBUCF-XVFCMESISA-N,244.2014,P19971,BE0002193,Thymidine phosphorylase,Humans,inhibitor,yes
DB02752,Tosyl-D-Proline,small molecule,experimental,[H][C@@]1(CCCN1S(=O)(=O)C1=CC=C(C)C=C1)C(O)=O,CGPHGPCHVUSFFA-LLVKDONJSA-N,269.317,P12461,BE0000021,Thymidylate synthase,Yeast,inhibitor,yes
DB02754,"9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine",small molecule,experimental,CCCCN1C(CC2=CC(OC)=C(OC)C(OC)=C2)=NC2=C(N)N=CN=C12,TUOSCZDRWRYPRS-UHFFFAOYSA-N,371.4335,P07900,BE0001120,Heat shock protein HSP 90-alpha,Humans,inhibitor,yes
DB02755,1-3 Sugar Ring of Pentamannosyl 6-Phosphate,small molecule,experimental,[H][C@]1(O)O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O[C@@]2([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O[C@@]3([H])O[C@]([H])(COP(O)(O)=O)[C@@]([H])(O)[C@]([H])(O)[C@]3([H])O)[C@]2([H])O)[C@]1([H])O,HDQMHAJOIVYOIP-NAVBLJQLSA-N,584.417,P20645,BE0004494,Cation-dependent mannose-6-phosphate receptor,Humans,inhibitor,yes
DB02762,RU79072,small molecule,experimental,OP(O)(=O)OC1=CC=CC2=CC=C(N=C12)C#N,NQLPTOOPFMPCHQ-UHFFFAOYSA-N,250.1473,P12931,BE0000838,Proto-oncogene tyrosine-protein kinase Src,Humans,inhibitor,yes
DB02765,R-9-(2-hydroxypropyl)adenine,small molecule,experimental,C[C@@H](O)CN1C=NC2=C1N=CN=C2N,MJZYTEBKXLVLMY-RXMQYKEDSA-N,193.2058,P04183,BE0001260,"Thymidine kinase, cytosolic",Humans,inhibitor,yes
DB02767,(R)-3-hydroxytetradecanoic acid,small molecule,experimental,CCCCCCCCCCC[C@@H](O)CC(O)=O,ATRNZOYKSNPPBF-CYBMUJFWSA-N,244.3703,O00206,BE0002442,Toll-like receptor 4,Humans,inhibitor,yes
DB02772,Sucrose,small molecule,approved;experimental;investigational,OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O,CZMRCDWAGMRECN-UGDNZRGBSA-N,342.2965,P00807,BE0000302,Beta-lactamase,Staphylococcus aureus,inhibitor,yes
DB02773,(3-Chloro-4-Propoxy-Phenyl)-Acetic Acid,small molecule,experimental,CCCOC1=CC=C(CC(O)=O)C=C1Cl,QEJHPAGTOOIBFT-UHFFFAOYSA-N,228.672,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB02778,"2,5-Anhydroglucitol-1,6-Biphosphate",small molecule,experimental,[H][C@]1(O)[C@]([H])(O)[C@]([H])(COP(O)(O)=O)O[C@]1([H])COP(O)(O)=O,WSMBXSQDFPTODV-JGWLITMVSA-N,324.1163,P09467,BE0002431,"Fructose-1,6-bisphosphatase 1",Humans,inhibitor,yes
DB02778,"2,5-Anhydroglucitol-1,6-Biphosphate",small molecule,experimental,[H][C@]1(O)[C@]([H])(O)[C@]([H])(COP(O)(O)=O)O[C@]1([H])COP(O)(O)=O,WSMBXSQDFPTODV-JGWLITMVSA-N,324.1163,O00757,BE0011215,"Fructose-1,6-bisphosphatase isozyme 2",Humans,inhibitor,yes
DB02779,Dodecyltrimethylammonium,small molecule,experimental,CCCCCCCCCCCC[N+](C)(C)C,VICYBMUVWHJEFT-UHFFFAOYSA-N,228.4372,Q06124,BE0001071,Tyrosine-protein phosphatase non-receptor type 11,Humans,inhibitor,yes
DB02789,Pregnenolone,small molecule,approved;experimental,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C,ORNBQBCIOKFOEO-QGVNFLHTSA-N,316.4776,P11474,BE0003722,Steroid hormone receptor ERR1,Humans,agonist,yes
DB02795,P-Anisic Acid,small molecule,experimental,COC1=CC=C(C=C1)C(O)=O,ZEYHEAKUIGZSGI-UHFFFAOYSA-N,152.1473,P04054,BE0003997,Phospholipase A2,Humans,inhibitor,yes
DB02796,9-deazainosine,small molecule,experimental,[H]N1C=C([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C2=C1C(=O)N=CN2[H],WKDMPDYUJKSXBW-KBHCAIDQSA-N,267.238,P00491,BE0000250,Purine nucleoside phosphorylase,Humans,inhibitor,yes
DB02797,3-Nitrophenylboronic Acid,small molecule,experimental,OB(O)C1=CC=CC(=C1)[N+]([O-])=O,ZNRGSYUVFVNSAW-UHFFFAOYSA-N,166.927,P00807,BE0000302,Beta-lactamase,Staphylococcus aureus,inhibitor,yes
DB02803,"3-Phenyl-1,2-Propandiol",small molecule,experimental,OC[C@@H](O)CC1=CC=CC=C1,JHWQMXKQJVAWKI-VIFPVBQESA-N,152.1904,P00797,BE0000270,Renin,Humans,inhibitor,yes
DB02809,"Brodimoprim-4,6-Dicarboxylate",small molecule,experimental,COC1=CC(CC2=C[NH+]=C(N)N=C2N)=CC(OCCC[C@@H](CCC([O-])=O)C([O-])=O)=C1Br,SZAVCZNFKJSWRN-LBPRGKRZSA-M,496.332,Q9HBH1,BE0002201,"Peptide deformylase, mitochondrial",Humans,inhibitor,yes
DB02810,N-(2-Acetamido)Iminodiacetic Acid,small molecule,experimental,NC(=O)CN(CC(O)=O)CC(O)=O,QZTKDVCDBIDYMD-UHFFFAOYSA-N,190.154,P68826,BE0002535,Peptide deformylase,Staphylococcus aureus,inhibitor,yes
DB02811,Diethyl phosphonate,small molecule,experimental,[H]P(=O)(OCC)OCC,MJUJXFBTEFXVKU-UHFFFAOYSA-N,138.1021,P06276,BE0002180,Cholinesterase,Humans,inhibitor,yes
DB02812,RWJ-56423,small molecule,experimental,[H]N([H])C(=NCCC[C@H](N([H])C(=O)[C@@H]1C[C@@H](O)CN1C(C)=O)C(=O)C1=NC2=CC=CC=C2S1)N([H])[H],VXDAVYUFYPFGDX-SNPRPXQTSA-N,446.523,P07477,BE0001739,Serine protease 1,Humans,inhibitor,yes
DB02818,Iodo-Willardiine,small molecule,experimental,N[C@@H](CN1C=C(I)C(=O)NC1=O)C(O)=O,AXXYLTBQIQBTES-BYPYZUCNSA-N,325.0606,P39086,BE0000346,"Glutamate receptor ionotropic, kainate 1",Humans,agonist,yes
DB02824,N-Pyridoxyl-Glycine-5-Monophosphate,small molecule,experimental,CC1=NC=C(COP(O)(O)=O)C(CNCC(O)=O)=C1O,FEVQWBMNLWUBTF-UHFFFAOYSA-N,306.2091,P11926,BE0000404,Ornithine decarboxylase,Humans,inhibitor,yes
DB02828,5-Fluorolevulinic Acid,small molecule,experimental,OC(=O)CCC(=O)CF,MBVLGMJBSFUHKW-UHFFFAOYSA-N,134.1057,P13716,BE0000050,Delta-aminolevulinic acid dehydratase,Humans,inhibitor,yes
DB02830,FR236913,small molecule,experimental,[H][C@](CO)(CCN1C=CC2=C1C=C(NC(=O)NCC1=CC=CC=C1)C=C2)N1C=NC(=C1)C(N)=O,KCCUBLLGAMGDJL-HXUWFJFHSA-N,446.5016,P00813,BE0002214,Adenosine deaminase,Humans,inhibitor,yes
DB02834,IDD552,small molecule,experimental,OC(=O)COC1=CC(F)=CC=C1C(=O)NCC1=NC2=C(S1)C(F)=CC(F)=C2F,ZCAGEXZTORJQDZ-UHFFFAOYSA-N,414.331,P15121,BE0000747,Aldo-keto reductase family 1 member B1,Humans,inhibitor,yes
DB02843,alpha-D-glucose-1-phosphate,small molecule,experimental,OC[C@H]1O[C@H](OP(O)(O)=O)[C@H](O)[C@@H](O)[C@@H]1O,HXXFSFRBOHSIMQ-VFUOTHLCSA-N,260.1358,P11217,BE0000916,"Glycogen phosphorylase, muscle form",Humans,inhibitor,yes
DB02852,Domoic Acid,small molecule,experimental,[H]\C(\C(\[H])=C(\C)[C@@]1([H])CN[C@]([H])(C(O)=O)[C@@]1([H])CC(O)=O)=C(\[H])[C@@]([H])(C)C(O)=O,VZFRNCSOCOPNDB-AOKDLOFSSA-N,311.3303,P39086,BE0000346,"Glutamate receptor ionotropic, kainate 1",Humans,agonist,yes
DB02857,Guanosine,small molecule,experimental;investigational,NC1=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(=O)N1,NYHBQMYGNKIUIF-UUOKFMHZSA-N,283.2407,P04293,BE0000308,DNA polymerase catalytic subunit,HHV-1,inhibitor,yes
DB02857,Guanosine,small molecule,experimental;investigational,NC1=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(=O)N1,NYHBQMYGNKIUIF-UUOKFMHZSA-N,283.2407,P08546,BE0000343,DNA polymerase catalytic subunit,HHV-5,inhibitor,yes
DB02857,Guanosine,small molecule,experimental;investigational,NC1=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(=O)N1,NYHBQMYGNKIUIF-UUOKFMHZSA-N,283.2407,P00491,BE0000250,Purine nucleoside phosphorylase,Humans,inhibitor,yes
DB02859,Soraphen A,small molecule,experimental,[H]\C1=C([H])/[C@@]([H])(OC)[C@]([H])(CCCC[C@]([H])(OC(=O)[C@@]([H])(C)[C@@]2(O)O[C@]([H])([C@@]([H])(C)[C@]([H])(O)[C@@]2([H])OC)[C@@]1([H])C)C1=CC=CC=C1)OC,WPMGNXPRKGXGBO-OFQQMTDKSA-N,520.6549,O00763,BE0000702,Acetyl-CoA carboxylase 2,Humans,inhibitor,yes
DB02860,Calyculin A,small molecule,experimental,[H][C@@]1(O[C@]2(C[C@@H](O)[C@H](C)[C@H](C\C=C\C3=COC(=N3)[C@@H](C)CCNC(=O)[C@@H](O)[C@@H](O)[C@H](COC)N(C)C)O2)C(C)(C)[C@H]1OP(O)(O)=O)[C@H](C[C@H](O)[C@H](C)[C@H](O)[C@H](C)\C=C(/C)\C(\C)=C\C=C\C(\C)=C/C#N)OC,FKAWLXNLHHIHLA-YCBIHMBMSA-N,1009.185,Q13621,BE0000502,Solute carrier family 12 member 1,Humans,blocker,yes
DB02866,Dansylamide,small molecule,experimental,CN(C)C1=C2C=CC=C(C2=CC=C1)S(N)(=O)=O,TYNBFJJKZPTRKS-UHFFFAOYSA-N,250.317,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB02877,Arotinoid acid,small molecule,experimental,C\C(=C/C1=CC=C(C=C1)C(O)=O)C1=CC=C2C(=C1)C(C)(C)CCC2(C)C,FOIVPCKZDPCJJY-JQIJEIRASA-N,348.4779,P10826,BE0000206,Retinoic acid receptor beta,Humans,inhibitor,yes
DB02878,3-(2-Aminoethyl)-4-(Aminomethyl)Heptanedioic Acid,small molecule,experimental,[H][C@](CN)(CCC(O)=O)[C@]([H])(CCN)CC(O)=O,QMRGRIXXWLVLTR-HTQZYQBOSA-N,232.2768,P13716,BE0000050,Delta-aminolevulinic acid dehydratase,Humans,inhibitor,yes
DB02884,3-Cyclohexyl-L-alanine,small molecule,experimental,N[C@@H](CC1CCCCC1)C(O)=O,ORQXBVXKBGUSBA-QMMMGPOBSA-N,171.2368,P54289,BE0000691,Voltage-dependent calcium channel subunit alpha-2/delta-1,Humans,inhibitor,yes
DB02888,FKB-001,small molecule,experimental,COC1=CC(=CC(OC)=C1OC)C(F)(F)C(=O)N1CCCC[C@H]1C(=O)O[C@@H](CCCC1=CC=CC=C1)CCCC1=CN=CC=C1,NBYCDVVSYOMFMS-VMPREFPWSA-N,624.7146,P62942,BE0000695,Peptidyl-prolyl cis-trans isomerase FKBP1A,Humans,inhibitor,yes
DB02893,D-Methionine,small molecule,approved;experimental;investigational,CSCC[C@@H](N)C(O)=O,FFEARJCKVFRZRR-SCSAIBSYSA-N,149.211,P50579,BE0001534,Methionine aminopeptidase 2,Humans,inhibitor,yes
DB02895,3-(Prop-2-Ene-1-Sulfinyl)-Propene-1-Thiol,small molecule,experimental,S\C=C\C[S@](=O)CC=C,HSVQDVSVQIMRSS-CDAZIORVSA-N,162.273,P00390,BE0000648,"Glutathione reductase, mitochondrial",Humans,inhibitor,yes
DB02899,N-Carboxymethionine,small molecule,experimental,[H][C@@](CCSC)(NC(O)=O)C(O)=O,LWQBAQJPCYBWJQ-BYPYZUCNSA-N,193.221,P12461,BE0000021,Thymidylate synthase,Yeast,inhibitor,yes
DB02900,alpha-D-mannose 6-phosphate,small molecule,experimental,O[C@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@@H]1O,NBSCHQHZLSJFNQ-PQMKYFCFSA-N,260.1358,P20645,BE0004494,Cation-dependent mannose-6-phosphate receptor,Humans,inhibitor,yes
DB02901,Stanolone,small molecule,illicit;investigational,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)CC[C@]12C,NVKAWKQGWWIWPM-ABEVXSGRSA-N,290.4403,P10275,BE0000132,Androgen receptor,Humans,agonist,yes
DB02908,RU78783,small molecule,experimental,OP(O)(=O)C(C1=CC=CC=C1)P(O)(O)=O,FRLTXWJJMCIUNT-UHFFFAOYSA-N,252.0982,P12931,BE0000838,Proto-oncogene tyrosine-protein kinase Src,Humans,inhibitor,yes
DB02911,"2,4-Diamino-6-Phenyl-5,6,7,8,-Tetrahydropteridine",small molecule,experimental,[H][C@]1(CNC2=C(N1)C(N)=NC(N)=N2)C1=CC=CC=C1,VEKRIXRQADJFAG-QMMMGPOBSA-N,242.2798,P29474,BE0000263,Nitric oxide synthase 3,Humans,inhibitor,yes
DB02921,(South)-Methanocarba-Thymidine,small molecule,experimental,CC1=CN(C(=O)NC1=O)[C@]12C[C@H]1[C@H](CO)[C@@H](O)C2,XRMLXZVSFIBRRJ-PEFMBERDSA-N,252.2664,P04183,BE0001260,"Thymidine kinase, cytosolic",Humans,inhibitor,yes
DB02925,Piretanide,small molecule,approved,NS(=O)(=O)C1=CC(=CC(N2CCCC2)=C1OC1=CC=CC=C1)C(O)=O,UJEWTUDSLQGTOA-UHFFFAOYSA-N,362.4,Q13621,BE0000502,Solute carrier family 12 member 1,Humans,inhibitor,yes
DB02938,Heptanoic acid,small molecule,experimental;investigational,CCCCCCC(O)=O,MNWFXJYAOYHMED-UHFFFAOYSA-N,130.1849,P04054,BE0003997,Phospholipase A2,Humans,inhibitor,yes
DB02953,2-Thiomethyl-3-Phenylpropanoic Acid,small molecule,experimental,[H][C@](CS)(CC1=CC=CC=C1)C(O)=O,ZUEBVBPVXLQMQR-SECBINFHSA-N,196.266,P22894,BE0001182,Neutrophil collagenase,Humans,inhibitor,yes
DB02954,(Carboxyhydroxyamino)Ethanoic Acid,small molecule,experimental,ON(CC(O)=O)C(O)=O,LJSQPIOQKDFEKE-UHFFFAOYSA-N,135.0755,Q9U8D3,BE0002700,Adenylosuccinate synthetase,Plasmodium falciparum,inhibitor,yes
DB02966,Fluoro-Willardiine,small molecule,experimental,N[C@@H](CN1C=C(F)C(=O)NC1=O)C(O)=O,DBWPFHJYSTVBCZ-BYPYZUCNSA-N,217.1545,P48058,BE0000830,Glutamate receptor 4,Humans,agonist,yes
DB02966,Fluoro-Willardiine,small molecule,experimental,N[C@@H](CN1C=C(F)C(=O)NC1=O)C(O)=O,DBWPFHJYSTVBCZ-BYPYZUCNSA-N,217.1545,P42261,BE0000640,Glutamate receptor 1,Humans,agonist,yes
DB02966,Fluoro-Willardiine,small molecule,experimental,N[C@@H](CN1C=C(F)C(=O)NC1=O)C(O)=O,DBWPFHJYSTVBCZ-BYPYZUCNSA-N,217.1545,P42263,BE0000831,Glutamate receptor 3,Humans,agonist,yes
DB02966,Fluoro-Willardiine,small molecule,experimental,N[C@@H](CN1C=C(F)C(=O)NC1=O)C(O)=O,DBWPFHJYSTVBCZ-BYPYZUCNSA-N,217.1545,P42262,BE0000829,Glutamate receptor 2,Humans,agonist,yes
DB02977,PNU177836,small molecule,experimental,[H][C@@](O)(N[C@@]([H])(CC1=CC=CC=C1)[C@]([H])(O)N[C@@]([H])(CC1=CC(C(O)=O)=C(OCC(O)=O)C=C1)[C@@]([H])(O)NCCCCC)OC(C)(C)C,WVFJFYADATXBBE-JIFQQKSFSA-N,605.7196,P18031,BE0000623,Tyrosine-protein phosphatase non-receptor type 1,Humans,inhibitor,yes
DB02979,"N1,N14-Bis((S-Methyl)Isothioureido)Tetradecane",small molecule,experimental,CS\C(N)=N\CCCCCCCCCCCCCC\N=C(/N)SC,IOKDMHHZKWLWKO-UHFFFAOYSA-N,374.651,P29474,BE0000263,Nitric oxide synthase 3,Humans,inhibitor,yes
DB02983,Para-Mercury-Benzenesulfonic Acid,small molecule,experimental,OS(=O)(=O)C1=CC=C([Hg])C=C1,KQAOIKIZSJJTII-UHFFFAOYSA-N,357.76,Q92731,BE0000792,Estrogen receptor beta,Humans,inhibitor,yes
DB02985,8-iodo-guanine,small molecule,experimental,NC1=NC(=O)C2=C(N1)N=C(I)N2,SXGFECRAKVVEJT-UHFFFAOYSA-N,277.0226,P00491,BE0000250,Purine nucleoside phosphorylase,Humans,inhibitor,yes
DB02986,"N-(2-Thienylmethyl)-2,5-Thiophenedisulfonamide",small molecule,experimental,NS(=O)(=O)C1=CC=C(S1)S(=O)(=O)NCC1=CC=CS1,STOTVDLYLKWVJB-UHFFFAOYSA-N,338.447,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB02990,S-(2-Acetamidoethyl) hexadecanethioate,small molecule,experimental,CCCCCCCCCCCCCCCC(=O)SCCNC(C)=O,GDVZALUOXPTSHD-UHFFFAOYSA-N,357.594,P9WGR1,BE0000332,Enoyl-[acyl-carrier-protein] reductase [NADH],Mycobacterium tuberculosis,inhibitor,yes
DB02991,S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Isothiourea,small molecule,experimental,CCS\C(N)=N\C1=CC=C(C=C1)C(F)(F)F,LCMOXIFARISMOH-UHFFFAOYSA-N,248.268,P29475,BE0000067,Nitric oxide synthase 1,Humans,inhibitor,yes
DB02994,Cacodylic acid,small molecule,experimental,C[As](C)(O)=O,OGGXGZAMXPVRFZ-UHFFFAOYSA-N,137.9974,P29474,BE0000263,Nitric oxide synthase 3,Humans,inhibitor,yes
DB02994,Cacodylic acid,small molecule,experimental,C[As](C)(O)=O,OGGXGZAMXPVRFZ-UHFFFAOYSA-N,137.9974,P15121,BE0000747,Aldo-keto reductase family 1 member B1,Humans,inhibitor,yes
DB02998,Metribolone,small molecule,experimental,[H][C@@]12CC[C@](C)(O)[C@@]1(C)C=CC1=C3CCC(=O)C=C3CC[C@@]21[H],CCCIJQPRIXGQOE-XWSJACJDSA-N,284.3927,P06401,BE0000557,Progesterone receptor,Humans,inhibitor,yes
DB02999,Quisqualic acid,small molecule,experimental,N[C@@H](CN1OC(=O)NC1=O)C(O)=O,ASNFTDCKZKHJSW-REOHCLBHSA-N,189.1262,Q13255,BE0000824,Metabotropic glutamate receptor 1,Humans,agonist,yes
DB02999,Quisqualic acid,small molecule,experimental,N[C@@H](CN1OC(=O)NC1=O)C(O)=O,ASNFTDCKZKHJSW-REOHCLBHSA-N,189.1262,P39086,BE0000346,"Glutamate receptor ionotropic, kainate 1",Humans,inhibitor,yes
DB02999,Quisqualic acid,small molecule,experimental,N[C@@H](CN1OC(=O)NC1=O)C(O)=O,ASNFTDCKZKHJSW-REOHCLBHSA-N,189.1262,Q14416,BE0000974,Metabotropic glutamate receptor 2,Humans,inhibitor,yes
DB02999,Quisqualic acid,small molecule,experimental,N[C@@H](CN1OC(=O)NC1=O)C(O)=O,ASNFTDCKZKHJSW-REOHCLBHSA-N,189.1262,Q14832,BE0002342,Metabotropic glutamate receptor 3,Humans,inhibitor,yes
DB02999,Quisqualic acid,small molecule,experimental,N[C@@H](CN1OC(=O)NC1=O)C(O)=O,ASNFTDCKZKHJSW-REOHCLBHSA-N,189.1262,P41594,BE0001192,Metabotropic glutamate receptor 5,Humans,inhibitor,yes
DB02999,Quisqualic acid,small molecule,experimental,N[C@@H](CN1OC(=O)NC1=O)C(O)=O,ASNFTDCKZKHJSW-REOHCLBHSA-N,189.1262,Q04609,BE0000568,Glutamate carboxypeptidase 2,Humans,inhibitor,yes
DB03000,S-9-(2-hydroxypropyl)adenine,small molecule,experimental,[H][C@@](C)(O)CN1C=NC2=C(N)N=CN=C12,MJZYTEBKXLVLMY-YFKPBYRVSA-N,193.2058,P04183,BE0001260,"Thymidine kinase, cytosolic",Humans,inhibitor,yes
DB03015,"6-hydroxy-1,6-dihydro purine nucleoside",small molecule,experimental,[H]N1C=[N+]([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C2=C1[C@H](O)N=CN2[H],WGRXVKRHIMUTPD-YOHZANMFSA-O,271.2499,P00813,BE0002214,Adenosine deaminase,Humans,inhibitor,yes
DB03017,Lauric acid,small molecule,approved;experimental,CCCCCCCCCCCC(O)=O,POULHZVOKOAJMA-UHFFFAOYSA-N,200.3178,O00206,BE0002442,Toll-like receptor 4,Humans,inhibitor,yes
DB03017,Lauric acid,small molecule,approved;experimental,CCCCCCCCCCCC(O)=O,POULHZVOKOAJMA-UHFFFAOYSA-N,200.3178,P02788,BE0000994,Lactotransferrin,Humans,inhibitor,yes
DB03017,Lauric acid,small molecule,approved;experimental,CCCCCCCCCCCC(O)=O,POULHZVOKOAJMA-UHFFFAOYSA-N,200.3178,P14555,BE0001640,"Phospholipase A2, membrane associated",Humans,inhibitor,yes
DB03024,2-Methyl-3-(2-Aminothiazolo)Propanal,small molecule,experimental,[H][C@](C)(CC1=CSC(N)=N1)C=O,KFMAJVLZSDMFBV-YFKPBYRVSA-N,170.232,P00797,BE0000270,Renin,Humans,inhibitor,yes
DB03028,1h-Benoximidazole-2-Carboxylic Acid,small molecule,experimental,OC(=O)C1=NC2=CC=CC=C2N1,RHXSYTACTOMVLJ-UHFFFAOYSA-N,162.1454,P07339,BE0000941,Cathepsin D,Humans,inhibitor,yes
DB03030,4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole,small molecule,experimental,CC1=CC=C(CN2C=NC(=C2)C2=CC=CS2)C=C1,UMOFOLLUKPBVQG-UHFFFAOYSA-N,254.35,P9WGR1,BE0000332,Enoyl-[acyl-carrier-protein] reductase [NADH],Mycobacterium tuberculosis,inhibitor,yes
DB03033,4-methoxybenzenesulfinate,small molecule,experimental,COC1=CC=C(C=C1)S([O-])=O,YVZWQPOTHRMEQW-UHFFFAOYSA-M,171.19,P45452,BE0000966,Collagenase 3,Humans,inhibitor,yes
DB03033,4-methoxybenzenesulfinate,small molecule,experimental,COC1=CC=C(C=C1)S([O-])=O,YVZWQPOTHRMEQW-UHFFFAOYSA-M,171.19,P08254,BE0001116,Stromelysin-1,Humans,inhibitor,yes
DB03038,LY341770,small molecule,experimental,[H]N([H])C1=NC(=O)C2=C(N([H])C=C2CCC2=CC=C(C=C2)C(=O)N([H])[C@@H](CCC2=NN([H])N=N2)C(O)=O)N1[H],MXAFDBCLWLMXSI-ZDUSSCGKSA-N,451.4386,P12461,BE0000021,Thymidylate synthase,Yeast,inhibitor,yes
DB03040,Nitrilotriacetic acid,small molecule,experimental,OC(=O)CN(CC(O)=O)CC(O)=O,MGFYIUFZLHCRTH-UHFFFAOYSA-N,191.1388,P02788,BE0000994,Lactotransferrin,Humans,inhibitor,yes
DB03044,Doramapimod,small molecule,investigational,CC1=CC=C(C=C1)N1N=C(C=C1NC(=O)NC1=CC=C(OCCN2CCOCC2)C2=C1C=CC=C2)C(C)(C)C,MVCOAUNKQVWQHZ-UHFFFAOYSA-N,527.6572,P08631,BE0001424,Tyrosine-protein kinase HCK,Humans,inhibitor,yes
DB03048,6-Carboxymethyluracil,small molecule,experimental,OC(=O)CC1=CC(=O)NC(=O)N1,NQAUNZZEYKWTHM-UHFFFAOYSA-N,170.1228,Q12882,BE0000960,Dihydropyrimidine dehydrogenase [NADP(+)],Humans,inhibitor,yes
DB03052,Dazoxiben,small molecule,experimental,OC(=O)C1=CC=C(OCCN2C=CN=C2)C=C1,XQGZSYKGWHUSDH-UHFFFAOYSA-N,232.2353,P24557,BE0001893,Thromboxane-A synthase,Humans,inhibitor,yes
DB03056,4-Piperidino-Piperidine,small molecule,experimental,C1CCN(CC1)C1CCNCC1,QDVBKXJMLILLLB-UHFFFAOYSA-N,168.2792,P23141,BE0002705,Liver carboxylesterase 1,Humans,inhibitor,yes
DB03060,Sri-9662,small molecule,experimental,COC1=CC(\C=C/C2=C(C)C3=C(N)N=C(N)N=C3N=C2)=C(OC)C=C1,WNDJHUNKXPAREB-PLNGDYQASA-N,337.3758,Q9HBH1,BE0002201,"Peptide deformylase, mitochondrial",Humans,inhibitor,yes
DB03065,7-Nitroindazole-2-Carboxamidine,small molecule,experimental,NC(=N)N1C=C2C=CC=C(C2=N1)[N+]([O-])=O,GFYAZUABYOOPCN-UHFFFAOYSA-N,205.1735,P29474,BE0000263,Nitric oxide synthase 3,Humans,inhibitor,yes
DB03070,Selenazole-4-carboxyamide-adenine dinucleotide,small molecule,experimental,[H]N([H])C(=O)C1=C[Se]C(=N1)[C@]1([H])O[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N=CN=C23)N([H])[H])[C@@H](O)[C@H]1O,SKNBJMQZTZPCPF-QZTLEVGFSA-N,716.35,P12268,BE0000722,Inosine-5'-monophosphate dehydrogenase 2,Humans,inhibitor,yes
DB03073,3-Methoxybenzamide,small molecule,experimental,COC1=CC(=CC=C1)C(N)=O,VKPLPDIMEREJJF-UHFFFAOYSA-N,151.1626,P09874,BE0001717,Poly [ADP-ribose] polymerase 1,Humans,inhibitor,yes
DB03078,PASBN,small molecule,experimental,O[P@@](=O)(OCC1=CC=CC=C1)OC1=C(C=O)C=CC=C1,PWDTUFYQEUEVQD-UHFFFAOYSA-N,292.2238,P12931,BE0000838,Proto-oncogene tyrosine-protein kinase Src,Humans,inhibitor,yes
DB03083,IC261,small molecule,experimental,COC1=CC(OC)=C(\C=C2\C(=O)NC3=CC=CC=C23)C(OC)=C1,JBJYTZXCZDNOJW-JLHYYAGUSA-N,311.3319,P48729,BE0009427,Casein kinase I isoform alpha,Humans,inhibitor,yes
DB03083,IC261,small molecule,experimental,COC1=CC(OC)=C(\C=C2\C(=O)NC3=CC=CC=C23)C(OC)=C1,JBJYTZXCZDNOJW-JLHYYAGUSA-N,311.3319,P49674,BE0003512,Casein kinase I isoform epsilon,Humans,inhibitor,yes
DB03088,Pidolic acid,small molecule,approved;investigational,OC(=O)[C@@H]1CCC(=O)N1,ODHCTXKNWHHXJC-VKHMYHEASA-N,129.114,P04746,BE0002639,Pancreatic alpha-amylase,Humans,inhibitor,yes
DB03092,5-Hydroxymethyl-Chonduritol,small molecule,experimental,[H][C@]1(O)C=C(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])O,PJPGMULJEYSZBS-VZFHVOOUSA-N,176.1672,P04746,BE0002639,Pancreatic alpha-amylase,Humans,inhibitor,yes
DB03096,2-Morpholinoethylamine,small molecule,experimental,NCCN1CCOCC1,RWIVICVCHVMHMU-UHFFFAOYSA-N,130.1882,P07339,BE0000941,Cathepsin D,Humans,inhibitor,yes
DB03100,6-Nitroindazole,small molecule,experimental,O=N(=O)C1=CC2=NNC=C2C=C1,ORZRMRUXSPNQQL-UHFFFAOYSA-N,163.1335,P29474,BE0000263,Nitric oxide synthase 3,Humans,inhibitor,yes
DB03100,6-Nitroindazole,small molecule,experimental,O=N(=O)C1=CC2=NNC=C2C=C1,ORZRMRUXSPNQQL-UHFFFAOYSA-N,163.1335,P35228,BE0000005,"Nitric oxide synthase, inducible",Humans,inhibitor,yes
DB03101,Ribose-1-Phosphate,small molecule,experimental,OC[C@H]1O[C@H](OP(O)(O)=O)[C@H](O)[C@@H]1O,YXJDFQJKERBOBM-TXICZTDVSA-N,230.1098,P00491,BE0000250,Purine nucleoside phosphorylase,Humans,inhibitor,yes
DB03104,2-[4-[(Z)-2-Acetamido-3-oxo-3-[[(3S)-2-oxo-1-[(4-phenylphenyl)methyl]azepan-3-yl]amino]prop-1-enyl]-2-formylphenyl]acetic acid,small molecule,experimental,CC(=O)N\C(=C/C1=CC=C(CC(O)=O)C(C=O)=C1)C(=O)N[C@H]1CCCCN(CC2=CC=C(C=C2)C2=CC=CC=C2)C1=O,NKMPOVPTYDXGEC-MNRBYUMSSA-N,567.6316,P12931,BE0000838,Proto-oncogene tyrosine-protein kinase Src,Humans,inhibitor,yes
DB03108,4-phospho-D-erythronic acid,small molecule,experimental,[H][C@@](O)(COP(O)(O)=O)[C@@]([H])(O)C(O)=O,ZCZXOHUILRHRQJ-PWNYCUMCSA-N,216.0832,P52209,BE0003559,"6-phosphogluconate dehydrogenase, decarboxylating",Humans,inhibitor,yes
DB03110,2-Chlorophenol,small molecule,experimental,OC1=CC=CC=C1Cl,ISPYQTSUDJAMAB-UHFFFAOYSA-N,128.556,Q16539,BE0001019,Mitogen-activated protein kinase 14,Humans,inhibitor,yes
DB03114,PAS219,small molecule,experimental,O[P@@](=O)(OCC1CCCCC1)OC1=C(C=O)C=CC=C1,YBEVTZVQKMYQPM-UHFFFAOYSA-N,298.2714,P12931,BE0000838,Proto-oncogene tyrosine-protein kinase Src,Humans,inhibitor,yes
DB03127,Benzamidine,small molecule,experimental,NC(=[NH2+])C1=CC=CC=C1,PXXJHWLDUBFPOL-UHFFFAOYSA-O,121.1598,P07477,BE0001739,Serine protease 1,Humans,inhibitor,yes
DB03127,Benzamidine,small molecule,experimental,NC(=[NH2+])C1=CC=CC=C1,PXXJHWLDUBFPOL-UHFFFAOYSA-O,121.1598,P00749,BE0000895,Urokinase-type plasminogen activator,Humans,inhibitor,yes
DB03127,Benzamidine,small molecule,experimental,NC(=[NH2+])C1=CC=CC=C1,PXXJHWLDUBFPOL-UHFFFAOYSA-O,121.1598,Q9Y5Y6,BE0001656,Suppressor of tumorigenicity 14 protein,Humans,inhibitor,yes
DB03136,4-Iodobenzo[B]Thiophene-2-Carboxamidine,small molecule,experimental,NC(=[NH2+])C1=CC2=C(S1)C=CC=C2I,YERQOXAYAFWFEJ-UHFFFAOYSA-O,303.143,P00734,BE0000048,Prothrombin,Humans,inhibitor,yes
DB03136,4-Iodobenzo[B]Thiophene-2-Carboxamidine,small molecule,experimental,NC(=[NH2+])C1=CC2=C(S1)C=CC=C2I,YERQOXAYAFWFEJ-UHFFFAOYSA-O,303.143,P00740,BE0000364,Coagulation factor IX,Humans,inhibitor,yes
DB03136,4-Iodobenzo[B]Thiophene-2-Carboxamidine,small molecule,experimental,NC(=[NH2+])C1=CC2=C(S1)C=CC=C2I,YERQOXAYAFWFEJ-UHFFFAOYSA-O,303.143,P00749,BE0000895,Urokinase-type plasminogen activator,Humans,inhibitor,yes
DB03140,4-Carboxyphenylboronic Acid,small molecule,experimental,OB(O)C1=CC=C(C=C1)C(O)=O,SIAVMDKGVRXFAX-UHFFFAOYSA-N,165.939,P00807,BE0000302,Beta-lactamase,Staphylococcus aureus,inhibitor,yes
DB03144,N(5)-[(hydroxyamino)(imino)methyl]-L-ornithine,small molecule,experimental,N[C@@H](CCCNC(=N)NO)C(O)=O,FQWRAVYMZULPNK-BYPYZUCNSA-N,190.2004,P29474,BE0000263,Nitric oxide synthase 3,Humans,inhibitor,yes
DB03144,N(5)-[(hydroxyamino)(imino)methyl]-L-ornithine,small molecule,experimental,N[C@@H](CCCNC(=N)NO)C(O)=O,FQWRAVYMZULPNK-BYPYZUCNSA-N,190.2004,P35228,BE0000005,"Nitric oxide synthase, inducible",Humans,inhibitor,yes
DB03144,N(5)-[(hydroxyamino)(imino)methyl]-L-ornithine,small molecule,experimental,N[C@@H](CCCNC(=N)NO)C(O)=O,FQWRAVYMZULPNK-BYPYZUCNSA-N,190.2004,P29475,BE0000067,Nitric oxide synthase 1,Humans,inhibitor,yes
DB03147,Flavin adenine dinucleotide,small molecule,approved,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2,VWWQXMAJTJZDQX-UYBVJOGSSA-N,785.5497,P16083,BE0000220,Ribosyldihydronicotinamide dehydrogenase [quinone],Humans,inhibitor,yes
DB03147,Flavin adenine dinucleotide,small molecule,approved,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2,VWWQXMAJTJZDQX-UYBVJOGSSA-N,785.5497,P29475,BE0000067,Nitric oxide synthase 1,Humans,inhibitor,yes
DB03147,Flavin adenine dinucleotide,small molecule,approved,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2,VWWQXMAJTJZDQX-UYBVJOGSSA-N,785.5497,Q12882,BE0000960,Dihydropyrimidine dehydrogenase [NADP(+)],Humans,inhibitor,yes
DB03147,Flavin adenine dinucleotide,small molecule,approved,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2,VWWQXMAJTJZDQX-UYBVJOGSSA-N,785.5497,P47989,BE0002204,Xanthine dehydrogenase/oxidase,Humans,inhibitor,yes
DB03147,Flavin adenine dinucleotide,small molecule,approved,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2,VWWQXMAJTJZDQX-UYBVJOGSSA-N,785.5497,P00390,BE0000648,"Glutathione reductase, mitochondrial",Humans,inhibitor,yes
DB03147,Flavin adenine dinucleotide,small molecule,approved,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2,VWWQXMAJTJZDQX-UYBVJOGSSA-N,785.5497,P15559,BE0001184,NAD(P)H dehydrogenase [quinone] 1,Humans,inhibitor,yes
DB03147,Flavin adenine dinucleotide,small molecule,approved,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2,VWWQXMAJTJZDQX-UYBVJOGSSA-N,785.5497,P21397,BE0002198,Amine oxidase [flavin-containing] A,Humans,inhibitor,yes
DB03147,Flavin adenine dinucleotide,small molecule,approved,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2,VWWQXMAJTJZDQX-UYBVJOGSSA-N,785.5497,Q16881,BE0001979,"Thioredoxin reductase 1, cytoplasmic",Humans,inhibitor,yes
DB03147,Flavin adenine dinucleotide,small molecule,approved,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2,VWWQXMAJTJZDQX-UYBVJOGSSA-N,785.5497,P27338,BE0002196,Amine oxidase [flavin-containing] B,Humans,inhibitor,yes
DB03148,Adenosine 5'-methylenediphosphate,small molecule,experimental,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)CP(O)(O)=O)[C@@H](O)[C@H]1O,OLCWZBFDIYXLAA-IOSLPCCCSA-N,425.2283,P21589,BE0001096,5'-nucleotidase,Humans,inhibitor,yes
DB03153,"3H-pyrazolo[4,3-d]pyrimidin-7-ol",small molecule,experimental,OC1=NC=NC2=C1N=NC2,OGCXIHWGXUQTCQ-UHFFFAOYSA-N,136.1115,P20035,BE0001516,Hypoxanthine-guanine-xanthine phosphoribosyltransferase,Plasmodium falciparum (isolate FCR-3 / Gambia),inhibitor,yes
DB03157,"N,O-didansyl-L-tyrosine",small molecule,experimental,[H]N([C@@H](CC1=CC=C(OS(=O)(=O)C2=CC=CC3=C2C=CC=C3N(C)C)C=C1)C(O)=O)S(=O)(=O)C1=CC=CC2=C1C=CC=C2N(C)C,LUBOPDUYHWABFG-NDEPHWFRSA-N,647.761,P12461,BE0000021,Thymidylate synthase,Yeast,inhibitor,yes
DB03159,CRA_8696,small molecule,experimental,NC(=[NH2+])C1=CC=C2NC(=CC2=C1)C1=CC=CC(=C1[O-])C1=CC=CC=C1,GAVRMVQHHVMXFD-UHFFFAOYSA-N,327.3792,P00734,BE0000048,Prothrombin,Humans,inhibitor,yes
DB03159,CRA_8696,small molecule,experimental,NC(=[NH2+])C1=CC=C2NC(=CC2=C1)C1=CC=CC(=C1[O-])C1=CC=CC=C1,GAVRMVQHHVMXFD-UHFFFAOYSA-N,327.3792,P00749,BE0000895,Urokinase-type plasminogen activator,Humans,inhibitor,yes
DB03203,Sphingosine,small molecule,experimental,[H]\C(CCCCCCCCCCCCC)=C(\[H])[C@@]([H])(O)[C@@]([H])(N)CO,WWUZIQQURGPMPG-KRWOKUGFSA-N,299.4919,Q9Y5K3,BE0000494,Choline-phosphate cytidylyltransferase B,Humans,inhibitor,yes
DB03206,Duvoglustat,small molecule,investigational,OC[C@H]1NC[C@H](O)[C@@H](O)[C@@H]1O,LXBIFEVIBLOUGU-JGWLITMVSA-N,163.1717,O43451,BE0000837,Maltase-glucoamylase,Humans,inhibitor,yes
DB03206,Duvoglustat,small molecule,investigational,OC[C@H]1NC[C@H](O)[C@@H](O)[C@@H]1O,LXBIFEVIBLOUGU-JGWLITMVSA-N,163.1717,P10253,BE0000876,Lysosomal alpha-glucosidase,Humans,inhibitor,yes
DB03206,Duvoglustat,small molecule,investigational,OC[C@H]1NC[C@H](O)[C@@H](O)[C@@H]1O,LXBIFEVIBLOUGU-JGWLITMVSA-N,163.1717,Q14697,BE0004698,Neutral alpha-glucosidase AB,Humans,inhibitor,yes
DB03206,Duvoglustat,small molecule,investigational,OC[C@H]1NC[C@H](O)[C@@H](O)[C@@H]1O,LXBIFEVIBLOUGU-JGWLITMVSA-N,163.1717,Q8TET4,BE0004699,Neutral alpha-glucosidase C,Humans,inhibitor,yes
DB03217,DPI59,small molecule,experimental,[H][C@@](O)(C1=CC=CC2=CC=CC=C12)P(O)(O)=O,AXIBZLYWMBUYRV-NSHDSACASA-N,238.1764,P12931,BE0000838,Proto-oncogene tyrosine-protein kinase Src,Humans,inhibitor,yes
DB03218,N-acetyl-N'-beta-D-glucopyranosyl urea,small molecule,experimental,CC(=O)NC(=O)N[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,UQKBNLXZEGBQAF-JAJWTYFOSA-N,264.2325,P11217,BE0000916,"Glycogen phosphorylase, muscle form",Humans,inhibitor,yes
DB03220,FR-234938,small molecule,experimental,C[C@H](O)[C@@H](CCC1=C2C=CC=CC2=CC=C1)N1C=NC(=C1)C(N)=O,OODDZQQDDOVCFD-SCLBCKFNSA-N,323.3889,P00813,BE0002214,Adenosine deaminase,Humans,inhibitor,yes
DB03221,AL7099A,small molecule,experimental,CN[C@@H]1CN(C2=CC(OC)=CC=C2)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,RMOXCYSVWCHXII-GFCCVEGCSA-N,403.497,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB03222,dATP,small molecule,experimental,NC1=NC=NC2=C1N=CN2[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1,SUYVUBYJARFZHO-RRKCRQDMSA-N,491.1816,Q96G91,BE0005499,P2Y purinoceptor 11,Humans,agonist,yes
DB03225,D-Tryptophan,small molecule,experimental,N[C@H](CC1=CNC2=CC=CC=C12)C(O)=O,QIVBCDIJIAJPQS-SECBINFHSA-N,204.2252,P49019,BE0000836,Hydroxycarboxylic acid receptor 3,Humans,agonist,yes
DB03254,4-Phenyl-1h-Imidazole,small molecule,experimental,N1C=NC=C1C1=CC=CC=C1,XHLKOHSAWQPOFO-UHFFFAOYSA-N,144.1732,P14902,BE0000693,"Indoleamine 2,3-dioxygenase 1",Humans,inhibitor,yes
DB03268,RU82197,small molecule,experimental,CC(=O)N[C@@H](CC1=CC(C=O)=C(C=C1)C(O)=O)C(=O)N[C@H]1CCCCN(CC2=CC=C(C=C2)C2=CC=CC=C2)C1=O,WKTQBTSOHBKBRW-VMPREFPWSA-N,555.6209,P12931,BE0000838,Proto-oncogene tyrosine-protein kinase Src,Humans,inhibitor,yes
DB03270,"2,6-Difluorobenzenesulfonamide",small molecule,experimental,NS(=O)(=O)C1=C(F)C=CC=C1F,RVVVGGCOFWWDEL-UHFFFAOYSA-N,193.171,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB03274,"2',5'-Dideoxyuridine",small molecule,experimental,[H]N1C(=O)C=CN([C@H]2C[C@H](O)[C@@H](C)O2)C1=O,FDCFKLBIAIKUKB-GKROBHDKSA-N,212.2026,P12461,BE0000021,Thymidylate synthase,Yeast,inhibitor,yes
DB03279,Dodecyl-Alpha-D-Maltoside,small molecule,experimental,[H][C@]1(O)[C@]([H])(O)[C@@]([H])(CO)O[C@]([H])(O[C@@]2([H])[C@]([H])(O)[C@@]([H])(O)[C@@]([H])(OCCCCCCCCCCCC)O[C@]2([H])CO)[C@]1([H])O,NLEBIOOXCVAHBD-YHBSTRCHSA-N,510.6154,P13631,BE0000144,Retinoic acid receptor gamma,Humans,inhibitor,yes
DB03280,p1-(5'-adenosyl)p5-(5'-thymidyl)pentaphosphate,small molecule,experimental,[H]N([H])C1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]4O[C@H](C[C@@H]4O)N4C=C(C)C(=O)N([H])C4=O)[C@@H](O)[C@H]3O)C2=NC=N1,JCFDSPQTEMXXLO-SLFMBYJQSA-N,891.3541,P04183,BE0001260,"Thymidine kinase, cytosolic",Humans,inhibitor,yes
DB03283,beta-L-fucose,small molecule,experimental,C[C@@H]1O[C@H](O)[C@@H](O)[C@H](O)[C@@H]1O,SHZGCJCMOBCMKK-KGJVWPDLSA-N,164.1565,P22303,BE0000426,Acetylcholinesterase,Humans,inhibitor,yes
DB03298,Phenylphosphate,small molecule,experimental,OP(O)(=O)OC1=CC=CC=C1,CMPQUABWPXYYSH-UHFFFAOYSA-N,174.0911,P12931,BE0000838,Proto-oncogene tyrosine-protein kinase Src,Humans,inhibitor,yes
DB03305,N(G)-Iminoethylornithine,small molecule,experimental,CC(=N)NCCC[C@H](N)C(O)=O,UYZFAUAYFLEHRC-LURJTMIESA-N,173.2129,P35228,BE0000005,"Nitric oxide synthase, inducible",Humans,inhibitor,yes
DB03305,N(G)-Iminoethylornithine,small molecule,experimental,CC(=N)NCCC[C@H](N)C(O)=O,UYZFAUAYFLEHRC-LURJTMIESA-N,173.2129,P29475,BE0000067,Nitric oxide synthase 1,Humans,inhibitor,yes
DB03305,N(G)-Iminoethylornithine,small molecule,experimental,CC(=N)NCCC[C@H](N)C(O)=O,UYZFAUAYFLEHRC-LURJTMIESA-N,173.2129,P29474,BE0000263,Nitric oxide synthase 3,Humans,inhibitor,yes
DB03306,RU78300,small molecule,experimental,COC1=CC=CC(C=O)=C1OP(O)(O)=O,CGEZBCISRKFHLZ-UHFFFAOYSA-N,232.1272,P12931,BE0000838,Proto-oncogene tyrosine-protein kinase Src,Humans,inhibitor,yes
DB03312,Brivudine,small molecule,approved;investigational,OC[C@H]1O[C@H](C[C@@H]1O)N1C=C(\C=C\Br)C(=O)NC1=O,ODZBBRURCPAEIQ-PIXDULNESA-N,333.135,O00142,BE0004639,"Thymidine kinase 2, mitochondrial",Humans,substrate,yes
DB03312,Brivudine,small molecule,approved;investigational,OC[C@H]1O[C@H](C[C@@H]1O)N1C=C(\C=C\Br)C(=O)NC1=O,ODZBBRURCPAEIQ-PIXDULNESA-N,333.135,P04183,BE0001260,"Thymidine kinase, cytosolic",Humans,inhibitor,yes
DB03312,Brivudine,small molecule,approved;investigational,OC[C@H]1O[C@H](C[C@@H]1O)N1C=C(\C=C\Br)C(=O)NC1=O,ODZBBRURCPAEIQ-PIXDULNESA-N,333.135,Q91CQ6,BE0009350,DNA polymerase,Human herpesvirus 1,inhibitor,yes
DB03313,Cephalosporin C,small molecule,experimental,[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)CCC[C@@H](N)C(O)=O)C(O)=O,HOKIDJSKDBPKTQ-GLXFQSAKSA-N,415.418,Q7CRA4,BE0004335,Penicillin-binding protein 1b,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB03313,Cephalosporin C,small molecule,experimental,[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)CCC[C@@H](N)C(O)=O)C(O)=O,HOKIDJSKDBPKTQ-GLXFQSAKSA-N,415.418,P0AD68,BE0002393,Peptidoglycan synthase FtsI,Escherichia coli (strain K12),antagonist,yes
DB03313,Cephalosporin C,small molecule,experimental,[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)CCC[C@@H](N)C(O)=O)C(O)=O,HOKIDJSKDBPKTQ-GLXFQSAKSA-N,415.418,Q8DR59,BE0004290,Penicillin-binding protein 1A,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB03313,Cephalosporin C,small molecule,experimental,[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)CCC[C@@H](N)C(O)=O)C(O)=O,HOKIDJSKDBPKTQ-GLXFQSAKSA-N,415.418,P0A3M6,BE0003624,Penicillin-binding protein 2B,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB03313,Cephalosporin C,small molecule,experimental,[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)CCC[C@@H](N)C(O)=O)C(O)=O,HOKIDJSKDBPKTQ-GLXFQSAKSA-N,415.418,Q8DNB6,BE0004644,Penicillin-binding protein 2a,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB03313,Cephalosporin C,small molecule,experimental,[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)CCC[C@@H](N)C(O)=O)C(O)=O,HOKIDJSKDBPKTQ-GLXFQSAKSA-N,415.418,Q75Y35,BE0004643,Penicillin-binding protein 3,Streptococcus pneumoniae,inhibitor,yes
DB03332,"5,6-Cyclic-Tetrahydropteridine",small molecule,experimental,NC1=NC2=C(N3[C@@H](COC3=O)CN2)C(=O)N1,XAZOBOCYEGBXHD-GSVOUGTGSA-N,223.1888,P29474,BE0000263,Nitric oxide synthase 3,Humans,inhibitor,yes
DB03336,BIA,small molecule,experimental,OC1=CC(=CC(=C1O)[N+]([O-])=O)C(=O)CCN1CCN(CC1)C1=CC(=CC=C1)C(F)(F)F,KVIVJQWOYSWCCZ-UHFFFAOYSA-N,439.3851,P21964,BE0002089,Catechol O-methyltransferase,Humans,inhibitor,yes
DB03338,Heptyl glucoside,small molecule,experimental,CCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,NIDYWHLDTIVRJT-UJPOAAIJSA-N,278.3419,P62942,BE0000695,Peptidyl-prolyl cis-trans isomerase FKBP1A,Humans,inhibitor,yes
DB03338,Heptyl glucoside,small molecule,experimental,CCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,NIDYWHLDTIVRJT-UJPOAAIJSA-N,278.3419,Q03181,BE0001007,Peroxisome proliferator-activated receptor delta,Humans,inhibitor,yes
DB03349,8-Bromo-Adenosine-5'-Monophosphate,small molecule,experimental,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C(Br)=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O,DNPIJKNXFSPNNY-UUOKFMHZSA-N,426.117,Q07343,BE0000487,"3',5'-cyclic-AMP phosphodiesterase 4B",Humans,inhibitor,yes
DB03351,Sri-9439,small molecule,experimental,CC1=C(CNC2=CC=CC3=NC=CC=C23)C=NC2=NC(N)=NC(N)=C12,KMSATRJZEXNGDP-UHFFFAOYSA-N,331.3745,Q9HBH1,BE0002201,"Peptide deformylase, mitochondrial",Humans,inhibitor,yes
DB03365,"4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline",small molecule,experimental,COC1=CC2=NC=NC(NC3=CC(O)=CC=C3)=C2C=C1OC,BNDYIYYKEIXHNK-UHFFFAOYSA-N,297.3086,P24941,BE0001072,Cyclin-dependent kinase 2,Humans,inhibitor,yes
DB03365,"4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline",small molecule,experimental,COC1=CC2=NC=NC(NC3=CC(O)=CC=C3)=C2C=C1OC,BNDYIYYKEIXHNK-UHFFFAOYSA-N,297.3086,P35968,BE0000369,Vascular endothelial growth factor receptor 2,Humans,inhibitor,yes
DB03367,PF-00356231,small molecule,experimental,[H][C@](CC(O)=O)(NC(=O)C1=CC(=CS1)C1=CC=C(C=C1)C1=CC=NC=C1)C1=CC=CC=C1,VMTJQZUZINLEKC-JOCHJYFZSA-N,428.503,P39900,BE0001198,Macrophage metalloelastase,Humans,inhibitor,yes
DB03370,FR239087,small molecule,experimental,[H][C@@](C)(O)[C@@]([H])(CCC1=CC=CC(Cl)=C1Cl)N1C=NC(=C1)C(N)=O,HCJYSIGJDKNVRU-TVQRCGJNSA-N,342.22,P00813,BE0002214,Adenosine deaminase,Humans,inhibitor,yes
DB03383,CP-320626,small molecule,experimental,OC1CCN(CC1)C(=O)[C@H](CC1=CC=C(F)C=C1)NC(=O)C1=CC2=C(N1)C=CC(Cl)=C2,YDCGVASFVACWKF-NRFANRHFSA-N,443.898,P10613,BE0000233,Lanosterol 14-alpha demethylase,Yeast,inhibitor,yes
DB03395,Enalkiren,small molecule,experimental,COC1=CC=C(C[C@H](NC(=O)CC(C)(C)N)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N[C@@H](CC2CCCCC2)[C@@H](O)[C@@H](O)CC(C)C)C=C1,KQXVERRYBYGQJZ-WRPDIKACSA-N,656.8557,P00797,BE0000270,Renin,Humans,inhibitor,yes
DB03397,Uridine-Diphosphate-N-Acetylglucosamine,small molecule,experimental,CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(=O)NC1=O,LFTYTUAZOPRMMI-CFRASDGPSA-N,607.3537,P0A749,BE0000468,UDP-N-acetylglucosamine 1-carboxyvinyltransferase,Escherichia coli (strain K12),inhibitor,yes
DB03401,"1D-myo-inositol 1,4,5-trisphosphate",small molecule,experimental,O[C@@H]1[C@H](O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H](O)[C@@H]1OP(O)(O)=O,MMWCIQZXVOZEGG-XJTPDSDZSA-N,420.0956,Q14643,BE0004522,"Inositol 1,4,5-trisphosphate-gated calcium channel ITPR1",Humans,inhibitor,yes
DB03401,"1D-myo-inositol 1,4,5-trisphosphate",small molecule,experimental,O[C@@H]1[C@H](O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H](O)[C@@H]1OP(O)(O)=O,MMWCIQZXVOZEGG-XJTPDSDZSA-N,420.0956,Q14573,BE0009595,"Inositol 1,4,5-trisphosphate-gated calcium channel ITPR3",Humans,inhibitor,yes
DB03401,"1D-myo-inositol 1,4,5-trisphosphate",small molecule,experimental,O[C@@H]1[C@H](O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H](O)[C@@H]1OP(O)(O)=O,MMWCIQZXVOZEGG-XJTPDSDZSA-N,420.0956,Q14571,BE0009594,"Inositol 1,4,5-trisphosphate-gated calcium channel ITPR2",Humans,inhibitor,yes
DB03411,"2-Hydroxymethyl-Pyrrolidine-3,4-Diol",small molecule,experimental,OC[C@@H]1NC[C@H](O)[C@H]1O,OQEBIHBLFRADNM-YUPRTTJUSA-N,133.1457,P00491,BE0000250,Purine nucleoside phosphorylase,Humans,inhibitor,yes
DB03424,Ubenimex,small molecule,investigational,CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)CC1=CC=CC=C1)C(O)=O,VGGGPCQERPFHOB-RDBSUJKOSA-N,308.3728,P09960,BE0001680,Leukotriene A-4 hydrolase,Humans,inhibitor,yes
DB03428,SU9516,small molecule,experimental,COC1=CC=C2NC(=O)\C(=C/C3=CN=CN3)C2=C1,QNUKRWAIZMBVCU-WCIBSUBMSA-N,241.2453,P24941,BE0001072,Cyclin-dependent kinase 2,Humans,inhibitor,yes
DB03428,SU9516,small molecule,experimental,COC1=CC=C2NC(=O)\C(=C/C3=CN=CN3)C2=C1,QNUKRWAIZMBVCU-WCIBSUBMSA-N,241.2453,Q00535,BE0000890,Cyclin-dependent kinase 5,Humans,inhibitor,yes
DB03428,SU9516,small molecule,experimental,COC1=CC=C2NC(=O)\C(=C/C3=CN=CN3)C2=C1,QNUKRWAIZMBVCU-WCIBSUBMSA-N,241.2453,P06493,BE0001082,Cyclin-dependent kinase 1,Humans,binder,yes
DB03439,"4,6-dideoxy-4-amino-alpha-D-glucose",small molecule,experimental,[H][C@]1(C)O[C@]([H])(O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])N,RJKBJEZZABBYBA-DVKNGEFBSA-N,163.1717,P04746,BE0002639,Pancreatic alpha-amylase,Humans,inhibitor,yes
DB03451,Lexacalcitol,small molecule,experimental,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@@H](C)OCCCC(O)(CC)CC,KLZOTDOJMRMLDX-YBBVPDDNSA-N,460.689,P11473,BE0000779,Vitamin D3 receptor,Humans,agonist,yes
DB03462,Thymine,small molecule,experimental,CC1=CNC(=O)NC1=O,RWQNBRDOKXIBIV-UHFFFAOYSA-N,126.1133,P19971,BE0002193,Thymidine phosphorylase,Humans,inhibitor,yes
DB03466,BMS184394,small molecule,experimental,CC1(C)CCC(C)(C)C2=C1C=CC(=C2)[C@@H](O)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O,AYAJZQYENGWICE-QHCPKHFHSA-N,388.4987,P13631,BE0000144,Retinoic acid receptor gamma,Humans,inhibitor,yes
DB03468,"1,2,3,4-Tetrahydro-Isoquinoline-7-Sulfonic Acid Amide",small molecule,experimental,NS(=O)(=O)C1=CC2=C(CCNC2)C=C1,UGLLZXSYRBMNOS-UHFFFAOYSA-N,212.269,P08913,BE0000289,Alpha-2A adrenergic receptor,Humans,inhibitor,yes
DB03477,1-Phenylsulfonamide-3-Trifluoromethyl-5-Parabromophenylpyrazole,small molecule,experimental,NS(=O)(=O)C1=CC=C(C=C1)N1N=C(C=C1C1=CC=C(Br)C=C1)C(F)(F)F,OYZKFVIVPRQRQQ-UHFFFAOYSA-N,446.242,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB03485,alpha-D-Fucopyranose,small molecule,experimental,C[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O,SHZGCJCMOBCMKK-PHYPRBDBSA-N,164.1565,P02788,BE0000994,Lactotransferrin,Humans,inhibitor,yes
DB03496,Alvocidib,small molecule,experimental;investigational,CN1CC[C@@H]([C@H](O)C1)C1=C(O)C=C(O)C2=C1OC(=CC2=O)C1=CC=CC=C1Cl,BIIVYFLTOXDAOV-YVEFUNNKSA-N,401.84,P11217,BE0000916,"Glycogen phosphorylase, muscle form",Humans,inhibitor,yes
DB03496,Alvocidib,small molecule,experimental;investigational,CN1CC[C@@H]([C@H](O)C1)C1=C(O)C=C(O)C2=C1OC(=CC2=O)C1=CC=CC=C1Cl,BIIVYFLTOXDAOV-YVEFUNNKSA-N,401.84,P50750,BE0002207,Cyclin-dependent kinase 9,Humans,inhibitor,yes
DB03509,2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide,small molecule,experimental,NC(=O)C1=CC=CC2=NC=C(N=C12)C1=CC=C(Cl)C=C1,FLYGLPYJEQPCFY-UHFFFAOYSA-N,283.712,P09874,BE0001717,Poly [ADP-ribose] polymerase 1,Humans,inhibitor,yes
DB03510,6-O-Phosphoryl Inosine Monophosphate,small molecule,experimental,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2N=CN=C3OP(O)(O)=O)[C@]([H])(O)[C@]1([H])O,RXRZOKQPANIEDW-KQYNXXCUSA-N,428.1859,Q9U8D3,BE0002700,Adenylosuccinate synthetase,Plasmodium falciparum,inhibitor,yes
DB03516,Eniluracil,small molecule,investigational,O=C1NC=C(C#C)C(=O)N1,JOZGNYDSEBIJDH-UHFFFAOYSA-N,136.1082,Q12882,BE0000960,Dihydropyrimidine dehydrogenase [NADP(+)],Humans,modulator,yes
DB03523,Brequinar,small molecule,experimental,CC1=C(N=C2C=CC(F)=CC2=C1C(O)=O)C1=CC=C(C=C1)C1=CC=CC=C1F,PHEZJEYUWHETKO-UHFFFAOYSA-N,375.3675,Q02127,BE0000382,"Dihydroorotate dehydrogenase (quinone), mitochondrial",Humans,modulator,yes
DB03525,RU79073,small molecule,experimental,OP(O)(=O)OC1=C2NCCCC2=CC=C1,NSJSAHCLJYVEDM-UHFFFAOYSA-N,229.1696,P12931,BE0000838,Proto-oncogene tyrosine-protein kinase Src,Humans,inhibitor,yes
DB03526,AL5927,small molecule,experimental,COC1=CC=C(CNS(=O)(=O)C2=CC=C(S2)S(N)(=O)=O)C=C1,LRRAIRJIZOLGPR-UHFFFAOYSA-N,362.445,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB03530,Acylated ceftazidime,small molecule,experimental,[H]N([H])C1=NC(=CS1)C(=N\OC(C)(C)C(O)=O)\C(=O)N([H])[C@H](C=O)[C@@]1([H])SCC(=C)C(=N1)C(O)=O,VEHPZKIFULQYFS-BZXVCXBKSA-N,469.492,P00807,BE0000302,Beta-lactamase,Staphylococcus aureus,inhibitor,yes
DB03535,Z-Pro-Prolinal,small molecule,experimental,[H][C@]1(CCCN1C(=O)[C@]1([H])CCCN1C(=O)OCC1=CC=CC=C1)C=O,ORZXYSPOAVJYRU-HOTGVXAUSA-N,330.3783,P48147,BE0002148,Prolyl endopeptidase,Humans,inhibitor,yes
DB03541,"10-Propargyl-5,8-Dideazafolic Acid",small molecule,experimental,[H][C@@](CCC(O)=O)(NC(=O)C1=CC=C(C=C1)N(CC#C)CC1=CC=C2NC(N)=NC(=O)C2=C1)C(O)=O,LTKHPMDRMUCUEB-IBGZPJMESA-N,477.4693,P12461,BE0000021,Thymidylate synthase,Yeast,inhibitor,yes
DB03541,"10-Propargyl-5,8-Dideazafolic Acid",small molecule,experimental,[H][C@@](CCC(O)=O)(NC(=O)C1=CC=C(C=C1)N(CC#C)CC1=CC=C2NC(N)=NC(=O)C2=C1)C(O)=O,LTKHPMDRMUCUEB-IBGZPJMESA-N,477.4693,P16083,BE0000220,Ribosyldihydronicotinamide dehydrogenase [quinone],Humans,inhibitor,yes
DB03552,3-Tyrosine,small molecule,experimental,N[C@@H](CC1=CC=CC(O)=C1)C(O)=O,JZKXXXDKRQWDET-QMMMGPOBSA-N,181.1885,P07101,BE0000614,Tyrosine 3-monooxygenase,Humans,inhibitor,yes
DB03553,Glutaric Acid,small molecule,experimental,OC(=O)CCCC(O)=O,JFCQEDHGNNZCLN-UHFFFAOYSA-N,132.1146,Q8TCC7,BE0003645,Organic anion transporter 3,Humans,inhibitor,yes
DB03554,5-Iodouracil,small molecule,experimental,IC1=CNC(=O)NC1=O,KSNXJLQDQOIRIP-UHFFFAOYSA-N,237.9833,Q12882,BE0000960,Dihydropyrimidine dehydrogenase [NADP(+)],Humans,inhibitor,yes
DB03558,SP-876,small molecule,experimental,OC(=O)CCNC(=O)[C@H]1CCCN1S(=O)(=O)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,SRAHBOKVSSZEHQ-LSDHHAIUSA-N,499.492,P12461,BE0000021,Thymidylate synthase,Yeast,inhibitor,yes
DB03560,P-Hydroxybenzaldehyde,small molecule,experimental,OC1=CC=C(C=O)C=C1,RGHHSNMVTDWUBI-UHFFFAOYSA-N,122.1213,P80404,BE0000253,"4-aminobutyrate aminotransferase, mitochondrial",Humans,inhibitor,yes
DB03560,P-Hydroxybenzaldehyde,small molecule,experimental,OC1=CC=C(C=O)C=C1,RGHHSNMVTDWUBI-UHFFFAOYSA-N,122.1213,P27338,BE0002196,Amine oxidase [flavin-containing] B,Humans,inhibitor,yes
DB03566,Spermidine,small molecule,experimental,NCCCCNCCCN,ATHGHQPFGPMSJY-UHFFFAOYSA-N,145.2459,Q16881,BE0001979,"Thioredoxin reductase 1, cytoplasmic",Humans,inhibitor,yes
DB03572,FR230513,small molecule,experimental,[H][C@](CO)(CCC1=CC=CC2=C1C=CC=C2)N1C=NC(=C1)C(N)=O,URGFTPMACWKJKU-OAHLLOKOSA-N,309.3624,P00813,BE0002214,Adenosine deaminase,Humans,inhibitor,yes
DB03573,WRR-99,small molecule,experimental,[H][C@](O)(CC(O)=O)C(=O)N[C@]([H])(CCC1=CC=CC=C1)C(=O)NCCC(C)C,KVZMXOVSHIMGNA-CVEARBPZSA-N,364.436,Q9UBX1,BE0001504,Cathepsin F,Humans,inhibitor,yes
DB03573,WRR-99,small molecule,experimental,[H][C@](O)(CC(O)=O)C(=O)N[C@]([H])(CCC1=CC=CC=C1)C(=O)NCCC(C)C,KVZMXOVSHIMGNA-CVEARBPZSA-N,364.436,P25779,BE0001292,Cruzipain,Trypanosoma cruzi,inhibitor,yes
DB03575,Phencyclidine,small molecule,illicit,C1CCN(CC1)C1(CCCCC1)C1=CC=CC=C1,JTJMJGYZQZDUJJ-UHFFFAOYSA-N,243.3871,Q8TCU5,BE0000641,"Glutamate receptor ionotropic, NMDA 3A",Humans,antagonist,yes
DB03575,Phencyclidine,small molecule,illicit,C1CCN(CC1)C1(CCCCC1)C1=CC=CC=C1,JTJMJGYZQZDUJJ-UHFFFAOYSA-N,243.3871,Q13224,BE0000417,"Glutamate receptor ionotropic, NMDA 2B",Humans,inhibitor,yes
DB03575,Phencyclidine,small molecule,illicit,C1CCN(CC1)C1(CCCCC1)C1=CC=CC=C1,JTJMJGYZQZDUJJ-UHFFFAOYSA-N,243.3871,Q12879,BE0000760,"Glutamate receptor ionotropic, NMDA 2A",Humans,inhibitor,yes
DB03575,Phencyclidine,small molecule,illicit,C1CCN(CC1)C1(CCCCC1)C1=CC=CC=C1,JTJMJGYZQZDUJJ-UHFFFAOYSA-N,243.3871,Q05586,BE0000365,"Glutamate receptor ionotropic, NMDA 1",Humans,inhibitor,yes
DB03585,Oxyphenbutazone,small molecule,approved;withdrawn,CCCCC1C(=O)N(N(C1=O)C1=CC=C(O)C=C1)C1=CC=CC=C1,HFHZKZSRXITVMK-UHFFFAOYSA-N,324.3737,P02768,BE0000530,Albumin,Humans,modulator,yes
DB03591,RU82209,small molecule,experimental,CC(=O)N[C@@H](CC1=CC=C(C=C1)C(F)(F)P(O)(O)=O)C(=O)N[C@H]1CCCCN(CC2=CC=C(C=C2)C2=CC=CC=C2)C1=O,LVZDQVATAQEMCX-NSOVKSMOSA-N,613.5887,P12931,BE0000838,Proto-oncogene tyrosine-protein kinase Src,Humans,inhibitor,yes
DB03592,Pterin-6-Yl-Methyl-Monophosphate,small molecule,experimental,NC1=NC2=NC=C(COP(O)(O)=O)N=C2C(=O)N1,AJXFJEHKGGCFNM-UHFFFAOYSA-N,273.1427,P0AC13,BE0000803,Dihydropteroate synthase,Escherichia coli (strain K12),inhibitor,yes
DB03596,N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide,small molecule,experimental,[H][C@@](CC)(CNC(=O)C1=CC=C(C=C1)S(N)(=O)=O)C1=CC2=C(NC=C2)C=C1,FSRPBGBMEKDSIJ-CYBMUJFWSA-N,371.453,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB03597,gamma-Glutamyl[S-(2-iodobenzyl)cysteinyl]glycine,small molecule,experimental,[H]N([H])[C@@H](CCC(=O)N([H])[C@@H](CSCC1=CC=CC=C1I)C(=O)N([H])CC(O)=O)C(O)=O,QFYJAEOZTBVJQM-STQMWFEESA-N,523.343,O76074,BE0000182,"cGMP-specific 3',5'-cyclic phosphodiesterase",Humans,inhibitor,yes
DB03601,5-deoxyflavanone,small molecule,experimental,OC1=CC=C(C=C1)[C@@H]1CC(=O)C2=CC=C(O)C=C2O1,FURUXTVZLHCCNA-AWEZNQCLSA-N,256.2534,P47989,BE0002204,Xanthine dehydrogenase/oxidase,Humans,inhibitor,yes
DB03601,5-deoxyflavanone,small molecule,experimental,OC1=CC=C(C=C1)[C@@H]1CC(=O)C2=CC=C(O)C=C2O1,FURUXTVZLHCCNA-AWEZNQCLSA-N,256.2534,P11511,BE0002090,Aromatase,Humans,inhibitor,yes
DB03604,Tiratricol,small molecule,investigational,OC(=O)CC1=CC(I)=C(OC2=CC=C(O)C(I)=C2)C(I)=C1,UOWZUVNAGUAEQC-UHFFFAOYSA-N,621.9323,P10827,BE0000687,Thyroid hormone receptor alpha,Humans,agonist,yes
DB03604,Tiratricol,small molecule,investigational,OC(=O)CC1=CC(I)=C(OC2=CC=C(O)C(I)=C2)C(I)=C1,UOWZUVNAGUAEQC-UHFFFAOYSA-N,621.9323,P10828,BE0000315,Thyroid hormone receptor beta,Humans,agonist,yes
DB03606,(S)-Rolipram,small molecule,experimental,[H][C@@]1(CNC(=O)C1)C1=CC=C(OC)C(OC2CCCC2)=C1,HJORMJIFDVBMOB-GFCCVEGCSA-N,275.348,P27815,BE0001133,"3',5'-cyclic-AMP phosphodiesterase 4A",Humans,inhibitor,yes
DB03606,(S)-Rolipram,small molecule,experimental,[H][C@@]1(CNC(=O)C1)C1=CC=C(OC)C(OC2CCCC2)=C1,HJORMJIFDVBMOB-GFCCVEGCSA-N,275.348,Q07343,BE0000487,"3',5'-cyclic-AMP phosphodiesterase 4B",Humans,inhibitor,yes
DB03609,3'-deoxyguanosine,small molecule,experimental,[H]N([H])C1=NC(=O)C2=C(N1[H])N(C=N2)[C@@H]1O[C@H](CO)C[C@H]1O,OROIAVZITJBGSM-OBXARNEKSA-N,267.2413,P00491,BE0000250,Purine nucleoside phosphorylase,Humans,inhibitor,yes
DB03614,Mecobalamin,small molecule,approved;investigational,C1(CC[C@@]2([C@@H](CC(N)=O)[C@@]3([C@@]4([N+]5=C([C@H]([C@@]4(CC(N)=O)C)CCC(N)=O)C(C)=C4[N+]6=C(C=C7[N+]8=C([C@H](C7(C)C)CCC(N)=O)C(C)=C2N3[Co-3]568([N+]2=CN([C@H]3O[C@@H]([C@@H](OP(O[C@@H](CN1)C)([O-])=O)[C@H]3O)CO)C1=CC(C)=C(C=C21)C)C)[C@H]([C@@]4(CC(N)=O)C)CCC(N)=O)C)[H])C)=O,JEWJRMKHSMTXPP-WZHZPDAFSA-L,1344.3823,Q99707,BE0000734,Methionine synthase,Humans,cofactor,yes
DB03615,Ribostamycin,small molecule,approved;experimental,[H][C@@]1(O[C@@H]2[C@@H](O)[C@H](N)C[C@H](N)[C@H]2O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2N)O[C@H](CO)[C@@H](O)[C@H]1O,NSKGQURZWSPSBC-VVPCINPTSA-N,454.4727,P0A7S3,BE0000279,30S ribosomal protein S12,Escherichia coli (strain K12),,yes
DB03621,"L-709,587",small molecule,experimental,[H]\C(=C(\C)[C@@]1([H])OC(=O)[C@]2([H])CCCCN2C(=O)C(=O)[C@]2(O)O[C@@]([H])([C@]([H])(C[C@@]2([H])C)OC)[C@]([H])(C[C@@]([H])(C)[C@]([H])(O)\C(C)=C([H])\[C@@]([H])(CC)C(=O)C[C@]([H])(O)[C@@]1([H])C)OC)[C@]1([H])CC[C@@]([H])(OC2=CC=C3N(C)C=CC3=C2)[C@@]([H])(C1)OC,APSPCHLQXFEUHG-CPBVNLROSA-N,937.1654,P62942,BE0000695,Peptidyl-prolyl cis-trans isomerase FKBP1A,Humans,inhibitor,yes
DB03623,"9-(4-Hydroxyphenyl)-2,7-Phenanthroline",small molecule,experimental,OC1=CC=C(C=C1)C1=CC2=C(C=CC3=C2C=NC=C3)N=C1,IUSSGTWHFMSCOY-UHFFFAOYSA-N,272.3007,P53779,BE0001097,Mitogen-activated protein kinase 10,Humans,inhibitor,yes
DB03628,ISO24,small molecule,experimental,CCC1=CC=C(NC(=O)P(O)(O)=O)C=C1,KGNSYMGWPCEFDZ-UHFFFAOYSA-N,229.1696,P12931,BE0000838,Proto-oncogene tyrosine-protein kinase Src,Humans,inhibitor,yes
DB03633,Lpc-Ether,small molecule,experimental,CCCCCCCCCCCCCCCCCCOC[C@@H](O)CO[P@@](O)(=O)OCC[N+](C)(C)C,XKBJVQHMEXMFDZ-AREMUKBSSA-O,510.7076,P04054,BE0003997,Phospholipase A2,Humans,inhibitor,yes
DB03643,CRA_1144,small molecule,experimental,NC(=[NH2+])C1=CC=C2NC(=NC2=C1)C1=CC=CC=C1[O-],URJKRCBBKTXOHS-UHFFFAOYSA-N,252.2713,P05981,BE0002128,Serine protease hepsin,Humans,inhibitor,yes
DB03657,1-deoxy-1-methoxycarbamido-beta-D-glucopyranose,small molecule,experimental,COC(=O)N[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,IZZJOGWXTFEDLL-XUUWZHRGSA-N,237.2072,P11217,BE0000916,"Glycogen phosphorylase, muscle form",Humans,inhibitor,yes
DB03660,4-Iodo-L-phenylalanine,small molecule,experimental,[H][C@](N)(CC1=CC=C(I)C=C1)C(O)=O,PZNQZSRPDOEBMS-QMMMGPOBSA-N,291.0857,P27487,BE0000854,Dipeptidyl peptidase 4,Humans,inhibitor,yes
DB03661,L-cysteic acid,small molecule,experimental,N[C@@H](CS(O)(=O)=O)C(O)=O,XVOYSCVBGLVSOL-REOHCLBHSA-N,169.156,P30305,BE0001705,M-phase inducer phosphatase 2,Humans,inhibitor,yes
DB03661,L-cysteic acid,small molecule,experimental,N[C@@H](CS(O)(=O)=O)C(O)=O,XVOYSCVBGLVSOL-REOHCLBHSA-N,169.156,P68826,BE0002535,Peptide deformylase,Staphylococcus aureus,inhibitor,yes
DB03661,L-cysteic acid,small molecule,experimental,N[C@@H](CS(O)(=O)=O)C(O)=O,XVOYSCVBGLVSOL-REOHCLBHSA-N,169.156,P18031,BE0000623,Tyrosine-protein phosphatase non-receptor type 1,Humans,inhibitor,yes
DB03661,L-cysteic acid,small molecule,experimental,N[C@@H](CS(O)(=O)=O)C(O)=O,XVOYSCVBGLVSOL-REOHCLBHSA-N,169.156,P07711,BE0002135,Procathepsin L,Humans,inhibitor,yes
DB03667,Acetic Acid Salicyloyl-Amino-Ester,small molecule,experimental,CC(=O)ONC(=O)C1=C(O)C=CC=C1,PCFWLDHLJWUGSU-UHFFFAOYSA-N,195.1721,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB03672,9-N-Phenylmethylamino-Tacrine,small molecule,experimental,C(NC1=C2C=CC=CC2=NC2=C1CCCC2)C1=CC=CC=C1,JYJAEHAURXXPSD-UHFFFAOYSA-N,288.3862,P06276,BE0002180,Cholinesterase,Humans,inhibitor,yes
DB03677,N-Cyclohexyl-N'-Decylurea,small molecule,experimental,CCCCCCCCCCNC(=O)NC1CCCCC1,LPXYBLIRYGCMPQ-UHFFFAOYSA-N,282.4647,P34913,BE0000950,Bifunctional epoxide hydrolase 2,Humans,inhibitor,yes
DB03685,Uridine monophosphate,small molecule,experimental,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(O)=O)N1C=CC(=O)NC1=O,DJJCXFVJDGTHFX-XVFCMESISA-N,324.1813,P12461,BE0000021,Thymidylate synthase,Yeast,inhibitor,yes
DB03691,WRR-112,small molecule,experimental,[H][C@](O)(CC(O)=O)C(=O)N[C@@]([H])(CCC1=CC=CC=C1)C(=O)NCCC(C)C,KVZMXOVSHIMGNA-HOTGVXAUSA-N,364.436,P25779,BE0001292,Cruzipain,Trypanosoma cruzi,inhibitor,yes
DB03691,WRR-112,small molecule,experimental,[H][C@](O)(CC(O)=O)C(=O)N[C@@]([H])(CCC1=CC=CC=C1)C(=O)NCCC(C)C,KVZMXOVSHIMGNA-HOTGVXAUSA-N,364.436,Q9UBX1,BE0001504,Cathepsin F,Humans,inhibitor,yes
DB03694,N-phenylthiourea,small molecule,experimental,NC(=S)NC1=CC=CC=C1,FULZLIGZKMKICU-UHFFFAOYSA-N,152.217,P14679,BE0000252,Tyrosinase,Humans,inhibitor,yes
DB03695,Piritrexim,small molecule,investigational,COC1=CC(CC2=C(C)C3=C(N=C2)N=C(N)N=C3N)=C(OC)C=C1,VJXSSYDSOJBUAV-UHFFFAOYSA-N,325.3651,P00374,BE0000330,Dihydrofolate reductase,Humans,modulator,yes
DB03697,4-Sulfonamide-[1-(4-Aminobutane)]Benzamide,small molecule,experimental,NCCCCNC(=O)C1=CC=C(C=C1)S(N)(=O)=O,ZDYFRIZTYRFPJC-UHFFFAOYSA-N,271.336,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB03701,Vanoxerine,small molecule,investigational,FC1=CC=C(C=C1)C(OCCN1CCN(CCCC2=CC=CC=C2)CC1)C1=CC=C(F)C=C1,NAUWTFJOPJWYOT-UHFFFAOYSA-N,450.574,Q01959,BE0000647,Sodium-dependent dopamine transporter,Humans,antagonist,yes
DB03705,6-Methylamino-5-Nitroisocytosine,small molecule,experimental,CNC1=C(C(=O)NC(N)=N1)[N+]([O-])=O,NMCMUSAXKISTKW-UHFFFAOYSA-N,185.1408,P0AC13,BE0000803,Dihydropteroate synthase,Escherichia coli (strain K12),inhibitor,yes
DB03707,S-Ethyl-N-Phenyl-Isothiourea,small molecule,experimental,CCS\C(N)=N\C1=CC=CC=C1,LAXNJIWNBHHMDO-UHFFFAOYSA-N,180.27,P29475,BE0000067,Nitric oxide synthase 1,Humans,inhibitor,yes
DB03707,S-Ethyl-N-Phenyl-Isothiourea,small molecule,experimental,CCS\C(N)=N\C1=CC=CC=C1,LAXNJIWNBHHMDO-UHFFFAOYSA-N,180.27,P29474,BE0000263,Nitric oxide synthase 3,Humans,inhibitor,yes
DB03709,Bicine,small molecule,experimental,OCCN(CCO)CC(O)=O,FSVCELGFZIQNCK-UHFFFAOYSA-N,163.1717,P00747,BE0000211,Plasminogen,Humans,inhibitor,yes
DB03712,RU85053,small molecule,experimental,CC(=O)N[C@@H](CC1=CC(C(O)=O)=C(CC(O)=O)C=C1)C(=O)N[C@H]1CCCCN(CC2=CC=C(C=C2)C2=CC=CC=C2)C1=O,CEKLBQMULVLLTD-VMPREFPWSA-N,585.6469,P12931,BE0000838,Proto-oncogene tyrosine-protein kinase Src,Humans,inhibitor,yes
DB03721,N-acetyl-alpha-neuraminic acid,small molecule,experimental,[H][C@]1(O[C@](O)(C[C@H](O)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO,SQVRNKJHWKZAKO-YRMXFSIDSA-N,309.2699,P16109,BE0001159,P-selectin,Humans,inhibitor,yes
DB03721,N-acetyl-alpha-neuraminic acid,small molecule,experimental,[H][C@]1(O[C@](O)(C[C@H](O)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO,SQVRNKJHWKZAKO-YRMXFSIDSA-N,309.2699,P16581,BE0001074,E-selectin,Humans,inhibitor,yes
DB03721,N-acetyl-alpha-neuraminic acid,small molecule,experimental,[H][C@]1(O[C@](O)(C[C@H](O)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO,SQVRNKJHWKZAKO-YRMXFSIDSA-N,309.2699,P23141,BE0002705,Liver carboxylesterase 1,Humans,inhibitor,yes
DB03722,"3,4-Dihydro-5-Methyl-Isoquinolinone",small molecule,experimental,CC1=CC=CC2=C1CCNC2=O,RLLZPXDJYADIEU-UHFFFAOYSA-N,161.2004,P09874,BE0001717,Poly [ADP-ribose] polymerase 1,Humans,inhibitor,yes
DB03729,2-Amino-1H-benzimidazol-5-ol,small molecule,experimental,NC1=NC2=C(N1)C=C(O)C=C2,FNSYWIPPPFVBAV-UHFFFAOYSA-N,149.15,P00749,BE0000895,Urokinase-type plasminogen activator,Humans,inhibitor,yes
DB03740,N-acetyl-alpha-D-glucosamine,small molecule,experimental,CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O,OVRNDRQMDRJTHS-PVFLNQBWSA-N,221.2078,P12821,BE0000221,Angiotensin-converting enzyme,Humans,inhibitor,yes
DB03740,N-acetyl-alpha-D-glucosamine,small molecule,experimental,CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O,OVRNDRQMDRJTHS-PVFLNQBWSA-N,221.2078,P22303,BE0000426,Acetylcholinesterase,Humans,inhibitor,yes
DB03740,N-acetyl-alpha-D-glucosamine,small molecule,experimental,CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O,OVRNDRQMDRJTHS-PVFLNQBWSA-N,221.2078,P04062,BE0000978,Lysosomal acid glucosylceramidase,Humans,inhibitor,yes
DB03752,P-(2'-Iodo-5'-Thenoyl)Hydrotropic Acid,small molecule,experimental,[H][C@@](C)(C(O)=O)C1=CC=C(C=C1)C(=O)C1=CC=C(I)S1,UIZPHGUBGPJBAR-QMMMGPOBSA-N,386.205,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB03754,Tromethamine,small molecule,approved,NC(CO)(CO)CO,LENZDBCJOHFCAS-UHFFFAOYSA-N,121.135,P17707,BE0000101,S-adenosylmethionine decarboxylase proenzyme,Humans,inhibitor,yes
DB03756,Doconexent,small molecule,approved;investigational,CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O,MBMBGCFOFBJSGT-KUBAVDMBSA-N,328.4883,Q07869,BE0000071,Peroxisome proliferator-activated receptor alpha,Humans,activator,yes
DB03756,Doconexent,small molecule,approved;investigational,CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O,MBMBGCFOFBJSGT-KUBAVDMBSA-N,328.4883,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB03756,Doconexent,small molecule,approved;investigational,CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O,MBMBGCFOFBJSGT-KUBAVDMBSA-N,328.4883,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB03756,Doconexent,small molecule,approved;investigational,CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O,MBMBGCFOFBJSGT-KUBAVDMBSA-N,328.4883,P37231,BE0000215,Peroxisome proliferator-activated receptor gamma,Humans,activator,yes
DB03756,Doconexent,small molecule,approved;investigational,CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O,MBMBGCFOFBJSGT-KUBAVDMBSA-N,328.4883,P19793,BE0000412,Retinoic acid receptor RXR-alpha,Humans,activator,yes
DB03756,Doconexent,small molecule,approved;investigational,CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O,MBMBGCFOFBJSGT-KUBAVDMBSA-N,328.4883,P28702,BE0000078,Retinoic acid receptor RXR-beta,Humans,activator,yes
DB03756,Doconexent,small molecule,approved;investigational,CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O,MBMBGCFOFBJSGT-KUBAVDMBSA-N,328.4883,P48443,BE0000707,Retinoic acid receptor RXR-gamma,Humans,activator,yes
DB03757,N-{[(2-Methyl-2-propanyl)oxy]carbonyl}-L-alanyl-L-alaninamide,small molecule,experimental,[H]N([H])C(=O)[C@H](C)N([H])C(=O)[C@H](C)N([H])C(=O)OC(C)(C)C,OAXZAMSRJZWMEV-BQBZGAKWSA-N,259.3021,Q9UNI1,BE0003758,Chymotrypsin-like elastase family member 1,Humans,inhibitor,yes
DB03758,Radicicol,small molecule,experimental,C[C@@H]1C[C@H]2O[C@@H]2\C=C/C=C/C(=O)CC2=C(Cl)C(O)=CC(O)=C2C(=O)O1,WYZWZEOGROVVHK-GTMNPGAYSA-N,364.777,P07900,BE0001120,Heat shock protein HSP 90-alpha,Humans,inhibitor,yes
DB03759,FG-9041,small molecule,experimental,[O-][N+](=O)C1=C(C=C2NC(=O)C(=O)NC2=C1)[N+]([O-])=O,RWVIMCIPOAXUDG-UHFFFAOYSA-N,252.142,P42261,BE0000640,Glutamate receptor 1,Humans,inhibitor,yes
DB03759,FG-9041,small molecule,experimental,[O-][N+](=O)C1=C(C=C2NC(=O)C(=O)NC2=C1)[N+]([O-])=O,RWVIMCIPOAXUDG-UHFFFAOYSA-N,252.142,P39086,BE0000346,"Glutamate receptor ionotropic, kainate 1",Humans,inhibitor,yes
DB03759,FG-9041,small molecule,experimental,[O-][N+](=O)C1=C(C=C2NC(=O)C(=O)NC2=C1)[N+]([O-])=O,RWVIMCIPOAXUDG-UHFFFAOYSA-N,252.142,Q13224,BE0000417,"Glutamate receptor ionotropic, NMDA 2B",Humans,inhibitor,yes
DB03759,FG-9041,small molecule,experimental,[O-][N+](=O)C1=C(C=C2NC(=O)C(=O)NC2=C1)[N+]([O-])=O,RWVIMCIPOAXUDG-UHFFFAOYSA-N,252.142,Q12879,BE0000760,"Glutamate receptor ionotropic, NMDA 2A",Humans,inhibitor,yes
DB03759,FG-9041,small molecule,experimental,[O-][N+](=O)C1=C(C=C2NC(=O)C(=O)NC2=C1)[N+]([O-])=O,RWVIMCIPOAXUDG-UHFFFAOYSA-N,252.142,Q05586,BE0000365,"Glutamate receptor ionotropic, NMDA 1",Humans,inhibitor,yes
DB03761,5-fluoro-2'-deoxyuridine-5'-monophosphate,small molecule,experimental,O[C@H]1C[C@@H](O[C@@H]1COP(O)(O)=O)N1C=C(F)C(=O)NC1=O,HFEKDTCAMMOLQP-RRKCRQDMSA-N,326.1723,P12461,BE0000021,Thymidylate synthase,Yeast,inhibitor,yes
DB03777,Bisindolylmaleimide I,small molecule,experimental,CN(C)CCCN1C=C(C2=C1C=CC=C2)C1=C(C(=O)NC1=O)C1=CNC2=C1C=CC=C2,QMGUOJYZJKLOLH-UHFFFAOYSA-N,412.4837,P45983,BE0003790,Mitogen-activated protein kinase 8,Humans,inhibitor,yes
DB03777,Bisindolylmaleimide I,small molecule,experimental,CN(C)CCCN1C=C(C2=C1C=CC=C2)C1=C(C(=O)NC1=O)C1=CNC2=C1C=CC=C2,QMGUOJYZJKLOLH-UHFFFAOYSA-N,412.4837,P06493,BE0001082,Cyclin-dependent kinase 1,Humans,inhibitor,yes
DB03777,Bisindolylmaleimide I,small molecule,experimental,CN(C)CCCN1C=C(C2=C1C=CC=C2)C1=C(C(=O)NC1=O)C1=CNC2=C1C=CC=C2,QMGUOJYZJKLOLH-UHFFFAOYSA-N,412.4837,P05129,BE0009588,Protein kinase C gamma type,Humans,inhibitor,yes
DB03777,Bisindolylmaleimide I,small molecule,experimental,CN(C)CCCN1C=C(C2=C1C=CC=C2)C1=C(C(=O)NC1=O)C1=CNC2=C1C=CC=C2,QMGUOJYZJKLOLH-UHFFFAOYSA-N,412.4837,P49841,BE0001065,Glycogen synthase kinase-3 beta,Humans,inhibitor,yes
DB03777,Bisindolylmaleimide I,small molecule,experimental,CN(C)CCCN1C=C(C2=C1C=CC=C2)C1=C(C(=O)NC1=O)C1=CNC2=C1C=CC=C2,QMGUOJYZJKLOLH-UHFFFAOYSA-N,412.4837,Q16539,BE0001019,Mitogen-activated protein kinase 14,Humans,inhibitor,yes
DB03777,Bisindolylmaleimide I,small molecule,experimental,CN(C)CCCN1C=C(C2=C1C=CC=C2)C1=C(C(=O)NC1=O)C1=CNC2=C1C=CC=C2,QMGUOJYZJKLOLH-UHFFFAOYSA-N,412.4837,Q15759,BE0003390,Mitogen-activated protein kinase 11,Humans,inhibitor,yes
DB03777,Bisindolylmaleimide I,small molecule,experimental,CN(C)CCCN1C=C(C2=C1C=CC=C2)C1=C(C(=O)NC1=O)C1=CNC2=C1C=CC=C2,QMGUOJYZJKLOLH-UHFFFAOYSA-N,412.4837,P06239,BE0000842,Tyrosine-protein kinase Lck,Humans,inhibitor,yes
DB03777,Bisindolylmaleimide I,small molecule,experimental,CN(C)CCCN1C=C(C2=C1C=CC=C2)C1=C(C(=O)NC1=O)C1=CNC2=C1C=CC=C2,QMGUOJYZJKLOLH-UHFFFAOYSA-N,412.4837,P31749,BE0000428,RAC-alpha serine/threonine-protein kinase,Humans,inhibitor,yes
DB03777,Bisindolylmaleimide I,small molecule,experimental,CN(C)CCCN1C=C(C2=C1C=CC=C2)C1=C(C(=O)NC1=O)C1=CNC2=C1C=CC=C2,QMGUOJYZJKLOLH-UHFFFAOYSA-N,412.4837,P14635,BE0010356,G2/mitotic-specific cyclin-B1,Humans,inhibitor,yes
DB03777,Bisindolylmaleimide I,small molecule,experimental,CN(C)CCCN1C=C(C2=C1C=CC=C2)C1=C(C(=O)NC1=O)C1=CNC2=C1C=CC=C2,QMGUOJYZJKLOLH-UHFFFAOYSA-N,412.4837,P28482,BE0000923,Mitogen-activated protein kinase 1,Humans,inhibitor,yes
DB03777,Bisindolylmaleimide I,small molecule,experimental,CN(C)CCCN1C=C(C2=C1C=CC=C2)C1=C(C(=O)NC1=O)C1=CNC2=C1C=CC=C2,QMGUOJYZJKLOLH-UHFFFAOYSA-N,412.4837,O00141,BE0004105,Serine/threonine-protein kinase Sgk1,Humans,inhibitor,yes
DB03777,Bisindolylmaleimide I,small molecule,experimental,CN(C)CCCN1C=C(C2=C1C=CC=C2)C1=C(C(=O)NC1=O)C1=CNC2=C1C=CC=C2,QMGUOJYZJKLOLH-UHFFFAOYSA-N,412.4837,P53778,BE0002790,Mitogen-activated protein kinase 12,Humans,inhibitor,yes
DB03777,Bisindolylmaleimide I,small molecule,experimental,CN(C)CCCN1C=C(C2=C1C=CC=C2)C1=C(C(=O)NC1=O)C1=CNC2=C1C=CC=C2,QMGUOJYZJKLOLH-UHFFFAOYSA-N,412.4837,P15917,BE0001363,Lethal factor,Bacillus anthracis,inhibitor,yes
DB03777,Bisindolylmaleimide I,small molecule,experimental,CN(C)CCCN1C=C(C2=C1C=CC=C2)C1=C(C(=O)NC1=O)C1=CNC2=C1C=CC=C2,QMGUOJYZJKLOLH-UHFFFAOYSA-N,412.4837,Q05513,BE0009589,Protein kinase C zeta type,Humans,inhibitor,yes
DB03777,Bisindolylmaleimide I,small molecule,experimental,CN(C)CCCN1C=C(C2=C1C=CC=C2)C1=C(C(=O)NC1=O)C1=CNC2=C1C=CC=C2,QMGUOJYZJKLOLH-UHFFFAOYSA-N,412.4837,Q13464,BE0001016,Rho-associated protein kinase 1,Humans,inhibitor,yes
DB03777,Bisindolylmaleimide I,small molecule,experimental,CN(C)CCCN1C=C(C2=C1C=CC=C2)C1=C(C(=O)NC1=O)C1=CNC2=C1C=CC=C2,QMGUOJYZJKLOLH-UHFFFAOYSA-N,412.4837,O14757,BE0003382,Serine/threonine-protein kinase Chk1,Humans,inhibitor,yes
DB03782,N-(1-adamantyl)-N'-(4-guanidinobenzyl)urea,small molecule,experimental,NC(N)=NC1=CC=C(CNC(=O)NC23CC4CC(CC(C4)C2)C3)C=C1,YQPLKJCBEOVDBS-UHFFFAOYSA-N,341.459,P00749,BE0000895,Urokinase-type plasminogen activator,Humans,inhibitor,yes
DB03783,Phenacetin,small molecule,withdrawn,CCOC1=CC=C(NC(C)=O)C=C1,CPJSUEIXXCENMM-UHFFFAOYSA-N,179.2157,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB03783,Phenacetin,small molecule,withdrawn,CCOC1=CC=C(NC(C)=O)C=C1,CPJSUEIXXCENMM-UHFFFAOYSA-N,179.2157,P20839,BE0000761,Inosine-5'-monophosphate dehydrogenase 1,Humans,inhibitor,yes
DB03788,GC-24,small molecule,experimental,CC1=CC(OCC(O)=O)=CC(C)=C1CC1=CC=C(O)C(CC2=CC=CC=C2)=C1,JYHIGYLGYNCMGI-UHFFFAOYSA-N,376.445,P10828,BE0000315,Thyroid hormone receptor beta,Humans,inhibitor,yes
DB03791,GW-3965,small molecule,experimental,OC(=O)CC1=CC=CC(OCCCN(CC(C2=CC=CC=C2)C2=CC=CC=C2)CC2=CC=CC(=C2Cl)C(F)(F)F)=C1,NAXSRXHZFIBFMI-UHFFFAOYSA-N,582.052,P55055,BE0001598,Oxysterols receptor LXR-beta,Humans,inhibitor,yes
DB03791,GW-3965,small molecule,experimental,OC(=O)CC1=CC=CC(OCCCN(CC(C2=CC=CC=C2)C2=CC=CC=C2)CC2=CC=CC(=C2Cl)C(F)(F)F)=C1,NAXSRXHZFIBFMI-UHFFFAOYSA-N,582.052,Q13133,BE0003781,Oxysterols receptor LXR-alpha,Humans,inhibitor,yes
DB03793,Benzoic acid,small molecule,approved;investigational,OC(=O)C1=CC=CC=C1,WPYMKLBDIGXBTP-UHFFFAOYSA-N,122.123,P51151,BE0001710,Ras-related protein Rab-9A,Humans,inhibitor,yes
DB03796,Palmitic Acid,small molecule,approved,CCCCCCCCCCCCCCCC(O)=O,IPCSVZSSVZVIGE-UHFFFAOYSA-N,256.4241,P15090,BE0001194,"Fatty acid-binding protein, adipocyte",Humans,inhibitor,yes
DB03796,Palmitic Acid,small molecule,approved,CCCCCCCCCCCCCCCC(O)=O,IPCSVZSSVZVIGE-UHFFFAOYSA-N,256.4241,Q01469,BE0001984,Fatty acid-binding protein 5,Humans,inhibitor,yes
DB03798,2'-Deoxycytidine-5'-Monophosphate,small molecule,experimental,NC1=NC(=O)N(C=C1)[C@H]1C[C@H](O)[C@@H](COP(O)(O)=O)O1,NCMVOABPESMRCP-SHYZEUOFSA-N,307.1971,P12461,BE0000021,Thymidylate synthase,Yeast,inhibitor,yes
DB03800,Deoxyuridine monophosphate,small molecule,experimental,O[C@H]1C[C@@H](O[C@@H]1COP(O)(O)=O)N1C=CC(=O)NC1=O,JSRLJPSBLDHEIO-SHYZEUOFSA-N,308.1819,P12461,BE0000021,Thymidylate synthase,Yeast,inhibitor,yes
DB03801,Lysine Nz-Carboxylic Acid,small molecule,experimental,N[C@@H](CCCCNC(O)=O)C(O)=O,PWIKLEYMFKCERQ-YFKPBYRVSA-N,190.1971,P24941,BE0001072,Cyclin-dependent kinase 2,Humans,inhibitor,yes
DB03804,5-Bromothienyldeoxyuridine,small molecule,experimental,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])CO)N1C=C(C2=CC=C(Br)S2)C(=O)NC1=O,IGUZFFOBAZCVRK-VAOFZXAKSA-N,389.222,P04183,BE0001260,"Thymidine kinase, cytosolic",Humans,inhibitor,yes
DB03809,9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine,small molecule,experimental,CCCCN1C(CC2=CC=CC(OC)=C2)=NC2=C(N)N=CN=C12,BWLWUGBHOXIUBP-UHFFFAOYSA-N,311.3815,P07900,BE0001120,Heat shock protein HSP 90-alpha,Humans,inhibitor,yes
DB03814,2-(N-morpholino)ethanesulfonic acid,small molecule,experimental,OS(=O)(=O)CCN1CCOCC1,SXGZJKUKBWWHRA-UHFFFAOYSA-N,195.237,P28845,BE0000329,11-beta-hydroxysteroid dehydrogenase 1,Humans,inhibitor,yes
DB03814,2-(N-morpholino)ethanesulfonic acid,small molecule,experimental,OS(=O)(=O)CCN1CCOCC1,SXGZJKUKBWWHRA-UHFFFAOYSA-N,195.237,Q9HBH1,BE0002201,"Peptide deformylase, mitochondrial",Humans,inhibitor,yes
DB03814,2-(N-morpholino)ethanesulfonic acid,small molecule,experimental,OS(=O)(=O)CCN1CCOCC1,SXGZJKUKBWWHRA-UHFFFAOYSA-N,195.237,P00807,BE0000302,Beta-lactamase,Staphylococcus aureus,inhibitor,yes
DB03814,2-(N-morpholino)ethanesulfonic acid,small molecule,experimental,OS(=O)(=O)CCN1CCOCC1,SXGZJKUKBWWHRA-UHFFFAOYSA-N,195.237,P22303,BE0000426,Acetylcholinesterase,Humans,inhibitor,yes
DB03814,2-(N-morpholino)ethanesulfonic acid,small molecule,experimental,OS(=O)(=O)CCN1CCOCC1,SXGZJKUKBWWHRA-UHFFFAOYSA-N,195.237,P17169,BE0001423,Glutamine--fructose-6-phosphate aminotransferase [isomerizing],Escherichia coli (strain K12),inhibitor,yes
DB03814,2-(N-morpholino)ethanesulfonic acid,small molecule,experimental,OS(=O)(=O)CCN1CCOCC1,SXGZJKUKBWWHRA-UHFFFAOYSA-N,195.237,P23946,BE0001038,Chymase,Humans,inhibitor,yes
DB03814,2-(N-morpholino)ethanesulfonic acid,small molecule,experimental,OS(=O)(=O)CCN1CCOCC1,SXGZJKUKBWWHRA-UHFFFAOYSA-N,195.237,P06276,BE0002180,Cholinesterase,Humans,inhibitor,yes
DB03818,N-[Tosyl-D-Prolinyl]Amino-Ethanethiol,small molecule,experimental,[H][C@@]1(CCCN1S(=O)(=O)C1=CC=C(C)C=C1)C(=O)NCCS,NWUYDTGYTUQMDG-CYBMUJFWSA-N,328.45,P12461,BE0000021,Thymidylate synthase,Yeast,inhibitor,yes
DB03819,Salicylhydroxamic Acid,small molecule,experimental,ONC(=O)C1=CC=CC=C1O,HBROZNQEVUILML-UHFFFAOYSA-N,153.1354,Q08210,BE0000612,"Dihydroorotate dehydrogenase (quinone), mitochondrial",Plasmodium falciparum (isolate 3D7),inhibitor,yes
DB03822,Ethyl dihydrogen phosphate,small molecule,experimental,CCOP(O)(O)=O,ZJXZSIYSNXKHEA-UHFFFAOYSA-N,126.0483,P06276,BE0002180,Cholinesterase,Humans,inhibitor,yes
DB03828,RU78299,small molecule,experimental,CC1=CC(C=O)=C(OP(O)(O)=O)C(C=O)=C1,NAYNUXXSJZLKPW-UHFFFAOYSA-N,244.1379,P12931,BE0000838,Proto-oncogene tyrosine-protein kinase Src,Humans,inhibitor,yes
DB03841,Niraxostat,small molecule,experimental,CC(C)(C)COC1=C(C=C(C=C1)N1C=C(C=N1)C(O)=O)C#N,AETHRPHBGJAIBT-UHFFFAOYSA-N,299.3245,P47989,BE0002204,Xanthine dehydrogenase/oxidase,Humans,inhibitor,yes
DB03844,"N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide",small molecule,experimental,NS(=O)(=O)C1=CC=C(C=C1)C(=O)NCC1=C(F)C=CC=C1F,ZFNCKGXGCCDDFN-UHFFFAOYSA-N,326.318,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB03847,gamma-carboxy-L-glutamic acid,small molecule,experimental,N[C@@H](CC(C(O)=O)C(O)=O)C(O)=O,UHBYWPGGCSDKFX-VKHMYHEASA-N,191.1388,P00734,BE0000048,Prothrombin,Humans,inhibitor,yes
DB03847,gamma-carboxy-L-glutamic acid,small molecule,experimental,N[C@@H](CC(C(O)=O)C(O)=O)C(O)=O,UHBYWPGGCSDKFX-VKHMYHEASA-N,191.1388,P00740,BE0000364,Coagulation factor IX,Humans,inhibitor,yes
DB03847,gamma-carboxy-L-glutamic acid,small molecule,experimental,N[C@@H](CC(C(O)=O)C(O)=O)C(O)=O,UHBYWPGGCSDKFX-VKHMYHEASA-N,191.1388,P00742,BE0000216,Coagulation factor X,Humans,inhibitor,yes
DB03849,Cilomilast,small molecule,investigational,COC1=C(OC2CCCC2)C=C(C=C1)[C@]1(CC[C@@H](CC1)C(O)=O)C#N,CFBUZOUXXHZCFB-OYOVHJISSA-N,343.4168,Q08499,BE0001287,"3',5'-cyclic-AMP phosphodiesterase 4D",Humans,inhibitor,yes
DB03849,Cilomilast,small molecule,investigational,COC1=C(OC2CCCC2)C=C(C=C1)[C@]1(CC[C@@H](CC1)C(O)=O)C#N,CFBUZOUXXHZCFB-OYOVHJISSA-N,343.4168,P27815,BE0001133,"3',5'-cyclic-AMP phosphodiesterase 4A",Humans,inhibitor,yes
DB03849,Cilomilast,small molecule,investigational,COC1=C(OC2CCCC2)C=C(C=C1)[C@]1(CC[C@@H](CC1)C(O)=O)C#N,CFBUZOUXXHZCFB-OYOVHJISSA-N,343.4168,Q07343,BE0000487,"3',5'-cyclic-AMP phosphodiesterase 4B",Humans,inhibitor,yes
DB03851,Carbazole Butanoic Acid,small molecule,experimental,OC(=O)CCCN1C2=CC=CC=C2C2=C1C=CC=C2,HQAKVYGASUTQHH-UHFFFAOYSA-N,253.2958,P15090,BE0001194,"Fatty acid-binding protein, adipocyte",Humans,inhibitor,yes
DB03851,Carbazole Butanoic Acid,small molecule,experimental,OC(=O)CCCN1C2=CC=CC=C2C2=C1C=CC=C2,HQAKVYGASUTQHH-UHFFFAOYSA-N,253.2958,Q01469,BE0001984,Fatty acid-binding protein 5,Humans,inhibitor,yes
DB03852,Eucalyptol,small molecule,experimental;nutraceutical,C[C@@]12CC[C@@H](CC1)C(C)(C)O2,WEEGYLXZBRQIMU-WAAGHKOSSA-N,154.2493,Q7Z2W7,BE0001186,Transient receptor potential cation channel subfamily M member 8,Humans,activator,yes
DB03860,ICI-164384,small molecule,experimental,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3C[C@@H](CCCCCCCCCCC(=O)N(C)CCCC)[C@@]21[H],BVVFOLSZMQVDKV-KXQIQQEYSA-N,525.8054,P03372,BE0000123,Estrogen receptor,Humans,inhibitor,yes
DB03860,ICI-164384,small molecule,experimental,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3C[C@@H](CCCCCCCCCCC(=O)N(C)CCCC)[C@@]21[H],BVVFOLSZMQVDKV-KXQIQQEYSA-N,525.8054,Q92731,BE0000792,Estrogen receptor beta,Humans,inhibitor,yes
DB03866,Prostaglandin G2,small molecule,experimental,[H][C@@](CCCCC)(OO)\C=C\[C@@]1([H])[C@@]2([H])C[C@]([H])(OO2)[C@]1([H])C\C=C/CCCC(O)=O,SGUKUZOVHSFKPH-YNNPMVKQSA-N,368.4645,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB03867,3-nitro-L-tyrosine,small molecule,experimental,N[C@@H](CC1=CC(=C(O)C=C1)[N+]([O-])=O)C(O)=O,FBTSQILOGYXGMD-LURJTMIESA-N,226.1861,P00390,BE0000648,"Glutathione reductase, mitochondrial",Humans,inhibitor,yes
DB03876,"Thieno[2,3-B]Pyridine-2-Carboxamidine",small molecule,experimental,NC(=[NH2+])C1=CC2=C(S1)N=CC=C2,GZEJMYFXZMUAEC-UHFFFAOYSA-O,178.234,P00749,BE0000895,Urokinase-type plasminogen activator,Humans,inhibitor,yes
DB03877,AL-4623,small molecule,experimental,CCN[C@H]1CN(CCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,XACIEZJJSXJZMD-VIFPVBQESA-N,369.481,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB03880,Batimastat,small molecule,experimental,[H][C@@](CC1=CC=CC=C1)(NC(=O)[C@]([H])(CC(C)C)[C@]([H])(CSC1=CC=CS1)C(=O)NO)C(=O)NC,XFILPEOLDIKJHX-QYZOEREBSA-N,477.64,P08254,BE0001116,Stromelysin-1,Humans,modulator,yes
DB03886,Biopterin,small molecule,experimental,C[C@@H](O)[C@@H](O)C1=CN=C2N=C(N)NC(=O)C2=N1,LHQIJBMDNUYRAM-AWFVSMACSA-N,237.2153,Q9HBH1,BE0002201,"Peptide deformylase, mitochondrial",Humans,inhibitor,yes
DB03892,5-N-Allyl-arginine,small molecule,experimental,N[C@@H](CCC\[NH+]=C(/N)NCC=C)C(O)=O,ZPQWZDPOLXVMOU-ZETCQYMHSA-O,215.2728,P29475,BE0000067,Nitric oxide synthase 1,Humans,inhibitor,yes
DB03894,N-Propargyl-1(S)-Aminoindan,small molecule,experimental,[H][C@@]1(CCC2=C1C=CC=C2)NCC#C,RUOKEQAAGRXIBM-LBPRGKRZSA-N,171.2383,P27338,BE0002196,Amine oxidase [flavin-containing] B,Humans,inhibitor,yes
DB03899,9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine,small molecule,experimental,CCCCN1C(CC2=CC=C(OC)C=C2)=NC2=C(N)N=CN=C12,NVYATAJRTRFKSW-UHFFFAOYSA-N,311.3815,P07900,BE0001120,Heat shock protein HSP 90-alpha,Humans,inhibitor,yes
DB03906,2-Phenylheme,small molecule,experimental,CC1=C(C=C)C2=CC3=[N+]4C(=CC5=C(C)C(CCC(O)=O)=C6N5[Fe]44N2C1=CC1=[N+]4C(C(CCC(O)=O)=C1C)=C6C1=CC=CC=C1)C(C=C)=C3C,RHCCVTLDOSIQDM-NULOGZTHSA-L,692.583,P09601,BE0000735,Heme oxygenase 1,Humans,inhibitor,yes
DB03909,"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",small molecule,experimental,[H][C@]1(COP(O)(=O)OP(O)(=O)CP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O,UFZTZBNSLXELAL-IOSLPCCCSA-N,505.2082,P06213,BE0000033,Insulin receptor,Humans,inhibitor,yes
DB03910,"S,S'-(1,3-Phenylene-Bis(1,2-Ethanediyl))Bis-Isothiourea",small molecule,experimental,NC(=N)SCCC1=CC(CCSC(N)=N)=CC=C1,YEUSLPIIQGZHQB-UHFFFAOYSA-N,282.428,P35228,BE0000005,"Nitric oxide synthase, inducible",Humans,inhibitor,yes
DB03918,"6S-5,6,7,8-Tetrahydrobiopterin",small molecule,experimental,[H][C@@]1(CNC2=C(N1)C(=O)N=C(N)N2)[C@H](O)[C@@H](C)O,FNKQXYHWGSIFBK-ZMIZWQJLSA-N,241.2471,P29474,BE0000263,Nitric oxide synthase 3,Humans,inhibitor,yes
DB03921,4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline,small molecule,experimental,N1C=C(C(=N1)C1=NC=CC=C1)C1=C2C=CC=CC2=NC=C1,IBCXZJCWDGCXQT-UHFFFAOYSA-N,272.304,P36897,BE0003782,TGF-beta receptor type-1,Humans,inhibitor,yes
DB03932,LFA703,small molecule,experimental,[H][C@](C)(CC)C(=O)O[C@@]1([H])C[C@@]([H])(C)C=C2C=C[C@]([H])(C)[C@]([H])(CC[C@@]3([H])C[C@@]([H])(O)CC(=O)N3CC3=CC4=C(C=C3)C(CO)=C(OC)C=C4)[C@@]12[H],WPVRNXUYVXQXPY-YFAYRSKXSA-N,603.7881,P20701,BE0000516,Integrin alpha-L,Humans,inhibitor,yes
DB03942,Carboxylic PRPP,small molecule,experimental,[H][C@]1(O)[C@@]([H])(O)[C@]([H])(C[C@]1([H])COP(O)(O)=O)OP(O)(=O)OP(O)(O)=O,OICBXEWBKALHHB-MOJAZDJTSA-N,388.0968,P20035,BE0001516,Hypoxanthine-guanine-xanthine phosphoribosyltransferase,Plasmodium falciparum (isolate FCR-3 / Gambia),inhibitor,yes
DB03945,"N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium",small molecule,experimental,C[N+](C)(C)CCOP(O)(O)=O,YHHSONZFOIEMCP-UHFFFAOYSA-O,184.1507,P02741,BE0000877,C-reactive protein,Humans,inhibitor,yes
DB03948,"6-Chloropurine Riboside, 5'-Monophosphate",small molecule,experimental,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(Cl)[NH+]=CN=C23)[C@]([H])(O)[C@]1([H])O,ALOBOMYIOYNCBS-KQYNXXCUSA-O,367.66,Q06203,BE0000374,Amidophosphoribosyltransferase,Humans,inhibitor,yes
DB03948,"6-Chloropurine Riboside, 5'-Monophosphate",small molecule,experimental,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(Cl)[NH+]=CN=C23)[C@]([H])(O)[C@]1([H])O,ALOBOMYIOYNCBS-KQYNXXCUSA-O,367.66,P12268,BE0000722,Inosine-5'-monophosphate dehydrogenase 2,Humans,inhibitor,yes
DB03953,Thiocitrulline,small molecule,experimental,[H]N([H])[C@@H](CCCN([H])C(=S)N([H])[H])C(O)=O,BKGWACHYAMTLAF-BYPYZUCNSA-N,191.251,P35228,BE0000005,"Nitric oxide synthase, inducible",Humans,inhibitor,yes
DB03957,SP2456,small molecule,experimental,[H]N([H])C(=N[C@H](C1CCCCC1)C(=O)N([H])CC(=O)N1CCC(CC1)C1=CC(=NN1[H])C1=C(Cl)C(Cl)=CC=C1)N([H])[H],SSSXBBASYYVGCI-HSZRJFAPSA-N,534.481,P60568,BE0001029,Interleukin-2,Humans,inhibitor,yes
DB03959,"N,O6-Disulfo-Glucosamine",small molecule,experimental,[H][C@]1(O)O[C@]([H])(COS(O)(=O)=O)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])NS(O)(=O)=O,DQTRACMFIGDHSN-UKFBFLRUSA-N,339.298,P14210,BE0001121,Hepatocyte growth factor,Humans,inhibitor,yes
DB03959,"N,O6-Disulfo-Glucosamine",small molecule,experimental,[H][C@]1(O)O[C@]([H])(COS(O)(=O)=O)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])NS(O)(=O)=O,DQTRACMFIGDHSN-UKFBFLRUSA-N,339.298,P05230,BE0000689,Fibroblast growth factor 1,Humans,inhibitor,yes
DB03959,"N,O6-Disulfo-Glucosamine",small molecule,experimental,[H][C@]1(O)O[C@]([H])(COS(O)(=O)=O)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])NS(O)(=O)=O,DQTRACMFIGDHSN-UKFBFLRUSA-N,339.298,P09038,BE0001015,Fibroblast growth factor 2,Humans,inhibitor,yes
DB03966,Clorobiocin,small molecule,experimental,CO[C@@H]1[C@@H](OC(=O)C2=CC=C(C)N2)[C@@H](O)[C@H](OC2=C(Cl)C3=C(C=C2)C(O)=C(NC(=O)C2=CC(CC=C(C)C)=C(O)C=C2)C(=O)O3)OC1(C)C,FJAQNRBDVKIIKK-LFLQOBSNSA-N,697.128,Q02880,BE0002425,DNA topoisomerase 2-beta,Humans,inhibitor,yes
DB03966,Clorobiocin,small molecule,experimental,CO[C@@H]1[C@@H](OC(=O)C2=CC=C(C)N2)[C@@H](O)[C@H](OC2=C(Cl)C3=C(C=C2)C(O)=C(NC(=O)C2=CC(CC=C(C)C)=C(O)C=C2)C(=O)O3)OC1(C)C,FJAQNRBDVKIIKK-LFLQOBSNSA-N,697.128,P11388,BE0000742,DNA topoisomerase 2-alpha,Humans,inhibitor,yes
DB03968,"1-Methyl-2-Oxy-5,5-Dimethyl Pyrrolidine",small molecule,experimental,CN1C(=O)CCC1(C)C,YARDEGUIPATLSG-UHFFFAOYSA-N,127.1842,P00797,BE0000270,Renin,Humans,inhibitor,yes
DB03974,L-homoarginine,small molecule,experimental,N[C@@H](CCCCNC(N)=N)C(O)=O,QUOGESRFPZDMMT-YFKPBYRVSA-N,188.2275,P29474,BE0000263,Nitric oxide synthase 3,Humans,inhibitor,yes
DB03975,Mercuribenzoic Acid,small molecule,experimental,OC(=O)C1=CC=C([Hg])C=C1,FVFZSVRSDNUCGG-UHFFFAOYSA-N,321.7,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB03977,Trimethyllysine,small molecule,experimental,C[N+](C)(C)CCCC[C@H](N)C(O)=O,MXNRLFUSFKVQSK-QMMMGPOBSA-O,189.2752,P0DP24,BE0008705,Calmodulin-2,Humans,inhibitor,yes
DB03977,Trimethyllysine,small molecule,experimental,C[N+](C)(C)CCCC[C@H](N)C(O)=O,MXNRLFUSFKVQSK-QMMMGPOBSA-O,189.2752,P0DP23,BE0012563,Calmodulin-1,Humans,inhibitor,yes
DB03977,Trimethyllysine,small molecule,experimental,C[N+](C)(C)CCCC[C@H](N)C(O)=O,MXNRLFUSFKVQSK-QMMMGPOBSA-O,189.2752,P0DP25,BE0008706,Calmodulin-3,Humans,inhibitor,yes
DB03980,4-(Fluorophenyl)-1-Cyclopropylmethyl-5-(2-Amino-4-Pyrimidinyl)Imidazole,small molecule,experimental,NC1=NC(=CC=N1)C1=C(N=CN1CC1CC1)C1=CC=C(F)C=C1,DFEYXQGDDCDXJK-UHFFFAOYSA-N,309.3408,Q16539,BE0001019,Mitogen-activated protein kinase 14,Humans,inhibitor,yes
DB04001,6-(Oxalyl-Amino)-1h-Indole-5-Carboxylic Acid,small molecule,experimental,OC(=O)C(=O)NC1=CC2=C(C=CN2)C=C1C(O)=O,AHWMERGBWWROMM-UHFFFAOYSA-N,248.1916,P18031,BE0000623,Tyrosine-protein phosphatase non-receptor type 1,Humans,inhibitor,yes
DB04005,Uridine 5'-triphosphate,small molecule,experimental;investigational,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(=O)OP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O,PGAVKCOVUIYSFO-XVFCMESISA-N,484.1411,P41231,BE0002401,P2Y purinoceptor 2,Humans,modulator,yes
DB04005,Uridine 5'-triphosphate,small molecule,experimental;investigational,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(=O)OP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O,PGAVKCOVUIYSFO-XVFCMESISA-N,484.1411,Q15077,BE0014552,P2Y purinoceptor 6,Humans,agonist,yes
DB04005,Uridine 5'-triphosphate,small molecule,experimental;investigational,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(=O)OP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O,PGAVKCOVUIYSFO-XVFCMESISA-N,484.1411,P51582,BE0009822,P2Y purinoceptor 4,Humans,agonist,yes
DB04005,Uridine 5'-triphosphate,small molecule,experimental;investigational,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(=O)OP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O,PGAVKCOVUIYSFO-XVFCMESISA-N,484.1411,Q96G91,BE0005499,P2Y purinoceptor 11,Humans,agonist,yes
DB04007,Bromo-WR99210,small molecule,experimental,CC1(C)N=C(N)N=C(N)N1OCCCOC1=CC=C(Br)C=C1,MPXYCOHVHSXSDC-UHFFFAOYSA-N,370.245,Q9HBH1,BE0002201,"Peptide deformylase, mitochondrial",Humans,inhibitor,yes
DB04010,2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide,small molecule,experimental,COC1=CC=CC(=C1)C1=NC2=C(N1)C=CC=C2C(N)=O,NVVWVYYHTKCIAE-UHFFFAOYSA-N,267.2826,P09874,BE0001717,Poly [ADP-ribose] polymerase 1,Humans,inhibitor,yes
DB04014,Alsterpaullone,small molecule,experimental,[O-][N+](=O)C1=CC2=C(NC3=C2CC(=O)NC2=C3C=CC=C2)C=C1,OLUKILHGKRVDCT-UHFFFAOYSA-N,293.2768,P24941,BE0001072,Cyclin-dependent kinase 2,Humans,inhibitor,yes
DB04014,Alsterpaullone,small molecule,experimental,[O-][N+](=O)C1=CC2=C(NC3=C2CC(=O)NC2=C3C=CC=C2)C=C1,OLUKILHGKRVDCT-UHFFFAOYSA-N,293.2768,Q00535,BE0000890,Cyclin-dependent kinase 5,Humans,inhibitor,yes
DB04014,Alsterpaullone,small molecule,experimental,[O-][N+](=O)C1=CC2=C(NC3=C2CC(=O)NC2=C3C=CC=C2)C=C1,OLUKILHGKRVDCT-UHFFFAOYSA-N,293.2768,P06493,BE0001082,Cyclin-dependent kinase 1,Humans,inhibitor,yes
DB04017,Clorgiline,small molecule,experimental,CN(CCCOC1=CC=C(Cl)C=C1Cl)CC#C,BTFHLQRNAMSNLC-UHFFFAOYSA-N,272.17,P21397,BE0002198,Amine oxidase [flavin-containing] A,Humans,inhibitor,yes
DB04021,MF268,small molecule,experimental,[H][C@]1(C)CN(CCCCCCCCNC=O)C[C@@]([H])(C)O1,UXVBAZRPAJEAHR-GASCZTMLSA-N,270.4109,P22303,BE0000426,Acetylcholinesterase,Humans,inhibitor,yes
DB04022,Guanosine tetraphosphate,small molecule,experimental,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](OP(O)(=O)OP(O)(O)=O)[C@H]2O)C(=O)N1,BUFLLCUFNHESEH-UUOKFMHZSA-N,603.1603,P20035,BE0001516,Hypoxanthine-guanine-xanthine phosphoribosyltransferase,Plasmodium falciparum (isolate FCR-3 / Gambia),inhibitor,yes
DB04029,Phenylalanylamide,small molecule,experimental,N[C@@H](CC1=CC=CC=C1)C(N)=O,OBSIQMZKFXFYLV-QMMMGPOBSA-N,164.2044,P25103,BE0000384,Substance-P receptor,Humans,inhibitor,yes
DB04044,4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid,small molecule,experimental,OC(=O)C1=C(C=C(OC2=C(NC(=O)C3=CC(=CC=C3)[N+]([O-])=O)C=CC=C2)C=C1)C(O)=O,NAQUAVBNIYTIIS-UHFFFAOYSA-N,422.3445,P11217,BE0000916,"Glycogen phosphorylase, muscle form",Humans,inhibitor,yes
DB04047,6-hydroxymethylpterin diphosphate,small molecule,experimental,[H]N([H])C1=NC(=O)C2=NC(COP(O)(=O)OP(O)(O)=O)=CN=C2N1[H],AMDUVUKDRBIVAH-UHFFFAOYSA-N,353.1226,P0AC13,BE0000803,Dihydropteroate synthase,Escherichia coli (strain K12),inhibitor,yes
DB04066,p-Coumaric acid,small molecule,experimental,OC(=O)\C=C\C1=CC=C(O)C=C1,NGSWKAQJJWESNS-ZZXKWVIFSA-N,164.158,O43570,BE0001653,Carbonic anhydrase 12,Humans,inhibitor,yes
DB04066,p-Coumaric acid,small molecule,experimental,OC(=O)\C=C\C1=CC=C(O)C=C1,NGSWKAQJJWESNS-ZZXKWVIFSA-N,164.158,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB04066,p-Coumaric acid,small molecule,experimental,OC(=O)\C=C\C1=CC=C(O)C=C1,NGSWKAQJJWESNS-ZZXKWVIFSA-N,164.158,Q9ULX7,BE0003634,Carbonic anhydrase 14,Humans,inhibitor,yes
DB04066,p-Coumaric acid,small molecule,experimental,OC(=O)\C=C\C1=CC=C(O)C=C1,NGSWKAQJJWESNS-ZZXKWVIFSA-N,164.158,Q16790,BE0002437,Carbonic anhydrase 9,Humans,inhibitor,yes
DB04066,p-Coumaric acid,small molecule,experimental,OC(=O)\C=C\C1=CC=C(O)C=C1,NGSWKAQJJWESNS-ZZXKWVIFSA-N,164.158,P23280,BE0003628,Carbonic anhydrase 6,Humans,inhibitor,yes
DB04066,p-Coumaric acid,small molecule,experimental,OC(=O)\C=C\C1=CC=C(O)C=C1,NGSWKAQJJWESNS-ZZXKWVIFSA-N,164.158,P00915,BE0000267,Carbonic anhydrase 1,Humans,inhibitor,yes
DB04066,p-Coumaric acid,small molecule,experimental,OC(=O)\C=C\C1=CC=C(O)C=C1,NGSWKAQJJWESNS-ZZXKWVIFSA-N,164.158,P22748,BE0000535,Carbonic anhydrase 4,Humans,inhibitor,yes
DB04076,Hypoxanthine,small molecule,experimental,O=C1N=CNC2=C1NC=N2,FDGQSTZJBFJUBT-UHFFFAOYSA-N,136.1115,P00491,BE0000250,Purine nucleoside phosphorylase,Humans,inhibitor,yes
DB04080,RU78191,small molecule,experimental,OC(=O)C(C(O)=O)C1=CC=CC=C1,WWYDYZMNFQIYPT-UHFFFAOYSA-N,180.1574,P12931,BE0000838,Proto-oncogene tyrosine-protein kinase Src,Humans,inhibitor,yes
DB04089,AL5300,small molecule,experimental,[H][C@]1(O)CN(CC2=CC=CS2)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,HHPUQNGRNUOYCD-VIFPVBQESA-N,380.483,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB04095,9-Deazahypoxanthine,small molecule,experimental,O=C1NC=NC2=C1NC=C2,UWMXUDUWVFWJPX-UHFFFAOYSA-N,135.1234,P00491,BE0000250,Purine nucleoside phosphorylase,Humans,inhibitor,yes
DB04106,Fotemustine,small molecule,investigational,CCOP(=O)(OCC)C(C)NC(=O)N(CCCl)N=O,YAKWPXVTIGTRJH-UHFFFAOYSA-N,315.69,Q16881,BE0001979,"Thioredoxin reductase 1, cytoplasmic",Humans,inhibitor,yes
DB04115,Berberine,small molecule,approved;investigational,COC1=CC=C2C=C3C4=CC5=C(OCO5)C=C4CC[N+]3=CC2=C1OC,YBHILYKTIRIUTE-UHFFFAOYSA-N,336.3612,O14746,BE0002449,Telomerase reverse transcriptase,Humans,inhibitor,yes
DB04129,Willardiine,small molecule,experimental,NOC(=O)CCN1C=CC(=O)NC1=O,KCGPSMHZJWSWPT-UHFFFAOYSA-N,199.166,P42261,BE0000640,Glutamate receptor 1,Humans,inhibitor,yes
DB04132,S-Hexylglutathione,small molecule,experimental,CCCCCCSC[C@H](NC(=O)CC[C@H](N)C(O)=O)C(=O)NCC(O)=O,HXJDWCWJDCOHDG-RYUDHWBXSA-N,391.483,O60760,BE0001167,Hematopoietic prostaglandin D synthase,Humans,inhibitor,yes
DB04133,Degraded Cephaloridine,small molecule,experimental,[H][C@@](NC(=O)CC1=CC=CS1)(C=O)[C@]1([H])NC(C(O)=O)=C(C)CS1,SFVACKBZMIZHCK-ZWNOBZJWSA-N,340.418,Q8XJ01,BE0000576,Penicillin-binding protein 1A,Clostridium perfringens (strain 13 / Type A),inhibitor,yes
DB04133,Degraded Cephaloridine,small molecule,experimental,[H][C@@](NC(=O)CC1=CC=CS1)(C=O)[C@]1([H])NC(C(O)=O)=C(C)CS1,SFVACKBZMIZHCK-ZWNOBZJWSA-N,340.418,P00807,BE0000302,Beta-lactamase,Staphylococcus aureus,inhibitor,yes
DB04137,Guanosine-5'-Triphosphate,small molecule,experimental,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1,XKMLYUALXHKNFT-UUOKFMHZSA-N,523.1804,P30793,BE0001055,GTP cyclohydrolase 1,Humans,inhibitor,yes
DB04137,Guanosine-5'-Triphosphate,small molecule,experimental,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1,XKMLYUALXHKNFT-UUOKFMHZSA-N,523.1804,P26662,BE0001245,Genome polyprotein,HCV,inhibitor,yes
DB04139,6-Hydroxypropylthymine,small molecule,experimental,CC1=C(CCCO)NC(=O)NC1=O,OIEJBPVNLZZLGQ-UHFFFAOYSA-N,184.1925,P04183,BE0001260,"Thymidine kinase, cytosolic",Humans,inhibitor,yes
DB04147,Dodecyldimethylamine N-oxide,small molecule,experimental,CCCCCCCCCCCC[N+](C)(C)[O-],SYELZBGXAIXKHU-UHFFFAOYSA-N,229.402,Q08210,BE0000612,"Dihydroorotate dehydrogenase (quinone), mitochondrial",Plasmodium falciparum (isolate 3D7),inhibitor,yes
DB04149,(R)-Rolipram,small molecule,experimental,[H][C@]1(CNC(=O)C1)C1=CC(OC2CCCC2)=C(OC)C=C1,HJORMJIFDVBMOB-LBPRGKRZSA-N,275.3428,P27815,BE0001133,"3',5'-cyclic-AMP phosphodiesterase 4A",Humans,inhibitor,yes
DB04149,(R)-Rolipram,small molecule,experimental,[H][C@]1(CNC(=O)C1)C1=CC(OC2CCCC2)=C(OC)C=C1,HJORMJIFDVBMOB-LBPRGKRZSA-N,275.3428,Q07343,BE0000487,"3',5'-cyclic-AMP phosphodiesterase 4B",Humans,inhibitor,yes
DB04152,"2-Amino-3-(3-Hydroxy-7,8-Dihydro-6h-Cyclohepta[D]-4-Isoxazolyl)Propionic Acid",small molecule,experimental,N[C@@H](CC1=CCCCC2=C1C(=O)NO2)C(O)=O,HJEPOXZLPHUVFE-ZETCQYMHSA-N,238.2399,P39086,BE0000346,"Glutamate receptor ionotropic, kainate 1",Humans,agonist,yes
DB04163,"5-Phenylsulfanyl-2,4-Quinazolinediamine",small molecule,experimental,NC1=NC2=C(C(N)=N1)C(SC1=CC=CC=C1)=CC=C2,BUFDQCGCADQQQY-UHFFFAOYSA-N,268.337,Q9HBH1,BE0002201,"Peptide deformylase, mitochondrial",Humans,inhibitor,yes
DB04177,Digitoxigenin,small molecule,experimental,[H][C@]12CC[C@]3([H])[C@]([H])(CC[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@H](O)C2,XZTUSOXSLKTKJQ-CESUGQOBSA-N,374.5137,P05023,BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,Humans,inhibitor,yes
DB04178,Di-Stearoyl-3-Sn-Phosphatidylcholine,small molecule,experimental,[H][C@@](COC(=O)CCCCCCCCCCCCCCCCC)(COP(O)(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,NRJAVPSFFCBXDT-HUESYALOSA-O,791.1531,P12235,BE0000599,ADP/ATP translocase 1,Humans,inhibitor,yes
DB04195,Heptulose-2-Phosphate,small molecule,experimental,C[C@]1(OP(O)(O)=O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,QZBAZODTRUGOQS-XUUWZHRGSA-N,274.1624,P11217,BE0000916,"Glycogen phosphorylase, muscle form",Humans,inhibitor,yes
DB04196,Pteroic acid,small molecule,experimental,NC1=NC2=NC=C(CNC3=CC=C(C=C3)C(O)=O)N=C2C(=O)N1,JOAQINSXLLMRCV-UHFFFAOYSA-N,312.2835,P0AC13,BE0000803,Dihydropteroate synthase,Escherichia coli (strain K12),inhibitor,yes
DB04198,Formycin B,small molecule,experimental,[H][C@]1(CO)O[C@@]([H])(C2=C3N=CNC(=O)C3=NN2)[C@]([H])(O)[C@]1([H])O,MTCJZZBQNCXKAP-KSYZLYKTSA-N,268.2261,P20035,BE0001516,Hypoxanthine-guanine-xanthine phosphoribosyltransferase,Plasmodium falciparum (isolate FCR-3 / Gambia),inhibitor,yes
DB04202,Isoformononetin,small molecule,experimental,COC1=CC=C2C(=O)C(=COC2=C1)C1=CC=C(O)C=C1,LNIQZRIHAMVRJA-UHFFFAOYSA-N,268.2641,P05091,BE0000133,"Aldehyde dehydrogenase, mitochondrial",Humans,inhibitor,yes
DB04203,3-Mercuri-4-Aminobenzenesulfonamide,small molecule,experimental,NC1=CC=C(C=C1[Hg])S(N)(=O)=O,KGGLGSZFQPTPPT-UHFFFAOYSA-N,371.79,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB04209,Dequalinium,small molecule,approved;investigational,CC1=CC(N)=C2C=CC=CC2=[N+]1CCCCCCCCCC[N+]1=C(C)C=C(N)C2=C1C=CC=C2,PCSWXVJAIHCTMO-UHFFFAOYSA-P,456.6654,Q92952,BE0004425,Small conductance calcium-activated potassium channel protein 1,Humans,blocker,yes
DB04209,Dequalinium,small molecule,approved;investigational,CC1=CC(N)=C2C=CC=CC2=[N+]1CCCCCCCCCC[N+]1=C(C)C=C(N)C2=C1C=CC=C2,PCSWXVJAIHCTMO-UHFFFAOYSA-P,456.6654,Q16280,BE0014924,Cyclic nucleotide-gated channel alpha-2,Humans,blocker,yes
DB04209,Dequalinium,small molecule,approved;investigational,CC1=CC(N)=C2C=CC=CC2=[N+]1CCCCCCCCCC[N+]1=C(C)C=C(N)C2=C1C=CC=C2,PCSWXVJAIHCTMO-UHFFFAOYSA-P,456.6654,Q9H2S1,BE0004426,Small conductance calcium-activated potassium channel protein 2,Humans,blocker,yes
DB04209,Dequalinium,small molecule,approved;investigational,CC1=CC(N)=C2C=CC=CC2=[N+]1CCCCCCCCCC[N+]1=C(C)C=C(N)C2=C1C=CC=C2,PCSWXVJAIHCTMO-UHFFFAOYSA-P,456.6654,P98170,BE0001156,E3 ubiquitin-protein ligase XIAP,Humans,antagonist;inhibitor,yes
DB04209,Dequalinium,small molecule,approved;investigational,CC1=CC(N)=C2C=CC=CC2=[N+]1CCCCCCCCCC[N+]1=C(C)C=C(N)C2=C1C=CC=C2,PCSWXVJAIHCTMO-UHFFFAOYSA-P,456.6654,P29973,BE0005300,Cyclic nucleotide-gated channel alpha-1,Humans,blocker,yes
DB04209,Dequalinium,small molecule,approved;investigational,CC1=CC(N)=C2C=CC=CC2=[N+]1CCCCCCCCCC[N+]1=C(C)C=C(N)C2=C1C=CC=C2,PCSWXVJAIHCTMO-UHFFFAOYSA-P,456.6654,Q9UGI6,BE0004427,Small conductance calcium-activated potassium channel protein 3,Humans,blocker,yes
DB04213,N-Cyclohexyl-N'-(Propyl)Phenyl Urea,small molecule,experimental,O=C(NCCCC1=CC=CC=C1)NC1CCCCC1,HBTZVNKXMFGOOJ-UHFFFAOYSA-N,260.3746,P34913,BE0000950,Bifunctional epoxide hydrolase 2,Humans,inhibitor,yes
DB04214,4-Nitrophenyl Phosphate,small molecule,experimental,OP(O)(=O)OC1=CC=C(C=C1)[N+]([O-])=O,XZKIHKMTEMTJQX-UHFFFAOYSA-N,219.0887,P00915,BE0000267,Carbonic anhydrase 1,Humans,inhibitor,yes
DB04214,4-Nitrophenyl Phosphate,small molecule,experimental,OP(O)(=O)OC1=CC=C(C=C1)[N+]([O-])=O,XZKIHKMTEMTJQX-UHFFFAOYSA-N,219.0887,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB04216,Quercetin,small molecule,experimental;investigational,OC1=CC2=C(C(O)=C1)C(=O)C(O)=C(O2)C1=CC=C(O)C(O)=C1,REFJWTPEDVJJIY-UHFFFAOYSA-N,302.2357,P40763,BE0003462,Signal transducer and activator of transcription 3,Humans,inhibitor,yes
DB04216,Quercetin,small molecule,experimental;investigational,OC1=CC2=C(C(O)=C1)C(=O)C(O)=C(O2)C1=CC=C(O)C(O)=C1,REFJWTPEDVJJIY-UHFFFAOYSA-N,302.2357,Q7L5N7,BE0016122,Lysophosphatidylcholine acyltransferase 2,Humans,inhibitor,yes
DB04216,Quercetin,small molecule,experimental;investigational,OC1=CC2=C(C(O)=C1)C(=O)C(O)=C(O2)C1=CC=C(O)C(O)=C1,REFJWTPEDVJJIY-UHFFFAOYSA-N,302.2357,Q8NF37,BE0017259,Lysophosphatidylcholine acyltransferase 1,Humans,inhibitor,yes
DB04218,1-Deaza-Adenosine,small molecule,experimental,[H][C@]1(CO)O[C@@]([H])(N2C=NC3=C(N)C=CN=C23)[C@]([H])(O)[C@]1([H])O,NVUDDRWKCUAERS-PNHWDRBUSA-N,266.2533,P00813,BE0002214,Adenosine deaminase,Humans,inhibitor,yes
DB04223,Nitroarginine,small molecule,experimental;investigational,N[C@@H](CCCNC(=N)N[N+]([O-])=O)C(O)=O,MRAUNPAHJZDYCK-BYPYZUCNSA-N,219.1985,P29475,BE0000067,Nitric oxide synthase 1,Humans,inhibitor,yes
DB04223,Nitroarginine,small molecule,experimental;investigational,N[C@@H](CCCNC(=N)N[N+]([O-])=O)C(O)=O,MRAUNPAHJZDYCK-BYPYZUCNSA-N,219.1985,P29474,BE0000263,Nitric oxide synthase 3,Humans,inhibitor,yes
DB04224,Oleic Acid,small molecule,approved;investigational;vet_approved,CCCCCCCC\C=C\CCCCCCCC(O)=O,ZQPPMHVWECSIRJ-MDZDMXLPSA-N,282.4614,P15090,BE0001194,"Fatty acid-binding protein, adipocyte",Humans,inhibitor,yes
DB04224,Oleic Acid,small molecule,approved;investigational;vet_approved,CCCCCCCC\C=C\CCCCCCCC(O)=O,ZQPPMHVWECSIRJ-MDZDMXLPSA-N,282.4614,P07148,BE0003998,"Fatty acid-binding protein, liver",Humans,inhibitor,yes
DB04233,(Hydroxyethyloxy)Tri(Ethyloxy)Octane,small molecule,experimental,CCCCCCCCOCCOCCOCCOCCO,FEOZZFHAVXYAMB-UHFFFAOYSA-N,306.4382,P16233,BE0000683,Pancreatic triacylglycerol lipase,Humans,inhibitor,yes
DB04242,4-hydroxybenzoic acid,small molecule,experimental,OC(=O)C1=CC=C(O)C=C1,FJKROLUGYXJWQN-UHFFFAOYSA-N,138.122,P27338,BE0002196,Amine oxidase [flavin-containing] B,Humans,inhibitor,yes
DB04253,Tretazicar,small molecule,investigational,NC(=O)C1=CC(N2CC2)=C(C=C1[N+]([O-])=O)[N+]([O-])=O,WOCXQMCIOTUMJV-UHFFFAOYSA-N,252.1836,P16083,BE0000220,Ribosyldihydronicotinamide dehydrogenase [quinone],Humans,inhibitor,yes
DB04256,(S)-alpha-methyl-4-carboxyphenylglycine,small molecule,experimental,C[C@@](N)(C(O)=O)C1=CC=C(C=C1)C(O)=O,DNCAZYRLRMTVSF-JTQLQIEISA-N,209.1986,Q14416,BE0000974,Metabotropic glutamate receptor 2,Humans,antagonist,yes
DB04256,(S)-alpha-methyl-4-carboxyphenylglycine,small molecule,experimental,C[C@@](N)(C(O)=O)C1=CC=C(C=C1)C(O)=O,DNCAZYRLRMTVSF-JTQLQIEISA-N,209.1986,P41594,BE0001192,Metabotropic glutamate receptor 5,Humans,antagonist,yes
DB04256,(S)-alpha-methyl-4-carboxyphenylglycine,small molecule,experimental,C[C@@](N)(C(O)=O)C1=CC=C(C=C1)C(O)=O,DNCAZYRLRMTVSF-JTQLQIEISA-N,209.1986,Q14832,BE0002342,Metabotropic glutamate receptor 3,Humans,antagonist,yes
DB04256,(S)-alpha-methyl-4-carboxyphenylglycine,small molecule,experimental,C[C@@](N)(C(O)=O)C1=CC=C(C=C1)C(O)=O,DNCAZYRLRMTVSF-JTQLQIEISA-N,209.1986,Q13255,BE0000824,Metabotropic glutamate receptor 1,Humans,antagonist,yes
DB04258,Seocalcitol,small molecule,investigational,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@H](C)\C=C\C=C\C(O)(CC)CC,LVLLALCJVJNGQQ-SEODYNFXSA-N,454.6844,P11473,BE0000779,Vitamin D3 receptor,Humans,inhibitor,yes
DB04260,"9-(5,5-Difluoro-5-Phosphonopentyl)Guanine",small molecule,experimental,NC1=NC2=C(N=CN2CCCCC(F)(F)P(O)(O)=O)C(=O)N1,JANQQPWTLXUSCD-UHFFFAOYSA-N,337.2198,P00491,BE0000250,Purine nucleoside phosphorylase,Humans,inhibitor,yes
DB04263,Geneticin,small molecule,experimental,[H][C@]1(O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O[C@]([H])([C@@H](C)O)[C@@H](O)[C@H](O)[C@H]1N,BRZYSWJRSDMWLG-DJWUNRQOSA-N,496.5524,P11926,BE0000404,Ornithine decarboxylase,Humans,inhibitor,yes
DB04264,"(10R)-10-formyl-5,8,10-trideazafolic acid",small molecule,experimental,[H]N([H])C1=NC(=O)C2=C(C=CC(C[C@@H](C(O)=O)C3=CC=C(C=C3)C(=O)N([H])[C@@H](CCC(O)=O)C(O)=O)=C2)N1[H],DAOQLLQRJAXMGY-PBHICJAKSA-N,482.4428,P22102,BE0000882,Trifunctional purine biosynthetic protein adenosine-3,Humans,inhibitor,yes
DB04272,Citric acid,small molecule,approved;nutraceutical;vet_approved,OC(=O)CC(O)(CC(O)=O)C(O)=O,KRKNYBCHXYNGOX-UHFFFAOYSA-N,192.1235,C7C422,BE0009973,Metallo-beta-lactamase type 2,Klebsiella pneumoniae,inhibitor,yes
DB04272,Citric acid,small molecule,approved;nutraceutical;vet_approved,OC(=O)CC(O)(CC(O)=O)C(O)=O,KRKNYBCHXYNGOX-UHFFFAOYSA-N,192.1235,P10613,BE0000233,Lanosterol 14-alpha demethylase,Yeast,binder,yes
DB04272,Citric acid,small molecule,approved;nutraceutical;vet_approved,OC(=O)CC(O)(CC(O)=O)C(O)=O,KRKNYBCHXYNGOX-UHFFFAOYSA-N,192.1235,Q9HBA0,BE0009159,Transient receptor potential cation channel subfamily V member 4,Humans,activator,yes
DB04272,Citric acid,small molecule,approved;nutraceutical;vet_approved,OC(=O)CC(O)(CC(O)=O)C(O)=O,KRKNYBCHXYNGOX-UHFFFAOYSA-N,192.1235,P15121,BE0000747,Aldo-keto reductase family 1 member B1,Humans,inhibitor,yes
DB04272,Citric acid,small molecule,approved;nutraceutical;vet_approved,OC(=O)CC(O)(CC(O)=O)C(O)=O,KRKNYBCHXYNGOX-UHFFFAOYSA-N,192.1235,P39126,BE0001524,Isocitrate dehydrogenase [NADP],Bacillus subtilis (strain 168),substrate;inhibitor,yes
DB04272,Citric acid,small molecule,approved;nutraceutical;vet_approved,OC(=O)CC(O)(CC(O)=O)C(O)=O,KRKNYBCHXYNGOX-UHFFFAOYSA-N,192.1235,P00808,BE0001482,Beta-lactamase,Bacillus licheniformis,weak inhibitor,yes
DB04275,N-acetylserotonin,small molecule,experimental,CC(=O)NCCC1=CNC2=C1C=C(O)C=C2,MVAWJSIDNICKHF-UHFFFAOYSA-N,218.2518,P48039,BE0000515,Melatonin receptor type 1A,Humans,inhibitor,yes
DB04286,beta-D-Ribopyranose,small molecule,experimental,O[C@@H]1CO[C@@H](O)[C@H](O)[C@@H]1O,SRBFZHDQGSBBOR-TXICZTDVSA-N,150.1299,P12821,BE0000221,Angiotensin-converting enzyme,Humans,inhibitor,yes
DB04287,KH064,small molecule,experimental,[H]N([C@@H](CCC(O)=O)CC1=CC=C(OCC2=CC=CC=C2)C=C1)C(=O)CCCCCCC1=CC=CC=C1,KWLUIYFCMHKLKY-NDEPHWFRSA-N,487.6298,P14555,BE0001640,"Phospholipase A2, membrane associated",Humans,inhibitor,yes
DB04289,Genz-10850,small molecule,experimental,O=C(N1CCN(CC1)C1C2=CC=CC=C2C2=CC=CC=C12)C1=CC2=C(NC=C2)C=C1,YYMZSGIXLQPFAC-UHFFFAOYSA-N,393.4803,P9WGR1,BE0000332,Enoyl-[acyl-carrier-protein] reductase [NADH],Mycobacterium tuberculosis,inhibitor,yes
DB04295,N-(Benzoylcarbamoyl)-beta-D-glucopyranosylamine,small molecule,experimental,[H]N([C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C(=O)N([H])C(=O)C1=CC=CC=C1,JSBCZGSPFATCOV-BZNQNGANSA-N,326.3019,P11217,BE0000916,"Glycogen phosphorylase, muscle form",Humans,inhibitor,yes
DB04306,"5-[(4-Methylphenyl)Sulfanyl]-2,4-Quinazolinediamine",small molecule,experimental,CC1=CC=C(SC2=CC=CC3=C2C(N)=NC(N)=N3)C=C1,UOJFGEAPSYQDIP-UHFFFAOYSA-N,282.363,Q9HBH1,BE0002201,"Peptide deformylase, mitochondrial",Humans,inhibitor,yes
DB04310,2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide,small molecule,experimental,[H][C@@](CCCCC)(CC(=O)NO)C(=O)N[C@@]([H])(C(C)C)C(=O)N1CCC[C@@]1([H])CO,XJLATMLVMSFZBN-VYDXJSESSA-N,385.4983,P68826,BE0002535,Peptide deformylase,Staphylococcus aureus,inhibitor,yes
DB04315,Guanosine-5'-Diphosphate,small molecule,experimental,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1,QGWNDRXFNXRZMB-UUOKFMHZSA-N,443.2005,P21980,BE0001035,Protein-glutamine gamma-glutamyltransferase 2,Humans,inhibitor,yes
DB04315,Guanosine-5'-Diphosphate,small molecule,experimental,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1,QGWNDRXFNXRZMB-UUOKFMHZSA-N,443.2005,Q00080,BE0009166,Elongation factor 1-alpha,Plasmodium falciparum (isolate K1 / Thailand),inhibitor,yes
DB04315,Guanosine-5'-Diphosphate,small molecule,experimental,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1,QGWNDRXFNXRZMB-UUOKFMHZSA-N,443.2005,Q9U8D3,BE0002700,Adenylosuccinate synthetase,Plasmodium falciparum,inhibitor,yes
DB04315,Guanosine-5'-Diphosphate,small molecule,experimental,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1,QGWNDRXFNXRZMB-UUOKFMHZSA-N,443.2005,P51151,BE0001710,Ras-related protein Rab-9A,Humans,inhibitor,yes
DB04325,Phenethylamine,small molecule,experimental,NCCC1=CC=CC=C1,BHHGXPLMPWCGHP-UHFFFAOYSA-N,121.1796,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,inhibitor,yes
DB04334,6-hydroxydopa quinone,small molecule,experimental,N[C@@H](CC1=CC(=O)C(O)=CC1=O)C(O)=O,AGMJSPIGDFKRRO-YFKPBYRVSA-N,211.1715,Q16853,BE0001002,Amine oxidase [copper-containing] 3,Humans,inhibitor,yes
DB04338,SB220025,small molecule,experimental,NC1=NC=CC(=N1)C1=C(N=CN1C1CCNCC1)C1=CC=C(F)C=C1,VSPFURGQAYMVAN-UHFFFAOYSA-N,338.3821,Q16539,BE0001019,Mitogen-activated protein kinase 14,Humans,inhibitor,yes
DB04338,SB220025,small molecule,experimental,NC1=NC=CC(=N1)C1=C(N=CN1C1CCNCC1)C1=CC=C(F)C=C1,VSPFURGQAYMVAN-UHFFFAOYSA-N,338.3821,P28482,BE0000923,Mitogen-activated protein kinase 1,Humans,inhibitor,yes
DB04339,Carbocisteine,small molecule,approved;investigational,N[C@@H](CSCC(O)=O)C(O)=O,GBFLZEXEOZUWRN-VKHMYHEASA-N,179.194,Q14145,BE0004756,Kelch-like ECH-associated protein 1,Humans,modulator,yes
DB04339,Carbocisteine,small molecule,approved;investigational,N[C@@H](CSCC(O)=O)C(O)=O,GBFLZEXEOZUWRN-VKHMYHEASA-N,179.194,Q16236,BE0010121,Nuclear factor erythroid 2-related factor 2,Humans,activator,yes
DB04348,Taurocholic acid,small molecule,approved;experimental,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@]12C)[C@H](C)CCC(=O)NCCS(O)(=O)=O,WBWWGRHZICKQGZ-HZAMXZRMSA-N,515.703,Q12908,BE0003643,Ileal sodium/bile acid cotransporter,Humans,modulator,yes
DB04348,Taurocholic acid,small molecule,approved;experimental,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@]12C)[C@H](C)CCC(=O)NCCS(O)(=O)=O,WBWWGRHZICKQGZ-HZAMXZRMSA-N,515.703,Q8TDU6,BE0005788,G-protein coupled bile acid receptor 1,Humans,modulator,yes
DB04348,Taurocholic acid,small molecule,approved;experimental,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@]12C)[C@H](C)CCC(=O)NCCS(O)(=O)=O,WBWWGRHZICKQGZ-HZAMXZRMSA-N,515.703,P19835,BE0004523,Bile salt-activated lipase,Humans,inhibitor,yes
DB04356,9-Deazaguanine,small molecule,experimental,NC1=NC2=C(NC=C2)C(=O)N1,FFYPRJYSJODFFD-UHFFFAOYSA-N,150.138,P20035,BE0001516,Hypoxanthine-guanine-xanthine phosphoribosyltransferase,Plasmodium falciparum (isolate FCR-3 / Gambia),inhibitor,yes
DB04360,Benzo[B]Thiophene-2-Boronic Acid,small molecule,experimental,OB(O)C1=CC2=C(S1)C=CC=C2,YNCYPMUJDDXIRH-UHFFFAOYSA-N,178.016,P00807,BE0000302,Beta-lactamase,Staphylococcus aureus,inhibitor,yes
DB04365,Arecoline,small molecule,experimental,COC(=O)C1=CCCN(C)C1,HJJPJSXJAXAIPN-UHFFFAOYSA-N,155.1943,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,inhibitor,yes
DB04367,Debromohymenialdisine,small molecule,experimental,NC1=NC(=O)\C(N1)=C1/CCNC(=O)C2=C1C=CN2,JYRJOQGKGMHTOO-VURMDHGXSA-N,245.2373,O96017,BE0003381,Serine/threonine-protein kinase Chk2,Humans,inhibitor,yes
DB04367,Debromohymenialdisine,small molecule,experimental,NC1=NC(=O)\C(N1)=C1/CCNC(=O)C2=C1C=CN2,JYRJOQGKGMHTOO-VURMDHGXSA-N,245.2373,O14757,BE0003382,Serine/threonine-protein kinase Chk1,Humans,inhibitor,yes
DB04367,Debromohymenialdisine,small molecule,experimental,NC1=NC(=O)\C(N1)=C1/CCNC(=O)C2=C1C=CN2,JYRJOQGKGMHTOO-VURMDHGXSA-N,245.2373,Q02750,BE0000870,Dual specificity mitogen-activated protein kinase kinase 1,Humans,inhibitor,yes
DB04367,Debromohymenialdisine,small molecule,experimental,NC1=NC(=O)\C(N1)=C1/CCNC(=O)C2=C1C=CN2,JYRJOQGKGMHTOO-VURMDHGXSA-N,245.2373,P28482,BE0000923,Mitogen-activated protein kinase 1,Humans,inhibitor,yes
DB04367,Debromohymenialdisine,small molecule,experimental,NC1=NC(=O)\C(N1)=C1/CCNC(=O)C2=C1C=CN2,JYRJOQGKGMHTOO-VURMDHGXSA-N,245.2373,P04049,BE0000036,RAF proto-oncogene serine/threonine-protein kinase,Humans,inhibitor,yes
DB04368,Bb-3497,small molecule,experimental,[H][C@@](CCCC)(CN(O)C=O)C(=O)N[C@]([H])(C(=O)N(C)C)C(C)(C)C,AVDLWYHBABSSHC-CHWSQXEVSA-N,329.435,P68826,BE0002535,Peptide deformylase,Staphylococcus aureus,inhibitor,yes
DB04371,AL6528,small molecule,experimental,COC1=CC(=CC=C1)N1C=CC2=C(SC(=C2)S(N)(=O)=O)S1(=O)=O,FBBLOSCXOZYUSS-UHFFFAOYSA-N,372.44,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB04376,13-Acetylphorbol,small molecule,experimental,[H][C@]12[C@]3([H])C=C(CO)C[C@]4(O)C(=O)C(C)=C[C@@]4([H])[C@@]3(O)[C@]([H])(C)[C@@]([H])(O)[C@@]1(OC(C)=O)C2(C)C,SDSVJYOOAPRSDA-RPCQODIISA-N,406.4694,Q05655,BE0002417,Protein kinase C delta type,Humans,inhibitor,yes
DB04377,Meglutol,small molecule,experimental,CC(O)(CC(O)=O)CC(O)=O,NPOAOTPXWNWTSH-UHFFFAOYSA-N,162.1406,P04035,BE0000574,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Humans,inhibitor,yes
DB04379,N-Methyl-N-(Methylbenzyl)Formamide,small molecule,experimental,[H][C@@](C)(N(C)C=O)C1=CC=CC=C1,YYPINKULTUCCJA-VIFPVBQESA-N,163.2163,P00797,BE0000270,Renin,Humans,inhibitor,yes
DB04387,1-Hydroxy-2-Amino-3-Cyclohexylpropane,small molecule,experimental,N[C@H](CO)CC1CCCCC1,QWDRYURVUDZKSG-VIFPVBQESA-N,157.2533,P00797,BE0000270,Renin,Humans,inhibitor,yes
DB04389,Ado-P-Ch2-P-Ps-Ado,small molecule,experimental,[H][C@]1(COP(O)(=O)CP(O)(=O)O[P@](O)(=S)OC[C@@]2([H])O[C@@]([H])(N3C=NC4=C(N)N=CN=C34)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O,UJCWOSLCGXVJOD-LCHUORCTSA-N,770.5,P49789,BE0001687,Bis(5'-adenosyl)-triphosphatase,Humans,inhibitor,yes
DB04392,"Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]",small molecule,experimental,[H][C@@]1(C[C@@]2([H])C(=O)OC3=C(C=CC=C3)C2=O)C(=O)OC2=CC=CC=C2C1=O,HIZKPJUTKKJDGA-BETUJISGSA-N,336.295,P15559,BE0001184,NAD(P)H dehydrogenase [quinone] 1,Humans,inhibitor,yes
DB04393,Soneclosan,small molecule,experimental,OC1=C(OC2=CC=C(Cl)C=C2)C=CC(Cl)=C1,BYNQFCJOHGOKSS-UHFFFAOYSA-N,255.097,P9WGR1,BE0000332,Enoyl-[acyl-carrier-protein] reductase [NADH],Mycobacterium tuberculosis,inhibitor,yes
DB04400,"L-erythro-7,8-dihydrobiopterin",small molecule,experimental,C[C@H](O)[C@H](O)C1=NC2=C(NC1)NC(N)=NC2=O,FEMXZDUTFRTWPE-DZSWIPIPSA-N,239.2312,P35228,BE0000005,"Nitric oxide synthase, inducible",Humans,inhibitor,yes
DB04400,"L-erythro-7,8-dihydrobiopterin",small molecule,experimental,C[C@H](O)[C@H](O)C1=NC2=C(NC1)NC(N)=NC2=O,FEMXZDUTFRTWPE-DZSWIPIPSA-N,239.2312,P07101,BE0000614,Tyrosine 3-monooxygenase,Humans,inhibitor,yes
DB04409,Naphthalene Trisulfonate,small molecule,experimental,[O-]S(=O)(=O)C1=CC2=C(C=C1)C(=CC(=C2)S([O-])(=O)=O)S([O-])(=O)=O,ZPBSAMLXSQCSOX-UHFFFAOYSA-K,365.336,P05230,BE0000689,Fibroblast growth factor 1,Humans,inhibitor,yes
DB04426,Alpha-Methyl-N-Acetyl-D-Glucosamine,small molecule,experimental,[H][C@]1(CO)O[C@@]([H])(OC)[C@]([H])(NC(C)=O)[C@@]([H])(O)[C@]1([H])O,ZEVOCXOZYFLVKN-JGKVKWKGSA-N,235.2344,P16581,BE0001074,E-selectin,Humans,inhibitor,yes
DB04426,Alpha-Methyl-N-Acetyl-D-Glucosamine,small molecule,experimental,[H][C@]1(CO)O[C@@]([H])(OC)[C@]([H])(NC(C)=O)[C@@]([H])(O)[C@]1([H])O,ZEVOCXOZYFLVKN-JGKVKWKGSA-N,235.2344,P16109,BE0001159,P-selectin,Humans,inhibitor,yes
DB04440,Nebularine,small molecule,experimental,[H][C@]1(CO)O[C@@]([H])(N2C=NC3=CN=CN=C23)[C@]([H])(O)[C@]1([H])O,MRWXACSTFXYYMV-FDDDBJFASA-N,252.2267,P00813,BE0002214,Adenosine deaminase,Humans,inhibitor,yes
DB04452,Aminoquinuride,small molecule,experimental,CC1=NC2=CC=C(NC(=O)NC3=CC4=C(C=C3)N=C(C)C=C4N)C=C2C(N)=C1,HOUSDILKOJMENG-UHFFFAOYSA-N,372.4231,P15917,BE0001363,Lethal factor,Bacillus anthracis,inhibitor,yes
DB04457,2'-Deoxyguanosine-5'-Monophosphate,small molecule,experimental,NC1=NC(=O)C2=C(N1)N(C=N2)[C@H]1C[C@H](O)[C@@H](COP(O)(O)=O)O1,LTFMZDNNPPEQNG-KVQBGUIXSA-N,347.2212,P12461,BE0000021,Thymidylate synthase,Yeast,inhibitor,yes
DB04459,"3,4-Dichloroisocoumarin",small molecule,experimental,ClC1=C(Cl)C2=CC=CC=C2C(=O)O1,SUGXUUGGLDCZKB-UHFFFAOYSA-N,215.033,P08246,BE0000394,Neutrophil elastase,Humans,inhibitor,yes
DB04460,(C8-S)-Hydantocidin 5'-phosphate,small molecule,experimental,[H]N1C(=O)N(CCC[C@H](N(O)CO)C(O)=O)C(=O)[C@]11O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O,MAXSFYCTFIBEAR-FUIMDIGMSA-N,459.2998,Q9U8D3,BE0002700,Adenylosuccinate synthetase,Plasmodium falciparum,inhibitor,yes
DB04462,Tetrabromo-2-Benzotriazole,small molecule,experimental,[H]N1N=C2C(=N1)C(Br)=C(Br)C(Br)=C2Br,OMZYUVOATZSGJY-UHFFFAOYSA-N,434.708,P45983,BE0003790,Mitogen-activated protein kinase 8,Humans,inhibitor,yes
DB04462,Tetrabromo-2-Benzotriazole,small molecule,experimental,[H]N1N=C2C(=N1)C(Br)=C(Br)C(Br)=C2Br,OMZYUVOATZSGJY-UHFFFAOYSA-N,434.708,P49841,BE0001065,Glycogen synthase kinase-3 beta,Humans,inhibitor,yes
DB04462,Tetrabromo-2-Benzotriazole,small molecule,experimental,[H]N1N=C2C(=N1)C(Br)=C(Br)C(Br)=C2Br,OMZYUVOATZSGJY-UHFFFAOYSA-N,434.708,P53778,BE0002790,Mitogen-activated protein kinase 12,Humans,inhibitor,yes
DB04462,Tetrabromo-2-Benzotriazole,small molecule,experimental,[H]N1N=C2C(=N1)C(Br)=C(Br)C(Br)=C2Br,OMZYUVOATZSGJY-UHFFFAOYSA-N,434.708,Q13464,BE0001016,Rho-associated protein kinase 1,Humans,inhibitor,yes
DB04462,Tetrabromo-2-Benzotriazole,small molecule,experimental,[H]N1N=C2C(=N1)C(Br)=C(Br)C(Br)=C2Br,OMZYUVOATZSGJY-UHFFFAOYSA-N,434.708,P23443,BE0010424,Ribosomal protein S6 kinase beta-1,Humans,inhibitor,yes
DB04462,Tetrabromo-2-Benzotriazole,small molecule,experimental,[H]N1N=C2C(=N1)C(Br)=C(Br)C(Br)=C2Br,OMZYUVOATZSGJY-UHFFFAOYSA-N,434.708,O14757,BE0003382,Serine/threonine-protein kinase Chk1,Humans,inhibitor,yes
DB04462,Tetrabromo-2-Benzotriazole,small molecule,experimental,[H]N1N=C2C(=N1)C(Br)=C(Br)C(Br)=C2Br,OMZYUVOATZSGJY-UHFFFAOYSA-N,434.708,Q13131,BE0000677,5'-AMP-activated protein kinase catalytic subunit alpha-1,Humans,inhibitor,yes
DB04462,Tetrabromo-2-Benzotriazole,small molecule,experimental,[H]N1N=C2C(=N1)C(Br)=C(Br)C(Br)=C2Br,OMZYUVOATZSGJY-UHFFFAOYSA-N,434.708,Q9Y478,BE0000254,5'-AMP-activated protein kinase subunit beta-1,Humans,inhibitor,yes
DB04462,Tetrabromo-2-Benzotriazole,small molecule,experimental,[H]N1N=C2C(=N1)C(Br)=C(Br)C(Br)=C2Br,OMZYUVOATZSGJY-UHFFFAOYSA-N,434.708,P54619,BE0009988,5'-AMP-activated protein kinase subunit gamma-1,Humans,inhibitor,yes
DB04462,Tetrabromo-2-Benzotriazole,small molecule,experimental,[H]N1N=C2C(=N1)C(Br)=C(Br)C(Br)=C2Br,OMZYUVOATZSGJY-UHFFFAOYSA-N,434.708,O00141,BE0004105,Serine/threonine-protein kinase Sgk1,Humans,inhibitor,yes
DB04462,Tetrabromo-2-Benzotriazole,small molecule,experimental,[H]N1N=C2C(=N1)C(Br)=C(Br)C(Br)=C2Br,OMZYUVOATZSGJY-UHFFFAOYSA-N,434.708,P28482,BE0000923,Mitogen-activated protein kinase 1,Humans,inhibitor,yes
DB04462,Tetrabromo-2-Benzotriazole,small molecule,experimental,[H]N1N=C2C(=N1)C(Br)=C(Br)C(Br)=C2Br,OMZYUVOATZSGJY-UHFFFAOYSA-N,434.708,Q16539,BE0001019,Mitogen-activated protein kinase 14,Humans,inhibitor,yes
DB04462,Tetrabromo-2-Benzotriazole,small molecule,experimental,[H]N1N=C2C(=N1)C(Br)=C(Br)C(Br)=C2Br,OMZYUVOATZSGJY-UHFFFAOYSA-N,434.708,Q15759,BE0003390,Mitogen-activated protein kinase 11,Humans,inhibitor,yes
DB04462,Tetrabromo-2-Benzotriazole,small molecule,experimental,[H]N1N=C2C(=N1)C(Br)=C(Br)C(Br)=C2Br,OMZYUVOATZSGJY-UHFFFAOYSA-N,434.708,Q02750,BE0000870,Dual specificity mitogen-activated protein kinase kinase 1,Humans,inhibitor,yes
DB04462,Tetrabromo-2-Benzotriazole,small molecule,experimental,[H]N1N=C2C(=N1)C(Br)=C(Br)C(Br)=C2Br,OMZYUVOATZSGJY-UHFFFAOYSA-N,434.708,P06239,BE0000842,Tyrosine-protein kinase Lck,Humans,inhibitor,yes
DB04462,Tetrabromo-2-Benzotriazole,small molecule,experimental,[H]N1N=C2C(=N1)C(Br)=C(Br)C(Br)=C2Br,OMZYUVOATZSGJY-UHFFFAOYSA-N,434.708,P31749,BE0000428,RAC-alpha serine/threonine-protein kinase,Humans,inhibitor,yes
DB04462,Tetrabromo-2-Benzotriazole,small molecule,experimental,[H]N1N=C2C(=N1)C(Br)=C(Br)C(Br)=C2Br,OMZYUVOATZSGJY-UHFFFAOYSA-N,434.708,P17252,BE0001132,Protein kinase C alpha type,Humans,inhibitor,yes
DB04462,Tetrabromo-2-Benzotriazole,small molecule,experimental,[H]N1N=C2C(=N1)C(Br)=C(Br)C(Br)=C2Br,OMZYUVOATZSGJY-UHFFFAOYSA-N,434.708,P68400,BE0001209,Casein kinase II subunit alpha,Humans,inhibitor,yes
DB04464,N-Formylmethionine,small molecule,experimental,[H]C(=O)N[C@@H](CCSC)C(O)=O,PYUSHNKNPOHWEZ-YFKPBYRVSA-N,177.221,P03897,BE0000196,NADH-ubiquinone oxidoreductase chain 3,Humans,inhibitor,yes
DB04464,N-Formylmethionine,small molecule,experimental,[H]C(=O)N[C@@H](CCSC)C(O)=O,PYUSHNKNPOHWEZ-YFKPBYRVSA-N,177.221,P01008,BE0000280,Antithrombin-III,Humans,inhibitor,yes
DB04466,SR12813,small molecule,experimental,CCOP(=O)(OCC)C(=CC1=CC(=C(O)C(=C1)C(C)(C)C)C(C)(C)C)P(=O)(OCC)OCC,YQLJDECYQDRSBI-UHFFFAOYSA-N,504.5336,P04035,BE0000574,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Humans,modulator,yes
DB04468,Afimoxifene,small molecule,investigational,CC\C(=C(/C1=CC=C(O)C=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,TXUZVZSFRXZGTL-QPLCGJKRSA-N,387.514,P03372,BE0000123,Estrogen receptor,Humans,modulator,yes
DB04474,8-anilinonaphthalene-1-sulfonic acid,small molecule,experimental,OS(=O)(=O)C1=CC=CC2=CC=CC(NC3=CC=CC=C3)=C12,FWEOQOXTVHGIFQ-UHFFFAOYSA-N,299.344,P07148,BE0003998,"Fatty acid-binding protein, liver",Humans,inhibitor,yes
DB04487,N-Methylleucine,small molecule,experimental,CN[C@H](CC(C)C)C(O)=O,XJODGRWDFZVTKW-ZCFIWIBFSA-N,145.1995,P02778,BE0000934,C-X-C motif chemokine 10,Humans,inhibitor,yes
DB04491,Diisopropylphosphono Group,small molecule,experimental,CC(C)OP(=O)OC(C)C,BLKXLEPPVDUHBY-UHFFFAOYSA-N,166.1553,P27487,BE0000854,Dipeptidyl peptidase 4,Humans,inhibitor,yes
DB04493,Fructose-6-phosphate,small molecule,experimental,OCC(=O)[C@@H](O)[C@H](O)[C@H](O)COP(O)(O)=O,GSXOAOHZAIYLCY-HSUXUTPPSA-N,260.1358,P09467,BE0002431,"Fructose-1,6-bisphosphatase 1",Humans,inhibitor,yes
DB04493,Fructose-6-phosphate,small molecule,experimental,OCC(=O)[C@@H](O)[C@H](O)[C@H](O)COP(O)(O)=O,GSXOAOHZAIYLCY-HSUXUTPPSA-N,260.1358,O00757,BE0011215,"Fructose-1,6-bisphosphatase isozyme 2",Humans,inhibitor,yes
DB04495,Paratoulene phosphate,small molecule,experimental,CC(=O)N[C@@H](CC1=CC=C(OP(O)(O)=O)C=C1)C(=O)N[C@H]1CCCCN(CC2=CC=C(C=C2)C2=CC=CC=C2)C1=O,GGPXNASQNUOIPB-NSOVKSMOSA-N,579.5806,P12931,BE0000838,Proto-oncogene tyrosine-protein kinase Src,Humans,inhibitor,yes
DB04502,WRR-204,small molecule,experimental,O=C(N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC1=CC=CC=C1)CCS(=O)(=O)OC1=CC=CC=C1)OCC1=CC=CC=C1,SUGQHICXCRBQOI-CDZUIXILSA-N,600.724,P25779,BE0001292,Cruzipain,Trypanosoma cruzi,inhibitor,yes
DB04503,Sp-722,small molecule,experimental,[H][C@@](CCC(O)=O)(NC(=O)C1=CC=C(C=C1)S(=O)(=O)N1CCC[C@]1([H])C(O)=O)C(O)=O,NDDOUBGQRWFVQM-QWHCGFSZSA-N,428.414,P12461,BE0000021,Thymidylate synthase,Yeast,inhibitor,yes
DB04509,N-Methylnaloxonium,small molecule,experimental,C[N@@+]1(CC=C)CC[C@]23[C@H]4OC5=C(O)C=CC(C[C@@H]1[C@]2(O)CCC4=O)=C35,PCSQOABIHJXZMR-YNUHATHGSA-O,342.4089,P23141,BE0002705,Liver carboxylesterase 1,Humans,inhibitor,yes
DB04522,Dexfosfoserine,small molecule,experimental,N[C@@H](COP(O)(O)=O)C(O)=O,BZQFBWGGLXLEPQ-REOHCLBHSA-N,185.0725,O15530,BE0001193,3-phosphoinositide-dependent protein kinase 1,Humans,inhibitor,yes
DB04522,Dexfosfoserine,small molecule,experimental,N[C@@H](COP(O)(O)=O)C(O)=O,BZQFBWGGLXLEPQ-REOHCLBHSA-N,185.0725,P11217,BE0000916,"Glycogen phosphorylase, muscle form",Humans,inhibitor,yes
DB04522,Dexfosfoserine,small molecule,experimental,N[C@@H](COP(O)(O)=O)C(O)=O,BZQFBWGGLXLEPQ-REOHCLBHSA-N,185.0725,Q04759,BE0001385,Protein kinase C theta type,Humans,inhibitor,yes
DB04523,Tert-Butyl(1s)-1-Cyclohexyl-2-Oxoethylcarbamate,small molecule,experimental,[H][C@@](NC(=O)OC(C)(C)C)(C=O)C1CCCCC1,BDSGOSWEKUGHOV-LLVKDONJSA-N,241.3266,P43235,BE0003417,Cathepsin K,Humans,inhibitor,yes
DB04530,"S,S-(2-Hydroxyethyl)Thiocysteine",small molecule,experimental,N[C@@H](CSSCCO)C(O)=O,YPUBRSXDQSFQBA-BYPYZUCNSA-N,197.276,P12461,BE0000021,Thymidylate synthase,Yeast,inhibitor,yes
DB04530,"S,S-(2-Hydroxyethyl)Thiocysteine",small molecule,experimental,N[C@@H](CSSCCO)C(O)=O,YPUBRSXDQSFQBA-BYPYZUCNSA-N,197.276,P13716,BE0000050,Delta-aminolevulinic acid dehydratase,Humans,inhibitor,yes
DB04530,"S,S-(2-Hydroxyethyl)Thiocysteine",small molecule,experimental,N[C@@H](CSSCCO)C(O)=O,YPUBRSXDQSFQBA-BYPYZUCNSA-N,197.276,Q07343,BE0000487,"3',5'-cyclic-AMP phosphodiesterase 4B",Humans,inhibitor,yes
DB04531,S-Benzylcysteine,small molecule,experimental,N[C@@H](CSCC1=CC=CC=C1)C(O)=O,GHBAYRBVXCRIHT-VIFPVBQESA-N,211.281,P16455,BE0001145,Methylated-DNA--protein-cysteine methyltransferase,Humans,inhibitor,yes
DB04534,5-Nitroindazole,small molecule,experimental,[O-][N+](=O)C1=CC=C2NN=CC2=C1,WSGURAYTCUVDQL-UHFFFAOYSA-N,163.1335,P35228,BE0000005,"Nitric oxide synthase, inducible",Humans,inhibitor,yes
DB04534,5-Nitroindazole,small molecule,experimental,[O-][N+](=O)C1=CC=C2NN=CC2=C1,WSGURAYTCUVDQL-UHFFFAOYSA-N,163.1335,P29474,BE0000263,Nitric oxide synthase 3,Humans,inhibitor,yes
DB04540,Cholesterol,small molecule,approved;investigational,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC=C4C[C@@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCCC(C)C,HVYWMOMLDIMFJA-DPAQBDIFSA-N,386.6535,Q9Y5K3,BE0000494,Choline-phosphate cytidylyltransferase B,Humans,activator,yes
DB04545,Afegostat,small molecule,experimental;investigational,OC[C@H]1CNC[C@@H](O)[C@@H]1O,QPYJXFZUIJOGNX-HSUXUTPPSA-N,147.1723,P04062,BE0000978,Lysosomal acid glucosylceramidase,Humans,inhibitor,yes
DB04552,Niflumic acid,small molecule,experimental,OC(=O)C1=C(NC2=CC=CC(=C2)C(F)(F)F)N=CC=C1,JZFPYUNJRRFVQU-UHFFFAOYSA-N,282.218,P04054,BE0003997,Phospholipase A2,Humans,inhibitor,yes
DB04552,Niflumic acid,small molecule,experimental,OC(=O)C1=C(NC2=CC=CC(=C2)C(F)(F)F)N=CC=C1,JZFPYUNJRRFVQU-UHFFFAOYSA-N,282.218,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB04556,NAP-226-90,small molecule,experimental,C[C@H](N(C)C)C1=CC(O)=CC=C1,GQZXRLWUYONVCP-QMMMGPOBSA-N,165.2322,P22303,BE0000426,Acetylcholinesterase,Humans,inhibitor,yes
DB04557,Arachidonic Acid,small molecule,experimental,CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O,YZXBAPSDXZZRGB-DOFZRALJSA-N,304.4669,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB04559,N-(Chlorophenyl)-N'-hydroxyguanidine,small molecule,experimental,N\C(NO)=N/C1=CC=C(Cl)C=C1,JYBXKTLYOMPMQY-UHFFFAOYSA-N,185.611,P29474,BE0000263,Nitric oxide synthase 3,Humans,inhibitor,yes
DB04560,"4,7-Dioxosebacic Acid",small molecule,experimental,OC(=O)CCC(=O)CCC(=O)CCC(O)=O,DUAWJQCMZICMIK-UHFFFAOYSA-N,230.2146,P13716,BE0000050,Delta-aminolevulinic acid dehydratase,Humans,inhibitor,yes
DB04566,Inosinic Acid,small molecule,experimental,O[C@@H]1[C@@H](COP(O)(O)=O)O[C@H]([C@@H]1O)N1C=NC2=C1N=CNC2=O,GRSZFWQUAKGDAV-KQYNXXCUSA-N,348.206,P20839,BE0000761,Inosine-5'-monophosphate dehydrogenase 1,Humans,inhibitor,yes
DB04566,Inosinic Acid,small molecule,experimental,O[C@@H]1[C@@H](COP(O)(O)=O)O[C@H]([C@@H]1O)N1C=NC2=C1N=CNC2=O,GRSZFWQUAKGDAV-KQYNXXCUSA-N,348.206,P20035,BE0001516,Hypoxanthine-guanine-xanthine phosphoribosyltransferase,Plasmodium falciparum (isolate FCR-3 / Gambia),inhibitor,yes
DB04566,Inosinic Acid,small molecule,experimental,O[C@@H]1[C@@H](COP(O)(O)=O)O[C@H]([C@@H]1O)N1C=NC2=C1N=CNC2=O,GRSZFWQUAKGDAV-KQYNXXCUSA-N,348.206,Q9U8D3,BE0002700,Adenylosuccinate synthetase,Plasmodium falciparum,inhibitor,yes
DB04566,Inosinic Acid,small molecule,experimental,O[C@@H]1[C@@H](COP(O)(O)=O)O[C@H]([C@@H]1O)N1C=NC2=C1N=CNC2=O,GRSZFWQUAKGDAV-KQYNXXCUSA-N,348.206,P12268,BE0000722,Inosine-5'-monophosphate dehydrogenase 2,Humans,inhibitor,yes
DB04566,Inosinic Acid,small molecule,experimental,O[C@@H]1[C@@H](COP(O)(O)=O)O[C@H]([C@@H]1O)N1C=NC2=C1N=CNC2=O,GRSZFWQUAKGDAV-KQYNXXCUSA-N,348.206,P11217,BE0000916,"Glycogen phosphorylase, muscle form",Humans,inhibitor,yes
DB04570,Latamoxef,small molecule,approved;investigational,[H][C@]12OCC(CSC3=NN=NN3C)=C(N1C(=O)[C@]2(NC(=O)C(C(O)=O)C1=CC=C(O)C=C1)OC)C(O)=O,JWCSIUVGFCSJCK-CAVRMKNVSA-N,520.473,P0AD68,BE0002393,Peptidoglycan synthase FtsI,Escherichia coli (strain K12),binder,yes
DB04570,Latamoxef,small molecule,approved;investigational,[H][C@]12OCC(CSC3=NN=NN3C)=C(N1C(=O)[C@]2(NC(=O)C(C(O)=O)C1=CC=C(O)C=C1)OC)C(O)=O,JWCSIUVGFCSJCK-CAVRMKNVSA-N,520.473,P42971,BE0000790,Penicillin-binding protein 3,Bacillus subtilis (strain 168),inhibitor,yes
DB04571,Trioxsalen,small molecule,approved,CC1=CC2=CC3=C(OC(=O)C=C3C)C(C)=C2O1,FMHHVULEAZTJMA-UHFFFAOYSA-N,228.2433,,BE0004796,DNA,Humans,cross-linking/alkylation,yes
DB04572,Thiotepa,small molecule,approved;investigational,S=P(N1CC1)(N1CC1)N1CC1,FOCVUCIESVLUNU-UHFFFAOYSA-N,189.218,,BE0004796,DNA,Humans,cross-linking/alkylation,yes
DB04573,Estriol,small molecule,approved;investigational;vet_approved,[H][C@@]12C[C@@H](O)[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,PROQIPRRNZUXQM-ZXXIGWHRSA-N,288.3814,P03372,BE0000123,Estrogen receptor,Humans,agonist,yes
DB04574,Estrone sulfate,small molecule,approved,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OS(O)(=O)=O)C=C3,JKKFKPJIXZFSSB-CBZIJGRNSA-N,350.429,P03372,BE0000123,Estrogen receptor,Humans,agonist,yes
DB04575,Quinestrol,small molecule,approved,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OC1CCCC1)C=C3,PWZUUYSISTUNDW-VAFBSOEGSA-N,364.5204,P03372,BE0000123,Estrogen receptor,Humans,agonist;modulator,yes
DB04576,Fleroxacin,small molecule,experimental,CN1CCN(CC1)C1=C(F)C=C2C(=O)C(=CN(CCF)C2=C1F)C(O)=O,XBJBPGROQZJDOJ-UHFFFAOYSA-N,369.344,Q02880,BE0002425,DNA topoisomerase 2-beta,Humans,inhibitor,yes
DB04576,Fleroxacin,small molecule,experimental,CN1CCN(CC1)C1=C(F)C=C2C(=O)C(=CN(CCF)C2=C1F)C(O)=O,XBJBPGROQZJDOJ-UHFFFAOYSA-N,369.344,P43700,BE0000366,DNA gyrase subunit A,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd),inhibitor,yes
DB04576,Fleroxacin,small molecule,experimental,CN1CCN(CC1)C1=C(F)C=C2C(=O)C(=CN(CCF)C2=C1F)C(O)=O,XBJBPGROQZJDOJ-UHFFFAOYSA-N,369.344,P43702,BE0000429,DNA topoisomerase 4 subunit A,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd),inhibitor,yes
DB04576,Fleroxacin,small molecule,experimental,CN1CCN(CC1)C1=C(F)C=C2C(=O)C(=CN(CCF)C2=C1F)C(O)=O,XBJBPGROQZJDOJ-UHFFFAOYSA-N,369.344,P11388,BE0000742,DNA topoisomerase 2-alpha,Humans,inhibitor,yes
DB04577,1-(1-phenylcyclopentyl)methylamine,small molecule,experimental,NCC1(CCCC1)C1=CC=CC=C1,SJWOFBVBNFLWLP-UHFFFAOYSA-N,175.2701,P27487,BE0000854,Dipeptidyl peptidase 4,Humans,inhibitor,yes
DB04581,1-benzylimidazole,small molecule,experimental,C(N1C=CN=C1)C1=CC=CC=C1,KKKDZZRICRFGSD-UHFFFAOYSA-N,158.1998,P15538,BE0000731,"Cytochrome P450 11B1, mitochondrial",Humans,inhibitor,yes
DB04586,o-Bromophenol,small molecule,experimental,OC1=CC=CC=C1Br,VADKRMSMGWJZCF-UHFFFAOYSA-N,173.007,P12461,BE0000021,Thymidylate synthase,Yeast,inhibitor,yes
DB04599,Aniracetam,small molecule,experimental,COC1=CC=C(C=C1)C(=O)N1CCCC1=O,ZXNRTKGTQJPIJK-UHFFFAOYSA-N,219.2365,P14416,BE0000756,D(2) dopamine receptor,Humans,inhibitor,yes
DB04599,Aniracetam,small molecule,experimental,COC1=CC=C(C=C1)C(=O)N1CCCC1=O,ZXNRTKGTQJPIJK-UHFFFAOYSA-N,219.2365,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,inhibitor,yes
DB04607,"PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE",small molecule,experimental,NS(=O)(=O)C1=CC=C(NC2=CN3C=C(C=CC3=N2)C(=O)C2=C(Cl)C=CC=C2Cl)C=C1,UQAWGIKJINAKIZ-UHFFFAOYSA-N,461.321,P24941,BE0001072,Cyclin-dependent kinase 2,Humans,inhibitor,yes
DB04614,(R)-tacrine(10)-hupyridone,small molecule,experimental,O=C1NC2=C(C=C1)[C@@H](CCC2)NCCCCCCCCCCNC1=C2CCCCC2=NC2=CC=CC=C12,ROTFGKJJMRTWBD-HHHXNRCGSA-N,500.718,P22303,BE0000426,Acetylcholinesterase,Humans,inhibitor,yes
DB04615,(S)-tacrine(10)-hupyridone,small molecule,experimental,O=C1NC2=C(C=C1)[C@H](CCC2)NCCCCCCCCCCNC1=C2CCCCC2=NC2=CC=CC=C12,ROTFGKJJMRTWBD-MHZLTWQESA-N,500.718,P22303,BE0000426,Acetylcholinesterase,Humans,inhibitor,yes
DB04616,TACRINE(8)-4-AMINOQUINOLINE,small molecule,experimental,C(CCCCNC1=C2CCCCC2=NC2=CC=CC=C12)CCCNC1=CC=NC2=CC=CC=C12,UNVOAAWEEGAXTN-UHFFFAOYSA-N,452.6336,P22303,BE0000426,Acetylcholinesterase,Humans,inhibitor,yes
DB04620,Cycloleucine,small molecule,experimental,NC1(CCCC1)C(O)=O,NILQLFBWTXNUOE-UHFFFAOYSA-N,129.157,Q05586,BE0000365,"Glutamate receptor ionotropic, NMDA 1",Humans,inhibitor,yes
DB04630,Aldosterone,small molecule,experimental;investigational,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(=O)CC[C@]4(C)[C@@]3([H])[C@@H](O)C[C@]12C=O)C(=O)CO,PQSUYGKTWSAVDQ-ZVIOFETBSA-N,360.444,Q13621,BE0000502,Solute carrier family 12 member 1,Humans,blocker,yes
DB04630,Aldosterone,small molecule,experimental;investigational,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(=O)CC[C@]4(C)[C@@]3([H])[C@@H](O)C[C@]12C=O)C(=O)CO,PQSUYGKTWSAVDQ-ZVIOFETBSA-N,360.444,P08235,BE0000668,Mineralocorticoid receptor,Humans,agonist,yes
DB04652,Corticosterone,small molecule,experimental,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(=O)CC[C@]4(C)[C@@]3([H])[C@@]([H])(O)C[C@]12C)C(=O)CO,OMFXVFTZEKFJBZ-HJTSIMOOSA-N,346.4605,P28845,BE0000329,11-beta-hydroxysteroid dehydrogenase 1,Humans,substrate;product of,yes
DB04652,Corticosterone,small molecule,experimental,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(=O)CC[C@]4(C)[C@@]3([H])[C@@]([H])(O)C[C@]12C)C(=O)CO,OMFXVFTZEKFJBZ-HJTSIMOOSA-N,346.4605,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB04652,Corticosterone,small molecule,experimental,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(=O)CC[C@]4(C)[C@@]3([H])[C@@]([H])(O)C[C@]12C)C(=O)CO,OMFXVFTZEKFJBZ-HJTSIMOOSA-N,346.4605,Q15788,BE0003728,Nuclear receptor coactivator 1,Humans,,yes
DB04652,Corticosterone,small molecule,experimental,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(=O)CC[C@]4(C)[C@@]3([H])[C@@]([H])(O)C[C@]12C)C(=O)CO,OMFXVFTZEKFJBZ-HJTSIMOOSA-N,346.4605,P08235,BE0000668,Mineralocorticoid receptor,Humans,inhibitor,yes
DB04655,Metoprine,small molecule,experimental,CC1=C(C(N)=NC(N)=N1)C1=CC(Cl)=C(Cl)C=C1,VQJHOPSWBGJHQS-UHFFFAOYSA-N,269.13,Q9HBH1,BE0002201,"Peptide deformylase, mitochondrial",Humans,inhibitor,yes
DB04655,Metoprine,small molecule,experimental,CC1=C(C(N)=NC(N)=N1)C1=CC(Cl)=C(Cl)C=C1,VQJHOPSWBGJHQS-UHFFFAOYSA-N,269.13,P50135,BE0002436,Histamine N-methyltransferase,Humans,inhibitor,yes
DB04658,Calystegine B2,small molecule,experimental,[H][C@]12CC[C@](O)(N1)[C@@H](O)[C@H](O)[C@H]2O,FXFBVZOJVHCEDO-IBISWUOJSA-N,175.1824,P06280,BE0002422,Alpha-galactosidase A,Humans,inhibitor,yes
DB04660,Choline alfoscerate,small molecule,experimental;investigational,[H][C@@](O)(CO)COP([O-])(=O)OCC[N+](C)(C)C,SUHOQUVVVLNYQR-MRVPVSSYSA-N,257.223,P08912,BE0000247,Muscarinic acetylcholine receptor M5,Humans,modulator,yes
DB04665,Coumarin,small molecule,experimental,O=C1OC2=CC=CC=C2C=C1,ZYGHJZDHTFUPRJ-UHFFFAOYSA-N,146.1427,P22748,BE0000535,Carbonic anhydrase 4,Humans,inhibitor,yes
DB04665,Coumarin,small molecule,experimental,O=C1OC2=CC=CC=C2C=C1,ZYGHJZDHTFUPRJ-UHFFFAOYSA-N,146.1427,P00915,BE0000267,Carbonic anhydrase 1,Humans,inhibitor,yes
DB04665,Coumarin,small molecule,experimental,O=C1OC2=CC=CC=C2C=C1,ZYGHJZDHTFUPRJ-UHFFFAOYSA-N,146.1427,P23280,BE0003628,Carbonic anhydrase 6,Humans,inhibitor,yes
DB04665,Coumarin,small molecule,experimental,O=C1OC2=CC=CC=C2C=C1,ZYGHJZDHTFUPRJ-UHFFFAOYSA-N,146.1427,Q16790,BE0002437,Carbonic anhydrase 9,Humans,inhibitor,yes
DB04665,Coumarin,small molecule,experimental,O=C1OC2=CC=CC=C2C=C1,ZYGHJZDHTFUPRJ-UHFFFAOYSA-N,146.1427,Q9ULX7,BE0003634,Carbonic anhydrase 14,Humans,inhibitor,yes
DB04665,Coumarin,small molecule,experimental,O=C1OC2=CC=CC=C2C=C1,ZYGHJZDHTFUPRJ-UHFFFAOYSA-N,146.1427,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB04665,Coumarin,small molecule,experimental,O=C1OC2=CC=CC=C2C=C1,ZYGHJZDHTFUPRJ-UHFFFAOYSA-N,146.1427,O43570,BE0001653,Carbonic anhydrase 12,Humans,inhibitor,yes
DB04674,"2-HYDROXY-3,5-DIIODOBENZOIC ACID",small molecule,experimental,OC(=O)C1=C(O)C(I)=CC(I)=C1,DHZVWQPHNWDCFS-UHFFFAOYSA-N,389.9138,P25101,BE0000521,Endothelin-1 receptor,Humans,inhibitor,yes
DB04696,"4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN",small molecule,experimental,OC1=C(Br)C=C(C=C1)C1(OC(=O)C2=C3C(C=CC=C13)=C(Cl)C=C2)C1=CC(Br)=C(O)C=C1,GFGZCXHXQCQRFP-UHFFFAOYSA-N,560.619,P12461,BE0000021,Thymidylate synthase,Yeast,inhibitor,yes
DB04703,Hesperidin,small molecule,approved;investigational,COC1=CC=C(C=C1O)[C@@H]1CC(=O)C2=C(O1)C=C(O[C@@H]1O[C@H](CO[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)[C@@H](O)[C@H](O)[C@H]1O)C=C2O,QUQPHWDTPGMPEX-QJBIFVCTSA-N,610.5606,Q00975,BE0002226,Voltage-dependent N-type calcium channel subunit alpha-1B,Humans,inhibitor,yes
DB04705,25-Hydroxycholesterol,small molecule,experimental,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC=C4C[C@@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCCC(C)(C)O,INBGSXNNRGWLJU-ZHHJOTBYSA-N,402.6529,P51449,BE0013275,Nuclear receptor ROR-gamma,Humans,agonist,yes
DB04707,Hydroxyfasudil,small molecule,experimental,O=C1NC=CC2=C(C=CC=C12)S(=O)(=O)N1CCCNCC1,ZAVGJDAFCZAWSZ-UHFFFAOYSA-N,307.368,P51788,BE0000765,Chloride channel protein 2,Humans,activator,yes
DB04707,Hydroxyfasudil,small molecule,experimental,O=C1NC=CC2=C(C=CC=C12)S(=O)(=O)N1CCCNCC1,ZAVGJDAFCZAWSZ-UHFFFAOYSA-N,307.368,Q13464,BE0001016,Rho-associated protein kinase 1,Humans,inhibitor,yes
DB04711,Iodipamide,small molecule,approved,OC(=O)C1=C(I)C(NC(=O)CCCCC(=O)NC2=C(I)C=C(I)C(C(O)=O)=C2I)=C(I)C=C1I,FFINMCNLQNTKLU-UHFFFAOYSA-N,1139.7618,P02768,BE0000530,Albumin,Humans,binder,yes
DB04714,ISOPENTENYL PYROPHOSPHATE,small molecule,experimental,CC(=C)CCO[P@](O)(=O)OP(O)(O)=O,NUHSROFQTUXZQQ-UHFFFAOYSA-N,246.0921,P14324,BE0000776,Farnesyl pyrophosphate synthase,Humans,inhibitor,yes
DB04716,"2-tert-butyl-9-fluoro-1,6-dihydrobenzo[h]imidazo[4,5-f]isoquinolin-7-one",small molecule,experimental,CC(C)(C)C1=NC2=C3C=CNC(=O)C3=C3C=C(F)C=CC3=C2N1,VNDWQCSOSCCWIP-UHFFFAOYSA-N,309.3375,O60674,BE0002408,Tyrosine-protein kinase JAK2,Humans,inhibitor,yes
DB04716,"2-tert-butyl-9-fluoro-1,6-dihydrobenzo[h]imidazo[4,5-f]isoquinolin-7-one",small molecule,experimental,CC(C)(C)C1=NC2=C3C=CNC(=O)C3=C3C=C(F)C=CC3=C2N1,VNDWQCSOSCCWIP-UHFFFAOYSA-N,309.3375,P52333,BE0003493,Tyrosine-protein kinase JAK3,Humans,inhibitor,yes
DB04716,"2-tert-butyl-9-fluoro-1,6-dihydrobenzo[h]imidazo[4,5-f]isoquinolin-7-one",small molecule,experimental,CC(C)(C)C1=NC2=C3C=CNC(=O)C3=C3C=C(F)C=CC3=C2N1,VNDWQCSOSCCWIP-UHFFFAOYSA-N,309.3375,P29597,BE0004146,Non-receptor tyrosine-protein kinase TYK2,Humans,inhibitor,yes
DB04719,"DIMETHYL-(4,5,6,7-TETRABROMO-1H-BENZOIMIDAZOL-2-YL)-AMINE",small molecule,experimental,CN(C)C1=NC2=C(Br)C(Br)=C(Br)C(Br)=C2N1,SLPJGDQJLTYWCI-UHFFFAOYSA-N,476.788,Q13627,BE0004012,Dual specificity tyrosine-phosphorylation-regulated kinase 1A,Humans,inhibitor,yes
DB04719,"DIMETHYL-(4,5,6,7-TETRABROMO-1H-BENZOIMIDAZOL-2-YL)-AMINE",small molecule,experimental,CN(C)C1=NC2=C(Br)C(Br)=C(Br)C(Br)=C2N1,SLPJGDQJLTYWCI-UHFFFAOYSA-N,476.788,Q92630,BE0017531,Dual specificity tyrosine-phosphorylation-regulated kinase 2,Humans,inhibitor,yes
DB04723,2-(3-GUANIDINOPHENYL)-3-MERCAPTOPROPANOIC ACID,small molecule,experimental,NC(N)=NC1=CC=CC(=C1)[C@@H](CS)C(O)=O,YHBCRXAIIVZWEW-MRVPVSSYSA-N,239.294,Q96IY4,BE0003407,Carboxypeptidase B2,Humans,inhibitor,yes
DB04725,Licofelone,small molecule,investigational,CC1(C)CN2C(CC(O)=O)=C(C(=C2C1)C1=CC=CC=C1)C1=CC=C(Cl)C=C1,UAWXGRJVZSAUSZ-UHFFFAOYSA-N,379.879,P09917,BE0000248,Polyunsaturated fatty acid 5-lipoxygenase,Humans,inhibitor,yes
DB04728,Lividomycin A,small molecule,experimental,NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)C[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O,DBLVDAUGBTYDFR-SWMBIRFSSA-N,761.7697,O14746,BE0002449,Telomerase reverse transcriptase,Humans,inhibitor,yes
DB04729,Gentamicin C1a,small molecule,experimental,CN[C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@H](N)C[C@H](N)[C@@H](O[C@H]3O[C@H](CN)CC[C@H]3N)[C@@H]2O)OC[C@]1(C)O,VEGXETMJINRLTH-BOZYPMBZSA-N,449.5423,P0A7S3,BE0000279,30S ribosomal protein S12,Escherichia coli (strain K12),adduct,yes
DB04729,Gentamicin C1a,small molecule,experimental,CN[C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@H](N)C[C@H](N)[C@@H](O[C@H]3O[C@H](CN)CC[C@H]3N)[C@@H]2O)OC[C@]1(C)O,VEGXETMJINRLTH-BOZYPMBZSA-N,449.5423,,BE0004799,16S ribosomal RNA,Enteric bacteria and other eubacteria,adduct,yes
DB04743,Nimesulide,small molecule,approved;investigational;withdrawn,CS(=O)(=O)NC1=C(OC2=CC=CC=C2)C=C(C=C1)[N+]([O-])=O,HYWYRSMBCFDLJT-UHFFFAOYSA-N,308.31,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB04743,Nimesulide,small molecule,approved;investigational;withdrawn,CS(=O)(=O)NC1=C(OC2=CC=CC=C2)C=C(C=C1)[N+]([O-])=O,HYWYRSMBCFDLJT-UHFFFAOYSA-N,308.31,P50591,BE0010497,Tumor necrosis factor ligand superfamily member 10,Humans,modulator,yes
DB04743,Nimesulide,small molecule,approved;investigational;withdrawn,CS(=O)(=O)NC1=C(OC2=CC=CC=C2)C=C(C=C1)[N+]([O-])=O,HYWYRSMBCFDLJT-UHFFFAOYSA-N,308.31,P02788,BE0000994,Lactotransferrin,Humans,inhibitor,yes
DB04745,2-Hydroxyquinoline,small molecule,experimental,O=C1NC2=C(C=CC=C2)C=C1,LISFMEBWQUVKPJ-UHFFFAOYSA-N,145.158,P11388,BE0000742,DNA topoisomerase 2-alpha,Humans,inhibitor,yes
DB04745,2-Hydroxyquinoline,small molecule,experimental,O=C1NC2=C(C=CC=C2)C=C1,LISFMEBWQUVKPJ-UHFFFAOYSA-N,145.158,Q02880,BE0002425,DNA topoisomerase 2-beta,Humans,inhibitor,yes
DB04751,Purvalanol A,small molecule,experimental,[H][C@@](CO)(NC1=NC(NC2=CC=CC(Cl)=C2)=C2N=CN(C(C)C)C2=N1)C(C)C,PMXCMJLOPOFPBT-HNNXBMFYSA-N,388.894,P24941,BE0001072,Cyclin-dependent kinase 2,Humans,inhibitor,yes
DB04751,Purvalanol A,small molecule,experimental,[H][C@@](CO)(NC1=NC(NC2=CC=CC(Cl)=C2)=C2N=CN(C(C)C)C2=N1)C(C)C,PMXCMJLOPOFPBT-HNNXBMFYSA-N,388.894,P06493,BE0001082,Cyclin-dependent kinase 1,Humans,inhibitor,yes
DB04753,"9-DEAZAINOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE",small molecule,experimental,OC[C@H]1O[C@H]([C@@H]2O[C@H](CP(O)(O)=O)O[C@H]12)C1=CNC2=C1NC=NC2=O,ZOEDLCUBOBTIHG-USQSKNHBSA-N,373.2552,P00491,BE0000250,Purine nucleoside phosphorylase,Humans,inhibitor,yes
DB04754,"GUANOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE",small molecule,experimental,NC1=NC(=O)C2=C(N1)N(C=N2)[C@@H]1O[C@H](CO)[C@H]2O[C@@H](CP(O)(O)=O)O[C@@H]12,HYAPEMYRVFIHDJ-QWEIRQIHSA-N,389.2579,P00491,BE0000250,Purine nucleoside phosphorylase,Humans,inhibitor,yes
DB04757,"GUANOSINE-2',3'-O-METHYLIDENEPHOSPHONATE",small molecule,experimental,NC1=NC(=O)C2=C(N1)N(C=N2)[C@@H]1O[C@H](CO)[C@H]2O[C@@H](O[C@@H]12)P(O)(O)=O,GKAPYWCOOQBBHV-KXSYMAMXSA-N,375.2313,P00491,BE0000250,Purine nucleoside phosphorylase,Humans,inhibitor,yes
DB04769,"5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE",small molecule,experimental,O=C1NC(=O)\C(S1)=C\C1=CC2=C(C=C1)N=CC=N2,SQWZFLMPDUSYGV-POHAHGRESA-N,257.268,P48736,BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",Humans,inhibitor,yes
DB04769,"5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE",small molecule,experimental,O=C1NC(=O)\C(S1)=C\C1=CC2=C(C=C1)N=CC=N2,SQWZFLMPDUSYGV-POHAHGRESA-N,257.268,P27338,BE0002196,Amine oxidase [flavin-containing] B,Humans,inhibitor,yes
DB04786,Suramin,small molecule,investigational,CC1=C(NC(=O)C2=CC(NC(=O)NC3=CC=CC(=C3)C(=O)NC3=C(C)C=CC(=C3)C(=O)NC3=C4C(C=C(C=C4S(O)(=O)=O)S(O)(=O)=O)=C(C=C3)S(O)(=O)=O)=CC=C2)C=C(C=C1)C(=O)NC1=C2C(C=C(C=C2S(O)(=O)=O)S(O)(=O)=O)=C(C=C1)S(O)(=O)=O,FIAFUQMPZJWCLV-UHFFFAOYSA-N,1297.28,Q9Y251,BE0001064,Heparanase,Humans,inhibitor,yes
DB04786,Suramin,small molecule,investigational,CC1=C(NC(=O)C2=CC(NC(=O)NC3=CC=CC(=C3)C(=O)NC3=C(C)C=CC(=C3)C(=O)NC3=C4C(C=C(C=C4S(O)(=O)=O)S(O)(=O)=O)=C(C=C3)S(O)(=O)=O)=CC=C2)C=C(C=C1)C(=O)NC1=C2C(C=C(C=C2S(O)(=O)=O)S(O)(=O)=O)=C(C=C1)S(O)(=O)=O,FIAFUQMPZJWCLV-UHFFFAOYSA-N,1297.28,P41231,BE0002401,P2Y purinoceptor 2,Humans,antagonist,yes
DB04786,Suramin,small molecule,investigational,CC1=C(NC(=O)C2=CC(NC(=O)NC3=CC=CC(=C3)C(=O)NC3=C(C)C=CC(=C3)C(=O)NC3=C4C(C=C(C=C4S(O)(=O)=O)S(O)(=O)=O)=C(C=C3)S(O)(=O)=O)=CC=C2)C=C(C=C1)C(=O)NC1=C2C(C=C(C=C2S(O)(=O)=O)S(O)(=O)=O)=C(C=C1)S(O)(=O)=O,FIAFUQMPZJWCLV-UHFFFAOYSA-N,1297.28,Q9NXA8,BE0003362,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",Humans,inhibitor,yes
DB04786,Suramin,small molecule,investigational,CC1=C(NC(=O)C2=CC(NC(=O)NC3=CC=CC(=C3)C(=O)NC3=C(C)C=CC(=C3)C(=O)NC3=C4C(C=C(C=C4S(O)(=O)=O)S(O)(=O)=O)=C(C=C3)S(O)(=O)=O)=CC=C2)C=C(C=C1)C(=O)NC1=C2C(C=C(C=C2S(O)(=O)=O)S(O)(=O)=O)=C(C=C1)S(O)(=O)=O,FIAFUQMPZJWCLV-UHFFFAOYSA-N,1297.28,P23945,BE0000387,Follicle-stimulating hormone receptor,Humans,antagonist,yes
DB04787,Tanaproget,small molecule,investigational,CN1C(=CC=C1C1=CC=C2NC(=S)OC(C)(C)C2=C1)C#N,PYVFWTPEBMRKSR-UHFFFAOYSA-N,297.375,P06401,BE0000557,Progesterone receptor,Humans,agonist,yes
DB04794,Bifonazole,small molecule,approved;investigational,C1=CN(C=N1)C(C1=CC=CC=C1)C1=CC=C(C=C1)C1=CC=CC=C1,OCAPBUJLXMYKEJ-UHFFFAOYSA-N,310.3917,P10613,BE0000233,Lanosterol 14-alpha demethylase,Yeast,inhibitor,yes
DB04795,Thenoyltrifluoroacetone,small molecule,experimental,FC(F)(F)C(=O)CC(=O)C1=CC=CS1,TXBBUSUXYMIVOS-UHFFFAOYSA-N,222.184,P23141,BE0002705,Liver carboxylesterase 1,Humans,inhibitor,yes
DB04796,Inecalcitol,small molecule,investigational,[H][C@@]1(CC[C@]2([H])\C(CCC[C@]12C)=C\C=C1C[C@@H](O)C[C@H](O)C1)[C@H](C)CC#CC(C)(C)O,HHGRMHMXKPQNGF-WNSNRMDMSA-N,400.603,P11473,BE0000779,Vitamin D3 receptor,Humans,agonist,yes
DB04797,Triazolopyridine,small molecule,experimental,CC(C)C1=NN=C2C=CC(=CN12)C1=C(N=CO1)C1=CC=C(F)C=C1,OVCXRBARSPBVMC-UHFFFAOYSA-N,322.3363,Q16539,BE0001019,Mitogen-activated protein kinase 14,Humans,inhibitor,yes
DB04800,1-METHYL-3-PHENYL-1H-PYRAZOL-5-YLSULFAMIC ACID,small molecule,experimental,CN1N=C(C=C1NS(O)(=O)=O)C1=CC=CC=C1,OTZLVSGSRPNRFT-UHFFFAOYSA-N,253.278,P18031,BE0000623,Tyrosine-protein phosphatase non-receptor type 1,Humans,inhibitor,yes
DB04801,cis-Vaccenic acid,small molecule,experimental,CCCCCC\C=C/CCCCCCCCCC(O)=O,UWHZIFQPPBDJPM-FPLPWBNLSA-N,282.4614,Q03181,BE0001007,Peroxisome proliferator-activated receptor delta,Humans,inhibitor,yes
DB04812,Benoxaprofen,small molecule,approved;withdrawn,CC(C(O)=O)C1=CC2=C(OC(=N2)C2=CC=C(Cl)C=C2)C=C1,MITFXPHMIHQXPI-UHFFFAOYSA-N,301.724,P24752,BE0000069,"Acetyl-CoA acetyltransferase, mitochondrial",Humans,inhibitor,yes
DB04813,Bithionol,small molecule,approved;withdrawn,OC1=C(SC2=C(O)C(Cl)=CC(Cl)=C2)C=C(Cl)C=C1Cl,JFIOVJDNOJYLKP-UHFFFAOYSA-N,356.052,P03372,BE0000123,Estrogen receptor,Humans,inhibitor,yes
DB04813,Bithionol,small molecule,approved;withdrawn,OC1=C(SC2=C(O)C(Cl)=CC(Cl)=C2)C=C(Cl)C=C1Cl,JFIOVJDNOJYLKP-UHFFFAOYSA-N,356.052,P17655,BE0012693,Calpain-2 catalytic subunit,Humans,inhibitor,yes
DB04813,Bithionol,small molecule,approved;withdrawn,OC1=C(SC2=C(O)C(Cl)=CC(Cl)=C2)C=C(Cl)C=C1Cl,JFIOVJDNOJYLKP-UHFFFAOYSA-N,356.052,Q92731,BE0000792,Estrogen receptor beta,Humans,inhibitor,yes
DB04813,Bithionol,small molecule,approved;withdrawn,OC1=C(SC2=C(O)C(Cl)=CC(Cl)=C2)C=C(Cl)C=C1Cl,JFIOVJDNOJYLKP-UHFFFAOYSA-N,356.052,Q07820,BE0003511,Induced myeloid leukemia cell differentiation protein Mcl-1,Humans,inhibitor,yes
DB04815,Clioquinol,small molecule,approved;vet_approved;withdrawn,OC1=C(I)C=C(Cl)C2=C1N=CC=C2,QCDFBFJGMNKBDO-UHFFFAOYSA-N,305.5,P41145,BE0000632,Kappa-type opioid receptor,Humans,inhibitor,yes
DB04817,Metamizole,small molecule,approved;investigational;withdrawn,CN(CS(O)(=O)=O)C1=C(C)N(C)N(C1=O)C1=CC=CC=C1,LVWZTYCIRDMTEY-UHFFFAOYSA-N,311.36,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB04818,Iproniazid,small molecule,withdrawn,CC(C)NNC(=O)C1=CC=NC=C1,NYMGNSNKLVNMIA-UHFFFAOYSA-N,179.219,P21397,BE0002198,Amine oxidase [flavin-containing] A,Humans,inhibitor,yes
DB04818,Iproniazid,small molecule,withdrawn,CC(C)NNC(=O)C1=CC=NC=C1,NYMGNSNKLVNMIA-UHFFFAOYSA-N,179.219,P27338,BE0002196,Amine oxidase [flavin-containing] B,Humans,inhibitor,yes
DB04821,Nomifensine,small molecule,approved;withdrawn,CN1CC(C2=CC=CC=C2)C2=C(C1)C(N)=CC=C2,XXPANQJNYNUNES-UHFFFAOYSA-N,238.3275,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB04825,Prenylamine,small molecule,approved;withdrawn,CC(CC1=CC=CC=C1)NCCC(C1=CC=CC=C1)C1=CC=CC=C1,IFFPICMESYHZPQ-UHFFFAOYSA-N,329.4779,Q9H1R3,BE0004946,"Myosin light chain kinase 2, skeletal/cardiac muscle",Humans,inhibitor,yes
DB04825,Prenylamine,small molecule,approved;withdrawn,CC(CC1=CC=CC=C1)NCCC(C1=CC=CC=C1)C1=CC=CC=C1,IFFPICMESYHZPQ-UHFFFAOYSA-N,329.4779,P0DP23,BE0027477,Calmodulin,Humans,,yes
DB04828,Zomepirac,small molecule,withdrawn,CN1C(CC(O)=O)=CC(C)=C1C(=O)C1=CC=C(Cl)C=C1,ZXVNMYWKKDOREA-UHFFFAOYSA-N,291.73,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,modulator,yes
DB04828,Zomepirac,small molecule,withdrawn,CN1C(CC(O)=O)=CC(C)=C1C(=O)C1=CC=C(Cl)C=C1,ZXVNMYWKKDOREA-UHFFFAOYSA-N,291.73,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,modulator,yes
DB04829,Lysergic acid diethylamide,small molecule,illicit;investigational;withdrawn,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N(CC)CC,VAYOSLLFUXYJDT-RDTXWAMCSA-N,323.432,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,inhibitor,yes
DB04829,Lysergic acid diethylamide,small molecule,illicit;investigational;withdrawn,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N(CC)CC,VAYOSLLFUXYJDT-RDTXWAMCSA-N,323.432,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,inhibitor,yes
DB04832,Zimelidine,small molecule,approved;withdrawn,CN(C)C\C=C(\C1=CC=C(Br)C=C1)C1=CC=CN=C1,OYPPVKRFBIWMSX-SXGWCWSVSA-N,317.23,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB04834,Rapacuronium,small molecule,approved;withdrawn,[H][C@@]12C[C@@H]([C@H](OC(=O)CC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)N1CCCCC1)[N+]1(CC=C)CCCCC1,HTIKWNNIPGXLGM-YLINKJIISA-N,597.904,P08172,BE0000560,Muscarinic acetylcholine receptor M2,Humans,antagonist,yes
DB04835,Maraviroc,small molecule,approved;investigational,CC(C)C1=NN=C(C)N1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)C1=CC=CC=C1,GSNHKUDZZFZSJB-QYOOZWMWSA-N,513.6655,P51681,BE0000911,C-C chemokine receptor type 5,Humans,antagonist;inhibitor,yes
DB04836,Amineptine,small molecule,illicit;withdrawn,OC(=O)CCCCCCNC1C2=CC=CC=C2CCC2=CC=CC=C12,ONNOFKFOZAJDHT-UHFFFAOYSA-N,337.463,Q01959,BE0000647,Sodium-dependent dopamine transporter,Humans,inhibitor,yes
DB04837,Clofedanol,small molecule,approved;withdrawn,CN(C)CCC(O)(C1=CC=CC=C1)C1=CC=CC=C1Cl,WRCHFMBCVFFYEQ-UHFFFAOYSA-N,289.8,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB04839,Cyproterone acetate,small molecule,approved;investigational,[H][C@@]12C[C@]1([H])[C@@]1(C)C(=CC2=O)C(Cl)=C[C@@]2([H])[C@]3([H])CC[C@](OC(C)=O)(C(C)=O)[C@@]3(C)CC[C@]12[H],UWFYSQMTEOIJJG-FDTZYFLXSA-N,416.938,P10275,BE0000132,Androgen receptor,Humans,antagonist,yes
DB04840,Debrisoquine,small molecule,approved;investigational,NC(=N)N1CCC2=CC=CC=C2C1,JWPGJSVJDAJRLW-UHFFFAOYSA-N,175.2303,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,inducer,yes
DB04841,Flunarizine,small molecule,approved,FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1,SMANXXCATUTDDT-QPJJXVBHSA-N,404.4948,O00555,BE0000356,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,Humans,inhibitor,yes
DB04841,Flunarizine,small molecule,approved,FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1,SMANXXCATUTDDT-QPJJXVBHSA-N,404.4948,O43497,BE0000483,Voltage-dependent T-type calcium channel subunit alpha-1G,Humans,inhibitor,yes
DB04841,Flunarizine,small molecule,approved,FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1,SMANXXCATUTDDT-QPJJXVBHSA-N,404.4948,O95180,BE0000864,Voltage-dependent T-type calcium channel subunit alpha-1H,Humans,inhibitor,yes
DB04841,Flunarizine,small molecule,approved,FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1,SMANXXCATUTDDT-QPJJXVBHSA-N,404.4948,Q9P0X4,BE0000012,Voltage-dependent T-type calcium channel subunit alpha-1I,Humans,inhibitor,yes
DB04841,Flunarizine,small molecule,approved,FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1,SMANXXCATUTDDT-QPJJXVBHSA-N,404.4948,P0DP23,BE0027477,Calmodulin,Humans,antagonist,yes
DB04842,Fluspirilene,small molecule,approved;investigational,FC1=CC=C(C=C1)C(CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1)C1=CC=C(F)C=C1,QOYHHIBFXOOADH-UHFFFAOYSA-N,475.5727,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB04843,Mepenzolate,small molecule,approved,C[N+]1(C)CCCC(C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1,GKNPSSNBBWDAGH-UHFFFAOYSA-N,340.436,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,antagonist,yes
DB04843,Mepenzolate,small molecule,approved,C[N+]1(C)CCCC(C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1,GKNPSSNBBWDAGH-UHFFFAOYSA-N,340.436,P08912,BE0000247,Muscarinic acetylcholine receptor M5,Humans,antagonist,yes
DB04843,Mepenzolate,small molecule,approved,C[N+]1(C)CCCC(C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1,GKNPSSNBBWDAGH-UHFFFAOYSA-N,340.436,P20309,BE0000045,Muscarinic acetylcholine receptor M3,Humans,antagonist,yes
DB04844,Tetrabenazine,small molecule,approved;investigational,COC1=C(OC)C=C2C3CC(=O)C(CC(C)C)CN3CCC2=C1,MKJIEFSOBYUXJB-UHFFFAOYSA-N,317.4226,Q05940,BE0000118,Synaptic vesicular amine transporter,Humans,inhibitor,yes
DB04845,Ixabepilone,small molecule,approved;investigational,[H][C@]12C[C@H](NC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)CCC[C@@]1(C)O2)C(\C)=C\C1=CSC(C)=N1,FABUFPQFXZVHFB-PVYNADRNSA-N,506.7,Q13509,BE0001415,Tubulin beta-3 chain,Humans,inhibitor,yes
DB04846,Celiprolol,small molecule,approved;investigational,CCN(CC)C(=O)NC1=CC=C(OCC(O)CNC(C)(C)C)C(=C1)C(C)=O,JOATXPAWOHTVSZ-UHFFFAOYSA-N,379.501,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,antagonist,yes
DB04846,Celiprolol,small molecule,approved;investigational,CCN(CC)C(=O)NC1=CC=C(OCC(O)CNC(C)(C)C)C(=C1)C(C)=O,JOATXPAWOHTVSZ-UHFFFAOYSA-N,379.501,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,agonist,yes
DB04847,Roxadustat,small molecule,approved;investigational,CC1=NC(C(=O)NCC(O)=O)=C(O)C2=C1C=C(OC1=CC=CC=C1)C=C2,YOZBGTLTNGAVFU-UHFFFAOYSA-N,352.346,Q9GZT9,BE0002217,Egl nine homolog 1,Humans,inhibitor,yes
DB04847,Roxadustat,small molecule,approved;investigational,CC1=NC(C(=O)NCC(O)=O)=C(O)C2=C1C=C(OC1=CC=CC=C1)C=C2,YOZBGTLTNGAVFU-UHFFFAOYSA-N,352.346,Q96KS0,BE0002211,Prolyl hydroxylase EGLN2,Humans,inhibitor,yes
DB04847,Roxadustat,small molecule,approved;investigational,CC1=NC(C(=O)NCC(O)=O)=C(O)C2=C1C=C(OC1=CC=CC=C1)C=C2,YOZBGTLTNGAVFU-UHFFFAOYSA-N,352.346,Q9H6Z9,BE0002219,Prolyl hydroxylase EGLN3,Humans,inhibitor,yes
DB04849,Cediranib,small molecule,investigational,COC1=CC2=C(C=C1OCCCN1CCCC1)N=CN=C2OC1=C(F)C2=C(NC(C)=C2)C=C1,XXJWYDDUDKYVKI-UHFFFAOYSA-N,450.5053,P35968,BE0000369,Vascular endothelial growth factor receptor 2,Humans,inhibitor,yes
DB04850,Posizolid,small molecule,investigational,OC[C@H](O)C(=O)N1CCC(=CC1)C1=C(F)C=C(C=C1F)N1C[C@H](COC2=NOC=C2)OC1=O,HBUJYEUPIIJJOS-PBHICJAKSA-N,465.41,,BE0004800,23S ribosomal RNA,Enteric bacteria and other eubacteria,antagonist;blocker,yes
DB04851,Biricodar,small molecule,investigational,COC1=CC(=CC(OC)=C1OC)C(=O)C(=O)N1CCCC[C@H]1C(=O)OC(CCCC1=CN=CC=C1)CCCC1=CN=CC=C1,CGVWPQOFHSAKRR-NDEPHWFRSA-N,603.716,P08183,BE0001032,ATP-dependent translocase ABCB1,Humans,modulator,yes
DB04852,Implitapide,small molecule,investigational,CC1=NC2=C(C3=CC=CC=C3N2CC2=CC(=CC=C2)[C@H](C2CCCC2)C(=O)N[C@@H](CO)C2=CC=CC=C2)C(C)=C1,AMNXBQPRODZJQR-DITALETJSA-N,531.6872,P55157,BE0000232,Microsomal triglyceride transfer protein large subunit,Humans,inhibitor,yes
DB04853,Binodenoson,small molecule,investigational,OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=C(N\N=C\C3CCCCC3)N=C12,XJFMHMFFBSOEPR-DNZQAUTHSA-N,391.4249,P29274,BE0000924,Adenosine receptor A2a,Humans,agonist,yes
DB04854,Febuxostat,small molecule,approved,CC(C)COC1=C(C=C(C=C1)C1=NC(C)=C(S1)C(O)=O)C#N,BQSJTQLCZDPROO-UHFFFAOYSA-N,316.375,P47989,BE0002204,Xanthine dehydrogenase/oxidase,Humans,inhibitor,yes
DB04855,Dronedarone,small molecule,approved,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2,ZQTNQVWKHCQYLQ-UHFFFAOYSA-N,556.756,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,antagonist,yes
DB04855,Dronedarone,small molecule,approved,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2,ZQTNQVWKHCQYLQ-UHFFFAOYSA-N,556.756,P22460,BE0004717,Potassium voltage-gated channel subfamily A member 5,Humans,blocker,yes
DB04855,Dronedarone,small molecule,approved,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2,ZQTNQVWKHCQYLQ-UHFFFAOYSA-N,556.756,P35368,BE0000575,Alpha-1B adrenergic receptor,Humans,antagonist,yes
DB04855,Dronedarone,small molecule,approved,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2,ZQTNQVWKHCQYLQ-UHFFFAOYSA-N,556.756,P25100,BE0000715,Alpha-1D adrenergic receptor,Humans,antagonist,yes
DB04855,Dronedarone,small molecule,approved,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2,ZQTNQVWKHCQYLQ-UHFFFAOYSA-N,556.756,P08913,BE0000289,Alpha-2A adrenergic receptor,Humans,antagonist,yes
DB04855,Dronedarone,small molecule,approved,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2,ZQTNQVWKHCQYLQ-UHFFFAOYSA-N,556.756,P18089,BE0000572,Alpha-2B adrenergic receptor,Humans,antagonist,yes
DB04855,Dronedarone,small molecule,approved,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2,ZQTNQVWKHCQYLQ-UHFFFAOYSA-N,556.756,P18825,BE0000342,Alpha-2C adrenergic receptor,Humans,antagonist,yes
DB04855,Dronedarone,small molecule,approved,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2,ZQTNQVWKHCQYLQ-UHFFFAOYSA-N,556.756,Q12809,BE0000090,Voltage-gated inwardly rectifying potassium channel KCNH2,Humans,inhibitor,yes
DB04855,Dronedarone,small molecule,approved,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2,ZQTNQVWKHCQYLQ-UHFFFAOYSA-N,556.756,Q13936,BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,Humans,inhibitor,yes
DB04855,Dronedarone,small molecule,approved,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2,ZQTNQVWKHCQYLQ-UHFFFAOYSA-N,556.756,Q01668,BE0002359,Voltage-dependent L-type calcium channel subunit alpha-1D,Humans,inhibitor,yes
DB04855,Dronedarone,small molecule,approved,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2,ZQTNQVWKHCQYLQ-UHFFFAOYSA-N,556.756,O60840,BE0002357,Voltage-dependent L-type calcium channel subunit alpha-1F,Humans,inhibitor,yes
DB04855,Dronedarone,small molecule,approved,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2,ZQTNQVWKHCQYLQ-UHFFFAOYSA-N,556.756,Q13698,BE0002355,Voltage-dependent L-type calcium channel subunit alpha-1S,Humans,inhibitor,yes
DB04855,Dronedarone,small molecule,approved,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2,ZQTNQVWKHCQYLQ-UHFFFAOYSA-N,556.756,Q02641,BE0000303,Voltage-dependent L-type calcium channel subunit beta-1,Humans,inhibitor,yes
DB04855,Dronedarone,small molecule,approved,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2,ZQTNQVWKHCQYLQ-UHFFFAOYSA-N,556.756,Q08289,BE0002354,Voltage-dependent L-type calcium channel subunit beta-2,Humans,inhibitor,yes
DB04855,Dronedarone,small molecule,approved,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2,ZQTNQVWKHCQYLQ-UHFFFAOYSA-N,556.756,P54284,BE0002358,Voltage-dependent L-type calcium channel subunit beta-3,Humans,inhibitor,yes
DB04855,Dronedarone,small molecule,approved,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2,ZQTNQVWKHCQYLQ-UHFFFAOYSA-N,556.756,O00305,BE0002356,Voltage-dependent L-type calcium channel subunit beta-4,Humans,inhibitor,yes
DB04855,Dronedarone,small molecule,approved,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2,ZQTNQVWKHCQYLQ-UHFFFAOYSA-N,556.756,O95069,BE0000210,Potassium channel subfamily K member 2,Humans,inhibitor,yes
DB04855,Dronedarone,small molecule,approved,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2,ZQTNQVWKHCQYLQ-UHFFFAOYSA-N,556.756,Q14524,BE0000197,Sodium channel protein type 5 subunit alpha,Humans,inhibitor,yes
DB04855,Dronedarone,small molecule,approved,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2,ZQTNQVWKHCQYLQ-UHFFFAOYSA-N,556.756,P48549,BE0001028,G protein-activated inward rectifier potassium channel 1,Humans,inhibitor,yes
DB04855,Dronedarone,small molecule,approved,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2,ZQTNQVWKHCQYLQ-UHFFFAOYSA-N,556.756,P51787,BE0000672,Potassium voltage-gated channel subfamily KQT member 1,Humans,inhibitor,yes
DB04855,Dronedarone,small molecule,approved,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2,ZQTNQVWKHCQYLQ-UHFFFAOYSA-N,556.756,Q14500,BE0009631,Inward rectifier potassium channel,Humans,inhibitor,yes
DB04855,Dronedarone,small molecule,approved,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2,ZQTNQVWKHCQYLQ-UHFFFAOYSA-N,556.756,P32418,BE0000986,Sodium/calcium exchanger 1,Humans,inhibitor,yes
DB04855,Dronedarone,small molecule,approved,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2,ZQTNQVWKHCQYLQ-UHFFFAOYSA-N,556.756,Q9UK17,BE0003604,A-type voltage-gated potassium channel KCND3,Humans,inhibitor,yes
DB04856,Dexloxiglumide,small molecule,investigational,CCCCCN(CCCOC)C(=O)[C@@H](CCC(O)=O)NC(=O)C1=CC(Cl)=C(Cl)C=C1,QNQZBKQEIFTHFZ-GOSISDBHSA-N,461.379,P32239,BE0001158,Gastrin/cholecystokinin type B receptor,Humans,inhibitor,yes
DB04856,Dexloxiglumide,small molecule,investigational,CCCCCN(CCCOC)C(=O)[C@@H](CCC(O)=O)NC(=O)C1=CC(Cl)=C(Cl)C=C1,QNQZBKQEIFTHFZ-GOSISDBHSA-N,461.379,P32238,BE0000402,Cholecystokinin receptor type A,Humans,inhibitor,yes
DB04857,Brasofensine,small molecule,investigational,[H][C@@]12CC[C@@]([H])(N1C)[C@]([H])(\C=N\OC)[C@H](C2)C1=CC(Cl)=C(Cl)C=C1,NRLIFEGHTNUYFL-QJDHNRDASA-N,327.25,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,modulator,yes
DB04858,Tirapazamine,small molecule,investigational,NC1=[N+]([O-])C2=C(C=CC=C2)[N+]([O-])=N1,ORYDPOVDJJZGHQ-UHFFFAOYSA-N,178.151,P11388,BE0000742,DNA topoisomerase 2-alpha,Humans,modulator,yes
DB04858,Tirapazamine,small molecule,investigational,NC1=[N+]([O-])C2=C(C=CC=C2)[N+]([O-])=N1,ORYDPOVDJJZGHQ-UHFFFAOYSA-N,178.151,Q02880,BE0002425,DNA topoisomerase 2-beta,Humans,modulator,yes
DB04859,Zanapezil,small molecule,investigational,O=C(CCC1CCN(CC2=CC=CC=C2)CC1)C1=CC2=C(CCCCN2)C=C1,PMBLXLOXUGVTGB-UHFFFAOYSA-N,376.5344,P22303,BE0000426,Acetylcholinesterase,Humans,inhibitor,yes
DB04860,Isatoribine,small molecule,investigational,NC1=NC(=O)C2=C(N1)N([C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)C(=O)S2,TZYVRXZQAWPIAB-FCLHUMLKSA-N,316.29,Q9NYK1,BE0000155,Toll-like receptor 7,Humans,agonist,yes
DB04861,Nebivolol,small molecule,approved;investigational,OC(CNCC(O)C1CCC2=C(O1)C=CC(F)=C2)C1CCC2=C(O1)C=CC(F)=C2,KOHIRBRYDXPAMZ-UHFFFAOYSA-N,405.435,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,antagonist,yes
DB04862,Merimepodib,small molecule,investigational,COC1=C(C=CC(NC(=O)NC2=CC=CC(CNC(=O)O[C@H]3CCOC3)=C2)=C1)C1=CN=CO1,JBPUGFODGPKTDW-SFHVURJKSA-N,452.4599,P20839,BE0000761,Inosine-5'-monophosphate dehydrogenase 1,Humans,inhibitor,yes
DB04862,Merimepodib,small molecule,investigational,COC1=C(C=CC(NC(=O)NC2=CC=CC(CNC(=O)O[C@H]3CCOC3)=C2)=C1)C1=CN=CO1,JBPUGFODGPKTDW-SFHVURJKSA-N,452.4599,P04626,BE0000511,Receptor tyrosine-protein kinase erbB-2,Humans,inhibitor,yes
DB04862,Merimepodib,small molecule,investigational,COC1=C(C=CC(NC(=O)NC2=CC=CC(CNC(=O)O[C@H]3CCOC3)=C2)=C1)C1=CN=CO1,JBPUGFODGPKTDW-SFHVURJKSA-N,452.4599,P00533,BE0000767,Epidermal growth factor receptor,Humans,inhibitor,yes
DB04863,Lefradafiban,small molecule,investigational,[H][C@@]1(COC2=CC=C(C=C2)C2=CC=C(C=C2)C(=N)NC(=O)OC)C[C@@H](CC(=O)OC)C(=O)N1,PGCFXITVMNNKON-ROUUACIJSA-N,439.4611,P08514,BE0000439,Integrin alpha-IIb,Humans,modulator,yes
DB04863,Lefradafiban,small molecule,investigational,[H][C@@]1(COC2=CC=C(C=C2)C2=CC=C(C=C2)C(=N)NC(=O)OC)C[C@@H](CC(=O)OC)C(=O)N1,PGCFXITVMNNKON-ROUUACIJSA-N,439.4611,P05106,BE0001155,Integrin beta-3,Humans,modulator,yes
DB04864,Huperzine A,small molecule,approved;experimental,[H][C@@]12CC3=C(C=CC(=O)N3)[C@@](N)(CC(C)=C1)\C2=C\C,ZRJBHWIHUMBLCN-YQEJDHNASA-N,242.3162,P22303,BE0000426,Acetylcholinesterase,Humans,inhibitor,yes
DB04865,Omacetaxine mepesuccinate,small molecule,approved;investigational,[H][C@@]1(OC(=O)[C@@](O)(CCCC(C)(C)O)CC(=O)OC)C(OC)=C[C@]23CCCN2CCC2=CC4=C(OCO4)C=C2[C@]13[H],HYFHYPWGAURHIV-JFIAXGOJSA-N,545.6213,P20276,BE0004749,50S ribosomal protein L2,Haloarcula marismortui (strain ATCC 43049 / DSM 3752 / JCM 8966 / VKM B-1809),antagonist,yes
DB04865,Omacetaxine mepesuccinate,small molecule,approved;investigational,[H][C@@]1(OC(=O)[C@@](O)(CCCC(C)(C)O)CC(=O)OC)C(OC)=C[C@]23CCCN2CCC2=CC4=C(OCO4)C=C2[C@]13[H],HYFHYPWGAURHIV-JFIAXGOJSA-N,545.6213,P39023,BE0003833,Large ribosomal subunit protein uL3,Humans,antagonist,yes
DB04867,Lintitript,small molecule,investigational,OC(=O)CN1C(=CC2=CC=CC=C12)C(=O)NC1=NC(=CS1)C1=CC=CC=C1Cl,ILNRQFBVVQUOLP-UHFFFAOYSA-N,411.861,P32238,BE0000402,Cholecystokinin receptor type A,Humans,antagonist,yes
DB04868,Nilotinib,small molecule,approved;investigational,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,HHZIURLSWUIHRB-UHFFFAOYSA-N,529.5158,P00519,BE0000014,Tyrosine-protein kinase ABL1,Humans,inhibitor,yes
DB04870,Oleoyl-estrone,small molecule,investigational,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OC(=O)CCCCCCC\C=C/CCCCCCCC)C=C3,IMIPDPVHGGHVNH-YWVHRCQQSA-N,534.8122,Q14832,BE0002342,Metabotropic glutamate receptor 3,Humans,agonist,yes
DB04870,Oleoyl-estrone,small molecule,investigational,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OC(=O)CCCCCCC\C=C/CCCCCCCC)C=C3,IMIPDPVHGGHVNH-YWVHRCQQSA-N,534.8122,Q14416,BE0000974,Metabotropic glutamate receptor 2,Humans,agonist,yes
DB04871,Lorcaserin,small molecule,approved;withdrawn,C[C@H]1CNCCC2=CC=C(Cl)C=C12,XTTZERNUQAFMOF-QMMMGPOBSA-N,195.69,P28335,BE0000533,5-hydroxytryptamine receptor 2C,Humans,agonist,yes
DB04872,Osanetant,small molecule,investigational,CN(C(C)=O)C1(CCN(CCC[C@@]2(CCCN(C2)C(=O)C2=CC=CC=C2)C2=CC(Cl)=C(Cl)C=C2)CC1)C1=CC=CC=C1,DZOJBGLFWINFBF-UMSFTDKQSA-N,606.625,P29371,BE0002371,Neuromedin-K receptor,Humans,antagonist,yes
DB04873,Piboserod,small molecule,investigational,CCCCN1CCC(CNC(=O)C2=C3OCCCN3C3=CC=CC=C23)CC1,KVCSJPATKXABRQ-UHFFFAOYSA-N,369.5004,Q13639,BE0000084,5-hydroxytryptamine receptor 4,Humans,antagonist,yes
DB04875,Pralnacasan,small molecule,investigational,CCO[C@@H]1OC(=O)C[C@@H]1NC(=O)[C@@H]1CCCN2N1C(=O)[C@H](CCC2=O)NC(=O)C1=NC=CC2=CC=CC=C12,CXAGHAZMQSCAKJ-WAHHBDPQSA-N,523.5378,P29466,BE0000444,Caspase-1,Humans,modulator,yes
DB04876,Vildagliptin,small molecule,approved;investigational,OC12CC3CC(C1)CC(C3)(C2)NCC(=O)N1CCC[C@H]1C#N,SYOKIDBDQMKNDQ-XWTIBIIYSA-N,303.3993,P27487,BE0000854,Dipeptidyl peptidase 4,Humans,inhibitor,yes
DB04878,Voglibose,small molecule,investigational,OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O,FZNCGRZWXLXZSZ-CIQUZCHMSA-N,267.2762,O43451,BE0000837,Maltase-glucoamylase,Humans,inhibitor,yes
DB04879,Vatalanib,small molecule,investigational,ClC1=CC=C(NC2=NN=C(CC3=CC=NC=C3)C3=CC=CC=C23)C=C1,YCOYDOIWSSHVCK-UHFFFAOYSA-N,346.813,P00533,BE0000767,Epidermal growth factor receptor,Humans,inhibitor,yes
DB04879,Vatalanib,small molecule,investigational,ClC1=CC=C(NC2=NN=C(CC3=CC=NC=C3)C3=CC=CC=C23)C=C1,YCOYDOIWSSHVCK-UHFFFAOYSA-N,346.813,P35916,BE0000023,Vascular endothelial growth factor receptor 3,Humans,inhibitor,yes
DB04879,Vatalanib,small molecule,investigational,ClC1=CC=C(NC2=NN=C(CC3=CC=NC=C3)C3=CC=CC=C23)C=C1,YCOYDOIWSSHVCK-UHFFFAOYSA-N,346.813,P35968,BE0000369,Vascular endothelial growth factor receptor 2,Humans,inhibitor,yes
DB04879,Vatalanib,small molecule,investigational,ClC1=CC=C(NC2=NN=C(CC3=CC=NC=C3)C3=CC=CC=C23)C=C1,YCOYDOIWSSHVCK-UHFFFAOYSA-N,346.813,P17948,BE0000029,Vascular endothelial growth factor receptor 1,Humans,inhibitor,yes
DB04880,Enoximone,small molecule,approved;investigational,CSC1=CC=C(C=C1)C(=O)C1=C(C)NC(=O)N1,ZJKNESGOIKRXQY-UHFFFAOYSA-N,248.301,Q14432,BE0000436,"cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A",Humans,inhibitor,yes
DB04881,Elacridar,small molecule,investigational,COC1=CC=CC2=C1NC1=C(C=CC=C1C(=O)NC1=CC=C(CCN3CCC4=CC(OC)=C(OC)C=C4C3)C=C1)C2=O,OSFCMRGOZNQUSW-UHFFFAOYSA-N,563.6429,P08183,BE0001032,ATP-dependent translocase ABCB1,Humans,inhibitor,yes
DB04882,Edotecarin,small molecule,investigational,OCC(CO)NN1C(=O)C2=C3C(NC4=C3C=CC(O)=C4)=C3N([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C4=C(C=CC(O)=C4)C3=C2C1=O,QMVPQBFHUJZJCS-NTKFZFFISA-N,608.56,P11387,BE0000971,DNA topoisomerase 1,Humans,inhibitor,yes
DB04883,Darusentan,small molecule,investigational,COC1=CC(OC)=NC(O[C@H](C(O)=O)C(OC)(C2=CC=CC=C2)C2=CC=CC=C2)=N1,FEJVSJIALLTFRP-LJQANCHMSA-N,410.4199,P25101,BE0000521,Endothelin-1 receptor,Humans,antagonist,yes
DB04885,Cilansetron,small molecule,investigational,CC1=NC=CN1C[C@H]1CCC2=C(C3=CC=CC4=C3N2CCC4)C1=O,NCNFDKWULDWJDS-OAHLLOKOSA-N,319.4002,P46098,BE0000311,5-hydroxytryptamine receptor 3A,Humans,modulator,yes
DB04886,Calanolide A,small molecule,investigational,CCCC1=CC(=O)OC2=C1C1=C(C=CC(C)(C)O1)C1=C2[C@@H](O)[C@H](C)[C@@H](C)O1,NIDRYBLTWYFCFV-FMTVUPSXSA-N,370.4388,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB04887,Brecanavir,small molecule,investigational,[H][C@]12OCC[C@@]1([H])[C@H](CO2)OC(=O)N[C@@H](CC1=CC=C(OCC2=CSC(C)=N2)C=C1)[C@H](O)CN(CC(C)C)S(=O)(=O)C1=CC2=C(OCO2)C=C1,JORVRJNILJXMMG-OLNQLETPSA-N,703.823,P03366,BE0002050,Gag-Pol polyprotein,,modulator,yes
DB04888,Bifeprunox,small molecule,investigational,O=C1NC2=C(O1)C(=CC=C2)N1CCN(CC2=CC(=CC=C2)C2=CC=CC=C2)CC1,CYGODHVAJQTCBG-UHFFFAOYSA-N,385.4583,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,modulator,yes
DB04888,Bifeprunox,small molecule,investigational,O=C1NC2=C(O1)C(=CC=C2)N1CCN(CC2=CC(=CC=C2)C2=CC=CC=C2)CC1,CYGODHVAJQTCBG-UHFFFAOYSA-N,385.4583,P14416,BE0000756,D(2) dopamine receptor,Humans,modulator,yes
DB04889,Bicifadine,small molecule,investigational,CC1=CC=C(C=C1)C12CC1CNC2,OFYVIGTWSQPCLF-UHFFFAOYSA-N,173.2542,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,modulator,yes
DB04889,Bicifadine,small molecule,investigational,CC1=CC=C(C=C1)C12CC1CNC2,OFYVIGTWSQPCLF-UHFFFAOYSA-N,173.2542,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,modulator,yes
DB04890,Bepotastine,small molecule,approved,OC(=O)CCCN1CCC(CC1)OC(C1=CC=C(Cl)C=C1)C1=CC=CC=N1,YWGDOWXRIALTES-UHFFFAOYSA-N,388.888,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB04892,Phenserine,small molecule,investigational,[H][C@]12N(C)CC[C@@]1(C)C1=C(C=CC(OC(=O)NC3=CC=CC=C3)=C1)N2C,PBHFNBQPZCRWQP-QUCCMNQESA-N,337.4155,P22303,BE0000426,Acetylcholinesterase,Humans,inhibitor,yes
DB04892,Phenserine,small molecule,investigational,[H][C@]12N(C)CC[C@@]1(C)C1=C(C=CC(OC(=O)NC3=CC=CC=C3)=C1)N2C,PBHFNBQPZCRWQP-QUCCMNQESA-N,337.4155,P06276,BE0002180,Cholinesterase,Humans,inhibitor,yes
DB04896,Milnacipran,small molecule,approved;investigational,CCN(CC)C(=O)C1(CC1CN)C1=CC=CC=C1,GJJFMKBJSRMPLA-UHFFFAOYSA-N,246.354,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB04896,Milnacipran,small molecule,approved;investigational,CCN(CC)C(=O)C1(CC1CN)C1=CC=CC=C1,GJJFMKBJSRMPLA-UHFFFAOYSA-N,246.354,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,inhibitor,yes
DB04898,Ximelagatran,small molecule,approved;investigational;withdrawn,CCOC(=O)CN[C@@H](C(=O)N1CC[C@H]1C(=O)NCC1=CC=C(C=C1)C(\N)=N\O)C1CCCCC1,ZXIBCJHYVWYIKI-PZJWPPBQSA-N,473.5652,P00734,BE0000048,Prothrombin,Humans,inhibitor,yes
DB04903,Pagoclone,small molecule,investigational,CC(C)CCC(=O)CC1N(C(=O)C2=CC=CC=C12)C1=NC2=C(C=CC(Cl)=N2)C=C1,HIUPRQPBWVEQJJ-UHFFFAOYSA-N,407.893,Q99928,BE0003594,Gamma-aminobutyric acid receptor subunit gamma-3,Humans,modulator,yes
DB04905,Tesmilifene,small molecule,investigational,CCN(CC)CCOC1=CC=C(CC2=CC=CC=C2)C=C1,NFIXBCVWIPOYCD-UHFFFAOYSA-N,283.4079,P08183,BE0001032,ATP-dependent translocase ABCB1,Humans,inducer,yes
DB04908,Flibanserin,small molecule,approved;investigational,FC(F)(F)C1=CC(=CC=C1)N1CCN(CCN2C(=O)NC3=CC=CC=C23)CC1,PPRRDFIXUUSXRA-UHFFFAOYSA-N,390.4021,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,agonist,yes
DB04908,Flibanserin,small molecule,approved;investigational,FC(F)(F)C1=CC(=CC=C1)N1CCN(CCN2C(=O)NC3=CC=CC=C23)CC1,PPRRDFIXUUSXRA-UHFFFAOYSA-N,390.4021,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB04908,Flibanserin,small molecule,approved;investigational,FC(F)(F)C1=CC(=CC=C1)N1CCN(CCN2C(=O)NC3=CC=CC=C23)CC1,PPRRDFIXUUSXRA-UHFFFAOYSA-N,390.4021,P21917,BE0000389,D(4) dopamine receptor,Humans,antagonist;agonist,yes
DB04911,Oritavancin,small molecule,approved;investigational,CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(NCC5=CC=C(C=C5)C5=CC=C(Cl)C=C5)[C@@H](O)[C@H](C)O4)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]1C3=CC(=C(O)C=C3)C3=C(O)C=C(O)C=C3[C@H](NC(=O)[C@@H](NC1=O)[C@H](O[C@H]1C[C@](C)(N)[C@@H](O)[C@H](C)O1)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2,VHFGEBVPHAGQPI-LXKZPTCJSA-N,1793.101,P0AC13,BE0000803,Dihydropteroate synthase,Escherichia coli (strain K12),inhibitor,yes
DB04911,Oritavancin,small molecule,approved;investigational,CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(NCC5=CC=C(C=C5)C5=CC=C(Cl)C=C5)[C@@H](O)[C@H](C)O4)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]1C3=CC(=C(O)C=C3)C3=C(O)C=C(O)C=C3[C@H](NC(=O)[C@@H](NC1=O)[C@H](O[C@H]1C[C@](C)(N)[C@@H](O)[C@H](C)O1)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2,VHFGEBVPHAGQPI-LXKZPTCJSA-N,1793.101,,BE0009912,Peptidoglycan precursors,,binder,yes
DB04911,Oritavancin,small molecule,approved;investigational,CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(NCC5=CC=C(C=C5)C5=CC=C(Cl)C=C5)[C@@H](O)[C@H](C)O4)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]1C3=CC(=C(O)C=C3)C3=C(O)C=C(O)C=C3[C@H](NC(=O)[C@@H](NC1=O)[C@H](O[C@H]1C[C@](C)(N)[C@@H](O)[C@H](C)O1)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2,VHFGEBVPHAGQPI-LXKZPTCJSA-N,1793.101,,BE0009913,Bacterial cell wall peptide bridging segments,Staphylococcus aureus,inhibitor,yes
DB04911,Oritavancin,small molecule,approved;investigational,CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(NCC5=CC=C(C=C5)C5=CC=C(Cl)C=C5)[C@@H](O)[C@H](C)O4)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]1C3=CC(=C(O)C=C3)C3=C(O)C=C(O)C=C3[C@H](NC(=O)[C@@H](NC1=O)[C@H](O[C@H]1C[C@](C)(N)[C@@H](O)[C@H](C)O1)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2,VHFGEBVPHAGQPI-LXKZPTCJSA-N,1793.101,,BE0009914,Pentaglycyl bridging segment,Staphylococcus aureus,disruptor,yes
DB04915,Idronoxil,small molecule,investigational,OC1=CC=C(C=C1)C1=CC2=C(OC1)C=C(O)C=C2,ZZUBHVMHNVYXRR-UHFFFAOYSA-N,240.254,P98170,BE0001156,E3 ubiquitin-protein ligase XIAP,Humans,modulator,yes
DB04915,Idronoxil,small molecule,investigational,OC1=CC=C(C=C1)C1=CC2=C(OC1)C=C(O)C=C2,ZZUBHVMHNVYXRR-UHFFFAOYSA-N,240.254,Q9NYA1,BE0004728,Sphingosine kinase 1,Humans,modulator,yes
DB04917,Renzapride,small molecule,investigational,COC1=C(C=CC(N)=C1Cl)C(=O)NC1CCN2CCCC1C2,YFUAYKVMQVBSNG-UHFFFAOYSA-N,323.818,Q13639,BE0000084,5-hydroxytryptamine receptor 4,Humans,modulator,yes
DB04918,Ceftobiprole,small molecule,approved;investigational,[H][C@@]1(NC(=O)C(=N/O)\C2=NSC(N)=N2)C(=O)N2C(C(O)=O)=C(CS[C@]12[H])\C=C1/CCN(C1=O)[C@]1([H])CCNC1,VOAZJEPQLGBXGO-SDAWRPRTSA-N,534.57,Q7DHH4,BE0002391,MecA,Staphylococcus aureus,inhibitor,yes
DB04918,Ceftobiprole,small molecule,approved;investigational,[H][C@@]1(NC(=O)C(=N/O)\C2=NSC(N)=N2)C(=O)N2C(C(O)=O)=C(CS[C@]12[H])\C=C1/CCN(C1=O)[C@]1([H])CCNC1,VOAZJEPQLGBXGO-SDAWRPRTSA-N,534.57,P14677,BE0002392,Penicillin-binding protein 2x,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4),inhibitor,yes
DB04918,Ceftobiprole,small molecule,approved;investigational,[H][C@@]1(NC(=O)C(=N/O)\C2=NSC(N)=N2)C(=O)N2C(C(O)=O)=C(CS[C@]12[H])\C=C1/CCN(C1=O)[C@]1([H])CCNC1,VOAZJEPQLGBXGO-SDAWRPRTSA-N,534.57,P0A3M6,BE0003624,Penicillin-binding protein 2B,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB04918,Ceftobiprole,small molecule,approved;investigational,[H][C@@]1(NC(=O)C(=N/O)\C2=NSC(N)=N2)C(=O)N2C(C(O)=O)=C(CS[C@]12[H])\C=C1/CCN(C1=O)[C@]1([H])CCNC1,VOAZJEPQLGBXGO-SDAWRPRTSA-N,534.57,P59676,BE0001868,Penicillin-binding protein 2X,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB04920,Clevidipine,small molecule,approved;investigational,CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(Cl)=C1Cl)C(=O)OC,KPBZROQVTHLCDU-UHFFFAOYSA-N,456.316,O60840,BE0002357,Voltage-dependent L-type calcium channel subunit alpha-1F,Humans,blocker,yes
DB04920,Clevidipine,small molecule,approved;investigational,CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(Cl)=C1Cl)C(=O)OC,KPBZROQVTHLCDU-UHFFFAOYSA-N,456.316,Q13698,BE0002355,Voltage-dependent L-type calcium channel subunit alpha-1S,Humans,blocker,yes
DB04920,Clevidipine,small molecule,approved;investigational,CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(Cl)=C1Cl)C(=O)OC,KPBZROQVTHLCDU-UHFFFAOYSA-N,456.316,Q01668,BE0002359,Voltage-dependent L-type calcium channel subunit alpha-1D,Humans,blocker,yes
DB04920,Clevidipine,small molecule,approved;investigational,CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(Cl)=C1Cl)C(=O)OC,KPBZROQVTHLCDU-UHFFFAOYSA-N,456.316,Q13936,BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,Humans,blocker,yes
DB04930,Permethrin,small molecule,approved;investigational,CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC(OC2=CC=CC=C2)=CC=C1,RLLPVAHGXHCWKJ-UHFFFAOYSA-N,391.288,P35498,BE0000141,Sodium channel protein type 1 subunit alpha,Humans,inhibitor,yes
DB04931,Afamelanotide,small molecule,approved;investigational,CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(N)=O,UAHFGYDRQSXQEB-LEBBXHLNSA-N,1646.8452,P32245,BE0009682,Melanocortin receptor 4,Humans,inhibitor,yes
DB04931,Afamelanotide,small molecule,approved;investigational,CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(N)=O,UAHFGYDRQSXQEB-LEBBXHLNSA-N,1646.8452,Q01726,BE0002447,Melanocyte-stimulating hormone receptor,Humans,agonist,yes
DB04933,Eritoran,small molecule,investigational,CCCCCCCCCCCC(=O)CC(=O)N[C@H]1[C@@H](OP(O)(O)=O)O[C@H](CO[C@@H]2O[C@H](COC)[C@@H](OP(O)(O)=O)[C@H](OCC[C@@H](CCCCCCC)OC)[C@H]2NC(=O)CCCCCCCCC\C=C/CCCCCC)[C@@H](O)[C@@H]1OCCCCCCCCCC,BPSMYQFMCXXNPC-MFCPCZTFSA-N,1313.6562,O00206,BE0002442,Toll-like receptor 4,Humans,inhibitor,yes
DB04938,Ospemifene,small molecule,approved;investigational,OCCOC1=CC=C(C=C1)C(=C(\CCCl)C1=CC=CC=C1)\C1=CC=CC=C1,LUMKNAVTFCDUIE-VHXPQNKSSA-N,378.891,P03372,BE0000123,Estrogen receptor,Humans,antagonist;agonist,yes
DB04942,Tamibarotene,small molecule,investigational,CC1(C)CCC(C)(C)C2=C1C=CC(NC(=O)C1=CC=C(C=C1)C(O)=O)=C2,MUTNCGKQJGXKEM-UHFFFAOYSA-N,351.4388,P10276,BE0000663,Retinoic acid receptor alpha,Humans,agonist,yes
DB04942,Tamibarotene,small molecule,investigational,CC1(C)CCC(C)(C)C2=C1C=CC(NC(=O)C1=CC=C(C=C1)C(O)=O)=C2,MUTNCGKQJGXKEM-UHFFFAOYSA-N,351.4388,P10826,BE0000206,Retinoic acid receptor beta,Humans,agonist,yes
DB04944,Acadesine,small molecule,investigational,[H][C@]1(CO)O[C@]([H])([C@H](O)[C@@H]1O)N1C=NC(C(N)=O)=C1N,RTRQQBHATOEIAF-UUOKFMHZSA-N,258.2313,Q13131,BE0000677,5'-AMP-activated protein kinase catalytic subunit alpha-1,Humans,modulator,yes
DB04944,Acadesine,small molecule,investigational,[H][C@]1(CO)O[C@]([H])([C@H](O)[C@@H]1O)N1C=NC(C(N)=O)=C1N,RTRQQBHATOEIAF-UUOKFMHZSA-N,258.2313,Q9Y478,BE0000254,5'-AMP-activated protein kinase subunit beta-1,Humans,modulator,yes
DB04944,Acadesine,small molecule,investigational,[H][C@]1(CO)O[C@]([H])([C@H](O)[C@@H]1O)N1C=NC(C(N)=O)=C1N,RTRQQBHATOEIAF-UUOKFMHZSA-N,258.2313,P54619,BE0009988,5'-AMP-activated protein kinase subunit gamma-1,Humans,modulator,yes
DB04946,Iloperidone,small molecule,approved,COC1=C(OCCCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C=CC(=C1)C(C)=O,XMXHEBAFVSFQEX-UHFFFAOYSA-N,426.4806,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB04946,Iloperidone,small molecule,approved,COC1=C(OCCCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C=CC(=C1)C(C)=O,XMXHEBAFVSFQEX-UHFFFAOYSA-N,426.4806,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB04947,Altropane,small molecule,investigational,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)C1=CC=C(F)C=C1)C(=O)OC)N2C\C=C\I,GTQLIPQFXVKRKJ-UNSMHXHVSA-N,429.2677,Q01959,BE0000647,Sodium-dependent dopamine transporter,Humans,inhibitor,yes
DB04948,Lofexidine,small molecule,approved;investigational,CC(OC1=C(Cl)C=CC=C1Cl)C1=NCCN1,KSMAGQUYOIHWFS-UHFFFAOYSA-N,259.132,P08913,BE0000289,Alpha-2A adrenergic receptor,Humans,agonist,yes
DB04951,Pirfenidone,small molecule,approved;investigational,CC1=CN(C(=O)C=C1)C1=CC=CC=C1,ISWRGOKTTBVCFA-UHFFFAOYSA-N,185.2218,P01137,BE0000984,Transforming growth factor beta-1 proprotein,Humans,modulator,yes
DB04953,Ezogabine,small molecule,approved;investigational,CCOC(=O)NC1=C(N)C=C(NCC2=CC=C(F)C=C2)C=C1,PCOBBVZJEWWZFR-UHFFFAOYSA-N,303.3314,O43525,BE0002398,Potassium voltage-gated channel subfamily KQT member 3,Humans,modulator,yes
DB04954,Tecadenoson,small molecule,investigational,OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N[C@@H]3CCOC3)N=CN=C12,OESBDSFYJMDRJY-BAYCTPFLSA-N,337.3312,P30542,BE0000013,Adenosine receptor A1,Humans,agonist,yes
DB04960,Tipifarnib,small molecule,investigational,CN1C=NC=C1[C@@](N)(C1=CC=C(Cl)C=C1)C1=CC2=C(C=C1)N(C)C(=O)C=C2C1=CC(Cl)=CC=C1,PLHJCIYEEKOWNM-HHHXNRCGSA-N,489.396,P14324,BE0000776,Farnesyl pyrophosphate synthase,Humans,inhibitor,yes
DB04960,Tipifarnib,small molecule,investigational,CN1C=NC=C1[C@@](N)(C1=CC=C(Cl)C=C1)C1=CC2=C(C=C1)N(C)C(=O)C=C2C1=CC(Cl)=CC=C1,PLHJCIYEEKOWNM-HHHXNRCGSA-N,489.396,P49354,BE0002373,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,Humans,modulator,yes
DB04960,Tipifarnib,small molecule,investigational,CN1C=NC=C1[C@@](N)(C1=CC=C(Cl)C=C1)C1=CC2=C(C=C1)N(C)C(=O)C=C2C1=CC(Cl)=CC=C1,PLHJCIYEEKOWNM-HHHXNRCGSA-N,489.396,P49356,BE0002372,Protein farnesyltransferase subunit beta,Humans,modulator,yes
DB04967,Lucanthone,small molecule,investigational,CCN(CC)CCNC1=C2C(=O)C3=CC=CC=C3SC2=C(C)C=C1,FBQPGGIHOFZRGH-UHFFFAOYSA-N,340.482,P11388,BE0000742,DNA topoisomerase 2-alpha,Humans,inhibitor,yes
DB04967,Lucanthone,small molecule,investigational,CCN(CC)CCNC1=C2C(=O)C3=CC=CC=C3SC2=C(C)C=C1,FBQPGGIHOFZRGH-UHFFFAOYSA-N,340.482,Q02880,BE0002425,DNA topoisomerase 2-beta,Humans,inhibitor,yes
DB04967,Lucanthone,small molecule,investigational,CCN(CC)CCNC1=C2C(=O)C3=CC=CC=C3SC2=C(C)C=C1,FBQPGGIHOFZRGH-UHFFFAOYSA-N,340.482,P27695,BE0002414,DNA repair nuclease/redox regulator APEX1,Humans,inhibitor,yes
DB04967,Lucanthone,small molecule,investigational,CCN(CC)CCNC1=C2C(=O)C3=CC=CC=C3SC2=C(C)C=C1,FBQPGGIHOFZRGH-UHFFFAOYSA-N,340.482,,BE0004796,DNA,Humans,intercalation,yes
DB04967,Lucanthone,small molecule,investigational,CCN(CC)CCNC1=C2C(=O)C3=CC=CC=C3SC2=C(C)C=C1,FBQPGGIHOFZRGH-UHFFFAOYSA-N,340.482,P11387,BE0000971,DNA topoisomerase 1,Humans,inhibitor,yes
DB04971,Reglitazar,small molecule,investigational,CC1=C(CCOC2=CC=C(CC3C(=O)NOC3=O)C=C2)N=C(O1)C1=CC=CC=C1,QBQLYIISSRXYKL-UHFFFAOYSA-N,392.411,Q07869,BE0000071,Peroxisome proliferator-activated receptor alpha,Humans,agonist,yes
DB04972,Canfosfamide,small molecule,investigational,N[C@@H](CCC(=O)N[C@@H](CS(=O)(=O)CCOP(=O)(N(CCCl)CCCl)N(CCCl)CCCl)C(=O)N[C@@H](C(O)=O)C1=CC=CC=C1)C(O)=O,OJLHWPALWODJPQ-QNWVGRARSA-N,787.46,P09211,BE0000814,Glutathione S-transferase P,Humans,modulator,yes
DB04974,Rimiducid,small molecule,investigational,CC[C@H](C(=O)N1CCCC[C@H]1C(=O)O[C@H](CCC1=CC=C(OC)C(OC)=C1)C1=CC(OCC(=O)NCCNC(=O)COC2=CC=CC(=C2)[C@@H](CCC2=CC=C(OC)C(OC)=C2)OC(=O)[C@@H]2CCCCN2C(=O)[C@@H](CC)C2=CC(OC)=C(OC)C(OC)=C2)=CC=C1)C1=CC(OC)=C(OC)C(OC)=C1,GQLCLPLEEOUJQC-ZTQDTCGGSA-N,1411.65,P62942,BE0000695,Peptidyl-prolyl cis-trans isomerase FKBP1A,Humans,modulator,yes
DB04975,Banoxantrone,small molecule,investigational,C[N+](C)([O-])CCNC1=CC=C(NCC[N+](C)(C)[O-])C2=C1C(=O)C1=C(O)C=CC(O)=C1C2=O,YZBAXVICWUUHGG-UHFFFAOYSA-N,444.488,Q02880,BE0002425,DNA topoisomerase 2-beta,Humans,modulator,yes
DB04975,Banoxantrone,small molecule,investigational,C[N+](C)([O-])CCNC1=CC=C(NCC[N+](C)(C)[O-])C2=C1C(=O)C1=C(O)C=CC(O)=C1C2=O,YZBAXVICWUUHGG-UHFFFAOYSA-N,444.488,P11388,BE0000742,DNA topoisomerase 2-alpha,Humans,modulator,yes
DB04977,Plitidepsin,small molecule,investigational,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](C)C(=O)[C@@H](OC(=O)C[C@H](O)[C@]([H])(NC(=O)[C@@H](NC(=O)[C@@H](CC(C)C)N(C)C(=O)[C@@H]1CCCN1C(=O)C(C)=O)[C@@H](C)OC(=O)[C@H](CC1=CC=C(OC)C=C1)N(C)C2=O)[C@@H](C)CC)C(C)C,UUSZLLQJYRSZIS-LXNNNBEUSA-N,1110.357,P50897,BE0004538,Palmitoyl-protein thioesterase 1,Humans,modulator,yes
DB04983,Denufosol,small molecule,investigational,[H]N([H])C1=NC(=O)N(C=C1)[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=CC(=O)N([H])C2=O)O1,FPNPSEMJLALQSA-MIYUEGBISA-N,773.323,P41231,BE0002401,P2Y purinoceptor 2,Humans,agonist,yes
DB05009,Apadenoson,small molecule,investigational,CCNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=C(N=C2N)C#CC[C@H]1CC[C@@H](CC1)C(=O)OC,FLEVIENZILQUKB-XTWQNQIISA-N,486.529,P29274,BE0000924,Adenosine receptor A2a,Humans,agonist,yes
DB05010,SGS-742,small molecule,investigational,CCCCP(O)(=O)CCCN,ONNMDRQRSGKZCN-UHFFFAOYSA-N,179.2,Q9UBS5,BE0000217,Gamma-aminobutyric acid type B receptor subunit 1,Humans,modulator,yes
DB05010,SGS-742,small molecule,investigational,CCCCP(O)(=O)CCCN,ONNMDRQRSGKZCN-UHFFFAOYSA-N,179.2,O75899,BE0002340,Gamma-aminobutyric acid type B receptor subunit 2,Humans,modulator,yes
DB05013,Ingenol mebutate,small molecule,approved,[H][C@@]12C[C@@H](C)[C@]34C=C(C)[C@H](OC(=O)C(\C)=C/C)[C@@]3(O)[C@H](O)C(CO)=C[C@@]([H])(C4=O)[C@]1([H])C2(C)C,VDJHFHXMUKFKET-UXMMOKKRSA-N,430.541,Q05655,BE0002417,Protein kinase C delta type,Humans,ligand,yes
DB05013,Ingenol mebutate,small molecule,approved,[H][C@@]12C[C@@H](C)[C@]34C=C(C)[C@H](OC(=O)C(\C)=C/C)[C@@]3(O)[C@H](O)C(CO)=C[C@@]([H])(C4=O)[C@]1([H])C2(C)C,VDJHFHXMUKFKET-UXMMOKKRSA-N,430.541,P17252,BE0001132,Protein kinase C alpha type,Humans,ligand,yes
DB05015,Belinostat,small molecule,approved;investigational,ONC(=O)\C=C\C1=CC=CC(=C1)S(=O)(=O)NC1=CC=CC=C1,NCNRHFGMJRPRSK-MDZDMXLPSA-N,318.35,Q13547,BE0008667,Histone deacetylase,Humans,inhibitor,yes
DB05016,Ataluren,small molecule,approved;investigational,OC(=O)C1=CC=CC(=C1)C1=NOC(=N1)C1=CC=CC=C1F,OOUGLTULBSNHNF-UHFFFAOYSA-N,284.242,P11532,BE0009794,Dystrophin,Humans,modulator,yes
DB05018,Migalastat,small molecule,approved;investigational,OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O,LXBIFEVIBLOUGU-DPYQTVNSSA-N,163.1717,P06280,BE0002422,Alpha-galactosidase A,Humans,stabilization,yes
DB05034,Ularitide,small molecule,investigational,CC[C@H](C)[C@@H]1NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)CNC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CSSC[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)CNC1=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O,IUCCYQIEZNQWRS-DWWHXVEHSA-N,3505.926,P16066,BE0000556,Atrial natriuretic peptide receptor 1,Humans,modulator,yes
DB05038,Anatibant,small molecule,investigational,CC1=CC(C)=C2C=CC=C(OCC3=C(Cl)C=CC(=C3Cl)S(=O)(=O)N3CCC[C@H]3C(=O)NCCCNC(=O)C3=CC=C(C=C3)C(N)=N)C2=N1,XUHBBTKJWIBQMY-MHZLTWQESA-N,711.66,P30411,BE0003513,B2 bradykinin receptor,Humans,antagonist,yes
DB05039,Indacaterol,small molecule,approved,CCC1=C(CC)C=C2CC(CC2=C1)NC[C@H](O)C1=C2C=CC(=O)NC2=C(O)C=C1,QZZUEBNBZAPZLX-QFIPXVFZSA-N,392.4907,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,agonist,yes
DB05053,MB-07803,small molecule,investigational,CCOC(=O)C(C)(C)NP(=O)(NC(C)(C)C(=O)OCC)C1=CC=C(O1)C1=C(SC(N)=N1)C(=O)C(C)(C)C,CTKZZUXRWBCFEI-UHFFFAOYSA-N,556.61,O00757,BE0011215,"Fructose-1,6-bisphosphatase isozyme 2",Humans,modulator,yes
DB05053,MB-07803,small molecule,investigational,CCOC(=O)C(C)(C)NP(=O)(NC(C)(C)C(=O)OCC)C1=CC=C(O1)C1=C(SC(N)=N1)C(=O)C(C)(C)C,CTKZZUXRWBCFEI-UHFFFAOYSA-N,556.61,P09467,BE0002431,"Fructose-1,6-bisphosphatase 1",Humans,modulator,yes
DB05057,Erdosteine,small molecule,approved;investigational,OC(=O)CSCC(=O)NC1CCSC1=O,QGFORSXNKQLDNO-UHFFFAOYSA-N,249.307,Q9UNI1,BE0003758,Chymotrypsin-like elastase family member 1,Humans,modulator,yes
DB05075,TG-100801,small molecule,investigational,CC1=C2N=C(NC3=CC=C(OCCN4CCCC4)C=C3)N=NC2=CC(=C1)C1=CC(OC(=O)C2=CC=CC=C2)=CC=C1Cl,JMGXJHWTVBGOKG-UHFFFAOYSA-N,580.09,P49767,BE0010101,Vascular endothelial growth factor C,Humans,inhibitor,yes
DB05075,TG-100801,small molecule,investigational,CC1=C2N=C(NC3=CC=C(OCCN4CCCC4)C=C3)N=NC2=CC(=C1)C1=CC(OC(=O)C2=CC=CC=C2)=CC=C1Cl,JMGXJHWTVBGOKG-UHFFFAOYSA-N,580.09,O43915,BE0010102,Vascular endothelial growth factor D,Humans,inhibitor,yes
DB05075,TG-100801,small molecule,investigational,CC1=C2N=C(NC3=CC=C(OCCN4CCCC4)C=C3)N=NC2=CC(=C1)C1=CC(OC(=O)C2=CC=CC=C2)=CC=C1Cl,JMGXJHWTVBGOKG-UHFFFAOYSA-N,580.09,P15692,BE0000163,"Vascular endothelial growth factor A, long form",Humans,inhibitor,yes
DB05075,TG-100801,small molecule,investigational,CC1=C2N=C(NC3=CC=C(OCCN4CCCC4)C=C3)N=NC2=CC(=C1)C1=CC(OC(=O)C2=CC=CC=C2)=CC=C1Cl,JMGXJHWTVBGOKG-UHFFFAOYSA-N,580.09,P49765,BE0004736,Vascular endothelial growth factor B,Humans,inhibitor,yes
DB05087,Ganaxolone,small molecule,approved;investigational,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@](C)(O)CC[C@]12C,PGTVWKLGGCQMBR-FLBATMFCSA-N,332.528,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB05095,Cimicoxib,small molecule,investigational,COC1=C(F)C=C(C=C1)C1=C(Cl)N=CN1C1=CC=C(C=C1)S(N)(=O)=O,KYXDNECMRLFQMZ-UHFFFAOYSA-N,381.809,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,modulator,yes
DB05100,Prinomastat,small molecule,investigational,CC1(C)SCCN([C@H]1C(=O)NO)S(=O)(=O)C1=CC=C(OC2=CC=NC=C2)C=C1,YKPYIPVDTNNYCN-INIZCTEOSA-N,423.506,P08253,BE0000642,72 kDa type IV collagenase,Humans,inhibitor,yes
DB05100,Prinomastat,small molecule,investigational,CC1(C)SCCN([C@H]1C(=O)NO)S(=O)(=O)C1=CC=C(OC2=CC=NC=C2)C=C1,YKPYIPVDTNNYCN-INIZCTEOSA-N,423.506,P03956,BE0000920,Interstitial collagenase,Humans,inhibitor,yes
DB05100,Prinomastat,small molecule,investigational,CC1(C)SCCN([C@H]1C(=O)NO)S(=O)(=O)C1=CC=C(OC2=CC=NC=C2)C=C1,YKPYIPVDTNNYCN-INIZCTEOSA-N,423.506,P09237,BE0003690,Matrilysin,Humans,inhibitor,yes
DB05102,Rupintrivir,small molecule,investigational,CCOC(=O)\C=C\[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@@H](CC(=O)[C@H](C(C)C)NC(=O)C1=NOC(C)=C1)CC1=CC=C(F)C=C1,CAYJBRBGZBCZKO-BHGBQCOSSA-N,598.6624,P04936,BE0001494,Genome polyprotein,HRV-2,modulator,yes
DB05103,AN-9,small molecule,investigational,CCCC(=O)OCOC(=O)C(C)(C)C,GYKLFBYWXZYSOW-UHFFFAOYSA-N,202.25,Q13547,BE0002365,Histone deacetylase 1,Humans,inhibitor,yes
DB05103,AN-9,small molecule,investigational,CCCC(=O)OCOC(=O)C(C)(C)C,GYKLFBYWXZYSOW-UHFFFAOYSA-N,202.25,P10415,BE0000246,Apoptosis regulator Bcl-2,Humans,downregulator,yes
DB05103,AN-9,small molecule,investigational,CCCC(=O)OCOC(=O)C(C)(C)C,GYKLFBYWXZYSOW-UHFFFAOYSA-N,202.25,Q14790,BE0003460,Caspase-8,Humans,regulator,yes
DB05104,Asimadoline,small molecule,investigational,CN([C@H](CN1CC[C@H](O)C1)C1=CC=CC=C1)C(=O)C(C1=CC=CC=C1)C1=CC=CC=C1,JHLHNYVMZCADTC-LOSJGSFVSA-N,414.5393,P41145,BE0000632,Kappa-type opioid receptor,Humans,agonist,yes
DB05107,16-Bromoepiandrosterone,small molecule,investigational,[H][C@@]12C[C@@H](Br)C(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@@H](O)CC[C@]12C,CWVMWSZEMZOUPC-JUAXIXHSSA-N,369.336,P10275,BE0000132,Androgen receptor,Humans,inhibitor,yes
DB05109,Trabectedin,small molecule,approved;investigational,[H][C@@]12[C@@H]3SC[C@]4(NCCC5=C4C=C(OC)C(O)=C5)C(=O)OC[C@H](N1[C@@H](O)[C@@H]1CC4=CC(C)=C(OC)C(O)=C4[C@H]2N1C)C1=C2OCOC2=C(C)C(OC(C)=O)=C31,PKVRCIRHQMSYJX-AIFWHQITSA-N,761.837,,BE0004796,DNA,Humans,binder,yes
DB05116,Thymectacin,small molecule,investigational,COC(=O)[C@H](C)NP(=O)(OC[C@H]1O[C@H](C[C@@H]1O)N1C=C(\C=C\Br)C(=O)NC1=O)OC1=CC=CC=C1,CFBLUORPOFELCE-BACVZHSASA-N,574.321,P12461,BE0000021,Thymidylate synthase,Yeast,binder,yes
DB05119,Rilapladib,small molecule,investigational,COCCN1CCC(CC1)N(CC1=CC=C(C=C1)C1=CC=C(C=C1)C(F)(F)F)C(=O)CN1C(SCC2=C(F)C(F)=CC=C2)=CC(=O)C2=C1C=CC=C2,NNBGCSGCRSCFEA-UHFFFAOYSA-N,735.81,P04183,BE0001260,"Thymidine kinase, cytosolic",Humans,inhibitor,yes
DB05119,Rilapladib,small molecule,investigational,COCCN1CCC(CC1)N(CC1=CC=C(C=C1)C1=CC=C(C=C1)C(F)(F)F)C(=O)CN1C(SCC2=C(F)C(F)=CC=C2)=CC(=O)C2=C1C=CC=C2,NNBGCSGCRSCFEA-UHFFFAOYSA-N,735.81,P04054,BE0003997,Phospholipase A2,Humans,modulator,yes
DB05119,Rilapladib,small molecule,investigational,COCCN1CCC(CC1)N(CC1=CC=C(C=C1)C1=CC=C(C=C1)C(F)(F)F)C(=O)CN1C(SCC2=C(F)C(F)=CC=C2)=CC(=O)C2=C1C=CC=C2,NNBGCSGCRSCFEA-UHFFFAOYSA-N,735.81,Q13093,BE0002409,Platelet-activating factor acetylhydrolase,Humans,inhibitor,yes
DB05129,Elsamitrucin,small molecule,investigational,CO[C@@H]1[C@@H](N)[C@@H](O[C@H]2[C@H](OC3=CC=CC4=C3C3=C5C(C(=O)OC6=C5C(=C(C)C=C6)C(=O)O3)=C4O)O[C@H](C)[C@H](O)[C@]2(C)O)O[C@H](C)[C@@H]1O,MGQRRMONVLMKJL-KWJIQSIXSA-N,653.6299,P11388,BE0000742,DNA topoisomerase 2-alpha,Humans,modulator,yes
DB05129,Elsamitrucin,small molecule,investigational,CO[C@@H]1[C@@H](N)[C@@H](O[C@H]2[C@H](OC3=CC=CC4=C3C3=C5C(C(=O)OC6=C5C(=C(C)C=C6)C(=O)O3)=C4O)O[C@H](C)[C@H](O)[C@]2(C)O)O[C@H](C)[C@@H]1O,MGQRRMONVLMKJL-KWJIQSIXSA-N,653.6299,Q02880,BE0002425,DNA topoisomerase 2-beta,Humans,modulator,yes
DB05134,Tanespimycin,small molecule,investigational,[H]/C1=C([H])/[C@]([H])(OC)[C@@]([H])(OC(O)=N)C(C)=C([H])[C@]([H])(C)[C@@]([H])(O)[C@]([H])(C[C@]([H])(C)CC2=C(NCC=C)C(=O)C=C(N=C(O)\C(C)=C\1/[H])C2=O)OC,AYUNIORJHRXIBJ-TXHRRWQRSA-N,585.698,P07900,BE0001120,Heat shock protein HSP 90-alpha,Humans,inhibitor,yes
DB05137,Lobeline,small molecule,investigational,CN1[C@H](C[C@H](O)C2=CC=CC=C2)CCC[C@@H]1CC(=O)C1=CC=CC=C1,MXYUKLILVYORSK-HBMCJLEFSA-N,337.4553,Q05940,BE0000118,Synaptic vesicular amine transporter,Humans,inhibitor,yes
DB05152,NGX267,small molecule,investigational,CC[C@@H]1SC2(CCN(C)CC2)NC1=O,PHOZOHFUXHPOCK-QMMMGPOBSA-N,214.33,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,agonist,yes
DB05154,Pretomanid,small molecule,approved,[O-][N+](=O)C1=CN2C[C@@H](COC2=N1)OCC1=CC=C(OC(F)(F)F)C=C1,ZLHZLMOSPGACSZ-NSHDSACASA-N,359.2574,P9WPB7,BE0003738,Cyclopropane mycolic acid synthase 1,Mycobacterium tuberculosis,inhibitor,yes
DB05154,Pretomanid,small molecule,approved,[O-][N+](=O)C1=CN2C[C@@H](COC2=N1)OCC1=CC=C(OC(F)(F)F)C=C1,ZLHZLMOSPGACSZ-NSHDSACASA-N,359.2574,P9WPB5,BE0001211,Cyclopropane mycolic acid synthase 2,Mycobacterium tuberculosis,inhibitor,yes
DB05154,Pretomanid,small molecule,approved,[O-][N+](=O)C1=CN2C[C@@H](COC2=N1)OCC1=CC=C(OC(F)(F)F)C=C1,ZLHZLMOSPGACSZ-NSHDSACASA-N,359.2574,P9WPB3,BE0002521,Cyclopropane mycolic acid synthase 3,Mycobacterium tuberculosis,inhibitor,yes
DB05155,CR665,small molecule,investigational,CCCC[C@@H](NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](N)CC1=CC=CC=C1)C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC1=CC=NC=C1,DBOGGOVKHSCMNB-OMRVPHBLSA-N,671.847,P41145,BE0000632,Kappa-type opioid receptor,Humans,agonist,yes
DB05168,Vintafolide,small molecule,investigational,[H][C@@]12N3CC[C@@]11C4=CC(=C(OC)C=C4N(C)[C@@]1([H])[C@](O)([C@H](O)[C@]2(CC)C=CC3)C(=O)NNC(=O)OCCSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(O)=O)NC(=O)CC[C@H](NC(=O)C1=CC=C(NCC2=CNC3=NC(N)=NC(=O)C3=N2)C=C1)C(O)=O)C(O)=O)[C@]1(C[C@@]2([H])C[N@](C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC,KUZYSQSABONDME-QRLOMCMNSA-N,1917.06,P15328,BE0003405,Folate receptor alpha,Humans,modulator,yes
DB05169,AT9283,small molecule,investigational,OC(NC1=CNN=C1C1=NC2=C(N1)C=CC(CN1CCOCC1)=C2)=NC1CC1,LOLPPWBBNUVNQZ-UHFFFAOYSA-N,381.44,Q96GD4,BE0003404,Aurora kinase B,Humans,modulator,yes
DB05169,AT9283,small molecule,investigational,OC(NC1=CNN=C1C1=NC2=C(N1)C=CC(CN1CCOCC1)=C2)=NC1CC1,LOLPPWBBNUVNQZ-UHFFFAOYSA-N,381.44,O14965,BE0000991,Aurora kinase A,Humans,modulator,yes
DB05171,E-2012,small molecule,investigational,[H]\C(C1=CC(OC)=C(C=C1)N1C=NC(C)=C1)=C1\CCCN(C1=O)[C@@]([H])(C)C1=CC=C(F)C=C1,PUOAETJYKQITMO-LANLRWRYSA-N,419.5,Q8WW43,BE0017533,Gamma-secretase subunit APH-1B,Humans,modulator,yes
DB05171,E-2012,small molecule,investigational,[H]\C(C1=CC(OC)=C(C=C1)N1C=NC(C)=C1)=C1\CCCN(C1=O)[C@@]([H])(C)C1=CC=C(F)C=C1,PUOAETJYKQITMO-LANLRWRYSA-N,419.5,Q92542,BE0017775,Nicastrin,Humans,modulator,yes
DB05171,E-2012,small molecule,investigational,[H]\C(C1=CC(OC)=C(C=C1)N1C=NC(C)=C1)=C1\CCCN(C1=O)[C@@]([H])(C)C1=CC=C(F)C=C1,PUOAETJYKQITMO-LANLRWRYSA-N,419.5,P49768,BE0010960,Presenilin-1,Humans,modulator,yes
DB05171,E-2012,small molecule,investigational,[H]\C(C1=CC(OC)=C(C=C1)N1C=NC(C)=C1)=C1\CCCN(C1=O)[C@@]([H])(C)C1=CC=C(F)C=C1,PUOAETJYKQITMO-LANLRWRYSA-N,419.5,Q96BI3,BE0003409,Gamma-secretase subunit APH-1A,Humans,modulator,yes
DB05171,E-2012,small molecule,investigational,[H]\C(C1=CC(OC)=C(C=C1)N1C=NC(C)=C1)=C1\CCCN(C1=O)[C@@]([H])(C)C1=CC=C(F)C=C1,PUOAETJYKQITMO-LANLRWRYSA-N,419.5,Q9NZ42,BE0003410,Gamma-secretase subunit PEN-2,Humans,modulator,yes
DB05187,Elafibranor,small molecule,approved;investigational,CSC1=CC=C(C=C1)C(=O)\C=C\C1=CC(C)=C(OC(C)(C)C(O)=O)C(C)=C1,AFLFKFHDSCQHOL-IZZDOVSWSA-N,384.49,Q07869,BE0000071,Peroxisome proliferator-activated receptor alpha,Humans,agonist,yes
DB05187,Elafibranor,small molecule,approved;investigational,CSC1=CC=C(C=C1)C(=O)\C=C\C1=CC(C)=C(OC(C)(C)C(O)=O)C(C)=C1,AFLFKFHDSCQHOL-IZZDOVSWSA-N,384.49,Q03181,BE0001007,Peroxisome proliferator-activated receptor delta,Humans,agonist,yes
DB05187,Elafibranor,small molecule,approved;investigational,CSC1=CC=C(C=C1)C(=O)\C=C\C1=CC(C)=C(OC(C)(C)C(O)=O)C(C)=C1,AFLFKFHDSCQHOL-IZZDOVSWSA-N,384.49,P37231,BE0000215,Peroxisome proliferator-activated receptor gamma,Humans,agonist,yes
DB05219,Crisaborole,small molecule,approved;investigational,OB1OCC2=C1C=CC(OC1=CC=C(C=C1)C#N)=C2,USZAGAREISWJDP-UHFFFAOYSA-N,251.05,P27815,BE0001133,"3',5'-cyclic-AMP phosphodiesterase 4A",Humans,inhibitor,yes
DB05219,Crisaborole,small molecule,approved;investigational,OB1OCC2=C1C=CC(OC1=CC=C(C=C1)C#N)=C2,USZAGAREISWJDP-UHFFFAOYSA-N,251.05,Q07343,BE0000487,"3',5'-cyclic-AMP phosphodiesterase 4B",Humans,inhibitor,yes
DB05219,Crisaborole,small molecule,approved;investigational,OB1OCC2=C1C=CC(OC1=CC=C(C=C1)C#N)=C2,USZAGAREISWJDP-UHFFFAOYSA-N,251.05,Q08493,BE0002353,"3',5'-cyclic-AMP phosphodiesterase 4C",Humans,inhibitor,yes
DB05219,Crisaborole,small molecule,approved;investigational,OB1OCC2=C1C=CC(OC1=CC=C(C=C1)C#N)=C2,USZAGAREISWJDP-UHFFFAOYSA-N,251.05,Q08499,BE0001287,"3',5'-cyclic-AMP phosphodiesterase 4D",Humans,inhibitor,yes
DB05220,Alisertib,small molecule,investigational,COC1=CC(NC2=NC=C3CN=C(C4=CC(Cl)=CC=C4C3=N2)C2=C(OC)C=CC=C2F)=CC=C1C(O)=O,ZLHFILGSQDJULK-UHFFFAOYSA-N,518.93,O14965,BE0000991,Aurora kinase A,Humans,inhibitor;regulator,yes
DB05229,Beraprost,small molecule,investigational,[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)C(C)CC#CC)[C@@]1([H])C1=C(O2)C(CCCC(O)=O)=CC=C1,CTPOHARTNNSRSR-APJZLKAGSA-N,398.499,P43119,BE0000475,Prostacyclin receptor,Humans,agonist,yes
DB05232,Tetrodotoxin,small molecule,investigational,[H][C@]12OC3([O-])OC(C4C(O)[NH+]=C(N)NC4(C1O)[C@@H]3O)C2(O)CO,SLBCPBUVHCASIJ-UFHSVNPDSA-O,319.268,Q14524,BE0000197,Sodium channel protein type 5 subunit alpha,Humans,blocker,yes
DB05234,LGD2941,small molecule,investigational,C[C@@H]1CC[C@H]([C@@H](O)C(F)(F)F)N1C1=CC2=C(NC(=O)C=C2C(F)(F)F)C=C1,HWLLYFXDDGGHOE-BCSUUIJWSA-N,394.3116,P10275,BE0000132,Androgen receptor,Humans,modulator,yes
DB05239,Cobimetinib,small molecule,approved;investigational,OC1(CN(C1)C(=O)C1=C(NC2=C(F)C=C(I)C=C2)C(F)=C(F)C=C1)[C@@H]1CCCCN1,BSMCAPRUBJMWDF-KRWDZBQOSA-N,531.318,Q02750,BE0000870,Dual specificity mitogen-activated protein kinase kinase 1,Humans,inhibitor,yes
DB05245,Silver sulfadiazine,small molecule,approved;vet_approved,[Ag+].NC1=CC=C(C=C1)S(=O)(=O)[N-]C1=NC=CC=N1,UEJSSZHHYBHCEL-UHFFFAOYSA-N,357.137,,BE0004796,DNA,Humans,binder,yes
DB05245,Silver sulfadiazine,small molecule,approved;vet_approved,[Ag+].NC1=CC=C(C=C1)S(=O)(=O)[N-]C1=NC=CC=N1,UEJSSZHHYBHCEL-UHFFFAOYSA-N,357.137,P0AC13,BE0000803,Dihydropteroate synthase,Escherichia coli (strain K12),binder,yes
DB05246,Methsuximide,small molecule,approved,CN1C(=O)CC(C)(C1=O)C1=CC=CC=C1,AJXPJJZHWIXJCJ-UHFFFAOYSA-N,203.2371,O43497,BE0000483,Voltage-dependent T-type calcium channel subunit alpha-1G,Humans,inhibitor,yes
DB05252,Fenoxaprop-ethyl,small molecule,investigational,CCOC(=O)C(C)OC1=CC=C(OC2=NC3=C(O2)C=C(Cl)C=C3)C=C1,PQKBPHSEKWERTG-UHFFFAOYSA-N,361.776,P29474,BE0000263,Nitric oxide synthase 3,Humans,stimulator,yes
DB05255,Ronacaleret,small molecule,investigational,CC(C)(CC1CC2=C(C1)C=CC=C2)NC[C@@H](O)COC1=CC(CCC(O)=O)=CC(F)=C1F,FQJISUPNMFRIFZ-HXUWFJFHSA-N,447.523,P41180,BE0000509,Extracellular calcium-sensing receptor,Humans,antagonist,yes
DB05262,Oxypurinol,small molecule,investigational,O=C1NC2=C(C=NN2)C(=O)N1,HXNFUBHNUDHIGC-UHFFFAOYSA-N,152.1109,P47989,BE0002204,Xanthine dehydrogenase/oxidase,Humans,inhibitor,yes
DB05265,Ecabet,small molecule,investigational,[H][C@@]12CCC3=CC(C(C)C)=C(C=C3[C@@]1(C)CCC[C@@]2(C)C(O)=O)S(O)(=O)=O,IWCWQNVIUXZOMJ-MISYRCLQSA-N,380.498,P18314,BE0000334,Urease subunit alpha,Enterobacter aerogenes,inhibitor,yes
DB05265,Ecabet,small molecule,investigational,[H][C@@]12CCC3=CC(C(C)C)=C(C=C3[C@@]1(C)CCC[C@@]2(C)C(O)=O)S(O)(=O)=O,IWCWQNVIUXZOMJ-MISYRCLQSA-N,380.498,Q8NFA2,BE0002423,NADPH oxidase organizer 1,Humans,antagonist,yes
DB05266,Ibudilast,small molecule,investigational,CC(C)C(=O)C1=C2C=CC=CN2N=C1C(C)C,ZJVFLBOZORBYFE-UHFFFAOYSA-N,230.3055,P27815,BE0001133,"3',5'-cyclic-AMP phosphodiesterase 4A",Humans,inhibitor,yes
DB05266,Ibudilast,small molecule,investigational,CC(C)C(=O)C1=C2C=CC=CN2N=C1C(C)C,ZJVFLBOZORBYFE-UHFFFAOYSA-N,230.3055,Q07343,BE0000487,"3',5'-cyclic-AMP phosphodiesterase 4B",Humans,inhibitor,yes
DB05266,Ibudilast,small molecule,investigational,CC(C)C(=O)C1=C2C=CC=CN2N=C1C(C)C,ZJVFLBOZORBYFE-UHFFFAOYSA-N,230.3055,Q08493,BE0002353,"3',5'-cyclic-AMP phosphodiesterase 4C",Humans,inhibitor,yes
DB05271,Rotigotine,small molecule,approved,CCCN(CCC1=CC=CS1)[C@H]1CCC2=C(O)C=CC=C2C1,KFQYTPMOWPVWEJ-INIZCTEOSA-N,315.48,P35462,BE0000581,D(3) dopamine receptor,Humans,agonist,yes
DB05271,Rotigotine,small molecule,approved,CCCN(CCC1=CC=CS1)[C@H]1CCC2=C(O)C=CC=C2C1,KFQYTPMOWPVWEJ-INIZCTEOSA-N,315.48,P21917,BE0000389,D(4) dopamine receptor,Humans,agonist,yes
DB05271,Rotigotine,small molecule,approved,CCCN(CCC1=CC=CS1)[C@H]1CCC2=C(O)C=CC=C2C1,KFQYTPMOWPVWEJ-INIZCTEOSA-N,315.48,P14416,BE0000756,D(2) dopamine receptor,Humans,agonist,yes
DB05289,Tarenflurbil,small molecule,investigational,C[C@@H](C(O)=O)C1=CC(F)=C(C=C1)C1=CC=CC=C1,SYTBZMRGLBWNTM-SNVBAGLBSA-N,244.2609,Q8WW43,BE0017533,Gamma-secretase subunit APH-1B,Humans,inhibitor,yes
DB05289,Tarenflurbil,small molecule,investigational,C[C@@H](C(O)=O)C1=CC(F)=C(C=C1)C1=CC=CC=C1,SYTBZMRGLBWNTM-SNVBAGLBSA-N,244.2609,Q92542,BE0017775,Nicastrin,Humans,inhibitor,yes
DB05289,Tarenflurbil,small molecule,investigational,C[C@@H](C(O)=O)C1=CC(F)=C(C=C1)C1=CC=CC=C1,SYTBZMRGLBWNTM-SNVBAGLBSA-N,244.2609,Q96BI3,BE0003409,Gamma-secretase subunit APH-1A,Humans,inhibitor,yes
DB05289,Tarenflurbil,small molecule,investigational,C[C@@H](C(O)=O)C1=CC(F)=C(C=C1)C1=CC=CC=C1,SYTBZMRGLBWNTM-SNVBAGLBSA-N,244.2609,Q9NZ42,BE0003410,Gamma-secretase subunit PEN-2,Humans,inhibitor,yes
DB05289,Tarenflurbil,small molecule,investigational,C[C@@H](C(O)=O)C1=CC(F)=C(C=C1)C1=CC=CC=C1,SYTBZMRGLBWNTM-SNVBAGLBSA-N,244.2609,P49768,BE0010960,Presenilin-1,Humans,inhibitor,yes
DB05289,Tarenflurbil,small molecule,investigational,C[C@@H](C(O)=O)C1=CC(F)=C(C=C1)C1=CC=CC=C1,SYTBZMRGLBWNTM-SNVBAGLBSA-N,244.2609,P49810,BE0011014,Presenilin-2,Humans,inhibitor,yes
DB05294,Vandetanib,small molecule,approved,COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1,UHTHHESEBZOYNR-UHFFFAOYSA-N,475.354,P35968,BE0000369,Vascular endothelial growth factor receptor 2,Humans,inhibitor,yes
DB05294,Vandetanib,small molecule,approved,COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1,UHTHHESEBZOYNR-UHFFFAOYSA-N,475.354,P07949,BE0002411,Proto-oncogene tyrosine-protein kinase receptor Ret,Humans,inhibitor,yes
DB05294,Vandetanib,small molecule,approved,COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1,UHTHHESEBZOYNR-UHFFFAOYSA-N,475.354,P00533,BE0000767,Epidermal growth factor receptor,Humans,inhibitor,yes
DB05296,Motexafin lutetium,small molecule,investigational,[Lu+3].CC([O-])=O.CC([O-])=O.CCC1=C2[N-]C(\C=C3/N=C(/C=N/C4=CC(OCCOCCOCCOC)=C(OCCOCCOCCOC)C=C4\N=C\C4=N\C(=C/2)\C(CCCO)=C4C)C(C)=C3CCCO)=C1CC,ZCISRIHHEXSWIR-WRIGXHCHSA-L,1166.136,P07288,BE0008983,Prostate-specific antigen,Humans,modulator,yes
DB05316,Pimavanserin,small molecule,approved;investigational,CC(C)COC1=CC=C(CNC(=O)N(CC2=CC=C(F)C=C2)C2CCN(C)CC2)C=C1,RKEWSXXUOLRFBX-UHFFFAOYSA-N,427.564,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,inverse agonist,yes
DB05327,Ranirestat,small molecule,investigational,FC1=C(CN2C(=O)C3=CC=CN3[C@@]3(CC(=O)NC3=O)C2=O)C=CC(Br)=C1,QCVNMNYRNIMDKV-QGZVFWFLSA-N,420.189,P15121,BE0000747,Aldo-keto reductase family 1 member B1,Humans,inhibitor,yes
DB05339,MN-305,small molecule,investigational,Cl.C(CNC[C@H]1COC2=CC=CC=C2O1)COC1=CC2=C(OCO2)C=C1,GGNCUSDIUUCNKE-RSAXXLAASA-N,379.835,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,agonist,yes
DB05343,Arundic acid,small molecule,investigational,CCCCCC[C@@H](CCC)C(O)=O,YCYMCMYLORLIJX-SNVBAGLBSA-N,186.2912,P13945,BE0001012,Beta-3 adrenergic receptor,Humans,agonist,yes
DB05343,Arundic acid,small molecule,investigational,CCCCCC[C@@H](CCC)C(O)=O,YCYMCMYLORLIJX-SNVBAGLBSA-N,186.2912,P04271,BE0001177,Protein S100-B,Humans,modulator,yes
DB05351,Dexlansoprazole,small molecule,approved;investigational,CC1=C(OCC(F)(F)F)C=CN=C1C[S@@](=O)C1=NC2=CC=CC=C2N1,MJIHNNLFOKEZEW-RUZDIDTESA-N,369.36,P20648,BE0000349,Potassium-transporting ATPase alpha chain 1,Humans,inhibitor,yes
DB05351,Dexlansoprazole,small molecule,approved;investigational,CC1=C(OCC(F)(F)F)C=CN=C1C[S@@](=O)C1=NC2=CC=CC=C2N1,MJIHNNLFOKEZEW-RUZDIDTESA-N,369.36,P51164,BE0000619,Potassium-transporting ATPase subunit beta,Humans,inhibitor,yes
DB05395,Amibegron,small molecule,investigational,[H][C@](O)(CN[C@@]1([H])CCC2=C(C1)C=C(OCC(=O)OCC)C=C2)C1=CC(Cl)=CC=C1,RDJQCOBTKKAQAH-FPOVZHCZSA-N,403.9,P13945,BE0001012,Beta-3 adrenergic receptor,Humans,agonist,yes
DB05407,TBC-3711,small molecule,investigational,CC(=O)C1=C(NC(=O)C2=C(C=CS2)S(=O)(=O)NC2=C(C)C(C)=NO2)C(C)=CC(C)=C1,IAYNHDZSSDUYHY-UHFFFAOYSA-N,447.52,P25101,BE0000521,Endothelin-1 receptor,Humans,antagonist,yes
DB05409,NCX 701,small molecule,investigational,CC(=O)NC1=CC=C(OC(=O)CCCO[N+]([O-])=O)C=C1,XTMOQAKCOFLCRZ-UHFFFAOYSA-N,282.2494,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,modulator,yes
DB05409,NCX 701,small molecule,investigational,CC(=O)NC1=CC=C(OC(=O)CCCO[N+]([O-])=O)C=C1,XTMOQAKCOFLCRZ-UHFFFAOYSA-N,282.2494,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,modulator,yes
DB05412,Talmapimod,small molecule,investigational,[H][C@]1(C)CN(C(=O)C2=C(Cl)C=C3N(C)C=C(C(=O)C(=O)N(C)C)C3=C2)[C@]([H])(C)CN1CC1=CC=C(F)C=C1,ZMELOYOKMZBMRB-DLBZAZTESA-N,513.004,Q16539,BE0001019,Mitogen-activated protein kinase 14,Humans,modulator,yes
DB05414,Pipendoxifene,small molecule,investigational,CC1=C(N(CC2=CC=C(OCCN3CCCCC3)C=C2)C2=C1C=C(O)C=C2)C1=CC=C(O)C=C1,JICOGKJOQXTAIP-UHFFFAOYSA-N,456.576,P03372,BE0000123,Estrogen receptor,Humans,inhibitor,yes
DB05414,Pipendoxifene,small molecule,investigational,CC1=C(N(CC2=CC=C(OCCN3CCCCC3)C=C2)C2=C1C=C(O)C=C2)C1=CC=C(O)C=C1,JICOGKJOQXTAIP-UHFFFAOYSA-N,456.576,Q92731,BE0000792,Estrogen receptor beta,Humans,inhibitor,yes
DB05420,Gallium maltolate,small molecule,investigational,[Ga+3].CC1=C([O-])C(=O)C=CO1.CC1=C([O-])C(=O)C=CO1.CC1=C([O-])C(=O)C=CO1,ASYYOZSDALANRF-UHFFFAOYSA-K,445.032,P31350,BE0002450,Ribonucleoside-diphosphate reductase subunit M2,Humans,binder,yes
DB05421,CP-122721,small molecule,investigational,COC1=CC=C(OC(F)(F)F)C=C1CN[C@H]1CCCN[C@H]1C1=CC=CC=C1,ZIWFCOIGUNPHPM-HKUYNNGSSA-N,380.404,P25103,BE0000384,Substance-P receptor,Humans,antagonist,yes
DB05422,OPC-14523,small molecule,investigational,COC1=CC=CC2=C1CCC(=O)N2CCCN1CCN(CC1)C1=CC=CC(Cl)=C1,TZZGTNZBLPCBIS-UHFFFAOYSA-N,413.95,Q99720,BE0000156,Sigma non-opioid intracellular receptor 1,Humans,modulator,yes
DB05422,OPC-14523,small molecule,investigational,COC1=CC=CC2=C1CCC(=O)N2CCCN1CCN(CC1)C1=CC=CC(Cl)=C1,TZZGTNZBLPCBIS-UHFFFAOYSA-N,413.95,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,modulator,yes
DB05423,ORG-34517,small molecule,investigational,[H][C@@]12CC[C@@](O)(C#CC)[C@@]1(C)C[C@H](C1=CC=C3OCOC3=C1)C1=C3CCC(=O)C=C3CC[C@@]21[H],DFELGYQKEOCHOA-BZAFBGKRSA-N,430.544,P04150,BE0000794,Glucocorticoid receptor,Humans,antagonist,yes
DB05424,Canertinib,small molecule,investigational,FC1=C(Cl)C=C(NC2=NC=NC3=CC(OCCCN4CCOCC4)=C(NC(=O)C=C)C=C23)C=C1,OMZCMEYTWSXEPZ-UHFFFAOYSA-N,485.938,P04626,BE0000511,Receptor tyrosine-protein kinase erbB-2,Humans,inhibitor,yes
DB05424,Canertinib,small molecule,investigational,FC1=C(Cl)C=C(NC2=NC=NC3=CC(OCCCN4CCOCC4)=C(NC(=O)C=C)C=C23)C=C1,OMZCMEYTWSXEPZ-UHFFFAOYSA-N,485.938,P31749,BE0000428,RAC-alpha serine/threonine-protein kinase,Humans,inhibitor,yes
DB05424,Canertinib,small molecule,investigational,FC1=C(Cl)C=C(NC2=NC=NC3=CC(OCCCN4CCOCC4)=C(NC(=O)C=C)C=C23)C=C1,OMZCMEYTWSXEPZ-UHFFFAOYSA-N,485.938,Q15303,BE0004772,Receptor tyrosine-protein kinase erbB-4,Humans,inhibitor,yes
DB05424,Canertinib,small molecule,investigational,FC1=C(Cl)C=C(NC2=NC=NC3=CC(OCCCN4CCOCC4)=C(NC(=O)C=C)C=C23)C=C1,OMZCMEYTWSXEPZ-UHFFFAOYSA-N,485.938,P00533,BE0000767,Epidermal growth factor receptor,Humans,inhibitor,yes
DB05428,Motexafin gadolinium,small molecule,investigational,[Gd+3].CC([O-])=O.CC([O-])=O.CCC1=C(CC)/C2=C/C3=N/C(=C\N=C4/C=C(OCCOCCOCCOC)C(OCCOCCOCCOC)=C/C/4=N\C=C4/N=C(/C=C\1\[N-]\2)C(CCCO)=C4C)/C(C)=C3CCCO,VAZLWPAHMORDGR-WRIGXHCHSA-L,1148.4,P30044,BE0000907,"Peroxiredoxin-5, mitochondrial",Humans,modulator,yes
DB05431,MLN-977,small molecule,investigational,NC(=O)N(O)CCC#C[C@@H]1CC[C@@H](COC2=CC=C(F)C=C2)O1,YANONWCPCKIWEC-CABCVRRESA-N,322.336,P09917,BE0000248,Polyunsaturated fatty acid 5-lipoxygenase,Humans,inhibitor,yes
DB05434,ABT-510,small molecule,investigational,CCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)CN(C)C(C)=O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC,RIWLPSIAFBLILR-WVNGMBSFSA-N,994.2317,P07996,BE0010410,Thrombospondin-1,Humans,modulator,yes
DB05442,Etiprednol dicloacetate,small molecule,investigational,[H][C@@]12CC[C@](OC(=O)C(Cl)Cl)(C(=O)OCC)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,QAIOVDNCIZSSSF-RFAJLIJZSA-N,485.4,P04150,BE0000794,Glucocorticoid receptor,Humans,modulator,yes
DB05444,Iroxanadine,small molecule,investigational,C(C1CONC(=N1)C1=CN=CC=C1)N1CCCCC1,QWVRTSZDKPRPDF-UHFFFAOYSA-N,260.3348,P0DMV8,BE0010433,Heat shock 70 kDa protein 1A,Humans,modulator,yes
DB05444,Iroxanadine,small molecule,investigational,C(C1CONC(=N1)C1=CN=CC=C1)N1CCCCC1,QWVRTSZDKPRPDF-UHFFFAOYSA-N,260.3348,P0DMV9,BE0012549,Heat shock 70 kDa protein 1B,Humans,modulator,yes
DB05448,PX-12,small molecule,investigational,CCC(C)SSC1=NC=CN1,BPBPYQWMFCTCNG-UHFFFAOYSA-N,188.314,P10599,BE0004965,Thioredoxin,Humans,inhibitor,yes
DB05448,PX-12,small molecule,investigational,CCC(C)SSC1=NC=CN1,BPBPYQWMFCTCNG-UHFFFAOYSA-N,188.314,Q16881,BE0001979,"Thioredoxin reductase 1, cytoplasmic",Humans,inhibitor,yes
DB05454,Paliroden,small molecule,investigational,FC(F)(F)C1=CC(=CC=C1)C1=CCN(CCC2=CC=C(C=C2)C2=CC=CC=C2)CC1,CNEWKIDCGDXBDE-UHFFFAOYSA-N,407.48,P42262,BE0000829,Glutamate receptor 2,Humans,modulator,yes
DB05458,Pozanicline,small molecule,investigational,CC1=C(OC[C@@H]2CCCN2)C=CC=N1,YRVIKLBSVVNSHF-JTQLQIEISA-N,192.2575,P43681,BE0000849,Neuronal acetylcholine receptor subunit alpha-4,Humans,modulator,yes
DB05458,Pozanicline,small molecule,investigational,CC1=C(OC[C@@H]2CCCN2)C=CC=N1,YRVIKLBSVVNSHF-JTQLQIEISA-N,192.2575,P17787,BE0000850,Neuronal acetylcholine receptor subunit beta-2,Humans,modulator,yes
DB05460,Ezatiostat,small molecule,investigational,CCOC(=O)[C@@H](N)CCC(=O)N[C@@H](CSCC1=CC=CC=C1)C(=O)N[C@@H](C(=O)OCC)C1=CC=CC=C1,GWEJFLVSOGNLSS-WPFOTENUSA-N,529.648,P09211,BE0000814,Glutathione S-transferase P,Humans,modulator,yes
DB05465,Tandutinib,small molecule,investigational,COC1=C(OCCCN2CCCCC2)C=C2N=CN=C(N3CCN(CC3)C(=O)NC3=CC=C(OC(C)C)C=C3)C2=C1,UXXQOJXBIDBUAC-UHFFFAOYSA-N,562.703,P36888,BE0000147,Receptor-type tyrosine-protein kinase FLT3,Humans,inhibitor,yes
DB05467,Palovarotene,small molecule,approved;investigational,CC1(C)CCC(C)(C)C2=C1C=C(CN1C=CC=N1)C(\C=C\C1=CC=C(C=C1)C(O)=O)=C2,YTFHCXIPDIHOIA-DHZHZOJOSA-N,414.549,P13631,BE0000144,Retinoic acid receptor gamma,Humans,agonist,yes
DB05470,VX-702,small molecule,investigational,NC(=O)N(C1=CC=C(C(N)=O)C(=N1)C1=CC=C(F)C=C1F)C1=C(F)C=CC=C1F,FYSRKRZDBHOFAY-UHFFFAOYSA-N,404.325,Q16539,BE0001019,Mitogen-activated protein kinase 14,Humans,modulator,yes
DB05475,Golotimod,small molecule,investigational,N[C@H](CCC(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(O)=O)C(O)=O,CATMPQFFVNKDEY-YPMHNXCESA-N,333.3392,P40763,BE0003462,Signal transducer and activator of transcription 3,Humans,inhibitor,yes
DB05482,SN-38,small molecule,investigational,CCC1=C2C=C(O)C=CC2=NC2=C1CN1C2=CC2=C(COC(=O)[C@]2(O)CC)C1=O,FJHBVJOVLFPMQE-QFIPXVFZSA-N,392.4046,P11387,BE0000971,DNA topoisomerase 1,Humans,inhibitor,yes
DB05490,AMG-131,small molecule,investigational,ClC1=CC=C(C(Cl)=C1)S(=O)(=O)NC1=CC(Cl)=C(OC2=CN=C3C=CC=CC3=C2)C(Cl)=C1,NMRWDFUZLLQSBN-UHFFFAOYSA-N,514.209,P37231,BE0000215,Peroxisome proliferator-activated receptor gamma,Humans,partial agonist,yes
DB05495,PG-530742,small molecule,investigational,COC1=CC=C(C=C1)C(=O)NC1=CC=C(C=C1)S(=O)(=O)NC(CC#CCN1CCOCC1)C(O)=O,JAYVKNDQKXUNOJ-UHFFFAOYSA-N,501.55,P08254,BE0001116,Stromelysin-1,Humans,inhibitor,yes
DB05501,Mavorixafor,small molecule,approved;investigational,NCCCCN(CC1=NC2=CC=CC=C2N1)[C@H]1CCCC2=C1N=CC=C2,WVLHHLRVNDMIAR-IBGZPJMESA-N,349.482,P61073,BE0000919,C-X-C chemokine receptor type 4,Humans,antagonist;inhibitor,yes
DB05511,Piclidenoson,small molecule,investigational,CNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(NCC3=CC(I)=CC=C3)N=CN=C12,HUJXGQILHAUCCV-MOROJQBDSA-N,510.2857,P0DMS8,BE0000354,Adenosine receptor A3,Humans,agonist,yes
DB05513,Atiprimod,small molecule,investigational,CCCC1(CCC)CCC2(CCN(CCCN(CC)CC)C2)CC1,SERHTTSLBVGRBY-UHFFFAOYSA-N,336.608,P40763,BE0003462,Signal transducer and activator of transcription 3,Humans,inhibitor,yes
DB05521,Telaprevir,small molecule,approved;withdrawn,[H][C@@]12CCC[C@]1([H])[C@H](N(C2)C(=O)[C@@H](NC(=O)[C@@H](NC(=O)C1=NC=CN=C1)C1CCCCC1)C(C)(C)C)C(=O)N[C@@H](CCC)C(=O)C(=O)NC1CC1,BBAWEDCPNXPBQM-GDEBMMAJSA-N,679.8493,P26664,BE0003427,Genome polyprotein,,modulator,yes
DB05521,Telaprevir,small molecule,approved;withdrawn,[H][C@@]12CCC[C@]1([H])[C@H](N(C2)C(=O)[C@@H](NC(=O)[C@@H](NC(=O)C1=NC=CN=C1)C1CCCCC1)C(C)(C)C)C(=O)N[C@@H](CCC)C(=O)C(=O)NC1CC1,BBAWEDCPNXPBQM-GDEBMMAJSA-N,679.8493,B0B3C9,BE0004701,Genome polyprotein,Hepatitis C Virus,inhibitor,yes
DB05524,Pelitinib,small molecule,investigational,CCOC1=CC2=C(C=C1NC(=O)\C=C\CN(C)C)C(NC1=CC(Cl)=C(F)C=C1)=C(C=N2)C#N,WVUNYSQLFKLYNI-AATRIKPKSA-N,467.93,P00533,BE0000767,Epidermal growth factor receptor,Humans,modulator,yes
DB05541,Brivaracetam,small molecule,approved;investigational,CCC[C@H]1CN([C@@H](CC)C(N)=O)C(=O)C1,MSYKRHVOOPPJKU-BDAKNGLRSA-N,212.2887,P35498,BE0004901,Sodium channel protein,Humans,inhibitor,yes
DB05542,Naronapride,small molecule,investigational,CO[C@H]1CN(CCCCCC(=O)O[C@H]2CN3CCC2CC3)CC[C@H]1NC(=O)C1=C(OC)C=C(N)C(Cl)=C1,VGDDOIZXGFJDRC-VJTSUQJLSA-N,537.1,Q13639,BE0000084,5-hydroxytryptamine receptor 4,Humans,agonist,yes
DB05552,TG100-115,small molecule,investigational,NC1=NC(N)=C2N=C(C3=CC=CC(O)=C3)C(=NC2=N1)C1=CC(O)=CC=C1,UJIAQDJKSXQLIT-UHFFFAOYSA-N,346.35,O00329,BE0002406,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",Humans,inhibitor,yes
DB05552,TG100-115,small molecule,investigational,NC1=NC(N)=C2N=C(C3=CC=CC(O)=C3)C(=NC2=N1)C1=CC(O)=CC=C1,UJIAQDJKSXQLIT-UHFFFAOYSA-N,346.35,P48736,BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",Humans,inhibitor,yes
DB05565,PBT-1033,small molecule,investigational,CN(C)CC1=CC=C2C(Cl)=CC(Cl)=C(O)C2=N1,YZPOQCQXOSEMAZ-UHFFFAOYSA-N,271.14,P10636,BE0003474,Microtubule-associated protein tau,Humans,modulator,yes
DB05575,Motesanib,small molecule,investigational,CC1(C)CNC2=CC(NC(=O)C3=C(NCC4=CC=NC=C4)N=CC=C3)=CC=C12,RAHBGWKEPAQNFF-UHFFFAOYSA-N,373.4509,P35968,BE0000369,Vascular endothelial growth factor receptor 2,Humans,inhibitor,yes
DB05575,Motesanib,small molecule,investigational,CC1(C)CNC2=CC(NC(=O)C3=C(NCC4=CC=NC=C4)N=CC=C3)=CC=C12,RAHBGWKEPAQNFF-UHFFFAOYSA-N,373.4509,P10721,BE0000453,Mast/stem cell growth factor receptor Kit,Humans,inhibitor,yes
DB05586,Facinicline,small molecule,investigational,[H]N([C@@H]1CN2CCC1CC2)C(=O)C1=NN([H])C2=CC=CC=C12,TXCYUSKWBHUVEP-CYBMUJFWSA-N,270.336,P36544,BE0002341,Neuronal acetylcholine receptor subunit alpha-7,Humans,antagonist,yes
DB05590,Bedoradrine,small molecule,investigational,CN(C)C(=O)COC1=CC=C2CC[C@@H](CC2=C1)NC[C@H](O)C1=CC=C(O)C(CCO)=C1,OANCEOSLKSTLTA-REWPJTCUSA-N,428.529,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,agonist,yes
DB05592,Blarcamesine,small molecule,investigational,CN(C)CC1CCOC1(C1=CC=CC=C1)C1=CC=CC=C1,BOTHKNZTGGXFEQ-UHFFFAOYSA-N,281.399,Q99720,BE0000156,Sigma non-opioid intracellular receptor 1,Humans,agonist,yes
DB05592,Blarcamesine,small molecule,investigational,CN(C)CC1CCOC1(C1=CC=CC=C1)C1=CC=CC=C1,BOTHKNZTGGXFEQ-UHFFFAOYSA-N,281.399,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,agonist,yes
DB05608,MKC-1,small molecule,investigational,CN1C=C(C2=CC=CC=C12)C1=C(C(=O)NC1=O)C1=CN(C)C2=CC(=CC=C12)[N+]([O-])=O,OVSKGTONMLKNPZ-UHFFFAOYSA-N,400.394,P11802,BE0002216,Cyclin-dependent kinase 4,Humans,inhibitor,yes
DB05608,MKC-1,small molecule,investigational,CN1C=C(C2=CC=CC=C12)C1=C(C(=O)NC1=O)C1=CN(C)C2=CC(=CC=C12)[N+]([O-])=O,OVSKGTONMLKNPZ-UHFFFAOYSA-N,400.394,P24941,BE0001072,Cyclin-dependent kinase 2,Humans,inhibitor,yes
DB05608,MKC-1,small molecule,investigational,CN1C=C(C2=CC=CC=C12)C1=C(C(=O)NC1=O)C1=CN(C)C2=CC(=CC=C12)[N+]([O-])=O,OVSKGTONMLKNPZ-UHFFFAOYSA-N,400.394,P06493,BE0001082,Cyclin-dependent kinase 1,Humans,inhibitor,yes
DB05611,Apilimod,small molecule,investigational,CC1=CC=CC(\C=N\NC2=CC(=NC(OCCC3=CC=CC=N3)=N2)N2CCOCC2)=C1,HSKAZIJJKRAJAV-KOEQRZSOSA-N,418.501,Q9Y2I7,BE0021269,1-phosphatidylinositol 3-phosphate 5-kinase,Humans,inhibitor,yes
DB05611,Apilimod,small molecule,investigational,CC1=CC=CC(\C=N\NC2=CC(=NC(OCCC3=CC=CC=N3)=N2)N2CCOCC2)=C1,HSKAZIJJKRAJAV-KOEQRZSOSA-N,418.501,P29459,BE0012862,Interleukin-12 subunit alpha,Humans,inhibitor,yes
DB05624,Teverelix,small molecule,investigational,CC(C)C[C@H](NC(=O)[C@@H](CCCCNC(N)=O)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1=CC=CN=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC2=C(C=CC=C2)C=C1)NC(C)=O)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,NOENHWMKHNSHGX-IAOPALDYSA-N,1459.16,P30968,BE0000203,Gonadotropin-releasing hormone receptor,Humans,antagonist,yes
DB05625,CTCE-9908,small molecule,investigational,CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCCCC[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N)CCCCN)C(C)C)C(N)=O,VUYRSKROGTWHDC-HZGLMRDYSA-N,1927.288,P61073,BE0000919,C-X-C chemokine receptor type 4,Humans,modulator,yes
DB05630,Sodium stibogluconate,small molecule,approved;investigational,O.O.O.O.O.O.O.O.O.[Na+].[Na+].[Na+].[H][C@@]1(O[Sb]2(O)(O[Sb]34([O-])O[C@@H](C([O-])=O)[C@@]([H])(O3)[C@]([H])(O4)[C@H](O)CO)O[C@@H](C([O-])=O)[C@@]1([H])O2)[C@H](O)CO,YQDGWZZYGYKDLR-UZVLBLASSA-K,907.88,P11387,BE0000971,DNA topoisomerase 1,Humans,inhibitor,yes
DB05631,ALT-2074,small molecule,investigational,CC1(C)CN[Se]C2=CC=CC=C12,FXRYWOJYVGJZLE-UHFFFAOYSA-N,226.18,P35228,BE0000005,"Nitric oxide synthase, inducible",Humans,modulator,yes
DB05645,Larazotide,small molecule,investigational,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)CN)C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O,ORFLZNAGUTZRLQ-ZMBVWFSWSA-N,725.845,P00738,BE0009911,Haptoglobin,Humans,modulator,yes
DB05650,OT-551,small molecule,investigational,CC1(C)CC(CC(C)(C)N1O)OC(=O)C1CC1,ZWEXEKJLDHNLLA-UHFFFAOYSA-N,241.331,Q16236,BE0010121,Nuclear factor erythroid 2-related factor 2,Humans,inhibitor,yes
DB05653,IRX-5183,small molecule,investigational,CC1(C)CCC(C)(C)C2=C1C=C(C(=O)NC1=CC(F)=C(C(O)=O)C(F)=C1)C(O)=C2Cl,PNAWUIKCVQSLFG-UHFFFAOYSA-N,437.87,P10276,BE0000663,Retinoic acid receptor alpha,Humans,agonist,yes
DB05660,D-JNKI-1,small molecule,investigational,CC(C)C[C@@H](NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)[C@H]1CCCN1C(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](NC(=O)[C@H]1CCCN1C(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](CO)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](N)CC(O)=O)C(C)C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@H]([C@H](C)O)C(=O)N[C@H]([C@H](C)O)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H](CCCCN)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)N1CCC[C@@H]1C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(O)=O,HRMVIAFZYCCHGF-BMCUWHFPSA-N,3823.498,P45983,BE0003790,Mitogen-activated protein kinase 8,Humans,modulator,yes
DB05660,D-JNKI-1,small molecule,investigational,CC(C)C[C@@H](NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)[C@H]1CCCN1C(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](NC(=O)[C@H]1CCCN1C(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](CO)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](N)CC(O)=O)C(C)C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@H]([C@H](C)O)C(=O)N[C@H]([C@H](C)O)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H](CCCCN)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)N1CCC[C@@H]1C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(O)=O,HRMVIAFZYCCHGF-BMCUWHFPSA-N,3823.498,P45984,BE0003772,Mitogen-activated protein kinase 9,Humans,modulator,yes
DB05660,D-JNKI-1,small molecule,investigational,CC(C)C[C@@H](NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)[C@H]1CCCN1C(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](NC(=O)[C@H]1CCCN1C(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](CO)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](N)CC(O)=O)C(C)C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@H]([C@H](C)O)C(=O)N[C@H]([C@H](C)O)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H](CCCCN)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)N1CCC[C@@H]1C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(O)=O,HRMVIAFZYCCHGF-BMCUWHFPSA-N,3823.498,P53779,BE0001097,Mitogen-activated protein kinase 10,Humans,modulator,yes
DB05667,Levoketoconazole,small molecule,approved;investigational,CC(=O)N1CCN(CC1)C1=CC=C(OC[C@@H]2CO[C@](CN3C=CN=C3)(O2)C2=CC=C(Cl)C=C2Cl)C=C1,XMAYWYJOQHXEEK-ZEQKJWHPSA-N,531.431,P05093,BE0000344,"Steroid 17-alpha-hydroxylase/17,20 lyase",Humans,inhibitor,yes
DB05667,Levoketoconazole,small molecule,approved;investigational,CC(=O)N1CCN(CC1)C1=CC=C(OC[C@@H]2CO[C@](CN3C=CN=C3)(O2)C2=CC=C(Cl)C=C2Cl)C=C1,XMAYWYJOQHXEEK-ZEQKJWHPSA-N,531.431,P15538,BE0000731,"Cytochrome P450 11B1, mitochondrial",Humans,inhibitor,yes
DB05667,Levoketoconazole,small molecule,approved;investigational,CC(=O)N1CCN(CC1)C1=CC=C(OC[C@@H]2CO[C@](CN3C=CN=C3)(O2)C2=CC=C(Cl)C=C2Cl)C=C1,XMAYWYJOQHXEEK-ZEQKJWHPSA-N,531.431,P19099,BE0003542,"Cytochrome P450 11B2, mitochondrial",Humans,inhibitor,yes
DB05667,Levoketoconazole,small molecule,approved;investigational,CC(=O)N1CCN(CC1)C1=CC=C(OC[C@@H]2CO[C@](CN3C=CN=C3)(O2)C2=CC=C(Cl)C=C2Cl)C=C1,XMAYWYJOQHXEEK-ZEQKJWHPSA-N,531.431,P05108,BE0003537,"Cholesterol side-chain cleavage enzyme, mitochondrial",Humans,inhibitor,yes
DB05668,Palifosfamide,small molecule,investigational,OP(=O)(NCCCl)NCCCl,BKCJZNIZRWYHBN-UHFFFAOYSA-N,221.022,P26358,BE0000892,DNA (cytosine-5)-methyltransferase 1,Humans,inhibitor,yes
DB05676,Apremilast,small molecule,approved;investigational,CCOC1=CC(=CC=C1OC)[C@@H](CS(C)(=O)=O)N1C(=O)C2=CC=CC(NC(C)=O)=C2C1=O,IMOZEMNVLZVGJZ-QGZVFWFLSA-N,460.5,Q86V67,BE0009697,Phosphodiesterase isozyme 4,Humans,inhibitor,yes
DB05676,Apremilast,small molecule,approved;investigational,CCOC1=CC(=CC=C1OC)[C@@H](CS(C)(=O)=O)N1C(=O)C2=CC=CC(NC(C)=O)=C2C1=O,IMOZEMNVLZVGJZ-QGZVFWFLSA-N,460.5,P11802,BE0002216,Cyclin-dependent kinase 4,Humans,inhibitor,yes
DB05676,Apremilast,small molecule,approved;investigational,CCOC1=CC(=CC=C1OC)[C@@H](CS(C)(=O)=O)N1C(=O)C2=CC=CC(NC(C)=O)=C2C1=O,IMOZEMNVLZVGJZ-QGZVFWFLSA-N,460.5,Q00534,BE0002212,Cyclin-dependent kinase 6,Humans,inhibitor,yes
DB05695,NPS-2143,small molecule,investigational,CC(C)(CC1=CC=C2C=CC=CC2=C1)NC[C@@H](O)COC1=CC=CC(Cl)=C1C#N,PZUJQWHTIRWCID-HXUWFJFHSA-N,408.93,P41180,BE0000509,Extracellular calcium-sensing receptor,Humans,antagonist,yes
DB05708,GTS-21,small molecule,investigational,[H]\C(=C1\CCCN=C1C1=CN=CC=C1)C1=C(OC)C=C(OC)C=C1,RPYWXZCFYPVCNQ-RVDMUPIBSA-N,308.3743,P36544,BE0002341,Neuronal acetylcholine receptor subunit alpha-7,Humans,agonist,yes
DB05710,Gantacurium,small molecule,investigational,COC1=CC(C[C@@H]2C3=CC(OC)=C(OC)C=C3CC[N@@+]2(C)CCCOC(=O)C(\Cl)=C\C(=O)OCCC[N@@+]2(C)CCC3=CC(OC)=C(OC)C=C3[C@@H]2C2=CC(OC)=C(OC)C(OC)=C2)=CC(OC)=C1OC,ZQLDXCSTJFLRPY-RWBXLJKRSA-N,993.58,P32297,BE0003585,Neuronal acetylcholine receptor subunit alpha-3,Humans,antagonist,yes
DB05713,LY-517717,small molecule,investigational,CN1CCC(CC1)N1CCN(CC1)C(=O)[C@H](NC(=O)C1=CC=C2C=CNC2=C1)C1=CC=CC=C1,VYNKVNDKAOGAAQ-RUZDIDTESA-N,459.594,P00742,BE0000216,Coagulation factor X,Humans,inhibitor,yes
DB05721,EVT 201,small molecule,investigational,CN(C)CC1=NC(=NO1)C1=C2CN(C)C(=O)C3=C(C=CC=C3Cl)N2C=N1,JCYLWUVDHLVGER-UHFFFAOYSA-N,372.81,Q99928,BE0003594,Gamma-aminobutyric acid receptor subunit gamma-3,Humans,modulator,yes
DB05721,EVT 201,small molecule,investigational,CN(C)CC1=NC(=NO1)C1=C2CN(C)C(=O)C3=C(C=CC=C3Cl)N2C=N1,JCYLWUVDHLVGER-UHFFFAOYSA-N,372.81,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,modulator,yes
DB05724,alpha-Conotoxin VC 1.1,small molecule,investigational,CC[C@H](C)[C@@H]1NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC2=CNC=N2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]2CSSC[C@H](NC(=O)CN)C(=O)N[C@@H](CSSC[C@H](NC1=O)C(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N2,KJQOYUHYAZGPIZ-PIJHVLQJSA-N,1806.98,Q9GZZ6,BE0000411,Neuronal acetylcholine receptor subunit alpha-10,Humans,modulator,yes
DB05738,Vapitadine,small molecule,investigational,NC(=O)C1=CN=C2N1CCC1=C(C=CC=C1)C21CCNCC1,VQWGYPVNVICKFC-UHFFFAOYSA-N,296.374,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB05766,Norclozapine,small molecule,investigational,ClC1=CC=C2NC3=C(C=CC=C3)C(=NC2=C1)N1CCNCC1,JNNOSTQEZICQQP-UHFFFAOYSA-N,312.797,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,modulator,yes
DB05786,Irofulven,small molecule,investigational,CC1=C(CO)C2=C(C)C3(CC3)[C@@](C)(O)C(=O)C2=C1,NICJCIQSJJKZAH-AWEZNQCLSA-N,246.3016,O96017,BE0003381,Serine/threonine-protein kinase Chk2,Humans,modulator,yes
DB05792,Arylacenamide,small molecule,investigational,Cl.CCN(C\C=C/C1=CC(Cl)=C(C=C1)C1CCCCC1)C1CCCCC1,HKHPCMBPASXYGP-KVVVOXFISA-N,396.437,Q15125,BE0004877,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase",Humans,modulator,yes
DB05796,Daglutril,small molecule,investigational,CCOC(=O)[C@H](CCC1=CC=CC=C1)CC1(CCCC1)C(=O)N[C@H]1CCC2=CC=CC=C2N(CC(O)=O)C1=O,XMQODGUTLZXUGZ-RPBOFIJWSA-N,534.6432,P08473,BE0000266,Neprilysin,Humans,modulator,yes
DB05805,NS-2359,small molecule,investigational,COC[C@H]1[C@H]2CC[C@@H](C[C@@H]1C1=CC(Cl)=C(Cl)C=C1)N2C,PGYDXVBZYKQYCS-VPWBDBDCSA-N,314.25,Q01959,BE0000647,Sodium-dependent dopamine transporter,Humans,inhibitor,yes
DB05805,NS-2359,small molecule,investigational,COC[C@H]1[C@H]2CC[C@@H](C[C@@H]1C1=CC(Cl)=C(Cl)C=C1)N2C,PGYDXVBZYKQYCS-VPWBDBDCSA-N,314.25,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,inhibitor,yes
DB05805,NS-2359,small molecule,investigational,COC[C@H]1[C@H]2CC[C@@H](C[C@@H]1C1=CC(Cl)=C(Cl)C=C1)N2C,PGYDXVBZYKQYCS-VPWBDBDCSA-N,314.25,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB05806,Cositecan,small molecule,investigational,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=C(CC[Si](C)(C)C)C4=CC=CC=C4N=C13)C2=O,POADTFBBIXOWFJ-VWLOTQADSA-N,448.5863,P11387,BE0000971,DNA topoisomerase 1,Humans,inhibitor,yes
DB05812,Abiraterone,small molecule,approved,[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C,GZOSMCIZMLWJML-VJLLXTKPSA-N,349.509,P05093,BE0000344,"Steroid 17-alpha-hydroxylase/17,20 lyase",Humans,inhibitor,yes
DB05814,GPI-1485,small molecule,investigational,CCC(C)(C)C(=O)C(=O)N1CCC[C@H]1C(O)=O,FOPALECPEUVCTL-QMMMGPOBSA-N,241.287,P62942,BE0000695,Peptidyl-prolyl cis-trans isomerase FKBP1A,Humans,binder,yes
DB05838,OPC-51803,small molecule,investigational,CC(C)NC(=O)C[C@H]1CCCN(C(=O)C2=C(Cl)C=C(C=C2)N2CCCC2)C2=CC=CC=C12,INGXCNVWWKKWOO-LJQANCHMSA-N,454.004,P30518,BE0000293,Vasopressin V2 receptor,Humans,agonist,yes
DB05861,Tasquinimod,small molecule,investigational,COC1=CC=CC2=C1C(O)=C(C(=O)N(C)C1=CC=C(C=C1)C(F)(F)F)C(=O)N2C,ONDYALNGTUAJDX-UHFFFAOYSA-N,406.361,P06702,BE0008993,Protein S100-A9,Humans,modulator,yes
DB05864,PPI-2458,small molecule,investigational,[H][C@@]1([C@H](OC)[C@@H](CC[C@]11CO1)OC(=O)N[C@H](C(C)C)C(N)=O)[C@@]1(C)O[C@@H]1CC=C(C)C,QBDVVYNLLXGUGN-XGTBZJOHSA-N,424.531,P50579,BE0001534,Methionine aminopeptidase 2,Humans,inhibitor,yes
DB05868,Ciluprevir,small molecule,investigational,COC1=CC2=C(C=C1)C(O[C@H]1CN3C(=O)[C@H](CCCCC\C=C/[C@]4([H])C[C@@]4(C(O)=O)NC(=O)[C@]3([H])C1)NC(=O)OC1CCCC1)=CC(=N2)C1=CSC(NC(C)C)=N1,PJZPDFUUXKKDNB-KNINVFKUSA-N,774.925,P26664,BE0003427,Genome polyprotein,,inhibitor,yes
DB05871,UC-781,small molecule,investigational,CC(C)=CCOC1=C(Cl)C=CC(NC(=S)C2=C(C)OC=C2)=C1,YZHIXLCGPOTQNB-UHFFFAOYSA-N,335.848,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB05874,AEOL-10150,small molecule,investigational,[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Mn+3].CCN1C=C[N+](CC)=C1\C1=C2/C=CC(=N2)\C(=C2/[N-]\C(\C=C2)=C(/C2=N/C(/C=C2)=C(\C2=CC=C1[N-]2)C1=[N+](CC)C=CN1CC)C1=[N+](CC)C=CN1CC)\C1=[N+](CC)C=CN1CC,XMYHQLIAYLLEKT-UHFFFAOYSA-I,1175.05,P00441,BE0002390,Superoxide dismutase [Cu-Zn],Humans,modulator,yes
DB05884,HCV-086,small molecule,investigational,CNC(=O)C1=C(OC2=CC(NS(C)(=O)=O)=C(OC(C)C)C=C12)C1=CC=C(F)C=C1,VBRUONUESYTIDA-UHFFFAOYSA-N,420.455,P26664,BE0003427,Genome polyprotein,,inhibitor,yes
DB05885,Seletracetam,small molecule,investigational,CC[C@H](N1C[C@@H](CC1=O)C=C(F)F)C(N)=O,ANWPENAPCIFDSZ-RQJHMYQMSA-N,232.2272,Q7L0J3,BE0000993,Synaptic vesicle glycoprotein 2A,Humans,modulator,yes
DB05885,Seletracetam,small molecule,investigational,CC[C@H](N1C[C@@H](CC1=O)C=C(F)F)C(N)=O,ANWPENAPCIFDSZ-RQJHMYQMSA-N,232.2272,Q00975,BE0002226,Voltage-dependent N-type calcium channel subunit alpha-1B,Humans,blocker,yes
DB05905,TD-2749,small molecule,investigational,CC(C)N1N=C(C(=O)N[C@@H]2C[C@@H]3CC[C@H](C2)N3CCN2CCN(CC2)C(C)=O)C2=CC=CC=C12,ZQMXTDPQEHZTBG-KOUNCHBCSA-N,466.63,Q13639,BE0000084,5-hydroxytryptamine receptor 4,Humans,agonist,yes
DB05913,OSI-930,small molecule,investigational,FC(F)(F)OC1=CC=C(NC(=O)C2=C(NCC3=CC=NC4=CC=CC=C34)C=CS2)C=C1,FGTCROZDHDSNIO-UHFFFAOYSA-N,443.44,P35968,BE0000369,Vascular endothelial growth factor receptor 2,Humans,modulator,yes
DB05913,OSI-930,small molecule,investigational,FC(F)(F)OC1=CC=C(NC(=O)C2=C(NCC3=CC=NC4=CC=CC=C34)C=CS2)C=C1,FGTCROZDHDSNIO-UHFFFAOYSA-N,443.44,P10721,BE0000453,Mast/stem cell growth factor receptor Kit,Humans,modulator,yes
DB05936,CVT-6883,small molecule,investigational,CCCN1C(=O)N(CC)C2=C(NC(=N2)C2=CN(CC3=CC=CC(=C3)C(F)(F)F)N=C2)C1=O,KOYXXLLNCXWUNF-UHFFFAOYSA-N,446.434,P29275,BE0000241,Adenosine receptor A2b,Humans,modulator,yes
DB05938,Edonerpic,small molecule,investigational,OC1CN(CCCOCCC2=CC3=C(SC=C3)C=C2)C1,HQNACSFBDBYLJP-UHFFFAOYSA-N,291.41,P05067,BE0003392,Amyloid-beta precursor protein,Humans,inhibitor,yes
DB05939,MK-0354,small molecule,investigational,C1CC2=C(C1)C(=NN2)C1=NNN=N1,LTQYSJKGRPGMPO-UHFFFAOYSA-N,176.183,Q8TDS4,BE0000635,Hydroxycarboxylic acid receptor 2,Humans,inhibitor,yes
DB05943,Resatorvid,small molecule,investigational,[H][C@]1(CCCC=C1C(=O)OCC)S(=O)(=O)NC1=C(Cl)C=C(F)C=C1,LEEIJTHMHDMWLJ-CQSZACIVSA-N,361.81,O00206,BE0002442,Toll-like receptor 4,Humans,antagonist,yes
DB05944,Varlitinib,small molecule,investigational,C[C@@H]1COC(NC2=CC=C3N=CN=C(NC4=CC=C(OCC5=NC=CS5)C(Cl)=C4)C3=C2)=N1,UWXSAYUXVSFDBQ-CYBMUJFWSA-N,466.94,P00533,BE0000767,Epidermal growth factor receptor,Humans,modulator,yes
DB05944,Varlitinib,small molecule,investigational,C[C@@H]1COC(NC2=CC=C3N=CN=C(NC4=CC=C(OCC5=NC=CS5)C(Cl)=C4)C3=C2)=N1,UWXSAYUXVSFDBQ-CYBMUJFWSA-N,466.94,P04626,BE0000511,Receptor tyrosine-protein kinase erbB-2,Humans,modulator,yes
DB05956,EVT-101,small molecule,investigational,Cl.Cl.CC1=NC=CN1CC1=CC(=CN=N1)C1=CC=C(F)C(=C1)C(F)F,OJBLXSPBJMGZDN-UHFFFAOYSA-N,391.22,Q13224,BE0000417,"Glutamate receptor ionotropic, NMDA 2B",Humans,antagonist,yes
DB05959,ENMD-1198,small molecule,investigational,COC1=C(C=C2CC[C@H]3[C@@H]4CC=C[C@@]4(C)CC[C@@H]3C2=C1)C(N)=O,YQJWOUQGXATDAE-ACNBBOPNSA-N,311.425,Q16665,BE0002374,Hypoxia-inducible factor 1-alpha,Humans,inhibitor,yes
DB05961,PPL-100,small molecule,investigational,COC(=O)N[C@@H](C(C1=CC=CC=C1)C1=CC=CC=C1)C(=O)NCCCC[C@@H](CO)N(CC(C)C)S(=O)(=O)C1=CC=C(N)C=C1,QAHLFXYLXBBCPS-IZEXYCQBSA-N,624.791,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB05964,Amitifadine,small molecule,investigational,[H][C@]12C[C@]1(CNC2)C1=CC(Cl)=C(Cl)C=C1,BSMNRYCSBFHEMQ-KCJUWKMLSA-N,228.12,Q01959,BE0000647,Sodium-dependent dopamine transporter,Humans,inhibitor,yes
DB05964,Amitifadine,small molecule,investigational,[H][C@]12C[C@]1(CNC2)C1=CC(Cl)=C(Cl)C=C1,BSMNRYCSBFHEMQ-KCJUWKMLSA-N,228.12,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB05964,Amitifadine,small molecule,investigational,[H][C@]12C[C@]1(CNC2)C1=CC(Cl)=C(Cl)C=C1,BSMNRYCSBFHEMQ-KCJUWKMLSA-N,228.12,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,inhibitor,yes
DB05969,SNS-032,small molecule,investigational,CC(C)(C)C1=CN=C(CSC2=CN=C(NC(=O)C3CCNCC3)S2)O1,OUSFTKFNBAZUKL-UHFFFAOYSA-N,380.53,P50750,BE0002207,Cyclin-dependent kinase 9,Humans,inhibitor,yes
DB05969,SNS-032,small molecule,investigational,CC(C)(C)C1=CN=C(CSC2=CN=C(NC(=O)C3CCNCC3)S2)O1,OUSFTKFNBAZUKL-UHFFFAOYSA-N,380.53,P24941,BE0001072,Cyclin-dependent kinase 2,Humans,inhibitor,yes
DB05969,SNS-032,small molecule,investigational,CC(C)(C)C1=CN=C(CSC2=CN=C(NC(=O)C3CCNCC3)S2)O1,OUSFTKFNBAZUKL-UHFFFAOYSA-N,380.53,P50613,BE0001913,Cyclin-dependent kinase 7,Humans,inhibitor,yes
DB05970,LY-2599506,small molecule,investigational,O=C(NC1=CN=CC=N1)[C@H](CC1CCOCC1)C1=CC=C(C=C1)S(=O)(=O)C1CC1,DQIITKNITDKAJZ-LJQANCHMSA-N,415.51,P35557,BE0001056,Hexokinase-4,Humans,inhibitor,yes
DB05984,RAF-265,small molecule,investigational,CN1C(NC2=CC=C(C=C2)C(F)(F)F)=NC2=CC(OC3=CC=NC(=C3)C3=NC=C(N3)C(F)(F)F)=CC=C12,YABJJWZLRMPFSI-UHFFFAOYSA-N,518.423,P35968,BE0000369,Vascular endothelial growth factor receptor 2,Humans,modulator,yes
DB05990,Obeticholic acid,small molecule,approved,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)[C@H](CC)[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O,ZXERDUOLZKYMJM-ZWECCWDJSA-N,420.6252,Q96RI1,BE0001777,Bile acid receptor,Humans,agonist,yes
DB05992,Plinabulin,small molecule,investigational,CC(C)(C)C1=C(\C=C2/NC(=O)\C(NC2=O)=C\C2=CC=CC=C2)N=CN1,UNRCMCRRFYFGFX-TYPNBTCFSA-N,336.395,Q14232,BE0014461,Translation initiation factor eIF2B subunit alpha,Humans,stimulator,yes
DB05992,Plinabulin,small molecule,investigational,CC(C)(C)C1=C(\C=C2/NC(=O)\C(NC2=O)=C\C2=CC=CC=C2)N=CN1,UNRCMCRRFYFGFX-TYPNBTCFSA-N,336.395,P49770,BE0013252,Translation initiation factor eIF2B subunit beta,Humans,stimulator,yes
DB05993,PRX-07034,small molecule,investigational,Cl.COC1=C(OC)C(=CC(Cl)=C1)C(C)NC1=CC(=CC=C1S(C)(=O)=O)N1CCNCC1,PILCQJJJAFRKHO-UHFFFAOYSA-N,490.44,P50406,BE0000945,5-hydroxytryptamine receptor 6,Humans,antagonist,yes
DB05998,T-5224,small molecule,investigational,OC(=O)CCC1=CC(=CC=C1OCC1=CC2=C(C=C1)C(O)=NO2)C(=O)C1=C(O)C=C(OC2CCCC2)C=C1,DALCQQSLNPLQFZ-UHFFFAOYSA-N,517.534,P05412,BE0001040,Transcription factor Jun,Humans,inhibitor,yes
DB06013,Aldoxorubicin,small molecule,investigational,COC1=C2C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]4C[C@H](N)[C@H](O)[C@H](C)O4)C(\CO)=N\NC(=O)CCCCCN4C(=O)C=CC4=O)C(O)=C3C(=O)C2=CC=C1,OBMJQRLIQQTJLR-USGQOSEYSA-N,750.758,P11388,BE0000742,DNA topoisomerase 2-alpha,Humans,inhibitor,yes
DB06013,Aldoxorubicin,small molecule,investigational,COC1=C2C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]4C[C@H](N)[C@H](O)[C@H](C)O4)C(\CO)=N\NC(=O)CCCCCN4C(=O)C=CC4=O)C(O)=C3C(=O)C2=CC=C1,OBMJQRLIQQTJLR-USGQOSEYSA-N,750.758,Q02880,BE0002425,DNA topoisomerase 2-beta,Humans,modulator,yes
DB06016,Cariprazine,small molecule,approved;investigational,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)C2=C(Cl)C(Cl)=CC=C2)CC1,KPWSJANDNDDRMB-QAQDUYKDSA-N,427.41,P35462,BE0000581,D(3) dopamine receptor,Humans,partial agonist,yes
DB06016,Cariprazine,small molecule,approved;investigational,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)C2=C(Cl)C(Cl)=CC=C2)CC1,KPWSJANDNDDRMB-QAQDUYKDSA-N,427.41,P14416,BE0000756,D(2) dopamine receptor,Humans,partial agonist,yes
DB06027,NGD-4715,small molecule,investigational,COC1=C(OC)C=C(CN2CCN(CC2)C2=NC(OC)=C(Br)C=C2)C=C1,VAKYVNYLCIABRV-UHFFFAOYSA-N,422.323,Q99705,BE0003478,Melanin-concentrating hormone receptor 1,Humans,antagonist,yes
DB06040,Filanesib,small molecule,investigational,CON(C)C(=O)N1N=C(S[C@@]1(CCCN)C1=CC=CC=C1)C1=CC(F)=CC=C1F,LLXISKGBWFTGEI-FQEVSTJZSA-N,420.48,P52732,BE0001852,Kinesin-like protein KIF11,Humans,inhibitor,yes
DB06070,SNX-5422,small molecule,investigational,CC1(C)CC2=C(C(=NN2C2=CC(N[C@H]3CC[C@@H](CC3)OC(=O)CN)=C(C=C2)C(N)=O)C(F)(F)F)C(=O)C1,AVDSOVJPJZVBTC-CTYIDZIISA-N,521.541,P07900,BE0001120,Heat shock protein HSP 90-alpha,Humans,inhibitor,yes
DB06070,SNX-5422,small molecule,investigational,CC1(C)CC2=C(C(=NN2C2=CC(N[C@H]3CC[C@@H](CC3)OC(=O)CN)=C(C=C2)C(N)=O)C(F)(F)F)C(=O)C1,AVDSOVJPJZVBTC-CTYIDZIISA-N,521.541,P08238,BE0001898,Heat shock protein HSP 90-beta,Humans,inhibitor,yes
DB06077,Lumateperone,small molecule,approved;investigational,[H][C@]12CCN(CCCC(=O)C3=CC=C(F)C=C3)C[C@@]1([H])C1=CC=CC3=C1N2CCN3C,HOIIHACBCFLJET-SFTDATJTSA-N,393.506,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB06077,Lumateperone,small molecule,approved;investigational,[H][C@]12CCN(CCCC(=O)C3=CC=C(F)C=C3)C[C@@]1([H])C1=CC=CC3=C1N2CCN3C,HOIIHACBCFLJET-SFTDATJTSA-N,393.506,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB06077,Lumateperone,small molecule,approved;investigational,[H][C@]12CCN(CCCC(=O)C3=CC=C(F)C=C3)C[C@@]1([H])C1=CC=CC3=C1N2CCN3C,HOIIHACBCFLJET-SFTDATJTSA-N,393.506,P14416,BE0000756,D(2) dopamine receptor,Humans,partial agonist,yes
DB06080,Linifanib,small molecule,investigational,CC1=CC(NC(=O)NC2=CC=C(C=C2)C2=C3C(N)=NNC3=CC=C2)=C(F)C=C1,MPVGZUGXCQEXTM-UHFFFAOYSA-N,375.407,P35916,BE0000023,Vascular endothelial growth factor receptor 3,Humans,modulator,yes
DB06082,PX-478,small molecule,investigational,Cl.Cl.N[C@@H](CC1=CC=C(C=C1)[N+]([O-])(CCCl)CCCl)C(O)=O,GIGCDIVNDFQKRA-LTCKWSDVSA-N,394.11,Q16665,BE0002374,Hypoxia-inducible factor 1-alpha,Humans,inhibitor,yes
DB06083,Tapinarof,small molecule,approved;investigational,CC(C)C1=C(O)C=C(\C=C\C2=CC=CC=C2)C=C1O,ZISJNXNHJRQYJO-CMDGGOBGSA-N,254.329,P35869,BE0003721,Aryl hydrocarbon receptor,Humans,agonist,yes
DB06090,Bradanicline,small molecule,investigational,[H][C@@]1(CC2=CC=CN=C2)N2CCC(CC2)[C@@]1([H])NC(=O)C1=CC2=C(O1)C=CC=C2,OXKRFEWMSWPKKV-GHTZIAJQSA-N,361.445,P36544,BE0002341,Neuronal acetylcholine receptor subunit alpha-7,Humans,agonist,yes
DB06119,Cenobamate,small molecule,approved;investigational,NC(=O)O[C@@H](CN1N=CN=N1)C1=C(Cl)C=CC=C1,GFHAXPJGXSQLPT-VIFPVBQESA-N,267.67,P35498,BE0009738,Voltage-gated sodium channel alpha subunit,Humans,inhibitor,yes
DB06133,Dimethylcurcumin,small molecule,investigational,COC1=CC=C(\C=C\C(\O)=C\C(=O)\C=C\C2=CC(OC)=C(OC)C=C2)C=C1OC,ZMGUKFHHNQMKJI-CIOHCNBKSA-N,396.439,P10275,BE0000132,Androgen receptor,Humans,inhibitor,yes
DB06134,SNS-314,small molecule,investigational,ClC1=CC=CC(NC(=O)NC2=NC=C(CCNC3=C4SC=CC4=NC=N3)S2)=C1,FAYAUAZLLLJJGH-UHFFFAOYSA-N,430.934,Q96GD4,BE0003404,Aurora kinase B,Humans,inhibitor,yes
DB06134,SNS-314,small molecule,investigational,ClC1=CC=CC(NC(=O)NC2=NC=C(CCNC3=C4SC=CC4=NC=N3)S2)=C1,FAYAUAZLLLJJGH-UHFFFAOYSA-N,430.934,Q9UQB9,BE0004601,Aurora kinase C,Humans,inhibitor,yes
DB06134,SNS-314,small molecule,investigational,ClC1=CC=CC(NC(=O)NC2=NC=C(CCNC3=C4SC=CC4=NC=N3)S2)=C1,FAYAUAZLLLJJGH-UHFFFAOYSA-N,430.934,O14965,BE0000991,Aurora kinase A,Humans,inhibitor,yes
DB06137,Tirbanibulin,small molecule,approved;investigational,O=C(CC1=CC=C(C=N1)C1=CC=C(OCCN2CCOCC2)C=C1)NCC1=CC=CC=C1,HUNGUWOZPQBXGX-UHFFFAOYSA-N,431.536,P07437,BE0000143,Tubulin beta chain,Humans,inhibitor,yes
DB06137,Tirbanibulin,small molecule,approved;investigational,O=C(CC1=CC=C(C=N1)C1=CC=C(OCCN2CCOCC2)C=C1)NCC1=CC=CC=C1,HUNGUWOZPQBXGX-UHFFFAOYSA-N,431.536,P12931,BE0000838,Proto-oncogene tyrosine-protein kinase Src,Humans,inhibitor,yes
DB06140,SUVN-502,small molecule,investigational,COC1=CC=C2N(C=C(CN3CCN(C)CC3)C2=C1)S(=O)(=O)C1=CC=CC=C1Br,GWCYPEHWIZXYFZ-UHFFFAOYSA-N,478.41,P50406,BE0000945,5-hydroxytryptamine receptor 6,Humans,antagonist,yes
DB06144,Sertindole,small molecule,approved;investigational;withdrawn,FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,440.941,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB06144,Sertindole,small molecule,approved;investigational;withdrawn,FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,440.941,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB06144,Sertindole,small molecule,approved;investigational;withdrawn,FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,440.941,P28335,BE0000533,5-hydroxytryptamine receptor 2C,Humans,antagonist,yes
DB06144,Sertindole,small molecule,approved;investigational;withdrawn,FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,440.941,P50406,BE0000945,5-hydroxytryptamine receptor 6,Humans,antagonist,yes
DB06145,Spiramycin,small molecule,approved,[H][C@@]1(CC[C@@H]([C@@H](C)O1)N(C)C)O[C@H]1\C=C\C=C\C[C@@H](C)OC(=O)C[C@@H](O)[C@H](OC)[C@@H](O[C@]2([H])O[C@H](C)[C@@H](O[C@@]3([H])C[C@@](C)(O)[C@@H](O)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@@H](CC=O)C[C@H]1C,ACTOXUHEUCPTEW-CEUOBAOPSA-N,843.065,Q9A1X4,BE0000843,50S ribosomal protein L3,Streptococcus pyogenes serotype M1,antagonist;inhibitor,yes
DB06147,Sulfathiazole,small molecule,approved;vet_approved;withdrawn,NC1=CC=C(C=C1)S(=O)(=O)NC1=NC=CS1,JNMRHUJNCSQMMB-UHFFFAOYSA-N,255.317,Q27738,BE0002360,Dihydropteroate synthetase,Plasmodium falciparum,inhibitor,yes
DB06149,Teicoplanin,small molecule,approved;investigational,CCCCCCCCCC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2OC3=C(Cl)C=C(C=C3)[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3NC(C)=O)[C@@H]3NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]5NC(=O)[C@@H](CC6=CC=C(OC1=CC4=C2)C(Cl)=C6)NC(=O)[C@H](N)C1=CC=C(O)C(OC2=CC(O)=CC5=C2)=C1)C1=CC=C(O)C(=C1)C1=C(C=C(O)C=C1OC1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O)[C@H](NC3=O)C(O)=O,BJNLLBUOHPVGFT-CAYRISATSA-N,1879.67,,BE0004826,D-Ala-D-Ala moiety of NAM/NAG peptide subunits of peptidoglycan,Gram-positive Bacteria,inhibitor,yes
DB06151,Acetylcysteine,small molecule,approved;investigational,CC(=O)N[C@@H](CS)C(O)=O,PWKSKIMOESPYIA-BYPYZUCNSA-N,163.195,P48637,BE0000185,Glutathione synthetase,Humans,stimulator,yes
DB06151,Acetylcysteine,small molecule,approved;investigational,CC(=O)N[C@@H](CS)C(O)=O,PWKSKIMOESPYIA-BYPYZUCNSA-N,163.195,Q9UPY5,BE0000030,Cystine/glutamate transporter,Humans,activator,yes
DB06152,Nylidrin,small molecule,approved,CC(CCC1=CC=CC=C1)NC(C)C(O)C1=CC=C(O)C=C1,PTGXAUBQBSGPKF-UHFFFAOYSA-N,299.414,P48551,BE0000385,Interferon alpha/beta receptor 2,Humans,agonist,yes
DB06154,Pentaerythritol tetranitrate,small molecule,approved,[O-][N+](=O)OCC(CO[N+]([O-])=O)(CO[N+]([O-])=O)CO[N+]([O-])=O,TZRXHJWUDPFEEY-UHFFFAOYSA-N,316.1366,P69905,BE0000130,Hemoglobin subunit alpha,Humans,agonist,yes
DB06154,Pentaerythritol tetranitrate,small molecule,approved,[O-][N+](=O)OCC(CO[N+]([O-])=O)(CO[N+]([O-])=O)CO[N+]([O-])=O,TZRXHJWUDPFEEY-UHFFFAOYSA-N,316.1366,P68871,BE0000629,Hemoglobin subunit beta,Humans,agonist,yes
DB06155,Rimonabant,small molecule,approved;investigational,CC1=C(N(N=C1C(=O)NN1CCCCC1)C1=C(Cl)C=C(Cl)C=C1)C1=CC=C(Cl)C=C1,JZCPYUJPEARBJL-UHFFFAOYSA-N,463.787,P21554,BE0000061,Cannabinoid receptor 1,Humans,antagonist,yes
DB06156,Tesofensine,small molecule,investigational,CCOC[C@H]1[C@H]2CC[C@@H](C[C@@H]1C1=CC(Cl)=C(Cl)C=C1)N2C,VCVWXKKWDOJNIT-ZOMKSWQUSA-N,328.28,P06213,BE0000033,Insulin receptor,Humans,inhibitor,yes
DB06157,Istaroxime,small molecule,investigational,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC(=O)[C@@]2([H])CC(CC[C@]12C)=NOCCN,MPYLDWFDPHRTEG-IFVNMTGRSA-N,360.498,P05023,BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,Humans,inhibitor,yes
DB06157,Istaroxime,small molecule,investigational,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC(=O)[C@@]2([H])CC(CC[C@]12C)=NOCCN,MPYLDWFDPHRTEG-IFVNMTGRSA-N,360.498,P13637,BE0005047,Sodium/potassium-transporting ATPase subunit alpha-3,Humans,inhibitor,yes
DB06157,Istaroxime,small molecule,investigational,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC(=O)[C@@]2([H])CC(CC[C@]12C)=NOCCN,MPYLDWFDPHRTEG-IFVNMTGRSA-N,360.498,P05026,BE0004994,Sodium/potassium-transporting ATPase subunit beta-1,Humans,inhibitor,yes
DB06157,Istaroxime,small molecule,investigational,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC(=O)[C@@]2([H])CC(CC[C@]12C)=NOCCN,MPYLDWFDPHRTEG-IFVNMTGRSA-N,360.498,P14415,BE0005018,Sodium/potassium-transporting ATPase subunit beta-2,Humans,inhibitor,yes
DB06157,Istaroxime,small molecule,investigational,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC(=O)[C@@]2([H])CC(CC[C@]12C)=NOCCN,MPYLDWFDPHRTEG-IFVNMTGRSA-N,360.498,P54709,BE0005026,Sodium/potassium-transporting ATPase subunit beta-3,Humans,inhibitor,yes
DB06157,Istaroxime,small molecule,investigational,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC(=O)[C@@]2([H])CC(CC[C@]12C)=NOCCN,MPYLDWFDPHRTEG-IFVNMTGRSA-N,360.498,P50993,BE0005034,Sodium/potassium-transporting ATPase subunit alpha-2,Humans,inhibitor,yes
DB06159,Rubitecan,small molecule,investigational,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=C1N=C1C=CC=C(C1=C3)[N+]([O-])=O)C2=O,VHXNKPBCCMUMSW-FQEVSTJZSA-N,393.355,P11387,BE0000971,DNA topoisomerase 1,Humans,inhibitor,yes
DB06160,Garenoxacin,small molecule,investigational,C[C@H]1NCC2=CC(=CC=C12)C1=CC=C2C(=O)C(=CN(C3CC3)C2=C1OC(F)F)C(O)=O,NJDRXTDGYFKORP-LLVKDONJSA-N,426.42,P11388,BE0000742,DNA topoisomerase 2-alpha,Humans,inhibitor,yes
DB06160,Garenoxacin,small molecule,investigational,C[C@H]1NCC2=CC(=CC=C12)C1=CC=C2C(=O)C(=CN(C3CC3)C2=C1OC(F)F)C(O)=O,NJDRXTDGYFKORP-LLVKDONJSA-N,426.42,Q02880,BE0002425,DNA topoisomerase 2-beta,Humans,inhibitor,yes
DB06163,Plevitrexed,small molecule,investigational,CC1=NC(=O)C2=CC(CN(CC#C)C3=CC=C(C(=O)N[C@@H](CCC4=NN=NN4)C(O)=O)C(F)=C3)=C(C)C=C2N1,IEJSCSAMMLUINT-NRFANRHFSA-N,532.536,P12461,BE0000021,Thymidylate synthase,Yeast,inhibitor,yes
DB06176,Romidepsin,small molecule,approved;investigational,C\C=C1/NC(=O)[C@H]2CSSCC\C=C\[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@@H](NC1=O)C(C)C,OHRURASPPZQGQM-GCCNXGTGSA-N,540.69,Q13547,BE0002365,Histone deacetylase 1,Humans,antagonist;inhibitor,yes
DB06176,Romidepsin,small molecule,approved;investigational,C\C=C1/NC(=O)[C@H]2CSSCC\C=C\[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@@H](NC1=O)C(C)C,OHRURASPPZQGQM-GCCNXGTGSA-N,540.69,Q92769,BE0002366,Histone deacetylase 2,Humans,antagonist;inhibitor,yes
DB06178,Talotrexin,small molecule,investigational,NC1=NC(N)=C2N=C(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCCNC(=O)C3=CC=CC=C3C(O)=O)C(O)=O)C=NC2=N1,NYQPLPNEESYGNO-IBGZPJMESA-N,573.56,P15328,BE0003405,Folate receptor alpha,Humans,antagonist,yes
DB06182,Talabostat,small molecule,investigational,CC(C)[C@H](N)C(=O)N1CCC[C@H]1B(O)O,FKCMADOPPWWGNZ-YUMQZZPRSA-N,214.07,Q12884,BE0003507,Prolyl endopeptidase FAP,Humans,inhibitor,yes
DB06182,Talabostat,small molecule,investigational,CC(C)[C@H](N)C(=O)N1CCC[C@H]1B(O)O,FKCMADOPPWWGNZ-YUMQZZPRSA-N,214.07,Q86TI2,BE0016313,Dipeptidyl peptidase 9,Humans,inhibitor,yes
DB06182,Talabostat,small molecule,investigational,CC(C)[C@H](N)C(=O)N1CCC[C@H]1B(O)O,FKCMADOPPWWGNZ-YUMQZZPRSA-N,214.07,Q6V1X1,BE0015938,Dipeptidyl peptidase 8,Humans,inhibitor,yes
DB06185,Forodesine,small molecule,investigational,OC[C@H]1N[C@H]([C@H](O)[C@@H]1O)C1=CNC2=C1N=CNC2=O,IWKXDMQDITUYRK-KUBHLMPHSA-N,266.2533,P00491,BE0000250,Purine nucleoside phosphorylase,Humans,inhibitor,yes
DB06188,Ispinesib,small molecule,investigational,CC(C)[C@@H](N(CCCN)C(=O)C1=CC=C(C)C=C1)C1=NC2=CC(Cl)=CC=C2C(=O)N1CC1=CC=CC=C1,QJZRFPJCWMNVAV-HHHXNRCGSA-N,517.07,P52732,BE0001852,Kinesin-like protein KIF11,Humans,inhibitor,yes
DB06190,Solabegron,small molecule,investigational,[H][C@](O)(CNCCNC1=CC(=CC=C1)C1=CC(=CC=C1)C(O)=O)C1=CC=CC(Cl)=C1,LLDXOPKUNJTIRF-QFIPXVFZSA-N,410.9,P13945,BE0001012,Beta-3 adrenergic receptor,Humans,agonist,yes
DB06191,Zosuquidar,small molecule,investigational,[H][C@]12C3=CC=CC=C3[C@H](N3CCN(C[C@@H](O)COC4=CC=CC5=C4C=CC=N5)CC3)C3=CC=CC=C3[C@@]1([H])C2(F)F,IHOVFYSQUDPMCN-DBEBIPAYSA-N,527.616,P08183,BE0001032,ATP-dependent translocase ABCB1,Humans,inhibitor,yes
DB06191,Zosuquidar,small molecule,investigational,[H][C@]12C3=CC=CC=C3[C@H](N3CCN(C[C@@H](O)COC4=CC=CC5=C4C=CC=N5)CC3)C3=CC=CC=C3[C@@]1([H])C2(F)F,IHOVFYSQUDPMCN-DBEBIPAYSA-N,527.616,P21439,BE0003641,Phosphatidylcholine translocator ABCB4,Humans,modulator,yes
DB06193,Pixantrone,small molecule,approved;investigational,NCCNC1=CC=C(NCCN)C2=C1C(=O)C1=C(C=NC=C1)C2=O,PEZPMAYDXJQYRV-UHFFFAOYSA-N,325.372,P11388,BE0000742,DNA topoisomerase 2-alpha,Humans,modulator,yes
DB06193,Pixantrone,small molecule,approved;investigational,NCCNC1=CC=C(NCCN)C2=C1C(=O)C1=C(C=NC=C1)C2=O,PEZPMAYDXJQYRV-UHFFFAOYSA-N,325.372,Q02880,BE0002425,DNA topoisomerase 2-beta,Humans,modulator,yes
DB06194,Elocalcitol,small molecule,investigational,CCC(O)(CC)\C=C\C[C@H](C)C1=CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@@](F)([H])C1=C,LRLWXBHFPGSUOX-GJQYOBCGSA-N,442.6489,P11473,BE0000779,Vitamin D3 receptor,Humans,agonist,yes
DB06195,Seliciclib,small molecule,investigational,CC[C@H](CO)NC1=NC(NCC2=CC=CC=C2)=C2N=CN(C(C)C)C2=N1,BTIHMVBBUGXLCJ-OAHLLOKOSA-N,354.4493,P24941,BE0001072,Cyclin-dependent kinase 2,Humans,inhibitor,yes
DB06195,Seliciclib,small molecule,investigational,CC[C@H](CO)NC1=NC(NCC2=CC=CC=C2)=C2N=CN(C(C)C)C2=N1,BTIHMVBBUGXLCJ-OAHLLOKOSA-N,354.4493,P50613,BE0001913,Cyclin-dependent kinase 7,Humans,inhibitor,yes
DB06195,Seliciclib,small molecule,investigational,CC[C@H](CO)NC1=NC(NCC2=CC=CC=C2)=C2N=CN(C(C)C)C2=N1,BTIHMVBBUGXLCJ-OAHLLOKOSA-N,354.4493,P06493,BE0001082,Cyclin-dependent kinase 1,Humans,inhibitor,yes
DB06197,Bimosiamose,small molecule,investigational,[H][C@]1(CO)O[C@]([H])(OC2=C(C=C(CCCCCCC3=CC(=C(O[C@@]4([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@]4([H])O)C=C3)C3=CC=CC(CC(O)=O)=C3)C=C2)C2=CC=CC(CC(O)=O)=C2)[C@@]([H])(O)[C@@]([H])(O)[C@]1([H])O,RYWCQJDEHXJHRI-XJMXIVSISA-N,862.922,P16581,BE0001074,E-selectin,Humans,inhibitor,yes
DB06198,Alovudine,small molecule,investigational,CC1=CN([C@H]2C[C@H](F)[C@@H](CO)O2)C(=O)NC1=O,UXCAQJAQSWSNPQ-XLPZGREQSA-N,244.222,P03366,BE0002050,Gag-Pol polyprotein,,modulator,yes
DB06199,Atrasentan,small molecule,investigational,CCCCN(CCCC)C(=O)CN1C[C@@H]([C@H]([C@@H]1C1=CC=C(OC)C=C1)C(O)=O)C1=CC2=C(OCO2)C=C1,MOTJMGVDPWRKOC-QPVYNBJUSA-N,510.6218,P25101,BE0000521,Endothelin-1 receptor,Humans,antagonist,yes
DB06202,Lasofoxifene,small molecule,approved;investigational,[H][C@@]1(CCC2=CC(O)=CC=C2[C@@]1([H])C1=CC=C(OCCN2CCCC2)C=C1)C1=CC=CC=C1,GXESHMAMLJKROZ-IAPPQJPRSA-N,413.5512,P03420,BE0010205,Fusion glycoprotein F0,Human respiratory syncytial virus A (strain A2),modulator,yes
DB06202,Lasofoxifene,small molecule,approved;investigational,[H][C@@]1(CCC2=CC(O)=CC=C2[C@@]1([H])C1=CC=C(OCCN2CCCC2)C=C1)C1=CC=CC=C1,GXESHMAMLJKROZ-IAPPQJPRSA-N,413.5512,P03372,BE0000123,Estrogen receptor,Humans,antagonist;agonist;negative modulator,yes
DB06202,Lasofoxifene,small molecule,approved;investigational,[H][C@@]1(CCC2=CC(O)=CC=C2[C@@]1([H])C1=CC=C(OCCN2CCCC2)C=C1)C1=CC=CC=C1,GXESHMAMLJKROZ-IAPPQJPRSA-N,413.5512,Q92731,BE0000792,Estrogen receptor beta,Humans,agonist,yes
DB06203,Alogliptin,small molecule,approved,CN1C(=O)C=C(N2CCC[C@@H](N)C2)N(CC2=C(C=CC=C2)C#N)C1=O,ZSBOMTDTBDDKMP-OAHLLOKOSA-N,339.3916,P27487,BE0000854,Dipeptidyl peptidase 4,Humans,inhibitor,yes
DB06204,Tapentadol,small molecule,approved,CC[C@H]([C@@H](C)CN(C)C)C1=CC(O)=CC=C1,KWTWDQCKEHXFFR-SMDDNHRTSA-N,221.3385,P35372,BE0000770,Mu-type opioid receptor,Humans,agonist,yes
DB06204,Tapentadol,small molecule,approved,CC[C@H]([C@@H](C)CN(C)C)C1=CC(O)=CC=C1,KWTWDQCKEHXFFR-SMDDNHRTSA-N,221.3385,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,inhibitor,yes
DB06207,Silodosin,small molecule,approved,C[C@H](CC1=CC2=C(N(CCCO)CC2)C(=C1)C(N)=O)NCCOC1=CC=CC=C1OCC(F)(F)F,PNCPYILNMDWPEY-QGZVFWFLSA-N,495.5345,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,antagonist,yes
DB06207,Silodosin,small molecule,approved,C[C@H](CC1=CC2=C(N(CCCO)CC2)C(=C1)C(N)=O)NCCOC1=CC=CC=C1OCC(F)(F)F,PNCPYILNMDWPEY-QGZVFWFLSA-N,495.5345,P25100,BE0000715,Alpha-1D adrenergic receptor,Humans,antagonist,yes
DB06207,Silodosin,small molecule,approved,C[C@H](CC1=CC2=C(N(CCCO)CC2)C(=C1)C(N)=O)NCCOC1=CC=CC=C1OCC(F)(F)F,PNCPYILNMDWPEY-QGZVFWFLSA-N,495.5345,P35368,BE0000575,Alpha-1B adrenergic receptor,Humans,antagonist,yes
DB06209,Prasugrel,small molecule,approved,CC(=O)OC1=CC2=C(CCN(C2)C(C(=O)C2CC2)C2=CC=CC=C2F)S1,DTGLZDAWLRGWQN-UHFFFAOYSA-N,373.441,Q9H244,BE0000110,P2Y purinoceptor 12,Humans,antagonist,yes
DB06210,Eltrombopag,small molecule,approved,CC1=NN(C(=O)\C1=N/NC1=CC=CC(C2=CC=CC(=C2)C(O)=O)=C1O)C1=CC=C(C)C(C)=C1,XDXWLKQMMKQXPV-QYQHSDTDSA-N,442.4666,P40238,BE0003440,Thrombopoietin receptor,Humans,agonist,yes
DB06211,Doripenem,small molecule,approved;investigational,[H][C@]12[C@@H](C)C(S[C@@H]3CN[C@H](CNS(N)(=O)=O)C3)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,AVAACINZEOAHHE-VFZPANTDSA-N,420.504,P0AC13,BE0000803,Dihydropteroate synthase,Escherichia coli (strain K12),inhibitor,yes
DB06211,Doripenem,small molecule,approved;investigational,[H][C@]12[C@@H](C)C(S[C@@H]3CN[C@H](CNS(N)(=O)=O)C3)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,AVAACINZEOAHHE-VFZPANTDSA-N,420.504,P02918,BE0000588,Penicillin-binding protein 1A,Escherichia coli (strain K12),antagonist;inhibitor,yes
DB06211,Doripenem,small molecule,approved;investigational,[H][C@]12[C@@H](C)C(S[C@@H]3CN[C@H](CNS(N)(=O)=O)C3)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,AVAACINZEOAHHE-VFZPANTDSA-N,420.504,P02919,BE0000488,Penicillin-binding protein 1B,Escherichia coli (strain K12),antagonist;inhibitor,yes
DB06211,Doripenem,small molecule,approved;investigational,[H][C@]12[C@@H](C)C(S[C@@H]3CN[C@H](CNS(N)(=O)=O)C3)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,AVAACINZEOAHHE-VFZPANTDSA-N,420.504,P0AD65,BE0003579,Penicillin-binding protein 2,Escherichia coli (strain K12),antagonist;inhibitor,yes
DB06211,Doripenem,small molecule,approved;investigational,[H][C@]12[C@@H](C)C(S[C@@H]3CN[C@H](CNS(N)(=O)=O)C3)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,AVAACINZEOAHHE-VFZPANTDSA-N,420.504,Q51504,BE0004647,Cell division protein,Pseudomonas aeruginosa,antagonist;inhibitor,yes
DB06211,Doripenem,small molecule,approved;investigational,[H][C@]12[C@@H](C)C(S[C@@H]3CN[C@H](CNS(N)(=O)=O)C3)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,AVAACINZEOAHHE-VFZPANTDSA-N,420.504,P72355,BE0008485,Penicillin-binding protein 4,Staphylococcus aureus,antagonist;inhibitor,yes
DB06212,Tolvaptan,small molecule,approved,CC1=CC=CC=C1C(=O)NC1=CC(C)=C(C=C1)C(=O)N1CCC[C@@H](O)C2=C1C=CC(Cl)=C2,GYHCTFXIZSNGJT-XMMPIXPASA-N,448.941,P30518,BE0000293,Vasopressin V2 receptor,Humans,antagonist,yes
DB06213,Regadenoson,small molecule,approved;investigational,CNC(=O)C1=CN(N=C1)C1=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(N)=N1,LZPZPHGJDAGEJZ-AKAIJSEGSA-N,390.354,P29274,BE0000924,Adenosine receptor A2a,Humans,agonist,yes
DB06216,Asenapine,small molecule,approved,CN1CC2C(C1)C1=C(OC3=CC=C(Cl)C=C23)C=CC=C1,VSWBSWWIRNCQIJ-UHFFFAOYSA-N,285.77,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB06216,Asenapine,small molecule,approved,CN1CC2C(C1)C1=C(OC3=CC=C(Cl)C=C23)C=CC=C1,VSWBSWWIRNCQIJ-UHFFFAOYSA-N,285.77,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB06217,Vernakalant,small molecule,approved;investigational,COC1=C(OC)C=C(CCO[C@@H]2CCCC[C@H]2N2CC[C@@H](O)C2)C=C1,VBHQKCBVWWUUKN-KZNAEPCWSA-N,349.471,Q14524,BE0000197,Sodium channel protein type 5 subunit alpha,Humans,blocker,yes
DB06217,Vernakalant,small molecule,approved;investigational,COC1=C(OC)C=C(CCO[C@@H]2CCCC[C@H]2N2CC[C@@H](O)C2)C=C1,VBHQKCBVWWUUKN-KZNAEPCWSA-N,349.471,P22460,BE0004717,Potassium voltage-gated channel subfamily A member 5,Humans,blocker,yes
DB06217,Vernakalant,small molecule,approved;investigational,COC1=C(OC)C=C(CCO[C@@H]2CCCC[C@H]2N2CC[C@@H](O)C2)C=C1,VBHQKCBVWWUUKN-KZNAEPCWSA-N,349.471,Q9UK17,BE0003604,A-type voltage-gated potassium channel KCND3,Humans,blocker,yes
DB06218,Lacosamide,small molecule,approved,COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1,VPPJLAIAVCUEMN-GFCCVEGCSA-N,250.2936,Q16555,BE0005806,Dihydropyrimidinase-related protein 2,Humans,modulator,yes
DB06218,Lacosamide,small molecule,approved,COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1,VPPJLAIAVCUEMN-GFCCVEGCSA-N,250.2936,Q9UI33,BE0000192,Sodium channel protein type 11 subunit alpha,Humans,inhibitor,yes
DB06228,Rivaroxaban,small molecule,approved,ClC1=CC=C(S1)C(=O)NC[C@H]1CN(C(=O)O1)C1=CC=C(C=C1)N1CCOCC1=O,KGFYHTZWPPHNLQ-AWEZNQCLSA-N,435.881,P00742,BE0000216,Coagulation factor X,Humans,antagonist,yes
DB06229,Ocaperidone,small molecule,investigational,CC1=CC=CN2C(=O)C(CCN3CCC(CC3)C3=NOC4=CC(F)=CC=C34)=C(C)N=C12,ZZQNEJILGNNOEP-UHFFFAOYSA-N,420.488,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,modulator,yes
DB06229,Ocaperidone,small molecule,investigational,CC1=CC=CN2C(=O)C(CCN3CCC(CC3)C3=NOC4=CC(F)=CC=C34)=C(C)N=C12,ZZQNEJILGNNOEP-UHFFFAOYSA-N,420.488,P14416,BE0000756,D(2) dopamine receptor,Humans,modulator,yes
DB06230,Nalmefene,small molecule,approved;investigational;withdrawn,OC1=CC=C2C[C@H]3N(CC4CC4)CC[C@@]45[C@@H](OC1=C24)C(=C)CC[C@@]35O,WJBLNOPPDWQMCH-MBPVOVBZSA-N,339.435,P41145,BE0000632,Kappa-type opioid receptor,Humans,partial agonist,yes
DB06230,Nalmefene,small molecule,approved;investigational;withdrawn,OC1=CC=C2C[C@H]3N(CC4CC4)CC[C@@]45[C@@H](OC1=C24)C(=C)CC[C@@]35O,WJBLNOPPDWQMCH-MBPVOVBZSA-N,339.435,P41143,BE0000420,Delta-type opioid receptor,Humans,antagonist,yes
DB06230,Nalmefene,small molecule,approved;investigational;withdrawn,OC1=CC=C2C[C@H]3N(CC4CC4)CC[C@@]45[C@@H](OC1=C24)C(=C)CC[C@@]35O,WJBLNOPPDWQMCH-MBPVOVBZSA-N,339.435,P35372,BE0000770,Mu-type opioid receptor,Humans,antagonist,yes
DB06233,Ridaforolimus,small molecule,investigational,CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1OP(C)(C)=O,BUROJSBIWGDYCN-GAUTUEMISA-N,990.222,P42345,BE0002386,Serine/threonine-protein kinase mTOR,Humans,inhibitor,yes
DB06234,Maribavir,small molecule,approved;investigational,CC(C)NC1=NC2=CC(Cl)=C(Cl)C=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O,KJFBVJALEQWJBS-XUXIUFHCSA-N,376.23,P16788,BE0003484,Serine/threonine protein kinase UL97,HHV-5,inhibitor,yes
DB06235,Vadimezan,small molecule,investigational,CC1=C(C)C2=C(C=C1)C(=O)C1=CC=CC(CC(O)=O)=C1O2,XGOYIMQSIKSOBS-UHFFFAOYSA-N,282.2907,Q01201,BE0013795,Transcription factor RelB,Humans,modulator,yes
DB06235,Vadimezan,small molecule,investigational,CC1=C(C)C2=C(C=C1)C(=O)C1=CC=CC(CC(O)=O)=C1O2,XGOYIMQSIKSOBS-UHFFFAOYSA-N,282.2907,P19838,BE0001086,Nuclear factor NF-kappa-B p105 subunit,Humans,modulator,yes
DB06235,Vadimezan,small molecule,investigational,CC1=C(C)C2=C(C=C1)C(=O)C1=CC=CC(CC(O)=O)=C1O2,XGOYIMQSIKSOBS-UHFFFAOYSA-N,282.2907,Q00653,BE0002387,Nuclear factor NF-kappa-B p100 subunit,Humans,modulator,yes
DB06235,Vadimezan,small molecule,investigational,CC1=C(C)C2=C(C=C1)C(=O)C1=CC=CC(CC(O)=O)=C1O2,XGOYIMQSIKSOBS-UHFFFAOYSA-N,282.2907,Q04206,BE0005551,Transcription factor p65,Humans,modulator,yes
DB06235,Vadimezan,small molecule,investigational,CC1=C(C)C2=C(C=C1)C(=O)C1=CC=CC(CC(O)=O)=C1O2,XGOYIMQSIKSOBS-UHFFFAOYSA-N,282.2907,Q04864,BE0010782,Proto-oncogene c-Rel,Humans,modulator,yes
DB06236,Elvucitabine,small molecule,investigational,NC1=NC(=O)N(C=C1F)[C@H]1O[C@@H](CO)C=C1,HSBKFSPNDWWPSL-VDTYLAMSSA-N,227.195,P03366,BE0002050,Gag-Pol polyprotein,,modulator,yes
DB06237,Avanafil,small molecule,approved,COC1=C(Cl)C=C(CNC2=C(C=NC(=N2)N2CCC[C@H]2CO)C(=O)NCC2=NC=CC=N2)C=C1,WEAJZXNPAWBCOA-INIZCTEOSA-N,483.951,O76074,BE0000182,"cGMP-specific 3',5'-cyclic phosphodiesterase",Humans,inhibitor,yes
DB06240,Tariquidar,small molecule,investigational,COC1=CC2=C(CN(CCC3=CC=C(NC(=O)C4=CC(OC)=C(OC)C=C4NC(=O)C4=CN=C5C=CC=CC5=C4)C=C3)CC2)C=C1OC,LGGHDPFKSSRQNS-UHFFFAOYSA-N,646.744,P08183,BE0001032,ATP-dependent translocase ABCB1,Humans,modulator,yes
DB06243,Eflornithine,small molecule,approved;withdrawn,NCCCC(N)(C(F)F)C(O)=O,VLCYCQAOQCDTCN-UHFFFAOYSA-N,182.171,P11926,BE0000404,Ornithine decarboxylase,Humans,inhibitor,yes
DB06246,Exisulind,small molecule,investigational,CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(C=C1)S(C)(=O)=O,MVGSNCBCUWPVDA-MFOYZWKCSA-N,372.41,O76074,BE0000182,"cGMP-specific 3',5'-cyclic phosphodiesterase",Humans,modulator,yes
DB06248,Amelubant,small molecule,investigational,CCOC(=O)NC(=N)C1=CC=C(OCC2=CC=CC(COC3=CC=C(C=C3)C(C)(C)C3=CC=C(O)C=C3)=C2)C=C1,SBVYURPQULDJTI-UHFFFAOYSA-N,538.644,Q15722,BE0003490,Leukotriene B4 receptor 1,Humans,antagonist,yes
DB06249,Arzoxifene,small molecule,approved;investigational,COC1=CC=C(C=C1)C1=C(OC2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2,MCGDSOGUHLTADD-UHFFFAOYSA-N,475.6,P03372,BE0000123,Estrogen receptor,Humans,inhibitor,yes
DB06249,Arzoxifene,small molecule,approved;investigational,COC1=CC=C(C=C1)C1=C(OC2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2,MCGDSOGUHLTADD-UHFFFAOYSA-N,475.6,Q92731,BE0000792,Estrogen receptor beta,Humans,inhibitor,yes
DB06251,Dersalazine,small molecule,investigational,CC1=NC2=CN=CC=C2N1CC1CCN(CC1)C(=O)\C=C(\C1=CC=CC=C1)C1=CC=C(C=C1)\N=N\C1=CC(C(O)=O)=C(O)C=C1,AYEAMZDTWLXZIJ-RKOUKRECSA-N,600.679,P25105,BE0005561,Platelet-activating factor receptor,Humans,inhibitor,yes
DB06255,Incadronic acid,small molecule,experimental,OP(O)(=O)C(NC1CCCCCC1)P(O)(O)=O,LWRDQHOZTAOILO-UHFFFAOYSA-N,287.189,P14324,BE0000776,Farnesyl pyrophosphate synthase,Humans,inhibitor,yes
DB06258,Bimoclomol,small molecule,investigational,OC(CO\N=C(/Cl)C1=CN=CC=C1)CN1CCCCC1,NMOVJBAGBXIKCG-VKAVYKQESA-N,297.781,P0DMV9,BE0012549,Heat shock 70 kDa protein 1B,Humans,modulator,yes
DB06258,Bimoclomol,small molecule,investigational,OC(CO\N=C(/Cl)C1=CN=CC=C1)CN1CCCCC1,NMOVJBAGBXIKCG-VKAVYKQESA-N,297.781,P0DMV8,BE0010433,Heat shock 70 kDa protein 1A,Humans,modulator,yes
DB06262,Droxidopa,small molecule,approved;investigational,N[C@@H]([C@H](O)C1=CC(O)=C(O)C=C1)C(O)=O,QXWYKJLNLSIPIN-JGVFFNPUSA-N,213.189,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,agonist,yes
DB06262,Droxidopa,small molecule,approved;investigational,N[C@@H]([C@H](O)C1=CC(O)=C(O)C=C1)C(O)=O,QXWYKJLNLSIPIN-JGVFFNPUSA-N,213.189,P35368,BE0000575,Alpha-1B adrenergic receptor,Humans,agonist,yes
DB06262,Droxidopa,small molecule,approved;investigational,N[C@@H]([C@H](O)C1=CC(O)=C(O)C=C1)C(O)=O,QXWYKJLNLSIPIN-JGVFFNPUSA-N,213.189,P25100,BE0000715,Alpha-1D adrenergic receptor,Humans,agonist,yes
DB06262,Droxidopa,small molecule,approved;investigational,N[C@@H]([C@H](O)C1=CC(O)=C(O)C=C1)C(O)=O,QXWYKJLNLSIPIN-JGVFFNPUSA-N,213.189,P08913,BE0000289,Alpha-2A adrenergic receptor,Humans,agonist,yes
DB06262,Droxidopa,small molecule,approved;investigational,N[C@@H]([C@H](O)C1=CC(O)=C(O)C=C1)C(O)=O,QXWYKJLNLSIPIN-JGVFFNPUSA-N,213.189,P18089,BE0000572,Alpha-2B adrenergic receptor,Humans,agonist,yes
DB06262,Droxidopa,small molecule,approved;investigational,N[C@@H]([C@H](O)C1=CC(O)=C(O)C=C1)C(O)=O,QXWYKJLNLSIPIN-JGVFFNPUSA-N,213.189,P18825,BE0000342,Alpha-2C adrenergic receptor,Humans,agonist,yes
DB06262,Droxidopa,small molecule,approved;investigational,N[C@@H]([C@H](O)C1=CC(O)=C(O)C=C1)C(O)=O,QXWYKJLNLSIPIN-JGVFFNPUSA-N,213.189,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,agonist,yes
DB06262,Droxidopa,small molecule,approved;investigational,N[C@@H]([C@H](O)C1=CC(O)=C(O)C=C1)C(O)=O,QXWYKJLNLSIPIN-JGVFFNPUSA-N,213.189,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,agonist,yes
DB06262,Droxidopa,small molecule,approved;investigational,N[C@@H]([C@H](O)C1=CC(O)=C(O)C=C1)C(O)=O,QXWYKJLNLSIPIN-JGVFFNPUSA-N,213.189,P13945,BE0001012,Beta-3 adrenergic receptor,Humans,agonist,yes
DB06264,Tolperisone,small molecule,investigational,CC(CN1CCCCC1)C(=O)C1=CC=C(C)C=C1,FSKFPVLPFLJRQB-UHFFFAOYSA-N,245.366,Q9UI33,BE0000192,Sodium channel protein type 11 subunit alpha,Humans,modulator,yes
DB06267,Udenafil,small molecule,approved;investigational,CCCOC1=C(C=C(C=C1)S(=O)(=O)NCCC1CCCN1C)C1=NC(=O)C2=C(N1)C(CCC)=NN2C,IYFNEFQTYQPVOC-UHFFFAOYSA-N,516.656,O76074,BE0000182,"cGMP-specific 3',5'-cyclic phosphodiesterase",Humans,inhibitor,yes
DB06268,Sitaxentan,small molecule,approved;investigational;withdrawn,CC1=NOC(NS(=O)(=O)C2=C(SC=C2)C(=O)CC2=CC3=C(OCO3)C=C2C)=C1Cl,PHWXUGHIIBDVKD-UHFFFAOYSA-N,454.905,P25101,BE0000521,Endothelin-1 receptor,Humans,antagonist,yes
DB06274,Alvimopan,small molecule,approved;investigational,C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)NCC(O)=O)CC[C@@]1(C)C1=CC(O)=CC=C1,UPNUIXSCZBYVBB-JVFUWBCBSA-N,424.5326,P35372,BE0000770,Mu-type opioid receptor,Humans,antagonist,yes
DB06276,Tanomastat,small molecule,investigational,OC(=O)[C@@H](CSC1=CC=CC=C1)CC(=O)C1=CC=C(C=C1)C1=CC=C(Cl)C=C1,JXAGDPXECXQWBC-LJQANCHMSA-N,410.91,P08253,BE0000642,72 kDa type IV collagenase,Humans,inhibitor,yes
DB06280,Senicapoc,small molecule,investigational,NC(=O)C(C1=CC=CC=C1)(C1=CC=C(F)C=C1)C1=CC=C(F)C=C1,SCTZUZTYRMOMKT-UHFFFAOYSA-N,323.343,O15554,BE0000415,Intermediate conductance calcium-activated potassium channel protein 4,Humans,modulator,yes
DB06281,Torcetrapib,small molecule,investigational,CCOC(=O)N1[C@H](CC)C[C@H](N(CC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)C(=O)OC)C2=C1C=CC(=C2)C(F)(F)F,CMSGWTNRGKRWGS-NQIIRXRSSA-N,600.4733,P11597,BE0003516,Cholesteryl ester transfer protein,Humans,antagonist,yes
DB06282,Levocetirizine,small molecule,approved,OC(=O)COCCN1CCN(CC1)[C@H](C1=CC=CC=C1)C1=CC=C(Cl)C=C1,ZKLPARSLTMPFCP-OAQYLSRUSA-N,388.89,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist;inhibitor,yes
DB06287,Temsirolimus,small molecule,approved,OCC(C)(CO)C(=O)O[C@@H]1CC[C@@H](C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@@H](OC)C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)C[C@H]1OC,CBPNZQVSJQDFBE-FUXHJELOSA-N,1030.2871,P42345,BE0002386,Serine/threonine-protein kinase mTOR,Humans,inhibitor,yes
DB06288,Amisulpride,small molecule,approved;investigational,CCN1CCCC1CNC(=O)C1=CC(=C(N)C=C1OC)S(=O)(=O)CC,NTJOBXMMWNYJFB-UHFFFAOYSA-N,369.479,P34969,BE0000650,5-hydroxytryptamine receptor 7,Humans,antagonist,yes
DB06288,Amisulpride,small molecule,approved;investigational,CCN1CCCC1CNC(=O)C1=CC(=C(N)C=C1OC)S(=O)(=O)CC,NTJOBXMMWNYJFB-UHFFFAOYSA-N,369.479,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB06288,Amisulpride,small molecule,approved;investigational,CCN1CCCC1CNC(=O)C1=CC(=C(N)C=C1OC)S(=O)(=O)CC,NTJOBXMMWNYJFB-UHFFFAOYSA-N,369.479,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB06288,Amisulpride,small molecule,approved;investigational,CCN1CCCC1CNC(=O)C1=CC(=C(N)C=C1OC)S(=O)(=O)CC,NTJOBXMMWNYJFB-UHFFFAOYSA-N,369.479,P35462,BE0000581,D(3) dopamine receptor,Humans,antagonist,yes
DB06290,Simeprevir,small molecule,approved,[H][C@]12C[C@]1(NC(=O)[C@]1([H])C[C@H](C[C@@]1([H])C(=O)N(C)CCCC\C=C/2)OC1=CC(=NC2=C1C=CC(OC)=C2C)C1=NC(=CS1)C(C)C)C(=O)NS(=O)(=O)C1CC1,JTZZSQYMACOLNN-VDWJNHBNSA-N,749.939,P26664,BE0003427,Genome polyprotein,,modulator,yes
DB06290,Simeprevir,small molecule,approved,[H][C@]12C[C@]1(NC(=O)[C@]1([H])C[C@H](C[C@@]1([H])C(=O)N(C)CCCC\C=C/2)OC1=CC(=NC2=C1C=CC(OC)=C2C)C1=NC(=CS1)C(C)C)C(=O)NS(=O)(=O)C1CC1,JTZZSQYMACOLNN-VDWJNHBNSA-N,749.939,Q91RS4,BE0004004,NS3 protease,Hepatitis C Virus,inhibitor,yes
DB06290,Simeprevir,small molecule,approved,[H][C@]12C[C@]1(NC(=O)[C@]1([H])C[C@H](C[C@@]1([H])C(=O)N(C)CCCC\C=C/2)OC1=CC(=NC2=C1C=CC(OC)=C2C)C1=NC(=CS1)C(C)C)C(=O)NS(=O)(=O)C1CC1,JTZZSQYMACOLNN-VDWJNHBNSA-N,749.939,B0B3C9,BE0004701,Genome polyprotein,Hepatitis C Virus,inhibitor,yes
DB06292,Dapagliflozin,small molecule,approved,CCOC1=CC=C(CC2=C(Cl)C=CC(=C2)[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C1,JVHXJTBJCFBINQ-ADAARDCZSA-N,408.873,P31639,BE0004753,Sodium/glucose cotransporter 2,Humans,antagonist;inhibitor,yes
DB06295,Pramiconazole,small molecule,investigational,CC(C)N1CCN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@H]2OC[C@@](CN3C=NC=N3)(O2)C2=CC=C(F)C=C2F)C=C1,AEKNYBWUEYNWMJ-QWOOXDRHSA-N,659.739,P10613,BE0000233,Lanosterol 14-alpha demethylase,Yeast,modulator,yes
DB06297,LX-2931,small molecule,investigational,C\C(=N/O)C1=NC=C(N1)[C@@H](O)[C@H](O)[C@H](O)CO,AMXVYJYMZLDINS-RSWLNLDNSA-N,245.235,O95470,BE0000778,Sphingosine-1-phosphate lyase 1,Humans,inhibitor,yes
DB06306,Onalespib,small molecule,investigational,CC(C)C1=CC(C(=O)N2CC3=CC=C(CN4CCN(C)CC4)C=C3C2)=C(O)C=C1O,IFRGXKKQHBVPCQ-UHFFFAOYSA-N,409.53,P07900,BE0001120,Heat shock protein HSP 90-alpha,Humans,inhibitor,yes
DB06311,Darapladib,small molecule,investigational,CCN(CC)CCN(CC1=CC=C(C=C1)C1=CC=C(C=C1)C(F)(F)F)C(=O)CN1C2=C(CCC2)C(=O)N=C1SCC1=CC=C(F)C=C1,WDPFJWLDPVQCAJ-UHFFFAOYSA-N,666.78,P04054,BE0003997,Phospholipase A2,Humans,modulator,yes
DB06314,SGX-523,small molecule,investigational,CN1C=C(C=N1)C1=NN2C(SC3=CC=C4N=CC=CC4=C3)=NN=C2C=C1,BCZUAADEACICHN-UHFFFAOYSA-N,359.408,P08581,BE0000915,Hepatocyte growth factor receptor,Humans,inhibitor,yes
DB06333,Trodusquemine,small molecule,investigational,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@@]4([H])C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)NCCCNCCCCNCCCN)[C@H](C)CC[C@@H](OS(O)(=O)=O)C(C)C,WUJVPODXELZABP-FWJXURDUSA-N,685.07,P18031,BE0000623,Tyrosine-protein phosphatase non-receptor type 1,Humans,inhibitor,yes
DB06334,Tucidinostat,small molecule,investigational,NC1=CC(F)=CC=C1NC(=O)C1=CC=C(CNC(=O)\C=C\C2=CN=CC=C2)C=C1,SZMJVTADHFNAIS-BJMVGYQFSA-N,390.418,Q13547,BE0002365,Histone deacetylase 1,Humans,modulator,yes
DB06335,Saxagliptin,small molecule,approved,[H][C@@]12C[C@]1([H])N([C@@H](C2)C#N)C(=O)[C@@H](N)C12CC3CC(CC(O)(C3)C1)C2,QGJUIPDUBHWZPV-SGTAVMJGSA-N,315.41,P27487,BE0000854,Dipeptidyl peptidase 4,Humans,inhibitor,yes
DB06345,AR-9281,small molecule,investigational,CC(=O)N1CCC(CC1)NC(=O)NC12CC3CC(CC(C3)C1)C2,HUDQLWBKJOMXSZ-UHFFFAOYSA-N,319.449,P34913,BE0000950,Bifunctional epoxide hydrolase 2,Humans,inhibitor,yes
DB06346,Fiboflapon,small molecule,investigational,CCOC1=CC=C(C=N1)C1=CC=C(CN2C(CC(C)(C)C(O)=O)=C(SC(C)(C)C)C3=CC(OCC4=CC=C(C)C=N4)=CC=C23)C=C1,DFQGDHBGRSTTHX-UHFFFAOYSA-N,637.84,P20292,BE0002382,Arachidonate 5-lipoxygenase-activating protein,Humans,inhibitor,yes
DB06347,Cenisertib,small molecule,investigational,[H][C@@]12C[C@@]([H])(C=C1)[C@@H]([C@@H]2NC1=C(F)C=NC(NC2=CC=C(N3CCN(C)CC3)C(C)=C2)=N1)C(N)=O,KSOVGRCOLZZTPF-QMKUDKLTSA-N,451.55,Q96GD4,BE0003404,Aurora kinase B,Humans,inhibitor,yes
DB06347,Cenisertib,small molecule,investigational,[H][C@@]12C[C@@]([H])(C=C1)[C@@H]([C@@H]2NC1=C(F)C=NC(NC2=CC=C(N3CCN(C)CC3)C(C)=C2)=N1)C(N)=O,KSOVGRCOLZZTPF-QMKUDKLTSA-N,451.55,O14965,BE0000991,Aurora kinase A,Humans,inhibitor,yes
DB06350,Elinogrel,small molecule,investigational,CNC1=C(F)C=C2C(NC(=O)N(C2=O)C2=CC=C(NC(=O)NS(=O)(=O)C3=CC=C(Cl)S3)C=C2)=C1,LGSDFTPAICUONK-UHFFFAOYSA-N,523.94,Q9H244,BE0000110,P2Y purinoceptor 12,Humans,antagonist,yes
DB06354,Tezampanel,small molecule,investigational,[H][C@]1(CCC2=NN=NN2)CC[C@@]2([H])CN[C@@]([H])(C[C@@]2([H])C1)C(O)=O,ZXFRFPSZAKNPQQ-YTWAJWBKSA-N,279.344,P39086,BE0000346,"Glutamate receptor ionotropic, kainate 1",Humans,modulator,yes
DB06358,Iclaprim,small molecule,investigational,COC1=CC(CC2=CN=C(N)N=C2N)=C2C=CC(OC2=C1OC)C1CC1,HWJPWWYTGBZDEG-UHFFFAOYSA-N,354.41,P0ABQ4,BE0002010,Dihydrofolate reductase,Escherichia coli (strain K12),modulator,yes
DB06358,Iclaprim,small molecule,investigational,COC1=CC(CC2=CN=C(N)N=C2N)=C2C=CC(OC2=C1OC)C1CC1,HWJPWWYTGBZDEG-UHFFFAOYSA-N,354.41,P00374,BE0000330,Dihydrofolate reductase,Humans,inhibitor,yes
DB06362,Becatecarin,small molecule,investigational,CCN(CC)CCN1C(=O)C2=C(C1=O)C1=C(N([C@@H]3O[C@H](CO)[C@@H](OC)[C@H](O)[C@H]3O)C3=C(Cl)C=CC=C13)C1=C2C2=C(N1)C(Cl)=CC=C2,JSKFWUPVIZYJMR-UDOAKELVSA-N,669.56,P11387,BE0000971,DNA topoisomerase 1,Humans,modulator,yes
DB06364,XR5944,small molecule,investigational,[H]N(CCN([H])CCN([H])C(=O)C1=CC=CC2=NC3=CC=CC(C)=C3N=C12)CCN([H])C(=O)C1=CC=CC2=NC3=CC=CC(C)=C3N=C12,SFOADSRLCHRTKT-UHFFFAOYSA-N,586.7,P11388,BE0000742,DNA topoisomerase 2-alpha,Humans,modulator,yes
DB06364,XR5944,small molecule,investigational,[H]N(CCN([H])CCN([H])C(=O)C1=CC=CC2=NC3=CC=CC(C)=C3N=C12)CCN([H])C(=O)C1=CC=CC2=NC3=CC=CC(C)=C3N=C12,SFOADSRLCHRTKT-UHFFFAOYSA-N,586.7,Q02880,BE0002425,DNA topoisomerase 2-beta,Humans,modulator,yes
DB06367,Relacatib,small molecule,investigational,CC(C)C[C@H](NC(=O)C1=CC2=CC=CC=C2O1)C(=O)N[C@H]1CC[C@@H](C)N(CC1=O)S(=O)(=O)C1=CC=CC=N1,BWYBBMQLUKXECQ-GIVPXCGWSA-N,540.64,P43235,BE0003417,Cathepsin K,Humans,inhibitor,yes
DB06370,Indisulam,small molecule,investigational,NS(=O)(=O)C1=CC=C(C=C1)S(=O)(=O)NC1=CC=CC2=C1NC=C2Cl,SETFNECMODOHTO-UHFFFAOYSA-N,385.846,Q16790,BE0002437,Carbonic anhydrase 9,Humans,modulator,yes
DB06374,Elacestrant,small molecule,approved;investigational,CCNCCC1=CC=C(CN(CC)C2=C(C=CC(OC)=C2)[C@@H]2CCC3=CC(O)=CC=C3C2)C=C1,SIFNOOUKXBRGGB-AREMUKBSSA-N,458.646,P03372,BE0000123,Estrogen receptor,Humans,antagonist,yes
DB06393,Xaliproden,small molecule,investigational,FC(F)(F)C1=CC(=CC=C1)C1=CCN(CCC2=CC3=CC=CC=C3C=C2)CC1,WJJYZXPHLSLMGE-UHFFFAOYSA-N,381.442,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,antagonist,yes
DB06395,Abafungin,small molecule,investigational,CC1=CC(C)=C(OC2=CC=CC=C2C2=CSC(N=C3NCCCN3)=N2)C=C1,TYBHXIFFPVFXQW-UHFFFAOYSA-N,378.49,P10613,BE0000233,Lanosterol 14-alpha demethylase,Yeast,inhibitor,yes
DB06397,Nicaraven,small molecule,investigational,CC(CNC(=O)C1=CC=CN=C1)NC(=O)C1=CC=CN=C1,KTXBOOWDLPUROC-UHFFFAOYSA-N,284.319,P09874,BE0001717,Poly [ADP-ribose] polymerase 1,Humans,modulator,yes
DB06401,Bazedoxifene,small molecule,approved;investigational,CC1=C(N(CC2=CC=C(OCCN3CCCCCC3)C=C2)C2=C1C=C(O)C=C2)C1=CC=C(O)C=C1,UCJGJABZCDBEDK-UHFFFAOYSA-N,470.613,P03372,BE0000123,Estrogen receptor,Humans,antagonist;agonist,yes
DB06402,Telavancin,small molecule,approved,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2OC2=C3OC4=CC=C(C=C4Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]4C(C=C2OC2=C(Cl)C=C(C=C2)[C@@H](O)[C@@H]2NC(=O)[C@H](NC4=O)C4=CC(=C(O)C=C4)C4=C(O)C(CNCP(O)(O)=O)=C(O)C=C4[C@H](NC2=O)C(O)=O)=C3)O[C@@H](C)[C@H]1O,ONUMZHGUFYIKPM-MXNFEBESSA-N,1755.65,Q15822,BE0000738,Neuronal acetylcholine receptor subunit alpha-2,Humans,agonist,yes
DB06402,Telavancin,small molecule,approved,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2OC2=C3OC4=CC=C(C=C4Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]4C(C=C2OC2=C(Cl)C=C(C=C2)[C@@H](O)[C@@H]2NC(=O)[C@H](NC4=O)C4=CC(=C(O)C=C4)C4=C(O)C(CNCP(O)(O)=O)=C(O)C=C4[C@H](NC2=O)C(O)=O)=C3)O[C@@H](C)[C@H]1O,ONUMZHGUFYIKPM-MXNFEBESSA-N,1755.65,P32297,BE0003585,Neuronal acetylcholine receptor subunit alpha-3,Humans,agonist,yes
DB06402,Telavancin,small molecule,approved,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2OC2=C3OC4=CC=C(C=C4Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]4C(C=C2OC2=C(Cl)C=C(C=C2)[C@@H](O)[C@@H]2NC(=O)[C@H](NC4=O)C4=CC(=C(O)C=C4)C4=C(O)C(CNCP(O)(O)=O)=C(O)C=C4[C@H](NC2=O)C(O)=O)=C3)O[C@@H](C)[C@H]1O,ONUMZHGUFYIKPM-MXNFEBESSA-N,1755.65,P34998,BE0008658,Corticotropin-releasing factor receptor 1,Humans,antagonist,yes
DB06403,Ambrisentan,small molecule,approved;investigational,COC([C@H](OC1=NC(C)=CC(C)=N1)C(O)=O)(C1=CC=CC=C1)C1=CC=CC=C1,OUJTZYPIHDYQMC-LJQANCHMSA-N,378.428,P25101,BE0000521,Endothelin-1 receptor,Humans,antagonist,yes
DB06406,Idraparinux,small molecule,investigational,[H][C@]1(O[C@H]2[C@H](OC)[C@@H](OC)[C@]([H])(O[C@@H]3[C@@H](COS(O)(=O)=O)O[C@]([H])(O[C@H]4[C@H](OC)[C@@H](OC)[C@]([H])(O[C@@H]5[C@@H](COS(O)(=O)=O)O[C@H](OC)[C@H](OS(O)(=O)=O)[C@H]5OS(O)(=O)=O)O[C@H]4C(O)=O)[C@H](OS(O)(=O)=O)[C@H]3OS(O)(=O)=O)O[C@@H]2C(O)=O)O[C@H](COS(O)(=O)=O)[C@@H](OC)[C@H](OC)[C@H]1OC,AJBMORBNKXNZSF-COSHMZDQSA-N,1529.3,P00742,BE0000216,Coagulation factor X,Humans,inhibitor,yes
DB06408,Taribavirin,small molecule,investigational,NC(=N)C1=NN(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,NHKZSTHOYNWEEZ-AFCXAGJDSA-N,243.223,P20839,BE0000761,Inosine-5'-monophosphate dehydrogenase 1,Humans,inhibitor,yes
DB06409,Morphine glucuronide,small molecule,investigational,[H][C@]12C=C[C@H](O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)[C@@H]3OC4=C5C(C[C@H]1N(C)CC[C@@]235)=CC=C4O,GNJCUHZOSOYIEC-GAROZEBRSA-N,461.4618,P35372,BE0000770,Mu-type opioid receptor,Humans,agonist,yes
DB06412,Oxymetholone,small molecule,approved;illicit,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)\C(C[C@]12C)=C/O,ICMWWNHDUZJFDW-DHODBPELSA-N,332.484,P10275,BE0000132,Androgen receptor,Humans,agonist;activator,yes
DB06413,Armodafinil,small molecule,approved;investigational,NC(=O)C[S@@](=O)C(C1=CC=CC=C1)C1=CC=CC=C1,YFGHCGITMMYXAQ-LJQANCHMSA-N,273.35,P25100,BE0000715,Alpha-1D adrenergic receptor,Humans,agonist,yes
DB06413,Armodafinil,small molecule,approved;investigational,NC(=O)C[S@@](=O)C(C1=CC=CC=C1)C1=CC=CC=C1,YFGHCGITMMYXAQ-LJQANCHMSA-N,273.35,Q01959,BE0000647,Sodium-dependent dopamine transporter,Humans,antagonist;inhibitor,yes
DB06414,Etravirine,small molecule,approved,CC1=CC(=CC(C)=C1OC1=C(Br)C(N)=NC(NC2=CC=C(C=C2)C#N)=N1)C#N,PYGWGZALEOIKDF-UHFFFAOYSA-N,435.277,P03366,BE0002050,Gag-Pol polyprotein,,modulator,yes
DB06419,Cethromycin,small molecule,investigational,[H]C(CO[C@]1(C)C[C@@H](C)C(=O)[C@H](C)[C@H]2NC(=O)O[C@]2(C)[C@@H](CC)OC(=O)[C@H](C)C(=O)[C@H](C)[C@H]1O[C@@H]1O[C@H](C)C[C@@H]([C@H]1O)N(C)C)=C([H])C1=CC2=C(C=CC=C2)N=C1,PENDGIOBPJLVBT-AMXFZXBBSA-N,765.945,,BE0004800,23S ribosomal RNA,Enteric bacteria and other eubacteria,antagonist,yes
DB06421,Declopramide,small molecule,investigational,CCN(CC)CCNC(=O)C1=CC=C(N)C(Cl)=C1,YEYAKZXEBSVURO-UHFFFAOYSA-N,269.77,P14416,BE0000756,D(2) dopamine receptor,Humans,modulator,yes
DB06421,Declopramide,small molecule,investigational,CCN(CC)CCNC(=O)C1=CC=C(N)C(Cl)=C1,YEYAKZXEBSVURO-UHFFFAOYSA-N,269.77,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,modulator,yes
DB06429,Talnetant,small molecule,investigational,CCC(NC(=O)C1=C(O)C(=NC2=CC=CC=C12)C1=CC=CC=C1)C1=CC=CC=C1,BIAVGWDGIJKWRM-UHFFFAOYSA-N,382.4544,P29371,BE0002371,Neuromedin-K receptor,Humans,antagonist,yes
DB06433,Tezacitabine,small molecule,investigational,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)\C1=C/F,GFFXZLZWLOBBLO-ASKVSEFXSA-N,257.2184,P31350,BE0002450,Ribonucleoside-diphosphate reductase subunit M2,Humans,modulator,yes
DB06435,Tarazepide,small molecule,investigational,CN1C2=CC=CC=C2C(=N[C@H](NC(=O)C2=CC3=CC=CC4=C3N2CCC4)C1=O)C1=CC=CC=C1,CZPILLBHPRAPCB-AREMUKBSSA-N,448.526,P32238,BE0000402,Cholecystokinin receptor type A,Humans,antagonist,yes
DB06436,Semaxanib,small molecule,investigational,CC1=CC(C)=C(N1)\C=C1/C(=O)NC2=CC=CC=C12,WUWDLXZGHZSWQZ-WQLSENKSSA-N,238.2845,P35869,BE0003721,Aryl hydrocarbon receptor,Humans,modulator,yes
DB06436,Semaxanib,small molecule,investigational,CC1=CC(C)=C(N1)\C=C1/C(=O)NC2=CC=CC=C12,WUWDLXZGHZSWQZ-WQLSENKSSA-N,238.2845,P09619,BE0000205,Platelet-derived growth factor receptor beta,Humans,inhibitor,yes
DB06436,Semaxanib,small molecule,investigational,CC1=CC(C)=C(N1)\C=C1/C(=O)NC2=CC=CC=C12,WUWDLXZGHZSWQZ-WQLSENKSSA-N,238.2845,P17948,BE0000029,Vascular endothelial growth factor receptor 1,Humans,inhibitor,yes
DB06436,Semaxanib,small molecule,investigational,CC1=CC(C)=C(N1)\C=C1/C(=O)NC2=CC=CC=C12,WUWDLXZGHZSWQZ-WQLSENKSSA-N,238.2845,P07949,BE0002411,Proto-oncogene tyrosine-protein kinase receptor Ret,Humans,inhibitor,yes
DB06436,Semaxanib,small molecule,investigational,CC1=CC(C)=C(N1)\C=C1/C(=O)NC2=CC=CC=C12,WUWDLXZGHZSWQZ-WQLSENKSSA-N,238.2845,P40238,BE0003440,Thrombopoietin receptor,Humans,modulator,yes
DB06436,Semaxanib,small molecule,investigational,CC1=CC(C)=C(N1)\C=C1/C(=O)NC2=CC=CC=C12,WUWDLXZGHZSWQZ-WQLSENKSSA-N,238.2845,P11362,BE0002131,Fibroblast growth factor receptor 1,Humans,inhibitor,yes
DB06436,Semaxanib,small molecule,investigational,CC1=CC(C)=C(N1)\C=C1/C(=O)NC2=CC=CC=C12,WUWDLXZGHZSWQZ-WQLSENKSSA-N,238.2845,P16234,BE0000852,Platelet-derived growth factor receptor alpha,Humans,inhibitor,yes
DB06436,Semaxanib,small molecule,investigational,CC1=CC(C)=C(N1)\C=C1/C(=O)NC2=CC=CC=C12,WUWDLXZGHZSWQZ-WQLSENKSSA-N,238.2845,P10721,BE0000453,Mast/stem cell growth factor receptor Kit,Humans,inhibitor,yes
DB06436,Semaxanib,small molecule,investigational,CC1=CC(C)=C(N1)\C=C1/C(=O)NC2=CC=CC=C12,WUWDLXZGHZSWQZ-WQLSENKSSA-N,238.2845,P35968,BE0000369,Vascular endothelial growth factor receptor 2,Humans,inhibitor,yes
DB06441,Cangrelor,small molecule,approved,CSCCNC1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)C(Cl)(Cl)P(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC(SCCC(F)(F)F)=N1,PAEBIVWUMLRPSK-IDTAVKCVSA-N,776.35,Q9H244,BE0000110,P2Y purinoceptor 12,Humans,inhibitor,yes
DB06442,Avasimibe,small molecule,investigational,CC(C)C1=CC(C(C)C)=C(CC(=O)NS(=O)(=O)OC2=C(C=CC=C2C(C)C)C(C)C)C(=C1)C(C)C,PTQXTEKSNBVPQJ-UHFFFAOYSA-N,501.73,P23141,BE0002705,Liver carboxylesterase 1,Humans,inhibitor,yes
DB06448,Lonafarnib,small molecule,approved;investigational,NC(=O)N1CCC(CC(=O)N2CCC(CC2)[C@H]2C3=C(CCC4=C2C(Br)=CC(Cl)=C4)C=C(Br)C=N3)CC1,DHMTURDWPRKSOA-RUZDIDTESA-N,638.822,P49354,BE0002373,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,Humans,inhibitor,yes
DB06448,Lonafarnib,small molecule,approved;investigational,NC(=O)N1CCC(CC(=O)N2CCC(CC2)[C@H]2C3=C(CCC4=C2C(Br)=CC(Cl)=C4)C=C(Br)C=N3)CC1,DHMTURDWPRKSOA-RUZDIDTESA-N,638.822,P49356,BE0002372,Protein farnesyltransferase subunit beta,Humans,inhibitor,yes
DB06454,Sarizotan,small molecule,investigational,FC1=CC=C(C=C1)C1=CN=CC(CNC[C@H]2CCC3=CC=CC=C3O2)=C1,HKFMQJUJWSFOLY-OAQYLSRUSA-N,348.421,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,modulator,yes
DB06455,Meclinertant,small molecule,investigational,COC1=CC=CC(OC)=C1C1=CC(=NN1C1=C2C=CC(Cl)=CC2=NC=C1)C(=O)NC1(C2CC3CC(C2)CC1C3)C(O)=O,DYLJVOXRWLXDIG-UHFFFAOYSA-N,587.07,P30989,BE0013004,Neurotensin receptor type 1,Humans,antagonist,yes
DB06457,Tecastemizole,small molecule,investigational,FC1=CC=C(CN2C(NC3CCNCC3)=NC3=CC=CC=C23)C=C1,SFOVDSLXFUGAIV-UHFFFAOYSA-N,324.403,P35367,BE0000442,Histamine H1 receptor,Humans,modulator,yes
DB06460,Enrasentan,small molecule,investigational,CCCOC1=CC=C2[C@@H]([C@H]([C@@H](C2=C1)C1=CC=C(OC)C=C1OCCO)C(O)=O)C1=CC=C2OCOC2=C1,GLCKXJLCYIJMRB-UPRLRBBYSA-N,506.551,P25101,BE0000521,Endothelin-1 receptor,Humans,modulator,yes
DB06460,Enrasentan,small molecule,investigational,CCCOC1=CC=C2[C@@H]([C@H]([C@@H](C2=C1)C1=CC=C(OC)C=C1OCCO)C(O)=O)C1=CC=C2OCOC2=C1,GLCKXJLCYIJMRB-UPRLRBBYSA-N,506.551,P24530,BE0000043,Endothelin receptor type B,Humans,modulator,yes
DB06461,Squalamine,small molecule,investigational,CC(C)[C@@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@H]4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)NCCCNCCCCN)OS(O)(=O)=O,UIRKNQLZZXALBI-MSVGPLKSSA-N,627.97,P49767,BE0010101,Vascular endothelial growth factor C,Humans,modulator,yes
DB06461,Squalamine,small molecule,investigational,CC(C)[C@@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@H]4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)NCCCNCCCCN)OS(O)(=O)=O,UIRKNQLZZXALBI-MSVGPLKSSA-N,627.97,O43915,BE0010102,Vascular endothelial growth factor D,Humans,modulator,yes
DB06461,Squalamine,small molecule,investigational,CC(C)[C@@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@H]4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)NCCCNCCCCN)OS(O)(=O)=O,UIRKNQLZZXALBI-MSVGPLKSSA-N,627.97,P09038,BE0001015,Fibroblast growth factor 2,Humans,modulator,yes
DB06461,Squalamine,small molecule,investigational,CC(C)[C@@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@H]4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)NCCCNCCCCN)OS(O)(=O)=O,UIRKNQLZZXALBI-MSVGPLKSSA-N,627.97,P04085,BE0010246,Platelet-derived growth factor subunit A,Humans,inhibitor,yes
DB06461,Squalamine,small molecule,investigational,CC(C)[C@@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@H]4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)NCCCNCCCCN)OS(O)(=O)=O,UIRKNQLZZXALBI-MSVGPLKSSA-N,627.97,P15692,BE0000163,"Vascular endothelial growth factor A, long form",Humans,modulator,yes
DB06461,Squalamine,small molecule,investigational,CC(C)[C@@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@H]4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)NCCCNCCCCN)OS(O)(=O)=O,UIRKNQLZZXALBI-MSVGPLKSSA-N,627.97,P49765,BE0004736,Vascular endothelial growth factor B,Humans,modulator,yes
DB06468,Cariporide,small molecule,investigational,CC(C)C1=CC=C(C=C1S(C)(=O)=O)C(=O)NC(N)=N,IWXNYAIICFKCTM-UHFFFAOYSA-N,283.35,P19634,BE0000752,Sodium/hydrogen exchanger 1,Humans,inhibitor,yes
DB06468,Cariporide,small molecule,investigational,CC(C)C1=CC=C(C=C1S(C)(=O)=O)C(=O)NC(N)=N,IWXNYAIICFKCTM-UHFFFAOYSA-N,283.35,P48764,BE0009757,Sodium/hydrogen exchanger 3,Humans,inhibitor,yes
DB06469,Lestaurtinib,small molecule,investigational,C[C@]12O[C@H](C[C@]1(O)CO)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C3C(=O)NC4)C3=CC=CC=C3N21,UIARLYUEJFELEN-DMVVYWCZSA-N,439.471,P36888,BE0000147,Receptor-type tyrosine-protein kinase FLT3,Humans,modulator,yes
DB06470,Clomethiazole,small molecule,investigational,CC1=C(CCCl)SC=N1,PCLITLDOTJTVDJ-UHFFFAOYSA-N,161.65,Q99928,BE0003594,Gamma-aminobutyric acid receptor subunit gamma-3,Humans,modulator,yes
DB06472,Fradafiban,small molecule,investigational,NC(=N)C1=CC=C(C=C1)C1=CC=C(OC[C@@H]2C[C@@H](CC(O)=O)C(=O)N2)C=C1,IKZACQMAVUIGPY-HOTGVXAUSA-N,367.405,P08514,BE0000439,Integrin alpha-IIb,Humans,modulator,yes
DB06472,Fradafiban,small molecule,investigational,NC(=N)C1=CC=C(C=C1)C1=CC=C(OC[C@@H]2C[C@@H](CC(O)=O)C(=O)N2)C=C1,IKZACQMAVUIGPY-HOTGVXAUSA-N,367.405,P05106,BE0001155,Integrin beta-3,Humans,modulator,yes
DB06477,Sumanirole,small molecule,investigational,CN[C@H]1CN2C(=O)NC3=CC=CC(C1)=C23,RKZSNTNMEFVBDT-MRVPVSSYSA-N,203.245,P14416,BE0000756,D(2) dopamine receptor,Humans,agonist,yes
DB06480,Prucalopride,small molecule,approved,COCCCN1CCC(CC1)NC(=O)C1=C2OCCC2=C(N)C(Cl)=C1,ZPMNHBXQOOVQJL-UHFFFAOYSA-N,367.87,Q13639,BE0000084,5-hydroxytryptamine receptor 4,Humans,agonist,yes
DB06484,FK352B,small molecule,investigational,OC(=O)C[C@H]1CCCCN1C(=O)\C=C\C1=C2C=CC=CN2N=C1C1=CC=CC=C1,UWTYIJJJSYDUQM-QFQMRYFISA-N,389.455,P30542,BE0000013,Adenosine receptor A1,Humans,antagonist,yes
DB06486,Enzastaurin,small molecule,investigational,CN1C=C(C2=CC=CC=C12)C1=C(C(=O)NC1=O)C1=CN(C2CCN(CC3=CC=CC=N3)CC2)C2=CC=CC=C12,AXRCEOKUDYDWLF-UHFFFAOYSA-N,515.617,P05771,BE0000872,Protein kinase C beta type,Humans,modulator,yes
DB06486,Enzastaurin,small molecule,investigational,CN1C=C(C2=CC=CC=C12)C1=C(C(=O)NC1=O)C1=CN(C2CCN(CC3=CC=CC=N3)CC2)C2=CC=CC=C12,AXRCEOKUDYDWLF-UHFFFAOYSA-N,515.617,P48736,BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",Humans,inhibitor,yes
DB06486,Enzastaurin,small molecule,investigational,CN1C=C(C2=CC=CC=C12)C1=C(C(=O)NC1=O)C1=CN(C2CCN(CC3=CC=CC=N3)CC2)C2=CC=CC=C12,AXRCEOKUDYDWLF-UHFFFAOYSA-N,515.617,P31749,BE0000428,RAC-alpha serine/threonine-protein kinase,Humans,inhibitor,yes
DB06494,Sufugolix,small molecule,investigational,CONC(=O)NC1=CC=C(C=C1)C1=C(CN(C)CC2=CC=CC=C2)C2=C(S1)N(CC1=C(F)C=CC=C1F)C(=O)N(C2=O)C1=CC=CC=C1,UCQSBGOFELXYIN-UHFFFAOYSA-N,667.73,P30968,BE0000203,Gonadotropin-releasing hormone receptor,Humans,inhibitor,yes
DB06499,Furaprofen,small molecule,investigational,CC(C(O)=O)C1=CC=CC2=C1OC=C2C1=CC=CC=C1,ODZUWQAFWMLWCF-UHFFFAOYSA-N,266.296,P26664,BE0003427,Genome polyprotein,,modulator,yes
DB06504,S-8510,small molecule,investigational,C1CC2=C(CO1)C1=C(NC(=N1)C1=NOC=C1)C=N2,ITPFSYAYHHPKRT-UHFFFAOYSA-N,242.238,P30536,BE0000736,Translocator protein,Humans,agonist,yes
DB06506,Repinotan,small molecule,investigational,O=C1N(CCCCNC[C@H]2CCC3=CC=CC=C3O2)S(=O)(=O)C2=CC=CC=C12,YGYBFMRFXNDIPO-QGZVFWFLSA-N,400.49,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,antagonist,yes
DB06508,GW-559090,small molecule,investigational,CC(C)C[C@H](NC(=O)COC1=CC=CC=C1C)C(=O)N[C@@H](CC1=CC=C(OC(=O)N2CCC(CC2)C(N)=O)C=C1)C(O)=O,RZMCXMNNXGCFQG-DQEYMECFSA-N,596.681,P08648,BE0008988,Integrin alpha-5,Humans,antagonist,yes
DB06510,Muraglitazar,small molecule,investigational,COC1=CC=C(OC(=O)N(CC(O)=O)CC2=CC=C(OCCC3=C(C)OC(=N3)C3=CC=CC=C3)C=C2)C=C1,IRLWJILLXJGJTD-UHFFFAOYSA-N,516.55,P37231,BE0000215,Peroxisome proliferator-activated receptor gamma,Humans,modulator,yes
DB06510,Muraglitazar,small molecule,investigational,COC1=CC=C(OC(=O)N(CC(O)=O)CC2=CC=C(OCCC3=C(C)OC(=N3)C3=CC=CC=C3)C=C2)C=C1,IRLWJILLXJGJTD-UHFFFAOYSA-N,516.55,Q07869,BE0000071,Peroxisome proliferator-activated receptor alpha,Humans,modulator,yes
DB06515,Resiniferatoxin,small molecule,investigational,[H][C@]12O[C@]3(CC4=CC=CC=C4)O[C@]1(C[C@@]([H])(C)[C@]1(O3)[C@]3([H])C=C(C)C(=O)[C@@]3(O)CC(COC(=O)CC3=CC(OC)=C(O)C=C3)=C[C@@]21[H])C(C)=C,DSDNAKHZNJAGHN-MXTYGGKSSA-N,628.718,Q8NER1,BE0001023,Transient receptor potential cation channel subfamily V member 1,Humans,activator,yes
DB06518,R-1487,small molecule,investigational,CN1C(=O)C(OC2=CC=C(F)C=C2F)=CC2=C1N=C(NC1CCOCC1)N=C2,KKKRKRMVJRHDMG-UHFFFAOYSA-N,388.368,Q16539,BE0001019,Mitogen-activated protein kinase 14,Humans,inhibitor,yes
DB06519,Edaglitazone,small molecule,investigational,CC1=C(CCOC2=C3C=CSC3=C(CC3SC(=O)NC3=O)C=C2)N=C(O1)C1=CC=CC=C1,HAAXAFNSRADSMK-UHFFFAOYSA-N,464.55,P37231,BE0000215,Peroxisome proliferator-activated receptor gamma,Humans,modulator,yes
DB06521,Ertiprotafib,small molecule,investigational,CC1=C(C)C2=C(C3=CC(C)=C(O[C@H](CC4=CC=CC=C4)C(O)=O)C(C)=C3)C3=CC=CC=C3C(Br)=C2S1,FONCZICQWCUXEB-RUZDIDTESA-N,559.52,P18031,BE0000623,Tyrosine-protein phosphatase non-receptor type 1,Humans,inhibitor,yes
DB06525,Ganstigmine,small molecule,investigational,CCC1=C(NC(=O)OC2=CC3=C(C=C2)N(C)[C@H]2ON(C)CC[C@@]32C)C=CC=C1,ZOBDWFRKFSPCRB-UNMCSNQZSA-N,381.476,P22303,BE0000426,Acetylcholinesterase,Humans,inhibitor,yes
DB06527,Tramiprosate,small molecule,investigational,NCCCS(O)(=O)=O,SNKZJIOFVMKAOJ-UHFFFAOYSA-N,139.173,P05067,BE0003392,Amyloid-beta precursor protein,Humans,antagonist,yes
DB06529,Ocinaplon,small molecule,investigational,O=C(C1=C2N=CC=C(N2N=C1)C1=CC=NC=C1)C1=CC=CC=N1,OQJFBUOFGHPMSR-UHFFFAOYSA-N,301.309,Q99928,BE0003594,Gamma-aminobutyric acid receptor subunit gamma-3,Humans,modulator,yes
DB06530,Resiquimod,small molecule,investigational,CCOCC1=NC2=C(N)N=C3C=CC=CC3=C2N1CC(C)(C)O,BXNMTOQRYBFHNZ-UHFFFAOYSA-N,314.3822,Q9NYK1,BE0000155,Toll-like receptor 7,Humans,modulator,yes
DB06530,Resiquimod,small molecule,investigational,CCOCC1=NC2=C(N)N=C3C=CC=CC3=C2N1CC(C)(C)O,BXNMTOQRYBFHNZ-UHFFFAOYSA-N,314.3822,Q9NR97,BE0003518,Toll-like receptor 8,Humans,modulator,yes
DB06536,Tesaglitazar,small molecule,investigational,CCO[C@@H](CC1=CC=C(OCCC2=CC=C(OS(C)(=O)=O)C=C2)C=C1)C(O)=O,CXGTZJYQWSUFET-IBGZPJMESA-N,408.465,P37231,BE0000215,Peroxisome proliferator-activated receptor gamma,Humans,modulator,yes
DB06536,Tesaglitazar,small molecule,investigational,CCO[C@@H](CC1=CC=C(OCCC2=CC=C(OS(C)(=O)=O)C=C2)C=C1)C(O)=O,CXGTZJYQWSUFET-IBGZPJMESA-N,408.465,Q07869,BE0000071,Peroxisome proliferator-activated receptor alpha,Humans,modulator,yes
DB06538,Robalzotan,small molecule,investigational,NC(=O)C1=C2C[C@H](COC2=C(F)C=C1)N(C1CCC1)C1CCC1,MQTUXRKNJYPMCG-CYBMUJFWSA-N,318.392,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,antagonist,yes
DB06548,Minodronic acid,small molecule,investigational,OC(CC1=CN=C2C=CC=CN12)(P(O)(O)=O)P(O)(O)=O,VMMKGHQPQIEGSQ-UHFFFAOYSA-N,322.1483,P14324,BE0000776,Farnesyl pyrophosphate synthase,Humans,inhibitor,yes
DB06548,Minodronic acid,small molecule,investigational,OC(CC1=CN=C2C=CC=CN12)(P(O)(O)=O)P(O)(O)=O,VMMKGHQPQIEGSQ-UHFFFAOYSA-N,322.1483,O95749,BE0003570,Geranylgeranyl pyrophosphate synthase,Humans,inhibitor,yes
DB06549,Labradimil,small molecule,investigational,COC1=CC=C(C[C@@H](CN[C@@H](CCCN=C(N)N)C(O)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CO)NC(=O)[C@H](CC2=CC=CS2)NC(=O)CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H]2CCCN2C(=O)[C@@H](N)CCCN=C(N)N)C=C1,IDXCXSCCZNCXCL-XMADEQCMSA-N,1098.29,P30411,BE0003513,B2 bradykinin receptor,Humans,agonist,yes
DB06554,Gaboxadol,small molecule,investigational,O=C1NOC2=C1CCNC2,ZXRVKCBLGJOCEE-UHFFFAOYSA-N,140.1399,O14764,BE0003599,Gamma-aminobutyric acid receptor subunit delta,Humans,modulator,yes
DB06555,Siramesine,small molecule,investigational,FC1=CC=C(C=C1)N1C=C(CCCCN2CCC3(CC2)OCC2=CC=CC=C32)C2=CC=CC=C12,XWAONOGAGZNUSF-UHFFFAOYSA-N,454.589,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,inhibitor,yes
DB06555,Siramesine,small molecule,investigational,FC1=CC=C(C=C1)N1C=C(CCCCN2CCC3(CC2)OCC2=CC=CC=C32)C2=CC=CC=C12,XWAONOGAGZNUSF-UHFFFAOYSA-N,454.589,P25100,BE0000715,Alpha-1D adrenergic receptor,Humans,inhibitor,yes
DB06555,Siramesine,small molecule,investigational,FC1=CC=C(C=C1)N1C=C(CCCCN2CCC3(CC2)OCC2=CC=CC=C32)C2=CC=CC=C12,XWAONOGAGZNUSF-UHFFFAOYSA-N,454.589,P35368,BE0000575,Alpha-1B adrenergic receptor,Humans,inhibitor,yes
DB06578,Tonabersat,small molecule,investigational,CC(=O)C1=CC=C2OC(C)(C)[C@@H](O)[C@@H](NC(=O)C3=CC=C(F)C(Cl)=C3)C2=C1,XLIIRNOPGJTBJD-ROUUACIJSA-N,391.82,P28221,BE0000659,5-hydroxytryptamine receptor 1D,Humans,agonist,yes
DB06579,Adipiplon,small molecule,investigational,CCCC1=C(CN2C=CN=C2C2=C(F)C=CC=N2)N=CN2N=C(C)N=C12,UAMAIHOEGLEXSV-UHFFFAOYSA-N,351.389,P14867,BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,Humans,partial agonist,yes
DB06579,Adipiplon,small molecule,investigational,CCCC1=C(CN2C=CN=C2C2=C(F)C=CC=N2)N=CN2N=C(C)N=C12,UAMAIHOEGLEXSV-UHFFFAOYSA-N,351.389,P34903,BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,Humans,modulator,yes
DB06580,Celgosivir,small molecule,investigational,CCCC(=O)O[C@H]1CN2CC[C@H](O)[C@@H]2[C@@H](O)[C@@H]1O,HTJGLYIJVSDQAE-VWNXEWBOSA-N,259.302,O43451,BE0000837,Maltase-glucoamylase,Humans,modulator,yes
DB06582,Dextofisopam,small molecule,investigational,CC[C@@H]1C2=CC(OC)=C(OC)C=C2C(=NN=C1C)C1=CC=C(OC)C(OC)=C1,RUJBDQSFYCKFAA-HNNXBMFYSA-N,382.46,P30536,BE0000736,Translocator protein,Humans,agonist,yes
DB06586,Cetilistat,small molecule,investigational,CCCCCCCCCCCCCCCCOC1=NC2=C(C=C(C)C=C2)C(=O)O1,MVCQKIKWYUURMU-UHFFFAOYSA-N,401.5821,Q9Y5X9,BE0021370,Endothelial lipase,Humans,modulator,yes
DB06586,Cetilistat,small molecule,investigational,CCCCCCCCCCCCCCCCOC1=NC2=C(C=C(C)C=C2)C(=O)O1,MVCQKIKWYUURMU-UHFFFAOYSA-N,401.5821,P07098,BE0003620,Gastric triacylglycerol lipase,Humans,modulator,yes
DB06587,Mitemcinal,small molecule,investigational,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C(C)C)[C@@]2(C)CC(C)=C(O2)[C@H](C)C(=O)[C@]1(C)OC,BELMMAAWNYFCGF-PZXAHSFZSA-N,755.987,O43193,BE0003521,Motilin receptor,Humans,agonist,yes
DB06589,Pazopanib,small molecule,approved,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=CC=NC(NC2=CC=C(C)C(=C2)S(N)(=O)=O)=N1,CUIHSIWYWATEQL-UHFFFAOYSA-N,437.518,P17948,BE0000029,Vascular endothelial growth factor receptor 1,Humans,inhibitor,yes
DB06589,Pazopanib,small molecule,approved,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=CC=NC(NC2=CC=C(C)C(=C2)S(N)(=O)=O)=N1,CUIHSIWYWATEQL-UHFFFAOYSA-N,437.518,P35968,BE0000369,Vascular endothelial growth factor receptor 2,Humans,inhibitor,yes
DB06589,Pazopanib,small molecule,approved,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=CC=NC(NC2=CC=C(C)C(=C2)S(N)(=O)=O)=N1,CUIHSIWYWATEQL-UHFFFAOYSA-N,437.518,P35916,BE0000023,Vascular endothelial growth factor receptor 3,Humans,inhibitor,yes
DB06589,Pazopanib,small molecule,approved,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=CC=NC(NC2=CC=C(C)C(=C2)S(N)(=O)=O)=N1,CUIHSIWYWATEQL-UHFFFAOYSA-N,437.518,P16234,BE0000852,Platelet-derived growth factor receptor alpha,Humans,inhibitor,yes
DB06589,Pazopanib,small molecule,approved,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=CC=NC(NC2=CC=C(C)C(=C2)S(N)(=O)=O)=N1,CUIHSIWYWATEQL-UHFFFAOYSA-N,437.518,P09619,BE0000205,Platelet-derived growth factor receptor beta,Humans,inhibitor,yes
DB06589,Pazopanib,small molecule,approved,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=CC=NC(NC2=CC=C(C)C(=C2)S(N)(=O)=O)=N1,CUIHSIWYWATEQL-UHFFFAOYSA-N,437.518,P10721,BE0000453,Mast/stem cell growth factor receptor Kit,Humans,inhibitor,yes
DB06590,Ceftaroline fosamil,small molecule,approved;investigational,[H][C@]12SCC(SC3=NC(=CS3)C3=CC=[N+](C)C=C3)=C(N1C(=O)[C@H]2NC(=O)C(=N/OCC)\C1=NSC(NP(O)(O)=O)=N1)C([O-])=O,ZCCUWMICIWSJIX-NQJJCJBVSA-N,684.67,P0AEB2,BE0004840,Penicillin-binding protein,Gram positive and gram negative bacteria,inhibitor,yes
DB06594,Agomelatine,small molecule,approved;investigational,COC1=CC2=C(CCNC(C)=O)C=CC=C2C=C1,YJYPHIXNFHFHND-UHFFFAOYSA-N,243.301,P28335,BE0000533,5-hydroxytryptamine receptor 2C,Humans,antagonist,yes
DB06594,Agomelatine,small molecule,approved;investigational,COC1=CC2=C(CCNC(C)=O)C=CC=C2C=C1,YJYPHIXNFHFHND-UHFFFAOYSA-N,243.301,P48039,BE0000515,Melatonin receptor type 1A,Humans,agonist,yes
DB06594,Agomelatine,small molecule,approved;investigational,COC1=CC2=C(CCNC(C)=O)C=CC=C2C=C1,YJYPHIXNFHFHND-UHFFFAOYSA-N,243.301,P49286,BE0000327,Melatonin receptor type 1B,Humans,agonist,yes
DB06595,Midostaurin,small molecule,approved;investigational,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O)N(C)C(=O)C1=CC=CC=C1,BMGQWWVMWDBQGC-IIFHNQTCSA-N,570.649,P05129,BE0009588,Protein kinase C gamma type,Humans,inhibitor,yes
DB06595,Midostaurin,small molecule,approved;investigational,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O)N(C)C(=O)C1=CC=CC=C1,BMGQWWVMWDBQGC-IIFHNQTCSA-N,570.649,P17252,BE0001132,Protein kinase C alpha type,Humans,antagonist;inhibitor,yes
DB06595,Midostaurin,small molecule,approved;investigational,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O)N(C)C(=O)C1=CC=CC=C1,BMGQWWVMWDBQGC-IIFHNQTCSA-N,570.649,P35968,BE0000369,Vascular endothelial growth factor receptor 2,Humans,antagonist;inhibitor,yes
DB06595,Midostaurin,small molecule,approved;investigational,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O)N(C)C(=O)C1=CC=CC=C1,BMGQWWVMWDBQGC-IIFHNQTCSA-N,570.649,P16234,BE0000852,Platelet-derived growth factor receptor alpha,Humans,antagonist;inhibitor,yes
DB06595,Midostaurin,small molecule,approved;investigational,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O)N(C)C(=O)C1=CC=CC=C1,BMGQWWVMWDBQGC-IIFHNQTCSA-N,570.649,P09619,BE0000205,Platelet-derived growth factor receptor beta,Humans,antagonist;inhibitor,yes
DB06595,Midostaurin,small molecule,approved;investigational,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O)N(C)C(=O)C1=CC=CC=C1,BMGQWWVMWDBQGC-IIFHNQTCSA-N,570.649,P36888,BE0000147,Receptor-type tyrosine-protein kinase FLT3,Humans,antagonist;inhibitor,yes
DB06597,Estradiol sulfamate,small molecule,investigational,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(OS(N)(=O)=O)C=C3CC[C@@]21[H],YXYXCSOJKUAPJI-ZBRFXRBCSA-N,351.46,P08842,BE0001197,Steryl-sulfatase,Humans,inhibitor,yes
DB06600,Nemonoxacin,small molecule,investigational,COC1=C2N(C=C(C(O)=O)C(=O)C2=CC=C1N1C[C@@H](C)C[C@H](N)C1)C1CC1,AVPQPGFLVZTJOR-RYUDHWBXSA-N,371.437,P20831,BE0008385,DNA gyrase subunit A,Staphylococcus aureus,inhibitor,yes
DB06600,Nemonoxacin,small molecule,investigational,COC1=C2N(C=C(C(O)=O)C(=O)C2=CC=C1N1C[C@@H](C)C[C@H](N)C1)C1CC1,AVPQPGFLVZTJOR-RYUDHWBXSA-N,371.437,P0A0K8,BE0002388,DNA gyrase subunit B,Staphylococcus aureus,inhibitor,yes
DB06603,Panobinostat,small molecule,approved;investigational,CC1=C(CCNCC2=CC=C(\C=C\C(=O)NO)C=C2)C2=CC=CC=C2N1,FPOHNWQLNRZRFC-ZHACJKMWSA-N,349.434,Q13547,BE0002365,Histone deacetylase 1,Humans,inhibitor,yes
DB06603,Panobinostat,small molecule,approved;investigational,CC1=C(CCNCC2=CC=C(\C=C\C(=O)NO)C=C2)C2=CC=CC=C2N1,FPOHNWQLNRZRFC-ZHACJKMWSA-N,349.434,Q13547,BE0008667,Histone deacetylase,Humans,inhibitor,yes
DB06604,Ilepatril,small molecule,investigational,[H][C@]12CCC[C@H](N1C(=O)[C@H](CC1=C2C=CC=C1)NC(=O)[C@@H](SC(C)=O)C(C)C)C(O)=O,FXKFFTMLFPWYFH-RDGPPVDQSA-N,432.533,P08473,BE0000266,Neprilysin,Humans,modulator,yes
DB06604,Ilepatril,small molecule,investigational,[H][C@]12CCC[C@H](N1C(=O)[C@H](CC1=C2C=CC=C1)NC(=O)[C@@H](SC(C)=O)C(C)C)C(O)=O,FXKFFTMLFPWYFH-RDGPPVDQSA-N,432.533,P12821,BE0000221,Angiotensin-converting enzyme,Humans,modulator,yes
DB06605,Apixaban,small molecule,approved,COC1=CC=C(C=C1)N1N=C(C(N)=O)C2=C1C(=O)N(CC2)C1=CC=C(C=C1)N1CCCCC1=O,QNZCBYKSOIHPEH-UHFFFAOYSA-N,459.4971,P00742,BE0000216,Coagulation factor X,Humans,inhibitor,yes
DB06609,Odiparcil,small molecule,investigational,[H][C@@]1(O)CS[C@@]([H])(OC2=CC3=C(C=C2)C(C)=CC(=O)O3)[C@]([H])(O)[C@@]1([H])O,JRHNIQQUVJOPQC-AQNFWKISSA-N,324.35,P00734,BE0000048,Prothrombin,Humans,inhibitor,yes
DB06614,Peramivir,small molecule,approved;investigational,[H][C@@]1([C@@H](NC(C)=O)C(CC)CC)[C@H](O)[C@H](C[C@H]1NC(N)=N)C(O)=O,XRQDFNLINLXZLB-CKIKVBCHSA-N,328.4072,P03472,BE0001667,Neuraminidase,Influenza A virus (strain A/Tern/Australia/G70C/1975 H11N9),inhibitor,yes
DB06614,Peramivir,small molecule,approved;investigational,[H][C@@]1([C@@H](NC(C)=O)C(CC)CC)[C@H](O)[C@H](C[C@H]1NC(N)=N)C(O)=O,XRQDFNLINLXZLB-CKIKVBCHSA-N,328.4072,P06818,BE0000057,Neuraminidase,Influenza A virus (strain A/Bangkok/1/1979 H3N2),inhibitor,yes
DB06614,Peramivir,small molecule,approved;investigational,[H][C@@]1([C@@H](NC(C)=O)C(CC)CC)[C@H](O)[C@H](C[C@H]1NC(N)=N)C(O)=O,XRQDFNLINLXZLB-CKIKVBCHSA-N,328.4072,P27907,BE0003527,Neuraminidase,Influenza B virus (strain B/Beijing/1/1987),inhibitor,yes
DB06616,Bosutinib,small molecule,approved,COC1=CC(NC2=C(C=NC3=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23)C#N)=C(Cl)C=C1Cl,UBPYILGKFZZVDX-UHFFFAOYSA-N,530.446,P00519,BE0000014,Tyrosine-protein kinase ABL1,Humans,inhibitor,yes
DB06616,Bosutinib,small molecule,approved,COC1=CC(NC2=C(C=NC3=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23)C#N)=C(Cl)C=C1Cl,UBPYILGKFZZVDX-UHFFFAOYSA-N,530.446,P07948,BE0004315,Tyrosine-protein kinase Lyn,Humans,inhibitor,yes
DB06616,Bosutinib,small molecule,approved,COC1=CC(NC2=C(C=NC3=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23)C#N)=C(Cl)C=C1Cl,UBPYILGKFZZVDX-UHFFFAOYSA-N,530.446,P12931,BE0000838,Proto-oncogene tyrosine-protein kinase Src,Humans,inhibitor,yes
DB06616,Bosutinib,small molecule,approved,COC1=CC(NC2=C(C=NC3=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23)C#N)=C(Cl)C=C1Cl,UBPYILGKFZZVDX-UHFFFAOYSA-N,530.446,Q02750,BE0000870,Dual specificity mitogen-activated protein kinase kinase 1,Humans,inhibitor,yes
DB06616,Bosutinib,small molecule,approved,COC1=CC(NC2=C(C=NC3=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23)C#N)=C(Cl)C=C1Cl,UBPYILGKFZZVDX-UHFFFAOYSA-N,530.446,P36507,BE0004744,Dual specificity mitogen-activated protein kinase kinase 2,Humans,inhibitor,yes
DB06616,Bosutinib,small molecule,approved,COC1=CC(NC2=C(C=NC3=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23)C#N)=C(Cl)C=C1Cl,UBPYILGKFZZVDX-UHFFFAOYSA-N,530.446,Q9Y2U5,BE0004745,Mitogen-activated protein kinase kinase kinase 2,Humans,inhibitor,yes
DB06616,Bosutinib,small molecule,approved,COC1=CC(NC2=C(C=NC3=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23)C#N)=C(Cl)C=C1Cl,UBPYILGKFZZVDX-UHFFFAOYSA-N,530.446,Q13555,BE0004384,Calcium/calmodulin-dependent protein kinase type II subunit gamma,Humans,inhibitor,yes
DB06616,Bosutinib,small molecule,approved,COC1=CC(NC2=C(C=NC3=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23)C#N)=C(Cl)C=C1Cl,UBPYILGKFZZVDX-UHFFFAOYSA-N,530.446,P09769,BE0005539,Tyrosine-protein kinase Fgr,Humans,inhibitor,yes
DB06616,Bosutinib,small molecule,approved,COC1=CC(NC2=C(C=NC3=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23)C#N)=C(Cl)C=C1Cl,UBPYILGKFZZVDX-UHFFFAOYSA-N,530.446,P08631,BE0001424,Tyrosine-protein kinase HCK,Humans,inhibitor,yes
DB06616,Bosutinib,small molecule,approved,COC1=CC(NC2=C(C=NC3=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23)C#N)=C(Cl)C=C1Cl,UBPYILGKFZZVDX-UHFFFAOYSA-N,530.446,P42680,BE0009385,Tyrosine-protein kinase Tec,Humans,inhibitor,yes
DB06616,Bosutinib,small molecule,approved,COC1=CC(NC2=C(C=NC3=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23)C#N)=C(Cl)C=C1Cl,UBPYILGKFZZVDX-UHFFFAOYSA-N,530.446,Q9H2G2,BE0004041,STE20-like serine/threonine-protein kinase,Humans,inhibitor,yes
DB06618,Cutamesine,small molecule,investigational,COC1=C(OC)C=C(CCN2CCN(CCCC3=CC=CC=C3)CC2)C=C1,UVSWWUWQVAQPJR-UHFFFAOYSA-N,368.521,Q99720,BE0000156,Sigma non-opioid intracellular receptor 1,Humans,agonist,yes
DB06619,Amdoxovir,small molecule,investigational,NC1=NC(N)=C2N=CN([C@H]3CO[C@@H](CO)O3)C2=N1,RLAHNGKRJJEIJL-RFZPGFLSSA-N,252.234,P03366,BE0002050,Gag-Pol polyprotein,,modulator,yes
DB06620,Aplindore,small molecule,investigational,O=C1CC2=C3O[C@@H](CNCC4=CC=CC=C4)COC3=CC=C2N1,DYJIKHYBKVODAC-ZDUSSCGKSA-N,310.353,P14416,BE0000756,D(2) dopamine receptor,Humans,agonist,yes
DB06622,7-beta-Hydroxyepiandrosterone,small molecule,investigational,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@H](O)C[C@@]2([H])C[C@@H](O)CC[C@]12C,VFPMCLQMAUVEHD-UCPSWNCLSA-N,306.446,O60760,BE0001167,Hematopoietic prostaglandin D synthase,Humans,stimulator,yes
DB06624,Taranabant,small molecule,investigational,C[C@H](NC(=O)C(C)(C)OC1=CC=C(C=N1)C(F)(F)F)[C@@H](CC1=CC=C(Cl)C=C1)C1=CC=CC(=C1)C#N,QLYKJCMUNUWAGO-GAJHUEQPSA-N,515.96,P21554,BE0000061,Cannabinoid receptor 1,Humans,antagonist,yes
DB06625,Vipadenant,small molecule,investigational,CC1=CC(CN2N=NC3=C(N=C(N)N=C23)C2=CC=CO2)=CC=C1N,HQSBCDPYXDGTCL-UHFFFAOYSA-N,321.344,P29274,BE0000924,Adenosine receptor A2a,Humans,antagonist,yes
DB06626,Axitinib,small molecule,approved;investigational,CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1,RITAVMQDGBJQJZ-FMIVXFBMSA-N,386.47,P00519,BE0000014,Tyrosine-protein kinase ABL1,Humans,inhibitor,yes
DB06626,Axitinib,small molecule,approved;investigational,CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1,RITAVMQDGBJQJZ-FMIVXFBMSA-N,386.47,P17948,BE0000029,Vascular endothelial growth factor receptor 1,Humans,inhibitor,yes
DB06626,Axitinib,small molecule,approved;investigational,CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1,RITAVMQDGBJQJZ-FMIVXFBMSA-N,386.47,P35968,BE0000369,Vascular endothelial growth factor receptor 2,Humans,inhibitor,yes
DB06626,Axitinib,small molecule,approved;investigational,CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1,RITAVMQDGBJQJZ-FMIVXFBMSA-N,386.47,P35916,BE0000023,Vascular endothelial growth factor receptor 3,Humans,inhibitor,yes
DB06629,Zibotentan,small molecule,investigational,COC1=NC(C)=CN=C1NS(=O)(=O)C1=CC=CN=C1C1=CC=C(C=C1)C1=NN=CO1,FJHHZXWJVIEFGJ-UHFFFAOYSA-N,424.44,P25101,BE0000521,Endothelin-1 receptor,Humans,antagonist,yes
DB06630,Anacetrapib,small molecule,investigational,COC1=CC(F)=C(C=C1C1=CC=C(C=C1CN1[C@@H](C)[C@H](OC1=O)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)C(F)(F)F)C(C)C,MZZLGJHLQGUVPN-HAWMADMCSA-N,637.518,P11597,BE0003516,Cholesteryl ester transfer protein,Humans,inhibitor,yes
DB06634,Casopitant,small molecule,investigational,C[C@@H](N(C)C(=O)N1CC[C@@H](C[C@@H]1C1=CC=C(F)C=C1C)N1CCN(CC1)C(C)=O)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F,XGGTZCKQRWXCHW-WMTVXVAQSA-N,616.625,P25103,BE0000384,Substance-P receptor,Humans,antagonist,yes
DB06635,Otamixaban,small molecule,investigational,COC(=O)[C@H](CC1=CC(=CC=C1)C(N)=N)[C@@H](C)NC(=O)C1=CC=C(C=C1)C1=CC=[N+]([O-])C=C1,PFGVNLZDWRZPJW-OPAMFIHVSA-N,446.4983,P00742,BE0000216,Coagulation factor X,Humans,inhibitor,yes
DB06636,Isavuconazonium,small molecule,approved;investigational,[H]C(C)(OC(=O)N(C)C1=C(COC(=O)CNC)C=CC=N1)[N+]1=CN(C[C@](O)(C2=C(F)C=CC(F)=C2)[C@@]([H])(C)C2=NC(=CS2)C2=CC=C(C=C2)C#N)N=C1,RSWOJTICKMKTER-QXLBVTBOSA-N,717.77,P50859,BE0000690,Lanosterol 14-alpha demethylase,,inhibitor,yes
DB06638,Quarfloxin,small molecule,investigational,CN1CCC[C@H]1CCNC(=O)C1=CN2C3=C(OC4=C2C(=CC(F)=C4N2CCC(C2)C2=CN=CC=N2)C1=O)C=C1C=CC=CC1=C3,WOQIDNWTQOYDLF-CGAIIQECSA-N,604.686,P19338,BE0012796,Nucleolin,Humans,inhibitor,yes
DB06641,Perifosine,small molecule,investigational,CCCCCCCCCCCCCCCCCCOP([O-])(=O)OC1CC[N+](C)(C)CC1,SZFPYBIJACMNJV-UHFFFAOYSA-N,461.668,P48736,BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",Humans,modulator,yes
DB06645,Anamorelin,small molecule,investigational,CN(C)N(C)C(=O)[C@@]1(CC2=CC=CC=C2)CCCN(C1)C(=O)[C@@H](CC1=CNC2=CC=CC=C12)NC(=O)C(C)(C)N,VQPFSIRUEPQQPP-MXBOTTGLSA-N,546.716,Q92847,BE0003383,Growth hormone secretagogue receptor type 1,Humans,stimulator,yes
DB06645,Anamorelin,small molecule,investigational,CN(C)N(C)C(=O)[C@@]1(CC2=CC=CC=C2)CCCN(C1)C(=O)[C@@H](CC1=CNC2=CC=CC=C12)NC(=O)C(C)(C)N,VQPFSIRUEPQQPP-MXBOTTGLSA-N,546.716,P10253,BE0000876,Lysosomal alpha-glucosidase,Humans,modulator,yes
DB06645,Anamorelin,small molecule,investigational,CN(C)N(C)C(=O)[C@@]1(CC2=CC=CC=C2)CCCN(C1)C(=O)[C@@H](CC1=CNC2=CC=CC=C12)NC(=O)C(C)(C)N,VQPFSIRUEPQQPP-MXBOTTGLSA-N,546.716,Q14697,BE0004698,Neutral alpha-glucosidase AB,Humans,modulator,yes
DB06645,Anamorelin,small molecule,investigational,CN(C)N(C)C(=O)[C@@]1(CC2=CC=CC=C2)CCCN(C1)C(=O)[C@@H](CC1=CNC2=CC=CC=C12)NC(=O)C(C)(C)N,VQPFSIRUEPQQPP-MXBOTTGLSA-N,546.716,Q8TET4,BE0004699,Neutral alpha-glucosidase C,Humans,modulator,yes
DB06649,Priralfinamide,small molecule,investigational,C[C@H](NCC1=CC=C(OCC2=CC=CC=C2F)C=C1)C(N)=O,BHJIBOFHEFDSAU-LBPRGKRZSA-N,302.349,Q00975,BE0002226,Voltage-dependent N-type calcium channel subunit alpha-1B,Humans,blocker,yes
DB06651,DiaPep 277,small molecule,investigational,[H][C@](C)(O)[C@]([H])(N=C(O)[C@]([H])(CC(C)C)N=C(O)[C@]([H])(CO)N=C(O)[C@]([H])(CC(O)=O)N=C(O)[C@]([H])(CC(C)C)N=C(O)[C@]([H])(C)N=C(O)[C@]1([H])CCCN1C(=O)[C@@]([H])(N=C(O)[C@@]([H])(N=C(O)[C@]([H])(CCCNC(N)=N)N=C(O)[C@]([H])(CC(C)C)N=C(O)[C@]([H])(CC(C)C)N=C(O)[C@]([H])(C)N=C(O)[C@@]([H])(N=C(O)CN=C(O)CN=C(O)CN=C(O)[C@]([H])(CC(C)C)N=C(O)[C@@]([H])(N)C(C)C)C(C)C)C(C)C)[C@@]([H])(C)CC)C(=O)N1CCC[C@@]1([H])C(O)=N[C@@]([H])(C)C(O)=N[C@@]([H])(CC(O)=N)C(O)=N[C@@]([H])(CCC(O)=O)C(O)=N[C@@]([H])(CC(O)=O)C(O)=O,VGGRNGOEDNBLPH-YJHCMWSWSA-N,2390.768,P10809,BE0008956,"60 kDa heat shock protein, mitochondrial",Humans,modulator,yes
DB06652,Vicriviroc,small molecule,investigational,COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)C1=C(C)N=CN=C1C)C1=CC=C(C=C1)C(F)(F)F,CNPVJJQCETWNEU-CYFREDJKSA-N,533.6288,P51681,BE0000911,C-C chemokine receptor type 5,Humans,antagonist,yes
DB06654,Safinamide,small molecule,approved;investigational,C[C@H](NCC1=CC=C(OCC2=CC(F)=CC=C2)C=C1)C(N)=O,NEMGRZFTLSKBAP-LBPRGKRZSA-N,302.349,P27338,BE0002196,Amine oxidase [flavin-containing] B,Humans,antagonist,yes
DB06656,TAS-106,small molecule,investigational,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@](O)(C#C)[C@H]1O,JFIWEPHGRUDAJN-DYUFWOLASA-N,267.241,P9WGY9,BE0010989,DNA-directed RNA polymerase subunit beta,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),modulator,yes
DB06656,TAS-106,small molecule,investigational,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@](O)(C#C)[C@H]1O,JFIWEPHGRUDAJN-DYUFWOLASA-N,267.241,P9WGY7,BE0000186,DNA-directed RNA polymerase subunit beta',Mycobacterium tuberculosis,modulator,yes
DB06660,Saredutant,small molecule,investigational,CN(C[C@@H](CCN1CCC(CC1)(NC(C)=O)C1=CC=CC=C1)C1=CC=C(Cl)C(Cl)=C1)C(=O)C1=CC=CC=C1,PGKXDIMONUAMFR-AREMUKBSSA-N,552.54,P21452,BE0002222,Substance-K receptor,Humans,antagonist,yes
DB06663,Pasireotide,small molecule,approved,NCCCC[C@@H]1NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@@H](NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(OCC3=CC=CC=C3)C=C2)NC1=O)OC(=O)NCCN)C1=CC=CC=C1,VMZMNAABQBOLAK-DBILLSOUSA-N,1047.2062,P32745,BE0003529,Somatostatin receptor type 3,Humans,inhibitor,yes
DB06663,Pasireotide,small molecule,approved,NCCCC[C@@H]1NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@@H](NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(OCC3=CC=CC=C3)C=C2)NC1=O)OC(=O)NCCN)C1=CC=CC=C1,VMZMNAABQBOLAK-DBILLSOUSA-N,1047.2062,P30872,BE0000452,Somatostatin receptor type 1,Humans,inhibitor,yes
DB06663,Pasireotide,small molecule,approved,NCCCC[C@@H]1NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@@H](NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(OCC3=CC=CC=C3)C=C2)NC1=O)OC(=O)NCCN)C1=CC=CC=C1,VMZMNAABQBOLAK-DBILLSOUSA-N,1047.2062,P30874,BE0003528,Somatostatin receptor type 2,Humans,inhibitor,yes
DB06663,Pasireotide,small molecule,approved,NCCCC[C@@H]1NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@@H](NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(OCC3=CC=CC=C3)C=C2)NC1=O)OC(=O)NCCN)C1=CC=CC=C1,VMZMNAABQBOLAK-DBILLSOUSA-N,1047.2062,P35346,BE0002147,Somatostatin receptor type 5,Humans,inhibitor,yes
DB06666,Lixivaptan,small molecule,investigational,CC1=CC=C(F)C=C1C(=O)NC1=CC=C(C(=O)N2CC3=CC=CN3CC3=C2C=CC=C3)C(Cl)=C1,PPHTXRNHTVLQED-UHFFFAOYSA-N,473.93,P19113,BE0000002,Histidine decarboxylase,Humans,inhibitor,yes
DB06666,Lixivaptan,small molecule,investigational,CC1=CC=C(F)C=C1C(=O)NC1=CC=C(C(=O)N2CC3=CC=CN3CC3=C2C=CC=C3)C(Cl)=C1,PPHTXRNHTVLQED-UHFFFAOYSA-N,473.93,P30518,BE0000293,Vasopressin V2 receptor,Humans,antagonist,yes
DB06670,Odanacatib,small molecule,investigational,CC(C)(F)C[C@H](N[C@@H](C1=CC=C(C=C1)C1=CC=C(C=C1)S(C)(=O)=O)C(F)(F)F)C(=O)NC1(CC1)C#N,FWIVDMJALNEADT-SFTDATJTSA-N,525.56,P43235,BE0003417,Cathepsin K,Humans,inhibitor,yes
DB06673,Almorexant,small molecule,investigational,CNC(=O)[C@H](N1CCC2=CC(OC)=C(OC)C=C2[C@@H]1CCC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,DKMACHNQISHMDN-RPLLCQBOSA-N,512.573,O43613,BE0005864,Orexin/Hypocretin receptor type 1,Humans,antagonist,yes
DB06677,Clazosentan,small molecule,investigational,COC1=CC=CC=C1OC1=C(NS(=O)(=O)C2=CC=C(C)C=N2)N=C(N=C1OCCO)C1=CC=NC(=C1)C1=NN=NN1,LFWCJABOXHSRGC-UHFFFAOYSA-N,577.58,P25101,BE0000521,Endothelin-1 receptor,Humans,antagonist,yes
DB06680,Asoprisnil,small molecule,investigational,[H]\C(=N/O)C1=CC=C(C=C1)[C@@]1([H])C[C@@]2(C)[C@@]([H])(CC[C@]2(COC)OC)[C@]2([H])CCC3=CC(=O)CCC3=C12,GJMNAFGEUJBOCE-MEQIQULJSA-N,449.5818,P06401,BE0000557,Progesterone receptor,Humans,modulator,yes
DB06682,Naproxcinod,small molecule,investigational,COC1=CC2=CC=C(C=C2C=C1)[C@H](C)C(=O)OCCCCO[N+]([O-])=O,AKFJWRDCWYYTIG-ZDUSSCGKSA-N,347.367,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,modulator,yes
DB06682,Naproxcinod,small molecule,investigational,COC1=CC2=CC=C(C=C2C=C1)[C@H](C)C(=O)OCCCCO[N+]([O-])=O,AKFJWRDCWYYTIG-ZDUSSCGKSA-N,347.367,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,modulator,yes
DB06684,Vilazodone,small molecule,approved,NC(=O)C1=CC2=CC(=CC=C2O1)N1CCN(CCCCC2=CNC3=C2C=C(C=C3)C#N)CC1,SGEGOXDYSFKCPT-UHFFFAOYSA-N,441.5249,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB06685,Laquinimod,small molecule,investigational,CCN(C(=O)C1=C(O)C2=C(C=CC=C2Cl)N(C)C1=O)C1=CC=CC=C1,GKWPCEFFIHSJOE-UHFFFAOYSA-N,356.81,Q01201,BE0013795,Transcription factor RelB,Humans,modulator,yes
DB06685,Laquinimod,small molecule,investigational,CCN(C(=O)C1=C(O)C2=C(C=CC=C2Cl)N(C)C1=O)C1=CC=CC=C1,GKWPCEFFIHSJOE-UHFFFAOYSA-N,356.81,P19838,BE0001086,Nuclear factor NF-kappa-B p105 subunit,Humans,modulator,yes
DB06685,Laquinimod,small molecule,investigational,CCN(C(=O)C1=C(O)C2=C(C=CC=C2Cl)N(C)C1=O)C1=CC=CC=C1,GKWPCEFFIHSJOE-UHFFFAOYSA-N,356.81,Q00653,BE0002387,Nuclear factor NF-kappa-B p100 subunit,Humans,modulator,yes
DB06685,Laquinimod,small molecule,investigational,CCN(C(=O)C1=C(O)C2=C(C=CC=C2Cl)N(C)C1=O)C1=CC=CC=C1,GKWPCEFFIHSJOE-UHFFFAOYSA-N,356.81,Q04206,BE0005551,Transcription factor p65,Humans,modulator,yes
DB06685,Laquinimod,small molecule,investigational,CCN(C(=O)C1=C(O)C2=C(C=CC=C2Cl)N(C)C1=O)C1=CC=CC=C1,GKWPCEFFIHSJOE-UHFFFAOYSA-N,356.81,Q04864,BE0010782,Proto-oncogene c-Rel,Humans,modulator,yes
DB06685,Laquinimod,small molecule,investigational,CCN(C(=O)C1=C(O)C2=C(C=CC=C2Cl)N(C)C1=O)C1=CC=CC=C1,GKWPCEFFIHSJOE-UHFFFAOYSA-N,356.81,P19875,BE0010525,C-X-C motif chemokine 2,Humans,modulator,yes
DB06689,Ethanolamine oleate,small molecule,approved,NCCO.CCCCCCCC\C=C/CCCCCCCC(O)=O,KGWDUNBJIMUFAP-KVVVOXFISA-N,343.5444,,BE0004817,Calcium ions,Humans,chelator,yes
DB06689,Ethanolamine oleate,small molecule,approved,NCCO.CCCCCCCC\C=C/CCCCCCCC(O)=O,KGWDUNBJIMUFAP-KVVVOXFISA-N,343.5444,P00748,BE0004672,Coagulation factor XII,Humans,activator,yes
DB06691,Mepyramine,small molecule,approved;vet_approved,COC1=CC=C(CN(CCN(C)C)C2=NC=CC=C2)C=C1,YECBIJXISLIIDS-UHFFFAOYSA-N,285.384,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB06693,Mevastatin,small molecule,experimental,[H][C@]12[C@H](CCC=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)[C@@H](C)CC,AJLFOPYRIVGYMJ-INTXDZFKSA-N,390.52,P04035,BE0000574,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Humans,inhibitor,yes
DB06694,Xylometazoline,small molecule,approved;investigational,CC1=CC(=CC(C)=C1CC1=NCCN1)C(C)(C)C,HUCJFAOMUPXHDK-UHFFFAOYSA-N,244.3752,P08913,BE0000289,Alpha-2A adrenergic receptor,Humans,agonist,yes
DB06694,Xylometazoline,small molecule,approved;investigational,CC1=CC(=CC(C)=C1CC1=NCCN1)C(C)(C)C,HUCJFAOMUPXHDK-UHFFFAOYSA-N,244.3752,P18089,BE0000572,Alpha-2B adrenergic receptor,Humans,agonist,yes
DB06694,Xylometazoline,small molecule,approved;investigational,CC1=CC(=CC(C)=C1CC1=NCCN1)C(C)(C)C,HUCJFAOMUPXHDK-UHFFFAOYSA-N,244.3752,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,agonist;partial agonist,yes
DB06695,Dabigatran etexilate,small molecule,approved,CCCCCCOC(=O)\N=C(\N)C1=CC=C(NCC2=NC3=C(C=CC(=C3)C(=O)N(CCC(=O)OCC)C3=NC=CC=C3)N2C)C=C1,KSGXQBZTULBEEQ-UHFFFAOYSA-N,627.7332,P00734,BE0000048,Prothrombin,Humans,inhibitor,yes
DB06696,Arbekacin,small molecule,experimental;investigational,NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O,MKKYBZZTJQGVCD-XTCKQBCOSA-N,552.619,P0A7S3,BE0000279,30S ribosomal protein S12,Escherichia coli (strain K12),inhibitor,yes
DB06697,Artemether,small molecule,approved,[H][C@@]12CC[C@@H](C)[C@]3([H])CC[C@@]4(C)OO[C@@]13[C@]([H])(O[C@H](OC)[C@@H]2C)O4,SXYIRMFQILZOAM-HVNFFKDJSA-N,298.3746,P05023,BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,Humans,binder,yes
DB06698,Betahistine,small molecule,approved;investigational,CNCCC1=CC=CC=N1,UUQMNUMQCIQDMZ-UHFFFAOYSA-N,136.1943,P35367,BE0000442,Histamine H1 receptor,Humans,agonist,yes
DB06698,Betahistine,small molecule,approved;investigational,CNCCC1=CC=CC=N1,UUQMNUMQCIQDMZ-UHFFFAOYSA-N,136.1943,Q9Y5N1,BE0000968,Histamine H3 receptor,Humans,antagonist,yes
DB06699,Degarelix,small molecule,approved,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC=C(NC(N)=O)C=C1)NC(=O)[C@H](CC1=CC=C(NC(=O)[C@@H]2CC(=O)NC(=O)N2)C=C1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1=CC=CN=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC=C2C=CC=CC2=C1)NC(C)=O)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,MEUCPCLKGZSHTA-XYAYPHGZSA-N,1632.29,P30968,BE0000203,Gonadotropin-releasing hormone receptor,Humans,antagonist,yes
DB06700,Desvenlafaxine,small molecule,approved;investigational,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,KYYIDSXMWOZKMP-UHFFFAOYSA-N,263.3752,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,inhibitor,yes
DB06700,Desvenlafaxine,small molecule,approved;investigational,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,KYYIDSXMWOZKMP-UHFFFAOYSA-N,263.3752,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB06701,Dexmethylphenidate,small molecule,approved;investigational,[H][C@@](C(=O)OC)(C1=CC=CC=C1)[C@@]1([H])CCCCN1,DUGOZIWVEXMGBE-CHWSQXEVSA-N,233.3062,Q01959,BE0000647,Sodium-dependent dopamine transporter,Humans,inhibitor,yes
DB06701,Dexmethylphenidate,small molecule,approved;investigational,[H][C@@](C(=O)OC)(C1=CC=CC=C1)[C@@]1([H])CCCCN1,DUGOZIWVEXMGBE-CHWSQXEVSA-N,233.3062,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,inhibitor,yes
DB06702,Fesoterodine,small molecule,approved,CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(OC(=O)C(C)C)C=CC(CO)=C1)C(C)C,DCCSDBARQIPTGU-HSZRJFAPSA-N,411.5769,P20309,BE0000045,Muscarinic acetylcholine receptor M3,Humans,antagonist,yes
DB06704,Iobenguane,small molecule,approved;investigational,NC(N)=NCC1=CC(I)=CC=C1,PDWUPXJEEYOOTR-UHFFFAOYSA-N,275.0896,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,modulator,yes
DB06705,Gadofosveset trisodium,small molecule,approved,[Na+].[Na+].[Na+].[Gd+3].[O-]C(=O)CN(CCN(CC([O-])=O)CC([O-])=O)C[C@H](COP([O-])(=O)OC1CCC(CC1)(C1=CC=CC=C1)C1=CC=CC=C1)N(CC([O-])=O)CC([O-])=O,XGOSYNSWSRUASG-SSMZTGFVSA-H,1003.85,P02768,BE0000530,Albumin,Humans,binder,yes
DB06706,Isometheptene,small molecule,approved,CNC(C)CCC=C(C)C,XVQUOJBERHHONY-UHFFFAOYSA-N,141.2539,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,agonist,yes
DB06706,Isometheptene,small molecule,approved,CNC(C)CCC=C(C)C,XVQUOJBERHHONY-UHFFFAOYSA-N,141.2539,Q05940,BE0000118,Synaptic vesicular amine transporter,Humans,inhibitor,yes
DB06707,Levonordefrin,small molecule,approved,C[C@H](N)[C@H](O)C1=CC(O)=C(O)C=C1,GEFQWZLICWMTKF-CDUCUWFYSA-N,183.2044,P25100,BE0000715,Alpha-1D adrenergic receptor,Humans,inhibitor,yes
DB06707,Levonordefrin,small molecule,approved,C[C@H](N)[C@H](O)C1=CC(O)=C(O)C=C1,GEFQWZLICWMTKF-CDUCUWFYSA-N,183.2044,P35368,BE0000575,Alpha-1B adrenergic receptor,Humans,inhibitor,yes
DB06707,Levonordefrin,small molecule,approved,C[C@H](N)[C@H](O)C1=CC(O)=C(O)C=C1,GEFQWZLICWMTKF-CDUCUWFYSA-N,183.2044,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,inhibitor,yes
DB06707,Levonordefrin,small molecule,approved,C[C@H](N)[C@H](O)C1=CC(O)=C(O)C=C1,GEFQWZLICWMTKF-CDUCUWFYSA-N,183.2044,P08913,BE0004864,Alpha-2 adrenergic receptors,Humans,agonist,yes
DB06708,Lumefantrine,small molecule,approved,CCCCN(CCCC)CC(O)C1=C2C(=CC(Cl)=C1)\C(=C/C1=CC=C(Cl)C=C1)C1=C2C=CC(Cl)=C1,DYLGFOYVTXJFJP-MYYYXRDXSA-N,528.94,P05023,BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,Humans,binder,yes
DB06709,Methacholine,small molecule,approved;investigational,CC(C[N+](C)(C)C)OC(C)=O,NZWOPGCLSHLLPA-UHFFFAOYSA-N,160.234,P20309,BE0000045,Muscarinic acetylcholine receptor M3,Humans,agonist,yes
DB06709,Methacholine,small molecule,approved;investigational,CC(C[N+](C)(C)C)OC(C)=O,NZWOPGCLSHLLPA-UHFFFAOYSA-N,160.234,P08172,BE0000560,Muscarinic acetylcholine receptor M2,Humans,agonist,yes
DB06710,Methyltestosterone,small molecule,approved,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,GCKMFJBGXUYNAG-HLXURNFRSA-N,302.451,P10275,BE0000132,Androgen receptor,Humans,agonist,yes
DB06711,Naphazoline,small molecule,approved;investigational,C(C1=NCCN1)C1=CC=CC2=CC=CC=C12,CNIIGCLFLJGOGP-UHFFFAOYSA-N,210.2744,P14416,BE0000756,D(2) dopamine receptor,Humans,agonist,yes
DB06711,Naphazoline,small molecule,approved;investigational,C(C1=NCCN1)C1=CC=CC2=CC=CC=C12,CNIIGCLFLJGOGP-UHFFFAOYSA-N,210.2744,P08913,BE0000289,Alpha-2A adrenergic receptor,Humans,agonist,yes
DB06711,Naphazoline,small molecule,approved;investigational,C(C1=NCCN1)C1=CC=CC2=CC=CC=C12,CNIIGCLFLJGOGP-UHFFFAOYSA-N,210.2744,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,agonist,yes
DB06712,Nilvadipine,small molecule,approved;investigational,COC(=O)C1=C(NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C)C#N,FAIIFDPAEUKBEP-UHFFFAOYSA-N,385.3707,Q13936,BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,Humans,inhibitor,yes
DB06712,Nilvadipine,small molecule,approved;investigational,COC(=O)C1=C(NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C)C#N,FAIIFDPAEUKBEP-UHFFFAOYSA-N,385.3707,P54289,BE0000691,Voltage-dependent calcium channel subunit alpha-2/delta-1,Humans,inhibitor,yes
DB06712,Nilvadipine,small molecule,approved;investigational,COC(=O)C1=C(NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C)C#N,FAIIFDPAEUKBEP-UHFFFAOYSA-N,385.3707,Q08289,BE0002354,Voltage-dependent L-type calcium channel subunit beta-2,Humans,inhibitor,yes
DB06712,Nilvadipine,small molecule,approved;investigational,COC(=O)C1=C(NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C)C#N,FAIIFDPAEUKBEP-UHFFFAOYSA-N,385.3707,Q01668,BE0002359,Voltage-dependent L-type calcium channel subunit alpha-1D,Humans,inhibitor,yes
DB06713,Norelgestromin,small molecule,approved;investigational,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(C=C3CC[C@@]21[H])=NO,ISHXLNHNDMZNMC-XUDSTZEESA-N,327.468,P06401,BE0000557,Progesterone receptor,Humans,agonist,yes
DB06714,Propylhexedrine,small molecule,approved,CNC(C)CC1CCCCC1,JCRIVQIOJSSCQD-UHFFFAOYSA-N,155.2804,Q05940,BE0000118,Synaptic vesicular amine transporter,Humans,antagonist,yes
DB06714,Propylhexedrine,small molecule,approved,CNC(C)CC1CCCCC1,JCRIVQIOJSSCQD-UHFFFAOYSA-N,155.2804,P18825,BE0000342,Alpha-2C adrenergic receptor,Humans,modulator,yes
DB06716,Fospropofol,small molecule,approved;illicit;investigational,CC(C)C1=CC=CC(C(C)C)=C1OCOP(O)(O)=O,QVNNONOFASOXQV-UHFFFAOYSA-N,288.2766,P47870,BE0002346,Gamma-aminobutyric acid receptor subunit beta-2,Humans,potentiator,yes
DB06716,Fospropofol,small molecule,approved;illicit;investigational,CC(C)C1=CC=CC(C(C)C)=C1OCOP(O)(O)=O,QVNNONOFASOXQV-UHFFFAOYSA-N,288.2766,P28472,BE0002345,Gamma-aminobutyric acid receptor subunit beta-3,Humans,potentiator,yes
DB06717,Fosaprepitant,small molecule,approved,C[C@@H](O[C@H]1OCCN(CC2=NC(=O)N(N2)P(O)(O)=O)[C@H]1C1=CC=C(F)C=C1)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F,BARDROPHSZEBKC-OITMNORJSA-N,614.4066,P25103,BE0000384,Substance-P receptor,Humans,antagonist,yes
DB06718,Stanozolol,small molecule,approved;vet_approved,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC3=NNC=C3C[C@]12C,LKAJKIOFIWVMDJ-IYRCEVNGSA-N,328.4916,P10275,BE0000132,Androgen receptor,Humans,agonist,yes
DB06721,Gimatecan,small molecule,investigational,[H]\C(=N/OC(C)(C)C)C1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=CC=C12,UIVFUQKYVFCEKJ-OPTOVBNMSA-N,447.491,P11387,BE0000971,DNA topoisomerase 1,Humans,inhibitor,yes
DB06725,Lornoxicam,small molecule,approved;investigational,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C2=C(C=C(Cl)S2)S1(=O)=O,WLHQHAUOOXYABV-UHFFFAOYSA-N,371.81,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB06725,Lornoxicam,small molecule,approved;investigational,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C2=C(C=C(Cl)S2)S1(=O)=O,WLHQHAUOOXYABV-UHFFFAOYSA-N,371.81,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB06729,Sulfaphenazole,small molecule,approved,NC1=CC=C(C=C1)S(=O)(=O)NC1=CC=NN1C1=CC=CC=C1,QWCJHSGMANYXCW-UHFFFAOYSA-N,314.362,P0AC13,BE0000803,Dihydropteroate synthase,Escherichia coli (strain K12),inhibitor,yes
DB06729,Sulfaphenazole,small molecule,approved,NC1=CC=C(C=C1)S(=O)(=O)NC1=CC=NN1C1=CC=CC=C1,QWCJHSGMANYXCW-UHFFFAOYSA-N,314.362,P11712,BE0002793,Cytochrome P450 2C9,Humans,modulator,yes
DB06730,Gestodene,small molecule,investigational,CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1C=C[C@@]2(O)C#C,SIGSPDASOTUPFS-XUDSTZEESA-N,310.4299,P06401,BE0000557,Progesterone receptor,Humans,binder;activator,yes
DB06731,Seproxetine,small molecule,investigational,NCC[C@H](OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,WIQRCHMSJFFONW-HNNXBMFYSA-N,295.305,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,inhibitor,yes
DB06731,Seproxetine,small molecule,investigational,NCC[C@H](OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,WIQRCHMSJFFONW-HNNXBMFYSA-N,295.305,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB06731,Seproxetine,small molecule,investigational,NCC[C@H](OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,WIQRCHMSJFFONW-HNNXBMFYSA-N,295.305,Q01959,BE0000647,Sodium-dependent dopamine transporter,Humans,inhibitor,yes
DB06733,Bafilomycin A1,small molecule,experimental,CO[C@H]1\C=C\C=C(C)\C[C@H](C)[C@H](O)[C@H](C)\C=C(/C)\C=C(OC)\C(=O)O[C@@H]1[C@@H](C)[C@@H](O)[C@H](C)[C@@]1(O)C[C@@H](O)[C@H](C)[C@H](O1)C(C)C,XDHNQDDQEHDUTM-JQWOJBOSSA-N,622.84,P38606,BE0003569,V-type proton ATPase catalytic subunit A,Humans,inhibitor,yes
DB06734,Bafilomycin B1,small molecule,experimental,CO[C@H]1\C=C/C=C(C)\C[C@H](C)[C@H](O)[C@H](C)\C=C(\C)/C=C(OC)\C(=O)OC1[C@@H](C)[C@@H](O)[C@H](C)[C@@]1(O)C[C@@H](OC(=O)\C=C\C(=O)NC2=C(O)CCC2=O)[C@H](C)[C@H](O1)C(C)C,KFUFLYSBMNNJTF-MZYUNMTESA-N,815.998,P38606,BE0003569,V-type proton ATPase catalytic subunit A,Humans,inhibitor,yes
DB06735,Enclomiphene,small molecule,investigational,CCN(CC)CCOC1=CC=C(C=C1)C(=C(\Cl)C1=CC=CC=C1)\C1=CC=CC=C1,GKIRPKYJQBWNGO-OCEACIFDSA-N,405.97,P03372,BE0000123,Estrogen receptor,Humans,modulator,yes
DB06736,Aceclofenac,small molecule,approved;investigational,OC(=O)COC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,MNIPYSSQXLZQLJ-UHFFFAOYSA-N,354.18,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB06736,Aceclofenac,small molecule,approved;investigational,OC(=O)COC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,MNIPYSSQXLZQLJ-UHFFFAOYSA-N,354.18,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB06738,Ketobemidone,small molecule,investigational,CCC(=O)C1(CCN(C)CC1)C1=CC(O)=CC=C1,ALFGKMXHOUSVAD-UHFFFAOYSA-N,247.3327,P35372,BE0000770,Mu-type opioid receptor,Humans,agonist,yes
DB06738,Ketobemidone,small molecule,investigational,CCC(=O)C1(CCN(C)CC1)C1=CC(O)=CC=C1,ALFGKMXHOUSVAD-UHFFFAOYSA-N,247.3327,P41145,BE0000632,Kappa-type opioid receptor,Humans,agonist,yes
DB06738,Ketobemidone,small molecule,investigational,CCC(=O)C1(CCN(C)CC1)C1=CC(O)=CC=C1,ALFGKMXHOUSVAD-UHFFFAOYSA-N,247.3327,P41143,BE0000420,Delta-type opioid receptor,Humans,agonist,yes
DB06739,Seratrodast,small molecule,experimental,CC1=C(C)C(=O)C(C(CCCCCC(O)=O)C2=CC=CC=C2)=C(C)C1=O,ZBVKEHDGYSLCCC-UHFFFAOYSA-N,354.446,P21731,BE0000759,Thromboxane A2 receptor,Humans,antagonist,yes
DB06741,Gavestinel,small molecule,investigational,OC(=O)C1=C(\C=C\C(=O)NC2=CC=CC=C2)C2=C(Cl)C=C(Cl)C=C2N1,WZBNEZWCNKUOSM-VOTSOKGWSA-N,375.21,P23415,BE0000433,Glycine receptor subunit alpha-1,Humans,modulator,yes
DB06741,Gavestinel,small molecule,investigational,OC(=O)C1=C(\C=C\C(=O)NC2=CC=CC=C2)C2=C(Cl)C=C(Cl)C=C2N1,WZBNEZWCNKUOSM-VOTSOKGWSA-N,375.21,P23416,BE0000745,Glycine receptor subunit alpha-2,Humans,modulator,yes
DB06741,Gavestinel,small molecule,investigational,OC(=O)C1=C(\C=C\C(=O)NC2=CC=CC=C2)C2=C(Cl)C=C(Cl)C=C2N1,WZBNEZWCNKUOSM-VOTSOKGWSA-N,375.21,O75311,BE0000414,Glycine receptor subunit alpha-3,Humans,modulator,yes
DB06741,Gavestinel,small molecule,investigational,OC(=O)C1=C(\C=C\C(=O)NC2=CC=CC=C2)C2=C(Cl)C=C(Cl)C=C2N1,WZBNEZWCNKUOSM-VOTSOKGWSA-N,375.21,P48167,BE0000055,Glycine receptor subunit beta,Humans,modulator,yes
DB06743,Ginkgolide A,small molecule,nutraceutical,C[C@@H]1C(=O)O[C@H]2C[C@@]34[C@H]5C[C@@H](C(C)(C)C)[C@@]33[C@@H](O)C(=O)O[C@H]3O[C@@]4(C(=O)O5)[C@@]12O,FPUXKXIZEIDQKW-VKMVSBOZSA-N,408.3992,P23415,BE0000433,Glycine receptor subunit alpha-1,Humans,inhibitor,yes
DB06743,Ginkgolide A,small molecule,nutraceutical,C[C@@H]1C(=O)O[C@H]2C[C@@]34[C@H]5C[C@@H](C(C)(C)C)[C@@]33[C@@H](O)C(=O)O[C@H]3O[C@@]4(C(=O)O5)[C@@]12O,FPUXKXIZEIDQKW-VKMVSBOZSA-N,408.3992,P23416,BE0000745,Glycine receptor subunit alpha-2,Humans,inhibitor,yes
DB06743,Ginkgolide A,small molecule,nutraceutical,C[C@@H]1C(=O)O[C@H]2C[C@@]34[C@H]5C[C@@H](C(C)(C)C)[C@@]33[C@@H](O)C(=O)O[C@H]3O[C@@]4(C(=O)O5)[C@@]12O,FPUXKXIZEIDQKW-VKMVSBOZSA-N,408.3992,O75311,BE0000414,Glycine receptor subunit alpha-3,Humans,inhibitor,yes
DB06743,Ginkgolide A,small molecule,nutraceutical,C[C@@H]1C(=O)O[C@H]2C[C@@]34[C@H]5C[C@@H](C(C)(C)C)[C@@]33[C@@H](O)C(=O)O[C@H]3O[C@@]4(C(=O)O5)[C@@]12O,FPUXKXIZEIDQKW-VKMVSBOZSA-N,408.3992,P48167,BE0000055,Glycine receptor subunit beta,Humans,inhibitor,yes
DB06751,Drotaverine,small molecule,approved;investigational,CCOC1=C(OCC)C=C(\C=C2/NCCC3=CC(OCC)=C(OCC)C=C23)C=C1,OMFNSKIUKYOYRG-MOSHPQCFSA-N,397.5072,P27815,BE0001133,"3',5'-cyclic-AMP phosphodiesterase 4A",Humans,inhibitor,yes
DB06755,Beta carotene,small molecule,approved;nutraceutical,C\C(\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C)CCCC1(C)C,OENHQHLEOONYIE-JLTXGRSLSA-N,536.888,,BE0009339,Free radicals,Humans,binder,yes
DB06763,Saralasin,small molecule,investigational,[H]N([H])C(=NCCC[C@H](N([H])C(=O)CN([H])C)C(=O)N([H])[C@@H](C(C)C)C(=O)N([H])[C@@H](CC1=CC=C(O)C=C1)C(=O)N([H])[C@@H](C(C)C)C(=O)N([H])[C@@H](CC1=CN=CN1[H])C(=O)N1CCC[C@H]1C(=O)N([H])[C@@H](C)C(O)=O)N([H])[H],PFGWGEPQIUAZME-NXSMLHPHSA-N,912.063,P50052,BE0003426,Type-2 angiotensin II receptor,Humans,inhibitor,yes
DB06763,Saralasin,small molecule,investigational,[H]N([H])C(=NCCC[C@H](N([H])C(=O)CN([H])C)C(=O)N([H])[C@@H](C(C)C)C(=O)N([H])[C@@H](CC1=CC=C(O)C=C1)C(=O)N([H])[C@@H](C(C)C)C(=O)N([H])[C@@H](CC1=CN=CN1[H])C(=O)N1CCC[C@H]1C(=O)N([H])[C@@H](C)C(O)=O)N([H])[H],PFGWGEPQIUAZME-NXSMLHPHSA-N,912.063,P30556,BE0000062,Type-1 angiotensin II receptor,Humans,inhibitor,yes
DB06764,Tetryzoline,small molecule,approved,C1CN=C(N1)C1CCCC2=CC=CC=C12,BYJAVTDNIXVSPW-UHFFFAOYSA-N,200.285,P35348,BE0004863,Alpha-1 adrenergic receptors,Humans,agonist,yes
DB06764,Tetryzoline,small molecule,approved,C1CN=C(N1)C1CCCC2=CC=CC=C12,BYJAVTDNIXVSPW-UHFFFAOYSA-N,200.285,P18825,BE0000342,Alpha-2C adrenergic receptor,Humans,modulator,yes
DB06766,Alcaftadine,small molecule,approved,CN1CCC(CC1)=C1C2=NC=C(C=O)N2CCC2=CC=CC=C12,MWTBKTRZPHJQLH-UHFFFAOYSA-N,307.3895,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB06769,Bendamustine,small molecule,approved;investigational,CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl,YTKUWDBFDASYHO-UHFFFAOYSA-N,358.263,,BE0004796,DNA,Humans,cross-linking/alkylation,yes
DB06771,Besifloxacin,small molecule,approved,N[C@@H]1CCCCN(C1)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1Cl)C(O)=O,QFFGVLORLPOAEC-SNVBAGLBSA-N,393.84,P43702,BE0000429,DNA topoisomerase 4 subunit A,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd),antagonist,yes
DB06771,Besifloxacin,small molecule,approved,N[C@@H]1CCCCN(C1)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1Cl)C(O)=O,QFFGVLORLPOAEC-SNVBAGLBSA-N,393.84,P0A0K8,BE0002388,DNA gyrase subunit B,Staphylococcus aureus,modulator,yes
DB06771,Besifloxacin,small molecule,approved,N[C@@H]1CCCCN(C1)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1Cl)C(O)=O,QFFGVLORLPOAEC-SNVBAGLBSA-N,393.84,P20831,BE0008385,DNA gyrase subunit A,Staphylococcus aureus,modulator,yes
DB06771,Besifloxacin,small molecule,approved,N[C@@H]1CCCCN(C1)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1Cl)C(O)=O,QFFGVLORLPOAEC-SNVBAGLBSA-N,393.84,P72525,BE0003726,DNA topoisomerase 4 subunit A,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4),antagonist,yes
DB06771,Besifloxacin,small molecule,approved,N[C@@H]1CCCCN(C1)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1Cl)C(O)=O,QFFGVLORLPOAEC-SNVBAGLBSA-N,393.84,P43700,BE0000366,DNA gyrase subunit A,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd),antagonist,yes
DB06771,Besifloxacin,small molecule,approved,N[C@@H]1CCCCN(C1)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1Cl)C(O)=O,QFFGVLORLPOAEC-SNVBAGLBSA-N,393.84,P72524,BE0003724,DNA gyrase subunit A,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4),antagonist,yes
DB06772,Cabazitaxel,small molecule,approved,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C4=CC=CC=C4)C(C)=C([C@@H](OC)C(=O)[C@]1(C)[C@H](C[C@H]1OC[C@@]21OC(C)=O)OC)C3(C)C,BMQGVNUXMIRLCK-OAGWZNDDSA-N,835.9324,Q9H4B7,BE0000026,Tubulin beta-1 chain,Humans,inhibitor,yes
DB06774,Capsaicin,small molecule,approved,COC1=C(O)C=CC(CNC(=O)CCCC\C=C\C(C)C)=C1,YKPUWZUDDOIDPM-SOFGYWHQSA-N,305.4119,Q8NER1,BE0001023,Transient receptor potential cation channel subfamily V member 1,Humans,agonist;regulator,yes
DB06775,Carglumic acid,small molecule,approved,NC(=O)N[C@@H](CCC(O)=O)C(O)=O,LCQLHJZYVOQKHU-VKHMYHEASA-N,190.154,P31327,BE0004671,"Carbamoyl-phosphate synthase [ammonia], mitochondrial",Humans,allosteric modulator,yes
DB06777,Chenodeoxycholic acid,small molecule,approved,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O,RUDATBOHQWOJDD-BSWAIDMHSA-N,392.572,Q96RI1,BE0001777,Bile acid receptor,Humans,agonist,yes
DB06781,Difluprednate,small molecule,approved,[H][C@@]12CC[C@](OC(=O)CCC)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,WYQPLTPSGFELIB-JTQPXKBDSA-N,508.5515,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB06781,Difluprednate,small molecule,approved,[H][C@@]12CC[C@](OC(=O)CCC)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,WYQPLTPSGFELIB-JTQPXKBDSA-N,508.5515,P04083,BE0000422,Annexin A1,Humans,agonist,yes
DB06782,Dimercaprol,small molecule,approved,OCC(S)CS,WQABCVAJNWAXTE-UHFFFAOYSA-N,124.225,,BE0004813,Arsenic,Humans,chelator,yes
DB06782,Dimercaprol,small molecule,approved,OCC(S)CS,WQABCVAJNWAXTE-UHFFFAOYSA-N,124.225,,BE0004802,Cadmium,Humans,chelator,yes
DB06782,Dimercaprol,small molecule,approved,OCC(S)CS,WQABCVAJNWAXTE-UHFFFAOYSA-N,124.225,,BE0004814,Mercury,Humans,chelator,yes
DB06785,Ganirelix,small molecule,approved,CCNC(NCC)=NCCCC[C@@H](NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1=CC=CN=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC2=CC=CC=C2C=C1)NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN=C(NCC)NCC)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,GJNXBNATEDXMAK-PFLSVRRQSA-N,1570.35,P30968,BE0000203,Gonadotropin-releasing hormone receptor,Humans,antagonist,yes
DB06786,Halcinonide,small molecule,approved;investigational;withdrawn,[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C,MUQNGPZZQDCDFT-JNQJZLCISA-N,454.96,P11474,BE0003722,Steroid hormone receptor ERR1,Humans,modulator,yes
DB06786,Halcinonide,small molecule,approved;investigational;withdrawn,[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C,MUQNGPZZQDCDFT-JNQJZLCISA-N,454.96,O95718,BE0005001,Steroid hormone receptor ERR2,Humans,modulator,yes
DB06786,Halcinonide,small molecule,approved;investigational;withdrawn,[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C,MUQNGPZZQDCDFT-JNQJZLCISA-N,454.96,P62508,BE0002088,Estrogen-related receptor gamma,Humans,modulator,yes
DB06787,Hexocyclium,small molecule,approved,C[N+]1(C)CCN(CC(O)(C2CCCCC2)C2=CC=CC=C2)CC1,ZRYHPQCHHOKSMD-UHFFFAOYSA-N,317.496,P20309,BE0000045,Muscarinic acetylcholine receptor M3,Humans,antagonist,yes
DB06788,Histrelin,small molecule,approved;withdrawn,CC(O)=O.CC(O)=O.CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC1=CN(CC2=CC=CC=C2)C=N1)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,BKEMVGVBBDMHKL-VYFXDUNUSA-N,1443.632,P30968,BE0000203,Gonadotropin-releasing hormone receptor,Humans,agonist,yes
DB06791,Lanreotide,small molecule,approved,[H]N([H])CCCCC1N([H])C(=O)C(CC2=CN([H])C3=CC=CC=C23)N([H])C(=O)C(CC2=CC=C(O)C=C2)N([H])C(=O)C(CSSCC(N([H])C(=O)C(N([H])C1=O)C(C)C)C(=O)N([H])C(C(C)O)C(=O)N([H])[H])N([H])C(=O)C(CC1=CC2=CC=CC=C2C=C1)N([H])[H],PUDHBTGHUJUUFI-UHFFFAOYSA-N,1096.33,P30874,BE0003528,Somatostatin receptor type 2,Humans,agonist,yes
DB06791,Lanreotide,small molecule,approved,[H]N([H])CCCCC1N([H])C(=O)C(CC2=CN([H])C3=CC=CC=C23)N([H])C(=O)C(CC2=CC=C(O)C=C2)N([H])C(=O)C(CSSCC(N([H])C(=O)C(N([H])C1=O)C(C)C)C(=O)N([H])C(C(C)O)C(=O)N([H])[H])N([H])C(=O)C(CC1=CC2=CC=CC=C2C=C1)N([H])[H],PUDHBTGHUJUUFI-UHFFFAOYSA-N,1096.33,P35346,BE0002147,Somatostatin receptor type 5,Humans,agonist,yes
DB06792,Lanthanum carbonate,small molecule,approved,[La+3].[La+3].[O-]C([O-])=O.[O-]C([O-])=O.[O-]C([O-])=O,NZPIUJUFIFZSPW-UHFFFAOYSA-H,457.835,,BE0004815,Phosphate,Humans,binder,yes
DB06793,Levopropoxyphene,small molecule,withdrawn,[H][C@](C)(CN(C)C)[C@@](CC1=CC=CC=C1)(OC(=O)CC)C1=CC=CC=C1,XLMALTXPSGQGBX-PGRDOPGGSA-N,339.479,P35372,BE0000770,Mu-type opioid receptor,Humans,modulator,yes
DB06795,Mafenide,small molecule,approved;vet_approved;withdrawn,NCC1=CC=C(C=C1)S(N)(=O)=O,TYMRLRRVMHJFTF-UHFFFAOYSA-N,186.232,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB06795,Mafenide,small molecule,approved;vet_approved;withdrawn,NCC1=CC=C(C=C1)S(N)(=O)=O,TYMRLRRVMHJFTF-UHFFFAOYSA-N,186.232,O43570,BE0001653,Carbonic anhydrase 12,Humans,inhibitor,yes
DB06795,Mafenide,small molecule,approved;vet_approved;withdrawn,NCC1=CC=C(C=C1)S(N)(=O)=O,TYMRLRRVMHJFTF-UHFFFAOYSA-N,186.232,Q9ULX7,BE0003634,Carbonic anhydrase 14,Humans,inhibitor,yes
DB06795,Mafenide,small molecule,approved;vet_approved;withdrawn,NCC1=CC=C(C=C1)S(N)(=O)=O,TYMRLRRVMHJFTF-UHFFFAOYSA-N,186.232,P22748,BE0000535,Carbonic anhydrase 4,Humans,inhibitor,yes
DB06797,Mebutamate,small molecule,approved,CCC(C)C(C)(COC(N)=O)COC(N)=O,LEROTMJVBFSIMP-UHFFFAOYSA-N,232.2768,Q99928,BE0003594,Gamma-aminobutyric acid receptor subunit gamma-3,Humans,modulator,yes
DB06800,Methylnaltrexone,small molecule,approved,C[N@+]1(CC2CC2)CC[C@]23[C@H]4OC5=C(O)C=CC(C[C@@H]1[C@]2(O)CCC4=O)=C35,JVLBPIPGETUEET-WIXLDOGYSA-O,356.441,P35372,BE0000770,Mu-type opioid receptor,Humans,antagonist,yes
DB06800,Methylnaltrexone,small molecule,approved,C[N@+]1(CC2CC2)CC[C@]23[C@H]4OC5=C(O)C=CC(C[C@@H]1[C@]2(O)CCC4=O)=C35,JVLBPIPGETUEET-WIXLDOGYSA-O,356.441,P32245,BE0009682,Melanocortin receptor 4,Humans,agonist,yes
DB06802,Nepafenac,small molecule,approved;investigational,NC(=O)CC1=CC=CC(C(=O)C2=CC=CC=C2)=C1N,QEFAQIPZVLVERP-UHFFFAOYSA-N,254.2839,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB06802,Nepafenac,small molecule,approved;investigational,NC(=O)CC1=CC=CC(C(=O)C2=CC=CC=C2)=C1N,QEFAQIPZVLVERP-UHFFFAOYSA-N,254.2839,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB06808,Piperacetazine,small molecule,approved;vet_approved;withdrawn,CC(=O)C1=CC2=C(SC3=CC=CC=C3N2CCCN2CCC(CCO)CC2)C=C1,BTFMCMVEUCGQDX-UHFFFAOYSA-N,410.58,P14416,BE0000756,D(2) dopamine receptor,Humans,modulator,yes
DB06809,Plerixafor,small molecule,approved;investigational,C(N1CCCNCCNCCCNCC1)C1=CC=C(CN2CCCNCCNCCCNCC2)C=C1,YIQPUIGJQJDJOS-UHFFFAOYSA-N,502.782,P61073,BE0000919,C-X-C chemokine receptor type 4,Humans,antagonist;inhibitor,yes
DB06810,Plicamycin,small molecule,approved;investigational;withdrawn,CO[C@@H]([C@@H]1CC2=CC3=CC(O[C@H]4C[C@@H](O[C@H]5C[C@@H](O)[C@H](O)[C@@H](C)O5)[C@H](O)[C@@H](C)O4)=C(C)C(O)=C3C(O)=C2C(=O)[C@H]1O[C@H]1C[C@@H](O[C@H]2C[C@@H](O[C@H]3C[C@](C)(O)[C@H](O)[C@@H](C)O3)[C@@H](O)[C@@H](C)O2)[C@H](O)[C@@H](C)O1)C(=O)[C@@H](O)[C@@H](C)O,CFCUWKMKBJTWLW-BKHRDMLASA-N,1085.1454,,BE0004796,DNA,Humans,antagonist,yes
DB06813,Pralatrexate,small molecule,approved;investigational,NC1=NC2=NC=C(CC(CC#C)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N=C2C(N)=N1,OGSBUKJUDHAQEA-WMCAAGNKSA-N,477.4726,P00374,BE0000330,Dihydrofolate reductase,Humans,substrate;inhibitor,yes
DB06813,Pralatrexate,small molecule,approved;investigational,NC1=NC2=NC=C(CC(CC#C)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N=C2C(N)=N1,OGSBUKJUDHAQEA-WMCAAGNKSA-N,477.4726,Q9HBH1,BE0002201,"Peptide deformylase, mitochondrial",Humans,inhibitor,yes
DB06813,Pralatrexate,small molecule,approved;investigational,NC1=NC2=NC=C(CC(CC#C)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N=C2C(N)=N1,OGSBUKJUDHAQEA-WMCAAGNKSA-N,477.4726,Q05932,BE0000700,"Folylpolyglutamate synthase, mitochondrial",Humans,substrate,yes
DB06814,Protokylol,small molecule,approved;vet_approved,CC(CC1=CC=C2OCOC2=C1)NCC(O)C1=CC=C(O)C(O)=C1,LUMAEVHDZXIGEP-UHFFFAOYSA-N,331.368,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,agonist,yes
DB06814,Protokylol,small molecule,approved;vet_approved,CC(CC1=CC=C2OCOC2=C1)NCC(O)C1=CC=C(O)C(O)=C1,LUMAEVHDZXIGEP-UHFFFAOYSA-N,331.368,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,modulator,yes
DB06815,Pyrithione,small molecule,approved,[O-][N+]1=C(S)C=CC=C1,FGVVTMRZYROCTH-UHFFFAOYSA-N,127.16,P51787,BE0000672,Potassium voltage-gated channel subfamily KQT member 1,Humans,activator,yes
DB06817,Raltegravir,small molecule,approved,CN1C(=O)C(O)=C(N=C1C(C)(C)NC(=O)C1=NN=C(C)O1)C(=O)NCC1=CC=C(F)C=C1,CZFFBEXEKNGXKS-UHFFFAOYSA-N,444.4163,P03366,BE0002050,Gag-Pol polyprotein,,modulator,yes
DB06817,Raltegravir,small molecule,approved,CN1C(=O)C(O)=C(N=C1C(C)(C)NC(=O)C1=NN=C(C)O1)C(=O)NCC1=CC=C(F)C=C1,CZFFBEXEKNGXKS-UHFFFAOYSA-N,444.4163,Q7ZJM1,BE0004855,Integrase,Human immunodeficiency virus 1,inhibitor,yes
DB06819,Phenylbutyric acid,small molecule,approved;investigational,OC(=O)CCCC1=CC=CC=C1,OBKXEAXTFZPCHS-UHFFFAOYSA-N,164.2011,Q13547,BE0002365,Histone deacetylase 1,Humans,inhibitor,yes
DB06819,Phenylbutyric acid,small molecule,approved;investigational,OC(=O)CCCC1=CC=CC=C1,OBKXEAXTFZPCHS-UHFFFAOYSA-N,164.2011,P17252,BE0001132,Protein kinase C alpha type,Humans,modulator,yes
DB06820,Sulconazole,small molecule,approved,ClC1=CC=C(CSC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1,AFNXATANNDIXLG-UHFFFAOYSA-N,397.74,P50859,BE0000690,Lanosterol 14-alpha demethylase,,inhibitor,yes
DB06821,Sulfameter,small molecule,approved,COC1=CN=C(NS(=O)(=O)C2=CC=C(N)C=C2)N=C1,GPTONYMQFTZPKC-UHFFFAOYSA-N,280.3,P0AC13,BE0000803,Dihydropteroate synthase,Escherichia coli (strain K12),inhibitor,yes
DB06824,Triethylenetetramine,small molecule,approved;investigational,NCCNCCNCCN,VILCJCGEZXAXTO-UHFFFAOYSA-N,146.2339,Q9ULX7,BE0003634,Carbonic anhydrase 14,Humans,inhibitor,yes
DB06825,Triptorelin,small molecule,approved;vet_approved,CC(C)C[C@H](NC(=O)[C@@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O,VXKHXGOKWPXYNA-PGBVPBMZSA-N,1311.473,P30968,BE0000203,Gonadotropin-releasing hormone receptor,Humans,agonist,yes
DB06827,Viomycin,small molecule,approved,[H][C@@]1(C[C@H](O)NC(=N)N1)[C@]1([H])NC(=O)\C(NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CNC1=O)NC(=O)C[C@@H](N)CCCN)=C\NC(N)=O,GXFAIFRPOKBQRV-GHXCTMGLSA-N,685.69,P9WJ63,BE0009727,16S/23S rRNA (cytidine-2'-O)-methyltransferase TlyA,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),inhibitor,yes
DB06828,5-[2-(1H-pyrrol-1-yl)ethoxy]-1H-indole,small molecule,experimental,C(CN1C=CC=C1)OC1=CC2=C(NC=C2)C=C1,NSZDJRLPCLOQAM-UHFFFAOYSA-N,226.2738,P09960,BE0001680,Leukotriene A-4 hydrolase,Humans,inhibitor,yes
DB06830,"(1-HYDROXYHEPTANE-1,1-DIYL)BIS(PHOSPHONIC ACID)",small molecule,experimental,CCCCCCC(O)(P(O)(O)=O)P(O)(O)=O,IJEGNOYPWRBKAE-UHFFFAOYSA-N,276.1611,P14324,BE0000776,Farnesyl pyrophosphate synthase,Humans,inhibitor,yes
DB06832,Prinaberel,small molecule,investigational,OC1=CC2=C(OC(=N2)C2=CC=C(O)C(F)=C2)C(C=C)=C1,MQIMZDXIAHJKQP-UHFFFAOYSA-N,271.2432,Q92731,BE0000792,Estrogen receptor beta,Humans,agonist,yes
DB06833,1-CYCLOHEXYL-N-{[1-(4-METHYLPHENYL)-1H-INDOL-3-YL]METHYL}METHANAMINE,small molecule,experimental,CC1=CC=C(C=C1)N1C=C(CNCC2CCCCC2)C2=CC=CC=C12,MMIJMYOYKAKQPN-UHFFFAOYSA-N,332.4818,P11474,BE0003722,Steroid hormone receptor ERR1,Humans,antagonist,yes
DB06836,"N-(5-{4-Chloro-3-[(2-hydroxyethyl)sulfamoyl]phenyl}-4-methyl-1,3-thiazol-2-yl)acetamide",small molecule,experimental,[H]N(CCO)S(=O)(=O)C1=C(Cl)C=CC(=C1)C1=C(C)N=C(S1)N([H])C(C)=O,JFVNFXCESCXMBC-UHFFFAOYSA-N,389.878,Q9UBF8,BE0009513,Phosphatidylinositol 4-kinase beta,Humans,inhibitor,yes
DB06838,methyl L-phenylalaninate,small molecule,experimental,COC(=O)[C@@H](N)CC1=CC=CC=C1,VSDUZFOSJDMAFZ-VIFPVBQESA-N,179.2157,P00734,BE0000048,Prothrombin,Humans,inhibitor,yes
DB06851,N-(pyridin-3-ylmethyl)aniline,small molecule,experimental,C(NC1=CC=CC=C1)C1=CC=CN=C1,BJXLHKJBRORJJJ-UHFFFAOYSA-N,184.2371,P09960,BE0001680,Leukotriene A-4 hydrolase,Humans,inhibitor,yes
DB06861,6-(2-HYDROXY-CYCLOPENTYL)-7-OXO-HEPTANAMIDINE,small molecule,experimental,[H][C@](CCCCC(N)=N)(C=O)[C@@]1([H])CCC[C@]1([H])O,FCDJKFJACUMSOZ-AXFHLTTASA-N,226.3153,P00734,BE0000048,Prothrombin,Humans,inhibitor,yes
DB06867,"3,6,9,12,15,18-HEXAOXAICOSANE",small molecule,experimental,CCOCCOCCOCCOCCOCCOCC,IXFAFGFZFQHRLB-UHFFFAOYSA-N,294.3844,Q13526,BE0003739,Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1,Humans,inhibitor,yes
DB06871,17-METHYL-17-ALPHA-DIHYDROEQUILENIN,small molecule,experimental,[H][C@@]12CC[C@@](C)(O)[C@@]1(C)CCC1=C2C=CC2=CC(O)=CC=C12,FQMQOMRDADWGJJ-GBESFXJTSA-N,282.3768,P03372,BE0000123,Estrogen receptor,Humans,inhibitor,yes
DB06875,ERB-196,small molecule,experimental,OC1=CC=C2C=C(C=C(C#N)C2=C1)C1=CC=C(O)C(F)=C1,NSSOSHDCWCMNDM-UHFFFAOYSA-N,279.2652,Q92731,BE0000792,Estrogen receptor beta,Humans,agonist,yes
DB06911,D-leucyl-N-(3-chlorobenzyl)-L-prolinamide,small molecule,experimental,[H][C@@](N)(CC(C)C)C(=O)N1CCC[C@@]1([H])C(=O)NCC1=CC(Cl)=CC=C1,FHVBVJXZKNCSLP-CVEARBPZSA-N,351.871,P00734,BE0000048,Prothrombin,Humans,inhibitor,yes
DB06917,(4-fluorophenyl)(pyridin-4-yl)methanone,small molecule,experimental,FC1=CC=C(C=C1)C(=O)C1=CC=NC=C1,WTRWBYGUMQEFFI-UHFFFAOYSA-N,201.1964,P09960,BE0001680,Leukotriene A-4 hydrolase,Humans,inhibitor,yes
DB06919,D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide,small molecule,experimental,[H][C@@](N)(CC1=CC=CC=C1)C(=O)N1CCC[C@@]1([H])C(=O)NCC1=CC(Cl)=CC=C1,CJHLRGCXPGIPCB-MOPGFXCFSA-N,385.887,P00734,BE0000048,Prothrombin,Humans,inhibitor,yes
DB06920,Eribaxaban,small molecule,experimental,[H][C@@]1(CN(C(=O)NC2=CC=C(Cl)C=C2)[C@]([H])(C1)C(=O)NC1=CC=C(C=C1F)N1C=CC=CC1=O)OC,QQBKAVAGLMGMHI-WIYYLYMNSA-N,484.907,P00742,BE0000216,Coagulation factor X,Humans,inhibitor,yes
DB06926,"(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid",small molecule,experimental,[H][C@](O)(CCCCC)\C=C\C=C/CCCCCCCC(O)=O,HNICUWMFWZBIFP-IRQZEAMPSA-N,296.4449,P37231,BE0000215,Peroxisome proliferator-activated receptor gamma,Humans,inhibitor,yes
DB06948,2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE,small molecule,experimental,C(OC1=C2NC=NC2=NC(NC2=CC=CC=C2)=N1)C1CCCCC1,XWWRLKIBRPJQJX-UHFFFAOYSA-N,323.3922,P24941,BE0001072,Cyclin-dependent kinase 2,Humans,inhibitor,yes
DB06973,Bisphenol A,small molecule,experimental,CC(C)(C1=CC=C(O)C=C1)C1=CC=C(O)C=C1,IISBACLAFKSPIT-UHFFFAOYSA-N,228.2863,P10275,BE0000132,Androgen receptor,Humans,antagonist,yes
DB06973,Bisphenol A,small molecule,experimental,CC(C)(C1=CC=C(O)C=C1)C1=CC=C(O)C=C1,IISBACLAFKSPIT-UHFFFAOYSA-N,228.2863,Q92731,BE0000792,Estrogen receptor beta,Humans,agonist,yes
DB06996,D-leucyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,small molecule,experimental,[H][C@@](N)(CC(C)C)C(=O)N1CCC[C@@]1([H])C(=O)NCC1=CC=C(C=C1)C(N)=N,XFNMDMGNNKIXBT-CVEARBPZSA-N,359.4659,P00734,BE0000048,Prothrombin,Humans,inhibitor,yes
DB06999,PLX-4720,small molecule,experimental,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,YZDJQTHVDDOVHR-UHFFFAOYSA-N,413.826,P35968,BE0000369,Vascular endothelial growth factor receptor 2,Humans,inhibitor,yes
DB06999,PLX-4720,small molecule,experimental,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=C2C=C(Cl)C=N3)=C1F,YZDJQTHVDDOVHR-UHFFFAOYSA-N,413.826,P15056,BE0000634,Serine/threonine-protein kinase B-raf,Humans,inhibitor,yes
DB07002,4-({4-[(4-methoxypyridin-2-yl)amino]piperidin-1-yl}carbonyl)benzonitrile,small molecule,experimental,COC1=CC=NC(NC2CCN(CC2)C(=O)C2=CC=C(C=C2)C#N)=C1,SZUVGMCKKLJAFX-UHFFFAOYSA-N,336.3877,P35228,BE0000005,"Nitric oxide synthase, inducible",Humans,inhibitor,yes
DB07002,4-({4-[(4-methoxypyridin-2-yl)amino]piperidin-1-yl}carbonyl)benzonitrile,small molecule,experimental,COC1=CC=NC(NC2CCN(CC2)C(=O)C2=CC=C(C=C2)C#N)=C1,SZUVGMCKKLJAFX-UHFFFAOYSA-N,336.3877,P29475,BE0000067,Nitric oxide synthase 1,Humans,inhibitor,yes
DB07027,D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide,small molecule,experimental,[H][C@@](N)(CC1=CC=CC=C1)C(=O)N1CCC[C@@]1([H])C(=O)NCC1=CC=CC(F)=C1,JGZSVYZIJHGHMA-MOPGFXCFSA-N,369.4326,P00734,BE0000048,Prothrombin,Humans,inhibitor,yes
DB07031,"3-Fluoro-4-{[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)acetyl]amino}benzoic acid",small molecule,experimental,CC1(C)CCC(C)(C)C2=C1C=CC(=C2)[C@@H](O)C(=O)NC1=C(F)C=C(C=C1)C(O)=O,AANFHDFOMFRLLR-LJQANCHMSA-N,399.4552,P13631,BE0000144,Retinoic acid receptor gamma,Humans,agonist,yes
DB07032,2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL,small molecule,experimental,OC1=CC=C(C=C1)C1=CC2=C(O1)C=CC(O)=C2,SNNNDCMXZYWCCI-UHFFFAOYSA-N,226.2274,Q92731,BE0000792,Estrogen receptor beta,Humans,inhibitor,yes
DB07032,2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL,small molecule,experimental,OC1=CC=C(C=C1)C1=CC2=C(O1)C=CC(O)=C2,SNNNDCMXZYWCCI-UHFFFAOYSA-N,226.2274,P03372,BE0000123,Estrogen receptor,Humans,inhibitor,yes
DB07038,2-(cyclohexylamino)benzoic acid,small molecule,experimental,OC(=O)C1=CC=CC=C1NC1CCCCC1,JSXMFCCPQQJLCR-UHFFFAOYSA-N,219.2796,O14757,BE0003382,Serine/threonine-protein kinase Chk1,Humans,inhibitor,yes
DB07050,"5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide",small molecule,experimental,NS(=O)(=O)C1=NN=C(NS(=O)(=O)C2=CC=CC=C2)S1,PWDGTQXZLNDOKS-UHFFFAOYSA-N,320.369,Q9ULX7,BE0003634,Carbonic anhydrase 14,Humans,inhibitor,yes
DB07050,"5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide",small molecule,experimental,NS(=O)(=O)C1=NN=C(NS(=O)(=O)C2=CC=CC=C2)S1,PWDGTQXZLNDOKS-UHFFFAOYSA-N,320.369,P22748,BE0000535,Carbonic anhydrase 4,Humans,inhibitor,yes
DB07050,"5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide",small molecule,experimental,NS(=O)(=O)C1=NN=C(NS(=O)(=O)C2=CC=CC=C2)S1,PWDGTQXZLNDOKS-UHFFFAOYSA-N,320.369,P00915,BE0000267,Carbonic anhydrase 1,Humans,inhibitor,yes
DB07050,"5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide",small molecule,experimental,NS(=O)(=O)C1=NN=C(NS(=O)(=O)C2=CC=CC=C2)S1,PWDGTQXZLNDOKS-UHFFFAOYSA-N,320.369,P23280,BE0003628,Carbonic anhydrase 6,Humans,inhibitor,yes
DB07050,"5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide",small molecule,experimental,NS(=O)(=O)C1=NN=C(NS(=O)(=O)C2=CC=CC=C2)S1,PWDGTQXZLNDOKS-UHFFFAOYSA-N,320.369,Q16790,BE0002437,Carbonic anhydrase 9,Humans,inhibitor,yes
DB07050,"5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide",small molecule,experimental,NS(=O)(=O)C1=NN=C(NS(=O)(=O)C2=CC=CC=C2)S1,PWDGTQXZLNDOKS-UHFFFAOYSA-N,320.369,O43570,BE0001653,Carbonic anhydrase 12,Humans,inhibitor,yes
DB07050,"5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide",small molecule,experimental,NS(=O)(=O)C1=NN=C(NS(=O)(=O)C2=CC=CC=C2)S1,PWDGTQXZLNDOKS-UHFFFAOYSA-N,320.369,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB07063,Lidorestat,small molecule,investigational,OC(=O)CN1C=C(CC2=NC3=C(F)C(F)=CC(F)=C3S2)C2=C1C=CC=C2,KYHVTMFADJNSGS-UHFFFAOYSA-N,376.352,P15121,BE0000747,Aldo-keto reductase family 1 member B1,Humans,inhibitor,yes
DB07078,"(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE",small molecule,experimental,COC1=CC(=CC=C1O)C1=CC2=C(C=C1)\C(=C\C1=CC=CN1)C(=O)N2,AYSXURJZVXBSRV-WJDWOHSUSA-N,332.3526,O14757,BE0003382,Serine/threonine-protein kinase Chk1,Humans,inhibitor,yes
DB07083,beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide,small molecule,experimental,[H][C@@](N)(C(C1=CC=CC=C1)C1=CC=CC=C1)C(=O)N1CCC[C@@]1([H])C(=O)NCCC,HZKKJPDVZGOOPU-PZJWPPBQSA-N,379.4953,P00734,BE0000048,Prothrombin,Humans,inhibitor,yes
DB07094,"1-(2,2'-bithiophen-5-yl)methanamine",small molecule,experimental,NCC1=CC=C(S1)C1=CC=CS1,FHYTVXBZSXZMGD-UHFFFAOYSA-N,195.304,P09960,BE0001680,Leukotriene A-4 hydrolase,Humans,inhibitor,yes
DB07096,"6-AMINO-BENZO[DE]ISOQUINOLINE-1,3-DIONE",small molecule,experimental,NC1=CC=C2C(=O)NC(=O)C3=CC=CC1=C23,SSMIFVHARFVINF-UHFFFAOYSA-N,212.2041,P09874,BE0001717,Poly [ADP-ribose] polymerase 1,Humans,inhibitor,yes
DB07099,N-[4-(benzyloxy)phenyl]glycinamide,small molecule,experimental,NCC(=O)NC1=CC=C(OCC2=CC=CC=C2)C=C1,YJPUATSIKWOSST-UHFFFAOYSA-N,256.2997,P09960,BE0001680,Leukotriene A-4 hydrolase,Humans,inhibitor,yes
DB07102,(2S)-2-amino-5-oxo-5-[(4-phenylmethoxyphenyl)amino]pentanoic acid,small molecule,experimental,[H][C@](N)(CCC(=O)NC1=CC=C(OCC2=CC=CC=C2)C=C1)C(O)=O,BYSBXIPCDJNEBG-INIZCTEOSA-N,328.3624,P09960,BE0001680,Leukotriene A-4 hydrolase,Humans,inhibitor,yes
DB07104,4-amino-N-[4-(benzyloxy)phenyl]butanamide,small molecule,experimental,NCCCC(=O)NC1=CC=C(OCC2=CC=CC=C2)C=C1,QTWBKNVNGVYTNZ-UHFFFAOYSA-N,284.3529,P09960,BE0001680,Leukotriene A-4 hydrolase,Humans,inhibitor,yes
DB07106,SKF-91488,small molecule,experimental,CN(C)CCCCSC(N)=N,UFYJLJINUGVUHO-UHFFFAOYSA-N,175.295,P50135,BE0002436,Histamine N-methyltransferase,Humans,inhibitor,yes
DB07108,"4'-FLUORO-1,1'-BIPHENYL-4-CARBOXYLIC ACID",small molecule,experimental,OC(=O)C1=CC=C(C=C1)C1=CC=C(F)C=C1,LXWNTLBMNCXRQN-UHFFFAOYSA-N,216.2078,Q07817,BE0003510,Bcl-2-like protein 1,Humans,inhibitor,yes
DB07114,4-[(METHYLSULFONYL)AMINO]BENZOIC ACID,small molecule,experimental,CS(=O)(=O)NC1=CC=C(C=C1)C(O)=O,SROHFTOYGFCJAF-UHFFFAOYSA-N,215.226,P00807,BE0000302,Beta-lactamase,Staphylococcus aureus,inhibitor,yes
DB07119,1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL,small molecule,experimental,OC1=CC=C(C=C1)C1=CC=C2C(C=CC(O)=C2Cl)=C1,YHEHVRSGKUYDON-UHFFFAOYSA-N,270.71,P03372,BE0000123,Estrogen receptor,Humans,inhibitor,yes
DB07119,1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL,small molecule,experimental,OC1=CC=C(C=C1)C1=CC=C2C(C=CC(O)=C2Cl)=C1,YHEHVRSGKUYDON-UHFFFAOYSA-N,270.71,Q92731,BE0000792,Estrogen receptor beta,Humans,inhibitor,yes
DB07122,1-[4-(2-oxo-2-phenylethyl)phenyl]guanidine,small molecule,experimental,NC(N)=NC1=CC=C(CC(=O)C2=CC=CC=C2)C=C1,MERNPSIIBFTCAI-UHFFFAOYSA-N,253.2991,P00749,BE0000895,Urokinase-type plasminogen activator,Humans,inhibitor,yes
DB07123,N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE,small molecule,experimental,CC1=CC=C(C=C1)C(=O)N1CCC(CC2=CC=CC=C2)CC1,DVOLWKZEIDCCES-UHFFFAOYSA-N,293.4027,P9WGR1,BE0000332,Enoyl-[acyl-carrier-protein] reductase [NADH],Mycobacterium tuberculosis,inhibitor,yes
DB07126,O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE,small molecule,experimental,NS(=O)(=O)C1=CC=C(NC2=NC(OCC3CCCCC3)=C3N=CNC3=N2)C=C1,OWXORKPNCHJYOF-UHFFFAOYSA-N,402.471,O14757,BE0003382,Serine/threonine-protein kinase Chk1,Humans,inhibitor,yes
DB07126,O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE,small molecule,experimental,NS(=O)(=O)C1=CC=C(NC2=NC(OCC3CCCCC3)=C3N=CNC3=N2)C=C1,OWXORKPNCHJYOF-UHFFFAOYSA-N,402.471,P49841,BE0001065,Glycogen synthase kinase-3 beta,Humans,inhibitor,yes
DB07126,O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE,small molecule,experimental,NS(=O)(=O)C1=CC=C(NC2=NC(OCC3CCCCC3)=C3N=CNC3=N2)C=C1,OWXORKPNCHJYOF-UHFFFAOYSA-N,402.471,P11802,BE0002216,Cyclin-dependent kinase 4,Humans,inhibitor,yes
DB07126,O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE,small molecule,experimental,NS(=O)(=O)C1=CC=C(NC2=NC(OCC3CCCCC3)=C3N=CNC3=N2)C=C1,OWXORKPNCHJYOF-UHFFFAOYSA-N,402.471,P24941,BE0001072,Cyclin-dependent kinase 2,Humans,inhibitor,yes
DB07129,"(2R)-1-(2,6-dimethylphenoxy)propan-2-amine",small molecule,experimental,[H][C@](C)(N)COC1=C(C)C=CC=C1C,VLPIATFUUWWMKC-SNVBAGLBSA-N,179.2588,P00749,BE0000895,Urokinase-type plasminogen activator,Humans,inhibitor,yes
DB07133,D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide,small molecule,experimental,[H][C@@](N)(CC1=CC=CC=C1)C(=O)N1CCC[C@@]1([H])C(=O)NCC1=CC(C)=CC=C1,CHKWABXWPATIIG-UXHICEINSA-N,365.4687,P00734,BE0000048,Prothrombin,Humans,inhibitor,yes
DB07138,Neflamapimod,small molecule,investigational,FC1=CC(F)=C(SC2=NN3C=NC(=O)C(=C3C=C2)C2=C(Cl)C=CC=C2Cl)C=C1,VEPKQEUBKLEPRA-UHFFFAOYSA-N,436.262,Q15759,BE0003390,Mitogen-activated protein kinase 11,Humans,inhibitor,yes
DB07138,Neflamapimod,small molecule,investigational,FC1=CC(F)=C(SC2=NN3C=NC(=O)C(=C3C=C2)C2=C(Cl)C=CC=C2Cl)C=C1,VEPKQEUBKLEPRA-UHFFFAOYSA-N,436.262,P53778,BE0002790,Mitogen-activated protein kinase 12,Humans,inhibitor,yes
DB07138,Neflamapimod,small molecule,investigational,FC1=CC(F)=C(SC2=NN3C=NC(=O)C(=C3C=C2)C2=C(Cl)C=CC=C2Cl)C=C1,VEPKQEUBKLEPRA-UHFFFAOYSA-N,436.262,Q16539,BE0001019,Mitogen-activated protein kinase 14,Humans,inhibitor,yes
DB07139,3-[5-(3-nitrophenyl)thiophen-2-yl]propanoic acid,small molecule,experimental,OC(=O)CCC1=CC=C(S1)C1=CC(=CC=C1)[N+]([O-])=O,IHKCOKRMJRDWAL-UHFFFAOYSA-N,277.296,P15121,BE0000747,Aldo-keto reductase family 1 member B1,Humans,inhibitor,yes
DB07143,D-phenylalanyl-N-benzyl-L-prolinamide,small molecule,experimental,[H][C@@](N)(CC1=CC=CC=C1)C(=O)N1CCC[C@@]1([H])C(=O)NCC1=CC=CC=C1,MEPJWLFTTFHOQO-MOPGFXCFSA-N,351.4421,P00734,BE0000048,Prothrombin,Humans,inhibitor,yes
DB07145,(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE,small molecule,experimental,[H][C@](C)(N1CC[C@](C)(C1=O)C1=CC=C(OCC2=CC(C)=NC3=CC=CC=C23)C=C1)C(=O)NO,YDMIPBHQKFOFQW-NSYGIPOTSA-N,433.4996,Q9BZ11,BE0019245,Disintegrin and metalloproteinase domain-containing protein 33,Humans,inhibitor,yes
DB07145,(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE,small molecule,experimental,[H][C@](C)(N1CC[C@](C)(C1=O)C1=CC=C(OCC2=CC(C)=NC3=CC=CC=C23)C=C1)C(=O)NO,YDMIPBHQKFOFQW-NSYGIPOTSA-N,433.4996,P50281,BE0003692,Matrix metalloproteinase-14,Humans,inhibitor,yes
DB07145,(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE,small molecule,experimental,[H][C@](C)(N1CC[C@](C)(C1=O)C1=CC=C(OCC2=CC(C)=NC3=CC=CC=C23)C=C1)C(=O)NO,YDMIPBHQKFOFQW-NSYGIPOTSA-N,433.4996,P14780,BE0000058,Matrix metalloproteinase-9,Humans,inhibitor,yes
DB07145,(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE,small molecule,experimental,[H][C@](C)(N1CC[C@](C)(C1=O)C1=CC=C(OCC2=CC(C)=NC3=CC=CC=C23)C=C1)C(=O)NO,YDMIPBHQKFOFQW-NSYGIPOTSA-N,433.4996,P08253,BE0000642,72 kDa type IV collagenase,Humans,inhibitor,yes
DB07145,(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE,small molecule,experimental,[H][C@](C)(N1CC[C@](C)(C1=O)C1=CC=C(OCC2=CC(C)=NC3=CC=CC=C23)C=C1)C(=O)NO,YDMIPBHQKFOFQW-NSYGIPOTSA-N,433.4996,P08254,BE0001116,Stromelysin-1,Humans,inhibitor,yes
DB07145,(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE,small molecule,experimental,[H][C@](C)(N1CC[C@](C)(C1=O)C1=CC=C(OCC2=CC(C)=NC3=CC=CC=C23)C=C1)C(=O)NO,YDMIPBHQKFOFQW-NSYGIPOTSA-N,433.4996,P22894,BE0001182,Neutrophil collagenase,Humans,inhibitor,yes
DB07145,(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE,small molecule,experimental,[H][C@](C)(N1CC[C@](C)(C1=O)C1=CC=C(OCC2=CC(C)=NC3=CC=CC=C23)C=C1)C(=O)NO,YDMIPBHQKFOFQW-NSYGIPOTSA-N,433.4996,P01375,BE0000704,Tumor necrosis factor,Humans,inhibitor,yes
DB07145,(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE,small molecule,experimental,[H][C@](C)(N1CC[C@](C)(C1=O)C1=CC=C(OCC2=CC(C)=NC3=CC=CC=C23)C=C1)C(=O)NO,YDMIPBHQKFOFQW-NSYGIPOTSA-N,433.4996,P09237,BE0003690,Matrilysin,Humans,inhibitor,yes
DB07145,(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE,small molecule,experimental,[H][C@](C)(N1CC[C@](C)(C1=O)C1=CC=C(OCC2=CC(C)=NC3=CC=CC=C23)C=C1)C(=O)NO,YDMIPBHQKFOFQW-NSYGIPOTSA-N,433.4996,P45452,BE0000966,Collagenase 3,Humans,inhibitor,yes
DB07145,(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE,small molecule,experimental,[H][C@](C)(N1CC[C@](C)(C1=O)C1=CC=C(OCC2=CC(C)=NC3=CC=CC=C23)C=C1)C(=O)NO,YDMIPBHQKFOFQW-NSYGIPOTSA-N,433.4996,P78536,BE0003754,Disintegrin and metalloproteinase domain-containing protein 17,Humans,inhibitor,yes
DB07149,"(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one",small molecule,experimental,[H][C@]1(CCF)CNC(=O)C2=C1NC(=C2)C1=NC(N)=NC=C1,LCBAQTCTQXHTJG-ZETCQYMHSA-N,275.2816,P06493,BE0001082,Cyclin-dependent kinase 1,Humans,inhibitor,yes
DB07149,"(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one",small molecule,experimental,[H][C@]1(CCF)CNC(=O)C2=C1NC(=C2)C1=NC(N)=NC=C1,LCBAQTCTQXHTJG-ZETCQYMHSA-N,275.2816,O00311,BE0010851,Cell division cycle 7-related protein kinase,Humans,inhibitor,yes
DB07149,"(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one",small molecule,experimental,[H][C@]1(CCF)CNC(=O)C2=C1NC(=C2)C1=NC(N)=NC=C1,LCBAQTCTQXHTJG-ZETCQYMHSA-N,275.2816,P24941,BE0001072,Cyclin-dependent kinase 2,Humans,inhibitor,yes
DB07149,"(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one",small molecule,experimental,[H][C@]1(CCF)CNC(=O)C2=C1NC(=C2)C1=NC(N)=NC=C1,LCBAQTCTQXHTJG-ZETCQYMHSA-N,275.2816,P50750,BE0002207,Cyclin-dependent kinase 9,Humans,inhibitor,yes
DB07149,"(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one",small molecule,experimental,[H][C@]1(CCF)CNC(=O)C2=C1NC(=C2)C1=NC(N)=NC=C1,LCBAQTCTQXHTJG-ZETCQYMHSA-N,275.2816,P49841,BE0001065,Glycogen synthase kinase-3 beta,Humans,inhibitor,yes
DB07150,4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME,small molecule,experimental,O\N=C\C1=C2C=CC=CC2=C(C=C1)C1=CC=C(O)C=C1,VYQQTWUZKPWPRL-WOJGMQOQSA-N,263.2906,Q92731,BE0000792,Estrogen receptor beta,Humans,inhibitor,yes
DB07159,Tamatinib,small molecule,experimental;investigational,COC1=CC(NC2=NC=C(F)C(NC3=CC=C4OC(C)(C)C(=O)NC4=N3)=N2)=CC(OC)=C1OC,NHHQJBCNYHBUSI-UHFFFAOYSA-N,470.4536,P43405,BE0001316,Tyrosine-protein kinase SYK,Humans,inhibitor,yes
DB07159,Tamatinib,small molecule,experimental;investigational,COC1=CC(NC2=NC=C(F)C(NC3=CC=C4OC(C)(C)C(=O)NC4=N3)=N2)=CC(OC)=C1OC,NHHQJBCNYHBUSI-UHFFFAOYSA-N,470.4536,P07949,BE0002411,Proto-oncogene tyrosine-protein kinase receptor Ret,Humans,inhibitor,yes
DB07161,5-phenyl-1H-indazol-3-amine,small molecule,experimental,NC1=NNC2=CC=C(C=C12)C1=CC=CC=C1,ZCUSNQPYUNLATP-UHFFFAOYSA-N,209.2465,O60674,BE0002408,Tyrosine-protein kinase JAK2,Humans,inhibitor,yes
DB07173,"7-(5-DEOXY-BETA-D-RIBOFURANOSYL)-5-IODO-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE",small molecule,experimental,[H][C@]1(C)O[C@@]([H])(N2C=C(I)C3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O,NTXUAWGNGBSCRS-TZQXKBMNSA-N,376.1504,P55263,BE0003540,Adenosine kinase,Humans,inhibitor,yes
DB07178,5-PENTYL-2-PHENOXYPHENOL,small molecule,experimental,CCCCCC1=CC(O)=C(OC2=CC=CC=C2)C=C1,OJLYTHOKCYLPMA-UHFFFAOYSA-N,256.3395,P9WGR1,BE0000332,Enoyl-[acyl-carrier-protein] reductase [NADH],Mycobacterium tuberculosis,inhibitor,yes
DB07187,CP-744809,small molecule,experimental,CC1=C(OC2=CC=C(Cl)C=C12)S(=O)(=O)C1=NNC(=O)C=C1,FXFPQPNUMWQRAO-UHFFFAOYSA-N,324.74,P15121,BE0000747,Aldo-keto reductase family 1 member B1,Humans,inhibitor,yes
DB07196,N-methyl-1-(2-thiophen-2-ylphenyl)methanamine,small molecule,experimental,CNCC1=CC=CC=C1C1=CC=CS1,MRKJJEJYTBOUTH-UHFFFAOYSA-N,203.303,P09960,BE0001680,Leukotriene A-4 hydrolase,Humans,inhibitor,yes
DB07203,6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE,small molecule,experimental,ClC1=CC=CC(NC2=NC(OCC3CCCCC3)=C3NC=NC3=N2)=C1,OUEGMEMDEAOAEG-UHFFFAOYSA-N,357.837,P24941,BE0001072,Cyclin-dependent kinase 2,Humans,inhibitor,yes
DB07227,L-778123,small molecule,experimental,ClC1=CC(=CC=C1)N1CCN(CC2=CN=CN2CC2=CC=C(C=C2)C#N)CC1=O,JNUGFGAVPBYSHF-UHFFFAOYSA-N,405.88,P49354,BE0002373,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,Humans,modulator,yes
DB07227,L-778123,small molecule,experimental,ClC1=CC(=CC=C1)N1CCN(CC2=CN=CN2CC2=CC=C(C=C2)C#N)CC1=O,JNUGFGAVPBYSHF-UHFFFAOYSA-N,405.88,P49356,BE0002372,Protein farnesyltransferase subunit beta,Humans,modulator,yes
DB07227,L-778123,small molecule,experimental,ClC1=CC(=CC=C1)N1CCN(CC2=CN=CN2CC2=CC=C(C=C2)C#N)CC1=O,JNUGFGAVPBYSHF-UHFFFAOYSA-N,405.88,P53609,BE0001142,Geranylgeranyl transferase type-1 subunit beta,Humans,modulator,yes
DB07238,Nesbuvir,small molecule,investigational,CNC(=O)C1=C(OC2=CC(N(CCO)S(C)(=O)=O)=C(C=C12)C1CC1)C1=CC=C(F)C=C1,WTDWVLJJJOTABN-UHFFFAOYSA-N,446.492,P26664,BE0003427,Genome polyprotein,,inhibitor,yes
DB07259,1-(4-thiophen-2-ylphenyl)methanamine,small molecule,experimental,NCC1=CC=C(C=C1)C1=CC=CS1,YKNLMMDEWQZCLJ-UHFFFAOYSA-N,189.277,P09960,BE0001680,Leukotriene A-4 hydrolase,Humans,inhibitor,yes
DB07260,N-benzyl-4-[(2R)-pyrrolidin-2-ylmethoxy]aniline,small molecule,experimental,[H][C@]1(COC2=CC=C(NCC3=CC=CC=C3)C=C2)CCCN1,HITMFLNAOQIZSN-QGZVFWFLSA-N,282.3801,P09960,BE0001680,Leukotriene A-4 hydrolase,Humans,inhibitor,yes
DB07278,GW-813893,small molecule,experimental,C[C@H](N1CC[C@H](NS(=O)(=O)\C=C\C2=CC=C(Cl)S2)C1=O)C(=O)N1CCOCC1,ACEFOQMQINFMRW-DYCFVMESSA-N,447.957,P00742,BE0000216,Coagulation factor X,Humans,inhibitor,yes
DB07286,BMS-564929,small molecule,experimental,[H][C@@]1(O)CCN2C(=O)N(C(=O)[C@]12[H])C1=C(C)C(Cl)=C(C=C1)C#N,KEJORAMIZFOODM-PWSUYJOCSA-N,305.716,P10275,BE0000132,Androgen receptor,Humans,inhibitor,yes
DB07288,N-(4-chlorophenyl)-2-[(pyridin-4-ylmethyl)amino]benzamide,small molecule,experimental,ClC1=CC=C(NC(=O)C2=C(NCC3=CC=NC=C3)C=CC=C2)C=C1,GGPZCOONYBPZEW-UHFFFAOYSA-N,337.803,P35968,BE0000369,Vascular endothelial growth factor receptor 2,Humans,inhibitor,yes
DB07292,"4-(2-amino-1,3-thiazol-4-yl)phenol",small molecule,experimental,NC1=NC(=CS1)C1=CC=C(O)C=C1,QGSJYYIRAFRPIT-UHFFFAOYSA-N,192.238,P09467,BE0002431,"Fructose-1,6-bisphosphatase 1",Humans,inhibitor,yes
DB07292,"4-(2-amino-1,3-thiazol-4-yl)phenol",small molecule,experimental,NC1=NC(=CS1)C1=CC=C(O)C=C1,QGSJYYIRAFRPIT-UHFFFAOYSA-N,192.238,O00757,BE0011215,"Fructose-1,6-bisphosphatase isozyme 2",Humans,inhibitor,yes
DB07292,"4-(2-amino-1,3-thiazol-4-yl)phenol",small molecule,experimental,NC1=NC(=CS1)C1=CC=C(O)C=C1,QGSJYYIRAFRPIT-UHFFFAOYSA-N,192.238,P09960,BE0001680,Leukotriene A-4 hydrolase,Humans,inhibitor,yes
DB07302,9(S)-HODE,small molecule,experimental,CCCCC\C=C/C=C/[C@@H](O)CCCCCCCC(O)=O,NPDSHTNEKLQQIJ-UINYOVNOSA-N,296.4449,P37231,BE0000215,Peroxisome proliferator-activated receptor gamma,Humans,inhibitor,yes
DB07309,5-BROMO-2-{[(4-CHLOROPHENYL)SULFONYL]AMINO}BENZOIC ACID,small molecule,experimental,OC(=O)C1=C(NS(=O)(=O)C2=CC=C(Cl)C=C2)C=CC(Br)=C1,JDVLYAYDIMUAAC-UHFFFAOYSA-N,390.637,P50579,BE0001534,Methionine aminopeptidase 2,Humans,inhibitor,yes
DB07313,5-METHYL-2-[(PHENYLSULFONYL)AMINO]BENZOIC ACID,small molecule,experimental,CC1=CC=C(NS(=O)(=O)C2=CC=CC=C2)C(=C1)C(O)=O,HXQLTRSIZRSFTR-UHFFFAOYSA-N,291.322,P50579,BE0001534,Methionine aminopeptidase 2,Humans,inhibitor,yes
DB07319,"6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE",small molecule,experimental,NC1=NC(=NC(N)=N1)C1=CC2=CC=CC=C2C=C1Br,RXSSKAZHCZWJPP-UHFFFAOYSA-N,316.156,P07900,BE0001120,Heat shock protein HSP 90-alpha,Humans,inhibitor,yes
DB07330,A-620223,small molecule,experimental,CCCN1CCC(CC1)C1=NC2=CC=CC(C(N)=O)=C2N1,KXSIHXHEHABEJX-UHFFFAOYSA-N,286.3721,P09874,BE0001717,Poly [ADP-ribose] polymerase 1,Humans,inhibitor,yes
DB07340,Reversine,small molecule,experimental,C1CCC(CC1)NC1=NC(NC2=CC=C(C=C2)N2CCOCC2)=NC2=C1N=CN2,ZFLJHSQHILSNCM-UHFFFAOYSA-N,393.4854,P0DMS8,BE0000354,Adenosine receptor A3,Humans,inhibitor,yes
DB07340,Reversine,small molecule,experimental,C1CCC(CC1)NC1=NC(NC2=CC=C(C=C2)N2CCOCC2)=NC2=C1N=CN2,ZFLJHSQHILSNCM-UHFFFAOYSA-N,393.4854,Q02750,BE0000870,Dual specificity mitogen-activated protein kinase kinase 1,Humans,inhibitor,yes
DB07342,1-(adamantan-1-yl)-2-(1H-imidazol-1-yl)ethanone,small molecule,experimental,[H]C12CC3([H])CC([H])(C1)CC(C2)(C3)C(=O)CN1C=CN=C1,BBCQJSMDKDHVKG-BVMXXOESSA-N,244.3321,P09601,BE0000735,Heme oxygenase 1,Humans,inhibitor,yes
DB07352,Apigenin,small molecule,experimental,OC1=CC=C(C=C1)C1=CC(=O)C2=C(O1)C=C(O)C=C2O,KZNIFHPLKGYRTM-UHFFFAOYSA-N,270.2369,P68400,BE0001209,Casein kinase II subunit alpha,Humans,inhibitor,yes
DB07352,Apigenin,small molecule,experimental,OC1=CC=C(C=C1)C1=CC(=O)C2=C(O1)C=C(O)C=C2O,KZNIFHPLKGYRTM-UHFFFAOYSA-N,270.2369,P15121,BE0000747,Aldo-keto reductase family 1 member B1,Humans,inhibitor,yes
DB07352,Apigenin,small molecule,experimental,OC1=CC=C(C=C1)C1=CC(=O)C2=C(O1)C=C(O)C=C2O,KZNIFHPLKGYRTM-UHFFFAOYSA-N,270.2369,Q16678,BE0001111,Cytochrome P450 1B1,Humans,inhibitor,yes
DB07352,Apigenin,small molecule,experimental,OC1=CC=C(C=C1)C1=CC(=O)C2=C(O1)C=C(O)C=C2O,KZNIFHPLKGYRTM-UHFFFAOYSA-N,270.2369,P11511,BE0002090,Aromatase,Humans,inhibitor,yes
DB07352,Apigenin,small molecule,experimental,OC1=CC=C(C=C1)C1=CC(=O)C2=C(O1)C=C(O)C=C2O,KZNIFHPLKGYRTM-UHFFFAOYSA-N,270.2369,P10275,BE0000132,Androgen receptor,Humans,inhibitor,yes
DB07352,Apigenin,small molecule,experimental,OC1=CC=C(C=C1)C1=CC(=O)C2=C(O1)C=C(O)C=C2O,KZNIFHPLKGYRTM-UHFFFAOYSA-N,270.2369,Q00534,BE0002212,Cyclin-dependent kinase 6,Humans,inhibitor,yes
DB07352,Apigenin,small molecule,experimental,OC1=CC=C(C=C1)C1=CC(=O)C2=C(O1)C=C(O)C=C2O,KZNIFHPLKGYRTM-UHFFFAOYSA-N,270.2369,P14061,BE0000194,17-beta-hydroxysteroid dehydrogenase type 1,Humans,inhibitor,yes
DB07353,"4-(2,5-DIAMINO-5-HYDROXY-PENTYL)-PHENOL",small molecule,experimental,[H][C@](N)(O)CC[C@@]([H])(N)CC1=CC=C(O)C=C1,VTBBVHAOBBELOH-KOLCDFICSA-N,210.2728,P00734,BE0000048,Prothrombin,Humans,inhibitor,yes
DB07373,Boldione,small molecule,experimental,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,LUJVUUWNAPIQQI-QAGGRKNESA-N,284.3927,P11511,BE0002090,Aromatase,Humans,inhibitor,yes
DB07377,"N'-((2S,3R)-3-AMINO-2-HYDROXY-5-(ISOPROPYLSULFANYL)PENTANOYL)-N-3-CHLOROBENZOYL HYDRAZIDE",small molecule,experimental,[H][C@@](N)(CCSC(C)C)[C@]([H])(O)C(=O)NNC(=O)C1=CC(Cl)=CC=C1,BYBVYIPUGPZRSX-OLZOCXBDSA-N,359.871,P50579,BE0001534,Methionine aminopeptidase 2,Humans,inhibitor,yes
DB07382,"N~2~-1H-benzimidazol-5-yl-N~4~-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine",small molecule,experimental,C1CC1C1=NNC(NC2=CC=NC(NC3=CC4=C(NC=N4)C=C3)=N2)=C1,WJNBSTLIALIIEW-UHFFFAOYSA-N,332.3625,O75460,BE0003839,Serine/threonine-protein kinase/endoribonuclease IRE1,Humans,inhibitor,yes
DB07390,"2-[3-(5-Mercapto-[1,3,4]thiadiazol-2-yl)-ureido]-N-methyl-3-phenyl-propionamide",small molecule,experimental,CNC(=O)[C@H](CC1=CC=CC=C1)NC(=O)NC1=NNC(=S)S1,RKWXKADYTDWZIJ-VIFPVBQESA-N,337.421,P08253,BE0000642,72 kDa type IV collagenase,Humans,inhibitor,yes
DB07390,"2-[3-(5-Mercapto-[1,3,4]thiadiazol-2-yl)-ureido]-N-methyl-3-phenyl-propionamide",small molecule,experimental,CNC(=O)[C@H](CC1=CC=CC=C1)NC(=O)NC1=NNC(=S)S1,RKWXKADYTDWZIJ-VIFPVBQESA-N,337.421,P08254,BE0001116,Stromelysin-1,Humans,inhibitor,yes
DB07404,BPH-608,small molecule,experimental,OC(CC1=CC=CC(=C1)C1=CC(=CC=C1)C1=CC=CC=C1)(P(O)(O)=O)P(O)(O)=O,YXQQNSYZOQHKHD-UHFFFAOYSA-N,434.3161,P14324,BE0000776,Farnesyl pyrophosphate synthase,Humans,inhibitor,yes
DB07405,"1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE",small molecule,experimental,NC1=NC2(CCN(CC2)C(=O)C2=CC=C(N=C2)C#N)NC2=C(F)C=CC(F)=C12,GIZYIOOBBUHOBS-UHFFFAOYSA-N,382.3667,P29475,BE0000067,Nitric oxide synthase 1,Humans,inhibitor,yes
DB07405,"1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE",small molecule,experimental,NC1=NC2(CCN(CC2)C(=O)C2=CC=C(N=C2)C#N)NC2=C(F)C=CC(F)=C12,GIZYIOOBBUHOBS-UHFFFAOYSA-N,382.3667,P35228,BE0000005,"Nitric oxide synthase, inducible",Humans,inhibitor,yes
DB07409,"(1-HYDROXY-1-PHOSPHONO-2-[1,1';4',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID",small molecule,experimental,OC(CC1=CC=CC(=C1)C1=CC=C(C=C1)C1=CC=CC=C1)(P(O)(O)=O)P(O)(O)=O,MPBUFKZCEBTBSK-UHFFFAOYSA-N,434.3161,P14324,BE0000776,Farnesyl pyrophosphate synthase,Humans,inhibitor,yes
DB07410,[2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID,small molecule,experimental,OC(CC1=CC(=CC=C1)C1=CC=CC2=C1OC1=C2C=CC=C1)(P(O)(O)=O)P(O)(O)=O,BYVXAUZOTGITQZ-UHFFFAOYSA-N,448.2996,P14324,BE0000776,Farnesyl pyrophosphate synthase,Humans,inhibitor,yes
DB07412,1-biphenyl-2-ylmethanamine,small molecule,experimental,NCC1=C(C=CC=C1)C1=CC=CC=C1,YHXKXVFQHWJYOD-UHFFFAOYSA-N,183.249,P27487,BE0000854,Dipeptidyl peptidase 4,Humans,inhibitor,yes
DB07423,Andarine,small molecule,experimental,CC(=O)NC1=CC=C(OC[C@](C)(O)C(=O)NC2=CC=C(C(=C2)C(F)(F)F)[N+]([O-])=O)C=C1,YVXVTLGIDOACBJ-SFHVURJKSA-N,441.3579,P10275,BE0000132,Androgen receptor,Humans,agonist,yes
DB07425,Sobetirome,small molecule,investigational,CC(C)C1=C(O)C=CC(CC2=C(C)C=C(OCC(O)=O)C=C2C)=C1,QNAZTOHXCZPOSA-UHFFFAOYSA-N,328.4022,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,agonist,yes
DB07426,"[1-HYDROXY-2-(1,1':3',1''-TERPHENYL-3-YLOXY)ETHANE-1,1-DIYL]BIS(PHOSPHONIC ACID)",small molecule,experimental,OC(COC1=CC=CC(=C1)C1=CC=CC(=C1)C1=CC=CC=C1)(P(O)(O)=O)P(O)(O)=O,NWIARQRYIRVYCM-UHFFFAOYSA-N,450.3155,P14324,BE0000776,Farnesyl pyrophosphate synthase,Humans,inhibitor,yes
DB07427,2-[(2-methoxy-5-methylphenoxy)methyl]pyridine,small molecule,experimental,COC1=C(OCC2=NC=CC=C2)C=C(C)C=C1,AVXQTLSOXWQOHO-UHFFFAOYSA-N,229.2744,P69905,BE0000130,Hemoglobin subunit alpha,Humans,inhibitor,yes
DB07428,4-[(5-methoxy-2-methylphenoxy)methyl]pyridine,small molecule,experimental,COC1=CC(OCC2=CC=NC=C2)=C(C)C=C1,MBHBRRBLXCXQKV-UHFFFAOYSA-N,229.2744,P69905,BE0000130,Hemoglobin subunit alpha,Humans,inhibitor,yes
DB07430,"(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one",small molecule,experimental,[H][C@@]1(C)CNC2=C(SC3=C2C2=C(C=C3)N=C(C=C2)C2=CN=C(C)C=C2)C(=O)N1,CMWRPDHVGMHLSZ-GFCCVEGCSA-N,374.459,P49137,BE0001373,MAP kinase-activated protein kinase 2,Humans,inhibitor,yes
DB07436,N-(1-PHENYL-PROPYL)-FORMAMIDE,small molecule,experimental,[H][C@](CC)(NC=O)C1=CC=CC=C1,UERJGKDKJBSKQN-SNVBAGLBSA-N,163.2163,P16753,BE0001331,Capsid scaffolding protein,HHV-5,inhibitor,yes
DB07440,4-TERT-BUTYLBENZENESULFONIC ACID,small molecule,experimental,CC(C)(C)C1=CC=C(C=C1)S(O)(=O)=O,LZQMCUIWYRQLOG-UHFFFAOYSA-N,214.281,P00734,BE0000048,Prothrombin,Humans,inhibitor,yes
DB07443,(2Z)-N-biphenyl-4-yl-2-cyano-3-hydroxybut-2-enamide,small molecule,experimental,C\C(O)=C(/C#N)C(=O)NC1=CC=C(C=C1)C1=CC=CC=C1,MUVPBAIVOHJDOC-VBKFSLOCSA-N,278.3053,Q08210,BE0000612,"Dihydroorotate dehydrogenase (quinone), mitochondrial",Plasmodium falciparum (isolate 3D7),inhibitor,yes
DB07446,N-(biphenyl-4-ylsulfonyl)-D-leucine,small molecule,experimental,[H][C@](CC(C)C)(NS(=O)(=O)C1=CC=C(C=C1)C1=CC=CC=C1)C(O)=O,FBSVJQQVDISETN-QGZVFWFLSA-N,347.429,P39900,BE0001198,Macrophage metalloelastase,Humans,inhibitor,yes
DB07453,alpha-Naphthoflavone,small molecule,experimental,O=C1C=C(OC2=C1C=CC1=C2C=CC=C1)C1=CC=CC=C1,VFMMPHCGEFXGIP-UHFFFAOYSA-N,272.2974,P78527,BE0002385,DNA-dependent protein kinase catalytic subunit,Humans,inhibitor,yes
DB07453,alpha-Naphthoflavone,small molecule,experimental,O=C1C=C(OC2=C1C=CC1=C2C=CC=C1)C1=CC=CC=C1,VFMMPHCGEFXGIP-UHFFFAOYSA-N,272.2974,P11511,BE0002090,Aromatase,Humans,inhibitor,yes
DB07459,4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE,small molecule,experimental,O=C(NCC1=NC=CC=C1)C1=CC=C(OC2=CC=CC=C2)C=C1,HVLSCZSVTCNAQX-UHFFFAOYSA-N,304.3425,Q16539,BE0001019,Mitogen-activated protein kinase 14,Humans,inhibitor,yes
DB07462,"(3,4-DIHYDROXY-2-NITROPHENYL)(PHENYL)METHANONE",small molecule,experimental,OC1=CC=C(C(=O)C2=CC=CC=C2)C(=C1O)[N+]([O-])=O,ICLKAUQIPVFHOI-UHFFFAOYSA-N,259.2143,P21964,BE0002089,Catechol O-methyltransferase,Humans,inhibitor,yes
DB07476,N-[4-(AMINOSULFONYL)PHENYL]-2-MERCAPTOBENZAMIDE,small molecule,experimental,NS(=O)(=O)C1=CC=C(NC(=O)C2=CC=CC=C2S)C=C1,MRLVIVXGUGNENL-UHFFFAOYSA-N,308.376,P00915,BE0000267,Carbonic anhydrase 1,Humans,inhibitor,yes
DB07476,N-[4-(AMINOSULFONYL)PHENYL]-2-MERCAPTOBENZAMIDE,small molecule,experimental,NS(=O)(=O)C1=CC=C(NC(=O)C2=CC=CC=C2S)C=C1,MRLVIVXGUGNENL-UHFFFAOYSA-N,308.376,Q16790,BE0002437,Carbonic anhydrase 9,Humans,inhibitor,yes
DB07476,N-[4-(AMINOSULFONYL)PHENYL]-2-MERCAPTOBENZAMIDE,small molecule,experimental,NS(=O)(=O)C1=CC=C(NC(=O)C2=CC=CC=C2S)C=C1,MRLVIVXGUGNENL-UHFFFAOYSA-N,308.376,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB07477,Felbinac,small molecule,experimental,OC(=O)CC1=CC=C(C=C1)C1=CC=CC=C1,QRZAKQDHEVVFRX-UHFFFAOYSA-N,212.2439,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,modulator,yes
DB07477,Felbinac,small molecule,experimental,OC(=O)CC1=CC=C(C=C1)C1=CC=CC=C1,QRZAKQDHEVVFRX-UHFFFAOYSA-N,212.2439,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,modulator,yes
DB07496,"1,3-diphenylurea",small molecule,experimental,O=C(NC1=CC=CC=C1)NC1=CC=CC=C1,GWEHVDNNLFDJLR-UHFFFAOYSA-N,212.2472,P34913,BE0000950,Bifunctional epoxide hydrolase 2,Humans,inhibitor,yes
DB07503,"(5E)-5-[(2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL)METHYLENE]-1,3-THIAZOLIDINE-2,4-DIONE",small molecule,experimental,FC1(F)OC2=C(O1)C=C(\C=C1/SC(=O)NC1=O)C=C2,SRLVNYDXMUGOFI-YWEYNIOJSA-N,285.224,P48736,BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",Humans,inhibitor,yes
DB07512,7-[(3-CHLOROBENZYL)OXY]-2-OXO-2H-CHROMENE-4-CARBALDEHYDE,small molecule,experimental,ClC1=CC=CC(COC2=CC=C3C(OC(=O)C=C3C=O)=C2)=C1,ZOCADHRNWNJARU-UHFFFAOYSA-N,314.72,P21397,BE0002198,Amine oxidase [flavin-containing] A,Humans,inhibitor,yes
DB07512,7-[(3-CHLOROBENZYL)OXY]-2-OXO-2H-CHROMENE-4-CARBALDEHYDE,small molecule,experimental,ClC1=CC=CC(COC2=CC=C3C(OC(=O)C=C3C=O)=C2)=C1,ZOCADHRNWNJARU-UHFFFAOYSA-N,314.72,P27338,BE0002196,Amine oxidase [flavin-containing] B,Humans,inhibitor,yes
DB07525,"3-(3-methoxybenzyl)-1H-pyrrolo[2,3-b]pyridine",small molecule,experimental,COC1=CC=CC(CC2=CNC3=C2C=CC=N3)=C1,GHQCCHWTDLTMJT-UHFFFAOYSA-N,238.2845,P11362,BE0002131,Fibroblast growth factor receptor 1,Humans,inhibitor,yes
DB07545,N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE,small molecule,experimental,FC(F)(F)C1=CC=CC(NC2=NC(NC3=CC(NC(=O)C4CC4)=CC=C3)=NC=C2)=C1,RDTDWGQDFJPTPD-UHFFFAOYSA-N,413.3957,Q9UQB9,BE0004601,Aurora kinase C,Humans,inhibitor,yes
DB07553,"9,9,9-TRIFLUORO-8-OXO-N-PHENYLNONANAMIDE",small molecule,experimental,FC(F)(F)C(=O)CCCCCCC(=O)NC1=CC=CC=C1,KRCXZGYVOZSCSF-UHFFFAOYSA-N,301.3041,Q9BY41,BE0001608,Histone deacetylase 8,Humans,inhibitor,yes
DB07553,"9,9,9-TRIFLUORO-8-OXO-N-PHENYLNONANAMIDE",small molecule,experimental,FC(F)(F)C(=O)CCCCCCC(=O)NC1=CC=CC=C1,KRCXZGYVOZSCSF-UHFFFAOYSA-N,301.3041,P56524,BE0003523,Histone deacetylase 4,Humans,inhibitor,yes
DB07553,"9,9,9-TRIFLUORO-8-OXO-N-PHENYLNONANAMIDE",small molecule,experimental,FC(F)(F)C(=O)CCCCCCC(=O)NC1=CC=CC=C1,KRCXZGYVOZSCSF-UHFFFAOYSA-N,301.3041,Q13547,BE0002365,Histone deacetylase 1,Humans,inhibitor,yes
DB07553,"9,9,9-TRIFLUORO-8-OXO-N-PHENYLNONANAMIDE",small molecule,experimental,FC(F)(F)C(=O)CCCCCCC(=O)NC1=CC=CC=C1,KRCXZGYVOZSCSF-UHFFFAOYSA-N,301.3041,Q9UBN7,BE0002368,Histone deacetylase 6,Humans,inhibitor,yes
DB07553,"9,9,9-TRIFLUORO-8-OXO-N-PHENYLNONANAMIDE",small molecule,experimental,FC(F)(F)C(=O)CCCCCCC(=O)NC1=CC=CC=C1,KRCXZGYVOZSCSF-UHFFFAOYSA-N,301.3041,Q92769,BE0002366,Histone deacetylase 2,Humans,inhibitor,yes
DB07553,"9,9,9-TRIFLUORO-8-OXO-N-PHENYLNONANAMIDE",small molecule,experimental,FC(F)(F)C(=O)CCCCCCC(=O)NC1=CC=CC=C1,KRCXZGYVOZSCSF-UHFFFAOYSA-N,301.3041,Q969S8,BE0009579,Polyamine deacetylase HDAC10,Humans,inhibitor,yes
DB07556,CGS-27023,small molecule,experimental,COC1=CC=C(C=C1)S(=O)(=O)N(CC1=CC=CN=C1)[C@H](C(C)C)C(=O)NO,BSIZUMJRKYHEBR-QGZVFWFLSA-N,393.457,P22894,BE0001182,Neutrophil collagenase,Humans,inhibitor,yes
DB07556,CGS-27023,small molecule,experimental,COC1=CC=C(C=C1)S(=O)(=O)N(CC1=CC=CN=C1)[C@H](C(C)C)C(=O)NO,BSIZUMJRKYHEBR-QGZVFWFLSA-N,393.457,O75173,BE0004687,A disintegrin and metalloproteinase with thrombospondin motifs 4,Humans,inhibitor,yes
DB07556,CGS-27023,small molecule,experimental,COC1=CC=C(C=C1)S(=O)(=O)N(CC1=CC=CN=C1)[C@H](C(C)C)C(=O)NO,BSIZUMJRKYHEBR-QGZVFWFLSA-N,393.457,P08253,BE0000642,72 kDa type IV collagenase,Humans,inhibitor,yes
DB07556,CGS-27023,small molecule,experimental,COC1=CC=C(C=C1)S(=O)(=O)N(CC1=CC=CN=C1)[C@H](C(C)C)C(=O)NO,BSIZUMJRKYHEBR-QGZVFWFLSA-N,393.457,P50281,BE0003692,Matrix metalloproteinase-14,Humans,inhibitor,yes
DB07556,CGS-27023,small molecule,experimental,COC1=CC=C(C=C1)S(=O)(=O)N(CC1=CC=CN=C1)[C@H](C(C)C)C(=O)NO,BSIZUMJRKYHEBR-QGZVFWFLSA-N,393.457,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB07556,CGS-27023,small molecule,experimental,COC1=CC=C(C=C1)S(=O)(=O)N(CC1=CC=CN=C1)[C@H](C(C)C)C(=O)NO,BSIZUMJRKYHEBR-QGZVFWFLSA-N,393.457,P45452,BE0000966,Collagenase 3,Humans,inhibitor,yes
DB07556,CGS-27023,small molecule,experimental,COC1=CC=C(C=C1)S(=O)(=O)N(CC1=CC=CN=C1)[C@H](C(C)C)C(=O)NO,BSIZUMJRKYHEBR-QGZVFWFLSA-N,393.457,P15917,BE0001363,Lethal factor,Bacillus anthracis,inhibitor,yes
DB07556,CGS-27023,small molecule,experimental,COC1=CC=C(C=C1)S(=O)(=O)N(CC1=CC=CN=C1)[C@H](C(C)C)C(=O)NO,BSIZUMJRKYHEBR-QGZVFWFLSA-N,393.457,P08254,BE0001116,Stromelysin-1,Humans,inhibitor,yes
DB07556,CGS-27023,small molecule,experimental,COC1=CC=C(C=C1)S(=O)(=O)N(CC1=CC=CN=C1)[C@H](C(C)C)C(=O)NO,BSIZUMJRKYHEBR-QGZVFWFLSA-N,393.457,Q16790,BE0002437,Carbonic anhydrase 9,Humans,inhibitor,yes
DB07556,CGS-27023,small molecule,experimental,COC1=CC=C(C=C1)S(=O)(=O)N(CC1=CC=CN=C1)[C@H](C(C)C)C(=O)NO,BSIZUMJRKYHEBR-QGZVFWFLSA-N,393.457,P14780,BE0000058,Matrix metalloproteinase-9,Humans,inhibitor,yes
DB07556,CGS-27023,small molecule,experimental,COC1=CC=C(C=C1)S(=O)(=O)N(CC1=CC=CN=C1)[C@H](C(C)C)C(=O)NO,BSIZUMJRKYHEBR-QGZVFWFLSA-N,393.457,P09237,BE0003690,Matrilysin,Humans,inhibitor,yes
DB07556,CGS-27023,small molecule,experimental,COC1=CC=C(C=C1)S(=O)(=O)N(CC1=CC=CN=C1)[C@H](C(C)C)C(=O)NO,BSIZUMJRKYHEBR-QGZVFWFLSA-N,393.457,P03956,BE0000920,Interstitial collagenase,Humans,inhibitor,yes
DB07557,"3,20-Pregnanedione",small molecule,experimental,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@]2([H])CC(=O)CC[C@]12C,XMRPGKVKISIQBV-XWOJZHJZSA-N,316.4776,P19793,BE0000412,Retinoic acid receptor RXR-alpha,Humans,inhibitor,yes
DB07557,"3,20-Pregnanedione",small molecule,experimental,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@]2([H])CC(=O)CC[C@]12C,XMRPGKVKISIQBV-XWOJZHJZSA-N,316.4776,Q14994,BE0003848,Nuclear receptor subfamily 1 group I member 3,Humans,inhibitor,yes
DB07577,"2,4-Diamino-5-phenyl-6-ethylpyrimidine",small molecule,experimental,CCC1=C(C(N)=NC(N)=N1)C1=CC=CC=C1,XREDUPOVEQDQQS-UHFFFAOYSA-N,214.2664,P12461,BE0000021,Thymidylate synthase,Yeast,inhibitor,yes
DB07593,1-(PHENYLMETHYL)CYCLOPENTYL[(1S)-1-FORMYLPENTYL]CARBAMATE,small molecule,experimental,[H][C@@](CCCC)(NC(=O)OC1(CC2=CC=CC=C2)CCCC1)C=O,ONABDOMWRCXLPX-KRWDZBQOSA-N,317.4226,P07711,BE0002135,Procathepsin L,Humans,inhibitor,yes
DB07593,1-(PHENYLMETHYL)CYCLOPENTYL[(1S)-1-FORMYLPENTYL]CARBAMATE,small molecule,experimental,[H][C@@](CCCC)(NC(=O)OC1(CC2=CC=CC=C2)CCCC1)C=O,ONABDOMWRCXLPX-KRWDZBQOSA-N,317.4226,P43235,BE0003417,Cathepsin K,Humans,inhibitor,yes
DB07594,CCT-018159,small molecule,experimental,CCC1=C(O)C=C(O)C(=C1)C1=C(C(C)=NN1)C1=CC2=C(OCCO2)C=C1,OWPMENVYXDJDOW-UHFFFAOYSA-N,352.3838,P07900,BE0001120,Heat shock protein HSP 90-alpha,Humans,inhibitor,yes
DB07615,Tranilast,small molecule,investigational,COC1=CC=C(\C=C\C(=O)NC2=CC=CC=C2C(O)=O)C=C1OC,NZHGWWWHIYHZNX-CSKARUKUSA-N,327.3313,P08842,BE0001197,Steryl-sulfatase,Humans,inhibitor,yes
DB07615,Tranilast,small molecule,investigational,COC1=CC=C(\C=C\C(=O)NC2=CC=CC=C2C(O)=O)C=C1OC,NZHGWWWHIYHZNX-CSKARUKUSA-N,327.3313,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB07621,(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE,small molecule,experimental,NCC1=CC=C(O1)C1=CC=CN=C1,LENAVORGWBTPJR-UHFFFAOYSA-N,174.1992,P10635,BE0002363,Cytochrome P450 2D6,Humans,inhibitor,yes
DB07637,Dibromotyrosine,small molecule,experimental,[H][C@](N)(CC1=CC(Br)=C(O)C(Br)=C1)C(O)=O,COESHZUDRKCEPA-ZETCQYMHSA-N,338.981,P19235,BE0000654,Erythropoietin receptor,Humans,inhibitor,yes
DB07641,Decyl(dimethyl)phosphine oxide,small molecule,experimental,CCCCCCCCCCP(C)(C)=O,GSVLCKASFMVUSW-UHFFFAOYSA-N,218.3159,P21397,BE0002198,Amine oxidase [flavin-containing] A,Humans,inhibitor,yes
DB07645,Sebacic acid,small molecule,experimental,OC(=O)CCCCCCCCC(O)=O,CXMXRPHRNRROMY-UHFFFAOYSA-N,202.2475,P69905,BE0000130,Hemoglobin subunit alpha,Humans,inhibitor,yes
DB07646,"UNDECYLAMINE-N,N-DIMETHYL-N-OXIDE",small molecule,experimental,CCCCCCCCCCC[N+](C)(C)[O-],OZHBUVQCJMARBN-UHFFFAOYSA-N,215.3755,Q08210,BE0000612,"Dihydroorotate dehydrogenase (quinone), mitochondrial",Plasmodium falciparum (isolate 3D7),inhibitor,yes
DB07653,"N-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE",small molecule,experimental,OC(=O)CNC1=NC=NC2=C1C(=C(O2)C1=CC=CC=C1)C1=CC=CC=C1,VXTCEUDVOCLEJG-UHFFFAOYSA-N,345.3514,O14757,BE0003382,Serine/threonine-protein kinase Chk1,Humans,inhibitor,yes
DB07658,AC-(D)Phe-pro-borolys-OH,small molecule,experimental,CC(=O)N[C@H](CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)B(O)O,UCQIHCRMWNRFNP-QYZOEREBSA-N,432.322,P00734,BE0000048,Prothrombin,Humans,inhibitor,yes
DB07659,AC-(D)PHE-PRO-BOROHOMOLYS-OH,small molecule,experimental,[H][C@@](CCCCCN)(NC(=O)[C@]1([H])CCCN1C(=O)[C@@]([H])(CC1=CC=CC=C1)NC(C)=O)B(O)O,AILSWIBFGYYZTK-AABGKKOBSA-N,446.348,P00734,BE0000048,Prothrombin,Humans,inhibitor,yes
DB07660,AC-(D)PHE-PRO-BOROHOMOORNITHINE-OH,small molecule,experimental,[H][C@@](CCCN)(NC(=O)[C@]1([H])CCCN1C(=O)[C@@]([H])(CC1=CC=CC=C1)NC(C)=O)B(O)O,YKWKWNKWBGQECF-SQNIBIBYSA-N,418.295,P00734,BE0000048,Prothrombin,Humans,inhibitor,yes
DB07662,PD-168393,small molecule,experimental,BrC1=CC(NC2=C3C=C(NC(=O)C=C)C=CC3=NC=N2)=CC=C1,HTUBKQUPEREOGA-UHFFFAOYSA-N,369.215,P00533,BE0000767,Epidermal growth factor receptor,Humans,inhibitor,yes
DB07662,PD-168393,small molecule,experimental,BrC1=CC(NC2=C3C=C(NC(=O)C=C)C=CC3=NC=N2)=CC=C1,HTUBKQUPEREOGA-UHFFFAOYSA-N,369.215,P04626,BE0000511,Receptor tyrosine-protein kinase erbB-2,Humans,inhibitor,yes
DB07664,K-00546,small molecule,experimental,NC1=NC(NC2=CC=C(C=C2)S(N)(=O)=O)=NN1C(=S)NC1=C(F)C=CC=C1F,ARIOBGGRZJITQX-UHFFFAOYSA-N,425.436,P17948,BE0000029,Vascular endothelial growth factor receptor 1,Humans,inhibitor,yes
DB07664,K-00546,small molecule,experimental,NC1=NC(NC2=CC=C(C=C2)S(N)(=O)=O)=NN1C(=S)NC1=C(F)C=CC=C1F,ARIOBGGRZJITQX-UHFFFAOYSA-N,425.436,P06493,BE0001082,Cyclin-dependent kinase 1,Humans,inhibitor,yes
DB07664,K-00546,small molecule,experimental,NC1=NC(NC2=CC=C(C=C2)S(N)(=O)=O)=NN1C(=S)NC1=C(F)C=CC=C1F,ARIOBGGRZJITQX-UHFFFAOYSA-N,425.436,P24941,BE0001072,Cyclin-dependent kinase 2,Humans,inhibitor,yes
DB07677,"2-methyl-3,5,7,8-tetrahydro-4H-thiopyrano[4,3-d]pyrimidin-4-one",small molecule,experimental,CC1=NC2=C(CSCC2)C(=O)N1,HRYKZAKEAVZGJD-UHFFFAOYSA-N,182.243,P09874,BE0001717,Poly [ADP-ribose] polymerase 1,Humans,inhibitor,yes
DB07681,DODECANESULFONATE ION,small molecule,experimental,CCCCCCCCCCCCS([O-])(=O)=O,LDMOEFOXLIZJOW-UHFFFAOYSA-M,249.39,P06276,BE0002180,Cholinesterase,Humans,inhibitor,yes
DB07683,"N-(dibenzo[b,d]thiophen-3-ylsulfonyl)-L-valine",small molecule,experimental,[H][C@](NS(=O)(=O)C1=CC2=C(C=C1)C1=CC=CC=C1S2)(C(C)C)C(O)=O,RZWYSEXQXOXWKA-INIZCTEOSA-N,363.451,P39900,BE0001198,Macrophage metalloelastase,Humans,inhibitor,yes
DB07684,5-(DIMETHYLAMINO)-2-NAPHTHALENESULFONIC ACID,small molecule,experimental,CN(C)C1=C2C=CC(=CC2=CC=C1)S(O)(=O)=O,VENHBDIMAAXWKI-UHFFFAOYSA-N,251.302,P00750,BE0001088,Tissue-type plasminogen activator,Humans,inhibitor,yes
DB07708,3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,small molecule,experimental,OC1=CC=C(C=C1)N1N=C2C=CC(O)=CC2=C1Cl,ZNHQDSBJVFFIAK-UHFFFAOYSA-N,260.676,P03372,BE0000123,Estrogen receptor,Humans,inhibitor,yes
DB07711,"(2S,3R)-3-(6-amino-9H-purin-9-yl)nonan-2-ol",small molecule,experimental,[H][C@@](C)(O)[C@@]([H])(CCCCCC)N1C=NC2=C(N)N=CN=C12,IOSAAWHGJUZBOG-WDEREUQCSA-N,277.3653,P00813,BE0002214,Adenosine deaminase,Humans,inhibitor,yes
DB07712,3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,small molecule,experimental,CCC1=C2C=C(O)C=CC2=NN1C1=CC=C(O)C=C1,XBMVVMYGKMGLJX-UHFFFAOYSA-N,254.2839,P03372,BE0000123,Estrogen receptor,Humans,inhibitor,yes
DB07715,Emodin,small molecule,investigational,CC1=CC(O)=C2C(=O)C3=C(C=C(O)C=C3O)C(=O)C2=C1,RHMXXJGYXNZAPX-UHFFFAOYSA-N,270.2369,P68400,BE0001209,Casein kinase II subunit alpha,Humans,inhibitor,yes
DB07718,4-Hydroxyphenylpyruvic acid,small molecule,experimental,OC(=O)C(=O)CC1=CC=C(O)C=C1,KKADPXVIOXHVKN-UHFFFAOYSA-N,180.1574,P00734,BE0000048,Prothrombin,Humans,inhibitor,yes
DB07718,4-Hydroxyphenylpyruvic acid,small molecule,experimental,OC(=O)C(=O)CC1=CC=C(O)C=C1,KKADPXVIOXHVKN-UHFFFAOYSA-N,180.1574,P14174,BE0001855,Macrophage migration inhibitory factor,Humans,inhibitor,yes
DB07723,3-(5-methoxy-1H-indol-3-yl)propanoic acid,small molecule,experimental,COC1=CC=C2NC=C(CCC(O)=O)C2=C1,ZLSZCJIWILJKMR-UHFFFAOYSA-N,219.2365,P37231,BE0000215,Peroxisome proliferator-activated receptor gamma,Humans,inhibitor,yes
DB07724,Indeglitazar,small molecule,experimental,COC1=CC=C(C=C1)S(=O)(=O)N1C=C(CCC(O)=O)C2=CC(OC)=CC=C12,YMPALHOKRBVHOJ-UHFFFAOYSA-N,389.422,Q07869,BE0000071,Peroxisome proliferator-activated receptor alpha,Humans,agonist,yes
DB07724,Indeglitazar,small molecule,experimental,COC1=CC=C(C=C1)S(=O)(=O)N1C=C(CCC(O)=O)C2=CC(OC)=CC=C12,YMPALHOKRBVHOJ-UHFFFAOYSA-N,389.422,P37231,BE0000215,Peroxisome proliferator-activated receptor gamma,Humans,agonist,yes
DB07724,Indeglitazar,small molecule,experimental,COC1=CC=C(C=C1)S(=O)(=O)N1C=C(CCC(O)=O)C2=CC(OC)=CC=C12,YMPALHOKRBVHOJ-UHFFFAOYSA-N,389.422,Q03181,BE0001007,Peroxisome proliferator-activated receptor delta,Humans,agonist,yes
DB07742,"N-(2,3-DIFLUORO-BENZYL)-4-SULFAMOYL-BENZAMIDE",small molecule,experimental,NS(=O)(=O)C1=CC=C(C=C1)C(=O)NCC1=CC=CC(F)=C1F,QASSMVGOSBNFQY-UHFFFAOYSA-N,326.318,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB07767,Ferulic acid,small molecule,experimental,COC1=CC(\C=C\C(O)=O)=CC=C1O,KSEBMYQBYZTDHS-HWKANZROSA-N,194.184,O43570,BE0001653,Carbonic anhydrase 12,Humans,inhibitor,yes
DB07767,Ferulic acid,small molecule,experimental,COC1=CC(\C=C\C(O)=O)=CC=C1O,KSEBMYQBYZTDHS-HWKANZROSA-N,194.184,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB07767,Ferulic acid,small molecule,experimental,COC1=CC(\C=C\C(O)=O)=CC=C1O,KSEBMYQBYZTDHS-HWKANZROSA-N,194.184,Q9ULX7,BE0003634,Carbonic anhydrase 14,Humans,inhibitor,yes
DB07767,Ferulic acid,small molecule,experimental,COC1=CC(\C=C\C(O)=O)=CC=C1O,KSEBMYQBYZTDHS-HWKANZROSA-N,194.184,Q16790,BE0002437,Carbonic anhydrase 9,Humans,inhibitor,yes
DB07767,Ferulic acid,small molecule,experimental,COC1=CC(\C=C\C(O)=O)=CC=C1O,KSEBMYQBYZTDHS-HWKANZROSA-N,194.184,P23280,BE0003628,Carbonic anhydrase 6,Humans,inhibitor,yes
DB07767,Ferulic acid,small molecule,experimental,COC1=CC(\C=C\C(O)=O)=CC=C1O,KSEBMYQBYZTDHS-HWKANZROSA-N,194.184,P00915,BE0000267,Carbonic anhydrase 1,Humans,inhibitor,yes
DB07767,Ferulic acid,small molecule,experimental,COC1=CC(\C=C\C(O)=O)=CC=C1O,KSEBMYQBYZTDHS-HWKANZROSA-N,194.184,P22748,BE0000535,Carbonic anhydrase 4,Humans,inhibitor,yes
DB07767,Ferulic acid,small molecule,experimental,COC1=CC(\C=C\C(O)=O)=CC=C1O,KSEBMYQBYZTDHS-HWKANZROSA-N,194.184,P27338,BE0002196,Amine oxidase [flavin-containing] B,Humans,inhibitor,yes
DB07776,Flavone,small molecule,approved;experimental,O=C1C=C(OC2=CC=CC=C12)C1=CC=CC=C1,VHBFFQKBGNRLFZ-UHFFFAOYSA-N,222.2387,P11511,BE0002090,Aromatase,Humans,inhibitor,yes
DB07776,Flavone,small molecule,approved;experimental,O=C1C=C(OC2=CC=CC=C12)C1=CC=CC=C1,VHBFFQKBGNRLFZ-UHFFFAOYSA-N,222.2387,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,inhibitor,yes
DB07776,Flavone,small molecule,approved;experimental,O=C1C=C(OC2=CC=CC=C12)C1=CC=CC=C1,VHBFFQKBGNRLFZ-UHFFFAOYSA-N,222.2387,P10275,BE0000132,Androgen receptor,Humans,inhibitor,yes
DB07776,Flavone,small molecule,approved;experimental,O=C1C=C(OC2=CC=CC=C12)C1=CC=CC=C1,VHBFFQKBGNRLFZ-UHFFFAOYSA-N,222.2387,P0DMS8,BE0000354,Adenosine receptor A3,Humans,antagonist,yes
DB07776,Flavone,small molecule,approved;experimental,O=C1C=C(OC2=CC=CC=C12)C1=CC=CC=C1,VHBFFQKBGNRLFZ-UHFFFAOYSA-N,222.2387,P29275,BE0000241,Adenosine receptor A2b,Humans,antagonist,yes
DB07776,Flavone,small molecule,approved;experimental,O=C1C=C(OC2=CC=CC=C12)C1=CC=CC=C1,VHBFFQKBGNRLFZ-UHFFFAOYSA-N,222.2387,P30542,BE0000013,Adenosine receptor A1,Humans,antagonist,yes
DB07780,Farnesyl diphosphate,small molecule,experimental,CC(C)=CCC\C(C)=C\CC\C(C)=C\COP(O)(=O)OP(O)(O)=O,VWFJDQUYCIWHTN-YFVJMOTDSA-N,382.33,P37268,BE0002444,Squalene synthase,Humans,modulator,yes
DB07794,"5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE",small molecule,experimental,NC1=NNC2=C1C=C(N=N2)C1=C2C=CC=CN2N=C1C1=CC=CC=C1,XVECMUKVOMUNLE-UHFFFAOYSA-N,327.3427,P28482,BE0000923,Mitogen-activated protein kinase 1,Humans,inhibitor,yes
DB07795,Fisetin,small molecule,experimental,OC1=CC2=C(C=C1)C(=O)C(O)=C(O2)C1=CC=C(O)C(O)=C1,XHEFDIBZLJXQHF-UHFFFAOYSA-N,286.2363,Q00534,BE0002212,Cyclin-dependent kinase 6,Humans,inhibitor,yes
DB07795,Fisetin,small molecule,experimental,OC1=CC2=C(C=C1)C(=O)C(O)=C(O2)C1=CC=C(O)C(O)=C1,XHEFDIBZLJXQHF-UHFFFAOYSA-N,286.2363,P49327,BE0000959,Fatty acid synthase,Humans,inhibitor,yes
DB07803,2-phenyl-1H-imidazole-4-carboxylic acid,small molecule,experimental,OC(=O)C1=CNC(=N1)C1=CC=CC=C1,XCAXKZJNJCKTQH-UHFFFAOYSA-N,188.1827,P00807,BE0000302,Beta-lactamase,Staphylococcus aureus,inhibitor,yes
DB07810,Phloretin,small molecule,experimental,OC1=CC=C(CCC(=O)C2=C(O)C=C(O)C=C2O)C=C1,VGEREEWJJVICBM-UHFFFAOYSA-N,274.2687,Q9UHI7,BE0000168,Solute carrier family 23 member 1,Humans,inhibitor,yes
DB07829,4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDINE,small molecule,experimental,FC1=CC=C(C=C1)C1=NNC=C1C1=CC=NC=C1,BILJSHVAAVZERY-UHFFFAOYSA-N,239.2477,Q16539,BE0001019,Mitogen-activated protein kinase 14,Humans,inhibitor,yes
DB07841,Geranylgeranyl diphosphate,small molecule,experimental,CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCOP(O)(=O)OP(O)(O)=O,OINNEUNVOZHBOX-UHFFFAOYSA-N,450.449,P14324,BE0000776,Farnesyl pyrophosphate synthase,Humans,inhibitor,yes
DB07841,Geranylgeranyl diphosphate,small molecule,experimental,CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCOP(O)(=O)OP(O)(O)=O,OINNEUNVOZHBOX-UHFFFAOYSA-N,450.449,P49354,BE0002373,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,Humans,inhibitor,yes
DB07841,Geranylgeranyl diphosphate,small molecule,experimental,CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCOP(O)(=O)OP(O)(O)=O,OINNEUNVOZHBOX-UHFFFAOYSA-N,450.449,P49356,BE0002372,Protein farnesyltransferase subunit beta,Humans,inhibitor,yes
DB07842,(2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid,small molecule,experimental,[H][C@@](CC1=CC=CC=C1)(OC1=CC=C(CC)C=C1)C(O)=O,CJMVTSLLWMPEKQ-INIZCTEOSA-N,270.323,P37231,BE0000215,Peroxisome proliferator-activated receptor gamma,Humans,inhibitor,yes
DB07863,2-chloro-5-nitro-N-phenylbenzamide,small molecule,experimental,[O-][N+](=O)C1=CC=C(Cl)C(=C1)C(=O)NC1=CC=CC=C1,DNTSIBUQMRRYIU-UHFFFAOYSA-N,276.675,P19793,BE0000412,Retinoic acid receptor RXR-alpha,Humans,inhibitor,yes
DB07863,2-chloro-5-nitro-N-phenylbenzamide,small molecule,experimental,[O-][N+](=O)C1=CC=C(Cl)C(=C1)C(=O)NC1=CC=CC=C1,DNTSIBUQMRRYIU-UHFFFAOYSA-N,276.675,P37231,BE0000215,Peroxisome proliferator-activated receptor gamma,Humans,inhibitor,yes
DB07873,Lauryl alcohol diphosphonic acid,small molecule,experimental,CCCCCCCCCCCC(O)(P(O)(O)=O)P(O)(O)=O,KKVZONPEMODBBG-UHFFFAOYSA-N,346.294,P14324,BE0000776,Farnesyl pyrophosphate synthase,Humans,inhibitor,yes
DB07876,(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE,small molecule,experimental,[H][C@]1(C)CNCCCN1S(=O)(=O)C1=C2C(C)=CN=CC2=CC=C1,AWDORCFLUJZUQS-ZDUSSCGKSA-N,319.422,Q13464,BE0001016,Rho-associated protein kinase 1,Humans,inhibitor,yes
DB07884,Opaviraline,small molecule,experimental,CC[C@@H]1N(C(=O)OC(C)C)C2=C(NC1=O)C=CC(F)=C2,KELNNWMENBUHNS-NSHDSACASA-N,280.2948,P03366,BE0002050,Gag-Pol polyprotein,,modulator,yes
DB07892,1-(2-HYDROXYETHYLOXYMETHYL)-6-PHENYL THIOTHYMINE,small molecule,experimental,CC1=C(SC2=CC=CC=C2)N(COCCO)C(=O)NC1=O,HDMHBHNRWDNNCD-UHFFFAOYSA-N,308.353,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB07897,1-(HYDROXYMETHYLENEAMINO)-8-HYDROXY-OCTANE,small molecule,experimental,OCCCCCCCCNCO,SJEVZMRZAJQYFZ-UHFFFAOYSA-N,175.2685,P00734,BE0000048,Prothrombin,Humans,inhibitor,yes
DB07917,4-(BENZHYDRYLOXY)-1-[3-(1H-TETRAAZOL-5-YL)PROPYL]PIPERIDINE,small molecule,experimental,C(CN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1)CC1=NN=NN1,TZQGXAHOROZEKN-UHFFFAOYSA-N,377.4827,O60760,BE0001167,Hematopoietic prostaglandin D synthase,Humans,inhibitor,yes
DB07919,Harmine,small molecule,experimental,COC1=CC2=C(C=C1)C1=C(N2)C(C)=NC=C1,BXNJHAXVSOCGBA-UHFFFAOYSA-N,212.2472,Q92630,BE0017531,Dual specificity tyrosine-phosphorylation-regulated kinase 2,Humans,inhibitor,yes
DB07919,Harmine,small molecule,experimental,COC1=CC2=C(C=C1)C1=C(N2)C(C)=NC=C1,BXNJHAXVSOCGBA-UHFFFAOYSA-N,212.2472,O43781,BE0011693,Dual specificity tyrosine-phosphorylation-regulated kinase 3,Humans,inhibitor,yes
DB07919,Harmine,small molecule,experimental,COC1=CC2=C(C=C1)C1=C(N2)C(C)=NC=C1,BXNJHAXVSOCGBA-UHFFFAOYSA-N,212.2472,Q13627,BE0004012,Dual specificity tyrosine-phosphorylation-regulated kinase 1A,Humans,inhibitor,yes
DB07919,Harmine,small molecule,experimental,COC1=CC2=C(C=C1)C1=C(N2)C(C)=NC=C1,BXNJHAXVSOCGBA-UHFFFAOYSA-N,212.2472,P21397,BE0002198,Amine oxidase [flavin-containing] A,Humans,inhibitor,yes
DB07920,N-oxo-2-[(4-phenylphenyl)sulfonylamino]ethanamide,small molecule,experimental,O=NC(=O)CNS(=O)(=O)C1=CC=C(C=C1)C1=CC=CC=C1,OGRPZMQLAVBWPV-UHFFFAOYSA-N,304.321,P39900,BE0001198,Macrophage metalloelastase,Humans,inhibitor,yes
DB07922,N-oxo-2-(phenylsulfonylamino)ethanamide,small molecule,experimental,O=NC(=O)CNS(=O)(=O)C1=CC=CC=C1,LBEMJFIVKDOIBO-UHFFFAOYSA-N,228.225,P39900,BE0001198,Macrophage metalloelastase,Humans,inhibitor,yes
DB07926,N-[3-(N'-HYDROXYCARBOXAMIDO)-2-(2-METHYLPROPYL)-PROPANOYL]-O-TYROSINE-N-METHYLAMIDE,small molecule,experimental,[H][C@@](CC(C)C)(CC(=O)NO)C(=O)N[C@@]([H])(CC1=CC=C(OC)C=C1)C(=O)NC,QYZPDCGWIJYZMN-ZBFHGGJFSA-N,379.4507,P14780,BE0000058,Matrix metalloproteinase-9,Humans,inhibitor,yes
DB07926,N-[3-(N'-HYDROXYCARBOXAMIDO)-2-(2-METHYLPROPYL)-PROPANOYL]-O-TYROSINE-N-METHYLAMIDE,small molecule,experimental,[H][C@@](CC(C)C)(CC(=O)NO)C(=O)N[C@@]([H])(CC1=CC=C(OC)C=C1)C(=O)NC,QYZPDCGWIJYZMN-ZBFHGGJFSA-N,379.4507,O75173,BE0004687,A disintegrin and metalloproteinase with thrombospondin motifs 4,Humans,inhibitor,yes
DB07926,N-[3-(N'-HYDROXYCARBOXAMIDO)-2-(2-METHYLPROPYL)-PROPANOYL]-O-TYROSINE-N-METHYLAMIDE,small molecule,experimental,[H][C@@](CC(C)C)(CC(=O)NO)C(=O)N[C@@]([H])(CC1=CC=C(OC)C=C1)C(=O)NC,QYZPDCGWIJYZMN-ZBFHGGJFSA-N,379.4507,P22894,BE0001182,Neutrophil collagenase,Humans,inhibitor,yes
DB07926,N-[3-(N'-HYDROXYCARBOXAMIDO)-2-(2-METHYLPROPYL)-PROPANOYL]-O-TYROSINE-N-METHYLAMIDE,small molecule,experimental,[H][C@@](CC(C)C)(CC(=O)NO)C(=O)N[C@@]([H])(CC1=CC=C(OC)C=C1)C(=O)NC,QYZPDCGWIJYZMN-ZBFHGGJFSA-N,379.4507,P08254,BE0001116,Stromelysin-1,Humans,inhibitor,yes
DB07926,N-[3-(N'-HYDROXYCARBOXAMIDO)-2-(2-METHYLPROPYL)-PROPANOYL]-O-TYROSINE-N-METHYLAMIDE,small molecule,experimental,[H][C@@](CC(C)C)(CC(=O)NO)C(=O)N[C@@]([H])(CC1=CC=C(OC)C=C1)C(=O)NC,QYZPDCGWIJYZMN-ZBFHGGJFSA-N,379.4507,P08253,BE0000642,72 kDa type IV collagenase,Humans,inhibitor,yes
DB07926,N-[3-(N'-HYDROXYCARBOXAMIDO)-2-(2-METHYLPROPYL)-PROPANOYL]-O-TYROSINE-N-METHYLAMIDE,small molecule,experimental,[H][C@@](CC(C)C)(CC(=O)NO)C(=O)N[C@@]([H])(CC1=CC=C(OC)C=C1)C(=O)NC,QYZPDCGWIJYZMN-ZBFHGGJFSA-N,379.4507,P09237,BE0003690,Matrilysin,Humans,inhibitor,yes
DB07926,N-[3-(N'-HYDROXYCARBOXAMIDO)-2-(2-METHYLPROPYL)-PROPANOYL]-O-TYROSINE-N-METHYLAMIDE,small molecule,experimental,[H][C@@](CC(C)C)(CC(=O)NO)C(=O)N[C@@]([H])(CC1=CC=C(OC)C=C1)C(=O)NC,QYZPDCGWIJYZMN-ZBFHGGJFSA-N,379.4507,Q9UNA0,BE0003730,A disintegrin and metalloproteinase with thrombospondin motifs 5,Humans,inhibitor,yes
DB07926,N-[3-(N'-HYDROXYCARBOXAMIDO)-2-(2-METHYLPROPYL)-PROPANOYL]-O-TYROSINE-N-METHYLAMIDE,small molecule,experimental,[H][C@@](CC(C)C)(CC(=O)NO)C(=O)N[C@@]([H])(CC1=CC=C(OC)C=C1)C(=O)NC,QYZPDCGWIJYZMN-ZBFHGGJFSA-N,379.4507,P03956,BE0000920,Interstitial collagenase,Humans,inhibitor,yes
DB07933,Erteberel,small molecule,experimental;investigational,[H][C@@]12CCC[C@]1([H])[C@@]([H])(OC1=C2C=C(O)C=C1)C1=CC=C(O)C=C1,XIESSJVMWNJCGZ-VKJFTORMSA-N,282.3337,Q92731,BE0000792,Estrogen receptor beta,Humans,agonist,yes
DB07940,"9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE",small molecule,experimental,IC1=CC=CC(CNC2=C3CCCCC3=NC3=C2C=CC=C3)=C1,ZUCWQTWGZGIYPV-UHFFFAOYSA-N,414.2827,P06276,BE0002180,Cholinesterase,Humans,inhibitor,yes
DB07954,3-isobutyl-1-methyl-7H-xanthine,small molecule,experimental,CC(C)CN1C2=C(N=CN2)C(=O)N(C)C1=O,APIXJSLKIYYUKG-UHFFFAOYSA-N,222.2438,P30542,BE0000013,Adenosine receptor A1,Humans,antagonist,yes
DB07954,3-isobutyl-1-methyl-7H-xanthine,small molecule,experimental,CC(C)CN1C2=C(N=CN2)C(=O)N(C)C1=O,APIXJSLKIYYUKG-UHFFFAOYSA-N,222.2438,Q14432,BE0000436,"cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A",Humans,inhibitor,yes
DB07954,3-isobutyl-1-methyl-7H-xanthine,small molecule,experimental,CC(C)CN1C2=C(N=CN2)C(=O)N(C)C1=O,APIXJSLKIYYUKG-UHFFFAOYSA-N,222.2438,P29274,BE0000924,Adenosine receptor A2a,Humans,inhibitor,yes
DB07954,3-isobutyl-1-methyl-7H-xanthine,small molecule,experimental,CC(C)CN1C2=C(N=CN2)C(=O)N(C)C1=O,APIXJSLKIYYUKG-UHFFFAOYSA-N,222.2438,Q07343,BE0000487,"3',5'-cyclic-AMP phosphodiesterase 4B",Humans,inhibitor,yes
DB07954,3-isobutyl-1-methyl-7H-xanthine,small molecule,experimental,CC(C)CN1C2=C(N=CN2)C(=O)N(C)C1=O,APIXJSLKIYYUKG-UHFFFAOYSA-N,222.2438,P29275,BE0000241,Adenosine receptor A2b,Humans,inhibitor,yes
DB07954,3-isobutyl-1-methyl-7H-xanthine,small molecule,experimental,CC(C)CN1C2=C(N=CN2)C(=O)N(C)C1=O,APIXJSLKIYYUKG-UHFFFAOYSA-N,222.2438,P27815,BE0001133,"3',5'-cyclic-AMP phosphodiesterase 4A",Humans,inhibitor,yes
DB07954,3-isobutyl-1-methyl-7H-xanthine,small molecule,experimental,CC(C)CN1C2=C(N=CN2)C(=O)N(C)C1=O,APIXJSLKIYYUKG-UHFFFAOYSA-N,222.2438,P0DMS8,BE0000354,Adenosine receptor A3,Humans,inhibitor,yes
DB07954,3-isobutyl-1-methyl-7H-xanthine,small molecule,experimental,CC(C)CN1C2=C(N=CN2)C(=O)N(C)C1=O,APIXJSLKIYYUKG-UHFFFAOYSA-N,222.2438,Q08499,BE0001287,"3',5'-cyclic-AMP phosphodiesterase 4D",Humans,inhibitor,yes
DB07954,3-isobutyl-1-methyl-7H-xanthine,small molecule,experimental,CC(C)CN1C2=C(N=CN2)C(=O)N(C)C1=O,APIXJSLKIYYUKG-UHFFFAOYSA-N,222.2438,O76074,BE0000182,"cGMP-specific 3',5'-cyclic phosphodiesterase",Humans,inhibitor,yes
DB07954,3-isobutyl-1-methyl-7H-xanthine,small molecule,experimental,CC(C)CN1C2=C(N=CN2)C(=O)N(C)C1=O,APIXJSLKIYYUKG-UHFFFAOYSA-N,222.2438,O00408,BE0002085,"cGMP-dependent 3',5'-cyclic phosphodiesterase",Humans,inhibitor,yes
DB07955,(2-BROMOETHYL)(2-'FORMYL-4'-AMINOPHENYL) ACETATE,small molecule,experimental,NC1=CC(C=O)=C(CC(=O)OCCBr)C=C1,SMKXVWWBCFWRMP-UHFFFAOYSA-N,286.122,Q9UNI1,BE0003758,Chymotrypsin-like elastase family member 1,Humans,inhibitor,yes
DB07983,1-(4-IODOBENZOYL)-5-METHOXY-2-METHYL INDOLE-3-ACETIC ACID,small molecule,experimental,COC1=CC=C2N(C(=O)C3=CC=C(I)C=C3)C(C)=C(CC(O)=O)C2=C1,CXBFZYKAVCAPSV-UHFFFAOYSA-N,449.2391,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB07988,"2-[3-(5-Mercapto-[1,3,4]thiadiazol-2yl)-ureido]-N-methyl-3-pentafluorophenyl-propionamide",small molecule,experimental,CNC(=O)[C@H](CC1=C(F)C(F)=C(F)C(F)=C1F)NC(=O)NC1=NN=C(S)S1,HZAXNPDJVFUGDS-BYPYZUCNSA-N,427.373,P08254,BE0001116,Stromelysin-1,Humans,inhibitor,yes
DB07995,H-89,small molecule,experimental,BrC1=CC=C(\C=C\CNCCNS(=O)(=O)C2=CC=CC3=C2C=CN=C3)C=C1,ZKZXNDJNWUTGDK-NSCUHMNNSA-N,446.361,P17612,BE0003761,cAMP-dependent protein kinase catalytic subunit alpha,Humans,inhibitor,yes
DB07997,N-[2-(METHYLAMINO)ETHYL]-5-ISOQUINOLINESULFONAMIDE,small molecule,experimental,CNCCNS(=O)(=O)C1=CC=CC2=C1C=CN=C2,PJWUXKNZVMEPPH-UHFFFAOYSA-N,265.331,P29973,BE0005300,Cyclic nucleotide-gated channel alpha-1,Humans,blocker,yes
DB08003,ISOTHIAZOLIDINONE ANALOG,small molecule,experimental,[H][C@@](CC1=CC=C(C=C1)[C@]1([H])CC(=O)NS1(=O)=O)(NC(=O)[C@]([H])(CC1=CC=CC=C1)NC(C)=O)C(N)=O,UILYPHAKDBTKQV-UFYCRDLUSA-N,486.541,P18031,BE0000623,Tyrosine-protein phosphatase non-receptor type 1,Humans,inhibitor,yes
DB08009,SU-11652,small molecule,experimental,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(Cl)C=C3)=C1C,XPLJEFSRINKZLC-ATVHPVEESA-N,414.928,P09619,BE0000205,Platelet-derived growth factor receptor beta,Humans,inhibitor,yes
DB08009,SU-11652,small molecule,experimental,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(Cl)C=C3)=C1C,XPLJEFSRINKZLC-ATVHPVEESA-N,414.928,P16234,BE0000852,Platelet-derived growth factor receptor alpha,Humans,inhibitor,yes
DB08009,SU-11652,small molecule,experimental,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(Cl)C=C3)=C1C,XPLJEFSRINKZLC-ATVHPVEESA-N,414.928,P17948,BE0000029,Vascular endothelial growth factor receptor 1,Humans,inhibitor,yes
DB08009,SU-11652,small molecule,experimental,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(Cl)C=C3)=C1C,XPLJEFSRINKZLC-ATVHPVEESA-N,414.928,P35968,BE0000369,Vascular endothelial growth factor receptor 2,Humans,inhibitor,yes
DB08012,Pirodavir,small molecule,experimental,CCOC(=O)C1=CC=C(OCCC2CCN(CC2)C2=CC=C(C)N=N2)C=C1,KCHIOGFOPPOUJC-UHFFFAOYSA-N,369.4574,P23008,BE0004018,Genome polyprotein,HRV-1A,modulator,yes
DB08037,MK-0731,small molecule,experimental,CN([C@H]1CCN(C)C[C@H]1F)C(=O)N1CC(=C[C@@]1(CO)C1=CC=CC=C1)C1=C(F)C=CC(F)=C1,MYBGWENAVMIGMM-GIFXNVAJSA-N,459.5039,P52732,BE0001852,Kinesin-like protein KIF11,Humans,inhibitor,yes
DB08039,"(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE",small molecule,experimental,CN(C)S(=O)(=O)C1=CC=C2NC(=O)\C(=C/C3=CC4=C(CCCC4)N3)C2=C1,LOGJQOUIVKBFGH-YBEGLDIGSA-N,371.453,Q96GD4,BE0003404,Aurora kinase B,Humans,inhibitor,yes
DB08039,"(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE",small molecule,experimental,CN(C)S(=O)(=O)C1=CC=C2NC(=O)\C(=C/C3=CC4=C(CCCC4)N3)C2=C1,LOGJQOUIVKBFGH-YBEGLDIGSA-N,371.453,Q9UQB9,BE0004601,Aurora kinase C,Humans,inhibitor,yes
DB08039,"(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE",small molecule,experimental,CN(C)S(=O)(=O)C1=CC=C2NC(=O)\C(=C/C3=CC4=C(CCCC4)N3)C2=C1,LOGJQOUIVKBFGH-YBEGLDIGSA-N,371.453,P12931,BE0000838,Proto-oncogene tyrosine-protein kinase Src,Humans,inhibitor,yes
DB08039,"(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE",small molecule,experimental,CN(C)S(=O)(=O)C1=CC=C2NC(=O)\C(=C/C3=CC4=C(CCCC4)N3)C2=C1,LOGJQOUIVKBFGH-YBEGLDIGSA-N,371.453,P06239,BE0000842,Tyrosine-protein kinase Lck,Humans,inhibitor,yes
DB08039,"(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE",small molecule,experimental,CN(C)S(=O)(=O)C1=CC=C2NC(=O)\C(=C/C3=CC4=C(CCCC4)N3)C2=C1,LOGJQOUIVKBFGH-YBEGLDIGSA-N,371.453,Q13131,BE0000677,5'-AMP-activated protein kinase catalytic subunit alpha-1,Humans,inhibitor,yes
DB08039,"(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE",small molecule,experimental,CN(C)S(=O)(=O)C1=CC=C2NC(=O)\C(=C/C3=CC4=C(CCCC4)N3)C2=C1,LOGJQOUIVKBFGH-YBEGLDIGSA-N,371.453,Q9Y478,BE0000254,5'-AMP-activated protein kinase subunit beta-1,Humans,inhibitor,yes
DB08039,"(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE",small molecule,experimental,CN(C)S(=O)(=O)C1=CC=C2NC(=O)\C(=C/C3=CC4=C(CCCC4)N3)C2=C1,LOGJQOUIVKBFGH-YBEGLDIGSA-N,371.453,P54619,BE0009988,5'-AMP-activated protein kinase subunit gamma-1,Humans,inhibitor,yes
DB08040,Kelatorphan,small molecule,experimental,C[C@H](NC(=O)[C@@H](CC(=O)NO)CC1=CC=CC=C1)C(O)=O,OJCFZTVYDSKXNM-GXSJLCMTSA-N,294.3031,P15144,BE0001078,Aminopeptidase N,Humans,inhibitor,yes
DB08040,Kelatorphan,small molecule,experimental,C[C@H](NC(=O)[C@@H](CC(=O)NO)CC1=CC=CC=C1)C(O)=O,OJCFZTVYDSKXNM-GXSJLCMTSA-N,294.3031,Q07075,BE0002271,Glutamyl aminopeptidase,Humans,inhibitor,yes
DB08044,ABT-341,small molecule,experimental,[H][C@]1(N)CC(=CC[C@]1([H])C1=CC(F)=C(F)C=C1F)C(=O)N1CCN2C(C1)=NN=C2C(F)(F)F,NVVSPGQEXMJZIR-BMIGLBTASA-N,445.3616,P27487,BE0000854,Dipeptidyl peptidase 4,Humans,inhibitor,yes
DB08048,"4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL",small molecule,experimental,OC1=CC=C2C(NN=C2C2=CC=C(O)C=C2O)=C1,WLDZDEMGKFWJNR-UHFFFAOYSA-N,242.2301,P03372,BE0000123,Estrogen receptor,Humans,inhibitor,yes
DB08049,"7,8-dihydroxy-4-phenyl-2H-chromen-2-one",small molecule,experimental,OC1=CC=C2C(OC(=O)C=C2C2=CC=CC=C2)=C1O,JRVIIPJSVKTPBK-UHFFFAOYSA-N,254.2375,P21964,BE0002089,Catechol O-methyltransferase,Humans,inhibitor,yes
DB08052,PP-121,small molecule,experimental,NC1=NC=NC2=C1C(=NN2C1CCCC1)C1=CC2=C(NC=C2)N=C1,NVRXTLZYXZNATH-UHFFFAOYSA-N,319.3638,P00533,BE0000767,Epidermal growth factor receptor,Humans,inhibitor,yes
DB08052,PP-121,small molecule,experimental,NC1=NC=NC2=C1C(=NN2C1CCCC1)C1=CC2=C(NC=C2)N=C1,NVRXTLZYXZNATH-UHFFFAOYSA-N,319.3638,P78527,BE0002385,DNA-dependent protein kinase catalytic subunit,Humans,inhibitor,yes
DB08052,PP-121,small molecule,experimental,NC1=NC=NC2=C1C(=NN2C1CCCC1)C1=CC2=C(NC=C2)N=C1,NVRXTLZYXZNATH-UHFFFAOYSA-N,319.3638,P35968,BE0000369,Vascular endothelial growth factor receptor 2,Humans,inhibitor,yes
DB08052,PP-121,small molecule,experimental,NC1=NC=NC2=C1C(=NN2C1CCCC1)C1=CC2=C(NC=C2)N=C1,NVRXTLZYXZNATH-UHFFFAOYSA-N,319.3638,P48736,BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",Humans,inhibitor,yes
DB08052,PP-121,small molecule,experimental,NC1=NC=NC2=C1C(=NN2C1CCCC1)C1=CC2=C(NC=C2)N=C1,NVRXTLZYXZNATH-UHFFFAOYSA-N,319.3638,P16234,BE0000852,Platelet-derived growth factor receptor alpha,Humans,inhibitor,yes
DB08052,PP-121,small molecule,experimental,NC1=NC=NC2=C1C(=NN2C1CCCC1)C1=CC2=C(NC=C2)N=C1,NVRXTLZYXZNATH-UHFFFAOYSA-N,319.3638,P00519,BE0000014,Tyrosine-protein kinase ABL1,Humans,inhibitor,yes
DB08052,PP-121,small molecule,experimental,NC1=NC=NC2=C1C(=NN2C1CCCC1)C1=CC2=C(NC=C2)N=C1,NVRXTLZYXZNATH-UHFFFAOYSA-N,319.3638,P08631,BE0001424,Tyrosine-protein kinase HCK,Humans,inhibitor,yes
DB08052,PP-121,small molecule,experimental,NC1=NC=NC2=C1C(=NN2C1CCCC1)C1=CC2=C(NC=C2)N=C1,NVRXTLZYXZNATH-UHFFFAOYSA-N,319.3638,P42338,BE0002407,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",Humans,inhibitor,yes
DB08052,PP-121,small molecule,experimental,NC1=NC=NC2=C1C(=NN2C1CCCC1)C1=CC2=C(NC=C2)N=C1,NVRXTLZYXZNATH-UHFFFAOYSA-N,319.3638,P42345,BE0002386,Serine/threonine-protein kinase mTOR,Humans,inhibitor,yes
DB08052,PP-121,small molecule,experimental,NC1=NC=NC2=C1C(=NN2C1CCCC1)C1=CC2=C(NC=C2)N=C1,NVRXTLZYXZNATH-UHFFFAOYSA-N,319.3638,P12931,BE0000838,Proto-oncogene tyrosine-protein kinase Src,Humans,inhibitor,yes
DB08058,"4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one",small molecule,experimental,FC1=CC=C(CC2=NNC(=O)C3=CC=CC=C23)C=C1C(=O)N1CCCNCC1,HGEPGGJUGUMFHT-UHFFFAOYSA-N,380.4154,P09874,BE0001717,Poly [ADP-ribose] polymerase 1,Humans,inhibitor,yes
DB08059,Wortmannin,small molecule,experimental,[H][C@@]12CCC(=O)[C@@]1(C)C[C@@H](OC(C)=O)C1=C2C(=O)C2=C3C(=CO2)C(=O)O[C@H](COC)[C@]13C,QDLHCMPXEPAAMD-QAIWCSMKSA-N,428.4319,O00329,BE0002406,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",Humans,inhibitor,yes
DB08059,Wortmannin,small molecule,experimental,[H][C@@]12CCC(=O)[C@@]1(C)C[C@@H](OC(C)=O)C1=C2C(=O)C2=C3C(=CO2)C(=O)O[C@H](COC)[C@]13C,QDLHCMPXEPAAMD-QAIWCSMKSA-N,428.4319,P48736,BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",Humans,inhibitor,yes
DB08061,4-[3-(4-CHLOROPHENYL)-1H-PYRAZOL-5-YL]PIPERIDINE,small molecule,experimental,ClC1=CC=C(C=C1)C1=NNC(=C1)C1CCNCC1,GELALLNTKKLQLM-UHFFFAOYSA-N,261.75,P00734,BE0000048,Prothrombin,Humans,inhibitor,yes
DB08065,2-(1H-pyrazol-3-yl)-1H-benzimidazole,small molecule,experimental,N1C=CC(=N1)C1=NC2=CC=CC=C2N1,IYTGPPNUOLLGBE-UHFFFAOYSA-N,184.1973,O14965,BE0000991,Aurora kinase A,Humans,inhibitor,yes
DB08073,(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE,small molecule,experimental,[H][C@@](N)(COC1=CN=CC(=C1)C1=CC=C2NN=C(C)C2=C1)CC1=CNC2=CC=CC=C12,YWTBGJGMTBHQTM-IBGZPJMESA-N,397.4723,P31749,BE0000428,RAC-alpha serine/threonine-protein kinase,Humans,inhibitor,yes
DB08078,{4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]phenoxy}acetic acid,small molecule,experimental,CCCC1=C(OCCCOC2=CC=C(OCC(O)=O)C=C2)C=CC(C(C)=O)=C1O,HBBVCKCCQCQCTJ-UHFFFAOYSA-N,402.4376,Q03181,BE0001007,Peroxisome proliferator-activated receptor delta,Humans,agonist,yes
DB08084,IDD594,small molecule,experimental,OC(=O)COC1=CC(F)=CC=C1C(=S)NCC1=CC=C(Br)C=C1F,JCZUIWYXULSXSW-UHFFFAOYSA-N,416.237,P15121,BE0000747,Aldo-keto reductase family 1 member B1,Humans,inhibitor,yes
DB08085,1-(4-HEXYLPHENYL)PROP-2-EN-1-ONE,small molecule,experimental,CCCCCCC1=CC=C(C=C1)C(=O)C=C,IINHTEWASPUCMH-UHFFFAOYSA-N,216.3187,P10828,BE0000315,Thyroid hormone receptor beta,Humans,inhibitor,yes
DB08089,LGD-2226,small molecule,experimental,FC(F)(F)CN(CC(F)(F)F)C1=CC2=C(NC(=O)C=C2C(F)(F)F)C=C1,ULBPQWIGZUGPHU-UHFFFAOYSA-N,392.2197,P10275,BE0000132,Androgen receptor,Humans,inhibitor,yes
DB08093,3-(1-NAPHTHYLMETHOXY)PYRIDIN-2-AMINE,small molecule,experimental,NC1=C(OCC2=CC=CC3=CC=CC=C23)C=CC=N1,SZANYTFSQVBOBA-UHFFFAOYSA-N,250.2952,Q16539,BE0001019,Mitogen-activated protein kinase 14,Humans,inhibitor,yes
DB08094,RO-4584820,small molecule,investigational,COC1=CC=C(F)C(F)=C1C(=O)C1=CN=C(NC2CCN(CC2)S(C)(=O)=O)N=C1N,JRNJNYBQQYBCLE-UHFFFAOYSA-N,441.452,P11802,BE0002216,Cyclin-dependent kinase 4,Humans,inhibitor,yes
DB08094,RO-4584820,small molecule,investigational,COC1=CC=C(F)C(F)=C1C(=O)C1=CN=C(NC2CCN(CC2)S(C)(=O)=O)N=C1N,JRNJNYBQQYBCLE-UHFFFAOYSA-N,441.452,P06493,BE0001082,Cyclin-dependent kinase 1,Humans,inhibitor,yes
DB08094,RO-4584820,small molecule,investigational,COC1=CC=C(F)C(F)=C1C(=O)C1=CN=C(NC2CCN(CC2)S(C)(=O)=O)N=C1N,JRNJNYBQQYBCLE-UHFFFAOYSA-N,441.452,P50613,BE0001913,Cyclin-dependent kinase 7,Humans,inhibitor,yes
DB08094,RO-4584820,small molecule,investigational,COC1=CC=C(F)C(F)=C1C(=O)C1=CN=C(NC2CCN(CC2)S(C)(=O)=O)N=C1N,JRNJNYBQQYBCLE-UHFFFAOYSA-N,441.452,P24941,BE0001072,Cyclin-dependent kinase 2,Humans,inhibitor,yes
DB08121,(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid,small molecule,experimental,[H][C@@](CC1=CC=CC=C1)(OC1=CC=C(C=C1)C1=CC=CC=C1)C(O)=O,TZTPJJNNACUQQR-FQEVSTJZSA-N,318.3658,P37231,BE0000215,Peroxisome proliferator-activated receptor gamma,Humans,inhibitor,yes
DB08132,5-hydroxynaphthalene-1-sulfonamide,small molecule,experimental,NS(=O)(=O)C1=C2C=CC=C(O)C2=CC=C1,NFVBVKHGDDDCEA-UHFFFAOYSA-N,223.248,P24941,BE0001072,Cyclin-dependent kinase 2,Humans,inhibitor,yes
DB08133,N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide,small molecule,experimental,NS(=O)(=O)C1=CC=C(NC(=O)C2=NNC3=C2C=CC=C3)C=C1,MNHPHKFLWAPNOV-UHFFFAOYSA-N,316.335,P24941,BE0001072,Cyclin-dependent kinase 2,Humans,inhibitor,yes
DB08134,4-[(6-chloropyrazin-2-yl)amino]benzenesulfonamide,small molecule,experimental,NS(=O)(=O)C1=CC=C(NC2=NC(Cl)=CN=C2)C=C1,RSNSGNZRUMHXAY-UHFFFAOYSA-N,284.722,P24941,BE0001072,Cyclin-dependent kinase 2,Humans,inhibitor,yes
DB08135,N-phenyl-1H-pyrazole-3-carboxamide,small molecule,experimental,O=C(NC1=CC=CC=C1)C1=NNC=C1,WMZYZYFPPQOFKY-UHFFFAOYSA-N,187.198,P24941,BE0001072,Cyclin-dependent kinase 2,Humans,inhibitor,yes
DB08142,AT-7519,small molecule,investigational,ClC1=CC=CC(Cl)=C1C(=O)NC1=CNN=C1C(=O)NC1CCNCC1,OVPNQJVDAFNBDN-UHFFFAOYSA-N,382.244,P24941,BE0001072,Cyclin-dependent kinase 2,Humans,inhibitor,yes
DB08155,N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE,small molecule,experimental,CC(=O)NCCC1=CC=C(C=C1)S(N)(=O)=O,IIMGUEXQORZTID-UHFFFAOYSA-N,242.295,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB08155,N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE,small molecule,experimental,CC(=O)NCCC1=CC=C(C=C1)S(N)(=O)=O,IIMGUEXQORZTID-UHFFFAOYSA-N,242.295,P00915,BE0000267,Carbonic anhydrase 1,Humans,inhibitor,yes
DB08156,3-[4-(AMINOSULFONYL)PHENYL]PROPANOIC ACID,small molecule,experimental,NS(=O)(=O)C1=CC=C(CCC(O)=O)C=C1,JUEONDBIBADVGD-UHFFFAOYSA-N,229.253,P00915,BE0000267,Carbonic anhydrase 1,Humans,inhibitor,yes
DB08156,3-[4-(AMINOSULFONYL)PHENYL]PROPANOIC ACID,small molecule,experimental,NS(=O)(=O)C1=CC=C(CCC(O)=O)C=C1,JUEONDBIBADVGD-UHFFFAOYSA-N,229.253,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB08157,ETHYL 3-[4-(AMINOSULFONYL)PHENYL]PROPANOATE,small molecule,experimental,CCOC(=O)CCC1=CC=C(C=C1)S(N)(=O)=O,OJBJALUJMRMNIR-UHFFFAOYSA-N,257.306,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB08157,ETHYL 3-[4-(AMINOSULFONYL)PHENYL]PROPANOATE,small molecule,experimental,CCOC(=O)CCC1=CC=C(C=C1)S(N)(=O)=O,OJBJALUJMRMNIR-UHFFFAOYSA-N,257.306,P00915,BE0000267,Carbonic anhydrase 1,Humans,inhibitor,yes
DB08162,Fasudil,small molecule,investigational,O=S(=O)(N1CCCNCC1)C1=CC=CC2=C1C=CN=C2,NGOGFTYYXHNFQH-UHFFFAOYSA-N,291.369,Q13464,BE0001016,Rho-associated protein kinase 1,Humans,inhibitor,yes
DB08165,indane-5-sulfonamide,small molecule,experimental,NS(=O)(=O)C1=CC=C2CCCC2=C1,XVQJTFMKKZBBSX-UHFFFAOYSA-N,197.254,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB08165,indane-5-sulfonamide,small molecule,experimental,NS(=O)(=O)C1=CC=C2CCCC2=C1,XVQJTFMKKZBBSX-UHFFFAOYSA-N,197.254,Q9ULX7,BE0003634,Carbonic anhydrase 14,Humans,inhibitor,yes
DB08165,indane-5-sulfonamide,small molecule,experimental,NS(=O)(=O)C1=CC=C2CCCC2=C1,XVQJTFMKKZBBSX-UHFFFAOYSA-N,197.254,O43570,BE0001653,Carbonic anhydrase 12,Humans,inhibitor,yes
DB08165,indane-5-sulfonamide,small molecule,experimental,NS(=O)(=O)C1=CC=C2CCCC2=C1,XVQJTFMKKZBBSX-UHFFFAOYSA-N,197.254,P00915,BE0000267,Carbonic anhydrase 1,Humans,inhibitor,yes
DB08167,Methylthioninium,small molecule,experimental;investigational,CN(C)C1=CC2=[S+]C3=CC(=CC=C3N=C2C=C1)N(C)C,RBTBFTRPCNLSDE-UHFFFAOYSA-N,284.399,P22303,BE0000426,Acetylcholinesterase,Humans,inhibitor,yes
DB08168,Coumarin 120,small molecule,experimental,CC1=CC(=O)OC2=C1C=CC(N)=C2,GLNDAGDHSLMOKX-UHFFFAOYSA-N,175.184,P62937,BE0001014,Peptidyl-prolyl cis-trans isomerase A,Humans,inhibitor,yes
DB08178,"4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine",small molecule,experimental,COC1=C2C(NC=C2C2=NC(N)=NC=C2)=NC=C1,GGEWEQJWGGJUHO-UHFFFAOYSA-N,241.2486,P50750,BE0002207,Cyclin-dependent kinase 9,Humans,inhibitor,yes
DB08178,"4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine",small molecule,experimental,COC1=C2C(NC=C2C2=NC(N)=NC=C2)=NC=C1,GGEWEQJWGGJUHO-UHFFFAOYSA-N,241.2486,P24941,BE0001072,Cyclin-dependent kinase 2,Humans,inhibitor,yes
DB08180,2-[METHYL-(5-GERANYL-4-METHYL-PENT-3-ENYL)-AMINO]-ETHYL-DIPHOSPHATE,small molecule,experimental,CN(CCO[P@@](O)(=O)OP(O)(O)=O)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C,OEMBPHBKZPOPBN-NWLVNBMCSA-N,453.4471,P14324,BE0000776,Farnesyl pyrophosphate synthase,Humans,inhibitor,yes
DB08182,"4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine",small molecule,experimental,CCCOC1=C2C(NC=C2C2=NC(N)=NC=C2)=NC=C1,ZHMRPXZRUZLCNL-UHFFFAOYSA-N,269.3018,P50750,BE0002207,Cyclin-dependent kinase 9,Humans,inhibitor,yes
DB08182,"4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine",small molecule,experimental,CCCOC1=C2C(NC=C2C2=NC(N)=NC=C2)=NC=C1,ZHMRPXZRUZLCNL-UHFFFAOYSA-N,269.3018,P24941,BE0001072,Cyclin-dependent kinase 2,Humans,inhibitor,yes
DB08188,Emivirine,small molecule,investigational,CCOCN1C(=O)NC(=O)C(C(C)C)=C1CC1=CC=CC=C1,MLILORUFDVLTSP-UHFFFAOYSA-N,302.3682,P03366,BE0002050,Gag-Pol polyprotein,,modulator,yes
DB08190,N-[2-(2-iodo-5-methoxy-1H-indol-3-yl)ethyl]acetamide,small molecule,experimental,COC1=CC=C2NC(I)=C(CCNC(C)=O)C2=C1,FJDDSMSDZHURBJ-UHFFFAOYSA-N,358.1749,P48039,BE0000515,Melatonin receptor type 1A,Humans,agonist,yes
DB08190,N-[2-(2-iodo-5-methoxy-1H-indol-3-yl)ethyl]acetamide,small molecule,experimental,COC1=CC=C2NC(I)=C(CCNC(C)=O)C2=C1,FJDDSMSDZHURBJ-UHFFFAOYSA-N,358.1749,P49286,BE0000327,Melatonin receptor type 1B,Humans,inhibitor,yes
DB08190,N-[2-(2-iodo-5-methoxy-1H-indol-3-yl)ethyl]acetamide,small molecule,experimental,COC1=CC=C2NC(I)=C(CCNC(C)=O)C2=C1,FJDDSMSDZHURBJ-UHFFFAOYSA-N,358.1749,P16083,BE0000220,Ribosyldihydronicotinamide dehydrogenase [quinone],Humans,inhibitor,yes
DB08192,2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE,small molecule,experimental,[H][C@]1(CC2=C(CN1)C=CC=C2)C1=NC(C(O)=O)=C(S1)C(C)C,HCUGCUQZFBURHR-LBPRGKRZSA-N,302.391,P12931,BE0000838,Proto-oncogene tyrosine-protein kinase Src,Humans,inhibitor,yes
DB08200,(1R)-menthyl hexyl phosphonate group,small molecule,experimental,CCCCCCP(O)(=O)O[C@@H]1C[C@H](C)CC[C@H]1C(C)C,WAVIZOVSJOXCKT-OWCLPIDISA-N,304.4052,P06276,BE0002180,Cholinesterase,Humans,inhibitor,yes
DB08201,(1S)-menthyl hexyl phosphonate group,small molecule,experimental,CCCCCCP(O)(=O)O[C@H]1C[C@@H](C)CC[C@@H]1C(C)C,WAVIZOVSJOXCKT-XHSDSOJGSA-N,304.4052,P06276,BE0002180,Cholinesterase,Humans,inhibitor,yes
DB08204,3-DIPHENOL-6-NITRO-3H-BENZO[DE]ISOCHROMEN-1-ONE,small molecule,experimental,OC1=CC=C(C=C1)C1(OC(=O)C2=CC=CC3=C(C=CC1=C23)[N+]([O-])=O)C1=CC=C(O)C=C1,FLWABCQDXUKNQY-UHFFFAOYSA-N,413.379,P12461,BE0000021,Thymidylate synthase,Yeast,inhibitor,yes
DB08214,4-(1H-IMIDAZOL-1-YL)PHENOL,small molecule,experimental,OC1=CC=C(C=C1)N1C=CN=C1,CYKCUAPYWQDIKR-UHFFFAOYSA-N,160.1726,P35228,BE0000005,"Nitric oxide synthase, inducible",Humans,inhibitor,yes
DB08222,METHOXYUNDECYLPHOSPHINIC ACID,small molecule,experimental,CCCCCCCCCCC[P@@](O)(=O)OC,JBVUSHKPEBKWQP-UHFFFAOYSA-N,250.3147,P16233,BE0000683,Pancreatic triacylglycerol lipase,Humans,inhibitor,yes
DB08228,"5,8-dimethoxy-1,4-dimethylquinolin-2(1H)-one",small molecule,experimental,COC1=C2N(C)C(=O)C=C(C)C2=C(OC)C=C1,FTGZPMFPUDKJBX-UHFFFAOYSA-N,233.2631,P16083,BE0000220,Ribosyldihydronicotinamide dehydrogenase [quinone],Humans,inhibitor,yes
DB08231,Myristic acid,small molecule,experimental,CCCCCCCCCCCCCC(O)=O,TUNFSRHWOTWDNC-UHFFFAOYSA-N,228.3709,P00519,BE0000014,Tyrosine-protein kinase ABL1,Humans,inhibitor,yes
DB08231,Myristic acid,small molecule,experimental,CCCCCCCCCCCCCC(O)=O,TUNFSRHWOTWDNC-UHFFFAOYSA-N,228.3709,P0DP23,BE0012563,Calmodulin-1,Humans,inhibitor,yes
DB08231,Myristic acid,small molecule,experimental,CCCCCCCCCCCCCC(O)=O,TUNFSRHWOTWDNC-UHFFFAOYSA-N,228.3709,P0DP25,BE0008706,Calmodulin-3,Humans,inhibitor,yes
DB08231,Myristic acid,small molecule,experimental,CCCCCCCCCCCCCC(O)=O,TUNFSRHWOTWDNC-UHFFFAOYSA-N,228.3709,P0DP24,BE0008705,Calmodulin-2,Humans,inhibitor,yes
DB08231,Myristic acid,small molecule,experimental,CCCCCCCCCCCCCC(O)=O,TUNFSRHWOTWDNC-UHFFFAOYSA-N,228.3709,O00206,BE0002442,Toll-like receptor 4,Humans,inhibitor,yes
DB08231,Myristic acid,small molecule,experimental,CCCCCCCCCCCCCC(O)=O,TUNFSRHWOTWDNC-UHFFFAOYSA-N,228.3709,P62942,BE0000695,Peptidyl-prolyl cis-trans isomerase FKBP1A,Humans,inhibitor,yes
DB08233,6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE,small molecule,experimental,OC1=CC=C(NC2=NC(OCC3CCCCC3)=C3N=CNC3=N2)C=C1,RFSDQDHHBKYQOD-UHFFFAOYSA-N,339.3916,P24941,BE0001072,Cyclin-dependent kinase 2,Humans,inhibitor,yes
DB08238,5-aminonaphthalene-2-sulfonic acid,small molecule,experimental,NC1=C2C=CC(=CC2=CC=C1)S(O)(=O)=O,UWPJYQYRSWYIGZ-UHFFFAOYSA-N,223.248,P05230,BE0000689,Fibroblast growth factor 1,Humans,inhibitor,yes
DB08249,"3,6,9,12,15-PENTAOXATRICOSAN-1-OL",small molecule,experimental,CCCCCCCCOCCOCCOCCOCCOCCO,MJELOWOAIAAUJT-UHFFFAOYSA-N,350.4907,Q08210,BE0000612,"Dihydroorotate dehydrogenase (quinone), mitochondrial",Plasmodium falciparum (isolate 3D7),inhibitor,yes
DB08254,2-Naphthalenesulfonic acid,small molecule,experimental,OS(=O)(=O)C1=CC2=CC=CC=C2C=C1,KVBGVZZKJNLNJU-UHFFFAOYSA-N,208.234,P00734,BE0000048,Prothrombin,Humans,inhibitor,yes
DB08256,N-[(CYCLOHEXYLAMINO)CARBONYL]GLYCINE,small molecule,experimental,OC(=O)CNC(=O)NC1CCCCC1,NVORCMBCUHQRDL-UHFFFAOYSA-N,200.2349,P34913,BE0000950,Bifunctional epoxide hydrolase 2,Humans,inhibitor,yes
DB08257,4-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}BUTANOIC ACID,small molecule,experimental,OC(=O)CCCNC(=O)NC1CCCCC1,WSVFRGGLURJIMG-UHFFFAOYSA-N,228.2881,P34913,BE0000950,Bifunctional epoxide hydrolase 2,Humans,inhibitor,yes
DB08258,6-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEXANOIC ACID,small molecule,experimental,OC(=O)CCCCCNC(=O)NC1CCCCC1,KFTVEPYSUSWBRD-UHFFFAOYSA-N,256.3413,P34913,BE0000950,Bifunctional epoxide hydrolase 2,Humans,inhibitor,yes
DB08262,"2,6-dicarboxynaphthalene",small molecule,experimental,OC(=O)C1=CC2=CC=C(C=C2C=C1)C(O)=O,RXOHFPCZGPKIRD-UHFFFAOYSA-N,216.1895,P69905,BE0000130,Hemoglobin subunit alpha,Humans,inhibitor,yes
DB08312,"6-CYCLOHEXYLMETHYLOXY-5-NITROSO-PYRIMIDINE-2,4-DIAMINE",small molecule,experimental,NC1=NC(N)=C(N=O)C(OCC2CCCCC2)=N1,DGWXOLHKVGDQLN-UHFFFAOYSA-N,251.285,P24941,BE0001072,Cyclin-dependent kinase 2,Humans,inhibitor,yes
DB08321,"(1S,2S,3R,6R)-4-(hydroxymethyl)-6-(octylamino)cyclohex-4-ene-1,2,3-triol",small molecule,experimental,[H][C@@]1(O)C(CO)=C[C@@]([H])(NCCCCCCCC)[C@]([H])(O)[C@@]1([H])O,UPZUHYMBTUUPML-KBXIAJHMSA-N,287.3951,P04062,BE0000978,Lysosomal acid glucosylceramidase,Humans,inhibitor,yes
DB08324,N-3-OXO-DODECANOYL-L-HOMOSERINE LACTONE,small molecule,experimental,[H][C@@]1(CCOC1=O)NC(=O)CC(=O)CCCCCCCCC,PHSRRHGYXQCRPU-AWEZNQCLSA-N,297.3899,P00749,BE0000895,Urokinase-type plasminogen activator,Humans,inhibitor,yes
DB08329,Sulthiame,small molecule,approved,NS(=O)(=O)C1=CC=C(C=C1)N1CCCCS1(=O)=O,HMHVCUVYZFYAJI-UHFFFAOYSA-N,290.359,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB08339,PD-166326,small molecule,experimental,CN1C(=O)C(=CC2=CN=C(NC3=CC=CC(CO)=C3)N=C12)C1=C(Cl)C=CC=C1Cl,ZIQFYVPVJZEOFS-UHFFFAOYSA-N,427.283,P10721,BE0000453,Mast/stem cell growth factor receptor Kit,Humans,inhibitor,yes
DB08339,PD-166326,small molecule,experimental,CN1C(=O)C(=CC2=CN=C(NC3=CC=CC(CO)=C3)N=C12)C1=C(Cl)C=CC=C1Cl,ZIQFYVPVJZEOFS-UHFFFAOYSA-N,427.283,Q16539,BE0001019,Mitogen-activated protein kinase 14,Humans,inhibitor,yes
DB08339,PD-166326,small molecule,experimental,CN1C(=O)C(=CC2=CN=C(NC3=CC=CC(CO)=C3)N=C12)C1=C(Cl)C=CC=C1Cl,ZIQFYVPVJZEOFS-UHFFFAOYSA-N,427.283,P06239,BE0000842,Tyrosine-protein kinase Lck,Humans,inhibitor,yes
DB08339,PD-166326,small molecule,experimental,CN1C(=O)C(=CC2=CN=C(NC3=CC=CC(CO)=C3)N=C12)C1=C(Cl)C=CC=C1Cl,ZIQFYVPVJZEOFS-UHFFFAOYSA-N,427.283,P11362,BE0002131,Fibroblast growth factor receptor 1,Humans,inhibitor,yes
DB08339,PD-166326,small molecule,experimental,CN1C(=O)C(=CC2=CN=C(NC3=CC=CC(CO)=C3)N=C12)C1=C(Cl)C=CC=C1Cl,ZIQFYVPVJZEOFS-UHFFFAOYSA-N,427.283,P09619,BE0000205,Platelet-derived growth factor receptor beta,Humans,inhibitor,yes
DB08339,PD-166326,small molecule,experimental,CN1C(=O)C(=CC2=CN=C(NC3=CC=CC(CO)=C3)N=C12)C1=C(Cl)C=CC=C1Cl,ZIQFYVPVJZEOFS-UHFFFAOYSA-N,427.283,P00533,BE0000767,Epidermal growth factor receptor,Humans,inhibitor,yes
DB08339,PD-166326,small molecule,experimental,CN1C(=O)C(=CC2=CN=C(NC3=CC=CC(CO)=C3)N=C12)C1=C(Cl)C=CC=C1Cl,ZIQFYVPVJZEOFS-UHFFFAOYSA-N,427.283,P16234,BE0000852,Platelet-derived growth factor receptor alpha,Humans,inhibitor,yes
DB08339,PD-166326,small molecule,experimental,CN1C(=O)C(=CC2=CN=C(NC3=CC=CC(CO)=C3)N=C12)C1=C(Cl)C=CC=C1Cl,ZIQFYVPVJZEOFS-UHFFFAOYSA-N,427.283,P12931,BE0000838,Proto-oncogene tyrosine-protein kinase Src,Humans,inhibitor,yes
DB08339,PD-166326,small molecule,experimental,CN1C(=O)C(=CC2=CN=C(NC3=CC=CC(CO)=C3)N=C12)C1=C(Cl)C=CC=C1Cl,ZIQFYVPVJZEOFS-UHFFFAOYSA-N,427.283,P00519,BE0000014,Tyrosine-protein kinase ABL1,Humans,inhibitor,yes
DB08348,"N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE",small molecule,experimental,CN(C)CC(=O)NC1=CC2=C(NC(=O)C3=CC=CC=C23)C=C1,UYJZZVDLGDDTCL-UHFFFAOYSA-N,295.3358,P09874,BE0001717,Poly [ADP-ribose] polymerase 1,Humans,inhibitor,yes
DB08357,Diethylene glycol diethyl ether,small molecule,experimental,CCOCCOCCOCC,RRQYJINTUHWNHW-UHFFFAOYSA-N,162.2267,P22303,BE0000426,Acetylcholinesterase,Humans,inhibitor,yes
DB08358,"2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",small molecule,experimental,O=C1NCCC2=C1C=C(N2)C1=CC(=NC=C1)C1=CC2=C(C=CC=C2)N=C1,OWFLADWRSCINST-UHFFFAOYSA-N,340.3779,Q8IW41,BE0009478,MAP kinase-activated protein kinase 5,Humans,inhibitor,yes
DB08358,"2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",small molecule,experimental,O=C1NCCC2=C1C=C(N2)C1=CC(=NC=C1)C1=CC2=C(C=CC=C2)N=C1,OWFLADWRSCINST-UHFFFAOYSA-N,340.3779,P49137,BE0001373,MAP kinase-activated protein kinase 2,Humans,inhibitor,yes
DB08361,"2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide",small molecule,experimental,[H][C@]1(N)CCCC[C@@]1([H])NC1=NC(NC2=CC=CC(C)=C2)=C(C=N1)C(N)=O,NZNTWOVDIXCHHS-LSDHHAIUSA-N,340.4228,P43405,BE0001316,Tyrosine-protein kinase SYK,Humans,inhibitor,yes
DB08363,1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine,small molecule,experimental,CCN1C2=CC=C(CNC)C=C2C2=C1C=CC=C2,LBPNOEAFWYTTEB-UHFFFAOYSA-N,238.3275,P04637,BE0003380,Cellular tumor antigen p53,Humans,inhibitor,yes
DB08371,p-Benzoyl-L-phenylalanine,small molecule,experimental,N[C@@H](CC1=CC=C(C=C1)C(=O)C1=CC=CC=C1)C(O)=O,TVIDEEHSOPHZBR-AWEZNQCLSA-N,269.2952,P18031,BE0000623,Tyrosine-protein phosphatase non-receptor type 1,Humans,inhibitor,yes
DB08382,Gosogliptin,small molecule,investigational,[H][C@]1(CN[C@@]([H])(C1)C(=O)N1CCC(F)(F)C1)N1CCN(CC1)C1=NC=CC=N1,QWEWGXUTRTXFRF-KBPBESRZSA-N,366.4089,P27487,BE0000854,Dipeptidyl peptidase 4,Humans,inhibitor,yes
DB08387,Mardepodect,small molecule,investigational,CN1C=C(C(=N1)C1=CC=C(OCC2=NC3=CC=CC=C3C=C2)C=C1)C1=CC=NC=C1,AZEXWHKOMMASPA-UHFFFAOYSA-N,392.4525,Q9Y233,BE0000631,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",Humans,inhibitor,yes
DB08388,"5-(2-ETHOXYETHYL)-5-[4-(4-FLUOROPHENOXY)PHENOXY]PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE",small molecule,experimental,CCOCCC1(OC2=CC=C(OC3=CC=C(F)C=C3)C=C2)C(=O)NC(=O)NC1=O,XRSYNYGEEYTXJV-UHFFFAOYSA-N,402.3731,P45452,BE0000966,Collagenase 3,Humans,inhibitor,yes
DB08398,"2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine",small molecule,investigational,CN1C(N)=NC2=NC=C(C=C12)C1=CC=CC=C1,UQVKZNNCIHJZLS-UHFFFAOYSA-N,224.2612,P03372,BE0000123,Estrogen receptor,Humans,inhibitor,yes
DB08403,METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID,small molecule,experimental,[H][C@@](CC(C)C)(CC(=O)NO)C(=O)N[C@@]([H])(CC1=CC=CC=C1)C(=O)NC,MOPRTFSMCQNUCT-CABCVRRESA-N,349.4247,P22894,BE0001182,Neutrophil collagenase,Humans,inhibitor,yes
DB08403,METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID,small molecule,experimental,[H][C@@](CC(C)C)(CC(=O)NO)C(=O)N[C@@]([H])(CC1=CC=CC=C1)C(=O)NC,MOPRTFSMCQNUCT-CABCVRRESA-N,349.4247,P03956,BE0000920,Interstitial collagenase,Humans,inhibitor,yes
DB08414,PNU-142721,small molecule,experimental,C[C@H](SC1=NC(Cl)=CC(N)=N1)C1=CC2=C(OC=C2)C=N1,ATCRIOJPQXDFNY-ZETCQYMHSA-N,306.771,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB08416,"(9BETA,13ALPHA,14BETA,17ALPHA)-2-METHOXYESTRA-1,3,5(10)-TRIENE-3,17-DIYL DISULFAMATE",small molecule,experimental,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=C(C=C(OC)C(OS(N)(=O)=O)=C4)[C@@]3([H])CC[C@]12C)OS(N)(=O)=O,AQSNIXKAKUZPSI-SSTWWWIQSA-N,460.565,P08842,BE0001197,Steryl-sulfatase,Humans,inhibitor,yes
DB08416,"(9BETA,13ALPHA,14BETA,17ALPHA)-2-METHOXYESTRA-1,3,5(10)-TRIENE-3,17-DIYL DISULFAMATE",small molecule,experimental,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=C(C=C(OC)C(OS(N)(=O)=O)=C4)[C@@]3([H])CC[C@]12C)OS(N)(=O)=O,AQSNIXKAKUZPSI-SSTWWWIQSA-N,460.565,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB08424,"[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE",small molecule,experimental,[H][C@](O)(CO)COC1=CC(=CC=C1)C(=O)C1=C(N)N(N=C1)C1=CC=C(F)C=C1,IJDQETGUEUJVTB-HNNXBMFYSA-N,371.3623,Q16539,BE0001019,Mitogen-activated protein kinase 14,Humans,inhibitor,yes
DB08436,"8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-",small molecule,experimental,CCCCN1C(CC2=CC3=C(OCO3)C=C2)=NC2=C(N)N=CN=C12,JCDXXNIRWRRGBX-UHFFFAOYSA-N,325.3651,P07900,BE0001120,Heat shock protein HSP 90-alpha,Humans,inhibitor,yes
DB08439,Parecoxib,small molecule,approved,CCC(=O)NS(=O)(=O)C1=CC=C(C=C1)C1=C(C)ON=C1C1=CC=CC=C1,TZRHLKRLEZJVIJ-UHFFFAOYSA-N,370.422,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB08439,Parecoxib,small molecule,approved,CCC(=O)NS(=O)(=O)C1=CC=C(C=C1)C1=C(C)ON=C1C1=CC=CC=C1,TZRHLKRLEZJVIJ-UHFFFAOYSA-N,370.422,P02788,BE0000994,Lactotransferrin,Humans,inhibitor,yes
DB08443,"2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol",small molecule,experimental,OC1=CC(O)=C(C(=O)N2C=CC=C2)C(O)=C1,RYGSNHBTZDYVSS-UHFFFAOYSA-N,219.1935,P07900,BE0001120,Heat shock protein HSP 90-alpha,Humans,inhibitor,yes
DB08454,N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE,small molecule,experimental,CC1=CC(NC2=C3C=CC=CC3=NC(=N2)C2=CC=CC=C2)=NN1,JYCUVOXSZBECAY-UHFFFAOYSA-N,301.3452,Q9UQB9,BE0004601,Aurora kinase C,Humans,inhibitor,yes
DB08454,N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE,small molecule,experimental,CC1=CC(NC2=C3C=CC=CC3=NC(=N2)C2=CC=CC=C2)=NN1,JYCUVOXSZBECAY-UHFFFAOYSA-N,301.3452,P49841,BE0001065,Glycogen synthase kinase-3 beta,Humans,inhibitor,yes
DB08454,N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE,small molecule,experimental,CC1=CC(NC2=C3C=CC=CC3=NC(=N2)C2=CC=CC=C2)=NN1,JYCUVOXSZBECAY-UHFFFAOYSA-N,301.3452,P12931,BE0000838,Proto-oncogene tyrosine-protein kinase Src,Humans,inhibitor,yes
DB08462,N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE,small molecule,experimental,C=CC(=O)NC1=CC=C2N=CN=C(NC3=CC=CC=C3)C2=C1,JGWHILNNHLDARR-UHFFFAOYSA-N,290.3193,P00533,BE0000767,Epidermal growth factor receptor,Humans,inhibitor,yes
DB08462,N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE,small molecule,experimental,C=CC(=O)NC1=CC=C2N=CN=C(NC3=CC=CC=C3)C2=C1,JGWHILNNHLDARR-UHFFFAOYSA-N,290.3193,P12931,BE0000838,Proto-oncogene tyrosine-protein kinase Src,Humans,inhibitor,yes
DB08466,"5-[2-(4-hydroxyphenyl)ethyl]benzene-1,3-diol",small molecule,experimental,OC1=CC=C(CCC2=CC(O)=CC(O)=C2)C=C1,HITJFUSPLYBJPE-UHFFFAOYSA-N,230.2592,P09960,BE0001680,Leukotriene A-4 hydrolase,Humans,inhibitor,yes
DB08473,Dichlororibofuranosylbenzimidazole,small molecule,experimental,OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=CC(Cl)=C(Cl)C=C12,XHSQDZXAVJRBMX-DDHJBXDOSA-N,319.141,P68400,BE0001209,Casein kinase II subunit alpha,Humans,inhibitor,yes
DB08476,3-AMINO-AZACYCLOTRIDECAN-2-ONE,small molecule,experimental,[H][C@]1(N)CCCCCCCCCCNC1=O,CQZLEYBEPASILI-NSHDSACASA-N,212.3318,P22894,BE0001182,Neutrophil collagenase,Humans,inhibitor,yes
DB08480,4-HYDROXY-N-PROPARGYL-1(R)-AMINOINDAN,small molecule,experimental,[H][C@]1(CCC2=C1C=CC=C2O)\N=C\C=C,OFWOPQIDDNCCLL-KAQJVSAMSA-N,187.2377,P27338,BE0002196,Amine oxidase [flavin-containing] B,Humans,inhibitor,yes
DB08482,[[1-[N-HYDROXY-ACETAMIDYL]-3-METHYL-BUTYL]-CARBONYL-LEUCINYL]-ALANINE ETHYL ESTER,small molecule,experimental,[H][C@@](C)(NC(=O)[C@]([H])(CC(C)C)NC(=O)[C@]([H])(CC(C)C)CC(=O)NO)C(=O)OCC,XKRONJXEXGFBRZ-ZNMIVQPWSA-N,401.4977,P03956,BE0000920,Interstitial collagenase,Humans,inhibitor,yes
DB08484,4-AMINO-N-[(2-SULFANYLETHYL)CARBAMOYL]BENZENESULFONAMIDE,small molecule,experimental,NC1=CC=C(C=C1)S(=O)(=O)NC(=O)NCCS,LHVDNDIAMJOEKH-UHFFFAOYSA-N,275.348,P09467,BE0002431,"Fructose-1,6-bisphosphatase 1",Humans,inhibitor,yes
DB08484,4-AMINO-N-[(2-SULFANYLETHYL)CARBAMOYL]BENZENESULFONAMIDE,small molecule,experimental,NC1=CC=C(C=C1)S(=O)(=O)NC(=O)NCCS,LHVDNDIAMJOEKH-UHFFFAOYSA-N,275.348,O00757,BE0011215,"Fructose-1,6-bisphosphatase isozyme 2",Humans,inhibitor,yes
DB08486,Efaproxiral,small molecule,investigational,CC1=CC(NC(=O)CC2=CC=C(OC(C)(C)C(O)=O)C=C2)=CC(C)=C1,BNFRJXLZYUTIII-UHFFFAOYSA-N,341.4009,P69905,BE0000130,Hemoglobin subunit alpha,Humans,inhibitor,yes
DB08490,CTS-1027,small molecule,experimental;investigational,ONC(=O)C1(CS(=O)(=O)C2=CC=C(OC3=CC=C(Cl)C=C3)C=C2)CCOCC1,ROSNVSQTEGHUKU-UHFFFAOYSA-N,425.883,P08254,BE0001116,Stromelysin-1,Humans,inhibitor,yes
DB08490,CTS-1027,small molecule,experimental;investigational,ONC(=O)C1(CS(=O)(=O)C2=CC=C(OC3=CC=C(Cl)C=C3)C=C2)CCOCC1,ROSNVSQTEGHUKU-UHFFFAOYSA-N,425.883,P03956,BE0000920,Interstitial collagenase,Humans,inhibitor,yes
DB08490,CTS-1027,small molecule,experimental;investigational,ONC(=O)C1(CS(=O)(=O)C2=CC=C(OC3=CC=C(Cl)C=C3)C=C2)CCOCC1,ROSNVSQTEGHUKU-UHFFFAOYSA-N,425.883,P08253,BE0000642,72 kDa type IV collagenase,Humans,inhibitor,yes
DB08490,CTS-1027,small molecule,experimental;investigational,ONC(=O)C1(CS(=O)(=O)C2=CC=C(OC3=CC=C(Cl)C=C3)C=C2)CCOCC1,ROSNVSQTEGHUKU-UHFFFAOYSA-N,425.883,P14780,BE0000058,Matrix metalloproteinase-9,Humans,inhibitor,yes
DB08490,CTS-1027,small molecule,experimental;investigational,ONC(=O)C1(CS(=O)(=O)C2=CC=C(OC3=CC=C(Cl)C=C3)C=C2)CCOCC1,ROSNVSQTEGHUKU-UHFFFAOYSA-N,425.883,P45452,BE0000966,Collagenase 3,Humans,inhibitor,yes
DB08492,(2E)-3-(2-OCT-1-YN-1-YLPHENYL)ACRYLIC ACID,small molecule,experimental,CCCCCCC#CC1=CC=CC=C1\C=C\C(O)=O,KRDSGPLHVQJFLM-BUHFOSPRSA-N,256.3395,P16050,BE0000309,Polyunsaturated fatty acid lipoxygenase ALOX15,Humans,inhibitor,yes
DB08502,Capravirine,small molecule,investigational,CC(C)C1=C(SC2=CC(Cl)=CC(Cl)=C2)N(CC2=CC=NC=C2)C(COC(N)=O)=N1,YQXCVAGCMNFUMQ-UHFFFAOYSA-N,451.369,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB08517,Sakuranetin,small molecule,experimental,COC1=CC(O)=C2C(=O)C[C@H](OC2=C1)C1=CC=C(O)C=C1,DJOJDHGQRNZXQQ-AWEZNQCLSA-N,286.2794,P29275,BE0000241,Adenosine receptor A2b,Humans,antagonist,yes
DB08517,Sakuranetin,small molecule,experimental,COC1=CC(O)=C2C(=O)C[C@H](OC2=C1)C1=CC=C(O)C=C1,DJOJDHGQRNZXQQ-AWEZNQCLSA-N,286.2794,P30542,BE0000013,Adenosine receptor A1,Humans,antagonist,yes
DB08517,Sakuranetin,small molecule,experimental,COC1=CC(O)=C2C(=O)C[C@H](OC2=C1)C1=CC=C(O)C=C1,DJOJDHGQRNZXQQ-AWEZNQCLSA-N,286.2794,P0DMS8,BE0000354,Adenosine receptor A3,Humans,antagonist,yes
DB08522,4-(4-FLUOROPHENYL)-1-CYCLOROPROPYLMETHYL-5-(4-PYRIDYL)-IMIDAZOLE,small molecule,experimental,FC1=CC=C(C=C1)C1=C(N(CC2CC2)C=N1)C1=CC=NC=C1,ROKOFZNQCIIJMI-UHFFFAOYSA-N,293.3381,Q16539,BE0001019,Mitogen-activated protein kinase 14,Humans,inhibitor,yes
DB08523,[HYDROXY(3-PHENYLPROPYL)AMINO]METHANOL,small molecule,experimental,OCN(O)CCCC1=CC=CC=C1,GELOPWXSYZDPJT-UHFFFAOYSA-N,181.2316,P68826,BE0002535,Peptide deformylase,Staphylococcus aureus,inhibitor,yes
DB08524,2-(3-BENZOYLPHENOXY)ETHYL(HYDROXY)FORMAMIDE,small molecule,experimental,ON(CCOC1=CC=CC(=C1)C(=O)C1=CC=CC=C1)C=O,ZHFKBNAHHTUQBH-UHFFFAOYSA-N,285.2946,P68826,BE0002535,Peptide deformylase,Staphylococcus aureus,inhibitor,yes
DB08525,HYDROXY[3-(6-METHYLPYRIDIN-2-YL)PROPYL]FORMAMIDE,small molecule,experimental,CC1=NC(CCCN(O)C=O)=CC=C1,FJYUGRZKJXCRFF-UHFFFAOYSA-N,194.2304,P68826,BE0002535,Peptide deformylase,Staphylococcus aureus,inhibitor,yes
DB08550,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",small molecule,experimental,ClC1=CC=C2CCNCC2=C1Cl,WFPUBEDBBOGGIQ-UHFFFAOYSA-N,202.08,P18089,BE0000572,Alpha-2B adrenergic receptor,Humans,inhibitor,yes
DB08550,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",small molecule,experimental,ClC1=CC=C2CCNCC2=C1Cl,WFPUBEDBBOGGIQ-UHFFFAOYSA-N,202.08,P18825,BE0000342,Alpha-2C adrenergic receptor,Humans,inhibitor,yes
DB08550,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",small molecule,experimental,ClC1=CC=C2CCNCC2=C1Cl,WFPUBEDBBOGGIQ-UHFFFAOYSA-N,202.08,P08913,BE0000289,Alpha-2A adrenergic receptor,Humans,inhibitor,yes
DB08568,A-674563,small molecule,experimental,CC1=NNC2=C1C=C(C=C2)C1=CC(OC[C@@H](N)CC2=CC=CC=C2)=CN=C1,BPNUQXPIQBZCMR-IBGZPJMESA-N,358.4363,P31749,BE0000428,RAC-alpha serine/threonine-protein kinase,Humans,inhibitor,yes
DB08576,"1-(5-TERT-BUTYL-1,3,4-OXADIAZOL-2-YL)-2-(METHYLAMINO)ETHANONE",small molecule,experimental,CNCC(=O)C1=NN=C(O1)C(C)(C)C,CLBJJWUUSJAAPJ-UHFFFAOYSA-N,197.2343,P03372,BE0000123,Estrogen receptor,Humans,modulator,yes
DB08577,3-[(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE]-2-INDOLINONE,small molecule,experimental,CC1=CNC(\C=C2/C(=O)NC3=CC=CC=C23)=C1CCC(O)=O,JNDVEAXZWJIOKB-JYRVWZFOSA-N,296.3205,P22607,BE0002133,Fibroblast growth factor receptor 3,Humans,inhibitor,yes
DB08593,"1,2,5-THIADIAZOLIDIN-3-ONE-1,1-DIOXIDE",small molecule,experimental,O=C1CN(C2=CC=CC=C2)S(=O)(=O)N1,LDCZCUKQWRZSDT-UHFFFAOYSA-N,212.226,P18031,BE0000623,Tyrosine-protein phosphatase non-receptor type 1,Humans,inhibitor,yes
DB08594,TERT-BUTYL 2-CYANO-2-METHYLHYDRAZINECARBOXYLATE,small molecule,experimental,CN(NC(=O)OC(C)(C)C)C#N,SWELYBAPJHIOQT-UHFFFAOYSA-N,171.197,P43235,BE0003417,Cathepsin K,Humans,inhibitor,yes
DB08597,Dorsomorphin,small molecule,experimental,C(CN1CCCCC1)OC1=CC=C(C=C1)C1=CN2N=CC(=C2N=C1)C1=CC=NC=C1,XHBVYDAKJHETMP-UHFFFAOYSA-N,399.4882,Q13131,BE0000677,5'-AMP-activated protein kinase catalytic subunit alpha-1,Humans,inhibitor,yes
DB08597,Dorsomorphin,small molecule,experimental,C(CN1CCCCC1)OC1=CC=C(C=C1)C1=CN2N=CC(=C2N=C1)C1=CC=NC=C1,XHBVYDAKJHETMP-UHFFFAOYSA-N,399.4882,Q9Y478,BE0000254,5'-AMP-activated protein kinase subunit beta-1,Humans,inhibitor,yes
DB08597,Dorsomorphin,small molecule,experimental,C(CN1CCCCC1)OC1=CC=C(C=C1)C1=CN2N=CC(=C2N=C1)C1=CC=NC=C1,XHBVYDAKJHETMP-UHFFFAOYSA-N,399.4882,P54619,BE0009988,5'-AMP-activated protein kinase subunit gamma-1,Humans,inhibitor,yes
DB08598,R-82913,small molecule,experimental,C[C@H]1CN2C(=S)NC3=CC(Cl)=CC(CN1CC=C(C)C)=C23,RCSLUNOLLUVOOG-NSHDSACASA-N,321.868,P03366,BE0002050,Gag-Pol polyprotein,,modulator,yes
DB08599,N-[(4-methoxyphenyl)sulfonyl]-D-alanine,small molecule,experimental,[H][C@](C)(NS(=O)(=O)C1=CC=C(OC)C=C1)C(O)=O,XTCIPBHRVYICGT-SSDOTTSWSA-N,259.279,P39900,BE0001198,Macrophage metalloelastase,Humans,inhibitor,yes
DB08600,Tivirapine,small molecule,experimental,[H]N1C(=S)N2C[C@H](C)N(CC=C(C)C)CC3=C(Cl)C=CC1=C23,ZNFFMCYSMBXZQU-NSHDSACASA-N,321.868,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB08601,Tributyltin,small molecule,experimental,[H][Sn](CCCC)(CCCC)CCCC,DBGVGMSCBYYSLD-UHFFFAOYSA-N,290.05,P19793,BE0000412,Retinoic acid receptor RXR-alpha,Humans,inhibitor,yes
DB08611,"2-[(2',3',4'-TRIFLUOROBIPHENYL-2-YL)OXY]ETHANOL",small molecule,experimental,OCCOC1=C(C=CC=C1)C1=C(F)C(F)=C(F)C=C1,AGXPXFPIOHNDAN-UHFFFAOYSA-N,268.2311,P25774,BE0001646,Cathepsin S,Humans,inhibitor,yes
DB08612,"1,1,1-TRIFLUORO-3-(OCTYLTHIO)ACETONE",small molecule,experimental,CCCCCCCCSCC(=O)C(F)(F)F,WMQHRXUKAYSPPK-UHFFFAOYSA-N,256.328,P23141,BE0002705,Liver carboxylesterase 1,Humans,inhibitor,yes
DB08626,Thiorphan,small molecule,experimental,[H][C@](CS)(CC1=CC=CC=C1)C(=O)NCC(O)=O,LJJKNPQAGWVLDQ-SNVBAGLBSA-N,253.317,P08473,BE0000266,Neprilysin,Humans,inhibitor,yes
DB08632,Trimesic acid,small molecule,experimental,OC(=O)C1=CC(=CC(=C1)C(O)=O)C(O)=O,QMKYBPDZANOJGF-UHFFFAOYSA-N,210.1403,P69905,BE0000130,Hemoglobin subunit alpha,Humans,inhibitor,yes
DB08633,TNP-470,small molecule,investigational,[H][C@]1(CC=C(C)C)O[C@]1(C)[C@@]1([H])[C@]([H])(OC)[C@@]([H])(CC[C@]11CO1)OC(=O)NC(=O)CCl,MSHZHSPISPJWHW-PVDLLORBSA-N,401.882,P50579,BE0001534,Methionine aminopeptidase 2,Humans,inhibitor,yes
DB08634,6-BENZYL-1-BENZYLOXYMETHYL-5-ISOPROPYL URACIL,small molecule,experimental,CC(C)C1=C(CC2=CC=CC=C2)N(COCC2=CC=CC=C2)C(=O)NC1=O,KSAAUHMSLCPIEX-UHFFFAOYSA-N,364.4376,P03366,BE0002050,Gag-Pol polyprotein,,modulator,yes
DB08639,Dapivirine,small molecule,investigational,CC1=CC(C)=C(NC2=NC(NC3=CC=C(C=C3)C#N)=NC=C2)C(C)=C1,ILAYIAGXTHKHNT-UHFFFAOYSA-N,329.3984,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB08651,3'-THIO-THYMIDINE-5'-PHOSPHATE,small molecule,experimental,[H][C@]1(S)C[C@@]([H])(O[C@]1([H])COP(O)(O)=O)N1C=C(C)C(=O)NC1=O,BORVFKJZAOEGOO-GJMOJQLCSA-N,338.274,Q02880,BE0002425,DNA topoisomerase 2-beta,Humans,inhibitor,yes
DB08653,Tryptamine,small molecule,experimental,NCCC1=CNC2=CC=CC=C12,APJYDQYYACXCRM-UHFFFAOYSA-N,160.2157,P27338,BE0002196,Amine oxidase [flavin-containing] B,Humans,inhibitor,yes
DB08653,Tryptamine,small molecule,experimental,NCCC1=CNC2=CC=CC=C12,APJYDQYYACXCRM-UHFFFAOYSA-N,160.2157,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,inhibitor,yes
DB08653,Tryptamine,small molecule,experimental,NCCC1=CNC2=CC=CC=C12,APJYDQYYACXCRM-UHFFFAOYSA-N,160.2157,P21397,BE0002198,Amine oxidase [flavin-containing] A,Humans,inhibitor,yes
DB08658,Ethyl hydrogen diethylamidophosphate,small molecule,experimental,CCO[P@](O)(=O)N(CC)CC,DUNFIZRDIMDMIH-UHFFFAOYSA-N,181.1699,P06276,BE0002180,Cholinesterase,Humans,inhibitor,yes
DB08681,1-METHYL ETHYL 2-CHLORO-5-[[[(1-METHYLETHOXY)THIOOXO]METHYL]AMINO]-BENZOATE,small molecule,experimental,CC(C)OC(=S)NC1=CC(C(=O)OC(C)C)=C(Cl)C=C1,AXTNFJKQZPETJA-UHFFFAOYSA-N,315.816,P03366,BE0002050,Gag-Pol polyprotein,,modulator,yes
DB08682,"1-METHYL ETHYL 1-CHLORO-5-[[(5,6DIHYDRO-2-METHYL-1,4-OXATHIIN-3-YL)CARBONYL]AMINO]BENZOATE",small molecule,experimental,CC(C)OC(=O)C1=C(Cl)C=CC(NC(=O)C2=C(C)OCCS2)=C1,FMQGUMRNTBJHEA-UHFFFAOYSA-N,355.836,P03366,BE0002050,Gag-Pol polyprotein,,modulator,yes
DB08683,"REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE",small molecule,experimental,[H][C@]12CC[C@]([H])(O1)N1C3=C(C=CC=C3)C3=C4C(=O)NC(=O)C4=C4C5=C(C=CC=C5)N2C4=C13,OTPNDVKVEAIXTI-IYBDPMFKSA-N,393.3942,O14757,BE0003382,Serine/threonine-protein kinase Chk1,Humans,inhibitor,yes
DB08691,"ethyl 3-[(E)-2-amino-1-cyanoethenyl]-6,7-dichloro-1-methyl-1H-indole-2-carboxylate",small molecule,experimental,CCOC(=O)C1=C(\C(=C/N)C#N)C2=C(N1C)C(Cl)=C(Cl)C=C2,CXJCGSPAPOTTSF-VURMDHGXSA-N,338.189,P49759,BE0001824,Dual specificity protein kinase CLK1,Humans,inhibitor,yes
DB08691,"ethyl 3-[(E)-2-amino-1-cyanoethenyl]-6,7-dichloro-1-methyl-1H-indole-2-carboxylate",small molecule,experimental,CCOC(=O)C1=C(\C(=C/N)C#N)C2=C(N1C)C(Cl)=C(Cl)C=C2,CXJCGSPAPOTTSF-VURMDHGXSA-N,338.189,Q13627,BE0004012,Dual specificity tyrosine-phosphorylation-regulated kinase 1A,Humans,inhibitor,yes
DB08754,N-Caffeoyltyramine,small molecule,experimental,OC1=CC=C(CCNC(=O)\C=C\C2=CC(O)=C(O)C=C2)C=C1,VSHUQLRHTJOKTA-XBXARRHUSA-N,299.3212,P14679,BE0000252,Tyrosinase,Humans,inhibitor,yes
DB08756,Y-27632,small molecule,experimental,[H][C@@]1(CC[C@@H](CC1)C(=O)NC1=CC=NC=C1)[C@@H](C)N,IYOZTVGMEWJPKR-IJLUTSLNSA-N,247.336,P00734,BE0000048,Prothrombin,Humans,inhibitor,yes
DB08760,(2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid,small molecule,experimental,[H][C@@](CC1=CC=CC=C1)(OC1=CC=C(Cl)C=C1)C(O)=O,CPBLTMSKPQDJPW-AWEZNQCLSA-N,276.715,P37231,BE0000215,Peroxisome proliferator-activated receptor gamma,Humans,inhibitor,yes
DB08765,"6-HYDROXY-1,3-BENZOTHIAZOLE-2-SULFONAMIDE",small molecule,experimental,NS(=O)(=O)C1=NC2=C(S1)C=C(O)C=C2,NOOBQTYVTDBXTL-UHFFFAOYSA-N,230.264,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB08765,"6-HYDROXY-1,3-BENZOTHIAZOLE-2-SULFONAMIDE",small molecule,experimental,NS(=O)(=O)C1=NC2=C(S1)C=C(O)C=C2,NOOBQTYVTDBXTL-UHFFFAOYSA-N,230.264,P14174,BE0001855,Macrophage migration inhibitory factor,Humans,inhibitor,yes
DB08768,N(6)-dimethylallyladenine,small molecule,experimental,CC(C)=CCNC1=NC=NC2=C1N=CN2,HYVABZIGRDEKCD-UHFFFAOYSA-N,203.2437,P24941,BE0001072,Cyclin-dependent kinase 2,Humans,inhibitor,yes
DB08770,"4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol",small molecule,experimental,NC1=NC(NCCC2=CC=C(O)C=C2)=NC2=NC(=NN12)C1=CC=CO1,PWTBZOIUWZOPFT-UHFFFAOYSA-N,337.336,P30542,BE0000013,Adenosine receptor A1,Humans,inhibitor,yes
DB08770,"4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol",small molecule,experimental,NC1=NC(NCCC2=CC=C(O)C=C2)=NC2=NC(=NN12)C1=CC=CO1,PWTBZOIUWZOPFT-UHFFFAOYSA-N,337.336,P29275,BE0000241,Adenosine receptor A2b,Humans,inhibitor,yes
DB08770,"4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol",small molecule,experimental,NC1=NC(NCCC2=CC=C(O)C=C2)=NC2=NC(=NN12)C1=CC=CO1,PWTBZOIUWZOPFT-UHFFFAOYSA-N,337.336,P29274,BE0000924,Adenosine receptor A2a,Humans,inhibitor,yes
DB08772,Zopolrestat,small molecule,experimental,OC(=O)CC1=NN(CC2=NC3=C(S2)C=CC(=C3)C(F)(F)F)C(=O)C2=C1C=CC=C2,BCSVCWVQNOXFGL-UHFFFAOYSA-N,419.377,P15121,BE0000747,Aldo-keto reductase family 1 member B1,Humans,modulator,yes
DB08780,6-MORPHOLIN-4-YL-9H-PURINE,small molecule,experimental,C1CN(CCO1)C1=C2N=CNC2=NC=N1,MEOMXKNIFWDDGZ-UHFFFAOYSA-N,205.2165,O14757,BE0003382,Serine/threonine-protein kinase Chk1,Humans,inhibitor,yes
DB08782,4-(2-AMINOETHYL)BENZENESULFONAMIDE,small molecule,experimental,NCCC1=CC=C(C=C1)S(N)(=O)=O,FXNSVEQMUYPYJS-UHFFFAOYSA-N,200.258,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB08782,4-(2-AMINOETHYL)BENZENESULFONAMIDE,small molecule,experimental,NCCC1=CC=C(C=C1)S(N)(=O)=O,FXNSVEQMUYPYJS-UHFFFAOYSA-N,200.258,P22748,BE0000535,Carbonic anhydrase 4,Humans,inhibitor,yes
DB08782,4-(2-AMINOETHYL)BENZENESULFONAMIDE,small molecule,experimental,NCCC1=CC=C(C=C1)S(N)(=O)=O,FXNSVEQMUYPYJS-UHFFFAOYSA-N,200.258,O43570,BE0001653,Carbonic anhydrase 12,Humans,inhibitor,yes
DB08782,4-(2-AMINOETHYL)BENZENESULFONAMIDE,small molecule,experimental,NCCC1=CC=C(C=C1)S(N)(=O)=O,FXNSVEQMUYPYJS-UHFFFAOYSA-N,200.258,Q16790,BE0002437,Carbonic anhydrase 9,Humans,inhibitor,yes
DB08782,4-(2-AMINOETHYL)BENZENESULFONAMIDE,small molecule,experimental,NCCC1=CC=C(C=C1)S(N)(=O)=O,FXNSVEQMUYPYJS-UHFFFAOYSA-N,200.258,Q9ULX7,BE0003634,Carbonic anhydrase 14,Humans,inhibitor,yes
DB08782,4-(2-AMINOETHYL)BENZENESULFONAMIDE,small molecule,experimental,NCCC1=CC=C(C=C1)S(N)(=O)=O,FXNSVEQMUYPYJS-UHFFFAOYSA-N,200.258,P00915,BE0000267,Carbonic anhydrase 1,Humans,inhibitor,yes
DB08786,4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine,small molecule,experimental,COCCOC1=NC(N)=NC(C)=C1,VCJHOFUOIQHNBC-UHFFFAOYSA-N,183.2077,P07900,BE0001120,Heat shock protein HSP 90-alpha,Humans,inhibitor,yes
DB08795,Azidocillin,small molecule,experimental,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N=[N+]=[N-])C1=CC=CC=C1)C(O)=O,ODFHGIPNGIAMDK-NJBDSQKTSA-N,375.402,Q8DNB6,BE0004644,Penicillin-binding protein 2a,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB08795,Azidocillin,small molecule,experimental,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N=[N+]=[N-])C1=CC=CC=C1)C(O)=O,ODFHGIPNGIAMDK-NJBDSQKTSA-N,375.402,Q7CRA4,BE0004335,Penicillin-binding protein 1b,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB08795,Azidocillin,small molecule,experimental,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N=[N+]=[N-])C1=CC=CC=C1)C(O)=O,ODFHGIPNGIAMDK-NJBDSQKTSA-N,375.402,Q75Y35,BE0004643,Penicillin-binding protein 3,Streptococcus pneumoniae,inhibitor,yes
DB08795,Azidocillin,small molecule,experimental,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N=[N+]=[N-])C1=CC=CC=C1)C(O)=O,ODFHGIPNGIAMDK-NJBDSQKTSA-N,375.402,Q8DR59,BE0004290,Penicillin-binding protein 1A,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB08795,Azidocillin,small molecule,experimental,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N=[N+]=[N-])C1=CC=CC=C1)C(O)=O,ODFHGIPNGIAMDK-NJBDSQKTSA-N,375.402,P0A3M6,BE0003624,Penicillin-binding protein 2B,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB08798,Sulfamoxole,small molecule,experimental,CC1=C(C)N=C(NS(=O)(=O)C2=CC=C(N)C=C2)O1,CYFLXLSBHQBMFT-UHFFFAOYSA-N,267.304,Q27738,BE0002360,Dihydropteroate synthetase,Plasmodium falciparum,inhibitor,yes
DB08799,Antazoline,small molecule,approved,C(N(CC1=CC=CC=C1)C1=CC=CC=C1)C1=NCCN1,REYFJDPCWQRWAA-UHFFFAOYSA-N,265.3529,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB08800,Chloropyramine,small molecule,experimental,CN(C)CCN(CC1=CC=C(Cl)C=C1)C1=CC=CC=N1,ICKFFNBDFNZJSX-UHFFFAOYSA-N,289.803,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB08801,Dimetindene,small molecule,approved;investigational,CC(C1=C(CCN(C)C)CC2=CC=CC=C12)C1=CC=CC=N1,MVMQESMQSYOVGV-UHFFFAOYSA-N,292.418,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB08801,Dimetindene,small molecule,approved;investigational,CC(C1=C(CCN(C)C)CC2=CC=CC=C12)C1=CC=CC=N1,MVMQESMQSYOVGV-UHFFFAOYSA-N,292.418,P08172,BE0000560,Muscarinic acetylcholine receptor M2,Humans,antagonist,yes
DB08802,Isothipendyl,small molecule,experimental,CC(CN1C2=CC=CC=C2SC2=C1N=CC=C2)N(C)C,OQJBSDFFQWMKBQ-UHFFFAOYSA-N,285.407,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB08804,Nandrolone decanoate,small molecule,approved;illicit,[H][C@@]12CC[C@H](OC(=O)CCCCCCCCC)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],JKWKMORAXJQQSR-MOPIKTETSA-N,428.6472,P10275,BE0000132,Androgen receptor,Humans,agonist,yes
DB08805,Metiamide,small molecule,experimental,CNC(=S)NCCSCC1=C(C)NC=N1,FPBPLBWLMYGIQR-UHFFFAOYSA-N,244.38,P25021,BE0000112,Histamine H2 receptor,Humans,antagonist,yes
DB08806,Roxatidine acetate,small molecule,experimental,CC(=O)OCC(=O)NCCCOC1=CC=CC(CN2CCCCC2)=C1,SMTZFNFIKUPEJC-UHFFFAOYSA-N,348.4366,P25021,BE0000112,Histamine H2 receptor,Humans,antagonist,yes
DB08807,Bopindolol,small molecule,experimental,CC1=CC2=C(N1)C=CC=C2OCC(CNC(C)(C)C)OC(=O)C1=CC=CC=C1,UUOJIACWOAYWEZ-UHFFFAOYSA-N,380.48,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,antagonist;partial agonist,yes
DB08807,Bopindolol,small molecule,experimental,CC1=CC2=C(N1)C=CC=C2OCC(CNC(C)(C)C)OC(=O)C1=CC=CC=C1,UUOJIACWOAYWEZ-UHFFFAOYSA-N,380.48,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,antagonist;partial agonist,yes
DB08807,Bopindolol,small molecule,experimental,CC1=CC2=C(N1)C=CC=C2OCC(CNC(C)(C)C)OC(=O)C1=CC=CC=C1,UUOJIACWOAYWEZ-UHFFFAOYSA-N,380.48,P13945,BE0001012,Beta-3 adrenergic receptor,Humans,modulator,yes
DB08808,Bupranolol,small molecule,experimental,CC1=CC(OCC(O)CNC(C)(C)C)=C(Cl)C=C1,HQIRNZOQPUAHHV-UHFFFAOYSA-N,271.783,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,antagonist,yes
DB08809,Dichloroacetic acid,small molecule,approved;investigational,OC(=O)C(Cl)Cl,JXTHNDFMNIQAHM-UHFFFAOYSA-N,128.942,Q15118,BE0003862,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial",Humans,inhibitor,yes
DB08810,Cinitapride,small molecule,investigational,CCOC1=CC(N)=C(C=C1C(=O)NC1CCN(CC2CCC=CC2)CC1)[N+]([O-])=O,ZDLBNXXKDMLZMF-UHFFFAOYSA-N,402.4873,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,agonist,yes
DB08810,Cinitapride,small molecule,investigational,CCOC1=CC(N)=C(C=C1C(=O)NC1CCN(CC2CCC=CC2)CC1)[N+]([O-])=O,ZDLBNXXKDMLZMF-UHFFFAOYSA-N,402.4873,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB08811,Tofisopam,small molecule,experimental,CCC1C2=CC(OC)=C(OC)C=C2C(=NN=C1C)C1=CC(OC)=C(OC)C=C1,RUJBDQSFYCKFAA-UHFFFAOYSA-N,382.4528,Q9Y233,BE0000631,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",Humans,inhibitor,yes
DB08811,Tofisopam,small molecule,experimental,CCC1C2=CC(OC)=C(OC)C=C2C(=NN=C1C)C1=CC(OC)=C(OC)C=C1,RUJBDQSFYCKFAA-UHFFFAOYSA-N,382.4528,P27815,BE0001133,"3',5'-cyclic-AMP phosphodiesterase 4A",Humans,inhibitor,yes
DB08811,Tofisopam,small molecule,experimental,CCC1C2=CC(OC)=C(OC)C=C2C(=NN=C1C)C1=CC(OC)=C(OC)C=C1,RUJBDQSFYCKFAA-UHFFFAOYSA-N,382.4528,O00408,BE0002085,"cGMP-dependent 3',5'-cyclic phosphodiesterase",Humans,inhibitor,yes
DB08814,Triflusal,small molecule,approved;investigational,CC(=O)OC1=C(C=CC(=C1)C(F)(F)F)C(O)=O,RMWVZGDJPAKBDE-UHFFFAOYSA-N,248.157,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,antagonist,yes
DB08814,Triflusal,small molecule,approved;investigational,CC(=O)OC1=C(C=CC(=C1)C(F)(F)F)C(O)=O,RMWVZGDJPAKBDE-UHFFFAOYSA-N,248.157,P19838,BE0001086,Nuclear factor NF-kappa-B p105 subunit,Humans,antagonist,yes
DB08814,Triflusal,small molecule,approved;investigational,CC(=O)OC1=C(C=CC(=C1)C(F)(F)F)C(O)=O,RMWVZGDJPAKBDE-UHFFFAOYSA-N,248.157,P35228,BE0000005,"Nitric oxide synthase, inducible",Humans,agonist,yes
DB08814,Triflusal,small molecule,approved;investigational,CC(=O)OC1=C(C=CC(=C1)C(F)(F)F)C(O)=O,RMWVZGDJPAKBDE-UHFFFAOYSA-N,248.157,Q9Y233,BE0000631,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",Humans,antagonist,yes
DB08815,Lurasidone,small molecule,approved;investigational,[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O,PQXKDMSYBGKCJA-CVTJIBDQSA-N,492.676,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB08815,Lurasidone,small molecule,approved;investigational,[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O,PQXKDMSYBGKCJA-CVTJIBDQSA-N,492.676,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB08816,Ticagrelor,small molecule,approved,CCCSC1=NC2=C(N=NN2[C@@H]2C[C@H](OCCO)[C@@H](O)[C@H]2O)C(N[C@@H]2C[C@H]2C2=CC(F)=C(F)C=C2)=N1,OEKWJQXRCDYSHL-FNOIDJSQSA-N,522.568,Q9H244,BE0000110,P2Y purinoceptor 12,Humans,inhibitor,yes
DB08818,Hyaluronic acid,small molecule,approved;vet_approved,CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@@H]1O[C@@H]([C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)C(O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)[C@H]2NC(C)=O)[C@H](O)[C@H]1O)C(O)=O,KIUKXJAPPMFGSW-MNSSHETKSA-N,776.6486,P16070,BE0001113,CD44 antigen,Humans,binder,yes
DB08818,Hyaluronic acid,small molecule,approved;vet_approved,CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@@H]1O[C@@H]([C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)C(O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)[C@H]2NC(C)=O)[C@H](O)[C@H]1O)C(O)=O,KIUKXJAPPMFGSW-MNSSHETKSA-N,776.6486,P05362,BE0001085,Intercellular adhesion molecule 1,Humans,inhibitor;binder,yes
DB08818,Hyaluronic acid,small molecule,approved;vet_approved,CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@@H]1O[C@@H]([C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)C(O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)[C@H]2NC(C)=O)[C@H](O)[C@H]1O)C(O)=O,KIUKXJAPPMFGSW-MNSSHETKSA-N,776.6486,O75330,BE0004702,Hyaluronan mediated motility receptor,Humans,binder,yes
DB08818,Hyaluronic acid,small molecule,approved;vet_approved,CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@@H]1O[C@@H]([C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)C(O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)[C@H]2NC(C)=O)[C@H](O)[C@H]1O)C(O)=O,KIUKXJAPPMFGSW-MNSSHETKSA-N,776.6486,Q9Y5Y7,BE0010044,Lymphatic vessel endothelial hyaluronic acid receptor 1,Humans,modulator,yes
DB08819,Tafluprost,small molecule,approved,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\C(F)(F)COC1=CC=CC=C1,WSNODXPBBALQOF-VEJSHDCNSA-N,452.5313,P43088,BE0000610,Prostaglandin F2-alpha receptor,Humans,agonist,yes
DB08820,Ivacaftor,small molecule,approved,CC(C)(C)C1=CC(=C(O)C=C1NC(=O)C1=CNC2=CC=CC=C2C1=O)C(C)(C)C,PURKAOJPTOLRMP-UHFFFAOYSA-N,392.4907,P13569,BE0001195,Cystic fibrosis transmembrane conductance regulator,Humans,potentiator,yes
DB08822,Azilsartan medoxomil,small molecule,approved;investigational,CCOC1=NC2=C(N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NOC(=O)N1)C(=CC=C2)C(=O)OCC1=C(C)OC(=O)O1,QJFSABGVXDWMIW-UHFFFAOYSA-N,568.5336,P30556,BE0000062,Type-1 angiotensin II receptor,Humans,antagonist,yes
DB08823,Spinosad,small molecule,approved;investigational;vet_approved,[H][C@]1(C[C@@]2([H])C=C[C@@]3([H])[C@]4([H])CC(=O)O[C@@]([H])(CC)CCC[C@]([H])(O[C@@]5([H])CC[C@]([H])(N(C)C)[C@@]([H])(C)O5)[C@@]([H])(C)C(=O)C4=C[C@@]3([H])[C@]2([H])C1)O[C@]1([H])O[C@@]([H])(C)[C@]([H])(OC)[C@@]([H])(OC)[C@@]1([H])OC.[H][C@]1(C[C@@]2([H])C(C)=C[C@@]3([H])[C@]4([H])CC(=O)O[C@@]([H])(CC)CCC[C@]([H])(O[C@@]5([H])CC[C@]([H])(N(C)C)[C@@]([H])(C)O5)[C@@]([H])(C)C(=O)C4=C[C@@]3([H])[C@]2([H])C1)O[C@]1([H])O[C@@]([H])(C)[C@]([H])(OC)[C@@]([H])(OC)[C@@]1([H])OC,JFLRKDZMHNBDQS-SGSTVUCESA-N,1477.963,P36544,BE0002341,Neuronal acetylcholine receptor subunit alpha-7,Humans,antagonist,yes
DB08824,Ioflupane I-123,small molecule,approved,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)C1=CC=C([123I])C=C1)C(=O)OC)N2CCCF,HXWLAJVUJSVENX-HFIFKADTSA-N,427.291,Q01959,BE0000647,Sodium-dependent dopamine transporter,Humans,modulator,yes
DB08826,Deferiprone,small molecule,approved,CN1C=CC(=O)C(O)=C1C,TZXKOCQBRNJULO-UHFFFAOYSA-N,139.1519,,BE0004807,Iron,Humans,chelator,yes
DB08827,Lomitapide,small molecule,approved;investigational,FC(F)(F)CNC(=O)C1(CCCCN2CCC(CC2)NC(=O)C2=C(C=CC=C2)C2=CC=C(C=C2)C(F)(F)F)C2=CC=CC=C2C2=CC=CC=C12,MBBCVAKAJPKAKM-UHFFFAOYSA-N,693.7204,P55157,BE0000232,Microsomal triglyceride transfer protein large subunit,Humans,antagonist,yes
DB08828,Vismodegib,small molecule,approved;investigational,CS(=O)(=O)C1=CC(Cl)=C(C=C1)C(=O)NC1=CC=C(Cl)C(=C1)C1=CC=CC=N1,BPQMGSKTAYIVFO-UHFFFAOYSA-N,421.297,Q99835,BE0004659,Protein smoothened,Humans,antagonist;inhibitor,yes
DB08837,Tetraethylammonium,small molecule,experimental;investigational,CC[N+](CC)(CC)CC,CBXCPBUEXACCNR-UHFFFAOYSA-N,130.2511,O43525,BE0002398,Potassium voltage-gated channel subfamily KQT member 3,Humans,blocker,yes
DB08837,Tetraethylammonium,small molecule,experimental;investigational,CC[N+](CC)(CC)CC,CBXCPBUEXACCNR-UHFFFAOYSA-N,130.2511,Q6UVM3,BE0015626,Potassium channel subfamily T member 2,Humans,blocker,yes
DB08837,Tetraethylammonium,small molecule,experimental;investigational,CC[N+](CC)(CC)CC,CBXCPBUEXACCNR-UHFFFAOYSA-N,130.2511,Q5JUK3,BE0015369,Potassium channel subfamily T member 1,Humans,blocker,yes
DB08837,Tetraethylammonium,small molecule,experimental;investigational,CC[N+](CC)(CC)CC,CBXCPBUEXACCNR-UHFFFAOYSA-N,130.2511,Q86W47,BE0004424,Calcium-activated potassium channel subunit beta-4,Humans,inhibitor,yes
DB08837,Tetraethylammonium,small molecule,experimental;investigational,CC[N+](CC)(CC)CC,CBXCPBUEXACCNR-UHFFFAOYSA-N,130.2511,P22460,BE0004717,Potassium voltage-gated channel subfamily A member 5,Humans,blocker,yes
DB08837,Tetraethylammonium,small molecule,experimental;investigational,CC[N+](CC)(CC)CC,CBXCPBUEXACCNR-UHFFFAOYSA-N,130.2511,P29972,BE0000880,Aquaporin-1,Humans,inhibitor,yes
DB08837,Tetraethylammonium,small molecule,experimental;investigational,CC[N+](CC)(CC)CC,CBXCPBUEXACCNR-UHFFFAOYSA-N,130.2511,Q9H2S1,BE0004426,Small conductance calcium-activated potassium channel protein 2,Humans,blocker,yes
DB08837,Tetraethylammonium,small molecule,experimental;investigational,CC[N+](CC)(CC)CC,CBXCPBUEXACCNR-UHFFFAOYSA-N,130.2511,Q9UGI6,BE0004427,Small conductance calcium-activated potassium channel protein 3,Humans,blocker,yes
DB08837,Tetraethylammonium,small molecule,experimental;investigational,CC[N+](CC)(CC)CC,CBXCPBUEXACCNR-UHFFFAOYSA-N,130.2511,Q96FL8,BE0003657,Multidrug and toxin extrusion protein 1,Humans,modulator,yes
DB08837,Tetraethylammonium,small molecule,experimental;investigational,CC[N+](CC)(CC)CC,CBXCPBUEXACCNR-UHFFFAOYSA-N,130.2511,P22001,BE0004716,Potassium voltage-gated channel subfamily A member 3,Humans,blocker,yes
DB08837,Tetraethylammonium,small molecule,experimental;investigational,CC[N+](CC)(CC)CC,CBXCPBUEXACCNR-UHFFFAOYSA-N,130.2511,Q92952,BE0004425,Small conductance calcium-activated potassium channel protein 1,Humans,blocker,yes
DB08838,Agmatine,small molecule,experimental,NCCCCNC(N)=N,QYPPJABKJHAVHS-UHFFFAOYSA-N,130.1915,P18825,BE0000342,Alpha-2C adrenergic receptor,Humans,agonist,yes
DB08838,Agmatine,small molecule,experimental,NCCCCNC(N)=N,QYPPJABKJHAVHS-UHFFFAOYSA-N,130.1915,Q9Y2I1,BE0003580,Nischarin,Humans,agonist,yes
DB08838,Agmatine,small molecule,experimental,NCCCCNC(N)=N,QYPPJABKJHAVHS-UHFFFAOYSA-N,130.1915,P02708,BE0004661,Acetylcholine receptor subunit alpha,Humans,antagonist,yes
DB08838,Agmatine,small molecule,experimental,NCCCCNC(N)=N,QYPPJABKJHAVHS-UHFFFAOYSA-N,130.1915,Q05586,BE0000365,"Glutamate receptor ionotropic, NMDA 1",Humans,antagonist,yes
DB08838,Agmatine,small molecule,experimental,NCCCCNC(N)=N,QYPPJABKJHAVHS-UHFFFAOYSA-N,130.1915,P48048,BE0000644,ATP-sensitive inward rectifier potassium channel 1,Humans,antagonist,yes
DB08838,Agmatine,small molecule,experimental,NCCCCNC(N)=N,QYPPJABKJHAVHS-UHFFFAOYSA-N,130.1915,Q00975,BE0002226,Voltage-dependent N-type calcium channel subunit alpha-1B,Humans,antagonist,yes
DB08838,Agmatine,small molecule,experimental,NCCCCNC(N)=N,QYPPJABKJHAVHS-UHFFFAOYSA-N,130.1915,Q9UHC3,BE0004768,Acid-sensing ion channel 3,Humans,agonist,yes
DB08839,Serotonin,small molecule,investigational;nutraceutical,NCCC1=CNC2=CC=C(O)C=C12,QZAYGJVTTNCVMB-UHFFFAOYSA-N,176.2151,P28222,BE0000797,5-hydroxytryptamine receptor 1B,Humans,inhibitor,yes
DB08839,Serotonin,small molecule,investigational;nutraceutical,NCCC1=CNC2=CC=C(O)C=C12,QZAYGJVTTNCVMB-UHFFFAOYSA-N,176.2151,P34969,BE0000650,5-hydroxytryptamine receptor 7,Humans,inhibitor,yes
DB08839,Serotonin,small molecule,investigational;nutraceutical,NCCC1=CNC2=CC=C(O)C=C12,QZAYGJVTTNCVMB-UHFFFAOYSA-N,176.2151,P41595,BE0000393,5-hydroxytryptamine receptor 2B,Humans,inhibitor,yes
DB08839,Serotonin,small molecule,investigational;nutraceutical,NCCC1=CNC2=CC=C(O)C=C12,QZAYGJVTTNCVMB-UHFFFAOYSA-N,176.2151,P0DMS8,BE0000354,Adenosine receptor A3,Humans,inhibitor,yes
DB08839,Serotonin,small molecule,investigational;nutraceutical,NCCC1=CNC2=CC=C(O)C=C12,QZAYGJVTTNCVMB-UHFFFAOYSA-N,176.2151,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,inhibitor,yes
DB08839,Serotonin,small molecule,investigational;nutraceutical,NCCC1=CNC2=CC=C(O)C=C12,QZAYGJVTTNCVMB-UHFFFAOYSA-N,176.2151,P28335,BE0000533,5-hydroxytryptamine receptor 2C,Humans,inhibitor,yes
DB08839,Serotonin,small molecule,investigational;nutraceutical,NCCC1=CNC2=CC=C(O)C=C12,QZAYGJVTTNCVMB-UHFFFAOYSA-N,176.2151,Q13639,BE0000084,5-hydroxytryptamine receptor 4,Humans,inhibitor,yes
DB08839,Serotonin,small molecule,investigational;nutraceutical,NCCC1=CNC2=CC=C(O)C=C12,QZAYGJVTTNCVMB-UHFFFAOYSA-N,176.2151,P47898,BE0004688,5-hydroxytryptamine receptor 5A,Humans,inhibitor,yes
DB08839,Serotonin,small molecule,investigational;nutraceutical,NCCC1=CNC2=CC=C(O)C=C12,QZAYGJVTTNCVMB-UHFFFAOYSA-N,176.2151,P28221,BE0000659,5-hydroxytryptamine receptor 1D,Humans,inhibitor,yes
DB08839,Serotonin,small molecule,investigational;nutraceutical,NCCC1=CNC2=CC=C(O)C=C12,QZAYGJVTTNCVMB-UHFFFAOYSA-N,176.2151,P50406,BE0000945,5-hydroxytryptamine receptor 6,Humans,inhibitor,yes
DB08839,Serotonin,small molecule,investigational;nutraceutical,NCCC1=CNC2=CC=C(O)C=C12,QZAYGJVTTNCVMB-UHFFFAOYSA-N,176.2151,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,inhibitor,yes
DB08839,Serotonin,small molecule,investigational;nutraceutical,NCCC1=CNC2=CC=C(O)C=C12,QZAYGJVTTNCVMB-UHFFFAOYSA-N,176.2151,P46098,BE0000311,5-hydroxytryptamine receptor 3A,Humans,inhibitor,yes
DB08839,Serotonin,small molecule,investigational;nutraceutical,NCCC1=CNC2=CC=C(O)C=C12,QZAYGJVTTNCVMB-UHFFFAOYSA-N,176.2151,O95264,BE0009583,5-hydroxytryptamine receptor 3B,Humans,inhibitor,yes
DB08841,Tyramine,small molecule,investigational;nutraceutical,NCCC1=CC=C(O)C=C1,DZGWFCGJZKJUFP-UHFFFAOYSA-N,137.179,Q96RJ0,BE0001044,Trace amine-associated receptor 1,Humans,agonist,yes
DB08846,Ellagic acid,small molecule,investigational,OC1=C(O)C2=C3C(=C1)C(=O)OC1=C3C(=CC(O)=C1O)C(=O)O2,AFSDNFLWKVMVRB-UHFFFAOYSA-N,302.1926,P0DMV8,BE0010433,Heat shock 70 kDa protein 1A,Humans,inhibitor,yes
DB08846,Ellagic acid,small molecule,investigational,OC1=C(O)C2=C3C(=C1)C(=O)OC1=C3C(=CC(O)=C1O)C(=O)O2,AFSDNFLWKVMVRB-UHFFFAOYSA-N,302.1926,P0DMV9,BE0012549,Heat shock 70 kDa protein 1B,Humans,inhibitor,yes
DB08846,Ellagic acid,small molecule,investigational,OC1=C(O)C2=C3C(=C1)C(=O)OC1=C3C(=CC(O)=C1O)C(=O)O2,AFSDNFLWKVMVRB-UHFFFAOYSA-N,302.1926,P49841,BE0001065,Glycogen synthase kinase-3 beta,Humans,inhibitor,yes
DB08846,Ellagic acid,small molecule,investigational,OC1=C(O)C2=C3C(=C1)C(=O)OC1=C3C(=CC(O)=C1O)C(=O)O2,AFSDNFLWKVMVRB-UHFFFAOYSA-N,302.1926,O43570,BE0001653,Carbonic anhydrase 12,Humans,inhibitor,yes
DB08846,Ellagic acid,small molecule,investigational,OC1=C(O)C2=C3C(=C1)C(=O)OC1=C3C(=CC(O)=C1O)C(=O)O2,AFSDNFLWKVMVRB-UHFFFAOYSA-N,302.1926,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB08846,Ellagic acid,small molecule,investigational,OC1=C(O)C2=C3C(=C1)C(=O)OC1=C3C(=CC(O)=C1O)C(=O)O2,AFSDNFLWKVMVRB-UHFFFAOYSA-N,302.1926,Q9ULX7,BE0003634,Carbonic anhydrase 14,Humans,inhibitor,yes
DB08846,Ellagic acid,small molecule,investigational,OC1=C(O)C2=C3C(=C1)C(=O)OC1=C3C(=CC(O)=C1O)C(=O)O2,AFSDNFLWKVMVRB-UHFFFAOYSA-N,302.1926,P23280,BE0003628,Carbonic anhydrase 6,Humans,inhibitor,yes
DB08846,Ellagic acid,small molecule,investigational,OC1=C(O)C2=C3C(=C1)C(=O)OC1=C3C(=CC(O)=C1O)C(=O)O2,AFSDNFLWKVMVRB-UHFFFAOYSA-N,302.1926,P43405,BE0001316,Tyrosine-protein kinase SYK,Humans,inhibitor,yes
DB08846,Ellagic acid,small molecule,investigational,OC1=C(O)C2=C3C(=C1)C(=O)OC1=C3C(=CC(O)=C1O)C(=O)O2,AFSDNFLWKVMVRB-UHFFFAOYSA-N,302.1926,Q16790,BE0002437,Carbonic anhydrase 9,Humans,inhibitor,yes
DB08846,Ellagic acid,small molecule,investigational,OC1=C(O)C2=C3C(=C1)C(=O)OC1=C3C(=CC(O)=C1O)C(=O)O2,AFSDNFLWKVMVRB-UHFFFAOYSA-N,302.1926,P00915,BE0000267,Carbonic anhydrase 1,Humans,inhibitor,yes
DB08846,Ellagic acid,small molecule,investigational,OC1=C(O)C2=C3C(=C1)C(=O)OC1=C3C(=CC(O)=C1O)C(=O)O2,AFSDNFLWKVMVRB-UHFFFAOYSA-N,302.1926,Q14534,BE0000577,Squalene monooxygenase,Humans,inhibitor,yes
DB08846,Ellagic acid,small molecule,investigational,OC1=C(O)C2=C3C(=C1)C(=O)OC1=C3C(=CC(O)=C1O)C(=O)O2,AFSDNFLWKVMVRB-UHFFFAOYSA-N,302.1926,P22748,BE0000535,Carbonic anhydrase 4,Humans,inhibitor,yes
DB08846,Ellagic acid,small molecule,investigational,OC1=C(O)C2=C3C(=C1)C(=O)OC1=C3C(=CC(O)=C1O)C(=O)O2,AFSDNFLWKVMVRB-UHFFFAOYSA-N,302.1926,P68400,BE0001209,Casein kinase II subunit alpha,Humans,inhibitor,yes
DB08849,Nipecotic acid,small molecule,experimental,OC(=O)C1CCCNC1,XJLSEXAGTJCILF-UHFFFAOYSA-N,129.159,P30531,BE0000249,Sodium- and chloride-dependent GABA transporter 1,Humans,inhibitor,yes
DB08849,Nipecotic acid,small molecule,experimental,OC(=O)C1CCCNC1,XJLSEXAGTJCILF-UHFFFAOYSA-N,129.159,P48066,BE0004733,Sodium- and chloride-dependent GABA transporter 3,Humans,inhibitor,yes
DB08849,Nipecotic acid,small molecule,experimental,OC(=O)C1CCCNC1,XJLSEXAGTJCILF-UHFFFAOYSA-N,129.159,P80404,BE0000253,"4-aminobutyrate aminotransferase, mitochondrial",Humans,inhibitor,yes
DB08849,Nipecotic acid,small molecule,experimental,OC(=O)C1CCCNC1,XJLSEXAGTJCILF-UHFFFAOYSA-N,129.159,P0DMS8,BE0000354,Adenosine receptor A3,Humans,inhibitor,yes
DB08855,Leukotriene C4,small molecule,experimental;investigational,CCCCC\C=C/C\C=C/C=C/C=C/[C@@H](SC[C@H](NC(=O)CC[C@H](N)C(O)=O)C(=O)NCC(O)=O)[C@@H](O)CCCC(O)=O,GWNVDXQDILPJIG-NXOLIXFESA-N,625.774,Q9Y271,BE0000705,Cysteinyl leukotriene receptor 1,Humans,agonist,yes
DB08855,Leukotriene C4,small molecule,experimental;investigational,CCCCC\C=C/C\C=C/C=C/C=C/[C@@H](SC[C@H](NC(=O)CC[C@H](N)C(O)=O)C(=O)NCC(O)=O)[C@@H](O)CCCC(O)=O,GWNVDXQDILPJIG-NXOLIXFESA-N,625.774,Q9NS75,BE0000099,Cysteinyl leukotriene receptor 2,Humans,agonist,yes
DB08856,DADLE,small molecule,experimental,CC(C)C[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1)C(O)=O,ZHUJMSMQIPIPTF-IBURTVSXSA-N,569.659,P41143,BE0000420,Delta-type opioid receptor,Humans,agonist,yes
DB08856,DADLE,small molecule,experimental,CC(C)C[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1)C(O)=O,ZHUJMSMQIPIPTF-IBURTVSXSA-N,569.659,P35372,BE0000770,Mu-type opioid receptor,Humans,inhibitor,yes
DB08860,Pitavastatin,small molecule,approved,O[C@H](C[C@H](O)\C=C\C1=C(N=C2C=CC=CC2=C1C1=CC=C(F)C=C1)C1CC1)CC(O)=O,VGYFMXBACGZSIL-MCBHFWOFSA-N,421.4608,P04035,BE0000574,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Humans,inhibitor,yes
DB08861,DPDPE,small molecule,experimental,CC1(C)SSC(C)(C)[C@@H](NC(=O)[C@@H](N)CC2=CC=C(O)C=C2)C(=O)NCC(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@H]1C(O)=O,MCMMCRYPQBNCPH-WMIMKTLMSA-N,645.79,P35372,BE0000770,Mu-type opioid receptor,Humans,inhibitor,yes
DB08861,DPDPE,small molecule,experimental,CC1(C)SSC(C)(C)[C@@H](NC(=O)[C@@H](N)CC2=CC=C(O)C=C2)C(=O)NCC(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@H]1C(O)=O,MCMMCRYPQBNCPH-WMIMKTLMSA-N,645.79,P41143,BE0000420,Delta-type opioid receptor,Humans,inhibitor,yes
DB08861,DPDPE,small molecule,experimental,CC1(C)SSC(C)(C)[C@@H](NC(=O)[C@@H](N)CC2=CC=C(O)C=C2)C(=O)NCC(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@H]1C(O)=O,MCMMCRYPQBNCPH-WMIMKTLMSA-N,645.79,P41145,BE0000632,Kappa-type opioid receptor,Humans,inhibitor,yes
DB08864,Rilpivirine,small molecule,approved,CC1=CC(\C=C\C#N)=CC(C)=C1NC1=CC=NC(NC2=CC=C(C=C2)C#N)=N1,YIBOMRUWOWDFLG-ONEGZZNKSA-N,366.4185,Q72547,BE0004136,Reverse transcriptase/RNaseH,Human immunodeficiency virus 1,inhibitor,yes
DB08864,Rilpivirine,small molecule,approved,CC1=CC(\C=C\C#N)=CC(C)=C1NC1=CC=NC(NC2=CC=C(C=C2)C#N)=N1,YIBOMRUWOWDFLG-ONEGZZNKSA-N,366.4185,Q9Y5Y9,BE0000177,Sodium channel protein type 10 subunit alpha,Humans,inhibitor,yes
DB08864,Rilpivirine,small molecule,approved,CC1=CC(\C=C\C#N)=CC(C)=C1NC1=CC=NC(NC2=CC=C(C=C2)C#N)=N1,YIBOMRUWOWDFLG-ONEGZZNKSA-N,366.4185,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB08865,Crizotinib,small molecule,approved;investigational,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,KTEIFNKAUNYNJU-GFCCVEGCSA-N,450.337,Q9UM73,BE0000359,ALK tyrosine kinase receptor,Humans,inhibitor,yes
DB08865,Crizotinib,small molecule,approved;investigational,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,KTEIFNKAUNYNJU-GFCCVEGCSA-N,450.337,P08581,BE0000915,Hepatocyte growth factor receptor,Humans,inhibitor,yes
DB08865,Crizotinib,small molecule,approved;investigational,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,KTEIFNKAUNYNJU-GFCCVEGCSA-N,450.337,P08922,BE0009534,Proto-oncogene tyrosine-protein kinase ROS,Humans,inhibitor,yes
DB08865,Crizotinib,small molecule,approved;investigational,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,KTEIFNKAUNYNJU-GFCCVEGCSA-N,450.337,Q04912,BE0009490,Macrophage-stimulating protein receptor,Humans,inhibitor,yes
DB08867,Ulipristal,small molecule,approved,CN(C)C1=CC=C(C=C1)[C@H]1C[C@@]2(C)[C@@H](CC[C@]2(O)C(C)=O)[C@@H]2CCC3=CC(=O)CCC3=C12,HKDLNTKNLJPAIY-WKWWZUSTSA-N,433.592,P06401,BE0000557,Progesterone receptor,Humans,modulator,yes
DB08867,Ulipristal,small molecule,approved,CN(C)C1=CC=C(C=C1)[C@H]1C[C@@]2(C)[C@@H](CC[C@]2(O)C(C)=O)[C@@H]2CCC3=CC(=O)CCC3=C12,HKDLNTKNLJPAIY-WKWWZUSTSA-N,433.592,P04150,BE0000794,Glucocorticoid receptor,Humans,antagonist,yes
DB08868,Fingolimod,small molecule,approved;investigational,CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1,KKGQTZUTZRNORY-UHFFFAOYSA-N,307.4708,P35462,BE0000581,D(3) dopamine receptor,Humans,antagonist,yes
DB08868,Fingolimod,small molecule,approved;investigational,CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1,KKGQTZUTZRNORY-UHFFFAOYSA-N,307.4708,Q9NYA1,BE0004728,Sphingosine kinase 1,Humans,inhibitor,yes
DB08868,Fingolimod,small molecule,approved;investigational,CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1,KKGQTZUTZRNORY-UHFFFAOYSA-N,307.4708,Q9H228,BE0002432,Sphingosine 1-phosphate receptor 5,Humans,modulator,yes
DB08868,Fingolimod,small molecule,approved;investigational,CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1,KKGQTZUTZRNORY-UHFFFAOYSA-N,307.4708,P21453,BE0008652,Sphingosine 1-phosphate receptor 1,Humans,modulator,yes
DB08868,Fingolimod,small molecule,approved;investigational,CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1,KKGQTZUTZRNORY-UHFFFAOYSA-N,307.4708,Q99500,BE0009881,Sphingosine 1-phosphate receptor 3,Humans,modulator,yes
DB08871,Eribulin,small molecule,approved;investigational,[H][C@@]12CC(=C)[C@]([H])(CC[C@@]3([H])C[C@@H](C)C(=C)[C@@]([H])(C[C@]4([H])O[C@H](C[C@H](O)CN)[C@H](OC)[C@@]4([H])CC(=O)C[C@@]4([H])CC[C@]5([H])O[C@@]6([H])[C@H]7O[C@@]8(C[C@]7([H])O[C@@]6([H])[C@@]([H])(O8)[C@@]5([H])O4)CC1)O3)O2,UFNVPOGXISZXJD-JBQZKEIOSA-N,729.908,Q9H4B7,BE0000026,Tubulin beta-1 chain,Humans,inhibitor,yes
DB08872,Gabapentin enacarbil,small molecule,approved;investigational,CC(C)C(=O)OC(C)OC(=O)NCC1(CC(O)=O)CCCCC1,TZDUHAJSIBHXDL-UHFFFAOYSA-N,329.393,Q9Y289,BE0000094,Sodium-dependent multivitamin transporter,Humans,modulator,yes
DB08873,Boceprevir,small molecule,approved;withdrawn,[H][C@]12CN([C@H](C(=O)NC(CC3CCC3)C(=O)C(N)=O)[C@@]1([H])C2(C)C)C(=O)[C@@H](NC(=O)NC(C)(C)C)C(C)(C)C,LHHCSNFAOIFYRV-DOVBMPENSA-N,519.6767,B0B3C9,BE0004701,Genome polyprotein,Hepatitis C Virus,inhibitor,yes
DB08873,Boceprevir,small molecule,approved;withdrawn,[H][C@]12CN([C@H](C(=O)NC(CC3CCC3)C(=O)C(N)=O)[C@@]1([H])C2(C)C)C(=O)[C@@H](NC(=O)NC(C)(C)C)C(C)(C)C,LHHCSNFAOIFYRV-DOVBMPENSA-N,519.6767,P26664,BE0003427,Genome polyprotein,,modulator,yes
DB08874,Fidaxomicin,small molecule,approved,[H][C@@]1(O[C@@H]2[C@@H](CC)\C=C(C)\[C@@H](O)C\C=C\C=C(CO[C@@H]3O[C@H](C)[C@@H](OC(=O)C4=C(CC)C(Cl)=C(O)C(Cl)=C4O)[C@H](O)[C@@H]3OC)\C(=O)O[C@@H](C\C=C(/C)\C=C2/C)[C@@H](C)O)OC(C)(C)[C@@H](OC(=O)C(C)C)[C@H](O)[C@@H]1O,ZVGNESXIJDCBKN-UUEYKCAUSA-N,1058.05,Q18BX5,BE0004732,RNA polymerase sigma factor SigA,Clostridium difficile (strain 630),inhibitor,yes
DB08875,Cabozantinib,small molecule,approved;investigational,COC1=CC2=C(C=C1OC)C(OC1=CC=C(NC(=O)C3(CC3)C(=O)NC3=CC=C(F)C=C3)C=C1)=CC=N2,ONIQOQHATWINJY-UHFFFAOYSA-N,501.514,P08581,BE0000915,Hepatocyte growth factor receptor,Humans,antagonist,yes
DB08875,Cabozantinib,small molecule,approved;investigational,COC1=CC2=C(C=C1OC)C(OC1=CC=C(NC(=O)C3(CC3)C(=O)NC3=CC=C(F)C=C3)C=C1)=CC=N2,ONIQOQHATWINJY-UHFFFAOYSA-N,501.514,P35968,BE0000369,Vascular endothelial growth factor receptor 2,Humans,antagonist,yes
DB08875,Cabozantinib,small molecule,approved;investigational,COC1=CC2=C(C=C1OC)C(OC1=CC=C(NC(=O)C3(CC3)C(=O)NC3=CC=C(F)C=C3)C=C1)=CC=N2,ONIQOQHATWINJY-UHFFFAOYSA-N,501.514,P07949,BE0002411,Proto-oncogene tyrosine-protein kinase receptor Ret,Humans,antagonist,yes
DB08877,Ruxolitinib,small molecule,approved,N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1,HFNKQEVNSGCOJV-OAHLLOKOSA-N,306.365,Q03405,BE0000717,Urokinase plasminogen activator surface receptor,Humans,inhibitor,yes
DB08877,Ruxolitinib,small molecule,approved,N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1,HFNKQEVNSGCOJV-OAHLLOKOSA-N,306.365,O60674,BE0002408,Tyrosine-protein kinase JAK2,Humans,inhibitor,yes
DB08877,Ruxolitinib,small molecule,approved,N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1,HFNKQEVNSGCOJV-OAHLLOKOSA-N,306.365,P23458,BE0004145,Tyrosine-protein kinase JAK1,Humans,inhibitor,yes
DB08877,Ruxolitinib,small molecule,approved,N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1,HFNKQEVNSGCOJV-OAHLLOKOSA-N,306.365,P52333,BE0003493,Tyrosine-protein kinase JAK3,Humans,inhibitor,yes
DB08877,Ruxolitinib,small molecule,approved,N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1,HFNKQEVNSGCOJV-OAHLLOKOSA-N,306.365,P29597,BE0004146,Non-receptor tyrosine-protein kinase TYK2,Humans,inhibitor,yes
DB08878,Aminopterin,small molecule,investigational;withdrawn,NC1=NC2=C(N=C(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=N2)C(N)=N1,TVZGACDUOSZQKY-LBPRGKRZSA-N,440.4127,Q9HBH1,BE0002201,"Peptide deformylase, mitochondrial",Humans,inhibitor,yes
DB08880,Teriflunomide,small molecule,approved,C\C(O)=C(/C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F,UTNUDOFZCWSZMS-YFHOEESVSA-N,270.2073,Q08210,BE0000612,"Dihydroorotate dehydrogenase (quinone), mitochondrial",Plasmodium falciparum (isolate 3D7),inhibitor,yes
DB08880,Teriflunomide,small molecule,approved,C\C(O)=C(/C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F,UTNUDOFZCWSZMS-YFHOEESVSA-N,270.2073,P04035,BE0000574,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Humans,inhibitor,yes
DB08881,Vemurafenib,small molecule,approved,CCCS(=O)(=O)NC1=C(F)C(C(=O)C2=CNC3=NC=C(C=C23)C2=CC=C(Cl)C=C2)=C(F)C=C1,GPXBXXGIAQBQNI-UHFFFAOYSA-N,489.922,P15056,BE0000634,Serine/threonine-protein kinase B-raf,Humans,inhibitor,yes
DB08882,Linagliptin,small molecule,approved,CC#CCN1C(=NC2=C1C(=O)N(CC1=NC3=C(C=CC=C3)C(C)=N1)C(=O)N2C)N1CCC[C@@H](N)C1,LTXREWYXXSTFRX-QGZVFWFLSA-N,472.5422,P27487,BE0000854,Dipeptidyl peptidase 4,Humans,inhibitor,yes
DB08883,Perampanel,small molecule,approved,O=C1N(C=C(C=C1C1=CC=CC=C1C#N)C1=NC=CC=C1)C1=CC=CC=C1,PRMWGUBFXWROHD-UHFFFAOYSA-N,349.393,P42262,BE0000829,Glutamate receptor 2,Humans,inhibitor,yes
DB08883,Perampanel,small molecule,approved,O=C1N(C=C(C=C1C1=CC=CC=C1C#N)C1=NC=CC=C1)C1=CC=CC=C1,PRMWGUBFXWROHD-UHFFFAOYSA-N,349.393,P42263,BE0000831,Glutamate receptor 3,Humans,inhibitor,yes
DB08883,Perampanel,small molecule,approved,O=C1N(C=C(C=C1C1=CC=CC=C1C#N)C1=NC=CC=C1)C1=CC=CC=C1,PRMWGUBFXWROHD-UHFFFAOYSA-N,349.393,P48058,BE0000830,Glutamate receptor 4,Humans,inhibitor,yes
DB08883,Perampanel,small molecule,approved,O=C1N(C=C(C=C1C1=CC=CC=C1C#N)C1=NC=CC=C1)C1=CC=CC=C1,PRMWGUBFXWROHD-UHFFFAOYSA-N,349.393,P42261,BE0000640,Glutamate receptor 1,Humans,antagonist,yes
DB08889,Carfilzomib,small molecule,approved;investigational,CC(C)C[C@H](NC(=O)[C@H](CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1,BLMPQMFVWMYDKT-NZTKNTHTSA-N,719.9099,P28074,BE0002348,Proteasome subunit beta type-5,Humans,inhibitor,yes
DB08889,Carfilzomib,small molecule,approved;investigational,CC(C)C[C@H](NC(=O)[C@H](CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1,BLMPQMFVWMYDKT-NZTKNTHTSA-N,719.9099,P28062,BE0004739,Proteasome subunit beta type-8,Humans,inhibitor,yes
DB08889,Carfilzomib,small molecule,approved;investigational,CC(C)C[C@H](NC(=O)[C@H](CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1,BLMPQMFVWMYDKT-NZTKNTHTSA-N,719.9099,P20618,BE0002347,Proteasome subunit beta type-1,Humans,inhibitor,yes
DB08889,Carfilzomib,small molecule,approved;investigational,CC(C)C[C@H](NC(=O)[C@H](CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1,BLMPQMFVWMYDKT-NZTKNTHTSA-N,719.9099,P28065,BE0004737,Proteasome subunit beta type-9,Humans,inhibitor,yes
DB08889,Carfilzomib,small molecule,approved;investigational,CC(C)C[C@H](NC(=O)[C@H](CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1,BLMPQMFVWMYDKT-NZTKNTHTSA-N,719.9099,P49721,BE0002349,Proteasome subunit beta type-2,Humans,inhibitor,yes
DB08889,Carfilzomib,small molecule,approved;investigational,CC(C)C[C@H](NC(=O)[C@H](CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1,BLMPQMFVWMYDKT-NZTKNTHTSA-N,719.9099,P40306,BE0004738,Proteasome subunit beta type-10,Humans,inhibitor,yes
DB08890,Linaclotide,small molecule,approved,[H][C@]1(CSSC[C@]2([H])NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]3CSSC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CSSC[C@H](N)C(=O)N3)NC2=O)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)NCC(=O)N1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O,KXGCNMMJRFDFNR-WDRJZQOASA-N,1526.736,P25092,BE0003502,Guanylyl cyclase C,Humans,agonist,yes
DB08891,Arbaclofen,small molecule,investigational,[H][C@@](CN)(CC(O)=O)C1=CC=C(Cl)C=C1,KPYSYYIEGFHWSV-QMMMGPOBSA-N,213.661,Q9UBS5,BE0000217,Gamma-aminobutyric acid type B receptor subunit 1,Humans,agonist,yes
DB08891,Arbaclofen,small molecule,investigational,[H][C@@](CN)(CC(O)=O)C1=CC=C(Cl)C=C1,KPYSYYIEGFHWSV-QMMMGPOBSA-N,213.661,O75899,BE0002340,Gamma-aminobutyric acid type B receptor subunit 2,Humans,agonist,yes
DB08892,Arbaclofen Placarbil,small molecule,investigational,CC(C)[C@H](OC(=O)NC[C@H](CC(O)=O)C1=CC=C(Cl)C=C1)OC(=O)C(C)C,JXTAALBWJQJLGN-KSSFIOAISA-N,399.87,Q9UBS5,BE0000217,Gamma-aminobutyric acid type B receptor subunit 1,Humans,agonist,yes
DB08892,Arbaclofen Placarbil,small molecule,investigational,CC(C)[C@H](OC(=O)NC[C@H](CC(O)=O)C1=CC=C(Cl)C=C1)OC(=O)C(C)C,JXTAALBWJQJLGN-KSSFIOAISA-N,399.87,Q99928,BE0003594,Gamma-aminobutyric acid receptor subunit gamma-3,Humans,agonist,yes
DB08892,Arbaclofen Placarbil,small molecule,investigational,CC(C)[C@H](OC(=O)NC[C@H](CC(O)=O)C1=CC=C(Cl)C=C1)OC(=O)C(C)C,JXTAALBWJQJLGN-KSSFIOAISA-N,399.87,O75899,BE0002340,Gamma-aminobutyric acid type B receptor subunit 2,Humans,agonist,yes
DB08893,Mirabegron,small molecule,approved,NC1=NC(CC(=O)NC2=CC=C(CCNC[C@H](O)C3=CC=CC=C3)C=C2)=CS1,PBAPPPCECJKMCM-IBGZPJMESA-N,396.506,P13945,BE0001012,Beta-3 adrenergic receptor,Humans,agonist,yes
DB08895,Tofacitinib,small molecule,approved;investigational,C[C@@H]1CCN(C[C@@H]1N(C)C1=NC=NC2=C1C=CN2)C(=O)CC#N,UJLAWZDWDVHWOW-YPMHNXCESA-N,312.3696,P23458,BE0004145,Tyrosine-protein kinase JAK1,Humans,inhibitor,yes
DB08895,Tofacitinib,small molecule,approved;investigational,C[C@@H]1CCN(C[C@@H]1N(C)C1=NC=NC2=C1C=CN2)C(=O)CC#N,UJLAWZDWDVHWOW-YPMHNXCESA-N,312.3696,O60674,BE0002408,Tyrosine-protein kinase JAK2,Humans,antagonist;inhibitor,yes
DB08895,Tofacitinib,small molecule,approved;investigational,C[C@@H]1CCN(C[C@@H]1N(C)C1=NC=NC2=C1C=CN2)C(=O)CC#N,UJLAWZDWDVHWOW-YPMHNXCESA-N,312.3696,P52333,BE0003493,Tyrosine-protein kinase JAK3,Humans,inhibitor,yes
DB08896,Regorafenib,small molecule,approved,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,482.815,P17948,BE0000029,Vascular endothelial growth factor receptor 1,Humans,inhibitor,yes
DB08896,Regorafenib,small molecule,approved,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,482.815,P35968,BE0000369,Vascular endothelial growth factor receptor 2,Humans,inhibitor,yes
DB08896,Regorafenib,small molecule,approved,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,482.815,P35916,BE0000023,Vascular endothelial growth factor receptor 3,Humans,inhibitor,yes
DB08896,Regorafenib,small molecule,approved,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,482.815,P10721,BE0000453,Mast/stem cell growth factor receptor Kit,Humans,inhibitor,yes
DB08896,Regorafenib,small molecule,approved,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,482.815,P16234,BE0000852,Platelet-derived growth factor receptor alpha,Humans,inhibitor,yes
DB08896,Regorafenib,small molecule,approved,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,482.815,P09619,BE0000205,Platelet-derived growth factor receptor beta,Humans,inhibitor,yes
DB08896,Regorafenib,small molecule,approved,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,482.815,P11362,BE0002131,Fibroblast growth factor receptor 1,Humans,inhibitor,yes
DB08896,Regorafenib,small molecule,approved,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,482.815,P21802,BE0000748,Fibroblast growth factor receptor 2,Humans,inhibitor,yes
DB08896,Regorafenib,small molecule,approved,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,482.815,Q02763,BE0003379,Angiopoietin-1 receptor,Humans,inhibitor,yes
DB08896,Regorafenib,small molecule,approved,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,482.815,Q16832,BE0004741,Discoidin domain-containing receptor 2,Humans,inhibitor,yes
DB08896,Regorafenib,small molecule,approved,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,482.815,P04629,BE0001039,High affinity nerve growth factor receptor,Humans,inhibitor,yes
DB08896,Regorafenib,small molecule,approved,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,482.815,P29317,BE0000841,Ephrin type-A receptor 2,Humans,inhibitor,yes
DB08896,Regorafenib,small molecule,approved,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,482.815,P04049,BE0000036,RAF proto-oncogene serine/threonine-protein kinase,Humans,inhibitor,yes
DB08896,Regorafenib,small molecule,approved,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,482.815,P15056,BE0000634,Serine/threonine-protein kinase B-raf,Humans,inhibitor,yes
DB08896,Regorafenib,small molecule,approved,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,482.815,Q15759,BE0003390,Mitogen-activated protein kinase 11,Humans,inhibitor,yes
DB08896,Regorafenib,small molecule,approved,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,482.815,P42685,BE0004742,Tyrosine-protein kinase FRK,Humans,inhibitor,yes
DB08896,Regorafenib,small molecule,approved,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,482.815,P00519,BE0000014,Tyrosine-protein kinase ABL1,Humans,inhibitor,yes
DB08896,Regorafenib,small molecule,approved,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,482.815,P07949,BE0002411,Proto-oncogene tyrosine-protein kinase receptor Ret,Humans,inhibitor,yes
DB08897,Aclidinium,small molecule,approved,OC(C(=O)O[C@H]1C[N+]2(CCCOC3=CC=CC=C3)CCC1CC2)(C1=CC=CS1)C1=CC=CS1,ASMXXROZKSBQIH-VITNCHFBSA-N,484.651,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,antagonist,yes
DB08897,Aclidinium,small molecule,approved,OC(C(=O)O[C@H]1C[N+]2(CCCOC3=CC=CC=C3)CCC1CC2)(C1=CC=CS1)C1=CC=CS1,ASMXXROZKSBQIH-VITNCHFBSA-N,484.651,P08172,BE0000560,Muscarinic acetylcholine receptor M2,Humans,antagonist,yes
DB08897,Aclidinium,small molecule,approved,OC(C(=O)O[C@H]1C[N+]2(CCCOC3=CC=CC=C3)CCC1CC2)(C1=CC=CS1)C1=CC=CS1,ASMXXROZKSBQIH-VITNCHFBSA-N,484.651,P20309,BE0000045,Muscarinic acetylcholine receptor M3,Humans,antagonist,yes
DB08897,Aclidinium,small molecule,approved,OC(C(=O)O[C@H]1C[N+]2(CCCOC3=CC=CC=C3)CCC1CC2)(C1=CC=CS1)C1=CC=CS1,ASMXXROZKSBQIH-VITNCHFBSA-N,484.651,P08173,BE0000405,Muscarinic acetylcholine receptor M4,Humans,antagonist,yes
DB08897,Aclidinium,small molecule,approved,OC(C(=O)O[C@H]1C[N+]2(CCCOC3=CC=CC=C3)CCC1CC2)(C1=CC=CS1)C1=CC=CS1,ASMXXROZKSBQIH-VITNCHFBSA-N,484.651,P08912,BE0000247,Muscarinic acetylcholine receptor M5,Humans,antagonist,yes
DB08899,Enzalutamide,small molecule,approved,CNC(=O)C1=C(F)C=C(C=C1)N1C(=S)N(C(=O)C1(C)C)C1=CC=C(C#N)C(=C1)C(F)(F)F,WXCXUHSOUPDCQV-UHFFFAOYSA-N,464.436,P10275,BE0000132,Androgen receptor,Humans,inhibitor,yes
DB08901,Ponatinib,small molecule,approved;investigational,CN1CCN(CC2=CC=C(NC(=O)C3=CC(C#CC4=CN=C5C=CC=NN45)=C(C)C=C3)C=C2C(F)(F)F)CC1,PHXJVRSECIGDHY-UHFFFAOYSA-N,532.5595,P00519,BE0000014,Tyrosine-protein kinase ABL1,Humans,inhibitor,yes
DB08901,Ponatinib,small molecule,approved;investigational,CN1CCN(CC2=CC=C(NC(=O)C3=CC(C#CC4=CN=C5C=CC=NN45)=C(C)C=C3)C=C2C(F)(F)F)CC1,PHXJVRSECIGDHY-UHFFFAOYSA-N,532.5595,P11274,BE0004743,Breakpoint cluster region protein,Humans,inhibitor,yes
DB08903,Bedaquiline,small molecule,approved,COC1=NC2=C(C=C(Br)C=C2)C=C1[C@@H](C1=CC=CC=C1)[C@@](O)(CCN(C)C)C1=CC=CC2=C1C=CC=C2,QUIJNHUBAXPXFS-XLJNKUFUSA-N,555.505,P9WPS1,BE0004748,ATP synthase subunit c,Mycobacterium tuberculosis,inhibitor,yes
DB08905,Formestane,small molecule,approved;investigational;withdrawn,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=C(O)C(=O)CC[C@]12C,OSVMTWJCGUFAOD-KZQROQTASA-N,302.4079,P11511,BE0002090,Aromatase,Humans,inhibitor,yes
DB08906,Fluticasone furoate,small molecule,approved,[H][C@@]12C[C@@H](C)[C@](OC(=O)C3=CC=CO3)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,XTULMSXFIHGYFS-VLSRWLAYSA-N,538.576,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB08907,Canagliflozin,small molecule,approved,[H][C@]1(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C1=CC=C(C)C(CC2=CC=C(S2)C2=CC=C(F)C=C2)=C1,XTNGUQKDFGDXSJ-ZXGKGEBGSA-N,444.516,P31639,BE0004753,Sodium/glucose cotransporter 2,Humans,inhibitor,yes
DB08908,Dimethyl fumarate,small molecule,approved;investigational,[H]\C(=C(\[H])C(=O)OC)C(=O)OC,LDCRTTXIJACKKU-ONEGZZNKSA-N,144.1253,Q14145,BE0004756,Kelch-like ECH-associated protein 1,Humans,binder,yes
DB08910,Pomalidomide,small molecule,approved,NC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,UVSMNLNDYGZFPF-UHFFFAOYSA-N,273.2441,Q96SW2,BE0004755,Protein cereblon,Humans,inhibitor,yes
DB08910,Pomalidomide,small molecule,approved,NC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,UVSMNLNDYGZFPF-UHFFFAOYSA-N,273.2441,P01375,BE0000704,Tumor necrosis factor,Humans,inhibitor,yes
DB08910,Pomalidomide,small molecule,approved,NC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,UVSMNLNDYGZFPF-UHFFFAOYSA-N,273.2441,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB08911,Trametinib,small molecule,approved,CN1C(=O)C(C)=C2N(C(=O)N(C3CC3)C(=O)C2=C1NC1=CC=C(I)C=C1F)C1=CC(NC(C)=O)=CC=C1,LIRYPHYGHXZJBZ-UHFFFAOYSA-N,615.3948,Q02750,BE0000870,Dual specificity mitogen-activated protein kinase kinase 1,Humans,inhibitor,yes
DB08911,Trametinib,small molecule,approved,CN1C(=O)C(C)=C2N(C(=O)N(C3CC3)C(=O)C2=C1NC1=CC=C(I)C=C1F)C1=CC(NC(C)=O)=CC=C1,LIRYPHYGHXZJBZ-UHFFFAOYSA-N,615.3948,P36507,BE0004744,Dual specificity mitogen-activated protein kinase kinase 2,Humans,inhibitor,yes
DB08912,Dabrafenib,small molecule,approved;investigational,CC(C)(C)C1=NC(=C(S1)C1=NC(N)=NC=C1)C1=C(F)C(NS(=O)(=O)C2=C(F)C=CC=C2F)=CC=C1,BFSMGDJOXZAERB-UHFFFAOYSA-N,519.562,P15056,BE0000634,Serine/threonine-protein kinase B-raf,Humans,inhibitor,yes
DB08912,Dabrafenib,small molecule,approved;investigational,CC(C)(C)C1=NC(=C(S1)C1=NC(N)=NC=C1)C1=C(F)C(NS(=O)(=O)C2=C(F)C=CC=C2F)=CC=C1,BFSMGDJOXZAERB-UHFFFAOYSA-N,519.562,P04049,BE0000036,RAF proto-oncogene serine/threonine-protein kinase,Humans,inhibitor,yes
DB08915,Aleglitazar,small molecule,investigational,CO[C@@H](CC1=CC=C(OCCC2=C(C)OC(=N2)C2=CC=CC=C2)C2=C1SC=C2)C(O)=O,DAYKLWSKQJBGCS-NRFANRHFSA-N,437.508,Q07869,BE0000071,Peroxisome proliferator-activated receptor alpha,Humans,agonist,yes
DB08915,Aleglitazar,small molecule,investigational,CO[C@@H](CC1=CC=C(OCCC2=C(C)OC(=N2)C2=CC=CC=C2)C2=C1SC=C2)C(O)=O,DAYKLWSKQJBGCS-NRFANRHFSA-N,437.508,P37231,BE0000215,Peroxisome proliferator-activated receptor gamma,Humans,agonist,yes
DB08916,Afatinib,small molecule,approved,CN(C)C\C=C\C(=O)NC1=C(O[C@H]2CCOC2)C=C2N=CN=C(NC3=CC(Cl)=C(F)C=C3)C2=C1,ULXXDDBFHOBEHA-CWDCEQMOSA-N,485.938,P00533,BE0000767,Epidermal growth factor receptor,Humans,inhibitor,yes
DB08916,Afatinib,small molecule,approved,CN(C)C\C=C\C(=O)NC1=C(O[C@H]2CCOC2)C=C2N=CN=C(NC3=CC(Cl)=C(F)C=C3)C2=C1,ULXXDDBFHOBEHA-CWDCEQMOSA-N,485.938,P04626,BE0000511,Receptor tyrosine-protein kinase erbB-2,Humans,inhibitor,yes
DB08916,Afatinib,small molecule,approved,CN(C)C\C=C\C(=O)NC1=C(O[C@H]2CCOC2)C=C2N=CN=C(NC3=CC(Cl)=C(F)C=C3)C2=C1,ULXXDDBFHOBEHA-CWDCEQMOSA-N,485.938,Q15303,BE0004772,Receptor tyrosine-protein kinase erbB-4,Humans,inhibitor,yes
DB08918,Levomilnacipran,small molecule,approved;investigational,CCN(CC)C(=O)[C@]1(C[C@H]1CN)C1=CC=CC=C1,GJJFMKBJSRMPLA-DZGCQCFKSA-N,246.348,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB08918,Levomilnacipran,small molecule,approved;investigational,CCN(CC)C(=O)[C@]1(C[C@H]1CN)C1=CC=CC=C1,GJJFMKBJSRMPLA-DZGCQCFKSA-N,246.348,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,inhibitor,yes
DB08922,Perospirone,small molecule,experimental,[H][C@@]12CCCC[C@]1([H])C(=O)N(CCCCN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O,FBVFZWUMDDXLLG-HDICACEKSA-N,426.58,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,inverse agonist,yes
DB08922,Perospirone,small molecule,experimental,[H][C@@]12CCCC[C@]1([H])C(=O)N(CCCCN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O,FBVFZWUMDDXLLG-HDICACEKSA-N,426.58,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB08922,Perospirone,small molecule,experimental,[H][C@@]12CCCC[C@]1([H])C(=O)N(CCCCN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O,FBVFZWUMDDXLLG-HDICACEKSA-N,426.58,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,partial agonist,yes
DB08930,Dolutegravir,small molecule,approved,[H][C@]12CN3C=C(C(=O)NCC4=CC=C(F)C=C4F)C(=O)C(O)=C3C(=O)N1[C@H](C)CCO2,RHWKPHLQXYSBKR-BMIGLBTASA-N,419.3788,P03366,BE0002050,Gag-Pol polyprotein,,modulator,yes
DB08930,Dolutegravir,small molecule,approved,[H][C@]12CN3C=C(C(=O)NCC4=CC=C(F)C=C4F)C(=O)C(O)=C3C(=O)N1[C@H](C)CCO2,RHWKPHLQXYSBKR-BMIGLBTASA-N,419.3788,Q7ZJM1,BE0004855,Integrase,Human immunodeficiency virus 1,inhibitor,yes
DB08931,Riociguat,small molecule,approved,COC(=O)N(C)C1=C(N)N=C(N=C1N)C1=NN(CC2=C(F)C=CC=C2)C2=C1C=CC=N2,WXXSNCNJFUAIDG-UHFFFAOYSA-N,422.4157,Q02846,BE0013774,Retinal guanylyl cyclase 1,Humans,modulator,yes
DB08931,Riociguat,small molecule,approved,COC(=O)N(C)C1=C(N)N=C(N=C1N)C1=NN(CC2=C(F)C=CC=C2)C2=C1C=CC=N2,WXXSNCNJFUAIDG-UHFFFAOYSA-N,422.4157,P33402,BE0003578,Guanylate cyclase soluble subunit alpha-2,Humans,agonist;stimulator,yes
DB08932,Macitentan,small molecule,approved,CCCNS(=O)(=O)NC1=C(C(OCCOC2=NC=C(Br)C=N2)=NC=N1)C1=CC=C(Br)C=C1,JGCMEBMXRHSZKX-UHFFFAOYSA-N,588.273,P25101,BE0000521,Endothelin-1 receptor,Humans,antagonist,yes
DB08933,Luliconazole,small molecule,approved,ClC1=CC(Cl)=C(C=C1)[C@@H]1CS\C(S1)=C(\C#N)N1C=CN=C1,YTAOBBFIOAEMLL-REQDGWNSSA-N,354.27,P10613,BE0000233,Lanosterol 14-alpha demethylase,Yeast,inhibitor,yes
DB08934,Sofosbuvir,small molecule,approved,CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](N2C=CC(=O)NC2=O)[C@](C)(F)[C@@H]1O)OC1=CC=CC=C1,TTZHDVOVKQGIBA-IQWMDFIBSA-N,529.458,P26664,BE0003427,Genome polyprotein,,modulator,yes
DB08934,Sofosbuvir,small molecule,approved,CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](N2C=CC(=O)NC2=O)[C@](C)(F)[C@@H]1O)OC1=CC=CC=C1,TTZHDVOVKQGIBA-IQWMDFIBSA-N,529.458,O39930,BE0002403,RNA-dependent RNA-polymerase,Hepatitis C Virus,inhibitor,yes
DB08936,Chlorcyclizine,small molecule,approved,CN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,WFNAKBGANONZEQ-UHFFFAOYSA-N,300.826,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB08943,Isoconazole,small molecule,approved,ClC1=CC(Cl)=C(C=C1)C(CN1C=CN=C1)OCC1=C(Cl)C=CC=C1Cl,MPIPASJGOJYODL-UHFFFAOYSA-N,416.129,P05093,BE0000344,"Steroid 17-alpha-hydroxylase/17,20 lyase",Humans,inhibitor,yes
DB08949,Inositol nicotinate,small molecule,approved;withdrawn,O=C(O[C@H]1[C@H](OC(=O)C2=CC=CN=C2)[C@@H](OC(=O)C2=CC=CN=C2)[C@H](OC(=O)C2=CC=CN=C2)[C@H](OC(=O)C2=CC=CN=C2)[C@@H]1OC(=O)C1=CC=CN=C1)C1=CC=CN=C1,MFZCIDXOLLEMOO-GYSGTQPESA-N,810.732,P49019,BE0000836,Hydroxycarboxylic acid receptor 3,Humans,agonist,yes
DB08949,Inositol nicotinate,small molecule,approved;withdrawn,O=C(O[C@H]1[C@H](OC(=O)C2=CC=CN=C2)[C@@H](OC(=O)C2=CC=CN=C2)[C@H](OC(=O)C2=CC=CN=C2)[C@H](OC(=O)C2=CC=CN=C2)[C@@H]1OC(=O)C1=CC=CN=C1)C1=CC=CN=C1,MFZCIDXOLLEMOO-GYSGTQPESA-N,810.732,Q8TDS4,BE0000635,Hydroxycarboxylic acid receptor 2,Humans,agonist,yes
DB08950,Indoramin,small molecule,approved;withdrawn,O=C(NC1CCN(CCC2=CNC3=C2C=CC=C3)CC1)C1=CC=CC=C1,JXZZEXZZKAWDSP-UHFFFAOYSA-N,347.4534,P25100,BE0000715,Alpha-1D adrenergic receptor,Humans,inhibitor,yes
DB08950,Indoramin,small molecule,approved;withdrawn,O=C(NC1CCN(CCC2=CNC3=C2C=CC=C3)CC1)C1=CC=CC=C1,JXZZEXZZKAWDSP-UHFFFAOYSA-N,347.4534,P18825,BE0000342,Alpha-2C adrenergic receptor,Humans,inhibitor,yes
DB08950,Indoramin,small molecule,approved;withdrawn,O=C(NC1CCN(CCC2=CNC3=C2C=CC=C3)CC1)C1=CC=CC=C1,JXZZEXZZKAWDSP-UHFFFAOYSA-N,347.4534,P18089,BE0000572,Alpha-2B adrenergic receptor,Humans,inhibitor,yes
DB08951,Indoprofen,small molecule,withdrawn,CC(C(O)=O)C1=CC=C(C=C1)N1CC2=CC=CC=C2C1=O,RJMIEHBSYVWVIN-UHFFFAOYSA-N,281.3059,P25024,BE0003552,C-X-C chemokine receptor type 1,Humans,inhibitor,yes
DB08951,Indoprofen,small molecule,withdrawn,CC(C(O)=O)C1=CC=C(C=C1)N1CC2=CC=CC=C2C1=O,RJMIEHBSYVWVIN-UHFFFAOYSA-N,281.3059,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB08951,Indoprofen,small molecule,withdrawn,CC(C(O)=O)C1=CC=C(C=C1)N1CC2=CC=CC=C2C1=O,RJMIEHBSYVWVIN-UHFFFAOYSA-N,281.3059,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB08951,Indoprofen,small molecule,withdrawn,CC(C(O)=O)C1=CC=C(C=C1)N1CC2=CC=CC=C2C1=O,RJMIEHBSYVWVIN-UHFFFAOYSA-N,281.3059,P07148,BE0003998,"Fatty acid-binding protein, liver",Humans,inhibitor,yes
DB08951,Indoprofen,small molecule,withdrawn,CC(C(O)=O)C1=CC=C(C=C1)N1CC2=CC=CC=C2C1=O,RJMIEHBSYVWVIN-UHFFFAOYSA-N,281.3059,P25025,BE0010516,C-X-C chemokine receptor type 2,Humans,inhibitor,yes
DB08954,Ifenprodil,small molecule,investigational;withdrawn,CC(C(O)C1=CC=C(O)C=C1)N1CCC(CC2=CC=CC=C2)CC1,UYNVMODNBIQBMV-UHFFFAOYSA-N,325.4446,Q13224,BE0000417,"Glutamate receptor ionotropic, NMDA 2B",Humans,antagonist,yes
DB08954,Ifenprodil,small molecule,investigational;withdrawn,CC(C(O)C1=CC=C(O)C=C1)N1CCC(CC2=CC=CC=C2)CC1,UYNVMODNBIQBMV-UHFFFAOYSA-N,325.4446,Q9UNI1,BE0003758,Chymotrypsin-like elastase family member 1,Humans,inhibitor,yes
DB08954,Ifenprodil,small molecule,investigational;withdrawn,CC(C(O)C1=CC=C(O)C=C1)N1CCC(CC2=CC=CC=C2)CC1,UYNVMODNBIQBMV-UHFFFAOYSA-N,325.4446,Q05586,BE0000365,"Glutamate receptor ionotropic, NMDA 1",Humans,antagonist,yes
DB08955,Ibuproxam,small molecule,withdrawn,CC(C)CC1=CC=C(C=C1)C(C)C(=O)NO,BYPIURIATSUHDW-UHFFFAOYSA-N,221.2955,P09917,BE0000248,Polyunsaturated fatty acid 5-lipoxygenase,Humans,inhibitor,yes
DB08960,Hexamethonium,small molecule,experimental,C[N+](C)(C)CCCCCC[N+](C)(C)C,VZJFGSRCJCXDSG-UHFFFAOYSA-N,202.38,Q15822,BE0000738,Neuronal acetylcholine receptor subunit alpha-2,Humans,antagonist,yes
DB08960,Hexamethonium,small molecule,experimental,C[N+](C)(C)CCCCCC[N+](C)(C)C,VZJFGSRCJCXDSG-UHFFFAOYSA-N,202.38,Q08210,BE0000612,"Dihydroorotate dehydrogenase (quinone), mitochondrial",Plasmodium falciparum (isolate 3D7),inhibitor,yes
DB08964,Gemeprost,small molecule,approved;withdrawn,CCCCC(C)(C)[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC\C=C\C(=O)OC,KYBOHGVERHWSSV-VNIVIJDLSA-N,394.552,P43115,BE0002375,Prostaglandin E2 receptor EP3 subtype,Humans,agonist,yes
DB08980,Fendiline,small molecule,withdrawn,CC(NCCC(C1=CC=CC=C1)C1=CC=CC=C1)C1=CC=CC=C1,NMKSAYKQLCHXDK-UHFFFAOYSA-N,315.4513,P41595,BE0000393,5-hydroxytryptamine receptor 2B,Humans,inhibitor,yes
DB08981,Fenbufen,small molecule,approved,OC(=O)CCC(=O)C1=CC=C(C=C1)C1=CC=CC=C1,ZPAKPRAICRBAOD-UHFFFAOYSA-N,254.2806,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB08981,Fenbufen,small molecule,approved,OC(=O)CCC(=O)C1=CC=C(C=C1)C1=CC=CC=C1,ZPAKPRAICRBAOD-UHFFFAOYSA-N,254.2806,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB08996,Dimetacrine,small molecule,experimental;withdrawn,CN(C)CCCN1C2=CC=CC=C2C(C)(C)C2=CC=CC=C12,RYQOGSFEJBUZBX-UHFFFAOYSA-N,294.4338,P22303,BE0000426,Acetylcholinesterase,Humans,antagonist,yes
DB09000,Cyamemazine,small molecule,experimental,CC(CN(C)C)CN1C2=CC=CC=C2SC2=C1C=C(C=C2)C#N,SLFGIOIONGJGRT-UHFFFAOYSA-N,323.455,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB09000,Cyamemazine,small molecule,experimental,CC(CN(C)C)CN1C2=CC=CC=C2SC2=C1C=C(C=C2)C#N,SLFGIOIONGJGRT-UHFFFAOYSA-N,323.455,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,antagonist,yes
DB09000,Cyamemazine,small molecule,experimental,CC(CN(C)C)CN1C2=CC=CC=C2SC2=C1C=C(C=C2)C#N,SLFGIOIONGJGRT-UHFFFAOYSA-N,323.455,P34969,BE0000650,5-hydroxytryptamine receptor 7,Humans,antagonist,yes
DB09000,Cyamemazine,small molecule,experimental,CC(CN(C)C)CN1C2=CC=CC=C2SC2=C1C=C(C=C2)C#N,SLFGIOIONGJGRT-UHFFFAOYSA-N,323.455,P28335,BE0000533,5-hydroxytryptamine receptor 2C,Humans,antagonist,yes
DB09009,Articaine,small molecule,approved,CCCNC(C)C(=O)NC1=C(SC=C1C)C(=O)OC,QTGIAADRBBLJGA-UHFFFAOYSA-N,284.374,P35498,BE0009738,Voltage-gated sodium channel alpha subunit,Humans,inhibitor,yes
DB09014,Captodiame,small molecule,experimental,CCCCSC1=CC=C(C=C1)C(SCCN(C)C)C1=CC=CC=C1,IZLPZXSZLLELBJ-UHFFFAOYSA-N,359.592,P28335,BE0000533,5-hydroxytryptamine receptor 2C,Humans,antagonist,yes
DB09014,Captodiame,small molecule,experimental,CCCCSC1=CC=C(C=C1)C(SCCN(C)C)C1=CC=CC=C1,IZLPZXSZLLELBJ-UHFFFAOYSA-N,359.592,Q99720,BE0000156,Sigma non-opioid intracellular receptor 1,Humans,agonist,yes
DB09014,Captodiame,small molecule,experimental,CCCCSC1=CC=C(C=C1)C(SCCN(C)C)C1=CC=CC=C1,IZLPZXSZLLELBJ-UHFFFAOYSA-N,359.592,P35462,BE0000581,D(3) dopamine receptor,Humans,agonist,yes
DB09017,Brotizolam,small molecule,investigational;withdrawn,CC1=NN=C2CN=C(C3=C(SC(Br)=C3)N12)C1=CC=CC=C1Cl,UMSGKTJDUHERQW-UHFFFAOYSA-N,393.689,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB09017,Brotizolam,small molecule,investigational;withdrawn,CC1=NN=C2CN=C(C3=C(SC(Br)=C3)N12)C1=CC=CC=C1Cl,UMSGKTJDUHERQW-UHFFFAOYSA-N,393.689,P14867,BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,Humans,ligand,yes
DB09018,Bromopride,small molecule,investigational,CCN(CC)CCNC(=O)C1=CC(Br)=C(N)C=C1OC,GIYAQDDTCWHPPL-UHFFFAOYSA-N,344.247,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB09019,Bromhexine,small molecule,approved,CN(CC1=CC(Br)=CC(Br)=C1N)C1CCCCC1,OJGDCBLYJGHCIH-UHFFFAOYSA-N,376.13,O15393,BE0009920,Transmembrane protease serine 2,Humans,inhibitor,yes
DB09019,Bromhexine,small molecule,approved,CN(CC1=CC(Br)=CC(Br)=C1N)C1CCCCC1,OJGDCBLYJGHCIH-UHFFFAOYSA-N,376.13,Q9BYF1,BE0000982,Angiotensin-converting enzyme 2,Humans,binder,yes
DB09020,Bisacodyl,small molecule,approved,CC(=O)OC1=CC=C(C=C1)C(C1=CC=C(OC(C)=O)C=C1)C1=CC=CC=N1,KHOITXIGCFIULA-UHFFFAOYSA-N,361.3906,Q92482,BE0009664,Aquaporin-3,Humans,negative modulator,yes
DB09020,Bisacodyl,small molecule,approved,CC(=O)OC1=CC=C(C=C1)C(C1=CC=C(OC(C)=O)C=C1)C1=CC=CC=N1,KHOITXIGCFIULA-UHFFFAOYSA-N,361.3906,P05023,BE0010055,Sodium/Potassium Transporting ATPase,Humans,inhibitor,yes
DB09023,Benactyzine,small molecule,withdrawn,CCN(CC)CCOC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1,IVQOFBKHQCTVQV-UHFFFAOYSA-N,327.4174,P08912,BE0000247,Muscarinic acetylcholine receptor M5,Humans,antagonist,yes
DB09026,Aliskiren,small molecule,approved;investigational,COCCCOC1=C(OC)C=CC(C[C@@H](C[C@H](N)[C@@H](O)C[C@@H](C(C)C)C(=O)NCC(C)(C)C(N)=O)C(C)C)=C1,UXOWGYHJODZGMF-QORCZRPOSA-N,551.7583,P00797,BE0000270,Renin,Humans,inhibitor,yes
DB09027,Ledipasvir,small molecule,approved,COC(=O)N[C@@H](C(C)C)C(=O)N1CC2(CC2)C[C@H]1C1=NC(=CN1)C1=CC=C2C3=CC=C(C=C3C(F)(F)C2=C1)C1=CC=C2NC(=NC2=C1)[C@@H]1[C@H]2CC[C@H](C2)N1C(=O)[C@@H](NC(=O)OC)C(C)C,VRTWBAAJJOHBQU-KMWAZVGDSA-N,888.9999,P26664,BE0003427,Genome polyprotein,,modulator,yes
DB09027,Ledipasvir,small molecule,approved,COC(=O)N[C@@H](C(C)C)C(=O)N1CC2(CC2)C[C@H]1C1=NC(=CN1)C1=CC=C2C3=CC=C(C=C3C(F)(F)C2=C1)C1=CC=C2NC(=NC2=C1)[C@@H]1[C@H]2CC[C@H](C2)N1C(=O)[C@@H](NC(=O)OC)C(C)C,VRTWBAAJJOHBQU-KMWAZVGDSA-N,888.9999,Q5L478,BE0008651,Nonstructural protein 5A,Hepatitis C Virus,inhibitor,yes
DB09028,Cytisine,small molecule,experimental,O=C1C=CC=C2[C@H]3CNC[C@H](C3)CN12,ANJTVLIZGCUXLD-DTWKUNHWSA-N,190.2417,Q15822,BE0000738,Neuronal acetylcholine receptor subunit alpha-2,Humans,inhibitor,yes
DB09028,Cytisine,small molecule,experimental,O=C1C=CC=C2[C@H]3CNC[C@H](C3)CN12,ANJTVLIZGCUXLD-DTWKUNHWSA-N,190.2417,P30926,BE0003584,Neuronal acetylcholine receptor subunit beta-4,Humans,inhibitor,yes
DB09030,Vorapaxar,small molecule,approved,[H][C@@]12C[C@]3([H])C[C@@H](CC[C@@]3([H])[C@H](\C=C\C3=CC=C(C=N3)C3=CC(F)=CC=C3)[C@]1([H])[C@@H](C)OC2=O)NC(=O)OCC,ZBGXUVOIWDMMJE-QHNZEKIYSA-N,492.5817,P25116,BE0000928,Proteinase-activated receptor 1,Humans,antagonist,yes
DB09031,Miltefosine,small molecule,approved;investigational,CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C,PQLXHQMOHUQAKB-UHFFFAOYSA-N,407.576,P04054,BE0003997,Phospholipase A2,Humans,inhibitor,yes
DB09034,Suvorexant,small molecule,approved;investigational,[H][C@@]1(C)CCN(CCN1C(=O)C1=C(C=CC(C)=C1)N1N=CC=N1)C1=NC2=C(O1)C=CC(Cl)=C2,JYTNQNCOQXFQPK-MRXNPFEDSA-N,450.93,O43613,BE0005864,Orexin/Hypocretin receptor type 1,Humans,antagonist,yes
DB09034,Suvorexant,small molecule,approved;investigational,[H][C@@]1(C)CCN(CCN1C(=O)C1=C(C=CC(C)=C1)N1N=CC=N1)C1=NC2=C(O1)C=CC(Cl)=C2,JYTNQNCOQXFQPK-MRXNPFEDSA-N,450.93,O43614,BE0005865,Orexin receptor type 2,Humans,antagonist,yes
DB09038,Empagliflozin,small molecule,approved,OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C1=CC=C(Cl)C(CC2=CC=C(O[C@H]3CCOC3)C=C2)=C1,OBWASQILIWPZMG-QZMOQZSNSA-N,450.91,P31639,BE0004753,Sodium/glucose cotransporter 2,Humans,inhibitor,yes
DB09039,Eliglustat,small molecule,approved;investigational,CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)C1=CC=C2OCCOC2=C1,FJZZPCZKBUKGGU-AUSIDOKSSA-N,404.551,Q16739,BE0000477,Ceramide glucosyltransferase,Humans,inhibitor,yes
DB09040,Efinaconazole,small molecule,approved,C[C@@H](N1CCC(=C)CC1)[C@](O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,NFEZZTICAUWDHU-RDTXWAMCSA-N,348.398,P50859,BE0000690,Lanosterol 14-alpha demethylase,,inhibitor,yes
DB09040,Efinaconazole,small molecule,approved,C[C@@H](N1CCC(=C)CC1)[C@](O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,NFEZZTICAUWDHU-RDTXWAMCSA-N,348.398,P10613,BE0000233,Lanosterol 14-alpha demethylase,Yeast,inhibitor,yes
DB09041,Tavaborole,small molecule,approved;investigational,OB1OCC2=CC(F)=CC=C12,LFQDNHWZDQTITF-UHFFFAOYSA-N,151.93,A0A178ESV1,BE0010215,leucine--tRNA ligase,Trichophyton rubrum,inhibitor,yes
DB09042,Tedizolid phosphate,small molecule,approved,CN1N=NC(=N1)C1=CC=C(C=N1)C1=CC=C(C=C1F)N1C[C@H](COP(O)(O)=O)OC1=O,QCGUSIANLFXSGE-GFCCVEGCSA-N,450.323,,BE0004800,23S ribosomal RNA,Enteric bacteria and other eubacteria,inhibitor,yes
DB09047,Finafloxacin,small molecule,approved;investigational,[H][C@]12CN(C[C@]1([H])OCCN2)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1C#N)C(O)=O,FYMHQCNFKNMJAV-HOTGVXAUSA-N,398.394,P43700,BE0000366,DNA gyrase subunit A,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd),inhibitor,yes
DB09047,Finafloxacin,small molecule,approved;investigational,[H][C@]12CN(C[C@]1([H])OCCN2)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1C#N)C(O)=O,FYMHQCNFKNMJAV-HOTGVXAUSA-N,398.394,P0A0K8,BE0002388,DNA gyrase subunit B,Staphylococcus aureus,inhibitor,yes
DB09047,Finafloxacin,small molecule,approved;investigational,[H][C@]12CN(C[C@]1([H])OCCN2)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1C#N)C(O)=O,FYMHQCNFKNMJAV-HOTGVXAUSA-N,398.394,P20831,BE0008385,DNA gyrase subunit A,Staphylococcus aureus,inhibitor,yes
DB09047,Finafloxacin,small molecule,approved;investigational,[H][C@]12CN(C[C@]1([H])OCCN2)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1C#N)C(O)=O,FYMHQCNFKNMJAV-HOTGVXAUSA-N,398.394,P43702,BE0000429,DNA topoisomerase 4 subunit A,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd),inhibitor,yes
DB09047,Finafloxacin,small molecule,approved;investigational,[H][C@]12CN(C[C@]1([H])OCCN2)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1C#N)C(O)=O,FYMHQCNFKNMJAV-HOTGVXAUSA-N,398.394,P11388,BE0000742,DNA topoisomerase 2-alpha,Humans,inhibitor,yes
DB09048,Netupitant,small molecule,approved;investigational,CN(C(=O)C(C)(C)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)C1=CN=C(C=C1C1=CC=CC=C1C)N1CCN(C)CC1,WAXQNWCZJDTGBU-UHFFFAOYSA-N,578.603,P25103,BE0000384,Substance-P receptor,Humans,antagonist,yes
DB09049,Naloxegol,small molecule,approved,COCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC=C)[C@H]1O5,XNKCCCKFOQNXKV-ZRSCBOBOSA-N,651.794,P35372,BE0000770,Mu-type opioid receptor,Humans,antagonist,yes
DB09050,Ceftolozane,small molecule,approved;investigational,CN1C(N)=C(NC(=O)NCCN)C=[N+]1CC1=C(N2[C@H](SC1)[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=NSC(N)=N1)C2=O)C([O-])=O,JHFNIHVVXRKLEF-DCZLAGFPSA-N,666.69,Q9X6W0,BE0003687,Penicillin-binding protein 1B,Pseudomonas aeruginosa,inhibitor,yes
DB09050,Ceftolozane,small molecule,approved;investigational,CN1C(N)=C(NC(=O)NCCN)C=[N+]1CC1=C(N2[C@H](SC1)[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=NSC(N)=N1)C2=O)C([O-])=O,JHFNIHVVXRKLEF-DCZLAGFPSA-N,666.69,Q51504,BE0004647,Cell division protein,Pseudomonas aeruginosa,inhibitor,yes
DB09050,Ceftolozane,small molecule,approved;investigational,CN1C(N)=C(NC(=O)NCCN)C=[N+]1CC1=C(N2[C@H](SC1)[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=NSC(N)=N1)C2=O)C([O-])=O,JHFNIHVVXRKLEF-DCZLAGFPSA-N,666.69,P76577,BE0003723,Penicillin-binding protein 1C,Escherichia coli (strain K12),inhibitor,yes
DB09050,Ceftolozane,small molecule,approved;investigational,CN1C(N)=C(NC(=O)NCCN)C=[N+]1CC1=C(N2[C@H](SC1)[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=NSC(N)=N1)C2=O)C([O-])=O,JHFNIHVVXRKLEF-DCZLAGFPSA-N,666.69,P0AD65,BE0003579,Penicillin-binding protein 2,Escherichia coli (strain K12),inhibitor,yes
DB09050,Ceftolozane,small molecule,approved;investigational,CN1C(N)=C(NC(=O)NCCN)C=[N+]1CC1=C(N2[C@H](SC1)[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=NSC(N)=N1)C2=O)C([O-])=O,JHFNIHVVXRKLEF-DCZLAGFPSA-N,666.69,P0AEB2,BE0004840,Penicillin-binding protein,Gram positive and gram negative bacteria,inhibitor,yes
DB09053,Ibrutinib,small molecule,approved,NC1=NC=NC2=C1C(=NN2[C@@H]1CCCN(C1)C(=O)C=C)C1=CC=C(OC2=CC=CC=C2)C=C1,XYFPWWZEPKGCCK-GOSISDBHSA-N,440.507,Q06187,BE0001284,Tyrosine-protein kinase BTK,Humans,inhibitor,yes
DB09054,Idelalisib,small molecule,approved,[H][C@@](CC)(NC1=NC=NC2=C1N=CN2)C1=NC2=CC=CC(F)=C2C(=O)N1C1=CC=CC=C1,IFSDAJWBUCMOAH-HNNXBMFYSA-N,415.432,O00329,BE0002406,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",Humans,inhibitor,yes
DB09059,Atosiban,small molecule,approved;investigational,[H][C@]1(NC(=O)[C@@]([H])(NC(=O)[C@@H](CC2=CC=C(OCC)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)[C@@H](C)CC)[C@@H](C)O,VWXRQYYUEIYXCZ-OBIMUBPZSA-N,994.19,P30559,BE0000844,Oxytocin receptor,Humans,antagonist,yes
DB09060,Avibactam,small molecule,approved,NC(=O)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(O)(=O)=O,NDCUAPJVLWFHHB-UHNVWZDZSA-N,265.24,P62593,BE0003894,Beta-lactamase TEM,Escherichia coli,inhibitor,yes
DB09060,Avibactam,small molecule,approved,NC(=O)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(O)(=O)=O,NDCUAPJVLWFHHB-UHNVWZDZSA-N,265.24,Q939N4,BE0002831,Beta-lactamase CTX-M,Escherichia coli,inhibitor,yes
DB09060,Avibactam,small molecule,approved,NC(=O)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(O)(=O)=O,NDCUAPJVLWFHHB-UHNVWZDZSA-N,265.24,P05364,BE0001430,Beta-lactamase,Enterobacter cloacae,inhibitor,yes
DB09060,Avibactam,small molecule,approved,NC(=O)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(O)(=O)=O,NDCUAPJVLWFHHB-UHNVWZDZSA-N,265.24,P0AD63,BE0002015,Beta-lactamase SHV-1,Escherichia coli,inhibitor,yes
DB09060,Avibactam,small molecule,approved,NC(=O)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(O)(=O)=O,NDCUAPJVLWFHHB-UHNVWZDZSA-N,265.24,P0A9Z7,BE0002029,Beta-lactamase SHV-2,Escherichia coli,inhibitor,yes
DB09060,Avibactam,small molecule,approved,NC(=O)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(O)(=O)=O,NDCUAPJVLWFHHB-UHNVWZDZSA-N,265.24,P0AD64,BE0004185,Beta-lactamase SHV-1,Klebsiella pneumoniae,inhibitor,yes
DB09060,Avibactam,small molecule,approved,NC(=O)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(O)(=O)=O,NDCUAPJVLWFHHB-UHNVWZDZSA-N,265.24,A0A023W3H0,BE0008648,Class D OXA-48 carbapenemase,Klebsiella pneumoniae,inhibitor,yes
DB09060,Avibactam,small molecule,approved,NC(=O)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(O)(=O)=O,NDCUAPJVLWFHHB-UHNVWZDZSA-N,265.24,Q9F663,BE0008649,Carbapenem-hydrolyzing beta-lactamase KPC,Klebsiella pneumoniae,inhibitor,yes
DB09060,Avibactam,small molecule,approved,NC(=O)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(O)(=O)=O,NDCUAPJVLWFHHB-UHNVWZDZSA-N,265.24,Q9EXV5,BE0008650,Beta-lactamase UOE-1,Escherichia coli,inhibitor,yes
DB09060,Avibactam,small molecule,approved,NC(=O)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(O)(=O)=O,NDCUAPJVLWFHHB-UHNVWZDZSA-N,265.24,P37321,BE0008647,Extended-spectrum beta-lactamase PER-1,Pseudomonas aeruginosa,inhibitor,yes
DB09061,Cannabidiol,small molecule,approved;investigational,CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1,QHMBSVQNZZTUGM-ZWKOTPCHSA-N,314.469,P21554,BE0000061,Cannabinoid receptor 1,Humans,antagonist;modulator,yes
DB09061,Cannabidiol,small molecule,approved;investigational,CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1,QHMBSVQNZZTUGM-ZWKOTPCHSA-N,314.469,P34972,BE0000095,Cannabinoid receptor 2,Humans,antagonist;inverse agonist,yes
DB09063,Ceritinib,small molecule,approved,CC(C)OC1=C(NC2=NC=C(Cl)C(N2)=NC2=CC=CC=C2S(=O)(=O)C(C)C)C=C(C)C(=C1)C1CCNCC1,VERWOWGGCGHDQE-UHFFFAOYSA-N,558.135,Q9UM73,BE0000359,ALK tyrosine kinase receptor,Humans,antagonist,yes
DB09064,Ciprofibrate,small molecule,approved;investigational,CC(C)(OC1=CC=C(C=C1)C1CC1(Cl)Cl)C(O)=O,KPSRODZRAIWAKH-UHFFFAOYSA-N,289.15,Q07869,BE0000071,Peroxisome proliferator-activated receptor alpha,Humans,agonist,yes
DB09065,Cobicistat,small molecule,approved,CC(C)C1=NC(CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](CC2=CC=CC=C2)NC(=O)OCC2=CN=CS2)CC2=CC=CC=C2)=CS1,ZCIGNRJZKPOIKD-CQXVEOKZSA-N,776.03,P08684,BE0002638,Cytochrome P450 3A4,Humans,inhibitor,yes
DB09065,Cobicistat,small molecule,approved,CC(C)C1=NC(CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](CC2=CC=CC=C2)NC(=O)OCC2=CN=CS2)CC2=CC=CC=C2)=CS1,ZCIGNRJZKPOIKD-CQXVEOKZSA-N,776.03,P20815,BE0002362,Cytochrome P450 3A5,Humans,inhibitor,yes
DB09065,Cobicistat,small molecule,approved,CC(C)C1=NC(CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](CC2=CC=CC=C2)NC(=O)OCC2=CN=CS2)CC2=CC=CC=C2)=CS1,ZCIGNRJZKPOIKD-CQXVEOKZSA-N,776.03,P24462,BE0003612,Cytochrome P450 3A7,Humans,inhibitor,yes
DB09068,Vortioxetine,small molecule,approved;investigational,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,YQNWZWMKLDQSAC-UHFFFAOYSA-N,298.45,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB09068,Vortioxetine,small molecule,approved;investigational,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,YQNWZWMKLDQSAC-UHFFFAOYSA-N,298.45,P46098,BE0000311,5-hydroxytryptamine receptor 3A,Humans,antagonist,yes
DB09068,Vortioxetine,small molecule,approved;investigational,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,YQNWZWMKLDQSAC-UHFFFAOYSA-N,298.45,P34969,BE0000650,5-hydroxytryptamine receptor 7,Humans,antagonist,yes
DB09068,Vortioxetine,small molecule,approved;investigational,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,YQNWZWMKLDQSAC-UHFFFAOYSA-N,298.45,P28222,BE0000797,5-hydroxytryptamine receptor 1B,Humans,partial agonist,yes
DB09068,Vortioxetine,small molecule,approved;investigational,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,YQNWZWMKLDQSAC-UHFFFAOYSA-N,298.45,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,agonist,yes
DB09070,Tibolone,small molecule,approved;investigational,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC(=O)CC3)C[C@@]([H])(C)[C@@]21[H],WZDGZWOAQTVYBX-XOINTXKNSA-N,312.453,P03372,BE0000123,Estrogen receptor,Humans,antagonist;agonist,yes
DB09071,Tasimelteon,small molecule,approved;investigational,CCC(=O)NC[C@@H]1C[C@H]1C1=CC=CC2=C1CCO2,PTOIAAWZLUQTIO-GXFFZTMASA-N,245.322,P48039,BE0000515,Melatonin receptor type 1A,Humans,agonist,yes
DB09071,Tasimelteon,small molecule,approved;investigational,CCC(=O)NC[C@@H]1C[C@H]1C1=CC=CC2=C1CCO2,PTOIAAWZLUQTIO-GXFFZTMASA-N,245.322,P49286,BE0000327,Melatonin receptor type 1B,Humans,agonist,yes
DB09073,Palbociclib,small molecule,approved;investigational,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,AHJRHEGDXFFMBM-UHFFFAOYSA-N,447.5328,P11802,BE0002216,Cyclin-dependent kinase 4,Humans,inhibitor,yes
DB09073,Palbociclib,small molecule,approved;investigational,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,AHJRHEGDXFFMBM-UHFFFAOYSA-N,447.5328,Q00534,BE0002212,Cyclin-dependent kinase 6,Humans,inhibitor,yes
DB09074,Olaparib,small molecule,approved,FC1=CC=C(CC2=NNC(=O)C3=CC=CC=C23)C=C1C(=O)N1CCN(CC1)C(=O)C1CC1,FDLYAMZZIXQODN-UHFFFAOYSA-N,434.4628,P09874,BE0001717,Poly [ADP-ribose] polymerase 1,Humans,inhibitor,yes
DB09074,Olaparib,small molecule,approved,FC1=CC=C(CC2=NNC(=O)C3=CC=CC=C23)C=C1C(=O)N1CCN(CC1)C(=O)C1CC1,FDLYAMZZIXQODN-UHFFFAOYSA-N,434.4628,Q9UGN5,BE0003798,Poly [ADP-ribose] polymerase 2,Humans,inhibitor,yes
DB09074,Olaparib,small molecule,approved,FC1=CC=C(CC2=NNC(=O)C3=CC=CC=C23)C=C1C(=O)N1CCN(CC1)C(=O)C1CC1,FDLYAMZZIXQODN-UHFFFAOYSA-N,434.4628,Q9Y6F1,BE0004049,Protein mono-ADP-ribosyltransferase PARP3,Humans,inhibitor,yes
DB09075,Edoxaban,small molecule,approved,CN(C)C(=O)[C@H]1CC[C@H](NC(=O)C(=O)NC2=NC=C(Cl)C=C2)[C@@H](C1)NC(=O)C1=NC2=C(CN(C)CC2)S1,HGVDHZBSSITLCT-JLJPHGGASA-N,548.06,P00742,BE0000216,Coagulation factor X,Humans,inhibitor,yes
DB09076,Umeclidinium,small molecule,approved,OC(C1=CC=CC=C1)(C1=CC=CC=C1)C12CC[N+](CCOCC3=CC=CC=C3)(CC1)CC2,FVTWTVQXNAJTQP-UHFFFAOYSA-N,428.595,P20309,BE0000045,Muscarinic acetylcholine receptor M3,Humans,antagonist,yes
DB09078,Lenvatinib,small molecule,approved;investigational,COC1=C(C=C2C(OC3=CC=C(NC(=O)NC4CC4)C(Cl)=C3)=CC=NC2=C1)C(N)=O,WOSKHXYHFSIKNG-UHFFFAOYSA-N,426.86,P17948,BE0000029,Vascular endothelial growth factor receptor 1,Humans,inhibitor,yes
DB09078,Lenvatinib,small molecule,approved;investigational,COC1=C(C=C2C(OC3=CC=C(NC(=O)NC4CC4)C(Cl)=C3)=CC=NC2=C1)C(N)=O,WOSKHXYHFSIKNG-UHFFFAOYSA-N,426.86,P35968,BE0000369,Vascular endothelial growth factor receptor 2,Humans,inhibitor,yes
DB09078,Lenvatinib,small molecule,approved;investigational,COC1=C(C=C2C(OC3=CC=C(NC(=O)NC4CC4)C(Cl)=C3)=CC=NC2=C1)C(N)=O,WOSKHXYHFSIKNG-UHFFFAOYSA-N,426.86,P35916,BE0000023,Vascular endothelial growth factor receptor 3,Humans,inhibitor,yes
DB09078,Lenvatinib,small molecule,approved;investigational,COC1=C(C=C2C(OC3=CC=C(NC(=O)NC4CC4)C(Cl)=C3)=CC=NC2=C1)C(N)=O,WOSKHXYHFSIKNG-UHFFFAOYSA-N,426.86,P11362,BE0002131,Fibroblast growth factor receptor 1,Humans,inhibitor,yes
DB09078,Lenvatinib,small molecule,approved;investigational,COC1=C(C=C2C(OC3=CC=C(NC(=O)NC4CC4)C(Cl)=C3)=CC=NC2=C1)C(N)=O,WOSKHXYHFSIKNG-UHFFFAOYSA-N,426.86,P21802,BE0000748,Fibroblast growth factor receptor 2,Humans,inhibitor,yes
DB09078,Lenvatinib,small molecule,approved;investigational,COC1=C(C=C2C(OC3=CC=C(NC(=O)NC4CC4)C(Cl)=C3)=CC=NC2=C1)C(N)=O,WOSKHXYHFSIKNG-UHFFFAOYSA-N,426.86,P22607,BE0002133,Fibroblast growth factor receptor 3,Humans,inhibitor,yes
DB09078,Lenvatinib,small molecule,approved;investigational,COC1=C(C=C2C(OC3=CC=C(NC(=O)NC4CC4)C(Cl)=C3)=CC=NC2=C1)C(N)=O,WOSKHXYHFSIKNG-UHFFFAOYSA-N,426.86,P22455,BE0001203,Fibroblast growth factor receptor 4,Humans,inhibitor,yes
DB09078,Lenvatinib,small molecule,approved;investigational,COC1=C(C=C2C(OC3=CC=C(NC(=O)NC4CC4)C(Cl)=C3)=CC=NC2=C1)C(N)=O,WOSKHXYHFSIKNG-UHFFFAOYSA-N,426.86,P16234,BE0000852,Platelet-derived growth factor receptor alpha,Humans,inhibitor,yes
DB09078,Lenvatinib,small molecule,approved;investigational,COC1=C(C=C2C(OC3=CC=C(NC(=O)NC4CC4)C(Cl)=C3)=CC=NC2=C1)C(N)=O,WOSKHXYHFSIKNG-UHFFFAOYSA-N,426.86,P07949,BE0002411,Proto-oncogene tyrosine-protein kinase receptor Ret,Humans,inhibitor,yes
DB09078,Lenvatinib,small molecule,approved;investigational,COC1=C(C=C2C(OC3=CC=C(NC(=O)NC4CC4)C(Cl)=C3)=CC=NC2=C1)C(N)=O,WOSKHXYHFSIKNG-UHFFFAOYSA-N,426.86,P10721,BE0000453,Mast/stem cell growth factor receptor Kit,Humans,inhibitor,yes
DB09079,Nintedanib,small molecule,approved,COC(=O)C1=CC=C2C(NC(=O)\C2=C(/NC2=CC=C(C=C2)N(C)C(=O)CN2CCN(C)CC2)C2=CC=CC=C2)=C1,XZXHXSATPCNXJR-ZIADKAODSA-N,539.6248,P17948,BE0000029,Vascular endothelial growth factor receptor 1,Humans,inhibitor,yes
DB09079,Nintedanib,small molecule,approved,COC(=O)C1=CC=C2C(NC(=O)\C2=C(/NC2=CC=C(C=C2)N(C)C(=O)CN2CCN(C)CC2)C2=CC=CC=C2)=C1,XZXHXSATPCNXJR-ZIADKAODSA-N,539.6248,P35968,BE0000369,Vascular endothelial growth factor receptor 2,Humans,inhibitor,yes
DB09079,Nintedanib,small molecule,approved,COC(=O)C1=CC=C2C(NC(=O)\C2=C(/NC2=CC=C(C=C2)N(C)C(=O)CN2CCN(C)CC2)C2=CC=CC=C2)=C1,XZXHXSATPCNXJR-ZIADKAODSA-N,539.6248,P35916,BE0000023,Vascular endothelial growth factor receptor 3,Humans,inhibitor,yes
DB09079,Nintedanib,small molecule,approved,COC(=O)C1=CC=C2C(NC(=O)\C2=C(/NC2=CC=C(C=C2)N(C)C(=O)CN2CCN(C)CC2)C2=CC=CC=C2)=C1,XZXHXSATPCNXJR-ZIADKAODSA-N,539.6248,P16234,BE0000852,Platelet-derived growth factor receptor alpha,Humans,inhibitor,yes
DB09079,Nintedanib,small molecule,approved,COC(=O)C1=CC=C2C(NC(=O)\C2=C(/NC2=CC=C(C=C2)N(C)C(=O)CN2CCN(C)CC2)C2=CC=CC=C2)=C1,XZXHXSATPCNXJR-ZIADKAODSA-N,539.6248,P09619,BE0000205,Platelet-derived growth factor receptor beta,Humans,inhibitor,yes
DB09079,Nintedanib,small molecule,approved,COC(=O)C1=CC=C2C(NC(=O)\C2=C(/NC2=CC=C(C=C2)N(C)C(=O)CN2CCN(C)CC2)C2=CC=CC=C2)=C1,XZXHXSATPCNXJR-ZIADKAODSA-N,539.6248,P11362,BE0002131,Fibroblast growth factor receptor 1,Humans,inhibitor,yes
DB09079,Nintedanib,small molecule,approved,COC(=O)C1=CC=C2C(NC(=O)\C2=C(/NC2=CC=C(C=C2)N(C)C(=O)CN2CCN(C)CC2)C2=CC=CC=C2)=C1,XZXHXSATPCNXJR-ZIADKAODSA-N,539.6248,P21802,BE0000748,Fibroblast growth factor receptor 2,Humans,inhibitor,yes
DB09079,Nintedanib,small molecule,approved,COC(=O)C1=CC=C2C(NC(=O)\C2=C(/NC2=CC=C(C=C2)N(C)C(=O)CN2CCN(C)CC2)C2=CC=CC=C2)=C1,XZXHXSATPCNXJR-ZIADKAODSA-N,539.6248,P22607,BE0002133,Fibroblast growth factor receptor 3,Humans,inhibitor,yes
DB09080,Olodaterol,small molecule,approved,COC1=CC=C(CC(C)(C)NC[C@H](O)C2=C3OCC(=O)NC3=CC(O)=C2)C=C1,COUYJEVMBVSIHV-SFHVURJKSA-N,386.448,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,agonist,yes
DB09082,Vilanterol,small molecule,approved,OCC1=C(O)C=CC(=C1)[C@@H](O)CNCCCCCCOCCOCC1=C(Cl)C=CC=C1Cl,DAFYYTQWSAWIGS-DEOSSOPVSA-N,486.43,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,agonist,yes
DB09084,Benzydamine,small molecule,approved,CN(C)CCCOC1=NN(CC2=CC=CC=C2)C2=CC=CC=C12,CNBGNNVCVSKAQZ-UHFFFAOYSA-N,309.413,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB09084,Benzydamine,small molecule,approved,CN(C)CCCOC1=NN(CC2=CC=CC=C2)C2=CC=CC=C12,CNBGNNVCVSKAQZ-UHFFFAOYSA-N,309.413,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB09085,Tetracaine,small molecule,approved;vet_approved,CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C,GKCBAIGFKIBETG-UHFFFAOYSA-N,264.369,P21817,BE0000739,Ryanodine receptor 1,Humans,modulator,yes
DB09085,Tetracaine,small molecule,approved;vet_approved,CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C,GKCBAIGFKIBETG-UHFFFAOYSA-N,264.369,Q9Y5Y9,BE0000177,Sodium channel protein type 10 subunit alpha,Humans,inhibitor,yes
DB09085,Tetracaine,small molecule,approved;vet_approved,CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C,GKCBAIGFKIBETG-UHFFFAOYSA-N,264.369,Q92736,BE0005295,Ryanodine receptor 2,Humans,modulator,yes
DB09085,Tetracaine,small molecule,approved;vet_approved,CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C,GKCBAIGFKIBETG-UHFFFAOYSA-N,264.369,P35498,BE0009738,Voltage-gated sodium channel alpha subunit,Humans,blocker,yes
DB09086,Eugenol,small molecule,approved,COC1=C(O)C=CC(CC=C)=C1,RRAFCDWBNXTKKO-UHFFFAOYSA-N,164.2011,P27338,BE0002196,Amine oxidase [flavin-containing] B,Humans,inhibitor,yes
DB09088,Amylocaine,small molecule,approved;withdrawn,CCC(C)(CN(C)C)OC(=O)C1=CC=CC=C1,FDMBBCOBEAVDAO-UHFFFAOYSA-N,235.327,P35498,BE0009738,Voltage-gated sodium channel alpha subunit,Humans,blocker,yes
DB09089,Trimebutine,small molecule,approved,CCC(COC(=O)C1=CC(OC)=C(OC)C(OC)=C1)(N(C)C)C1=CC=CC=C1,LORDFXWUHHSAQU-UHFFFAOYSA-N,387.476,P35372,BE0000770,Mu-type opioid receptor,Humans,agonist,yes
DB09089,Trimebutine,small molecule,approved,CCC(COC(=O)C1=CC(OC)=C(OC)C(OC)=C1)(N(C)C)C1=CC=CC=C1,LORDFXWUHHSAQU-UHFFFAOYSA-N,387.476,Q13936,BE0008715,Voltage-dependent L-type calcium channel,Humans,inhibitor,yes
DB09089,Trimebutine,small molecule,approved,CCC(COC(=O)C1=CC(OC)=C(OC)C(OC)=C1)(N(C)C)C1=CC=CC=C1,LORDFXWUHHSAQU-UHFFFAOYSA-N,387.476,Q12791,BE0004906,Calcium-activated potassium channel,Humans,inhibitor,yes
DB09089,Trimebutine,small molecule,approved,CCC(COC(=O)C1=CC(OC)=C(OC)C(OC)=C1)(N(C)C)C1=CC=CC=C1,LORDFXWUHHSAQU-UHFFFAOYSA-N,387.476,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,antagonist,yes
DB09089,Trimebutine,small molecule,approved,CCC(COC(=O)C1=CC(OC)=C(OC)C(OC)=C1)(N(C)C)C1=CC=CC=C1,LORDFXWUHHSAQU-UHFFFAOYSA-N,387.476,P08172,BE0000560,Muscarinic acetylcholine receptor M2,Humans,antagonist,yes
DB09089,Trimebutine,small molecule,approved,CCC(COC(=O)C1=CC(OC)=C(OC)C(OC)=C1)(N(C)C)C1=CC=CC=C1,LORDFXWUHHSAQU-UHFFFAOYSA-N,387.476,P20309,BE0000045,Muscarinic acetylcholine receptor M3,Humans,antagonist,yes
DB09089,Trimebutine,small molecule,approved,CCC(COC(=O)C1=CC(OC)=C(OC)C(OC)=C1)(N(C)C)C1=CC=CC=C1,LORDFXWUHHSAQU-UHFFFAOYSA-N,387.476,P08173,BE0000405,Muscarinic acetylcholine receptor M4,Humans,antagonist,yes
DB09090,Pinaverium,small molecule,approved,COC1=C(OC)C=C(C[N+]2(CCOCCC3CCC4CC3C4(C)C)CCOCC2)C(Br)=C1,DDHUTBKXLWCZCO-UHFFFAOYSA-N,511.52,Q13698,BE0002355,Voltage-dependent L-type calcium channel subunit alpha-1S,Humans,antagonist;inhibitor,yes
DB09091,Tixocortol,small molecule,approved;withdrawn,[H][C@@]12CC[C@](O)(C(=O)CS)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,YWDBSCORAARPPF-VWUMJDOOSA-N,378.53,P04150,BE0000794,Glucocorticoid receptor,Humans,binder,yes
DB09091,Tixocortol,small molecule,approved;withdrawn,[H][C@@]12CC[C@](O)(C(=O)CS)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,YWDBSCORAARPPF-VWUMJDOOSA-N,378.53,Q92769,BE0002366,Histone deacetylase 2,Humans,stimulator,yes
DB09092,Xanthinol,small molecule,approved;withdrawn,CN(CCO)CC(O)CN1C=NC2=C1C(=O)N(C)C(=O)N2C,DSFGXPJYDCSWTA-UHFFFAOYSA-N,311.342,Q13423,BE0000008,"NAD(P) transhydrogenase, mitochondrial",Humans,cofactor,yes
DB09092,Xanthinol,small molecule,approved;withdrawn,CN(CCO)CC(O)CN1C=NC2=C1C(=O)N(C)C(=O)N2C,DSFGXPJYDCSWTA-UHFFFAOYSA-N,311.342,P04406,BE0000542,Glyceraldehyde-3-phosphate dehydrogenase,Humans,cofactor,yes
DB09092,Xanthinol,small molecule,approved;withdrawn,CN(CCO)CC(O)CN1C=NC2=C1C(=O)N(C)C(=O)N2C,DSFGXPJYDCSWTA-UHFFFAOYSA-N,311.342,P50213,BE0000011,"Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial",Humans,cofactor,yes
DB09092,Xanthinol,small molecule,approved;withdrawn,CN(CCO)CC(O)CN1C=NC2=C1C(=O)N(C)C(=O)N2C,DSFGXPJYDCSWTA-UHFFFAOYSA-N,311.342,Q02218,BE0000162,2-oxoglutarate dehydrogenase complex component E1,Humans,cofactor,yes
DB09092,Xanthinol,small molecule,approved;withdrawn,CN(CCO)CC(O)CN1C=NC2=C1C(=O)N(C)C(=O)N2C,DSFGXPJYDCSWTA-UHFFFAOYSA-N,311.342,P40926,BE0000780,"Malate dehydrogenase, mitochondrial",Humans,cofactor,yes
DB09093,Chlortetracycline,small molecule,approved;investigational;vet_approved,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC(Cl)=C1[C@@]3(C)O,CYDMQBQPVICBEU-XRNKAMNCSA-N,478.88,,BE0004799,16S ribosomal RNA,Enteric bacteria and other eubacteria,inhibitor,yes
DB09093,Chlortetracycline,small molecule,approved;investigational;vet_approved,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC(Cl)=C1[C@@]3(C)O,CYDMQBQPVICBEU-XRNKAMNCSA-N,478.88,P0A7V3,BE0004651,30S ribosomal protein S3,Escherichia coli (strain K12),inhibitor,yes
DB09093,Chlortetracycline,small molecule,approved;investigational;vet_approved,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC(Cl)=C1[C@@]3(C)O,CYDMQBQPVICBEU-XRNKAMNCSA-N,478.88,P0A7W7,BE0004652,30S ribosomal protein S8,Escherichia coli (strain K12),inhibitor,yes
DB09093,Chlortetracycline,small molecule,approved;investigational;vet_approved,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC(Cl)=C1[C@@]3(C)O,CYDMQBQPVICBEU-XRNKAMNCSA-N,478.88,P0A7U3,BE0003710,30S ribosomal protein S19,Escherichia coli (strain K12),inhibitor,yes
DB09093,Chlortetracycline,small molecule,approved;investigational;vet_approved,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC(Cl)=C1[C@@]3(C)O,CYDMQBQPVICBEU-XRNKAMNCSA-N,478.88,P0AG59,BE0003708,30S ribosomal protein S14,Escherichia coli (strain K12),inhibitor,yes
DB09093,Chlortetracycline,small molecule,approved;investigational;vet_approved,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC(Cl)=C1[C@@]3(C)O,CYDMQBQPVICBEU-XRNKAMNCSA-N,478.88,P02359,BE0004653,30S ribosomal protein S7,Escherichia coli (strain K12),inhibitor,yes
DB09095,Difluocortolone,small molecule,approved;investigational;withdrawn,[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,OGPWIDANBSLJPC-RFPWEZLHSA-N,394.459,P12429,BE0003201,Annexin A3,Humans,inducer,yes
DB09095,Difluocortolone,small molecule,approved;investigational;withdrawn,[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,OGPWIDANBSLJPC-RFPWEZLHSA-N,394.459,P04150,BE0000794,Glucocorticoid receptor,Humans,binder,yes
DB09097,Quinagolide,small molecule,approved;investigational,[H][C@]12C[C@@H](CN(CCC)[C@]1([H])CC1=CC=CC(O)=C1C2)NS(=O)(=O)N(CC)CC,GDFGTRDCCWFXTG-ZIFCJYIRSA-N,395.56,P14416,BE0000756,D(2) dopamine receptor,Humans,agonist,yes
DB09099,Somatostatin,small molecule,approved;investigational,C[C@@H](O)[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CO)NC1=O)C(O)=O)NC(=O)CNC(=O)[C@H](C)N)[C@@H](C)O,NHXLMOGPVYXJNR-ATOGVRKGSA-N,1637.9,P35372,BE0000770,Mu-type opioid receptor,Humans,inhibitor,yes
DB09099,Somatostatin,small molecule,approved;investigational,C[C@@H](O)[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CO)NC1=O)C(O)=O)NC(=O)CNC(=O)[C@H](C)N)[C@@H](C)O,NHXLMOGPVYXJNR-ATOGVRKGSA-N,1637.9,P41143,BE0000420,Delta-type opioid receptor,Humans,inhibitor,yes
DB09099,Somatostatin,small molecule,approved;investigational,C[C@@H](O)[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CO)NC1=O)C(O)=O)NC(=O)CNC(=O)[C@H](C)N)[C@@H](C)O,NHXLMOGPVYXJNR-ATOGVRKGSA-N,1637.9,P30872,BE0000452,Somatostatin receptor type 1,Humans,agonist,yes
DB09099,Somatostatin,small molecule,approved;investigational,C[C@@H](O)[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CO)NC1=O)C(O)=O)NC(=O)CNC(=O)[C@H](C)N)[C@@H](C)O,NHXLMOGPVYXJNR-ATOGVRKGSA-N,1637.9,P30874,BE0003528,Somatostatin receptor type 2,Humans,agonist,yes
DB09099,Somatostatin,small molecule,approved;investigational,C[C@@H](O)[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CO)NC1=O)C(O)=O)NC(=O)CNC(=O)[C@H](C)N)[C@@H](C)O,NHXLMOGPVYXJNR-ATOGVRKGSA-N,1637.9,P32745,BE0003529,Somatostatin receptor type 3,Humans,agonist,yes
DB09099,Somatostatin,small molecule,approved;investigational,C[C@@H](O)[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CO)NC1=O)C(O)=O)NC(=O)CNC(=O)[C@H](C)N)[C@@H](C)O,NHXLMOGPVYXJNR-ATOGVRKGSA-N,1637.9,P31391,BE0009273,Somatostatin receptor type 4,Humans,agonist,yes
DB09099,Somatostatin,small molecule,approved;investigational,C[C@@H](O)[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CO)NC1=O)C(O)=O)NC(=O)CNC(=O)[C@H](C)N)[C@@H](C)O,NHXLMOGPVYXJNR-ATOGVRKGSA-N,1637.9,P35346,BE0002147,Somatostatin receptor type 5,Humans,agonist,yes
DB09101,Elvitegravir,small molecule,approved,[H][C@@](CO)(C(C)C)N1C=C(C(O)=O)C(=O)C2=C1C=C(OC)C(CC1=C(F)C(Cl)=CC=C1)=C2,JUZYLCPPVHEVSV-LJQANCHMSA-N,447.884,Q7ZJM1,BE0004855,Integrase,Human immunodeficiency virus 1,inhibitor,yes
DB09101,Elvitegravir,small molecule,approved,[H][C@@](CO)(C(C)C)N1C=C(C(O)=O)C(=O)C2=C1C=C(OC)C(CC1=C(F)C(Cl)=CC=C1)=C2,JUZYLCPPVHEVSV-LJQANCHMSA-N,447.884,P03366,BE0002050,Gag-Pol polyprotein,,modulator,yes
DB09102,Daclatasvir,small molecule,approved;investigational,COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C1=NC=C(N1)C1=CC=C(C=C1)C1=CC=C(C=C1)C1=CN=C(N1)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)OC)C(C)C,FKRSSPOQAMALKA-CUPIEXAXSA-N,738.89,P26664,BE0003427,Genome polyprotein,,inhibitor,yes
DB09102,Daclatasvir,small molecule,approved;investigational,COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C1=NC=C(N1)C1=CC=C(C=C1)C1=CC=C(C=C1)C1=CN=C(N1)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)OC)C(C)C,FKRSSPOQAMALKA-CUPIEXAXSA-N,738.89,Q5L478,BE0008651,Nonstructural protein 5A,Hepatitis C Virus,inhibitor,yes
DB09118,Stiripentol,small molecule,approved,CC(C)(C)C(O)\C=C\C1=CC2=C(OCO2)C=C1,IBLNKMRFIPWSOY-FNORWQNLSA-N,234.295,P14867,BE0004797,GABA(A) Receptor,Humans,agonist;positive allosteric modulator,yes
DB09118,Stiripentol,small molecule,approved,CC(C)(C)C(O)\C=C\C1=CC2=C(OCO2)C=C1,IBLNKMRFIPWSOY-FNORWQNLSA-N,234.295,Q99928,BE0003594,Gamma-aminobutyric acid receptor subunit gamma-3,Humans,modulator,yes
DB09118,Stiripentol,small molecule,approved,CC(C)(C)C(O)\C=C\C1=CC2=C(OCO2)C=C1,IBLNKMRFIPWSOY-FNORWQNLSA-N,234.295,P00338,BE0000425,L-lactate dehydrogenase A chain,Humans,inhibitor,yes
DB09118,Stiripentol,small molecule,approved,CC(C)(C)C(O)\C=C\C1=CC2=C(OCO2)C=C1,IBLNKMRFIPWSOY-FNORWQNLSA-N,234.295,P07195,BE0000068,L-lactate dehydrogenase B chain,Humans,inhibitor,yes
DB09119,Eslicarbazepine acetate,small molecule,approved,CC(=O)O[C@H]1CC2=CC=CC=C2N(C(N)=O)C2=CC=CC=C12,QIALRBLEEWJACW-INIZCTEOSA-N,296.326,Q99571,BE0005793,P2X purinoceptor 4,Humans,antagonist,yes
DB09120,Zucapsaicin,small molecule,approved;investigational,COC1=C(O)C=CC(CNC(=O)CCCC\C=C/C(C)C)=C1,YKPUWZUDDOIDPM-VURMDHGXSA-N,305.4119,Q8NER1,BE0001023,Transient receptor potential cation channel subfamily V member 1,Humans,agonist;activator,yes
DB09123,Dienogest,small molecule,approved,[H][C@@]12CC[C@@](O)(CC#N)[C@@]1(C)CCC1=C3CCC(=O)C=C3CC[C@@]21[H],AZFLJNIPTRTECV-FUMNGEBKSA-N,311.425,P06401,BE0000557,Progesterone receptor,Humans,agonist,yes
DB09123,Dienogest,small molecule,approved,[H][C@@]12CC[C@@](O)(CC#N)[C@@]1(C)CCC1=C3CCC(=O)C=C3CC[C@@]21[H],AZFLJNIPTRTECV-FUMNGEBKSA-N,311.425,P10275,BE0000132,Androgen receptor,Humans,antagonist,yes
DB09124,Medrogestone,small molecule,approved;withdrawn,[H][C@@]12CC[C@](C)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C=C(C)C2=CC(=O)CC[C@]12C,HCFSGRMEEXUOSS-JXEXPEPMSA-N,340.507,P06401,BE0000557,Progesterone receptor,Humans,ligand,yes
DB09129,Chromic chloride,small molecule,approved,[Cl-].[Cl-].[Cl-].[Cr+3],QSWDMMVNRMROPK-UHFFFAOYSA-K,158.355,P06213,BE0000033,Insulin receptor,Humans,activator,yes
DB09143,Sonidegib,small molecule,approved;investigational,[H][C@]1(C)CN(C[C@@]([H])(C)O1)C1=CC=C(NC(=O)C2=CC=CC(=C2C)C2=CC=C(OC(F)(F)F)C=C2)C=N1,VZZJRYRQSPEMTK-CALCHBBNSA-N,485.507,Q99835,BE0004659,Protein smoothened,Humans,antagonist,yes
DB09148,Florbetaben F-18,small molecule,approved,CNC1=CC=C(\C=C\C2=CC=C(OCCOCCOCC[18F])C=C2)C=C1,NCWZOASIUQVOFA-FWZJPQCDSA-N,358.444,P05067,BE0003392,Amyloid-beta precursor protein,Humans,binder,yes
DB09149,Florbetapir F-18,small molecule,approved;investigational,[H]N(C1=C([H])C([H])=C(\C([H])=C(/[H])C2=C([H])N=C(OC([H])([H])C([H])([H])OC([H])([H])C([H])([H])OC([H])([H])C([H])([H])[18F])C([H])=C2[H])C([H])=C1[H])C([H])([H])[H],YNDIAUKFXKEXSV-CRYLGTRXSA-N,359.432,P05067,BE0003392,Amyloid-beta precursor protein,Humans,modulator,yes
DB09149,Florbetapir F-18,small molecule,approved;investigational,[H]N(C1=C([H])C([H])=C(\C([H])=C(/[H])C2=C([H])N=C(OC([H])([H])C([H])([H])OC([H])([H])C([H])([H])OC([H])([H])C([H])([H])[18F])C([H])=C2[H])C([H])=C1[H])C([H])([H])[H],YNDIAUKFXKEXSV-CRYLGTRXSA-N,359.432,,BE0011000,Beta amyloid plaque,Humans,binder,yes
DB09151,Flutemetamol (18F),small molecule,approved;investigational,CNC1=C([18F])C=C(C=C1)C1=NC2=CC=C(O)C=C2S1,VVECGOCJFKTUAX-HUYCHCPVSA-N,273.32,P05067,BE0003392,Amyloid-beta precursor protein,Humans,binder,yes
DB09154,Sodium citrate,small molecule,approved;investigational,[Na+].[Na+].[Na+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O,HRXKRNGNAMMEHJ-UHFFFAOYSA-K,258.068,P22748,BE0000535,Carbonic anhydrase 4,Humans,inhibitor,yes
DB09158,Trypan blue free acid,small molecule,approved,CC1=CC(=CC=C1\N=N\C1=C(C=C2C=C(C=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C=C(C=C2C=C1S(O)(=O)=O)S(O)(=O)=O,ZBNARPCCDMHDDV-HVMBLDELSA-N,872.87,P18031,BE0000623,Tyrosine-protein phosphatase non-receptor type 1,Humans,inhibitor,yes
DB09166,Etizolam,small molecule,experimental,CCC1=CC2=C(S1)N1C(C)=NN=C1CN=C2C1=CC=CC=C1Cl,VMZUTJCNQWMAGF-UHFFFAOYSA-N,342.846,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB09166,Etizolam,small molecule,experimental,CCC1=CC2=C(S1)N1C(C)=NN=C1CN=C2C1=CC=CC=C1Cl,VMZUTJCNQWMAGF-UHFFFAOYSA-N,342.846,P14867,BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,Humans,ligand,yes
DB09167,Dosulepin,small molecule,approved,CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12,PHTUQLWOUWZIMZ-GZTJUZNOSA-N,295.44,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,antagonist,yes
DB09167,Dosulepin,small molecule,approved,CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12,PHTUQLWOUWZIMZ-GZTJUZNOSA-N,295.44,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB09167,Dosulepin,small molecule,approved,CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12,PHTUQLWOUWZIMZ-GZTJUZNOSA-N,295.44,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB09167,Dosulepin,small molecule,approved,CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12,PHTUQLWOUWZIMZ-GZTJUZNOSA-N,295.44,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,antagonist,yes
DB09167,Dosulepin,small molecule,approved,CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12,PHTUQLWOUWZIMZ-GZTJUZNOSA-N,295.44,P08172,BE0000560,Muscarinic acetylcholine receptor M2,Humans,antagonist,yes
DB09167,Dosulepin,small molecule,approved,CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12,PHTUQLWOUWZIMZ-GZTJUZNOSA-N,295.44,P20309,BE0000045,Muscarinic acetylcholine receptor M3,Humans,antagonist,yes
DB09167,Dosulepin,small molecule,approved,CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12,PHTUQLWOUWZIMZ-GZTJUZNOSA-N,295.44,P08173,BE0000405,Muscarinic acetylcholine receptor M4,Humans,antagonist,yes
DB09167,Dosulepin,small molecule,approved,CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12,PHTUQLWOUWZIMZ-GZTJUZNOSA-N,295.44,P08912,BE0000247,Muscarinic acetylcholine receptor M5,Humans,antagonist,yes
DB09167,Dosulepin,small molecule,approved,CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12,PHTUQLWOUWZIMZ-GZTJUZNOSA-N,295.44,P08913,BE0004864,Alpha-2 adrenergic receptors,Humans,antagonist,yes
DB09167,Dosulepin,small molecule,approved,CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12,PHTUQLWOUWZIMZ-GZTJUZNOSA-N,295.44,P35348,BE0004863,Alpha-1 adrenergic receptors,Humans,antagonist,yes
DB09167,Dosulepin,small molecule,approved,CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12,PHTUQLWOUWZIMZ-GZTJUZNOSA-N,295.44,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,inhibitor,yes
DB09167,Dosulepin,small molecule,approved,CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12,PHTUQLWOUWZIMZ-GZTJUZNOSA-N,295.44,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB09173,Butyrfentanyl,small molecule,illicit,CCCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,QQOMYEQLWQJRKK-UHFFFAOYSA-N,350.506,P35372,BE0000770,Mu-type opioid receptor,Humans,agonist,yes
DB09174,Lofentanil,small molecule,illicit,CCC(=O)N(C1=CC=CC=C1)[C@]1(CCN(CCC2=CC=CC=C2)C[C@H]1C)C(=O)OC,IMYHGORQCPYVBZ-NLFFAJNJSA-N,408.542,P35372,BE0000770,Mu-type opioid receptor,Humans,inhibitor,yes
DB09174,Lofentanil,small molecule,illicit,CCC(=O)N(C1=CC=CC=C1)[C@]1(CCN(CCC2=CC=CC=C2)C[C@H]1C)C(=O)OC,IMYHGORQCPYVBZ-NLFFAJNJSA-N,408.542,P41145,BE0000632,Kappa-type opioid receptor,Humans,inhibitor,yes
DB09174,Lofentanil,small molecule,illicit,CCC(=O)N(C1=CC=CC=C1)[C@]1(CCN(CCC2=CC=CC=C2)C[C@H]1C)C(=O)OC,IMYHGORQCPYVBZ-NLFFAJNJSA-N,408.542,P41143,BE0000420,Delta-type opioid receptor,Humans,inhibitor,yes
DB09181,Trefentanil,small molecule,experimental,CCN1N=NN(CCN2CCC(CC2)(N(C(=O)CC)C2=CC=CC=C2F)C2=CC=CC=C2)C1=O,RJSCINHYBGMIFT-UHFFFAOYSA-N,466.561,P35372,BE0000770,Mu-type opioid receptor,Humans,agonist,yes
DB09183,Dasabuvir,small molecule,approved,COC1=C(C=C(C=C1C1=CC2=CC=C(NS(C)(=O)=O)C=C2C=C1)N1C=CC(=O)NC1=O)C(C)(C)C,NBRBXGKOEOGLOI-UHFFFAOYSA-N,493.58,P26664,BE0003427,Genome polyprotein,,inhibitor,yes
DB09183,Dasabuvir,small molecule,approved,COC1=C(C=C(C=C1C1=CC2=CC=C(NS(C)(=O)=O)C=C2C=C1)N1C=CC(=O)NC1=O)C(C)(C)C,NBRBXGKOEOGLOI-UHFFFAOYSA-N,493.58,P87764,BE0008655,Nonstructural protein 5b,,inhibitor,yes
DB09185,Viloxazine,small molecule,approved;investigational;withdrawn,CCOC1=CC=CC=C1OCC1CNCCO1,YWPHCCPCQOJSGZ-UHFFFAOYSA-N,237.299,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,inhibitor,yes
DB09185,Viloxazine,small molecule,approved;investigational;withdrawn,CCOC1=CC=CC=C1OCC1CNCCO1,YWPHCCPCQOJSGZ-UHFFFAOYSA-N,237.299,P41595,BE0000393,5-hydroxytryptamine receptor 2B,Humans,antagonist,yes
DB09185,Viloxazine,small molecule,approved;investigational;withdrawn,CCOC1=CC=CC=C1OCC1CNCCO1,YWPHCCPCQOJSGZ-UHFFFAOYSA-N,237.299,P28335,BE0000533,5-hydroxytryptamine receptor 2C,Humans,agonist,yes
DB09186,Nisoxetine,small molecule,experimental,CNCCC(OC1=CC=CC=C1OC)C1=CC=CC=C1,ITJNARMNRKSWTA-UHFFFAOYSA-N,271.36,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,inhibitor,yes
DB09186,Nisoxetine,small molecule,experimental,CNCCC(OC1=CC=CC=C1OC)C1=CC=CC=C1,ITJNARMNRKSWTA-UHFFFAOYSA-N,271.36,Q01959,BE0000647,Sodium-dependent dopamine transporter,Humans,inhibitor,yes
DB09186,Nisoxetine,small molecule,experimental,CNCCC(OC1=CC=CC=C1OC)C1=CC=CC=C1,ITJNARMNRKSWTA-UHFFFAOYSA-N,271.36,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB09194,Etoperidone,small molecule,withdrawn,CCN1C(=O)N(CCCN2CCN(CC2)C2=CC=CC(Cl)=C2)N=C1CC,IZBNNCFOBMGTQX-UHFFFAOYSA-N,377.92,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB09194,Etoperidone,small molecule,withdrawn,CCN1C(=O)N(CCCN2CCN(CC2)C2=CC=CC(Cl)=C2)N=C1CC,IZBNNCFOBMGTQX-UHFFFAOYSA-N,377.92,P28335,BE0000533,5-hydroxytryptamine receptor 2C,Humans,agonist,yes
DB09195,Lorpiprazole,small molecule,approved,[H][C@@]12CCC[C@]1([H])C1=NN=C(CCN3CCN(CC3)C3=CC=CC(=C3)C(F)(F)F)N1C2,BNRMWKUVWLKDQJ-YJBOKZPZSA-N,405.469,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB09195,Lorpiprazole,small molecule,approved,[H][C@@]12CCC[C@]1([H])C1=NN=C(CCN3CCN(CC3)C3=CC=CC(=C3)C(F)(F)F)N1C2,BNRMWKUVWLKDQJ-YJBOKZPZSA-N,405.469,P28335,BE0000533,5-hydroxytryptamine receptor 2C,Humans,antagonist,yes
DB09195,Lorpiprazole,small molecule,approved,[H][C@@]12CCC[C@]1([H])C1=NN=C(CCN3CCN(CC3)C3=CC=CC(=C3)C(F)(F)F)N1C2,BNRMWKUVWLKDQJ-YJBOKZPZSA-N,405.469,P35348,BE0004863,Alpha-1 adrenergic receptors,Humans,antagonist,yes
DB09195,Lorpiprazole,small molecule,approved,[H][C@@]12CCC[C@]1([H])C1=NN=C(CCN3CCN(CC3)C3=CC=CC(=C3)C(F)(F)F)N1C2,BNRMWKUVWLKDQJ-YJBOKZPZSA-N,405.469,P08913,BE0004864,Alpha-2 adrenergic receptors,Humans,antagonist,yes
DB09195,Lorpiprazole,small molecule,approved,[H][C@@]12CCC[C@]1([H])C1=NN=C(CCN3CCN(CC3)C3=CC=CC(=C3)C(F)(F)F)N1C2,BNRMWKUVWLKDQJ-YJBOKZPZSA-N,405.469,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB09195,Lorpiprazole,small molecule,approved,[H][C@@]12CCC[C@]1([H])C1=NN=C(CCN3CCN(CC3)C3=CC=CC(=C3)C(F)(F)F)N1C2,BNRMWKUVWLKDQJ-YJBOKZPZSA-N,405.469,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,antagonist,yes
DB09196,Lubazodone,small molecule,experimental,[H]N1CCO[C@H](COC2=C3CCCC3=C(F)C=C2)C1,HTODIQZHVCHVGM-JTQLQIEISA-N,251.301,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,inhibitor,yes
DB09196,Lubazodone,small molecule,experimental,[H]N1CCO[C@H](COC2=C3CCCC3=C(F)C=C2)C1,HTODIQZHVCHVGM-JTQLQIEISA-N,251.301,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB09198,Lobeglitazone,small molecule,experimental,COC1=CC=C(OC2=NC=NC(=C2)N(C)CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,CHHXEZSCHQVSRE-UHFFFAOYSA-N,480.54,Q07869,BE0000071,Peroxisome proliferator-activated receptor alpha,Humans,agonist,yes
DB09198,Lobeglitazone,small molecule,experimental,COC1=CC=C(OC2=NC=NC(=C2)N(C)CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,CHHXEZSCHQVSRE-UHFFFAOYSA-N,480.54,P37231,BE0000215,Peroxisome proliferator-activated receptor gamma,Humans,activator,yes
DB09199,Netoglitazone,small molecule,experimental,FC1=C(COC2=CC=C3C=C(CC4SC(=O)NC4=O)C=CC3=C2)C=CC=C1,PKWDZWYVIHVNKS-UHFFFAOYSA-N,381.42,P37231,BE0000215,Peroxisome proliferator-activated receptor gamma,Humans,modulator,yes
DB09200,Rivoglitazone,small molecule,experimental;investigational,COC1=CC=C2N=C(COC3=CC=C(CC4SC(=O)NC4=O)C=C3)N(C)C2=C1,XMSXOLDPMGMWTH-UHFFFAOYSA-N,397.45,P37231,BE0000215,Peroxisome proliferator-activated receptor gamma,Humans,agonist,yes
DB09201,Ciglitazone,small molecule,experimental,CC1(COC2=CC=C(CC3SC(=O)NC3=O)C=C2)CCCCC1,YZFWTZACSRHJQD-UHFFFAOYSA-N,333.45,P37231,BE0000215,Peroxisome proliferator-activated receptor gamma,Humans,agonist,yes
DB09202,Cirazoline,small molecule,experimental,[H]N1CCN=C1COC1=CC=CC=C1C1CC1,YAORIDZYZDUZCM-UHFFFAOYSA-N,216.284,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,agonist,yes
DB09202,Cirazoline,small molecule,experimental,[H]N1CCN=C1COC1=CC=CC=C1C1CC1,YAORIDZYZDUZCM-UHFFFAOYSA-N,216.284,P18825,BE0000342,Alpha-2C adrenergic receptor,Humans,agonist,yes
DB09202,Cirazoline,small molecule,experimental,[H]N1CCN=C1COC1=CC=CC=C1C1CC1,YAORIDZYZDUZCM-UHFFFAOYSA-N,216.284,P35368,BE0000575,Alpha-1B adrenergic receptor,Humans,partial agonist,yes
DB09202,Cirazoline,small molecule,experimental,[H]N1CCN=C1COC1=CC=CC=C1C1CC1,YAORIDZYZDUZCM-UHFFFAOYSA-N,216.284,P25100,BE0000715,Alpha-1D adrenergic receptor,Humans,partial agonist,yes
DB09202,Cirazoline,small molecule,experimental,[H]N1CCN=C1COC1=CC=CC=C1C1CC1,YAORIDZYZDUZCM-UHFFFAOYSA-N,216.284,P08913,BE0004864,Alpha-2 adrenergic receptors,Humans,antagonist,yes
DB09204,Arotinolol,small molecule,investigational,CC(C)(C)NCC(O)CSC1=NC(=CS1)C1=CC=C(S1)C(N)=O,BHIAIPWSVYSKJS-UHFFFAOYSA-N,371.53,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,antagonist,yes
DB09204,Arotinolol,small molecule,investigational,CC(C)(C)NCC(O)CSC1=NC(=CS1)C1=CC=C(S1)C(N)=O,BHIAIPWSVYSKJS-UHFFFAOYSA-N,371.53,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,antagonist,yes
DB09204,Arotinolol,small molecule,investigational,CC(C)(C)NCC(O)CSC1=NC(=CS1)C1=CC=C(S1)C(N)=O,BHIAIPWSVYSKJS-UHFFFAOYSA-N,371.53,P35348,BE0004863,Alpha-1 adrenergic receptors,Humans,antagonist,yes
DB09205,Moxisylyte,small molecule,approved;investigational,CC(C)C1=C(OCCN(C)C)C=C(C)C(OC(C)=O)=C1,VRYMTAVOXVTQEF-UHFFFAOYSA-N,279.38,P25100,BE0000715,Alpha-1D adrenergic receptor,Humans,modulator,yes
DB09205,Moxisylyte,small molecule,approved;investigational,CC(C)C1=C(OCCN(C)C)C=C(C)C(OC(C)=O)=C1,VRYMTAVOXVTQEF-UHFFFAOYSA-N,279.38,P35348,BE0004888,Alpha adrenergic receptor,Humans,antagonist,yes
DB09206,Trimazosin,small molecule,experimental,COC1=CC2=C(N=C(N=C2N)N2CCN(CC2)C(=O)OCC(C)(C)O)C(OC)=C1OC,YNZXWQJZEDLQEG-UHFFFAOYSA-N,435.481,P25100,BE0000715,Alpha-1D adrenergic receptor,Humans,modulator,yes
DB09209,Pholcodine,small molecule,approved;illicit,[H][C@@]12OC3=C(OCCN4CCOCC4)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,GPFAJKDEDBRFOS-FKQDBXSBSA-N,398.4953,P35372,BE0000770,Mu-type opioid receptor,Humans,antagonist,yes
DB09209,Pholcodine,small molecule,approved;illicit,[H][C@@]12OC3=C(OCCN4CCOCC4)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,GPFAJKDEDBRFOS-FKQDBXSBSA-N,398.4953,P41145,BE0000632,Kappa-type opioid receptor,Humans,antagonist,yes
DB09211,Limaprost,small molecule,investigational,CCCC[C@H](C)C[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC\C=C\C(O)=O,OJZYRQPMEIEQFC-UAWLTFRCSA-N,380.525,P43116,BE0000368,Prostaglandin E2 receptor EP2 subtype,Humans,agonist,yes
DB09212,Loxoprofen,small molecule,approved,CC(C(O)=O)C1=CC=C(CC2CCCC2=O)C=C1,YMBXTVYHTMGZDW-UHFFFAOYSA-N,246.3016,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,antagonist,yes
DB09212,Loxoprofen,small molecule,approved,CC(C(O)=O)C1=CC=C(CC2CCCC2=O)C=C1,YMBXTVYHTMGZDW-UHFFFAOYSA-N,246.3016,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,antagonist,yes
DB09213,Dexibuprofen,small molecule,approved;investigational,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O,HEFNNWSXXWATRW-JTQLQIEISA-N,206.2808,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB09215,Droxicam,small molecule,withdrawn,CN1C2=C(OC(=O)N(C2=O)C2=CC=CC=N2)C2=CC=CC=C2S1(=O)=O,OEHFRZLKGRKFAS-UHFFFAOYSA-N,357.34,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB09215,Droxicam,small molecule,withdrawn,CN1C2=C(OC(=O)N(C2=O)C2=CC=CC=N2)C2=CC=CC=C2S1(=O)=O,OEHFRZLKGRKFAS-UHFFFAOYSA-N,357.34,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB09216,Tolfenamic acid,small molecule,approved;investigational,CC1=C(Cl)C=CC=C1NC1=CC=CC=C1C(O)=O,YEZNLOUZAIOMLT-UHFFFAOYSA-N,261.704,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,antagonist,yes
DB09216,Tolfenamic acid,small molecule,approved;investigational,CC1=C(Cl)C=CC=C1NC1=CC=CC=C1C(O)=O,YEZNLOUZAIOMLT-UHFFFAOYSA-N,261.704,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,antagonist,yes
DB09217,Firocoxib,small molecule,experimental;vet_approved,CC1(C)OC(=O)C(OCC2CC2)=C1C1=CC=C(C=C1)S(C)(=O)=O,FULAPETWGIGNMT-UHFFFAOYSA-N,336.4,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB09220,Nicorandil,small molecule,approved;investigational,[O-][N+](=O)OCCNC(=O)C1=CC=CN=C1,LBHIOVVIQHSOQN-UHFFFAOYSA-N,211.177,O60706,BE0000469,ATP-binding cassette sub-family C member 9,Humans,activator,yes
DB09223,Blonanserin,small molecule,investigational,CCN1CCN(CC1)C1=NC2=C(CCCCCC2)C(=C1)C1=CC=C(F)C=C1,XVGOZDAJGBALKS-UHFFFAOYSA-N,367.512,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB09223,Blonanserin,small molecule,investigational,CCN1CCN(CC1)C1=NC2=C(CCCCCC2)C(=C1)C1=CC=C(F)C=C1,XVGOZDAJGBALKS-UHFFFAOYSA-N,367.512,P35462,BE0000581,D(3) dopamine receptor,Humans,antagonist,yes
DB09223,Blonanserin,small molecule,investigational,CCN1CCN(CC1)C1=NC2=C(CCCCCC2)C(=C1)C1=CC=C(F)C=C1,XVGOZDAJGBALKS-UHFFFAOYSA-N,367.512,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB09224,Melperone,small molecule,investigational,CC1CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1,DKMFBWQBDIGMHM-UHFFFAOYSA-N,263.356,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB09225,Zotepine,small molecule,approved;investigational;withdrawn,CN(C)CCOC1=CC2=CC=CC=C2SC2=CC=C(Cl)C=C12,HDOZVRUNCMBHFH-UHFFFAOYSA-N,331.86,P21728,BE0004889,D(1) dopamine receptor,Humans,antagonist,yes
DB09225,Zotepine,small molecule,approved;investigational;withdrawn,CN(C)CCOC1=CC2=CC=CC=C2SC2=CC=C(Cl)C=C12,HDOZVRUNCMBHFH-UHFFFAOYSA-N,331.86,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB09225,Zotepine,small molecule,approved;investigational;withdrawn,CN(C)CCOC1=CC2=CC=CC=C2SC2=CC=C(Cl)C=C12,HDOZVRUNCMBHFH-UHFFFAOYSA-N,331.86,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB09225,Zotepine,small molecule,approved;investigational;withdrawn,CN(C)CCOC1=CC2=CC=CC=C2SC2=CC=C(Cl)C=C12,HDOZVRUNCMBHFH-UHFFFAOYSA-N,331.86,P34969,BE0000650,5-hydroxytryptamine receptor 7,Humans,antagonist,yes
DB09225,Zotepine,small molecule,approved;investigational;withdrawn,CN(C)CCOC1=CC2=CC=CC=C2SC2=CC=C(Cl)C=C12,HDOZVRUNCMBHFH-UHFFFAOYSA-N,331.86,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,antagonist,yes
DB09225,Zotepine,small molecule,approved;investigational;withdrawn,CN(C)CCOC1=CC2=CC=CC=C2SC2=CC=C(Cl)C=C12,HDOZVRUNCMBHFH-UHFFFAOYSA-N,331.86,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,antagonist,yes
DB09227,Barnidipine,small molecule,experimental,COC(=O)C1=C(C)NC(C)=C([C@H]1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)O[C@H]1CCN(CC2=CC=CC=C2)C1,VXMOONUMYLCFJD-DHLKQENFSA-N,491.544,Q13936,BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,Humans,antagonist,yes
DB09229,Aranidipine,small molecule,experimental,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OCC(C)=O,NCUCGYYHUFIYNU-UHFFFAOYSA-N,388.376,Q13936,BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,Humans,antagonist,yes
DB09229,Aranidipine,small molecule,experimental,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OCC(C)=O,NCUCGYYHUFIYNU-UHFFFAOYSA-N,388.376,Q01668,BE0002359,Voltage-dependent L-type calcium channel subunit alpha-1D,Humans,antagonist,yes
DB09229,Aranidipine,small molecule,experimental,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OCC(C)=O,NCUCGYYHUFIYNU-UHFFFAOYSA-N,388.376,O60840,BE0002357,Voltage-dependent L-type calcium channel subunit alpha-1F,Humans,antagonist,yes
DB09229,Aranidipine,small molecule,experimental,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OCC(C)=O,NCUCGYYHUFIYNU-UHFFFAOYSA-N,388.376,Q13698,BE0002355,Voltage-dependent L-type calcium channel subunit alpha-1S,Humans,antagonist,yes
DB09231,Benidipine,small molecule,experimental,COC(=O)C1=C(C)NC(C)=C([C@@H]1C1=CC=CC(=C1)[N+]([O-])=O)C(=O)O[C@@H]1CCCN(CC2=CC=CC=C2)C1,QZVNQOLPLYWLHQ-ZEQKJWHPSA-N,505.571,Q13936,BE0008715,Voltage-dependent L-type calcium channel,Humans,antagonist,yes
DB09231,Benidipine,small molecule,experimental,COC(=O)C1=C(C)NC(C)=C([C@@H]1C1=CC=CC(=C1)[N+]([O-])=O)C(=O)O[C@@H]1CCCN(CC2=CC=CC=C2)C1,QZVNQOLPLYWLHQ-ZEQKJWHPSA-N,505.571,Q00975,BE0002226,Voltage-dependent N-type calcium channel subunit alpha-1B,Humans,antagonist,yes
DB09231,Benidipine,small molecule,experimental,COC(=O)C1=C(C)NC(C)=C([C@@H]1C1=CC=CC(=C1)[N+]([O-])=O)C(=O)O[C@@H]1CCCN(CC2=CC=CC=C2)C1,QZVNQOLPLYWLHQ-ZEQKJWHPSA-N,505.571,O43497,BE0008716,Voltage-dependent T-type calcium channel,Humans,antagonist,yes
DB09232,Cilnidipine,small molecule,investigational,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(=C1)[N+]([O-])=O)C(=O)OC\C=C\C1=CC=CC=C1,KJEBULYHNRNJTE-DHZHZOJOSA-N,492.528,Q00975,BE0002226,Voltage-dependent N-type calcium channel subunit alpha-1B,Humans,antagonist,yes
DB09232,Cilnidipine,small molecule,investigational,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(=C1)[N+]([O-])=O)C(=O)OC\C=C\C1=CC=CC=C1,KJEBULYHNRNJTE-DHZHZOJOSA-N,492.528,Q13936,BE0008715,Voltage-dependent L-type calcium channel,Humans,antagonist,yes
DB09235,Efonidipine,small molecule,experimental,CC1=C(C(C2=CC=CC(=C2)[N+]([O-])=O)C(=C(C)N1)P1(=O)OCC(C)(C)CO1)C(=O)OCCN(CC1=CC=CC=C1)C1=CC=CC=C1,NSVFSAJIGAJDMR-UHFFFAOYSA-N,631.666,Q13936,BE0009739,Voltage gated L-type calcium channel,Humans,blocker,yes
DB09235,Efonidipine,small molecule,experimental,CC1=C(C(C2=CC=CC(=C2)[N+]([O-])=O)C(=C(C)N1)P1(=O)OCC(C)(C)CO1)C(=O)OCCN(CC1=CC=CC=C1)C1=CC=CC=C1,NSVFSAJIGAJDMR-UHFFFAOYSA-N,631.666,Q06432,BE0004902,Voltage-dependent calcium channel,Humans,inhibitor,yes
DB09235,Efonidipine,small molecule,experimental,CC1=C(C(C2=CC=CC(=C2)[N+]([O-])=O)C(=C(C)N1)P1(=O)OCC(C)(C)CO1)C(=O)OCCN(CC1=CC=CC=C1)C1=CC=CC=C1,NSVFSAJIGAJDMR-UHFFFAOYSA-N,631.666,O43497,BE0008716,Voltage-dependent T-type calcium channel,Humans,inhibitor,yes
DB09235,Efonidipine,small molecule,experimental,CC1=C(C(C2=CC=CC(=C2)[N+]([O-])=O)C(=C(C)N1)P1(=O)OCC(C)(C)CO1)C(=O)OCCN(CC1=CC=CC=C1)C1=CC=CC=C1,NSVFSAJIGAJDMR-UHFFFAOYSA-N,631.666,O43497,BE0000483,Voltage-dependent T-type calcium channel subunit alpha-1G,Humans,inhibitor,yes
DB09235,Efonidipine,small molecule,experimental,CC1=C(C(C2=CC=CC(=C2)[N+]([O-])=O)C(=C(C)N1)P1(=O)OCC(C)(C)CO1)C(=O)OCCN(CC1=CC=CC=C1)C1=CC=CC=C1,NSVFSAJIGAJDMR-UHFFFAOYSA-N,631.666,O95180,BE0000864,Voltage-dependent T-type calcium channel subunit alpha-1H,Humans,inhibitor,yes
DB09236,Lacidipine,small molecule,approved;investigational,CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1\C=C\C(=O)OC(C)(C)C)C(=O)OCC,GKQPCPXONLDCMU-CCEZHUSRSA-N,455.551,Q13936,BE0008715,Voltage-dependent L-type calcium channel,Humans,antagonist,yes
DB09237,Levamlodipine,small molecule,approved;investigational,CCOC(=O)C1=C(COCCN)NC(C)=C([C@@H]1C1=CC=CC=C1Cl)C(=O)OC,HTIQEAQVCYTUBX-KRWDZBQOSA-N,408.88,Q13936,BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,Humans,antagonist,yes
DB09237,Levamlodipine,small molecule,approved;investigational,CCOC(=O)C1=C(COCCN)NC(C)=C([C@@H]1C1=CC=CC=C1Cl)C(=O)OC,HTIQEAQVCYTUBX-KRWDZBQOSA-N,408.88,Q01668,BE0002359,Voltage-dependent L-type calcium channel subunit alpha-1D,Humans,antagonist,yes
DB09238,Manidipine,small molecule,approved;investigational,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)N(=O)=O)C(=O)OCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1,ANEBWFXPVPTEET-UHFFFAOYSA-N,610.711,Q13936,BE0008715,Voltage-dependent L-type calcium channel,Humans,blocker,yes
DB09238,Manidipine,small molecule,approved;investigational,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)N(=O)=O)C(=O)OCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1,ANEBWFXPVPTEET-UHFFFAOYSA-N,610.711,Q13936,BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,Humans,inhibitor,yes
DB09238,Manidipine,small molecule,approved;investigational,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)N(=O)=O)C(=O)OCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1,ANEBWFXPVPTEET-UHFFFAOYSA-N,610.711,P25779,BE0001292,Cruzipain,Trypanosoma cruzi,inhibitor,yes
DB09238,Manidipine,small molecule,approved;investigational,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)N(=O)=O)C(=O)OCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1,ANEBWFXPVPTEET-UHFFFAOYSA-N,610.711,Q01668,BE0002359,Voltage-dependent L-type calcium channel subunit alpha-1D,Humans,inhibitor,yes
DB09238,Manidipine,small molecule,approved;investigational,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)N(=O)=O)C(=O)OCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1,ANEBWFXPVPTEET-UHFFFAOYSA-N,610.711,O43497,BE0008716,Voltage-dependent T-type calcium channel,Humans,inhibitor;blocker,yes
DB09241,Methylene blue,small molecule,approved;investigational,[Cl-].CN(C)C1=CC2=[S+]C3=C(C=CC(=C3)N(C)C)N=C2C=C1,CXKWCBBOMKCUKX-UHFFFAOYSA-M,319.85,P33402,BE0003578,Guanylate cyclase soluble subunit alpha-2,Humans,inhibitor,yes
DB09241,Methylene blue,small molecule,approved;investigational,[Cl-].CN(C)C1=CC2=[S+]C3=C(C=CC(=C3)N(C)C)N=C2C=C1,CXKWCBBOMKCUKX-UHFFFAOYSA-M,319.85,P29475,BE0000067,Nitric oxide synthase 1,Humans,inhibitor,yes
DB09242,Moxonidine,small molecule,approved;investigational,COC1=NC(C)=NC(Cl)=C1NC1=NCCN1,WPNJAUFVNXKLIM-UHFFFAOYSA-N,241.677,P18825,BE0000342,Alpha-2C adrenergic receptor,Humans,inhibitor,yes
DB09242,Moxonidine,small molecule,approved;investigational,COC1=NC(C)=NC(Cl)=C1NC1=NCCN1,WPNJAUFVNXKLIM-UHFFFAOYSA-N,241.677,P18089,BE0000572,Alpha-2B adrenergic receptor,Humans,inhibitor,yes
DB09242,Moxonidine,small molecule,approved;investigational,COC1=NC(C)=NC(Cl)=C1NC1=NCCN1,WPNJAUFVNXKLIM-UHFFFAOYSA-N,241.677,P08913,BE0000289,Alpha-2A adrenergic receptor,Humans,agonist,yes
DB09242,Moxonidine,small molecule,approved;investigational,COC1=NC(C)=NC(Cl)=C1NC1=NCCN1,WPNJAUFVNXKLIM-UHFFFAOYSA-N,241.677,Q9Y2I1,BE0003580,Nischarin,Humans,agonist,yes
DB09245,Toloxatone,small molecule,experimental,CC1=CC(=CC=C1)N1CC(CO)OC1=O,MXUNKHLAEDCYJL-UHFFFAOYSA-N,207.229,P27338,BE0002196,Amine oxidase [flavin-containing] B,Humans,inhibitor,yes
DB09256,Tegafur,small molecule,approved;investigational,FC1=CN(C2CCCO2)C(=O)NC1=O,WFWLQNSHRPWKFK-UHFFFAOYSA-N,200.169,P04818,BE0000324,Thymidylate synthase,Humans,inhibitor,yes
DB09257,Gimeracil,small molecule,approved,OC1=CC(=O)NC=C1Cl,ZPLQIPFOCGIIHV-UHFFFAOYSA-N,145.54,Q12882,BE0000960,Dihydropyrimidine dehydrogenase [NADP(+)],Humans,inhibitor,yes
DB09262,Imidafenacin,small molecule,investigational,CC1=NC=CN1CCC(C(N)=O)(C1=CC=CC=C1)C1=CC=CC=C1,SQKXYSGRELMAAU-UHFFFAOYSA-N,319.408,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,antagonist,yes
DB09262,Imidafenacin,small molecule,investigational,CC1=NC=CN1CCC(C(N)=O)(C1=CC=CC=C1)C1=CC=CC=C1,SQKXYSGRELMAAU-UHFFFAOYSA-N,319.408,P08172,BE0000560,Muscarinic acetylcholine receptor M2,Humans,antagonist,yes
DB09262,Imidafenacin,small molecule,investigational,CC1=NC=CN1CCC(C(N)=O)(C1=CC=CC=C1)C1=CC=CC=C1,SQKXYSGRELMAAU-UHFFFAOYSA-N,319.408,P20309,BE0000045,Muscarinic acetylcholine receptor M3,Humans,antagonist,yes
DB09270,Ubidecarenone,small molecule,approved;investigational;nutraceutical,COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O,ACTIUHUUMQJHFO-UPTCCGCDSA-N,863.3435,P56181,BE0000027,"NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial",Humans,cofactor,yes
DB09270,Ubidecarenone,small molecule,approved;investigational;nutraceutical,COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O,ACTIUHUUMQJHFO-UPTCCGCDSA-N,863.3435,P31040,BE0000176,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",Humans,cofactor,yes
DB09271,Cimetropium,small molecule,experimental;investigational,[H][C@](CO)(C(=O)O[C@@]1([H])C[C@@]2([H])[C@]3([H])O[C@]3([H])[C@@]([H])(C1)[N+]2(C)CC1CC1)C1=CC=CC=C1,QVVOZYKELHAIPX-WVHCHWADSA-N,358.457,P08912,BE0000247,Muscarinic acetylcholine receptor M5,Humans,modulator,yes
DB09272,Eluxadoline,small molecule,approved;investigational,COC1=CC=C(CN([C@@H](C)C2=NC(=CN2)C2=CC=CC=C2)C(=O)[C@@H](N)CC2=C(C)C=C(C=C2C)C(N)=O)C=C1C(O)=O,QFNHIDANIVGXPE-FNZWTVRRSA-N,569.662,P35372,BE0000770,Mu-type opioid receptor,Humans,agonist,yes
DB09272,Eluxadoline,small molecule,approved;investigational,COC1=CC=C(CN([C@@H](C)C2=NC(=CN2)C2=CC=CC=C2)C(=O)[C@@H](N)CC2=C(C)C=C(C=C2C)C(N)=O)C=C1C(O)=O,QFNHIDANIVGXPE-FNZWTVRRSA-N,569.662,P41143,BE0000420,Delta-type opioid receptor,Humans,antagonist,yes
DB09272,Eluxadoline,small molecule,approved;investigational,COC1=CC=C(CN([C@@H](C)C2=NC(=CN2)C2=CC=CC=C2)C(=O)[C@@H](N)CC2=C(C)C=C(C=C2C)C(N)=O)C=C1C(O)=O,QFNHIDANIVGXPE-FNZWTVRRSA-N,569.662,P41145,BE0000632,Kappa-type opioid receptor,Humans,agonist,yes
DB09273,Doxofylline,small molecule,experimental,CN1C2=C(N(CC3OCCO3)C=N2)C(=O)N(C)C1=O,HWXIGFIVGWUZAO-UHFFFAOYSA-N,266.257,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,agonist,yes
DB09273,Doxofylline,small molecule,experimental,CN1C2=C(N(CC3OCCO3)C=N2)C(=O)N(C)C1=O,HWXIGFIVGWUZAO-UHFFFAOYSA-N,266.257,O00408,BE0002085,"cGMP-dependent 3',5'-cyclic phosphodiesterase",Humans,inhibitor,yes
DB09274,Artesunate,small molecule,approved;investigational,[H][C@@]12CC[C@@H](C)[C@]3([H])CC[C@@]4(C)OO[C@@]13[C@]([H])(O[C@@H](OC(=O)CCC(O)=O)[C@@H]2C)O4,FIHJKUPKCHIPAT-AHIGJZGOSA-N,384.425,P04926,BE0008642,Malaria protein EXP-1,Plasmodium falciparum,inhibitor,yes
DB09279,Fimasartan,small molecule,investigational,CCCCC1=NC(C)=C(CC(=S)N(C)C)C(=O)N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1,AMEROGPZOLAFBN-UHFFFAOYSA-N,501.65,P30556,BE0000062,Type-1 angiotensin II receptor,Humans,antagonist,yes
DB09280,Lumacaftor,small molecule,approved,CC1=CC=C(NC(=O)C2(CC2)C2=CC=C3OC(F)(F)OC3=C2)N=C1C1=CC(=CC=C1)C(O)=O,UFSKUSARDNFIRC-UHFFFAOYSA-N,452.414,P13569,BE0001195,Cystic fibrosis transmembrane conductance regulator,Humans,modulator,yes
DB09282,Molsidomine,small molecule,approved;investigational,CCOC(=O)[N-]C1=C[N+](=NO1)N1CCOCC1,XLFWDASMENKTKL-UHFFFAOYSA-N,242.235,P33402,BE0003578,Guanylate cyclase soluble subunit alpha-2,Humans,agonist,yes
DB09283,Trapidil,small molecule,experimental,CCN(CC)C1=CC(C)=NC2=NC=NN12,GSNOZLZNQMLSKJ-UHFFFAOYSA-N,205.265,P22607,BE0002133,Fibroblast growth factor receptor 3,Humans,inhibitor,yes
DB09283,Trapidil,small molecule,experimental,CCN(CC)C1=CC(C)=NC2=NC=NN12,GSNOZLZNQMLSKJ-UHFFFAOYSA-N,205.265,P27815,BE0004922,Cyclic nucleotide phosphodiesterase,Humans,inhibitor,yes
DB09285,Morniflumate,small molecule,experimental,FC(F)(F)C1=CC(NC2=C(C=CC=N2)C(=O)OCCN2CCOCC2)=CC=C1,LDXSPUSKBDTEKA-UHFFFAOYSA-N,395.382,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,modulator,yes
DB09285,Morniflumate,small molecule,experimental,FC(F)(F)C1=CC(NC2=C(C=CC=N2)C(=O)OCCN2CCOCC2)=CC=C1,LDXSPUSKBDTEKA-UHFFFAOYSA-N,395.382,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,modulator,yes
DB09288,Propacetamol,small molecule,experimental,CCN(CC)CC(=O)OC1=CC=C(NC(C)=O)C=C1,QTGAJCQTLIRCFL-UHFFFAOYSA-N,264.325,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,antagonist,yes
DB09288,Propacetamol,small molecule,experimental,CCN(CC)CC(=O)OC1=CC=C(NC(C)=O)C=C1,QTGAJCQTLIRCFL-UHFFFAOYSA-N,264.325,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,antagonist,yes
DB09288,Propacetamol,small molecule,experimental,CCN(CC)CC(=O)OC1=CC=C(NC(C)=O)C=C1,QTGAJCQTLIRCFL-UHFFFAOYSA-N,264.325,Q8NER1,BE0001023,Transient receptor potential cation channel subfamily V member 1,Humans,antagonist,yes
DB09288,Propacetamol,small molecule,experimental,CCN(CC)CC(=O)OC1=CC=C(NC(C)=O)C=C1,QTGAJCQTLIRCFL-UHFFFAOYSA-N,264.325,P21554,BE0000061,Cannabinoid receptor 1,Humans,antagonist,yes
DB09289,Tianeptine,small molecule,investigational,CN1C2=CC=CC=C2C(NCCCCCCC(O)=O)C2=C(C=C(Cl)C=C2)S1(=O)=O,JICJBGPOMZQUBB-UHFFFAOYSA-N,436.952,P35372,BE0000770,Mu-type opioid receptor,Humans,agonist,yes
DB09289,Tianeptine,small molecule,investigational,CN1C2=CC=CC=C2C(NCCCCCCC(O)=O)C2=C(C=C(Cl)C=C2)S1(=O)=O,JICJBGPOMZQUBB-UHFFFAOYSA-N,436.952,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB09291,Rolapitant,small molecule,approved;investigational,C[C@@H](OC[C@]1(CC[C@]2(CCC(=O)N2)CN1)C1=CC=CC=C1)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F,FIVSJYGQAIEMOC-ZGNKEGEESA-N,500.485,P25103,BE0000384,Substance-P receptor,Humans,antagonist,yes
DB09292,Sacubitril,small molecule,approved,CCOC(=O)[C@H](C)C[C@@H](CC1=CC=C(C=C1)C1=CC=CC=C1)NC(=O)CCC(O)=O,PYNXFZCZUAOOQC-UTKZUKDTSA-N,411.498,P08473,BE0000266,Neprilysin,Humans,antagonist;inhibitor,yes
DB09296,Ombitasvir,small molecule,approved;investigational,COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)NC1=CC=C(C=C1)[C@@H]1CC[C@H](N1C1=CC=C(C=C1)C(C)(C)C)C1=CC=C(NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)OC)C(C)C)C=C1,PIDFDZJZLOTZTM-KHVQSSSXSA-N,894.127,Q5L478,BE0008651,Nonstructural protein 5A,Hepatitis C Virus,inhibitor,yes
DB09296,Ombitasvir,small molecule,approved;investigational,COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)NC1=CC=C(C=C1)[C@@H]1CC[C@H](N1C1=CC=C(C=C1)C(C)(C)C)C1=CC=C(NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)OC)C(C)C)C=C1,PIDFDZJZLOTZTM-KHVQSSSXSA-N,894.127,P26664,BE0003427,Genome polyprotein,,modulator,yes
DB09297,Paritaprevir,small molecule,approved;investigational,[H][C@@]12C[C@]1(NC(=O)[C@]1([H])C[C@H](CN1C(=O)[C@H](CCCCC\C=C/2)NC(=O)C1=CN=C(C)C=N1)OC1=NC2=C(C=CC=C2)C2=C1C=CC=C2)C(=O)NS(=O)(=O)C1CC1,UAUIUKWPKRJZJV-QPLHLKROSA-N,765.89,B0B3C9,BE0004701,Genome polyprotein,Hepatitis C Virus,inhibitor,yes
DB09297,Paritaprevir,small molecule,approved;investigational,[H][C@@]12C[C@]1(NC(=O)[C@]1([H])C[C@H](CN1C(=O)[C@H](CCCCC\C=C/2)NC(=O)C1=CN=C(C)C=N1)OC1=NC2=C(C=CC=C2)C2=C1C=CC=C2)C(=O)NS(=O)(=O)C1CC1,UAUIUKWPKRJZJV-QPLHLKROSA-N,765.89,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB09299,Tenofovir alafenamide,small molecule,approved,CC(C)OC(=O)[C@H](C)N[P@](=O)(CO[C@H](C)CN1C=NC2=C(N)N=CN=C12)OC1=CC=CC=C1,LDEKQSIMHVQZJK-CAQYMETFSA-N,476.474,Q72547,BE0004136,Reverse transcriptase/RNaseH,Human immunodeficiency virus 1,inhibitor,yes
DB09299,Tenofovir alafenamide,small molecule,approved,CC(C)OC(=O)[C@H](C)N[P@](=O)(CO[C@H](C)CN1C=NC2=C(N)N=CN=C12)OC1=CC=CC=C1,LDEKQSIMHVQZJK-CAQYMETFSA-N,476.474,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB09300,Butylscopolamine,small molecule,approved;investigational;vet_approved,CCCC[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1,YBCNXCRZPWQOBR-WVHCHWADSA-N,360.473,P20309,BE0000045,Muscarinic acetylcholine receptor M3,Humans,antagonist,yes
DB09300,Butylscopolamine,small molecule,approved;investigational;vet_approved,CCCC[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1,YBCNXCRZPWQOBR-WVHCHWADSA-N,360.473,P08912,BE0000247,Muscarinic acetylcholine receptor M5,Humans,modulator,yes
DB09319,Carindacillin,small molecule,approved;investigational,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C(C(=O)OC1=CC2=C(CCC2)C=C1)C1=CC=CC=C1)C(O)=O,JIRBAUWICKGBFE-MNRDOXJOSA-N,494.56,P0AEB2,BE0004840,Penicillin-binding protein,Gram positive and gram negative bacteria,inhibitor,yes
DB09320,Procaine benzylpenicillin,small molecule,approved;vet_approved,CCN(CC)CCOC(=O)C1=CC=C(N)C=C1.[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)CC1=CC=CC=C1)C(O)=O,WHRVRSCEWKLAHX-LQDWTQKMSA-N,570.71,P0AEB2,BE0004840,Penicillin-binding protein,Gram positive and gram negative bacteria,binder,yes
DB09324,Sulbactam,small molecule,approved,[H][C@@]12CC(=O)N1[C@@]([H])(C(O)=O)C(C)(C)S2(=O)=O,FKENQMMABCRJMK-RITPCOANSA-N,233.242,P00807,BE0000302,Beta-lactamase,Staphylococcus aureus,inhibitor,yes
DB09327,Tegafur-uracil,small molecule,approved;investigational,O=C1NC=CC(=O)N1.FC1=CN(C2CCCO2)C(=O)NC1=O,DHMYGZIEILLVNR-UHFFFAOYSA-N,312.257,Q12882,BE0000960,Dihydropyrimidine dehydrogenase [NADP(+)],Humans,antagonist,yes
DB09327,Tegafur-uracil,small molecule,approved;investigational,O=C1NC=CC(=O)N1.FC1=CN(C2CCCO2)C(=O)NC1=O,DHMYGZIEILLVNR-UHFFFAOYSA-N,312.257,P04818,BE0000324,Thymidylate synthase,Humans,antagonist,yes
DB09327,Tegafur-uracil,small molecule,approved;investigational,O=C1NC=CC(=O)N1.FC1=CN(C2CCCO2)C(=O)NC1=O,DHMYGZIEILLVNR-UHFFFAOYSA-N,312.257,,BE0004810,RNA,Humans,,yes
DB09327,Tegafur-uracil,small molecule,approved;investigational,O=C1NC=CC(=O)N1.FC1=CN(C2CCCO2)C(=O)NC1=O,DHMYGZIEILLVNR-UHFFFAOYSA-N,312.257,,BE0004796,DNA,Humans,,yes
DB09330,Osimertinib,small molecule,approved,COC1=C(NC2=NC=CC(=N2)C2=CN(C)C3=C2C=CC=C3)C=C(NC(=O)C=C)C(=C1)N(C)CCN(C)C,DUYJMQONPNNFPI-UHFFFAOYSA-N,499.619,P00533,BE0000767,Epidermal growth factor receptor,Humans,inhibitor;regulator,yes
DB09333,Iopodic acid,small molecule,approved;investigational;withdrawn,CN(C)C=NC1=C(I)C=C(I)C(CCC(O)=O)=C1I,YQNFBOJPTAXAKV-UHFFFAOYSA-N,597.961,P55073,BE0009333,Thyroxine 5-deiodinase,Humans,antagonist,yes
DB09342,Propoxycaine,small molecule,approved,CCCOC1=CC(N)=CC=C1C(=O)OCCN(CC)CC,CAJIGINSTLKQMM-UHFFFAOYSA-N,294.395,P35498,BE0009738,Voltage-gated sodium channel alpha subunit,Humans,blocker,yes
DB09343,Tipiracil,small molecule,approved;investigational,ClC1=C(CN2CCCC2=N)NC(=O)NC1=O,QQHMKNYGKVVGCZ-UHFFFAOYSA-N,242.662,P19971,BE0002193,Thymidine phosphorylase,Humans,inhibitor,yes
DB09345,Pramocaine,small molecule,approved,CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1,DQKXQSGTHWVTAD-UHFFFAOYSA-N,293.407,P35498,BE0009738,Voltage-gated sodium channel alpha subunit,Humans,blocker,yes
DB09351,Levobetaxolol,small molecule,approved;investigational,CC(C)NC[C@H](O)COC1=CC=C(CCOCC2CC2)C=C1,NWIUTZDMDHAVTP-KRWDZBQOSA-N,307.434,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,antagonist,yes
DB09352,Hydroxyamphetamine,small molecule,approved,CC(N)CC1=CC=C(O)C=C1,GIKNHHRFLCDOEU-UHFFFAOYSA-N,151.2056,Q96RJ0,BE0001044,Trace amine-associated receptor 1,Humans,modulator,yes
DB09361,Evans blue,small molecule,investigational,[Na+].[Na+].[Na+].[Na+].CC1=CC(=CC=C1\N=N\C1=C([O-])C2=C(C=C1)C(=CC(=C2N)S(O)(=O)=O)S([O-])(=O)=O)C1=CC=C(\N=N\C2=C([O-])C3=C(C=C2)C(=CC(=C3N)S(O)(=O)=O)S([O-])(=O)=O)C(C)=C1,ATNOAWAQFYGAOY-GPTZEZBUSA-J,960.79,P02768,BE0000530,Albumin,Humans,modulator,yes
DB09372,Tannic acid,small molecule,approved,OC1=CC(=CC(O)=C1O)C(=O)OC1=C(O)C(O)=CC(=C1)C(=O)OC[C@H]1OC(OC(=O)C2=CC(OC(=O)C3=CC(O)=C(O)C(O)=C3)=C(O)C(O)=C2)[C@H](OC(=O)C2=CC(OC(=O)C3=CC(O)=C(O)C(O)=C3)=C(O)C(O)=C2)[C@@H](OC(=O)C2=CC(OC(=O)C3=CC(O)=C(O)C(O)=C3)=C(O)C(O)=C2)[C@@H]1OC(=O)C1=CC(OC(=O)C2=CC(O)=C(O)C(O)=C2)=C(O)C(O)=C1,LRBQNJMCXXYXIU-YIILYMKVSA-N,1701.206,Q5XXA6,BE0004746,Anoctamin-1,Humans,blocker,yes
DB09383,Meprednisone,small molecule,approved;investigational,[H][C@]1(C)C[C@@]2([H])[C@]3([H])CCC4=CC(=O)C=C[C@]4(C)[C@@]3([H])C(=O)C[C@]2(C)[C@@]1(O)C(=O)CO,PIDANAQULIKBQS-RNUIGHNZSA-N,372.461,P04150,BE0000794,Glucocorticoid receptor,Humans,modulator,yes
DB09389,Norgestrel,small molecule,approved,CCC12CCC3C(CCC4=CC(=O)CCC34)C1CCC2(O)C#C,WWYNJERNGUHSAO-UHFFFAOYSA-N,312.453,P06401,BE0000557,Progesterone receptor,Humans,binder,yes
DB09389,Norgestrel,small molecule,approved,CCC12CCC3C(CCC4=CC(=O)CCC34)C1CCC2(O)C#C,WWYNJERNGUHSAO-UHFFFAOYSA-N,312.453,P18405,BE0000539,3-oxo-5-alpha-steroid 4-dehydrogenase 1,Humans,inhibitor,yes
DB09401,Isosorbide,small molecule,approved;investigational,[H][C@]1(O)CO[C@]2([H])[C@]([H])(O)CO[C@]12[H],KLDXJTOLSGUMSJ-JGWLITMVSA-N,146.1412,Q02108,BE0010064,Guanylate cyclase,Humans,activator,yes
DB09418,Potassium perchlorate,small molecule,approved;investigational,[K+].[O-][Cl](=O)(=O)=O,YLMGFJXSLBMXHK-UHFFFAOYSA-M,138.549,Q92911,BE0009346,Sodium/iodide cotransporter,Humans,inhibitor,yes
DB09421,Protirelin,small molecule,approved;investigational,[H][C@@](CC1=CN=CN1)(NC(=O)[C@]1([H])CCC(=O)N1)C(=O)N1CCC[C@@]1([H])C(N)=O,XNSAINXGIQZQOO-SRVKXCTJSA-N,362.3837,P34981,BE0008659,Thyrotropin-releasing hormone receptor,Humans,ligand,yes
DB09477,Enalaprilat,small molecule,approved,[H][C@@](C)(N[C@@]([H])(CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@@]1([H])C(O)=O,LZFZMUMEGBBDTC-QEJZJMRPSA-N,348.3936,P12821,BE0000221,Angiotensin-converting enzyme,Humans,inhibitor,yes
DB09488,Acrivastine,small molecule,approved,[H]\C(CN1CCCC1)=C(\C1=CC=C(C)C=C1)C1=CC=CC(=N1)C(\[H])=C(/[H])C(O)=O,PWACSDKDOHSSQD-IUTFFREVSA-N,348.4382,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB09517,Sodium ferric gluconate complex,small molecule,approved,[O--].[O--].[O--].[Na+].[Fe+3].[Fe+3].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O,MQBDAEHWGRMADS-XNHLMZCASA-M,2089.309,P02792,BE0000085,Ferritin light chain,Humans,binding,yes
DB09517,Sodium ferric gluconate complex,small molecule,approved,[O--].[O--].[O--].[Na+].[Fe+3].[Fe+3].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O,MQBDAEHWGRMADS-XNHLMZCASA-M,2089.309,P68871,BE0000629,Hemoglobin subunit beta,Humans,binding,yes
DB09543,Methyl salicylate,small molecule,approved;vet_approved,COC(=O)C1=CC=CC=C1O,OSWPMRLSEDHDFF-UHFFFAOYSA-N,152.1473,O75762,BE0001122,Transient receptor potential cation channel subfamily A member 1,Humans,activator,yes
DB09552,Thonzonium,small molecule,approved,CCCCCCCCCCCCCCCC[N+](C)(C)CCN(CC1=CC=C(OC)C=C1)C1=NC=CC=N1,IOYZYMQFUSNATM-UHFFFAOYSA-N,511.818,P21283,BE0004525,V-type proton ATPase subunit C 1,Humans,inhibitor,yes
DB09555,Dexchlorpheniramine maleate,small molecule,approved,OC(=O)\C=C/C(O)=O.CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C1=CC=CC=N1,DBAKFASWICGISY-DASCVMRKSA-N,390.86,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB09570,Ixazomib,small molecule,approved;investigational,CC(C)C[C@H](NC(=O)CNC(=O)C1=CC(Cl)=CC=C1Cl)B(O)O,MXAYKZJJDUDWDS-LBPRGKRZSA-N,361.03,P28074,BE0002348,Proteasome subunit beta type-5,Humans,inhibitor,yes
DB11071,Phenyl salicylate,small molecule,approved,OC1=CC=CC=C1C(=O)OC1=CC=CC=C1,ZQBAKBUEJOMQEX-UHFFFAOYSA-N,214.2167,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB11071,Phenyl salicylate,small molecule,approved,OC1=CC=CC=C1C(=O)OC1=CC=CC=C1,ZQBAKBUEJOMQEX-UHFFFAOYSA-N,214.2167,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB11079,Trolamine salicylate,small molecule,approved,OCCN(CCO)CCO.OC(=O)C1=CC=CC=C1O,UEVAMYPIMMOEFW-UHFFFAOYSA-N,287.312,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB11079,Trolamine salicylate,small molecule,approved,OCCN(CCO)CCO.OC(=O)C1=CC=CC=C1O,UEVAMYPIMMOEFW-UHFFFAOYSA-N,287.312,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB11145,Oxyquinoline,small molecule,approved;vet_approved,OC1=CC=CC2=C1N=CC=C2,MCJGNVYPOGVAJF-UHFFFAOYSA-N,145.158,P50579,BE0001534,Methionine aminopeptidase 2,Humans,inhibitor,yes
DB11148,Butamben,small molecule,approved;withdrawn,CCCCOC(=O)C1=CC=C(N)C=C1,IUWVALYLNVXWKX-UHFFFAOYSA-N,193.246,Q06432,BE0004902,Voltage-dependent calcium channel,Humans,inhibitor,yes
DB11148,Butamben,small molecule,approved;withdrawn,CCCCOC(=O)C1=CC=C(N)C=C1,IUWVALYLNVXWKX-UHFFFAOYSA-N,193.246,P48048,BE0004905,ATP-sensitive potassium channel,Humans,antagonist,yes
DB11155,Triclocarban,small molecule,approved,ClC1=CC=C(NC(=O)NC2=CC(Cl)=C(Cl)C=C2)C=C1,ICUTUKXCWQYESQ-UHFFFAOYSA-N,315.58,Q6GI75,BE0004347,Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI,Staphylococcus aureus (strain MRSA252),antagonist,yes
DB11157,Anthralin,small molecule,approved,OC1=CC=CC2=C1C(=O)C1=C(O)C=CC=C1C2,NUZWLKWWNNJHPT-UHFFFAOYSA-N,226.231,P35908,BE0009063,"Keratin, type II cytoskeletal 2 epidermal",Humans,antagonist,yes
DB11157,Anthralin,small molecule,approved,OC1=CC=CC2=C1C(=O)C1=C(O)C=CC=C1C2,NUZWLKWWNNJHPT-UHFFFAOYSA-N,226.231,Q99456,BE0004660,"Keratin, type I cytoskeletal 12",Humans,antagonist,yes
DB11160,Phenyltoloxamine,small molecule,approved,CN(C)CCOC1=CC=CC=C1CC1=CC=CC=C1,IZRPKIZLIFYYKR-UHFFFAOYSA-N,255.361,P14416,BE0000756,D(2) dopamine receptor,Humans,inhibitor,yes
DB11160,Phenyltoloxamine,small molecule,approved,CN(C)CCOC1=CC=CC=C1CC1=CC=CC=C1,IZRPKIZLIFYYKR-UHFFFAOYSA-N,255.361,P21918,BE0000145,D(1B) dopamine receptor,Humans,inhibitor,yes
DB11160,Phenyltoloxamine,small molecule,approved,CN(C)CCOC1=CC=CC=C1CC1=CC=CC=C1,IZRPKIZLIFYYKR-UHFFFAOYSA-N,255.361,P21728,BE0000020,D(1A) dopamine receptor,Humans,inhibitor,yes
DB11160,Phenyltoloxamine,small molecule,approved,CN(C)CCOC1=CC=CC=C1CC1=CC=CC=C1,IZRPKIZLIFYYKR-UHFFFAOYSA-N,255.361,P21917,BE0000389,D(4) dopamine receptor,Humans,inhibitor,yes
DB11160,Phenyltoloxamine,small molecule,approved,CN(C)CCOC1=CC=CC=C1CC1=CC=CC=C1,IZRPKIZLIFYYKR-UHFFFAOYSA-N,255.361,P70174,BE0009144,Histamine H1 receptor,Mouse,inverse agonist,yes
DB11181,Homatropine,small molecule,approved,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(O)C1=CC=CC=C1)N2C,ZTVIKZXZYLEVOL-MCOXGKPRSA-N,275.348,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,antagonist,yes
DB11181,Homatropine,small molecule,approved,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(O)C1=CC=CC=C1)N2C,ZTVIKZXZYLEVOL-MCOXGKPRSA-N,275.348,P08172,BE0000560,Muscarinic acetylcholine receptor M2,Humans,antagonist,yes
DB11181,Homatropine,small molecule,approved,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(O)C1=CC=CC=C1)N2C,ZTVIKZXZYLEVOL-MCOXGKPRSA-N,275.348,P20309,BE0000045,Muscarinic acetylcholine receptor M3,Humans,antagonist,yes
DB11181,Homatropine,small molecule,approved,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(O)C1=CC=CC=C1)N2C,ZTVIKZXZYLEVOL-MCOXGKPRSA-N,275.348,P08173,BE0000405,Muscarinic acetylcholine receptor M4,Humans,antagonist,yes
DB11181,Homatropine,small molecule,approved,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(O)C1=CC=CC=C1)N2C,ZTVIKZXZYLEVOL-MCOXGKPRSA-N,275.348,P08912,BE0000247,Muscarinic acetylcholine receptor M5,Humans,antagonist,yes
DB11185,Sulisobenzone,small molecule,experimental,COC1=C(C=C(C(=O)C2=CC=CC=C2)C(O)=C1)S(O)(=O)=O,CXVGEDCSTKKODG-UHFFFAOYSA-N,308.3,,BE0009373,Skin epithelial cells,Humans,protector,yes
DB11186,Pentoxyverine,small molecule,approved;investigational;withdrawn,CCN(CC)CCOCCOC(=O)C1(CCCC1)C1=CC=CC=C1,CFJMRBQWBDQYMK-UHFFFAOYSA-N,333.472,Q99720,BE0000156,Sigma non-opioid intracellular receptor 1,Humans,agonist,yes
DB11200,Aluminum zirconium octachlorohydrex gly,small molecule,approved,O.O.[Al+3].[Cl-].[Zr+4].NCC([O-])=O,WYANSMZYIOPJFV-UHFFFAOYSA-L,263.74,,BE0009546,Sweat ducts,Humans,antagonist,yes
DB11201,Menthyl salicylate,small molecule,approved,CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1O,SJOXEWUZWQYCGL-DVOMOZLQSA-N,276.376,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,antagonist,yes
DB11201,Menthyl salicylate,small molecule,approved,CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1O,SJOXEWUZWQYCGL-DVOMOZLQSA-N,276.376,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,antagonist,yes
DB11217,Arbutin,small molecule,approved,OC[C@H]1O[C@@H](OC2=CC=C(O)C=C2)[C@H](O)[C@@H](O)[C@@H]1O,BJRNKVDFDLYUGJ-RMPHRYRLSA-N,272.2512,P14679,BE0000252,Tyrosinase,Humans,inhibitor,yes
DB11235,Thonzylamine,small molecule,approved,COC1=CC=C(CN(CCN(C)C)C2=NC=CC=N2)C=C1,GULNIHOSWFYMRN-UHFFFAOYSA-N,286.379,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB11254,Hexylresorcinol,small molecule,approved,CCCCCCC1=C(O)C=C(O)C=C1,WFJIVOKAWHGMBH-UHFFFAOYSA-N,194.2701,P14679,BE0000252,Tyrosinase,Humans,inhibitor,yes
DB11259,Diosmetin,small molecule,experimental,COC1=C(O)C=C(C=C1)C1=CC(=O)C2=C(O1)C=C(O)C=C2O,MBNGWHIJMBWFHU-UHFFFAOYSA-N,300.2629,Q16678,BE0001111,Cytochrome P450 1B1,Humans,inhibitor,yes
DB11259,Diosmetin,small molecule,experimental,COC1=C(O)C=C(C=C1)C1=CC(=O)C2=C(O1)C=C(O)C=C2O,MBNGWHIJMBWFHU-UHFFFAOYSA-N,300.2629,P40763,BE0003462,Signal transducer and activator of transcription 3,Humans,inhibitor,yes
DB11268,Protocatechualdehyde,small molecule,experimental,[H]C(=O)C1=CC(O)=C(O)C=C1,IBGBGRVKPALMCQ-UHFFFAOYSA-N,138.1207,P27338,BE0002196,Amine oxidase [flavin-containing] B,Humans,inhibitor,yes
DB11273,Dihydroergocornine,small molecule,approved,[H][C@@]12CCCN1C(=O)[C@H](C(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C,SEALOBQTUQIVGU-QNIJNHAOSA-N,563.699,P08908,BE0004862,Serotonin Receptors,Humans,antagonist;agonist,yes
DB11273,Dihydroergocornine,small molecule,approved,[H][C@@]12CCCN1C(=O)[C@H](C(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C,SEALOBQTUQIVGU-QNIJNHAOSA-N,563.699,P08588,BE0004872,Beta adrenergic receptor,Humans,antagonist;agonist,yes
DB11273,Dihydroergocornine,small molecule,approved,[H][C@@]12CCCN1C(=O)[C@H](C(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C,SEALOBQTUQIVGU-QNIJNHAOSA-N,563.699,P35348,BE0004888,Alpha adrenergic receptor,Humans,antagonist;agonist,yes
DB11274,Dihydro-alpha-ergocryptine,small molecule,approved,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C,PBUNVLRHZGSROC-VTIMJTGVSA-N,577.726,P34969,BE0000650,5-hydroxytryptamine receptor 7,Humans,antagonist,yes
DB11274,Dihydro-alpha-ergocryptine,small molecule,approved,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C,PBUNVLRHZGSROC-VTIMJTGVSA-N,577.726,P41595,BE0000393,5-hydroxytryptamine receptor 2B,Humans,agonist,yes
DB11274,Dihydro-alpha-ergocryptine,small molecule,approved,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C,PBUNVLRHZGSROC-VTIMJTGVSA-N,577.726,P14416,BE0000756,D(2) dopamine receptor,Humans,agonist,yes
DB11274,Dihydro-alpha-ergocryptine,small molecule,approved,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C,PBUNVLRHZGSROC-VTIMJTGVSA-N,577.726,P21728,BE0004889,D(1) dopamine receptor,Humans,partial agonist,yes
DB11274,Dihydro-alpha-ergocryptine,small molecule,approved,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C,PBUNVLRHZGSROC-VTIMJTGVSA-N,577.726,P35462,BE0000581,D(3) dopamine receptor,Humans,partial agonist,yes
DB11275,Epicriptine,small molecule,approved,[H][C@@]12CCCN1C(=O)[C@]([H])([C@H](C)CC)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C,SBFXHXZNBNFPHV-PXXBSISHSA-N,577.726,P21728,BE0009376,Dopamine receptor,Humans,agonist,yes
DB11278,DL-Methylephedrine,small molecule,approved,C[C@@H]([C@H](O)C1=CC=CC=C1)N(C)C,FMCGSUUBYTWNDP-ONGXEEELSA-N,179.263,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,agonist,yes
DB11278,DL-Methylephedrine,small molecule,approved,C[C@@H]([C@H](O)C1=CC=CC=C1)N(C)C,FMCGSUUBYTWNDP-ONGXEEELSA-N,179.263,P08913,BE0000289,Alpha-2A adrenergic receptor,Humans,agonist,yes
DB11278,DL-Methylephedrine,small molecule,approved,C[C@@H]([C@H](O)C1=CC=CC=C1)N(C)C,FMCGSUUBYTWNDP-ONGXEEELSA-N,179.263,P35348,BE0004888,Alpha adrenergic receptor,Humans,agonist,yes
DB11278,DL-Methylephedrine,small molecule,approved,C[C@@H]([C@H](O)C1=CC=CC=C1)N(C)C,FMCGSUUBYTWNDP-ONGXEEELSA-N,179.263,P08588,BE0004872,Beta adrenergic receptor,Humans,agonist,yes
DB11288,Borneol,small molecule,experimental,CC1(C)C2CCC1(C)C(O)C2,DTGKSKDOIYIVQL-UHFFFAOYSA-N,154.2493,Q8NET8,BE0003416,Transient receptor potential cation channel subfamily V member 3,Humans,activator,yes
DB11315,Methscopolamine,small molecule,approved,C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1,LZCOQTDXKCNBEE-IKIFYQGPSA-N,318.392,P20309,BE0000045,Muscarinic acetylcholine receptor M3,Humans,antagonist,yes
DB11315,Methscopolamine,small molecule,approved,C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1,LZCOQTDXKCNBEE-IKIFYQGPSA-N,318.392,P08172,BE0000560,Muscarinic acetylcholine receptor M2,Humans,antagonist,yes
DB11323,Glycol salicylate,small molecule,approved,OCCOC(=O)C1=CC=CC=C1O,LVYLCBNXHHHPSB-UHFFFAOYSA-N,182.175,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,antagonist,yes
DB11323,Glycol salicylate,small molecule,approved,OCCOC(=O)C1=CC=CC=C1O,LVYLCBNXHHHPSB-UHFFFAOYSA-N,182.175,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,antagonist,yes
DB11324,Nonivamide,small molecule,investigational,CCCCCCCCC(=O)NCC1=CC(OC)=C(O)C=C1,RGOVYLWUIBMPGK-UHFFFAOYSA-N,293.4012,Q8NER1,BE0001023,Transient receptor potential cation channel subfamily V member 1,Humans,agonist,yes
DB11327,Dipyrithione,small molecule,approved,[O-][N+]1=CC=CC=C1SSC1=CC=CC=[N+]1[O-],ZHDBTKPXEJDTTQ-UHFFFAOYSA-N,252.31,P35228,BE0000005,"Nitric oxide synthase, inducible",Humans,antagonist,yes
DB11327,Dipyrithione,small molecule,approved,[O-][N+]1=CC=CC=C1SSC1=CC=CC=[N+]1[O-],ZHDBTKPXEJDTTQ-UHFFFAOYSA-N,252.31,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,,yes
DB11328,Tetradecyl hydrogen sulfate (ester),small molecule,approved,CCCCC(CC)CCC(CC(C)C)OS(O)(=O)=O,GROJOWHVXQYQGN-UHFFFAOYSA-N,294.45,Q9UNN8,BE0001161,Endothelial protein C receptor,Humans,antagonist,yes
DB11332,Sinapultide,small molecule,approved,CC(C)C[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O,QSIRXSYRKZHJHX-TWXHAJHVSA-N,2469.45,,BE0009352,Lung epithelial cells,Humans,agonist,yes
DB11345,(S)-camphor,small molecule,experimental,CC1(C)[C@H]2CC[C@]1(C)C(=O)C2,DSSYKIVIOFKYAU-OIBJUYFYSA-N,152.2334,Q8NER1,BE0001023,Transient receptor potential cation channel subfamily V member 1,Humans,agonist;activator,yes
DB11345,(S)-camphor,small molecule,experimental,CC1(C)[C@H]2CC[C@]1(C)C(=O)C2,DSSYKIVIOFKYAU-OIBJUYFYSA-N,152.2334,Q8NET8,BE0003416,Transient receptor potential cation channel subfamily V member 3,Humans,agonist;activator,yes
DB11345,(S)-camphor,small molecule,experimental,CC1(C)[C@H]2CC[C@]1(C)C(=O)C2,DSSYKIVIOFKYAU-OIBJUYFYSA-N,152.2334,O75762,BE0001122,Transient receptor potential cation channel subfamily A member 1,Humans,inhibitor,yes
DB11345,(S)-camphor,small molecule,experimental,CC1(C)[C@H]2CC[C@]1(C)C(=O)C2,DSSYKIVIOFKYAU-OIBJUYFYSA-N,152.2334,Q7Z2W7,BE0001186,Transient receptor potential cation channel subfamily M member 8,Humans,activator,yes
DB11362,Selexipag,small molecule,approved,CC(C)N(CCCCOCC(=O)NS(C)(=O)=O)C1=NC(C2=CC=CC=C2)=C(N=C1)C1=CC=CC=C1,QXWZQTURMXZVHJ-UHFFFAOYSA-N,496.63,P43119,BE0000475,Prostacyclin receptor,Humans,agonist,yes
DB11363,Alectinib,small molecule,approved;investigational,CCC1=CC2=C(C=C1N1CCC(CC1)N1CCOCC1)C(C)(C)C1=C(C3=CC=C(C=C3N1)C#N)C2=O,KDGFLJKFZUIJMX-UHFFFAOYSA-N,482.6166,Q9UM73,BE0000359,ALK tyrosine kinase receptor,Humans,inhibitor,yes
DB11365,Sennosides,small molecule,experimental,OCC1OC(OC2=C3C(=O)C4=C(C=C(C=C4O)C(O)=O)C(C4C5=CC=CC(OC6OC(CO)C(O)C(O)C6O)=C5C(=O)C5=C4C=C(C=C5O)C(O)=O)C3=CC=C2)C(O)C(O)C1O,IPQVTOJGNYVQEO-UHFFFAOYSA-N,862.746,Q92482,BE0009664,Aquaporin-3,Humans,inhibitor,yes
DB11366,Roquinimex,small molecule,investigational,CN(C(=O)C1=C(O)C2=C(C=CC=C2)N(C)C1=O)C1=CC=CC=C1,SGOOQMRIPALTEL-UHFFFAOYSA-N,308.337,P60568,BE0001029,Interleukin-2,Humans,modulator,yes
DB11367,Cefroxadine,small molecule,withdrawn,[H][C@]12SCC(OC)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CCC=CC1)C(O)=O,RDMOROXKXONCAL-UEKVPHQBSA-N,365.4,P02919,BE0000488,Penicillin-binding protein 1B,Escherichia coli (strain K12),inhibitor,yes
DB11376,Azaperone,small molecule,investigational;vet_approved,FC1=CC=C(C=C1)C(=O)CCCN1CCN(CC1)C1=CC=CC=N1,XTKDAFGWCDAMPY-UHFFFAOYSA-N,327.403,P35462,BE0000581,D(3) dopamine receptor,Humans,inhibitor,yes
DB11376,Azaperone,small molecule,investigational;vet_approved,FC1=CC=C(C=C1)C(=O)CCCN1CCN(CC1)C1=CC=CC=N1,XTKDAFGWCDAMPY-UHFFFAOYSA-N,327.403,P14416,BE0000756,D(2) dopamine receptor,Humans,inhibitor,yes
DB11393,Danofloxacin,small molecule,experimental;vet_approved,[H][C@]12CN(C3=C(F)C=C4C(=O)C(=CN(C5CC5)C4=C3)C(O)=O)[C@]([H])(CN1C)C2,QMLVECGLEOSESV-RYUDHWBXSA-N,357.385,P20831,BE0008385,DNA gyrase subunit A,Staphylococcus aureus,modulator,yes
DB11393,Danofloxacin,small molecule,experimental;vet_approved,[H][C@]12CN(C3=C(F)C=C4C(=O)C(=CN(C5CC5)C4=C3)C(O)=O)[C@]([H])(CN1C)C2,QMLVECGLEOSESV-RYUDHWBXSA-N,357.385,P0A0K8,BE0002388,DNA gyrase subunit B,Staphylococcus aureus,modulator,yes
DB11399,Dirlotapide,small molecule,investigational;vet_approved,CN(CC1=CC=CC=C1)C(=O)[C@@H](NC(=O)C1=CC2=C(C=CC(NC(=O)C3=CC=CC=C3C3=CC=C(C=C3)C(F)(F)F)=C2)N1C)C1=CC=CC=C1,TUOSYWCFRFNJBS-BHVANESWSA-N,674.724,P55157,BE0000232,Microsomal triglyceride transfer protein large subunit,Humans,inhibitor,yes
DB11425,Luprostiol,small molecule,experimental;vet_approved,O[C@H](COC1=CC(Cl)=CC=C1)CS[C@@H]1[C@@H](O)C[C@@H](O)[C@H]1C\C=C/CCCC(O)=O,KFUDFIMHDRJVLV-OZCLATTGSA-N,444.97,P10275,BE0000132,Androgen receptor,Humans,inhibitor,yes
DB11428,Medetomidine,small molecule,experimental;vet_approved,CC(C1=CN=CN1)C1=CC=CC(C)=C1C,CUHVIMMYOGQXCV-UHFFFAOYSA-N,200.2795,P08913,BE0000289,Alpha-2A adrenergic receptor,Humans,inhibitor,yes
DB11428,Medetomidine,small molecule,experimental;vet_approved,CC(C1=CN=CN1)C1=CC=CC(C)=C1C,CUHVIMMYOGQXCV-UHFFFAOYSA-N,200.2795,P35368,BE0000575,Alpha-1B adrenergic receptor,Humans,inhibitor,yes
DB11428,Medetomidine,small molecule,experimental;vet_approved,CC(C1=CN=CN1)C1=CC=CC(C)=C1C,CUHVIMMYOGQXCV-UHFFFAOYSA-N,200.2795,P25100,BE0000715,Alpha-1D adrenergic receptor,Humans,inhibitor,yes
DB11428,Medetomidine,small molecule,experimental;vet_approved,CC(C1=CN=CN1)C1=CC=CC(C)=C1C,CUHVIMMYOGQXCV-UHFFFAOYSA-N,200.2795,P18089,BE0000572,Alpha-2B adrenergic receptor,Humans,inhibitor,yes
DB11428,Medetomidine,small molecule,experimental;vet_approved,CC(C1=CN=CN1)C1=CC=CC(C)=C1C,CUHVIMMYOGQXCV-UHFFFAOYSA-N,200.2795,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,inhibitor,yes
DB11428,Medetomidine,small molecule,experimental;vet_approved,CC(C1=CN=CN1)C1=CC=CC(C)=C1C,CUHVIMMYOGQXCV-UHFFFAOYSA-N,200.2795,P18825,BE0000342,Alpha-2C adrenergic receptor,Humans,inhibitor,yes
DB11429,Mibolerone,small molecule,vet_approved,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3C[C@@H](C)[C@@]21[H],PTQMMNYJKCSPET-OMHQDGTGSA-N,302.458,P10275,BE0000132,Androgen receptor,Humans,agonist,yes
DB11431,Moxidectin,small molecule,approved;investigational;vet_approved,[H][C@@]12OC\C3=C/C=C/[C@H](C)C\C(C)=C\C[C@]4([H])C[C@@]([H])(C[C@]5(C\C(=N/OC)[C@H](C)[C@H](O5)C(\C)=C\C(C)C)O4)OC(=O)[C@]([H])(C=C(C)[C@H]1O)[C@@]23O,YZBLFMPOMVTDJY-LSGXYNIPSA-N,639.83,Q25634,BE0009555,Glutamate-gated chloride channel,Onchocerca volvulus,binder,yes
DB11431,Moxidectin,small molecule,approved;investigational;vet_approved,[H][C@@]12OC\C3=C/C=C/[C@H](C)C\C(C)=C\C[C@]4([H])C[C@@]([H])(C[C@]5(C\C(=N/OC)[C@H](C)[C@H](O5)C(\C)=C\C(C)C)O4)OC(=O)[C@]([H])(C=C(C)[C@H]1O)[C@@]23O,YZBLFMPOMVTDJY-LSGXYNIPSA-N,639.83,,BE0009556,GABA-A gated chloride channel,Onchocerca volvulus,binder,yes
DB11466,Tepoxalin,small molecule,vet_approved,COC1=CC=C(C=C1)N1N=C(CCC(=O)N(C)O)C=C1C1=CC=C(Cl)C=C1,XYKWNRUXCOIMFZ-UHFFFAOYSA-N,385.85,P05112,BE0003520,Interleukin-4,Humans,inhibitor,yes
DB11466,Tepoxalin,small molecule,vet_approved,COC1=CC=C(C=C1)N1N=C(CCC(=O)N(C)O)C=C1C1=CC=C(Cl)C=C1,XYKWNRUXCOIMFZ-UHFFFAOYSA-N,385.85,P09917,BE0000248,Polyunsaturated fatty acid 5-lipoxygenase,Humans,inhibitor,yes
DB11477,Xylazine,small molecule,vet_approved,CC1=CC=CC(C)=C1NC1=NCCCS1,BPICBUSOMSTKRF-UHFFFAOYSA-N,220.33,P18089,BE0000572,Alpha-2B adrenergic receptor,Humans,agonist,yes
DB11477,Xylazine,small molecule,vet_approved,CC1=CC=CC(C)=C1NC1=NCCCS1,BPICBUSOMSTKRF-UHFFFAOYSA-N,220.33,P18825,BE0000342,Alpha-2C adrenergic receptor,Humans,agonist,yes
DB11477,Xylazine,small molecule,vet_approved,CC1=CC=CC(C)=C1NC1=NCCCS1,BPICBUSOMSTKRF-UHFFFAOYSA-N,220.33,P08913,BE0004864,Alpha-2 adrenergic receptors,Humans,agonist,yes
DB11490,Nalorphine,small molecule,experimental;vet_approved,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC=C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,UIQMVEYFGZJHCZ-SSTWWWIQSA-N,311.381,P41145,BE0000632,Kappa-type opioid receptor,Humans,agonist,yes
DB11496,2-mercaptobenzothiazole,small molecule,approved;experimental;vet_approved,S=C1NC2=C(S1)C=CC=C2,YXIWHUQXZSMYRE-UHFFFAOYSA-N,167.251,P07202,BE0000507,Thyroid peroxidase,Humans,inhibitor,yes
DB11504,Caramiphen,small molecule,experimental;vet_approved,CCN(CC)CCOC(=O)C1(CCCC1)C1=CC=CC=C1,OFAIGZWCDGNZGT-UHFFFAOYSA-N,289.419,P08172,BE0000560,Muscarinic acetylcholine receptor M2,Humans,inhibitor,yes
DB11504,Caramiphen,small molecule,experimental;vet_approved,CCN(CC)CCOC(=O)C1(CCCC1)C1=CC=CC=C1,OFAIGZWCDGNZGT-UHFFFAOYSA-N,289.419,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,inhibitor,yes
DB11507,Cloprostenol,small molecule,vet_approved,[H]\C(CCCC(O)=O)=C(/[H])C[C@@]1([H])[C@@]([H])(O)C[C@@]([H])(O)[C@]1([H])C(\[H])=C(/[H])[C@@]([H])(O)COC1=CC=CC(Cl)=C1,VJGGHXVGBSZVMZ-QIZQQNKQSA-N,424.92,P34995,BE0000064,Prostaglandin E2 receptor EP1 subtype,Humans,agonist,yes
DB11507,Cloprostenol,small molecule,vet_approved,[H]\C(CCCC(O)=O)=C(/[H])C[C@@]1([H])[C@@]([H])(O)C[C@@]([H])(O)[C@]1([H])C(\[H])=C(/[H])[C@@]([H])(O)COC1=CC=CC(Cl)=C1,VJGGHXVGBSZVMZ-QIZQQNKQSA-N,424.92,P43088,BE0000610,Prostaglandin F2-alpha receptor,Humans,agonist,yes
DB11507,Cloprostenol,small molecule,vet_approved,[H]\C(CCCC(O)=O)=C(/[H])C[C@@]1([H])[C@@]([H])(O)C[C@@]([H])(O)[C@]1([H])C(\[H])=C(/[H])[C@@]([H])(O)COC1=CC=CC(Cl)=C1,VJGGHXVGBSZVMZ-QIZQQNKQSA-N,424.92,P43115,BE0002375,Prostaglandin E2 receptor EP3 subtype,Humans,agonist,yes
DB11507,Cloprostenol,small molecule,vet_approved,[H]\C(CCCC(O)=O)=C(/[H])C[C@@]1([H])[C@@]([H])(O)C[C@@]([H])(O)[C@]1([H])C(\[H])=C(/[H])[C@@]([H])(O)COC1=CC=CC(Cl)=C1,VJGGHXVGBSZVMZ-QIZQQNKQSA-N,424.92,P21731,BE0000759,Thromboxane A2 receptor,Humans,agonist,yes
DB11507,Cloprostenol,small molecule,vet_approved,[H]\C(CCCC(O)=O)=C(/[H])C[C@@]1([H])[C@@]([H])(O)C[C@@]([H])(O)[C@]1([H])C(\[H])=C(/[H])[C@@]([H])(O)COC1=CC=CC(Cl)=C1,VJGGHXVGBSZVMZ-QIZQQNKQSA-N,424.92,Q13258,BE0000296,Prostaglandin D2 receptor,Humans,agonist,yes
DB11519,Fluprostenol,small molecule,vet_approved,[H]\C(CCCC(O)=O)=C(/[H])C[C@@]1([H])[C@@]([H])(O)C[C@@]([H])(O)[C@]1([H])C(\[H])=C(/[H])[C@@]([H])(O)COC1=CC=CC(=C1)C(F)(F)F,WWSWYXNVCBLWNZ-QIZQQNKQSA-N,458.474,P21731,BE0000759,Thromboxane A2 receptor,Humans,agonist,yes
DB11519,Fluprostenol,small molecule,vet_approved,[H]\C(CCCC(O)=O)=C(/[H])C[C@@]1([H])[C@@]([H])(O)C[C@@]([H])(O)[C@]1([H])C(\[H])=C(/[H])[C@@]([H])(O)COC1=CC=CC(=C1)C(F)(F)F,WWSWYXNVCBLWNZ-QIZQQNKQSA-N,458.474,P43115,BE0002375,Prostaglandin E2 receptor EP3 subtype,Humans,agonist,yes
DB11519,Fluprostenol,small molecule,vet_approved,[H]\C(CCCC(O)=O)=C(/[H])C[C@@]1([H])[C@@]([H])(O)C[C@@]([H])(O)[C@]1([H])C(\[H])=C(/[H])[C@@]([H])(O)COC1=CC=CC(=C1)C(F)(F)F,WWSWYXNVCBLWNZ-QIZQQNKQSA-N,458.474,P43088,BE0000610,Prostaglandin F2-alpha receptor,Humans,agonist,yes
DB11521,Imidocarb,small molecule,vet_approved,O=C(NC1=CC=CC(=C1)C1=NCCN1)NC1=CC=CC(=C1)C1=NCCN1,SCEVFJUWLLRELN-UHFFFAOYSA-N,348.41,P22303,BE0000426,Acetylcholinesterase,Humans,inhibitor,yes
DB11526,Masitinib,small molecule,investigational;vet_approved,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC(=CS3)C3=CN=CC=C3)=C2)CC1,WJEOLQLKVOPQFV-UHFFFAOYSA-N,498.65,P12931,BE0000838,Proto-oncogene tyrosine-protein kinase Src,Humans,inhibitor,yes
DB11560,Lesinurad,small molecule,approved;investigational,OC(=O)CSC1=NN=C(Br)N1C1=CC=C(C2CC2)C2=C1C=CC=C2,FGQFOYHRJSUHMR-UHFFFAOYSA-N,404.28,Q96S37,BE0004782,Solute carrier family 22 member 12,Humans,inhibitor,yes
DB11560,Lesinurad,small molecule,approved;investigational,OC(=O)CSC1=NN=C(Br)N1C1=CC=C(C2CC2)C2=C1C=CC=C2,FGQFOYHRJSUHMR-UHFFFAOYSA-N,404.28,Q9NSA0,BE0000879,Solute carrier family 22 member 11,Humans,inhibitor,yes
DB11574,Elbasvir,small molecule,approved,[H][C@]1(CCCN1C(=O)[C@@H](NC(=O)OC)C(C)C)C1=NC=C(N1)C1=CC2=C(C=C1)N1[C@@H](OC3=C(C=CC(=C3)C3=CN=C(N3)[C@]3([H])CCCN3C(=O)[C@@H](NC(=O)OC)C(C)C)C1=C2)C1=CC=CC=C1,BVAZQCUMNICBAQ-PZHYSIFUSA-N,882.035,Q5L478,BE0008651,Nonstructural protein 5A,Hepatitis C Virus,inhibitor,yes
DB11575,Grazoprevir,small molecule,approved,COC1=CC2=NC3=C(CCCCC[C@@H]4C[C@H]4OC(=O)N[C@H](C(=O)N4C[C@@H](C[C@H]4C(=O)N[C@@]4(C[C@H]4C=C)C(=O)NS(=O)(=O)C4CC4)O3)C(C)(C)C)N=C2C=C1,OBMNJSNZOWALQB-NCQNOWPTSA-N,766.903,B0B3C9,BE0004701,Genome polyprotein,Hepatitis C Virus,antagonist,yes
DB11581,Venetoclax,small molecule,approved;investigational,CC1(C)CCC(CN2CCN(CC2)C2=CC=C(C(=O)NS(=O)(=O)C3=CC=C(NCC4CCOCC4)C(=C3)[N+]([O-])=O)C(OC3=CN=C4NC=CC4=C3)=C2)=C(C1)C1=CC=C(Cl)C=C1,LQBVNQSMGBZMKD-UHFFFAOYSA-N,868.45,P10415,BE0000246,Apoptosis regulator Bcl-2,Humans,antagonist;inhibitor,yes
DB11582,Thiocolchicoside,small molecule,experimental,COC1=C(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C2CC[C@H](NC(C)=O)C3=CC(=O)C(SC)=CC=C3C2=C1OC,LEQAKWQJCITZNK-AXHKHJLKSA-N,563.62,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,inhibitor,yes
DB11582,Thiocolchicoside,small molecule,experimental,COC1=C(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C2CC[C@H](NC(C)=O)C3=CC(=O)C(SC)=CC=C3C2=C1OC,LEQAKWQJCITZNK-AXHKHJLKSA-N,563.62,P47870,BE0002346,Gamma-aminobutyric acid receptor subunit beta-2,Humans,inhibitor,yes
DB11582,Thiocolchicoside,small molecule,experimental,COC1=C(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C2CC[C@H](NC(C)=O)C3=CC(=O)C(SC)=CC=C3C2=C1OC,LEQAKWQJCITZNK-AXHKHJLKSA-N,563.62,P23416,BE0000745,Glycine receptor subunit alpha-2,Humans,inhibitor,yes
DB11582,Thiocolchicoside,small molecule,experimental,COC1=C(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C2CC[C@H](NC(C)=O)C3=CC(=O)C(SC)=CC=C3C2=C1OC,LEQAKWQJCITZNK-AXHKHJLKSA-N,563.62,O75311,BE0000414,Glycine receptor subunit alpha-3,Humans,inhibitor,yes
DB11582,Thiocolchicoside,small molecule,experimental,COC1=C(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C2CC[C@H](NC(C)=O)C3=CC(=O)C(SC)=CC=C3C2=C1OC,LEQAKWQJCITZNK-AXHKHJLKSA-N,563.62,P48167,BE0000055,Glycine receptor subunit beta,Humans,inhibitor,yes
DB11582,Thiocolchicoside,small molecule,experimental,COC1=C(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C2CC[C@H](NC(C)=O)C3=CC(=O)C(SC)=CC=C3C2=C1OC,LEQAKWQJCITZNK-AXHKHJLKSA-N,563.62,P18507,BE0003592,Gamma-aminobutyric acid receptor subunit gamma-2,Humans,inhibitor,yes
DB11582,Thiocolchicoside,small molecule,experimental,COC1=C(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C2CC[C@H](NC(C)=O)C3=CC(=O)C(SC)=CC=C3C2=C1OC,LEQAKWQJCITZNK-AXHKHJLKSA-N,563.62,P14867,BE0004797,GABA(A) Receptor,Humans,antagonist,yes
DB11584,Pipradrol,small molecule,approved,[H]N1CCCCC1C(O)(C1=CC=CC=C1)C1=CC=CC=C1,XSWHNYGMWWVAIE-UHFFFAOYSA-N,267.372,P21728,BE0004889,D(1) dopamine receptor,Humans,agonist,yes
DB11586,Asunaprevir,small molecule,approved;investigational;withdrawn,COC1=CN=C(O[C@@H]2C[C@H](N(C2)C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)N[C@@]2(C[C@H]2C=C)C(=O)NS(=O)(=O)C2CC2)C2=C1C=CC(Cl)=C2,XRWSZZJLZRKHHD-WVWIJVSJSA-N,748.286,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB11586,Asunaprevir,small molecule,approved;investigational;withdrawn,COC1=CN=C(O[C@@H]2C[C@H](N(C2)C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)N[C@@]2(C[C@H]2C=C)C(=O)NS(=O)(=O)C2CC2)C2=C1C=CC(Cl)=C2,XRWSZZJLZRKHHD-WVWIJVSJSA-N,748.286,P26663,BE0001478,Genome polyprotein,Hepatitis C virus genotype 1b (isolate BK),inhibitor,yes
DB11587,Etafedrine,small molecule,approved,CCN(C)[C@@H](C)[C@H](O)C1=CC=CC=C1,IRVLBORJKFZWMI-JQWIXIFHSA-N,193.29,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,agonist,yes
DB11591,Bilastine,small molecule,approved;investigational,CCOCCN1C(=NC2=CC=CC=C12)C1CCN(CCC2=CC=C(C=C2)C(C)(C)C(O)=O)CC1,ACCMWZWAEFYUGZ-UHFFFAOYSA-N,463.622,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB11611,Lifitegrast,small molecule,approved,CS(=O)(=O)C1=CC(C[C@H](NC(=O)C2=C(Cl)C3=C(CN(CC3)C(=O)C3=CC=C4C=COC4=C3)C=C2Cl)C(O)=O)=CC=C1,JFOZKMSJYSPYLN-QHCPKHFHSA-N,615.48,P05362,BE0001085,Intercellular adhesion molecule 1,Humans,inhibitor,yes
DB11611,Lifitegrast,small molecule,approved,CS(=O)(=O)C1=CC(C[C@H](NC(=O)C2=C(Cl)C3=C(CN(CC3)C(=O)C3=CC=C4C=COC4=C3)C=C2Cl)C(O)=O)=CC=C1,JFOZKMSJYSPYLN-QHCPKHFHSA-N,615.48,P20701,BE0000516,Integrin alpha-L,Humans,antagonist,yes
DB11613,Velpatasvir,small molecule,approved;investigational,COC[C@H]1C[C@H](N(C1)C(=O)[C@H](NC(=O)OC)C1=CC=CC=C1)C1=NC=C(N1)C1=CC=C2C(COC3=CC4=C(C=CC5=C4NC(=N5)[C@@H]4CC[C@H](C)N4C(=O)[C@@H](NC(=O)OC)C(C)C)C=C23)=C1,FHCUMDQMBHQXKK-CDIODLITSA-N,883.019,Q5L478,BE0008651,Nonstructural protein 5A,Hepatitis C Virus,inhibitor,yes
DB11614,Rupatadine,small molecule,approved,CC1=CC(CN2CCC(CC2)=C2C3=CC=C(Cl)C=C3CCC3=C2N=CC=C3)=CN=C1,WUZYKBABMWJHDL-UHFFFAOYSA-N,415.97,P25105,BE0005561,Platelet-activating factor receptor,Humans,antagonist,yes
DB11614,Rupatadine,small molecule,approved,CC1=CC(CN2CCC(CC2)=C2C3=CC=C(Cl)C=C3CCC3=C2N=CC=C3)=CN=C1,WUZYKBABMWJHDL-UHFFFAOYSA-N,415.97,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB11617,Aclarubicin,small molecule,investigational,CC[C@@]1(O)C[C@H](O[C@H]2C[C@@H]([C@H](O[C@H]3C[C@H](O)[C@H](O[C@H]4CCC(=O)[C@H](C)O4)[C@H](C)O3)[C@H](C)O2)N(C)C)C2=C(O)C3=C(C=C2[C@H]1C(=O)OC)C(=O)C1=C(C(O)=CC=C1)C3=O,USZYSDMBJDPRIF-SVEJIMAYSA-N,811.878,P11388,BE0000742,DNA topoisomerase 2-alpha,Humans,inhibitor,yes
DB11617,Aclarubicin,small molecule,investigational,CC[C@@]1(O)C[C@H](O[C@H]2C[C@@H]([C@H](O[C@H]3C[C@H](O)[C@H](O[C@H]4CCC(=O)[C@H](C)O4)[C@H](C)O3)[C@H](C)O2)N(C)C)C2=C(O)C3=C(C=C2[C@H]1C(=O)OC)C(=O)C1=C(C(O)=CC=C1)C3=O,USZYSDMBJDPRIF-SVEJIMAYSA-N,811.878,Q02880,BE0002425,DNA topoisomerase 2-beta,Humans,inhibitor,yes
DB11619,Gestrinone,small molecule,approved,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)C=CC1=C3CCC(=O)C=C3CC[C@@]21[H],BJJXHLWLUDYTGC-ANULTFPQSA-N,308.4141,P06401,BE0000557,Progesterone receptor,Humans,antagonist;agonist,yes
DB11619,Gestrinone,small molecule,approved,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)C=CC1=C3CCC(=O)C=C3CC[C@@]21[H],BJJXHLWLUDYTGC-ANULTFPQSA-N,308.4141,P04150,BE0000794,Glucocorticoid receptor,Humans,antagonist,yes
DB11619,Gestrinone,small molecule,approved,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)C=CC1=C3CCC(=O)C=C3CC[C@@]21[H],BJJXHLWLUDYTGC-ANULTFPQSA-N,308.4141,P10275,BE0000132,Androgen receptor,Humans,antagonist,yes
DB11619,Gestrinone,small molecule,approved,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)C=CC1=C3CCC(=O)C=C3CC[C@@]21[H],BJJXHLWLUDYTGC-ANULTFPQSA-N,308.4141,P30968,BE0000203,Gonadotropin-releasing hormone receptor,Humans,antagonist,yes
DB11619,Gestrinone,small molecule,approved,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)C=CC1=C3CCC(=O)C=C3CC[C@@]21[H],BJJXHLWLUDYTGC-ANULTFPQSA-N,308.4141,P03372,BE0000123,Estrogen receptor,Humans,antagonist;agonist,yes
DB11620,Neridronic Acid,small molecule,experimental;investigational,NCCCCCC(O)(P(O)(O)=O)P(O)(O)=O,PUUSSSIBPPTKTP-UHFFFAOYSA-N,277.15,P14324,BE0000776,Farnesyl pyrophosphate synthase,Humans,inhibitor,yes
DB11623,Candoxatrilat,small molecule,experimental,COCCOC[C@H](CC1(CCCC1)C(=O)N[C@H]1CC[C@H](CC1)C(O)=O)C(O)=O,ACZWIDANLCXHBM-HRCADAONSA-N,399.484,P08473,BE0000266,Neprilysin,Humans,inhibitor,yes
DB11629,Laropiprant,small molecule,approved;investigational;withdrawn,CS(=O)(=O)C1=C2N(CC3=CC=C(Cl)C=C3)C3=C(CC[C@@H]3CC(O)=O)C2=CC(F)=C1,NXFFJDQHYLNEJK-CYBMUJFWSA-N,435.89,P43116,BE0000368,Prostaglandin E2 receptor EP2 subtype,Humans,inhibitor,yes
DB11629,Laropiprant,small molecule,approved;investigational;withdrawn,CS(=O)(=O)C1=C2N(CC3=CC=C(Cl)C=C3)C3=C(CC[C@@H]3CC(O)=O)C2=CC(F)=C1,NXFFJDQHYLNEJK-CYBMUJFWSA-N,435.89,P04035,BE0000574,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Humans,inhibitor,yes
DB11629,Laropiprant,small molecule,approved;investigational;withdrawn,CS(=O)(=O)C1=C2N(CC3=CC=C(Cl)C=C3)C3=C(CC[C@@H]3CC(O)=O)C2=CC(F)=C1,NXFFJDQHYLNEJK-CYBMUJFWSA-N,435.89,P21731,BE0000759,Thromboxane A2 receptor,Humans,inhibitor,yes
DB11629,Laropiprant,small molecule,approved;investigational;withdrawn,CS(=O)(=O)C1=C2N(CC3=CC=C(Cl)C=C3)C3=C(CC[C@@H]3CC(O)=O)C2=CC(F)=C1,NXFFJDQHYLNEJK-CYBMUJFWSA-N,435.89,Q13258,BE0000296,Prostaglandin D2 receptor,Humans,inhibitor,yes
DB11629,Laropiprant,small molecule,approved;investigational;withdrawn,CS(=O)(=O)C1=C2N(CC3=CC=C(Cl)C=C3)C3=C(CC[C@@H]3CC(O)=O)C2=CC(F)=C1,NXFFJDQHYLNEJK-CYBMUJFWSA-N,435.89,P43119,BE0000475,Prostacyclin receptor,Humans,inhibitor,yes
DB11629,Laropiprant,small molecule,approved;investigational;withdrawn,CS(=O)(=O)C1=C2N(CC3=CC=C(Cl)C=C3)C3=C(CC[C@@H]3CC(O)=O)C2=CC(F)=C1,NXFFJDQHYLNEJK-CYBMUJFWSA-N,435.89,Q9Y5Y4,BE0003561,Prostaglandin D2 receptor 2,Humans,inhibitor,yes
DB11629,Laropiprant,small molecule,approved;investigational;withdrawn,CS(=O)(=O)C1=C2N(CC3=CC=C(Cl)C=C3)C3=C(CC[C@@H]3CC(O)=O)C2=CC(F)=C1,NXFFJDQHYLNEJK-CYBMUJFWSA-N,435.89,P43088,BE0000610,Prostaglandin F2-alpha receptor,Humans,inhibitor,yes
DB11632,Opicapone,small molecule,approved;investigational,CC1=C(C2=NOC(=N2)C2=CC(=C(O)C(O)=C2)[N+]([O-])=O)C(Cl)=[N+]([O-])C(C)=C1Cl,ASOADIZOVZTJSR-UHFFFAOYSA-N,413.17,P21964,BE0002089,Catechol O-methyltransferase,Humans,inhibitor,yes
DB11633,Isavuconazole,small molecule,approved;investigational,C[C@@H](C1=NC(=CS1)C1=CC=C(C=C1)C#N)[C@](O)(CN1C=NC=N1)C1=C(F)C=CC(F)=C1,DDFOUSQFMYRUQK-RCDICMHDSA-N,437.47,P50859,BE0000690,Lanosterol 14-alpha demethylase,,inhibitor,yes
DB11641,Vinflunine,small molecule,approved;investigational,CC[C@@]12C=CCN3CC[C@@]4([C@H]13)[C@@H](N(C)C1=CC(OC)=C(C=C41)[C@]1(C[C@@H]3C[C@H](C[N@@](C3)CC3=C1NC1=CC=CC=C31)C(C)(F)F)C(=O)OC)[C@](O)([C@@H]2OC(C)=O)C(=O)OC,NMDYYWFGPIMTKO-KLCPSUAYSA-N,816.944,P07437,BE0000143,Tubulin beta chain,Humans,inhibitor,yes
DB11642,Pitolisant,small molecule,approved;investigational,ClC1=CC=C(CCCOCCCN2CCCCC2)C=C1,NNACHAUCXXVJSP-UHFFFAOYSA-N,295.85,Q9Y5N1,BE0000968,Histamine H3 receptor,Humans,antagonist;inverse agonist,yes
DB11644,Tafamidis,small molecule,approved;investigational,OC(=O)C1=CC=C2N=C(OC2=C1)C1=CC(Cl)=CC(Cl)=C1,TXEIIPDJKFWEEC-UHFFFAOYSA-N,308.116,P02766,BE0000337,Transthyretin,Humans,chaperone,yes
DB11645,PF-4191834,small molecule,investigational,CN1N=CC=C1C1=CC=C(SC2=CC=CC(=C2)C2(CCOCC2)C(N)=O)C=C1,DVNQWYLVSNPCJZ-UHFFFAOYSA-N,393.51,P09917,BE0000248,Polyunsaturated fatty acid 5-lipoxygenase,Humans,inhibitor,yes
DB11647,Incyclinide,small molecule,investigational,[H][C@@]12CC3=C(C(O)=CC=C3)C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)C[C@]1([H])C2,ZXFCRFYULUUSDW-OWXODZSWSA-N,371.345,P08253,BE0000642,72 kDa type IV collagenase,Humans,inhibitor,yes
DB11648,Afuresertib,small molecule,investigational,CN1N=CC(Cl)=C1C1=C(Cl)SC(=C1)C(=O)N[C@H](CN)CC1=CC=CC(F)=C1,AFJRDFWMXUECEW-LBPRGKRZSA-N,427.32,P31749,BE0000428,RAC-alpha serine/threonine-protein kinase,Humans,modulator,yes
DB11649,Lersivirine,small molecule,investigational,CCC1=NN(CCO)C(CC)=C1OC1=CC(=CC(=C1)C#N)C#N,MCPUZZJBAHRIPO-UHFFFAOYSA-N,310.3504,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB11650,HT-0712,small molecule,investigational,COC1=CC=C(C=C1OC1CCCC1)[C@H]1CNC(=O)[C@H](CC2=CC(C)=CC=C2)C1,ABEJDMOBAFLQNJ-NHCUHLMSSA-N,393.527,Q08499,BE0001287,"3',5'-cyclic-AMP phosphodiesterase 4D",Humans,inhibitor,yes
DB11650,HT-0712,small molecule,investigational,COC1=CC=C(C=C1OC1CCCC1)[C@H]1CNC(=O)[C@H](CC2=CC(C)=CC=C2)C1,ABEJDMOBAFLQNJ-NHCUHLMSSA-N,393.527,P27815,BE0001133,"3',5'-cyclic-AMP phosphodiesterase 4A",Humans,inhibitor,yes
DB11650,HT-0712,small molecule,investigational,COC1=CC=C(C=C1OC1CCCC1)[C@H]1CNC(=O)[C@H](CC2=CC(C)=CC=C2)C1,ABEJDMOBAFLQNJ-NHCUHLMSSA-N,393.527,Q07343,BE0000487,"3',5'-cyclic-AMP phosphodiesterase 4B",Humans,inhibitor,yes
DB11651,Dactolisib,small molecule,investigational,CN1C(=O)N(C2=C1C=NC1=CC=C(C=C21)C1=CN=C2C=CC=CC2=C1)C1=CC=C(C=C1)C(C)(C)C#N,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,469.548,P42345,BE0002386,Serine/threonine-protein kinase mTOR,Humans,modulator,yes
DB11651,Dactolisib,small molecule,investigational,CN1C(=O)N(C2=C1C=NC1=CC=C(C=C21)C1=CN=C2C=CC=CC2=C1)C1=CC=C(C=C1)C(C)(C)C#N,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,469.548,P48736,BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",Humans,modulator,yes
DB11652,Tucatinib,small molecule,approved;investigational,CC1=CC(NC2=NC=NC3=CC=C(NC4=NC(C)(C)CO4)C=C23)=CC=C1OC1=CC2=NC=NN2C=C1,SDEAXTCZPQIFQM-UHFFFAOYSA-N,480.532,P04626,BE0000511,Receptor tyrosine-protein kinase erbB-2,Humans,inhibitor,yes
DB11655,Evacetrapib,small molecule,investigational,CN1N=NC(=N1)N(CC1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)[C@H]1CCCN(C[C@H]2CC[C@@H](CC2)C(O)=O)C2=C1C=C(C)C=C2C,IHIUGIVXARLYHP-YBXDKENTSA-N,638.659,P11597,BE0003516,Cholesteryl ester transfer protein,Humans,inhibitor,yes
DB11656,Rebamipide,small molecule,approved;investigational,OC(=O)C(CC1=CC(=O)NC2=C1C=CC=C2)NC(=O)C1=CC=C(Cl)C=C1,ALLWOAVDORUJLA-UHFFFAOYSA-N,370.79,P21462,BE0000995,fMet-Leu-Phe receptor,Humans,antagonist,yes
DB11658,QAV-680,small molecule,investigational,CC1=C(CC(O)=O)C2=CC=CN=C2N1CC1=CC=C(C=C1)S(C)(=O)=O,YOPFAMROKXHVCQ-UHFFFAOYSA-N,358.41,Q9Y5Y4,BE0003561,Prostaglandin D2 receptor 2,Humans,antagonist,yes
DB11660,Latanoprostene bunod,small molecule,approved;investigational,O[C@H](CC[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(=O)OCCCCO[N+]([O-])=O)CCC1=CC=CC=C1,LOVMMUBRQUFEAH-UIEAZXIASA-N,507.624,P43088,BE0000610,Prostaglandin F2-alpha receptor,Humans,agonist,yes
DB11662,Rabusertib,small molecule,investigational,CC1=NC=C(NC(=O)NC2=C(OC[C@@H]3CNCCO3)C=C(C)C(Br)=C2)N=C1,SYYBDNPGDKKJDU-ZDUSSCGKSA-N,436.31,O14757,BE0003382,Serine/threonine-protein kinase Chk1,Humans,modulator,yes
DB11663,Pictilisib,small molecule,investigational,CS(=O)(=O)N1CCN(CC2=CC3=C(S2)C(=NC(=N3)C2=C3C=NNC3=CC=C2)N2CCOCC2)CC1,LHNIIDJUOCFXAP-UHFFFAOYSA-N,513.636,P48736,BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",Humans,inhibitor,yes
DB11665,BMS-690514,small molecule,investigational,COC1=CC=CC(NC2=NC=NN3C=CC(CN4CC[C@@H](N)[C@H](O)C4)=C23)=C1,CSGQVNMSRKWUSH-IAGOWNOFSA-N,368.441,P35968,BE0000369,Vascular endothelial growth factor receptor 2,Humans,inhibitor,yes
DB11665,BMS-690514,small molecule,investigational,COC1=CC=CC(NC2=NC=NN3C=CC(CN4CC[C@@H](N)[C@H](O)C4)=C23)=C1,CSGQVNMSRKWUSH-IAGOWNOFSA-N,368.441,P00533,BE0000767,Epidermal growth factor receptor,Humans,inhibitor,yes
DB11665,BMS-690514,small molecule,investigational,COC1=CC=CC(NC2=NC=NN3C=CC(CN4CC[C@@H](N)[C@H](O)C4)=C23)=C1,CSGQVNMSRKWUSH-IAGOWNOFSA-N,368.441,P04626,BE0000511,Receptor tyrosine-protein kinase erbB-2,Humans,inhibitor,yes
DB11665,BMS-690514,small molecule,investigational,COC1=CC=CC(NC2=NC=NN3C=CC(CN4CC[C@@H](N)[C@H](O)C4)=C23)=C1,CSGQVNMSRKWUSH-IAGOWNOFSA-N,368.441,P36888,BE0000147,Receptor-type tyrosine-protein kinase FLT3,Humans,inhibitor,yes
DB11666,Buparlisib,small molecule,investigational,NC1=CC(=C(C=N1)C1=NC(=NC(=C1)N1CCOCC1)N1CCOCC1)C(F)(F)F,CWHUFRVAEUJCEF-UHFFFAOYSA-N,410.3935,O00329,BE0002406,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",Humans,inhibitor,yes
DB11666,Buparlisib,small molecule,investigational,NC1=CC(=C(C=N1)C1=NC(=NC(=C1)N1CCOCC1)N1CCOCC1)C(F)(F)F,CWHUFRVAEUJCEF-UHFFFAOYSA-N,410.3935,P48736,BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",Humans,inhibitor,yes
DB11666,Buparlisib,small molecule,investigational,NC1=CC(=C(C=N1)C1=NC(=NC(=C1)N1CCOCC1)N1CCOCC1)C(F)(F)F,CWHUFRVAEUJCEF-UHFFFAOYSA-N,410.3935,P42338,BE0002407,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",Humans,inhibitor,yes
DB11666,Buparlisib,small molecule,investigational,NC1=CC(=C(C=N1)C1=NC(=NC(=C1)N1CCOCC1)N1CCOCC1)C(F)(F)F,CWHUFRVAEUJCEF-UHFFFAOYSA-N,410.3935,P42336,BE0002379,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",Humans,inhibitor,yes
DB11669,Ortataxel,small molecule,investigational,CC(C)C[C@H](NC(=O)OC(C)(C)C)[C@@H](O)C(=O)O[C@H]1[C@@H]2OC(=O)O[C@@]22[C@@H](OC(=O)C3=CC=CC=C3)[C@@H]3[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C(=C1C)C2(C)C)OC(C)=O,BWKDAMBGCPRVPI-ZQRPHVBESA-N,871.93,P01375,BE0000704,Tumor necrosis factor,Humans,inhibitor,yes
DB11671,AZD-4877,small molecule,investigational,CC(C)C(N(CCCN)C(=O)C1=CC=C(C)C=C1)C1=NC2=C(C(C)=NS2)C(=O)N1CC1=CC=CC=C1,SMFXSYMLJDHGIE-UHFFFAOYSA-N,503.67,P52732,BE0001852,Kinesin-like protein KIF11,Humans,inhibitor,yes
DB11672,Curcumin,small molecule,approved;investigational,COC1=CC(\C=C\C(=O)CC(=O)\C=C\C2=CC(OC)=C(O)C=C2)=CC=C1O,VFLDPWHFBUODDF-FCXRPNKRSA-N,368.3799,P08684,BE0002638,Cytochrome P450 3A4,Humans,inhibitor,yes
DB11672,Curcumin,small molecule,approved;investigational,COC1=CC(\C=C\C(=O)CC(=O)\C=C\C2=CC(OC)=C(O)C=C2)=CC=C1O,VFLDPWHFBUODDF-FCXRPNKRSA-N,368.3799,P35228,BE0000005,"Nitric oxide synthase, inducible",Humans,inhibitor,yes
DB11672,Curcumin,small molecule,approved;investigational,COC1=CC(\C=C\C(=O)CC(=O)\C=C\C2=CC(OC)=C(O)C=C2)=CC=C1O,VFLDPWHFBUODDF-FCXRPNKRSA-N,368.3799,Q9ULX7,BE0003634,Carbonic anhydrase 14,Humans,inhibitor,yes
DB11672,Curcumin,small molecule,approved;investigational,COC1=CC(\C=C\C(=O)CC(=O)\C=C\C2=CC(OC)=C(O)C=C2)=CC=C1O,VFLDPWHFBUODDF-FCXRPNKRSA-N,368.3799,P00915,BE0000267,Carbonic anhydrase 1,Humans,inhibitor,yes
DB11672,Curcumin,small molecule,approved;investigational,COC1=CC(\C=C\C(=O)CC(=O)\C=C\C2=CC(OC)=C(O)C=C2)=CC=C1O,VFLDPWHFBUODDF-FCXRPNKRSA-N,368.3799,P45452,BE0000966,Collagenase 3,Humans,inhibitor,yes
DB11672,Curcumin,small molecule,approved;investigational,COC1=CC(\C=C\C(=O)CC(=O)\C=C\C2=CC(OC)=C(O)C=C2)=CC=C1O,VFLDPWHFBUODDF-FCXRPNKRSA-N,368.3799,Q9UBC3,BE0010009,DNA (cytosine-5)-methyltransferase 3B,Humans,inhibitor,yes
DB11672,Curcumin,small molecule,approved;investigational,COC1=CC(\C=C\C(=O)CC(=O)\C=C\C2=CC(OC)=C(O)C=C2)=CC=C1O,VFLDPWHFBUODDF-FCXRPNKRSA-N,368.3799,P47989,BE0002204,Xanthine dehydrogenase/oxidase,Humans,inhibitor,yes
DB11672,Curcumin,small molecule,approved;investigational,COC1=CC(\C=C\C(=O)CC(=O)\C=C\C2=CC(OC)=C(O)C=C2)=CC=C1O,VFLDPWHFBUODDF-FCXRPNKRSA-N,368.3799,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB11672,Curcumin,small molecule,approved;investigational,COC1=CC(\C=C\C(=O)CC(=O)\C=C\C2=CC(OC)=C(O)C=C2)=CC=C1O,VFLDPWHFBUODDF-FCXRPNKRSA-N,368.3799,P14780,BE0000058,Matrix metalloproteinase-9,Humans,inhibitor,yes
DB11672,Curcumin,small molecule,approved;investigational,COC1=CC(\C=C\C(=O)CC(=O)\C=C\C2=CC(OC)=C(O)C=C2)=CC=C1O,VFLDPWHFBUODDF-FCXRPNKRSA-N,368.3799,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB11672,Curcumin,small molecule,approved;investigational,COC1=CC(\C=C\C(=O)CC(=O)\C=C\C2=CC(OC)=C(O)C=C2)=CC=C1O,VFLDPWHFBUODDF-FCXRPNKRSA-N,368.3799,P22748,BE0000535,Carbonic anhydrase 4,Humans,inhibitor,yes
DB11672,Curcumin,small molecule,approved;investigational,COC1=CC(\C=C\C(=O)CC(=O)\C=C\C2=CC(OC)=C(O)C=C2)=CC=C1O,VFLDPWHFBUODDF-FCXRPNKRSA-N,368.3799,P05067,BE0003392,Amyloid-beta precursor protein,Humans,inhibitor,yes
DB11672,Curcumin,small molecule,approved;investigational,COC1=CC(\C=C\C(=O)CC(=O)\C=C\C2=CC(OC)=C(O)C=C2)=CC=C1O,VFLDPWHFBUODDF-FCXRPNKRSA-N,368.3799,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB11672,Curcumin,small molecule,approved;investigational,COC1=CC(\C=C\C(=O)CC(=O)\C=C\C2=CC(OC)=C(O)C=C2)=CC=C1O,VFLDPWHFBUODDF-FCXRPNKRSA-N,368.3799,O43570,BE0001653,Carbonic anhydrase 12,Humans,inhibitor,yes
DB11672,Curcumin,small molecule,approved;investigational,COC1=CC(\C=C\C(=O)CC(=O)\C=C\C2=CC(OC)=C(O)C=C2)=CC=C1O,VFLDPWHFBUODDF-FCXRPNKRSA-N,368.3799,P23280,BE0003628,Carbonic anhydrase 6,Humans,inhibitor,yes
DB11672,Curcumin,small molecule,approved;investigational,COC1=CC(\C=C\C(=O)CC(=O)\C=C\C2=CC(OC)=C(O)C=C2)=CC=C1O,VFLDPWHFBUODDF-FCXRPNKRSA-N,368.3799,Q16790,BE0002437,Carbonic anhydrase 9,Humans,inhibitor,yes
DB11673,Pyridoxamine,small molecule,investigational,CC1=C(O)C(CN)=C(CO)C=N1,NHZMQXZHNVQTQA-UHFFFAOYSA-N,168.1931,Q15109,BE0010032,Advanced glycosylation end product-specific receptor,Humans,inhibitor,yes
DB11674,Equol,small molecule,investigational,OC1=CC=C(C=C1)[C@H]1COC2=C(C1)C=CC(O)=C2,ADFCQWZHKCXPAJ-GFCCVEGCSA-N,242.2699,Q92731,BE0000792,Estrogen receptor beta,Humans,agonist,yes
DB11675,Mosapride,small molecule,investigational,CCOC1=CC(N)=C(Cl)C=C1C(=O)NCC1CN(CC2=CC=C(F)C=C2)CCO1,YPELFRMCRYSPKZ-UHFFFAOYSA-N,421.9,Q13639,BE0000084,5-hydroxytryptamine receptor 4,Humans,agonist,yes
DB11676,Galidesivir,small molecule,investigational,[H][C@]1(N[C@H](CO)[C@@H](O)[C@H]1O)C1=CNC2=C1N=CN=C2N,AMFDITJFBUXZQN-KUBHLMPHSA-N,265.2685,Q05318,BE0009862,RNA-directed RNA polymerase L,Zaire ebolavirus (strain Mayinga-76),inhibitor,yes
DB11679,Fruquintinib,small molecule,approved;investigational,CNC(=O)C1=C(C)OC2=CC(OC3=NC=NC4=CC(OC)=C(OC)C=C34)=CC=C12,BALLNEJQLSTPIO-UHFFFAOYSA-N,393.399,P17948,BE0000029,Vascular endothelial growth factor receptor 1,Humans,inhibitor,yes
DB11679,Fruquintinib,small molecule,approved;investigational,CNC(=O)C1=C(C)OC2=CC(OC3=NC=NC4=CC(OC)=C(OC)C=C34)=CC=C12,BALLNEJQLSTPIO-UHFFFAOYSA-N,393.399,P35968,BE0000369,Vascular endothelial growth factor receptor 2,Humans,inhibitor,yes
DB11679,Fruquintinib,small molecule,approved;investigational,CNC(=O)C1=C(C)OC2=CC(OC3=NC=NC4=CC(OC)=C(OC)C=C34)=CC=C12,BALLNEJQLSTPIO-UHFFFAOYSA-N,393.399,P35916,BE0000023,Vascular endothelial growth factor receptor 3,Humans,inhibitor,yes
DB11681,Tofimilast,small molecule,investigational,CCC1=NN(C2CCCC2)C2=C1CCN1C(=NN=C21)C1=CC=CS1,DHCOPPHTVOXDKU-UHFFFAOYSA-N,339.46,Q07343,BE0000487,"3',5'-cyclic-AMP phosphodiesterase 4B",Humans,inhibitor,yes
DB11681,Tofimilast,small molecule,investigational,CCC1=NN(C2CCCC2)C2=C1CCN1C(=NN=C21)C1=CC=CS1,DHCOPPHTVOXDKU-UHFFFAOYSA-N,339.46,Q08499,BE0001287,"3',5'-cyclic-AMP phosphodiesterase 4D",Humans,inhibitor,yes
DB11681,Tofimilast,small molecule,investigational,CCC1=NN(C2CCCC2)C2=C1CCN1C(=NN=C21)C1=CC=CS1,DHCOPPHTVOXDKU-UHFFFAOYSA-N,339.46,P27815,BE0001133,"3',5'-cyclic-AMP phosphodiesterase 4A",Humans,inhibitor,yes
DB11682,Daprodustat,small molecule,approved;investigational,OC(=O)CNC(=O)C1C(=O)N(C2CCCCC2)C(=O)N(C2CCCCC2)C1=O,RUEYEZADQJCKGV-UHFFFAOYSA-N,393.44,Q9GZT9,BE0002217,Egl nine homolog 1,Humans,inhibitor,yes
DB11682,Daprodustat,small molecule,approved;investigational,OC(=O)CNC(=O)C1C(=O)N(C2CCCCC2)C(=O)N(C2CCCCC2)C1=O,RUEYEZADQJCKGV-UHFFFAOYSA-N,393.44,Q96KS0,BE0002211,Prolyl hydroxylase EGLN2,Humans,inhibitor,yes
DB11682,Daprodustat,small molecule,approved;investigational,OC(=O)CNC(=O)C1C(=O)N(C2CCCCC2)C(=O)N(C2CCCCC2)C1=O,RUEYEZADQJCKGV-UHFFFAOYSA-N,393.44,Q9H6Z9,BE0002219,Prolyl hydroxylase EGLN3,Humans,inhibitor,yes
DB11684,Eprenetapopt,small molecule,investigational,COCC1(CO)N2CCC(CC2)C1=O,BGBNULCRKBVAKL-UHFFFAOYSA-N,199.25,P04637,BE0003380,Cellular tumor antigen p53,Humans,stimulator,yes
DB11689,Selumetinib,small molecule,approved;investigational,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,CYOHGALHFOKKQC-UHFFFAOYSA-N,457.68,Q02750,BE0000870,Dual specificity mitogen-activated protein kinase kinase 1,Humans,inhibitor,yes
DB11689,Selumetinib,small molecule,approved;investigational,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,CYOHGALHFOKKQC-UHFFFAOYSA-N,457.68,P36507,BE0004744,Dual specificity mitogen-activated protein kinase kinase 2,Humans,inhibitor,yes
DB11691,Naldemedine,small molecule,approved;investigational,[H][C@@]12OC3=C4C(C[C@@]5([H])N(CC6CC6)CC[C@@]14[C@@]5(O)CC(C(=O)NC(C)(C)C1=NC(=NO1)C1=CC=CC=C1)=C2O)=CC=C3O,AXQACEQYCPKDMV-RZAWKFBISA-N,570.646,P35372,BE0000770,Mu-type opioid receptor,Humans,antagonist,yes
DB11691,Naldemedine,small molecule,approved;investigational,[H][C@@]12OC3=C4C(C[C@@]5([H])N(CC6CC6)CC[C@@]14[C@@]5(O)CC(C(=O)NC(C)(C)C1=NC(=NO1)C1=CC=CC=C1)=C2O)=CC=C3O,AXQACEQYCPKDMV-RZAWKFBISA-N,570.646,P41143,BE0000420,Delta-type opioid receptor,Humans,antagonist,yes
DB11691,Naldemedine,small molecule,approved;investigational,[H][C@@]12OC3=C4C(C[C@@]5([H])N(CC6CC6)CC[C@@]14[C@@]5(O)CC(C(=O)NC(C)(C)C1=NC(=NO1)C1=CC=CC=C1)=C2O)=CC=C3O,AXQACEQYCPKDMV-RZAWKFBISA-N,570.646,P41145,BE0000632,Kappa-type opioid receptor,Humans,antagonist,yes
DB11692,Pavinetant,small molecule,investigational,CC[C@H](NC(=O)C1=C(NS(C)(=O)=O)C(=NC2=CC=CC=C12)C1=CC=CC=C1)C1=CC=CC=C1,QYTBBBAHNIWFOD-NRFANRHFSA-N,459.56,P29371,BE0002371,Neuromedin-K receptor,Humans,antagonist,yes
DB11693,Voclosporin,small molecule,approved;investigational,[H][C@@]1([C@H](O)[C@H](C)C\C=C\C=C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC1=O)C(C)C,BICRTLVBTLFLRD-PTWUADNWSA-N,1214.646,P49069,BE0000379,Guided entry of tail-anchored proteins factor CAMLG,Humans,binder,yes
DB11693,Voclosporin,small molecule,approved;investigational,[H][C@@]1([C@H](O)[C@H](C)C\C=C\C=C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC1=O)C(C)C,BICRTLVBTLFLRD-PTWUADNWSA-N,1214.646,Q08209,BE0004238,Protein phosphatase 3 catalytic subunit alpha,Humans,inhibitor,yes
DB11693,Voclosporin,small molecule,approved;investigational,[H][C@@]1([C@H](O)[C@H](C)C\C=C\C=C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC1=O)C(C)C,BICRTLVBTLFLRD-PTWUADNWSA-N,1214.646,P63098,BE0000358,Calcineurin subunit B type 1,Humans,inhibitor,yes
DB11693,Voclosporin,small molecule,approved;investigational,[H][C@@]1([C@H](O)[C@H](C)C\C=C\C=C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC1=O)C(C)C,BICRTLVBTLFLRD-PTWUADNWSA-N,1214.646,Q96LZ3,BE0002143,Calcineurin subunit B type 2,Humans,inhibitor,yes
DB11694,Ilorasertib,small molecule,investigational,NC1=C2C(SC=C2C2=CC=C(NC(=O)NC3=CC(F)=CC=C3)C=C2)=C(C=N1)C1=CN(CCO)N=C1,WPHKIQPVPYJNAX-UHFFFAOYSA-N,488.54,O14965,BE0000991,Aurora kinase A,Humans,modulator,yes
DB11694,Ilorasertib,small molecule,investigational,NC1=C2C(SC=C2C2=CC=C(NC(=O)NC3=CC(F)=CC=C3)C=C2)=C(C=N1)C1=CN(CCO)N=C1,WPHKIQPVPYJNAX-UHFFFAOYSA-N,488.54,Q96GD4,BE0003404,Aurora kinase B,Humans,modulator,yes
DB11694,Ilorasertib,small molecule,investigational,NC1=C2C(SC=C2C2=CC=C(NC(=O)NC3=CC(F)=CC=C3)C=C2)=C(C=N1)C1=CN(CCO)N=C1,WPHKIQPVPYJNAX-UHFFFAOYSA-N,488.54,Q9UQB9,BE0004601,Aurora kinase C,Humans,modulator,yes
DB11697,Pacritinib,small molecule,approved;investigational,C(CN1CCCC1)OC1=CC=C2NC3=NC=CC(=N3)C3=CC(COC\C=C\COCC1=C2)=CC=C3,HWXVIOGONBBTBY-ONEGZZNKSA-N,472.589,P52333,BE0003493,Tyrosine-protein kinase JAK3,Humans,modulator,yes
DB11697,Pacritinib,small molecule,approved;investigational,C(CN1CCCC1)OC1=CC=C2NC3=NC=CC(=N3)C3=CC(COC\C=C\COCC1=C2)=CC=C3,HWXVIOGONBBTBY-ONEGZZNKSA-N,472.589,O60674,BE0002408,Tyrosine-protein kinase JAK2,Humans,inhibitor,yes
DB11697,Pacritinib,small molecule,approved;investigational,C(CN1CCCC1)OC1=CC=C2NC3=NC=CC(=N3)C3=CC(COC\C=C\COCC1=C2)=CC=C3,HWXVIOGONBBTBY-ONEGZZNKSA-N,472.589,P36888,BE0000147,Receptor-type tyrosine-protein kinase FLT3,Humans,inhibitor,yes
DB11698,Ipragliflozin,small molecule,investigational,OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C1=CC=C(F)C(CC2=CC3=CC=CC=C3S2)=C1,AHFWIQIYAXSLBA-RQXATKFSSA-N,404.45,P31639,BE0004753,Sodium/glucose cotransporter 2,Humans,modulator,yes
DB11699,Tropisetron,small molecule,approved;investigational,[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(=O)C1=CNC3=CC=CC=C13)N2C,ZNRGQMMCGHDTEI-ITGUQSILSA-N,284.3529,P46098,BE0000311,5-hydroxytryptamine receptor 3A,Humans,antagonist,yes
DB11700,Setmelanotide,small molecule,approved;investigational,[H]N([H])C(=O)[C@@H]1CSSC[C@H](N([H])C(=O)[C@H](CCCN=C(N([H])[H])N([H])[H])N([H])C(C)=O)C(=O)N[C@H](C)C(=O)N[C@@H](CC2=CN=CN2[H])C(=O)N[C@H](CC2=CC=CC=C2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC2=CN([H])C3=CC=CC=C23)C(=O)N1,HDHDTKMUACZDAA-PHNIDTBTSA-N,1117.32,P32245,BE0009682,Melanocortin receptor 4,Humans,agonist,yes
DB11703,Acalabrutinib,small molecule,approved;investigational,CC#CC(=O)N1CCC[C@H]1C1=NC(=C2N1C=CN=C2N)C1=CC=C(C=C1)C(=O)NC1=CC=CC=N1,WDENQIQQYWYTPO-IBGZPJMESA-N,465.517,Q06187,BE0001284,Tyrosine-protein kinase BTK,Humans,inhibitor,yes
DB11704,Adomeglivant,small molecule,investigational,CC1=CC(O[C@@H](CCC(F)(F)F)C2=CC=C(C=C2)C(=O)NCCC(O)=O)=CC(C)=C1C1=CC=C(C=C1)C(C)(C)C,FASLTMSUPQDLIB-MHZLTWQESA-N,555.638,P47871,BE0000527,Glucagon receptor,Humans,antagonist,yes
DB11706,Vixotrigine,small molecule,investigational,NC(=O)[C@@H]1CC[C@@H](N1)C1=CC=C(OCC2=CC=CC=C2F)C=C1,JESCETIFNOFKEU-SJORKVTESA-N,314.36,Q15858,BE0001143,Sodium channel protein type 9 subunit alpha,Humans,inhibitor,yes
DB11708,Peficitinib,small molecule,investigational,NC(=O)C1=CN=C2NC=CC2=C1N[C@H]1[C@H]2CC3C[C@@H]1C[C@@](O)(C3)C2,DREIJXJRTLTGJC-RRBRBRQDSA-N,326.4,P52333,BE0003493,Tyrosine-protein kinase JAK3,Humans,inhibitor,yes
DB11708,Peficitinib,small molecule,investigational,NC(=O)C1=CN=C2NC=CC2=C1N[C@H]1[C@H]2CC3C[C@@H]1C[C@@](O)(C3)C2,DREIJXJRTLTGJC-RRBRBRQDSA-N,326.4,P23458,BE0004145,Tyrosine-protein kinase JAK1,Humans,inhibitor,yes
DB11712,Tezacaftor,small molecule,approved;investigational,CC(C)(CO)C1=CC2=CC(NC(=O)C3(CC3)C3=CC=C4OC(F)(F)OC4=C3)=C(F)C=C2N1C[C@@H](O)CO,MJUVRTYWUMPBTR-MRXNPFEDSA-N,520.505,P13569,BE0001195,Cystic fibrosis transmembrane conductance regulator,Humans,positive allosteric modulator,yes
DB11717,Epacadostat,small molecule,investigational,NS(=O)(=O)NCCNC1=NON=C1\C(NC1=CC=C(F)C(Br)=C1)=N\O,FBKMWOJEPMPVTQ-UHFFFAOYSA-N,438.23,P14902,BE0000693,"Indoleamine 2,3-dioxygenase 1",Humans,inhibitor,yes
DB11718,Encorafenib,small molecule,approved;investigational,COC(=O)N[C@@H](C)CNC1=NC=CC(=N1)C1=CN(N=C1C1=CC(Cl)=CC(NS(C)(=O)=O)=C1F)C(C)C,CMJCXYNUCSMDBY-ZDUSSCGKSA-N,540.01,P15056,BE0000634,Serine/threonine-protein kinase B-raf,Humans,inhibitor,yes
DB11718,Encorafenib,small molecule,approved;investigational,COC(=O)N[C@@H](C)CNC1=NC=CC(=N1)C1=CN(N=C1C1=CC(Cl)=CC(NS(C)(=O)=O)=C1F)C(C)C,CMJCXYNUCSMDBY-ZDUSSCGKSA-N,540.01,P24385,BE0001027,G1/S-specific cyclin-D1,Humans,inhibitor,yes
DB11718,Encorafenib,small molecule,approved;investigational,COC(=O)N[C@@H](C)CNC1=NC=CC(=N1)C1=CN(N=C1C1=CC(Cl)=CC(NS(C)(=O)=O)=C1F)C(C)C,CMJCXYNUCSMDBY-ZDUSSCGKSA-N,540.01,P04049,BE0000036,RAF proto-oncogene serine/threonine-protein kinase,Humans,inhibitor,yes
DB11718,Encorafenib,small molecule,approved;investigational,COC(=O)N[C@@H](C)CNC1=NC=CC(=N1)C1=CN(N=C1C1=CC(Cl)=CC(NS(C)(=O)=O)=C1F)C(C)C,CMJCXYNUCSMDBY-ZDUSSCGKSA-N,540.01,P45983,BE0003790,Mitogen-activated protein kinase 8,Humans,inhibitor,yes
DB11718,Encorafenib,small molecule,approved;investigational,COC(=O)N[C@@H](C)CNC1=NC=CC(=N1)C1=CN(N=C1C1=CC(Cl)=CC(NS(C)(=O)=O)=C1F)C(C)C,CMJCXYNUCSMDBY-ZDUSSCGKSA-N,540.01,P45984,BE0003772,Mitogen-activated protein kinase 9,Humans,inhibitor,yes
DB11718,Encorafenib,small molecule,approved;investigational,COC(=O)N[C@@H](C)CNC1=NC=CC(=N1)C1=CN(N=C1C1=CC(Cl)=CC(NS(C)(=O)=O)=C1F)C(C)C,CMJCXYNUCSMDBY-ZDUSSCGKSA-N,540.01,P53779,BE0001097,Mitogen-activated protein kinase 10,Humans,inhibitor,yes
DB11718,Encorafenib,small molecule,approved;investigational,COC(=O)N[C@@H](C)CNC1=NC=CC(=N1)C1=CN(N=C1C1=CC(Cl)=CC(NS(C)(=O)=O)=C1F)C(C)C,CMJCXYNUCSMDBY-ZDUSSCGKSA-N,540.01,P53667,BE0004759,LIM domain kinase 1,Humans,inhibitor,yes
DB11718,Encorafenib,small molecule,approved;investigational,COC(=O)N[C@@H](C)CNC1=NC=CC(=N1)C1=CN(N=C1C1=CC(Cl)=CC(NS(C)(=O)=O)=C1F)C(C)C,CMJCXYNUCSMDBY-ZDUSSCGKSA-N,540.01,P53671,BE0009456,LIM domain kinase 2,Humans,inhibitor,yes
DB11718,Encorafenib,small molecule,approved;investigational,COC(=O)N[C@@H](C)CNC1=NC=CC(=N1)C1=CN(N=C1C1=CC(Cl)=CC(NS(C)(=O)=O)=C1F)C(C)C,CMJCXYNUCSMDBY-ZDUSSCGKSA-N,540.01,P45985,BE0010122,Dual specificity mitogen-activated protein kinase kinase 4,Humans,inhibitor,yes
DB11718,Encorafenib,small molecule,approved;investigational,COC(=O)N[C@@H](C)CNC1=NC=CC(=N1)C1=CN(N=C1C1=CC(Cl)=CC(NS(C)(=O)=O)=C1F)C(C)C,CMJCXYNUCSMDBY-ZDUSSCGKSA-N,540.01,Q9NRP7,BE0009388,Serine/threonine-protein kinase 36,Humans,inhibitor,yes
DB11720,Angiotensin 1-7,small molecule,investigational,[H][C@](NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)([C@@H](C)CC)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N1CCC[C@H]1C(O)=O,PVHLMTREZMEJCG-GDTLVBQBSA-N,899.02,P04201,BE0012496,Proto-oncogene Mas,Humans,agonist,yes
DB11721,Mitoglitazone,small molecule,investigational,CCC1=CN=C(C=C1)C(=O)COC1=CC=C(CC2SC(=O)NC2=O)C=C1,IRNJSRAGRIZIHD-UHFFFAOYSA-N,370.422,P06213,BE0000033,Insulin receptor,Humans,modulator,yes
DB11723,Dutogliptin,small molecule,investigational,OB(O)[C@@H]1CCCN1C(=O)CN[C@@H]1CCNC1,DVJAMEIQRSHVKC-BDAKNGLRSA-N,241.1,P27487,BE0000854,Dipeptidyl peptidase 4,Humans,inhibitor,yes
DB11724,Bombesin,small molecule,investigational,[H]N=C(N([H])[H])N([H])CCC[C@H](N([H])C(=O)[C@H](CCC(=O)N([H])[H])N([H])C(=O)[C@@H]1CCC(=O)N1[H])C(=O)N([H])[C@@H](CC(C)C)C(=O)N([H])CC(=O)N([H])[C@@H](CC(=O)N([H])[H])C(=O)N([H])[C@@H](CCC(=O)N([H])[H])C(=O)N([H])[C@@H](CC1=CN([H])C2=CC=CC=C12)C(=O)N([H])[C@@H](C)C(=O)N([H])[C@@H](C(C)C)C(=O)N([H])CC(=O)N([H])[C@@H](CC1=CN([H])C=N1)C(=O)N([H])[C@@H](CC(C)C)C(=O)N([H])[C@@H](CCSC)C(=O)N([H])[H],QXZBMSIDSOZZHK-DOPDSADYSA-N,1619.87,P30550,BE0012984,Gastrin-releasing peptide receptor,Humans,agonist,yes
DB11724,Bombesin,small molecule,investigational,[H]N=C(N([H])[H])N([H])CCC[C@H](N([H])C(=O)[C@H](CCC(=O)N([H])[H])N([H])C(=O)[C@@H]1CCC(=O)N1[H])C(=O)N([H])[C@@H](CC(C)C)C(=O)N([H])CC(=O)N([H])[C@@H](CC(=O)N([H])[H])C(=O)N([H])[C@@H](CCC(=O)N([H])[H])C(=O)N([H])[C@@H](CC1=CN([H])C2=CC=CC=C12)C(=O)N([H])[C@@H](C)C(=O)N([H])[C@@H](C(C)C)C(=O)N([H])CC(=O)N([H])[C@@H](CC1=CN([H])C=N1)C(=O)N([H])[C@@H](CC(C)C)C(=O)N([H])[C@@H](CCSC)C(=O)N([H])[H],QXZBMSIDSOZZHK-DOPDSADYSA-N,1619.87,P32247,BE0013148,Bombesin receptor subtype-3,Humans,agonist,yes
DB11724,Bombesin,small molecule,investigational,[H]N=C(N([H])[H])N([H])CCC[C@H](N([H])C(=O)[C@H](CCC(=O)N([H])[H])N([H])C(=O)[C@@H]1CCC(=O)N1[H])C(=O)N([H])[C@@H](CC(C)C)C(=O)N([H])CC(=O)N([H])[C@@H](CC(=O)N([H])[H])C(=O)N([H])[C@@H](CCC(=O)N([H])[H])C(=O)N([H])[C@@H](CC1=CN([H])C2=CC=CC=C12)C(=O)N([H])[C@@H](C)C(=O)N([H])[C@@H](C(C)C)C(=O)N([H])CC(=O)N([H])[C@@H](CC1=CN([H])C=N1)C(=O)N([H])[C@@H](CC(C)C)C(=O)N([H])[C@@H](CCSC)C(=O)N([H])[H],QXZBMSIDSOZZHK-DOPDSADYSA-N,1619.87,P28336,BE0013104,Neuromedin-B receptor,Humans,agonist,yes
DB11725,Latrepirdine,small molecule,investigational,CN1CCC2=C(C1)C1=CC(C)=CC=C1N2CCC1=CC=C(C)N=C1,JNODQFNWMXFMEV-UHFFFAOYSA-N,319.452,P50406,BE0000945,5-hydroxytryptamine receptor 6,Humans,inhibitor,yes
DB11725,Latrepirdine,small molecule,investigational,CN1CCC2=C(C1)C1=CC(C)=CC=C1N2CCC1=CC=C(C)N=C1,JNODQFNWMXFMEV-UHFFFAOYSA-N,319.452,P35367,BE0000442,Histamine H1 receptor,Humans,inhibitor,yes
DB11726,Encenicline,small molecule,investigational,ClC1=C2SC(=CC2=CC=C1)C(=O)N[C@H]1CN2CCC1CC2,SSRDSYXGYPJKRR-ZDUSSCGKSA-N,320.84,P36544,BE0002341,Neuronal acetylcholine receptor subunit alpha-7,Humans,partial agonist,yes
DB11729,Linerixibat,small molecule,investigational,CCCC[C@]1(CC)CS(=O)(=O)C2=CC(CNC(CC(O)=O)CC(O)=O)=C(OC)C=C2[C@H](N1)C1=CC=CC=C1,CZGVOBIGEBDYTP-VSGBNLITSA-N,546.68,Q12908,BE0003643,Ileal sodium/bile acid cotransporter,Humans,modulator,yes
DB11730,Ribociclib,small molecule,approved;investigational,CN(C)C(=O)C1=CC2=CN=C(NC3=CC=C(C=N3)N3CCNCC3)N=C2N1C1CCCC1,RHXHGRAEPCAFML-UHFFFAOYSA-N,434.548,P11802,BE0002216,Cyclin-dependent kinase 4,Humans,antagonist;inhibitor,yes
DB11730,Ribociclib,small molecule,approved;investigational,CN(C)C(=O)C1=CC2=CN=C(NC3=CC=C(C=N3)N3CCNCC3)N=C2N1C1CCCC1,RHXHGRAEPCAFML-UHFFFAOYSA-N,434.548,Q00534,BE0002212,Cyclin-dependent kinase 6,Humans,antagonist;inhibitor,yes
DB11732,Lasmiditan,small molecule,approved;investigational,CN1CCC(CC1)C(=O)C1=CC=CC(NC(=O)C2=C(F)C=C(F)C=C2F)=N1,XEDHVZKDSYZQBF-UHFFFAOYSA-N,377.367,P30939,BE0000460,5-hydroxytryptamine receptor 1F,Humans,agonist,yes
DB11734,Fedovapagon,small molecule,investigational,CN(C)C(=O)[C@@H]1CCCN1C(=O)NCC1=CC=C(C=C1C)C(=O)N1CCCCC2=C1C=CC=C2,RUOLFWZIFNQQGH-DEOSSOPVSA-N,462.594,P30518,BE0000293,Vasopressin V2 receptor,Humans,inhibitor,yes
DB11736,PF-00489791,small molecule,investigational,CCOCCN1N=C(C(=O)NS(C)(=O)=O)C2=NC(=NC(NC3=CC(C)=CC=N3)=C12)N(C)CC,ZUHZNKJIJDAJFD-UHFFFAOYSA-N,476.56,O76074,BE0000182,"cGMP-specific 3',5'-cyclic phosphodiesterase",Humans,inhibitor,yes
DB11737,Icotinib,small molecule,experimental;investigational,C#CC1=CC=CC(NC2=NC=NC3=CC4=C(OCCOCCOCCO4)C=C23)=C1,QQLKULDARVNMAL-UHFFFAOYSA-N,391.427,P00533,BE0000767,Epidermal growth factor receptor,Humans,antagonist,yes
DB11738,Rilmenidine,small molecule,approved;investigational,C1CC1C(NC1=NCCO1)C1CC1,CQXADFVORZEARL-UHFFFAOYSA-N,180.251,P18825,BE0000342,Alpha-2C adrenergic receptor,Humans,modulator,yes
DB11739,Vonoprazan,small molecule,approved;investigational,CNCC1=CN(C(=C1)C1=CC=CC=C1F)S(=O)(=O)C1=CC=CN=C1,BFDBKMOZYNOTPK-UHFFFAOYSA-N,345.39,P20648,BE0009378,Hydrogen potassium ATPase,Humans,inhibitor,yes
DB11740,Adavosertib,small molecule,investigational,CN1CCN(CC1)C1=CC=C(NC2=NC=C3C(=O)N(CC=C)N(C3=N2)C2=NC(=CC=C2)C(C)(C)O)C=C1,BKWJAKQVGHWELA-UHFFFAOYSA-N,500.607,P30291,BE0003335,Wee1-like protein kinase,Humans,inhibitor,yes
DB11741,Famitinib,small molecule,investigational,CCN(CC)CCN1CCC2=C(C(C)=C(N2)\C=C2/C(=O)NC3=CC=C(F)C=C23)C1=O,GKEYKDOLBLYGRB-LGMDPLHJSA-N,410.493,P16234,BE0000852,Platelet-derived growth factor receptor alpha,Humans,inhibitor,yes
DB11741,Famitinib,small molecule,investigational,CCN(CC)CCN1CCC2=C(C(C)=C(N2)\C=C2/C(=O)NC3=CC=C(F)C=C23)C1=O,GKEYKDOLBLYGRB-LGMDPLHJSA-N,410.493,P36888,BE0000147,Receptor-type tyrosine-protein kinase FLT3,Humans,inhibitor,yes
DB11741,Famitinib,small molecule,investigational,CCN(CC)CCN1CCC2=C(C(C)=C(N2)\C=C2/C(=O)NC3=CC=C(F)C=C23)C1=O,GKEYKDOLBLYGRB-LGMDPLHJSA-N,410.493,P10721,BE0000453,Mast/stem cell growth factor receptor Kit,Humans,inhibitor,yes
DB11741,Famitinib,small molecule,investigational,CCN(CC)CCN1CCC2=C(C(C)=C(N2)\C=C2/C(=O)NC3=CC=C(F)C=C23)C1=O,GKEYKDOLBLYGRB-LGMDPLHJSA-N,410.493,P09619,BE0000205,Platelet-derived growth factor receptor beta,Humans,inhibitor,yes
DB11741,Famitinib,small molecule,investigational,CCN(CC)CCN1CCC2=C(C(C)=C(N2)\C=C2/C(=O)NC3=CC=C(F)C=C23)C1=O,GKEYKDOLBLYGRB-LGMDPLHJSA-N,410.493,P17948,BE0000029,Vascular endothelial growth factor receptor 1,Humans,inhibitor,yes
DB11741,Famitinib,small molecule,investigational,CCN(CC)CCN1CCC2=C(C(C)=C(N2)\C=C2/C(=O)NC3=CC=C(F)C=C23)C1=O,GKEYKDOLBLYGRB-LGMDPLHJSA-N,410.493,P35916,BE0000023,Vascular endothelial growth factor receptor 3,Humans,inhibitor,yes
DB11741,Famitinib,small molecule,investigational,CCN(CC)CCN1CCC2=C(C(C)=C(N2)\C=C2/C(=O)NC3=CC=C(F)C=C23)C1=O,GKEYKDOLBLYGRB-LGMDPLHJSA-N,410.493,P35968,BE0000369,Vascular endothelial growth factor receptor 2,Humans,inhibitor,yes
DB11743,Ipatasertib,small molecule,investigational,[H][C@](CNC(C)C)(C(=O)N1CCN(CC1)C1=NC=NC2=C1[C@]([H])(C)C[C@@]2([H])O)C1=CC=C(Cl)C=C1,GRZXWCHAXNAUHY-NSISKUIASA-N,457.996,P31749,BE0000428,RAC-alpha serine/threonine-protein kinase,Humans,inhibitor,yes
DB11745,Otenabant,small molecule,investigational,CCNC1(CCN(CC1)C1=C2N=C(N(C2=NC=N1)C1=CC=C(Cl)C=C1)C1=CC=CC=C1Cl)C(N)=O,UNAZAADNBYXMIV-UHFFFAOYSA-N,510.42,P21554,BE0000061,Cannabinoid receptor 1,Humans,antagonist,yes
DB11750,Clobetasol,small molecule,approved;experimental;investigational,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,FCSHDIVRCWTZOX-DVTGEIKXSA-N,410.907,P04054,BE0003997,Phospholipase A2,Humans,inhibitor,yes
DB11751,Cabotegravir,small molecule,approved;investigational,[H][C@@]12CN3C=C(C(=O)NCC4=C(F)C=C(F)C=C4)C(=O)C(O)=C3C(=O)N1[C@@H](C)CO2,WCWSTNLSLKSJPK-LKFCYVNXSA-N,405.358,Q7ZJM1,BE0004855,Integrase,Human immunodeficiency virus 1,inhibitor,yes
DB11751,Cabotegravir,small molecule,approved;investigational,[H][C@@]12CN3C=C(C(=O)NCC4=C(F)C=C(F)C=C4)C(=O)C(O)=C3C(=O)N1[C@@H](C)CO2,WCWSTNLSLKSJPK-LKFCYVNXSA-N,405.358,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB11752,Bryostatin 1,small molecule,investigational,[H][C@]12C[C@H](OC(C)=O)C(C)(C)[C@](O)(C[C@]3([H])C\C(C[C@@]([H])(O3)\C=C\C(C)(C)[C@]3(O)O[C@@]([H])(C\C(=C/C(=O)OC)[C@@H]3OC(=O)\C=C\C=C\CCC)C[C@@]([H])(OC(=O)C[C@H](O)C1)[C@@H](C)O)=C\C(=O)OC)O2,MJQUEDHRCUIRLF-TVIXENOKSA-N,905.044,Q02156,BE0003431,Protein kinase C epsilon type,Humans,activator,yes
DB11753,Rifamycin,small molecule,approved;investigational,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C)C(O)=C4C(O)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C=C(O)C4=C3C2=O,HJYYPODYNSCCOU-ODRIEIDWSA-N,697.778,P9WGY9,BE0010989,DNA-directed RNA polymerase subunit beta,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),inhibitor,yes
DB11753,Rifamycin,small molecule,approved;investigational,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C)C(O)=C4C(O)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C=C(O)C4=C3C2=O,HJYYPODYNSCCOU-ODRIEIDWSA-N,697.778,P9WGY7,BE0000186,DNA-directed RNA polymerase subunit beta',Mycobacterium tuberculosis,inhibitor,yes
DB11753,Rifamycin,small molecule,approved;investigational,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C)C(O)=C4C(O)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C=C(O)C4=C3C2=O,HJYYPODYNSCCOU-ODRIEIDWSA-N,697.778,P0A8V2,BE0000257,DNA-directed RNA polymerase subunit beta,Escherichia coli (strain K12),binder,yes
DB11753,Rifamycin,small molecule,approved;investigational,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C)C(O)=C4C(O)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C=C(O)C4=C3C2=O,HJYYPODYNSCCOU-ODRIEIDWSA-N,697.778,P0A7Z4,BE0000461,DNA-directed RNA polymerase subunit alpha,Escherichia coli (strain K12),binder,yes
DB11753,Rifamycin,small molecule,approved;investigational,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C)C(O)=C4C(O)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C=C(O)C4=C3C2=O,HJYYPODYNSCCOU-ODRIEIDWSA-N,697.778,P0A8T7,BE0003707,DNA-directed RNA polymerase subunit beta',Escherichia coli (strain K12),binder,yes
DB11755,Tetrahydrocannabivarin,small molecule,investigational,CCCC1=CC(O)=C2[C@@H]3C=C(C)CC[C@H]3C(C)(C)OC2=C1,ZROLHBHDLIHEMS-HUUCEWRRSA-N,286.415,Q8NET8,BE0003416,Transient receptor potential cation channel subfamily V member 3,Humans,activator,yes
DB11755,Tetrahydrocannabivarin,small molecule,investigational,CCCC1=CC(O)=C2[C@@H]3C=C(C)CC[C@H]3C(C)(C)OC2=C1,ZROLHBHDLIHEMS-HUUCEWRRSA-N,286.415,P21554,BE0000061,Cannabinoid receptor 1,Humans,antagonist,yes
DB11755,Tetrahydrocannabivarin,small molecule,investigational,CCCC1=CC(O)=C2[C@@H]3C=C(C)CC[C@H]3C(C)(C)OC2=C1,ZROLHBHDLIHEMS-HUUCEWRRSA-N,286.415,Q9Y2T6,BE0005802,G-protein coupled receptor 55,Humans,partial agonist,yes
DB11755,Tetrahydrocannabivarin,small molecule,investigational,CCCC1=CC(O)=C2[C@@H]3C=C(C)CC[C@H]3C(C)(C)OC2=C1,ZROLHBHDLIHEMS-HUUCEWRRSA-N,286.415,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,agonist,yes
DB11755,Tetrahydrocannabivarin,small molecule,investigational,CCCC1=CC(O)=C2[C@@H]3C=C(C)CC[C@H]3C(C)(C)OC2=C1,ZROLHBHDLIHEMS-HUUCEWRRSA-N,286.415,Q9Y5S1,BE0009158,Transient receptor potential cation channel subfamily V member 2,Humans,agonist,yes
DB11755,Tetrahydrocannabivarin,small molecule,investigational,CCCC1=CC(O)=C2[C@@H]3C=C(C)CC[C@H]3C(C)(C)OC2=C1,ZROLHBHDLIHEMS-HUUCEWRRSA-N,286.415,Q7Z2W7,BE0001186,Transient receptor potential cation channel subfamily M member 8,Humans,antagonist,yes
DB11755,Tetrahydrocannabivarin,small molecule,investigational,CCCC1=CC(O)=C2[C@@H]3C=C(C)CC[C@H]3C(C)(C)OC2=C1,ZROLHBHDLIHEMS-HUUCEWRRSA-N,286.415,O75762,BE0001122,Transient receptor potential cation channel subfamily A member 1,Humans,agonist,yes
DB11757,Istradefylline,small molecule,approved;investigational,[H]\C(=C(\[H])C1=CC(OC)=C(OC)C=C1)C1=NC2=C(N1C)C(=O)N(CC)C(=O)N2CC,IQVRBWUUXZMOPW-PKNBQFBNSA-N,384.436,P29274,BE0000924,Adenosine receptor A2a,Humans,antagonist,yes
DB11758,Cenicriviroc,small molecule,investigational,CCCCOCCOC1=CC=C(C=C1)C1=CC2=C(C=C1)N(CC(C)C)CCC\C(=C/2)C(=O)NC1=CC=C(C=C1)[S@@](=O)CC1=CN=CN1CCC,PNDKCRDVVKJPKG-WHERJAGFSA-N,696.95,P51681,BE0000911,C-C chemokine receptor type 5,Humans,modulator,yes
DB11759,Pevonedistat,small molecule,investigational,[H][C@]1(O)C[C@@]([H])(C[C@@]1([H])COS(N)(=O)=O)N1C=CC2=C(N[C@@]3([H])CCC4=CC=CC=C34)N=CN=C12,MPUQHZXIXSTTDU-QXGSTGNESA-N,443.519,Q8TBC4,BE0017091,NEDD8-activating enzyme E1 catalytic subunit,Humans,modulator,yes
DB11759,Pevonedistat,small molecule,investigational,[H][C@]1(O)C[C@@]([H])(C[C@@]1([H])COS(N)(=O)=O)N1C=CC2=C(N[C@@]3([H])CCC4=CC=CC=C34)N=CN=C12,MPUQHZXIXSTTDU-QXGSTGNESA-N,443.519,Q15843,BE0014813,Ubiquitin-like protein NEDD8,Humans,inhibitor,yes
DB11759,Pevonedistat,small molecule,investigational,[H][C@]1(O)C[C@@]([H])(C[C@@]1([H])COS(N)(=O)=O)N1C=CC2=C(N[C@@]3([H])CCC4=CC=CC=C34)N=CN=C12,MPUQHZXIXSTTDU-QXGSTGNESA-N,443.519,Q13564,BE0000202,NEDD8-activating enzyme E1 regulatory subunit,Humans,modulator,yes
DB11760,Talazoparib,small molecule,approved;investigational,CN1N=CN=C1[C@@H]1[C@H](NC2=C3C1=NNC(=O)C3=CC(F)=C2)C1=CC=C(F)C=C1,HWGQMRYQVZSGDQ-HZPDHXFCSA-N,380.359,P09874,BE0001717,Poly [ADP-ribose] polymerase 1,Humans,inhibitor,yes
DB11760,Talazoparib,small molecule,approved;investigational,CN1N=CN=C1[C@@H]1[C@H](NC2=C3C1=NNC(=O)C3=CC(F)=C2)C1=CC=C(F)C=C1,HWGQMRYQVZSGDQ-HZPDHXFCSA-N,380.359,Q9UGN5,BE0003798,Poly [ADP-ribose] polymerase 2,Humans,inhibitor,yes
DB11761,Tenapanor,small molecule,approved;investigational,CN1C[C@@H](C2=CC(=CC=C2)S(=O)(=O)NCCOCCOCCNC(=O)NCCCCNC(=O)NCCOCCOCCNS(=O)(=O)C2=CC(=CC=C2)[C@@H]2CN(C)CC3=C2C=C(Cl)C=C3Cl)C2=C(C1)C(Cl)=CC(Cl)=C2,DNHPDWGIXIMXSA-CXNSMIOJSA-N,1145.04,P48764,BE0009757,Sodium/hydrogen exchanger 3,Humans,inhibitor,yes
DB11763,Momelotinib,small molecule,approved;investigational,O=C(NCC#N)C1=CC=C(C=C1)C1=CC=NC(NC2=CC=C(C=C2)N2CCOCC2)=N1,ZVHNDZWQTBEVRY-UHFFFAOYSA-N,414.469,P23458,BE0004145,Tyrosine-protein kinase JAK1,Humans,inhibitor,yes
DB11763,Momelotinib,small molecule,approved;investigational,O=C(NCC#N)C1=CC=C(C=C1)C1=CC=NC(NC2=CC=C(C=C2)N2CCOCC2)=N1,ZVHNDZWQTBEVRY-UHFFFAOYSA-N,414.469,O60674,BE0002408,Tyrosine-protein kinase JAK2,Humans,inhibitor,yes
DB11765,PF-04991532,small molecule,investigational,OC(=O)C1=CC=C(NC(=O)[C@H](CC2CCCC2)N2C=NC(=C2)C(F)(F)F)N=C1,GKMLFBRLRVQVJO-ZDUSSCGKSA-N,396.3637,P35557,BE0001056,Hexokinase-4,Humans,activator,yes
DB11769,Funapide,small molecule,investigational,FC(F)(F)C1=CC=C(CN2C(=O)[C@@]3(COC4=C3C=C3OCOC3=C4)C3=CC=CC=C23)O1,NEBUOXBYNAHKFV-NRFANRHFSA-N,429.351,Q15858,BE0001143,Sodium channel protein type 9 subunit alpha,Humans,inhibitor,yes
DB11773,BMS-903452,small molecule,investigational,CS(=O)(=O)C1=CC=C(N2C=C(Cl)C(OC3CCN(CC3)C3=NC=C(Cl)C=N3)=CC2=O)C(F)=C1,OGIAVRWXUPYGGC-UHFFFAOYSA-N,513.37,Q8TDV5,BE0003378,Glucose-dependent insulinotropic receptor,Humans,modulator,yes
DB11774,Pazufloxacin,small molecule,investigational,[H][C@]1(C)COC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2C1(N)CC1,XAGMUUZPGZWTRP-ZETCQYMHSA-N,318.304,P20831,BE0008385,DNA gyrase subunit A,Staphylococcus aureus,inhibitor,yes
DB11774,Pazufloxacin,small molecule,investigational,[H][C@]1(C)COC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2C1(N)CC1,XAGMUUZPGZWTRP-ZETCQYMHSA-N,318.304,P0A0K8,BE0002388,DNA gyrase subunit B,Staphylococcus aureus,inhibitor,yes
DB11774,Pazufloxacin,small molecule,investigational,[H][C@]1(C)COC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2C1(N)CC1,XAGMUUZPGZWTRP-ZETCQYMHSA-N,318.304,P0AFI2,BE0000798,DNA topoisomerase 4 subunit A,Escherichia coli (strain K12),inhibitor,yes
DB11775,PF-03758309,small molecule,investigational,CN(C)C[C@@H](NC(=O)N1CC2=C(NN=C2NC2=C3SC=CC3=NC(C)=N2)C1(C)C)C1=CC=CC=C1,AYCPARAPKDAOEN-LJQANCHMSA-N,490.63,O96013,BE0009508,Serine/threonine-protein kinase PAK 4,Humans,inhibitor,yes
DB11778,Danusertib,small molecule,investigational,CO[C@@H](C(=O)N1CC2=C(C1)C(NC(=O)C1=CC=C(C=C1)N1CCN(C)CC1)=NN2)C1=CC=CC=C1,XKFTZKGMDDZMJI-HSZRJFAPSA-N,474.565,Q9UQB9,BE0004601,Aurora kinase C,Humans,inhibitor,yes
DB11778,Danusertib,small molecule,investigational,CO[C@@H](C(=O)N1CC2=C(C1)C(NC(=O)C1=CC=C(C=C1)N1CCN(C)CC1)=NN2)C1=CC=CC=C1,XKFTZKGMDDZMJI-HSZRJFAPSA-N,474.565,O14965,BE0000991,Aurora kinase A,Humans,inhibitor,yes
DB11778,Danusertib,small molecule,investigational,CO[C@@H](C(=O)N1CC2=C(C1)C(NC(=O)C1=CC=C(C=C1)N1CCN(C)CC1)=NN2)C1=CC=CC=C1,XKFTZKGMDDZMJI-HSZRJFAPSA-N,474.565,Q96GD4,BE0003404,Aurora kinase B,Humans,inhibitor,yes
DB11779,Danoprevir,small molecule,investigational,CC(C)(C)OC(=O)N[C@H]1CCCCC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C1=O)OC(=O)N1CC2=CC=CC(F)=C2C1)C(=O)NS(=O)(=O)C1CC1,ZVTDLPBHTSMEJZ-JSZLBQEHSA-N,731.84,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB11781,Tosedostat,small molecule,investigational,CC(C)C[C@H]([C@H](O)C(=O)NO)C(=O)N[C@H](C(=O)OC1CCCC1)C1=CC=CC=C1,FWFGIHPGRQZWIW-SQNIBIBYSA-N,406.479,P55786,BE0003419,Puromycin-sensitive aminopeptidase,Humans,inhibitor,yes
DB11782,Birinapant,small molecule,investigational,CC[C@H](NC(=O)[C@H](C)NC)C(=O)N1C[C@@H](O)C[C@H]1CC1=C(NC2=CC(F)=CC=C12)C1=C(C[C@@H]2C[C@H](O)CN2C(=O)[C@H](CC)NC(=O)[C@H](C)NC)C2=CC=C(F)C=C2N1,PKWRMUKBEYJEIX-DXXQBUJASA-N,806.957,P98170,BE0001156,E3 ubiquitin-protein ligase XIAP,Humans,modulator,yes
DB11782,Birinapant,small molecule,investigational,CC[C@H](NC(=O)[C@H](C)NC)C(=O)N1C[C@@H](O)C[C@H]1CC1=C(NC2=CC(F)=CC=C12)C1=C(C[C@@H]2C[C@H](O)CN2C(=O)[C@H](CC)NC(=O)[C@H](C)NC)C2=CC=C(F)C=C2N1,PKWRMUKBEYJEIX-DXXQBUJASA-N,806.957,Q13490,BE0010675,Baculoviral IAP repeat-containing protein 2,Humans,modulator,yes
DB11783,Imidapril,small molecule,investigational,[H][C@@](C)(N[C@@]([H])(CCC1=CC=CC=C1)C(=O)OCC)C(=O)N1C(=O)N(C)C[C@@]1([H])C(O)=O,KLZWOWYOHUKJIG-BPUTZDHNSA-N,405.4449,P12821,BE0000221,Angiotensin-converting enzyme,Humans,modulator,yes
DB11785,Anisodamine,small molecule,investigational,CN1[C@@H]2C[C@H](O)[C@H]1C[C@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,WTQYWNWRJNXDEG-RBZJEDDUSA-N,305.374,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,modulator,yes
DB11790,Radafaxine,small molecule,investigational,C[C@@H]1NC(C)(C)CO[C@@]1(O)C1=CC=CC(Cl)=C1,RCOBKSKAZMVBHT-TVQRCGJNSA-N,255.74,Q01959,BE0000647,Sodium-dependent dopamine transporter,Humans,inhibitor,yes
DB11790,Radafaxine,small molecule,investigational,C[C@@H]1NC(C)(C)CO[C@@]1(O)C1=CC=CC(Cl)=C1,RCOBKSKAZMVBHT-TVQRCGJNSA-N,255.74,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,inhibitor,yes
DB11791,Capmatinib,small molecule,approved;investigational,CNC(=O)C1=C(F)C=C(C=C1)C1=NN2C(CC3=CC4=C(C=C3)N=CC=C4)=CN=C2N=C1,LIOLIMKSCNQPLV-UHFFFAOYSA-N,412.428,P08581,BE0000915,Hepatocyte growth factor receptor,Humans,inhibitor,yes
DB11793,Niraparib,small molecule,approved;investigational,NC(=O)C1=CC=CC2=CN(N=C12)C1=CC=C(C=C1)[C@@H]1CCCNC1,PCHKPVIQAHNQLW-CQSZACIVSA-N,320.396,P09874,BE0001717,Poly [ADP-ribose] polymerase 1,Humans,inhibitor,yes
DB11793,Niraparib,small molecule,approved;investigational,NC(=O)C1=CC=CC2=CN(N=C12)C1=CC=C(C=C1)[C@@H]1CCCNC1,PCHKPVIQAHNQLW-CQSZACIVSA-N,320.396,Q9UGN5,BE0003798,Poly [ADP-ribose] polymerase 2,Humans,inhibitor,yes
DB11794,Berzosertib,small molecule,investigational,CNCC1=CC=C(C=C1)C1=NOC(=C1)C1=NC(=CN=C1N)C1=CC=C(C=C1)S(=O)(=O)C(C)C,JZCWLJDSIRUGIN-UHFFFAOYSA-N,463.56,Q13535,BE0010060,Serine/threonine-protein kinase ATR,Humans,inhibitor,yes
DB11795,GSK-2636771,small molecule,investigational,CC1=NC2=C(C=C(C=C2N1CC1=C(C)C(=CC=C1)C(F)(F)F)N1CCOCC1)C(O)=O,XTKLTGBKIDQGQL-UHFFFAOYSA-N,433.431,P42338,BE0002407,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",Humans,inhibitor,yes
DB11796,Fostemsavir,small molecule,approved;investigational,COC1=CN=C(N2C=NC(C)=N2)C2=C1C(=CN2COP(O)(O)=O)C(=O)C(=O)N1CCN(CC1)C(=O)C1=CC=CC=C1,SWMDAPWAQQTBOG-UHFFFAOYSA-N,583.498,P12488,BE0002838,Envelope glycoprotein gp160,HIV-1,inhibitor,yes
DB11798,Tanzisertib,small molecule,investigational,[H][C@@]1(CCOC1)N1C(NC2=C(F)C=C(F)C=C2F)=NC2=CN=C(N[C@@]3([H])CC[C@]([H])(O)CC3)N=C12,IBGLGMOPHJQDJB-IHRRRGAJSA-N,448.4415,P45983,BE0003790,Mitogen-activated protein kinase 8,Humans,modulator,yes
DB11798,Tanzisertib,small molecule,investigational,[H][C@@]1(CCOC1)N1C(NC2=C(F)C=C(F)C=C2F)=NC2=CN=C(N[C@@]3([H])CC[C@]([H])(O)CC3)N=C12,IBGLGMOPHJQDJB-IHRRRGAJSA-N,448.4415,P45984,BE0003772,Mitogen-activated protein kinase 9,Humans,modulator,yes
DB11798,Tanzisertib,small molecule,investigational,[H][C@@]1(CCOC1)N1C(NC2=C(F)C=C(F)C=C2F)=NC2=CN=C(N[C@@]3([H])CC[C@]([H])(O)CC3)N=C12,IBGLGMOPHJQDJB-IHRRRGAJSA-N,448.4415,P53779,BE0001097,Mitogen-activated protein kinase 10,Humans,modulator,yes
DB11799,Bictegravir,small molecule,approved;investigational,OC1=C2N(C[C@H]3O[C@@H]4CC[C@@H](C4)N3C2=O)C=C(C(=O)NCC2=C(F)C=C(F)C=C2F)C1=O,SOLUWJRYJLAZCX-LYOVBCGYSA-N,449.386,Q72547,BE0004136,Reverse transcriptase/RNaseH,Human immunodeficiency virus 1,antagonist,yes
DB11799,Bictegravir,small molecule,approved;investigational,OC1=C2N(C[C@H]3O[C@@H]4CC[C@@H](C4)N3C2=O)C=C(C(=O)NCC2=C(F)C=C(F)C=C2F)C1=O,SOLUWJRYJLAZCX-LYOVBCGYSA-N,449.386,Q7ZJM1,BE0004855,Integrase,Human immunodeficiency virus 1,antagonist,yes
DB11800,Tivozanib,small molecule,approved;investigational,COC1=C(OC)C=C2C(OC3=CC(Cl)=C(NC(=O)NC4=NOC(C)=C4)C=C3)=CC=NC2=C1,SPMVMDHWKHCIDT-UHFFFAOYSA-N,454.863,P17948,BE0000029,Vascular endothelial growth factor receptor 1,Humans,inhibitor,yes
DB11800,Tivozanib,small molecule,approved;investigational,COC1=C(OC)C=C2C(OC3=CC(Cl)=C(NC(=O)NC4=NOC(C)=C4)C=C3)=CC=NC2=C1,SPMVMDHWKHCIDT-UHFFFAOYSA-N,454.863,P35968,BE0000369,Vascular endothelial growth factor receptor 2,Humans,inhibitor,yes
DB11800,Tivozanib,small molecule,approved;investigational,COC1=C(OC)C=C2C(OC3=CC(Cl)=C(NC(=O)NC4=NOC(C)=C4)C=C3)=CC=NC2=C1,SPMVMDHWKHCIDT-UHFFFAOYSA-N,454.863,P35916,BE0000023,Vascular endothelial growth factor receptor 3,Humans,inhibitor,yes
DB11800,Tivozanib,small molecule,approved;investigational,COC1=C(OC)C=C2C(OC3=CC(Cl)=C(NC(=O)NC4=NOC(C)=C4)C=C3)=CC=NC2=C1,SPMVMDHWKHCIDT-UHFFFAOYSA-N,454.863,P10721,BE0000453,Mast/stem cell growth factor receptor Kit,Humans,inhibitor,yes
DB11800,Tivozanib,small molecule,approved;investigational,COC1=C(OC)C=C2C(OC3=CC(Cl)=C(NC(=O)NC4=NOC(C)=C4)C=C3)=CC=NC2=C1,SPMVMDHWKHCIDT-UHFFFAOYSA-N,454.863,P09619,BE0000205,Platelet-derived growth factor receptor beta,Humans,inhibitor,yes
DB11805,Saracatinib,small molecule,investigational,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,OUKYUETWWIPKQR-UHFFFAOYSA-N,542.026,P12931,BE0000838,Proto-oncogene tyrosine-protein kinase Src,Humans,modulator,yes
DB11805,Saracatinib,small molecule,investigational,CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1,OUKYUETWWIPKQR-UHFFFAOYSA-N,542.026,P00519,BE0000014,Tyrosine-protein kinase ABL1,Humans,modulator,yes
DB11806,VTP-194204,small molecule,investigational,C\C(\C=C\[C@@H]1C[C@]1(C)C1=CC=C2C(=C1)C(C)(C)CCC2(C)C)=C/C(O)=O,BOOOLEGQBVUTKC-NVQSDHBMSA-N,352.518,P48443,BE0000707,Retinoic acid receptor RXR-gamma,Humans,modulator,yes
DB11807,Dexmecamylamine,small molecule,investigational,CN[C@@]1(C)[C@@H]2CC[C@@H](C2)C1(C)C,IMYZQPCYWPFTAG-NGZCFLSTSA-N,167.296,P17787,BE0000850,Neuronal acetylcholine receptor subunit beta-2,Humans,antagonist,yes
DB11808,Faldaprevir,small molecule,investigational,COC1=C(Br)C2=C(C=C1)C(O[C@@H]1C[C@H](N(C1)C(=O)[C@@H](NC(=O)OC1CCCC1)C(C)(C)C)C(=O)N[C@@]1(C[C@H]1C=C)C(O)=O)=CC(=N2)C1=CSC(NC(=O)C(C)C)=N1,LLGDPTDZOVKFDU-XUHJSTDZSA-N,869.821,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB11811,Arhalofenate,small molecule,investigational,CC(=O)NCCOC(=O)[C@H](OC1=CC=CC(=C1)C(F)(F)F)C1=CC=C(Cl)C=C1,BJBCSGQLZQGGIQ-QGZVFWFLSA-N,415.79,P37231,BE0000215,Peroxisome proliferator-activated receptor gamma,Humans,agonist,yes
DB11813,Mipsagargin,small molecule,investigational,CCCCCCCC(=O)O[C@@H]1[C@@H](OC(=O)C(\C)=C/C)C(C)=C2[C@@H]3OC(=O)[C@@](C)(O)[C@@]3(O)[C@H](C[C@](C)(OC(C)=O)[C@@H]12)OC(=O)CCCCCCCCCCCNC(=O)C[C@H](N)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCC(O)=O)C(O)=O)C(O)=O)C(O)=O)C(O)=O,UPYNTAIBQVNPIH-ODMLWHIESA-N,1409.541,Q04609,BE0000568,Glutamate carboxypeptidase 2,Humans,inhibitor,yes
DB11814,PF-03882845,small molecule,investigational,OC(=O)C1=CC2=C(C=C1)C1=NN([C@@H](C3CCCC3)[C@H]1CC2)C1=CC=C(C#N)C(Cl)=C1,XNULRSOGWPFPBL-REWPJTCUSA-N,419.91,P08235,BE0000668,Mineralocorticoid receptor,Humans,modulator,yes
DB11815,Tilarginine,small molecule,approved;investigational,CNC(=N)NCCC[C@H](N)C(O)=O,NTNWOCRCBQPEKQ-YFKPBYRVSA-N,188.2275,P29474,BE0000263,Nitric oxide synthase 3,Humans,modulator,yes
DB11816,Omecamtiv Mecarbil,small molecule,investigational,COC(=O)N1CCN(CC2=C(F)C(NC(=O)NC3=CC=C(C)N=C3)=CC=C2)CC1,RFUBTTPMWSKEIW-UHFFFAOYSA-N,401.442,Q14896,BE0014590,"Myosin-binding protein C, cardiac-type",Humans,modulator,yes
DB11817,Baricitinib,small molecule,approved;investigational,CCS(=O)(=O)N1CC(CC#N)(C1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1,XUZMWHLSFXCVMG-UHFFFAOYSA-N,371.42,P23458,BE0004145,Tyrosine-protein kinase JAK1,Humans,inhibitor,yes
DB11817,Baricitinib,small molecule,approved;investigational,CCS(=O)(=O)N1CC(CC#N)(C1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1,XUZMWHLSFXCVMG-UHFFFAOYSA-N,371.42,O60674,BE0002408,Tyrosine-protein kinase JAK2,Humans,inhibitor,yes
DB11817,Baricitinib,small molecule,approved;investigational,CCS(=O)(=O)N1CC(CC#N)(C1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1,XUZMWHLSFXCVMG-UHFFFAOYSA-N,371.42,P52333,BE0003493,Tyrosine-protein kinase JAK3,Humans,inhibitor,yes
DB11818,Retosiban,small molecule,investigational,CC[C@H](C)[C@H]1N([C@@H](C(=O)N2CCOCC2)C2=COC(C)=N2)C(=O)[C@H](NC1=O)C1CC2=CC=CC=C2C1,PLVGDGRBPMVYPB-FDUHJNRSSA-N,494.592,P30559,BE0000844,Oxytocin receptor,Humans,modulator,yes
DB11819,ASP-4058,small molecule,investigational,C[C@H](OC1=CC=C(C=C1C(F)(F)F)C1=NC(=NO1)C1=CC=C2NC=NC2=C1)C(F)(F)F,NJNXCJPSMWKXHO-VIFPVBQESA-N,442.321,P21453,BE0008652,Sphingosine 1-phosphate receptor 1,Humans,modulator,yes
DB11819,ASP-4058,small molecule,investigational,C[C@H](OC1=CC=C(C=C1C(F)(F)F)C1=NC(=NO1)C1=CC=C2NC=NC2=C1)C(F)(F)F,NJNXCJPSMWKXHO-VIFPVBQESA-N,442.321,Q9H228,BE0002432,Sphingosine 1-phosphate receptor 5,Humans,modulator,yes
DB11822,TMC-647055,small molecule,investigational,COC1=CC=C2C3=C(C4CCCCC4)C4=CC=C5C=C4N3CC(=CC2=C1)C(=O)N(C)CCOCCN(C)S(=O)(=O)NC5=O,UOBYJVFBFSLCTQ-UHFFFAOYSA-N,606.74,P26664,BE0003427,Genome polyprotein,,inhibitor,yes
DB11823,Esketamine,small molecule,approved;investigational,CN[C@@]1(CCCCC1=O)C1=CC=CC=C1Cl,YQEZLKZALYSWHR-ZDUSSCGKSA-N,237.73,Q05586,BE0004956,NMDA receptor,Humans,antagonist,yes
DB11823,Esketamine,small molecule,approved;investigational,CN[C@@]1(CCCCC1=O)C1=CC=CC=C1Cl,YQEZLKZALYSWHR-ZDUSSCGKSA-N,237.73,Q13224,BE0000417,"Glutamate receptor ionotropic, NMDA 2B",Humans,antagonist,yes
DB11825,Mirogabalin,small molecule,investigational,CCC1=C[C@@H]2[C@@H](C[C@]2(CN)CC(O)=O)C1,FTBQORVNHOIASH-CKYFFXLPSA-N,209.289,P54289,BE0000691,Voltage-dependent calcium channel subunit alpha-2/delta-1,Humans,modulator,yes
DB11827,Ertugliflozin,small molecule,approved;investigational,CCOC1=CC=C(CC2=CC(=CC=C2Cl)[C@]23OC[C@](CO)(O2)[C@@H](O)[C@H](O)[C@H]3O)C=C1,MCIACXAZCBVDEE-CUUWFGFTSA-N,436.89,P31639,BE0004753,Sodium/glucose cotransporter 2,Humans,inhibitor,yes
DB11828,Neratinib,small molecule,approved;investigational,CCOC1=C(NC(=O)\C=C\CN(C)C)C=C2C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C(C=NC2=C1)C#N,JWNPDZNEKVCWMY-VQHVLOKHSA-N,557.05,P35968,BE0000369,Vascular endothelial growth factor receptor 2,Humans,inhibitor,yes
DB11828,Neratinib,small molecule,approved;investigational,CCOC1=C(NC(=O)\C=C\CN(C)C)C=C2C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C(C=NC2=C1)C#N,JWNPDZNEKVCWMY-VQHVLOKHSA-N,557.05,P04626,BE0000511,Receptor tyrosine-protein kinase erbB-2,Humans,inhibitor,yes
DB11828,Neratinib,small molecule,approved;investigational,CCOC1=C(NC(=O)\C=C\CN(C)C)C=C2C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C(C=NC2=C1)C#N,JWNPDZNEKVCWMY-VQHVLOKHSA-N,557.05,P00533,BE0000767,Epidermal growth factor receptor,Humans,inhibitor,yes
DB11829,Ruboxistaurin,small molecule,investigational,CN(C)C[C@@H]1CCN2C=C(C3=C2C=CC=C3)C2=C(C(=O)NC2=O)C2=CN(CCO1)C1=C2C=CC=C1,ZCBUQCWBWNUWSU-SFHVURJKSA-N,468.5469,Q9HBH1,BE0002201,"Peptide deformylase, mitochondrial",Humans,inhibitor,yes
DB11829,Ruboxistaurin,small molecule,investigational,CN(C)C[C@@H]1CCN2C=C(C3=C2C=CC=C3)C2=C(C(=O)NC2=O)C2=CN(CCO1)C1=C2C=CC=C1,ZCBUQCWBWNUWSU-SFHVURJKSA-N,468.5469,P05771,BE0000872,Protein kinase C beta type,Humans,inhibitor,yes
DB11830,Mocetinostat,small molecule,investigational,NC1=CC=CC=C1NC(=O)C1=CC=C(CNC2=NC=CC(=N2)C2=CC=CN=C2)C=C1,HRNLUBSXIHFDHP-UHFFFAOYSA-N,396.454,Q13547,BE0002365,Histone deacetylase 1,Humans,inhibitor,yes
DB11832,Crenolanib,small molecule,investigational,CC1(COC2=CC=C3N(C=NC3=C2)C2=CC=C3C=CC=C(N4CCC(N)CC4)C3=N2)COC1,DYNHJHQFHQTFTP-UHFFFAOYSA-N,443.551,P16234,BE0000852,Platelet-derived growth factor receptor alpha,Humans,modulator,yes
DB11832,Crenolanib,small molecule,investigational,CC1(COC2=CC=C3N(C=NC3=C2)C2=CC=C3C=CC=C(N4CCC(N)CC4)C3=N2)COC1,DYNHJHQFHQTFTP-UHFFFAOYSA-N,443.551,P12931,BE0000838,Proto-oncogene tyrosine-protein kinase Src,Humans,inhibitor,yes
DB11833,Basimglurant,small molecule,investigational,CC1=NC(C#CC2=CC=NC(Cl)=C2)=C(C)N1C1=CC=C(F)C=C1,UPZWINBEAHDTLA-UHFFFAOYSA-N,325.77,P41594,BE0001192,Metabotropic glutamate receptor 5,Humans,antagonist,yes
DB11836,Sapanisertib,small molecule,investigational,CC(C)N1N=C(C2=C(N)N=CN=C12)C1=CC=C2OC(N)=NC2=C1,GYLDXIAOMVERTK-UHFFFAOYSA-N,309.333,P42345,BE0002386,Serine/threonine-protein kinase mTOR,Humans,inhibitor,yes
DB11837,Osilodrostat,small molecule,approved;investigational,FC1=C(C=CC(=C1)C#N)[C@H]1CCC2=CN=CN12,USUZGMWDZDXMDG-CYBMUJFWSA-N,227.242,P15538,BE0000731,"Cytochrome P450 11B1, mitochondrial",Humans,inhibitor,yes
DB11838,Revamilast,small molecule,investigational,[O-][N+]1=CC(Cl)=C(NC(=O)C2=CC=C(OC(F)F)C3=C2C2=CN=CC=C2O3)C(Cl)=C1,IXQHNBONEVULTL-UHFFFAOYSA-N,440.18,Q08499,BE0001287,"3',5'-cyclic-AMP phosphodiesterase 4D",Humans,inhibitor,yes
DB11838,Revamilast,small molecule,investigational,[O-][N+]1=CC(Cl)=C(NC(=O)C2=CC=C(OC(F)F)C3=C2C2=CN=CC=C2O3)C(Cl)=C1,IXQHNBONEVULTL-UHFFFAOYSA-N,440.18,Q07343,BE0000487,"3',5'-cyclic-AMP phosphodiesterase 4B",Humans,inhibitor,yes
DB11838,Revamilast,small molecule,investigational,[O-][N+]1=CC(Cl)=C(NC(=O)C2=CC=C(OC(F)F)C3=C2C2=CN=CC=C2O3)C(Cl)=C1,IXQHNBONEVULTL-UHFFFAOYSA-N,440.18,P27815,BE0001133,"3',5'-cyclic-AMP phosphodiesterase 4A",Humans,inhibitor,yes
DB11839,PZ-128,small molecule,investigational,CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(N)=O,VZRIKWNVDCTBTF-BKGFHLQYSA-N,1086.479,P25116,BE0000928,Proteinase-activated receptor 1,Humans,antagonist,yes
DB11841,Entinostat,small molecule,investigational,NC1=CC=CC=C1NC(=O)C1=CC=C(CNC(=O)OCC2=CN=CC=C2)C=C1,INVTYAOGFAGBOE-UHFFFAOYSA-N,376.416,Q13547,BE0008667,Histone deacetylase,Humans,inhibitor,yes
DB11841,Entinostat,small molecule,investigational,NC1=CC=CC=C1NC(=O)C1=CC=C(CNC(=O)OCC2=CN=CC=C2)C=C1,INVTYAOGFAGBOE-UHFFFAOYSA-N,376.416,Q13547,BE0002365,Histone deacetylase 1,Humans,inhibitor,yes
DB11845,Lucitanib,small molecule,investigational,CNC(=O)C1=C2C=CC(OC3=C4C=C(OC)C(OCC5(N)CC5)=CC4=NC=C3)=CC2=CC=C1,CUDVHEFYRIWYQD-UHFFFAOYSA-N,443.503,P11362,BE0002131,Fibroblast growth factor receptor 1,Humans,inhibitor,yes
DB11845,Lucitanib,small molecule,investigational,CNC(=O)C1=C2C=CC(OC3=C4C=C(OC)C(OCC5(N)CC5)=CC4=NC=C3)=CC2=CC=C1,CUDVHEFYRIWYQD-UHFFFAOYSA-N,443.503,P21802,BE0000748,Fibroblast growth factor receptor 2,Humans,inhibitor,yes
DB11845,Lucitanib,small molecule,investigational,CNC(=O)C1=C2C=CC(OC3=C4C=C(OC)C(OCC5(N)CC5)=CC4=NC=C3)=CC2=CC=C1,CUDVHEFYRIWYQD-UHFFFAOYSA-N,443.503,P35968,BE0000369,Vascular endothelial growth factor receptor 2,Humans,inhibitor,yes
DB11845,Lucitanib,small molecule,investigational,CNC(=O)C1=C2C=CC(OC3=C4C=C(OC)C(OCC5(N)CC5)=CC4=NC=C3)=CC2=CC=C1,CUDVHEFYRIWYQD-UHFFFAOYSA-N,443.503,P16234,BE0000852,Platelet-derived growth factor receptor alpha,Humans,inhibitor,yes
DB11845,Lucitanib,small molecule,investigational,CNC(=O)C1=C2C=CC(OC3=C4C=C(OC)C(OCC5(N)CC5)=CC4=NC=C3)=CC2=CC=C1,CUDVHEFYRIWYQD-UHFFFAOYSA-N,443.503,P22607,BE0002133,Fibroblast growth factor receptor 3,Humans,inhibitor,yes
DB11845,Lucitanib,small molecule,investigational,CNC(=O)C1=C2C=CC(OC3=C4C=C(OC)C(OCC5(N)CC5)=CC4=NC=C3)=CC2=CC=C1,CUDVHEFYRIWYQD-UHFFFAOYSA-N,443.503,P35916,BE0000023,Vascular endothelial growth factor receptor 3,Humans,inhibitor,yes
DB11845,Lucitanib,small molecule,investigational,CNC(=O)C1=C2C=CC(OC3=C4C=C(OC)C(OCC5(N)CC5)=CC4=NC=C3)=CC2=CC=C1,CUDVHEFYRIWYQD-UHFFFAOYSA-N,443.503,P09619,BE0000205,Platelet-derived growth factor receptor beta,Humans,inhibitor,yes
DB11845,Lucitanib,small molecule,investigational,CNC(=O)C1=C2C=CC(OC3=C4C=C(OC)C(OCC5(N)CC5)=CC4=NC=C3)=CC2=CC=C1,CUDVHEFYRIWYQD-UHFFFAOYSA-N,443.503,P17948,BE0000029,Vascular endothelial growth factor receptor 1,Humans,inhibitor,yes
DB11848,Mannose 6-phosphate,small molecule,investigational,[H][C@@](O)(COP(O)(O)=O)[C@@]([H])(O)[C@]([H])(O)[C@]([H])(O)C=O,VFRROHXSMXFLSN-KVTDHHQDSA-N,260.1358,P11717,BE0003623,Cation-independent mannose-6-phosphate receptor,Humans,modulator,yes
DB11851,Bafetinib,small molecule,investigational,CN(C)[C@H]1CCN(CC2=C(C=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CN=C3)=C2)C(F)(F)F)C1,ZGBAJMQHJDFTQJ-DEOSSOPVSA-N,576.6153,P07948,BE0004315,Tyrosine-protein kinase Lyn,Humans,modulator,yes
DB11852,Tegobuvir,small molecule,investigational,FC1=CC=CC=C1C1=NC2=CN(CC3=CC=C(N=N3)C3=CC=C(C=C3C(F)(F)F)C(F)(F)F)C=CC2=N1,XBEQSQDCBSKCHJ-UHFFFAOYSA-N,517.411,P26664,BE0003427,Genome polyprotein,,inhibitor,yes
DB11853,Relugolix,small molecule,approved;investigational,CONC(=O)NC1=CC=C(C=C1)C1=C(CN(C)C)C2=C(S1)N(CC1=C(F)C=CC=C1F)C(=O)N(C2=O)C1=CC=C(OC)N=N1,AOMXMOCNKJTRQP-UHFFFAOYSA-N,623.64,P30968,BE0000203,Gonadotropin-releasing hormone receptor,Humans,antagonist,yes
DB11855,Revefenacin,small molecule,approved;investigational,CN(CCN1CCC(CC1)OC(=O)NC1=CC=CC=C1C1=CC=CC=C1)C(=O)C1=CC=C(CN2CCC(CC2)C(N)=O)C=C1,FYDWDCIFZSGNBU-UHFFFAOYSA-N,597.76,P11229,BE0004890,Muscarinic acetylcholine receptor,Humans,antagonist,yes
DB11858,Leukotriene D4,small molecule,investigational,CCCCC\C=C/C\C=C/C=C/C=C/[C@@H](SC[C@H](N)C(=O)NCC(O)=O)[C@@H](O)CCCC(O)=O,YEESKJGWJFYOOK-IJHYULJSSA-N,496.66,Q9Y271,BE0000705,Cysteinyl leukotriene receptor 1,Humans,agonist,yes
DB11858,Leukotriene D4,small molecule,investigational,CCCCC\C=C/C\C=C/C=C/C=C/[C@@H](SC[C@H](N)C(=O)NCC(O)=O)[C@@H](O)CCCC(O)=O,YEESKJGWJFYOOK-IJHYULJSSA-N,496.66,Q9NS75,BE0000099,Cysteinyl leukotriene receptor 2,Humans,agonist,yes
DB11859,Brexanolone,small molecule,approved;investigational,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(C)=O,AURFZBICLPNKBZ-SYBPFIFISA-N,318.4935,O14764,BE0003599,Gamma-aminobutyric acid receptor subunit delta,Humans,inhibitor,yes
DB11859,Brexanolone,small molecule,approved;investigational,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(C)=O,AURFZBICLPNKBZ-SYBPFIFISA-N,318.4935,Q99928,BE0003594,Gamma-aminobutyric acid receptor subunit gamma-3,Humans,modulator,yes
DB11859,Brexanolone,small molecule,approved;investigational,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(C)=O,AURFZBICLPNKBZ-SYBPFIFISA-N,318.4935,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB11859,Brexanolone,small molecule,approved;investigational,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(C)=O,AURFZBICLPNKBZ-SYBPFIFISA-N,318.4935,P18507,BE0003592,Gamma-aminobutyric acid receptor subunit gamma-2,Humans,inhibitor,yes
DB11859,Brexanolone,small molecule,approved;investigational,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(C)=O,AURFZBICLPNKBZ-SYBPFIFISA-N,318.4935,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,inhibitor,yes
DB11859,Brexanolone,small molecule,approved;investigational,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(C)=O,AURFZBICLPNKBZ-SYBPFIFISA-N,318.4935,P47870,BE0002346,Gamma-aminobutyric acid receptor subunit beta-2,Humans,inhibitor,yes
DB11861,Litronesib,small molecule,investigational,CCNCCS(=O)(=O)NC[C@]1(SC(NC(=O)C(C)(C)C)=NN1C(=O)C(C)(C)C)C1=CC=CC=C1,YVAFBXLHPINSIK-QHCPKHFHSA-N,511.7,P52732,BE0001852,Kinesin-like protein KIF11,Humans,modulator,yes
DB11863,Alvelestat,small molecule,investigational,CN1N=CC=C1C1=C(C)N(C2=CC=CC(=C2)C(F)(F)F)C(=O)C(=C1)C(=O)NCC1=NC=C(C=C1)S(C)(=O)=O,QNQZWEGMKJBHEM-UHFFFAOYSA-N,545.54,P08246,BE0000394,Neutrophil elastase,Humans,inhibitor,yes
DB11864,Preladenant,small molecule,investigational,COCCOC1=CC=C(C=C1)N1CCN(CCN2N=CC3=C2N=C(N)N2N=C(N=C32)C2=CC=CO2)CC1,DTYWJKSSUANMHD-UHFFFAOYSA-N,503.567,P29274,BE0000924,Adenosine receptor A2a,Humans,antagonist,yes
DB11865,Brivanib alaninate,small molecule,investigational,C[C@H](COC1=CN2N=CN=C(OC3=CC=C4NC(C)=CC4=C3F)C2=C1C)OC(=O)[C@H](C)N,LTEJRLHKIYCEOX-OCCSQVGLSA-N,441.463,P22607,BE0002133,Fibroblast growth factor receptor 3,Humans,inhibitor,yes
DB11867,JNJ-39393406,small molecule,investigational,CN(C)C(=O)CCN1N=C(NC2=CC=C3OC(F)(F)OC3=C2)N=C1C1=CC=NC=C1,IURMHZBQEYNQOH-UHFFFAOYSA-N,416.389,P36544,BE0002341,Neuronal acetylcholine receptor subunit alpha-7,Humans,modulator,yes
DB11869,Valspodar,small molecule,investigational,C\C=C\C[C@@H](C)C(=O)[C@@H]1N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@@H](NC1=O)C(C)C)C(C)C,YJDYDFNKCBANTM-QCWCSKBGSA-N,1214.646,P00742,BE0000216,Coagulation factor X,Humans,inhibitor,yes
DB11870,RG-4733,small molecule,investigational,CC(C)(C(=O)NCC(F)(F)C(F)(F)F)C(=O)N[C@H]1C2=CC=CC=C2C2=CC=CC=C2NC1=O,OJPLJFIFUQPSJR-INIZCTEOSA-N,469.412,Q8WW43,BE0017533,Gamma-secretase subunit APH-1B,Humans,modulator,yes
DB11870,RG-4733,small molecule,investigational,CC(C)(C(=O)NCC(F)(F)C(F)(F)F)C(=O)N[C@H]1C2=CC=CC=C2C2=CC=CC=C2NC1=O,OJPLJFIFUQPSJR-INIZCTEOSA-N,469.412,Q92542,BE0017775,Nicastrin,Humans,modulator,yes
DB11870,RG-4733,small molecule,investigational,CC(C)(C(=O)NCC(F)(F)C(F)(F)F)C(=O)N[C@H]1C2=CC=CC=C2C2=CC=CC=C2NC1=O,OJPLJFIFUQPSJR-INIZCTEOSA-N,469.412,Q96BI3,BE0003409,Gamma-secretase subunit APH-1A,Humans,modulator,yes
DB11870,RG-4733,small molecule,investigational,CC(C)(C(=O)NCC(F)(F)C(F)(F)F)C(=O)N[C@H]1C2=CC=CC=C2C2=CC=CC=C2NC1=O,OJPLJFIFUQPSJR-INIZCTEOSA-N,469.412,Q9NZ42,BE0003410,Gamma-secretase subunit PEN-2,Humans,modulator,yes
DB11870,RG-4733,small molecule,investigational,CC(C)(C(=O)NCC(F)(F)C(F)(F)F)C(=O)N[C@H]1C2=CC=CC=C2C2=CC=CC=C2NC1=O,OJPLJFIFUQPSJR-INIZCTEOSA-N,469.412,P49768,BE0010960,Presenilin-1,Humans,modulator,yes
DB11871,PF-00610355,small molecule,investigational,CC(C)(CC1=CC=CC(CC(=O)NCC2=CC=CC(=C2)C2=CC=C(O)C=C2)=C1)NC[C@H](O)C1=CC=C(O)C(NS(C)(=O)=O)=C1,YPHDIMUXXABSSO-YTTGMZPUSA-N,617.76,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,agonist,yes
DB11873,Verinurad,small molecule,investigational,CC(C)(SC1=CC=NC=C1C1=C2C=CC=CC2=C(C=C1)C#N)C(O)=O,YYBOLPLTQDKXPM-UHFFFAOYSA-N,348.42,Q96S37,BE0004782,Solute carrier family 22 member 12,Humans,modulator,yes
DB11877,Basmisanil,small molecule,investigational,CC1=C(COC2=CC=C(C=N2)C(=O)N2CCS(=O)(=O)CC2)C(=NO1)C1=CC=C(F)C=C1,VCGRFBXVSFAGGA-UHFFFAOYSA-N,445.47,P31644,BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,Humans,modulator,yes
DB11878,Filibuvir,small molecule,investigational,CCC1=CC(CC[C@@]2(CC(O)=C(CC3=NN4C(=N3)N=C(C)C=C4C)C(=O)O2)C2CCCC2)=CC(CC)=N1,SLVAPEZTBDBAPI-GDLZYMKVSA-N,503.6358,P26664,BE0003427,Genome polyprotein,,inhibitor,yes
DB11883,SB-705498,small molecule,investigational,FC(F)(F)C1=CC=C(N=C1)N1CC[C@H](C1)NC(=O)NC1=CC=CC=C1Br,JYILLRHXRVTRSH-GFCCVEGCSA-N,429.241,Q8NER1,BE0001023,Transient receptor potential cation channel subfamily V member 1,Humans,blocker,yes
DB11885,Anlotinib,small molecule,investigational,COC1=CC2=C(OC3=CC=C4NC(C)=CC4=C3F)C=CN=C2C=C1OCC1(N)CC1,KSMZEXLVHXZPEF-UHFFFAOYSA-N,407.445,P12931,BE0000838,Proto-oncogene tyrosine-protein kinase Src,Humans,inhibitor,yes
DB11886,Infigratinib,small molecule,approved;investigational,CCN1CCN(CC1)C1=CC=C(NC2=CC(=NC=N2)N(C)C(=O)NC2=C(Cl)C(OC)=CC(OC)=C2Cl)C=C1,QADPYRIHXKWUSV-UHFFFAOYSA-N,560.475,P11362,BE0002131,Fibroblast growth factor receptor 1,Humans,inhibitor,yes
DB11886,Infigratinib,small molecule,approved;investigational,CCN1CCN(CC1)C1=CC=C(NC2=CC(=NC=N2)N(C)C(=O)NC2=C(Cl)C(OC)=CC(OC)=C2Cl)C=C1,QADPYRIHXKWUSV-UHFFFAOYSA-N,560.475,P21802,BE0000748,Fibroblast growth factor receptor 2,Humans,inhibitor,yes
DB11886,Infigratinib,small molecule,approved;investigational,CCN1CCN(CC1)C1=CC=C(NC2=CC(=NC=N2)N(C)C(=O)NC2=C(Cl)C(OC)=CC(OC)=C2Cl)C=C1,QADPYRIHXKWUSV-UHFFFAOYSA-N,560.475,P22607,BE0002133,Fibroblast growth factor receptor 3,Humans,inhibitor,yes
DB11886,Infigratinib,small molecule,approved;investigational,CCN1CCN(CC1)C1=CC=C(NC2=CC(=NC=N2)N(C)C(=O)NC2=C(Cl)C(OC)=CC(OC)=C2Cl)C=C1,QADPYRIHXKWUSV-UHFFFAOYSA-N,560.475,P22455,BE0001203,Fibroblast growth factor receptor 4,Humans,inhibitor,yes
DB11891,Fimepinostat,small molecule,investigational,COC1=CC=C(C=N1)C1=NC(N2CCOCC2)=C2SC(CN(C)C3=NC=C(C=N3)C(=O)NO)=CC2=N1,JOWXJLIFIIOYMS-UHFFFAOYSA-N,508.56,P48736,BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",Humans,modulator,yes
DB11892,Prulifloxacin,small molecule,investigational,CC1SC2=C(C(O)=O)C(=O)C3=CC(F)=C(C=C3N12)N1CCN(CC2=C(C)OC(=O)O2)CC1,PWNMXPDKBYZCOO-UHFFFAOYSA-N,461.46,P0AFI2,BE0000798,DNA topoisomerase 4 subunit A,Escherichia coli (strain K12),inhibitor,yes
DB11892,Prulifloxacin,small molecule,investigational,CC1SC2=C(C(O)=O)C(=O)C3=CC(F)=C(C=C3N12)N1CCN(CC2=C(C)OC(=O)O2)CC1,PWNMXPDKBYZCOO-UHFFFAOYSA-N,461.46,P20831,BE0008385,DNA gyrase subunit A,Staphylococcus aureus,inhibitor,yes
DB11892,Prulifloxacin,small molecule,investigational,CC1SC2=C(C(O)=O)C(=O)C3=CC(F)=C(C=C3N12)N1CCN(CC2=C(C)OC(=O)O2)CC1,PWNMXPDKBYZCOO-UHFFFAOYSA-N,461.46,P0A0K8,BE0002388,DNA gyrase subunit B,Staphylococcus aureus,inhibitor,yes
DB11893,Avagacestat,small molecule,investigational,NC(=O)[C@@H](CCC(F)(F)F)N(CC1=CC=C(C=C1F)C1=NOC=N1)S(=O)(=O)C1=CC=C(Cl)C=C1,XEAOPVUAMONVLA-QGZVFWFLSA-N,520.88,Q96BI3,BE0003409,Gamma-secretase subunit APH-1A,Humans,modulator,yes
DB11893,Avagacestat,small molecule,investigational,NC(=O)[C@@H](CCC(F)(F)F)N(CC1=CC=C(C=C1F)C1=NOC=N1)S(=O)(=O)C1=CC=C(Cl)C=C1,XEAOPVUAMONVLA-QGZVFWFLSA-N,520.88,Q92542,BE0017775,Nicastrin,Humans,modulator,yes
DB11893,Avagacestat,small molecule,investigational,NC(=O)[C@@H](CCC(F)(F)F)N(CC1=CC=C(C=C1F)C1=NOC=N1)S(=O)(=O)C1=CC=C(Cl)C=C1,XEAOPVUAMONVLA-QGZVFWFLSA-N,520.88,Q8WW43,BE0017533,Gamma-secretase subunit APH-1B,Humans,modulator,yes
DB11893,Avagacestat,small molecule,investigational,NC(=O)[C@@H](CCC(F)(F)F)N(CC1=CC=C(C=C1F)C1=NOC=N1)S(=O)(=O)C1=CC=C(Cl)C=C1,XEAOPVUAMONVLA-QGZVFWFLSA-N,520.88,Q9NZ42,BE0003410,Gamma-secretase subunit PEN-2,Humans,modulator,yes
DB11893,Avagacestat,small molecule,investigational,NC(=O)[C@@H](CCC(F)(F)F)N(CC1=CC=C(C=C1F)C1=NOC=N1)S(=O)(=O)C1=CC=C(Cl)C=C1,XEAOPVUAMONVLA-QGZVFWFLSA-N,520.88,P49768,BE0010960,Presenilin-1,Humans,modulator,yes
DB11894,Efatutazone,small molecule,investigational,CN1C(COC2=CC=C(CC3SC(=O)NC3=O)C=C2)=NC2=CC=C(OC3=CC(C)=C(N)C(C)=C3)C=C12,JCYNMRJCUYVDBC-UHFFFAOYSA-N,502.59,P37231,BE0000215,Peroxisome proliferator-activated receptor gamma,Humans,agonist,yes
DB11896,Gedatolisib,small molecule,investigational,CN(C)C1CCN(CC1)C(=O)C1=CC=C(NC(=O)NC2=CC=C(C=C2)C2=NC(=NC(=N2)N2CCOCC2)N2CCOCC2)C=C1,DWZAEMINVBZMHQ-UHFFFAOYSA-N,615.739,P42345,BE0002386,Serine/threonine-protein kinase mTOR,Humans,modulator,yes
DB11896,Gedatolisib,small molecule,investigational,CN(C)C1CCN(CC1)C(=O)C1=CC=C(NC(=O)NC2=CC=C(C=C2)C2=NC(=NC(=N2)N2CCOCC2)N2CCOCC2)C=C1,DWZAEMINVBZMHQ-UHFFFAOYSA-N,615.739,P48736,BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",Humans,modulator,yes
DB11899,MK-8776,small molecule,investigational,CN1C=C(C=N1)C1=C2N=C([C@@H]3CCCNC3)C(Br)=C(N)N2N=C1,GMIZZEXBPRLVIV-SECBINFHSA-N,376.262,O14757,BE0003382,Serine/threonine-protein kinase Chk1,Humans,inhibitor,yes
DB11900,OC-459,small molecule,investigational,CC1=C(CC2=CC=C3C=CC=CC3=N2)C2=CC(F)=CC=C2N1CC(O)=O,FATGTHLOZSXOBC-UHFFFAOYSA-N,348.377,Q9Y5Y4,BE0003561,Prostaglandin D2 receptor 2,Humans,antagonist,yes
DB11901,Apalutamide,small molecule,approved;investigational,CNC(=O)C1=CC=C(C=C1F)N1C(=S)N(C(=O)C11CCC1)C1=CC(=C(N=C1)C#N)C(F)(F)F,HJBWBFZLDZWPHF-UHFFFAOYSA-N,477.44,P10275,BE0000132,Androgen receptor,Humans,antagonist,yes
DB11902,Gisadenafil,small molecule,investigational,CCOC1=NC=C(C=C1C1=NC2=C(CC)N(CCOC)N=C2C(=O)N1)S(=O)(=O)N1CCN(CC)CC1,YPFZMBHKIVDSNR-UHFFFAOYSA-N,519.62,O76074,BE0000182,"cGMP-specific 3',5'-cyclic phosphodiesterase",Humans,inhibitor,yes
DB11903,GW842166,small molecule,investigational,FC(F)(F)C1=NC(NC2=C(Cl)C=C(Cl)C=C2)=NC=C1C(=O)NCC1CCOCC1,TWQYWUXBZHPIIV-UHFFFAOYSA-N,449.26,P34972,BE0000095,Cannabinoid receptor 2,Humans,agonist,yes
DB11904,Flumatinib,small molecule,investigational,CN1CCN(CC2=CC=C(C=C2C(F)(F)F)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CC=CN=C3)=C(C)N=C2)CC1,BJCJYEYYYGBROF-UHFFFAOYSA-N,562.601,P00519,BE0000014,Tyrosine-protein kinase ABL1,Humans,inhibitor,yes
DB11906,Acyline,small molecule,investigational,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC=C(NC(C)=O)C=C1)NC(=O)[C@H](CC1=CC=C(NC(C)=O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1=CC=CN=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC=C2C=CC=CC2=C1)NC(C)=O)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,ZWNUQDJANZGVFO-YHSALVGYSA-N,1533.24,P30968,BE0000203,Gonadotropin-releasing hormone receptor,Humans,inhibitor,yes
DB11907,Rociletinib,small molecule,investigational,COC1=CC(=CC=C1NC1=NC=C(C(NC2=CC=CC(NC(=O)C=C)=C2)=N1)C(F)(F)F)N1CCN(CC1)C(C)=O,HUFOZJXAKZVRNJ-UHFFFAOYSA-N,555.562,P00533,BE0000767,Epidermal growth factor receptor,Humans,modulator,yes
DB11910,MK-0249,small molecule,investigational,CC1=NC2=CC=CC(=C2C(=O)N1C1=CC=C(OCCCN2CCCC2)C=C1)C(F)(F)F,DDDZBLNULGDPGA-UHFFFAOYSA-N,431.459,Q9Y5N1,BE0000968,Histamine H3 receptor,Humans,agonist,yes
DB11911,Galunisertib,small molecule,investigational,CC1=CC=CC(=N1)C1=NN2CCCC2=C1C1=C2C=C(C=CC2=NC=C1)C(N)=O,IVRXNBXKWIJUQB-UHFFFAOYSA-N,369.428,P36897,BE0003782,TGF-beta receptor type-1,Humans,modulator,yes
DB11911,Galunisertib,small molecule,investigational,CC1=CC=CC(=N1)C1=NN2CCCC2=C1C1=C2C=C(C=CC2=NC=C1)C(N)=O,IVRXNBXKWIJUQB-UHFFFAOYSA-N,369.428,P01137,BE0000984,Transforming growth factor beta-1 proprotein,Humans,inhibitor,yes
DB11912,Lanopepden,small molecule,investigational,CC1=NC(NNC(=O)[C@H](CC2CCCC2)CN(O)C=O)=C(F)C(=N1)N1CCN2CCOC[C@@H]2C1,SWHNZGMQMGFQGW-MSOLQXFVSA-N,479.557,P68826,BE0002535,Peptide deformylase,Staphylococcus aureus,modulator,yes
DB11913,LY-2090314,small molecule,investigational,FC1=CC2=C3N(CCN(C2)C(=O)N2CCCCC2)C=C(C3=C1)C1=C(C(=O)NC1=O)C1=CN=C2C=CC=CN12,HRJWTAWVFDCTGO-UHFFFAOYSA-N,512.545,P49840,BE0009446,Glycogen synthase kinase-3 alpha,Humans,modulator,yes
DB11913,LY-2090314,small molecule,investigational,FC1=CC2=C3N(CCN(C2)C(=O)N2CCCCC2)C=C(C3=C1)C1=C(C(=O)NC1=O)C1=CN=C2C=CC=CN12,HRJWTAWVFDCTGO-UHFFFAOYSA-N,512.545,P49841,BE0001065,Glycogen synthase kinase-3 beta,Humans,modulator,yes
DB11915,Valbenazine,small molecule,approved;investigational,COC1=C(OC)C=C2[C@H]3C[C@@H](OC(=O)[C@@H](N)C(C)C)[C@H](CC(C)C)CN3CCC2=C1,GEJDGVNQKABXKG-CFKGEZKQSA-N,418.578,Q05940,BE0000118,Synaptic vesicular amine transporter,Humans,inhibitor,yes
DB11918,Guadecitabine,small molecule,investigational,NC1=NC(=O)C2=C(N1)N(C=N2)[C@H]1C[C@H](O)[C@@H](COP(O)(=O)O[C@H]2C[C@@H](O[C@@H]2CO)N2C=NC(N)=NC2=O)O1,GUWXKKAWLCENJA-WGWHJZDNSA-N,557.417,P26358,BE0000892,DNA (cytosine-5)-methyltransferase 1,Humans,inhibitor,yes
DB11919,6-O-benzylguanine,small molecule,investigational,NC1=NC(OCC2=CC=CC=C2)=C2N=CNC2=N1,KRWMERLEINMZFT-UHFFFAOYSA-N,241.2486,P16455,BE0001145,Methylated-DNA--protein-cysteine methyltransferase,Humans,inhibitor,yes
DB11920,Lesogaberan,small molecule,investigational,NC[C@@H](F)CP(O)=O,LJNUIEQATDYXJH-GSVOUGTGSA-N,141.082,Q9UBS5,BE0000217,Gamma-aminobutyric acid type B receptor subunit 1,Humans,modulator,yes
DB11920,Lesogaberan,small molecule,investigational,NC[C@@H](F)CP(O)=O,LJNUIEQATDYXJH-GSVOUGTGSA-N,141.082,O75899,BE0002340,Gamma-aminobutyric acid type B receptor subunit 2,Humans,modulator,yes
DB11921,Deflazacort,small molecule,approved;investigational,[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@]([H])(O)C[C@]3(C)[C@@]1(N=C(C)O2)C(=O)COC(C)=O,FBHSPRKOSMHSIF-GRMWVWQJSA-N,441.524,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB11922,Danirixin,small molecule,investigational,CC1=C(NC(=O)NC2=CC=C(Cl)C(=C2O)S(=O)(=O)[C@H]2CCCNC2)C=CC=C1F,NGYNBSHYFOFVLS-LBPRGKRZSA-N,441.9,P25025,BE0010516,C-X-C chemokine receptor type 2,Humans,modulator,yes
DB11923,Decoglurant,small molecule,investigational,NC1=CC=C(C=N1)C#CC1=C2N=C(C=C(N2N=C1)C(F)(F)F)C1=CC=C(C=C1)C(F)(F)F,DMJHZVARRXJSEG-UHFFFAOYSA-N,447.344,Q14832,BE0002342,Metabotropic glutamate receptor 3,Humans,modulator,yes
DB11923,Decoglurant,small molecule,investigational,NC1=CC=C(C=N1)C#CC1=C2N=C(C=C(N2N=C1)C(F)(F)F)C1=CC=C(C=C1)C(F)(F)F,DMJHZVARRXJSEG-UHFFFAOYSA-N,447.344,Q14416,BE0000974,Metabotropic glutamate receptor 2,Humans,modulator,yes
DB11925,Vistusertib,small molecule,investigational,CNC(=O)C1=CC(=CC=C1)C1=CC=C2C(N=C(N=C2N2CCOC[C@@H]2C)N2CCOC[C@@H]2C)=N1,JUSFANSTBFGBAF-IRXDYDNUSA-N,462.554,Q9BPZ7,BE0018900,Target of rapamycin complex 2 subunit MAPKAP1,Humans,inhibitor,yes
DB11925,Vistusertib,small molecule,investigational,CNC(=O)C1=CC(=CC=C1)C1=CC=C2C(N=C(N=C2N2CCOC[C@@H]2C)N2CCOC[C@@H]2C)=N1,JUSFANSTBFGBAF-IRXDYDNUSA-N,462.554,P42345,BE0002386,Serine/threonine-protein kinase mTOR,Humans,inhibitor,yes
DB11929,Vaniprevir,small molecule,investigational,[H][C@]1(C[C@@H]2CN1C(=O)[C@@H](NC(=O)OCC(C)(C)CCCCC1=C3CN(CC3=CC=C1)C(=O)O2)C(C)(C)C)C(=O)N[C@@]1(C[C@H]1CC)C(=O)NS(=O)(=O)C1CC1,KUQWGLQLLVFLSM-ONAXAZCASA-N,757.936,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB11934,Epelsiban,small molecule,investigational,CC[C@H](C)[C@H]1N([C@@H](C(=O)N2CCOCC2)C2=CC=C(C)N=C2C)C(=O)[C@H](NC1=O)C1CC2=CC=CC=C2C1,UWHCWRQFNKUYCG-QUZACWSFSA-N,518.658,P30559,BE0000844,Oxytocin receptor,Humans,antagonist,yes
DB11936,Bempedoic acid,small molecule,approved;investigational,CC(C)(CCCCCC(O)CCCCCC(C)(C)C(O)=O)C(O)=O,HYHMLYSLQUKXKP-UHFFFAOYSA-N,344.492,P53396,BE0009867,ATP-citrate synthase,Humans,inhibitor,yes
DB11937,Kynurenic Acid,small molecule,investigational,OC(=O)C1=CC(=O)C2=CC=CC=C2N1,HCZHHEIFKROPDY-UHFFFAOYSA-N,189.1675,Q05586,BE0000365,"Glutamate receptor ionotropic, NMDA 1",Humans,inhibitor,yes
DB11937,Kynurenic Acid,small molecule,investigational,OC(=O)C1=CC(=O)C2=CC=CC=C2N1,HCZHHEIFKROPDY-UHFFFAOYSA-N,189.1675,Q13224,BE0000417,"Glutamate receptor ionotropic, NMDA 2B",Humans,inhibitor,yes
DB11937,Kynurenic Acid,small molecule,investigational,OC(=O)C1=CC(=O)C2=CC=CC=C2N1,HCZHHEIFKROPDY-UHFFFAOYSA-N,189.1675,Q12879,BE0000760,"Glutamate receptor ionotropic, NMDA 2A",Humans,inhibitor,yes
DB11938,Difelikefalin,small molecule,approved;investigational,CC(C)C[C@@H](NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](N)CC1=CC=CC=C1)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O,FWMNVWWHGCHHJJ-SKKKGAJSSA-N,679.863,P41145,BE0000632,Kappa-type opioid receptor,Humans,agonist,yes
DB11940,Triapine,small molecule,investigational,NC(=S)N\N=C\C1=C(N)C=CC=N1,XMYKNCNAZKMVQN-NYYWCZLTSA-N,195.24,P31350,BE0002450,Ribonucleoside-diphosphate reductase subunit M2,Humans,modulator,yes
DB11942,Selinexor,small molecule,approved;investigational,FC(F)(F)C1=CC(=CC(=C1)C1=NN(\C=C/C(=O)NNC2=NC=CN=C2)C=N1)C(F)(F)F,DEVSOMFAQLZNKR-RJRFIUFISA-N,443.313,O14980,BE0009694,Exportin-1,Humans,inhibitor,yes
DB11943,Delafloxacin,small molecule,approved;investigational,NC1=NC(N2C=C(C(O)=O)C(=O)C3=CC(F)=C(N4CC(O)C4)C(Cl)=C23)=C(F)C=C1F,DYDCPNMLZGFQTM-UHFFFAOYSA-N,440.76,P0AFI2,BE0000798,DNA topoisomerase 4 subunit A,Escherichia coli (strain K12),inhibitor,yes
DB11943,Delafloxacin,small molecule,approved;investigational,NC1=NC(N2C=C(C(O)=O)C(=O)C3=CC(F)=C(N4CC(O)C4)C(Cl)=C23)=C(F)C=C1F,DYDCPNMLZGFQTM-UHFFFAOYSA-N,440.76,P0AES4,BE0008382,DNA gyrase subunit A,Escherichia coli (strain K12),inhibitor,yes
DB11946,AZD-1981,small molecule,investigational,CC(=O)NC1=C2C(=CC=C1)N(CC(O)=O)C(C)=C2SC1=CC=C(Cl)C=C1,JWYIGNODXSRKGP-UHFFFAOYSA-N,388.87,Q9Y5Y4,BE0003561,Prostaglandin D2 receptor 2,Humans,antagonist,yes
DB11947,Pridopidine,small molecule,investigational,CCCN1CCC(CC1)C1=CC=CC(=C1)S(C)(=O)=O,YGKUEOZJFIXDGI-UHFFFAOYSA-N,281.41,P14416,BE0000756,D(2) dopamine receptor,Humans,modulator,yes
DB11948,Lapachone,small molecule,investigational,CC1(C)CCC2=C(O1)C1=CC=CC=C1C(=O)C2=O,QZPQTZZNNJUOLS-UHFFFAOYSA-N,242.274,P11387,BE0000971,DNA topoisomerase 1,Humans,modulator,yes
DB11949,Vestipitant,small molecule,investigational,C[C@@H](N(C)C(=O)N1CCNC[C@@H]1C1=CC=C(F)C=C1C)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F,SBBYBXSFWOLDDG-JLTOFOAXSA-N,491.454,P25103,BE0000384,Substance-P receptor,Humans,antagonist,yes
DB11950,Teneligliptin,small molecule,investigational,[H][C@]1(CN[C@@]([H])(C1)C(=O)N1CCSC1)N1CCN(CC1)C1=CC(C)=NN1C1=CC=CC=C1,WGRQANOPCQRCME-PMACEKPBSA-N,426.578,P27487,BE0000854,Dipeptidyl peptidase 4,Humans,modulator,yes
DB11951,Lemborexant,small molecule,approved;investigational,CC1=NC=C(OC[C@]2(C[C@H]2C(=O)NC2=NC=C(F)C=C2)C2=CC=CC(F)=C2)C(C)=N1,MUGXRYIUWFITCP-PGRDOPGGSA-N,410.425,O43613,BE0005864,Orexin/Hypocretin receptor type 1,Humans,antagonist,yes
DB11951,Lemborexant,small molecule,approved;investigational,CC1=NC=C(OC[C@]2(C[C@H]2C(=O)NC2=NC=C(F)C=C2)C2=CC=CC(F)=C2)C(C)=N1,MUGXRYIUWFITCP-PGRDOPGGSA-N,410.425,O43614,BE0005865,Orexin receptor type 2,Humans,antagonist,yes
DB11952,Duvelisib,small molecule,approved;investigational,C[C@H](NC1=C2N=CNC2=NC=N1)C1=CC2=CC=CC(Cl)=C2C(=O)N1C1=CC=CC=C1,SJVQHLPISAIATJ-ZDUSSCGKSA-N,416.87,P48736,BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",Humans,inhibitor,yes
DB11952,Duvelisib,small molecule,approved;investigational,C[C@H](NC1=C2N=CNC2=NC=N1)C1=CC2=CC=CC(Cl)=C2C(=O)N1C1=CC=CC=C1,SJVQHLPISAIATJ-ZDUSSCGKSA-N,416.87,O00329,BE0002406,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",Humans,inhibitor,yes
DB11953,PF-04447943,small molecule,investigational,C[C@@H]1CN(CC2=NC=CC=N2)C[C@H]1C1=NC2=C(C=NN2C2CCOCC2)C(=O)N1,IWXUVYOOUMLUTQ-CZUORRHYSA-N,395.4582,O76083,BE0003134,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",Humans,inhibitor,yes
DB11954,Lomibuvir,small molecule,investigational,C[C@H]1CC[C@@H](CC1)C(=O)N([C@H]1CC[C@H](O)CC1)C1=C(SC(=C1)C#CC(C)(C)C)C(O)=O,WPMJNLCLKAKMLA-VVPTUSLJSA-N,445.62,P26664,BE0003427,Genome polyprotein,,inhibitor,yes
DB11958,Brivanib,small molecule,investigational,C[C@@H](O)COC1=CN2N=CN=C(OC3=CC=C4NC(C)=CC4=C3F)C2=C1C,WCWUXEGQKLTGDX-LLVKDONJSA-N,370.384,P35968,BE0000369,Vascular endothelial growth factor receptor 2,Humans,modulator,yes
DB11960,Carboxyamidotriazole,small molecule,investigational,NC(=O)C1=C(N)N(CC2=CC(Cl)=C(C(=O)C3=CC=C(Cl)C=C3)C(Cl)=C2)N=N1,WNRZHQBJSXRYJK-UHFFFAOYSA-N,424.67,P08912,BE0000247,Muscarinic acetylcholine receptor M5,Humans,modulator,yes
DB11961,AZD-1236,small molecule,investigational,C[C@]1(CS(=O)(=O)N2CCC(CC2)OC2=CC=C(Cl)C=N2)NC(=O)NC1=O,SFJFBTPHDHUUPU-OAHLLOKOSA-N,402.85,P39900,BE0001198,Macrophage metalloelastase,Humans,inhibitor,yes
DB11962,GSK-1059615,small molecule,investigational,O=C1NC(=O)\C(S1)=C\C1=CC=C2N=CC=C(C3=CC=NC=C3)C2=C1,QDITZBLZQQZVEE-YBEGLDIGSA-N,333.37,P42345,BE0002386,Serine/threonine-protein kinase mTOR,Humans,inhibitor,yes
DB11962,GSK-1059615,small molecule,investigational,O=C1NC(=O)\C(S1)=C\C1=CC=C2N=CC=C(C3=CC=NC=C3)C2=C1,QDITZBLZQQZVEE-YBEGLDIGSA-N,333.37,P48736,BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",Humans,inhibitor,yes
DB11962,GSK-1059615,small molecule,investigational,O=C1NC(=O)\C(S1)=C\C1=CC=C2N=CC=C(C3=CC=NC=C3)C2=C1,QDITZBLZQQZVEE-YBEGLDIGSA-N,333.37,Q8NEB9,BE0003729,Phosphatidylinositol 3-kinase catalytic subunit type 3,Humans,inhibitor,yes
DB11963,Dacomitinib,small molecule,approved;investigational,COC1=C(NC(=O)\C=C\CN2CCCCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1,LVXJQMNHJWSHET-AATRIKPKSA-N,469.939,Q15303,BE0004772,Receptor tyrosine-protein kinase erbB-4,Humans,antagonist,yes
DB11963,Dacomitinib,small molecule,approved;investigational,COC1=C(NC(=O)\C=C\CN2CCCCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1,LVXJQMNHJWSHET-AATRIKPKSA-N,469.939,P04626,BE0000511,Receptor tyrosine-protein kinase erbB-2,Humans,antagonist,yes
DB11963,Dacomitinib,small molecule,approved;investigational,COC1=C(NC(=O)\C=C\CN2CCCCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1,LVXJQMNHJWSHET-AATRIKPKSA-N,469.939,P00533,BE0000767,Epidermal growth factor receptor,Humans,inhibitor,yes
DB11966,BMS-986094,small molecule,investigational,COC1=C2N=CN([C@@H]3O[C@H](COP(=O)(N[C@@H](C)C(=O)OCC(C)(C)C)OC4=C5C=CC=CC5=CC=C4)[C@@H](O)[C@@]3(C)O)C2=NC(N)=N1,YFXGICNMLCGLHJ-RSKRLRQZSA-N,658.649,P26664,BE0003427,Genome polyprotein,,inhibitor,yes
DB11967,Binimetinib,small molecule,approved;investigational,CN1C=NC2=C(F)C(NC3=CC=C(Br)C=C3F)=C(C=C12)C(=O)NOCCO,ACWZRVQXLIRSDF-UHFFFAOYSA-N,441.233,P36507,BE0004744,Dual specificity mitogen-activated protein kinase kinase 2,Humans,inhibitor,yes
DB11967,Binimetinib,small molecule,approved;investigational,CN1C=NC2=C(F)C(NC3=CC=C(Br)C=C3F)=C(C=C12)C(=O)NOCCO,ACWZRVQXLIRSDF-UHFFFAOYSA-N,441.233,Q02750,BE0000870,Dual specificity mitogen-activated protein kinase kinase 1,Humans,inhibitor,yes
DB11969,Uprosertib,small molecule,investigational,CN1N=CC(Cl)=C1C1=C(Cl)OC(=C1)C(=O)N[C@H](CN)CC1=CC=C(F)C(F)=C1,AXTAPYRUEKNRBA-JTQLQIEISA-N,429.25,Q9Y243,BE0010514,RAC-gamma serine/threonine-protein kinase,Humans,modulator,yes
DB11970,Burixafor,small molecule,investigational,NC1=NC(NC[C@H]2CC[C@H](CNCCCNC3CCCCC3)CC2)=NC(=C1)N1CCN(CCP(O)(O)=O)CC1,QLVSJMZJSABWRX-YHBQERECSA-N,566.732,P61073,BE0000919,C-X-C chemokine receptor type 4,Humans,inhibitor,yes
DB11971,Vilaprisan,small molecule,investigational,C[C@]12C[C@H](C3=CC=C(C=C3)S(C)(=O)=O)C3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@]2(O)C(F)(F)C(F)(F)F,JUFWQQVHQFDUOD-ANRPBIDPSA-N,544.58,P06401,BE0000557,Progesterone receptor,Humans,antagonist,yes
DB11973,Tesevatinib,small molecule,investigational,COC1=C(OC[C@H]2C[C@H]3CN(C)C[C@H]3C2)C=C2N=CN=C(NC3=CC=C(Cl)C(Cl)=C3F)C2=C1,HVXKQKFEHMGHSL-QKDCVEJESA-N,491.39,P54760,BE0002453,Ephrin type-B receptor 4,Humans,modulator,yes
DB11974,PF-04691502,small molecule,investigational,COC1=CC=C(C=N1)C1=CC2=C(C)N=C(N)N=C2N([C@H]2CC[C@@H](CC2)OCCO)C1=O,XDLYKKIQACFMJG-WKILWMFISA-N,425.4809,P42345,BE0002386,Serine/threonine-protein kinase mTOR,Humans,modulator,yes
DB11974,PF-04691502,small molecule,investigational,COC1=CC=C(C=N1)C1=CC2=C(C)N=C(N)N=C2N([C@H]2CC[C@@H](CC2)OCCO)C1=O,XDLYKKIQACFMJG-WKILWMFISA-N,425.4809,P48736,BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",Humans,modulator,yes
DB11977,Golvatinib,small molecule,investigational,CN1CCN(CC1)C1CCN(CC1)C(=O)NC1=CC(OC2=CC=C(NC(=O)C3(CC3)C(=O)NC3=CC=C(F)C=C3)C(F)=C2)=CC=N1,UQRCJCNVNUFYDX-UHFFFAOYSA-N,633.701,P35968,BE0000369,Vascular endothelial growth factor receptor 2,Humans,modulator,yes
DB11977,Golvatinib,small molecule,investigational,CN1CCN(CC1)C1CCN(CC1)C(=O)NC1=CC(OC2=CC=C(NC(=O)C3(CC3)C(=O)NC3=CC=C(F)C=C3)C(F)=C2)=CC=N1,UQRCJCNVNUFYDX-UHFFFAOYSA-N,633.701,P08581,BE0000915,Hepatocyte growth factor receptor,Humans,modulator,yes
DB11978,Glasdegib,small molecule,approved;investigational,CN1CC[C@H](C[C@@H]1C1=NC2=CC=CC=C2N1)NC(=O)NC1=CC=C(C=C1)C#N,SFNSLLSYNZWZQG-VQIMIIECSA-N,374.448,Q99835,BE0004659,Protein smoothened,Humans,inhibitor,yes
DB11978,Glasdegib,small molecule,approved;investigational,CN1CC[C@H](C[C@@H]1C1=NC2=CC=CC=C2N1)NC(=O)NC1=CC=C(C=C1)C#N,SFNSLLSYNZWZQG-VQIMIIECSA-N,374.448,P42345,BE0002386,Serine/threonine-protein kinase mTOR,Humans,inhibitor,yes
DB11979,Elagolix,small molecule,approved;investigational,COC1=CC=CC(=C1F)C1=C(C)N(CC2=C(C=CC=C2F)C(F)(F)F)C(=O)N(C[C@H](NCCCC(O)=O)C2=CC=CC=C2)C1=O,HEAUOKZIVMZVQL-VWLOTQADSA-N,631.6,P30968,BE0000203,Gonadotropin-releasing hormone receptor,Humans,antagonist,yes
DB11984,Letaxaban,small molecule,investigational,O[C@H](CS(=O)(=O)C1=CC=C2C=C(Cl)C=CC2=C1)C(=O)N1CCC(CC1)N1CCCNC1=O,GEHAEMCVKDPMKO-HXUWFJFHSA-N,479.977,P00742,BE0000216,Coagulation factor X,Humans,inhibitor,yes
DB11986,Entrectinib,small molecule,approved;investigational,CN1CCN(CC1)C1=CC=C(C(=O)NC2=NNC3=CC=C(CC4=CC(F)=CC(F)=C4)C=C23)C(NC2CCOCC2)=C1,HAYYBYPASCDWEQ-UHFFFAOYSA-N,560.65,Q9UM73,BE0000359,ALK tyrosine kinase receptor,Humans,inhibitor,yes
DB11986,Entrectinib,small molecule,approved;investigational,CN1CCN(CC1)C1=CC=C(C(=O)NC2=NNC3=CC=C(CC4=CC(F)=CC(F)=C4)C=C23)C(NC2CCOCC2)=C1,HAYYBYPASCDWEQ-UHFFFAOYSA-N,560.65,P04629,BE0001039,High affinity nerve growth factor receptor,Humans,inhibitor,yes
DB11986,Entrectinib,small molecule,approved;investigational,CN1CCN(CC1)C1=CC=C(C(=O)NC2=NNC3=CC=C(CC4=CC(F)=CC(F)=C4)C=C23)C(NC2CCOCC2)=C1,HAYYBYPASCDWEQ-UHFFFAOYSA-N,560.65,Q16288,BE0009501,NT-3 growth factor receptor,Humans,inhibitor,yes
DB11986,Entrectinib,small molecule,approved;investigational,CN1CCN(CC1)C1=CC=C(C(=O)NC2=NNC3=CC=C(CC4=CC(F)=CC(F)=C4)C=C23)C(NC2CCOCC2)=C1,HAYYBYPASCDWEQ-UHFFFAOYSA-N,560.65,P08922,BE0009534,Proto-oncogene tyrosine-protein kinase ROS,Humans,inhibitor,yes
DB11986,Entrectinib,small molecule,approved;investigational,CN1CCN(CC1)C1=CC=C(C(=O)NC2=NNC3=CC=C(CC4=CC(F)=CC(F)=C4)C=C23)C(NC2CCOCC2)=C1,HAYYBYPASCDWEQ-UHFFFAOYSA-N,560.65,Q16620,BE0003605,BDNF/NT-3 growth factors receptor,Humans,inhibitor,yes
DB11987,GSK-2018682,small molecule,investigational,CC(C)OC1=C(Cl)C=C(C=N1)C1=NC(=NO1)C1=C2C=CN(CCCC(O)=O)C2=CC=C1,NFIGDBFIDKDNIG-UHFFFAOYSA-N,440.88,P21453,BE0008652,Sphingosine 1-phosphate receptor 1,Humans,agonist,yes
DB11990,MK-0812,small molecule,investigational,CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@](CN2CCC3=C(C2)C=C(C=N3)C(F)(F)F)(C1)C(C)C,UNVWTBOGMHPKJM-CWKRKGSWSA-N,455.566,P41597,BE0003387,C-C chemokine receptor type 2,Humans,antagonist,yes
DB11992,Omarigliptin,small molecule,investigational,CS(=O)(=O)N1C=C2CN(CC2=N1)[C@H]1CO[C@@H]([C@@H](N)C1)C1=CC(F)=CC=C1F,MKMPWKUAHLTIBJ-ISTRZQFTSA-N,398.43,P27487,BE0000854,Dipeptidyl peptidase 4,Humans,modulator,yes
DB11993,PF-03463275,small molecule,investigational,[H][C@@]12CN(C)C[C@]1([H])[C@H]2CN(CC1=CC(Cl)=C(F)C=C1)C(=O)C1=CN(C)C=N1,KYLOBHXXQOZRKK-FICVDOATSA-N,376.86,P48067,BE0000940,Sodium- and chloride-dependent glycine transporter 1,Humans,inhibitor,yes
DB11994,Diacerein,small molecule,approved;investigational,CC(=O)OC1=CC=CC2=C1C(=O)C1=C(OC(C)=O)C=C(C=C1C2=O)C(O)=O,TYNLGDBUJLVSMA-UHFFFAOYSA-N,368.297,P01584,BE0001051,Interleukin-1 beta,Humans,inhibitor,yes
DB11995,Avatrombopag,small molecule,approved;investigational,OC(=O)C1CCN(CC1)C1=C(Cl)C=C(C=N1)C(=O)NC1=NC(C2=CC(Cl)=CS2)=C(S1)N1CCN(CC1)C1CCCCC1,OFZJKCQENFPZBH-UHFFFAOYSA-N,649.65,P40238,BE0003440,Thrombopoietin receptor,Humans,agonist,yes
DB11998,Sorivudine,small molecule,investigational,OC[C@H]1O[C@H]([C@@H](O)[C@@H]1O)N1C=C(\C=C\Br)C(=O)NC1=O,GCQYYIHYQMVWLT-HQNLTJAPSA-N,349.137,P03366,BE0002050,Gag-Pol polyprotein,,modulator,yes
DB11999,Vosaroxin,small molecule,investigational,CN[C@H]1CN(C[C@@H]1OC)C1=CC=C2C(=O)C(=CN(C3=NC=CS3)C2=N1)C(O)=O,XZAFZXJXZHRNAQ-STQMWFEESA-N,401.44,P11388,BE0000742,DNA topoisomerase 2-alpha,Humans,modulator,yes
DB11999,Vosaroxin,small molecule,investigational,CN[C@H]1CN(C[C@@H]1OC)C1=CC=C2C(=O)C(=CN(C3=NC=CS3)C2=N1)C(O)=O,XZAFZXJXZHRNAQ-STQMWFEESA-N,401.44,Q02880,BE0002425,DNA topoisomerase 2-beta,Humans,modulator,yes
DB12001,Abemaciclib,small molecule,approved;investigational,CCN1CCN(CC2=CC=C(NC3=NC=C(F)C(=N3)C3=CC(F)=C4N=C(C)N(C(C)C)C4=C3)N=C2)CC1,UZWDCWONPYILKI-UHFFFAOYSA-N,506.606,P11802,BE0002216,Cyclin-dependent kinase 4,Humans,inhibitor,yes
DB12001,Abemaciclib,small molecule,approved;investigational,CCN1CCN(CC2=CC=C(NC3=NC=C(F)C(=N3)C3=CC(F)=C4N=C(C)N(C(C)C)C4=C3)N=C2)CC1,UZWDCWONPYILKI-UHFFFAOYSA-N,506.606,Q00534,BE0002212,Cyclin-dependent kinase 6,Humans,inhibitor,yes
DB12004,Briciclib,small molecule,investigational,COC1=CC(OC)=C(\C=C\S(=O)(=O)CC2=CC=C(OC)C(OP(O)(O)=O)=C2)C(OC)=C1,LXENKEWVEVKKGV-BQYQJAHWSA-N,474.42,P24385,BE0001027,G1/S-specific cyclin-D1,Humans,inhibitor,yes
DB12005,Nirogacestat,small molecule,approved;investigational,CCC[C@H](N[C@H]1CCC2=CC(F)=CC(F)=C2C1)C(=O)NC1=CN(C=N1)C(C)(C)CNCC(C)(C)C,VFCRKLWBYMDAED-REWPJTCUSA-N,489.656,Q8WW43,BE0017533,Gamma-secretase subunit APH-1B,Humans,modulator,yes
DB12005,Nirogacestat,small molecule,approved;investigational,CCC[C@H](N[C@H]1CCC2=CC(F)=CC(F)=C2C1)C(=O)NC1=CN(C=N1)C(C)(C)CNCC(C)(C)C,VFCRKLWBYMDAED-REWPJTCUSA-N,489.656,Q92542,BE0017775,Nicastrin,Humans,modulator,yes
DB12005,Nirogacestat,small molecule,approved;investigational,CCC[C@H](N[C@H]1CCC2=CC(F)=CC(F)=C2C1)C(=O)NC1=CN(C=N1)C(C)(C)CNCC(C)(C)C,VFCRKLWBYMDAED-REWPJTCUSA-N,489.656,P49768,BE0010960,Presenilin-1,Humans,inhibitor,yes
DB12005,Nirogacestat,small molecule,approved;investigational,CCC[C@H](N[C@H]1CCC2=CC(F)=CC(F)=C2C1)C(=O)NC1=CN(C=N1)C(C)(C)CNCC(C)(C)C,VFCRKLWBYMDAED-REWPJTCUSA-N,489.656,Q9NZ42,BE0003410,Gamma-secretase subunit PEN-2,Humans,modulator,yes
DB12005,Nirogacestat,small molecule,approved;investigational,CCC[C@H](N[C@H]1CCC2=CC(F)=CC(F)=C2C1)C(=O)NC1=CN(C=N1)C(C)(C)CNCC(C)(C)C,VFCRKLWBYMDAED-REWPJTCUSA-N,489.656,Q96BI3,BE0003409,Gamma-secretase subunit APH-1A,Humans,modulator,yes
DB12005,Nirogacestat,small molecule,approved;investigational,CCC[C@H](N[C@H]1CCC2=CC(F)=CC(F)=C2C1)C(=O)NC1=CN(C=N1)C(C)(C)CNCC(C)(C)C,VFCRKLWBYMDAED-REWPJTCUSA-N,489.656,P49810,BE0011014,Presenilin-2,Humans,inhibitor,yes
DB12008,Prexasertib,small molecule,investigational,COC1=CC=CC(OCCCN)=C1C1=CC(NC2=CN=C(C=N2)C#N)=NN1,DOTGPNHGTYJDEP-UHFFFAOYSA-N,365.397,O14757,BE0003382,Serine/threonine-protein kinase Chk1,Humans,inhibitor,yes
DB12009,GW-406381,small molecule,investigational,CCOC1=CC=C(C=C1)C1=NN2N=CC=CC2=C1C1=CC=C(C=C1)S(C)(=O)=O,NXMZBNYLCVTRGB-UHFFFAOYSA-N,393.46,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB12010,Fostamatinib,small molecule,approved;investigational,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC,GKDRMWXFWHEQQT-UHFFFAOYSA-N,580.4595,P43405,BE0001316,Tyrosine-protein kinase SYK,Humans,inhibitor,yes
DB12011,Fevipiprant,small molecule,investigational,CC1=C(CC(O)=O)C2=CC=CN=C2N1CC1=CC=C(C=C1C(F)(F)F)S(C)(=O)=O,GFPPXZDRVCSVNR-UHFFFAOYSA-N,426.41,Q9Y5Y4,BE0003561,Prostaglandin D2 receptor 2,Humans,antagonist,yes
DB12013,Axelopran,small molecule,investigational,NC(=O)C1=CC=CC(=C1)[C@@H]1C[C@@H]2CC[C@H](C1)N2CCN(CC1CCCCC1)C(=O)[C@@H](O)CO,ATLYLVPZNWDJBW-KIHHCIJBSA-N,457.615,P35372,BE0000770,Mu-type opioid receptor,Humans,modulator,yes
DB12015,Alpelisib,small molecule,approved;investigational,CC1=C(SC(NC(=O)N2CCC[C@H]2C(N)=O)=N1)C1=CC(=NC=C1)C(C)(C)C(F)(F)F,STUWGJZDJHPWGZ-LBPRGKRZSA-N,441.47,P42336,BE0002379,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",Humans,inhibitor,yes
DB12016,Ponesimod,small molecule,approved;investigational,CCC\N=C1/S\C(=C/C2=CC=C(OC[C@H](O)CO)C(Cl)=C2)C(=O)N1C1=CC=CC=C1C,LPAUOXUZGSBGDU-STDDISTJSA-N,460.97,P21453,BE0008652,Sphingosine 1-phosphate receptor 1,Humans,agonist;modulator;regulator,yes
DB12017,Ozagrel,small molecule,investigational,OC(=O)\C=C\C1=CC=C(CN2C=CN=C2)C=C1,SHZKQBHERIJWAO-AATRIKPKSA-N,228.251,Q16539,BE0001019,Mitogen-activated protein kinase 14,Humans,inhibitor,yes
DB12020,Tecovirimat,small molecule,approved;investigational,FC(F)(F)C1=CC=C(C=C1)C(=O)NN1C(=O)[C@H]2[C@H]([C@H]3C=C[C@@H]2[C@@H]2C[C@H]32)C1=O,CSKDFZIMJXRJGH-VWLPUNTISA-N,376.335,P33815,BE0009559,Envelope protein F13,Variola virus (isolate Human/India/Ind3/1967),inhibitor,yes
DB12021,Dinaciclib,small molecule,investigational,CCC1=C2N=C(C=C(NCC3=CC=C[N+]([O-])=C3)N2N=C1)N1CCCC[C@H]1CCO,PIMQWRZWLQKKBJ-SFHVURJKSA-N,396.495,P50750,BE0002207,Cyclin-dependent kinase 9,Humans,inhibitor,yes
DB12021,Dinaciclib,small molecule,investigational,CCC1=C2N=C(C=C(NCC3=CC=C[N+]([O-])=C3)N2N=C1)N1CCCC[C@H]1CCO,PIMQWRZWLQKKBJ-SFHVURJKSA-N,396.495,P24941,BE0001072,Cyclin-dependent kinase 2,Humans,inhibitor,yes
DB12021,Dinaciclib,small molecule,investigational,CCC1=C2N=C(C=C(NCC3=CC=C[N+]([O-])=C3)N2N=C1)N1CCCC[C@H]1CCO,PIMQWRZWLQKKBJ-SFHVURJKSA-N,396.495,P06493,BE0001082,Cyclin-dependent kinase 1,Humans,inhibitor,yes
DB12022,Evatanepag,small molecule,investigational,CC(C)(C)C1=CC=C(CN(CC2=CC=CC(OCC(O)=O)=C2)S(=O)(=O)C2=CC=CN=C2)C=C1,WOHRHWDYFNWPNG-UHFFFAOYSA-N,468.57,P43116,BE0000368,Prostaglandin E2 receptor EP2 subtype,Humans,agonist,yes
DB12024,PF-04418948,small molecule,investigational,COC1=CC=C2C=C(OCC3(CN(C3)C(=O)C3=CC=C(F)C=C3)C(O)=O)C=CC2=C1,LWJGMYMNSNVCEM-UHFFFAOYSA-N,409.413,P43116,BE0000368,Prostaglandin E2 receptor EP2 subtype,Humans,antagonist,yes
DB12025,Triptolide,small molecule,investigational,CC(C)[C@]12O[C@H]1[C@@H]1O[C@]11[C@]3(O[C@H]3C[C@H]3C4=C(CC[C@]13C)C(=O)OC4)[C@@H]2O,DFBIRQPKNDILPW-CIVMWXNOSA-N,360.406,Q01201,BE0013795,Transcription factor RelB,Humans,inhibitor,yes
DB12025,Triptolide,small molecule,investigational,CC(C)[C@]12O[C@H]1[C@@H]1O[C@]11[C@]3(O[C@H]3C[C@H]3C4=C(CC[C@]13C)C(=O)OC4)[C@@H]2O,DFBIRQPKNDILPW-CIVMWXNOSA-N,360.406,P19838,BE0001086,Nuclear factor NF-kappa-B p105 subunit,Humans,inhibitor,yes
DB12025,Triptolide,small molecule,investigational,CC(C)[C@]12O[C@H]1[C@@H]1O[C@]11[C@]3(O[C@H]3C[C@H]3C4=C(CC[C@]13C)C(=O)OC4)[C@@H]2O,DFBIRQPKNDILPW-CIVMWXNOSA-N,360.406,Q00653,BE0002387,Nuclear factor NF-kappa-B p100 subunit,Humans,inhibitor,yes
DB12025,Triptolide,small molecule,investigational,CC(C)[C@]12O[C@H]1[C@@H]1O[C@]11[C@]3(O[C@H]3C[C@H]3C4=C(CC[C@]13C)C(=O)OC4)[C@@H]2O,DFBIRQPKNDILPW-CIVMWXNOSA-N,360.406,Q04206,BE0005551,Transcription factor p65,Humans,inhibitor,yes
DB12025,Triptolide,small molecule,investigational,CC(C)[C@]12O[C@H]1[C@@H]1O[C@]11[C@]3(O[C@H]3C[C@H]3C4=C(CC[C@]13C)C(=O)OC4)[C@@H]2O,DFBIRQPKNDILPW-CIVMWXNOSA-N,360.406,Q04864,BE0010782,Proto-oncogene c-Rel,Humans,inhibitor,yes
DB12026,Voxilaprevir,small molecule,approved;investigational,CC[C@@H]1[C@@H]2CN([C@@H]1C(=O)N[C@@]1(C[C@H]1C(F)F)C(=O)NS(=O)(=O)C1(C)CC1)C(=O)[C@@H](NC(=O)O[C@@H]1C[C@H]1CCCCC(F)(F)C1=C(O2)N=C2C=C(OC)C=CC2=N1)C(C)(C)C,MZBLZLWXUBZHSL-FZNJKFJKSA-N,868.94,B0B3C9,BE0004701,Genome polyprotein,Hepatitis C Virus,inhibitor,yes
DB12026,Voxilaprevir,small molecule,approved;investigational,CC[C@@H]1[C@@H]2CN([C@@H]1C(=O)N[C@@]1(C[C@H]1C(F)F)C(=O)NS(=O)(=O)C1(C)CC1)C(=O)[C@@H](NC(=O)O[C@@H]1C[C@H]1CCCCC(F)(F)C1=C(O2)N=C2C=C(OC)C=CC2=N1)C(C)(C)C,MZBLZLWXUBZHSL-FZNJKFJKSA-N,868.94,P26664,BE0003427,Genome polyprotein,,inhibitor,yes
DB12027,Serdemetan,small molecule,investigational,C(CC1=CNC2=CC=CC=C12)NC1=CC=C(NC2=CC=NC=C2)C=C1,CEGSUKYESLWKJP-UHFFFAOYSA-N,328.419,Q00987,BE0001003,E3 ubiquitin-protein ligase Mdm2,Humans,modulator,yes
DB12032,Atagabalin,small molecule,investigational,C[C@H]1CC(CN)(CC(O)=O)C[C@@H]1C,IUVMAUQEZFTTFB-YUMQZZPRSA-N,185.267,P54289,BE0000691,Voltage-dependent calcium channel subunit alpha-2/delta-1,Humans,inhibitor,yes
DB12036,Naquotinib,small molecule,investigational,CCC1=C(O[C@@H]2CCN(C2)C(=O)C=C)N=C(NC2=CC=C(C=C2)N2CCC(CC2)N2CCN(C)CC2)C(=N1)C(N)=O,QKDCLUARMDUUKN-XMMPIXPASA-N,562.719,P00533,BE0000767,Epidermal growth factor receptor,Humans,inhibitor,yes
DB12037,Vedroprevir,small molecule,investigational,CC[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)O[C@@H]1C[C@@H]2C[C@@H]2C1)C(C)(C)C)OC1=C2C=CC(OCCN3CCOCC3)=C(Cl)C2=NC(=C1)C1=CSC(NC(C)C)=N1)C(O)=O,OTXAMWFYPMNDME-FQQWJMKMSA-N,910.53,P26664,BE0003427,Genome polyprotein,,modulator,yes
DB12039,Epicatechin,small molecule,investigational,O[C@@H]1CC2=C(O)C=C(O)C=C2O[C@@H]1C1=CC(O)=C(O)C=C1,PFTAWBLQPZVEMU-UKRRQHHQSA-N,290.2681,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB12041,Mapracorat,small molecule,investigational,CC1=CC=C2C(NC[C@](O)(CC(C)(C)C3=CC(F)=CC4=C3OCC4)C(F)(F)F)=CC=CC2=N1,VJGFOYBQOIPQFY-XMMPIXPASA-N,462.489,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB12042,Ibodutant,small molecule,investigational,CC1=CC=C2C=C(SC2=C1)C(=O)NC1(CCCC1)C(=O)N[C@H](CC1=CC=CC=C1)C(=O)NCC1CCN(CC2CCOCC2)CC1,YQYSVMKCMIUCHY-WJOKGBTCSA-N,644.88,P21452,BE0002222,Substance-K receptor,Humans,antagonist,yes
DB12045,Mericitabine,small molecule,investigational,CC(C)C(=O)OC[C@H]1O[C@@H](N2C=CC(N)=NC2=O)[C@](C)(F)[C@@H]1OC(=O)C(C)C,MLESJYFEMSJZLZ-MAAOGQSESA-N,399.419,P26664,BE0003427,Genome polyprotein,,inhibitor,yes
DB12046,Atopaxar,small molecule,investigational,CCOC1=CC2=C(C(=N)N(CC(=O)C3=CC(=C(OC)C(=C3)N3CCOCC3)C(C)(C)C)C2)C(F)=C1OCC,QWKAUGRRIXBIPO-UHFFFAOYSA-N,527.637,P25116,BE0000928,Proteinase-activated receptor 1,Humans,antagonist,yes
DB12048,Savolitinib,small molecule,investigational,C[C@H](N1N=NC2=NC=C(N=C12)C1=CN(C)N=C1)C1=CN2C=CN=C2C=C1,XYDNMOZJKOGZLS-NSHDSACASA-N,345.37,P08581,BE0000915,Hepatocyte growth factor receptor,Humans,inhibitor,yes
DB12050,LY-3039478,small molecule,investigational,C[C@H](NC(=O)CCC(F)(F)F)C(=O)N[C@H]1C2=CC=CC=C2C2=CC=CN=C2N(CCO)C1=O,YCBAQKQAINQRFW-UGSOOPFHSA-N,464.445,Q99466,BE0010483,Neurogenic locus notch homolog protein 4,Humans,inhibitor,yes
DB12050,LY-3039478,small molecule,investigational,C[C@H](NC(=O)CCC(F)(F)F)C(=O)N[C@H]1C2=CC=CC=C2C2=CC=CN=C2N(CCO)C1=O,YCBAQKQAINQRFW-UGSOOPFHSA-N,464.445,P46531,BE0010326,Neurogenic locus notch homolog protein 1,Humans,inhibitor,yes
DB12051,Setrobuvir,small molecule,investigational,CS(=O)(=O)NC1=CC=C2NC(=NS(=O)(=O)C2=C1)C1=C(O)[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2N(CC2=CC=C(F)C=C2)C1=O,DEKOYVOWOVJMPM-RLHIPHHXSA-N,560.62,P26664,BE0003427,Genome polyprotein,,inhibitor,yes
DB12052,Icariin,small molecule,investigational,COC1=CC=C(C=C1)C1=C(O[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O)C(=O)C2=C(O)C=C(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)C(CC=C(C)C)=C2O1,TZJALUIVHRYQQB-XLRXWWTNSA-N,676.668,O76074,BE0000182,"cGMP-specific 3',5'-cyclic phosphodiesterase",Humans,inhibitor,yes
DB12054,BQ-123,small molecule,investigational,CC(C)C[C@@H]1NC(=O)[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H](CC(O)=O)NC(=O)[C@@H](CC2=CNC3=CC=CC=C23)NC1=O)C(C)C,VYCMAAOURFJIHD-PJNXIOHISA-N,610.712,P25101,BE0000521,Endothelin-1 receptor,Humans,antagonist,yes
DB12057,ORM-12741,small molecule,investigational,COC[C@@]1(C)CCCN2CCC3=C(OC4=CC=CC=C34)[C@H]12,OCUKPFWNSAAHRP-QZTJIDSGSA-N,285.387,P18825,BE0000342,Alpha-2C adrenergic receptor,Humans,antagonist,yes
DB12058,Recoflavone,small molecule,investigational,COC1=CC=C(C=C1OC)C1=CC(=O)C2=C(OC)C=C(OCC(O)=O)C=C2O1,BCPQOBQIVJZOFL-UHFFFAOYSA-N,386.356,P19838,BE0001086,Nuclear factor NF-kappa-B p105 subunit,Humans,modulator,yes
DB12058,Recoflavone,small molecule,investigational,COC1=CC=C(C=C1OC)C1=CC(=O)C2=C(OC)C=C(OCC(O)=O)C=C2O1,BCPQOBQIVJZOFL-UHFFFAOYSA-N,386.356,Q01201,BE0013795,Transcription factor RelB,Humans,modulator,yes
DB12058,Recoflavone,small molecule,investigational,COC1=CC=C(C=C1OC)C1=CC(=O)C2=C(OC)C=C(OCC(O)=O)C=C2O1,BCPQOBQIVJZOFL-UHFFFAOYSA-N,386.356,Q00653,BE0002387,Nuclear factor NF-kappa-B p100 subunit,Humans,modulator,yes
DB12058,Recoflavone,small molecule,investigational,COC1=CC=C(C=C1OC)C1=CC(=O)C2=C(OC)C=C(OCC(O)=O)C=C2O1,BCPQOBQIVJZOFL-UHFFFAOYSA-N,386.356,Q04206,BE0005551,Transcription factor p65,Humans,modulator,yes
DB12058,Recoflavone,small molecule,investigational,COC1=CC=C(C=C1OC)C1=CC(=O)C2=C(OC)C=C(OCC(O)=O)C=C2O1,BCPQOBQIVJZOFL-UHFFFAOYSA-N,386.356,Q04864,BE0010782,Proto-oncogene c-Rel,Humans,modulator,yes
DB12059,JNJ-40411813,small molecule,investigational,CCCCN1C=CC(N2CCC(CC2)C2=CC=CC=C2)=C(Cl)C1=O,HYOGJHCDLQSAHX-UHFFFAOYSA-N,344.88,Q14416,BE0000974,Metabotropic glutamate receptor 2,Humans,modulator,yes
DB12061,Pardoprunox,small molecule,investigational,CN1CCN(CC1)C1=C2OC(=O)NC2=CC=C1,YVPUUUDAZYFFQT-UHFFFAOYSA-N,233.271,P14416,BE0000756,D(2) dopamine receptor,Humans,agonist,yes
DB12063,CERC-301,small molecule,investigational,CC1=CC=C(COC(=O)N2CC[C@H](CNC3=NC=CC=N3)[C@H](F)C2)C=C1,RECBFDWSXWAXHY-IAGOWNOFSA-N,358.417,Q13224,BE0000417,"Glutamate receptor ionotropic, NMDA 2B",Humans,antagonist,yes
DB12064,BMS-777607,small molecule,investigational,CCOC1=C(C(=O)NC2=CC=C(OC3=C(Cl)C(N)=NC=C3)C(F)=C2)C(=O)N(C=C1)C1=CC=C(F)C=C1,VNBRGSXVFBYQNN-UHFFFAOYSA-N,512.893,P08581,BE0000915,Hepatocyte growth factor receptor,Humans,inhibitor,yes
DB12069,Sovaprevir,small molecule,investigational,COC1=CC2=NC(=CC(O[C@@H]3C[C@H](N(C3)C(=O)[C@@H](CC(=O)N3CCCCC3)C(C)(C)C)C(=O)N[C@@]3(C[C@H]3C=C)C(=O)NS(=O)(=O)C3CC3)=C2C=C1)C1=CC=CC=C1,MHFMTUBUVQZIRE-WINRQGAFSA-N,799.98,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB12070,Letermovir,small molecule,approved;investigational,COC1=CC=CC(=C1)N1CCN(CC1)C1=NC2=C(C=CC=C2F)[C@H](CC(O)=O)N1C1=CC(=CC=C1OC)C(F)(F)F,FWYSMLBETOMXAG-QHCPKHFHSA-N,572.561,F5HC79,BE0010221,CMV DNA Terminase Complex,Human Cytomegalovirus,inhibitor,yes
DB12071,Vabicaserin,small molecule,investigational,C1C[C@H]2CN3CCNCC4=C3C(=CC=C4)[C@H]2C1,NPTIPEQJIDTVKR-STQMWFEESA-N,228.339,P41595,BE0000393,5-hydroxytryptamine receptor 2B,Humans,modulator,yes
DB12071,Vabicaserin,small molecule,investigational,C1C[C@H]2CN3CCNCC4=C3C(=CC=C4)[C@H]2C1,NPTIPEQJIDTVKR-STQMWFEESA-N,228.339,P28335,BE0000533,5-hydroxytryptamine receptor 2C,Humans,modulator,yes
DB12072,Orantinib,small molecule,investigational,CC1=C(CCC(O)=O)C(C)=C(N1)\C=C1/C(=O)NC2=CC=CC=C12,NHFDRBXTEDBWCZ-ZROIWOOFSA-N,310.3471,P35968,BE0000369,Vascular endothelial growth factor receptor 2,Humans,inhibitor,yes
DB12072,Orantinib,small molecule,investigational,CC1=C(CCC(O)=O)C(C)=C(N1)\C=C1/C(=O)NC2=CC=CC=C12,NHFDRBXTEDBWCZ-ZROIWOOFSA-N,310.3471,O14965,BE0000991,Aurora kinase A,Humans,inhibitor,yes
DB12072,Orantinib,small molecule,investigational,CC1=C(CCC(O)=O)C(C)=C(N1)\C=C1/C(=O)NC2=CC=CC=C12,NHFDRBXTEDBWCZ-ZROIWOOFSA-N,310.3471,P11362,BE0002131,Fibroblast growth factor receptor 1,Humans,inhibitor,yes
DB12072,Orantinib,small molecule,investigational,CC1=C(CCC(O)=O)C(C)=C(N1)\C=C1/C(=O)NC2=CC=CC=C12,NHFDRBXTEDBWCZ-ZROIWOOFSA-N,310.3471,Q96GD4,BE0003404,Aurora kinase B,Humans,inhibitor,yes
DB12072,Orantinib,small molecule,investigational,CC1=C(CCC(O)=O)C(C)=C(N1)\C=C1/C(=O)NC2=CC=CC=C12,NHFDRBXTEDBWCZ-ZROIWOOFSA-N,310.3471,P37231,BE0000215,Peroxisome proliferator-activated receptor gamma,Humans,agonist,yes
DB12074,Censavudine,small molecule,investigational,CC1=CN([C@@H]2O[C@](CO)(C=C2)C#C)C(=O)NC1=O,OSYWBJSVKUFFSU-SKDRFNHKSA-N,248.238,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB12080,Ritobegron,small molecule,investigational,C[C@H](NCCC1=C(C)C=C(OCC(O)=O)C(C)=C1)[C@H](O)C1=CC=C(O)C=C1,VMMYRRFPMAGXNP-BTYIYWSLSA-N,373.449,P13945,BE0001012,Beta-3 adrenergic receptor,Humans,agonist,yes
DB12082,Vesnarinone,small molecule,investigational,COC1=C(OC)C=C(C=C1)C(=O)N1CCN(CC1)C1=CC=C2NC(=O)CCC2=C1,ZVNYJIZDIRKMBF-UHFFFAOYSA-N,395.4516,Q14432,BE0000436,"cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A",Humans,inhibitor,yes
DB12082,Vesnarinone,small molecule,investigational,COC1=C(OC)C=C(C=C1)C(=O)N1CCN(CC1)C1=CC=C2NC(=O)CCC2=C1,ZVNYJIZDIRKMBF-UHFFFAOYSA-N,395.4516,Q12809,BE0000090,Voltage-gated inwardly rectifying potassium channel KCNH2,Humans,inhibitor,yes
DB12084,ADP-597,small molecule,investigational,COC1=C(NC2=C(C)N=C(C=C2)S(C)(=O)=O)N=CN=C1OC1CCN(CC1)C(=O)OC(C)C,WPDCHTSXOPUOII-UHFFFAOYSA-N,479.55,Q8TDV5,BE0003378,Glucose-dependent insulinotropic receptor,Humans,agonist,yes
DB12085,LCL-161,small molecule,investigational,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1C1=NC(=CS1)C(=O)C1=CC=C(F)C=C1,UFPFGVNKHCLJJO-SSKFGXFMSA-N,500.63,P98170,BE0001156,E3 ubiquitin-protein ligase XIAP,Humans,modulator,yes
DB12085,LCL-161,small molecule,investigational,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1C1=NC(=CS1)C(=O)C1=CC=C(F)C=C1,UFPFGVNKHCLJJO-SSKFGXFMSA-N,500.63,Q13490,BE0010675,Baculoviral IAP repeat-containing protein 2,Humans,modulator,yes
DB12085,LCL-161,small molecule,investigational,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1C1=NC(=CS1)C(=O)C1=CC=C(F)C=C1,UFPFGVNKHCLJJO-SSKFGXFMSA-N,500.63,Q13489,BE0010674,Baculoviral IAP repeat-containing protein 3,Humans,modulator,yes
DB12085,LCL-161,small molecule,investigational,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1C1=NC(=CS1)C(=O)C1=CC=C(F)C=C1,UFPFGVNKHCLJJO-SSKFGXFMSA-N,500.63,Q13075,BE0010810,Baculoviral IAP repeat-containing protein 1,Humans,modulator,yes
DB12085,LCL-161,small molecule,investigational,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1C1=NC(=CS1)C(=O)C1=CC=C(F)C=C1,UFPFGVNKHCLJJO-SSKFGXFMSA-N,500.63,Q96CA5,BE0010707,Baculoviral IAP repeat-containing protein 7,Humans,modulator,yes
DB12085,LCL-161,small molecule,investigational,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1C1=NC(=CS1)C(=O)C1=CC=C(F)C=C1,UFPFGVNKHCLJJO-SSKFGXFMSA-N,500.63,O15392,BE0003408,Baculoviral IAP repeat-containing protein 5,Humans,modulator,yes
DB12086,Oxitropium,small molecule,investigational,CC[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1,NVOYVOBDTVTBDX-PMEUIYRNSA-N,332.419,P08912,BE0000247,Muscarinic acetylcholine receptor M5,Humans,modulator,yes
DB12088,TT-232,small molecule,investigational,C[C@@H](O)[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](N)CC2=CC=CC=C2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@H](CC2=CNC3=CC=CC=C23)C(=O)N[C@@H](CCCCN)C(=O)N1)C(N)=O,SNAJPQVDGYDQSW-DYCFWDQMSA-N,947.14,P14618,BE0000088,Pyruvate kinase PKM,Humans,modulator,yes
DB12092,Naftopidil,small molecule,investigational,COC1=CC=CC=C1N1CCN(CC(O)COC2=CC=CC3=CC=CC=C23)CC1,HRRBJVNMSRJFHQ-UHFFFAOYSA-N,392.499,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,inhibitor,yes
DB12094,Semapimod,small molecule,investigational,C\C(=N/NC(N)=N)C1=CC(=CC(NC(=O)CCCCCCCCC(=O)NC2=CC(=CC(=C2)C(\C)=N\NC(N)=N)C(\C)=N\NC(N)=N)=C1)C(\C)=N\NC(N)=N,PWDYHMBTPGXCSN-VCBMUGGBSA-N,744.914,P04049,BE0000036,RAF proto-oncogene serine/threonine-protein kinase,Humans,modulator,yes
DB12095,Telotristat ethyl,small molecule,approved;investigational,CCOC(=O)[C@@H](N)CC1=CC=C(C=C1)C1=NC(N)=NC(O[C@H](C2=CC=C(Cl)C=C2N2C=CC(C)=N2)C(F)(F)F)=C1,MDSQOJYHHZBZKA-GBXCKJPGSA-N,574.99,Q8IWU9,BE0000080,Tryptophan 5-hydroxylase 2,Humans,antagonist,yes
DB12095,Telotristat ethyl,small molecule,approved;investigational,CCOC(=O)[C@@H](N)CC1=CC=C(C=C1)C1=NC(N)=NC(O[C@H](C2=CC=C(Cl)C=C2N2C=CC(C)=N2)C(F)(F)F)=C1,MDSQOJYHHZBZKA-GBXCKJPGSA-N,574.99,P17752,BE0000121,Tryptophan 5-hydroxylase 1,Humans,antagonist,yes
DB12096,PF-05175157,small molecule,investigational,CC(C)N1N=CC2=C1C(=O)CC1(CCN(CC1)C(=O)C1=CC=C3N=C(C)NC3=C1)C2,BDXXSFOJPYSYOC-UHFFFAOYSA-N,405.502,O00763,BE0000702,Acetyl-CoA carboxylase 2,Humans,inhibitor,yes
DB12099,"UK-396,082",small molecule,investigational,[H][C@](CCCN)(CC1=CN(CCC)C=N1)C(O)=O,OTDGPKRCQXSTPV-JTQLQIEISA-N,239.314,Q96IY4,BE0003407,Carboxypeptidase B2,Humans,inhibitor,yes
DB12100,Abediterol,small molecule,investigational,O[C@@H](CNCCCCCCOCC(F)(F)C1=CC=CC=C1)C1=C2C=CC(=O)NC2=C(O)C=C1,SFYAXIFVXBKRPK-QFIPXVFZSA-N,460.522,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,agonist,yes
DB12101,Iberdomide,small molecule,investigational,O=C1N(CC2=C1C=CC=C2OCC1=CC=C(CN2CCOCC2)C=C1)[C@H]1CCC(=O)NC1=O,IXZOHGPZAQLIBH-NRFANRHFSA-N,449.507,Q96SW2,BE0004755,Protein cereblon,Humans,inhibitor,yes
DB12105,Imagabalin,small molecule,investigational,CCC[C@@H](C)C[C@H](N)CC(O)=O,JXEHXYFSIOYTAH-SFYZADRCSA-N,173.256,P54289,BE0000691,Voltage-dependent calcium channel subunit alpha-2/delta-1,Humans,agonist,yes
DB12107,Vaborbactam,small molecule,approved;investigational,OB1O[C@H](CC(O)=O)CC[C@@H]1NC(=O)CC1=CC=CS1,IOOWNWLVCOUUEX-WPRPVWTQSA-N,297.13,P05364,BE0001430,Beta-lactamase,Enterobacter cloacae,inhibitor,yes
DB12107,Vaborbactam,small molecule,approved;investigational,OB1O[C@H](CC(O)=O)CC[C@@H]1NC(=O)CC1=CC=CS1,IOOWNWLVCOUUEX-WPRPVWTQSA-N,297.13,P00807,BE0000302,Beta-lactamase,Staphylococcus aureus,inhibitor,yes
DB12107,Vaborbactam,small molecule,approved;investigational,OB1O[C@H](CC(O)=O)CC[C@@H]1NC(=O)CC1=CC=CS1,IOOWNWLVCOUUEX-WPRPVWTQSA-N,297.13,Q9F663,BE0008649,Carbapenem-hydrolyzing beta-lactamase KPC,Klebsiella pneumoniae,inhibitor,yes
DB12107,Vaborbactam,small molecule,approved;investigational,OB1O[C@H](CC(O)=O)CC[C@@H]1NC(=O)CC1=CC=CS1,IOOWNWLVCOUUEX-WPRPVWTQSA-N,297.13,Q93LQ9,BE0009747,Beta-lactamase,Klebsiella pneumoniae,inhibitor,yes
DB12107,Vaborbactam,small molecule,approved;investigational,OB1O[C@H](CC(O)=O)CC[C@@H]1NC(=O)CC1=CC=CS1,IOOWNWLVCOUUEX-WPRPVWTQSA-N,297.13,Q939N4,BE0002831,Beta-lactamase CTX-M,Escherichia coli,inhibitor,yes
DB12107,Vaborbactam,small molecule,approved;investigational,OB1O[C@H](CC(O)=O)CC[C@@H]1NC(=O)CC1=CC=CS1,IOOWNWLVCOUUEX-WPRPVWTQSA-N,297.13,A0A068JFB7,BE0009746,Beta-lactamase,Escherichia coli,inhibitor,yes
DB12107,Vaborbactam,small molecule,approved;investigational,OB1O[C@H](CC(O)=O)CC[C@@H]1NC(=O)CC1=CC=CS1,IOOWNWLVCOUUEX-WPRPVWTQSA-N,297.13,P0AD64,BE0004185,Beta-lactamase SHV-1,Klebsiella pneumoniae,inhibitor,yes
DB12107,Vaborbactam,small molecule,approved;investigational,OB1O[C@H](CC(O)=O)CC[C@@H]1NC(=O)CC1=CC=CS1,IOOWNWLVCOUUEX-WPRPVWTQSA-N,297.13,P62593,BE0003894,Beta-lactamase TEM,Escherichia coli,inhibitor,yes
DB12107,Vaborbactam,small molecule,approved;investigational,OB1O[C@H](CC(O)=O)CC[C@@H]1NC(=O)CC1=CC=CS1,IOOWNWLVCOUUEX-WPRPVWTQSA-N,297.13,Q9X757,BE0009745,Beta-lactamase,Klebsiella pneumoniae,inhibitor,yes
DB12107,Vaborbactam,small molecule,approved;investigational,OB1O[C@H](CC(O)=O)CC[C@@H]1NC(=O)CC1=CC=CS1,IOOWNWLVCOUUEX-WPRPVWTQSA-N,297.13,Q53IN1,BE0009360,Beta-lactamase,Klebsiella pneumoniae,inhibitor,yes
DB12108,Taselisib,small molecule,investigational,CC(C)N1N=C(C)N=C1C1=CN2CCOC3=CC(=CC=C3C2=N1)C1=CN(N=C1)C(C)(C)C(N)=O,BEUQXVWXFDOSAQ-UHFFFAOYSA-N,460.542,P42336,BE0002379,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",Humans,modulator,yes
DB12108,Taselisib,small molecule,investigational,CC(C)N1N=C(C)N=C1C1=CN2CCOC3=CC(=CC=C3C2=N1)C1=CN(N=C1)C(C)(C)C(N)=O,BEUQXVWXFDOSAQ-UHFFFAOYSA-N,460.542,P48736,BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",Humans,inhibitor,yes
DB12109,Devimistat,small molecule,investigational,OC(=O)CCCCC(CCSCC1=CC=CC=C1)SCC1=CC=CC=C1,ZYRLHJIMTROTBO-UHFFFAOYSA-N,388.58,Q02218,BE0000162,2-oxoglutarate dehydrogenase complex component E1,Humans,modulator,yes
DB12110,m-Chlorophenylpiperazine,small molecule,investigational,ClC1=CC(=CC=C1)N1CCNCC1,VHFVKMTVMIZMIK-UHFFFAOYSA-N,196.677,P28566,BE0000476,5-hydroxytryptamine receptor 1E,Humans,agonist,yes
DB12110,m-Chlorophenylpiperazine,small molecule,investigational,ClC1=CC(=CC=C1)N1CCNCC1,VHFVKMTVMIZMIK-UHFFFAOYSA-N,196.677,P34969,BE0000650,5-hydroxytryptamine receptor 7,Humans,agonist,yes
DB12110,m-Chlorophenylpiperazine,small molecule,investigational,ClC1=CC(=CC=C1)N1CCNCC1,VHFVKMTVMIZMIK-UHFFFAOYSA-N,196.677,P50406,BE0000945,5-hydroxytryptamine receptor 6,Humans,agonist,yes
DB12110,m-Chlorophenylpiperazine,small molecule,investigational,ClC1=CC(=CC=C1)N1CCNCC1,VHFVKMTVMIZMIK-UHFFFAOYSA-N,196.677,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,agonist,yes
DB12110,m-Chlorophenylpiperazine,small molecule,investigational,ClC1=CC(=CC=C1)N1CCNCC1,VHFVKMTVMIZMIK-UHFFFAOYSA-N,196.677,P41595,BE0000393,5-hydroxytryptamine receptor 2B,Humans,agonist,yes
DB12110,m-Chlorophenylpiperazine,small molecule,investigational,ClC1=CC(=CC=C1)N1CCNCC1,VHFVKMTVMIZMIK-UHFFFAOYSA-N,196.677,P28221,BE0000659,5-hydroxytryptamine receptor 1D,Humans,antagonist,yes
DB12110,m-Chlorophenylpiperazine,small molecule,investigational,ClC1=CC(=CC=C1)N1CCNCC1,VHFVKMTVMIZMIK-UHFFFAOYSA-N,196.677,P28335,BE0000533,5-hydroxytryptamine receptor 2C,Humans,agonist,yes
DB12111,MK-212,small molecule,investigational,ClC1=NC(=CN=C1)N1CCNCC1,CJAWPFJGFFNXQI-UHFFFAOYSA-N,198.65,P28335,BE0000533,5-hydroxytryptamine receptor 2C,Humans,modulator,yes
DB12113,CE-224535,small molecule,investigational,COC[C@H](O)CN1C(=O)C=NN(C1=O)C1=CC=C(Cl)C(=C1)C(=O)NCC1(O)CCCCCC1,FUCKCIVGBCBZNP-MRXNPFEDSA-N,480.95,Q99572,BE0009814,P2X purinoceptor 7,Humans,antagonist,yes
DB12114,Poziotinib,small molecule,investigational,COC1=C(OC2CCN(CC2)C(=O)C=C)C=C2C(NC3=CC=C(Cl)C(Cl)=C3F)=NC=NC2=C1,LPFWVDIFUFFKJU-UHFFFAOYSA-N,491.34,P04626,BE0000511,Receptor tyrosine-protein kinase erbB-2,Humans,inhibitor,yes
DB12114,Poziotinib,small molecule,investigational,COC1=C(OC2CCN(CC2)C(=O)C=C)C=C2C(NC3=CC=C(Cl)C(Cl)=C3F)=NC=NC2=C1,LPFWVDIFUFFKJU-UHFFFAOYSA-N,491.34,P00533,BE0000767,Epidermal growth factor receptor,Humans,inhibitor;binder,yes
DB12116,Epigallocatechin gallate,small molecule,investigational,OC1=CC(O)=C2C[C@@H](OC(=O)C3=CC(O)=C(O)C(O)=C3)[C@H](OC2=C1)C1=CC(O)=C(O)C(O)=C1,WMBWREPUVVBILR-WIYYLYMNSA-N,458.3717,P49327,BE0000959,Fatty acid synthase,Humans,inhibitor,yes
DB12116,Epigallocatechin gallate,small molecule,investigational,OC1=CC(O)=C2C[C@@H](OC(=O)C3=CC(O)=C(O)C(O)=C3)[C@H](OC2=C1)C1=CC(O)=C(O)C(O)=C1,WMBWREPUVVBILR-WIYYLYMNSA-N,458.3717,P40763,BE0003462,Signal transducer and activator of transcription 3,Humans,inhibitor,yes
DB12116,Epigallocatechin gallate,small molecule,investigational,OC1=CC(O)=C2C[C@@H](OC(=O)C3=CC(O)=C(O)C(O)=C3)[C@H](OC2=C1)C1=CC(O)=C(O)C(O)=C1,WMBWREPUVVBILR-WIYYLYMNSA-N,458.3717,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB12116,Epigallocatechin gallate,small molecule,investigational,OC1=CC(O)=C2C[C@@H](OC(=O)C3=CC(O)=C(O)C(O)=C3)[C@H](OC2=C1)C1=CC(O)=C(O)C(O)=C1,WMBWREPUVVBILR-WIYYLYMNSA-N,458.3717,P50281,BE0003692,Matrix metalloproteinase-14,Humans,inhibitor,yes
DB12116,Epigallocatechin gallate,small molecule,investigational,OC1=CC(O)=C2C[C@@H](OC(=O)C3=CC(O)=C(O)C(O)=C3)[C@H](OC2=C1)C1=CC(O)=C(O)C(O)=C1,WMBWREPUVVBILR-WIYYLYMNSA-N,458.3717,P08253,BE0000642,72 kDa type IV collagenase,Humans,inhibitor,yes
DB12116,Epigallocatechin gallate,small molecule,investigational,OC1=CC(O)=C2C[C@@H](OC(=O)C3=CC(O)=C(O)C(O)=C3)[C@H](OC2=C1)C1=CC(O)=C(O)C(O)=C1,WMBWREPUVVBILR-WIYYLYMNSA-N,458.3717,Q14534,BE0000577,Squalene monooxygenase,Humans,inhibitor,yes
DB12116,Epigallocatechin gallate,small molecule,investigational,OC1=CC(O)=C2C[C@@H](OC(=O)C3=CC(O)=C(O)C(O)=C3)[C@H](OC2=C1)C1=CC(O)=C(O)C(O)=C1,WMBWREPUVVBILR-WIYYLYMNSA-N,458.3717,P08246,BE0000394,Neutrophil elastase,Humans,inhibitor,yes
DB12116,Epigallocatechin gallate,small molecule,investigational,OC1=CC(O)=C2C[C@@H](OC(=O)C3=CC(O)=C(O)C(O)=C3)[C@H](OC2=C1)C1=CC(O)=C(O)C(O)=C1,WMBWREPUVVBILR-WIYYLYMNSA-N,458.3717,P21980,BE0001035,Protein-glutamine gamma-glutamyltransferase 2,Humans,inhibitor,yes
DB12120,Avoralstat,small molecule,investigational,COC1=CC(=C(C=C1C=C)C(=O)NC1=CC=C(C=C1)C(N)=N)C1=CC=C(N=C1C(O)=O)C(=O)NCC1CC1,TUWMKPVJGGWGNL-UHFFFAOYSA-N,513.554,P20151,BE0012874,Kallikrein-2,Humans,inhibitor,yes
DB12120,Avoralstat,small molecule,investigational,COC1=CC(=C(C=C1C=C)C(=O)NC1=CC=C(C=C1)C(N)=N)C1=CC=C(N=C1C(O)=O)C(=O)NCC1CC1,TUWMKPVJGGWGNL-UHFFFAOYSA-N,513.554,P01042,BE0001017,Kininogen-1,Humans,inhibitor,yes
DB12122,Figopitant,small molecule,investigational,CN(CCC1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)C(=O)[C@@H](N1CCN(CC2CC2)CC1)C1=CC=CC=C1,HUTHJVYJUPXHDF-DEOSSOPVSA-N,527.555,P25103,BE0000384,Substance-P receptor,Humans,antagonist,yes
DB12124,Namitecan,small molecule,investigational,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=C1N=C1C=CC=CC1=C3\C=N\OCCN)C2=O,IBTISPLPBBHVSU-UVOOVGFISA-N,434.452,P11387,BE0000971,DNA topoisomerase 1,Humans,inhibitor,yes
DB12125,Dianicline,small molecule,investigational,C1C[C@@]23C[N@@]1CC[C@@H]2OC1=C(C3)N=CC=C1,SUPRUPHAEXPGPF-QWHCGFSZSA-N,216.284,P43681,BE0000849,Neuronal acetylcholine receptor subunit alpha-4,Humans,modulator,yes
DB12125,Dianicline,small molecule,investigational,C1C[C@@]23C[N@@]1CC[C@@H]2OC1=C(C3)N=CC=C1,SUPRUPHAEXPGPF-QWHCGFSZSA-N,216.284,P17787,BE0000850,Neuronal acetylcholine receptor subunit beta-2,Humans,modulator,yes
DB12126,Bradykinin,small molecule,investigational,N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O,QXZGBUJJYSLZLT-FDISYFBBSA-N,1060.2085,P30411,BE0003513,B2 bradykinin receptor,Humans,inhibitor,yes
DB12128,Ulimorelin,small molecule,investigational,C[C@@H]1CN[C@@H](C2CC2)C(=O)N(C)[C@H](C)C(=O)N[C@H](CC2=CC=C(F)C=C2)C(=O)NCCCC2=CC=CC=C2O1,WGYPAJVJMXQXTR-ABNZCKJZSA-N,538.664,Q92847,BE0003383,Growth hormone secretagogue receptor type 1,Humans,agonist,yes
DB12129,Tideglusib,small molecule,investigational;withdrawn,O=C1SN(C(=O)N1CC1=CC=CC=C1)C1=C2C=CC=CC2=CC=C1,PMJIHLSCWIDGMD-UHFFFAOYSA-N,334.39,P49841,BE0001065,Glycogen synthase kinase-3 beta,Humans,antagonist,yes
DB12130,Lorlatinib,small molecule,approved;investigational,C[C@H]1OC2=C(N)N=CC(=C2)C2=C(C#N)N(C)N=C2CN(C)C(=O)C2=C1C=C(F)C=C2,IIXWYSCJSQVBQM-LLVKDONJSA-N,406.421,P08922,BE0009534,Proto-oncogene tyrosine-protein kinase ROS,Humans,inhibitor,yes
DB12130,Lorlatinib,small molecule,approved;investigational,C[C@H]1OC2=C(N)N=CC(=C2)C2=C(C#N)N(C)N=C2CN(C)C(=O)C2=C1C=C(F)C=C2,IIXWYSCJSQVBQM-LLVKDONJSA-N,406.421,Q9UM73,BE0000359,ALK tyrosine kinase receptor,Humans,inhibitor,yes
DB12134,Gepotidacin,small molecule,investigational,O=C1C=CC2=C3N1C[C@@H](CN1CCC(CC1)NCC1=CC4=C(OCCC4)C=N1)N3C(=O)C=N2,PZFAZQUREQIODZ-LJQANCHMSA-N,448.527,P11388,BE0000742,DNA topoisomerase 2-alpha,Humans,inhibitor,yes
DB12134,Gepotidacin,small molecule,investigational,O=C1C=CC2=C3N1C[C@@H](CN1CCC(CC1)NCC1=CC4=C(OCCC4)C=N1)N3C(=O)C=N2,PZFAZQUREQIODZ-LJQANCHMSA-N,448.527,Q02880,BE0002425,DNA topoisomerase 2-beta,Humans,inhibitor,yes
DB12135,Elubrixin,small molecule,investigational,OC1=C(C(Cl)=CC=C1NC(=O)NC1=C(Cl)C(F)=CC=C1)S(=O)(=O)N1CCNCC1,YQYFEGTYCUQBEI-UHFFFAOYSA-N,463.31,P25025,BE0010516,C-X-C chemokine receptor type 2,Humans,antagonist,yes
DB12137,GSK-256066,small molecule,investigational,COC1=CC=CC(NC2=C(C=NC3=C(C)C=C(C=C23)S(=O)(=O)C2=CC(=CC=C2)C(=O)N(C)C)C(N)=O)=C1,JFHROPTYMMSOLG-UHFFFAOYSA-N,518.584,P27815,BE0001133,"3',5'-cyclic-AMP phosphodiesterase 4A",Humans,inhibitor,yes
DB12139,Alisporivir,small molecule,investigational,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(CC)C(=O)[C@@H](C)N(C)C1=O)C(C)C,OLROWHGDTNFZBH-XEMWPYQTSA-N,1216.662,P49069,BE0000379,Guided entry of tail-anchored proteins factor CAMLG,Humans,inhibitor,yes
DB12140,Dilmapimod,small molecule,investigational,CC1=CC(F)=CC=C1C1=C2C=CC(=O)N(C2=NC(NC(CO)CO)=N1)C1=C(F)C=CC=C1F,ORVNHOYNEHYKJG-UHFFFAOYSA-N,456.425,Q16539,BE0001019,Mitogen-activated protein kinase 14,Humans,inhibitor,yes
DB12141,Gilteritinib,small molecule,approved;investigational,CCC1=C(NC2CCOCC2)N=C(NC2=CC=C(N3CCC(CC3)N3CCN(C)CC3)C(OC)=C2)C(=N1)C(N)=O,GYQYAJJFPNQOOW-UHFFFAOYSA-N,552.724,P36888,BE0000147,Receptor-type tyrosine-protein kinase FLT3,Humans,inhibitor,yes
DB12141,Gilteritinib,small molecule,approved;investigational,CCC1=C(NC2CCOCC2)N=C(NC2=CC=C(N3CCC(CC3)N3CCN(C)CC3)C(OC)=C2)C(=N1)C(N)=O,GYQYAJJFPNQOOW-UHFFFAOYSA-N,552.724,P30530,BE0009412,Tyrosine-protein kinase receptor UFO,Humans,inhibitor,yes
DB12141,Gilteritinib,small molecule,approved;investigational,CCC1=C(NC2CCOCC2)N=C(NC2=CC=C(N3CCC(CC3)N3CCN(C)CC3)C(OC)=C2)C(=N1)C(N)=O,GYQYAJJFPNQOOW-UHFFFAOYSA-N,552.724,Q9UM73,BE0000359,ALK tyrosine kinase receptor,Humans,inhibitor,yes
DB12143,Rezatomidine,small molecule,investigational,C[C@H](C1=CNC(=S)N1)C1=C(C)C(C)=CC=C1,WQXVKEDUCPMRRI-JTQLQIEISA-N,232.35,P18825,BE0000342,Alpha-2C adrenergic receptor,Humans,agonist,yes
DB12145,AZD-0328,small molecule,investigational,C1C2=C(O[C@]11CN3CCC1CC3)N=CC=C2,OCKIPDMKGPYYJS-ZDUSSCGKSA-N,216.284,P36544,BE0002341,Neuronal acetylcholine receptor subunit alpha-7,Humans,modulator,yes
DB12146,Rigosertib,small molecule,investigational,COC1=CC(OC)=C(\C=C\S(=O)(=O)CC2=CC=C(OC)C(NCC(O)=O)=C2)C(OC)=C1,OWBFCJROIKNMGD-BQYQJAHWSA-N,451.49,P53350,BE0003745,Serine/threonine-protein kinase PLK1,Humans,modulator,yes
DB12146,Rigosertib,small molecule,investigational,COC1=CC(OC)=C(\C=C\S(=O)(=O)CC2=CC=C(OC)C(NCC(O)=O)=C2)C(OC)=C1,OWBFCJROIKNMGD-BQYQJAHWSA-N,451.49,P48736,BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",Humans,modulator,yes
DB12147,Erdafitinib,small molecule,approved;investigational,COC1=CC(=CC(OC)=C1)N(CCNC(C)C)C1=CC=C2N=CC(=NC2=C1)C1=CN(C)N=C1,OLAHOMJCDNXHFI-UHFFFAOYSA-N,446.555,P11362,BE0002131,Fibroblast growth factor receptor 1,Humans,inhibitor,yes
DB12147,Erdafitinib,small molecule,approved;investigational,COC1=CC(=CC(OC)=C1)N(CCNC(C)C)C1=CC=C2N=CC(=NC2=C1)C1=CN(C)N=C1,OLAHOMJCDNXHFI-UHFFFAOYSA-N,446.555,P21802,BE0000748,Fibroblast growth factor receptor 2,Humans,inhibitor,yes
DB12147,Erdafitinib,small molecule,approved;investigational,COC1=CC(=CC(OC)=C1)N(CCNC(C)C)C1=CC=C2N=CC(=NC2=C1)C1=CN(C)N=C1,OLAHOMJCDNXHFI-UHFFFAOYSA-N,446.555,P22607,BE0002133,Fibroblast growth factor receptor 3,Humans,inhibitor,yes
DB12147,Erdafitinib,small molecule,approved;investigational,COC1=CC(=CC(OC)=C1)N(CCNC(C)C)C1=CC=C2N=CC(=NC2=C1)C1=CN(C)N=C1,OLAHOMJCDNXHFI-UHFFFAOYSA-N,446.555,P22455,BE0001203,Fibroblast growth factor receptor 4,Humans,inhibitor,yes
DB12148,Menatetrenone,small molecule,investigational,[H]\C(CC\C(C)=C(/[H])CC\C(C)=C(/[H])CC1=C(C)C(=O)C2=CC=CC=C2C1=O)=C(\C)CCC=C(C)C,DKHGMERMDICWDU-GHDNBGIDSA-N,444.659,P25779,BE0001292,Cruzipain,Trypanosoma cruzi,inhibitor,yes
DB12150,Pelubiprofen,small molecule,investigational,[H]\C(C1=CC=C(C=C1)C(C)C(O)=O)=C1\CCCCC1=O,AUZUGWXLBGZUPP-GXDHUFHOSA-N,258.317,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,modulator,yes
DB12150,Pelubiprofen,small molecule,investigational,[H]\C(C1=CC=C(C=C1)C(C)C(O)=O)=C1\CCCCC1=O,AUZUGWXLBGZUPP-GXDHUFHOSA-N,258.317,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,modulator,yes
DB12151,Brincidofovir,small molecule,approved;investigational,CCCCCCCCCCCCCCCCOCCCOP(O)(=O)CO[C@H](CO)CN1C=CC(N)=NC1=O,WXJFKKQWPMNTIM-VWLOTQADSA-N,561.701,Q7Z5Q5,BE0016315,DNA polymerase nu,Humans,inhibitor,yes
DB12151,Brincidofovir,small molecule,approved;investigational,CCCCCCCCCCCCCCCCOCCCOP(O)(=O)CO[C@H](CO)CN1C=CC(N)=NC1=O,WXJFKKQWPMNTIM-VWLOTQADSA-N,561.701,Q9HCU8,BE0020436,DNA polymerase delta subunit 4,Humans,inhibitor,yes
DB12151,Brincidofovir,small molecule,approved;investigational,CCCCCCCCCCCCCCCCOCCCOP(O)(=O)CO[C@H](CO)CN1C=CC(N)=NC1=O,WXJFKKQWPMNTIM-VWLOTQADSA-N,561.701,P28340,BE0013106,DNA polymerase delta catalytic subunit,Humans,inhibitor,yes
DB12151,Brincidofovir,small molecule,approved;investigational,CCCCCCCCCCCCCCCCOCCCOP(O)(=O)CO[C@H](CO)CN1C=CC(N)=NC1=O,WXJFKKQWPMNTIM-VWLOTQADSA-N,561.701,O75417,BE0010760,DNA polymerase theta,Humans,inhibitor,yes
DB12151,Brincidofovir,small molecule,approved;investigational,CCCCCCCCCCCCCCCCOCCCOP(O)(=O)CO[C@H](CO)CN1C=CC(N)=NC1=O,WXJFKKQWPMNTIM-VWLOTQADSA-N,561.701,P06746,BE0000113,DNA polymerase beta,Humans,inhibitor,yes
DB12151,Brincidofovir,small molecule,approved;investigational,CCCCCCCCCCCCCCCCOCCCOP(O)(=O)CO[C@H](CO)CN1C=CC(N)=NC1=O,WXJFKKQWPMNTIM-VWLOTQADSA-N,561.701,Q9UHN1,BE0010885,DNA polymerase subunit gamma-2,Humans,inhibitor,yes
DB12151,Brincidofovir,small molecule,approved;investigational,CCCCCCCCCCCCCCCCOCCCOP(O)(=O)CO[C@H](CO)CN1C=CC(N)=NC1=O,WXJFKKQWPMNTIM-VWLOTQADSA-N,561.701,P54098,BE0010884,DNA polymerase subunit gamma-1,Humans,inhibitor,yes
DB12151,Brincidofovir,small molecule,approved;investigational,CCCCCCCCCCCCCCCCOCCCOP(O)(=O)CO[C@H](CO)CN1C=CC(N)=NC1=O,WXJFKKQWPMNTIM-VWLOTQADSA-N,561.701,P56282,BE0003615,DNA polymerase epsilon subunit 2,Humans,inhibitor,yes
DB12151,Brincidofovir,small molecule,approved;investigational,CCCCCCCCCCCCCCCCOCCCOP(O)(=O)CO[C@H](CO)CN1C=CC(N)=NC1=O,WXJFKKQWPMNTIM-VWLOTQADSA-N,561.701,P0DOO6,BE0010068,DNA polymerase,Variola virus,inhibitor,yes
DB12151,Brincidofovir,small molecule,approved;investigational,CCCCCCCCCCCCCCCCOCCCOP(O)(=O)CO[C@H](CO)CN1C=CC(N)=NC1=O,WXJFKKQWPMNTIM-VWLOTQADSA-N,561.701,,BE0010070,Variola virus DNA,Variola virus,incorporation into and destabilization,yes
DB12154,Itacitinib,small molecule,investigational,FC1=C(N=CC=C1C(=O)N1CCC(CC1)N1CC(CC#N)(C1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1)C(F)(F)F,KTBSXLIQKWEBRB-UHFFFAOYSA-N,553.526,O60674,BE0002408,Tyrosine-protein kinase JAK2,Humans,inhibitor,yes
DB12154,Itacitinib,small molecule,investigational,FC1=C(N=CC=C1C(=O)N1CCC(CC1)N1CC(CC#N)(C1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1)C(F)(F)F,KTBSXLIQKWEBRB-UHFFFAOYSA-N,553.526,P23458,BE0004145,Tyrosine-protein kinase JAK1,Humans,inhibitor,yes
DB12155,Napabucasin,small molecule,investigational,CC(=O)C1=CC2=C(O1)C(=O)C1=CC=CC=C1C2=O,DPHUWDIXHNQOSY-UHFFFAOYSA-N,240.214,P40763,BE0003462,Signal transducer and activator of transcription 3,Humans,inhibitor,yes
DB12161,Deutetrabenazine,small molecule,approved;investigational,[2H]C([2H])([2H])OC1=CC2=C(C=C1OC([2H])([2H])[2H])[C@@H]1CC(=O)[C@@H](CC(C)C)CN1CC2,MKJIEFSOBYUXJB-WEZHFFAMSA-N,323.466,Q05940,BE0000118,Synaptic vesicular amine transporter,Humans,inhibitor,yes
DB12165,Presatovir,small molecule,investigational,CC1=CN2N=C(C=C2N=C1N1CC[C@H](N)C1)[C@@H]1CCCCN1C(=O)C1=CC(Cl)=CC=C1NS(C)(=O)=O,GOFXWTVKPWJNGD-UWJYYQICSA-N,532.06,P03420,BE0010205,Fusion glycoprotein F0,Human respiratory syncytial virus A (strain A2),inhibitor,yes
DB12167,LY-3023414,small molecule,investigational,CO[C@@H](C)CN1C(=O)N(C)C2=C1C1=CC(=CC=C1N=C2)C1=CC(=CN=C1)C(C)(C)O,ACCFLVVUVBJNGT-AWEZNQCLSA-N,406.486,P42345,BE0002386,Serine/threonine-protein kinase mTOR,Humans,modulator,yes
DB12167,LY-3023414,small molecule,investigational,CO[C@@H](C)CN1C(=O)N(C)C2=C1C1=CC(=CC=C1N=C2)C1=CC(=CN=C1)C(C)(C)O,ACCFLVVUVBJNGT-AWEZNQCLSA-N,406.486,P42336,BE0002379,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",Humans,modulator,yes
DB12174,CUDC-101,small molecule,investigational,COC1=C(OCCCCCCC(=O)NO)C=C2C(NC3=CC=CC(=C3)C#C)=NC=NC2=C1,PLIVFNIUGLLCEK-UHFFFAOYSA-N,434.496,P00533,BE0000767,Epidermal growth factor receptor,Humans,modulator,yes
DB12174,CUDC-101,small molecule,investigational,COC1=C(OCCCCCCC(=O)NO)C=C2C(NC3=CC=CC(=C3)C#C)=NC=NC2=C1,PLIVFNIUGLLCEK-UHFFFAOYSA-N,434.496,P04626,BE0000511,Receptor tyrosine-protein kinase erbB-2,Humans,modulator,yes
DB12178,Telinavir,small molecule,investigational,CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(N)=O)NC(=O)C1=CC=C2C=CC=CC2=N1)C(=O)NC(C)(C)C,ZILOOGIOHVCEKS-HZFUHODCSA-N,604.752,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB12180,Apitolisib,small molecule,investigational,C[C@H](O)C(=O)N1CCN(CC2=C(C)C3=NC(=NC(N4CCOCC4)=C3S2)C2=CN=C(N)N=C2)CC1,YOVVNQKCSKSHKT-HNNXBMFYSA-N,498.601,P42345,BE0002386,Serine/threonine-protein kinase mTOR,Humans,modulator,yes
DB12180,Apitolisib,small molecule,investigational,C[C@H](O)C(=O)N1CCN(CC2=C(C)C3=NC(=NC(N4CCOCC4)=C3S2)C2=CN=C(N)N=C2)CC1,YOVVNQKCSKSHKT-HNNXBMFYSA-N,498.601,P48736,BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",Humans,modulator,yes
DB12181,Dalcetrapib,small molecule,investigational,CCC(CC)CC1(CCCCC1)C(=O)NC1=CC=CC=C1SC(=O)C(C)C,YZQLWPMZQVHJED-UHFFFAOYSA-N,389.6,P11597,BE0003516,Cholesteryl ester transfer protein,Humans,inhibitor,yes
DB12183,Sapitinib,small molecule,investigational,CNC(=O)CN1CCC(CC1)OC1=C(OC)C=C2N=CN=C(NC3=CC=CC(Cl)=C3F)C2=C1,DFJSJLGUIXFDJP-UHFFFAOYSA-N,473.93,P04626,BE0000511,Receptor tyrosine-protein kinase erbB-2,Humans,inhibitor,yes
DB12184,Gepirone,small molecule,approved;investigational,CC1(C)CC(=O)N(CCCCN2CCN(CC2)C2=NC=CC=N2)C(=O)C1,QOIGKGMMAGJZNZ-UHFFFAOYSA-N,359.474,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,partial agonist,yes
DB12185,Exatecan,small molecule,investigational,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=C1N=C1C=C(F)C(C)=C4CC[C@H](N)C3=C14)C2=O,ZVYVPGLRVWUPMP-FYSMJZIKSA-N,435.455,P11387,BE0000971,DNA topoisomerase 1,Humans,inhibitor,yes
DB12186,SRT-2104,small molecule,investigational,CC1=C(SC(=N1)C1=CC=CN=C1)C(=O)NC1=CC=CC=C1C1=CN2C(CN3CCOCC3)=CSC2=N1,LAMQVIQMVKWXOC-UHFFFAOYSA-N,516.64,Q96EB6,BE0002461,NAD-dependent protein deacetylase sirtuin-1,Humans,modulator,yes
DB12188,Zicronapine,small molecule,investigational,CN1CCN(CC1(C)C)[C@@H]1C[C@H](C2=C1C=C(Cl)C=C2)C1=CC=CC=C1,BYPMJBXPNZMNQD-PZJWPPBQSA-N,354.92,P14416,BE0000756,D(2) dopamine receptor,Humans,modulator,yes
DB12188,Zicronapine,small molecule,investigational,CN1CCN(CC1(C)C)[C@@H]1C[C@H](C2=C1C=C(Cl)C=C2)C1=CC=CC=C1,BYPMJBXPNZMNQD-PZJWPPBQSA-N,354.92,P21728,BE0000020,D(1A) dopamine receptor,Humans,modulator,yes
DB12188,Zicronapine,small molecule,investigational,CN1CCN(CC1(C)C)[C@@H]1C[C@H](C2=C1C=C(Cl)C=C2)C1=CC=CC=C1,BYPMJBXPNZMNQD-PZJWPPBQSA-N,354.92,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,modulator,yes
DB12190,Faropenem,small molecule,investigational,[H][C@]12SC([C@H]3CCCO3)=C(N1C(=O)[C@@H]2[C@@H](C)O)C(O)=O,HGGAKXAHAYOLDJ-FHZUQPTBSA-N,285.316,P0AC13,BE0000803,Dihydropteroate synthase,Escherichia coli (strain K12),inhibitor,yes
DB12191,Obatoclax,small molecule,investigational,COC1=CC(=N\C1=C/C1=C(C)C=C(C)N1)C1=CC2=CC=CC=C2N1,RFTSSZJZXOSICM-GRSHGNNSSA-N,317.392,P10415,BE0000246,Apoptosis regulator Bcl-2,Humans,inhibitor,yes
DB12191,Obatoclax,small molecule,investigational,COC1=CC(=N\C1=C/C1=C(C)C=C(C)N1)C1=CC2=CC=CC=C2N1,RFTSSZJZXOSICM-GRSHGNNSSA-N,317.392,Q07820,BE0003511,Induced myeloid leukemia cell differentiation protein Mcl-1,Humans,inhibitor,yes
DB12191,Obatoclax,small molecule,investigational,COC1=CC(=N\C1=C/C1=C(C)C=C(C)N1)C1=CC2=CC=CC=C2N1,RFTSSZJZXOSICM-GRSHGNNSSA-N,317.392,Q07817,BE0003510,Bcl-2-like protein 1,Humans,inhibitor,yes
DB12193,Lenabasum,small molecule,investigational,[H][C@@]12CC(=CC[C@@]1([H])C(C)(C)OC1=CC(=CC(O)=C21)C(C)(C)CCCCCC)C(O)=O,YCHYFHOSGQABSW-RTBURBONSA-N,400.5509,P01375,BE0000704,Tumor necrosis factor,Humans,inhibitor,yes
DB12199,TRV-120027,small molecule,investigational,[H][C@](NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC)C(C)C)([C@@H](C)CC)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(O)=O,XIEWFECSPPTVQN-KMIMAYJXSA-N,926.09,P30556,BE0000062,Type-1 angiotensin II receptor,Humans,antagonist,yes
DB12200,Tivantinib,small molecule,investigational,O=C1NC(=O)[C@H]([C@@H]1C1=CNC2=CC=CC=C12)C1=CN2CCCC3=C2C1=CC=C3,UCEQXRCJXIVODC-PMACEKPBSA-N,369.424,P08581,BE0000915,Hepatocyte growth factor receptor,Humans,inhibitor,yes
DB12203,Tozadenant,small molecule,investigational,COC1=C2N=C(NC(=O)N3CCC(C)(O)CC3)SC2=C(C=C1)N1CCOCC1,XNBRWUQWSKXMPW-UHFFFAOYSA-N,406.5,P29274,BE0000924,Adenosine receptor A2a,Humans,antagonist,yes
DB12204,Terbogrel,small molecule,investigational,CC(C)(C)N\C(NC#N)=N\C1=CC(=CC=C1)C(=C/CCCC(O)=O)\C1=CC=CN=C1,XUTLOCQNGLJNSA-RGVLZGJSSA-N,405.502,P21731,BE0000759,Thromboxane A2 receptor,Humans,antagonist,yes
DB12206,N-6022,small molecule,investigational,CC1=CC(=CC=C1N1C(CCC(O)=O)=CC=C1C1=CC=C(C=C1)N1C=CN=C1)C(N)=O,YVPGZQLRPAGKLA-UHFFFAOYSA-N,414.4565,P16152,BE0003074,Carbonyl reductase [NADPH] 1,Humans,inhibitor,yes
DB12209,Tirasemtiv,small molecule,investigational,CCC(CC)N1C(=O)NC2=NC=C(N=C12)C#C,RSQGZEAXODVTOL-UHFFFAOYSA-N,230.271,P02585,BE0003566,"Troponin C, skeletal muscle",Humans,modulator,yes
DB12210,AZD-6280,small molecule,investigational,CCCNC(=O)C1=NN=C2C(=CC=CC2=C1N)C1=CC(OC)=CC=C1OC,NVWCZRPXYVDQEE-UHFFFAOYSA-N,366.421,P34903,BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,Humans,modulator,yes
DB12211,PSI-697,small molecule,investigational,OC(=O)C1=C2C=CC3=C(CCCC3)C2=NC(CC2=CC=C(Cl)C=C2)=C1O,DIEPFYNZGUUVHD-UHFFFAOYSA-N,367.83,P16109,BE0001159,P-selectin,Humans,inhibitor,yes
DB12218,Capivasertib,small molecule,approved;investigational,NC1(CCN(CC1)C1=C2C=CNC2=NC=N1)C(=O)N[C@@H](CCO)C1=CC=C(Cl)C=C1,JDUBGYFRJFOXQC-KRWDZBQOSA-N,428.915,P31749,BE0000428,RAC-alpha serine/threonine-protein kinase,Humans,inhibitor,yes
DB12218,Capivasertib,small molecule,approved;investigational,NC1(CCN(CC1)C1=C2C=CNC2=NC=N1)C(=O)N[C@@H](CCO)C1=CC=C(Cl)C=C1,JDUBGYFRJFOXQC-KRWDZBQOSA-N,428.915,P31751,BE0001172,RAC-beta serine/threonine-protein kinase,Humans,inhibitor,yes
DB12218,Capivasertib,small molecule,approved;investigational,NC1(CCN(CC1)C1=C2C=CNC2=NC=N1)C(=O)N[C@@H](CCO)C1=CC=C(Cl)C=C1,JDUBGYFRJFOXQC-KRWDZBQOSA-N,428.915,Q9Y243,BE0010514,RAC-gamma serine/threonine-protein kinase,Humans,inhibitor,yes
DB12220,ORG-25935,small molecule,investigational,COC1=CC=C2[C@H]([C@@H](CN(C)CC(O)=O)CCC2=C1)C1=CC=CC=C1,UEBBYLJZCHTLEG-UTKZUKDTSA-N,339.435,P48067,BE0000940,Sodium- and chloride-dependent glycine transporter 1,Humans,inhibitor,yes
DB12222,Lurtotecan,small molecule,investigational,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=C1N=C1C=C4OCCOC4=CC1=C3CN1CCN(C)CC1)C2=O,RVFGKBWWUQOIOU-NDEPHWFRSA-N,518.57,P11387,BE0000971,DNA topoisomerase 1,Humans,inhibitor,yes
DB12225,Beclabuvir,small molecule,investigational,COC1=CC=C2C3=C(C4CCCCC4)C4=CC=C(C=C4N3C[C@]3(C[C@H]3C2=C1)C(=O)N1[C@H]2CC[C@@H]1CN(C)C2)C(=O)NS(=O)(=O)N(C)C,ZTTKEBYSXUCBSE-QDFUAKMASA-N,659.838,P26664,BE0003427,Genome polyprotein,,inhibitor,yes
DB12226,Terameprocol,small molecule,investigational,COC1=CC=C(C[C@H](C)[C@H](C)CC2=CC=C(OC)C(OC)=C2)C=C1OC,ORQFDHFZSMXRLM-IYBDPMFKSA-N,358.478,P08047,BE0010335,Transcription factor Sp1,Humans,modulator,yes
DB12228,Telcagepant,small molecule,investigational,FC1=C(F)C(=CC=C1)[C@@H]1CC[C@@H](NC(=O)N2CCC(CC2)N2C(=O)NC3=C2C=CC=N3)C(=O)N(CC(F)(F)F)C1,CGDZXLJGHVKVIE-DNVCBOLYSA-N,566.523,Q16602,BE0009009,Calcitonin gene-related peptide type 1 receptor,Humans,antagonist,yes
DB12229,Cerlapirdine,small molecule,investigational,CN(C)CCCOC1=CC=C2NN=C(C2=C1)S(=O)(=O)C1=C2C=CC=CC2=CC=C1,NXQGEDVQXVTCDA-UHFFFAOYSA-N,409.5,P50406,BE0000945,5-hydroxytryptamine receptor 6,Humans,antagonist,yes
DB12230,Bunazosin,small molecule,investigational,CCCC(=O)N1CCCN(CC1)C1=NC(N)=C2C=C(OC)C(OC)=CC2=N1,RHLJLALHBZGAFM-UHFFFAOYSA-N,373.457,P25100,BE0000715,Alpha-1D adrenergic receptor,Humans,modulator,yes
DB12234,BMS-214662,small molecule,investigational,[H][C@@]1(CC2=CC=CC=C2)CN(CC2=CN=CN2)C2=C(CN1S(=O)(=O)C1=CC=CS1)C=C(C=C2)C#N,OLCWFLWEHWLBTO-HSZRJFAPSA-N,489.612,P49354,BE0002373,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,Humans,modulator,yes
DB12234,BMS-214662,small molecule,investigational,[H][C@@]1(CC2=CC=CC=C2)CN(CC2=CN=CN2)C2=C(CN1S(=O)(=O)C1=CC=CS1)C=C(C=C2)C#N,OLCWFLWEHWLBTO-HSZRJFAPSA-N,489.612,P49356,BE0002372,Protein farnesyltransferase subunit beta,Humans,modulator,yes
DB12235,Estetrol,small molecule,approved;investigational,[H][C@@]12[C@@H](O)[C@@H](O)[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3CC[C@@]21[H],AJIPIJNNOJSSQC-NYLIRDPKSA-N,304.3808,P03372,BE0000123,Estrogen receptor,Humans,agonist;modulator;regulator,yes
DB12236,Bexagliflozin,small molecule,approved;investigational,OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C1=CC=C(Cl)C(CC2=CC=C(OCCOC3CC3)C=C2)=C1,BTCRKOKVYTVOLU-SJSRKZJXSA-N,464.94,P31639,BE0004753,Sodium/glucose cotransporter 2,Humans,inhibitor,yes
DB12237,GW-274150,small molecule,investigational,CC(=N)NCCSCC[C@H](N)C(O)=O,MOLOJNHYNHBPCW-ZETCQYMHSA-N,219.3,P35228,BE0000005,"Nitric oxide synthase, inducible",Humans,modulator,yes
DB12239,Balicatib,small molecule,investigational,CCCN1CCN(CC1)C1=CC=C(C=C1)C(=O)NC1(CCCCC1)C(=O)NCC#N,LLCRBOWRJOUJAE-UHFFFAOYSA-N,411.55,P43235,BE0003417,Cathepsin K,Humans,inhibitor,yes
DB12242,AZD-7762,small molecule,investigational,NC(=O)NC1=C(SC(=C1)C1=CC=CC(F)=C1)C(=O)N[C@H]1CCCNC1,IAYGCINLNONXHY-LBPRGKRZSA-N,362.422,O14757,BE0003382,Serine/threonine-protein kinase Chk1,Humans,inhibitor,yes
DB12243,Edaravone,small molecule,approved;investigational,CC1=NN(C(=O)C1)C1=CC=CC=C1,QELUYTUMUWHWMC-UHFFFAOYSA-N,174.203,P10415,BE0000246,Apoptosis regulator Bcl-2,Humans,upregulator,yes
DB12244,CP-601927,small molecule,investigational,FC(F)(F)C1=CC2=C(C=C1)[C@H]1C[C@@H]2CNC1,RNOBTWYQAWEZHH-JGVFFNPUSA-N,227.23,P43681,BE0000849,Neuronal acetylcholine receptor subunit alpha-4,Humans,modulator,yes
DB12244,CP-601927,small molecule,investigational,FC(F)(F)C1=CC2=C(C=C1)[C@H]1C[C@@H]2CNC1,RNOBTWYQAWEZHH-JGVFFNPUSA-N,227.23,P17787,BE0000850,Neuronal acetylcholine receptor subunit beta-2,Humans,modulator,yes
DB12245,Triclabendazole,small molecule,approved;investigational,CSC1=NC2=C(N1)C=C(Cl)C(OC1=CC=CC(Cl)=C1Cl)=C2,NQPDXQQQCQDHHW-UHFFFAOYSA-N,359.65,P25779,BE0001292,Cruzipain,Trypanosoma cruzi,inhibitor,yes
DB12247,AZD-4547,small molecule,investigational,COC1=CC(OC)=CC(CCC2=CC(NC(=O)C3=CC=C(C=C3)N3C[C@H](C)N[C@H](C)C3)=NN2)=C1,VRQMAABPASPXMW-HDICACEKSA-N,463.582,P11362,BE0002131,Fibroblast growth factor receptor 1,Humans,modulator,yes
DB12253,GDC-0810,small molecule,investigational,CC\C(=C(\C1=CC=C(\C=C\C(O)=O)C=C1)C1=CC=C2NN=CC2=C1)C1=CC=C(F)C=C1Cl,BURHGPHDEVGCEZ-KJGLQBJMSA-N,446.91,P03372,BE0000123,Estrogen receptor,Humans,modulator,yes
DB12255,Vadadustat,small molecule,approved;investigational,OC(=O)CNC(=O)C1=C(O)C=C(C=N1)C1=CC(Cl)=CC=C1,JGRXMPYUTJLTKT-UHFFFAOYSA-N,306.7,Q9GZT9,BE0002217,Egl nine homolog 1,Humans,inhibitor,yes
DB12255,Vadadustat,small molecule,approved;investigational,OC(=O)CNC(=O)C1=C(O)C=C(C=N1)C1=CC(Cl)=CC=C1,JGRXMPYUTJLTKT-UHFFFAOYSA-N,306.7,Q96KS0,BE0002211,Prolyl hydroxylase EGLN2,Humans,inhibitor,yes
DB12255,Vadadustat,small molecule,approved;investigational,OC(=O)CNC(=O)C1=C(O)C=C(C=N1)C1=CC(Cl)=CC=C1,JGRXMPYUTJLTKT-UHFFFAOYSA-N,306.7,Q9H6Z9,BE0002219,Prolyl hydroxylase EGLN3,Humans,inhibitor,yes
DB12260,Radiprodil,small molecule,investigational,FC1=CC=C(CC2CCN(CC2)C(=O)C(=O)NC2=CC=C3NC(=O)OC3=C2)C=C1,GKGRZLGAQZPEHO-UHFFFAOYSA-N,397.406,Q13224,BE0000417,"Glutamate receptor ionotropic, NMDA 2B",Humans,antagonist,yes
DB12263,Begacestat,small molecule,investigational,OC[C@@H](NS(=O)(=O)C1=CC=C(Cl)S1)C(C(F)(F)F)C(F)(F)F,PSXOKXJMVRSARX-SCSAIBSYSA-N,391.73,Q8WW43,BE0017533,Gamma-secretase subunit APH-1B,Humans,modulator,yes
DB12263,Begacestat,small molecule,investigational,OC[C@@H](NS(=O)(=O)C1=CC=C(Cl)S1)C(C(F)(F)F)C(F)(F)F,PSXOKXJMVRSARX-SCSAIBSYSA-N,391.73,Q92542,BE0017775,Nicastrin,Humans,modulator,yes
DB12263,Begacestat,small molecule,investigational,OC[C@@H](NS(=O)(=O)C1=CC=C(Cl)S1)C(C(F)(F)F)C(F)(F)F,PSXOKXJMVRSARX-SCSAIBSYSA-N,391.73,Q96BI3,BE0003409,Gamma-secretase subunit APH-1A,Humans,modulator,yes
DB12263,Begacestat,small molecule,investigational,OC[C@@H](NS(=O)(=O)C1=CC=C(Cl)S1)C(C(F)(F)F)C(F)(F)F,PSXOKXJMVRSARX-SCSAIBSYSA-N,391.73,Q9NZ42,BE0003410,Gamma-secretase subunit PEN-2,Humans,modulator,yes
DB12263,Begacestat,small molecule,investigational,OC[C@@H](NS(=O)(=O)C1=CC=C(Cl)S1)C(C(F)(F)F)C(F)(F)F,PSXOKXJMVRSARX-SCSAIBSYSA-N,391.73,P49768,BE0010960,Presenilin-1,Humans,modulator,yes
DB12264,Atevirdine,small molecule,investigational,CCNC1=CC=CN=C1N1CCN(CC1)C(=O)C1=CC2=CC(OC)=CC=C2N1,UCPOMLWZWRTIAA-UHFFFAOYSA-N,379.464,P03366,BE0002050,Gag-Pol polyprotein,,modulator,yes
DB12266,Epofolate,small molecule,investigational,[H][C@]1(C)CCC[C@@H]2[C@H](C[C@H](OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)C(\C)=C\C1=CSC(C)=N1)N2CCOC(=O)OCCSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(O)=O)NC(=O)CC[C@H](NC(=O)C1=CC=C(NCC2=CN=C3N=C(N)NC(=O)C3=N2)C=C1)C(O)=O)C(O)=O,TURJYGRXEJIBGT-OCOMGVANSA-N,1569.74,P15328,BE0003405,Folate receptor alpha,Humans,modulator,yes
DB12267,Brigatinib,small molecule,approved;investigational,COC1=CC(=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2P(C)(C)=O)=N1)N1CCC(CC1)N1CCN(C)CC1,AILRADAXUVEEIR-UHFFFAOYSA-N,584.1,Q9UM73,BE0000359,ALK tyrosine kinase receptor,Humans,inhibitor,yes
DB12267,Brigatinib,small molecule,approved;investigational,COC1=CC(=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2P(C)(C)=O)=N1)N1CCC(CC1)N1CCN(C)CC1,AILRADAXUVEEIR-UHFFFAOYSA-N,584.1,P00533,BE0000767,Epidermal growth factor receptor,Humans,inhibitor,yes
DB12270,Losmapimod,small molecule,investigational,CC1=C(C=C(C=C1F)C(=O)NC1CC1)C1=CC=C(C=N1)C(=O)NCC(C)(C)C,KKYABQBFGDZVNQ-UHFFFAOYSA-N,383.467,Q16539,BE0001019,Mitogen-activated protein kinase 14,Humans,inhibitor,yes
DB12271,ORE-1001,small molecule,investigational,CC(C)C[C@H](N[C@@H](CC1=CN=CN1CC1=CC(Cl)=CC(Cl)=C1)C(O)=O)C(O)=O,NTCCRGGIJNDEAB-IRXDYDNUSA-N,428.31,Q9BYF1,BE0000982,Angiotensin-converting enzyme 2,Humans,inhibitor,yes
DB12272,Vidupiprant,small molecule,investigational,CC(C)(C)NC(=O)C1=CC=C(OC2=CC(F)=C(CC(O)=O)C=C2Cl)C(NS(=O)(=O)C2=CC=C(C=C2Cl)C2CC2)=C1,PFWVGKROPKKEDW-UHFFFAOYSA-N,609.49,Q9Y5Y4,BE0003561,Prostaglandin D2 receptor 2,Humans,modulator,yes
DB12272,Vidupiprant,small molecule,investigational,CC(C)(C)NC(=O)C1=CC=C(OC2=CC(F)=C(CC(O)=O)C=C2Cl)C(NS(=O)(=O)C2=CC=C(C=C2Cl)C2CC2)=C1,PFWVGKROPKKEDW-UHFFFAOYSA-N,609.49,Q13258,BE0000296,Prostaglandin D2 receptor,Humans,modulator,yes
DB12273,Ecopipam,small molecule,investigational,[H][C@]12CCC3=CC=CC=C3[C@]1([H])C1=CC(O)=C(Cl)C=C1CCN2C,DMJWENQHWZZWDF-PKOBYXMFSA-N,313.83,P21728,BE0000020,D(1A) dopamine receptor,Humans,modulator,yes
DB12275,Seviteronel,small molecule,investigational,CC(C)[C@@](O)(C1=CN=NN1)C1=CC=C2C=C(OC(F)F)C(OC(F)F)=CC2=C1,ZBRAJOQFSNYJMF-SFHVURJKSA-N,399.346,P05093,BE0000344,"Steroid 17-alpha-hydroxylase/17,20 lyase",Humans,inhibitor,yes
DB12276,Apomine,small molecule,investigational,CC(C)OP(=O)(OC(C)C)C(CC1=CC(=C(O)C(=C1)C(C)(C)C)C(C)(C)C)P(=O)(OC(C)C)OC(C)C,YLJOVCWVJCDPLN-UHFFFAOYSA-N,562.665,Q96RI1,BE0001777,Bile acid receptor,Humans,agonist,yes
DB12278,Propiverine,small molecule,approved;investigational,CCCOC(C(=O)OC1CCN(C)CC1)(C1=CC=CC=C1)C1=CC=CC=C1,QPCVHQBVMYCJOM-UHFFFAOYSA-N,367.4813,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,antagonist,yes
DB12278,Propiverine,small molecule,approved;investigational,CCCOC(C(=O)OC1CCN(C)CC1)(C1=CC=CC=C1)C1=CC=CC=C1,QPCVHQBVMYCJOM-UHFFFAOYSA-N,367.4813,P08172,BE0000560,Muscarinic acetylcholine receptor M2,Humans,antagonist,yes
DB12278,Propiverine,small molecule,approved;investigational,CCCOC(C(=O)OC1CCN(C)CC1)(C1=CC=CC=C1)C1=CC=CC=C1,QPCVHQBVMYCJOM-UHFFFAOYSA-N,367.4813,P20309,BE0000045,Muscarinic acetylcholine receptor M3,Humans,antagonist,yes
DB12278,Propiverine,small molecule,approved;investigational,CCCOC(C(=O)OC1CCN(C)CC1)(C1=CC=CC=C1)C1=CC=CC=C1,QPCVHQBVMYCJOM-UHFFFAOYSA-N,367.4813,P08912,BE0000247,Muscarinic acetylcholine receptor M5,Humans,antagonist,yes
DB12278,Propiverine,small molecule,approved;investigational,CCCOC(C(=O)OC1CCN(C)CC1)(C1=CC=CC=C1)C1=CC=CC=C1,QPCVHQBVMYCJOM-UHFFFAOYSA-N,367.4813,Q13936,BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,Humans,antagonist,yes
DB12278,Propiverine,small molecule,approved;investigational,CCCOC(C(=O)OC1CCN(C)CC1)(C1=CC=CC=C1)C1=CC=CC=C1,QPCVHQBVMYCJOM-UHFFFAOYSA-N,367.4813,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,antagonist,yes
DB12279,OBP-801,small molecule,investigational,CC(C)[C@H]1NC(=O)[C@H]2CSSCC\C=C\[C@H](CC(=O)N[C@H](C)C(=O)N2)OC(=O)C[C@@H]1O,XFLBOEMFLGLWFF-HDXRNPEWSA-N,473.6,Q13547,BE0002365,Histone deacetylase 1,Humans,inhibitor,yes
DB12280,AZD-5423,small molecule,investigational,COC1=CC(=CC=C1)[C@@H](OC1=CC=C2N(N=CC2=C1)C1=CC=C(F)C=C1)[C@H](C)NC(=O)C(F)(F)F,FCNQMDSJHADDFT-WNSKOXEYSA-N,487.455,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB12282,Defactinib,small molecule,investigational,CNC(=O)C1=CC=C(NC2=NC=C(C(NCC3=C(N=CC=N3)N(C)S(C)(=O)=O)=N2)C(F)(F)F)C=C1,FWLMVFUGMHIOAA-UHFFFAOYSA-N,510.5,Q05397,BE0003090,Focal adhesion kinase 1,Humans,inhibitor,yes
DB12283,Balapiravir,small molecule,investigational,CC(C)C(=O)OC[C@]1(O[C@H]([C@H](OC(=O)C(C)C)[C@@H]1OC(=O)C(C)C)N1C=CC(N)=NC1=O)N=[N+]=[N-],VKXWOLCNTHXCLF-DXEZIKHYSA-N,494.505,P26664,BE0003427,Genome polyprotein,,inhibitor,yes
DB12284,LY-2608204,small molecule,investigational,O=C(NC1=NC=C(SCCN2CCCC2)S1)[C@@]1(C[C@H]1C1CCCCC1)C1=CC=C(C=C1)S(=O)(=O)C1CC1,QIIVJLHCZUTGSD-CUBQBAPOSA-N,559.8,P35557,BE0001056,Hexokinase-4,Humans,activator,yes
DB12285,Verubecestat,small molecule,investigational,CN1C(N)=N[C@@](C)(CS1(=O)=O)C1=CC(NC(=O)C2=CC=C(F)C=N2)=CC=C1F,YHYKUSGACIYRML-KRWDZBQOSA-N,409.41,P56817,BE0000988,Beta-secretase 1,Humans,inhibitor,yes
DB12288,Piromelatine,small molecule,investigational,COC1=CC=C2NC=C(CCNC(=O)C3=CC(=O)C=CO3)C2=C1,PNTNBIHOAPJYDB-UHFFFAOYSA-N,312.325,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,agonist,yes
DB12288,Piromelatine,small molecule,investigational,COC1=CC=C2NC=C(CCNC(=O)C3=CC(=O)C=CO3)C2=C1,PNTNBIHOAPJYDB-UHFFFAOYSA-N,312.325,P28221,BE0000659,5-hydroxytryptamine receptor 1D,Humans,agonist,yes
DB12288,Piromelatine,small molecule,investigational,COC1=CC=C2NC=C(CCNC(=O)C3=CC(=O)C=CO3)C2=C1,PNTNBIHOAPJYDB-UHFFFAOYSA-N,312.325,P48039,BE0000515,Melatonin receptor type 1A,Humans,agonist,yes
DB12289,Darexaban,small molecule,investigational,COC1=CC=C(C=C1)C(=O)NC1=C(NC(=O)C2=CC=C(C=C2)N2CCCN(C)CC2)C(O)=CC=C1,IJNIQYINMSGIPS-UHFFFAOYSA-N,474.561,P00742,BE0000216,Coagulation factor X,Humans,inhibitor,yes
DB12290,Puerarin,small molecule,investigational,OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C1=C(O)C=CC2=C1OC=C(C2=O)C1=CC=C(O)C=C1,HKEAFJYKMMKDOR-VPRICQMDSA-N,416.3781,P28335,BE0000533,5-hydroxytryptamine receptor 2C,Humans,modulator,yes
DB12291,Tacedinaline,small molecule,investigational,CC(=O)NC1=CC=C(C=C1)C(=O)NC1=CC=CC=C1N,VAZAPHZUAVEOMC-UHFFFAOYSA-N,269.304,Q13547,BE0002365,Histone deacetylase 1,Humans,inhibitor,yes
DB12292,Barusiban,small molecule,investigational,CC[C@H](C)[C@@H]1NC(=O)[C@@H](CC2=CNC3=CC=CC=C23)NC(=O)CCSCC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC1=O)[C@H](C)CC)C(=O)N(C)[C@H](CO)CCCN,UGNGRKKDUVKQDF-IHOMMZCZSA-N,830.06,P30559,BE0000844,Oxytocin receptor,Humans,antagonist,yes
DB12295,Evodenoson,small molecule,investigational,COC(=O)N1CCC(CC#CC2=NC(N)=C3N=CN([C@@H]4O[C@@H]([C@@H](O)[C@H]4O)C(=O)NC4CC4)C3=N2)CC1,SQJXTUJMBYVDBB-RQXXJAGISA-N,499.528,P29274,BE0000924,Adenosine receptor A2a,Humans,agonist,yes
DB12298,5-Hydroxymethylfurfural,small molecule,investigational,OCC1=CC=C(O1)C=O,NOEGNKMFWQHSLB-UHFFFAOYSA-N,126.11,P69905,BE0000130,Hemoglobin subunit alpha,Humans,modulator,yes
DB12299,Bavisant,small molecule,investigational,O=C(N1CCN(CC1)C1CC1)C1=CC=C(CN2CCOCC2)C=C1,BGBVSGSIXIIREO-UHFFFAOYSA-N,329.444,Q9Y5N1,BE0000968,Histamine H3 receptor,Humans,antagonist,yes
DB12301,Doravirine,small molecule,approved;investigational,CN1C(=O)NN=C1CN1C=CC(=C(OC2=CC(=CC(Cl)=C2)C#N)C1=O)C(F)(F)F,ZIAOVIPSKUPPQW-UHFFFAOYSA-N,425.749,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB12302,CP-724714,small molecule,investigational,COCC(=O)NC\C=C\C1=CC=C2N=CN=C(NC3=CC=C(OC4=CC=C(C)N=C4)C(C)=C3)C2=C1,LLVZBTWPGQVVLW-SNAWJCMRSA-N,469.545,P04626,BE0000511,Receptor tyrosine-protein kinase erbB-2,Humans,inhibitor,yes
DB12303,Motolimod,small molecule,investigational,CCCN(CCC)C(=O)C1=CC2=CC=C(C=C2N=C(N)C1)C1=CC=C(C=C1)C(=O)N1CCCC1,QSPOQCXMGPDIHI-UHFFFAOYSA-N,458.606,Q9NR97,BE0003518,Toll-like receptor 8,Humans,modulator,yes
DB12305,Dasotraline,small molecule,investigational,N[C@@H]1CC[C@@H](C2=CC=C(Cl)C(Cl)=C2)C2=CC=CC=C12,SRPXSILJHWNFMK-MEDUHNTESA-N,292.2,Q01959,BE0000647,Sodium-dependent dopamine transporter,Humans,inhibitor,yes
DB12305,Dasotraline,small molecule,investigational,N[C@@H]1CC[C@@H](C2=CC=C(Cl)C(Cl)=C2)C2=CC=CC=C12,SRPXSILJHWNFMK-MEDUHNTESA-N,292.2,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,inhibitor,yes
DB12305,Dasotraline,small molecule,investigational,N[C@@H]1CC[C@@H](C2=CC=C(Cl)C(Cl)=C2)C2=CC=CC=C12,SRPXSILJHWNFMK-MEDUHNTESA-N,292.2,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,inhibitor,yes
DB12306,Cipargamin,small molecule,investigational,C[C@H]1CC2=C(NC3=CC(Cl)=C(F)C=C23)[C@@]2(N1)C(=O)NC1=CC=C(Cl)C=C21,CKLPLPZSUQEDRT-WPCRTTGESA-N,390.24,P0DMS8,BE0000354,Adenosine receptor A3,Humans,inhibitor,yes
DB12306,Cipargamin,small molecule,investigational,C[C@H]1CC2=C(NC3=CC(Cl)=C(F)C=C23)[C@@]2(N1)C(=O)NC1=CC=C(Cl)C=C21,CKLPLPZSUQEDRT-WPCRTTGESA-N,390.24,Q12809,BE0000090,Voltage-gated inwardly rectifying potassium channel KCNH2,Humans,inhibitor,yes
DB12307,Foretinib,small molecule,investigational,COC1=C(OCCCN2CCOCC2)C=C2N=CC=C(OC3=CC=C(NC(=O)C4(CC4)C(=O)NC4=CC=C(F)C=C4)C=C3F)C2=C1,CXQHYVUVSFXTMY-UHFFFAOYSA-N,632.6538,P08581,BE0000915,Hepatocyte growth factor receptor,Humans,modulator,yes
DB12307,Foretinib,small molecule,investigational,COC1=C(OCCCN2CCOCC2)C=C2N=CC=C(OC3=CC=C(NC(=O)C4(CC4)C(=O)NC4=CC=C(F)C=C4)C=C3F)C2=C1,CXQHYVUVSFXTMY-UHFFFAOYSA-N,632.6538,P35968,BE0000369,Vascular endothelial growth factor receptor 2,Humans,modulator,yes
DB12308,Eltanolone,small molecule,investigational,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@]2([H])C[C@H](O)CC[C@]12C,AURFZBICLPNKBZ-YZRLXODZSA-N,318.501,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,inhibitor,yes
DB12308,Eltanolone,small molecule,investigational,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@]2([H])C[C@H](O)CC[C@]12C,AURFZBICLPNKBZ-YZRLXODZSA-N,318.501,P47870,BE0002346,Gamma-aminobutyric acid receptor subunit beta-2,Humans,inhibitor,yes
DB12308,Eltanolone,small molecule,investigational,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@]2([H])C[C@H](O)CC[C@]12C,AURFZBICLPNKBZ-YZRLXODZSA-N,318.501,P18507,BE0003592,Gamma-aminobutyric acid receptor subunit gamma-2,Humans,inhibitor,yes
DB12309,GI-181771X,small molecule,investigational,CC(C)N(C(=O)CN1C2=CC=CC=C2N(C2=CC=CC=C2)C(=O)[C@@H](NC(=O)NC2=CC=CC(=C2)C(O)=O)C1=O)C1=CC=CC=C1,CABBMMXFOOZVMS-PMERELPUSA-N,605.651,P32238,BE0000402,Cholecystokinin receptor type A,Humans,agonist,yes
DB12312,ORG-25435,small molecule,investigational,CC[C@@H](N(CCOC)CCOC)C(=O)OC1=C(OC)C=C(C)C=C1OC,GKRFHHRXDUACIN-OAHLLOKOSA-N,369.458,Q99928,BE0003594,Gamma-aminobutyric acid receptor subunit gamma-3,Humans,modulator,yes
DB12313,Dopexamine,small molecule,approved;investigational,OC1=C(O)C=C(CCNCCCCCCNCCC2=CC=CC=C2)C=C1,RYBJORHCUPVNMB-UHFFFAOYSA-N,356.5017,P14416,BE0000756,D(2) dopamine receptor,Humans,modulator,yes
DB12314,Chlorproguanil,small molecule,investigational,CC(C)NC(=N)NC(=N)NC1=CC=C(Cl)C(Cl)=C1,ISZNZKHCRKXXAU-UHFFFAOYSA-N,288.18,Q9HBH1,BE0002201,"Peptide deformylase, mitochondrial",Humans,inhibitor,yes
DB12318,BMS-599626,small molecule,investigational,CC1=C2N(C=C1NC(=O)OC[C@@H]1COCCN1)N=CN=C2NC1=CC=C2N(CC3=CC=CC(F)=C3)N=CC2=C1,LUJZZYWHBDHDQX-QFIPXVFZSA-N,530.564,P00533,BE0000767,Epidermal growth factor receptor,Humans,inhibitor,yes
DB12318,BMS-599626,small molecule,investigational,CC1=C2N(C=C1NC(=O)OC[C@@H]1COCCN1)N=CN=C2NC1=CC=C2N(CC3=CC=CC(F)=C3)N=CC2=C1,LUJZZYWHBDHDQX-QFIPXVFZSA-N,530.564,P04626,BE0000511,Receptor tyrosine-protein kinase erbB-2,Humans,inhibitor,yes
DB12319,Benzbromarone,small molecule,investigational;withdrawn,CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C2=CC=CC=C2O1,WHQCHUCQKNIQEC-UHFFFAOYSA-N,424.083,Q5XXA6,BE0004746,Anoctamin-1,Humans,antagonist,yes
DB12319,Benzbromarone,small molecule,investigational;withdrawn,CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C2=CC=CC=C2O1,WHQCHUCQKNIQEC-UHFFFAOYSA-N,424.083,Q96S37,BE0004782,Solute carrier family 22 member 12,Humans,inhibitor,yes
DB12319,Benzbromarone,small molecule,investigational;withdrawn,CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C2=CC=CC=C2O1,WHQCHUCQKNIQEC-UHFFFAOYSA-N,424.083,P33527,BE0000785,Multidrug resistance-associated protein 1,Humans,stimulator,yes
DB12321,Ifetroban,small molecule,investigational,CCCCCNC(=O)C1=COC(=N1)[C@@H]1[C@H]2CC[C@H](O2)[C@@H]1CC1=CC=CC=C1CCC(O)=O,BBPRUNPUJIUXSE-DXKRWKNPSA-N,440.54,P21731,BE0000759,Thromboxane A2 receptor,Humans,antagonist,yes
DB12323,Radotinib,small molecule,investigational,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=N3)=C2)=CC(=C1)C(F)(F)F,DUPWHXBITIZIKZ-UHFFFAOYSA-N,530.515,P00519,BE0000014,Tyrosine-protein kinase ABL1,Humans,antagonist,yes
DB12325,Idasanutlin,small molecule,investigational,COC1=CC(=CC=C1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@@](C#N)([C@H]1C1=CC=CC(Cl)=C1F)C1=CC=C(Cl)C=C1F)C(O)=O,TVTXCJFHQKSQQM-LJQIRTBHSA-N,616.49,Q00987,BE0001003,E3 ubiquitin-protein ligase Mdm2,Humans,modulator,yes
DB12325,Idasanutlin,small molecule,investigational,COC1=CC(=CC=C1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@@](C#N)([C@H]1C1=CC=CC(Cl)=C1F)C1=CC=C(Cl)C=C1F)C(O)=O,TVTXCJFHQKSQQM-LJQIRTBHSA-N,616.49,Q15303,BE0004772,Receptor tyrosine-protein kinase erbB-4,Humans,inhibitor,yes
DB12326,Antroquinonol,small molecule,investigational,COC1=C(OC)C(=O)[C@H](C)[C@@H](C\C=C(/C)CC\C=C(/C)CCC=C(C)C)[C@H]1O,LJTSIMVOOOLKOL-FNRDIUJOSA-N,390.564,P26358,BE0000892,DNA (cytosine-5)-methyltransferase 1,Humans,inhibitor,yes
DB12327,Salvinorin A,small molecule,investigational,COC(=O)[C@@H]1C[C@H](OC(C)=O)C(=O)[C@H]2[C@@]1(C)CC[C@H]1C(=O)O[C@@H](C[C@]21C)C1=COC=C1,OBSYBRPAKCASQB-AGQYDFLVSA-N,432.469,P35372,BE0000770,Mu-type opioid receptor,Humans,inhibitor,yes
DB12327,Salvinorin A,small molecule,investigational,COC(=O)[C@@H]1C[C@H](OC(C)=O)C(=O)[C@H]2[C@@]1(C)CC[C@H]1C(=O)O[C@@H](C[C@]21C)C1=COC=C1,OBSYBRPAKCASQB-AGQYDFLVSA-N,432.469,P41143,BE0000420,Delta-type opioid receptor,Humans,inhibitor,yes
DB12327,Salvinorin A,small molecule,investigational,COC(=O)[C@@H]1C[C@H](OC(C)=O)C(=O)[C@H]2[C@@]1(C)CC[C@H]1C(=O)O[C@@H](C[C@]21C)C1=COC=C1,OBSYBRPAKCASQB-AGQYDFLVSA-N,432.469,P41145,BE0000632,Kappa-type opioid receptor,Humans,inhibitor,yes
DB12328,Cantharidin,small molecule,approved;investigational,[H][C@]12CC[C@]([H])(O1)[C@]1(C)C(=O)OC(=O)[C@]21C,DHZBEENLJMYSHQ-XCVPVQRUSA-N,196.202,P62136,BE0003810,Serine/threonine-protein phosphatase PP1-alpha catalytic subunit,Humans,inhibitor,yes
DB12329,Eravacycline,small molecule,approved;investigational,[H][C@@]12CC3=C(F)C=C(NC(=O)CN4CCCC4)C(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2,HLFSMUUOKPBTSM-ISIOAQNYSA-N,558.563,P0A7V8,BE0000019,30S ribosomal protein S4,Escherichia coli (strain K12),inhibitor,yes
DB12332,Rucaparib,small molecule,approved;investigational,CNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=C2C(N1)=CC(F)=C3,HMABYWSNWIZPAG-UHFFFAOYSA-N,323.371,P09874,BE0001717,Poly [ADP-ribose] polymerase 1,Humans,inhibitor,yes
DB12332,Rucaparib,small molecule,approved;investigational,CNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=C2C(N1)=CC(F)=C3,HMABYWSNWIZPAG-UHFFFAOYSA-N,323.371,Q9UGN5,BE0003798,Poly [ADP-ribose] polymerase 2,Humans,inhibitor,yes
DB12332,Rucaparib,small molecule,approved;investigational,CNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=C2C(N1)=CC(F)=C3,HMABYWSNWIZPAG-UHFFFAOYSA-N,323.371,Q9Y6F1,BE0004049,Protein mono-ADP-ribosyltransferase PARP3,Humans,inhibitor,yes
DB12340,Navitoclax,small molecule,investigational,[H][C@@](CCN1CCOCC1)(CSC1=CC=CC=C1)NC1=C(C=C(C=C1)S(=O)(=O)NC(=O)C1=CC=C(C=C1)N1CCN(CC2=C(CCC(C)(C)C2)C2=CC=C(Cl)C=C2)CC1)S(=O)(=O)C(F)(F)F,JLYAXFNOILIKPP-KXQOOQHDSA-N,974.613,Q07817,BE0003510,Bcl-2-like protein 1,Humans,inhibitor,yes
DB12340,Navitoclax,small molecule,investigational,[H][C@@](CCN1CCOCC1)(CSC1=CC=CC=C1)NC1=C(C=C(C=C1)S(=O)(=O)NC(=O)C1=CC=C(C=C1)N1CCN(CC2=C(CCC(C)(C)C2)C2=CC=C(Cl)C=C2)CC1)S(=O)(=O)C(F)(F)F,JLYAXFNOILIKPP-KXQOOQHDSA-N,974.613,P24385,BE0001027,G1/S-specific cyclin-D1,Humans,inhibitor,yes
DB12340,Navitoclax,small molecule,investigational,[H][C@@](CCN1CCOCC1)(CSC1=CC=CC=C1)NC1=C(C=C(C=C1)S(=O)(=O)NC(=O)C1=CC=C(C=C1)N1CCN(CC2=C(CCC(C)(C)C2)C2=CC=C(Cl)C=C2)CC1)S(=O)(=O)C(F)(F)F,JLYAXFNOILIKPP-KXQOOQHDSA-N,974.613,P10415,BE0000246,Apoptosis regulator Bcl-2,Humans,inhibitor,yes
DB12340,Navitoclax,small molecule,investigational,[H][C@@](CCN1CCOCC1)(CSC1=CC=CC=C1)NC1=C(C=C(C=C1)S(=O)(=O)NC(=O)C1=CC=C(C=C1)N1CCN(CC2=C(CCC(C)(C)C2)C2=CC=C(Cl)C=C2)CC1)S(=O)(=O)C(F)(F)F,JLYAXFNOILIKPP-KXQOOQHDSA-N,974.613,Q92843,BE0003420,Bcl-2-like protein 2,Humans,inhibitor,yes
DB12341,Aticaprant,small molecule,investigational,CC1=CC(=CC(C)=C1)[C@@H]1CCCN1CC1=CC=C(OC2=CC=C(C=C2F)C(N)=O)C=C1,ZHPMYDSXGRRERG-DEOSSOPVSA-N,418.512,P41145,BE0000632,Kappa-type opioid receptor,Humans,antagonist,yes
DB12345,MBX-2982,small molecule,investigational,CCC1=CN=C(N=C1)N1CCC(CC1)C1=NC(COC2=CC=C(C=C2)N2C=NN=N2)=CS1,NFTMKHWBOINJGM-UHFFFAOYSA-N,448.55,Q8TDV5,BE0003378,Glucose-dependent insulinotropic receptor,Humans,agonist,yes
DB12348,"5-amino-1,3,4-thiadiazole-2-thiol",small molecule,investigational,NC1=NN=C(S)S1,GDGIVSREGUOIJZ-UHFFFAOYSA-N,133.19,P00915,BE0000267,Carbonic anhydrase 1,Humans,inhibitor,yes
DB12348,"5-amino-1,3,4-thiadiazole-2-thiol",small molecule,investigational,NC1=NN=C(S)S1,GDGIVSREGUOIJZ-UHFFFAOYSA-N,133.19,Q16790,BE0002437,Carbonic anhydrase 9,Humans,inhibitor,yes
DB12348,"5-amino-1,3,4-thiadiazole-2-thiol",small molecule,investigational,NC1=NN=C(S)S1,GDGIVSREGUOIJZ-UHFFFAOYSA-N,133.19,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB12350,Rostafuroxin,small molecule,investigational,C[C@]12CC[C@H]3[C@@H](CC[C@@H]4C[C@@H](O)CC[C@]34C)[C@@]1(O)CC[C@]2(O)C1=COC=C1,AEAPORIZZWBIEX-DTBDINHYSA-N,374.521,P05026,BE0004994,Sodium/potassium-transporting ATPase subunit beta-1,Humans,modulator,yes
DB12350,Rostafuroxin,small molecule,investigational,C[C@]12CC[C@H]3[C@@H](CC[C@@H]4C[C@@H](O)CC[C@]34C)[C@@]1(O)CC[C@]2(O)C1=COC=C1,AEAPORIZZWBIEX-DTBDINHYSA-N,374.521,P14415,BE0005018,Sodium/potassium-transporting ATPase subunit beta-2,Humans,modulator,yes
DB12350,Rostafuroxin,small molecule,investigational,C[C@]12CC[C@H]3[C@@H](CC[C@@H]4C[C@@H](O)CC[C@]34C)[C@@]1(O)CC[C@]2(O)C1=COC=C1,AEAPORIZZWBIEX-DTBDINHYSA-N,374.521,P54709,BE0005026,Sodium/potassium-transporting ATPase subunit beta-3,Humans,modulator,yes
DB12350,Rostafuroxin,small molecule,investigational,C[C@]12CC[C@H]3[C@@H](CC[C@@H]4C[C@@H](O)CC[C@]34C)[C@@]1(O)CC[C@]2(O)C1=COC=C1,AEAPORIZZWBIEX-DTBDINHYSA-N,374.521,P05023,BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,Humans,modulator,yes
DB12350,Rostafuroxin,small molecule,investigational,C[C@]12CC[C@H]3[C@@H](CC[C@@H]4C[C@@H](O)CC[C@]34C)[C@@]1(O)CC[C@]2(O)C1=COC=C1,AEAPORIZZWBIEX-DTBDINHYSA-N,374.521,P50993,BE0005034,Sodium/potassium-transporting ATPase subunit alpha-2,Humans,modulator,yes
DB12350,Rostafuroxin,small molecule,investigational,C[C@]12CC[C@H]3[C@@H](CC[C@@H]4C[C@@H](O)CC[C@]34C)[C@@]1(O)CC[C@]2(O)C1=COC=C1,AEAPORIZZWBIEX-DTBDINHYSA-N,374.521,P13637,BE0005047,Sodium/potassium-transporting ATPase subunit alpha-3,Humans,modulator,yes
DB12353,Ulodesine,small molecule,investigational,OC[C@H]1CN(CC2=CNC3=C2N=CNC3=O)C[C@@H]1O,AFNHHLILYQEHKK-BDAKNGLRSA-N,264.285,P00491,BE0000250,Purine nucleoside phosphorylase,Humans,inhibitor,yes
DB12354,Imrecoxib,small molecule,investigational,CCCN1CC(=C(C1=O)C1=CC=C(C)C=C1)C1=CC=C(C=C1)S(C)(=O)=O,AXMZZGKKZDJGAZ-UHFFFAOYSA-N,369.48,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB12354,Imrecoxib,small molecule,investigational,CCCN1CC(=C(C1=O)C1=CC=C(C)C=C1)C1=CC=C(C=C1)S(C)(=O)=O,AXMZZGKKZDJGAZ-UHFFFAOYSA-N,369.48,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB12355,Netazepide,small molecule,investigational,CNC1=CC(NC(=O)N[C@@H]2N=C(C3=CC=CC=N3)C3=CC=CC=C3N(CC(=O)C(C)(C)C)C2=O)=CC=C1,YDZYKNJZCVIKPP-VWLOTQADSA-N,498.587,P32239,BE0001158,Gastrin/cholecystokinin type B receptor,Humans,inhibitor,yes
DB12357,BMS-863233,small molecule,investigational,[H][C@]1(CCCN1)C1=NC2=C(OC3=C2C=C(Cl)C=C3)C(=O)N1,JJWLXRKVUJDJKG-VIFPVBQESA-N,289.717,O00311,BE0010851,Cell division cycle 7-related protein kinase,Humans,modulator,yes
DB12359,BIIB021,small molecule,investigational,COC1=C(C)C=NC(CN2C=NC3=C(Cl)N=C(N)N=C23)=C1C,QULDDKSCVCJTPV-UHFFFAOYSA-N,318.762,P07900,BE0001120,Heat shock protein HSP 90-alpha,Humans,inhibitor,yes
DB12361,Piclozotan,small molecule,investigational,ClC1=COC2=CC=CC=C2C(=O)N1CCCCN1CCC(=CC1)C1=CC=CC=N1,URMTUEWUIGOJBW-UHFFFAOYSA-N,409.91,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,agonist,yes
DB12364,Betrixaban,small molecule,approved;investigational,COC1=CC=C(NC(=O)C2=CC=C(C=C2)C(=N)N(C)C)C(=C1)C(=O)NC1=CC=C(Cl)C=N1,XHOLNRLADUSQLD-UHFFFAOYSA-N,451.91,P00742,BE0000216,Coagulation factor X,Humans,inhibitor,yes
DB12369,Sotrastaurin,small molecule,investigational,CN1CCN(CC1)C1=NC(C2=C(C(=O)NC2=O)C2=CNC3=C2C=CC=C3)=C2C=CC=CC2=N1,OAVGBZOFDPFGPJ-UHFFFAOYSA-N,438.4812,Q04759,BE0001385,Protein kinase C theta type,Humans,inhibitor,yes
DB12369,Sotrastaurin,small molecule,investigational,CN1CCN(CC1)C1=NC(C2=C(C(=O)NC2=O)C2=CNC3=C2C=CC=C3)=C2C=CC=CC2=N1,OAVGBZOFDPFGPJ-UHFFFAOYSA-N,438.4812,P05771,BE0000872,Protein kinase C beta type,Humans,inhibitor,yes
DB12369,Sotrastaurin,small molecule,investigational,CN1CCN(CC1)C1=NC(C2=C(C(=O)NC2=O)C2=CNC3=C2C=CC=C3)=C2C=CC=CC2=N1,OAVGBZOFDPFGPJ-UHFFFAOYSA-N,438.4812,P17252,BE0001132,Protein kinase C alpha type,Humans,inhibitor,yes
DB12370,Ipamorelin,small molecule,investigational,CC(C)(N)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@H](CC1=CC=C2C=CC=CC2=C1)C(=O)N[C@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(N)=O,NEHWBYHLYZGBNO-BVEPWEIPSA-N,711.868,Q92847,BE0003383,Growth hormone secretagogue receptor type 1,Humans,modulator,yes
DB12371,Siponimod,small molecule,approved;investigational,CCC1=CC(=CC=C1CN1CC(C1)C(O)=O)C(\C)=N\OCC1=CC=C(C2CCCCC2)C(=C1)C(F)(F)F,KIHYPELVXPAIDH-HNSNBQBZSA-N,516.605,P21453,BE0008652,Sphingosine 1-phosphate receptor 1,Humans,modulator,yes
DB12375,Oglemilast,small molecule,investigational,CS(=O)(=O)NC1=CC2=C(OC3=C2C(=CC=C3OC(F)F)C(=O)NC2=C(Cl)C=NC=C2Cl)C=C1,OKFDRAHPFKMAJH-UHFFFAOYSA-N,516.3,P27815,BE0001133,"3',5'-cyclic-AMP phosphodiesterase 4A",Humans,inhibitor,yes
DB12375,Oglemilast,small molecule,investigational,CS(=O)(=O)NC1=CC2=C(OC3=C2C(=CC=C3OC(F)F)C(=O)NC2=C(Cl)C=NC=C2Cl)C=C1,OKFDRAHPFKMAJH-UHFFFAOYSA-N,516.3,Q07343,BE0000487,"3',5'-cyclic-AMP phosphodiesterase 4B",Humans,inhibitor,yes
DB12375,Oglemilast,small molecule,investigational,CS(=O)(=O)NC1=CC2=C(OC3=C2C(=CC=C3OC(F)F)C(=O)NC2=C(Cl)C=NC=C2Cl)C=C1,OKFDRAHPFKMAJH-UHFFFAOYSA-N,516.3,Q08499,BE0001287,"3',5'-cyclic-AMP phosphodiesterase 4D",Humans,inhibitor,yes
DB12377,Relebactam,small molecule,approved;investigational,OS(=O)(=O)ON1[C@H]2C[N@]([C@@H](CC2)C(=O)NC2CCNCC2)C1=O,SMOBCLHAZXOKDQ-ZJUUUORDSA-N,348.37,P00807,BE0000302,Beta-lactamase,Staphylococcus aureus,inhibitor,yes
DB12377,Relebactam,small molecule,approved;investigational,OS(=O)(=O)ON1[C@H]2C[N@]([C@@H](CC2)C(=O)NC2CCNCC2)C1=O,SMOBCLHAZXOKDQ-ZJUUUORDSA-N,348.37,P62593,BE0003894,Beta-lactamase TEM,Escherichia coli,inhibitor,yes
DB12377,Relebactam,small molecule,approved;investigational,OS(=O)(=O)ON1[C@H]2C[N@]([C@@H](CC2)C(=O)NC2CCNCC2)C1=O,SMOBCLHAZXOKDQ-ZJUUUORDSA-N,348.37,P0AD63,BE0002015,Beta-lactamase SHV-1,Escherichia coli,inhibitor,yes
DB12377,Relebactam,small molecule,approved;investigational,OS(=O)(=O)ON1[C@H]2C[N@]([C@@H](CC2)C(=O)NC2CCNCC2)C1=O,SMOBCLHAZXOKDQ-ZJUUUORDSA-N,348.37,Q939N4,BE0002831,Beta-lactamase CTX-M,Escherichia coli,inhibitor,yes
DB12377,Relebactam,small molecule,approved;investigational,OS(=O)(=O)ON1[C@H]2C[N@]([C@@H](CC2)C(=O)NC2CCNCC2)C1=O,SMOBCLHAZXOKDQ-ZJUUUORDSA-N,348.37,Q93LQ9,BE0009747,Beta-lactamase,Klebsiella pneumoniae,inhibitor,yes
DB12377,Relebactam,small molecule,approved;investigational,OS(=O)(=O)ON1[C@H]2C[N@]([C@@H](CC2)C(=O)NC2CCNCC2)C1=O,SMOBCLHAZXOKDQ-ZJUUUORDSA-N,348.37,P05364,BE0001430,Beta-lactamase,Enterobacter cloacae,inhibitor,yes
DB12378,Apricoxib,small molecule,investigational,CCOC1=CC=C(C=C1)C1=CC(C)=CN1C1=CC=C(C=C1)S(N)(=O)=O,JTMITOKKUMVWRT-UHFFFAOYSA-N,356.44,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB12380,GDC-0152,small molecule,investigational,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1C(=O)NC1=C(N=NS1)C1=CC=CC=C1,WZRFLSDVFPIXOV-LRQRDZAKSA-N,498.65,P98170,BE0001156,E3 ubiquitin-protein ligase XIAP,Humans,modulator,yes
DB12381,Merestinib,small molecule,investigational,CN1N=CC2=CC(OC3=C(F)C=C(NC(=O)C4=CC=C(C)N(C4=O)C4=CC=C(F)C=C4)C=C3)=C(C=C12)C1=CNN=C1,QHADVLVFMKEIIP-UHFFFAOYSA-N,552.5309,P08581,BE0000915,Hepatocyte growth factor receptor,Humans,modulator,yes
DB12384,Silatecan,small molecule,investigational,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=C1N=C1C=CC(O)=CC1=C3[Si](C)(C)C(C)(C)C)C2=O,XUSKJHCMMWAAHV-SANMLTNESA-N,478.62,P11387,BE0000971,DNA topoisomerase 1,Humans,inhibitor,yes
DB12385,10-hydroxycamptothecin,small molecule,investigational,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=C1N=C1C=CC(O)=CC1=C3)C2=O,HAWSQZCWOQZXHI-FQEVSTJZSA-N,364.357,P11387,BE0000971,DNA topoisomerase 1,Humans,inhibitor,yes
DB12387,OSI-027,small molecule,investigational,COC1=C2NC(=CC2=CC=C1)C1=C2N(N=CN=C2N)C(=N1)[C@H]1CC[C@@H](CC1)C(O)=O,JROFGZPOBKIAEW-HAQNSBGRSA-N,406.446,P42345,BE0002386,Serine/threonine-protein kinase mTOR,Humans,inhibitor,yes
DB12390,Seladelpar,small molecule,approved;investigational,CCO[C@H](COC1=CC=C(C=C1)C(F)(F)F)CSC1=CC=C(OCC(O)=O)C(C)=C1,JWHYSEDOYMYMNM-QGZVFWFLSA-N,444.47,Q03181,BE0001007,Peroxisome proliferator-activated receptor delta,Humans,agonist,yes
DB12392,Resminostat,small molecule,investigational,CN(C)CC1=CC=C(C=C1)S(=O)(=O)N1C=CC(\C=C\C(=O)NO)=C1,FECGNJPYVFEKOD-VMPITWQZSA-N,349.41,Q13547,BE0002365,Histone deacetylase 1,Humans,inhibitor,yes
DB12395,Esreboxetine,small molecule,investigational,[H][C@]1(CNCCO1)[C@@H](OC1=CC=CC=C1OCC)C1=CC=CC=C1,CBQGYUDMJHNJBX-OALUTQOASA-N,313.3908,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,blocker,yes
DB12399,Polmacoxib,small molecule,investigational,CC1(C)OC(=C(C1=O)C1=CC=CC(F)=C1)C1=CC=C(C=C1)S(N)(=O)=O,IJWPAFMIFNSIGD-UHFFFAOYSA-N,361.39,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB12399,Polmacoxib,small molecule,investigational,CC1(C)OC(=C(C1=O)C1=CC=CC(F)=C1)C1=CC=C(C=C1)S(N)(=O)=O,IJWPAFMIFNSIGD-UHFFFAOYSA-N,361.39,P00915,BE0000267,Carbonic anhydrase 1,Humans,inhibitor,yes
DB12399,Polmacoxib,small molecule,investigational,CC1(C)OC(=C(C1=O)C1=CC=CC(F)=C1)C1=CC=C(C=C1)S(N)(=O)=O,IJWPAFMIFNSIGD-UHFFFAOYSA-N,361.39,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB12400,Voxtalisib,small molecule,investigational,CCN1C(=O)C(=CC2=C(C)N=C(N)N=C12)C1=CC=NN1,RGHYDLZMTYDBDT-UHFFFAOYSA-N,270.296,P48736,BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",Humans,inhibitor,yes
DB12400,Voxtalisib,small molecule,investigational,CCN1C(=O)C(=CC2=C(C)N=C(N)N=C12)C1=CC=NN1,RGHYDLZMTYDBDT-UHFFFAOYSA-N,270.296,P42345,BE0002386,Serine/threonine-protein kinase mTOR,Humans,inhibitor,yes
DB12404,Remimazolam,small molecule,approved;investigational,COC(=O)CC[C@@H]1N=C(C2=CC=CC=N2)C2=CC(Br)=CC=C2N2C(C)=CN=C12,CYHWMBVXXDIZNZ-KRWDZBQOSA-N,439.313,Q99928,BE0003594,Gamma-aminobutyric acid receptor subunit gamma-3,Humans,agonist,yes
DB12404,Remimazolam,small molecule,approved;investigational,COC(=O)CC[C@@H]1N=C(C2=CC=CC=N2)C2=CC(Br)=CC=C2N2C(C)=CN=C12,CYHWMBVXXDIZNZ-KRWDZBQOSA-N,439.313,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB12404,Remimazolam,small molecule,approved;investigational,COC(=O)CC[C@@H]1N=C(C2=CC=CC=N2)C2=CC(Br)=CC=C2N2C(C)=CN=C12,CYHWMBVXXDIZNZ-KRWDZBQOSA-N,439.313,P14867,BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,Humans,ligand,yes
DB12405,Triciribine,small molecule,investigational,CN1N=C(N)C2=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C3=C2C1=NC=N3,HOGVTUZUJGHKPL-HTVVRFAVSA-N,320.309,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB12410,Sabarubicin,small molecule,investigational,[H][C@]1(N)C[C@]([H])(O[C@]2([H])[C@]([H])(C)O[C@]([H])(C[C@]2([H])O)O[C@@]2([H])C[C@@](O)(CC3=C(O)C4=C(C(O)=C23)C(=O)C2=CC=CC=C2C4=O)C(=O)CO)O[C@@]([H])(C)[C@@]1([H])O,VQHRZZISQVWPLK-UIRGBLDSSA-N,643.6351,P11388,BE0000742,DNA topoisomerase 2-alpha,Humans,modulator,yes
DB12410,Sabarubicin,small molecule,investigational,[H][C@]1(N)C[C@]([H])(O[C@]2([H])[C@]([H])(C)O[C@]([H])(C[C@]2([H])O)O[C@@]2([H])C[C@@](O)(CC3=C(O)C4=C(C(O)=C23)C(=O)C2=CC=CC=C2C4=O)C(=O)CO)O[C@@]([H])(C)[C@@]1([H])O,VQHRZZISQVWPLK-UIRGBLDSSA-N,643.6351,Q02880,BE0002425,DNA topoisomerase 2-beta,Humans,modulator,yes
DB12411,Bemcentinib,small molecule,investigational,NC1=NC(NC2=CC=C3CC[C@@H](CCC3=C2)N2CCCC2)=NN1C1=CC2=C(N=N1)C1=CC=CC=C1CCC2,KXMZDGSRSGHMMK-VWLOTQADSA-N,506.658,P0DTC2,BE0010022,Spike glycoprotein,SARS-CoV-2,inhibitor,yes
DB12411,Bemcentinib,small molecule,investigational,NC1=NC(NC2=CC=C3CC[C@@H](CCC3=C2)N2CCCC2)=NN1C1=CC2=C(N=N1)C1=CC=CC=C1CCC2,KXMZDGSRSGHMMK-VWLOTQADSA-N,506.658,P30530,BE0009412,Tyrosine-protein kinase receptor UFO,Humans,inhibitor,yes
DB12412,Gemigliptin,small molecule,investigational,N[C@H](CN1CC(F)(F)CCC1=O)CC(=O)N1CCC2=C(C1)N=C(N=C2C(F)(F)F)C(F)(F)F,ZWPRRQZNBDYKLH-VIFPVBQESA-N,489.37,P27487,BE0000854,Dipeptidyl peptidase 4,Humans,inhibitor,yes
DB12414,Usistapide,small molecule,investigational,COC(=O)[C@H](N1CCC(CC1)C1=CC=C(NC(=O)C2=CC=CC=C2C2=CC=C(C=C2)C(F)(F)F)C=C1)C1=CC=CC=C1,WSYALRNYQFNNGP-WJOKGBTCSA-N,572.628,P55157,BE0000232,Microsomal triglyceride transfer protein large subunit,Humans,inhibitor,yes
DB12415,Galeterone,small molecule,investigational,[H][C@@]12CC=C(N3C=NC4=CC=CC=C34)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C,PAFKTGFSEFKSQG-PAASFTFBSA-N,388.5451,P10275,BE0000132,Androgen receptor,Humans,inhibitor,yes
DB12416,VTP-27999,small molecule,investigational,[H][C@]1(CCCN(C1)C(=O)NC[C@H](C[C@H]1CCCOC1)NC)[C@@H](OCCNC(=O)OC)C1=CC=CC(Cl)=C1,NXWASIVXQMMPLM-ZXMXYHOLSA-N,525.081,P00797,BE0000270,Renin,Humans,inhibitor,yes
DB12417,Anagliptin,small molecule,investigational,CC1=NN2C=C(C=NC2=C1)C(=O)NCC(C)(C)NCC(=O)N1CCC[C@H]1C#N,LDXYBEHACFJIEL-HNNXBMFYSA-N,383.456,P27487,BE0000854,Dipeptidyl peptidase 4,Humans,modulator,yes
DB12418,Saccharin,small molecule,investigational,O=C1NS(=O)(=O)C2=C1C=CC=C2,CVHZOJJKTDOEJC-UHFFFAOYSA-N,183.185,P00915,BE0000267,Carbonic anhydrase 1,Humans,inhibitor,yes
DB12418,Saccharin,small molecule,investigational,O=C1NS(=O)(=O)C2=C1C=CC=C2,CVHZOJJKTDOEJC-UHFFFAOYSA-N,183.185,Q16790,BE0002437,Carbonic anhydrase 9,Humans,inhibitor,yes
DB12418,Saccharin,small molecule,investigational,O=C1NS(=O)(=O)C2=C1C=CC=C2,CVHZOJJKTDOEJC-UHFFFAOYSA-N,183.185,O43570,BE0001653,Carbonic anhydrase 12,Humans,inhibitor,yes
DB12418,Saccharin,small molecule,investigational,O=C1NS(=O)(=O)C2=C1C=CC=C2,CVHZOJJKTDOEJC-UHFFFAOYSA-N,183.185,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB12420,Diazepinomicin,small molecule,investigational,CC(C)=CCC\C(C)=C\CC\C(C)=C\CN1C2=CC(O)=CC(O)=C2NC2=C(C=CC=C2O)C1=O,SALVHVNECODMJP-GNUCVDFRSA-N,462.59,P30536,BE0000736,Translocator protein,Humans,modulator,yes
DB12423,Fozivudine Tidoxil,small molecule,investigational,CCCCCCCCCCCCSCC(COP(O)(=O)OC[C@H]1O[C@H](C[C@@H]1N=[N+]=[N-])N1C=C(C)C(=O)NC1=O)OCCCCCCCCCC,IBHARWXWOCPXCR-WELGVCPWSA-N,745.96,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB12424,MK-3207,small molecule,investigational,FC1=CC(=CC(F)=C1)[C@@H]1CNC2(CCCC2)C(=O)N1CC(=O)NC1=CC=C2C[C@]3(CC2=C1)C(=O)NC1=C3C=CC=N1,AZAANWYREOQRFB-SETSBSEESA-N,557.602,Q16602,BE0009009,Calcitonin gene-related peptide type 1 receptor,Humans,antagonist,yes
DB12427,Orvepitant,small molecule,investigational,C[C@@H](N(C)C(=O)N1CC[C@@H](C[C@@H]1C1=CC=C(F)C=C1C)N1CCN2[C@@H](CCC2=O)C1)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F,XWNBGDJPEXZSQM-VZOBGQTKSA-N,628.636,P25103,BE0000384,Substance-P receptor,Humans,antagonist,yes
DB12428,PAC-14028,small molecule,investigational,CCCC1=C(\C=C\C(=O)N[C@H](C)C2=CC(F)=C(NS(C)(=O)=O)C(F)=C2)C=CC(=N1)C(F)(F)F,UKGJZDSUJSPAJL-YPUOHESYSA-N,491.48,Q8NER1,BE0001023,Transient receptor potential cation channel subfamily V member 1,Humans,antagonist,yes
DB12429,CI-1040,small molecule,investigational,FC1=C(F)C(NC2=CC=C(I)C=C2Cl)=C(C=C1)C(=O)NOCC1CC1,GFMMXOIFOQCCGU-UHFFFAOYSA-N,478.66,Q13233,BE0003430,Mitogen-activated protein kinase kinase kinase 1,Humans,inhibitor,yes
DB12429,CI-1040,small molecule,investigational,FC1=C(F)C(NC2=CC=C(I)C=C2Cl)=C(C=C1)C(=O)NOCC1CC1,GFMMXOIFOQCCGU-UHFFFAOYSA-N,478.66,Q9Y2U5,BE0004745,Mitogen-activated protein kinase kinase kinase 2,Humans,inhibitor,yes
DB12429,CI-1040,small molecule,investigational,FC1=C(F)C(NC2=CC=C(I)C=C2Cl)=C(C=C1)C(=O)NOCC1CC1,GFMMXOIFOQCCGU-UHFFFAOYSA-N,478.66,O00141,BE0004105,Serine/threonine-protein kinase Sgk1,Humans,inhibitor,yes
DB12429,CI-1040,small molecule,investigational,FC1=C(F)C(NC2=CC=C(I)C=C2Cl)=C(C=C1)C(=O)NOCC1CC1,GFMMXOIFOQCCGU-UHFFFAOYSA-N,478.66,P28482,BE0000923,Mitogen-activated protein kinase 1,Humans,inhibitor,yes
DB12429,CI-1040,small molecule,investigational,FC1=C(F)C(NC2=CC=C(I)C=C2Cl)=C(C=C1)C(=O)NOCC1CC1,GFMMXOIFOQCCGU-UHFFFAOYSA-N,478.66,P23443,BE0010424,Ribosomal protein S6 kinase beta-1,Humans,inhibitor,yes
DB12429,CI-1040,small molecule,investigational,FC1=C(F)C(NC2=CC=C(I)C=C2Cl)=C(C=C1)C(=O)NOCC1CC1,GFMMXOIFOQCCGU-UHFFFAOYSA-N,478.66,Q13464,BE0001016,Rho-associated protein kinase 1,Humans,inhibitor,yes
DB12429,CI-1040,small molecule,investigational,FC1=C(F)C(NC2=CC=C(I)C=C2Cl)=C(C=C1)C(=O)NOCC1CC1,GFMMXOIFOQCCGU-UHFFFAOYSA-N,478.66,P45983,BE0003790,Mitogen-activated protein kinase 8,Humans,inhibitor,yes
DB12429,CI-1040,small molecule,investigational,FC1=C(F)C(NC2=CC=C(I)C=C2Cl)=C(C=C1)C(=O)NOCC1CC1,GFMMXOIFOQCCGU-UHFFFAOYSA-N,478.66,P17252,BE0001132,Protein kinase C alpha type,Humans,inhibitor,yes
DB12429,CI-1040,small molecule,investigational,FC1=C(F)C(NC2=CC=C(I)C=C2Cl)=C(C=C1)C(=O)NOCC1CC1,GFMMXOIFOQCCGU-UHFFFAOYSA-N,478.66,Q15759,BE0003390,Mitogen-activated protein kinase 11,Humans,inhibitor,yes
DB12429,CI-1040,small molecule,investigational,FC1=C(F)C(NC2=CC=C(I)C=C2Cl)=C(C=C1)C(=O)NOCC1CC1,GFMMXOIFOQCCGU-UHFFFAOYSA-N,478.66,Q16539,BE0001019,Mitogen-activated protein kinase 14,Humans,inhibitor,yes
DB12429,CI-1040,small molecule,investigational,FC1=C(F)C(NC2=CC=C(I)C=C2Cl)=C(C=C1)C(=O)NOCC1CC1,GFMMXOIFOQCCGU-UHFFFAOYSA-N,478.66,P06239,BE0000842,Tyrosine-protein kinase Lck,Humans,inhibitor,yes
DB12429,CI-1040,small molecule,investigational,FC1=C(F)C(NC2=CC=C(I)C=C2Cl)=C(C=C1)C(=O)NOCC1CC1,GFMMXOIFOQCCGU-UHFFFAOYSA-N,478.66,O14757,BE0003382,Serine/threonine-protein kinase Chk1,Humans,inhibitor,yes
DB12429,CI-1040,small molecule,investigational,FC1=C(F)C(NC2=CC=C(I)C=C2Cl)=C(C=C1)C(=O)NOCC1CC1,GFMMXOIFOQCCGU-UHFFFAOYSA-N,478.66,P53778,BE0002790,Mitogen-activated protein kinase 12,Humans,inhibitor,yes
DB12429,CI-1040,small molecule,investigational,FC1=C(F)C(NC2=CC=C(I)C=C2Cl)=C(C=C1)C(=O)NOCC1CC1,GFMMXOIFOQCCGU-UHFFFAOYSA-N,478.66,P49841,BE0001065,Glycogen synthase kinase-3 beta,Humans,inhibitor,yes
DB12429,CI-1040,small molecule,investigational,FC1=C(F)C(NC2=CC=C(I)C=C2Cl)=C(C=C1)C(=O)NOCC1CC1,GFMMXOIFOQCCGU-UHFFFAOYSA-N,478.66,P31749,BE0000428,RAC-alpha serine/threonine-protein kinase,Humans,inhibitor,yes
DB12432,CC-401,small molecule,investigational,C(CN1CCCCC1)OC1=CC=CC(=C1)C1=NNC2=CC=C(C=C12)C1=NNC=N1,XDJCLCLBSGGNKS-UHFFFAOYSA-N,388.475,P45983,BE0003790,Mitogen-activated protein kinase 8,Humans,modulator,yes
DB12432,CC-401,small molecule,investigational,C(CN1CCCCC1)OC1=CC=CC(=C1)C1=NNC2=CC=C(C=C12)C1=NNC=N1,XDJCLCLBSGGNKS-UHFFFAOYSA-N,388.475,P45984,BE0003772,Mitogen-activated protein kinase 9,Humans,modulator,yes
DB12432,CC-401,small molecule,investigational,C(CN1CCCCC1)OC1=CC=CC(=C1)C1=NNC2=CC=C(C=C12)C1=NNC=N1,XDJCLCLBSGGNKS-UHFFFAOYSA-N,388.475,P53779,BE0001097,Mitogen-activated protein kinase 10,Humans,modulator,yes
DB12433,SCH-900271,small molecule,investigational,CC1(CCCC2=CC(=O)OC3=C2C(=O)NC(=O)N3)CC1,ARJKMWXLIHZLQZ-UHFFFAOYSA-N,276.292,Q8TDS4,BE0000635,Hydroxycarboxylic acid receptor 2,Humans,modulator,yes
DB12435,Tipelukast,small molecule,investigational,CCCC1=C(O)C(=CC=C1SCCCOC1=C(CCC)C(OCCCC(O)=O)=C(C=C1)C(C)=O)C(C)=O,KPWYNAGOBXLMSE-UHFFFAOYSA-N,530.68,P09917,BE0000248,Polyunsaturated fatty acid 5-lipoxygenase,Humans,modulator,yes
DB12440,Verdiperstat,small molecule,investigational,CC(C)OCCN1C2=C(NC=C2)C(=O)NC1=S,FVJCUZCRPIMVLB-UHFFFAOYSA-N,253.32,P05164,BE0001075,Myeloperoxidase,Humans,inhibitor,yes
DB12441,Tavilermide,small molecule,investigational,NCCCC[C@@H]1NC(=O)[C@H](CCC(O)=O)NC(=O)C2=C(OCC[C@H](NC1=O)C(=O)NCC(O)=O)C=CC(=C2)[N+]([O-])=O,DVJXNXPFYJIACK-ULQDDVLXSA-N,580.551,P04629,BE0001039,High affinity nerve growth factor receptor,Humans,agonist,yes
DB12442,Alvespimycin,small molecule,investigational,CO[C@H]1C[C@H](C)CC2=C(NCCN(C)C)C(=O)C=C(NC(=O)\C(C)=C\C=C/[C@H](OC)[C@@H](OC(N)=O)\C(C)=C\[C@H](C)[C@H]1O)C2=O,KUFRQPKVAWMTJO-LMZWQJSESA-N,616.7455,P07900,BE0001120,Heat shock protein HSP 90-alpha,Humans,inhibitor,yes
DB12443,Sonedenoson,small molecule,investigational,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC(OCCC2=CC=C(Cl)C=C2)=N1,WUCQGGOGHZRELS-LSCFUAHRSA-N,421.84,P29274,BE0000924,Adenosine receptor A2a,Humans,agonist,yes
DB12445,Nitroaspirin,small molecule,investigational,CC(=O)OC1=CC=CC=C1C(=O)OC1=CC=CC(CO[N+]([O-])=O)=C1,IOJUJUOXKXMJNF-UHFFFAOYSA-N,331.28,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB12445,Nitroaspirin,small molecule,investigational,CC(=O)OC1=CC=CC=C1C(=O)OC1=CC=CC(CO[N+]([O-])=O)=C1,IOJUJUOXKXMJNF-UHFFFAOYSA-N,331.28,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB12446,Derenofylline,small molecule,investigational,O[C@H]1CC[C@@H](CC1)NC1=C2C=CNC2=NC(=N1)C1=CC=CC=C1,RBZNJGHIKXAKQE-HDJSIYSDSA-N,308.385,P30542,BE0000013,Adenosine receptor A1,Humans,antagonist,yes
DB12449,Tempol,small molecule,investigational,CC1(C)CC(O)CC(C)(C)N1[O],UZFMOKQJFYMBGY-UHFFFAOYSA-N,172.248,P00441,BE0002390,Superoxide dismutase [Cu-Zn],Humans,modulator,yes
DB12451,SCY-635,small molecule,investigational,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)(C)O)N(C)C(=O)[C@@H](SCCN(C)C)N(C)C1=O)C(C)C,AQHMBDAHQGYLIU-XNFHFXFQSA-N,1321.82,P49069,BE0000379,Guided entry of tail-anchored proteins factor CAMLG,Humans,modulator,yes
DB12452,Caprylic alcohol,small molecule,investigational,CCCCCCCCO,KBPLFHHGFOOTCA-UHFFFAOYSA-N,130.2279,P17302,BE0001095,Gap junction alpha-1 protein,Humans,inhibitor,yes
DB12455,Omadacycline,small molecule,approved;investigational,[H][C@@]12CC3=C(C=C(CNCC(C)(C)C)C(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2)N(C)C,JEECQCWWSTZDCK-IQZGDKDPSA-N,556.66,P0A7V3,BE0004651,30S ribosomal protein S3,Escherichia coli (strain K12),inhibitor,yes
DB12455,Omadacycline,small molecule,approved;investigational,[H][C@@]12CC3=C(C=C(CNCC(C)(C)C)C(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2)N(C)C,JEECQCWWSTZDCK-IQZGDKDPSA-N,556.66,P02359,BE0004653,30S ribosomal protein S7,Escherichia coli (strain K12),inhibitor,yes
DB12455,Omadacycline,small molecule,approved;investigational,[H][C@@]12CC3=C(C=C(CNCC(C)(C)C)C(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2)N(C)C,JEECQCWWSTZDCK-IQZGDKDPSA-N,556.66,P0A7W7,BE0004652,30S ribosomal protein S8,Escherichia coli (strain K12),inhibitor,yes
DB12455,Omadacycline,small molecule,approved;investigational,[H][C@@]12CC3=C(C=C(CNCC(C)(C)C)C(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2)N(C)C,JEECQCWWSTZDCK-IQZGDKDPSA-N,556.66,P0A7U3,BE0003710,30S ribosomal protein S19,Escherichia coli (strain K12),inhibitor,yes
DB12455,Omadacycline,small molecule,approved;investigational,[H][C@@]12CC3=C(C=C(CNCC(C)(C)C)C(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2)N(C)C,JEECQCWWSTZDCK-IQZGDKDPSA-N,556.66,P0AG59,BE0003708,30S ribosomal protein S14,Escherichia coli (strain K12),inhibitor,yes
DB12455,Omadacycline,small molecule,approved;investigational,[H][C@@]12CC3=C(C=C(CNCC(C)(C)C)C(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2)N(C)C,JEECQCWWSTZDCK-IQZGDKDPSA-N,556.66,,BE0004799,16S ribosomal RNA,Enteric bacteria and other eubacteria,inhibitor,yes
DB12457,Rimegepant,small molecule,approved;investigational,N[C@H]1[C@@H](CC[C@@H](OC(=O)N2CCC(CC2)N2C(=O)NC3=NC=CC=C23)C2=C1C=CC=N2)C1=C(F)C(F)=CC=C1,KRNAOFGYEFKHPB-ANJVHQHFSA-N,534.568,Q16602,BE0009009,Calcitonin gene-related peptide type 1 receptor,Humans,antagonist,yes
DB12459,Belotecan,small molecule,investigational,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=C1N=C1C=CC=CC1=C3CCNC(C)C)C2=O,LNHWXBUNXOXMRL-VWLOTQADSA-N,433.508,P11387,BE0000971,DNA topoisomerase 1,Humans,inhibitor,yes
DB12461,GLPG-0492,small molecule,investigational,CN1C(=O)N(C(=O)[C@@]1(CO)C1=CC=CC=C1)C1=CC=C(C#N)C(=C1)C(F)(F)F,VAJGULUVTFDTAS-GOSISDBHSA-N,389.334,P10275,BE0000132,Androgen receptor,Humans,modulator,yes
DB12462,Ralinepag,small molecule,investigational,OC(=O)COC[C@H]1CC[C@H](COC(=O)N(C2=CC=CC=C2)C2=CC=C(Cl)C=C2)CC1,NPDKXVKJRHPDQT-IYARVYRRSA-N,431.91,P43119,BE0000475,Prostacyclin receptor,Humans,agonist,yes
DB12463,Semagacestat,small molecule,investigational,CC(C)[C@H](O)C(=O)N[C@@H](C)C(=O)N[C@H]1C2=CC=CC=C2CCN(C)C1=O,PKXWXXPNHIWQHW-RCBQFDQVSA-N,361.442,Q8WW43,BE0017533,Gamma-secretase subunit APH-1B,Humans,modulator,yes
DB12463,Semagacestat,small molecule,investigational,CC(C)[C@H](O)C(=O)N[C@@H](C)C(=O)N[C@H]1C2=CC=CC=C2CCN(C)C1=O,PKXWXXPNHIWQHW-RCBQFDQVSA-N,361.442,Q92542,BE0017775,Nicastrin,Humans,modulator,yes
DB12463,Semagacestat,small molecule,investigational,CC(C)[C@H](O)C(=O)N[C@@H](C)C(=O)N[C@H]1C2=CC=CC=C2CCN(C)C1=O,PKXWXXPNHIWQHW-RCBQFDQVSA-N,361.442,Q96BI3,BE0003409,Gamma-secretase subunit APH-1A,Humans,modulator,yes
DB12463,Semagacestat,small molecule,investigational,CC(C)[C@H](O)C(=O)N[C@@H](C)C(=O)N[C@H]1C2=CC=CC=C2CCN(C)C1=O,PKXWXXPNHIWQHW-RCBQFDQVSA-N,361.442,Q9NZ42,BE0003410,Gamma-secretase subunit PEN-2,Humans,modulator,yes
DB12463,Semagacestat,small molecule,investigational,CC(C)[C@H](O)C(=O)N[C@@H](C)C(=O)N[C@H]1C2=CC=CC=C2CCN(C)C1=O,PKXWXXPNHIWQHW-RCBQFDQVSA-N,361.442,P49768,BE0010960,Presenilin-1,Humans,modulator,yes
DB12466,Favipiravir,small molecule,approved;investigational,NC(=O)C1=NC(F)=CN=C1O,ZCGNOVWYSGBHAU-UHFFFAOYSA-N,157.104,P9WGY9,BE0010989,DNA-directed RNA polymerase subunit beta,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),modulator,yes
DB12466,Favipiravir,small molecule,approved;investigational,NC(=O)C1=NC(F)=CN=C1O,ZCGNOVWYSGBHAU-UHFFFAOYSA-N,157.104,P9WGY7,BE0000186,DNA-directed RNA polymerase subunit beta',Mycobacterium tuberculosis,modulator,yes
DB12466,Favipiravir,small molecule,approved;investigational,NC(=O)C1=NC(F)=CN=C1O,ZCGNOVWYSGBHAU-UHFFFAOYSA-N,157.104,Q809M3,BE0009866,RNA-directed RNA polymerase catalytic subunit,Influenza A virus (strain A/Silky Chicken/Hong Kong/SF189/2001 H5N1 genotype A),,yes
DB12471,Ibrexafungerp,small molecule,approved;investigational,[H][C@]12CC[C@@]3([H])[C@@]4(C)COC[C@@]3(C[C@H]([C@@H]4OC[C@](C)(N)C(C)(C)C)N3N=CN=C3C3=CC=NC=C3)C1=CC[C@@]1(C)[C@H](C(O)=O)[C@](C)(CC[C@]21C)[C@H](C)C(C)C,BODYFEUFKHPRCK-ZCZMVWJSSA-N,730.051,P40989,BE0010066,"1,3-beta-glucan synthase component GSC2",Baker's yeast,inhibitor,yes
DB12476,CPG-52852,small molecule,investigational,CCC1=NC2=C(N1CCCCNS(C)(=O)=O)C1=CC=CC=C1N=C2N,YZOQZEXYFLXNKA-UHFFFAOYSA-N,361.46,Q9NYK1,BE0000155,Toll-like receptor 7,Humans,agonist,yes
DB12478,Piribedil,small molecule,investigational,C(N1CCN(CC1)C1=NC=CC=N1)C1=CC2=C(OCO2)C=C1,OQDPVLVUJFGPGQ-UHFFFAOYSA-N,298.346,P35462,BE0000581,D(3) dopamine receptor,Humans,agonist,yes
DB12478,Piribedil,small molecule,investigational,C(N1CCN(CC1)C1=NC=CC=N1)C1=CC2=C(OCO2)C=C1,OQDPVLVUJFGPGQ-UHFFFAOYSA-N,298.346,P18825,BE0000342,Alpha-2C adrenergic receptor,Humans,antagonist,yes
DB12478,Piribedil,small molecule,investigational,C(N1CCN(CC1)C1=NC=CC=N1)C1=CC2=C(OCO2)C=C1,OQDPVLVUJFGPGQ-UHFFFAOYSA-N,298.346,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,agonist,yes
DB12478,Piribedil,small molecule,investigational,C(N1CCN(CC1)C1=NC=CC=N1)C1=CC2=C(OCO2)C=C1,OQDPVLVUJFGPGQ-UHFFFAOYSA-N,298.346,P21917,BE0000389,D(4) dopamine receptor,Humans,antagonist,yes
DB12478,Piribedil,small molecule,investigational,C(N1CCN(CC1)C1=NC=CC=N1)C1=CC2=C(OCO2)C=C1,OQDPVLVUJFGPGQ-UHFFFAOYSA-N,298.346,P41595,BE0000393,5-hydroxytryptamine receptor 2B,Humans,antagonist,yes
DB12478,Piribedil,small molecule,investigational,C(N1CCN(CC1)C1=NC=CC=N1)C1=CC2=C(OCO2)C=C1,OQDPVLVUJFGPGQ-UHFFFAOYSA-N,298.346,P14416,BE0000756,D(2) dopamine receptor,Humans,agonist,yes
DB12480,Betulinic Acid,small molecule,approved;investigational,[H]OC(=O)[C@]12CC[C@@]([H])(C(C)=C)[C@]1([H])[C@@]1([H])CC[C@]3([H])[C@@]4(C)CC[C@]([H])(O[H])C(C)(C)[C@]4([H])CC[C@@]3(C)[C@]1(C)CC2,QGJZLNKBHJESQX-FZFNOLFKSA-N,456.711,P04293,BE0000308,DNA polymerase catalytic subunit,HHV-1,inhibitor,yes
DB12483,Copanlisib,small molecule,approved;investigational,COC1=C(OCCCN2CCOCC2)C=CC2=C1N=C(NC(=O)C1=CN=C(N)N=C1)N1CCN=C21,PZBCKZWLPGJMAO-UHFFFAOYSA-N,480.529,P42336,BE0002379,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",Humans,inhibitor,yes
DB12483,Copanlisib,small molecule,approved;investigational,COC1=C(OCCCN2CCOCC2)C=CC2=C1N=C(NC(=O)C1=CN=C(N)N=C1)N1CCN=C21,PZBCKZWLPGJMAO-UHFFFAOYSA-N,480.529,O00329,BE0002406,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",Humans,inhibitor,yes
DB12484,Tetrahydrouridine,small molecule,investigational,OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1CCC(O)NC1=O,UCKYOOZPSJFJIZ-XVKVHKPRSA-N,248.235,P32320,BE0002443,Cytidine deaminase,Humans,modulator,yes
DB12486,Elobixibat,small molecule,investigational,CCCCC1(CCCC)CN(C2=CC=CC=C2)C2=CC(SC)=C(OCC(=O)N[C@@H](C(=O)NCC(O)=O)C3=CC=CC=C3)C=C2S(=O)(=O)C1,XFLQIRAKKLNXRQ-UUWRZZSWSA-N,695.89,Q12908,BE0003643,Ileal sodium/bile acid cotransporter,Humans,modulator,yes
DB12487,Promestriene,small molecule,investigational,[H][C@@]12CC[C@H](OC)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OCCC)C=C3,IUWKNLFTJBHTSD-AANPDWTMSA-N,328.496,P03372,BE0000123,Estrogen receptor,Humans,modulator,yes
DB12491,Fasiglifam,small molecule,investigational,CC1=CC(OCCCS(C)(=O)=O)=CC(C)=C1C1=CC=CC(COC2=CC=C3[C@H](CC(O)=O)COC3=C2)=C1,BZCALJIHZVNMGJ-HSZRJFAPSA-N,524.63,O14842,BE0000688,Free fatty acid receptor 1,Humans,modulator,yes
DB12495,Selepressin,small molecule,investigational,CC[C@H](C)[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O,JCVQBJTWWDYUFQ-MRUTUVJXSA-N,1048.29,P37288,BE0000165,Vasopressin V1a receptor,Humans,agonist,yes
DB12499,Clascoterone,small molecule,approved;investigational,[H][C@@]12CC[C@](OC(=O)CC)(C(=O)CO)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,GPNHMOZDMYNCPO-PDUMRIMRSA-N,402.531,P10275,BE0000132,Androgen receptor,Humans,antagonist,yes
DB12500,Fedratinib,small molecule,approved;investigational,CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C,JOOXLOJCABQBSG-UHFFFAOYSA-N,524.678,O60674,BE0002408,Tyrosine-protein kinase JAK2,Humans,inhibitor,yes
DB12500,Fedratinib,small molecule,approved;investigational,CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C,JOOXLOJCABQBSG-UHFFFAOYSA-N,524.678,P36888,BE0000147,Receptor-type tyrosine-protein kinase FLT3,Humans,inhibitor,yes
DB12505,E-7820,small molecule,investigational,CC1=C2C(=CNC2=C(NS(=O)(=O)C2=CC=CC(=C2)C#N)C=C1)C#N,LWGUASZLXHYWIV-UHFFFAOYSA-N,336.37,P17301,BE0012664,Integrin alpha-2,Humans,inhibitor,yes
DB12507,Atecegatran metoxil,small molecule,investigational,CO\N=C(/N)C1=CC=C(CNC(=O)[C@@H]2CCN2C(=O)[C@H](O)C2=CC(OC(F)F)=CC(Cl)=C2)C=C1,XSNMGLZVFNDDPW-ZWKOTPCHSA-N,496.9,P00734,BE0000048,Prothrombin,Humans,inhibitor,yes
DB12509,Imeglimin,small molecule,investigational,C[C@@H]1NC(N)=NC(=N1)N(C)C,GFICWFZTBXUVIG-SCSAIBSYSA-N,155.205,Q13131,BE0000677,5'-AMP-activated protein kinase catalytic subunit alpha-1,Humans,modulator,yes
DB12509,Imeglimin,small molecule,investigational,C[C@@H]1NC(N)=NC(=N1)N(C)C,GFICWFZTBXUVIG-SCSAIBSYSA-N,155.205,Q9Y478,BE0000254,5'-AMP-activated protein kinase subunit beta-1,Humans,modulator,yes
DB12509,Imeglimin,small molecule,investigational,C[C@@H]1NC(N)=NC(=N1)N(C)C,GFICWFZTBXUVIG-SCSAIBSYSA-N,155.205,P54619,BE0009988,5'-AMP-activated protein kinase subunit gamma-1,Humans,modulator,yes
DB12511,Imiglitazar,small molecule,investigational,CC1=C(COC2=CC=C(CO\N=C(/CCC(O)=O)C3=CC=CC=C3)C=C2)N=C(O1)C1=CC=CC=C1,ULVDFHLHKNJICZ-QCWLDUFUSA-N,470.525,P37231,BE0000215,Peroxisome proliferator-activated receptor gamma,Humans,modulator,yes
DB12511,Imiglitazar,small molecule,investigational,CC1=C(COC2=CC=C(CO\N=C(/CCC(O)=O)C3=CC=CC=C3)C=C2)N=C(O1)C1=CC=CC=C1,ULVDFHLHKNJICZ-QCWLDUFUSA-N,470.525,Q07869,BE0000071,Peroxisome proliferator-activated receptor alpha,Humans,modulator,yes
DB12512,Verucerfont,small molecule,investigational,CC[C@H](NC1=CC(C)=NC2=C(C(C)=NN12)C1=CC=C(OC)C=C1C)C1=NC(C)=NO1,VKHVAUKFLBBZFJ-SFHVURJKSA-N,406.49,P34998,BE0008658,Corticotropin-releasing factor receptor 1,Humans,antagonist,yes
DB12513,Omaveloxolone,small molecule,approved;investigational,CC(F)(F)C(=O)N[C@]12CCC(C)(C)C[C@H]1[C@H]1C(=O)C=C3[C@@]4(C)C=C(C#N)C(=O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2,RJCWBNBKOKFWNY-IDPLTSGASA-N,554.723,Q16236,BE0010121,Nuclear factor erythroid 2-related factor 2,Humans,activator,yes
DB12514,Iofolastat I-123,small molecule,investigational,OC(=O)CC[C@H](NC(=O)N[C@@H](CCCCNCC1=CC=C([123I])C=C1)C(O)=O)C(O)=O,OXUUJYOSVPMNKP-ZANJDRPYSA-N,531.337,Q04609,BE0000568,Glutamate carboxypeptidase 2,Humans,inhibitor,yes
DB12515,9-aminocamptothecin,small molecule,investigational,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=C1N=C1C=CC=C(N)C1=C3)C2=O,FUXVKZWTXQUGMW-FQEVSTJZSA-N,363.373,P11387,BE0000971,DNA topoisomerase 1,Humans,inhibitor,yes
DB12518,Raclopride,small molecule,investigational,CCN1CCC[C@H]1CNC(=O)C1=C(O)C(Cl)=CC(Cl)=C1OC,WAOQONBSWFLFPE-VIFPVBQESA-N,347.24,P06213,BE0000033,Insulin receptor,Humans,stimulator,yes
DB12518,Raclopride,small molecule,investigational,CCN1CCC[C@H]1CNC(=O)C1=C(O)C(Cl)=CC(Cl)=C1OC,WAOQONBSWFLFPE-VIFPVBQESA-N,347.24,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB12522,Toreforant,small molecule,investigational,CN1CCC(CCCNC2=NC=C(C3=NC4=C(C)C=C(C)C=C4N3)C(C)=N2)CC1,FCRFVPZAXGJLPW-UHFFFAOYSA-N,392.551,Q9H3N8,BE0000146,Histamine H4 receptor,Humans,antagonist,yes
DB12523,Mizolastine,small molecule,approved;investigational,CN(C1CCN(CC1)C1=NC2=C(C=CC=C2)N1CC1=CC=C(F)C=C1)C1=NC=CC(=O)N1,PVLJETXTTWAYEW-UHFFFAOYSA-N,432.503,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB12524,BI-671800,small molecule,investigational,CN(C)C1=NC(CC2=CC=C(NC(=O)C3=CC=C(C=C3)C(F)(F)F)C=C2)=NC(N(C)C)=C1CC(O)=O,XEOSTBFUCNZKGS-UHFFFAOYSA-N,501.51,Q9Y5Y4,BE0003561,Prostaglandin D2 receptor 2,Humans,antagonist,yes
DB12526,Batefenterol,small molecule,investigational,COC1=CC(NC(=O)CCN2CCC(CC2)OC(=O)NC2=CC=CC=C2C2=CC=CC=C2)=C(Cl)C=C1CNC[C@H](O)C1=C2C=CC(=O)NC2=C(O)C=C1,URWYQGVSPQJGGB-DHUJRADRSA-N,740.25,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,modulator,yes
DB12527,Sofinicline,small molecule,investigational,ClC1=C(Cl)N=CC(=C1)N1C[C@@H]2CN[C@@H]2C1,MBQYQLWSBRANKQ-IMTBSYHQSA-N,244.12,P43681,BE0000849,Neuronal acetylcholine receptor subunit alpha-4,Humans,modulator,yes
DB12527,Sofinicline,small molecule,investigational,ClC1=C(Cl)N=CC(=C1)N1C[C@@H]2CN[C@@H]2C1,MBQYQLWSBRANKQ-IMTBSYHQSA-N,244.12,P17787,BE0000850,Neuronal acetylcholine receptor subunit beta-2,Humans,modulator,yes
DB12531,Lobucavir,small molecule,investigational,NC1=NC2=C(N=CN2[C@@H]2C[C@H](CO)[C@H]2CO)C(=O)N1,GWFOVSGRNGAGDL-FSDSQADBSA-N,265.273,P03366,BE0002050,Gag-Pol polyprotein,,modulator,yes
DB12532,Oxetacaine,small molecule,approved;investigational,CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)CC1=CC=CC=C1)C(C)(C)CC1=CC=CC=C1,FTLDJPRFCGDUFH-UHFFFAOYSA-N,467.654,P01350,BE0009548,Gastrin,Humans,inhibition of synthesis,yes
DB12535,AC-430,small molecule,investigational,CC1=CC(NC2=NC(=NC3=CC=CC=C23)C(O)C2=CC=C(F)C=C2)=NN1,DCRWIATZWHLIPN-UHFFFAOYSA-N,349.369,O60674,BE0002408,Tyrosine-protein kinase JAK2,Humans,modulator,yes
DB12537,"1,2-Benzodiazepine",small molecule,approved;investigational,N1N=CC=CC2=CC=CC=C12,SVUOLADPCWQTTE-UHFFFAOYSA-N,144.177,P30536,BE0000736,Translocator protein,Humans,agonist,yes
DB12539,Oltipraz,small molecule,investigational,CC1=C(SSC1=S)C1=CN=CC=N1,CKNAQFVBEHDJQV-UHFFFAOYSA-N,226.342,P21980,BE0001035,Protein-glutamine gamma-glutamyltransferase 2,Humans,inhibitor,yes
DB12541,SAR-405838,small molecule,investigational,CC(C)(C)C[C@@H]1N[C@H]([C@H](C2=C(F)C(Cl)=CC=C2)[C@]11C(=O)NC2=C1C=CC(Cl)=C2)C(=O)N[C@H]1CC[C@H](O)CC1,IDKAKZRYYDCJDU-HBMMIIHUSA-N,562.51,P04637,BE0003380,Cellular tumor antigen p53,Humans,modulator,yes
DB12542,GSK-356278,small molecule,investigational,CCN1N=CC2=C(NC3CCOCC3)C(=CN=C12)C1=NN=C(CC2=C(C)N=C(C)S2)O1,AWDJJMXJUOHGLC-UHFFFAOYSA-N,439.54,P27815,BE0001133,"3',5'-cyclic-AMP phosphodiesterase 4A",Humans,inhibitor,yes
DB12542,GSK-356278,small molecule,investigational,CCN1N=CC2=C(NC3CCOCC3)C(=CN=C12)C1=NN=C(CC2=C(C)N=C(C)S2)O1,AWDJJMXJUOHGLC-UHFFFAOYSA-N,439.54,Q08499,BE0001287,"3',5'-cyclic-AMP phosphodiesterase 4D",Humans,inhibitor,yes
DB12542,GSK-356278,small molecule,investigational,CCN1N=CC2=C(NC3CCOCC3)C(=CN=C12)C1=NN=C(CC2=C(C)N=C(C)S2)O1,AWDJJMXJUOHGLC-UHFFFAOYSA-N,439.54,Q07343,BE0000487,"3',5'-cyclic-AMP phosphodiesterase 4B",Humans,inhibitor,yes
DB12543,Samidorphan,small molecule,approved;investigational,NC(=O)C1=CC=C2C[C@H]3N(CC4CC4)CC[C@@]4(CC(=O)CC[C@@]34O)C2=C1O,RYIDHLJADOKWFM-MAODMQOUSA-N,370.449,P35372,BE0000770,Mu-type opioid receptor,Humans,antagonist,yes
DB12548,Sparsentan,small molecule,approved;investigational,CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C(COCC)=C1)C1=CC=CC=C1S(=O)(=O)NC1=NOC(C)=C1C,WRFHGDPIDHPWIQ-UHFFFAOYSA-N,592.76,P25101,BE0000521,Endothelin-1 receptor,Humans,antagonist,yes
DB12548,Sparsentan,small molecule,approved;investigational,CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C(COCC)=C1)C1=CC=CC=C1S(=O)(=O)NC1=NOC(C)=C1C,WRFHGDPIDHPWIQ-UHFFFAOYSA-N,592.76,P30556,BE0000062,Type-1 angiotensin II receptor,Humans,antagonist,yes
DB12549,Pyrazoloacridine,small molecule,investigational,COC1=CC=C2NC3=C4C(=CC=C3[N+]([O-])=O)N(CCCN(C)C)N=C4C2=C1,HZCWPKGYTCJSEB-UHFFFAOYSA-N,367.409,P11388,BE0000742,DNA topoisomerase 2-alpha,Humans,modulator,yes
DB12549,Pyrazoloacridine,small molecule,investigational,COC1=CC=C2NC3=C4C(=CC=C3[N+]([O-])=O)N(CCCN(C)C)N=C4C2=C1,HZCWPKGYTCJSEB-UHFFFAOYSA-N,367.409,Q02880,BE0002425,DNA topoisomerase 2-beta,Humans,modulator,yes
DB12550,Taladegib,small molecule,investigational,CN(C1CCN(CC1)C1=NN=C(C2=CC=NN2C)C2=CC=CC=C12)C(=O)C1=C(C=C(F)C=C1)C(F)(F)F,SZBGQDXLNMELTB-UHFFFAOYSA-N,512.502,Q99835,BE0004659,Protein smoothened,Humans,modulator,yes
DB12554,Mebeverine,small molecule,approved;investigational,CCN(CCCCOC(=O)C1=CC(OC)=C(OC)C=C1)C(C)CC1=CC=C(OC)C=C1,VYVKHNNGDFVQGA-UHFFFAOYSA-N,429.557,P08912,BE0000247,Muscarinic acetylcholine receptor M5,Humans,antagonist,yes
DB12555,Nelotanserin,small molecule,investigational,COC1=CC=C(NC(=O)NC2=CC=C(F)C=C2F)C=C1C1=C(Br)C=NN1C,COSPVUFTLGQDQL-UHFFFAOYSA-N,437.245,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,modulator,yes
DB12556,MK-5108,small molecule,investigational,OC(=O)[C@@]1(CC2=CC=CC(NC3=NC=CS3)=N2)CC[C@@H](CC1)OC1=C(F)C(Cl)=CC=C1,LCVIRAZGMYMNNT-VVONHTQRSA-N,461.94,Q96GD4,BE0003404,Aurora kinase B,Humans,inhibitor,yes
DB12557,FK-614,small molecule,investigational,CCCCCS(=O)(=O)NC(=O)C1=CC=C2N=C(C)N(CC3=CC=C(Cl)C=C3Cl)C2=C1,UYGZODVVDUIDDQ-UHFFFAOYSA-N,468.39,P37231,BE0000215,Peroxisome proliferator-activated receptor gamma,Humans,agonist,yes
DB12558,AEE-788,small molecule,investigational,CCN1CCN(CC2=CC=C(C=C2)C2=CC3=C(N2)N=CN=C3N[C@H](C)C2=CC=CC=C2)CC1,OONFNUWBHFSNBT-HXUWFJFHSA-N,440.5832,P21802,BE0000748,Fibroblast growth factor receptor 2,Humans,inhibitor,yes
DB12558,AEE-788,small molecule,investigational,CCN1CCN(CC2=CC=C(C=C2)C2=CC3=C(N2)N=CN=C3N[C@H](C)C2=CC=CC=C2)CC1,OONFNUWBHFSNBT-HXUWFJFHSA-N,440.5832,P22607,BE0002133,Fibroblast growth factor receptor 3,Humans,inhibitor,yes
DB12559,EC-17,small molecule,investigational,NC(=O)CC[C@H](N(CCNC(=S)NC1=CC=C2C(=C1)C(=O)OC21C2=CC=C(O)C=C2OC2=C1C=CC(O)=C2)C(=O)C1=CC=C(NCC2=CN=C3N=C(N)NC(=O)C3=N2)C=C1)C(O)=O,ZMTAPBHUSYTHBY-PMERELPUSA-N,872.87,P15328,BE0003405,Folate receptor alpha,Humans,modulator,yes
DB12561,WNT-974,small molecule,investigational,CC1=CC(=CC=N1)C1=NC=C(CC(=O)NC2=CC=C(C=N2)C2=CN=CC=N2)C=C1C,XXYGTCZJJLTAGH-UHFFFAOYSA-N,396.454,Q9H237,BE0019221,Protein-serine O-palmitoleoyltransferase porcupine,Humans,inhibitor,yes
DB12562,Setipiprant,small molecule,investigational,OC(=O)CN1C2=C(CN(CC2)C(=O)C2=CC=CC3=CC=CC=C23)C2=CC(F)=CC=C12,IHAXLPDVOWLUOS-UHFFFAOYSA-N,402.425,Q13258,BE0000296,Prostaglandin D2 receptor,Humans,antagonist,yes
DB12562,Setipiprant,small molecule,investigational,OC(=O)CN1C2=C(CN(CC2)C(=O)C2=CC=CC3=CC=CC=C23)C2=CC(F)=CC=C12,IHAXLPDVOWLUOS-UHFFFAOYSA-N,402.425,Q9Y5Y4,BE0003561,Prostaglandin D2 receptor 2,Humans,antagonist,yes
DB12564,Gemcitabine elaidate,small molecule,investigational,CCCCCCCC\C=C\CCCCCCCC(=O)OC[C@H]1O[C@@H](N2C=CC(N)=NC2=O)C(F)(F)[C@@H]1O,HESSNRGIEVBPRB-QDDPNBLJSA-N,527.654,P31350,BE0002450,Ribonucleoside-diphosphate reductase subunit M2,Humans,inhibitor,yes
DB12566,Decernotinib,small molecule,investigational,CC[C@@](C)(NC1=CC=NC(=N1)C1=CNC2=NC=CC=C12)C(=O)NCC(F)(F)F,ASUGUQWIHMTFJL-QGZVFWFLSA-N,392.386,P52333,BE0003493,Tyrosine-protein kinase JAK3,Humans,inhibitor,yes
DB12567,Camicinal,small molecule,investigational,C[C@H]1CN(CC2=CC=C(CC(=O)N3CCC(CC3)NC3=CC=CC(F)=C3)C=C2)CCN1,RZKDEGZIFSJVNA-IBGZPJMESA-N,424.564,O43193,BE0003521,Motilin receptor,Humans,modulator,yes
DB12569,Tonapofylline,small molecule,investigational,CCCN1C2=C(NC(=N2)C23CCC(CCC(O)=O)(CC2)CC3)C(=O)N(CCC)C1=O,ZWTVVWUOTJRXKM-UHFFFAOYSA-N,416.522,P30542,BE0000013,Adenosine receptor A1,Humans,inhibitor,yes
DB12569,Tonapofylline,small molecule,investigational,CCCN1C2=C(NC(=N2)C23CCC(CCC(O)=O)(CC2)CC3)C(=O)N(CCC)C1=O,ZWTVVWUOTJRXKM-UHFFFAOYSA-N,416.522,P29274,BE0000924,Adenosine receptor A2a,Humans,inhibitor,yes
DB12569,Tonapofylline,small molecule,investigational,CCCN1C2=C(NC(=N2)C23CCC(CCC(O)=O)(CC2)CC3)C(=O)N(CCC)C1=O,ZWTVVWUOTJRXKM-UHFFFAOYSA-N,416.522,P0DMS8,BE0000354,Adenosine receptor A3,Humans,inhibitor,yes
DB12569,Tonapofylline,small molecule,investigational,CCCN1C2=C(NC(=N2)C23CCC(CCC(O)=O)(CC2)CC3)C(=O)N(CCC)C1=O,ZWTVVWUOTJRXKM-UHFFFAOYSA-N,416.522,P29275,BE0000241,Adenosine receptor A2b,Humans,inhibitor,yes
DB12570,Onatasertib,small molecule,investigational,CO[C@H]1CC[C@@H](CC1)N1C(=O)CNC2=C1N=C(C=N2)C1=CN=C(C=C1)C(C)(C)O,UFKLYTOEMRFKAD-SHTZXODSSA-N,397.479,P42345,BE0002386,Serine/threonine-protein kinase mTOR,Humans,modulator,yes
DB12571,Rimacalib,small molecule,investigational,[H][C@@](C)(C1=NOC(NC(=N)N2CCOCC2)=C1)C1=CC=C(C(F)=C1)C1=CC=CC=C1,MYTIJGWONQOOLC-HNNXBMFYSA-N,394.45,Q9UQM7,BE0004076,Calcium/calmodulin-dependent protein kinase type II subunit alpha,Humans,modulator,yes
DB12571,Rimacalib,small molecule,investigational,[H][C@@](C)(C1=NOC(NC(=N)N2CCOCC2)=C1)C1=CC=C(C(F)=C1)C1=CC=CC=C1,MYTIJGWONQOOLC-HNNXBMFYSA-N,394.45,Q13554,BE0003792,Calcium/calmodulin-dependent protein kinase type II subunit beta,Humans,modulator,yes
DB12571,Rimacalib,small molecule,investigational,[H][C@@](C)(C1=NOC(NC(=N)N2CCOCC2)=C1)C1=CC=C(C(F)=C1)C1=CC=CC=C1,MYTIJGWONQOOLC-HNNXBMFYSA-N,394.45,Q13557,BE0004108,Calcium/calmodulin-dependent protein kinase type II subunit delta,Humans,modulator,yes
DB12571,Rimacalib,small molecule,investigational,[H][C@@](C)(C1=NOC(NC(=N)N2CCOCC2)=C1)C1=CC=C(C(F)=C1)C1=CC=CC=C1,MYTIJGWONQOOLC-HNNXBMFYSA-N,394.45,Q13555,BE0004384,Calcium/calmodulin-dependent protein kinase type II subunit gamma,Humans,modulator,yes
DB12572,Pexacerfont,small molecule,investigational,CC[C@@H](C)NC1=NC(C)=NC2=C(C(C)=NN12)C1=CC=C(OC)N=C1C,LBWQSAZEYIZZCE-SNVBAGLBSA-N,340.431,P34998,BE0008658,Corticotropin-releasing factor receptor 1,Humans,antagonist,yes
DB12576,AZD-3043,small molecule,investigational,CCCOC(=O)CC1=CC=C(OCC(=O)N(CC)CC)C(OCC)=C1,QPUVKSKJCNGSGT-UHFFFAOYSA-N,351.443,Q99928,BE0003594,Gamma-aminobutyric acid receptor subunit gamma-3,Humans,modulator,yes
DB12579,JNJ-37822681,small molecule,investigational,FC1=C(F)C=C(CN2CCC(CC2)NC2=CC=C(N=N2)C(F)(F)F)C=C1,UVUYWJWYRLJHEN-UHFFFAOYSA-N,372.343,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB12580,Tradipitant,small molecule,investigational,FC(F)(F)C1=CC(=CC(CN2N=NC(=C2C2=CC=NC=C2)C2=NC=CC=C2C(=O)C2=CC=CC=C2Cl)=C1)C(F)(F)F,CAVRKWRKTNINFF-UHFFFAOYSA-N,587.91,P25103,BE0000384,Substance-P receptor,Humans,antagonist,yes
DB12581,Ozarelix,small molecule,investigational,[H]N=C(N([H])[H])N([H])CCC[C@H](N([H])C(=O)[C@H](CCCC)N([H])C(=O)[C@@H](CCCCN([H])C(=O)N([H])[H])N([H])C(=O)[C@H](CC1=CC=C(O)C=C1)N(C)C(=O)[C@H](CO)N([H])C(=O)[C@@H](CC1=CN=CC=C1)N([H])C(=O)[C@@H](CC1=CC=C(Cl)C=C1)N([H])C(=O)[C@@H](CC1=CC2=CC=CC=C2C=C1)N([H])C(C)=O)C(=O)N1CCC[C@H]1C(=O)N([H])[C@H](C)C(=O)N([H])[H],KATZUZNTRINHDT-HALMFYTRSA-N,1459.12,P30968,BE0000203,Gonadotropin-releasing hormone receptor,Humans,modulator,yes
DB12582,Piperine,small molecule,investigational,O=C(\C=C\C=C\C1=CC2=C(OCO2)C=C1)N1CCCCC1,MXXWOMGUGJBKIW-YPCIICBESA-N,285.3377,P21397,BE0002198,Amine oxidase [flavin-containing] A,Humans,inhibitor,yes
DB12582,Piperine,small molecule,investigational,O=C(\C=C\C=C\C1=CC2=C(OCO2)C=C1)N1CCCCC1,MXXWOMGUGJBKIW-YPCIICBESA-N,285.3377,P27338,BE0002196,Amine oxidase [flavin-containing] B,Humans,inhibitor,yes
DB12588,AZD-1480,small molecule,investigational,C[C@H](NC1=NC=C(Cl)C(NC2=NNC(C)=C2)=N1)C1=NC=C(F)C=N1,PDOQBOJDRPLBQU-QMMMGPOBSA-N,348.766,O60674,BE0002408,Tyrosine-protein kinase JAK2,Humans,modulator,yes
DB12590,Indiplon,small molecule,investigational,CN(C(C)=O)C1=CC=CC(=C1)C1=CC=NC2=C(C=NN12)C(=O)C1=CC=CS1,CBIAWPMZSFFRGN-UHFFFAOYSA-N,376.43,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,agonist,yes
DB12591,BMS-911543,small molecule,investigational,CCN1C(=CC2=C3N(C)C=NC3=C(NC3=NN(C)C(C)=C3)N=C12)C(=O)N(C1CC1)C1CC1,JCINBYQJBYJGDM-UHFFFAOYSA-N,432.532,O60674,BE0002408,Tyrosine-protein kinase JAK2,Humans,modulator,yes
DB12594,AZD-9056,small molecule,investigational,OCCCNCCCC1=CC(C(=O)NCC23CC4CC(CC(C4)C2)C3)=C(Cl)C=C1,HSQAARMBHJCUOK-UHFFFAOYSA-N,419.01,Q99572,BE0009814,P2X purinoceptor 7,Humans,antagonist,yes
DB12597,Asciminib,small molecule,approved;investigational,O[C@@H]1CCN(C1)C1=C(C=C(C=N1)C(=O)NC1=CC=C(OC(F)(F)Cl)C=C1)C1=CC=NN1,VOVZXURTCKPRDQ-CQSZACIVSA-N,449.84,P00519,BE0000014,Tyrosine-protein kinase ABL1,Humans,inhibitor;allosteric modulator,yes
DB12598,Nafamostat,small molecule,investigational,NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC2=C(C=C1)C=C(C=C2)C(N)=N,MQQNFDZXWVTQEH-UHFFFAOYSA-N,347.378,P00734,BE0000048,Prothrombin,Humans,inhibitor,yes
DB12598,Nafamostat,small molecule,investigational,NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC2=C(C=C1)C=C(C=C2)C(N)=N,MQQNFDZXWVTQEH-UHFFFAOYSA-N,347.378,P00742,BE0000216,Coagulation factor X,Humans,inhibitor,yes
DB12598,Nafamostat,small molecule,investigational,NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC2=C(C=C1)C=C(C=C2)C(N)=N,MQQNFDZXWVTQEH-UHFFFAOYSA-N,347.378,P00748,BE0004672,Coagulation factor XII,Humans,inhibitor,yes
DB12598,Nafamostat,small molecule,investigational,NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC2=C(C=C1)C=C(C=C2)C(N)=N,MQQNFDZXWVTQEH-UHFFFAOYSA-N,347.378,P07477,BE0001739,Serine protease 1,Humans,inhibitor,yes
DB12598,Nafamostat,small molecule,investigational,NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC2=C(C=C1)C=C(C=C2)C(N)=N,MQQNFDZXWVTQEH-UHFFFAOYSA-N,347.378,P06870,BE0001091,Kallikrein-1,Humans,inhibitor,yes
DB12601,Sonolisib,small molecule,investigational,COC[C@H]1OC(=O)\C(=C\N(CC=C)CC=C)C2=C(O)C(=O)C3=C([C@@H](C[C@@]4(C)[C@H]3CCC4=O)OC(C)=O)[C@@]12C,QIUASFSNWYMDFS-NILGECQDSA-N,525.598,P48736,BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",Humans,inhibitor,yes
DB12606,Netivudine,small molecule,investigational,CC#CC1=CN([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)C(=O)NC1=O,QLOCVMVCRJOTTM-SDNRWEOFSA-N,282.252,P04293,BE0000308,DNA polymerase catalytic subunit,HHV-1,modulator,yes
DB12608,Emixustat,small molecule,investigational,NCC[C@@H](O)C1=CC(OCC2CCCCC2)=CC=C1,WJIGGYYSZBWCGC-MRXNPFEDSA-N,263.381,Q16518,BE0009149,Retinoid isomerohydrolase,Humans,inhibitor,yes
DB12610,Ebselen,small molecule,investigational,O=C1N([Se]C2=CC=CC=C12)C1=CC=CC=C1,DYEFUKCXAQOFHX-UHFFFAOYSA-N,274.192,P02768,BE0000530,Albumin,Humans,binder,yes
DB12610,Ebselen,small molecule,investigational,O=C1N([Se]C2=CC=CC=C12)C1=CC=CC=C1,DYEFUKCXAQOFHX-UHFFFAOYSA-N,274.192,O75164,BE0011989,Lysine-specific demethylase 4A,Humans,inhibitor,yes
DB12611,PF-477736,small molecule,investigational,CN1C=C(C=N1)C1=C2C=NNC(=O)C3=C2C(N1)=CC(NC(=O)[C@H](N)C1CCCCC1)=C3,NDEXUOWTGYUVGA-LJQANCHMSA-N,419.489,O14757,BE0003382,Serine/threonine-protein kinase Chk1,Humans,inhibitor,yes
DB12612,Ozanimod,small molecule,approved;investigational,CC(C)OC1=C(C=C(C=C1)C1=NC(=NO1)C1=C2CC[C@H](NCCO)C2=CC=C1)C#N,XRVDGNKRPOAQTN-FQEVSTJZSA-N,404.47,P21453,BE0008652,Sphingosine 1-phosphate receptor 1,Humans,agonist,yes
DB12612,Ozanimod,small molecule,approved;investigational,CC(C)OC1=C(C=C(C=C1)C1=NC(=NO1)C1=C2CC[C@H](NCCO)C2=CC=C1)C#N,XRVDGNKRPOAQTN-FQEVSTJZSA-N,404.47,Q9H228,BE0002432,Sphingosine 1-phosphate receptor 5,Humans,agonist,yes
DB12614,Reparixin,small molecule,investigational,CC(C)CC1=CC=C(C=C1)[C@@H](C)C(=O)NS(C)(=O)=O,KQDRVXQXKZXMHP-LLVKDONJSA-N,283.39,P25025,BE0010516,C-X-C chemokine receptor type 2,Humans,modulator,yes
DB12614,Reparixin,small molecule,investigational,CC(C)CC1=CC=C(C=C1)[C@@H](C)C(=O)NS(C)(=O)=O,KQDRVXQXKZXMHP-LLVKDONJSA-N,283.39,P25024,BE0003552,C-X-C chemokine receptor type 1,Humans,modulator,yes
DB12615,Plazomicin,small molecule,approved;investigational,CN[C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@@H](C[C@H](N)[C@@H](O[C@H]3OC(CNCCO)=CC[C@H]3N)[C@@H]2O)NC(=O)[C@@H](O)CCN)OC[C@]1(C)O,IYDYFVUFSPQPPV-PEXOCOHZSA-N,592.691,Q9UI43,BE0020789,"rRNA methyltransferase 2, mitochondrial",Humans,inhibitor,yes
DB12615,Plazomicin,small molecule,approved;investigational,CN[C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@@H](C[C@H](N)[C@@H](O[C@H]3OC(CNCCO)=CC[C@H]3N)[C@@H]2O)NC(=O)[C@@H](O)CCN)OC[C@]1(C)O,IYDYFVUFSPQPPV-PEXOCOHZSA-N,592.691,L0LZJ6,BE0009558,30S ribosomal protein S11,Enterobacteriaceae bacterium (strain FGI 57),inhibitor,yes
DB12617,Mizoribine,small molecule,investigational,NC(=O)C1=C(O)N(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,HZQDCMWJEBCWBR-UUOKFMHZSA-N,259.216,P20839,BE0000761,Inosine-5'-monophosphate dehydrogenase 1,Humans,inhibitor,yes
DB12622,Lupeol,small molecule,investigational,[H][C@]12[C@@H](CC[C@]1(C)CC[C@]1(C)[C@]2([H])CC[C@]2([H])[C@@]3(C)CC[C@H](O)C(C)(C)[C@]3([H])CC[C@@]12C)C(C)=C,MQYXUWHLBZFQQO-QGTGJCAVSA-N,426.729,P11388,BE0000742,DNA topoisomerase 2-alpha,Humans,inhibitor,yes
DB12622,Lupeol,small molecule,investigational,[H][C@]12[C@@H](CC[C@]1(C)CC[C@]1(C)[C@]2([H])CC[C@]2([H])[C@@]3(C)CC[C@H](O)C(C)(C)[C@]3([H])CC[C@@]12C)C(C)=C,MQYXUWHLBZFQQO-QGTGJCAVSA-N,426.729,Q02880,BE0002425,DNA topoisomerase 2-beta,Humans,inhibitor,yes
DB12623,Taprenepag,small molecule,investigational,OC(=O)COC1=CC=CC(CN(CC2=CC=C(C=C2)N2C=CC=N2)S(=O)(=O)C2=CC=CN=C2)=C1,MFFBXYNKZHTCEY-UHFFFAOYSA-N,478.52,P43116,BE0000368,Prostaglandin E2 receptor EP2 subtype,Humans,agonist,yes
DB12625,Evogliptin,small molecule,investigational,CC(C)(C)OC[C@H]1N(CCNC1=O)C(=O)C[C@H](N)CC1=CC(F)=C(F)C=C1F,LCDDAGSJHKEABN-MLGOLLRUSA-N,401.43,P27487,BE0000854,Dipeptidyl peptidase 4,Humans,inhibitor,yes
DB12627,GSK-1292263,small molecule,investigational,CC(C)C1=NOC(=N1)N1CCC(COC2=CC=C(N=C2)C2=CC=C(C=C2)S(C)(=O)=O)CC1,AYJRTVVIBJSSKN-UHFFFAOYSA-N,456.56,Q8TDV5,BE0003378,Glucose-dependent insulinotropic receptor,Humans,modulator,yes
DB12631,Aclerastide,small molecule,investigational,[H]N([C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N1CCC[C@H]1C(O)=O)C(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CCCC)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(O)=O,RUBMHAHMIJSMHA-LBWFYSSPSA-N,913.047,P04201,BE0012496,Proto-oncogene Mas,Humans,agonist,yes
DB12635,Aleplasinin,small molecule,investigational,CC1=CC=CC(=C1)C1=CC=C2N(CC3=CC=C(C=C3)C(C)(C)C)C=C(C(=O)C(O)=O)C2=C1,HSXLMAFNWCSZGP-UHFFFAOYSA-N,425.528,P05121,BE0000240,Plasminogen activator inhibitor 1,Humans,inhibitor,yes
DB12635,Aleplasinin,small molecule,investigational,CC1=CC=CC(=C1)C1=CC=C2N(CC3=CC=C(C=C3)C(C)(C)C)C=C(C(=O)C(O)=O)C2=C1,HSXLMAFNWCSZGP-UHFFFAOYSA-N,425.528,P05120,BE0000969,Plasminogen activator inhibitor 2,Humans,inhibitor,yes
DB12635,Aleplasinin,small molecule,investigational,CC1=CC=CC(=C1)C1=CC=C2N(CC3=CC=C(C=C3)C(C)(C)C)C=C(C(=O)C(O)=O)C2=C1,HSXLMAFNWCSZGP-UHFFFAOYSA-N,425.528,P05154,BE0002112,Plasma serine protease inhibitor,Humans,inhibitor,yes
DB12637,Onapristone,small molecule,investigational,CN(C)C1=CC=C(C=C1)[C@H]1C[C@]2(C)[C@@H](CC[C@]2(O)CCCO)[C@@H]2CCC3=CC(=O)CCC3=C12,IEXUMDBQLIVNHZ-YOUGDJEHSA-N,449.635,P06401,BE0000557,Progesterone receptor,Humans,modulator,yes
DB12638,Zelavespib,small molecule,investigational,CC(C)NCCCN1C(SC2=C(I)C=C3OCOC3=C2)=NC2=C(N)N=CN=C12,SUPVGFZUWFMATN-UHFFFAOYSA-N,512.368,P08238,BE0001898,Heat shock protein HSP 90-beta,Humans,inhibitor,yes
DB12641,Tedatioxetine,small molecule,investigational,CC1=CC=C(SC2=CC=CC=C2C2CCNCC2)C=C1,CVASBKDYSQKLSO-UHFFFAOYSA-N,283.43,P28335,BE0000533,5-hydroxytryptamine receptor 2C,Humans,modulator,yes
DB12643,Nelivaptan,small molecule,investigational,[H][C@]1(O)CN([C@@]([H])(C1)C(=O)N(C)C)[C@@]1(C(=O)N(C2=C1C=C(Cl)C=C2)S(=O)(=O)C1=C(OC)C=C(OC)C=C1)C1=CC=CC=C1OC,NJXZWIIMWNEOGJ-WEWKHQNJSA-N,630.11,P47901,BE0000773,Vasopressin V1b receptor,Humans,antagonist,yes
DB12643,Nelivaptan,small molecule,investigational,[H][C@]1(O)CN([C@@]([H])(C1)C(=O)N(C)C)[C@@]1(C(=O)N(C2=C1C=C(Cl)C=C2)S(=O)(=O)C1=C(OC)C=C(OC)C=C1)C1=CC=CC=C1OC,NJXZWIIMWNEOGJ-WEWKHQNJSA-N,630.11,P30518,BE0000293,Vasopressin V2 receptor,Humans,inhibitor,yes
DB12643,Nelivaptan,small molecule,investigational,[H][C@]1(O)CN([C@@]([H])(C1)C(=O)N(C)C)[C@@]1(C(=O)N(C2=C1C=C(Cl)C=C2)S(=O)(=O)C1=C(OC)C=C(OC)C=C1)C1=CC=CC=C1OC,NJXZWIIMWNEOGJ-WEWKHQNJSA-N,630.11,P30559,BE0000844,Oxytocin receptor,Humans,inhibitor,yes
DB12643,Nelivaptan,small molecule,investigational,[H][C@]1(O)CN([C@@]([H])(C1)C(=O)N(C)C)[C@@]1(C(=O)N(C2=C1C=C(Cl)C=C2)S(=O)(=O)C1=C(OC)C=C(OC)C=C1)C1=CC=CC=C1OC,NJXZWIIMWNEOGJ-WEWKHQNJSA-N,630.11,P37288,BE0000165,Vasopressin V1a receptor,Humans,inhibitor,yes
DB12644,AZD-2066,small molecule,investigational,C[C@@H](OC1=NN=C(N1C)C1=CC=NC=C1)C1=NOC(=C1)C1=CC=CC(Cl)=C1,SXWHYTICXCLKDG-GFCCVEGCSA-N,381.82,P41594,BE0001192,Metabotropic glutamate receptor 5,Humans,antagonist,yes
DB12645,Givinostat,small molecule,approved;investigational,CCN(CC)CC1=CC=C2C=C(COC(=O)NC3=CC=C(C=C3)C(=O)NO)C=CC2=C1,YALNUENQHAQXEA-UHFFFAOYSA-N,421.497,Q13547,BE0008667,Histone deacetylase,Humans,inhibitor,yes
DB12645,Givinostat,small molecule,approved;investigational,CCN(CC)CC1=CC=C2C=C(COC(=O)NC3=CC=C(C=C3)C(=O)NO)C=CC2=C1,YALNUENQHAQXEA-UHFFFAOYSA-N,421.497,O60674,BE0002408,Tyrosine-protein kinase JAK2,Humans,inhibitor,yes
DB12645,Givinostat,small molecule,approved;investigational,CCN(CC)CC1=CC=C2C=C(COC(=O)NC3=CC=C(C=C3)C(=O)NO)C=CC2=C1,YALNUENQHAQXEA-UHFFFAOYSA-N,421.497,Q13547,BE0002365,Histone deacetylase 1,Humans,inhibitor,yes
DB12647,Tocotrienol,small molecule,investigational,CC(C)=CCC\C(C)=C\CC\C(C)=C\CCC1(C)CCC2=CC(O)=CC=C2O1,GJJVAFUKOBZPCB-ZGRPYONQSA-N,382.5787,P04035,BE0000574,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Humans,inhibitor,yes
DB12648,Nona-arginine,small molecule,investigational,N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O,XUNKPNYCNUKOAU-VXJRNSOOSA-N,1423.716,P35228,BE0000005,"Nitric oxide synthase, inducible",Humans,modulator,yes
DB12651,Bardoxolone,small molecule,investigational,CC1(C)CC[C@@]2(CC[C@]3(C)[C@@H]([C@@H]2C1)C(=O)C=C1[C@@]2(C)C=C(C#N)C(=O)C(C)(C)[C@@H]2CC[C@@]31C)C(O)=O,TXGZJQLMVSIZEI-UQMAOPSPSA-N,491.672,P35228,BE0000005,"Nitric oxide synthase, inducible",Humans,inhibitor,yes
DB12661,Urapidil,small molecule,investigational,COC1=CC=CC=C1N1CCN(CCCNC2=CC(=O)N(C)C(=O)N2C)CC1,ICMGLRUYEQNHPF-UHFFFAOYSA-N,387.484,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,agonist,yes
DB12662,Naveglitazar,small molecule,investigational,CO[C@@H](CC1=CC=C(OCCCOC2=CC=C(OC3=CC=CC=C3)C=C2)C=C1)C(O)=O,OKJHGOPITGTTIM-DEOSSOPVSA-N,422.477,P37231,BE0000215,Peroxisome proliferator-activated receptor gamma,Humans,modulator,yes
DB12662,Naveglitazar,small molecule,investigational,CO[C@@H](CC1=CC=C(OCCCOC2=CC=C(OC3=CC=CC=C3)C=C2)C=C1)C(O)=O,OKJHGOPITGTTIM-DEOSSOPVSA-N,422.477,Q07869,BE0000071,Peroxisome proliferator-activated receptor alpha,Humans,modulator,yes
DB12664,Indantadol,small molecule,investigational,NC(=O)CNC1CC2=CC=CC=C2C1,MNLULKBKWKTZPE-UHFFFAOYSA-N,190.246,P27338,BE0002196,Amine oxidase [flavin-containing] B,Humans,inhibitor,yes
DB12664,Indantadol,small molecule,investigational,NC(=O)CNC1CC2=CC=CC=C2C1,MNLULKBKWKTZPE-UHFFFAOYSA-N,190.246,P21397,BE0002198,Amine oxidase [flavin-containing] A,Humans,inhibitor,yes
DB12665,Isoquercetin,small molecule,investigational,OC[C@H]1O[C@@H](OC2=C(OC3=C(C(O)=CC(O)=C3)C2=O)C2=CC=C(O)C(O)=C2)[C@H](O)[C@@H](O)[C@@H]1O,OVSQVDMCBVZWGM-QSOFNFLRSA-N,464.3763,P15121,BE0000747,Aldo-keto reductase family 1 member B1,Humans,inhibitor,yes
DB12665,Isoquercetin,small molecule,investigational,OC[C@H]1O[C@@H](OC2=C(OC3=C(C(O)=CC(O)=C3)C2=O)C2=CC=C(O)C(O)=C2)[C@H](O)[C@@H](O)[C@@H]1O,OVSQVDMCBVZWGM-QSOFNFLRSA-N,464.3763,P12821,BE0000221,Angiotensin-converting enzyme,Humans,inhibitor,yes
DB12666,Emapunil,small molecule,investigational,CCN(CC1=CC=CC=C1)C(=O)CN1C(=O)N(C)C2=CN=C(N=C12)C1=CC=CC=C1,NBMBIEOUVBHEBM-UHFFFAOYSA-N,401.47,P30536,BE0000736,Translocator protein,Humans,agonist,yes
DB12667,Protionamide,small molecule,approved;investigational,CCCC1=CC(=CC=N1)C(N)=S,VRDIULHPQTYCLN-UHFFFAOYSA-N,180.27,P9WGR1,BE0000332,Enoyl-[acyl-carrier-protein] reductase [NADH],Mycobacterium tuberculosis,inhibitor,yes
DB12668,Metenkefalin,small molecule,investigational,CSCC[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC1=CC=C(O)C=C1)C(O)=O,YFGBQHOOROIVKG-FKBYEOEOSA-N,573.67,P41143,BE0000420,Delta-type opioid receptor,Humans,agonist,yes
DB12669,4SC-203,small molecule,investigational,COC1=CC=C(C)C=C1NC(=O)NC1=NC2=CC=C(NC3=NC=NC4=CC(OCCCN5CCN(C)CC5)=C(OC)C=C34)C=C2S1,MAFACRSJGNJHCF-UHFFFAOYSA-N,642.78,P36888,BE0000147,Receptor-type tyrosine-protein kinase FLT3,Humans,modulator,yes
DB12670,Rolofylline,small molecule,investigational,CCCN1C2=C(NC(=N2)C23C[C@@H]4CC2C[C@H](C3)C4)C(=O)N(CCC)C1=O,PJBFVWGQFLYWCB-QUYAXPHCSA-N,356.47,P30542,BE0000013,Adenosine receptor A1,Humans,antagonist,yes
DB12671,Beloranib,small molecule,investigational,CO[C@@H]1[C@@H](CC[C@]2(CO2)[C@H]1[C@@]1(C)O[C@@H]1CC=C(C)C)OC(=O)\C=C\C1=CC=C(OCCN(C)C)C=C1,ZEZFKUBILQRZCK-MJSCXXSSSA-N,499.648,P50579,BE0001534,Methionine aminopeptidase 2,Humans,inhibitor,yes
DB12672,Icaritin,small molecule,investigational,COC1=CC=C(C=C1)C1=C(O)C(=O)C2=C(O)C=C(O)C(CC=C(C)C)=C2O1,TUUXBSASAQJECY-UHFFFAOYSA-N,368.385,P03372,BE0000123,Estrogen receptor,Humans,modulator,yes
DB12674,Lurbinectedin,small molecule,approved;investigational,[H][C@@]12[C@@H]3SC[C@]4(NCCC5=C4NC4=CC=C(OC)C=C54)C(=O)OC[C@H](N1[C@@H](O)[C@@H]1CC4=CC(C)=C(OC)C(O)=C4[C@@]2([H])N1C)C1=C2OCOC2=C(C)C(OC(C)=O)=C31,YDDMIZRDDREKEP-HWTBNCOESA-N,784.88,,BE0004796,DNA,Humans,adduct,yes
DB12675,PF-04995274,small molecule,investigational,OC1(CN2CCC(COC3=NOC4=CC=CC(O[C@@H]5CCOC5)=C34)CC2)CCOCC1,WLLOFQROROXOMO-GOSISDBHSA-N,432.517,Q13639,BE0000084,5-hydroxytryptamine receptor 4,Humans,agonist,yes
DB12679,WP-1066,small molecule,investigational,C[C@H](NC(=O)C(=C\C1=CC=CC(Br)=N1)\C#N)C1=CC=CC=C1,VFUAJMPDXIRPKO-LQELWAHVSA-N,356.223,P40763,BE0003462,Signal transducer and activator of transcription 3,Humans,inhibitor,yes
DB12680,Intepirdine,small molecule,investigational,O=S(=O)(C1=CC=CC=C1)C1=CN=C2C(C=CC=C2N2CCNCC2)=C1,JJZFWROHYSMCMU-UHFFFAOYSA-N,353.44,P50406,BE0000945,5-hydroxytryptamine receptor 6,Humans,antagonist,yes
DB12681,Salirasib,small molecule,investigational,CC(C)=CCC\C(C)=C\CC\C(C)=C\CSC1=CC=CC=C1C(O)=O,WUILNKCFCLNXOK-CFBAGHHKSA-N,358.54,P42345,BE0002386,Serine/threonine-protein kinase mTOR,Humans,modulator,yes
DB12681,Salirasib,small molecule,investigational,CC(C)=CCC\C(C)=C\CC\C(C)=C\CSC1=CC=CC=C1C(O)=O,WUILNKCFCLNXOK-CFBAGHHKSA-N,358.54,P01111,BE0010426,GTPase NRas,Humans,antagonist,yes
DB12682,Mubritinib,small molecule,investigational,FC(F)(F)C1=CC=C(\C=C\C2=NC(COC3=CC=C(CCCCN4C=CN=N4)C=C3)=CO2)C=C1,ZTFBIUXIQYRUNT-MDWZMJQESA-N,468.48,P00533,BE0000767,Epidermal growth factor receptor,Humans,inhibitor,yes
DB12682,Mubritinib,small molecule,investigational,FC(F)(F)C1=CC=C(\C=C\C2=NC(COC3=CC=C(CCCCN4C=CN=N4)C=C3)=CO2)C=C1,ZTFBIUXIQYRUNT-MDWZMJQESA-N,468.48,P04626,BE0000511,Receptor tyrosine-protein kinase erbB-2,Humans,inhibitor,yes
DB12686,PHA-793887,small molecule,investigational,CC(C)CC(=O)NC1=NNC2=C1CN(C(=O)C1CCN(C)CC1)C2(C)C,HUXYBQXJVXOMKX-UHFFFAOYSA-N,361.4817,P24941,BE0001072,Cyclin-dependent kinase 2,Humans,inhibitor,yes
DB12686,PHA-793887,small molecule,investigational,CC(C)CC(=O)NC1=NNC2=C1CN(C(=O)C1CCN(C)CC1)C2(C)C,HUXYBQXJVXOMKX-UHFFFAOYSA-N,361.4817,P11802,BE0002216,Cyclin-dependent kinase 4,Humans,inhibitor,yes
DB12686,PHA-793887,small molecule,investigational,CC(C)CC(=O)NC1=NNC2=C1CN(C(=O)C1CCN(C)CC1)C2(C)C,HUXYBQXJVXOMKX-UHFFFAOYSA-N,361.4817,P06493,BE0001082,Cyclin-dependent kinase 1,Humans,inhibitor,yes
DB12687,Vesatolimod,small molecule,investigational,CCCCOC1=NC(N)=C2NC(=O)CN(CC3=CC=CC(CN4CCCC4)=C3)C2=N1,VFOKSTCIRGDTBR-UHFFFAOYSA-N,410.522,Q9NYK1,BE0000155,Toll-like receptor 7,Humans,modulator,yes
DB12689,Azeliragon,small molecule,investigational,CCCCC1=NC(=CN1C1=CC=C(OC2=CC=C(Cl)C=C2)C=C1)C1=CC=C(OCCCN(CC)CC)C=C1,KJNNWYBAOPXVJY-UHFFFAOYSA-N,532.13,Q15109,BE0010032,Advanced glycosylation end product-specific receptor,Humans,antagonist,yes
DB12691,UK-432097,small molecule,investigational,CCNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=C(N=C2NCC(C1=CC=CC=C1)C1=CC=CC=C1)C(=O)NCCNC(=O)NC1CCN(CC1)C1=NC=CC=C1,ZOTHAEBAWXWVID-HXEFRTELSA-N,777.8713,P29274,BE0000924,Adenosine receptor A2a,Humans,agonist,yes
DB12693,Ritanserin,small molecule,investigational,CC1=C(CCN2CCC(CC2)=C(C2=CC=C(F)C=C2)C2=CC=C(F)C=C2)C(=O)N2C=CSC2=N1,JUQLTPCYUFPYKE-UHFFFAOYSA-N,477.57,P41595,BE0000393,5-hydroxytryptamine receptor 2B,Humans,antagonist,yes
DB12693,Ritanserin,small molecule,investigational,CC1=C(CCN2CCC(CC2)=C(C2=CC=C(F)C=C2)C2=CC=C(F)C=C2)C(=O)N2C=CSC2=N1,JUQLTPCYUFPYKE-UHFFFAOYSA-N,477.57,P28335,BE0000533,5-hydroxytryptamine receptor 2C,Humans,antagonist,yes
DB12693,Ritanserin,small molecule,investigational,CC1=C(CCN2CCC(CC2)=C(C2=CC=C(F)C=C2)C2=CC=C(F)C=C2)C(=O)N2C=CSC2=N1,JUQLTPCYUFPYKE-UHFFFAOYSA-N,477.57,Q00975,BE0002226,Voltage-dependent N-type calcium channel subunit alpha-1B,Humans,blocker,yes
DB12694,CE-326597,small molecule,investigational,CC(C)N(CC1=CC=CC=C1)C(=O)CN1C2=CC=CC=C2N2C(=NN=C2C2=CC=CC=C2)[C@H](CC2=CNC3=CC=CC=C23)C1=O,UBNMGTSDHSQBEL-PMERELPUSA-N,594.719,P32238,BE0000402,Cholecystokinin receptor type A,Humans,agonist,yes
DB12702,Velusetrag,small molecule,investigational,CC(C)N1C(=O)C(=CC2=CC=CC=C12)C(=O)N[C@@H]1C[C@@H]2CC[C@H](C1)N2C[C@@H](O)CN(C)S(C)(=O)=O,HXLOHDZQBKCUCR-WOZUAGRISA-N,504.65,Q13639,BE0000084,5-hydroxytryptamine receptor 4,Humans,agonist,yes
DB12703,Omipalisib,small molecule,investigational,COC1=C(NS(=O)(=O)C2=C(F)C=C(F)C=C2)C=C(C=N1)C1=CC2=C(C=CN=C2C=C1)C1=CN=NC=C1,CGBJSGAELGCMKE-UHFFFAOYSA-N,505.496,P48736,BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",Humans,modulator,yes
DB12704,Spiradoline,small molecule,investigational,[H][C@@]1(CC[C@@]2(CCCO2)C[C@]1([H])N1CCCC1)N(C)C(=O)CC1=CC(Cl)=C(Cl)C=C1,NYKCGQQJNVPOLU-ONTIZHBOSA-N,425.39,P41145,BE0000632,Kappa-type opioid receptor,Humans,agonist,yes
DB12710,Perazine,small molecule,approved;investigational,CN1CCN(CCCN2C3=CC=CC=C3SC3=CC=CC=C23)CC1,WEYVCQFUGFRXOM-UHFFFAOYSA-N,339.5,P14416,BE0000756,D(2) dopamine receptor,Humans,modulator,yes
DB12713,Sotagliflozin,small molecule,approved;investigational,CCOC1=CC=C(CC2=CC(=CC=C2Cl)[C@@H]2O[C@H](SC)[C@@H](O)[C@H](O)[C@H]2O)C=C1,QKDRXGFQVGOQKS-CRSSMBPESA-N,424.94,P31639,BE0004753,Sodium/glucose cotransporter 2,Humans,inhibitor,yes
DB12713,Sotagliflozin,small molecule,approved;investigational,CCOC1=CC=C(CC2=CC(=CC=C2Cl)[C@@H]2O[C@H](SC)[C@@H](O)[C@H](O)[C@H]2O)C=C1,QKDRXGFQVGOQKS-CRSSMBPESA-N,424.94,P13866,BE0004754,Sodium/glucose cotransporter 1,Humans,inhibitor,yes
DB12714,Nerispirdine,small molecule,investigational,CCCN(N1C=C(C)C2=CC=CC=C12)C1=CC=NC=C1F,BTDHTARYCBHHPJ-UHFFFAOYSA-N,283.35,Q12809,BE0000090,Voltage-gated inwardly rectifying potassium channel KCNH2,Humans,blocker,yes
DB12714,Nerispirdine,small molecule,investigational,CCCN(N1C=C(C)C2=CC=CC=C12)C1=CC=NC=C1F,BTDHTARYCBHHPJ-UHFFFAOYSA-N,283.35,Q9UI33,BE0000192,Sodium channel protein type 11 subunit alpha,Humans,blocker,yes
DB12715,MSX-122,small molecule,investigational,C(NC1=NC=CC=N1)C1=CC=C(CNC2=NC=CC=N2)C=C1,PXZXYRKDDXKDTK-UHFFFAOYSA-N,292.346,P61073,BE0000919,C-X-C chemokine receptor type 4,Humans,antagonist;partial antagonist,yes
DB12719,Turofexorate isopropyl,small molecule,investigational,CC(C)OC(=O)C1=CN(CC(C)(C)C2=C1NC1=CC=CC=C21)C(=O)C1=CC(F)=C(F)C=C1,INASOKQDNHHMRE-UHFFFAOYSA-N,438.4665,Q96RI1,BE0001777,Bile acid receptor,Humans,modulator,yes
DB12720,Nivocasan,small molecule,investigational,CC(C)[C@]1(CC(=NO1)C1=NC=CC2=CC=CC=C12)C(=O)N[C@H]1CC(=O)O[C@]1(O)CF,VYFGDLGHHBUDTQ-ZLGUVYLKSA-N,415.421,P29466,BE0000444,Caspase-1,Humans,modulator,yes
DB12724,AZD-7295,small molecule,investigational,CCCS(=O)(=O)N1CCN(CC2=CC=C(NC(=O)C3=CC=C(C=C3)C3=CC(NC(=O)C4CC4)=CC=C3OC(F)(F)F)C=C2)CC1,MAQDQJWCSSCURR-UHFFFAOYSA-N,644.71,P26664,BE0003427,Genome polyprotein,,modulator,yes
DB12725,Felcisetrag,small molecule,investigational,COC(=O)N1CCC(CN2CCC(CNC(=O)C3=C4NC(=NC4=CC=C3)C(C)C)CC2)CC1,MZOITCJKGUIQEI-UHFFFAOYSA-N,455.603,Q13639,BE0000084,5-hydroxytryptamine receptor 4,Humans,modulator,yes
DB12729,ASP-3026,small molecule,investigational,COC1=CC(=CC=C1NC1=NC(NC2=CC=CC=C2S(=O)(=O)C(C)C)=NC=N1)N1CCC(CC1)N1CCN(C)CC1,MGGBYMDAPCCKCT-UHFFFAOYSA-N,580.75,Q9UM73,BE0000359,ALK tyrosine kinase receptor,Humans,modulator,yes
DB12730,Dolastatin 10,small molecule,investigational,CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C1=NC=CS1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C,OFDNQWIFNXBECV-VFSYNPLYSA-N,785.1,Q13885,BE0003400,Tubulin beta-2A chain,Humans,inhibitor,yes
DB12731,Daporinad,small molecule,investigational,O=C(NCCCCC1CCN(CC1)C(=O)C1=CC=CC=C1)\C=C\C1=CC=CN=C1,KPBNHDGDUADAGP-VAWYXSNFSA-N,391.515,P43490,BE0002413,Nicotinamide phosphoribosyltransferase,Humans,inhibitor,yes
DB12733,Dipraglurant,small molecule,investigational,FC1=CN2C=C(CCC#CC3=CC=CC=N3)N=C2C=C1,LZXMUJCJAWVHPZ-UHFFFAOYSA-N,265.291,P41594,BE0001192,Metabotropic glutamate receptor 5,Humans,modulator,yes
DB12739,Bindarit,small molecule,investigational,CC(C)(OCC1=NN(CC2=CC=CC=C2)C2=CC=CC=C12)C(O)=O,MTHORRSSURHQPZ-UHFFFAOYSA-N,324.38,P13500,BE0001047,C-C motif chemokine 2,Humans,inhibitor,yes
DB12741,DTP-348,small molecule,investigational,CC1=NC=C(N1CCNS(N)(=O)=O)N(=O)=O,AVSMSXHPIYIKIJ-UHFFFAOYSA-N,249.248,Q16790,BE0002437,Carbonic anhydrase 9,Humans,inhibitor,yes
DB12742,Amuvatinib,small molecule,investigational,S=C(NCC1=CC=C2OCOC2=C1)N1CCN(CC1)C1=NC=NC2=C1OC1=C2C=CC=C1,FOFDIMHVKGYHRU-UHFFFAOYSA-N,447.51,P16234,BE0000852,Platelet-derived growth factor receptor alpha,Humans,modulator,yes
DB12742,Amuvatinib,small molecule,investigational,S=C(NCC1=CC=C2OCOC2=C1)N1CCN(CC1)C1=NC=NC2=C1OC1=C2C=CC=C1,FOFDIMHVKGYHRU-UHFFFAOYSA-N,447.51,P10721,BE0000453,Mast/stem cell growth factor receptor Kit,Humans,modulator,yes
DB12743,Z-160,small molecule,investigational,O=C(CC(C1=CC=CC=C1)C1=CC=CC=C1)N1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1,VCPMZDWBEWTGNW-UHFFFAOYSA-N,460.621,P54289,BE0000691,Voltage-dependent calcium channel subunit alpha-2/delta-1,Humans,inhibitor,yes
DB12744,CGI-1842,small molecule,investigational,COC1=CC=C(Br)C=C1NC(=O)NC1=C2C=CN(CC3=CC=NC(N)=C3)C2=CC=C1,ZXBFYBLSJMEBEP-UHFFFAOYSA-N,466.339,Q15303,BE0004772,Receptor tyrosine-protein kinase erbB-4,Humans,modulator,yes
DB12745,GSK-690693,small molecule,investigational,[H][C@]1(COC2=C3N(CC)C(=NC3=C(N=C2)C#CC(C)(C)O)C2=NON=C2N)CCCNC1,KGPGFQWBCSZGEL-ZDUSSCGKSA-N,425.4842,Q9Y243,BE0010514,RAC-gamma serine/threonine-protein kinase,Humans,modulator,yes
DB12746,AKN-028,small molecule,investigational,NC1=C(NC2=CC=C3NC=CC3=C2)N=C(C=N1)C1=CC=NC=C1,JLRIJKVMMZEKDF-UHFFFAOYSA-N,302.341,P36888,BE0000147,Receptor-type tyrosine-protein kinase FLT3,Humans,inhibitor,yes
DB12750,N-omega-nitro-L-arginine methyl ester,small molecule,investigational,COC(=O)[C@@H](N)CCCNC(=N)N[N+]([O-])=O,KCWZGJVSDFYRIX-YFKPBYRVSA-N,233.228,P29474,BE0000263,Nitric oxide synthase 3,Humans,inhibitor,yes
DB12752,Bucindolol,small molecule,investigational,CC(C)(CC1=CNC2=CC=CC=C12)NCC(O)COC1=CC=CC=C1C#N,FBMYKMYQHCBIGU-UHFFFAOYSA-N,363.461,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,modulator,yes
DB12752,Bucindolol,small molecule,investigational,CC(C)(CC1=CNC2=CC=CC=C12)NCC(O)COC1=CC=CC=C1C#N,FBMYKMYQHCBIGU-UHFFFAOYSA-N,363.461,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,modulator,yes
DB12755,Zoptarelin doxorubicin,small molecule,investigational,[H]OC[C@H](NC(=O)[C@H](CC1=CN([H])C2=C1C=CC=C2)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CC1=CC=C(O[H])C=C1)C(=O)N[C@H](CCCCNC(=O)CCCC(=O)OCC(=O)[C@@]1(O)C[C@H](O[C@@]2([H])C[C@H](N)[C@H](O)[C@H](C)O2)C2=C(O)C3=C(C(O)=C2C1)C(=O)C1=CC=CC(OC)=C1C3=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O,OOUACICUAVTCEC-LZHWUUGESA-N,1893.044,P30968,BE0000203,Gonadotropin-releasing hormone receptor,Humans,modulator,yes
DB12756,TAK-901,small molecule,investigational,CCS(=O)(=O)C1=CC=CC(=C1)C1=CC(C(=O)NC2CCN(C)CC2)=C(C)C2=C1C1=C(N2)N=CC(C)=C1,WKDACQVEJIVHMZ-UHFFFAOYSA-N,504.65,Q96GD4,BE0003404,Aurora kinase B,Humans,inhibitor,yes
DB12757,Pelitrexol,small molecule,investigational,CC1=C(CC[C@@H]2CNC3=C(C2)C(=O)NC(N)=N3)SC(=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,QXOPTIPQEVJERB-JQWIXIFHSA-N,463.51,P22102,BE0000882,Trifunctional purine biosynthetic protein adenosine-3,Humans,inhibitor,yes
DB12758,Atreleuton,small molecule,investigational,C[C@H](C#CC1=CC=C(CC2=CC=C(F)C=C2)S1)N(O)C(N)=O,MMSNEKOTSJRTRI-LLVKDONJSA-N,318.37,P09917,BE0000248,Polyunsaturated fatty acid 5-lipoxygenase,Humans,inhibitor,yes
DB12760,GW-493838,small molecule,investigational,CC(C)(C)C1=NN=C(O1)[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(NC3=CC=C(Cl)C=C3F)N=CN=C12,ZQYJPMPXQLNTPQ-QCUYGVNKSA-N,489.89,P30542,BE0000013,Adenosine receptor A1,Humans,modulator,yes
DB12762,Rabacfosadine,small molecule,investigational,CCOC(=O)[C@H](C)NP(=O)(COCCN1C=NC2=C(NC3CC3)N=C(N)N=C12)N[C@@H](C)C(=O)OCC,ANSPEDQTHURSFQ-KBPBESRZSA-N,526.535,P04293,BE0000308,DNA polymerase catalytic subunit,HHV-1,inhibitor,yes
DB12763,MK-1496,small molecule,investigational,C[C@H](N)C1=CC=C(C=C1)[C@H](O)CNC(C)(C)C,KUHBBYPXWKYKKR-GXFFZTMASA-N,236.359,P53350,BE0003745,Serine/threonine-protein kinase PLK1,Humans,inhibitor,yes
DB12764,Opaganib,small molecule,investigational,ClC1=CC=C(C=C1)C12CC3CC(CC(C3)(C1)C(=O)NCC1=CC=NC=C1)C2,CAOTVXGYTWCKQE-UHFFFAOYSA-N,380.92,Q9NRA0,BE0010025,Sphingosine kinase 2,Humans,inhibitor,yes
DB12774,AZD-8055,small molecule,investigational,COC1=CC=C(C=C1CO)C1=CC=C2C(=N1)N=C(N=C2N1CCOC[C@@H]1C)N1CCOC[C@@H]1C,KVLFRAWTRWDEDF-IRXDYDNUSA-N,465.554,P42345,BE0002386,Serine/threonine-protein kinase mTOR,Humans,inhibitor,yes
DB12778,Rivipansel,small molecule,investigational,[H][C@@](CC1CCCCC1)(O[C@H]1[C@@H](O)[C@@H](CO)O[C@@H](O[C@@H]2C[C@@H](C[C@H](NC(=O)C3=CC(=O)NC(=O)N3)[C@H]2O[C@@H]2O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]2O)C(=O)NCCNC(=O)COCCOCC(=O)NC2=C3C(=CC(=C2)S(O)(=O)=O)C=C(C=C3S(O)(=O)=O)S(O)(=O)=O)[C@@H]1OC(=O)C1=CC=CC=C1)C(O)=O,VXBNTHRZPJLRSS-PTCSXESPSA-N,1447.42,P16581,BE0001074,E-selectin,Humans,inhibitor,yes
DB12778,Rivipansel,small molecule,investigational,[H][C@@](CC1CCCCC1)(O[C@H]1[C@@H](O)[C@@H](CO)O[C@@H](O[C@@H]2C[C@@H](C[C@H](NC(=O)C3=CC(=O)NC(=O)N3)[C@H]2O[C@@H]2O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]2O)C(=O)NCCNC(=O)COCCOCC(=O)NC2=C3C(=CC(=C2)S(O)(=O)=O)C=C(C=C3S(O)(=O)=O)S(O)(=O)=O)[C@@H]1OC(=O)C1=CC=CC=C1)C(O)=O,VXBNTHRZPJLRSS-PTCSXESPSA-N,1447.42,P14151,BE0010361,L-selectin,Humans,inhibitor,yes
DB12778,Rivipansel,small molecule,investigational,[H][C@@](CC1CCCCC1)(O[C@H]1[C@@H](O)[C@@H](CO)O[C@@H](O[C@@H]2C[C@@H](C[C@H](NC(=O)C3=CC(=O)NC(=O)N3)[C@H]2O[C@@H]2O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]2O)C(=O)NCCNC(=O)COCCOCC(=O)NC2=C3C(=CC(=C2)S(O)(=O)=O)C=C(C=C3S(O)(=O)=O)S(O)(=O)=O)[C@@H]1OC(=O)C1=CC=CC=C1)C(O)=O,VXBNTHRZPJLRSS-PTCSXESPSA-N,1447.42,P16109,BE0001159,P-selectin,Humans,inhibitor,yes
DB12781,Balaglitazone,small molecule,investigational,CN1C(COC2=CC=C(CC3SC(=O)NC3=O)C=C2)=NC2=CC=CC=C2C1=O,IETKPTYAGKZLKY-UHFFFAOYSA-N,395.43,P37231,BE0000215,Peroxisome proliferator-activated receptor gamma,Humans,modulator,yes
DB12783,Benserazide,small molecule,approved;investigational,NC(CO)C(=O)NNCC1=C(O)C(O)=C(O)C=C1,BNQDCRGUHNALGH-UHFFFAOYSA-N,257.246,P20711,BE0002151,Aromatic-L-amino-acid decarboxylase,Humans,inhibitor,yes
DB12784,Ilginatinib,small molecule,investigational,C[C@H](NC1=CC(=CC(NC2=CN=CC=N2)=N1)C1=CN(C)N=C1)C1=CC=C(F)C=C1,UQTPDWDAYHAZNT-AWEZNQCLSA-N,389.438,O60674,BE0002408,Tyrosine-protein kinase JAK2,Humans,modulator,yes
DB12785,Furaprevir,small molecule,investigational,CC(C)OC1=CC=C(C=C1)C1=NC2=C(OC3=C2C=CC=C3)C(O[C@@H]2C[C@@H]3N(C2)C(=O)[C@H](CCCCC\C=C/[C@@H]2C[C@]2(NC3=O)C(=O)NS(=O)(=O)C2(C)CC2)NC(=O)OC2CCCC2)=N1,GZRNOYTVBWWFLJ-NTPALUMKSA-N,897.06,P26664,BE0003427,Genome polyprotein,,modulator,yes
DB12789,Dinoprost,small molecule,approved;investigational,[H]\C(CCCC(O)=O)=C(/[H])C[C@@]1([H])[C@@]([H])(O)C[C@@]([H])(O)[C@]1([H])C(\[H])=C(/[H])[C@@]([H])(O)CCCCC,PXGPLTODNUVGFL-YNNPMVKQSA-N,354.487,P43088,BE0000610,Prostaglandin F2-alpha receptor,Humans,agonist,yes
DB12789,Dinoprost,small molecule,approved;investigational,[H]\C(CCCC(O)=O)=C(/[H])C[C@@]1([H])[C@@]([H])(O)C[C@@]([H])(O)[C@]1([H])C(\[H])=C(/[H])[C@@]([H])(O)CCCCC,PXGPLTODNUVGFL-YNNPMVKQSA-N,354.487,P21731,BE0000759,Thromboxane A2 receptor,Humans,agonist,yes
DB12789,Dinoprost,small molecule,approved;investigational,[H]\C(CCCC(O)=O)=C(/[H])C[C@@]1([H])[C@@]([H])(O)C[C@@]([H])(O)[C@]1([H])C(\[H])=C(/[H])[C@@]([H])(O)CCCCC,PXGPLTODNUVGFL-YNNPMVKQSA-N,354.487,P34995,BE0000064,Prostaglandin E2 receptor EP1 subtype,Humans,agonist,yes
DB12789,Dinoprost,small molecule,approved;investigational,[H]\C(CCCC(O)=O)=C(/[H])C[C@@]1([H])[C@@]([H])(O)C[C@@]([H])(O)[C@]1([H])C(\[H])=C(/[H])[C@@]([H])(O)CCCCC,PXGPLTODNUVGFL-YNNPMVKQSA-N,354.487,P43115,BE0002375,Prostaglandin E2 receptor EP3 subtype,Humans,agonist,yes
DB12789,Dinoprost,small molecule,approved;investigational,[H]\C(CCCC(O)=O)=C(/[H])C[C@@]1([H])[C@@]([H])(O)C[C@@]([H])(O)[C@]1([H])C(\[H])=C(/[H])[C@@]([H])(O)CCCCC,PXGPLTODNUVGFL-YNNPMVKQSA-N,354.487,P43116,BE0000368,Prostaglandin E2 receptor EP2 subtype,Humans,agonist,yes
DB12789,Dinoprost,small molecule,approved;investigational,[H]\C(CCCC(O)=O)=C(/[H])C[C@@]1([H])[C@@]([H])(O)C[C@@]([H])(O)[C@]1([H])C(\[H])=C(/[H])[C@@]([H])(O)CCCCC,PXGPLTODNUVGFL-YNNPMVKQSA-N,354.487,P35408,BE0003522,Prostaglandin E2 receptor EP4 subtype,Humans,agonist,yes
DB12789,Dinoprost,small molecule,approved;investigational,[H]\C(CCCC(O)=O)=C(/[H])C[C@@]1([H])[C@@]([H])(O)C[C@@]([H])(O)[C@]1([H])C(\[H])=C(/[H])[C@@]([H])(O)CCCCC,PXGPLTODNUVGFL-YNNPMVKQSA-N,354.487,Q13258,BE0000296,Prostaglandin D2 receptor,Humans,agonist,yes
DB12789,Dinoprost,small molecule,approved;investigational,[H]\C(CCCC(O)=O)=C(/[H])C[C@@]1([H])[C@@]([H])(O)C[C@@]([H])(O)[C@]1([H])C(\[H])=C(/[H])[C@@]([H])(O)CCCCC,PXGPLTODNUVGFL-YNNPMVKQSA-N,354.487,Q9Y5Y4,BE0003561,Prostaglandin D2 receptor 2,Humans,agonist,yes
DB12795,CMX-2043,small molecule,investigational,C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)CCCC[C@@H]1CCSS1)C(O)=O,MQXRTCVZPIHBLD-TUAOUCFPSA-N,406.51,P31749,BE0000428,RAC-alpha serine/threonine-protein kinase,Humans,modulator,yes
DB12795,CMX-2043,small molecule,investigational,C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)CCCC[C@@H]1CCSS1)C(O)=O,MQXRTCVZPIHBLD-TUAOUCFPSA-N,406.51,P08581,BE0000915,Hepatocyte growth factor receptor,Humans,modulator,yes
DB12798,Relenopride,small molecule,investigational,COC1=CC(N)=C(Cl)C=C1C(=O)NCC1CCN(CC[C@H](OC(N)=O)C2=CC=C(F)C=C2)CC1,KGMMSPVVHZGPHL-NRFANRHFSA-N,492.98,Q13639,BE0000084,5-hydroxytryptamine receptor 4,Humans,agonist,yes
DB12799,Laniquidar,small molecule,investigational,COC(=O)C1=CN=C2N1CCC1=CC=CC=C1C2=C1CCN(CCC2=CC=C(OCC3=CC=C4C=CC=CC4=N3)C=C2)CC1,TULGGJGJQXESOO-UHFFFAOYSA-N,584.72,P21439,BE0003641,Phosphatidylcholine translocator ABCB4,Humans,modulator,yes
DB12802,Picropodophyllin,small molecule,investigational,COC1=CC(=CC(OC)=C1OC)[C@H]1[C@H]2[C@H](COC2=O)[C@@H](O)C2=CC3=C(OCO3)C=C12,YJGVMLPVUAXIQN-HAEOHBJNSA-N,414.41,P08069,BE0000858,Insulin-like growth factor 1 receptor,Humans,inhibitor,yes
DB12803,Dichloroisoproterenol,small molecule,investigational,CC(C)NCC(O)C1=CC=C(Cl)C(Cl)=C1,VKMGSWIFEHZQRS-UHFFFAOYSA-N,248.15,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,inhibitor,yes
DB12803,Dichloroisoproterenol,small molecule,investigational,CC(C)NCC(O)C1=CC=C(Cl)C(Cl)=C1,VKMGSWIFEHZQRS-UHFFFAOYSA-N,248.15,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,inhibitor,yes
DB12804,Daniquidone,small molecule,investigational,NC1=CC=C2N=C3N(CC2=C1)C(=O)C1=CC=CC=C31,SRIOCKJKFXAKHK-UHFFFAOYSA-N,249.273,P11387,BE0000971,DNA topoisomerase 1,Humans,modulator,yes
DB12804,Daniquidone,small molecule,investigational,NC1=CC=C2N=C3N(CC2=C1)C(=O)C1=CC=CC=C31,SRIOCKJKFXAKHK-UHFFFAOYSA-N,249.273,P11388,BE0000742,DNA topoisomerase 2-alpha,Humans,modulator,yes
DB12804,Daniquidone,small molecule,investigational,NC1=CC=C2N=C3N(CC2=C1)C(=O)C1=CC=CC=C31,SRIOCKJKFXAKHK-UHFFFAOYSA-N,249.273,Q02880,BE0002425,DNA topoisomerase 2-beta,Humans,modulator,yes
DB12805,Ataciguat,small molecule,investigational,ClC1=CC=C(S1)S(=O)(=O)NC1=C(C=C(Cl)C=C1)C(=O)NC1=CC=C(C=C1)S(=O)(=O)N1CCOCC1,PQHLRGARXNPFCF-UHFFFAOYSA-N,576.48,P16066,BE0000556,Atrial natriuretic peptide receptor 1,Humans,activator,yes
DB12806,GSK-1004723,small molecule,investigational,ClC1=CC=C(CC2=NN(C[C@H]3CCCN3CCCCC3=CC=C(OCCCN4CCCCCC4)C=C3)C(=O)C3=CC=CC=C23)C=C1,YANGEESWIGIKOP-UUWRZZSWSA-N,641.3,Q9Y5N1,BE0000968,Histamine H3 receptor,Humans,antagonist,yes
DB12806,GSK-1004723,small molecule,investigational,ClC1=CC=C(CC2=NN(C[C@H]3CCCN3CCCCC3=CC=C(OCCCN4CCCCCC4)C=C3)C(=O)C3=CC=CC=C23)C=C1,YANGEESWIGIKOP-UUWRZZSWSA-N,641.3,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB12808,Trifarotene,small molecule,approved;investigational,CC(C)(C)C1=CC(=CC=C1N1CCCC1)C1=CC(=CC=C1OCCO)C1=CC=C(C=C1)C(O)=O,MFBCDACCJCDGBA-UHFFFAOYSA-N,459.586,P13631,BE0000144,Retinoic acid receptor gamma,Humans,agonist,yes
DB12812,Palomid 529,small molecule,investigational,COC1=CC=C(COC2=C(OC)C=C3C(OC(=O)C4=CC(=CC=C34)C(C)O)=C2)C=C1,YEAHTLOYHVWAKW-UHFFFAOYSA-N,406.434,Q9BPZ7,BE0018900,Target of rapamycin complex 2 subunit MAPKAP1,Humans,inhibitor,yes
DB12817,Zoliflodacin,small molecule,investigational,[H][C@]12[C@H](C)O[C@H](C)CN1C1=C(CC22C(=O)NC(=O)NC2=O)C=C2C(ON=C2N2[C@@H](C)COC2=O)=C1F,ZSWMIFNWDQEXDT-ZESJGQACSA-N,487.444,P20831,BE0008385,DNA gyrase subunit A,Staphylococcus aureus,modulator,yes
DB12817,Zoliflodacin,small molecule,investigational,[H][C@]12[C@H](C)O[C@H](C)CN1C1=C(CC22C(=O)NC(=O)NC2=O)C=C2C(ON=C2N2[C@@H](C)COC2=O)=C1F,ZSWMIFNWDQEXDT-ZESJGQACSA-N,487.444,P0A0K8,BE0002388,DNA gyrase subunit B,Staphylococcus aureus,modulator,yes
DB12818,NM-3,small molecule,investigational,COC1=CC(O)=C2C(=O)OC(=CC2=C1)C(C)C(O)=O,BPZCXUROMKDLGX-UHFFFAOYSA-N,264.233,P15692,BE0000163,"Vascular endothelial growth factor A, long form",Humans,inhibitor,yes
DB12818,NM-3,small molecule,investigational,COC1=CC(O)=C2C(=O)OC(=CC2=C1)C(C)C(O)=O,BPZCXUROMKDLGX-UHFFFAOYSA-N,264.233,P49765,BE0004736,Vascular endothelial growth factor B,Humans,inhibitor,yes
DB12818,NM-3,small molecule,investigational,COC1=CC(O)=C2C(=O)OC(=CC2=C1)C(C)C(O)=O,BPZCXUROMKDLGX-UHFFFAOYSA-N,264.233,P49767,BE0010101,Vascular endothelial growth factor C,Humans,inhibitor,yes
DB12818,NM-3,small molecule,investigational,COC1=CC(O)=C2C(=O)OC(=CC2=C1)C(C)C(O)=O,BPZCXUROMKDLGX-UHFFFAOYSA-N,264.233,O43915,BE0010102,Vascular endothelial growth factor D,Humans,inhibitor,yes
DB12819,GSI-136,small molecule,investigational,CCC(CC)[C@@H](CO)NS(=O)(=O)C1=CC=C(Cl)S1,PYZFRRVBPNGCBX-SECBINFHSA-N,311.84,Q8WW43,BE0017533,Gamma-secretase subunit APH-1B,Humans,modulator,yes
DB12819,GSI-136,small molecule,investigational,CCC(CC)[C@@H](CO)NS(=O)(=O)C1=CC=C(Cl)S1,PYZFRRVBPNGCBX-SECBINFHSA-N,311.84,Q92542,BE0017775,Nicastrin,Humans,modulator,yes
DB12819,GSI-136,small molecule,investigational,CCC(CC)[C@@H](CO)NS(=O)(=O)C1=CC=C(Cl)S1,PYZFRRVBPNGCBX-SECBINFHSA-N,311.84,Q96BI3,BE0003409,Gamma-secretase subunit APH-1A,Humans,modulator,yes
DB12819,GSI-136,small molecule,investigational,CCC(CC)[C@@H](CO)NS(=O)(=O)C1=CC=C(Cl)S1,PYZFRRVBPNGCBX-SECBINFHSA-N,311.84,Q9NZ42,BE0003410,Gamma-secretase subunit PEN-2,Humans,modulator,yes
DB12819,GSI-136,small molecule,investigational,CCC(CC)[C@@H](CO)NS(=O)(=O)C1=CC=C(Cl)S1,PYZFRRVBPNGCBX-SECBINFHSA-N,311.84,P49768,BE0010960,Presenilin-1,Humans,modulator,yes
DB12823,Tecarfarin,small molecule,investigational,CC(OC(=O)C1=CC=C(CC2=C(O)C3=CC=CC=C3OC2=O)C=C1)(C(F)(F)F)C(F)(F)F,QFLNTQDOVCLQKW-UHFFFAOYSA-N,460.328,Q9BQB6,BE0000713,Vitamin K epoxide reductase complex subunit 1,Humans,inhibitor,yes
DB12825,Lefamulin,small molecule,approved;investigational,[H][C@@]12C(=O)CC[C@]11CCC(C)[C@@]2(C)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]1C)OC(=O)CS[C@@H]1CC[C@@H](N)C[C@H]1O,KPVIXBKIJXZQJX-CSOZIWFHSA-N,507.73,P61182,BE0009718,50S ribosomal protein L22,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4),binder,yes
DB12827,Indoximod,small molecule,investigational,CN1C=C(C[C@@H](N)C(O)=O)C2=CC=CC=C12,ZADWXFSZEAPBJS-SNVBAGLBSA-N,218.256,P14902,BE0000693,"Indoleamine 2,3-dioxygenase 1",Humans,inhibitor,yes
DB12830,Cebranopadol,small molecule,investigational,CN(C)[C@]1(CC[C@@]2(CC1)OCCC1=C2NC2=CC=C(F)C=C12)C1=CC=CC=C1,CSMVOZKEWSOFER-RQNOJGIXSA-N,378.491,P35372,BE0000770,Mu-type opioid receptor,Humans,modulator,yes
DB12831,Gabexate,small molecule,investigational,CCOC(=O)C1=CC=C(OC(=O)CCCCCNC(N)=N)C=C1,YKGYIDJEEQRWQH-UHFFFAOYSA-N,321.377,P03952,BE0002440,Plasma kallikrein,Humans,inhibitor,yes
DB12831,Gabexate,small molecule,investigational,CCOC(=O)C1=CC=C(OC(=O)CCCCCNC(N)=N)C=C1,YKGYIDJEEQRWQH-UHFFFAOYSA-N,321.377,P00734,BE0000048,Prothrombin,Humans,inhibitor,yes
DB12831,Gabexate,small molecule,investigational,CCOC(=O)C1=CC=C(OC(=O)CCCCCNC(N)=N)C=C1,YKGYIDJEEQRWQH-UHFFFAOYSA-N,321.377,P00747,BE0000211,Plasminogen,Humans,inhibitor,yes
DB12836,Grapiprant,small molecule,investigational;vet_approved,CCC1=NC2=C(C)N=C(C)C=C2N1C1=CC=C(CCNC(=O)NS(=O)(=O)C2=CC=C(C)C=C2)C=C1,HZVLFTCYCLXTGV-UHFFFAOYSA-N,491.61,P35408,BE0003522,Prostaglandin E2 receptor EP4 subtype,Humans,antagonist,yes
DB12838,Tetrasul,small molecule,investigational,ClC1=CC=C(SC2=C(Cl)C=C(Cl)C(Cl)=C2)C=C1,QUWSDLYBOVGOCW-UHFFFAOYSA-N,324.04,P18825,BE0000342,Alpha-2C adrenergic receptor,Humans,agonist,yes
DB12843,Oleandrin,small molecule,experimental;investigational,CO[C@H]1C[C@H](O[C@H]2CC[C@@]3(C)[C@H](CC[C@@H]4[C@@H]3CC[C@]3(C)[C@H]([C@H](C[C@]43O)OC(C)=O)C3=CC(=O)OC3)C2)O[C@@H](C)[C@@H]1O,JLPDBLFIVFSOCC-XYXFTTADSA-N,576.727,P05023,BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,Humans,inhibitor,yes
DB12843,Oleandrin,small molecule,experimental;investigational,CO[C@H]1C[C@H](O[C@H]2CC[C@@]3(C)[C@H](CC[C@@H]4[C@@H]3CC[C@]3(C)[C@H]([C@H](C[C@]43O)OC(C)=O)C3=CC(=O)OC3)C2)O[C@@H](C)[C@@H]1O,JLPDBLFIVFSOCC-XYXFTTADSA-N,576.727,P50993,BE0005034,Sodium/potassium-transporting ATPase subunit alpha-2,Humans,inhibitor,yes
DB12843,Oleandrin,small molecule,experimental;investigational,CO[C@H]1C[C@H](O[C@H]2CC[C@@]3(C)[C@H](CC[C@@H]4[C@@H]3CC[C@]3(C)[C@H]([C@H](C[C@]43O)OC(C)=O)C3=CC(=O)OC3)C2)O[C@@H](C)[C@@H]1O,JLPDBLFIVFSOCC-XYXFTTADSA-N,576.727,P13637,BE0005047,Sodium/potassium-transporting ATPase subunit alpha-3,Humans,inhibitor,yes
DB12843,Oleandrin,small molecule,experimental;investigational,CO[C@H]1C[C@H](O[C@H]2CC[C@@]3(C)[C@H](CC[C@@H]4[C@@H]3CC[C@]3(C)[C@H]([C@H](C[C@]43O)OC(C)=O)C3=CC(=O)OC3)C2)O[C@@H](C)[C@@H]1O,JLPDBLFIVFSOCC-XYXFTTADSA-N,576.727,P05026,BE0004994,Sodium/potassium-transporting ATPase subunit beta-1,Humans,inhibitor,yes
DB12843,Oleandrin,small molecule,experimental;investigational,CO[C@H]1C[C@H](O[C@H]2CC[C@@]3(C)[C@H](CC[C@@H]4[C@@H]3CC[C@]3(C)[C@H]([C@H](C[C@]43O)OC(C)=O)C3=CC(=O)OC3)C2)O[C@@H](C)[C@@H]1O,JLPDBLFIVFSOCC-XYXFTTADSA-N,576.727,P14415,BE0005018,Sodium/potassium-transporting ATPase subunit beta-2,Humans,inhibitor,yes
DB12843,Oleandrin,small molecule,experimental;investigational,CO[C@H]1C[C@H](O[C@H]2CC[C@@]3(C)[C@H](CC[C@@H]4[C@@H]3CC[C@]3(C)[C@H]([C@H](C[C@]43O)OC(C)=O)C3=CC(=O)OC3)C2)O[C@@H](C)[C@@H]1O,JLPDBLFIVFSOCC-XYXFTTADSA-N,576.727,P54709,BE0005026,Sodium/potassium-transporting ATPase subunit beta-3,Humans,inhibitor,yes
DB12847,Pyroxamide,small molecule,investigational,ONC(=O)CCCCCCC(=O)NC1=CN=CC=C1,PTJGLFIIZFVFJV-UHFFFAOYSA-N,265.313,Q13547,BE0002365,Histone deacetylase 1,Humans,inhibitor,yes
DB12848,PF-04217903,small molecule,investigational,OCCN1C=C(C=N1)C1=CN=C2N=NN(CC3=CC4=CC=CN=C4C=C3)C2=N1,PDMUGYOXRHVNMO-UHFFFAOYSA-N,372.392,P08581,BE0000915,Hepatocyte growth factor receptor,Humans,inhibitor,yes
DB12850,Etalocib,small molecule,investigational,CCCC1=C(OCCCOC2=CC(O)=C(C=C2CC)C2=CC=C(F)C=C2)C=CC=C1OC1=CC=CC=C1C(O)=O,YFIZRWPXUYFCSN-UHFFFAOYSA-N,544.619,Q15722,BE0003490,Leukotriene B4 receptor 1,Humans,antagonist,yes
DB12852,MK-0752,small molecule,investigational,OC(=O)CC[C@H]1CC[C@@](CC1)(C1=C(F)C=CC(F)=C1)S(=O)(=O)C1=CC=C(Cl)C=C1,XCGJIFAKUZNNOR-QCKZDCLWSA-N,442.9,Q9NZ42,BE0003410,Gamma-secretase subunit PEN-2,Humans,modulator,yes
DB12852,MK-0752,small molecule,investigational,OC(=O)CC[C@H]1CC[C@@](CC1)(C1=C(F)C=CC(F)=C1)S(=O)(=O)C1=CC=C(Cl)C=C1,XCGJIFAKUZNNOR-QCKZDCLWSA-N,442.9,Q92542,BE0017775,Nicastrin,Humans,modulator,yes
DB12852,MK-0752,small molecule,investigational,OC(=O)CC[C@H]1CC[C@@](CC1)(C1=C(F)C=CC(F)=C1)S(=O)(=O)C1=CC=C(Cl)C=C1,XCGJIFAKUZNNOR-QCKZDCLWSA-N,442.9,Q8WW43,BE0017533,Gamma-secretase subunit APH-1B,Humans,modulator,yes
DB12852,MK-0752,small molecule,investigational,OC(=O)CC[C@H]1CC[C@@](CC1)(C1=C(F)C=CC(F)=C1)S(=O)(=O)C1=CC=C(Cl)C=C1,XCGJIFAKUZNNOR-QCKZDCLWSA-N,442.9,P49768,BE0010960,Presenilin-1,Humans,modulator,yes
DB12853,DA-6886,small molecule,investigational,COC1=CC(N)=C(Cl)C=C1C(=O)NCC1CCN(CCCN2C=CN=N2)CC1,AULLTYAISZREAX-UHFFFAOYSA-N,406.92,Q13639,BE0000084,5-hydroxytryptamine receptor 4,Humans,agonist,yes
DB12854,BMS-908662,small molecule,investigational,COC(=O)NC1=NC2=CC(=CC=C2N1)C1(O)N(C(=O)C2=CC=CC=C12)C1=CC(Cl)=CC=C1C,MMNNTJYFHUDSKL-UHFFFAOYSA-N,462.89,P15056,BE0000634,Serine/threonine-protein kinase B-raf,Humans,inhibitor,yes
DB12855,Apricitabine,small molecule,investigational,NC1=NC(=O)N(C=C1)[C@H]1CO[C@@H](CO)S1,RYMCFYKJDVMSIR-RNFRBKRXSA-N,229.25,P03366,BE0002050,Gag-Pol polyprotein,,modulator,yes
DB12857,NVP-LEQ-506,small molecule,investigational,C[C@@H]1CN(CCN1C1=CN=C(C=N1)C(C)(C)O)C1=NN=C(CC2=CC=CC=C2)C(C)=C1C,POERAARDVFVDLO-QGZVFWFLSA-N,432.572,Q99835,BE0004659,Protein smoothened,Humans,inhibitor,yes
DB12858,LY-377604,small molecule,investigational,CC(C)(CC1=CC=C(OC2=CC=C(C=N2)C(N)=O)C=C1)NC[C@H](O)COC1=CC=CC2=C1C1=C(N2)C=CC=C1,RBSGUQYXRDKPAE-QFIPXVFZSA-N,524.621,P13945,BE0001012,Beta-3 adrenergic receptor,Humans,agonist,yes
DB12863,Sivelestat,small molecule,investigational,CC(C)(C)C(=O)OC1=CC=C(C=C1)S(=O)(=O)NC1=CC=CC=C1C(=O)NCC(O)=O,BTGNGJJLZOIYID-UHFFFAOYSA-N,434.46,P08246,BE0000394,Neutrophil elastase,Humans,inhibitor,yes
DB12863,Sivelestat,small molecule,investigational,CC(C)(C)C(=O)OC1=CC=C(C=C1)S(=O)(=O)NC1=CC=CC=C1C(=O)NCC(O)=O,BTGNGJJLZOIYID-UHFFFAOYSA-N,434.46,Q9UNI1,BE0003758,Chymotrypsin-like elastase family member 1,Humans,inhibitor,yes
DB12865,Etelcalcetide,small molecule,approved;investigational,C[C@@H](NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](C)NC(=O)[C@@H](CSSC[C@H](N)C(O)=O)NC(C)=O)C(=O)N[C@H](CCCNC(N)=N)C(N)=O,ANIAZGVDEUQPRI-ZJQCGQFWSA-N,1048.26,P41180,BE0000509,Extracellular calcium-sensing receptor,Humans,agonist,yes
DB12866,Pradigastat,small molecule,investigational,OC(=O)C[C@H]1CC[C@@H](CC1)C1=CC=C(C=C1)C1=NC=C(NC2=CN=C(C=C2)C(F)(F)F)C=C1,GXALXAKNHIROPE-QAQDUYKDSA-N,455.481,O75907,BE0012021,Diacylglycerol O-acyltransferase 1,Humans,modulator,yes
DB12868,Intoplicine,small molecule,investigational,CN(C)CCCNC1=NC=C(C)C2=C1C1=C(N2)C=CC2=CC(O)=CC=C12,QROONAIPJKQFMC-UHFFFAOYSA-N,348.45,P11387,BE0000971,DNA topoisomerase 1,Humans,modulator,yes
DB12869,Eliprodil,small molecule,investigational,OC(CN1CCC(CC2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,GGUSQTSTQSHJAH-UHFFFAOYSA-N,347.86,Q13224,BE0000417,"Glutamate receptor ionotropic, NMDA 2B",Humans,inhibitor,yes
DB12869,Eliprodil,small molecule,investigational,OC(CN1CCC(CC2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,GGUSQTSTQSHJAH-UHFFFAOYSA-N,347.86,Q05586,BE0000365,"Glutamate receptor ionotropic, NMDA 1",Humans,inhibitor,yes
DB12874,Quizartinib,small molecule,approved;investigational,CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1,CVWXJKQAOSCOAB-UHFFFAOYSA-N,560.67,P36888,BE0000147,Receptor-type tyrosine-protein kinase FLT3,Humans,inhibitor,yes
DB12875,Mavatrep,small molecule,investigational,CC(C)(O)C1=CC=CC=C1C1=CC=C2N=C(NC2=C1)\C=C\C1=CC=C(C=C1)C(F)(F)F,ORDHXXHTBUZRCN-NTEUORMPSA-N,422.451,Q8NER1,BE0001023,Transient receptor potential cation channel subfamily V member 1,Humans,antagonist,yes
DB12876,GS-9256,small molecule,investigational,COC1=C(Cl)C2=NC(=CC(O[C@@H]3C[C@@H]4N(C3)C(=O)[C@H](CCCCCCC[C@@H]3C[C@]3(NC4=O)P(O)(=O)CC3=C(F)C=CC=C3F)NC(=O)OC3CCCC3)=C2C=C1)C1=CSC(NC(C)C)=N1,RFGUWOCFYCYEDM-ZOMNBDOOSA-N,957.47,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB12877,Oxatomide,small molecule,approved;investigational,O=C1NC2=C(C=CC=C2)N1CCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1,BAINIUMDFURPJM-UHFFFAOYSA-N,426.564,P35367,BE0000442,Histamine H1 receptor,Humans,antagonist,yes
DB12879,Omigapil,small molecule,investigational,CN(CC#C)CC1=CC2=CC=CC=C2OC2=CC=CC=C12,QLMMOGWZCFQAPU-UHFFFAOYSA-N,275.3444,P04406,BE0000542,Glyceraldehyde-3-phosphate dehydrogenase,Humans,modulator,yes
DB12881,Indole-3-carbinol,small molecule,investigational,OCC1=CNC2=CC=CC=C12,IVYPNXXAYMYVSP-UHFFFAOYSA-N,147.1739,P25963,BE0003469,NF-kappa-B inhibitor alpha,Humans,inhibitor,yes
DB12883,Eltoprazine,small molecule,investigational,C1CN(CCN1)C1=C2OCCOC2=CC=C1,WVLHGCRWEHCIOT-UHFFFAOYSA-N,220.272,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,agonist,yes
DB12883,Eltoprazine,small molecule,investigational,C1CN(CCN1)C1=C2OCCOC2=CC=C1,WVLHGCRWEHCIOT-UHFFFAOYSA-N,220.272,P28335,BE0000533,5-hydroxytryptamine receptor 2C,Humans,antagonist,yes
DB12883,Eltoprazine,small molecule,investigational,C1CN(CCN1)C1=C2OCCOC2=CC=C1,WVLHGCRWEHCIOT-UHFFFAOYSA-N,220.272,P28222,BE0000797,5-hydroxytryptamine receptor 1B,Humans,agonist,yes
DB12884,Lavoltidine,small molecule,investigational,CN1N=C(CO)N=C1NCCCOC1=CC=CC(CN2CCCCC2)=C1,VTLNPNNUIJHJQB-UHFFFAOYSA-N,359.474,P25021,BE0000112,Histamine H2 receptor,Humans,antagonist,yes
DB12885,Namodenoson,small molecule,investigational,CNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(NCC3=CC=CC(I)=C3)N=C(Cl)N=C12,IPSYPUKKXMNCNQ-PFHKOEEOSA-N,544.73,P0DMS8,BE0000354,Adenosine receptor A3,Humans,agonist,yes
DB12886,GSK-1521498,small molecule,investigational,FC1=CC(=CC(F)=C1CNC1CC2=CC=CC=C2C1)C1=CC=CC(=C1)C1=NNC=N1,WIEDUMBCZQRGSY-UHFFFAOYSA-N,402.449,P35372,BE0000770,Mu-type opioid receptor,Humans,agonist,yes
DB12887,Tazemetostat,small molecule,approved;investigational,CCN(C1CCOCC1)C1=C(C)C(=CC(=C1)C1=CC=C(CN2CCOCC2)C=C1)C(=O)NCC1=C(C)C=C(C)NC1=O,NSQSAUGJQHDYNO-UHFFFAOYSA-N,572.75,Q15910,BE0009562,Histone-lysine N-methyltransferase EZH2,Humans,inhibitor,yes
DB12888,Ezutromid,small molecule,investigational,CCS(=O)(=O)C1=CC=C2OC(=NC2=C1)C1=CC=C2C=CC=CC2=C1,KSGCNXAZROJSNW-UHFFFAOYSA-N,337.39,P46939,BE0005835,Utrophin,Humans,upregulator,yes
DB12889,Velneperit,small molecule,investigational,CC(C)(C)S(=O)(=O)N[C@H]1CC[C@@H](CC1)C(=O)NC1=NC=C(C=C1)C(F)(F)F,WGEWUYACXPEFPO-AULYBMBSSA-N,407.45,Q15761,BE0002452,Neuropeptide Y receptor type 5,Humans,antagonist,yes
DB12890,Dihydrexidine,small molecule,investigational,OC1=C(O)C=C2[C@H]3[C@H](CCC2=C1)NCC1=CC=CC=C31,BGOQGUHWXBGXJW-YOEHRIQHSA-N,267.328,P21728,BE0000020,D(1A) dopamine receptor,Humans,inhibitor,yes
DB12894,Raluridine,small molecule,investigational,OC[C@H]1O[C@H](C[C@@H]1F)N1C=C(Cl)C(=O)NC1=O,WKVDSZYIGHLONN-RRKCRQDMSA-N,264.64,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB12895,Olitigaltin,small molecule,investigational,OC[C@H]1O[C@@H](S[C@@H]2O[C@H](CO)[C@H](O)[C@@H]([C@H]2O)N2C=C(N=N2)C2=CC=CC(F)=C2)[C@H](O)[C@H]([C@H]1O)N1C=C(N=N1)C1=CC(F)=CC=C1,YGIDGBAHDZEYMT-MQFIMZJJSA-N,648.64,P17931,BE0001353,Galectin-3,Humans,inhibitor,yes
DB12899,TT-301,small molecule,investigational,C1CN(CCN1C1=NC=CC=N1)C1=C(C=C(N=N1)C1=CC=CC=C1)C1=CC=NC=C1,ZPJGUEPHFXPAQF-UHFFFAOYSA-N,395.47,P01584,BE0001051,Interleukin-1 beta,Humans,inhibitor,yes
DB12900,Irdabisant,small molecule,investigational,C[C@@H]1CCCN1CCCOC1=CC=C(C=C1)C1=NNC(=O)C=C1,XUKROCVZGZNGSI-CQSZACIVSA-N,313.401,Q9Y5N1,BE0000968,Histamine H3 receptor,Humans,antagonist,yes
DB12903,DEBIO-1347,small molecule,investigational,CC1=NC2=CC=C(C=C2N1)N1N=CC(C(=O)C2=CC3=CC=CC=C3N2)=C1N,BEMNJULZEQTDJY-UHFFFAOYSA-N,356.389,P11362,BE0002131,Fibroblast growth factor receptor 1,Humans,inhibitor,yes
DB12903,DEBIO-1347,small molecule,investigational,CC1=NC2=CC=C(C=C2N1)N1N=CC(C(=O)C2=CC3=CC=CC=C3N2)=C1N,BEMNJULZEQTDJY-UHFFFAOYSA-N,356.389,P21802,BE0000748,Fibroblast growth factor receptor 2,Humans,inhibitor,yes
DB12903,DEBIO-1347,small molecule,investigational,CC1=NC2=CC=C(C=C2N1)N1N=CC(C(=O)C2=CC3=CC=CC=C3N2)=C1N,BEMNJULZEQTDJY-UHFFFAOYSA-N,356.389,P22607,BE0002133,Fibroblast growth factor receptor 3,Humans,inhibitor,yes
DB12904,ZSTK-474,small molecule,investigational,FC(F)C1=NC2=CC=CC=C2N1C1=NC(=NC(=N1)N1CCOCC1)N1CCOCC1,HGVNLRPZOWWDKD-UHFFFAOYSA-N,417.4125,P48736,BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",Humans,modulator,yes
DB12906,LY-2334737,small molecule,investigational,CCCC(CCC)C(=O)NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F,MEOYFIHNRBNEPI-UXIGCNINSA-N,389.4,P31350,BE0002450,Ribonucleoside-diphosphate reductase subunit M2,Humans,modulator,yes
DB12910,Emicerfont,small molecule,investigational,COC1=CC=C(N2CCC3=C2N=C(C)C=C3N2C=CC(=N2)N2CCNC2=O)C(C)=C1,JFHJGXQFESYQGY-UHFFFAOYSA-N,404.474,P34998,BE0008658,Corticotropin-releasing factor receptor 1,Humans,antagonist,yes
DB12912,Nolatrexed,small molecule,investigational,CC1=CC=C2N=C(N)NC(=O)C2=C1SC1=CC=NC=C1,XHWRWCSCBDLOLM-UHFFFAOYSA-N,284.34,P12461,BE0000021,Thymidylate synthase,Yeast,inhibitor,yes
DB12914,Resmetirom,small molecule,approved;investigational,CC(C)C1=CC(OC2=C(Cl)C=C(C=C2Cl)N2N=C(C#N)C(=O)NC2=O)=NNC1=O,FDBYIYFVSAHJLY-UHFFFAOYSA-N,435.22,P10828,BE0000315,Thyroid hormone receptor beta,Humans,partial agonist,yes
DB12919,T-62,small molecule,investigational,NC1=C(C(=O)C2=CC=C(Cl)C=C2)C2=C(CCCC2)S1,OTZVBZFYMFTYKH-UHFFFAOYSA-N,291.79,P29274,BE0000924,Adenosine receptor A2a,Humans,antagonist,yes
DB12920,Pinometostat,small molecule,investigational,[H][C@]1(CCC2=NC3=C(N2)C=C(C=C3)C(C)(C)C)C[C@]([H])(C1)N(C[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O)C(C)C,LXFOLMYKSYSZQS-LURJZOHASA-N,562.7063,Q8TEK3,BE0010820,"Histone-lysine N-methyltransferase, H3 lysine-79 specific",Humans,modulator,yes
DB12923,Gallopamil,small molecule,investigational,COC1=CC(=CC(OC)=C1OC)C(CCCN(C)CCC1=CC(OC)=C(OC)C=C1)(C#N)C(C)C,XQLWNAFCTODIRK-UHFFFAOYSA-N,484.637,P16615,BE0003477,Sarcoplasmic/endoplasmic reticulum calcium ATPase 2,Humans,inhibitor,yes
DB12923,Gallopamil,small molecule,investigational,COC1=CC(=CC(OC)=C1OC)C(CCCN(C)CCC1=CC(OC)=C(OC)C=C1)(C#N)C(C)C,XQLWNAFCTODIRK-UHFFFAOYSA-N,484.637,P12821,BE0000221,Angiotensin-converting enzyme,Humans,inhibitor,yes
DB12923,Gallopamil,small molecule,investigational,COC1=CC(=CC(OC)=C1OC)C(CCCN(C)CCC1=CC(OC)=C(OC)C=C1)(C#N)C(C)C,XQLWNAFCTODIRK-UHFFFAOYSA-N,484.637,P08473,BE0000266,Neprilysin,Humans,inhibitor,yes
DB12924,Ozenoxacin,small molecule,approved;investigational,CNC1=NC=C(C=C1C)C1=CC=C2C(=O)C(=CN(C3CC3)C2=C1C)C(O)=O,XPIJWUTXQAGSLK-UHFFFAOYSA-N,363.417,P43700,BE0000366,DNA gyrase subunit A,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd),inhibitor,yes
DB12924,Ozenoxacin,small molecule,approved;investigational,CNC1=NC=C(C=C1C)C1=CC=C2C(=O)C(=CN(C3CC3)C2=C1C)C(O)=O,XPIJWUTXQAGSLK-UHFFFAOYSA-N,363.417,P0AFI2,BE0000798,DNA topoisomerase 4 subunit A,Escherichia coli (strain K12),inhibitor,yes
DB12924,Ozenoxacin,small molecule,approved;investigational,CNC1=NC=C(C=C1C)C1=CC=C2C(=O)C(=CN(C3CC3)C2=C1C)C(O)=O,XPIJWUTXQAGSLK-UHFFFAOYSA-N,363.417,P0A0K8,BE0002388,DNA gyrase subunit B,Staphylococcus aureus,modulator,yes
DB12924,Ozenoxacin,small molecule,approved;investigational,CNC1=NC=C(C=C1C)C1=CC=C2C(=O)C(=CN(C3CC3)C2=C1C)C(O)=O,XPIJWUTXQAGSLK-UHFFFAOYSA-N,363.417,P20831,BE0008385,DNA gyrase subunit A,Staphylococcus aureus,modulator,yes
DB12929,JNJ-39220675,small molecule,investigational,FC1=CC=C(OC2=CC=C(C=N2)C(=O)N2CCCN(CC2)C2CCC2)C=C1,IQOWHZHNGJXGHG-UHFFFAOYSA-N,369.44,Q9Y5N1,BE0000968,Histamine H3 receptor,Humans,antagonist,yes
DB12931,Fenobam,small molecule,investigational,CN1CC(=O)N=C1NC(=O)NC1=CC=CC(Cl)=C1,DWPQODZAOSWNHB-UHFFFAOYSA-N,266.69,P41594,BE0001192,Metabotropic glutamate receptor 5,Humans,allosteric modulator,yes
DB12934,Granotapide,small molecule,investigational,CCOC(=O)C(COC(=O)CC1=CC=C(NC(=O)C2=CC=CC=C2C2=CC=C(C=C2)C(F)(F)F)C(=C1)C(=O)N(C)C)(C(=O)OCC)C1=CC=CC=C1,FPUQGCOBYOXAED-UHFFFAOYSA-N,718.726,P55157,BE0000232,Microsomal triglyceride transfer protein large subunit,Humans,inhibitor,yes
DB12935,Remogliflozin etabonate,small molecule,investigational,CCOC(=O)OC[C@H]1O[C@@H](OC2=NN(C(C)C)C(C)=C2CC2=CC=C(OC(C)C)C=C2)[C@H](O)[C@@H](O)[C@@H]1O,UAOCLDQAQNNEAX-ABMICEGHSA-N,522.595,P31639,BE0004753,Sodium/glucose cotransporter 2,Humans,inhibitor,yes
DB12935,Remogliflozin etabonate,small molecule,investigational,CCOC(=O)OC[C@H]1O[C@@H](OC2=NN(C(C)C)C(C)=C2CC2=CC=C(OC(C)C)C=C2)[C@H](O)[C@@H](O)[C@@H]1O,UAOCLDQAQNNEAX-ABMICEGHSA-N,522.595,Q9NY91,BE0020283,Probable glucose sensor protein SLC5A4,Humans,blocker,yes
DB12941,Darolutamide,small molecule,approved;investigational,C[C@@H](CN1C=CC(=N1)C1=CC=C(C#N)C(Cl)=C1)NC(=O)C1=NNC(=C1)C(C)O,BLIJXOOIHRSQRB-PXYINDEMSA-N,398.85,P10275,BE0000132,Androgen receptor,Humans,antagonist,yes
DB12946,DPCPX,small molecule,investigational,CCCN1C2=C(N=C(N2)C2CCCC2)C(=O)N(CCC)C1=O,FFBDFADSZUINTG-UHFFFAOYSA-N,304.394,P0DMS8,BE0000354,Adenosine receptor A3,Humans,inhibitor,yes
DB12946,DPCPX,small molecule,investigational,CCCN1C2=C(N=C(N2)C2CCCC2)C(=O)N(CCC)C1=O,FFBDFADSZUINTG-UHFFFAOYSA-N,304.394,P30542,BE0000013,Adenosine receptor A1,Humans,inhibitor,yes
DB12946,DPCPX,small molecule,investigational,CCCN1C2=C(N=C(N2)C2CCCC2)C(=O)N(CCC)C1=O,FFBDFADSZUINTG-UHFFFAOYSA-N,304.394,P29274,BE0000924,Adenosine receptor A2a,Humans,inhibitor,yes
DB12946,DPCPX,small molecule,investigational,CCCN1C2=C(N=C(N2)C2CCCC2)C(=O)N(CCC)C1=O,FFBDFADSZUINTG-UHFFFAOYSA-N,304.394,P29275,BE0000241,Adenosine receptor A2b,Humans,inhibitor,yes
DB12946,DPCPX,small molecule,investigational,CCCN1C2=C(N=C(N2)C2CCCC2)C(=O)N(CCC)C1=O,FFBDFADSZUINTG-UHFFFAOYSA-N,304.394,P21589,BE0001096,5'-nucleotidase,Humans,inhibitor,yes
DB12948,Didox,small molecule,investigational,ONC(=O)C1=CC(O)=C(O)C=C1,QJMCKEPOKRERLN-UHFFFAOYSA-N,169.136,P23921,BE0000325,Ribonucleoside-diphosphate reductase large subunit,Humans,inhibitor,yes
DB12948,Didox,small molecule,investigational,ONC(=O)C1=CC(O)=C(O)C=C1,QJMCKEPOKRERLN-UHFFFAOYSA-N,169.136,P31350,BE0002450,Ribonucleoside-diphosphate reductase subunit M2,Humans,inhibitor,yes
DB12948,Didox,small molecule,investigational,ONC(=O)C1=CC(O)=C(O)C=C1,QJMCKEPOKRERLN-UHFFFAOYSA-N,169.136,Q7LG56,BE0003613,Ribonucleoside-diphosphate reductase subunit M2 B,Humans,inhibitor,yes
DB12955,Delparantag,small molecule,investigational,COC1=CC=C(NC(=O)[C@H](CCCCN)NC(=O)C2=CC(NC(=O)[C@H](CCCCN)NC(=O)C3=CC(NC(=O)[C@H](CCCCN)NC(=O)C4=CC(NC(=O)[C@@H](N)CCCCN)=CC=C4OC)=CC=C3OC)=CC=C2OC)C=C1C(N)=O,PWFIFNGOPQUNIT-ITMZJIMRSA-N,1126.327,P01008,BE0000280,Antithrombin-III,Humans,antagonist,yes
DB12959,IOWH-032,small molecule,investigational,OC1=C(Br)C=C(C=C1Br)C1=NOC(=N1)C(=O)NCC1=CC=C(OC2=CC=CC=C2)C=C1,DSFNLJXHXBIKDS-UHFFFAOYSA-N,545.187,P13569,BE0001195,Cystic fibrosis transmembrane conductance regulator,Humans,inhibitor,yes
DB12960,INCB-9471,small molecule,investigational,CCO[C@@H]1CC2=CC(=CC=C2[C@H]1N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)C1=C(C)N=CN=C1C)C(F)(F)F,ZMCJFJZOSKEMOM-DNKZPPIMSA-N,559.678,P51681,BE0000911,C-C chemokine receptor type 5,Humans,antagonist,yes
DB12961,Leukotriene B4,small molecule,investigational,CCCCC\C=C/C[C@@H](O)\C=C\C=C\C=C/[C@@H](O)CCCC(O)=O,VNYSSYRCGWBHLG-AMOLWHMGSA-N,336.4657,Q15722,BE0003490,Leukotriene B4 receptor 1,Humans,agonist,yes
DB12961,Leukotriene B4,small molecule,investigational,CCCCC\C=C/C[C@@H](O)\C=C\C=C\C=C/[C@@H](O)CCCC(O)=O,VNYSSYRCGWBHLG-AMOLWHMGSA-N,336.4657,Q9NPC1,BE0003489,Leukotriene B4 receptor 2,Humans,inhibitor,yes
DB12962,CP-547632,small molecule,investigational,NC(=O)C1=C(NC(=O)NCCCCN2CCCC2)SN=C1OCC1=C(F)C=C(Br)C=C1F,HXHAJRMTJXHJJZ-UHFFFAOYSA-N,532.402,P35968,BE0000369,Vascular endothelial growth factor receptor 2,Humans,inhibitor,yes
DB12963,CCX-354,small molecule,investigational,COC1=CC(=CC=C1Cl)N1CCN(CC1)C(=O)CN1N=C(C2=NC=CN2)C2=CC=CN=C12,ZIMLRKWQDLVPEK-UHFFFAOYSA-N,451.92,P32246,BE0003509,C-C chemokine receptor type 1,Humans,antagonist,yes
DB12966,Falnidamol,small molecule,investigational,CN1CCC(CC1)NC1=NC=C2N=CN=C(NC3=CC=C(F)C(Cl)=C3)C2=N1,FTFRZXFNZVCRSK-UHFFFAOYSA-N,387.85,P00533,BE0000767,Epidermal growth factor receptor,Humans,antagonist,yes
DB12967,Mitoguazone,small molecule,investigational,C\C(\C=N\N=C(N)N)=N/N=C(N)N,MXWHMTNPTTVWDM-NXOFHUPFSA-N,184.2024,P17707,BE0000101,S-adenosylmethionine decarboxylase proenzyme,Humans,inhibitor,yes
DB12971,Pactimibe,small molecule,investigational,CCCCCCCCN1CCC2=C1C(NC(=O)C(C)(C)C)=C(C)C(CC(O)=O)=C2C,TXIIZHHIOHVWJD-UHFFFAOYSA-N,416.606,P23141,BE0002705,Liver carboxylesterase 1,Humans,inhibitor,yes
DB12973,Serlopitant,small molecule,investigational,C[C@@H](O[C@H]1CC[C@@H]2CN(C[C@H]2[C@@H]1C1=CC=C(F)C=C1)C1=CC(=O)CC1)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F,FLNYCRJBCNNHRH-OIYLJQICSA-N,555.537,P25103,BE0000384,Substance-P receptor,Humans,antagonist,yes
DB12978,Pexidartinib,small molecule,approved;investigational,FC(F)(F)C1=CC=C(CNC2=NC=C(CC3=CNC4=NC=C(Cl)C=C34)C=C2)C=N1,JGWRKYUXBBNENE-UHFFFAOYSA-N,417.82,P07333,BE0000853,Macrophage colony-stimulating factor 1 receptor,Humans,inhibitor,yes
DB12978,Pexidartinib,small molecule,approved;investigational,FC(F)(F)C1=CC=C(CNC2=NC=C(CC3=CNC4=NC=C(Cl)C=C34)C=C2)C=N1,JGWRKYUXBBNENE-UHFFFAOYSA-N,417.82,P10721,BE0000453,Mast/stem cell growth factor receptor Kit,Humans,inhibitor,yes
DB12978,Pexidartinib,small molecule,approved;investigational,FC(F)(F)C1=CC=C(CNC2=NC=C(CC3=CNC4=NC=C(Cl)C=C34)C=C2)C=N1,JGWRKYUXBBNENE-UHFFFAOYSA-N,417.82,P36888,BE0000147,Receptor-type tyrosine-protein kinase FLT3,Humans,inhibitor,yes
DB12980,CHS-828,small molecule,investigational,ClC1=CC=C(OCCCCCCN\C(NC#N)=N\C2=CC=NC=C2)C=C1,BOIPLTNGIAPDBY-UHFFFAOYSA-N,371.87,P43490,BE0002413,Nicotinamide phosphoribosyltransferase,Humans,inhibitor,yes
DB12986,VS-5584,small molecule,investigational,CC(C)N1C(C)=NC2=C(N=C(N=C12)N1CCOCC1)C1=CN=C(N)N=C1,QYBGBLQCOOISAR-UHFFFAOYSA-N,354.418,Q9BPZ7,BE0018900,Target of rapamycin complex 2 subunit MAPKAP1,Humans,inhibitor,yes
DB12986,VS-5584,small molecule,investigational,CC(C)N1C(C)=NC2=C(N=C(N=C12)N1CCOCC1)C1=CN=C(N)N=C1,QYBGBLQCOOISAR-UHFFFAOYSA-N,354.418,P42345,BE0002386,Serine/threonine-protein kinase mTOR,Humans,modulator,yes
DB12986,VS-5584,small molecule,investigational,CC(C)N1C(C)=NC2=C(N=C(N=C12)N1CCOCC1)C1=CN=C(N)N=C1,QYBGBLQCOOISAR-UHFFFAOYSA-N,354.418,P48736,BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",Humans,modulator,yes
DB12988,LY-518674,small molecule,investigational,CC1=CC=C(CN2N=C(CCCC3=CC=C(OC(C)(C)C(O)=O)C=C3)NC2=O)C=C1,PNHFDVSKDSLUFH-UHFFFAOYSA-N,409.486,Q07869,BE0000071,Peroxisome proliferator-activated receptor alpha,Humans,agonist,yes
DB12996,Acteoside,small molecule,investigational,C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](OCCC3=CC(O)=C(O)C=C3)O[C@H](CO)[C@H]2OC(=O)\C=C\C2=CC(O)=C(O)C=C2)[C@H](O)[C@H](O)[C@H]1O,FBSKJMQYURKNSU-ZLSOWSIRSA-N,624.5871,P17252,BE0001132,Protein kinase C alpha type,Humans,inhibitor,yes
DB12998,PF-00217830,small molecule,investigational,O=C1CCC2=CC=C(OCCCCN3CCN(CC3)C3=CC=CC4=CC=CC=C34)N=C2N1,QGNOXTFZOLDODX-UHFFFAOYSA-N,430.552,P14416,BE0000756,D(2) dopamine receptor,Humans,modulator,yes
DB12999,MK-6186,small molecule,investigational,ClC1=CC(OC2=C3C=NN(CC4=NNC5=NC=CC=C45)C3=CC=C2Cl)=CC(=C1)C#N,FZBAOOQVQXATRL-UHFFFAOYSA-N,435.27,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB13004,Mavoglurant,small molecule,investigational,COC(=O)N1CC[C@@H]2[C@H]1CCC[C@@]2(O)C#CC1=CC(C)=CC=C1,ZFPZEYHRWGMJCV-ZHALLVOQSA-N,313.397,P41594,BE0001192,Metabotropic glutamate receptor 5,Humans,modulator,yes
DB13005,Rebastinib,small molecule,investigational,CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC(=NN3C3=CC4=CC=CN=C4C=C3)C(C)(C)C)C(F)=C2)=CC=N1,WVXNSAVVKYZVOE-UHFFFAOYSA-N,553.5868,P00519,BE0000014,Tyrosine-protein kinase ABL1,Humans,modulator,yes
DB13005,Rebastinib,small molecule,investigational,CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC(=NN3C3=CC4=CC=CN=C4C=C3)C(C)(C)C)C(F)=C2)=CC=N1,WVXNSAVVKYZVOE-UHFFFAOYSA-N,553.5868,Q02763,BE0003379,Angiopoietin-1 receptor,Humans,inhibitor,yes
DB13006,Cibinetide,small molecule,investigational,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O,WZTIQQBMSJTRBR-WYKNNRPVSA-N,1257.324,P19235,BE0000654,Erythropoietin receptor,Humans,agonist,yes
DB13009,Carbendazim,small molecule,investigational,COC(=O)NC1=NC2=CC=CC=C2N1,TWFZGCMQGLPBSX-UHFFFAOYSA-N,191.1867,P35869,BE0003721,Aryl hydrocarbon receptor,Humans,agonist,yes
DB13010,4-isothioureidobutyronitrile,small molecule,investigational,NC(=N)SCCCC#N,PRDJGNVQBVXXEO-UHFFFAOYSA-N,143.21,P04637,BE0003380,Cellular tumor antigen p53,Humans,stimulator,yes
DB13012,AQX-1125,small molecule,investigational,C[C@]12CC[C@@H]([C@@H](CN)[C@@H]1CCC2=C)[C@@]1(C)CC[C@H](O)C[C@@H]1CO,MDEJTPWQNNMAQF-BVMLLJBZSA-N,321.505,Q92835,BE0010803,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",Humans,agonist,yes
DB13016,LY-2300559,small molecule,investigational,CCCC1=C(OCC2=CC=C(C=C2)[C@H](O)C2=CC=CC(=C2)C(O)=O)C=CC(C(C)=O)=C1O,DWQVYDLTPMGYNE-DEOSSOPVSA-N,434.488,Q14416,BE0000974,Metabotropic glutamate receptor 2,Humans,modulator,yes
DB13016,LY-2300559,small molecule,investigational,CCCC1=C(OCC2=CC=C(C=C2)[C@H](O)C2=CC=CC(=C2)C(O)=O)C=CC(C(C)=O)=C1O,DWQVYDLTPMGYNE-DEOSSOPVSA-N,434.488,Q9Y271,BE0000705,Cysteinyl leukotriene receptor 1,Humans,modulator,yes
DB13020,Apratastat,small molecule,investigational,CC1(C)SCCN([C@H]1C(=O)NO)S(=O)(=O)C1=CC=C(OCC#CCO)C=C1,MAVDNGWEBZTACC-HNNXBMFYSA-N,414.49,P03956,BE0000920,Interstitial collagenase,Humans,inhibitor,yes
DB13020,Apratastat,small molecule,investigational,CC1(C)SCCN([C@H]1C(=O)NO)S(=O)(=O)C1=CC=C(OCC#CCO)C=C1,MAVDNGWEBZTACC-HNNXBMFYSA-N,414.49,P45452,BE0000966,Collagenase 3,Humans,modulator,yes
DB13020,Apratastat,small molecule,investigational,CC1(C)SCCN([C@H]1C(=O)NO)S(=O)(=O)C1=CC=C(OCC#CCO)C=C1,MAVDNGWEBZTACC-HNNXBMFYSA-N,414.49,P78536,BE0003754,Disintegrin and metalloproteinase domain-containing protein 17,Humans,modulator,yes
DB13022,LY-2874455,small molecule,investigational,C[C@@H](OC1=CC=C2NN=C(\C=C\C3=CN(CCO)N=C3)C2=C1)C1=C(Cl)C=NC=C1Cl,GKJCVYLDJWTWQU-CXLRFSCWSA-N,444.32,P21802,BE0000748,Fibroblast growth factor receptor 2,Humans,modulator,yes
DB13023,IPI-493,small molecule,investigational,CO[C@H]1C[C@H](C)CC2=C(N)C(=O)C=C(NC(=O)\C(C)=C\C=C/[C@H](OC)[C@@H](OC(N)=O)\C(C)=C\[C@H](C)[C@H]1O)C2=O,XYFFWTYOFPSZRM-TWNAANEASA-N,545.633,P07900,BE0001120,Heat shock protein HSP 90-alpha,Humans,inhibitor,yes
DB13025,Tiapride,small molecule,investigational,CCN(CC)CCNC(=O)C1=CC(=CC=C1OC)S(C)(=O)=O,JTVPZMFULRWINT-UHFFFAOYSA-N,328.427,Q9Y5Y9,BE0000177,Sodium channel protein type 10 subunit alpha,Humans,inhibitor,yes
DB13025,Tiapride,small molecule,investigational,CCN(CC)CCNC(=O)C1=CC(=CC=C1OC)S(C)(=O)=O,JTVPZMFULRWINT-UHFFFAOYSA-N,328.427,P14416,BE0000756,D(2) dopamine receptor,Humans,blocker,yes
DB13025,Tiapride,small molecule,investigational,CCN(CC)CCNC(=O)C1=CC(=CC=C1OC)S(C)(=O)=O,JTVPZMFULRWINT-UHFFFAOYSA-N,328.427,P35462,BE0000581,D(3) dopamine receptor,Humans,blocker,yes
DB13025,Tiapride,small molecule,investigational,CCN(CC)CCNC(=O)C1=CC(=CC=C1OC)S(C)(=O)=O,JTVPZMFULRWINT-UHFFFAOYSA-N,328.427,P08908,BE0004862,Serotonin Receptors,Humans,antagonist,yes
DB13025,Tiapride,small molecule,investigational,CCN(CC)CCNC(=O)C1=CC(=CC=C1OC)S(C)(=O)=O,JTVPZMFULRWINT-UHFFFAOYSA-N,328.427,P35348,BE0004863,Alpha-1 adrenergic receptors,Humans,antagonist,yes
DB13025,Tiapride,small molecule,investigational,CCN(CC)CCNC(=O)C1=CC(=CC=C1OC)S(C)(=O)=O,JTVPZMFULRWINT-UHFFFAOYSA-N,328.427,P08913,BE0004864,Alpha-2 adrenergic receptors,Humans,antagonist,yes
DB13029,MK-0873,small molecule,investigational,[O-][N+]1=CC(=CC=C1)C#CC1=CC(=CC=C1)N1C=C(C(=O)NC2CC2)C(=O)C2=CC=CN=C12,JJWKQXNHYDJXKF-UHFFFAOYSA-N,422.444,P27815,BE0001133,"3',5'-cyclic-AMP phosphodiesterase 4A",Humans,inhibitor,yes
DB13029,MK-0873,small molecule,investigational,[O-][N+]1=CC(=CC=C1)C#CC1=CC(=CC=C1)N1C=C(C(=O)NC2CC2)C(=O)C2=CC=CN=C12,JJWKQXNHYDJXKF-UHFFFAOYSA-N,422.444,Q07343,BE0000487,"3',5'-cyclic-AMP phosphodiesterase 4B",Humans,inhibitor,yes
DB13029,MK-0873,small molecule,investigational,[O-][N+]1=CC(=CC=C1)C#CC1=CC(=CC=C1)N1C=C(C(=O)NC2CC2)C(=O)C2=CC=CN=C12,JJWKQXNHYDJXKF-UHFFFAOYSA-N,422.444,Q08499,BE0001287,"3',5'-cyclic-AMP phosphodiesterase 4D",Humans,inhibitor,yes
DB13035,AG-24322,small molecule,investigational,CCNCC1=CN=CC(=C1C)C1=CC=C2NN=C(C3=NC4=C(F)C=C(F)C=C4N3)C2=C1,MEKASOQEXYKAKM-UHFFFAOYSA-N,418.452,P24941,BE0001072,Cyclin-dependent kinase 2,Humans,inhibitor,yes
DB13035,AG-24322,small molecule,investigational,CCNCC1=CN=CC(=C1C)C1=CC=C2NN=C(C3=NC4=C(F)C=C(F)C=C4N3)C2=C1,MEKASOQEXYKAKM-UHFFFAOYSA-N,418.452,P11802,BE0002216,Cyclin-dependent kinase 4,Humans,inhibitor,yes
DB13035,AG-24322,small molecule,investigational,CCNCC1=CN=CC(=C1C)C1=CC=C2NN=C(C3=NC4=C(F)C=C(F)C=C4N3)C2=C1,MEKASOQEXYKAKM-UHFFFAOYSA-N,418.452,P06493,BE0001082,Cyclin-dependent kinase 1,Humans,inhibitor,yes
DB13036,Ramatroban,small molecule,investigational,[H][C@]1(CCC2=C(C1)C1=CC=CC=C1N2CCC(O)=O)NS(=O)(=O)C1=CC=C(F)C=C1,LDXDSHIEDAPSSA-OAHLLOKOSA-N,416.47,P21731,BE0000759,Thromboxane A2 receptor,Humans,antagonist,yes
DB13036,Ramatroban,small molecule,investigational,[H][C@]1(CCC2=C(C1)C1=CC=CC=C1N2CCC(O)=O)NS(=O)(=O)C1=CC=C(F)C=C1,LDXDSHIEDAPSSA-OAHLLOKOSA-N,416.47,Q9Y5Y4,BE0003561,Prostaglandin D2 receptor 2,Humans,antagonist,yes
DB13040,Gandotinib,small molecule,investigational,CC1=CC(NC2=NN3C(CC4=CC=C(Cl)C=C4F)=C(C)N=C3C(CN3CCOCC3)=C2)=NN1,SQSZANZGUXWJEA-UHFFFAOYSA-N,469.95,O60674,BE0002408,Tyrosine-protein kinase JAK2,Humans,modulator,yes
DB13041,Odalasvir,small molecule,investigational,COC(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](C[C@@H]2CCCC[C@H]12)C1=NC2=CC=C(C=C2N1)C1=CC2=CC=C1CCC1=CC=C(CC2)C(=C1)C1=CC=C2N=C(NC2=C1)[C@@H]1C[C@@H]2CCCC[C@@H]2N1C(=O)[C@@H](NC(=O)OC)C(C)C,LSYBRGMTRKJATA-IVEWBXRVSA-N,1001.286,P26664,BE0003427,Genome polyprotein,,modulator,yes
DB13044,Gossypol,small molecule,investigational,CC(C)C1=C2C=C(C)C(=C(O)C2=C(C=O)C(O)=C1O)C1=C(O)C2=C(C=O)C(O)=C(O)C(C(C)C)=C2C=C1C,QBKSWRVVCFFDOT-UHFFFAOYSA-N,518.5544,P10415,BE0000246,Apoptosis regulator Bcl-2,Humans,regulator,yes
DB13048,PAC-1,small molecule,investigational,OC1=C(\C=N\NC(=O)CN2CCN(CC3=CC=CC=C3)CC2)C=CC=C1CC=C,YQNRVGJCPCNMKT-LFVJCYFKSA-N,392.503,P42574,BE0001162,Caspase-3,Humans,activator,yes
DB13051,CH-5132799,small molecule,investigational,CS(=O)(=O)N1CCC2=C(N=C(N=C12)N1CCOCC1)C1=CN=C(N)N=C1,JEGHXKRHKHPBJD-UHFFFAOYSA-N,377.421,P42338,BE0002407,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",Humans,inhibitor,yes
DB13051,CH-5132799,small molecule,investigational,CS(=O)(=O)N1CCC2=C(N=C(N=C12)N1CCOCC1)C1=CN=C(N)N=C1,JEGHXKRHKHPBJD-UHFFFAOYSA-N,377.421,O00329,BE0002406,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",Humans,inhibitor,yes
DB13051,CH-5132799,small molecule,investigational,CS(=O)(=O)N1CCC2=C(N=C(N=C12)N1CCOCC1)C1=CN=C(N)N=C1,JEGHXKRHKHPBJD-UHFFFAOYSA-N,377.421,P42336,BE0002379,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",Humans,inhibitor,yes
DB13051,CH-5132799,small molecule,investigational,CS(=O)(=O)N1CCC2=C(N=C(N=C12)N1CCOCC1)C1=CN=C(N)N=C1,JEGHXKRHKHPBJD-UHFFFAOYSA-N,377.421,P48736,BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",Humans,modulator,yes
DB13052,Upamostat,small molecule,investigational,CCOC(=O)N1CCN(CC1)C(=O)[C@H](CC1=CC=CC(=C1)C(\N)=N/O)NS(=O)(=O)C1=C(C=C(C=C1C(C)C)C(C)C)C(C)C,HUASEDVYRABWCV-NDEPHWFRSA-N,629.82,P00749,BE0000895,Urokinase-type plasminogen activator,Humans,inhibitor,yes
DB13053,CP-195543,small molecule,investigational,O[C@@H]1[C@@H](CC2=CC=CC=C2)COC2=CC(=CC=C12)C1=CC(=CC=C1C(O)=O)C(F)(F)F,NZQDWKCNBOELAI-KSFYIVLOSA-N,428.407,Q15722,BE0003490,Leukotriene B4 receptor 1,Humans,antagonist,yes
DB13055,Oteseconazole,small molecule,approved;investigational,O[C@@](CN1C=NN=N1)(C1=CC=C(F)C=C1F)C(F)(F)C1=CC=C(C=N1)C1=CC=C(OCC(F)(F)F)C=C1,IDUYJRXRDSPPRC-NRFANRHFSA-N,527.403,P10613,BE0000233,Lanosterol 14-alpha demethylase,Yeast,inhibitor,yes
DB13059,PF-03814735,small molecule,investigational,CC(=O)NCC(=O)N1[C@H]2CC[C@@H]1C1=C2C=CC(NC2=NC=C(C(NC3CCC3)=N2)C(F)(F)F)=C1,RYYNGWLOYLRZLK-RBUKOAKNSA-N,474.488,O14965,BE0000991,Aurora kinase A,Humans,inhibitor,yes
DB13059,PF-03814735,small molecule,investigational,CC(=O)NCC(=O)N1[C@H]2CC[C@@H]1C1=C2C=CC(NC2=NC=C(C(NC3CCC3)=N2)C(F)(F)F)=C1,RYYNGWLOYLRZLK-RBUKOAKNSA-N,474.488,Q96GD4,BE0003404,Aurora kinase B,Humans,inhibitor,yes
DB13060,CEP-37440,small molecule,investigational,CNC(=O)C1=CC=CC=C1NC1=C(Cl)C=NC(NC2=CC=C3C[C@H](CCCC3=C2OC)N2CCN(CCO)CC2)=N1,BCSHRERPHLTPEE-NRFANRHFSA-N,580.13,Q05397,BE0003090,Focal adhesion kinase 1,Humans,modulator,yes
DB13061,MLN8054,small molecule,investigational,OC(=O)C1=CC=C(NC2=NC=C3CN=C(C4=C(C=CC(Cl)=C4)C3=N2)C2=C(F)C=CC=C2F)C=C1,HHFBDROWDBDFBR-UHFFFAOYSA-N,476.862,O14965,BE0000991,Aurora kinase A,Humans,inhibitor,yes
DB13062,ME-344,small molecule,investigational,CC1=C(O)C=CC2=C1OC[C@H]([C@H]2C1=CC=C(O)C=C1)C1=CC=C(O)C=C1,QVCAATSEPLQVBX-FPOVZHCZSA-N,348.398,Q9BPZ7,BE0018900,Target of rapamycin complex 2 subunit MAPKAP1,Humans,inhibitor,yes
DB13062,ME-344,small molecule,investigational,CC1=C(O)C=CC2=C1OC[C@H]([C@H]2C1=CC=C(O)C=C1)C1=CC=C(O)C=C1,QVCAATSEPLQVBX-FPOVZHCZSA-N,348.398,P42345,BE0002386,Serine/threonine-protein kinase mTOR,Humans,inhibitor,yes
DB13063,Parthenolide,small molecule,approved;investigational,C\C1=C/CC[C@@]2(C)O[C@H]2[C@H]2OC(=O)C(=C)[C@@H]2CC1,KTEXNACQROZXEV-SLXBATTESA-N,248.3175,Q04864,BE0010782,Proto-oncogene c-Rel,Humans,inhibitor,yes
DB13063,Parthenolide,small molecule,approved;investigational,C\C1=C/CC[C@@]2(C)O[C@H]2[C@H]2OC(=O)C(=C)[C@@H]2CC1,KTEXNACQROZXEV-SLXBATTESA-N,248.3175,Q01201,BE0013795,Transcription factor RelB,Humans,inhibitor,yes
DB13063,Parthenolide,small molecule,approved;investigational,C\C1=C/CC[C@@]2(C)O[C@H]2[C@H]2OC(=O)C(=C)[C@@H]2CC1,KTEXNACQROZXEV-SLXBATTESA-N,248.3175,O14920,BE0001154,Inhibitor of nuclear factor kappa-B kinase subunit beta,Humans,inhibitor,yes
DB13063,Parthenolide,small molecule,approved;investigational,C\C1=C/CC[C@@]2(C)O[C@H]2[C@H]2OC(=O)C(=C)[C@@H]2CC1,KTEXNACQROZXEV-SLXBATTESA-N,248.3175,P19838,BE0001086,Nuclear factor NF-kappa-B p105 subunit,Humans,inhibitor,yes
DB13063,Parthenolide,small molecule,approved;investigational,C\C1=C/CC[C@@]2(C)O[C@H]2[C@H]2OC(=O)C(=C)[C@@H]2CC1,KTEXNACQROZXEV-SLXBATTESA-N,248.3175,Q00653,BE0002387,Nuclear factor NF-kappa-B p100 subunit,Humans,inhibitor,yes
DB13063,Parthenolide,small molecule,approved;investigational,C\C1=C/CC[C@@]2(C)O[C@H]2[C@H]2OC(=O)C(=C)[C@@H]2CC1,KTEXNACQROZXEV-SLXBATTESA-N,248.3175,Q04206,BE0005551,Transcription factor p65,Humans,inhibitor,yes
DB13064,Tramazoline,small molecule,investigational,C1CN=C(NC2=CC=CC3=C2CCCC3)N1,QQJLHRRUATVHED-UHFFFAOYSA-N,215.3,P08913,BE0000289,Alpha-2A adrenergic receptor,Humans,inhibitor,yes
DB13064,Tramazoline,small molecule,investigational,C1CN=C(NC2=CC=CC3=C2CCCC3)N1,QQJLHRRUATVHED-UHFFFAOYSA-N,215.3,P18089,BE0000572,Alpha-2B adrenergic receptor,Humans,inhibitor,yes
DB13064,Tramazoline,small molecule,investigational,C1CN=C(NC2=CC=CC3=C2CCCC3)N1,QQJLHRRUATVHED-UHFFFAOYSA-N,215.3,P18825,BE0000342,Alpha-2C adrenergic receptor,Humans,inhibitor,yes
DB13066,Liarozole,small molecule,investigational,ClC1=CC=CC(=C1)C(N1C=CN=C1)C1=CC=C2N=CNC2=C1,UGFHIPBXIWJXNA-UHFFFAOYSA-N,308.77,O43174,BE0003480,Cytochrome P450 26A1,Humans,inhibitor,yes
DB13066,Liarozole,small molecule,investigational,ClC1=CC=CC(=C1)C(N1C=CN=C1)C1=CC=C2N=CNC2=C1,UGFHIPBXIWJXNA-UHFFFAOYSA-N,308.77,P11511,BE0002090,Aromatase,Humans,inhibitor,yes
DB13070,Surinabant,small molecule,investigational,CCC1=C(N(N=C1C(=O)NN1CCCCC1)C1=CC=C(Cl)C=C1Cl)C1=CC=C(Br)C=C1,HMXDWDSNPRNUKI-UHFFFAOYSA-N,522.27,P21554,BE0000061,Cannabinoid receptor 1,Humans,modulator,yes
DB13072,GDC-0349,small molecule,investigational,CCNC(=O)NC1=CC=C(C=C1)C1=NC2=C(CCN(C2)C2COC2)C(=N1)N1CCOC[C@@H]1C,RGJOJUGRHPQXGF-INIZCTEOSA-N,452.559,P42345,BE0002386,Serine/threonine-protein kinase mTOR,Humans,inhibitor,yes
DB13074,Macimorelin,small molecule,approved;investigational,CC(C)(N)C(=O)N[C@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@H](CC1=CNC2=CC=CC=C12)NC=O,UJVDJAPJQWZRFR-DHIUTWEWSA-N,474.565,Q92847,BE0003383,Growth hormone secretagogue receptor type 1,Humans,agonist,yes
DB13080,Roluperidone,small molecule,investigational,FC1=CC=C(C=C1)C(=O)CN1CCC(CN2CC3=CC=CC=C3C2=O)CC1,RNRYULFRLCBRQS-UHFFFAOYSA-N,366.436,Q5BJF2,BE0015084,Sigma intracellular receptor 2,Humans,antagonist,yes
DB13080,Roluperidone,small molecule,investigational,FC1=CC=C(C=C1)C(=O)CN1CCC(CN2CC3=CC=CC=C3C2=O)CC1,RNRYULFRLCBRQS-UHFFFAOYSA-N,366.436,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB13083,Talarozole,small molecule,investigational,CCC(CC)C(N1C=NC=N1)C1=CC=C(NC2=NC3=CC=CC=C3S2)C=C1,SNFYYXUGUBUECJ-UHFFFAOYSA-N,377.51,P21452,BE0002222,Substance-K receptor,Humans,antagonist,yes
DB13083,Talarozole,small molecule,investigational,CCC(CC)C(N1C=NC=N1)C1=CC=C(NC2=NC3=CC=CC=C3S2)C=C1,SNFYYXUGUBUECJ-UHFFFAOYSA-N,377.51,O43174,BE0003480,Cytochrome P450 26A1,Humans,inhibitor,yes
DB13087,Miridesap,small molecule,investigational,OC(=O)[C@H]1CCCN1C(=O)CCCCC(=O)N1CCC[C@@H]1C(O)=O,HZLAWYIBLZNRFZ-VXGBXAGGSA-N,340.376,P02743,BE0001213,Serum amyloid P-component,Humans,modulator,yes
DB13089,Enoxolone,small molecule,investigational,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O,MPDGHEJMBKOTSU-YKLVYJNSSA-N,470.694,P18031,BE0000623,Tyrosine-protein phosphatase non-receptor type 1,Humans,inhibitor,yes
DB13092,Meclocycline,small molecule,investigational,[H][C@@]12[C@@H](O)[C@]3([H])C(=C)C4=C(C(O)=CC=C4Cl)C(=O)C3=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C,GGQJXCQBBONZFX-IWVLMIASSA-N,476.87,P02359,BE0004653,30S ribosomal protein S7,Escherichia coli (strain K12),antagonist,yes
DB13093,TAK-593,small molecule,investigational,CN1N=C(C)C=C1C(=O)NC1=CC(OC2=NN3C=C(NC(=O)C4CC4)N=C3C=C2)=CC=C1C,DZFZXPPHBWCXPQ-UHFFFAOYSA-N,445.483,P35968,BE0000369,Vascular endothelial growth factor receptor 2,Humans,modulator,yes
DB13093,TAK-593,small molecule,investigational,CN1N=C(C)C=C1C(=O)NC1=CC(OC2=NN3C=C(NC(=O)C4CC4)N=C3C=C2)=CC=C1C,DZFZXPPHBWCXPQ-UHFFFAOYSA-N,445.483,P09619,BE0000205,Platelet-derived growth factor receptor beta,Humans,modulator,yes
DB13094,Pruvanserin,small molecule,investigational,FC1=CC=C(CCN2CCN(CC2)C(=O)C2=C3NC=C(C#N)C3=CC=C2)C=C1,AQRLDDAFYYAIJP-UHFFFAOYSA-N,376.435,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,modulator,yes
DB13095,JTK-853,small molecule,investigational,FC1=C(OC(F)(F)F)C=CC(CNC(=O)[C@H]2CN(CCN2S(=O)(=O)C2=CC=C(C=C2)C(F)(F)F)C2=NC3=C(S2)C=NC(=N3)C2CC2)=C1,JQLOVYLALGSISI-HXUWFJFHSA-N,704.639,P26664,BE0003427,Genome polyprotein,,inhibitor,yes
DB13097,1alpha-Hydroxyvitamin D5,small molecule,investigational,CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)C(C)C,NWFOBODUYTUMNC-VPSCEVSQSA-N,428.701,P00797,BE0000270,Renin,Humans,agonist,yes
DB13098,CT-2584,small molecule,investigational,CCCCCCCCCCCCNCC(O)CCCCCCCCCN1C(=O)N(C)C2=C(N(C)C=N2)C1=O,MZNMZWZGUGFQJP-UHFFFAOYSA-N,533.802,Q9Y5K3,BE0000494,Choline-phosphate cytidylyltransferase B,Humans,modulator,yes
DB13104,X-396,small molecule,investigational,C[C@@H](OC1=CC(=NN=C1N)C(=O)NC1=CC=C(C=C1)C(=O)N1CCN(C)CC1)C1=C(Cl)C=CC(F)=C1Cl,ONPGOSVDVDPBCY-CQSZACIVSA-N,547.41,Q9UM73,BE0000359,ALK tyrosine kinase receptor,Humans,inhibitor,yes
DB13106,Glycovir,small molecule,investigational,CCCCN1C[C@H](OC(=O)CCC)[C@@H](OC(=O)CCC)[C@H](OC(=O)CCC)[C@H]1COC(=O)CCC,MKGDNVHZSCXBKR-KYVQNOJUSA-N,499.645,O43451,BE0000837,Maltase-glucoamylase,Humans,inhibitor,yes
DB13107,QGC-001,small molecule,investigational,N[C@@H](CCS(O)(=O)=O)CSSC[C@@H](N)CCS(O)(=O)=O,HJPXZXVKLGEMGP-YUMQZZPRSA-N,368.5,Q07075,BE0002271,Glutamyl aminopeptidase,Humans,inhibitor,yes
DB13107,QGC-001,small molecule,investigational,N[C@@H](CCS(O)(=O)=O)CSSC[C@@H](N)CCS(O)(=O)=O,HJPXZXVKLGEMGP-YUMQZZPRSA-N,368.5,Q9ULA0,BE0002277,Aspartyl aminopeptidase,Humans,inhibitor,yes
DB13111,Chromanol,small molecule,investigational,CC1=C(O)C(C)=C2CCC(C)(C)OC2=C1C,SEBPXHSZHLFWRL-UHFFFAOYSA-N,220.3074,P10275,BE0000132,Androgen receptor,Humans,inhibitor,yes
DB13113,JNJ-38877605,small molecule,investigational,CN1C=C(C=N1)C1=NN2C(C=C1)=NN=C2C(F)(F)C1=CC=C2N=CC=CC2=C1,JRWCBEOAFGHNNU-UHFFFAOYSA-N,377.359,P08581,BE0000915,Hepatocyte growth factor receptor,Humans,inhibitor,yes
DB13118,Paquinimod,small molecule,investigational,CCN(C(=O)C1=C(O)C2=C(CC)C=CC=C2N(C)C1=O)C1=CC=CC=C1,DIKSYHCCYVYKRO-UHFFFAOYSA-N,350.418,P06702,BE0008993,Protein S100-A9,Humans,inhibitor,yes
DB13120,Deferitazole,small molecule,investigational,COCCOCCOCCOC1=C(O)C(=CC=C1)C1=N[C@](C)(CS1)C(O)=O,AWHIMFSHNAAMBM-GOSISDBHSA-N,399.46,P69905,BE0000130,Hemoglobin subunit alpha,Humans,modulator,yes
DB13122,Trabodenoson,small molecule,investigational,O[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@H]([C@@H]1O)N1C=NC2=C(NC3CCCC3)N=CN=C12,AQLVRTWKJDTWQQ-SDBHATRESA-N,380.361,P30542,BE0000013,Adenosine receptor A1,Humans,agonist,yes
DB13123,OTX-008,small molecule,investigational,CN(C)CCNC(=O)COC1=C2CC3=CC=CC(CC4=CC=CC(CC5=C(OCC(=O)NCCN(C)C)C(CC1=CC=C2)=CC=C5)=C4OCC(=O)NCCN(C)C)=C3OCC(=O)NCCN(C)C,CQVAQQNDZCZBSU-UHFFFAOYSA-N,937.196,P09382,BE0004493,Galectin-1,Humans,inhibitor,yes
DB13125,Lusutrombopag,small molecule,approved;investigational,CCCCCCO[C@@H](C)C1=C(OC)C(=CC=C1)C1=CSC(NC(=O)C2=CC(Cl)=C(\C=C(/C)C(O)=O)C(Cl)=C2)=N1,NOZIJMHMKORZBA-KJCUYJGMSA-N,591.54,P40238,BE0003440,Thrombopoietin receptor,Humans,agonist,yes
DB13132,Artemisinin,small molecule,investigational,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C(=O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4,BLUAFEHZUWYNDE-NNWCWBAJSA-N,282.336,Q08210,BE0000612,"Dihydroorotate dehydrogenase (quinone), mitochondrial",Plasmodium falciparum (isolate 3D7),inhibitor,yes
DB13138,Neladenoson bialanate,small molecule,investigational,C[C@H](N)C(=O)N[C@@H](C)C(=O)OCCOC1=CC=C(C=C1)C1=C(C#N)C(=NC(SCC2=CSC(=N2)C2=CC=C(Cl)C=C2)=C1C#N)N1CCCC1,WESNEIGKOAXSGX-VXKWHMMOSA-N,716.27,P30542,BE0000013,Adenosine receptor A1,Humans,agonist,yes
DB13139,Levosalbutamol,small molecule,approved;investigational,CC(C)(C)NC[C@H](O)C1=CC(CO)=C(O)C=C1,NDAUXUAQIAJITI-LBPRGKRZSA-N,239.3107,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,agonist,yes
DB13145,Nedaplatin,small molecule,approved;investigational,[H][N]([H])([H])[Pt]1(OCC(=O)O1)[N]([H])([H])[H],GYAVMUDJCHAASE-UHFFFAOYSA-M,303.181,,BE0004796,DNA,Humans,ligand,yes
DB13146,Fluciclovine (18F),small molecule,approved,N[C@]1(C[C@H]([18F])C1)C(O)=O,NTEDWGYJNHZKQW-DGMDOPGDSA-N,132.125,Q15758,BE0000236,Neutral amino acid transporter B(0),Humans,binder,yes
DB13146,Fluciclovine (18F),small molecule,approved,N[C@]1(C[C@H]([18F])C1)C(O)=O,NTEDWGYJNHZKQW-DGMDOPGDSA-N,132.125,Q9UM01,BE0004769,Y+L amino acid transporter 1,Humans,binder,yes
DB13146,Fluciclovine (18F),small molecule,approved,N[C@]1(C[C@H]([18F])C1)C(O)=O,NTEDWGYJNHZKQW-DGMDOPGDSA-N,132.125,Q8WY07,BE0000136,Cationic amino acid transporter 3,Humans,binder,yes
DB13158,Clobetasone,small molecule,approved,[H][C@]1(C)C[C@@]2([H])[C@]3([H])CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)C(=O)C[C@]2(C)[C@@]1(O)C(=O)CCl,XXIFVOHLGBURIG-OZCCCYNHSA-N,408.89,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB13164,Olmutinib,small molecule,investigational,CN1CCN(CC1)C1=CC=C(NC2=NC(OC3=CC=CC(NC(=O)C=C)=C3)=C3SC=CC3=N2)C=C1,FDMQDKQUTRLUBU-UHFFFAOYSA-N,486.59,P00533,BE0000767,Epidermal growth factor receptor,Humans,inhibitor,yes
DB13166,Zofenopril,small molecule,approved,C[C@H](CSC(=O)C1=CC=CC=C1)C(=O)N1C[C@H](C[C@H]1C(O)=O)SC1=CC=CC=C1,IAIDUHCBNLFXEF-MNEFBYGVSA-N,429.55,P12821,BE0000221,Angiotensin-converting enzyme,Humans,inhibitor,yes
DB13167,Alclofenac,small molecule,approved;withdrawn,OC(=O)CC1=CC(Cl)=C(OCC=C)C=C1,ARHWPKZXBHOEEE-UHFFFAOYSA-N,226.66,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,antagonist,yes
DB13169,Nandrolone,small molecule,experimental;investigational,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],NPAGDVCDWIYMMC-IZPLOLCNSA-N,274.3978,P10275,BE0000132,Androgen receptor,Humans,agonist,yes
DB13170,Plecanatide,small molecule,approved;investigational,[H][C@@]12CSSC[C@H](NC(=O)CNC(=O)[C@@]([H])(NC(=O)[C@]([H])(CSSC[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC2=O)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O,NSPHQWLKCGGCQR-DLJDZFDSSA-N,1681.89,P25092,BE0003502,Guanylyl cyclase C,Humans,modulator,yes
DB13170,Plecanatide,small molecule,approved;investigational,[H][C@@]12CSSC[C@H](NC(=O)CNC(=O)[C@@]([H])(NC(=O)[C@]([H])(CSSC[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC2=O)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O,NSPHQWLKCGGCQR-DLJDZFDSSA-N,1681.89,P33402,BE0003578,Guanylate cyclase soluble subunit alpha-2,Humans,agonist,yes
DB13171,Glyceryl 1-oleate,small molecule,experimental,[H]\C(CCCCCCCC)=C(/[H])CCCCCCCC(=O)OCC(O)CO,RZRNAYUHWVFMIP-KTKRTIGZSA-N,356.5399,Q8TDV5,BE0003378,Glucose-dependent insulinotropic receptor,Humans,agonist,yes
DB13174,Rhein,small molecule,experimental,OC(=O)C1=CC2=C(C(O)=C1)C(=O)C1=C(C=CC=C1O)C2=O,FCDLCPWAQCPTKC-UHFFFAOYSA-N,284.2204,P07900,BE0001120,Heat shock protein HSP 90-alpha,Humans,inhibitor,yes
DB13179,Troleandomycin,small molecule,approved,CO[C@H]1C[C@H](O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3OC(C)=O)N(C)C)[C@@H](C)C[C@@]3(CO3)C(=O)[C@H](C)[C@@H](OC(C)=O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C)O[C@@H](C)[C@@H]1OC(C)=O,LQCLVBQBTUVCEQ-QTFUVMRISA-N,813.9684,P49228,BE0003675,50S ribosomal protein L32,Deinococcus radiodurans (strain ATCC 13939 / DSM 20539 / JCM 16871 / LMG 4051 / NBRC 15346 / NCIMB 9279 / R1 / VKM B-1422),inhibitor,yes
DB13179,Troleandomycin,small molecule,approved,CO[C@H]1C[C@H](O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3OC(C)=O)N(C)C)[C@@H](C)C[C@@]3(CO3)C(=O)[C@H](C)[C@@H](OC(C)=O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C)O[C@@H](C)[C@@H]1OC(C)=O,LQCLVBQBTUVCEQ-QTFUVMRISA-N,813.9684,P60723,BE0003674,50S ribosomal protein L4,Escherichia coli (strain K12),inhibitor,yes
DB13182,Daidzein,small molecule,experimental,OC1=CC=C(C=C1)C1=COC2=C(C=CC(O)=C2)C1=O,ZQSIJRDFPHDXIC-UHFFFAOYSA-N,254.241,P11474,BE0003722,Steroid hormone receptor ERR1,Humans,agonist,yes
DB13182,Daidzein,small molecule,experimental,OC1=CC=C(C=C1)C1=COC2=C(C=CC(O)=C2)C1=O,ZQSIJRDFPHDXIC-UHFFFAOYSA-N,254.241,Q9UL62,BE0021113,Short transient receptor potential channel 5,Humans,activator,yes
DB13182,Daidzein,small molecule,experimental,OC1=CC=C(C=C1)C1=COC2=C(C=CC(O)=C2)C1=O,ZQSIJRDFPHDXIC-UHFFFAOYSA-N,254.241,P03372,BE0000123,Estrogen receptor,Humans,inhibitor,yes
DB13182,Daidzein,small molecule,experimental,OC1=CC=C(C=C1)C1=COC2=C(C=CC(O)=C2)C1=O,ZQSIJRDFPHDXIC-UHFFFAOYSA-N,254.241,Q92731,BE0000792,Estrogen receptor beta,Humans,inhibitor,yes
DB13182,Daidzein,small molecule,experimental,OC1=CC=C(C=C1)C1=COC2=C(C=CC(O)=C2)C1=O,ZQSIJRDFPHDXIC-UHFFFAOYSA-N,254.241,P15121,BE0000747,Aldo-keto reductase family 1 member B1,Humans,inhibitor,yes
DB13191,Phosphocreatine,small molecule,nutraceutical,CN(CC(O)=O)C(=N)NP(O)(O)=O,DRBBFCLWYRJSJZ-UHFFFAOYSA-N,211.1131,Q14353,BE0000567,Guanidinoacetate N-methyltransferase,Humans,product of,yes
DB13191,Phosphocreatine,small molecule,nutraceutical,CN(CC(O)=O)C(=N)NP(O)(O)=O,DRBBFCLWYRJSJZ-UHFFFAOYSA-N,211.1131,P48029,BE0000375,Sodium- and chloride-dependent creatine transporter 1,Humans,,yes
DB13191,Phosphocreatine,small molecule,nutraceutical,CN(CC(O)=O)C(=N)NP(O)(O)=O,DRBBFCLWYRJSJZ-UHFFFAOYSA-N,211.1131,P06732,BE0000714,Creatine kinase M-type,Humans,ligand,yes
DB13191,Phosphocreatine,small molecule,nutraceutical,CN(CC(O)=O)C(=N)NP(O)(O)=O,DRBBFCLWYRJSJZ-UHFFFAOYSA-N,211.1131,P12532,BE0000171,"Creatine kinase U-type, mitochondrial",Humans,ligand,yes
DB13191,Phosphocreatine,small molecule,nutraceutical,CN(CC(O)=O)C(=N)NP(O)(O)=O,DRBBFCLWYRJSJZ-UHFFFAOYSA-N,211.1131,P17540,BE0000410,"Creatine kinase S-type, mitochondrial",Humans,ligand,yes
DB13191,Phosphocreatine,small molecule,nutraceutical,CN(CC(O)=O)C(=N)NP(O)(O)=O,DRBBFCLWYRJSJZ-UHFFFAOYSA-N,211.1131,P12277,BE0000082,Creatine kinase B-type,Humans,ligand,yes
DB13243,Tiazofurine,small molecule,experimental,NC(=O)C1=CSC(=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,FVRDYQYEVDDKCR-DBRKOABJSA-N,260.267,P20839,BE0000761,Inosine-5'-monophosphate dehydrogenase 1,Humans,inhibitor,yes
DB13245,Thiram,small molecule,approved;experimental,CN(C)C(=S)SSC(=S)N(C)C,KUAZQDVKQLNFPE-UHFFFAOYSA-N,240.433,O60674,BE0002408,Tyrosine-protein kinase JAK2,Humans,inhibitor,yes
DB13247,Pramiracetam,small molecule,approved,CC(C)N(CCNC(=O)CN1CCCC1=O)C(C)C,ZULJGOSFKWFVRX-UHFFFAOYSA-N,269.389,P08912,BE0000247,Muscarinic acetylcholine receptor M5,Humans,modulator,yes
DB13251,Octopamine,small molecule,experimental,NCC(O)C1=CC=C(O)C=C1,QHGUCRYDKWKLMG-UHFFFAOYSA-N,153.1784,P00742,BE0000216,Coagulation factor X,Humans,inhibitor,yes
DB13254,Prifinium,small molecule,experimental,CC[N+]1(CC)CCC(C1C)=C(C1=CC=CC=C1)C1=CC=CC=C1,ZYEPZINLLPPBMI-UHFFFAOYSA-N,306.472,P08912,BE0000247,Muscarinic acetylcholine receptor M5,Humans,modulator,yes
DB13262,Aceclidine,small molecule,approved,CC(=O)OC1CN2CCC1CC2,WRJPSSPFHGNBMG-UHFFFAOYSA-N,169.224,P08912,BE0000247,Muscarinic acetylcholine receptor M5,Humans,inhibitor,yes
DB13262,Aceclidine,small molecule,approved,CC(=O)OC1CN2CCC1CC2,WRJPSSPFHGNBMG-UHFFFAOYSA-N,169.224,P08173,BE0000405,Muscarinic acetylcholine receptor M4,Humans,inhibitor,yes
DB13262,Aceclidine,small molecule,approved,CC(=O)OC1CN2CCC1CC2,WRJPSSPFHGNBMG-UHFFFAOYSA-N,169.224,P20309,BE0000045,Muscarinic acetylcholine receptor M3,Humans,inhibitor,yes
DB13262,Aceclidine,small molecule,approved,CC(=O)OC1CN2CCC1CC2,WRJPSSPFHGNBMG-UHFFFAOYSA-N,169.224,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,inhibitor,yes
DB13262,Aceclidine,small molecule,approved,CC(=O)OC1CN2CCC1CC2,WRJPSSPFHGNBMG-UHFFFAOYSA-N,169.224,P08172,BE0000560,Muscarinic acetylcholine receptor M2,Humans,inhibitor,yes
DB13269,Dichlorobenzyl alcohol,small molecule,approved,OCC1=C(Cl)C=C(Cl)C=C1,DBHODFSFBXJZNY-UHFFFAOYSA-N,177.02,P35498,BE0004901,Sodium channel protein,Humans,antagonist,yes
DB13308,Oxametacin,small molecule,experimental,COC1=CC=C2N(C(=O)C3=CC=C(Cl)C=C3)C(C)=C(CC(=O)NO)C2=C1,AJRNYCDWNITGHF-UHFFFAOYSA-N,372.81,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB13308,Oxametacin,small molecule,experimental,COC1=CC=C2N(C(=O)C3=CC=C(Cl)C=C3)C(C)=C(CC(=O)NO)C2=C1,AJRNYCDWNITGHF-UHFFFAOYSA-N,372.81,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB13312,Delapril,small molecule,investigational,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N(CC(O)=O)C1CC2=C(C1)C=CC=C2,WOUOLAUOZXOLJQ-MBSDFSHPSA-N,452.551,P12821,BE0000221,Angiotensin-converting enzyme,Humans,modulator,yes
DB13318,Demecolcine,small molecule,experimental,[H][C@@]1(CCC2=CC(OC)=C(OC)C(OC)=C2C2=CC=C(OC)C(=O)C=C12)NC,NNJPGOLRFBJNIW-HNNXBMFYSA-N,371.433,P46821,BE0013264,Microtubule-associated protein 1B,Humans,modulator,yes
DB13318,Demecolcine,small molecule,experimental,[H][C@@]1(CCC2=CC(OC)=C(OC)C(OC)=C2C2=CC=C(OC)C(=O)C=C12)NC,NNJPGOLRFBJNIW-HNNXBMFYSA-N,371.433,P78559,BE0001169,Microtubule-associated protein 1A,Humans,modulator,yes
DB13335,Pinazepam,small molecule,experimental,ClC1=CC2=C(C=C1)N(CC#C)C(=O)CN=C2C1=CC=CC=C1,MFZOSKPPVCIFMT-UHFFFAOYSA-N,308.762,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB13335,Pinazepam,small molecule,experimental,ClC1=CC2=C(C=C1)N(CC#C)C(=O)CN=C2C1=CC=CC=C1,MFZOSKPPVCIFMT-UHFFFAOYSA-N,308.762,P14867,BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,Humans,ligand,yes
DB13343,Tioxolone,small molecule,experimental,OC1=CC2=C(SC(=O)O2)C=C1,SLYPOVJCSQHITR-UHFFFAOYSA-N,168.17,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB13345,Dihydroergocristine,small molecule,approved;experimental,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C,DEQITUUQPICUMR-HJPBWRTMSA-N,611.743,P08908,BE0004862,Serotonin Receptors,Humans,antagonist,yes
DB13345,Dihydroergocristine,small molecule,approved;experimental,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C,DEQITUUQPICUMR-HJPBWRTMSA-N,611.743,P18825,BE0000342,Alpha-2C adrenergic receptor,Humans,modulator,yes
DB13345,Dihydroergocristine,small molecule,approved;experimental,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C,DEQITUUQPICUMR-HJPBWRTMSA-N,611.743,P08588,BE0004872,Beta adrenergic receptor,Humans,antagonist;agonist,yes
DB13345,Dihydroergocristine,small molecule,approved;experimental,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C,DEQITUUQPICUMR-HJPBWRTMSA-N,611.743,P35348,BE0004888,Alpha adrenergic receptor,Humans,antagonist;agonist,yes
DB13345,Dihydroergocristine,small molecule,approved;experimental,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C,DEQITUUQPICUMR-HJPBWRTMSA-N,611.743,P21728,BE0009376,Dopamine receptor,Humans,antagonist;agonist,yes
DB13346,Bufexamac,small molecule,approved;withdrawn,CCCCOC1=CC=C(CC(=O)NO)C=C1,MXJWRABVEGLYDG-UHFFFAOYSA-N,223.272,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB13346,Bufexamac,small molecule,approved;withdrawn,CCCCOC1=CC=C(CC(=O)NO)C=C1,MXJWRABVEGLYDG-UHFFFAOYSA-N,223.272,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB13373,Acriflavine,small molecule,experimental,[Cl-].NC1=CC2=NC3=C(C=CC(N)=C3)C=C2C=C1.C[N+]1=C2C=C(N)C=CC2=CC2=C1C=C(N)C=C2,PEJLNXHANOHNSU-UHFFFAOYSA-N,468.99,P03366,BE0002050,Gag-Pol polyprotein,,modulator,yes
DB13421,Edoxudine,small molecule,approved;investigational;withdrawn,CCC1=CN([C@H]2C[C@H](O)[C@@H](CO)O2)C(=O)NC1=O,XACKNLSZYYIACO-DJLDLDEBSA-N,256.258,P04183,BE0001260,"Thymidine kinase, cytosolic",Humans,inhibitor,yes
DB13421,Edoxudine,small molecule,approved;investigational;withdrawn,CCC1=CN([C@H]2C[C@H](O)[C@@H](CO)O2)C(=O)NC1=O,XACKNLSZYYIACO-DJLDLDEBSA-N,256.258,Q91CQ6,BE0009350,DNA polymerase,Human herpesvirus 1,inhibitor,yes
DB13431,Proglumide,small molecule,experimental,CCCN(CCC)C(=O)C(CCC(O)=O)NC(=O)C1=CC=CC=C1,DGMKFQYCZXERLX-UHFFFAOYSA-N,334.416,P32238,BE0000402,Cholecystokinin receptor type A,Humans,antagonist,yes
DB13437,Medazepam,small molecule,experimental,CN1CCN=C(C2=CC=CC=C2)C2=C1C=CC(Cl)=C2,YLCXGBZIZBEVPZ-UHFFFAOYSA-N,270.757,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB13437,Medazepam,small molecule,experimental,CN1CCN=C(C2=CC=CC=C2)C2=C1C=CC(Cl)=C2,YLCXGBZIZBEVPZ-UHFFFAOYSA-N,270.757,P14867,BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,Humans,ligand,yes
DB13472,Cyclofenil,small molecule,experimental,CC(=O)OC1=CC=C(C=C1)C(=C1CCCCC1)C1=CC=C(OC(C)=O)C=C1,GVOUFPWUYJWQSK-UHFFFAOYSA-N,364.441,P03372,BE0000123,Estrogen receptor,Humans,modulator,yes
DB13478,Meptazinol,small molecule,experimental,CCC1(CCCCN(C)C1)C1=CC(O)=CC=C1,JLICHNCFTLFZJN-UHFFFAOYSA-N,233.355,P06276,BE0002180,Cholinesterase,Humans,inhibitor,yes
DB13481,Tenidap,small molecule,experimental,NC(=O)N1C(=O)\C(=C(/O)C2=CC=CS2)C2=C1C=CC(Cl)=C2,LXIKEPCNDFVJKC-QXMHVHEDSA-N,320.75,P09917,BE0000248,Polyunsaturated fatty acid 5-lipoxygenase,Humans,modulator,yes
DB13495,Paraoxon,small molecule,experimental,CCOP(=O)(OCC)OC1=CC=C(C=C1)[N+]([O-])=O,WYMSBXTXOHUIGT-UHFFFAOYSA-N,275.195,P00915,BE0000267,Carbonic anhydrase 1,Humans,inhibitor,yes
DB13495,Paraoxon,small molecule,experimental,CCOP(=O)(OCC)OC1=CC=C(C=C1)[N+]([O-])=O,WYMSBXTXOHUIGT-UHFFFAOYSA-N,275.195,P21554,BE0000061,Cannabinoid receptor 1,Humans,inhibitor,yes
DB13495,Paraoxon,small molecule,experimental,CCOP(=O)(OCC)OC1=CC=C(C=C1)[N+]([O-])=O,WYMSBXTXOHUIGT-UHFFFAOYSA-N,275.195,P22303,BE0000426,Acetylcholinesterase,Humans,inhibitor,yes
DB13495,Paraoxon,small molecule,experimental,CCOP(=O)(OCC)OC1=CC=C(C=C1)[N+]([O-])=O,WYMSBXTXOHUIGT-UHFFFAOYSA-N,275.195,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB13502,Budipine,small molecule,experimental,CC(C)(C)N1CCC(CC1)(C1=CC=CC=C1)C1=CC=CC=C1,QIHLUZAFSSMXHQ-UHFFFAOYSA-N,293.454,P27338,BE0002196,Amine oxidase [flavin-containing] B,Humans,modulator,yes
DB13505,Emepronium,small molecule,experimental,CC[N+](C)(C)C(C)CC(C1=CC=CC=C1)C1=CC=CC=C1,JEJBJBKVPOWOQK-UHFFFAOYSA-N,282.45,P08912,BE0000247,Muscarinic acetylcholine receptor M5,Humans,modulator,yes
DB13511,Clebopride,small molecule,experimental,COC1=CC(N)=C(Cl)C=C1C(=O)NC1CCN(CC2=CC=CC=C2)CC1,BVPWJMCABCPUQY-UHFFFAOYSA-N,373.88,P14416,BE0000756,D(2) dopamine receptor,Humans,inhibitor,yes
DB13511,Clebopride,small molecule,experimental,COC1=CC(N)=C(Cl)C=C1C(=O)NC1CCN(CC2=CC=CC=C2)CC1,BVPWJMCABCPUQY-UHFFFAOYSA-N,373.88,P22303,BE0000426,Acetylcholinesterase,Humans,inhibitor,yes
DB13520,Metergoline,small molecule,approved,[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)[C@@]1([H])C[C@@H](CNC(=O)OCC1=CC=CC=C1)CN2C,WZHJKEUHNJHDLS-QTGUNEKASA-N,403.526,P28335,BE0000533,5-hydroxytryptamine receptor 2C,Humans,antagonist,yes
DB13520,Metergoline,small molecule,approved,[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)[C@@]1([H])C[C@@H](CNC(=O)OCC1=CC=CC=C1)CN2C,WZHJKEUHNJHDLS-QTGUNEKASA-N,403.526,P28222,BE0000797,5-hydroxytryptamine receptor 1B,Humans,antagonist,yes
DB13520,Metergoline,small molecule,approved,[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)[C@@]1([H])C[C@@H](CNC(=O)OCC1=CC=CC=C1)CN2C,WZHJKEUHNJHDLS-QTGUNEKASA-N,403.526,P28566,BE0000476,5-hydroxytryptamine receptor 1E,Humans,antagonist,yes
DB13520,Metergoline,small molecule,approved,[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)[C@@]1([H])C[C@@H](CNC(=O)OCC1=CC=CC=C1)CN2C,WZHJKEUHNJHDLS-QTGUNEKASA-N,403.526,P30939,BE0000460,5-hydroxytryptamine receptor 1F,Humans,antagonist,yes
DB13520,Metergoline,small molecule,approved,[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)[C@@]1([H])C[C@@H](CNC(=O)OCC1=CC=CC=C1)CN2C,WZHJKEUHNJHDLS-QTGUNEKASA-N,403.526,P47898,BE0004688,5-hydroxytryptamine receptor 5A,Humans,antagonist,yes
DB13520,Metergoline,small molecule,approved,[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)[C@@]1([H])C[C@@H](CNC(=O)OCC1=CC=CC=C1)CN2C,WZHJKEUHNJHDLS-QTGUNEKASA-N,403.526,P28221,BE0000659,5-hydroxytryptamine receptor 1D,Humans,antagonist,yes
DB13520,Metergoline,small molecule,approved,[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)[C@@]1([H])C[C@@H](CNC(=O)OCC1=CC=CC=C1)CN2C,WZHJKEUHNJHDLS-QTGUNEKASA-N,403.526,P41595,BE0000393,5-hydroxytryptamine receptor 2B,Humans,antagonist,yes
DB13520,Metergoline,small molecule,approved,[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)[C@@]1([H])C[C@@H](CNC(=O)OCC1=CC=CC=C1)CN2C,WZHJKEUHNJHDLS-QTGUNEKASA-N,403.526,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB13530,Mepindolol,small molecule,experimental,CC(C)NCC(O)COC1=CC=CC2=C1C=C(C)N2,NXWGWUVGUSFQJC-UHFFFAOYSA-N,262.353,P13945,BE0001012,Beta-3 adrenergic receptor,Humans,modulator,yes
DB13550,Bifemelane,small molecule,experimental,CNCCCCOC1=CC=CC=C1CC1=CC=CC=C1,QSQQPMHPCBLLGX-UHFFFAOYSA-N,269.388,P21397,BE0002198,Amine oxidase [flavin-containing] A,Humans,modulator,yes
DB13552,Trifluperidol,small molecule,experimental,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC(=CC=C1)C(F)(F)F,GPMXUUPHFNMNDH-UHFFFAOYSA-N,409.425,P23946,BE0001038,Chymase,Humans,modulator,yes
DB13559,Rimiterol,small molecule,experimental,O[C@@H]([C@@H]1CCCCN1)C1=CC(O)=C(O)C=C1,IYMMESGOJVNCKV-JOYOIKCWSA-N,223.272,P13945,BE0001012,Beta-3 adrenergic receptor,Humans,modulator,yes
DB13581,Rociverine,small molecule,experimental,CCN(CC)CC(C)OC(=O)[C@H]1CCCC[C@]1(O)C1CCCCC1,XPYLKZZOBVLVHB-QDKIRNHSSA-N,339.52,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,antagonist,yes
DB13581,Rociverine,small molecule,experimental,CCN(CC)CC(C)OC(=O)[C@H]1CCCC[C@]1(O)C1CCCCC1,XPYLKZZOBVLVHB-QDKIRNHSSA-N,339.52,P08172,BE0000560,Muscarinic acetylcholine receptor M2,Humans,antagonist,yes
DB13581,Rociverine,small molecule,experimental,CCN(CC)CC(C)OC(=O)[C@H]1CCCC[C@]1(O)C1CCCCC1,XPYLKZZOBVLVHB-QDKIRNHSSA-N,339.52,P20309,BE0000045,Muscarinic acetylcholine receptor M3,Humans,antagonist,yes
DB13581,Rociverine,small molecule,experimental,CCN(CC)CC(C)OC(=O)[C@H]1CCCC[C@]1(O)C1CCCCC1,XPYLKZZOBVLVHB-QDKIRNHSSA-N,339.52,P08173,BE0000405,Muscarinic acetylcholine receptor M4,Humans,antagonist,yes
DB13581,Rociverine,small molecule,experimental,CCN(CC)CC(C)OC(=O)[C@H]1CCCC[C@]1(O)C1CCCCC1,XPYLKZZOBVLVHB-QDKIRNHSSA-N,339.52,P08912,BE0000247,Muscarinic acetylcholine receptor M5,Humans,antagonist,yes
DB13596,Oxycinchophen,small molecule,experimental,OC(=O)C1=C(O)C(=NC2=CC=CC=C12)C1=CC=CC=C1,XAPRFLSJBSXESP-UHFFFAOYSA-N,265.2634,Q08210,BE0000612,"Dihydroorotate dehydrogenase (quinone), mitochondrial",Plasmodium falciparum (isolate 3D7),inhibitor,yes
DB13615,Mifamurtide,small molecule,approved;experimental,O.[Na+].CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCCNC(=O)[C@H](C)NC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@@H]([C@H](O)[C@H](O)CO)[C@@H](NC(C)=O)C=O)C(N)=O)OC(=O)CCCCCCCCCCCCCCC,NGIYLSFJGRLEMI-MHTUOZSYSA-M,1277.515,O00206,BE0002442,Toll-like receptor 4,Humans,ligand,yes
DB13615,Mifamurtide,small molecule,approved;experimental,O.[Na+].CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCCNC(=O)[C@H](C)NC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@@H]([C@H](O)[C@H](O)CO)[C@@H](NC(C)=O)C=O)C(N)=O)OC(=O)CCCCCCCCCCCCCCC,NGIYLSFJGRLEMI-MHTUOZSYSA-M,1277.515,Q9HC29,BE0009323,Nucleotide-binding oligomerization domain-containing protein 2,Humans,ligand,yes
DB13616,Melagatran,small molecule,experimental,[H][C@]1(CCN1C(=O)[C@H](NCC(O)=O)C1CCCCC1)C(=O)NCC1=CC=C(C=C1)C(N)=N,DKWNMCUOEDMMIN-PKOBYXMFSA-N,429.5126,P00734,BE0000048,Prothrombin,Humans,inhibitor,yes
DB13616,Melagatran,small molecule,experimental,[H][C@]1(CCN1C(=O)[C@H](NCC(O)=O)C1CCCCC1)C(=O)NCC1=CC=C(C=C1)C(N)=N,DKWNMCUOEDMMIN-PKOBYXMFSA-N,429.5126,P00747,BE0000211,Plasminogen,Humans,inhibitor,yes
DB13616,Melagatran,small molecule,experimental,[H][C@]1(CCN1C(=O)[C@H](NCC(O)=O)C1CCCCC1)C(=O)NCC1=CC=C(C=C1)C(N)=N,DKWNMCUOEDMMIN-PKOBYXMFSA-N,429.5126,P07477,BE0001739,Serine protease 1,Humans,inhibitor,yes
DB13616,Melagatran,small molecule,experimental,[H][C@]1(CCN1C(=O)[C@H](NCC(O)=O)C1CCCCC1)C(=O)NCC1=CC=C(C=C1)C(N)=N,DKWNMCUOEDMMIN-PKOBYXMFSA-N,429.5126,P00742,BE0000216,Coagulation factor X,Humans,inhibitor,yes
DB13643,Loprazolam,small molecule,experimental,[H]\C(N1CCN(C)CC1)=C1\N=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(=C3)N(=O)=O)N2C1=O,UTEFBSAVJNEPTR-RGEXLXHISA-N,464.904,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB13648,Alcuronium,small molecule,experimental,[H][C@@]12C[C@@]3([H])\C(C[N@+]1(CC=C)CC[C@@]21C2=C(C=CC=C2)N2\C=C4/[C@]5([H])N(\C=C3/[C@@]12[H])C1=C(C=CC=C1)[C@@]51CC[N@@+]2(CC=C)C\C(=C\CO)[C@]4([H])C[C@@]12[H])=C/CO,MUQUYTSLDVKIOF-CHJKCJHBSA-N,666.909,P36544,BE0002341,Neuronal acetylcholine receptor subunit alpha-7,Humans,inhibitor,yes
DB13665,Fluanisone,small molecule,experimental,COC1=CC=CC=C1N1CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1,IRYFCWPNDIUQOW-UHFFFAOYSA-N,356.441,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,inhibitor,yes
DB13665,Fluanisone,small molecule,experimental,COC1=CC=CC=C1N1CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1,IRYFCWPNDIUQOW-UHFFFAOYSA-N,356.441,P35368,BE0000575,Alpha-1B adrenergic receptor,Humans,inhibitor,yes
DB13665,Fluanisone,small molecule,experimental,COC1=CC=CC=C1N1CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1,IRYFCWPNDIUQOW-UHFFFAOYSA-N,356.441,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,inhibitor,yes
DB13665,Fluanisone,small molecule,experimental,COC1=CC=CC=C1N1CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1,IRYFCWPNDIUQOW-UHFFFAOYSA-N,356.441,P14416,BE0000756,D(2) dopamine receptor,Humans,inhibitor,yes
DB13665,Fluanisone,small molecule,experimental,COC1=CC=CC=C1N1CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1,IRYFCWPNDIUQOW-UHFFFAOYSA-N,356.441,P25100,BE0000715,Alpha-1D adrenergic receptor,Humans,inhibitor,yes
DB13667,Cefozopran,small molecule,experimental,[H][C@]12SCC(C[N+]3=C4C=CC=NN4C=C3)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=NSC(N)=N1)C([O-])=O,QDUIJCOKQCCXQY-WHJQOFBOSA-N,515.52,P0AC13,BE0000803,Dihydropteroate synthase,Escherichia coli (strain K12),inhibitor,yes
DB13715,Dilazep,small molecule,experimental,COC1=CC(=CC(OC)=C1OC)C(=O)OCCCN1CCCN(CCCOC(=O)C2=CC(OC)=C(OC)C(OC)=C2)CC1,QVZCXCJXTMIDME-UHFFFAOYSA-N,604.697,Q99808,BE0001204,Equilibrative nucleoside transporter 1,Humans,inhibitor,yes
DB13716,Dibutylphthalate,small molecule,experimental,CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC,DOIRQSBPFJWKBE-UHFFFAOYSA-N,278.3435,O75762,BE0001122,Transient receptor potential cation channel subfamily A member 1,Humans,activator,yes
DB13720,Diphemanil,small molecule,approved;vet_approved;withdrawn,C[N+]1(C)CCC(CC1)=C(C1=CC=CC=C1)C1=CC=CC=C1,LCTZPQRFOZKZNK-UHFFFAOYSA-N,278.418,P20309,BE0000045,Muscarinic acetylcholine receptor M3,Humans,antagonist,yes
DB13720,Diphemanil,small molecule,approved;vet_approved;withdrawn,C[N+]1(C)CCC(CC1)=C(C1=CC=CC=C1)C1=CC=CC=C1,LCTZPQRFOZKZNK-UHFFFAOYSA-N,278.418,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,modulator,yes
DB13746,Bioallethrin,small molecule,approved;experimental,CC(C)=CC1C(C(=O)OC2CC(=O)C(CC=C)=C2C)C1(C)C,ZCVAOQKBXKSDMS-UHFFFAOYSA-N,302.414,Q86DI9,BE0009367,Sodium channel protein,Pediculus humanus,modulator,yes
DB13750,Obidoxime,small molecule,experimental,O\N=C\C1=CC=[N+](COC[N+]2=CC=C(\C=N\O)C=C2)C=C1,HIGRLDNHDGYWQJ-UHFFFAOYSA-P,288.3018,P22303,BE0000426,Acetylcholinesterase,Humans,inhibitor,yes
DB13751,Glycyrrhizic acid,small molecule,approved;experimental,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O[C@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O,LPLVUJXQOOQHMX-QWBHMCJMSA-N,822.942,P28845,BE0000329,11-beta-hydroxysteroid dehydrogenase 1,Humans,antagonist,yes
DB13751,Glycyrrhizic acid,small molecule,approved;experimental,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O[C@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O,LPLVUJXQOOQHMX-QWBHMCJMSA-N,822.942,P01375,BE0000704,Tumor necrosis factor,Humans,antagonist,yes
DB13751,Glycyrrhizic acid,small molecule,approved;experimental,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O[C@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O,LPLVUJXQOOQHMX-QWBHMCJMSA-N,822.942,P42574,BE0001162,Caspase-3,Humans,antagonist,yes
DB13751,Glycyrrhizic acid,small molecule,approved;experimental,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O[C@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O,LPLVUJXQOOQHMX-QWBHMCJMSA-N,822.942,Q00653,BE0004903,Nuclear factor NF-kappa-B,Humans,translocation inhibitor,yes
DB13751,Glycyrrhizic acid,small molecule,approved;experimental,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O[C@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O,LPLVUJXQOOQHMX-QWBHMCJMSA-N,822.942,P06858,BE0000239,Lipoprotein lipase,Humans,inducer,yes
DB13757,Epanolol,small molecule,experimental,OC(CNCCNC(=O)CC1=CC=C(O)C=C1)COC1=CC=CC=C1C#N,YARKMNAWFIMDKV-UHFFFAOYSA-N,369.421,P13945,BE0001012,Beta-3 adrenergic receptor,Humans,modulator,yes
DB13766,Lidoflazine,small molecule,approved;experimental,CC1=CC=CC(C)=C1NC(=O)CN1CCN(CCCC(C2=CC=C(F)C=C2)C2=CC=C(F)C=C2)CC1,ZBIAKUMOEKILTF-UHFFFAOYSA-N,491.627,Q9NY46,BE0002082,Sodium channel protein type 3 subunit alpha,Humans,inhibitor,yes
DB13766,Lidoflazine,small molecule,approved;experimental,CC1=CC=CC(C)=C1NC(=O)CN1CCN(CCCC(C2=CC=C(F)C=C2)C2=CC=C(F)C=C2)CC1,ZBIAKUMOEKILTF-UHFFFAOYSA-N,491.627,Q99808,BE0001204,Equilibrative nucleoside transporter 1,Humans,inhibitor,yes
DB13767,Vorozole,small molecule,experimental,CN1N=NC2=CC=C(C=C12)[C@@H](N1C=NC=N1)C1=CC=C(Cl)C=C1,XLMPPFTZALNBFS-INIZCTEOSA-N,324.77,P11511,BE0002090,Aromatase,Humans,inhibitor,yes
DB13775,Tertatolol,small molecule,experimental,CC(C)(C)NCC(O)COC1=CC=CC2=C1SCCC2,HTWFXPCUFWKXOP-UHFFFAOYSA-N,295.44,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,inhibitor,yes
DB13777,Prenalterol,small molecule,experimental,CC(C)NC[C@H](O)COC1=CC=C(O)C=C1,ADUKCCWBEDSMEB-NSHDSACASA-N,225.288,P13945,BE0001012,Beta-3 adrenergic receptor,Humans,agonist,yes
DB13781,Xamoterol,small molecule,approved,OC(CNCCNC(=O)N1CCOCC1)COC1=CC=C(O)C=C1,DXPOSRCHIDYWHW-UHFFFAOYSA-N,339.392,P13945,BE0001012,Beta-3 adrenergic receptor,Humans,agonist,yes
DB13781,Xamoterol,small molecule,approved,OC(CNCCNC(=O)N1CCOCC1)COC1=CC=C(O)C=C1,DXPOSRCHIDYWHW-UHFFFAOYSA-N,339.392,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,partial agonist,yes
DB13783,Acemetacin,small molecule,approved;investigational,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(=O)OCC(O)=O,FSQKKOOTNAMONP-UHFFFAOYSA-N,415.83,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,antagonist,yes
DB13783,Acemetacin,small molecule,approved;investigational,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(=O)OCC(O)=O,FSQKKOOTNAMONP-UHFFFAOYSA-N,415.83,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,antagonist,yes
DB13791,Penfluridol,small molecule,experimental,OC1(CCN(CCCC(C2=CC=C(F)C=C2)C2=CC=C(F)C=C2)CC1)C1=CC(=C(Cl)C=C1)C(F)(F)F,MDLAAYDRRZXJIF-UHFFFAOYSA-N,523.97,O43497,BE0000483,Voltage-dependent T-type calcium channel subunit alpha-1G,Humans,blocker,yes
DB13793,Vinburnine,small molecule,experimental,[H][C@]12N3CCC[C@@]1(CC)CC(=O)N1C4=CC=CC=C4C(CC3)=C21,WYJAPUKIYAZSEM-MOPGFXCFSA-N,294.398,P20309,BE0000045,Muscarinic acetylcholine receptor M3,Humans,allosteric modulator,yes
DB13806,Linopirdine,small molecule,experimental,O=C1N(C2=CC=CC=C2C1(CC1=CC=NC=C1)CC1=CC=NC=C1)C1=CC=CC=C1,YEJCDKJIEMIWRQ-UHFFFAOYSA-N,391.474,O43525,BE0002398,Potassium voltage-gated channel subfamily KQT member 3,Humans,modulator,yes
DB13810,Dimemorfan,small molecule,experimental,CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC1=CC=C(C)C=C31,KBEZZLAAKIIPFK-NJAFHUGGSA-N,255.405,Q99720,BE0000156,Sigma non-opioid intracellular receptor 1,Humans,agonist,yes
DB13837,Doxefazepam,small molecule,experimental,OCCN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1F,VOJLELRQLPENHL-UHFFFAOYSA-N,348.756,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB13837,Doxefazepam,small molecule,experimental,OCCN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1F,VOJLELRQLPENHL-UHFFFAOYSA-N,348.756,P14867,BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,Humans,ligand,yes
DB13853,Anethole trithione,small molecule,approved;experimental,COC1=CC=C(C=C1)C1=CC(=S)SS1,KYLIZBIRMBGUOP-UHFFFAOYSA-N,240.35,P21980,BE0001035,Protein-glutamine gamma-glutamyltransferase 2,Humans,inhibitor,yes
DB13857,Demegestone,small molecule,experimental,[H][C@@]12CC[C@](C)(C(C)=O)[C@@]1(C)CCC1=C3CCC(=O)C=C3CC[C@@]21[H],JWAHBTQSSMYISL-MHTWAQMVSA-N,312.4458,P06401,BE0000557,Progesterone receptor,Humans,agonist,yes
DB13867,Fluticasone,small molecule,approved;experimental,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,MGNNYOODZCAHBA-GQKYHHCASA-N,444.51,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB13868,Adefovir,small molecule,investigational,NC1=C2N=CN(CCOCP(O)(O)=O)C2=NC=N1,SUPKOOSCJHTBAH-UHFFFAOYSA-N,273.1857,P24024,BE0000312,Protein P,HBV-D,inhibitor,yes
DB13868,Adefovir,small molecule,investigational,NC1=C2N=CN(CCOCP(O)(O)=O)C2=NC=N1,SUPKOOSCJHTBAH-UHFFFAOYSA-N,273.1857,P04293,BE0000308,DNA polymerase catalytic subunit,HHV-1,inhibitor,yes
DB13872,Lormetazepam,small molecule,approved,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1Cl,FJIKWRGCXUCUIG-UHFFFAOYSA-N,335.185,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB13872,Lormetazepam,small molecule,approved,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1Cl,FJIKWRGCXUCUIG-UHFFFAOYSA-N,335.185,P14867,BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,Humans,ligand,yes
DB13873,Fenofibric acid,small molecule,approved,CC(C)(OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1)C(O)=O,MQOBSOSZFYZQOK-UHFFFAOYSA-N,318.75,Q07869,BE0000071,Peroxisome proliferator-activated receptor alpha,Humans,agonist,yes
DB13873,Fenofibric acid,small molecule,approved,CC(C)(OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1)C(O)=O,MQOBSOSZFYZQOK-UHFFFAOYSA-N,318.75,P07148,BE0003998,"Fatty acid-binding protein, liver",Humans,inhibitor,yes
DB13874,Enasidenib,small molecule,approved;investigational,CC(C)(O)CNC1=NC(=NC(NC2=CC(=NC=C2)C(F)(F)F)=N1)C1=NC(=CC=C1)C(F)(F)F,DYLUUSLLRIQKOE-UHFFFAOYSA-N,473.383,O75874,BE0001251,Isocitrate dehydrogenase [NADP] cytoplasmic,Humans,inhibitor,yes
DB13874,Enasidenib,small molecule,approved;investigational,CC(C)(O)CNC1=NC(=NC(NC2=CC(=NC=C2)C(F)(F)F)=N1)C1=NC(=CC=C1)C(F)(F)F,DYLUUSLLRIQKOE-UHFFFAOYSA-N,473.383,P50213,BE0000011,"Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial",Humans,inhibitor,yes
DB13874,Enasidenib,small molecule,approved;investigational,CC(C)(O)CNC1=NC(=NC(NC2=CC(=NC=C2)C(F)(F)F)=N1)C1=NC(=CC=C1)C(F)(F)F,DYLUUSLLRIQKOE-UHFFFAOYSA-N,473.383,O43837,BE0000559,"Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial",Humans,inhibitor,yes
DB13874,Enasidenib,small molecule,approved;investigational,CC(C)(O)CNC1=NC(=NC(NC2=CC(=NC=C2)C(F)(F)F)=N1)C1=NC(=CC=C1)C(F)(F)F,DYLUUSLLRIQKOE-UHFFFAOYSA-N,473.383,P51553,BE0000771,"Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial",Humans,inhibitor,yes
DB13874,Enasidenib,small molecule,approved;investigational,CC(C)(O)CNC1=NC(=NC(NC2=CC(=NC=C2)C(F)(F)F)=N1)C1=NC(=CC=C1)C(F)(F)F,DYLUUSLLRIQKOE-UHFFFAOYSA-N,473.383,P48735,BE0004527,"Isocitrate dehydrogenase [NADP], mitochondrial",Humans,inhibitor,yes
DB13878,Pibrentasvir,small molecule,approved;investigational,CO[C@H](C)[C@H](NC(=O)OC)C(=O)N1CCC[C@H]1C1=NC2=C(N1)C=C(F)C(=C2)[C@H]1CC[C@@H](N1C1=CC(F)=C(N2CCC(CC2)C2=CC=C(F)C=C2)C(F)=C1)C1=CC2=C(NC(=N2)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)OC)[C@@H](C)OC)C=C1F,VJYSBPDEJWLKKJ-NLIMODCCSA-N,1113.201,Q5L478,BE0008651,Nonstructural protein 5A,Hepatitis C Virus,inhibitor,yes
DB13879,Glecaprevir,small molecule,approved;investigational,[H][C@@]12CN(C(=O)[C@@]([H])(NC(=O)O[C@]3([H])CCC[C@@]3([H])OC\C=C\C(F)(F)C3=NC4=C(C=CC=C4)N=C3O1)C(C)(C)C)[C@@]([H])(C2)C(=O)N[C@@]1(C[C@H]1C(F)F)C(=O)NS(=O)(=O)C1(C)CC1,MLSQGNCUYAMAHD-ITNVBOSISA-N,838.87,Q91RS4,BE0004004,NS3 protease,Hepatitis C Virus,inhibitor,yes
DB13879,Glecaprevir,small molecule,approved;investigational,[H][C@@]12CN(C(=O)[C@@]([H])(NC(=O)O[C@]3([H])CCC[C@@]3([H])OC\C=C\C(F)(F)C3=NC4=C(C=CC=C4)N=C3O1)C(C)(C)C)[C@@]([H])(C2)C(=O)N[C@@]1(C[C@H]1C(F)F)C(=O)NS(=O)(=O)C1(C)CC1,MLSQGNCUYAMAHD-ITNVBOSISA-N,838.87,B0B3C9,BE0004701,Genome polyprotein,Hepatitis C Virus,inhibitor,yes
DB13912,Coumermycin A1,small molecule,experimental,CO[C@H]1[C@H](OC(=O)C2=CC=C(C)N2)[C@H](O)[C@@H](OC2=C(C)C3=C(C=C2)C(O)=C(NC(=O)C2=C(C)C(=CN2)C(=O)NC2=C(O)C4=C(OC2=O)C(C)=C(O[C@H]2OC(C)(C)[C@@H](OC)[C@H](OC(=O)C5=CC=C(C)N5)[C@@H]2O)C=C4)C(=O)O3)OC1(C)C,WTIJXIZOODAMJT-IYKSDEDASA-N,1110.092,P0AES6,BE0000799,DNA gyrase subunit B,Escherichia coli (strain K12),inhibitor,yes
DB13914,Volixibat,small molecule,experimental;investigational,[H][C@@]1([C@@H](O)[C@](CC)(CCCC)CS(=O)(=O)C2=CC=C(C=C12)N(C)C)C1=CC=CC(NC(=O)N[C@@H]2O[C@H](COS(O)(=O)=O)[C@@H](O)[C@H](OCC3=CC=CC=C3)[C@H]2O)=C1,ULVBLFBUTQMAGZ-RTNCXNSASA-N,805.96,Q12908,BE0003643,Ileal sodium/bile acid cotransporter,Humans,inhibitor,yes
DB13919,Candesartan,small molecule,experimental,CCOC1=NC2=CC=CC(C(O)=O)=C2N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NN=NN1,HTQMVQVXFRQIKW-UHFFFAOYSA-N,440.454,P30556,BE0000062,Type-1 angiotensin II receptor,Humans,antagonist,yes
DB13920,Valopicitabine,small molecule,experimental,CC(C)[C@H](N)C(=O)O[C@@H]1[C@@H](CO)O[C@@H](N2C=CC(N)=NC2=O)[C@]1(C)O,TVRCRTJYMVTEFS-ICGCPXGVSA-N,356.379,P26664,BE0003427,Genome polyprotein,,modulator,yes
DB13925,Dotatate gallium Ga-68,small molecule,approved;investigational,[68Ga+3].C[C@@H](O)[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)CN2CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@H](CC2=CNC3=C2C=CC=C3)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(O)=O,XBJPSVQFCQFGDC-WSCOIBMGSA-K,1500.54,P30874,BE0003528,Somatostatin receptor type 2,Humans,binder,yes
DB13928,Semaglutide,small molecule,approved;investigational,CC[C@H](C)[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)C(C)(C)NC(=O)[C@@H](N)CC1=CN=CN1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O,DLSWIYLPEUIQAV-CCUURXOWSA-N,4113.641,P43220,BE0000857,Glucagon-like peptide 1 receptor,Humans,agonist,yes
DB13930,Ulixertinib,small molecule,investigational,[H]N([C@H](CO)C1=CC(Cl)=CC=C1)C(=O)C1=CC(=CN1[H])C1=CC(=NC=C1Cl)N([H])C(C)C,KSERXGMCDHOLSS-LJQANCHMSA-N,433.33,P29323,BE0004549,Ephrin type-B receptor 2,Humans,inhibitor,yes
DB13931,Netarsudil,small molecule,approved,CC1=CC(C)=C(C=C1)C(=O)OCC1=CC=C(C=C1)[C@@H](CN)C(=O)NC1=CC=C2C=NC=CC2=C1,OURRXQUGYQRVML-AREMUKBSSA-N,453.542,Q13464,BE0001016,Rho-associated protein kinase 1,Humans,inhibitor,yes
DB13931,Netarsudil,small molecule,approved,CC1=CC(C)=C(C=C1)C(=O)OCC1=CC=C(C=C1)[C@@H](CN)C(=O)NC1=CC=C2C=NC=CC2=C1,OURRXQUGYQRVML-AREMUKBSSA-N,453.542,O75116,BE0004191,Rho-associated protein kinase 2,Humans,inhibitor,yes
DB13931,Netarsudil,small molecule,approved,CC1=CC(C)=C(C=C1)C(=O)OCC1=CC=C(C=C1)[C@@H](CN)C(=O)NC1=CC=C2C=NC=CC2=C1,OURRXQUGYQRVML-AREMUKBSSA-N,453.542,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,inhibitor,yes
DB13939,RAD-140,small molecule,experimental;investigational,[H][C@@](C)(O)[C@@]([H])(NC1=C(C)C(Cl)=C(C=C1)C#N)C1=NN=C(O1)C1=CC=C(C=C1)C#N,XMBUPPIEVAFYHO-KPZWWZAWSA-N,393.83,P10275,BE0000132,Androgen receptor,Humans,modulator,yes
DB13943,Testosterone cypionate,small molecule,approved,[H][C@@]12CC[C@H](OC(=O)CCC3CCCC3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,HPFVBGJFAYZEBE-ZLQWOROUSA-N,412.614,P10275,BE0000132,Androgen receptor,Humans,agonist,yes
DB13944,Testosterone enanthate,small molecule,approved,[H][C@@]12CC[C@H](OC(=O)CCCCCC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,VOCBWIIFXDYGNZ-IXKNJLPQSA-N,400.594,P10275,BE0000132,Androgen receptor,Humans,agonist,yes
DB13946,Testosterone undecanoate,small molecule,approved;investigational,CCCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,UDSFVOAUHKGBEK-CNQKSJKFSA-N,456.711,P10275,BE0000132,Androgen receptor,Humans,agonist,yes
DB13950,WIN 55212-2,small molecule,experimental,CC1=C(C(=O)C2=CC=CC3=CC=CC=C23)C2=C3N1[C@H](CN1CCOCC1)COC3=CC=C2,HQVHOQAKMCMIIM-HXUWFJFHSA-N,426.516,P21554,BE0000061,Cannabinoid receptor 1,Humans,inhibitor,yes
DB13950,WIN 55212-2,small molecule,experimental,CC1=C(C(=O)C2=CC=CC3=CC=CC=C23)C2=C3N1[C@H](CN1CCOCC1)COC3=CC=C2,HQVHOQAKMCMIIM-HXUWFJFHSA-N,426.516,P34972,BE0000095,Cannabinoid receptor 2,Humans,inhibitor,yes
DB13952,Estradiol acetate,small molecule,approved;investigational;vet_approved,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(OC(C)=O)C=C3CC[C@@]21[H],FHXBMXJMKMWVRG-SLHNCBLASA-N,314.4186,P03372,BE0000123,Estrogen receptor,Humans,agonist,yes
DB13952,Estradiol acetate,small molecule,approved;investigational;vet_approved,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(OC(C)=O)C=C3CC[C@@]21[H],FHXBMXJMKMWVRG-SLHNCBLASA-N,314.4186,Q92731,BE0000792,Estrogen receptor beta,Humans,agonist,yes
DB13953,Estradiol benzoate,small molecule,approved;investigational;vet_approved,[H][C@]1(O)CC[C@@]2([H])[C@]3([H])CCC4=CC(OC(=O)C5=CC=CC=C5)=CC=C4[C@@]3([H])CC[C@]12C,UYIFTLBWAOGQBI-BZDYCCQFSA-N,376.488,P03372,BE0000123,Estrogen receptor,Humans,agonist,yes
DB13953,Estradiol benzoate,small molecule,approved;investigational;vet_approved,[H][C@]1(O)CC[C@@]2([H])[C@]3([H])CCC4=CC(OC(=O)C5=CC=CC=C5)=CC=C4[C@@]3([H])CC[C@]12C,UYIFTLBWAOGQBI-BZDYCCQFSA-N,376.488,Q92731,BE0000792,Estrogen receptor beta,Humans,agonist,yes
DB13954,Estradiol cypionate,small molecule,approved;investigational;vet_approved,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(O)=CC=C4[C@@]3([H])CC[C@]12C)OC(=O)CCC1CCCC1,UOACKFBJUYNSLK-XRKIENNPSA-N,396.5622,P03372,BE0000123,Estrogen receptor,Humans,agonist,yes
DB13954,Estradiol cypionate,small molecule,approved;investigational;vet_approved,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(O)=CC=C4[C@@]3([H])CC[C@]12C)OC(=O)CCC1CCCC1,UOACKFBJUYNSLK-XRKIENNPSA-N,396.5622,Q92731,BE0000792,Estrogen receptor beta,Humans,agonist,yes
DB13955,Estradiol dienanthate,small molecule,approved;investigational;vet_approved,CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(OC(=O)CCCCCC)=CC=C4[C@H]3CC[C@]12C,OVAHZPTYWMWNKO-CAHAWPIUSA-N,496.732,P03372,BE0000123,Estrogen receptor,Humans,agonist,yes
DB13955,Estradiol dienanthate,small molecule,approved;investigational;vet_approved,CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(OC(=O)CCCCCC)=CC=C4[C@H]3CC[C@]12C,OVAHZPTYWMWNKO-CAHAWPIUSA-N,496.732,Q92731,BE0000792,Estrogen receptor beta,Humans,agonist,yes
DB13956,Estradiol valerate,small molecule,approved;investigational;vet_approved,[H][C@@]12CC[C@H](OC(=O)CCCC)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,RSEPBGGWRJCQGY-RBRWEJTLSA-N,356.4984,P03372,BE0000123,Estrogen receptor,Humans,agonist,yes
DB13956,Estradiol valerate,small molecule,approved;investigational;vet_approved,[H][C@@]12CC[C@H](OC(=O)CCCC)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,RSEPBGGWRJCQGY-RBRWEJTLSA-N,356.4984,Q92731,BE0000792,Estrogen receptor beta,Humans,agonist,yes
DB13960,Bronopol,small molecule,approved,OCC(Br)(CO)[N+]([O-])=O,LVDKZNITIUWNER-UHFFFAOYSA-N,199.988,,BE0009370,Thiol groups,Humans,oxidizer,yes
DB13967,Patent Blue,small molecule,approved,CCN(CC)C1=CC=C(C=C1)C(=C1C=CC(C=C1)=[N+](CC)CC)C1=C(C=C(C(O)=C1)S(O)(=O)=O)S(O)(=O)=O,DHAHKSQXIXFZJB-UHFFFAOYSA-O,561.69,P02768,BE0000530,Albumin,Humans,binder,yes
DB13978,Selisistat,small molecule,experimental,NC(=O)C1CCCC2=C1NC1=C2C=C(Cl)C=C1,FUZYTVDVLBBXDL-UHFFFAOYSA-N,248.71,Q96EB6,BE0002461,NAD-dependent protein deacetylase sirtuin-1,Humans,inhibitor,yes
DB13981,Nomegestrol acetate,small molecule,approved;investigational,[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3C(C)=C[C@@]21[H],IIVBFTNIGYRNQY-YQLZSBIMSA-N,370.489,P03372,BE0000123,Estrogen receptor,Humans,modulator,yes
DB13985,Lutetium Lu 177 dotatate,small molecule,approved;investigational,[177Lu+3].C[C@@H](O)[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)CN2CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@H](CC2=CNC3=C2C=CC=C3)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(O)=O,MXDPZUIOZWKRAA-PRDSJKGBSA-K,1609.55,P30874,BE0003528,Somatostatin receptor type 2,Humans,agonist,yes
DB13985,Lutetium Lu 177 dotatate,small molecule,approved;investigational,[177Lu+3].C[C@@H](O)[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)CN2CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@H](CC2=CNC3=C2C=CC=C3)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(O)=O,MXDPZUIOZWKRAA-PRDSJKGBSA-K,1609.55,P30872,BE0000452,Somatostatin receptor type 1,Humans,agonist,yes
DB13985,Lutetium Lu 177 dotatate,small molecule,approved;investigational,[177Lu+3].C[C@@H](O)[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)CN2CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@H](CC2=CNC3=C2C=CC=C3)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(O)=O,MXDPZUIOZWKRAA-PRDSJKGBSA-K,1609.55,P32745,BE0003529,Somatostatin receptor type 3,Humans,agonist,yes
DB13985,Lutetium Lu 177 dotatate,small molecule,approved;investigational,[177Lu+3].C[C@@H](O)[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)CN2CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@H](CC2=CNC3=C2C=CC=C3)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(O)=O,MXDPZUIOZWKRAA-PRDSJKGBSA-K,1609.55,P31391,BE0009273,Somatostatin receptor type 4,Humans,agonist,yes
DB13985,Lutetium Lu 177 dotatate,small molecule,approved;investigational,[177Lu+3].C[C@@H](O)[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)CN2CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@H](CC2=CNC3=C2C=CC=C3)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(O)=O,MXDPZUIOZWKRAA-PRDSJKGBSA-K,1609.55,P35346,BE0002147,Somatostatin receptor type 5,Humans,agonist,yes
DB13993,MRK-409,small molecule,experimental,CN1N=CN=C1COC1=NN2C(C=C1C1CCC1)=NN=C2C1=C(F)C=CC=C1F,GOIFCXRIFSYPFG-UHFFFAOYSA-N,397.39,P47869,BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,Humans,modulator,yes
DB13993,MRK-409,small molecule,experimental,CN1N=CN=C1COC1=NN2C(C=C1C1CCC1)=NN=C2C1=C(F)C=CC=C1F,GOIFCXRIFSYPFG-UHFFFAOYSA-N,397.39,P34903,BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,Humans,modulator,yes
DB13994,AZD-7325,small molecule,investigational,CCCNC(=O)C1=C(N)C2=CC=CC(=C2N=N1)C1=C(F)C=CC=C1OC,KYDURMHFWXCKMW-UHFFFAOYSA-N,354.385,P34903,BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,Humans,positive allosteric modulator,yes
DB13994,AZD-7325,small molecule,investigational,CCCNC(=O)C1=C(N)C2=CC=CC(=C2N=N1)C1=C(F)C=CC=C1OC,KYDURMHFWXCKMW-UHFFFAOYSA-N,354.385,P47869,BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,Humans,positive allosteric modulator,yes
DB13995,Ferric pyrophosphate citrate,small molecule,approved;investigational,[Fe+3].[Fe+3].[Fe+3].[Fe+3].OP(O)(=O)OP(O)(O)=O.OP(O)(=O)OP(O)(O)=O.OP([O-])(=O)OP([O-])([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O,SXAWSYZURCZSDX-UHFFFAOYSA-B,1321.571,P02792,BE0000085,Ferritin light chain,Humans,binder,yes
DB13995,Ferric pyrophosphate citrate,small molecule,approved;investigational,[Fe+3].[Fe+3].[Fe+3].[Fe+3].OP(O)(=O)OP(O)(O)=O.OP(O)(=O)OP(O)(O)=O.OP([O-])(=O)OP([O-])([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O,SXAWSYZURCZSDX-UHFFFAOYSA-B,1321.571,P02794,BE0000399,Ferritin heavy chain,Humans,binder,yes
DB13995,Ferric pyrophosphate citrate,small molecule,approved;investigational,[Fe+3].[Fe+3].[Fe+3].[Fe+3].OP(O)(=O)OP(O)(O)=O.OP(O)(=O)OP(O)(O)=O.OP([O-])(=O)OP([O-])([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O,SXAWSYZURCZSDX-UHFFFAOYSA-B,1321.571,P69905,BE0000130,Hemoglobin subunit alpha,Humans,binder,yes
DB13995,Ferric pyrophosphate citrate,small molecule,approved;investigational,[Fe+3].[Fe+3].[Fe+3].[Fe+3].OP(O)(=O)OP(O)(O)=O.OP(O)(=O)OP(O)(O)=O.OP([O-])(=O)OP([O-])([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O,SXAWSYZURCZSDX-UHFFFAOYSA-B,1321.571,P68871,BE0000629,Hemoglobin subunit beta,Humans,binder,yes
DB13997,Baloxavir marboxil,small molecule,approved;investigational,[H][C@@]12COCCN1C(=O)C1=C(OCOC(=O)OC)C(=O)C=CN1N2[C@H]1C2=CC=C(F)C(F)=C2CSC2=CC=CC=C12,RZVPBGBYGMDSBG-GGAORHGYSA-N,571.55,P03433,BE0009736,Polymerase acidic protein,Influenza A virus (strain A/Puerto Rico/8/1934 H1N1),inhibitor,yes
DB14007,Pentetic acid,small molecule,approved,OC(=O)CN(CCN(CC(O)=O)CC(O)=O)CCN(CC(O)=O)CC(O)=O,QPCDCPDFJACHGM-UHFFFAOYSA-N,393.349,,BE0009341,Transuranium elements,Humans,chelator,yes
DB14010,"5-methoxy-N,N-dimethyltryptamine",small molecule,experimental;illicit,COC1=CC=C2NC=C(CCN(C)C)C2=C1,ZSTKHSQDNIGFLM-UHFFFAOYSA-N,218.2948,P50406,BE0000945,5-hydroxytryptamine receptor 6,Humans,inhibitor,yes
DB14010,"5-methoxy-N,N-dimethyltryptamine",small molecule,experimental;illicit,COC1=CC=C2NC=C(CCN(C)C)C2=C1,ZSTKHSQDNIGFLM-UHFFFAOYSA-N,218.2948,P41595,BE0000393,5-hydroxytryptamine receptor 2B,Humans,inhibitor,yes
DB14010,"5-methoxy-N,N-dimethyltryptamine",small molecule,experimental;illicit,COC1=CC=C2NC=C(CCN(C)C)C2=C1,ZSTKHSQDNIGFLM-UHFFFAOYSA-N,218.2948,P28335,BE0000533,5-hydroxytryptamine receptor 2C,Humans,inhibitor,yes
DB14011,Nabiximols,small molecule,investigational,[H][C@]1(CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1O)C(C)=C.[H][C@@]12CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1OC2(C)C,SSNHGLKFJISNTR-DYSNNVSPSA-N,628.938,P21554,BE0000061,Cannabinoid receptor 1,Humans,,yes
DB14011,Nabiximols,small molecule,investigational,[H][C@]1(CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1O)C(C)=C.[H][C@@]12CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1OC2(C)C,SSNHGLKFJISNTR-DYSNNVSPSA-N,628.938,P34972,BE0000095,Cannabinoid receptor 2,Humans,,yes
DB14017,H3B-8800,small molecule,investigational,C[C@H](\C=C\C=C(/C)[C@H]1OC(=O)C[C@H](O)CC[C@@](C)(O)[C@@H](OC(=O)N2CCN(C)CC2)\C=C\[C@@H]1C)C1=CC=CC=N1,YOIQWBAHJZGRFW-WVRLKXNASA-N,555.716,O75533,BE0009359,Splicing factor 3B subunit 1,Humans,inhibitor,yes
DB14018,Bromotheophylline,small molecule,approved,CN1C2=C(NC(Br)=N2)C(=O)N(C)C1=O,SKTFQHRVFFOHTQ-UHFFFAOYSA-N,259.063,P30542,BE0010284,Adenosine receptor,Humans,antagonist,yes
DB14019,Fosnetupitant,small molecule,approved,CN(C(=O)C(C)(C)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)C1=CN=C(C=C1C1=CC=CC=C1C)N1CC[N+](C)(COP(O)([O-])=O)CC1,HZIYEEMJNBKMJH-UHFFFAOYSA-N,688.608,P25103,BE0000384,Substance-P receptor,Humans,antagonist,yes
DB14020,Benzoin,small molecule,approved;experimental,OC(C(=O)C1=CC=CC=C1)C1=CC=CC=C1,ISAOCJYIOMOJEB-UHFFFAOYSA-N,212.2439,P23141,BE0002705,Liver carboxylesterase 1,Humans,inhibitor,yes
DB14025,Clinafloxacin,small molecule,investigational,NC1CCN(C1)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1Cl)C(O)=O,QGPKADBNRMWEQR-UHFFFAOYSA-N,365.79,P20831,BE0008385,DNA gyrase subunit A,Staphylococcus aureus,modulator,yes
DB14025,Clinafloxacin,small molecule,investigational,NC1CCN(C1)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1Cl)C(O)=O,QGPKADBNRMWEQR-UHFFFAOYSA-N,365.79,P0A0K8,BE0002388,DNA gyrase subunit B,Staphylococcus aureus,modulator,yes
DB14027,Taspoglutide,small molecule,investigational,CC[C@H](C)[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)C(C)(C)NC(=O)[C@@H](N)CC1=CNC=N1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NC(C)(C)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O,WRGVLTAWMNZWGT-VQSPYGJZSA-N,3339.763,P43220,BE0000857,Glucagon-like peptide 1 receptor,Humans,agonist,yes
DB14028,Nordazepam,small molecule,experimental,ClC1=CC=C2NC(=O)CN=C(C3=CC=CC=C3)C2=C1,AKPLHCDWDRPJGD-UHFFFAOYSA-N,270.714,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB14028,Nordazepam,small molecule,experimental,ClC1=CC=C2NC(=O)CN=C(C3=CC=CC=C3)C2=C1,AKPLHCDWDRPJGD-UHFFFAOYSA-N,270.714,P14867,BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,Humans,ligand,yes
DB14033,Acetyl sulfisoxazole,small molecule,approved;vet_approved,CC(=O)N(C1=C(C)C(C)=NO1)S(=O)(=O)C1=CC=C(N)C=C1,JFNWFXVFBDDWCX-UHFFFAOYSA-N,309.34,P0AC13,BE0000803,Dihydropteroate synthase,Escherichia coli (strain K12),inhibitor,yes
DB14034,Darglitazone,small molecule,experimental,CC1=C(CCC(=O)C2=CC=C(CC3SC(=O)NC3=O)C=C2)N=C(O1)C1=CC=CC=C1,QQKNSPHAFATFNQ-UHFFFAOYSA-N,420.48,P37231,BE0000215,Peroxisome proliferator-activated receptor gamma,Humans,agonist,yes
DB14035,Englitazone,small molecule,experimental,O=C1NC(=O)C(CC2=CC=C3O[C@@H](CC4=CC=CC=C4)CCC3=C2)S1,MVDXXGIBARMXSA-PYUWXLGESA-N,353.44,P37231,BE0000215,Peroxisome proliferator-activated receptor gamma,Humans,agonist,yes
DB14043,Palmidrol,small molecule,experimental;nutraceutical,CCCCCCCCCCCCCCCC(=O)NCCO,HXYVTAGFYLMHSO-UHFFFAOYSA-N,299.4919,P34972,BE0000095,Cannabinoid receptor 2,Humans,agonist,yes
DB14043,Palmidrol,small molecule,experimental;nutraceutical,CCCCCCCCCCCCCCCC(=O)NCCO,HXYVTAGFYLMHSO-UHFFFAOYSA-N,299.4919,Q8TDV5,BE0003378,Glucose-dependent insulinotropic receptor,Humans,agonist,yes
DB14043,Palmidrol,small molecule,experimental;nutraceutical,CCCCCCCCCCCCCCCC(=O)NCCO,HXYVTAGFYLMHSO-UHFFFAOYSA-N,299.4919,Q9Y2T6,BE0005802,G-protein coupled receptor 55,Humans,agonist,yes
DB14050,Cannabidivarin,small molecule,investigational,[H][C@]1(CCC(C)=C[C@H]1C1=C(O)C=C(CCC)C=C1O)C(C)=C,REOZWEGFPHTFEI-JKSUJKDBSA-N,286.415,Q8NER1,BE0001023,Transient receptor potential cation channel subfamily V member 1,Humans,agonist,yes
DB14050,Cannabidivarin,small molecule,investigational,[H][C@]1(CCC(C)=C[C@H]1C1=C(O)C=C(CCC)C=C1O)C(C)=C,REOZWEGFPHTFEI-JKSUJKDBSA-N,286.415,Q9Y5S1,BE0009158,Transient receptor potential cation channel subfamily V member 2,Humans,agonist,yes
DB14050,Cannabidivarin,small molecule,investigational,[H][C@]1(CCC(C)=C[C@H]1C1=C(O)C=C(CCC)C=C1O)C(C)=C,REOZWEGFPHTFEI-JKSUJKDBSA-N,286.415,O75762,BE0001122,Transient receptor potential cation channel subfamily A member 1,Humans,agonist,yes
DB14052,Malacidin B,small molecule,experimental,CCC(C)CC\C=C/C=C/C(=O)N[C@@H](C(C)C(O)=O)C(=O)N[C@H]1C(C)NC(=O)[C@@H]2C[C@@H](C)CN2C(=O)[C@@H](NC(=O)[C@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](NC1=O)C(C)C)C(O)C(O)=O)C(C)C(O)=O)C(C)C,SMTCDPMWINUUKC-AVBBYWJWSA-N,1263.411,,BE0009551,NAM/NAG peptide subunits of peptidoglycan,Gram positive bacteria,ligand,yes
DB14054,Asiatic acid,small molecule,experimental,[H][C@@]12CC[C@]3(C)[C@]([H])(CC=C4[C@]5([H])[C@@H](C)[C@H](C)CC[C@@]5(CC[C@@]34C)C(O)=O)[C@@]1(C)C[C@@H](O)[C@H](O)[C@@]2(C)CO,JXSVIVRDWWRQRT-UYDOISQJSA-N,488.6991,P11217,BE0000916,"Glycogen phosphorylase, muscle form",Humans,inhibitor,yes
DB14058,Basifungin,small molecule,experimental,CC[C@@H](C)[C@@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)N(C)C(=O)[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC2=CC=CC=C2)N(C)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)C(NC1=O)C(C)C)[C@H](C)C(C)C,YHSKJPXGXIYLHB-OTNPUQRPSA-N,1085.442,O13332,BE0009553,Inositol phosphorylceramide synthase,Yeast,inhibitor,yes
DB14059,SC-236,small molecule,experimental;investigational,NS(=O)(=O)C1=CC=C(C=C1)N1N=C(C=C1C1=CC=C(Cl)C=C1)C(F)(F)F,NSQNZEUFHPTJME-UHFFFAOYSA-N,401.79,Q8SPQ9,BE0009550,Cyclooxygenase 2,Canis lupus familiaris,inhibitor,yes
DB14059,SC-236,small molecule,experimental;investigational,NS(=O)(=O)C1=CC=C(C=C1)N1N=C(C=C1C1=CC=C(Cl)C=C1)C(F)(F)F,NSQNZEUFHPTJME-UHFFFAOYSA-N,401.79,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB14059,SC-236,small molecule,experimental;investigational,NS(=O)(=O)C1=CC=C(C=C1)N1N=C(C=C1C1=CC=C(Cl)C=C1)C(F)(F)F,NSQNZEUFHPTJME-UHFFFAOYSA-N,401.79,Q00653,BE0009554,Nuclear factor NF-kappa-B complex,Humans,inhibitor,yes
DB14060,NS-398,small molecule,experimental,CS(=O)(=O)NC1=CC=C(C=C1OC1CCCCC1)[N+]([O-])=O,KTDZCOWXCWUPEO-UHFFFAOYSA-N,314.357,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB14060,NS-398,small molecule,experimental,CS(=O)(=O)NC1=CC=C(C=C1OC1CCCCC1)[N+]([O-])=O,KTDZCOWXCWUPEO-UHFFFAOYSA-N,314.357,Q8SPQ9,BE0009550,Cyclooxygenase 2,Canis lupus familiaris,inhibitor,yes
DB14061,Hycanthone,small molecule,experimental,CCN(CC)CCNC1=C2C(=O)C3=CC=CC=C3SC2=C(CO)C=C1,MFZWMTSUNYWVBU-UHFFFAOYSA-N,356.48,P08183,BE0001032,ATP-dependent translocase ABCB1,Humans,inhibitor,yes
DB14062,Concanamycin A,small molecule,experimental,[H][C@@]1(OC(=O)\C(OC)=C\C(\C)=C\[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C\C(C)=C\C=C\[C@@H]1OC)[C@@H](C)[C@@H](O)[C@H](C)[C@@]1(O)C[C@@H](O[C@H]2C[C@@H](O)[C@H](OC(N)=O)[C@@H](C)O2)[C@H](C)[C@H](O1)\C=C\C,DJZCTUVALDDONK-HQMSUKCRSA-N,866.099,P08183,BE0001032,ATP-dependent translocase ABCB1,Humans,inhibitor,yes
DB14063,Dexverapamil,small molecule,experimental,COC1=CC=C(CCN(C)CCC[C@@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1OC,SGTNSNPWRIOYBX-HHHXNRCGSA-N,454.611,P08183,BE0001032,ATP-dependent translocase ABCB1,Humans,inhibitor,yes
DB14064,Emopamil,small molecule,experimental,CC(C)C(CCCN(C)CCC1=CC=CC=C1)(C#N)C1=CC=CC=C1,DWAWDSVKAUWFHC-UHFFFAOYSA-N,334.4977,P08183,BE0001032,ATP-dependent translocase ABCB1,Humans,inhibitor,yes
DB14065,Lomerizine,small molecule,experimental,COC1=CC=C(CN2CCN(CC2)C(C2=CC=C(F)C=C2)C2=CC=C(F)C=C2)C(OC)=C1OC,JQSAYKKFZOSZGJ-UHFFFAOYSA-N,468.545,Q14524,BE0000197,Sodium channel protein type 5 subunit alpha,Humans,inhibitor,yes
DB14065,Lomerizine,small molecule,experimental,COC1=CC=C(CN2CCN(CC2)C(C2=CC=C(F)C=C2)C2=CC=C(F)C=C2)C(OC)=C1OC,JQSAYKKFZOSZGJ-UHFFFAOYSA-N,468.545,Q00975,BE0002226,Voltage-dependent N-type calcium channel subunit alpha-1B,Humans,inhibitor,yes
DB14065,Lomerizine,small molecule,experimental,COC1=CC=C(CN2CCN(CC2)C(C2=CC=C(F)C=C2)C2=CC=C(F)C=C2)C(OC)=C1OC,JQSAYKKFZOSZGJ-UHFFFAOYSA-N,468.545,P08183,BE0001032,ATP-dependent translocase ABCB1,Humans,inhibitor,yes
DB14068,Dexniguldipine,small molecule,experimental,[H]N1C(C)=C([C@@H](C2=CC(=CC=C2)[N+]([O-])=O)C(C(=O)OCCCN2CCC(CC2)(C2=CC=CC=C2)C2=CC=CC=C2)=C1C)C(=O)OC,SVJMLYUFVDMUHP-MGBGTMOVSA-N,609.723,P21439,BE0003641,Phosphatidylcholine translocator ABCB4,Humans,modulator,yes
DB14069,ONT-093,small molecule,investigational,[H]\C(COCC)=C(\[H])C1=CC=C(C=C1)C1=NC(=C(N1)C1=CC=C(NC(C)C)C=C1)C1=CC=C(NC(C)C)C=C1,RSJCLODJSVZNQA-BQYQJAHWSA-N,494.683,P08183,BE0001032,ATP-dependent translocase ABCB1,Humans,inhibitor,yes
DB14070,HM-30181,small molecule,experimental,[H]N(C(=O)C1=CC(=O)C2=CC=CC=C2O1)C1=CC(OC)=C(OC)C=C1C1=NN(N=N1)C1=CC=C(CCN2CCC3=CC(OC)=C(OC)C=C3C2)C=C1,AHJUHHDDCJQACA-UHFFFAOYSA-N,688.741,P08183,BE0001032,ATP-dependent translocase ABCB1,Humans,inhibitor,yes
DB14070,HM-30181,small molecule,experimental,[H]N(C(=O)C1=CC(=O)C2=CC=CC=C2O1)C1=CC(OC)=C(OC)C=C1C1=NN(N=N1)C1=CC=C(CCN2CCC3=CC(OC)=C(OC)C=C3C2)C=C1,AHJUHHDDCJQACA-UHFFFAOYSA-N,688.741,P21439,BE0003641,Phosphatidylcholine translocator ABCB4,Humans,inhibitor,yes
DB14072,Reversin 121,small molecule,experimental,CC(C)(C)OC(=O)N[C@@H](CC(=O)OCC1=CC=CC=C1)C(=O)N[C@@H](CCCCNC(=O)OCC1=CC=CC=C1)C(=O)OC(C)(C)C,SVNKEDMVAQBLLN-SVBPBHIXSA-N,641.762,P08183,BE0001032,ATP-dependent translocase ABCB1,Humans,inhibitor,yes
DB14074,Icaridin,small molecule,experimental,CCC(C)OC(=O)N1CCCCC1CCO,QLHULAHOXSSASE-UHFFFAOYSA-N,229.3159,Q8T6S0,BE0009570,Odorant binding protein,Anopheles gambiae,ligand,yes
DB14086,Cianidanol,small molecule,approved;withdrawn,O[C@H]1CC2=C(O)C=C(O)C=C2O[C@@H]1C1=CC=C(O)C(O)=C1,PFTAWBLQPZVEMU-DZGCQCFKSA-N,290.2681,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB14086,Cianidanol,small molecule,approved;withdrawn,O[C@H]1CC2=C(O)C=C(O)C=C2O[C@@H]1C1=CC=C(O)C(O)=C1,PFTAWBLQPZVEMU-DZGCQCFKSA-N,290.2681,O43570,BE0001653,Carbonic anhydrase 12,Humans,inhibitor,yes
DB14086,Cianidanol,small molecule,approved;withdrawn,O[C@H]1CC2=C(O)C=C(O)C=C2O[C@@H]1C1=CC=C(O)C(O)=C1,PFTAWBLQPZVEMU-DZGCQCFKSA-N,290.2681,P23280,BE0003628,Carbonic anhydrase 6,Humans,inhibitor,yes
DB14086,Cianidanol,small molecule,approved;withdrawn,O[C@H]1CC2=C(O)C=C(O)C=C2O[C@@H]1C1=CC=C(O)C(O)=C1,PFTAWBLQPZVEMU-DZGCQCFKSA-N,290.2681,Q16790,BE0002437,Carbonic anhydrase 9,Humans,inhibitor,yes
DB14086,Cianidanol,small molecule,approved;withdrawn,O[C@H]1CC2=C(O)C=C(O)C=C2O[C@@H]1C1=CC=C(O)C(O)=C1,PFTAWBLQPZVEMU-DZGCQCFKSA-N,290.2681,Q9ULX7,BE0003634,Carbonic anhydrase 14,Humans,inhibitor,yes
DB14086,Cianidanol,small molecule,approved;withdrawn,O[C@H]1CC2=C(O)C=C(O)C=C2O[C@@H]1C1=CC=C(O)C(O)=C1,PFTAWBLQPZVEMU-DZGCQCFKSA-N,290.2681,P00915,BE0000267,Carbonic anhydrase 1,Humans,inhibitor,yes
DB14086,Cianidanol,small molecule,approved;withdrawn,O[C@H]1CC2=C(O)C=C(O)C=C2O[C@@H]1C1=CC=C(O)C(O)=C1,PFTAWBLQPZVEMU-DZGCQCFKSA-N,290.2681,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB14086,Cianidanol,small molecule,approved;withdrawn,O[C@H]1CC2=C(O)C=C(O)C=C2O[C@@H]1C1=CC=C(O)C(O)=C1,PFTAWBLQPZVEMU-DZGCQCFKSA-N,290.2681,P22748,BE0000535,Carbonic anhydrase 4,Humans,inhibitor,yes
DB14089,Dimercaptosuccinic acid,small molecule,approved;experimental,OC(=O)C(S)C(S)C(O)=O,ACTRVOBWPAIOHC-UHFFFAOYSA-N,182.218,,BE0004814,Mercury,Humans,chelator,yes
DB14089,Dimercaptosuccinic acid,small molecule,approved;experimental,OC(=O)C(S)C(S)C(O)=O,ACTRVOBWPAIOHC-UHFFFAOYSA-N,182.218,,BE0004813,Arsenic,Humans,chelator,yes
DB14104,Linoleic acid,small molecule,approved;experimental,CCCCC\C=C/C\C=C/CCCCCCCC(O)=O,OYHQOLUKZRVURQ-HZJYTTRNSA-N,280.4455,P15090,BE0001194,"Fatty acid-binding protein, adipocyte",Humans,inhibitor,yes
DB14126,Tenofovir,small molecule,experimental;investigational,C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(O)(O)=O,SGOIRFVFHAKUTI-ZCFIWIBFSA-N,287.2123,Q72547,BE0004136,Reverse transcriptase/RNaseH,Human immunodeficiency virus 1,inhibitor,yes
DB14126,Tenofovir,small molecule,experimental;investigational,C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(O)(O)=O,SGOIRFVFHAKUTI-ZCFIWIBFSA-N,287.2123,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB14126,Tenofovir,small molecule,experimental;investigational,C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(O)(O)=O,SGOIRFVFHAKUTI-ZCFIWIBFSA-N,287.2123,Q3MS49,BE0009677,Reverse transcriptase,HBV,inhibitor,yes
DB14126,Tenofovir,small molecule,experimental;investigational,C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(O)(O)=O,SGOIRFVFHAKUTI-ZCFIWIBFSA-N,287.2123,I6TLU5,BE0009678,DNA polymerase,Human herpesvirus 2 (strain 186),inhibitor,yes
DB14127,Sacubitrilat,small molecule,experimental,C[C@H](C[C@@H](CC1=CC=C(C=C1)C1=CC=CC=C1)NC(=O)CCC(O)=O)C(O)=O,DOBNVUFHFMVMDB-BEFAXECRSA-N,383.444,P08473,BE0000266,Neprilysin,Humans,inhibitor,yes
DB14128,Nadide,small molecule,experimental,NC(=O)C1=C[N+](=CC=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C2N=CN=C3N)[C@@H](O)[C@H]1O,BAWFJGJZGIEFAR-NNYOXOHSSA-N,663.4251,P14061,BE0000194,17-beta-hydroxysteroid dehydrogenase type 1,Humans,inhibitor,yes
DB14128,Nadide,small molecule,experimental,NC(=O)C1=C[N+](=CC=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C2N=CN=C3N)[C@@H](O)[C@H]1O,BAWFJGJZGIEFAR-NNYOXOHSSA-N,663.4251,P10253,BE0000876,Lysosomal alpha-glucosidase,Humans,inhibitor,yes
DB14128,Nadide,small molecule,experimental,NC(=O)C1=C[N+](=CC=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C2N=CN=C3N)[C@@H](O)[C@H]1O,BAWFJGJZGIEFAR-NNYOXOHSSA-N,663.4251,Q14697,BE0004698,Neutral alpha-glucosidase AB,Humans,inhibitor,yes
DB14128,Nadide,small molecule,experimental,NC(=O)C1=C[N+](=CC=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C2N=CN=C3N)[C@@H](O)[C@H]1O,BAWFJGJZGIEFAR-NNYOXOHSSA-N,663.4251,Q8TET4,BE0004699,Neutral alpha-glucosidase C,Humans,inhibitor,yes
DB14128,Nadide,small molecule,experimental,NC(=O)C1=C[N+](=CC=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C2N=CN=C3N)[C@@H](O)[C@H]1O,BAWFJGJZGIEFAR-NNYOXOHSSA-N,663.4251,P53004,BE0000741,Biliverdin reductase A,Humans,inhibitor,yes
DB14128,Nadide,small molecule,experimental,NC(=O)C1=C[N+](=CC=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C2N=CN=C3N)[C@@H](O)[C@H]1O,BAWFJGJZGIEFAR-NNYOXOHSSA-N,663.4251,P05091,BE0000133,"Aldehyde dehydrogenase, mitochondrial",Humans,inhibitor,yes
DB14128,Nadide,small molecule,experimental,NC(=O)C1=C[N+](=CC=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C2N=CN=C3N)[C@@H](O)[C@H]1O,BAWFJGJZGIEFAR-NNYOXOHSSA-N,663.4251,O43451,BE0000837,Maltase-glucoamylase,Humans,inhibitor,yes
DB14128,Nadide,small molecule,experimental,NC(=O)C1=C[N+](=CC=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C2N=CN=C3N)[C@@H](O)[C@H]1O,BAWFJGJZGIEFAR-NNYOXOHSSA-N,663.4251,P04035,BE0000574,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Humans,inhibitor,yes
DB14128,Nadide,small molecule,experimental,NC(=O)C1=C[N+](=CC=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C2N=CN=C3N)[C@@H](O)[C@H]1O,BAWFJGJZGIEFAR-NNYOXOHSSA-N,663.4251,P00390,BE0000648,"Glutathione reductase, mitochondrial",Humans,inhibitor,yes
DB14128,Nadide,small molecule,experimental,NC(=O)C1=C[N+](=CC=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C2N=CN=C3N)[C@@H](O)[C@H]1O,BAWFJGJZGIEFAR-NNYOXOHSSA-N,663.4251,P9WGR1,BE0000332,Enoyl-[acyl-carrier-protein] reductase [NADH],Mycobacterium tuberculosis,inhibitor,yes
DB14128,Nadide,small molecule,experimental,NC(=O)C1=C[N+](=CC=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C2N=CN=C3N)[C@@H](O)[C@H]1O,BAWFJGJZGIEFAR-NNYOXOHSSA-N,663.4251,P12268,BE0000722,Inosine-5'-monophosphate dehydrogenase 2,Humans,inhibitor,yes
DB14132,8-chlorotheophylline,small molecule,experimental,CN1C2=C(NC(Cl)=N2)C(=O)N(C)C1=O,RYIGNEOBDRVTHA-UHFFFAOYSA-N,214.609,P29274,BE0000924,Adenosine receptor A2a,Humans,antagonist,yes
DB14146,Loxicodegol,small molecule,investigational,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CC[C@]2([H])OCCOCCOCCOCCOCCOCCOC,RQHILGKAOIGUHU-XPLSERNMSA-N,595.73,P35372,BE0000770,Mu-type opioid receptor,Humans,agonist,yes
DB14174,Dipentamethylenethiuram disulfide,small molecule,approved;experimental,S=C(SSC(=S)N1CCCCC1)N1CCCCC1,KNBRWWCHBRQLNY-UHFFFAOYSA-N,320.55,P51648,BE0000600,Aldehyde dehydrogenase family 3 member A2,Humans,inhibitor,yes
DB14183,Geraniol,small molecule,approved;experimental,CC(C)=CCC\C(C)=C\CO,GLZPCOQZEFWAFX-JXMROGBWSA-N,154.253,Q7Z2W7,BE0001186,Transient receptor potential cation channel subfamily M member 8,Humans,activator,yes
DB14184,Cinnamaldehyde,small molecule,approved;experimental,O=C\C=C\C1=CC=CC=C1,KJPRLNWUNMBNBZ-QPJJXVBHSA-N,132.1592,Q8NET8,BE0003416,Transient receptor potential cation channel subfamily V member 3,Humans,activator,yes
DB14184,Cinnamaldehyde,small molecule,approved;experimental,O=C\C=C\C1=CC=CC=C1,KJPRLNWUNMBNBZ-QPJJXVBHSA-N,132.1592,O75762,BE0001122,Transient receptor potential cation channel subfamily A member 1,Humans,activator,yes
DB14185,Aripiprazole lauroxil,small molecule,approved;investigational,CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12,DDINXHAORAAYAD-UHFFFAOYSA-N,660.72,P14416,BE0000756,D(2) dopamine receptor,Humans,partial agonist,yes
DB14185,Aripiprazole lauroxil,small molecule,approved;investigational,CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12,DDINXHAORAAYAD-UHFFFAOYSA-N,660.72,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,partial agonist,yes
DB14185,Aripiprazole lauroxil,small molecule,approved;investigational,CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12,DDINXHAORAAYAD-UHFFFAOYSA-N,660.72,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB14187,Hydroxycitronellal,small molecule,approved;experimental,[H]C(=O)CC(C)CCCC(C)(C)O,WPFVBOQKRVRMJB-UHFFFAOYSA-N,172.2646,Q7Z2W7,BE0001186,Transient receptor potential cation channel subfamily M member 8,Humans,activator,yes
DB14210,Moexiprilat,small molecule,experimental,COC1=C(OC)C=C2CN([C@@H](CC2=C1)C(O)=O)C(=O)[C@H](C)N[C@@H](CCC1=CC=CC=C1)C(O)=O,CMPAGYDKASJORH-YSSFQJQWSA-N,470.5149,P12821,BE0000221,Angiotensin-converting enzyme,Humans,modulator,yes
DB14212,Methylparaben,small molecule,approved,COC(=O)C1=CC=C(O)C=C1,LXCFILQKKLGQFO-UHFFFAOYSA-N,152.1473,O75762,BE0001122,Transient receptor potential cation channel subfamily A member 1,Humans,activator,yes
DB14512,Mometasone furoate,small molecule,approved;investigational;vet_approved,[H][C@@]12C[C@@H](C)[C@](OC(=O)C3=CC=CO3)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,WOFMFGQZHJDGCX-ZULDAHANSA-N,521.429,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB14520,Tetraferric tricitrate decahydrate,small molecule,approved,O.O.O.O.O.O.O.O.O.O.[Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O.[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O.[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O,UISKQNNAQKPSDO-UHFFFAOYSA-E,967.803,P02786,BE0008725,Transferrin receptor protein 1,Humans,ligand,yes
DB14538,Hydrocortisone aceponate,small molecule,experimental;vet_approved,[H][C@@]12CC[C@](OC(=O)CC)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,MFBMYAOAMQLLPK-FZNHGJLXSA-N,460.567,P04083,BE0000422,Annexin A1,Humans,,yes
DB14538,Hydrocortisone aceponate,small molecule,experimental;vet_approved,[H][C@@]12CC[C@](OC(=O)CC)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,MFBMYAOAMQLLPK-FZNHGJLXSA-N,460.567,P04150,BE0000794,Glucocorticoid receptor,Humans,,yes
DB14539,Hydrocortisone acetate,small molecule,approved;vet_approved,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,ALEXXDVDDISNDU-JZYPGELDSA-N,404.4966,P04083,BE0000422,Annexin A1,Humans,agonist,yes
DB14539,Hydrocortisone acetate,small molecule,approved;vet_approved,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,ALEXXDVDDISNDU-JZYPGELDSA-N,404.4966,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB14540,Hydrocortisone butyrate,small molecule,approved;vet_approved,[H][C@@]12CC[C@](OC(=O)CCC)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,BMCQMVFGOVHVNG-TUFAYURCSA-N,432.557,P04083,BE0000422,Annexin A1,Humans,agonist,yes
DB14540,Hydrocortisone butyrate,small molecule,approved;vet_approved,[H][C@@]12CC[C@](OC(=O)CCC)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,BMCQMVFGOVHVNG-TUFAYURCSA-N,432.557,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB14541,Hydrocortisone cypionate,small molecule,approved;investigational;vet_approved,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC3CCCC3)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,DLVOSEUFIRPIRM-KAQKJVHQSA-N,486.649,P04083,BE0000422,Annexin A1,Humans,,yes
DB14541,Hydrocortisone cypionate,small molecule,approved;investigational;vet_approved,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC3CCCC3)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,DLVOSEUFIRPIRM-KAQKJVHQSA-N,486.649,P04150,BE0000794,Glucocorticoid receptor,Humans,,yes
DB14542,Hydrocortisone phosphate,small molecule,approved;vet_approved,[H][C@@]12CC[C@](O)(C(=O)COP(O)(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,BGSOJVFOEQLVMH-VWUMJDOOSA-N,442.445,P04083,BE0000422,Annexin A1,Humans,,yes
DB14542,Hydrocortisone phosphate,small molecule,approved;vet_approved,[H][C@@]12CC[C@](O)(C(=O)COP(O)(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,BGSOJVFOEQLVMH-VWUMJDOOSA-N,442.445,P04150,BE0000794,Glucocorticoid receptor,Humans,,yes
DB14543,Hydrocortisone probutate,small molecule,approved;vet_approved,[H][C@@]12CC[C@](OC(=O)CCC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,FOGXJPFPZOHSQS-AYVLZSQQSA-N,488.613,P04083,BE0000422,Annexin A1,Humans,agonist,yes
DB14543,Hydrocortisone probutate,small molecule,approved;vet_approved,[H][C@@]12CC[C@](OC(=O)CCC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,FOGXJPFPZOHSQS-AYVLZSQQSA-N,488.613,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB14544,Hydrocortisone valerate,small molecule,approved;vet_approved,[H][C@@]12CC[C@](OC(=O)CCCC)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,FZCHYNWYXKICIO-FZNHGJLXSA-N,446.5763,P04083,BE0000422,Annexin A1,Humans,agonist,yes
DB14544,Hydrocortisone valerate,small molecule,approved;vet_approved,[H][C@@]12CC[C@](OC(=O)CCCC)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,FZCHYNWYXKICIO-FZNHGJLXSA-N,446.5763,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB14568,Ivosidenib,small molecule,approved;investigational,[H][C@@](N(C(=O)[C@]1([H])CCC(=O)N1C1=NC=CC(=C1)C#N)C1=CC(F)=CN=C1)(C(=O)NC1CC(F)(F)C1)C1=C(Cl)C=CC=C1,WIJZXSAJMHAVGX-DHLKQENFSA-N,582.97,O75874,BE0001251,Isocitrate dehydrogenase [NADP] cytoplasmic,Humans,inhibitor,yes
DB14569,Tedizolid,small molecule,approved;investigational,CN1N=NC(=N1)C1=NC=C(C=C1)C1=C(F)C=C(C=C1)N1C[C@H](CO)OC1=O,XFALPSLJIHVRKE-GFCCVEGCSA-N,370.344,,BE0004800,23S ribosomal RNA,Enteric bacteria and other eubacteria,inhibitor,yes
DB14575,Eslicarbazepine,small molecule,approved,NC(=O)N1C2=C(C[C@H](O)C3=C1C=CC=C3)C=CC=C2,BMPDWHIDQYTSHX-AWEZNQCLSA-N,254.2839,Q9UI33,BE0000192,Sodium channel protein type 11 subunit alpha,Humans,inhibitor,yes
DB14575,Eslicarbazepine,small molecule,approved,NC(=O)N1C2=C(C[C@H](O)C3=C1C=CC=C3)C=CC=C2,BMPDWHIDQYTSHX-AWEZNQCLSA-N,254.2839,Q99571,BE0005793,P2X purinoceptor 4,Humans,,yes
DB14581,CPI-1205,small molecule,investigational,COC1=C(CNC(=O)C2=C(C)N([C@H](C)C3CCN(CC(F)(F)F)CC3)C3=CC=CC=C23)C(=O)NC(C)=C1,HPODOLXTMDHLLC-QGZVFWFLSA-N,518.581,Q15910,BE0009562,Histone-lysine N-methyltransferase EZH2,Humans,inhibitor,yes
DB14583,Segesterone acetate,small molecule,approved;experimental;investigational,[H][C@@]12CC(=C)[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],CKFBRGLGTWAVLG-GOMYTPFNSA-N,370.489,P06401,BE0000557,Progesterone receptor,Humans,agonist;activator,yes
DB14598,Edetate calcium disodium anhydrous,small molecule,approved,[Na+].[Na+].[Ca++].[O-]C(=O)CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O,SHWNNYZBHZIQQV-UHFFFAOYSA-J,374.268,,BE0004808,Lead,Humans,chelator,yes
DB14598,Edetate calcium disodium anhydrous,small molecule,approved,[Na+].[Na+].[Ca++].[O-]C(=O)CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O,SHWNNYZBHZIQQV-UHFFFAOYSA-J,374.268,,BE0004807,Iron,Humans,chelator,yes
DB14598,Edetate calcium disodium anhydrous,small molecule,approved,[Na+].[Na+].[Ca++].[O-]C(=O)CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O,SHWNNYZBHZIQQV-UHFFFAOYSA-J,374.268,,BE0004812,Manganese cation,Humans,chelator,yes
DB14600,Edetate disodium anhydrous,small molecule,approved;vet_approved,[Na+].[Na+].OC(=O)CN(CCN(CC(O)=O)CC([O-])=O)CC([O-])=O,ZGTMUACCHSMWAC-UHFFFAOYSA-L,336.2063,,BE0004808,Lead,Humans,chelator,yes
DB14631,Prednisolone phosphate,small molecule,approved;vet_approved,[H][C@@]12CC[C@](O)(C(=O)COP(O)(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,JDOZJEUDSLGTLU-VWUMJDOOSA-N,440.429,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB14636,Triciribine phosphate,small molecule,investigational,CN1N=C(N)C2=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C3=C2C1=NC=N3,URLYINUFLXOMHP-HTVVRFAVSA-N,400.2838,Q9Y243,BE0010514,RAC-gamma serine/threonine-protein kinase,Humans,modulator,yes
DB14639,Boldenone undecylenate,small molecule,illicit;vet_approved,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@@H]2OC(=O)CCCCCCCCC=C,AHMMSNQYOPMLSX-CNQKSJKFSA-N,452.679,P10275,BE0000132,Androgen receptor,Humans,,yes
DB14641,Estriol tripropionate,small molecule,experimental,[H][C@]1(C[C@@]2([H])[C@]3([H])CCC4=CC(OC(=O)CC)=CC=C4[C@@]3([H])CC[C@]2(C)[C@@]1([H])OC(=O)CC)OC(=O)CC,ONMZMZJEZHMWQL-REUUDLSRSA-N,456.5711,P03372,BE0000123,Estrogen receptor,Humans,,yes
DB14642,Lypressin,small molecule,approved,[H]N([H])C(=O)C[C@]1([H])NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@@H](N)CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)NC([H])(CCCCN)C(=O)NCC(N)=O,BJFIDCADFRDPIO-DZCXQCEKSA-N,1056.23,P37288,BE0000165,Vasopressin V1a receptor,Humans,,yes
DB14642,Lypressin,small molecule,approved,[H]N([H])C(=O)C[C@]1([H])NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@@H](N)CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)NC([H])(CCCCN)C(=O)NCC(N)=O,BJFIDCADFRDPIO-DZCXQCEKSA-N,1056.23,P30518,BE0000293,Vasopressin V2 receptor,Humans,,yes
DB14642,Lypressin,small molecule,approved,[H]N([H])C(=O)C[C@]1([H])NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@@H](N)CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)NC([H])(CCCCN)C(=O)NCC(N)=O,BJFIDCADFRDPIO-DZCXQCEKSA-N,1056.23,P47901,BE0000773,Vasopressin V1b receptor,Humans,,yes
DB14649,Dexamethasone acetate,small molecule,approved;investigational;vet_approved,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,AKUJBENLRBOFTD-RPRRAYFGSA-N,434.4977,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB14669,Betamethasone phosphate,small molecule,approved;vet_approved,[H][C@@]12C[C@H](C)[C@](O)(C(=O)COP(O)(O)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,VQODGRNSFPNSQE-DVTGEIKXSA-N,472.446,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB14672,Oxazepam acetate,small molecule,experimental,CC(=O)OC1N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2NC1=O,FYRWUTOZBRWYCS-UHFFFAOYSA-N,328.75,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB14672,Oxazepam acetate,small molecule,experimental,CC(=O)OC1N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2NC1=O,FYRWUTOZBRWYCS-UHFFFAOYSA-N,328.75,P14867,BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,Humans,ligand,yes
DB14715,Cinazepam,small molecule,experimental,OC(=O)CCC(=O)OC1N=C(C2=CC=CC=C2Cl)C2=CC(Br)=CC=C2NC1=O,NQTRBZXDWMDXAQ-UHFFFAOYSA-N,465.68,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB14715,Cinazepam,small molecule,experimental,OC(=O)CCC(=O)OC1N=C(C2=CC=CC=C2Cl)C2=CC(Br)=CC=C2NC1=O,NQTRBZXDWMDXAQ-UHFFFAOYSA-N,465.68,P14867,BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,Humans,ligand,yes
DB14719,Bentazepam,small molecule,experimental,O=C1CN=C(C2=C(N1)SC1=C2CCCC1)C1=CC=CC=C1,AIZFEOPQVZBNGH-UHFFFAOYSA-N,296.39,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB14719,Bentazepam,small molecule,experimental,O=C1CN=C(C2=C(N1)SC1=C2CCCC1)C1=CC=CC=C1,AIZFEOPQVZBNGH-UHFFFAOYSA-N,296.39,Q99928,BE0003594,Gamma-aminobutyric acid receptor subunit gamma-3,Humans,modulator,yes
DB14719,Bentazepam,small molecule,experimental,O=C1CN=C(C2=C(N1)SC1=C2CCCC1)C1=CC=CC=C1,AIZFEOPQVZBNGH-UHFFFAOYSA-N,296.39,P14867,BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,Humans,ligand,yes
DB14722,ADU-S100,small molecule,investigational,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H]2CO[P@](S)(=O)O[C@@H]3[C@H](O)[C@@H](CO[P@](S)(=O)O[C@H]2[C@H]1O)O[C@H]3N1C=NC2=C1N=CN=C2N,IZJJFUQKKZFVLH-YBVMPXGUSA-N,690.54,Q86WV6,BE0010703,Stimulator of interferon genes protein,Humans,activator,yes
DB14723,Larotrectinib,small molecule,approved;investigational,O[C@H]1CCN(C1)C(=O)NC1=C2N=C(C=CN2N=C1)N1CCC[C@@H]1C1=C(F)C=CC(F)=C1,NYNZQNWKBKUAII-KBXCAEBGSA-N,428.444,P04629,BE0001039,High affinity nerve growth factor receptor,Humans,inhibitor,yes
DB14723,Larotrectinib,small molecule,approved;investigational,O[C@H]1CCN(C1)C(=O)NC1=C2N=C(C=CN2N=C1)N1CCC[C@@H]1C1=C(F)C=CC(F)=C1,NYNZQNWKBKUAII-KBXCAEBGSA-N,428.444,Q16620,BE0003605,BDNF/NT-3 growth factors receptor,Humans,inhibitor,yes
DB14723,Larotrectinib,small molecule,approved;investigational,O[C@H]1CCN(C1)C(=O)NC1=C2N=C(C=CN2N=C1)N1CCC[C@@H]1C1=C(F)C=CC(F)=C1,NYNZQNWKBKUAII-KBXCAEBGSA-N,428.444,Q16288,BE0009501,NT-3 growth factor receptor,Humans,inhibitor,yes
DB14726,Dabigatran,small molecule,approved;investigational,CN1C(CNC2=CC=C(C=C2)C(N)=N)=NC2=C1C=CC(=C2)C(=O)N(CCC(O)=O)C1=NC=CC=C1,YBSJFWOBGCMAKL-UHFFFAOYSA-N,471.521,P00734,BE0000048,Prothrombin,Humans,inhibitor,yes
DB14733,Ceftobiprole medocaril,small molecule,approved;experimental;investigational,[H][C@@]1(NC(=O)C(=N/O)\C2=NSC(N)=N2)C(=O)N2C(C(O)=O)=C(CS[C@]12[H])\C=C1/CCN(C1=O)[C@]1([H])CCN(C1)C(=O)OCC1=C(C)OC(=O)O1,HFTSMHTWUFCYMJ-YIOMYIDASA-N,690.66,Q7DHH4,BE0002391,MecA,Staphylococcus aureus,inhibitor,yes
DB14733,Ceftobiprole medocaril,small molecule,approved;experimental;investigational,[H][C@@]1(NC(=O)C(=N/O)\C2=NSC(N)=N2)C(=O)N2C(C(O)=O)=C(CS[C@]12[H])\C=C1/CCN(C1=O)[C@]1([H])CCN(C1)C(=O)OCC1=C(C)OC(=O)O1,HFTSMHTWUFCYMJ-YIOMYIDASA-N,690.66,P0A3M6,BE0003624,Penicillin-binding protein 2B,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB14733,Ceftobiprole medocaril,small molecule,approved;experimental;investigational,[H][C@@]1(NC(=O)C(=N/O)\C2=NSC(N)=N2)C(=O)N2C(C(O)=O)=C(CS[C@]12[H])\C=C1/CCN(C1=O)[C@]1([H])CCN(C1)C(=O)OCC1=C(C)OC(=O)O1,HFTSMHTWUFCYMJ-YIOMYIDASA-N,690.66,P59676,BE0001868,Penicillin-binding protein 2X,Streptococcus pneumoniae (strain ATCC BAA-255 / R6),inhibitor,yes
DB14737,Cannabinol,small molecule,experimental;investigational,CCCCCC1=CC2=C(C(O)=C1)C1=C(C=CC(C)=C1)C(C)(C)O2,VBGLYOIFKLUMQG-UHFFFAOYSA-N,310.437,P21554,BE0000061,Cannabinoid receptor 1,Humans,agonist,yes
DB14761,Remdesivir,small molecule,approved;investigational,CCC(CC)COC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@](C#N)([C@H](O)[C@@H]1O)C1=CC=C2N1N=CN=C2N)OC1=CC=CC=C1,RWWYLEGWBNMMLJ-YSOARWBDSA-N,602.585,P0DTD1,BE0010016,Replicase polyprotein 1ab,SARS-CoV-2,inhibitor,yes
DB14763,Cycloguanil,small molecule,approved,CC1(C)N=C(N)N=C(N)N1C1=CC=C(Cl)C=C1,QMNFFXRFOJIOKZ-UHFFFAOYSA-N,251.715,Q9HBH1,BE0002201,"Peptide deformylase, mitochondrial",Humans,inhibitor,yes
DB14766,Etrasimod,small molecule,approved,OC(=O)C[C@H]1CCC2=C1NC1=C2C=C(OCC2=CC(=C(C=C2)C2CCCC2)C(F)(F)F)C=C1,MVGWUTBTXDYMND-QGZVFWFLSA-N,457.493,P21453,BE0008652,Sphingosine 1-phosphate receptor 1,Humans,modulator,yes
DB14766,Etrasimod,small molecule,approved,OC(=O)C[C@H]1CCC2=C1NC1=C2C=C(OCC2=CC(=C(C=C2)C2CCCC2)C(F)(F)F)C=C1,MVGWUTBTXDYMND-QGZVFWFLSA-N,457.493,O95977,BE0009882,Sphingosine 1-phosphate receptor 4,Humans,modulator,yes
DB14766,Etrasimod,small molecule,approved,OC(=O)C[C@H]1CCC2=C1NC1=C2C=C(OCC2=CC(=C(C=C2)C2CCCC2)C(F)(F)F)C=C1,MVGWUTBTXDYMND-QGZVFWFLSA-N,457.493,Q9H228,BE0002432,Sphingosine 1-phosphate receptor 5,Humans,modulator,yes
DB14770,Lanraplenib,small molecule,investigational,NC1=CN=CC(=N1)C1=CN2C=CN=C2C(NC2=CC=C(C=C2)N2CCN(CC2)C2COC2)=N1,XCIGZBVOUQVIPI-UHFFFAOYSA-N,443.515,P43405,BE0001316,Tyrosine-protein kinase SYK,Humans,inhibitor,yes
DB14773,Lifirafenib,small molecule,investigational,FC(F)(F)C1=CC2=C(C=C1)N=C(N2)[C@@H]1[C@H]2OC3=C(C=C(OC4=C5CCC(=O)NC5=NC=C4)C=C3)[C@@H]12,NGFFVZQXSRKHBM-FKBYEOEOSA-N,478.431,P15056,BE0000634,Serine/threonine-protein kinase B-raf,Humans,inhibitor,yes
DB14774,Balipodect,small molecule,investigational,COC1=CN(N=C(C2=CC=NN2C2=CC=CC=C2)C1=O)C1=CC=C(C=C1F)N1C=CC=N1,KVHRYLNQDWXAGI-UHFFFAOYSA-N,428.427,Q9Y233,BE0000631,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",Humans,inhibitor,yes
DB14779,LGD-6972,small molecule,investigational,CC1=CC(C)=C(C(C)=C1)C1=CC=C(NC(=O)[C@H](CC2=CC=C(C=C2)C(=O)NCCS(O)(=O)=O)C2=CC=C(C=C2)C2=CC=C(C=C2)C(C)(C)C)C=C1,HKJMCBYPVCGZFB-LDLOPFEMSA-N,702.91,P47871,BE0000527,Glucagon receptor,Humans,antagonist,yes
DB14785,Fenebrutinib,small molecule,investigational,C[C@H]1CN(CCN1C1=CC=C(NC2=CC(=CN(C)C2=O)C2=C(CO)C(=NC=C2)N2CCN3C4=C(CC(C)(C)C4)C=C3C2=O)N=C1)C1COC1,WNEODWDFDXWOLU-QHCPKHFHSA-N,664.811,Q06187,BE0001284,Tyrosine-protein kinase BTK,Humans,inhibitor,yes
DB14787,BMS-830216,small molecule,investigational,COC1=CC(=CC=C1OC[C@H](OP(O)(O)=O)C1CC1)N1C=NC2=C(SC(=C2)C2=CC=C(Cl)C=C2)C1=O,YDTUJCNTIMWHPJ-NRFANRHFSA-N,548.93,Q99705,BE0003478,Melanin-concentrating hormone receptor 1,Humans,antagonist,yes
DB14790,Zatolmilast,small molecule,investigational,OC(=O)CC1=CC=C(CC2=CC(=NC(=C2)C(F)(F)F)C2=CC(Cl)=CC=C2)C=C1,LTSUMTMGJHPGFX-UHFFFAOYSA-N,405.8,Q08499,BE0001287,"3',5'-cyclic-AMP phosphodiesterase 4D",Humans,inhibitor,yes
DB14791,GDC-0425,small molecule,investigational,CCN1CCC(CC1)OC1=C(N=CC2=C1C1=C(N2)N=CC=C1)C#N,XEZLBMHDUXSICI-UHFFFAOYSA-N,321.384,O14757,BE0003382,Serine/threonine-protein kinase Chk1,Humans,modulator,yes
DB14799,PF-06821497,small molecule,investigational,CO[C@H](C1COC1)C1=C(Cl)C2=C(CCN(CC3=C(OC)C=C(C)NC3=O)C2=O)C(Cl)=C1,RXCVUHMIWHRLDF-HXUWFJFHSA-N,467.34,Q15910,BE0009562,Histone-lysine N-methyltransferase EZH2,Humans,inhibitor,yes
DB14801,Lanifibranor,small molecule,investigational,OC(=O)CCCC1=CC2=C(C=CC(Cl)=C2)N1S(=O)(=O)C1=CC2=C(C=C1)N=CS2,OQDQIFQRNZIEEJ-UHFFFAOYSA-N,434.91,Q07869,BE0000071,Peroxisome proliferator-activated receptor alpha,Humans,agonist,yes
DB14801,Lanifibranor,small molecule,investigational,OC(=O)CCCC1=CC2=C(C=CC(Cl)=C2)N1S(=O)(=O)C1=CC2=C(C=C1)N=CS2,OQDQIFQRNZIEEJ-UHFFFAOYSA-N,434.91,Q03181,BE0001007,Peroxisome proliferator-activated receptor delta,Humans,agonist,yes
DB14801,Lanifibranor,small molecule,investigational,OC(=O)CCCC1=CC2=C(C=CC(Cl)=C2)N1S(=O)(=O)C1=CC2=C(C=C1)N=CS2,OQDQIFQRNZIEEJ-UHFFFAOYSA-N,434.91,P37231,BE0000215,Peroxisome proliferator-activated receptor gamma,Humans,agonist,yes
DB14802,ONO-2952,small molecule,investigational,COC1=C(C=CC(Cl)=C1)[C@@H]1N(CC2(CC2)C2=C1NC1=C2C(F)=CC=C1)C(C)=O,ZBQMTQGDBFZUBG-NRFANRHFSA-N,398.86,P30536,BE0000736,Translocator protein,Humans,antagonist,yes
DB14803,AMY-101,small molecule,investigational,CC[C@H](C)[C@H](NC(=O)[C@H](N)CC1=CC=C(O)C=C1)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](C)NC(=O)CN(C)C(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC2=CN(C)C3=C2C=CC=C3)NC(=O)[C@@H](NC1=O)C(C)C)C(=O)N(C)[C@@H]([C@@H](C)CC)C(N)=O,MUSGYEMSJUFFHT-MHLWMKJLSA-N,1789.11,P01024,BE0003455,Complement C3,Humans,inhibitor,yes
DB14805,Piflufolastat F 18,small molecule,approved;investigational,OC(=O)CC[C@H](NC(=O)N[C@@H](CCCCNC(=O)C1=CC=C([18F])N=C1)C(O)=O)C(O)=O,OLWVRJUNLXQDSP-MVBOSPHXSA-N,441.403,Q04609,BE0000568,Glutamate carboxypeptidase 2,Humans,binder,yes
DB14806,Avexitide,small molecule,investigational,CC[C@H](C)[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(N)=O,WSEVKKHALHSUMB-RYVRVIGHSA-N,3369.8,P43220,BE0000857,Glucagon-like peptide 1 receptor,Humans,antagonist,yes
DB14810,AZD-1656,small molecule,investigational,COC[C@H](C)OC1=CC(=CC(OC2=NC=C(N=C2)C(=O)N2CCC2)=C1)C(=O)NC1=NC=C(C)N=C1,FJEJHJINOKKDCW-INIZCTEOSA-N,478.509,P35557,BE0001056,Hexokinase-4,Humans,activator,yes
DB14813,PF-232798,small molecule,investigational,CC(C)C(=O)N1CCC2=C(C1)N=C(C)N2[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(C)=O)C1=CC=CC(F)=C1,QETUKYDWZIRTEI-QUMGSSFMSA-N,509.67,P51681,BE0000911,C-C chemokine receptor type 5,Humans,antagonist,yes
DB14822,SB-649868,small molecule,investigational,CC1=NC(C(=O)N2CCCC[C@H]2CNC(=O)C2=CC=CC3=C2C=CO3)=C(S1)C1=CC=C(F)C=C1,ZJXIUGNEAIHSBI-IBGZPJMESA-N,477.55,O43613,BE0005864,Orexin/Hypocretin receptor type 1,Humans,antagonist,yes
DB14823,Balovaptan,small molecule,investigational,CN1CC2=NN=C([C@H]3CC[C@@H](CC3)OC3=NC=CC=C3)N2C2=CC=C(Cl)C=C2C1,GMPZPHGHNDMRKL-RZDIXWSQSA-N,409.92,P37288,BE0000165,Vasopressin V1a receptor,Humans,antagonist,yes
DB14829,Uproleselan,small molecule,investigational,CC[C@H]1C[C@H](C[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@@H](CC3CCCCC3)C(O)=O)[C@H]2NC(C)=O)[C@@H]1O[C@@H]1O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]1O)C(=O)NCCNC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,LYSYOXNOOPBOSC-NGSKMYNLSA-N,1304.526,P16581,BE0001074,E-selectin,Humans,inhibitor,yes
DB14835,SUVN-G3031,small molecule,investigational,O=C(CN1CCOCC1)NC1=CC=C(OC2CCN(CC2)C2CCC2)C=C1,LNXDUSQEXVQFGP-UHFFFAOYSA-N,373.497,Q9Y5N1,BE0000968,Histamine H3 receptor,Humans,antagonist,yes
DB14840,Ripretinib,small molecule,approved,CCN1C(=O)C(=CC2=C1C=C(NC)N=C2)C1=C(Br)C=C(F)C(NC(=O)NC2=CC=CC=C2)=C1,CEFJVGZHQAGLHS-UHFFFAOYSA-N,510.367,P10721,BE0000453,Mast/stem cell growth factor receptor Kit,Humans,inhibitor,yes
DB14840,Ripretinib,small molecule,approved,CCN1C(=O)C(=CC2=C1C=C(NC)N=C2)C1=C(Br)C=C(F)C(NC(=O)NC2=CC=CC=C2)=C1,CEFJVGZHQAGLHS-UHFFFAOYSA-N,510.367,P09619,BE0000205,Platelet-derived growth factor receptor beta,Humans,inhibitor,yes
DB14840,Ripretinib,small molecule,approved,CCN1C(=O)C(=CC2=C1C=C(NC)N=C2)C1=C(Br)C=C(F)C(NC(=O)NC2=CC=CC=C2)=C1,CEFJVGZHQAGLHS-UHFFFAOYSA-N,510.367,Q02763,BE0003379,Angiopoietin-1 receptor,Humans,inhibitor,yes
DB14840,Ripretinib,small molecule,approved,CCN1C(=O)C(=CC2=C1C=C(NC)N=C2)C1=C(Br)C=C(F)C(NC(=O)NC2=CC=CC=C2)=C1,CEFJVGZHQAGLHS-UHFFFAOYSA-N,510.367,P35968,BE0000369,Vascular endothelial growth factor receptor 2,Humans,inhibitor,yes
DB14840,Ripretinib,small molecule,approved,CCN1C(=O)C(=CC2=C1C=C(NC)N=C2)C1=C(Br)C=C(F)C(NC(=O)NC2=CC=CC=C2)=C1,CEFJVGZHQAGLHS-UHFFFAOYSA-N,510.367,P15056,BE0000634,Serine/threonine-protein kinase B-raf,Humans,inhibitor,yes
DB14840,Ripretinib,small molecule,approved,CCN1C(=O)C(=CC2=C1C=C(NC)N=C2)C1=C(Br)C=C(F)C(NC(=O)NC2=CC=CC=C2)=C1,CEFJVGZHQAGLHS-UHFFFAOYSA-N,510.367,P16234,BE0000852,Platelet-derived growth factor receptor alpha,Humans,inhibitor,yes
DB14844,Dordaviprone,small molecule,investigational,CC1=CC=CC=C1CN1C2=NCCN2C2=C(CN(CC3=CC=CC=C3)CC2)C1=O,VLULRUCCHYVXOH-UHFFFAOYSA-N,386.499,P35462,BE0000581,D(3) dopamine receptor,Humans,antagonist,yes
DB14844,Dordaviprone,small molecule,investigational,CC1=CC=CC=C1CN1C2=NCCN2C2=C(CN(CC3=CC=CC=C3)CC2)C1=O,VLULRUCCHYVXOH-UHFFFAOYSA-N,386.499,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB14845,Filgotinib,small molecule,approved;investigational,O=C(NC1=NN2C(C=CC=C2C2=CC=C(CN3CCS(=O)(=O)CC3)C=C2)=N1)C1CC1,RIJLVEAXPNLDTC-UHFFFAOYSA-N,425.51,P23458,BE0004145,Tyrosine-protein kinase JAK1,Humans,inhibitor,yes
DB14846,Bimiralisib,small molecule,investigational,NC1=NC=C(C2=NC(=NC(=N2)N2CCOCC2)N2CCOCC2)C(=C1)C(F)(F)F,ADGGYDAFIHSYFI-UHFFFAOYSA-N,411.389,P42345,BE0002386,Serine/threonine-protein kinase mTOR,Humans,inhibitor,yes
DB14846,Bimiralisib,small molecule,investigational,NC1=NC=C(C2=NC(=NC(=N2)N2CCOCC2)N2CCOCC2)C(=C1)C(F)(F)F,ADGGYDAFIHSYFI-UHFFFAOYSA-N,411.389,P48736,BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",Humans,inhibitor,yes
DB14846,Bimiralisib,small molecule,investigational,NC1=NC=C(C2=NC(=NC(=N2)N2CCOCC2)N2CCOCC2)C(=C1)C(F)(F)F,ADGGYDAFIHSYFI-UHFFFAOYSA-N,411.389,P42338,BE0002407,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",Humans,inhibitor,yes
DB14849,Nebicapone,small molecule,investigational,OC1=C(O)C(=CC(=C1)C(=O)CC1=CC=CC=C1)[N+]([O-])=O,MRFOLGFFTUGAEB-UHFFFAOYSA-N,273.244,P21964,BE0002089,Catechol O-methyltransferase,Humans,inhibitor,yes
DB14850,Deleobuvir,small molecule,investigational,CN1C2=C(C=CC(\C=C\C(O)=O)=C2)N=C1C1(CCC1)NC(=O)C1=CC2=C(C=C1)C(C1CCCC1)=C(N2C)C1=NC=C(Br)C=N1,BMAIGAHXAJEULY-UKTHLTGXSA-N,653.581,P26664,BE0003427,Genome polyprotein,,inhibitor,yes
DB14854,TC-6987,small molecule,investigational,FC1=CC(=CC(F)=C1)C(=O)N[C@@H]1C2CCN(CC2)[C@H]1CC1=CN=CC=C1,UAKZGMMGIMKFMV-RBUKOAKNSA-N,357.405,P36544,BE0002341,Neuronal acetylcholine receptor subunit alpha-7,Humans,modulator,yes
DB14856,PF-05089771,small molecule,investigational,NC1=C(C=NN1)C1=CC(Cl)=CC=C1OC1=CC(F)=C(C=C1Cl)S(=O)(=O)NC1=CSC=N1,ZYSCOUXLBXGGIM-UHFFFAOYSA-N,500.34,Q15858,BE0001143,Sodium channel protein type 9 subunit alpha,Humans,blocker,yes
DB14856,PF-05089771,small molecule,investigational,NC1=C(C=NN1)C1=CC(Cl)=CC=C1OC1=CC(F)=C(C=C1Cl)S(=O)(=O)NC1=CSC=N1,ZYSCOUXLBXGGIM-UHFFFAOYSA-N,500.34,Q96S37,BE0004782,Solute carrier family 22 member 12,Humans,inhibitor,yes
DB14857,Avadomide,small molecule,investigational,CC1=NC2=C(C(N)=CC=C2)C(=O)N1C1CCC(=O)NC1=O,RSNPAKAFCAAMBH-UHFFFAOYSA-N,286.291,Q96SW2,BE0004755,Protein cereblon,Humans,modulator,yes
DB14859,Fosifloxuridine nafalbenamide,small molecule,investigational,C[C@H](NP(=O)(OC[C@H]1O[C@H](C[C@@H]1O)N1C=C(F)C(=O)NC1=O)OC1=C2C=CC=CC2=CC=C1)C(=O)OCC1=CC=CC=C1,BIOWRMNRHMERIO-ZVAHOJSLSA-N,613.535,P04818,BE0000324,Thymidylate synthase,Humans,inhibitor,yes
DB14860,Ensartinib,small molecule,investigational,C[C@@H](OC1=CC(=NN=C1N)C(=O)NC1=CC=C(C=C1)C(=O)N1C[C@H](C)N[C@H](C)C1)C1=C(Cl)C=CC(F)=C1Cl,GLYMPHUVMRFTFV-QLFBSQMISA-N,561.44,Q9UM73,BE0000359,ALK tyrosine kinase receptor,Humans,inhibitor,yes
DB14866,Amcasertib,small molecule,investigational,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=CC=C(C=C23)C2=CSC(=N2)C2=CC=CC=C2)=C1C,QDWKGEFGLQMDAM-ULJHMMPZSA-N,539.7,P16234,BE0000852,Platelet-derived growth factor receptor alpha,Humans,inhibitor,yes
DB14867,Parsaclisib,small molecule,investigational,CCOC1=C(C=C(Cl)C(F)=C1[C@@H]1CNC(=O)C1)[C@H](C)N1N=C(C)C2=C1N=CN=C2N,ZQPDJCIXJHUERQ-QWRGUYRKSA-N,432.88,O00329,BE0002406,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",Humans,inhibitor,yes
DB14868,AZD-8848,small molecule,investigational,CCCCOC1=NC2=C(NC(=O)N2CCCN(CCCN2CCOCC2)CC2=CC=CC(CC(=O)OC)=C2)C(N)=N1,FEFIBEHSXLKJGI-UHFFFAOYSA-N,569.707,Q9NYK1,BE0000155,Toll-like receptor 7,Humans,agonist,yes
DB14870,PF-5190457,small molecule,investigational,CC1=CN2C=C(CC(=O)N3CCC4(CN(C4)[C@@H]4CCC5=C4C=CC(=C5)C4=CC(C)=NC=N4)CC3)N=C2S1,ZIUDADZJCKGWKR-AREMUKBSSA-N,512.68,Q92847,BE0003383,Growth hormone secretagogue receptor type 1,Humans,modulator,yes
DB14875,AZD-4017,small molecule,investigational,CCCSC1=C(C=CC(=N1)N1CCC[C@@H](CC(O)=O)C1)C(=O)NC1CCCCC1,NCDZABJPWMBMIQ-INIZCTEOSA-N,419.581,P28845,BE0000329,11-beta-hydroxysteroid dehydrogenase 1,Humans,inhibitor,yes
DB14876,TAS-116,small molecule,investigational,CCC1=CC(=CC=C1N1N=C(C(C)C)C2=C1N=CC=C2N1C=NC(=C1)C1=CN(C)N=C1)C(N)=O,NVVPMZUGELHVMH-UHFFFAOYSA-N,454.538,P08238,BE0001898,Heat shock protein HSP 90-beta,Humans,inhibitor,yes
DB14879,Cefiderocol,small molecule,approved;investigational,[H][C@]12SCC(C[N+]3(CCNC(=O)C4=C(Cl)C(O)=C(O)C=C4)CCCC3)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC(N)=N1)C([O-])=O,DBPPRLRVDVJOCL-FQRUVTKNSA-N,752.21,Q51504,BE0004647,Cell division protein,Pseudomonas aeruginosa,inhibitor,yes
DB14879,Cefiderocol,small molecule,approved;investigational,[H][C@]12SCC(C[N+]3(CCNC(=O)C4=C(Cl)C(O)=C(O)C=C4)CCCC3)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC(N)=N1)C([O-])=O,DBPPRLRVDVJOCL-FQRUVTKNSA-N,752.21,Q07806,BE0003686,Penicillin-binding protein 1A,Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228),inhibitor,yes
DB14879,Cefiderocol,small molecule,approved;investigational,[H][C@]12SCC(C[N+]3(CCNC(=O)C4=C(Cl)C(O)=C(O)C=C4)CCCC3)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC(N)=N1)C([O-])=O,DBPPRLRVDVJOCL-FQRUVTKNSA-N,752.21,Q9X6W0,BE0003687,Penicillin-binding protein 1B,Pseudomonas aeruginosa,inhibitor,yes
DB14879,Cefiderocol,small molecule,approved;investigational,[H][C@]12SCC(C[N+]3(CCNC(=O)C4=C(Cl)C(O)=C(O)C=C4)CCCC3)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC(N)=N1)C([O-])=O,DBPPRLRVDVJOCL-FQRUVTKNSA-N,752.21,Q9X6V3,BE0004648,Penicillin-binding protein 2,Pseudomonas aeruginosa,inhibitor,yes
DB14879,Cefiderocol,small molecule,approved;investigational,[H][C@]12SCC(C[N+]3(CCNC(=O)C4=C(Cl)C(O)=C(O)C=C4)CCCC3)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC(N)=N1)C([O-])=O,DBPPRLRVDVJOCL-FQRUVTKNSA-N,752.21,P24228,BE0000744,D-alanyl-D-alanine carboxypeptidase DacB,Escherichia coli (strain K12),inhibitor,yes
DB14881,Oliceridine,small molecule,approved;investigational,COC1=C(CNCC[C@]2(CCOC3(CCCC3)C2)C2=NC=CC=C2)SC=C1,DMNOVGJWPASQDL-OAQYLSRUSA-N,386.55,P35372,BE0000770,Mu-type opioid receptor,Humans,agonist,yes
DB14886,BIO-11006,small molecule,investigational,C[C@@H](O)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)CNC(C)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O,KCSNGWMKFYVMKF-HGYIIGRXSA-N,1050.182,P29966,BE0012891,Myristoylated alanine-rich C-kinase substrate,Humans,inhibitor,yes
DB14887,PF-04620110,small molecule,investigational,NC1=NC=NC2=C1C(=O)N(CCO2)C1=CC=C(C=C1)[C@H]1CC[C@H](CC(O)=O)CC1,GEVVQZHMFVFGLN-HDJSIYSDSA-N,396.447,O75907,BE0012021,Diacylglycerol O-acyltransferase 1,Humans,inhibitor,yes
DB14889,Derazantinib,small molecule,investigational,COCCNCCC1=CC(NC2=NC=C3C[C@@H](C4=CC=CC=C4F)C4=CC=CC=C4C3=N2)=CC=C1,KPJDVVCDVBFRMU-AREMUKBSSA-N,468.576,P11362,BE0002131,Fibroblast growth factor receptor 1,Humans,inhibitor,yes
DB14890,Obicetrapib,small molecule,investigational,CCOC(=O)N1[C@H](CC)C[C@H](N(CC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)C2=NC=C(OCCCC(O)=O)C=N2)C2=C1C=CC(=C2)C(F)(F)F,NRWORBQAOQVYBJ-GJZUVCINSA-N,722.609,P11597,BE0003516,Cholesteryl ester transfer protein,Humans,inhibitor,yes
DB14894,Galicaftor,small molecule,investigational,OC(=O)C1=CC=C(C=C1)[C@H]1C[C@@H](NC(=O)C2(CC2)C2=CC3=C(OC(F)(F)O3)C=C2)C2=C(O1)C=C(OC(F)F)C=C2,QVDYQHXNAQHIKH-TZIWHRDSSA-N,559.47,P13569,BE0001195,Cystic fibrosis transmembrane conductance regulator,Humans,modulator,yes
DB14895,Vibegron,small molecule,approved;investigational,[H][C@@]1(CC[C@@H](CC2=CC=C(NC(=O)[C@@H]3CCC4=NC=CC(=O)N34)C=C2)N1)[C@H](O)C1=CC=CC=C1,DJXRIQMCROIRCZ-XOEOCAAJSA-N,444.535,P13945,BE0001012,Beta-3 adrenergic receptor,Humans,agonist,yes
DB14896,Selitrectinib,small molecule,investigational,C[C@@H]1CCC2=C(C=C(F)C=N2)[C@H]2CCCN2C2=NC3=C(C=NN3C=C2)C(=O)N1,OEBIHOVSAMBXIB-SJKOYZFVSA-N,380.427,P04629,BE0001039,High affinity nerve growth factor receptor,Humans,inhibitor,yes
DB14898,Retagliptin,small molecule,investigational,COC(=O)C1=C2CN(CCN2C(=N1)C(F)(F)F)C(=O)C[C@H](N)CC1=CC(F)=C(F)C=C1F,WIIAMRXFUJLYEF-SNVBAGLBSA-N,464.368,P27487,BE0000854,Dipeptidyl peptidase 4,Humans,inhibitor,yes
DB14900,ISO-1 F-18,small molecule,investigational,COC1=C(OC)C=C2CN(CCCCNC(=O)C3=C(OCC[18F])C=CC(C)=C3)CCC2=C1,QVRVXSZKCXFBTE-KPVNRNJOSA-N,443.55,Q5BJF2,BE0015084,Sigma intracellular receptor 2,Humans,ligand,yes
DB14909,Imetelstat,small molecule,approved;investigational,CCCCCCCCCCCCCCCC(=O)NCC(O)COP(S)(=O)OCC1OC(CC1NP(S)(=O)OCC1OC(CC1NP(S)(=O)OCC1OC(CC1NP(S)(=O)OCC1OC(CC1NP(S)(=O)OCC1OC(CC1NP(S)(=O)OCC1OC(CC1NP(S)(=O)OCC1OC(CC1NP(S)(=O)OCC1OC(CC1NP(S)(=O)OCC1OC(CC1NP(S)(=O)OCC1OC(CC1NP(S)(=O)OCC1OC(CC1NP(S)(=O)OCC1OC(CC1NP(S)(=O)OCC1OC(CC1N)N1C=NC2=C1N=CN=C2N)N1C=NC2=C1N=CN=C2N)N1C=CC(N)=NC1=O)N1C=NC2=C1N=CN=C2N)N1C=NC2=C1N=C(N)NC2=O)N1C=NC2=C1N=CN=C2N)N1C=C(C)C(=O)NC1=O)N1C=C(C)C(=O)NC1=O)N1C=NC2=C1N=C(N)NC2=O)N1C=NC2=C1N=C(N)NC2=O)N1C=NC2=C1N=C(N)NC2=O)N1C=NC2=C1N=CN=C2N)N1C=C(C)C(=O)NC1=O,LVZYXEALRXBLJZ-UHFFFAOYSA-N,4610.18,O14746,BE0002449,Telomerase reverse transcriptase,Humans,inhibitor,yes
DB14909,Imetelstat,small molecule,approved;investigational,CCCCCCCCCCCCCCCC(=O)NCC(O)COP(S)(=O)OCC1OC(CC1NP(S)(=O)OCC1OC(CC1NP(S)(=O)OCC1OC(CC1NP(S)(=O)OCC1OC(CC1NP(S)(=O)OCC1OC(CC1NP(S)(=O)OCC1OC(CC1NP(S)(=O)OCC1OC(CC1NP(S)(=O)OCC1OC(CC1NP(S)(=O)OCC1OC(CC1NP(S)(=O)OCC1OC(CC1NP(S)(=O)OCC1OC(CC1NP(S)(=O)OCC1OC(CC1NP(S)(=O)OCC1OC(CC1N)N1C=NC2=C1N=CN=C2N)N1C=NC2=C1N=CN=C2N)N1C=CC(N)=NC1=O)N1C=NC2=C1N=CN=C2N)N1C=NC2=C1N=C(N)NC2=O)N1C=NC2=C1N=CN=C2N)N1C=C(C)C(=O)NC1=O)N1C=C(C)C(=O)NC1=O)N1C=NC2=C1N=C(N)NC2=O)N1C=NC2=C1N=C(N)NC2=O)N1C=NC2=C1N=C(N)NC2=O)N1C=NC2=C1N=CN=C2N)N1C=C(C)C(=O)NC1=O,LVZYXEALRXBLJZ-UHFFFAOYSA-N,4610.18,,BE0011002,Human telomerase RNA component,Humans,binder,yes
DB14911,Risuteganib,small molecule,investigational,C[C@@H](O)[C@H](NC(=O)[C@H](CS(O)(=O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)CN)C(=O)N1CCC[C@H]1C(O)=O,MYZAXBZLEILEBR-RVFOSREFSA-N,637.67,P15692,BE0000163,"Vascular endothelial growth factor A, long form",Humans,modulator,yes
DB14911,Risuteganib,small molecule,investigational,C[C@@H](O)[C@H](NC(=O)[C@H](CS(O)(=O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)CN)C(=O)N1CCC[C@H]1C(O)=O,MYZAXBZLEILEBR-RVFOSREFSA-N,637.67,P49765,BE0004736,Vascular endothelial growth factor B,Humans,modulator,yes
DB14911,Risuteganib,small molecule,investigational,C[C@@H](O)[C@H](NC(=O)[C@H](CS(O)(=O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)CN)C(=O)N1CCC[C@H]1C(O)=O,MYZAXBZLEILEBR-RVFOSREFSA-N,637.67,P49767,BE0010101,Vascular endothelial growth factor C,Humans,modulator,yes
DB14911,Risuteganib,small molecule,investigational,C[C@@H](O)[C@H](NC(=O)[C@H](CS(O)(=O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)CN)C(=O)N1CCC[C@H]1C(O)=O,MYZAXBZLEILEBR-RVFOSREFSA-N,637.67,O43915,BE0010102,Vascular endothelial growth factor D,Humans,modulator,yes
DB14914,Flortaucipir F-18,small molecule,approved;investigational,[18F]C1=CC=C(C=N1)C1=CC=C2C(NC3=C2C=NC=C3)=C1,GETAAWDSFUCLBS-SJPDSGJFSA-N,262.278,P10636,BE0003474,Microtubule-associated protein tau,Humans,binder,yes
DB14916,Selonsertib,small molecule,investigational,CC(C)N1C=NN=C1C1=CC=CC(NC(=O)C2=CC(N3C=NC(=C3)C3CC3)=C(C)C=C2F)=N1,YIDDLAAKOYYGJG-UHFFFAOYSA-N,445.502,Q99683,BE0018876,Mitogen-activated protein kinase kinase kinase 5,Humans,inhibitor,yes
DB14918,Branaplam,small molecule,investigational,CC1(C)CC(CC(C)(C)N1)OC1=NN=C(C=C1)C1=C(O)C=C(C=C1)C1=CNN=C1,STWTUEAWRAIWJG-UHFFFAOYSA-N,393.491,Q16637,BE0010390,Survival motor neuron protein,Humans,modulator,yes
DB14921,Mavacamten,small molecule,approved;investigational,CC(C)N1C(=O)NC(N[C@@H](C)C2=CC=CC=C2)=CC1=O,RLCLASQCAPXVLM-NSHDSACASA-N,273.336,P12883,BE0004294,Myosin-7,Humans,inhibitory allosteric modulator,yes
DB14923,Satavaptan,small molecule,investigational,CCOC1=CC=C2N(C(=O)[C@@]3(CC[C@@H](CC3)OCCN3CCOCC3)C2=C1)S(=O)(=O)C1=CC=C(C=C1OC)C(=O)NC(C)(C)C,QKXJWFOKVQWEDZ-VCCCEUOBSA-N,643.8,P30518,BE0000293,Vasopressin V2 receptor,Humans,antagonist,yes
DB14924,Ritlecitinib,small molecule,approved;investigational,C[C@H]1CC[C@H](CN1C(=O)C=C)NC1=NC=NC2=C1C=CN2,CBRJPFGIXUFMTM-WDEREUQCSA-N,285.351,P52333,BE0003493,Tyrosine-protein kinase JAK3,Humans,inhibitor,yes
DB14924,Ritlecitinib,small molecule,approved;investigational,C[C@H]1CC[C@H](CN1C(=O)C=C)NC1=NC=NC2=C1C=CN2,CBRJPFGIXUFMTM-WDEREUQCSA-N,285.351,P42680,BE0009385,Tyrosine-protein kinase Tec,Humans,inhibitor,yes
DB14924,Ritlecitinib,small molecule,approved;investigational,C[C@H]1CC[C@H](CN1C(=O)C=C)NC1=NC=NC2=C1C=CN2,CBRJPFGIXUFMTM-WDEREUQCSA-N,285.351,Q08881,BE0001341,Tyrosine-protein kinase ITK/TSK,Humans,inhibitor,yes
DB14924,Ritlecitinib,small molecule,approved;investigational,C[C@H]1CC[C@H](CN1C(=O)C=C)NC1=NC=NC2=C1C=CN2,CBRJPFGIXUFMTM-WDEREUQCSA-N,285.351,P42681,BE0009403,Tyrosine-protein kinase TXK,Humans,inhibitor,yes
DB14924,Ritlecitinib,small molecule,approved;investigational,C[C@H]1CC[C@H](CN1C(=O)C=C)NC1=NC=NC2=C1C=CN2,CBRJPFGIXUFMTM-WDEREUQCSA-N,285.351,Q06187,BE0001284,Tyrosine-protein kinase BTK,Humans,inhibitor,yes
DB14924,Ritlecitinib,small molecule,approved;investigational,C[C@H]1CC[C@H](CN1C(=O)C=C)NC1=NC=NC2=C1C=CN2,CBRJPFGIXUFMTM-WDEREUQCSA-N,285.351,P51813,BE0009416,Cytoplasmic tyrosine-protein kinase BMX,Humans,inhibitor,yes
DB14925,Tenofovir exalidex,small molecule,investigational,CCCCCCCCCCCCCCCCOCCCOP(O)(=O)CO[C@H](C)CN1C=NC2=C1N=CN=C2N,SCTJKHUUZLXJIP-RUZDIDTESA-N,569.728,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB14935,Serabelisib,small molecule,investigational,NC1=NC2=CC(=CC=C2O1)C1=CN2C(C=C1)=NC=C2C(=O)N1CCOCC1,BLGWHBSBBJNKJO-UHFFFAOYSA-N,363.377,P42336,BE0002379,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",Humans,inhibitor,yes
DB14941,BMS-817399,small molecule,investigational,CC(C)[C@@H](NC(=O)NCC(C)(C)O)C(=O)N1CC[C@](O)(C2=CC=C(Cl)C=C2)C(C)(C)C1,GTDPZONCGOCXOD-JPYJTQIMSA-N,454.01,P32246,BE0003509,C-C chemokine receptor type 1,Humans,modulator,yes
DB14942,BMS-986141,small molecule,investigational,COC1=NN2C=C(N=C2S1)C1=CC2=C(O1)C=C(OC)C=C2OCC1=CSC(=N1)C1=CC=C(C=C1)C(=O)N(C)C,KEEBLYWBELVGPQ-UHFFFAOYSA-N,561.63,Q96IZ0,BE0018382,PRKC apoptosis WT1 regulator protein,Humans,antagonist,yes
DB14943,LGH-447,small molecule,investigational,C[C@@H]1C[C@H](N)C[C@@H](C1)C1=C(NC(=O)C2=NC(=C(F)C=C2)C2=C(F)C=CC=C2F)C=NC=C1,VRQXRVAKPDCRCI-ZNMIVQPWSA-N,440.47,Q9P1W9,BE0020600,Serine/threonine-protein kinase pim-2,Humans,modulator,yes
DB14944,Tarloxotinib,small molecule,investigational,CN1C=NC(=C1C[N+](C)(C)C\C=C\C(=O)NC1=NC=C2N=CN=C(NC3=CC(Br)=C(Cl)C=C3)C2=C1)[N+]([O-])=O,MUJMYVFVAWFUJL-SNAWJCMRSA-O,601.87,P04626,BE0000511,Receptor tyrosine-protein kinase erbB-2,Humans,inhibitor,yes
DB14944,Tarloxotinib,small molecule,investigational,CN1C=NC(=C1C[N+](C)(C)C\C=C\C(=O)NC1=NC=C2N=CN=C(NC3=CC(Br)=C(Cl)C=C3)C2=C1)[N+]([O-])=O,MUJMYVFVAWFUJL-SNAWJCMRSA-O,601.87,P00533,BE0000767,Epidermal growth factor receptor,Humans,inhibitor,yes
DB14946,PCO-371,small molecule,investigational,CC1=CC(=CC(C)=C1CCS(=O)(=O)N1CCC2(CC1)N=C(NC2=O)C1=CC=C(OC(F)(F)F)C=C1)N1C(=O)NC(=O)C1(C)C,LDZJFVOUPUFOHX-UHFFFAOYSA-N,635.66,Q03431,BE0003508,Parathyroid hormone/parathyroid hormone-related peptide receptor,Humans,agonist,yes
DB14948,BMS-986020,small molecule,investigational,C[C@@H](OC(=O)NC1=C(ON=C1C)C1=CC=C(C=C1)C1=CC=C(C=C1)C1(CC1)C(O)=O)C1=CC=CC=C1,GQBRZBHEPUQRPL-LJQANCHMSA-N,482.536,Q92633,BE0017535,Lysophosphatidic acid receptor 1,Humans,antagonist,yes
DB14966,Venglustat,small molecule,investigational,CC(C)(NC(=O)O[C@@H]1CN2CCC1CC2)C1=CSC(=N1)C1=CC=C(F)C=C1,YFHRCLAKZBDRHN-MRXNPFEDSA-N,389.49,Q16739,BE0000477,Ceramide glucosyltransferase,Humans,inhibitor,yes
DB14969,GTX-758,small molecule,investigational,OC1=CC=C(C=C1)N(C(=O)C1=CC=C(O)C(F)=C1)C1=CC=C(F)C=C1,FBCQEUMZZNVQKD-UHFFFAOYSA-N,341.314,P03372,BE0000123,Estrogen receptor,Humans,modulator,yes
DB14973,Abrocitinib,small molecule,approved;investigational,CCCS(=O)(=O)N[C@H]1C[C@H](C1)N(C)C1=C2C=CNC2=NC=N1,IUEWXNHSKRWHDY-PHIMTYICSA-N,323.42,P23458,BE0004145,Tyrosine-protein kinase JAK1,Humans,inhibitor,yes
DB14973,Abrocitinib,small molecule,approved;investigational,CCCS(=O)(=O)N[C@H]1C[C@H](C1)N(C)C1=C2C=CNC2=NC=N1,IUEWXNHSKRWHDY-PHIMTYICSA-N,323.42,O60674,BE0002408,Tyrosine-protein kinase JAK2,Humans,inhibitor,yes
DB14973,Abrocitinib,small molecule,approved;investigational,CCCS(=O)(=O)N[C@H]1C[C@H](C1)N(C)C1=C2C=CNC2=NC=N1,IUEWXNHSKRWHDY-PHIMTYICSA-N,323.42,P52333,BE0003493,Tyrosine-protein kinase JAK3,Humans,inhibitor,yes
DB14975,Voxelotor,small molecule,approved;investigational,CC(C)N1N=CC=C1C1=C(COC2=CC=CC(O)=C2C=O)C=CC=N1,FWCVZAQENIZVMY-UHFFFAOYSA-N,337.379,P69905,BE0000130,Hemoglobin subunit alpha,Humans,binder,yes
DB14976,Relacorilant,small molecule,investigational,CN1C=C(C=N1)S(=O)(=O)N1CCC2=CC3=C(C[C@@]2(C1)C(=O)C1=CC(=CC=N1)C(F)(F)F)C=NN3C1=CC=C(F)C=C1,WANIDIGFXJFFEL-SANMLTNESA-N,586.57,P04150,BE0000794,Glucocorticoid receptor,Humans,antagonist,yes
DB14977,Padsevonil,small molecule,investigational,COCC1=NN2C(CN3C[C@@H](CC(F)(F)Cl)CC3=O)=C(N=C2S1)C(F)(F)F,DCXFIOLWWRXEQH-SSDOTTSWSA-N,432.79,Q7L0J3,BE0000993,Synaptic vesicle glycoprotein 2A,Humans,inhibitor,yes
DB14979,Martinostat,small molecule,investigational,CN(CC1=CC=C(\C=C\C(=O)NO)C=C1)CC12CC3CC(CC(C3)C1)C2,WNIDBXBLQFPAJA-VOTSOKGWSA-N,354.494,Q8WUI4,BE0003525,Histone deacetylase 7,Humans,inhibitor,yes
DB14979,Martinostat,small molecule,investigational,CN(CC1=CC=C(\C=C\C(=O)NO)C=C1)CC12CC3CC(CC(C3)C1)C2,WNIDBXBLQFPAJA-VOTSOKGWSA-N,354.494,Q9UKV0,BE0000881,Histone deacetylase 9,Humans,inhibitor,yes
DB14979,Martinostat,small molecule,investigational,CN(CC1=CC=C(\C=C\C(=O)NO)C=C1)CC12CC3CC(CC(C3)C1)C2,WNIDBXBLQFPAJA-VOTSOKGWSA-N,354.494,Q9BY41,BE0001608,Histone deacetylase 8,Humans,inhibitor,yes
DB14979,Martinostat,small molecule,investigational,CN(CC1=CC=C(\C=C\C(=O)NO)C=C1)CC12CC3CC(CC(C3)C1)C2,WNIDBXBLQFPAJA-VOTSOKGWSA-N,354.494,P56524,BE0003523,Histone deacetylase 4,Humans,inhibitor,yes
DB14979,Martinostat,small molecule,investigational,CN(CC1=CC=C(\C=C\C(=O)NO)C=C1)CC12CC3CC(CC(C3)C1)C2,WNIDBXBLQFPAJA-VOTSOKGWSA-N,354.494,Q9UQL6,BE0009578,Histone deacetylase 5,Humans,inhibitor,yes
DB14979,Martinostat,small molecule,investigational,CN(CC1=CC=C(\C=C\C(=O)NO)C=C1)CC12CC3CC(CC(C3)C1)C2,WNIDBXBLQFPAJA-VOTSOKGWSA-N,354.494,Q9UBN7,BE0002368,Histone deacetylase 6,Humans,inhibitor,yes
DB14979,Martinostat,small molecule,investigational,CN(CC1=CC=C(\C=C\C(=O)NO)C=C1)CC12CC3CC(CC(C3)C1)C2,WNIDBXBLQFPAJA-VOTSOKGWSA-N,354.494,Q92769,BE0002366,Histone deacetylase 2,Humans,inhibitor,yes
DB14979,Martinostat,small molecule,investigational,CN(CC1=CC=C(\C=C\C(=O)NO)C=C1)CC12CC3CC(CC(C3)C1)C2,WNIDBXBLQFPAJA-VOTSOKGWSA-N,354.494,O15379,BE0002367,Histone deacetylase 3,Humans,inhibitor,yes
DB14979,Martinostat,small molecule,investigational,CN(CC1=CC=C(\C=C\C(=O)NO)C=C1)CC12CC3CC(CC(C3)C1)C2,WNIDBXBLQFPAJA-VOTSOKGWSA-N,354.494,Q13547,BE0002365,Histone deacetylase 1,Humans,inhibitor,yes
DB14980,AZD-6482,small molecule,investigational,C[C@@H](NC1=CC=CC=C1C(O)=O)C1=CC(C)=CN2C(=O)C=C(N=C12)N1CCOCC1,IRTDIKMSKMREGO-OAHLLOKOSA-N,408.458,P42338,BE0002407,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",Humans,modulator,yes
DB14982,Miransertib,small molecule,investigational,NC1=NC=CC=C1C1=NC2=CC=C(N=C2N1C1=CC=C(C=C1)C1(N)CCC1)C1=CC=CC=C1,HNFMVVHMKGFCMB-UHFFFAOYSA-N,432.531,Q9Y243,BE0010514,RAC-gamma serine/threonine-protein kinase,Humans,modulator,yes
DB14982,Miransertib,small molecule,investigational,NC1=NC=CC=C1C1=NC2=CC=C(N=C2N1C1=CC=C(C=C1)C1(N)CCC1)C1=CC=CC=C1,HNFMVVHMKGFCMB-UHFFFAOYSA-N,432.531,P31749,BE0000428,RAC-alpha serine/threonine-protein kinase,Humans,inhibitor,yes
DB14989,Umbralisib,small molecule,approved;investigational;withdrawn,CC(C)OC1=C(F)C=C(C=C1)C1=NN([C@@H](C)C2=C(C3=CC=CC(F)=C3)C(=O)C3=CC(F)=CC=C3O2)C2=C1C(N)=NC=N2,IUVCFHHAEHNCFT-INIZCTEOSA-N,571.56,P49674,BE0003512,Casein kinase I isoform epsilon,Humans,inhibitor,yes
DB14989,Umbralisib,small molecule,approved;investigational;withdrawn,CC(C)OC1=C(F)C=C(C=C1)C1=NN([C@@H](C)C2=C(C3=CC=CC(F)=C3)C(=O)C3=CC(F)=CC=C3O2)C2=C1C(N)=NC=N2,IUVCFHHAEHNCFT-INIZCTEOSA-N,571.56,O00329,BE0002406,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",Humans,inhibitor,yes
DB14993,Pyrotinib,small molecule,investigational,CCOC1=C(NC(=O)\C=C\[C@H]2CCCN2C)C=C2C(=C1)N=CC(C#N)=C2NC1=CC=C(OCC2=NC=CC=C2)C(Cl)=C1,SADXACCFNXBCFY-IYNHSRRRSA-N,583.09,P00533,BE0000767,Epidermal growth factor receptor,Humans,inhibitor,yes
DB14995,NP-G2-044,small molecule,investigational,CC1=C(C=CO1)C(=O)NC1=NN(CC2=CC=C(C=C2)C(F)(F)F)C2=CC=CC=C12,XLLRLAABUFOJPC-UHFFFAOYSA-N,399.373,Q16658,BE0014857,Fascin,Humans,inhibitor,yes
DB14998,Olorinab,small molecule,investigational,CC(C)(C)[C@@H](CO)NC(=O)C1=NN(C2=C1C[C@@H]1C[C@H]21)C1=C[N+]([O-])=CC=N1,ACSQLTBPYZSGBA-GMXVVIOVSA-N,357.414,P34972,BE0000095,Cannabinoid receptor 2,Humans,agonist,yes
DB15003,PF-06700841,small molecule,investigational,CN1C=C(NC2=NC=CC(=N2)N2C[C@@H]3CC[C@H](C2)N3C(=O)[C@@H]2CC2(F)F)C=N1,BUWBRTXGQRBBHG-MJBXVCDLSA-N,389.411,P29597,BE0004146,Non-receptor tyrosine-protein kinase TYK2,Humans,inhibitor,yes
DB15003,PF-06700841,small molecule,investigational,CN1C=C(NC2=NC=CC(=N2)N2C[C@@H]3CC[C@H](C2)N3C(=O)[C@@H]2CC2(F)F)C=N1,BUWBRTXGQRBBHG-MJBXVCDLSA-N,389.411,P23458,BE0004145,Tyrosine-protein kinase JAK1,Humans,inhibitor,yes
DB15009,PF-04937319,small molecule,investigational,CN(C)C(=O)C1=NC=C(OC2=CC(=CC3=C2C=C(C)O3)C(=O)NC2=NC=C(C)N=C2)C=N1,MASKQITXHVYVFL-UHFFFAOYSA-N,432.432,P35557,BE0001056,Hexokinase-4,Humans,modulator,yes
DB15010,Edasalonexent,small molecule,investigational,CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(=O)NCCNC(=O)C1=C(O)C=CC=C1,JQLBBYLGWHUHRW-KUBAVDMBSA-N,490.688,P19838,BE0001086,Nuclear factor NF-kappa-B p105 subunit,Humans,inhibitor,yes
DB15010,Edasalonexent,small molecule,investigational,CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(=O)NCCNC(=O)C1=C(O)C=CC=C1,JQLBBYLGWHUHRW-KUBAVDMBSA-N,490.688,Q01201,BE0013795,Transcription factor RelB,Humans,inhibitor,yes
DB15010,Edasalonexent,small molecule,investigational,CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(=O)NCCNC(=O)C1=C(O)C=CC=C1,JQLBBYLGWHUHRW-KUBAVDMBSA-N,490.688,Q00653,BE0002387,Nuclear factor NF-kappa-B p100 subunit,Humans,inhibitor,yes
DB15010,Edasalonexent,small molecule,investigational,CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(=O)NCCNC(=O)C1=C(O)C=CC=C1,JQLBBYLGWHUHRW-KUBAVDMBSA-N,490.688,Q04206,BE0005551,Transcription factor p65,Humans,inhibitor,yes
DB15010,Edasalonexent,small molecule,investigational,CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(=O)NCCNC(=O)C1=C(O)C=CC=C1,JQLBBYLGWHUHRW-KUBAVDMBSA-N,490.688,Q04864,BE0010782,Proto-oncogene c-Rel,Humans,inhibitor,yes
DB15011,Avacopan,small molecule,approved;investigational,CC1=CC=C(NC(=O)[C@H]2CCCN([C@H]2C2=CC=C(NC3CCCC3)C=C2)C(=O)C2=C(F)C=CC=C2C)C=C1C(F)(F)F,PUKBOVABABRILL-YZNIXAGQSA-N,581.656,P21730,BE0010095,C5a anaphylatoxin chemotactic receptor 1,Humans,antagonist,yes
DB15012,Farampator,small molecule,investigational,O=C(N1CCCCC1)C1=CC2=NON=C2C=C1,XFVRBYKKGGDPAJ-UHFFFAOYSA-N,231.255,P42261,BE0000640,Glutamate receptor 1,Humans,binder,yes
DB15021,Leriglitazone,small molecule,investigational,CC(O)C1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,OXVFDZYQLGRLCD-UHFFFAOYSA-N,372.438,P37231,BE0000215,Peroxisome proliferator-activated receptor gamma,Humans,agonist,yes
DB15027,Adriforant,small molecule,investigational,CN[C@@H]1CCN(C1)C1=CC(NCC2CC2)=NC(N)=N1,ISBHYKVAFKTATD-SNVBAGLBSA-N,262.361,Q9H3N8,BE0000146,Histamine H4 receptor,Humans,antagonist,yes
DB15029,AZD-8186,small molecule,investigational,C[C@@H](NC1=CC(F)=CC(F)=C1)C1=CC(=CC2=C1OC(=CC2=O)N1CCOCC1)C(=O)N(C)C,LMJFJIDLEAWOQJ-CQSZACIVSA-N,457.478,P48736,BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",Humans,inhibitor,yes
DB15029,AZD-8186,small molecule,investigational,C[C@@H](NC1=CC(F)=CC(F)=C1)C1=CC(=CC2=C1OC(=CC2=O)N1CCOCC1)C(=O)N(C)C,LMJFJIDLEAWOQJ-CQSZACIVSA-N,457.478,P42338,BE0002407,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",Humans,inhibitor,yes
DB15031,Daridorexant,small molecule,approved,COC1=CC(C(=O)N2CCC[C@@]2(C)C2=NC3=C(N2)C=CC(Cl)=C3C)=C(C=C1)N1N=CC=N1,NBGABHGMJVIVBW-QHCPKHFHSA-N,450.93,O43613,BE0005864,Orexin/Hypocretin receptor type 1,Humans,antagonist,yes
DB15031,Daridorexant,small molecule,approved,COC1=CC(C(=O)N2CCC[C@@]2(C)C2=NC3=C(N2)C=CC(Cl)=C3C)=C(C=C1)N1N=CC=N1,NBGABHGMJVIVBW-QHCPKHFHSA-N,450.93,O43614,BE0005865,Orexin receptor type 2,Humans,antagonist,yes
DB15033,Flortaucipir,small molecule,investigational,FC1=CC=C(C=N1)C1=CC=C2C(NC3=C2C=NC=C3)=C1,GETAAWDSFUCLBS-UHFFFAOYSA-N,263.275,P10636,BE0003474,Microtubule-associated protein tau,Humans,modulator,yes
DB15034,PRI-724,small molecule,investigational,C[C@H]1[C@H]2N([C@@H](CC3=CC=C(OP(O)(O)=O)C=C3)C(=O)N1CC1=CC=CC3=C1N=CC=C3)C(=O)CN(C)N2C(=O)NCC1=CC=CC=C1,VHOZWHQPEJGPCC-AZXNYEMZSA-N,658.652,Q92793,BE0004367,CREB-binding protein,Humans,modulator,yes
DB15035,Zanubrutinib,small molecule,approved;investigational,NC(=O)C1=C2NCC[C@@H](C3CCN(CC3)C(=O)C=C)N2N=C1C1=CC=C(OC2=CC=CC=C2)C=C1,RNOAOAWBMHREKO-QFIPXVFZSA-N,471.561,Q06187,BE0001284,Tyrosine-protein kinase BTK,Humans,inhibitor,yes
DB15036,Sitravatinib,small molecule,investigational,COCCNCC1=CC=C(N=C1)C1=CC2=C(S1)C(OC1=C(F)C=C(NC(=O)C3(CC3)C(=O)NC3=CC=C(F)C=C3)C=C1)=CC=N2,WLAVZAAODLTUSW-UHFFFAOYSA-N,629.68,P08581,BE0000915,Hepatocyte growth factor receptor,Humans,inhibitor,yes
DB15036,Sitravatinib,small molecule,investigational,COCCNCC1=CC=C(N=C1)C1=CC2=C(S1)C(OC1=C(F)C=C(NC(=O)C3(CC3)C(=O)NC3=CC=C(F)C=C3)C=C1)=CC=N2,WLAVZAAODLTUSW-UHFFFAOYSA-N,629.68,P35916,BE0000023,Vascular endothelial growth factor receptor 3,Humans,inhibitor,yes
DB15036,Sitravatinib,small molecule,investigational,COCCNCC1=CC=C(N=C1)C1=CC2=C(S1)C(OC1=C(F)C=C(NC(=O)C3(CC3)C(=O)NC3=CC=C(F)C=C3)C=C1)=CC=N2,WLAVZAAODLTUSW-UHFFFAOYSA-N,629.68,P35968,BE0000369,Vascular endothelial growth factor receptor 2,Humans,inhibitor,yes
DB15036,Sitravatinib,small molecule,investigational,COCCNCC1=CC=C(N=C1)C1=CC2=C(S1)C(OC1=C(F)C=C(NC(=O)C3(CC3)C(=O)NC3=CC=C(F)C=C3)C=C1)=CC=N2,WLAVZAAODLTUSW-UHFFFAOYSA-N,629.68,P07949,BE0002411,Proto-oncogene tyrosine-protein kinase receptor Ret,Humans,inhibitor,yes
DB15038,Litoxetine,small molecule,investigational,C(OC1CCNCC1)C1=CC=C2C=CC=CC2=C1,MJJDYOLPMGIWND-UHFFFAOYSA-N,241.334,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,modulator,yes
DB15046,LY-2881835,small molecule,investigational,CC#C[C@@H](CC(O)=O)C1=CC=C(OCC2=CC=C(CN3CCC4(CC3)C=CC3=C4C=CC=C3)C=C2)C=C1,FHRWHNJJQGSCQC-LJAQVGFWSA-N,491.631,O14842,BE0000688,Free fatty acid receptor 1,Humans,modulator,yes
DB15047,BMS-919373,small molecule,investigational,NS(=O)(=O)C1=CN=CC(=C1)C1=NC(NCC2=NC=CC=C2)=C2C(C=CC=C2C2=CC=CC=C2)=N1,XGKULQQVQWCASY-UHFFFAOYSA-N,468.54,P22460,BE0004717,Potassium voltage-gated channel subfamily A member 5,Humans,inhibitor,yes
DB15048,Licogliflozin,small molecule,investigational,CCC1=CC=C(C=C1CC1=CC2=C(OCCO2)C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,XFJAMQQAAMJFGB-ZQGJOIPISA-N,416.47,P13866,BE0004754,Sodium/glucose cotransporter 1,Humans,inhibitor,yes
DB15048,Licogliflozin,small molecule,investigational,CCC1=CC=C(C=C1CC1=CC2=C(OCCO2)C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,XFJAMQQAAMJFGB-ZQGJOIPISA-N,416.47,P31639,BE0004753,Sodium/glucose cotransporter 2,Humans,inhibitor,yes
DB15055,ABT-639,small molecule,investigational,FC1=CC=CC=C1NS(=O)(=O)C1=C(F)C=C(Cl)C(=C1)C(=O)N1CCN2CCC[C@@H]2C1,AGPIHNZOZNKRGT-CYBMUJFWSA-N,455.9,O95180,BE0000864,Voltage-dependent T-type calcium channel subunit alpha-1H,Humans,modulator,yes
DB15059,Aprocitentan,small molecule,approved;investigational,NS(=O)(=O)NC1=C(C(OCCOC2=NC=C(Br)C=N2)=NC=N1)C1=CC=C(Br)C=C1,DKULOVKANLVDEA-UHFFFAOYSA-N,546.19,P25101,BE0000521,Endothelin-1 receptor,Humans,antagonist,yes
DB15059,Aprocitentan,small molecule,approved;investigational,NS(=O)(=O)NC1=C(C(OCCOC2=NC=C(Br)C=N2)=NC=N1)C1=CC=C(Br)C=C1,DKULOVKANLVDEA-UHFFFAOYSA-N,546.19,P24530,BE0000043,Endothelin receptor type B,Humans,antagonist,yes
DB15063,Inarigivir soproxil,small molecule,investigational,CO[C@@H]1[C@H](OP(=O)(OC[C@H]2O[C@H](C[C@@H]2O)N2C=NC3=C2N=CN=C3N)SCOC(=O)OC(C)C)[C@@H](CO)O[C@H]1N1C=CC(=O)NC1=O,CJCYTUJOSMYXLE-JDLSZIHUSA-N,703.62,Q9HC29,BE0009323,Nucleotide-binding oligomerization domain-containing protein 2,Humans,modulator,yes
DB15065,PF-06291874,small molecule,investigational,CCC[C@H](OC1=CC(C)=C(N2C=C(C=N2)C(F)(F)F)C(C)=C1)C1=CC=C(C=C1)C(=O)NCCC(O)=O,IBDYYOQKQCCSDP-QFIPXVFZSA-N,503.522,P47871,BE0000527,Glucagon receptor,Humans,antagonist,yes
DB15068,Agerafenib,small molecule,investigational,COC1=C(OC)C=C2C(OC3=CC=CC(NC(=O)NC4=NOC(=C4)C(C)(C)C(F)(F)F)=C3)=NC=NC2=C1,DKNUPRMJNUQNHR-UHFFFAOYSA-N,517.465,P07949,BE0002411,Proto-oncogene tyrosine-protein kinase receptor Ret,Humans,inhibitor,yes
DB15068,Agerafenib,small molecule,investigational,COC1=C(OC)C=C2C(OC3=CC=CC(NC(=O)NC4=NOC(=C4)C(C)(C)C(F)(F)F)=C3)=NC=NC2=C1,DKNUPRMJNUQNHR-UHFFFAOYSA-N,517.465,P15056,BE0000634,Serine/threonine-protein kinase B-raf,Humans,inhibitor,yes
DB15071,Omidenepag isopropyl,small molecule,approved;investigational,CC(C)OC(=O)CNC1=CC=CC(CN(CC2=CC=C(C=C2)N2C=CC=N2)S(=O)(=O)C2=CC=CN=C2)=N1,VIQCWEGEHRBLAC-UHFFFAOYSA-N,520.61,P43116,BE0000368,Prostaglandin E2 receptor EP2 subtype,Humans,agonist,yes
DB15085,Fulacimstat,small molecule,investigational,CN1C(=O)OC2=CC(=CC=C12)N1C=C(C(O)=O)C(=O)N([C@@H]2CCC3=C(C=CC=C23)C(F)(F)F)C1=O,JDARDSVOVYVQST-MRXNPFEDSA-N,487.391,P23946,BE0001038,Chymase,Humans,inhibitor,yes
DB15091,Upadacitinib,small molecule,approved;investigational,CC[C@@H]1CN(C[C@@H]1C1=CN=C2C=NC3=C(C=CN3)N12)C(=O)NCC(F)(F)F,WYQFJHHDOKWSHR-MNOVXSKESA-N,380.375,P23458,BE0004145,Tyrosine-protein kinase JAK1,Humans,inhibitor,yes
DB15092,LY-2624803,small molecule,investigational,CC(C)(CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=CC=CC=C12)C(O)=O,UEFWDVMEDFCHGW-UHFFFAOYSA-N,379.46,P35367,BE0000442,Histamine H1 receptor,Humans,modulator,yes
DB15096,18-methoxycoronaridine,small molecule,investigational,COCC[C@H]1C[C@H]2CN3CCC4=C(NC5=C4C=CC=C5)[C@](C2)([C@H]13)C(=O)OC,DTJQBBHYRQYDEG-SVBQBFEESA-N,368.477,Q15822,BE0000738,Neuronal acetylcholine receptor subunit alpha-2,Humans,antagonist,yes
DB15096,18-methoxycoronaridine,small molecule,investigational,COCC[C@H]1C[C@H]2CN3CCC4=C(NC5=C4C=CC=C5)[C@](C2)([C@H]13)C(=O)OC,DTJQBBHYRQYDEG-SVBQBFEESA-N,368.477,P32297,BE0003585,Neuronal acetylcholine receptor subunit alpha-3,Humans,antagonist,yes
DB15097,Gefapixant,small molecule,approved;investigational,COC1=C(C=C(OC2=CN=C(N)N=C2N)C(=C1)C(C)C)S(N)(=O)=O,HLWURFKMDLAKOD-UHFFFAOYSA-N,353.4,P56373,BE0009818,P2X purinoceptor 3,Humans,antagonist,yes
DB15102,Pemigatinib,small molecule,approved;investigational,CCN1C(=O)N(CC2=CN=C3NC(CN4CCOCC4)=CC3=C12)C1=C(F)C(OC)=CC(OC)=C1F,HCDMJFOHIXMBOV-UHFFFAOYSA-N,487.508,P11362,BE0002131,Fibroblast growth factor receptor 1,Humans,inhibitor,yes
DB15102,Pemigatinib,small molecule,approved;investigational,CCN1C(=O)N(CC2=CN=C3NC(CN4CCOCC4)=CC3=C12)C1=C(F)C(OC)=CC(OC)=C1F,HCDMJFOHIXMBOV-UHFFFAOYSA-N,487.508,P21802,BE0000748,Fibroblast growth factor receptor 2,Humans,inhibitor,yes
DB15102,Pemigatinib,small molecule,approved;investigational,CCN1C(=O)N(CC2=CN=C3NC(CN4CCOCC4)=CC3=C12)C1=C(F)C(OC)=CC(OC)=C1F,HCDMJFOHIXMBOV-UHFFFAOYSA-N,487.508,P22607,BE0002133,Fibroblast growth factor receptor 3,Humans,inhibitor,yes
DB15106,Surufatinib,small molecule,investigational,CN(C)CCNS(=O)(=O)CC1=CC(NC2=NC(OC3=CC4=C(NC(C)=C4)C=C3)=CC=N2)=CC=C1,TTZSNFLLYPYKIL-UHFFFAOYSA-N,480.59,P11362,BE0002131,Fibroblast growth factor receptor 1,Humans,inhibitor,yes
DB15106,Surufatinib,small molecule,investigational,CN(C)CCNS(=O)(=O)CC1=CC(NC2=NC(OC3=CC4=C(NC(C)=C4)C=C3)=CC=N2)=CC=C1,TTZSNFLLYPYKIL-UHFFFAOYSA-N,480.59,P35968,BE0000369,Vascular endothelial growth factor receptor 2,Humans,inhibitor,yes
DB15106,Surufatinib,small molecule,investigational,CN(C)CCNS(=O)(=O)CC1=CC(NC2=NC(OC3=CC4=C(NC(C)=C4)C=C3)=CC=N2)=CC=C1,TTZSNFLLYPYKIL-UHFFFAOYSA-N,480.59,P35916,BE0000023,Vascular endothelial growth factor receptor 3,Humans,inhibitor,yes
DB15106,Surufatinib,small molecule,investigational,CN(C)CCNS(=O)(=O)CC1=CC(NC2=NC(OC3=CC4=C(NC(C)=C4)C=C3)=CC=N2)=CC=C1,TTZSNFLLYPYKIL-UHFFFAOYSA-N,480.59,P07333,BE0000853,Macrophage colony-stimulating factor 1 receptor,Humans,inhibitor,yes
DB15106,Surufatinib,small molecule,investigational,CN(C)CCNS(=O)(=O)CC1=CC(NC2=NC(OC3=CC4=C(NC(C)=C4)C=C3)=CC=N2)=CC=C1,TTZSNFLLYPYKIL-UHFFFAOYSA-N,480.59,P17948,BE0000029,Vascular endothelial growth factor receptor 1,Humans,inhibitor,yes
DB15110,Onvansertib,small molecule,investigational,CN1CCN(CC1)C1=CC(NC2=NC=C3CCC4=C(N(CCO)N=C4C(N)=O)C3=N2)=C(OC(F)(F)F)C=C1,QHLVBNKYJGBCQJ-UHFFFAOYSA-N,532.5182,P53350,BE0003745,Serine/threonine-protein kinase PLK1,Humans,inhibitor,yes
DB15114,Vamorolone,small molecule,approved;investigational,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)C3=CC[C@]2(C)[C@@]1(O)C(=O)CO,ZYTXTXAMMDTYDQ-DGEXFFLYSA-N,356.462,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB15120,GSK-239512,small molecule,investigational,O=C1CCCN1C1=CC=C(OC2=CC3=C(CCN(CC3)C3CCC3)C=C2)N=C1,YFRBKEVUUCQYOW-UHFFFAOYSA-N,377.488,Q9Y5N1,BE0000968,Histamine H3 receptor,Humans,inverse agonist,yes
DB15123,Dorzagliatin,small molecule,investigational,CC(C)C[C@H](N1CC(OC2=C(Cl)C=CC=C2)=CC1=O)C(=O)NC1=NN(C[C@@H](O)CO)C=C1,HMUMWSORCUWQJO-QAPCUYQASA-N,462.93,P35557,BE0001056,Hexokinase-4,Humans,activator,yes
DB15124,PF-05241328,small molecule,investigational,CC(C)COC1=NC=C(C=C1Cl)N1N=C(C)C2=C1C=CC(=C2)C(=O)NS(C)(=O)=O,RVTSXVZXEGFIPW-UHFFFAOYSA-N,436.91,Q15858,BE0001143,Sodium channel protein type 9 subunit alpha,Humans,inhibitor,yes
DB15126,IMG-7289,small molecule,investigational,CN1CCN(CC1)C(=O)[C@H](CCCN[C@@H]1C[C@H]1C1=CC=C(F)C=C1)NC(=O)C1=CC=C(C=C1)N1C=CN=N1,KQKBMHGOHXOHTD-KKUQBAQOSA-N,519.625,O60341,BE0010091,Lysine-specific histone demethylase 1A,Humans,inhibitor,yes
DB15130,Dexpramipexole,small molecule,investigational,CCCN[C@@H]1CCC2=C(C1)SC(N)=N2,FASDKYOPVNHBLU-SSDOTTSWSA-N,211.33,P05112,BE0003520,Interleukin-4,Humans,inhibitor,yes
DB15130,Dexpramipexole,small molecule,investigational,CCCN[C@@H]1CCC2=C(C1)SC(N)=N2,FASDKYOPVNHBLU-SSDOTTSWSA-N,211.33,P35225,BE0002438,Interleukin-13,Humans,inhibitor,yes
DB15132,AZD-8165,small molecule,investigational,CCC(=O)O[C@@H](C(=O)N1N=CC[C@H]1C(=O)NCC1=C(C=CC(Cl)=C1)N1C=NN=N1)C1=CC=C(F)C=C1,YUHNXUAATAMVKD-PZJWPPBQSA-N,513.91,P00734,BE0000048,Prothrombin,Humans,inhibitor,yes
DB15133,Tepotinib,small molecule,approved;investigational,CN1CCC(COC2=CN=C(N=C2)C2=CC(CN3N=C(C=CC3=O)C3=CC(=CC=C3)C#N)=CC=C2)CC1,AHYMHWXQRWRBKT-UHFFFAOYSA-N,492.583,P08581,BE0000915,Hepatocyte growth factor receptor,Humans,inhibitor,yes
DB15137,VK-2809,small molecule,investigational,CC(C)C1=CC(CC2=C(C)C=C(OC[P@@]3(=O)OCC[C@H](O3)C3=CC=CC(Cl)=C3)C=C2C)=CC=C1O,LGGPZDRLTDGYSQ-JADSYQMUSA-N,514.98,P10828,BE0000315,Thyroid hormone receptor beta,Humans,modulator,yes
DB15138,AZD-9496,small molecule,investigational,C[C@@H]1CC2=C(NC3=C2C=CC=C3)[C@H](N1CC(C)(C)F)C1=C(F)C=C(\C=C\C(O)=O)C=C1F,DFBDRVGWBHBJNR-BBNFHIFMSA-N,442.482,P03372,BE0000123,Estrogen receptor,Humans,antagonist,yes
DB15149,Futibatinib,small molecule,approved;investigational,COC1=CC(=CC(OC)=C1)C#CC1=NN([C@H]2CCN(C2)C(=O)C=C)C2=C1C(N)=NC=N2,KEIPNCCJPRMIAX-HNNXBMFYSA-N,418.457,P11362,BE0002131,Fibroblast growth factor receptor 1,Humans,inhibitor,yes
DB15149,Futibatinib,small molecule,approved;investigational,COC1=CC(=CC(OC)=C1)C#CC1=NN([C@H]2CCN(C2)C(=O)C=C)C2=C1C(N)=NC=N2,KEIPNCCJPRMIAX-HNNXBMFYSA-N,418.457,P21802,BE0000748,Fibroblast growth factor receptor 2,Humans,inhibitor,yes
DB15149,Futibatinib,small molecule,approved;investigational,COC1=CC(=CC(OC)=C1)C#CC1=NN([C@H]2CCN(C2)C(=O)C=C)C2=C1C(N)=NC=N2,KEIPNCCJPRMIAX-HNNXBMFYSA-N,418.457,P22607,BE0002133,Fibroblast growth factor receptor 3,Humans,inhibitor,yes
DB15149,Futibatinib,small molecule,approved;investigational,COC1=CC(=CC(OC)=C1)C#CC1=NN([C@H]2CCN(C2)C(=O)C=C)C2=C1C(N)=NC=N2,KEIPNCCJPRMIAX-HNNXBMFYSA-N,418.457,P22455,BE0001203,Fibroblast growth factor receptor 4,Humans,inhibitor,yes
DB15152,TMC-649128,small molecule,investigational,CC(C)C(=O)OC[C@]1(O[C@H]([C@@H](C)[C@@H]1OC(=O)C(C)C)N1C=CC(N)=NC1=O)N=[N+]=[N-],XJBILYMRFVHPJB-XJQUKVTJSA-N,422.442,P26664,BE0003427,Genome polyprotein,,inhibitor,yes
DB15156,ABT-072,small molecule,investigational,COC1=C(\C=C\C2=CC=C(NS(C)(=O)=O)C=C2)C=C(C=C1C(C)(C)C)N1C=CC(=O)NC1=O,XMZSTQYSBYEENY-RMKNXTFCSA-N,469.56,P26664,BE0003427,Genome polyprotein,,inhibitor,yes
DB15157,Voruciclib,small molecule,investigational,CN1CC[C@H]([C@@H]1CO)C1=C(O)C=C(O)C2=C1OC(=CC2=O)C1=CC=C(C=C1Cl)C(F)(F)F,MRPGRAKIAJJGMM-OCCSQVGLSA-N,469.84,P11802,BE0002216,Cyclin-dependent kinase 4,Humans,inhibitor,yes
DB15168,Cilofexor,small molecule,investigational,OC(=O)C1=CC=NC(=C1)N1CC(O)(C1)C1=C(Cl)C=C(OCC2=C(ON=C2C2=C(Cl)C=CC=C2Cl)C2CC2)C=C1,KZSKGLFYQAYZCO-UHFFFAOYSA-N,586.85,Q96RI1,BE0001777,Bile acid receptor,Humans,agonist,yes
DB15169,H3B-6527,small molecule,investigational,CCN1CCN(CC1)C1=CC=C(NC2=CC(=NC=N2)N(C)C(=O)NC2=C(Cl)C(OC)=CC(OC)=C2Cl)C(NC(=O)C=C)=C1,MBWRLLRCTIYXDW-UHFFFAOYSA-N,629.54,P22455,BE0001203,Fibroblast growth factor receptor 4,Humans,inhibitor,yes
DB15170,Evobrutinib,small molecule,investigational,NC1=NC=NC(NCC2CCN(CC2)C(=O)C=C)=C1C1=CC=C(OC2=CC=CC=C2)C=C1,QUIWHXQETADMGN-UHFFFAOYSA-N,429.524,Q06187,BE0001284,Tyrosine-protein kinase BTK,Humans,inhibitor,yes
DB15173,JNJ-42165279,small molecule,investigational,FC1(F)OC2=CC=C(CN3CCN(CC3)C(=O)NC3=C(Cl)C=CN=C3)C=C2O1,YWGYNGCRVZLMCS-UHFFFAOYSA-N,410.81,O00519,BE0002194,Fatty-acid amide hydrolase 1,Humans,inhibitor,yes
DB15186,Paxalisib,small molecule,investigational,CC1(C)OCCN2C1=NC1=C(N=C(N=C21)C1=CN=C(N)N=C1)N1CCOCC1,LGWACEZVCMBSKW-UHFFFAOYSA-N,382.428,P48736,BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",Humans,inhibitor,yes
DB15187,Dubermatinib,small molecule,investigational,CN(C)S(=O)(=O)C1=CC=CC=C1NC1=NC(NC2=CC=C(CN3CCN(C)CC3)C=C2)=NC=C1Cl,YUAALFPUEOYPNX-UHFFFAOYSA-N,516.06,P30530,BE0009412,Tyrosine-protein kinase receptor UFO,Humans,inhibitor,yes
DB15189,Birabresib,small molecule,investigational,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NC1=CC=C(O)C=C1)N=C2C1=CC=C(Cl)C=C1,GNMUEVRJHCWKTO-FQEVSTJZSA-N,491.99,P25440,BE0012869,Bromodomain-containing protein 2,Humans,modulator,yes
DB15189,Birabresib,small molecule,investigational,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NC1=CC=C(O)C=C1)N=C2C1=CC=C(Cl)C=C1,GNMUEVRJHCWKTO-FQEVSTJZSA-N,491.99,O60885,BE0010747,Bromodomain-containing protein 4,Humans,modulator,yes
DB15190,GLPG-0259,small molecule,investigational,CC(C)N1C[C@@H]2C[C@H]1CN2C1=CC=C(NC2=NC=C(N3N=CN=C23)C2=COC(=C2)C(N)=O)C=C1,YBFGSJUVEOYPIS-OALUTQOASA-N,458.526,Q8IW41,BE0009478,MAP kinase-activated protein kinase 5,Humans,inhibitor,yes
DB15192,ABT-288,small molecule,investigational,CN1C[C@H]2CCN([C@H]2C1)C1=CC=C(C=C1)C1=CC=C(C=C1)N1N=CC=CC1=O,GNIRITULTPTAQW-KNQAVFIVSA-N,372.472,Q9Y5N1,BE0000968,Histamine H3 receptor,Humans,modulator,yes
DB15194,Cotadutide,small molecule,investigational,CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCCC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CNC=N1)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)NCC(O)=O)C(O)=O,YEKUUBPJRPXMBM-PTCFZACGSA-N,3728.092,P01275,BE0010345,Pro-glucagon,Humans,agonist,yes
DB15205,Capromorelin,small molecule,investigational,CN1N=C2CCN(C[C@@]2(CC2=CC=CC=C2)C1=O)C(=O)[C@@H](COCC1=CC=CC=C1)NC(=O)C(C)(C)N,KVLLHLWBPNCVNR-SKCUWOTOSA-N,505.619,Q92847,BE0003383,Growth hormone secretagogue receptor type 1,Humans,agonist,yes
DB15212,Pemafibrate,small molecule,investigational,CC[C@@H](OC1=CC(CN(CCCOC2=CC=C(OC)C=C2)C2=NC3=C(O2)C=CC=C3)=CC=C1)C(O)=O,ZHKNLJLMDFQVHJ-RUZDIDTESA-N,490.556,Q07869,BE0000071,Peroxisome proliferator-activated receptor alpha,Humans,agonist,yes
DB15214,BMS-986104,small molecule,investigational,CCCCCC[C@@H]1CCC2=C(C1)C=CC(=C2)[C@H]1CC[C@](N)(CO)C1,BPMMYKAHRIEVDH-VOQZNFBZSA-N,329.528,P21453,BE0008652,Sphingosine 1-phosphate receptor 1,Humans,modulator,yes
DB15219,Tomivosertib,small molecule,investigational,CC1=C2N(C(=O)C(NC3=CC(N)=NC=N3)=C1)C1(CCCCC1)NC2=O,HKTBYUWLRDZAJK-UHFFFAOYSA-N,340.387,Q9BUB5,BE0009488,MAP kinase-interacting serine/threonine-protein kinase 1,Humans,inhibitor,yes
DB15219,Tomivosertib,small molecule,investigational,CC1=C2N(C(=O)C(NC3=CC(N)=NC=N3)=C1)C1(CCCCC1)NC2=O,HKTBYUWLRDZAJK-UHFFFAOYSA-N,340.387,Q9HBH9,BE0009489,MAP kinase-interacting serine/threonine-protein kinase 2,Humans,inhibitor,yes
DB15221,PF-06260414,small molecule,investigational,C[C@@H]1CNS(=O)(=O)N(C1)C1=CC2=CC=NC(C#N)=C2C=C1,ZKAVFOXYJCREBQ-SNVBAGLBSA-N,302.35,P10275,BE0000132,Androgen receptor,Humans,modulator,yes
DB15222,GS-6620,small molecule,investigational,CC(C)OC(=O)[C@H](C)NP(=O)(OC[C@H]1O[C@@](C#N)(C2=CC=C3N2N=CN=C3N)[C@](C)(O)[C@@H]1OC(=O)C(C)C)OC1=CC=CC=C1,YAAQYJCOIFNMKX-RSTNYOGXSA-N,644.622,P26664,BE0003427,Genome polyprotein,,inhibitor,yes
DB15227,Tirabrutinib,small molecule,investigational,CC#CC(=O)N1CC[C@H](C1)N1C(=O)N(C2=C(N)N=CN=C12)C1=CC=C(OC2=CC=CC=C2)C=C1,SEJLPXCPMNSRAM-GOSISDBHSA-N,454.49,Q06187,BE0001284,Tyrosine-protein kinase BTK,Humans,inhibitor,yes
DB15229,CNV-2197944,small molecule,investigational,C[C@H]1CN(CCN1C(=O)C1=CC=CN=C1C)S(=O)(=O)C1=CC=C(C=C1)C(F)(F)F,BLFJGFDZMABYMY-ZDUSSCGKSA-N,427.44,Q00975,BE0002226,Voltage-dependent N-type calcium channel subunit alpha-1B,Humans,blocker,yes
DB15232,Telaglenastat,small molecule,investigational,FC(F)(F)OC1=CC(CC(=O)NC2=NN=C(CCCCC3=NN=C(NC(=O)CC4=NC=CC=C4)S3)C=C2)=CC=C1,PRAAPINBUWJLGA-UHFFFAOYSA-N,571.58,O94925,BE0000825,"Glutaminase kidney isoform, mitochondrial",Humans,modulator,yes
DB15232,Telaglenastat,small molecule,investigational,FC(F)(F)OC1=CC(CC(=O)NC2=NN=C(CCCCC3=NN=C(NC(=O)CC4=NC=CC=C4)S3)C=C2)=CC=C1,PRAAPINBUWJLGA-UHFFFAOYSA-N,571.58,Q9UI32,BE0000003,"Glutaminase liver isoform, mitochondrial",Humans,modulator,yes
DB15233,Avapritinib,small molecule,approved;investigational,CN1C=C(C=N1)C1=CN2N=CN=C(N3CCN(CC3)C3=NC=C(C=N3)[C@@](C)(N)C3=CC=C(F)C=C3)C2=C1,DWYRIWUZIJHQKQ-SANMLTNESA-N,498.57,P16234,BE0000852,Platelet-derived growth factor receptor alpha,Humans,inhibitor,yes
DB15249,MK-6325,small molecule,investigational,COC1=CC2=C(C=C1)N=C1CCCCC[C@@H]3CCC[C@H]3OC(=O)N[C@H]3CCCCC\C=C\[C@@H]4C[C@]4(NC(=O)[C@@H]4C[C@H](CN4C3=O)OC1=N2)C(=O)NS(=O)(=O)C1(C)CC1,BLFKRFGLQFYXDF-WAZRELCSSA-N,821.0,P26664,BE0003427,Genome polyprotein,,modulator,yes
DB15250,Vercirnon,small molecule,investigational,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC1=C(C=C(Cl)C=C1)C(=O)C1=CC=[N+]([O-])C=C1,JRWROCIMSDXGOZ-UHFFFAOYSA-N,444.93,P51686,BE0002463,C-C chemokine receptor type 9,Humans,modulator,yes
DB15254,Avutometinib,small molecule,investigational,CNS(=O)(=O)NC1=C(F)C(CC2=C(C)C3=C(OC2=O)C=C(OC2=NC=CC=N2)C=C3)=CC=N1,LMMJFBMMJUMSJS-UHFFFAOYSA-N,471.46,P10398,BE0000434,Serine/threonine-protein kinase A-Raf,Humans,modulator,yes
DB15254,Avutometinib,small molecule,investigational,CNS(=O)(=O)NC1=C(F)C(CC2=C(C)C3=C(OC2=O)C=C(OC2=NC=CC=N2)C=C3)=CC=N1,LMMJFBMMJUMSJS-UHFFFAOYSA-N,471.46,P15056,BE0000634,Serine/threonine-protein kinase B-raf,Humans,modulator,yes
DB15254,Avutometinib,small molecule,investigational,CNS(=O)(=O)NC1=C(F)C(CC2=C(C)C3=C(OC2=O)C=C(OC2=NC=CC=N2)C=C3)=CC=N1,LMMJFBMMJUMSJS-UHFFFAOYSA-N,471.46,P04049,BE0000036,RAF proto-oncogene serine/threonine-protein kinase,Humans,modulator,yes
DB15256,Reldesemtiv,small molecule,investigational,NC(=O)C1=CN(C=C1)C1=CN=C(NC[C@@]2(C[C@H](F)C2)C2=NC=CC=C2F)N=C1,MQXWPWOCXGARRK-HJGJAMNPSA-N,384.391,P02585,BE0003566,"Troponin C, skeletal muscle",Humans,modulator,yes
DB15265,USL-311,small molecule,investigational,CC(C)N1CCC(CC1)N1CCCN(CC1)C1=CC=CC(=N1)C(=O)NC1=CC=NC=C1,XNUNVQKARNSSEO-UHFFFAOYSA-N,422.577,P61073,BE0000919,C-X-C chemokine receptor type 4,Humans,antagonist,yes
DB15266,Tovorafenib,small molecule,approved;investigational,C[C@@H](NC(=O)C1=C(Cl)C(N)=NC=N1)C1=NC=C(S1)C(=O)NC1=NC=C(Cl)C(=C1)C(F)(F)F,VWMJHAFYPMOMGF-ZCFIWIBFSA-N,506.29,P04049,BE0000036,RAF proto-oncogene serine/threonine-protein kinase,Humans,inhibitor,yes
DB15266,Tovorafenib,small molecule,approved;investigational,C[C@@H](NC(=O)C1=C(Cl)C(N)=NC=N1)C1=NC=C(S1)C(=O)NC1=NC=C(Cl)C(=C1)C(F)(F)F,VWMJHAFYPMOMGF-ZCFIWIBFSA-N,506.29,P10398,BE0000434,Serine/threonine-protein kinase A-Raf,Humans,inhibitor,yes
DB15266,Tovorafenib,small molecule,approved;investigational,C[C@@H](NC(=O)C1=C(Cl)C(N)=NC=N1)C1=NC=C(S1)C(=O)NC1=NC=C(Cl)C(=C1)C(F)(F)F,VWMJHAFYPMOMGF-ZCFIWIBFSA-N,506.29,P15056,BE0000634,Serine/threonine-protein kinase B-raf,Humans,inhibitor,yes
DB15273,VS-4718,small molecule,investigational,CNC(=O)C1=CC=CC=C1NC1=CC(NC2=C(OC)C=C(C=C2)N2CCOCC2)=NC=C1C(F)(F)F,IGUBBWJDMLCRIK-UHFFFAOYSA-N,501.51,Q05397,BE0003090,Focal adhesion kinase 1,Humans,inhibitor,yes
DB15275,Inavolisib,small molecule,approved;investigational,C[C@H](NC1=CC=C2C3=NC(=CN3CCOC2=C1)N1[C@@H](COC1=O)C(F)F)C(N)=O,SGEUNORSOZVTOL-CABZTGNLSA-N,407.378,P48736,BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",Humans,inhibitor,yes
DB15275,Inavolisib,small molecule,approved;investigational,C[C@H](NC1=CC=C2C3=NC(=CN3CCOC2=C1)N1[C@@H](COC1=O)C(F)F)C(N)=O,SGEUNORSOZVTOL-CABZTGNLSA-N,407.378,P42336,BE0002379,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",Humans,degradation,yes
DB15281,Ravoxertinib,small molecule,investigational,CN1N=CC=C1NC1=NC=CC(=N1)C1=CC(=O)N(C=C1)[C@H](CO)C1=CC(F)=C(Cl)C=C1,RZUOCXOYPYGSKL-GOSISDBHSA-N,440.86,P27361,BE0001062,Mitogen-activated protein kinase 3,Humans,modulator,yes
DB15281,Ravoxertinib,small molecule,investigational,CN1N=CC=C1NC1=NC=CC(=N1)C1=CC(=O)N(C=C1)[C@H](CO)C1=CC(F)=C(Cl)C=C1,RZUOCXOYPYGSKL-GOSISDBHSA-N,440.86,P28482,BE0000923,Mitogen-activated protein kinase 1,Humans,modulator,yes
DB15288,Etamicastat,small molecule,investigational,NCCC1=CNC(=S)N1[C@H]1COC2=C(C1)C=C(F)C=C2F,CWWWTTYMUOYSQA-LLVKDONJSA-N,311.35,P09172,BE0000138,Dopamine beta-hydroxylase,Humans,inhibitor,yes
DB15291,BMS-986142,small molecule,investigational,CN1C(=O)N(C(=O)C2=C1C(F)=CC=C2)C1=C(C)C(=CC=C1)C1=C2C3=C(C[C@H](CC3)C(C)(C)O)NC2=C(C=C1F)C(N)=O,ZRYMMWAJAFUANM-INIZCTEOSA-N,572.613,Q06187,BE0001284,Tyrosine-protein kinase BTK,Humans,inhibitor,yes
DB15293,Epalrestat,small molecule,investigational,C\C(\C=C1/SC(=S)N(CC(O)=O)C1=O)=C/C1=CC=CC=C1,CHNUOJQWGUIOLD-NFZZJPOKSA-N,319.39,P15121,BE0000747,Aldo-keto reductase family 1 member B1,Humans,inhibitor,yes
DB15294,SB-1578,small molecule,investigational,C(CN1CCCC1)OC1=C2COC\C=C\COCC3=CC=C(O3)C3=CC=NC(NC(C=C1)=C2)=N3,NNXDIGHYPZHXTR-ONEGZZNKSA-N,462.55,O60674,BE0002408,Tyrosine-protein kinase JAK2,Humans,inhibitor,yes
DB15295,Tenalisib,small molecule,investigational,CC[C@H](NC1=C2N=CNC2=NC=N1)C1=C(C(=O)C2=CC=CC=C2O1)C1=CC=CC(F)=C1,HDXDQPRPFRKGKZ-INIZCTEOSA-N,415.428,O00329,BE0002406,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",Humans,inhibitor,yes
DB15297,Petesicatib,small molecule,investigational,CN1C=C(C=N1)C1=CC(=C(C=C1)S(=O)(=O)[C@@H]1C[C@H](N(C1)C(=O)C1(CC1)C(F)(F)F)C(=O)NC1(CC1)C#N)C(F)(F)F,KXAAIORSMACJSI-AEFFLSMTSA-N,603.54,P25774,BE0001646,Cathepsin S,Humans,antagonist,yes
DB15299,Navtemadlin,small molecule,investigational,CC(C)[C@@H](CS(=O)(=O)C(C)C)N1[C@@H]([C@H](C[C@](C)(CC(O)=O)C1=O)C1=CC=CC(Cl)=C1)C1=CC=C(Cl)C=C1,DRLCSJFKKILATL-YWCVFVGNSA-N,568.55,Q00987,BE0001003,E3 ubiquitin-protein ligase Mdm2,Humans,modulator,yes
DB15310,Vactosertib,small molecule,investigational,CC1=NC(=CC=C1)C1=C(N=C(CNC2=C(F)C=CC=C2)N1)C1=CN2N=CN=C2C=C1,FJCDSQATIJKQKA-UHFFFAOYSA-N,399.433,P36897,BE0003782,TGF-beta receptor type-1,Humans,modulator,yes
DB15323,Trelagliptin,small molecule,investigational,CN1C(=O)C=C(N2CCC[C@@H](N)C2)N(CC2=CC(F)=CC=C2C#N)C1=O,IWYJYHUNXVAVAA-OAHLLOKOSA-N,357.389,P27487,BE0000854,Dipeptidyl peptidase 4,Humans,inhibitor,yes
DB15327,Abivertinib,small molecule,investigational,CN1CCN(CC1)C1=C(F)C=C(NC2=NC(OC3=CC=CC(NC(=O)C=C)=C3)=C3C=CNC3=N2)C=C1,UOFYSRZSLXWIQB-UHFFFAOYSA-N,487.539,P00533,BE0000767,Epidermal growth factor receptor,Humans,inhibitor,yes
DB15327,Abivertinib,small molecule,investigational,CN1CCN(CC1)C1=C(F)C=C(NC2=NC(OC3=CC=CC(NC(=O)C=C)=C3)=C3C=CNC3=N2)C=C1,UOFYSRZSLXWIQB-UHFFFAOYSA-N,487.539,Q06187,BE0001284,Tyrosine-protein kinase BTK,Humans,inhibitor,yes
DB15328,Ubrogepant,small molecule,approved;investigational,C[C@@H]1[C@@H](C[C@H](NC(=O)C2=CN=C3C[C@]4(CC3=C2)C(=O)NC2=NC=CC=C42)C(=O)N1CC(F)(F)F)C1=CC=CC=C1,DDOOFTLHJSMHLN-ZQHRPCGSSA-N,549.554,Q16602,BE0009009,Calcitonin gene-related peptide type 1 receptor,Humans,antagonist,yes
DB15334,Biochanin A,small molecule,investigational,COC1=CC=C(C=C1)C1=COC2=C(C(O)=CC(O)=C2)C1=O,WUADCCWRTIWANL-UHFFFAOYSA-N,284.267,P11474,BE0003722,Steroid hormone receptor ERR1,Humans,agonist,yes
DB15334,Biochanin A,small molecule,investigational,COC1=CC=C(C=C1)C1=COC2=C(C(O)=CC(O)=C2)C1=O,WUADCCWRTIWANL-UHFFFAOYSA-N,284.267,P11511,BE0002090,Aromatase,Humans,inhibitor,yes
DB15334,Biochanin A,small molecule,investigational,COC1=CC=C(C=C1)C1=COC2=C(C(O)=CC(O)=C2)C1=O,WUADCCWRTIWANL-UHFFFAOYSA-N,284.267,P49327,BE0000959,Fatty acid synthase,Humans,inhibitor,yes
DB15335,Formononetin,small molecule,investigational,COC1=CC=C(C=C1)C1=COC2=C(C=CC(O)=C2)C1=O,HKQYGTCOTHHOMP-UHFFFAOYSA-N,268.268,P31639,BE0004753,Sodium/glucose cotransporter 2,Humans,inhibitor,yes
DB15347,Branebrutinib,small molecule,investigational,CC#CC(=O)N[C@H]1CCCN(C1)C1=C2C(C)=C(C)NC2=C(C=C1F)C(N)=O,VJPPLCNBDLZIFG-ZDUSSCGKSA-N,370.428,Q06187,BE0001284,Tyrosine-protein kinase BTK,Humans,inhibitor,yes
DB15348,Ampreloxetine,small molecule,investigational,FC1=CC(F)=C(OCC2=CC=CC=C2C2CCNCC2)C(F)=C1,TZIALEBTHQWNAO-UHFFFAOYSA-N,321.343,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,modulator,yes
DB15348,Ampreloxetine,small molecule,investigational,FC1=CC(F)=C(OCC2=CC=CC=C2C2CCNCC2)C(F)=C1,TZIALEBTHQWNAO-UHFFFAOYSA-N,321.343,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,modulator,yes
DB15353,Nacubactam,small molecule,investigational,NCCONC(=O)[C@@H]1CC[C@@H]2C[N@]1C(=O)N2OS(O)(=O)=O,RSBPYSTVZQAADE-RQJHMYQMSA-N,324.31,P00807,BE0000302,Beta-lactamase,Staphylococcus aureus,inhibitor,yes
DB15355,PL-3994,small molecule,investigational,CCCCCCC(=O)N[C@@H]1CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](CCCC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CNC=N2)NC1=O)[C@@H](C)CC)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1C[C@@H](NC(=O)[C@@H]1CCCNC(N)=N)C(N)=O,HSHVZRILAMZYHY-HJNNUAIJSA-N,1875.21,P16066,BE0000556,Atrial natriuretic peptide receptor 1,Humans,agonist,yes
DB15356,SLV-334,small molecule,investigational,OC(=O)CN1C2=CC=CC=C2CC[C@H](NC(=O)C2(C[C@@H](CCC3=CC=CC4=CC=CC=C34)C(O)=O)CCCC2)C1=O,LOFDNSDPZTVIIO-VPUSJEBWSA-N,556.659,P08473,BE0000266,Neprilysin,Humans,modulator,yes
DB15357,Xanomeline,small molecule,approved;investigational,CCCCCCOC1=NSN=C1C1=CCCN(C)C1,JOLJIIDDOBNFHW-UHFFFAOYSA-N,281.42,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,agonist,yes
DB15357,Xanomeline,small molecule,approved;investigational,CCCCCCOC1=NSN=C1C1=CCCN(C)C1,JOLJIIDDOBNFHW-UHFFFAOYSA-N,281.42,P08173,BE0000405,Muscarinic acetylcholine receptor M4,Humans,agonist,yes
DB15357,Xanomeline,small molecule,approved;investigational,CCCCCCOC1=NSN=C1C1=CCCN(C)C1,JOLJIIDDOBNFHW-UHFFFAOYSA-N,281.42,P08172,BE0000560,Muscarinic acetylcholine receptor M2,Humans,agonist,yes
DB15357,Xanomeline,small molecule,approved;investigational,CCCCCCOC1=NSN=C1C1=CCCN(C)C1,JOLJIIDDOBNFHW-UHFFFAOYSA-N,281.42,P20309,BE0000045,Muscarinic acetylcholine receptor M3,Humans,agonist,yes
DB15357,Xanomeline,small molecule,approved;investigational,CCCCCCOC1=NSN=C1C1=CCCN(C)C1,JOLJIIDDOBNFHW-UHFFFAOYSA-N,281.42,P08912,BE0000247,Muscarinic acetylcholine receptor M5,Humans,agonist,yes
DB15358,JNJ-54175446,small molecule,investigational,C[C@H]1N(CCC2=C1N=NN2C1=NC=C(F)C=N1)C(=O)C1=C(Cl)C(=CC=C1)C(F)(F)F,CWFVVQFVGMFTBD-SECBINFHSA-N,440.79,Q99572,BE0009814,P2X purinoceptor 7,Humans,antagonist,yes
DB15367,LY-2623091,small molecule,investigational,C[C@H](CN1CCOCC1)N1C(NC(N)=O)=NC2=C1C=CC(\C=C1/C3=CC=CC=C3COC3=CC(F)=CC=C13)=C2,YPCLDHGBEKZGEB-RUDKWAFVSA-N,527.6,P08235,BE0000668,Mineralocorticoid receptor,Humans,antagonist,yes
DB15382,SAR-125844,small molecule,investigational,FC1=CC=C(C=C1)C1=NN2C(SC3=CC=C4N=C(NC(=O)NCCN5CCOCC5)SC4=C3)=NN=C2C=C1,ODIUNTQOXRXOIV-UHFFFAOYSA-N,550.63,P08581,BE0000915,Hepatocyte growth factor receptor,Humans,inhibitor,yes
DB15385,Acebilustat,small molecule,investigational,OC(=O)C1=CC=C(CN2C[C@@H]3C[C@H]2CN3CC2=CC=C(OC3=CC=C(C=C3)C3=NC=CO3)C=C2)C=C1,GERJIEKMNDGSCS-DQEYMECFSA-N,481.552,P09960,BE0001680,Leukotriene A-4 hydrolase,Humans,inhibitor,yes
DB15391,Elenbecestat,small molecule,investigational,C[C@H]1OC[C@@]2(N=C(N)SC[C@H]12)C1=CC(NC(=O)C2=NC=C(N=C2)C(F)F)=CC=C1F,AACUJFVOHGRMTR-DPXNYUHVSA-N,437.44,P56817,BE0000988,Beta-secretase 1,Humans,inhibitor,yes
DB15393,Telatinib,small molecule,investigational,CNC(=O)C1=CC(COC2=C3OC=CC3=C(NC3=CC=C(Cl)C=C3)N=N2)=CC=N1,QFCXANHHBCGMAS-UHFFFAOYSA-N,409.83,P35968,BE0000369,Vascular endothelial growth factor receptor 2,Humans,inhibitor,yes
DB15399,BMS-754807,small molecule,investigational,C[C@]1(CCCN1C1=NN2C=CC=C2C(NC2=NNC(=C2)C2CC2)=N1)C(=O)NC1=CN=C(F)C=C1,LQVXSNNAFNGRAH-QHCPKHFHSA-N,461.4948,P31749,BE0000428,RAC-alpha serine/threonine-protein kinase,Humans,inhibitor,yes
DB15401,Danicopan,small molecule,approved;investigational,CC(=O)C1=NN(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NC2=CC=CC(Br)=N2)C2=C1C=C(C=C2)C1=CN=C(C)N=C1,PIBARDGJJAGJAJ-NQIIRXRSSA-N,580.418,P00746,BE0001840,Complement factor D,Humans,inhibitor,yes
DB15406,GLPG-0974,small molecule,investigational,C[C@@]1(CCN1C(=O)C1=CSC2=C1C=CC=C2)C(=O)N(CCCC(O)=O)CC1=CC=CC(Cl)=C1,MPMKMQHJHDHPBE-RUZDIDTESA-N,485.0,O15552,BE0010131,Free fatty acid receptor 2,Humans,antagonist,yes
DB15407,Acalisib,small molecule,investigational,C[C@H](NC1=NC=NC2=C1NC=N2)C1=NC2=C(C=C(F)C=C2)C(=O)N1C1=CC=CC=C1,DOCINCLJNAXZQF-LBPRGKRZSA-N,401.405,O00329,BE0002406,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",Humans,inhibitor,yes
DB15408,Silmitasertib,small molecule,investigational,OC(=O)C1=CC2=C(C=C1)C1=C(C=CN=C1)C(NC1=CC(Cl)=CC=C1)=N2,MUOKSQABCJCOPU-UHFFFAOYSA-N,349.77,P68400,BE0001209,Casein kinase II subunit alpha,Humans,inhibitor,yes
DB15413,Pafolacianine,small molecule,approved;investigational,CC1(C)\C(=C/C=C2\CCCC(\C=C\C3=[N+](CCCCS(O)(=O)=O)C4=C(C=C(C=C4)S([O-])(=O)=O)C3(C)C)=C2OC2=CC=C(C[C@H](NC(=O)C3=CC=C(NCC4=CN=C5N=C(N)NC(=O)C5=N4)C=C3)C(O)=O)C=C2)N(CCCCS(O)(=O)=O)C2=C1C=C(C=C2)S(O)(=O)=O,PDXNSXLPXJFETD-DYVQZXGMSA-N,1326.49,P15328,BE0003405,Folate receptor alpha,Humans,ligand,yes
DB15416,PX-102,small molecule,investigational,OC(=O)C1=CC=C(C=C1)[C@H]1C[C@@H]1C1=C(Cl)C=C(OCC2=C(ON=C2C2=C(Cl)C=CC=C2Cl)C2CC2)C=C1,XBUXXJUEBFDQHD-NHCUHLMSSA-N,554.85,Q96RI1,BE0001777,Bile acid receptor,Humans,agonist,yes
DB15425,CYC-065,small molecule,investigational,CC[C@H](NC1=NC(NCC2=C(C)C=C(C)N=C2)=C2N=CN(C(C)C)C2=N1)[C@@H](C)O,DLPIYBKBHMZCJI-WBVHZDCISA-N,397.527,P50750,BE0002207,Cyclin-dependent kinase 9,Humans,inhibitor,yes
DB15425,CYC-065,small molecule,investigational,CC[C@H](NC1=NC(NCC2=C(C)C=C(C)N=C2)=C2N=CN(C(C)C)C2=N1)[C@@H](C)O,DLPIYBKBHMZCJI-WBVHZDCISA-N,397.527,P24941,BE0001072,Cyclin-dependent kinase 2,Humans,inhibitor,yes
DB15427,Fialuridine,small molecule,investigational,OC[C@H]1O[C@H]([C@@H](F)[C@@H]1O)N1C=C(I)C(=O)NC1=O,IPVFGAYTKQKGBM-BYPJNBLXSA-N,372.091,P04293,BE0000308,DNA polymerase catalytic subunit,HHV-1,modulator,yes
DB15431,M-2698,small molecule,investigational,NC(=O)C1=CC=CC2=C1N=CN=C2N[C@H](CN1CCC1)C1=CC(=C(Cl)C=C1)C(F)(F)F,HXAUJHZZPCBFPN-QGZVFWFLSA-N,449.86,P31749,BE0000428,RAC-alpha serine/threonine-protein kinase,Humans,inhibitor,yes
DB15431,M-2698,small molecule,investigational,NC(=O)C1=CC=CC2=C1N=CN=C2N[C@H](CN1CCC1)C1=CC(=C(Cl)C=C1)C(F)(F)F,HXAUJHZZPCBFPN-QGZVFWFLSA-N,449.86,Q9Y243,BE0010514,RAC-gamma serine/threonine-protein kinase,Humans,inhibitor,yes
DB15431,M-2698,small molecule,investigational,NC(=O)C1=CC=CC2=C1N=CN=C2N[C@H](CN1CCC1)C1=CC(=C(Cl)C=C1)C(F)(F)F,HXAUJHZZPCBFPN-QGZVFWFLSA-N,449.86,P23443,BE0010424,Ribosomal protein S6 kinase beta-1,Humans,inhibitor,yes
DB15442,Trilaciclib,small molecule,approved;investigational,CN1CCN(CC1)C1=CN=C(NC2=NC3=C(C=C4N3C3(CCCCC3)CNC4=O)C=N2)C=C1,PDGKHKMBHVFCMG-UHFFFAOYSA-N,446.559,P11802,BE0002216,Cyclin-dependent kinase 4,Humans,inhibitor,yes
DB15442,Trilaciclib,small molecule,approved;investigational,CN1CCN(CC1)C1=CN=C(NC2=NC3=C(C=C4N3C3(CCCCC3)CNC4=O)C=N2)C=C1,PDGKHKMBHVFCMG-UHFFFAOYSA-N,446.559,Q00534,BE0002212,Cyclin-dependent kinase 6,Humans,inhibitor,yes
DB15444,Elexacaftor,small molecule,approved;investigational,C[C@@H]1CN(C2=NC(=CC=C2C(=O)NS(=O)(=O)C2=CN(C)N=C2C)N2C=CC(OCC(C)(C)C(F)(F)F)=N2)C(C)(C)C1,MVRHVFSOIWFBTE-INIZCTEOSA-N,597.66,P13569,BE0001195,Cystic fibrosis transmembrane conductance regulator,Humans,positive allosteric modulator,yes
DB15446,Vidofludimus,small molecule,investigational,COC1=CC(=CC=C1)C1=CC=C(NC(=O)C2=C(CCC2)C(O)=O)C(F)=C1,XPRDUGXOWVXZLL-UHFFFAOYSA-N,355.365,Q02127,BE0000382,"Dihydroorotate dehydrogenase (quinone), mitochondrial",Humans,modulator,yes
DB15447,Setogepram,small molecule,investigational,CCCCCC1=CC(CC(O)=O)=CC=C1,PEGQOIGYZLJMIB-UHFFFAOYSA-N,206.285,Q9NQS5,BE0020007,G-protein coupled receptor 84,Humans,antagonist,yes
DB15447,Setogepram,small molecule,investigational,CCCCCC1=CC(CC(O)=O)=CC=C1,PEGQOIGYZLJMIB-UHFFFAOYSA-N,206.285,O14842,BE0000688,Free fatty acid receptor 1,Humans,agonist,yes
DB15449,Citarinostat,small molecule,investigational,ONC(=O)CCCCCCNC(=O)C1=CN=C(N=C1)N(C1=CC=CC=C1)C1=CC=CC=C1Cl,VLIUIBXPEDFJRF-UHFFFAOYSA-N,467.95,Q9UBN7,BE0002368,Histone deacetylase 6,Humans,inhibitor,yes
DB15450,PF-05105679,small molecule,investigational,C[C@@H](N(CC1=CC(=CC=C1)C(O)=O)C(=O)C1=CC2=C(C=CC=C2)N=C1)C1=CC=C(F)C=C1,BXNMZRPTQFVRFA-QGZVFWFLSA-N,428.463,Q7Z2W7,BE0001186,Transient receptor potential cation channel subfamily M member 8,Humans,modulator,yes
DB15456,Vericiguat,small molecule,approved;investigational,COC(=O)NC1=C(N)N=C(N=C1N)C1=NN(CC2=CC=CC=C2F)C2=C1C=C(F)C=N2,QZFHIXARHDBPBY-UHFFFAOYSA-N,426.388,Q02846,BE0013774,Retinal guanylyl cyclase 1,Humans,modulator,yes
DB15456,Vericiguat,small molecule,approved;investigational,COC(=O)NC1=C(N)N=C(N=C1N)C1=NN(CC2=CC=CC=C2F)C2=C1C=C(F)C=N2,QZFHIXARHDBPBY-UHFFFAOYSA-N,426.388,Q02153,BE0010029,Guanylate cyclase soluble subunit beta-1,Humans,stimulator,yes
DB15458,Norleucine,small molecule,investigational,CCCC[C@H](N)C(O)=O,LRQKBLKVPFOOQJ-YFKPBYRVSA-N,131.1729,P20823,BE0004514,Hepatocyte nuclear factor 1-alpha,Humans,inhibitor,yes
DB15460,AGG-523,small molecule,investigational,CC(C)(CC1=CC=C(F)C=C1)NC(=O)[C@H](CCC(O)=O)NC(=O)C1=CC=C(C=C1)C1=CC=CC=C1,JWQMTWCFNZSLNR-DEOSSOPVSA-N,476.548,Q9UNA0,BE0003730,A disintegrin and metalloproteinase with thrombospondin motifs 5,Humans,inhibitor,yes
DB15462,Fucoxanthin,small molecule,investigational,CC(=O)O[C@H]1CC(C)(C)C(=[C@@]=C\C(C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)C(=O)C[C@@]23O[C@]2(C)C[C@@H](O)CC3(C)C)[C@](C)(O)C1,SJWWTRQNNRNTPU-XJUZQKKNSA-N,658.92,P25963,BE0003469,NF-kappa-B inhibitor alpha,Humans,inhibitor,yes
DB15463,Belzutifan,small molecule,approved;investigational,CS(=O)(=O)C1=CC=C(OC2=CC(=CC(F)=C2)C#N)C2=C1[C@H](O)[C@H](F)[C@@H]2F,LOMMPXLFBTZENJ-ZACQAIPSSA-N,383.34,Q99814,BE0009679,Endothelial PAS domain-containing protein 1,Humans,inhibitor,yes
DB15465,Benzhydrocodone,small molecule,approved,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])CC=C2OC(=O)C1=CC=CC=C1,VPMRSLWWUXNYRY-NDOYXKHWSA-N,403.478,P35372,BE0000770,Mu-type opioid receptor,Humans,antagonist,yes
DB15466,Tallimustine,small molecule,experimental,CN1C=C(NC(=O)C2=CC(NC(=O)C3=CC(NC(=O)C4=CC=C(C=C4)N(CCCl)CCCl)=CN3C)=CN2C)C=C1C(=O)NCCC(N)=N,ARKYUICTMUZVEW-UHFFFAOYSA-N,697.62,P25025,BE0010516,C-X-C chemokine receptor type 2,Humans,antagonist,yes
DB15489,Mexazolam,small molecule,experimental,CC1COC2(N1CC(O)=NC1=C2C=C(Cl)C=C1)C1=CC=CC=C1Cl,ANUCDXCTICZJRH-UHFFFAOYSA-N,363.238,P14867,BE0008668,GABA(A) Receptor Benzodiazepine Binding Site,Humans,ligand,yes
DB15489,Mexazolam,small molecule,experimental,CC1COC2(N1CC(O)=NC1=C2C=C(Cl)C=C1)C1=CC=CC=C1Cl,ANUCDXCTICZJRH-UHFFFAOYSA-N,363.238,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB15490,Zuranolone,small molecule,approved;experimental,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@]4([H])C[C@](C)(O)CC[C@]4([H])[C@@]3([H])CC[C@]12C)C(=O)CN1C=C(C=N1)C#N,HARRKNSQXBRBGZ-GVKWWOCJSA-N,409.574,Q99928,BE0003594,Gamma-aminobutyric acid receptor subunit gamma-3,Humans,modulator,yes
DB15490,Zuranolone,small molecule,approved;experimental,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@]4([H])C[C@](C)(O)CC[C@]4([H])[C@@]3([H])CC[C@]12C)C(=O)CN1C=C(C=N1)C#N,HARRKNSQXBRBGZ-GVKWWOCJSA-N,409.574,P14867,BE0004797,GABA(A) Receptor,Humans,positive allosteric modulator,yes
DB15492,Eticlopride,small molecule,experimental,CCN1CCC[C@H]1CNC(=O)C1=C(O)C(CC)=CC(Cl)=C1OC,AADCDMQTJNYOSS-LBPRGKRZSA-N,340.845,P14416,BE0000756,D(2) dopamine receptor,Humans,inhibitor,yes
DB15493,Cambinol,small molecule,experimental,OC1=C(CC2=C(NC(=S)NC2=O)C2=CC=CC=C2)C2=CC=CC=C2C=C1,RVNSQVIUFZVNAU-UHFFFAOYSA-N,360.43,Q96EB6,BE0002461,NAD-dependent protein deacetylase sirtuin-1,Humans,inhibitor,yes
DB15493,Cambinol,small molecule,experimental,OC1=C(CC2=C(NC(=S)NC2=O)C2=CC=CC=C2)C2=CC=CC=C2C=C1,RVNSQVIUFZVNAU-UHFFFAOYSA-N,360.43,Q8IXJ6,BE0009759,NAD-dependent protein deacetylase sirtuin-2,Humans,inhibitor,yes
DB15494,Edotreotide gallium Ga-68,small molecule,approved,[68Ga+3].C[C@@H](O)[C@@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)CN2CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@H](CC2=CNC3=C2C=CC=C3)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1,PZBPHYLKIMOZPR-FIYGWYQWSA-K,1486.55,P30874,BE0003528,Somatostatin receptor type 2,Humans,ligand,yes
DB15494,Edotreotide gallium Ga-68,small molecule,approved,[68Ga+3].C[C@@H](O)[C@@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)CN2CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@H](CC2=CNC3=C2C=CC=C3)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1,PZBPHYLKIMOZPR-FIYGWYQWSA-K,1486.55,P35346,BE0002147,Somatostatin receptor type 5,Humans,ligand,yes
DB15494,Edotreotide gallium Ga-68,small molecule,approved,[68Ga+3].C[C@@H](O)[C@@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)CN2CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@H](CC2=CNC3=C2C=CC=C3)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1,PZBPHYLKIMOZPR-FIYGWYQWSA-K,1486.55,P32745,BE0003529,Somatostatin receptor type 3,Humans,ligand,yes
DB15494,Edotreotide gallium Ga-68,small molecule,approved,[68Ga+3].C[C@@H](O)[C@@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)CN2CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@H](CC2=CNC3=C2C=CC=C3)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1,PZBPHYLKIMOZPR-FIYGWYQWSA-K,1486.55,P30872,BE0000452,Somatostatin receptor type 1,Humans,ligand,yes
DB15495,Rocaglamide,small molecule,experimental,COC1=CC=C(C=C1)[C@@]12OC3=C(C(OC)=CC(OC)=C3)[C@]1(O)[C@H](O)[C@@H]([C@H]2C1=CC=CC=C1)C(=O)N(C)C,DAPAQENNNINUPW-IDAMAFBJSA-N,505.567,P35232,BE0009786,Prohibitin 1,Humans,inhibitor,yes
DB15495,Rocaglamide,small molecule,experimental,COC1=CC=C(C=C1)[C@@]12OC3=C(C(OC)=CC(OC)=C3)[C@]1(O)[C@H](O)[C@@H]([C@H]2C1=CC=CC=C1)C(=O)N(C)C,DAPAQENNNINUPW-IDAMAFBJSA-N,505.567,Q01201,BE0013795,Transcription factor RelB,Humans,inhibitor,yes
DB15495,Rocaglamide,small molecule,experimental,COC1=CC=C(C=C1)[C@@]12OC3=C(C(OC)=CC(OC)=C3)[C@]1(O)[C@H](O)[C@@H]([C@H]2C1=CC=CC=C1)C(=O)N(C)C,DAPAQENNNINUPW-IDAMAFBJSA-N,505.567,Q00653,BE0002387,Nuclear factor NF-kappa-B p100 subunit,Humans,inhibitor,yes
DB15495,Rocaglamide,small molecule,experimental,COC1=CC=C(C=C1)[C@@]12OC3=C(C(OC)=CC(OC)=C3)[C@]1(O)[C@H](O)[C@@H]([C@H]2C1=CC=CC=C1)C(=O)N(C)C,DAPAQENNNINUPW-IDAMAFBJSA-N,505.567,Q04206,BE0005551,Transcription factor p65,Humans,inhibitor,yes
DB15495,Rocaglamide,small molecule,experimental,COC1=CC=C(C=C1)[C@@]12OC3=C(C(OC)=CC(OC)=C3)[C@]1(O)[C@H](O)[C@@H]([C@H]2C1=CC=CC=C1)C(=O)N(C)C,DAPAQENNNINUPW-IDAMAFBJSA-N,505.567,Q04864,BE0010782,Proto-oncogene c-Rel,Humans,inhibitor,yes
DB15495,Rocaglamide,small molecule,experimental,COC1=CC=C(C=C1)[C@@]12OC3=C(C(OC)=CC(OC)=C3)[C@]1(O)[C@H](O)[C@@H]([C@H]2C1=CC=CC=C1)C(=O)N(C)C,DAPAQENNNINUPW-IDAMAFBJSA-N,505.567,P19838,BE0001086,Nuclear factor NF-kappa-B p105 subunit,Humans,inhibitor,yes
DB15495,Rocaglamide,small molecule,experimental,COC1=CC=C(C=C1)[C@@]12OC3=C(C(OC)=CC(OC)=C3)[C@]1(O)[C@H](O)[C@@H]([C@H]2C1=CC=CC=C1)C(=O)N(C)C,DAPAQENNNINUPW-IDAMAFBJSA-N,505.567,Q99623,BE0009007,Prohibitin-2,Humans,inhibitor,yes
DB15496,Didesmethylrocaglamide,small molecule,experimental,COC1=CC=C(C=C1)[C@@]12OC3=CC(OC)=CC(OC)=C3[C@]1(O)[C@H](O)[C@@H]([C@H]2C1=CC=CC=C1)C(N)=O,RMNPQEWLGQURNX-PXIJUOARSA-N,477.513,P35232,BE0009786,Prohibitin 1,Humans,inhibitor,yes
DB15496,Didesmethylrocaglamide,small molecule,experimental,COC1=CC=C(C=C1)[C@@]12OC3=CC(OC)=CC(OC)=C3[C@]1(O)[C@H](O)[C@@H]([C@H]2C1=CC=CC=C1)C(N)=O,RMNPQEWLGQURNX-PXIJUOARSA-N,477.513,Q99623,BE0009007,Prohibitin-2,Humans,inhibitor,yes
DB15498,BOS172722,small molecule,experimental,CCOC1=CC(=CC=C1NC1=NC=C2C=C(C)N=C(NCC(C)(C)C)C2=N1)C1=NN=CN1C,SGWLRDAOCLITOM-UHFFFAOYSA-N,446.559,P33981,BE0003791,Dual specificity protein kinase TTK,Humans,inhibitor,yes
DB15499,Cerdulatinib,small molecule,investigational,CCS(=O)(=O)N1CCN(CC1)C1=CC=C(NC2=NC=C(C(N)=O)C(NC3CC3)=N2)C=C1,BGLPECHZZQDNCD-UHFFFAOYSA-N,445.54,P52333,BE0003493,Tyrosine-protein kinase JAK3,Humans,inhibitor,yes
DB15499,Cerdulatinib,small molecule,investigational,CCS(=O)(=O)N1CCN(CC1)C1=CC=C(NC2=NC=C(C(N)=O)C(NC3CC3)=N2)C=C1,BGLPECHZZQDNCD-UHFFFAOYSA-N,445.54,O60674,BE0002408,Tyrosine-protein kinase JAK2,Humans,modulator,yes
DB15499,Cerdulatinib,small molecule,investigational,CCS(=O)(=O)N1CCN(CC1)C1=CC=C(NC2=NC=C(C(N)=O)C(NC3CC3)=N2)C=C1,BGLPECHZZQDNCD-UHFFFAOYSA-N,445.54,P43405,BE0001316,Tyrosine-protein kinase SYK,Humans,modulator,yes
DB15499,Cerdulatinib,small molecule,investigational,CCS(=O)(=O)N1CCN(CC1)C1=CC=C(NC2=NC=C(C(N)=O)C(NC3CC3)=N2)C=C1,BGLPECHZZQDNCD-UHFFFAOYSA-N,445.54,P23458,BE0004145,Tyrosine-protein kinase JAK1,Humans,inhibitor,yes
DB15565,Cilazaprilat,small molecule,experimental,OC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]1CCCN2CCC[C@H](N2C1=O)C(O)=O,UVAUYSRYXACKSC-ULQDDVLXSA-N,389.4455,P12821,BE0000221,Angiotensin-converting enzyme,Humans,,yes
DB15566,Prednisolone acetate,small molecule,approved;vet_approved,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@]([H])(O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,LRJOMUJRLNCICJ-JZYPGELDSA-N,402.4807,P04150,BE0000794,Glucocorticoid receptor,Humans,agonist,yes
DB15568,Adagrasib,small molecule,approved;investigational,[H][C@@]1(COC2=NC3=C(CCN(C3)C3=CC=CC4=C3C(Cl)=CC=C4)C(=N2)N2CCN(C(=O)C(F)=C)[C@@]([H])(CC#N)C2)CCCN1C,PEMUGDMSUDYLHU-ZEQRLZLVSA-N,604.13,P01116,BE0004071,GTPase KRas,Humans,inhibitor,yes
DB15569,Sotorasib,small molecule,approved;investigational,CC(C)C1=NC=CC(C)=C1N1C(=O)N=C(N2CCN(C[C@@H]2C)C(=O)C=C)C2=CC(F)=C(N=C12)C1=C(O)C=CC=C1F,NXQKSXLFSAEQCZ-SFHVURJKSA-N,560.606,P01116,BE0004071,GTPase KRas,Humans,inhibitor,yes
DB15581,Chrysin,small molecule,experimental,OC1=CC(O)=C2C(=O)C=C(OC2=C1)C1=CC=CC=C1,RTIXKCRFFJGDFG-UHFFFAOYSA-N,254.2375,P15121,BE0000747,Aldo-keto reductase family 1 member B1,Humans,inhibitor,yes
DB15581,Chrysin,small molecule,experimental,OC1=CC(O)=C2C(=O)C=C(OC2=C1)C1=CC=CC=C1,RTIXKCRFFJGDFG-UHFFFAOYSA-N,254.2375,Q16678,BE0001111,Cytochrome P450 1B1,Humans,inhibitor,yes
DB15581,Chrysin,small molecule,experimental,OC1=CC(O)=C2C(=O)C=C(OC2=C1)C1=CC=CC=C1,RTIXKCRFFJGDFG-UHFFFAOYSA-N,254.2375,P11511,BE0002090,Aromatase,Humans,inhibitor,yes
DB15581,Chrysin,small molecule,experimental,OC1=CC(O)=C2C(=O)C=C(OC2=C1)C1=CC=CC=C1,RTIXKCRFFJGDFG-UHFFFAOYSA-N,254.2375,Q00534,BE0002212,Cyclin-dependent kinase 6,Humans,inhibitor,yes
DB15584,Luteolin,small molecule,experimental,OC1=CC(O)=C2C(=O)C=C(OC2=C1)C1=CC=C(O)C(O)=C1,IQPNAANSBPBGFQ-UHFFFAOYSA-N,286.2363,P40763,BE0003462,Signal transducer and activator of transcription 3,Humans,inhibitor,yes
DB15584,Luteolin,small molecule,experimental,OC1=CC(O)=C2C(=O)C=C(OC2=C1)C1=CC=C(O)C(O)=C1,IQPNAANSBPBGFQ-UHFFFAOYSA-N,286.2363,Q7L5N7,BE0016122,Lysophosphatidylcholine acyltransferase 2,Humans,inhibitor,yes
DB15584,Luteolin,small molecule,experimental,OC1=CC(O)=C2C(=O)C=C(OC2=C1)C1=CC=C(O)C(O)=C1,IQPNAANSBPBGFQ-UHFFFAOYSA-N,286.2363,Q8NF37,BE0017259,Lysophosphatidylcholine acyltransferase 1,Humans,inhibitor,yes
DB15584,Luteolin,small molecule,experimental,OC1=CC(O)=C2C(=O)C=C(OC2=C1)C1=CC=C(O)C(O)=C1,IQPNAANSBPBGFQ-UHFFFAOYSA-N,286.2363,P11387,BE0000971,DNA topoisomerase 1,Humans,inhibitor,yes
DB15585,ORG-31710,small molecule,experimental,[H][C@@]12CC[C@@]3(CCCO3)[C@@]1(C)C[C@H](C1=CC=C(C=C1)N(C)C)C1=C3CCC(=O)C=C3[C@H](C)C[C@@]21[H],HFDGABTZPISMDD-IEVXGSBISA-N,445.647,P06401,BE0000557,Progesterone receptor,Humans,modulator,yes
DB15586,Patulin,small molecule,experimental,OC1OCC=C2OC(=O)C=C12,ZRWPUFFVAOMMNM-UHFFFAOYSA-N,154.1201,P26664,BE0003427,Genome polyprotein,,inhibitor,yes
DB15588,Ursolic acid,small molecule,experimental,[H][C@@]12[C@@H](C)[C@H](C)CC[C@@]1(CC[C@]1(C)C2=CC[C@]2([H])[C@@]3(C)CC[C@H](O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O,WCGUUGGRBIKTOS-GPOJBZKASA-N,456.711,P28845,BE0000329,11-beta-hydroxysteroid dehydrogenase 1,Humans,inhibitor,yes
DB15588,Ursolic acid,small molecule,experimental,[H][C@@]12[C@@H](C)[C@H](C)CC[C@@]1(CC[C@]1(C)C2=CC[C@]2([H])[C@@]3(C)CC[C@H](O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O,WCGUUGGRBIKTOS-GPOJBZKASA-N,456.711,P04054,BE0003997,Phospholipase A2,Humans,inhibitor,yes
DB15588,Ursolic acid,small molecule,experimental,[H][C@@]12[C@@H](C)[C@H](C)CC[C@@]1(CC[C@]1(C)C2=CC[C@]2([H])[C@@]3(C)CC[C@H](O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O,WCGUUGGRBIKTOS-GPOJBZKASA-N,456.711,P04293,BE0000308,DNA polymerase catalytic subunit,HHV-1,inhibitor,yes
DB15588,Ursolic acid,small molecule,experimental,[H][C@@]12[C@@H](C)[C@H](C)CC[C@@]1(CC[C@]1(C)C2=CC[C@]2([H])[C@@]3(C)CC[C@H](O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O,WCGUUGGRBIKTOS-GPOJBZKASA-N,456.711,P11217,BE0000916,"Glycogen phosphorylase, muscle form",Humans,inhibitor,yes
DB15588,Ursolic acid,small molecule,experimental,[H][C@@]12[C@@H](C)[C@H](C)CC[C@@]1(CC[C@]1(C)C2=CC[C@]2([H])[C@@]3(C)CC[C@H](O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O,WCGUUGGRBIKTOS-GPOJBZKASA-N,456.711,P18031,BE0000623,Tyrosine-protein phosphatase non-receptor type 1,Humans,inhibitor,yes
DB15594,Brilliant blue G,small molecule,approved,[Na+].CCOC1=CC=C(NC2=CC=C(C=C2)C(=C2\C=C/C(/C=C2C)=[N+](/CC)CC2=CC(=CC=C2)S([O-])(=O)=O)\C2=C(C)C=C(C=C2)N(CC)CC2=CC(=CC=C2)S([O-])(=O)=O)C=C1,RWVGQQGBQSJDQV-UHFFFAOYSA-M,854.02,,BE0009797,Internal limiting membrane (ILM),Humans,binder,yes
DB15623,TMC-310911,small molecule,investigational,[H][C@@]12CCO[C@]1([H])OC[C@@H]2OC(=O)N[C@@H](CC1=CC=CC=C1)[C@H](O)CN(CC(C)C)S(=O)(=O)C1=CC=C2N=C(NC3CCN(CC3)C3CCCC3)SC2=C1,JQUNFHFWXCXPRK-AMMMHQJVSA-N,755.987,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB15636,Zilucoplan,small molecule,approved,CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)NCCCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1=CNC2=NC=CC=C12)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)N(C)C(=O)[C@@H]1CC(=O)NCCCC[C@H](NC(C)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N1)C(C)(C)C)C1CCCCC1)C(O)=O)C(O)=O,JDXCOXKBIGBZSK-PSNKNOTQSA-N,3562.229,P01031,BE0000855,Complement C5,Humans,inhibitor,yes
DB15637,Fluzoparib,small molecule,investigational,FC1=CC=C(CC2=NNC(=O)C3=CC=CC=C23)C=C1C(=O)N1CCN2N=C(N=C2C1)C(F)(F)F,XJGXCBHXFWBOTN-UHFFFAOYSA-N,472.404,P09874,BE0001717,Poly [ADP-ribose] polymerase 1,Humans,inhibitor,yes
DB15639,AMG-337,small molecule,investigational,COCCOC1=CC2=C(C=CN([C@H](C)C3=NN=C4N3C=C(C=C4F)C3=CN(C)N=C3)C2=O)N=C1,DWHXUGDWKAIASB-CQSZACIVSA-N,463.473,P08581,BE0000915,Hepatocyte growth factor receptor,Humans,modulator,yes
DB15640,CDC-801,small molecule,investigational,COC1=CC=C(C=C1OC1CCCC1)C(CC(N)=O)N1C(=O)C2=C(C=CC=C2)C1=O,DDYUBCCTNHWSQM-UHFFFAOYSA-N,408.454,Q07343,BE0000487,"3',5'-cyclic-AMP phosphodiesterase 4B",Humans,inhibitor,yes
DB15640,CDC-801,small molecule,investigational,COC1=CC=C(C=C1OC1CCCC1)C(CC(N)=O)N1C(=O)C2=C(C=CC=C2)C1=O,DDYUBCCTNHWSQM-UHFFFAOYSA-N,408.454,Q08499,BE0001287,"3',5'-cyclic-AMP phosphodiesterase 4D",Humans,inhibitor,yes
DB15640,CDC-801,small molecule,investigational,COC1=CC=C(C=C1OC1CCCC1)C(CC(N)=O)N1C(=O)C2=C(C=CC=C2)C1=O,DDYUBCCTNHWSQM-UHFFFAOYSA-N,408.454,P27815,BE0001133,"3',5'-cyclic-AMP phosphodiesterase 4A",Humans,inhibitor,yes
DB15641,Droloxifene,small molecule,investigational,CC\C(=C(\C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC(O)=C1)C1=CC=CC=C1,ZQZFYGIXNQKOAV-OCEACIFDSA-N,387.523,P03372,BE0000123,Estrogen receptor,Humans,modulator,yes
DB15646,Fasitibant,small molecule,investigational,CC1=NC2=C(C=CC=C2OCC2=C(Cl)C=CC(=C2Cl)S(=O)(=O)NC2(CCOCC2)C(=O)N2CCN(CC2)C(=O)[C@@H](N)CCC[N+](C)(C)C)C(C)=C1,FQVSDHOWSLEEKJ-LJAQVGFWSA-N,764.78,P30411,BE0003513,B2 bradykinin receptor,Humans,antagonist,yes
DB15651,Valomaciclovir stearate,small molecule,investigational,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](CCOC(=O)[C@@H](N)C(C)C)CN1C=NC2=C1N=C(N)NC2=O,ACBSZTQIFTYFGH-IAPPQJPRSA-N,618.864,P04293,BE0000308,DNA polymerase catalytic subunit,HHV-1,modulator,yes
DB15652,Ravidasvir,small molecule,investigational,COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C1=NC(=CN1)C1=CC2=C(C=C1)C=C(C=C2)C1=CC2=C(NC(=N2)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)OC)C(C)C)C=C1,LCHMHYPWGWYXEL-ZYADHFCISA-N,762.912,P26664,BE0003427,Genome polyprotein,,modulator,yes
DB15665,SEP-363856,small molecule,investigational,CNC[C@@H]1OCCC2=C1SC=C2,ABDDQTDRAHXHOC-QMMMGPOBSA-N,183.27,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,agonist,yes
DB15665,SEP-363856,small molecule,investigational,CNC[C@@H]1OCCC2=C1SC=C2,ABDDQTDRAHXHOC-QMMMGPOBSA-N,183.27,Q96RJ0,BE0001044,Trace amine-associated receptor 1,Humans,agonist,yes
DB15669,Fezolinetant,small molecule,approved;investigational,C[C@H]1N(CCN2C1=NN=C2C1=NC(C)=NS1)C(=O)C1=CC=C(F)C=C1,PPSNFPASKFYPMN-SECBINFHSA-N,358.4,P29371,BE0002371,Neuromedin-K receptor,Humans,antagonist,yes
DB15670,Gusacitinib,small molecule,investigational,OC1CCN(CC1)C1=CC=C(NC2=C3C(=O)NN=CC3=NC(=N2)N2CCC(CC#N)CC2)C=C1,NLFLXLJXEIUQDL-UHFFFAOYSA-N,460.542,P43405,BE0001316,Tyrosine-protein kinase SYK,Humans,inhibitor,yes
DB15672,Rilematovir,small molecule,investigational,CS(=O)(=O)CCCN1C(CN2C(=O)N(CC(F)(F)F)C3=C2C=NC=C3)=CC2=C1C=CC(Cl)=C2,GTQTUABHRCWVLL-UHFFFAOYSA-N,500.92,P03420,BE0010205,Fusion glycoprotein F0,Human respiratory syncytial virus A (strain A2),inhibitor,yes
DB15673,Lenacapavir,small molecule,approved;investigational,[H][C@]12C[C@@]1([H])C(F)(F)C1=C2C(=NN1CC(=O)N[C@@H](CC1=CC(F)=CC(F)=C1)C1=NC(=CC=C1C1=CC=C(Cl)C2=C1N(CC(F)(F)F)N=C2NS(C)(=O)=O)C#CC(C)(C)S(C)(=O)=O)C(F)(F)F,BRYXUCLEHAUSDY-WEWMWRJBSA-N,968.28,P04585,BE0001594,Gag-Pol polyprotein,,inhibitor,yes
DB15674,Sisunatovir,small molecule,investigational,NCC1=CC2=C(C=C1)N(CCCC(F)(F)F)C(CN1C(=O)C3(CC3)C3=C1C=C(F)C=C3)=N2,JOPCJJSYRPUEDS-UHFFFAOYSA-N,446.45,P03420,BE0010205,Fusion glycoprotein F0,Human respiratory syncytial virus A (strain A2),inhibitor,yes
DB15685,Selpercatinib,small molecule,approved;investigational,COC1=NC=C(CN2C3CC2CN(C3)C2=CC=C(C=N2)C2=CC(OCC(C)(C)O)=CN3N=CC(C#N)=C23)C=C1,XIIOFHFUYBLOLW-UHFFFAOYSA-N,525.613,P07949,BE0002411,Proto-oncogene tyrosine-protein kinase receptor Ret,Humans,inhibitor,yes
DB15688,Zavegepant,small molecule,approved;investigational,CN1CCC(CC1)N1CCN(CC1)C(=O)[C@@H](CC1=CC2=C(NN=C2)C(C)=C1)NC(=O)N1CCC(CC1)C1=CC2=C(NC1=O)C=CC=C2,JJVAPHYEOZSKJZ-JGCGQSQUSA-N,638.817,Q16602,BE0009009,Calcitonin gene-related peptide type 1 receptor,Humans,antagonist,yes
DB15694,Cedazuridine,small molecule,approved;investigational,OC[C@H]1O[C@@H](N2CC[C@@H](O)NC2=O)C(F)(F)[C@@H]1O,VUDZSIYXZUYWSC-DBRKOABJSA-N,268.217,P32320,BE0002443,Cytidine deaminase,Humans,inhibitor,yes
DB15784,Carmoterol,small molecule,experimental,COC1=CC=C(C[C@@H](C)NC[C@H](O)C2=CC=C(O)C3=C2C=CC(=O)N3)C=C1,IHOXNOQMRZISPV-YJYMSZOUSA-N,368.433,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,agonist,yes
DB15791,MK-0668,small molecule,experimental,OC(=O)[C@H](CC1=CC=C(NC(=O)C2=C(Cl)C=NC=C2Cl)C=C1)NC(=O)[C@@H]1C[C@H](CN1S(=O)(=O)C1=CC=CC(=C1)C#N)NC1CCC1,USYYNLPEWBGIMJ-ICTDUYRTSA-N,685.58,P05556,BE0003575,Integrin beta-1,Humans,inhibitor,yes
DB15791,MK-0668,small molecule,experimental,OC(=O)[C@H](CC1=CC=C(NC(=O)C2=C(Cl)C=NC=C2Cl)C=C1)NC(=O)[C@@H]1C[C@H](CN1S(=O)(=O)C1=CC=CC(=C1)C#N)NC1CCC1,USYYNLPEWBGIMJ-ICTDUYRTSA-N,685.58,P13612,BE0000590,Integrin alpha-4,Humans,inhibitor,yes
DB15797,GC-373,small molecule,experimental,CC(C)C[C@H](NC(=O)OCC1=CC=CC=C1)C(=O)N[C@@H](CC1CCNC1=O)C=O,QYENXTYKACLCGO-FQECFTEESA-N,403.479,K9N7C7,BE0010019,Replicase polyprotein 1ab,Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012),inhibitor,yes
DB15797,GC-373,small molecule,experimental,CC(C)C[C@H](NC(=O)OCC1=CC=CC=C1)C(=O)N[C@@H](CC1CCNC1=O)C=O,QYENXTYKACLCGO-FQECFTEESA-N,403.479,K9N638,BE0010020,Replicase polyprotein 1a,Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012),inhibitor,yes
DB15822,Pralsetinib,small molecule,approved;investigational,CO[C@@]1(CC[C@@H](CC1)C1=NC(NC2=NNC(C)=C2)=CC(C)=N1)C(=O)N[C@@H](C)C1=CC=C(N=C1)N1C=C(F)C=N1,GBLBJPZSROAGMF-RWYJCYHVSA-N,533.612,P07949,BE0002411,Proto-oncogene tyrosine-protein kinase receptor Ret,Humans,inhibitor,yes
DB15873,Copper oxodotreotide Cu-64,small molecule,approved,[64Cu++].C[C@@H](O)[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)CN2CCN(CC(O)=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@H](CC2=CNC3=C2C=CC=C3)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(O)=O,IJRLLVFQGCCPPI-NVGRTJHCSA-L,1497.55,P30874,BE0003528,Somatostatin receptor type 2,Humans,binder,yes
DB15919,Diquafosol,small molecule,experimental,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(=O)NC1=O)N1C=CC(=O)NC1=O,NMLMACJWHPHKGR-NCOIDOBVSA-N,790.306,P41231,BE0002401,P2Y purinoceptor 2,Humans,agonist,yes
DB15932,Clemizole,small molecule,investigational,ClC1=CC=C(CN2C(CN3CCCC3)=NC3=CC=CC=C23)C=C1,CJXAEXPPLWQRFR-UHFFFAOYSA-N,325.84,P26664,BE0003427,Genome polyprotein,,modulator,yes
DB15949,Raubasine,small molecule,experimental,[H][C@]12CN3CCC4=C(NC5=CC=CC=C45)[C@]3([H])C[C@]1([H])C(=CO[C@H]2C)C(=O)OC,GRTOGORTSDXSFK-XJTZBENFSA-N,352.434,P08588,BE0000172,Beta-1 adrenergic receptor,Humans,modulator,yes
DB15954,Strychnine,small molecule,experimental,[H][C@]12C[C@@]3([H])C4=CCO[C@@]5([H])CC(=O)N6C7=CC=CC=C7[C@@]1(CCN2C4)[C@]6([H])[C@@]35[H],QMGVPVSNSZLJIA-FVWCLLPLSA-N,334.419,P23415,BE0000433,Glycine receptor subunit alpha-1,Humans,antagonist,yes
DB15954,Strychnine,small molecule,experimental,[H][C@]12C[C@@]3([H])C4=CCO[C@@]5([H])CC(=O)N6C7=CC=CC=C7[C@@]1(CCN2C4)[C@]6([H])[C@@]35[H],QMGVPVSNSZLJIA-FVWCLLPLSA-N,334.419,P23416,BE0000745,Glycine receptor subunit alpha-2,Humans,antagonist,yes
DB15954,Strychnine,small molecule,experimental,[H][C@]12C[C@@]3([H])C4=CCO[C@@]5([H])CC(=O)N6C7=CC=CC=C7[C@@]1(CCN2C4)[C@]6([H])[C@@]35[H],QMGVPVSNSZLJIA-FVWCLLPLSA-N,334.419,O75311,BE0000414,Glycine receptor subunit alpha-3,Humans,antagonist,yes
DB15954,Strychnine,small molecule,experimental,[H][C@]12C[C@@]3([H])C4=CCO[C@@]5([H])CC(=O)N6C7=CC=CC=C7[C@@]1(CCN2C4)[C@]6([H])[C@@]35[H],QMGVPVSNSZLJIA-FVWCLLPLSA-N,334.419,P48167,BE0000055,Glycine receptor subunit beta,Humans,antagonist,yes
DB15971,Clorotepine,small molecule,experimental,CN1CCN(CC1)C1CC2=CC=CC=C2SC2=C1C=C(Cl)C=C2,XRYLGRGAWQSVQW-UHFFFAOYSA-N,344.9,P28335,BE0000533,5-hydroxytryptamine receptor 2C,Humans,inhibitor,yes
DB15971,Clorotepine,small molecule,experimental,CN1CCN(CC1)C1CC2=CC=CC=C2SC2=C1C=C(Cl)C=C2,XRYLGRGAWQSVQW-UHFFFAOYSA-N,344.9,P35367,BE0000442,Histamine H1 receptor,Humans,inhibitor,yes
DB15971,Clorotepine,small molecule,experimental,CN1CCN(CC1)C1CC2=CC=CC=C2SC2=C1C=C(Cl)C=C2,XRYLGRGAWQSVQW-UHFFFAOYSA-N,344.9,P35368,BE0000575,Alpha-1B adrenergic receptor,Humans,inhibitor,yes
DB15971,Clorotepine,small molecule,experimental,CN1CCN(CC1)C1CC2=CC=CC=C2SC2=C1C=C(Cl)C=C2,XRYLGRGAWQSVQW-UHFFFAOYSA-N,344.9,P25100,BE0000715,Alpha-1D adrenergic receptor,Humans,inhibitor,yes
DB15971,Clorotepine,small molecule,experimental,CN1CCN(CC1)C1CC2=CC=CC=C2SC2=C1C=C(Cl)C=C2,XRYLGRGAWQSVQW-UHFFFAOYSA-N,344.9,P14416,BE0000756,D(2) dopamine receptor,Humans,inhibitor,yes
DB15971,Clorotepine,small molecule,experimental,CN1CCN(CC1)C1CC2=CC=CC=C2SC2=C1C=C(Cl)C=C2,XRYLGRGAWQSVQW-UHFFFAOYSA-N,344.9,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,inhibitor,yes
DB15971,Clorotepine,small molecule,experimental,CN1CCN(CC1)C1CC2=CC=CC=C2SC2=C1C=C(Cl)C=C2,XRYLGRGAWQSVQW-UHFFFAOYSA-N,344.9,P50406,BE0000945,5-hydroxytryptamine receptor 6,Humans,inhibitor,yes
DB15982,Berotralstat,small molecule,approved,NCC1=CC(=CC=C1)N1N=C(C=C1C(=O)NC1=CC(=CC=C1F)[C@H](NCC1CC1)C1=CC=CC(=C1)C#N)C(F)(F)F,UXNXMBYCBRBRFD-MUUNZHRXSA-N,562.573,P03952,BE0002440,Plasma kallikrein,Humans,inhibitor,yes
DB16013,SER-100,small molecule,investigational,CC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O,GJLXVWOMRRWCIB-MERZOTPQSA-N,1781.237,P41146,BE0002378,Nociceptin receptor,Humans,agonist,yes
DB16019,Gallium Ga-68 gozetotide,small molecule,approved,[68Ga+3].OC(=O)CC[C@H](NC(=O)N[C@@H](CCCCNC(=O)CCCCCNC(=O)CCC1=CC(CN(CCN(CC([O-])=O)CC2=C(O)C=CC(CCC([O-])=O)=C2)CC([O-])=O)=C(O)C=C1)C(O)=O)C(O)=O,AEBYHKKMCWUMKX-LNTZDJBBSA-K,1011.909,P07288,BE0008983,Prostate-specific antigen,Humans,binder,yes
DB16019,Gallium Ga-68 gozetotide,small molecule,approved,[68Ga+3].OC(=O)CC[C@H](NC(=O)N[C@@H](CCCCNC(=O)CCCCCNC(=O)CCC1=CC(CN(CCN(CC([O-])=O)CC2=C(O)C=CC(CCC([O-])=O)=C2)CC([O-])=O)=C(O)C=C1)C(O)=O)C(O)=O,AEBYHKKMCWUMKX-LNTZDJBBSA-K,1011.909,Q04609,BE0000568,Glutamate carboxypeptidase 2,Humans,binder,yes
DB16028,Azemiglitazone,small molecule,investigational,COC1=CC=CC(=C1)C(=O)COC1=CC=C(CC2SC(=O)NC2=O)C=C1,YAUMOGALQJYOJQ-UHFFFAOYSA-N,371.41,P06213,BE0000033,Insulin receptor,Humans,modulator,yes
DB16032,GW810781,small molecule,investigational,O\C(=C/C(=O)C1=CC=C(CC2=CC=C(F)C=C2)O1)C1=NNC=N1,HFHDGHOGHWXXDT-ZSOIEALJSA-N,313.288,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB16036,ABX-1431,small molecule,investigational,FC(F)(F)C(OC(=O)N1CCN(CC2=CC=C(C=C2N2CCCC2)C(F)(F)F)CC1)C(F)(F)F,SQZJGTOZFRNWCX-UHFFFAOYSA-N,507.401,Q99685,BE0018885,Monoglyceride lipase,Humans,inhibitor,yes
DB16038,PLX8394,small molecule,investigational,F[C@@H]1CCN(C1)S(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=NC=C(C=C23)C2=CN=C(N=C2)C2CC2)=C1F,YYACLQUDUDXAPA-MRXNPFEDSA-N,542.54,P15056,BE0000634,Serine/threonine-protein kinase B-raf,Humans,inhibitor,yes
DB16039,AN2898,small molecule,investigational,OB1OCC2=C1C=CC(OC1=CC(C#N)=C(C=C1)C#N)=C2,UBMGTTRDNUKZMT-UHFFFAOYSA-N,276.06,Q08499,BE0001287,"3',5'-cyclic-AMP phosphodiesterase 4D",Humans,inhibitor,yes
DB16039,AN2898,small molecule,investigational,OB1OCC2=C1C=CC(OC1=CC(C#N)=C(C=C1)C#N)=C2,UBMGTTRDNUKZMT-UHFFFAOYSA-N,276.06,Q07343,BE0000487,"3',5'-cyclic-AMP phosphodiesterase 4B",Humans,inhibitor,yes
DB16039,AN2898,small molecule,investigational,OB1OCC2=C1C=CC(OC1=CC(C#N)=C(C=C1)C#N)=C2,UBMGTTRDNUKZMT-UHFFFAOYSA-N,276.06,P27815,BE0001133,"3',5'-cyclic-AMP phosphodiesterase 4A",Humans,inhibitor,yes
DB16040,DU125530,small molecule,investigational,ClC1=CC(N2CCN(CCCCN3C(=O)C4=C(C=CC=C4)S3(=O)=O)CC2)=C2OCCOC2=C1,LYXKFNHUJJDTIA-UHFFFAOYSA-N,491.99,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,antagonist,yes
DB16043,PF-06882961,small molecule,investigational,OC(=O)C1=CC=C2N=C(CN3CCC(CC3)C3=NC(OCC4=CC=C(C=C4F)C#N)=CC=C3)N(C[C@@H]3CCO3)C2=C1,HYBAKUMPISVZQP-DEOSSOPVSA-N,555.61,P43220,BE0000857,Glucagon-like peptide 1 receptor,Humans,agonist,yes
DB16045,TERN-101,small molecule,investigational,CN1C=C(C(O)=O)C2=C1C=C(C=C2)N1CCC(CC1)OCC1=C(ON=C1C1=C(Cl)C=CC=C1Cl)C1CC1,RPVDFHPBGBMWID-UHFFFAOYSA-N,540.44,Q96RI1,BE0001777,Bile acid receptor,Humans,agonist,yes
DB16047,Elraglusib,small molecule,investigational,CN1C=C(C2=C1C=C1OCOC1=C2)C1=C(C(=O)NC1=O)C1=COC2=CC=C(F)C=C12,FARXPFGGGGLENU-UHFFFAOYSA-N,404.353,P49841,BE0001065,Glycogen synthase kinase-3 beta,Humans,inhibitor,yes
DB16048,BTRX-246040,small molecule,investigational,CC1=NN(C=C1CN1CCC2(CC1)OCC(F)(F)C1=C2SC(Cl)=C1)C1=NC=CC=C1CO,NKQHBJNRBKHUQR-UHFFFAOYSA-N,480.96,P41146,BE0002378,Nociceptin receptor,Humans,modulator,yes
DB16050,FF-10101-01,small molecule,investigational,CCCNC1=NC(NC2=CC=C(C=C2)C#N)=NC=C1C#CCCCNC(=O)[C@H](C)N(C)C(=O)\C=C\CN(C)C,HJFSVYUFOXAVAA-YUAYGMJFSA-N,530.677,P36888,BE0000147,Receptor-type tyrosine-protein kinase FLT3,Humans,inhibitor,yes
DB16051,MOL-4239,small molecule,investigational,C[C@H](NC(=O)C(=C\C=C\C1=CC=CC(Br)=N1)\C#N)C1=CC=CC=C1,IVAUEQVCSQZMGV-QIUCFAMLSA-N,382.261,P40763,BE0003462,Signal transducer and activator of transcription 3,Humans,inhibitor,yes
DB16053,ARRY-502,small molecule,investigational,COC1=CC(Cl)=CC=C1CCNC(=O)C1=CC=C(OC2=CC3=C(C=C2Cl)[C@H](CCO3)C(O)=O)C=C1,QIDYUNXQPQEJEC-IBGZPJMESA-N,516.37,Q9Y5Y4,BE0003561,Prostaglandin D2 receptor 2,Humans,modulator,yes
DB16055,PT-2385,small molecule,investigational,CS(=O)(=O)C1=C2[C@H](O)C(F)(F)CC2=C(OC2=CC(=CC(F)=C2)C#N)C=C1,ONBSHRSJOPSEGS-INIZCTEOSA-N,383.34,Q99814,BE0009679,Endothelial PAS domain-containing protein 1,Humans,inhibitor,yes
DB16055,PT-2385,small molecule,investigational,CS(=O)(=O)C1=C2[C@H](O)C(F)(F)CC2=C(OC2=CC(=CC(F)=C2)C#N)C=C1,ONBSHRSJOPSEGS-INIZCTEOSA-N,383.34,Q16665,BE0002374,Hypoxia-inducible factor 1-alpha,Humans,inhibitor,yes
DB16056,GZ-389988,small molecule,investigational,COC1=CC=C(COC2=CC=C(CN3C(N)=NC4=C3N=CC(=C4)C3=CN(C)N=C3)C=C2OC)C=C1,HVRWZFQFSQUILC-UHFFFAOYSA-N,470.533,Q16288,BE0009501,NT-3 growth factor receptor,Humans,inhibitor,yes
DB16056,GZ-389988,small molecule,investigational,COC1=CC=C(COC2=CC=C(CN3C(N)=NC4=C3N=CC(=C4)C3=CN(C)N=C3)C=C2OC)C=C1,HVRWZFQFSQUILC-UHFFFAOYSA-N,470.533,P04629,BE0001039,High affinity nerve growth factor receptor,Humans,inhibitor,yes
DB16056,GZ-389988,small molecule,investigational,COC1=CC=C(COC2=CC=C(CN3C(N)=NC4=C3N=CC(=C4)C3=CN(C)N=C3)C=C2OC)C=C1,HVRWZFQFSQUILC-UHFFFAOYSA-N,470.533,Q16620,BE0003605,BDNF/NT-3 growth factors receptor,Humans,inhibitor,yes
DB16061,Samuraciclib,small molecule,investigational,CC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)C=C(NCC3=CC=CC=C3)N2N=C1,YCVGLKWJKIKVBI-MJGOQNOKSA-N,394.523,P50613,BE0001913,Cyclin-dependent kinase 7,Humans,inhibitor,yes
DB16063,2X-121,small molecule,investigational,O=C1NN=C2NC(CN3CC4=C(C3)C=CC=C4)=NC3=C2C1=CC=C3,JLFSBHQQXIAQEC-UHFFFAOYSA-N,317.352,P09874,BE0001717,Poly [ADP-ribose] polymerase 1,Humans,inhibitor,yes
DB16063,2X-121,small molecule,investigational,O=C1NN=C2NC(CN3CC4=C(C3)C=CC=C4)=NC3=C2C1=CC=C3,JLFSBHQQXIAQEC-UHFFFAOYSA-N,317.352,O95271,BE0012352,Poly [ADP-ribose] polymerase tankyrase-1,Humans,inhibitor,yes
DB16063,2X-121,small molecule,investigational,O=C1NN=C2NC(CN3CC4=C(C3)C=CC=C4)=NC3=C2C1=CC=C3,JLFSBHQQXIAQEC-UHFFFAOYSA-N,317.352,Q9H2K2,BE0019375,Poly [ADP-ribose] polymerase tankyrase-2,Humans,inhibitor,yes
DB16063,2X-121,small molecule,investigational,O=C1NN=C2NC(CN3CC4=C(C3)C=CC=C4)=NC3=C2C1=CC=C3,JLFSBHQQXIAQEC-UHFFFAOYSA-N,317.352,Q9UGN5,BE0003798,Poly [ADP-ribose] polymerase 2,Humans,inhibitor,yes
DB16064,LY-3200882,small molecule,investigational,CC(C)(O)C1=CC(NC2=CC(OC3=CN(N=C3C3CCOCC3)C3CC3)=CC=N2)=CC=N1,PNPFMWIDAKQFPY-UHFFFAOYSA-N,435.528,P36897,BE0003782,TGF-beta receptor type-1,Humans,inhibitor,yes
DB16066,Ilacirnon,small molecule,investigational,CC1=CC(NS(=O)(=O)C2=CC=C(Cl)C(=C2)C(F)(F)F)=C(N=C1)C(=O)C1=C2C=CNC2=NC=N1,LUUMLYXKTPBTQR-UHFFFAOYSA-N,495.86,P41597,BE0003387,C-C chemokine receptor type 2,Humans,antagonist,yes
DB16067,Luvadaxistat,small molecule,investigational,OC1=CC(CCC2=CC=C(C=C2)C(F)(F)F)=NNC1=O,QBQMUMMSYHUDFM-UHFFFAOYSA-N,284.238,P14920,BE0004141,D-amino-acid oxidase,Humans,inhibitor,yes
DB16068,BTRX-335140,small molecule,investigational,CCC1=CC(F)=C2N=C(N3CCC(CC3)NC3CCOCC3)C(C3=NC(C)=NO3)=C(C)C2=C1,CQOJHAJWCDJEAT-UHFFFAOYSA-N,453.562,P41145,BE0000632,Kappa-type opioid receptor,Humans,antagonist,yes
DB16071,4'-Thio-fac,small molecule,investigational,NC1=NC(=O)N(C=C1)[C@@H]1S[C@H](CO)[C@@H](O)[C@@H]1F,NIDPJRZOVFIBQB-PXBUCIJWSA-N,261.27,P06746,BE0000113,DNA polymerase beta,Humans,inhibitor,yes
DB16072,ORP-101,small molecule,investigational,[H][C@@]12OC3=C4C(C[C@H]5N(CC6CC6)CC[C@@]14[C@@]51CC[C@@]2(OC)[C@]([H])(C1)[C@](C)(O)C(C)(C)C)=CC=C3OCCOC1=CC=C2C[C@H]3N(CC4CC4)CC[C@]45C2=C1O[C@@]4([H])[C@]1(CC[C@@]35C[C@]1([H])[C@](C)(O)C(C)(C)C)OC,LEQOVFCHMOTJKU-WJVXOHEGSA-N,961.338,P35372,BE0000770,Mu-type opioid receptor,Humans,inhibitor,yes
DB16072,ORP-101,small molecule,investigational,[H][C@@]12OC3=C4C(C[C@H]5N(CC6CC6)CC[C@@]14[C@@]51CC[C@@]2(OC)[C@]([H])(C1)[C@](C)(O)C(C)(C)C)=CC=C3OCCOC1=CC=C2C[C@H]3N(CC4CC4)CC[C@]45C2=C1O[C@@]4([H])[C@]1(CC[C@@]35C[C@]1([H])[C@](C)(O)C(C)(C)C)OC,LEQOVFCHMOTJKU-WJVXOHEGSA-N,961.338,P41145,BE0000632,Kappa-type opioid receptor,Humans,inhibitor,yes
DB16073,AZD8529,small molecule,investigational,CC1=CC(=CC2=C1C(=O)N(CC1=CC=C(OC(F)(F)F)C=C1)C2)C1=NC(CN2CCNCC2)=NO1,IPCYZQQFECEHLI-UHFFFAOYSA-N,487.483,Q13255,BE0000824,Metabotropic glutamate receptor 1,Humans,agonist,yes
DB16076,GSK2245035,small molecule,investigational,CCC[C@H](C)OC1=NC(N)=C2NC(=O)N(CCCCCN3CCCCC3)C2=N1,LFMPVTVPXHNXOT-HNNXBMFYSA-N,390.532,Q9NYK1,BE0000155,Toll-like receptor 7,Humans,modulator,yes
DB16079,Aclimostat,small molecule,investigational,[H][C@@]1([C@H](OC)[C@@H](CC[C@]11CO1)OC(=O)N1CC(CCN2CCOCC2)C1)[C@@]1(C)O[C@@H]1CC=C(C)C,QJWJPMLDQYEPPW-AUKZVGPFSA-N,478.63,P50579,BE0001534,Methionine aminopeptidase 2,Humans,inhibitor,yes
DB16080,Acolbifene,small molecule,investigational,CC1=C([C@@H](OC2=C1C=CC(O)=C2)C1=CC=C(OCCN2CCCCC2)C=C1)C1=CC=C(O)C=C1,DUYNJNWVGIWJRI-LJAQVGFWSA-N,457.57,P03372,BE0000123,Estrogen receptor,Humans,modulator,yes
DB16084,Iron (III) oxide adipate,small molecule,investigational,[O-]C(=O)CCCCC([O-])=O,WNLRTRBMVRJNCN-UHFFFAOYSA-L,144.127,Q8TCC7,BE0003645,Organic anion transporter 3,Humans,inhibitor,yes
DB16095,APG-1387,small molecule,investigational,[H][C@]12CC[C@H](N1C(=O)[C@H](CN(CC2)S(=O)(=O)C1=CC(=CC=C1)S(=O)(=O)N1CC[C@@]2([H])CC[C@H](N2C(=O)[C@H](C1)NC(=O)[C@H](C)NC)C(=O)NC(C1=CC=CC=C1)C1=CC=CC=C1)NC(=O)[C@H](C)NC)C(=O)NC(C1=CC=CC=C1)C1=CC=CC=C1,AKLBERUGKZNEJY-RTEPGWBGSA-N,1157.42,P98170,BE0001156,E3 ubiquitin-protein ligase XIAP,Humans,inhibitor,yes
DB16095,APG-1387,small molecule,investigational,[H][C@]12CC[C@H](N1C(=O)[C@H](CN(CC2)S(=O)(=O)C1=CC(=CC=C1)S(=O)(=O)N1CC[C@@]2([H])CC[C@H](N2C(=O)[C@H](C1)NC(=O)[C@H](C)NC)C(=O)NC(C1=CC=CC=C1)C1=CC=CC=C1)NC(=O)[C@H](C)NC)C(=O)NC(C1=CC=CC=C1)C1=CC=CC=C1,AKLBERUGKZNEJY-RTEPGWBGSA-N,1157.42,Q13490,BE0010675,Baculoviral IAP repeat-containing protein 2,Humans,inhibitor,yes
DB16095,APG-1387,small molecule,investigational,[H][C@]12CC[C@H](N1C(=O)[C@H](CN(CC2)S(=O)(=O)C1=CC(=CC=C1)S(=O)(=O)N1CC[C@@]2([H])CC[C@H](N2C(=O)[C@H](C1)NC(=O)[C@H](C)NC)C(=O)NC(C1=CC=CC=C1)C1=CC=CC=C1)NC(=O)[C@H](C)NC)C(=O)NC(C1=CC=CC=C1)C1=CC=CC=C1,AKLBERUGKZNEJY-RTEPGWBGSA-N,1157.42,Q13489,BE0010674,Baculoviral IAP repeat-containing protein 3,Humans,inhibitor,yes
DB16095,APG-1387,small molecule,investigational,[H][C@]12CC[C@H](N1C(=O)[C@H](CN(CC2)S(=O)(=O)C1=CC(=CC=C1)S(=O)(=O)N1CC[C@@]2([H])CC[C@H](N2C(=O)[C@H](C1)NC(=O)[C@H](C)NC)C(=O)NC(C1=CC=CC=C1)C1=CC=CC=C1)NC(=O)[C@H](C)NC)C(=O)NC(C1=CC=CC=C1)C1=CC=CC=C1,AKLBERUGKZNEJY-RTEPGWBGSA-N,1157.42,Q13075,BE0010810,Baculoviral IAP repeat-containing protein 1,Humans,inhibitor,yes
DB16095,APG-1387,small molecule,investigational,[H][C@]12CC[C@H](N1C(=O)[C@H](CN(CC2)S(=O)(=O)C1=CC(=CC=C1)S(=O)(=O)N1CC[C@@]2([H])CC[C@H](N2C(=O)[C@H](C1)NC(=O)[C@H](C)NC)C(=O)NC(C1=CC=CC=C1)C1=CC=CC=C1)NC(=O)[C@H](C)NC)C(=O)NC(C1=CC=CC=C1)C1=CC=CC=C1,AKLBERUGKZNEJY-RTEPGWBGSA-N,1157.42,Q96CA5,BE0010707,Baculoviral IAP repeat-containing protein 7,Humans,inhibitor,yes
DB16095,APG-1387,small molecule,investigational,[H][C@]12CC[C@H](N1C(=O)[C@H](CN(CC2)S(=O)(=O)C1=CC(=CC=C1)S(=O)(=O)N1CC[C@@]2([H])CC[C@H](N2C(=O)[C@H](C1)NC(=O)[C@H](C)NC)C(=O)NC(C1=CC=CC=C1)C1=CC=CC=C1)NC(=O)[C@H](C)NC)C(=O)NC(C1=CC=CC=C1)C1=CC=CC=C1,AKLBERUGKZNEJY-RTEPGWBGSA-N,1157.42,O15392,BE0003408,Baculoviral IAP repeat-containing protein 5,Humans,inhibitor,yes
DB16098,Atogepant,small molecule,approved;investigational,C[C@@H]1[C@@H](C[C@H](NC(=O)C2=CN=C3C[C@]4(CC3=C2)C(=O)NC2=C4C=CC=N2)C(=O)N1CC(F)(F)F)C1=C(F)C(F)=CC=C1F,QIVUCLWGARAQIO-OLIXTKCUSA-N,603.525,Q16602,BE0009009,Calcitonin gene-related peptide type 1 receptor,Humans,antagonist,yes
DB16101,Baicalein,small molecule,investigational,OC1=CC2=C(C(O)=C1O)C(=O)C=C(O2)C1=CC=CC=C1,FXNFHKRTJBSTCS-UHFFFAOYSA-N,270.24,Q04760,BE0000962,Lactoylglutathione lyase,Humans,inhibitor,yes
DB16101,Baicalein,small molecule,investigational,OC1=CC2=C(C(O)=C1O)C(=O)C=C(O2)C1=CC=CC=C1,FXNFHKRTJBSTCS-UHFFFAOYSA-N,270.24,P01375,BE0000704,Tumor necrosis factor,Humans,inhibitor,yes
DB16101,Baicalein,small molecule,investigational,OC1=CC2=C(C(O)=C1O)C(=O)C=C(O2)C1=CC=CC=C1,FXNFHKRTJBSTCS-UHFFFAOYSA-N,270.24,P47989,BE0002204,Xanthine dehydrogenase/oxidase,Humans,inhibitor,yes
DB16101,Baicalein,small molecule,investigational,OC1=CC2=C(C(O)=C1O)C(=O)C=C(O2)C1=CC=CC=C1,FXNFHKRTJBSTCS-UHFFFAOYSA-N,270.24,P14151,BE0010361,L-selectin,Humans,inhibitor,yes
DB16101,Baicalein,small molecule,investigational,OC1=CC2=C(C(O)=C1O)C(=O)C=C(O2)C1=CC=CC=C1,FXNFHKRTJBSTCS-UHFFFAOYSA-N,270.24,P48147,BE0002148,Prolyl endopeptidase,Humans,inhibitor,yes
DB16101,Baicalein,small molecule,investigational,OC1=CC2=C(C(O)=C1O)C(=O)C=C(O2)C1=CC=CC=C1,FXNFHKRTJBSTCS-UHFFFAOYSA-N,270.24,P16109,BE0001159,P-selectin,Humans,inhibitor,yes
DB16101,Baicalein,small molecule,investigational,OC1=CC2=C(C(O)=C1O)C(=O)C=C(O2)C1=CC=CC=C1,FXNFHKRTJBSTCS-UHFFFAOYSA-N,270.24,P09917,BE0000248,Polyunsaturated fatty acid 5-lipoxygenase,Humans,inhibitor,yes
DB16106,GSK2256098,small molecule,investigational,CONC(=O)C1=CC=CC=C1NC1=CC(NC2=CC(C)=NN2C(C)C)=NC=C1Cl,BVAHPPKGOOJSPU-UHFFFAOYSA-N,414.89,Q05397,BE0003090,Focal adhesion kinase 1,Humans,inhibitor,yes
DB16107,BI 2536,small molecule,investigational,CC[C@H]1N(C2CCCC2)C2=NC(NC3=CC=C(C=C3OC)C(=O)NC3CCN(C)CC3)=NC=C2N(C)C1=O,XQVVPGYIWAGRNI-JOCHJYFZSA-N,521.666,P53350,BE0003745,Serine/threonine-protein kinase PLK1,Humans,inhibitor,yes
DB16109,GED-0507-34-Levo,small molecule,investigational,CO[C@@H](CC1=CC=C(N)C=C1)C(O)=O,QLJYLJGYIDIJPT-VIFPVBQESA-N,195.218,P37231,BE0000215,Peroxisome proliferator-activated receptor gamma,Humans,agonist,yes
DB16112,OT-730,small molecule,investigational,CC1=CC(O)=C(O)C=C1C(=O)OC[C@H](CNC(C)(C)CNC(=O)C1CCOC1)OC(=O)C1(C)CC1,ANXXSWNMHQHOQC-DJNXLDHESA-N,492.569,P13945,BE0001012,Beta-3 adrenergic receptor,Humans,antagonist,yes
DB16118,Capadenoson,small molecule,investigational,NC1=NC(SCC2=CSC(=N2)C2=CC=C(Cl)C=C2)=C(C#N)C(C2=CC=C(OCCO)C=C2)=C1C#N,CITWCLNVRIKQAF-UHFFFAOYSA-N,520.02,P30542,BE0000013,Adenosine receptor A1,Humans,agonist,yes
DB16123,Ceralifimod,small molecule,investigational,CCCC1=CC=C(COC2=CC3=C(C=C2)C(C)=C(CN2CC(C2)C(O)=O)CC3)C(OC)=C1,QDDQIPUKAXBMBX-UHFFFAOYSA-N,435.564,P21453,BE0008652,Sphingosine 1-phosphate receptor 1,Humans,agonist,yes
DB16125,Ciforadenant,small molecule,investigational,CC1=CC=C(O1)C1=C2N=NN(CC3=CC=CC(CO[C@H]4CCOC4)=N3)C2=NC(N)=N1,KURQKNMKCGYWRJ-HNNXBMFYSA-N,407.434,P29274,BE0000924,Adenosine receptor A2a,Humans,antagonist,yes
DB16126,Cinaciguat,small molecule,investigational,OC(=O)CCCCN(CCC1=C(OCC2=CC=C(CCC3=CC=CC=C3)C=C2)C=CC=C1)CC1=CC=C(C=C1)C(O)=O,WPYWMXNXEZFMAK-UHFFFAOYSA-N,565.71,Q02153,BE0010029,Guanylate cyclase soluble subunit beta-1,Humans,activator,yes
DB16130,Dapansutrile,small molecule,investigational,CS(=O)(=O)CCC#N,LQFRYKBDZNPJSW-UHFFFAOYSA-N,133.17,Q96P20,BE0010347,"NACHT, LRR and PYD domains-containing protein 3",Humans,inhibitor,yes
DB16133,Delgocitinib,small molecule,investigational,C[C@H]1CN(C(=O)CC#N)[C@]11CCN(C1)C1=C2C=CNC2=NC=N1,LOWWYYZBZNSPDT-ZBEGNZNMSA-N,310.361,P23458,BE0004145,Tyrosine-protein kinase JAK1,Humans,inhibitor,yes
DB16133,Delgocitinib,small molecule,investigational,C[C@H]1CN(C(=O)CC#N)[C@]11CCN(C1)C1=C2C=CNC2=NC=N1,LOWWYYZBZNSPDT-ZBEGNZNMSA-N,310.361,O60674,BE0002408,Tyrosine-protein kinase JAK2,Humans,inhibitor,yes
DB16133,Delgocitinib,small molecule,investigational,C[C@H]1CN(C(=O)CC#N)[C@]11CCN(C1)C1=C2C=CNC2=NC=N1,LOWWYYZBZNSPDT-ZBEGNZNMSA-N,310.361,P52333,BE0003493,Tyrosine-protein kinase JAK3,Humans,inhibitor,yes
DB16133,Delgocitinib,small molecule,investigational,C[C@H]1CN(C(=O)CC#N)[C@]11CCN(C1)C1=C2C=CNC2=NC=N1,LOWWYYZBZNSPDT-ZBEGNZNMSA-N,310.361,P29597,BE0004146,Non-receptor tyrosine-protein kinase TYK2,Humans,inhibitor,yes
DB16134,Denagliptin,small molecule,investigational,N[C@@H](C(C1=CC=C(F)C=C1)C1=CC=C(F)C=C1)C(=O)N1C[C@@H](F)C[C@H]1C#N,URRAHSMDPCMOTH-LNLFQRSKSA-N,373.379,P27487,BE0000854,Dipeptidyl peptidase 4,Humans,inhibitor,yes
DB16137,Dezapelisib,small molecule,investigational,C[C@H](NC1=C2N=CNC2=NC=N1)C1=C(C(=O)N2C(C)=CSC2=N1)C1=CC=CC(F)=C1,RSIWALKZYXPAGW-NSHDSACASA-N,421.45,O00329,BE0002406,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",Humans,inhibitor,yes
DB16138,Diflomotecan,small molecule,investigational,CC[C@@]1(O)CC(=O)OCC2=C1C=C1N(CC3=CC4=CC(F)=C(F)C=C4N=C13)C2=O,LFQCJSBXBZRMTN-OAQYLSRUSA-N,398.366,P11387,BE0000971,DNA topoisomerase 1,Humans,inhibitor,yes
DB16145,Dotinurad,small molecule,investigational,OC1=C(Cl)C=C(C=C1Cl)C(=O)N1CS(=O)(=O)C2=CC=CC=C12,VOFLAIHEELWYGO-UHFFFAOYSA-N,358.19,Q96S37,BE0004782,Solute carrier family 22 member 12,Humans,inhibitor,yes
DB16146,Dynorphin,small molecule,investigational,[H][C@](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC1=CC=C(O)C=C1)([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O,JMNJYGMAUMANNW-FIXZTSJVSA-N,2147.523,P41145,BE0000632,Kappa-type opioid receptor,Humans,inhibitor,yes
DB16146,Dynorphin,small molecule,investigational,[H][C@](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC1=CC=C(O)C=C1)([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O,JMNJYGMAUMANNW-FIXZTSJVSA-N,2147.523,P35372,BE0000770,Mu-type opioid receptor,Humans,inhibitor,yes
DB16146,Dynorphin,small molecule,investigational,[H][C@](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC1=CC=C(O)C=C1)([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O,JMNJYGMAUMANNW-FIXZTSJVSA-N,2147.523,P41143,BE0000420,Delta-type opioid receptor,Humans,inhibitor,yes
DB16148,Ecraprost,small molecule,investigational,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(OC(=O)CCC)=C1CCCCCCC(=O)OCCCC,HITYEEHTEOQBAC-OSIGYOHNSA-N,480.686,P34995,BE0000064,Prostaglandin E2 receptor EP1 subtype,Humans,agonist,yes
DB16153,Eltanexor,small molecule,investigational,NC(=O)C(=C\N1C=NC(=N1)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)\C1=CN=CN=C1,JFBAVWVBLRIWHM-AWNIVKPZSA-N,428.298,O14980,BE0009694,Exportin-1,Humans,inhibitor,yes
DB16157,Ensifentrine,small molecule,approved;investigational,COC1=C(OC)C=C2C(CCN3C(=O)N(CCNC(N)=O)\C(C=C23)=N\C2=C(C)C=C(C)C=C2C)=C1,CSOBIBXVIYAXFM-BYNJWEBRSA-N,477.565,Q14432,BE0011003,Phosphodiesterase 3,Humans,inhibitor,yes
DB16157,Ensifentrine,small molecule,approved;investigational,COC1=C(OC)C=C2C(CCN3C(=O)N(CCNC(N)=O)\C(C=C23)=N\C2=C(C)C=C(C)C=C2C)=C1,CSOBIBXVIYAXFM-BYNJWEBRSA-N,477.565,P27815,BE0011004,Phosphodiesterase 4,Humans,inhibitor,yes
DB16159,Esflurbiprofen,small molecule,investigational,C[C@H](C(O)=O)C1=CC(F)=C(C=C1)C1=CC=CC=C1,SYTBZMRGLBWNTM-JTQLQIEISA-N,244.265,Q8WW43,BE0017533,Gamma-secretase subunit APH-1B,Humans,inhibitor,yes
DB16159,Esflurbiprofen,small molecule,investigational,C[C@H](C(O)=O)C1=CC(F)=C(C=C1)C1=CC=CC=C1,SYTBZMRGLBWNTM-JTQLQIEISA-N,244.265,Q92542,BE0017775,Nicastrin,Humans,inhibitor,yes
DB16159,Esflurbiprofen,small molecule,investigational,C[C@H](C(O)=O)C1=CC(F)=C(C=C1)C1=CC=CC=C1,SYTBZMRGLBWNTM-JTQLQIEISA-N,244.265,Q96BI3,BE0003409,Gamma-secretase subunit APH-1A,Humans,inhibitor,yes
DB16159,Esflurbiprofen,small molecule,investigational,C[C@H](C(O)=O)C1=CC(F)=C(C=C1)C1=CC=CC=C1,SYTBZMRGLBWNTM-JTQLQIEISA-N,244.265,Q9NZ42,BE0003410,Gamma-secretase subunit PEN-2,Humans,inhibitor,yes
DB16159,Esflurbiprofen,small molecule,investigational,C[C@H](C(O)=O)C1=CC(F)=C(C=C1)C1=CC=CC=C1,SYTBZMRGLBWNTM-JTQLQIEISA-N,244.265,P49768,BE0010960,Presenilin-1,Humans,inhibitor,yes
DB16159,Esflurbiprofen,small molecule,investigational,C[C@H](C(O)=O)C1=CC(F)=C(C=C1)C1=CC=CC=C1,SYTBZMRGLBWNTM-JTQLQIEISA-N,244.265,P49810,BE0011014,Presenilin-2,Humans,inhibitor,yes
DB16159,Esflurbiprofen,small molecule,investigational,C[C@H](C(O)=O)C1=CC(F)=C(C=C1)C1=CC=CC=C1,SYTBZMRGLBWNTM-JTQLQIEISA-N,244.265,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB16159,Esflurbiprofen,small molecule,investigational,C[C@H](C(O)=O)C1=CC(F)=C(C=C1)C1=CC=CC=C1,SYTBZMRGLBWNTM-JTQLQIEISA-N,244.265,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB16160,Tolinapant,small molecule,investigational,C[C@@H]1CN(CC(=O)N2CC(C)(C)C3=C2C=C(CC2=CC=C(F)C=C2)C(CO)=N3)[C@@H](CN2CCOC[C@H]2C)CN1,YCXOHEXZVKOGEV-DNRQZRRGSA-N,539.696,P98170,BE0001156,E3 ubiquitin-protein ligase XIAP,Humans,inhibitor,yes
DB16162,Exicorilant,small molecule,investigational,[H][C@@]12CCN(C[C@]1(CC1=C(C2)N(N=C1)C1=CC=C(F)C=C1)C(=O)C1=CC(=CC=N1)C(F)(F)F)S(=O)(=O)C1=NN(C)N=C1,HWJYJKAURRIWJM-GKVSMKOHSA-N,589.57,P04150,BE0000794,Glucocorticoid receptor,Humans,antagonist,yes
DB16165,Finerenone,small molecule,approved;investigational,CCOC1=NC=C(C)C2=C1[C@H](C1=CC=C(C=C1OC)C#N)C(C(N)=O)=C(C)N2,BTBHLEZXCOBLCY-QGZVFWFLSA-N,378.432,P08235,BE0000668,Mineralocorticoid receptor,Humans,antagonist,yes
DB16167,Fisogatinib,small molecule,investigational,COC1=CC(OC)=C(Cl)C(=C1Cl)C1=CC2=CN=C(N[C@@H]3COCC[C@@H]3NC(=O)C=C)N=C2C=C1,MGZKYOAQVGSSGC-DLBZAZTESA-N,503.38,P22455,BE0001203,Fibroblast growth factor receptor 4,Humans,inhibitor,yes
DB16168,Fluorocyclopentenylcytosine,small molecule,investigational,NC1=NC(=O)N(C=C1)[C@H]1[C@H](O)[C@H](O)C(CO)=C1F,QLLGKCJUPWYJON-HLTSFMKQSA-N,257.221,P26358,BE0000892,DNA (cytosine-5)-methyltransferase 1,Humans,inhibitor,yes
DB16186,PEN-866,small molecule,investigational,CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CCN4C=CC5=CC(=CC=C45)N4C(=O)NN=C4C4=CC(C(C)C)=C(O)C=C4O)CC3)C=C12,QTPZAEAYDWMVJO-GGCSAXROSA-N,879.971,P11387,BE0000971,DNA topoisomerase 1,Humans,inhibitor,yes
DB16191,Ifidancitinib,small molecule,investigational,COC1=C(F)C(C)=CC(NC2=NC=C(C)C(NC3=CC=C4OC(=O)NC4=C3)=N2)=C1,OYFMQDVLFYKOPZ-UHFFFAOYSA-N,395.394,P52333,BE0003493,Tyrosine-protein kinase JAK3,Humans,inhibitor,yes
DB16191,Ifidancitinib,small molecule,investigational,COC1=C(F)C(C)=CC(NC2=NC=C(C)C(NC3=CC=C4OC(=O)NC4=C3)=N2)=C1,OYFMQDVLFYKOPZ-UHFFFAOYSA-N,395.394,P23458,BE0004145,Tyrosine-protein kinase JAK1,Humans,inhibitor,yes
DB16192,Imaradenant,small molecule,investigational,CC1=NC(Cl)=CC(=C1)C1=NN=C(N)N=C1C1=CC=C(F)C=C1,NCWQLHHDGDXIJN-UHFFFAOYSA-N,315.74,P29274,BE0000924,Adenosine receptor A2a,Humans,antagonist,yes
DB16193,Tovinontrine,small molecule,investigational,C[C@@H]1CN(CC2=NC=CC=N2)C[C@H]1C1=CN2C(=NC=C2C(=O)N1)C1CCOCC1,GWGNPYYVGANHRJ-GDBMZVCRSA-N,394.479,O76083,BE0003134,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",Humans,inhibitor,yes
DB16200,Iptacopan,small molecule,approved;investigational,CCO[C@H]1CCN(CC2=C(OC)C=C(C)C3=C2C=CN3)[C@@H](C1)C1=CC=C(C=C1)C(O)=O,RENRQMCACQEWFC-UGKGYDQZSA-N,422.525,P00751,BE0001701,Complement factor B,Humans,inhibitor,yes
DB16205,Ispronicline,small molecule,investigational,CN[C@@H](C)C\C=C\C1=CC(OC(C)C)=CN=C1,RPCVIAXDAUMJJP-PZBABLGHSA-N,234.343,P43681,BE0000849,Neuronal acetylcholine receptor subunit alpha-4,Humans,modulator,yes
DB16205,Ispronicline,small molecule,investigational,CN[C@@H](C)C\C=C\C1=CC(OC(C)C)=CN=C1,RPCVIAXDAUMJJP-PZBABLGHSA-N,234.343,P17787,BE0000850,Neuronal acetylcholine receptor subunit beta-2,Humans,modulator,yes
DB16213,Ladostigil,small molecule,investigational,CCN(C)C(=O)OC1=CC2=C(CC[C@H]2NCC#C)C=C1,LHXOCOHMBFOVJS-OAHLLOKOSA-N,272.348,P27338,BE0002196,Amine oxidase [flavin-containing] B,Humans,inhibitor,yes
DB16213,Ladostigil,small molecule,investigational,CCN(C)C(=O)OC1=CC2=C(CC[C@H]2NCC#C)C=C1,LHXOCOHMBFOVJS-OAHLLOKOSA-N,272.348,P21397,BE0002198,Amine oxidase [flavin-containing] A,Humans,inhibitor,yes
DB16213,Ladostigil,small molecule,investigational,CCN(C)C(=O)OC1=CC2=C(CC[C@H]2NCC#C)C=C1,LHXOCOHMBFOVJS-OAHLLOKOSA-N,272.348,P22303,BE0000426,Acetylcholinesterase,Humans,inhibitor,yes
DB16214,Landipirdine,small molecule,investigational,NC(=O)NC[C@@H]1CCCC2=CC(=CC=C12)S(=O)(=O)C1=CC(F)=CC=C1,MTTHRRVVGMPYQG-ZDUSSCGKSA-N,362.42,P50406,BE0000945,5-hydroxytryptamine receptor 6,Humans,antagonist,yes
DB16214,Landipirdine,small molecule,investigational,NC(=O)NC[C@@H]1CCCC2=CC(=CC=C12)S(=O)(=O)C1=CC(F)=CC=C1,MTTHRRVVGMPYQG-ZDUSSCGKSA-N,362.42,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB16216,Lazertinib,small molecule,approved;investigational,COC1=C(NC2=NC=CC(=N2)N2C=C(CN(C)C)C(=N2)C2=CC=CC=C2)C=C(NC(=O)C=C)C(=C1)N1CCOCC1,RRMJMHOQSALEJJ-UHFFFAOYSA-N,554.655,P00533,BE0000767,Epidermal growth factor receptor,Humans,inhibitor,yes
DB16217,Leniolisib,small molecule,approved;investigational,CCC(=O)N1CC[C@@H](C1)NC1=C2CN(CCC2=NC=N1)C1=CN=C(OC)C(=C1)C(F)(F)F,MWKYMZXCGYXLPL-ZDUSSCGKSA-N,450.466,O00329,BE0002406,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",Humans,inhibitor,yes
DB16218,Lerociclib,small molecule,investigational,CC(C)N1CCN(CC1)C1=CC=C(NC2=NC=C3C=C4N(C3=N2)C2(CCCCC2)CNC4=O)N=C1,YPJRHEKCFKOVRT-UHFFFAOYSA-N,474.613,P11802,BE0002216,Cyclin-dependent kinase 4,Humans,inhibitor,yes
DB16218,Lerociclib,small molecule,investigational,CC(C)N1CCN(CC1)C1=CC=C(NC2=NC=C3C=C4N(C3=N2)C2(CCCCC2)CNC4=O)N=C1,YPJRHEKCFKOVRT-UHFFFAOYSA-N,474.613,Q00534,BE0002212,Cyclin-dependent kinase 6,Humans,inhibitor,yes
DB16221,Lonaprisan,small molecule,investigational,[H][C@@]12CC[C@@](O)(C(F)(F)C(F)(F)F)[C@@]1(C)C[C@H](C1=CC=C(C=C1)C(C)=O)C1=C3CCC(=O)C=C3CC[C@@]21[H],VHZPUDNSVGRVMB-RXDLHWJPSA-N,508.529,P06401,BE0000557,Progesterone receptor,Humans,inhibitor,yes
DB16221,Lonaprisan,small molecule,investigational,[H][C@@]12CC[C@@](O)(C(F)(F)C(F)(F)F)[C@@]1(C)C[C@H](C1=CC=C(C=C1)C(C)=O)C1=C3CCC(=O)C=C3CC[C@@]21[H],VHZPUDNSVGRVMB-RXDLHWJPSA-N,508.529,P04150,BE0000794,Glucocorticoid receptor,Humans,inhibitor,yes
DB16221,Lonaprisan,small molecule,investigational,[H][C@@]12CC[C@@](O)(C(F)(F)C(F)(F)F)[C@@]1(C)C[C@H](C1=CC=C(C=C1)C(C)=O)C1=C3CCC(=O)C=C3CC[C@@]21[H],VHZPUDNSVGRVMB-RXDLHWJPSA-N,508.529,P10275,BE0000132,Androgen receptor,Humans,inhibitor,yes
DB16226,Maralixibat,small molecule,approved;investigational,CCCCC1(CCCC)CS(=O)(=O)C2=CC=C(C=C2[C@H]([C@H]1O)C1=CC=C(OCC2=CC=C(C[N+]34CCN(CC3)CC4)C=C2)C=C1)N(C)C,STPKWKPURVSAJF-LJEWAXOPSA-N,674.96,Q12908,BE0003643,Ileal sodium/bile acid cotransporter,Humans,inhibitor,yes
DB16226,Maralixibat,small molecule,approved;investigational,CCCCC1(CCCC)CS(=O)(=O)C2=CC=C(C=C2[C@H]([C@H]1O)C1=CC=C(OCC2=CC=C(C[N+]34CCN(CC3)CC4)C=C2)C=C1)N(C)C,STPKWKPURVSAJF-LJEWAXOPSA-N,674.96,Q14973,BE0003644,Hepatic sodium/bile acid cotransporter,Humans,inhibitor,yes
DB16227,Masilukast,small molecule,investigational,COC1=CC(=CC=C1CC1=CN(C)C2=C1C=C(C=C2)C(=O)NC[C@H](C)CC(F)(F)F)C(=O)NS(=O)(=O)C1=CC=CC=C1C,ULMFXAMQUGLVGA-LJQANCHMSA-N,615.67,Q9Y271,BE0000705,Cysteinyl leukotriene receptor 1,Humans,modulator,yes
DB16232,Milciclib Maleate,small molecule,investigational,CNC(=O)C1=NN(C)C2=C1C(C)(C)CC1=C2N=C(NC2=CC=C(C=C2)N2CCN(C)CC2)N=C1,RXZMYLDMFYNEIM-UHFFFAOYSA-N,460.586,P24941,BE0001072,Cyclin-dependent kinase 2,Humans,inhibitor,yes
DB16233,Milvexian,small molecule,investigational,C[C@@H]1CCC[C@H](N2C=NC(=CC2=O)C2=CC(Cl)=CC=C2N2C=C(Cl)N=N2)C2=CC(=CC=N2)C2=C(NC1=O)C=NN2C(F)F,FSWFYCYPTDLKON-CMJOXMDJSA-N,626.45,P03951,BE0001021,Coagulation factor XI,Humans,inhibitor,yes
DB16236,Mitapivat,small molecule,approved;investigational,O=C(N1CCN(CC2CC2)CC1)C1=CC=C(NS(=O)(=O)C2=CC=CC3=C2N=CC=C3)C=C1,XAYGBKHKBBXDAK-UHFFFAOYSA-N,450.56,P30613,BE0000046,Pyruvate kinase PKLR,Humans,activator,yes
DB16239,Molibresib,small molecule,investigational,CCNC(=O)C[C@@H]1N=C(C2=CC=C(Cl)C=C2)C2=CC(OC)=CC=C2N2C(C)=NN=C12,AAAQFGUYHFJNHI-SFHVURJKSA-N,423.9,O60885,BE0010747,Bromodomain-containing protein 4,Humans,modulator,yes
DB16240,BMS-813160,small molecule,investigational,CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@H](NC2=NC=NC3=CC(=NN23)C(C)(C)C)C1=O)NC(C)(C)C,CMVHFGNTABZQJU-HCXYKTFWSA-N,484.649,P41597,BE0003387,C-C chemokine receptor type 2,Humans,modulator,yes
DB16240,BMS-813160,small molecule,investigational,CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@H](NC2=NC=NC3=CC(=NN23)C(C)(C)C)C1=O)NC(C)(C)C,CMVHFGNTABZQJU-HCXYKTFWSA-N,484.649,P51681,BE0000911,C-C chemokine receptor type 5,Humans,modulator,yes
DB16244,MK-0773,small molecule,investigational,[H][C@@]12CC[C@H](C(=O)NCC3=NC4=C(N3)C=CC=N4)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])N(C)C(=O)C(F)=C[C@]12C,GBEUKTWTUSPHEE-JWJWXJQQSA-N,479.6,P10275,BE0000132,Androgen receptor,Humans,modulator,yes
DB16250,Nazartinib,small molecule,investigational,CN(C)C\C=C\C(=O)N1CCCC[C@H](C1)N1C(NC(=O)C2=CC=NC(C)=C2)=NC2=C1C(Cl)=CC=C2,IOMMMLWIABWRKL-WUTDNEBXSA-N,495.02,P00533,BE0000767,Epidermal growth factor receptor,Humans,inhibitor,yes
DB16252,Nedisertib,small molecule,investigational,COC1=NN=C(C=C1)[C@@H](O)C1=C(Cl)C=C(F)C(=C1)C1=NC=NC2=C1C=CC(=C2)N1CCOCC1,MOWXJLUYGFNTAL-DEOSSOPVSA-N,481.91,P78527,BE0002385,DNA-dependent protein kinase catalytic subunit,Humans,inhibitor,yes
DB16254,Nevanimibe,small molecule,investigational,CC(C)C1=CC=CC(C(C)C)=C1NC(=O)NCC1(CCCC1)C1=CC=C(C=C1)N(C)C,PKKNCEXEVUFFFI-UHFFFAOYSA-N,421.629,P35610,BE0000105,Sterol O-acyltransferase 1,Humans,modulator,yes
DB16254,Nevanimibe,small molecule,investigational,CC(C)C1=CC=CC(C(C)C)=C1NC(=O)NCC1(CCCC1)C1=CC=C(C=C1)N(C)C,PKKNCEXEVUFFFI-UHFFFAOYSA-N,421.629,O75908,BE0004608,Sterol O-acyltransferase 2,Humans,modulator,yes
DB16255,Nidufexor,small molecule,investigational,CN1N=C(C(=O)N(CC2=CC=CC=C2)CC2=CC=C(C=C2)C(O)=O)C2=C1C1=C(OC2)C=CC(Cl)=C1,JYTIXGYXBIBOMN-UHFFFAOYSA-N,487.94,Q96RI1,BE0001777,Bile acid receptor,Humans,agonist,yes
DB16261,Odevixibat,small molecule,approved;investigational,CCCCC1(CCCC)CN(C2=CC=CC=C2)C2=CC(SC)=C(OCC(=O)N[C@@H](C(=O)N[C@@H](CC)C(O)=O)C3=CC=C(O)C=C3)C=C2S(=O)(=O)N1,XULSCZPZVQIMFM-IPZQJPLYSA-N,740.93,Q12908,BE0003643,Ileal sodium/bile acid cotransporter,Humans,inhibitor,yes
DB16266,Olodanrigan,small molecule,investigational,COC1=CC=C2CN([C@@H](CC2=C1OCC1=CC=CC=C1)C(O)=O)C(=O)C(C1=CC=CC=C1)C1=CC=CC=C1,GHBCIXGRCZIPNQ-MHZLTWQESA-N,507.586,P50052,BE0003426,Type-2 angiotensin II receptor,Humans,antagonist,yes
DB16267,Olutasidenib,small molecule,approved;investigational,C[C@H](NC1=CC=C(C#N)N(C)C1=O)C1=CC2=C(NC1=O)C=CC(Cl)=C2,NEQYWYXGTJDAKR-JTQLQIEISA-N,354.79,O75874,BE0001251,Isocitrate dehydrogenase [NADP] cytoplasmic,Humans,inhibitor,yes
DB16272,Orelabrutinib,small molecule,investigational,NC(=O)C1=CC=C(N=C1C1=CC=C(OC2=CC=CC=C2)C=C1)C1CCN(CC1)C(=O)C=C,MZPVEMOYADUARK-UHFFFAOYSA-N,427.504,Q06187,BE0001284,Tyrosine-protein kinase BTK,Humans,inhibitor,yes
DB16274,Osoresnontrine,small molecule,investigational,O=C1NC(CC2=NC=CC=C2)=NC2=C1C=NN2C1CCOCC1,BZTIJCSHNVZMES-UHFFFAOYSA-N,311.345,O76083,BE0003134,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",Humans,inhibitor,yes
DB16277,Paltusotine,small molecule,investigational,NC1CCN(CC1)C1=C(C=NC2=CC=C(C=C12)C1=C(O)C(=CC=C1)C#N)C1=CC(F)=CC(F)=C1,GHILNKWBALQPDP-UHFFFAOYSA-N,456.497,P30874,BE0003528,Somatostatin receptor type 2,Humans,agonist,yes
DB16288,Peoniflorin,small molecule,investigational,[H][C@@]12C[C@@]3(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@]1(COC(=O)C1=CC=CC=C1)[C@@]1([H])O[C@]2(O)C[C@]3(C)O1,YKRGDOXKVOZESV-WRJNSLSBSA-N,480.466,P30542,BE0000013,Adenosine receptor A1,Humans,modulator,yes
DB16294,Pexmetinib,small molecule,investigational,CC1=CC=C(C=C1)N1N=C(C=C1NC(=O)NCC1=CC(F)=CC=C1OC1=CC2=C(C=C1)N(CCO)N=C2)C(C)(C)C,LNMRSSIMGCDUTP-UHFFFAOYSA-N,556.642,Q02763,BE0003379,Angiopoietin-1 receptor,Humans,modulator,yes
DB16296,IPI-549,small molecule,investigational,C[C@H](NC(=O)C1=C2N=CC=CN2N=C1N)C1=CC2=C(C(=O)N1C1=CC=CC=C1)C(=CC=C2)C#CC1=CN(C)N=C1,XUMALORDVCFWKV-IBGZPJMESA-N,528.576,P48736,BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",Humans,inhibitor,yes
DB16299,Poseltinib,small molecule,investigational,CN1CCN(CC1)C1=CC=C(NC2=NC(OC3=CC=CC(NC(=O)C=C)=C3)=C3OC=CC3=N2)C=C1,LZMJNVRJMFMYQS-UHFFFAOYSA-N,470.533,Q06187,BE0001284,Tyrosine-protein kinase BTK,Humans,inhibitor,yes
DB16300,Praliciguat,small molecule,investigational,OC(CNC1=NC(=NC=C1F)C1=NN(CC2=C(F)C=CC=C2)C(=C1)C1=NOC=C1)(C(F)(F)F)C(F)(F)F,CYSJNTQNMDWAJV-UHFFFAOYSA-N,534.37,Q02108,BE0010061,Guanylate cyclase soluble subunit alpha-1,Humans,agonist,yes
DB16300,Praliciguat,small molecule,investigational,OC(CNC1=NC(=NC=C1F)C1=NN(CC2=C(F)C=CC=C2)C(=C1)C1=NOC=C1)(C(F)(F)F)C(F)(F)F,CYSJNTQNMDWAJV-UHFFFAOYSA-N,534.37,Q02153,BE0010029,Guanylate cyclase soluble subunit beta-1,Humans,agonist,yes
DB16305,Xevinapant,small molecule,investigational,[H][C@]12CC[C@H](N1C(=O)[C@H](CN(CC2)C(=O)CC(C)C)NC(=O)[C@H](C)NC)C(=O)NC(C1=CC=CC=C1)C1=CC=CC=C1,LSXUTRRVVSPWDZ-MKKUMYSQSA-N,561.727,P98170,BE0001156,E3 ubiquitin-protein ligase XIAP,Humans,modulator,yes
DB16305,Xevinapant,small molecule,investigational,[H][C@]12CC[C@H](N1C(=O)[C@H](CN(CC2)C(=O)CC(C)C)NC(=O)[C@H](C)NC)C(=O)NC(C1=CC=CC=C1)C1=CC=CC=C1,LSXUTRRVVSPWDZ-MKKUMYSQSA-N,561.727,Q13490,BE0010675,Baculoviral IAP repeat-containing protein 2,Humans,modulator,yes
DB16305,Xevinapant,small molecule,investigational,[H][C@]12CC[C@H](N1C(=O)[C@H](CN(CC2)C(=O)CC(C)C)NC(=O)[C@H](C)NC)C(=O)NC(C1=CC=CC=C1)C1=CC=CC=C1,LSXUTRRVVSPWDZ-MKKUMYSQSA-N,561.727,Q13489,BE0010674,Baculoviral IAP repeat-containing protein 3,Humans,modulator,yes
DB16305,Xevinapant,small molecule,investigational,[H][C@]12CC[C@H](N1C(=O)[C@H](CN(CC2)C(=O)CC(C)C)NC(=O)[C@H](C)NC)C(=O)NC(C1=CC=CC=C1)C1=CC=CC=C1,LSXUTRRVVSPWDZ-MKKUMYSQSA-N,561.727,Q13075,BE0010810,Baculoviral IAP repeat-containing protein 1,Humans,modulator,yes
DB16305,Xevinapant,small molecule,investigational,[H][C@]12CC[C@H](N1C(=O)[C@H](CN(CC2)C(=O)CC(C)C)NC(=O)[C@H](C)NC)C(=O)NC(C1=CC=CC=C1)C1=CC=CC=C1,LSXUTRRVVSPWDZ-MKKUMYSQSA-N,561.727,Q96CA5,BE0010707,Baculoviral IAP repeat-containing protein 7,Humans,modulator,yes
DB16305,Xevinapant,small molecule,investigational,[H][C@]12CC[C@H](N1C(=O)[C@H](CN(CC2)C(=O)CC(C)C)NC(=O)[C@H](C)NC)C(=O)NC(C1=CC=CC=C1)C1=CC=CC=C1,LSXUTRRVVSPWDZ-MKKUMYSQSA-N,561.727,O15392,BE0003408,Baculoviral IAP repeat-containing protein 5,Humans,modulator,yes
DB16310,Rezafungin,small molecule,approved;investigational,[H][C@](C)(O)[C@]1([H])\N=C(O)/[C@]([H])(C[C@@]([H])(O)[C@@]([H])(OCC[N+](C)(C)C)\N=C(O)/[C@@]2([H])N(C[C@]([H])(C)[C@]2([H])O)C(=O)[C@@]([H])(\N=C(O)/[C@@]([H])(\N=C(O)/[C@]2([H])C[C@@]([H])(O)CN2C1=O)[C@]([H])(O)[C@@]([H])(O)C1=CC=C(O)C=C1)[C@@]([H])(C)O)\N=C(/O)C1=CC=C(C=C1)C1=CC=C(C=C1)C1=CC=C(OCCCCC)C=C1,LNFCWEXGZIEGJW-TXSVMFMRSA-O,1226.411,A2QLK4,BE0004669,"1,3-beta-glucan synthase component FKS1",Aspergillus niger (strain CBS 513.88 / FGSC A1513),inhibitor,yes
DB16310,Rezafungin,small molecule,approved;investigational,[H][C@](C)(O)[C@]1([H])\N=C(O)/[C@]([H])(C[C@@]([H])(O)[C@@]([H])(OCC[N+](C)(C)C)\N=C(O)/[C@@]2([H])N(C[C@]([H])(C)[C@]2([H])O)C(=O)[C@@]([H])(\N=C(O)/[C@@]([H])(\N=C(O)/[C@]2([H])C[C@@]([H])(O)CN2C1=O)[C@]([H])(O)[C@@]([H])(O)C1=CC=C(O)C=C1)[C@@]([H])(C)O)\N=C(/O)C1=CC=C(C=C1)C1=CC=C(C=C1)C1=CC=C(OCCCCC)C=C1,LNFCWEXGZIEGJW-TXSVMFMRSA-O,1226.411,P40989,BE0010066,"1,3-beta-glucan synthase component GSC2",Baker's yeast,inhibitor,yes
DB16312,TNP-2092,small molecule,investigational,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C2=C(C(O)=C3C)C(O)=C(NC(=O)C(C)=C\C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@H](C)[C@H](OC(C)=O)[C@H]1C)C(\C=N\N1CCC(CC1)N(C)C1(CC1)[C@@H]1CCN(C1)C1=C(C)C3=C(C=C(C(O)=O)C(=O)N3C=C1F)C1CC1)=C2O,OPZFMLLAJBIKAN-JNEXSVMGSA-N,1205.388,P20831,BE0008385,DNA gyrase subunit A,Staphylococcus aureus,inhibitor,yes
DB16312,TNP-2092,small molecule,investigational,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C2=C(C(O)=C3C)C(O)=C(NC(=O)C(C)=C\C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@H](C)[C@H](OC(C)=O)[C@H]1C)C(\C=N\N1CCC(CC1)N(C)C1(CC1)[C@@H]1CCN(C1)C1=C(C)C3=C(C=C(C(O)=O)C(=O)N3C=C1F)C1CC1)=C2O,OPZFMLLAJBIKAN-JNEXSVMGSA-N,1205.388,P0A0K8,BE0002388,DNA gyrase subunit B,Staphylococcus aureus,inhibitor,yes
DB16312,TNP-2092,small molecule,investigational,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C2=C(C(O)=C3C)C(O)=C(NC(=O)C(C)=C\C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@H](C)[C@H](OC(C)=O)[C@H]1C)C(\C=N\N1CCC(CC1)N(C)C1(CC1)[C@@H]1CCN(C1)C1=C(C)C3=C(C=C(C(O)=O)C(=O)N3C=C1F)C1CC1)=C2O,OPZFMLLAJBIKAN-JNEXSVMGSA-N,1205.388,P0AFI2,BE0000798,DNA topoisomerase 4 subunit A,Escherichia coli (strain K12),inhibitor,yes
DB16315,Rivenprost,small molecule,investigational,COCC1=CC=CC(C[C@H](O)\C=C\[C@H]2[C@H](O)CC(=O)[C@@H]2CCSCCCC(=O)OC)=C1,FBQUXLIJKPWCAO-AZIFJQEOSA-N,450.59,P35408,BE0003522,Prostaglandin E2 receptor EP4 subtype,Humans,agonist,yes
DB16315,Rivenprost,small molecule,investigational,COCC1=CC=CC(C[C@H](O)\C=C\[C@H]2[C@H](O)CC(=O)[C@@H]2CCSCCCC(=O)OC)=C1,FBQUXLIJKPWCAO-AZIFJQEOSA-N,450.59,P34995,BE0010100,Prostaglandin E2 Receptors,Humans,agonist,yes
DB16319,GSK-2981278,small molecule,investigational,CCC1=CC=C(C=C1)N(CC(C)C)S(=O)(=O)C1=CC(CO)=C(OCC2CCOCC2)C=C1,LZLBRISQTJVZNP-UHFFFAOYSA-N,461.62,P51449,BE0013275,Nuclear receptor ROR-gamma,Humans,agonist,yes
DB16321,S-777469,small molecule,investigational,CCC1=C(C)C=C(C(=O)NC2(CCCCC2)C(O)=O)C(=O)N1CC1=CC=C(F)C=C1,JIYXOJFSPOFZPY-UHFFFAOYSA-N,414.477,P34972,BE0000095,Cannabinoid receptor 2,Humans,agonist,yes
DB16324,Selgantolimod,small molecule,investigational,CCCC[C@@](C)(CO)NC1=NC(N)=NC2=C1N=CC(F)=C2,HTCJUBZBSJQWBW-AWEZNQCLSA-N,293.346,Q9NR97,BE0003518,Toll-like receptor 8,Humans,agonist,yes
DB16325,Selodenoson,small molecule,investigational,CCNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=CN=C2NC1CCCC1,GWVQGVCXFNYGFP-PFHKOEEOSA-N,376.417,P30542,BE0000013,Adenosine receptor A1,Humans,agonist,yes
DB16330,Simurosertib,small molecule,investigational,CC1=NNC=C1C1=CC2=C(S1)C(=O)NC(=N2)[C@@H]1CC2CCN1CC2,XGVXKJKTISMIOW-ZDUSSCGKSA-N,341.43,O00311,BE0010851,Cell division cycle 7-related protein kinase,Humans,inhibitor,yes
DB16331,Siremadlin,small molecule,investigational,COC1=NC(OC)=C(C=N1)C1=NC2=C([C@@H](N(C2=O)C2=CC(Cl)=CN(C)C2=O)C2=CC=C(Cl)C=C2)N1C(C)C,AGBSXNCBIWWLHD-FQEVSTJZSA-N,555.42,Q00987,BE0001003,E3 ubiquitin-protein ligase Mdm2,Humans,inhibitor,yes
DB16331,Siremadlin,small molecule,investigational,COC1=NC(OC)=C(C=N1)C1=NC2=C([C@@H](N(C2=O)C2=CC(Cl)=CN(C)C2=O)C2=CC=C(Cl)C=C2)N1C(C)C,AGBSXNCBIWWLHD-FQEVSTJZSA-N,555.42,P04637,BE0003380,Cellular tumor antigen p53,Humans,inhibitor,yes
DB16332,Sodelglitazar,small molecule,investigational,CC1=C(CSC2=CC=C(OC(C)(C)C(O)=O)C(C)=C2)SC(=N1)C1=CC=C(C=C1F)C(F)(F)F,ZUGQWAYOWCBWGM-UHFFFAOYSA-N,499.54,Q03181,BE0001007,Peroxisome proliferator-activated receptor delta,Humans,agonist,yes
DB16332,Sodelglitazar,small molecule,investigational,CC1=C(CSC2=CC=C(OC(C)(C)C(O)=O)C(C)=C2)SC(=N1)C1=CC=C(C=C1F)C(F)(F)F,ZUGQWAYOWCBWGM-UHFFFAOYSA-N,499.54,P37231,BE0000215,Peroxisome proliferator-activated receptor gamma,Humans,agonist,yes
DB16332,Sodelglitazar,small molecule,investigational,CC1=C(CSC2=CC=C(OC(C)(C)C(O)=O)C(C)=C2)SC(=N1)C1=CC=C(C=C1F)C(F)(F)F,ZUGQWAYOWCBWGM-UHFFFAOYSA-N,499.54,Q07869,BE0000071,Peroxisome proliferator-activated receptor alpha,Humans,agonist,yes
DB16335,Sulopenem etzadroxil,small molecule,approved;investigational,[H][C@]12SC(S[C@H]3CC[S@@+]([O-])C3)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(=O)OCOC(=O)C(CC)CC,NBPVNGWRLGHULH-CSOWVJSESA-N,477.61,P0AD65,BE0003579,Penicillin-binding protein 2,Escherichia coli (strain K12),binder,yes
DB16335,Sulopenem etzadroxil,small molecule,approved;investigational,[H][C@]12SC(S[C@H]3CC[S@@+]([O-])C3)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(=O)OCOC(=O)C(CC)CC,NBPVNGWRLGHULH-CSOWVJSESA-N,477.61,P02918,BE0000588,Penicillin-binding protein 1A,Escherichia coli (strain K12),binder,yes
DB16335,Sulopenem etzadroxil,small molecule,approved;investigational,[H][C@]12SC(S[C@H]3CC[S@@+]([O-])C3)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(=O)OCOC(=O)C(CC)CC,NBPVNGWRLGHULH-CSOWVJSESA-N,477.61,P02919,BE0000488,Penicillin-binding protein 1B,Escherichia coli (strain K12),binder,yes
DB16335,Sulopenem etzadroxil,small molecule,approved;investigational,[H][C@]12SC(S[C@H]3CC[S@@+]([O-])C3)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(=O)OCOC(=O)C(CC)CC,NBPVNGWRLGHULH-CSOWVJSESA-N,477.61,P24228,BE0000744,D-alanyl-D-alanine carboxypeptidase DacB,Escherichia coli (strain K12),binder,yes
DB16335,Sulopenem etzadroxil,small molecule,approved;investigational,[H][C@]12SC(S[C@H]3CC[S@@+]([O-])C3)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(=O)OCOC(=O)C(CC)CC,NBPVNGWRLGHULH-CSOWVJSESA-N,477.61,P0AD68,BE0002393,Peptidoglycan synthase FtsI,Escherichia coli (strain K12),binder,yes
DB16335,Sulopenem etzadroxil,small molecule,approved;investigational,[H][C@]12SC(S[C@H]3CC[S@@+]([O-])C3)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(=O)OCOC(=O)C(CC)CC,NBPVNGWRLGHULH-CSOWVJSESA-N,477.61,P0AEB2,BE0002063,D-alanyl-D-alanine carboxypeptidase DacA,Escherichia coli (strain K12),binder,yes
DB16335,Sulopenem etzadroxil,small molecule,approved;investigational,[H][C@]12SC(S[C@H]3CC[S@@+]([O-])C3)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(=O)OCOC(=O)C(CC)CC,NBPVNGWRLGHULH-CSOWVJSESA-N,477.61,P08506,BE0003685,D-alanyl-D-alanine carboxypeptidase DacC,Escherichia coli (strain K12),binder,yes
DB16346,Veliflapon,small molecule,investigational,OC(=O)[C@H](C1CCCC1)C1=CC=C(OCC2=NC3=C(C=CC=C3)C=C2)C=C1,ZEYYDOLCHFETHQ-JOCHJYFZSA-N,361.441,P20292,BE0002382,Arachidonate 5-lipoxygenase-activating protein,Humans,inhibitor,yes
DB16351,Volinanserin,small molecule,investigational,COC1=C(OC)C(=CC=C1)[C@H](O)C1CCN(CCC2=CC=C(F)C=C2)CC1,HXTGXYRHXAGCFP-OAQYLSRUSA-N,373.468,Q12809,BE0000090,Voltage-gated inwardly rectifying potassium channel KCNH2,Humans,inhibitor,yes
DB16351,Volinanserin,small molecule,investigational,COC1=C(OC)C(=CC=C1)[C@H](O)C1CCN(CCC2=CC=C(F)C=C2)CC1,HXTGXYRHXAGCFP-OAQYLSRUSA-N,373.468,P28335,BE0000533,5-hydroxytryptamine receptor 2C,Humans,inhibitor,yes
DB16351,Volinanserin,small molecule,investigational,COC1=C(OC)C(=CC=C1)[C@H](O)C1CCN(CCC2=CC=C(F)C=C2)CC1,HXTGXYRHXAGCFP-OAQYLSRUSA-N,373.468,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,antagonist,yes
DB16353,Razuprotafib,small molecule,investigational,COC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=C(NS(O)(=O)=O)C=C1)C1=CSC(=N1)C1=CC=CS1,KWJDHELCGJFUHW-SFTDATJTSA-N,586.7,P23467,BE0003769,Receptor-type tyrosine-protein phosphatase beta,Humans,inhibitor,yes
DB16353,Razuprotafib,small molecule,investigational,COC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=C(NS(O)(=O)=O)C=C1)C1=CSC(=N1)C1=CC=CS1,KWJDHELCGJFUHW-SFTDATJTSA-N,586.7,Q02763,BE0003379,Angiopoietin-1 receptor,Humans,activator,yes
DB16390,Mobocertinib,small molecule,approved;investigational,COC1=C(NC2=NC=C(C(=O)OC(C)C)C(=N2)C2=CN(C)C3=C2C=CC=C3)C=C(NC(=O)C=C)C(=C1)N(C)CCN(C)C,AZSRSNUQCUDCGG-UHFFFAOYSA-N,585.709,P00533,BE0000767,Epidermal growth factor receptor,Humans,inhibitor,yes
DB16404,Carvacrol,small molecule,experimental,CC(C)C1=CC(O)=C(C)C=C1,RECUKUPTGUEGMW-UHFFFAOYSA-N,150.221,Q8NET8,BE0003416,Transient receptor potential cation channel subfamily V member 3,Humans,activator,yes
DB16446,Vafidemstat,small molecule,investigational,NC1=NN=C(CN[C@@H]2C[C@H]2C2=CC=C(OCC3=CC=CC=C3)C=C2)O1,XBBRLCXCBCZIOI-DLBZAZTESA-N,336.395,O60341,BE0010091,Lysine-specific histone demethylase 1A,Humans,inhibitor;binder;modulator,yes
DB16447,Thymoquinone,small molecule,investigational,CC(C)C1=CC(=O)C(C)=CC1=O,KEQHJBNSCLWCAE-UHFFFAOYSA-N,164.204,P04637,BE0003380,Cellular tumor antigen p53,Humans,inhibitor,yes
DB16447,Thymoquinone,small molecule,investigational,CC(C)C1=CC(=O)C(C)=CC1=O,KEQHJBNSCLWCAE-UHFFFAOYSA-N,164.204,P10415,BE0000246,Apoptosis regulator Bcl-2,Humans,inhibitor,yes
DB16447,Thymoquinone,small molecule,investigational,CC(C)C1=CC(=O)C(C)=CC1=O,KEQHJBNSCLWCAE-UHFFFAOYSA-N,164.204,Q07812,BE0010137,Apoptosis regulator BAX,Humans,inhibitor,yes
DB16492,SAR443122,small molecule,investigational,CN1C2=NC=CC=C2OC[C@H](NC(=O)C2=NN=C(CC3=CC=CC=C3)N2)C1=O,XUZICJHIIJCKQQ-ZDUSSCGKSA-N,378.392,Q13546,BE0009531,Receptor-interacting serine/threonine-protein kinase 1,Humans,inhibitor,yes
DB16495,Oleic monoethanolamide,small molecule,investigational,CCCCCCCC\C=C/CCCCCCCC(=O)NCCO,BOWVQLFMWHZBEF-KTKRTIGZSA-N,325.537,Q07869,BE0000071,Peroxisome proliferator-activated receptor alpha,Humans,agonist,yes
DB16495,Oleic monoethanolamide,small molecule,investigational,CCCCCCCC\C=C/CCCCCCCC(=O)NCCO,BOWVQLFMWHZBEF-KTKRTIGZSA-N,325.537,Q9Y2T6,BE0005802,G-protein coupled receptor 55,Humans,agonist,yes
DB16495,Oleic monoethanolamide,small molecule,investigational,CCCCCCCC\C=C/CCCCCCCC(=O)NCCO,BOWVQLFMWHZBEF-KTKRTIGZSA-N,325.537,Q8TDV5,BE0003378,Glucose-dependent insulinotropic receptor,Humans,agonist,yes
DB16495,Oleic monoethanolamide,small molecule,investigational,CCCCCCCC\C=C/CCCCCCCC(=O)NCCO,BOWVQLFMWHZBEF-KTKRTIGZSA-N,325.537,P21554,BE0000061,Cannabinoid receptor 1,Humans,inhibitor,yes
DB16502,Zunsemetinib,small molecule,investigational,CC1=CC(OCC2=NC=C(F)C=C2F)=C(Cl)C(=O)N1C1=C(C)C=NC(=C1)C1=NC(=NC=C1)C(C)(C)O,FQPQMJULRZINPV-UHFFFAOYSA-N,513.93,P49137,BE0001373,MAP kinase-activated protein kinase 2,Humans,inhibitor,yes
DB16514,PF-07304814,small molecule,investigational,[H][C@@]1(C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)C2=CC3=C(N2)C=CC=C3OC)C(=O)COP(O)(O)=O)CCNC1=O,FQKALOFOWPDTED-WBAXXEDZSA-N,552.521,P0DTD1,BE0010016,Replicase polyprotein 1ab,SARS-CoV-2,inhibitor,yes
DB16554,Metadoxine,small molecule,experimental,OC(=O)[C@@H]1CCC(=O)N1.CC1=NC=C(CO)C(CO)=C1O,RYKKQQUKJJGFMN-HVDRVSQOSA-N,298.295,P30531,BE0000249,Sodium- and chloride-dependent GABA transporter 1,Humans,modulator,yes
DB16580,Afimetoran,small molecule,investigational,CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC(N)=O)CC1)C1=CN2N=CN=C2C(C)=C1C,SNFVHLQYHFQOEP-UHFFFAOYSA-N,444.583,Q9NYK1,BE0000155,Toll-like receptor 7,Humans,antagonist,yes
DB16580,Afimetoran,small molecule,investigational,CC(C)C1=C(NC2=CC=C(C=C12)C1CCN(CC(N)=O)CC1)C1=CN2N=CN=C2C(C)=C1C,SNFVHLQYHFQOEP-UHFFFAOYSA-N,444.583,Q9NR97,BE0003518,Toll-like receptor 8,Humans,antagonist,yes
DB16623,Amidephrine,small molecule,experimental,CNCC(O)C1=CC(NS(C)(=O)=O)=CC=C1,ZHOWHMXTJFZXRB-UHFFFAOYSA-N,244.31,P18825,BE0000342,Alpha-2C adrenergic receptor,Humans,agonist,yes
DB16627,Melphalan flufenamide,small molecule,approved;withdrawn,CCOC(=O)[C@H](CC1=CC=C(F)C=C1)NC(=O)[C@@H](N)CC1=CC=C(C=C1)N(CCCl)CCCl,YQZNKYXGZSVEHI-VXKWHMMOSA-N,498.42,,BE0004796,DNA,Humans,cross-linking/alkylation,yes
DB16628,Fosdenopterin,small molecule,approved,[H][C@@]12COP(O)(=O)O[C@]1([H])C(O)(O)[C@]1([H])NC3=C(NC(N)=NC3=O)N[C@]1([H])O2,CZAKJJUNKNPTTO-AJFJRRQVSA-N,363.223,Q9NZB8,BE0011005,Molybdenum cofactor biosynthesis protein 1,Humans,substrate,yes
DB16628,Fosdenopterin,small molecule,approved,[H][C@@]12COP(O)(=O)O[C@]1([H])C(O)(O)[C@]1([H])NC3=C(NC(N)=NC3=O)N[C@]1([H])O2,CZAKJJUNKNPTTO-AJFJRRQVSA-N,363.223,P47989,BE0002204,Xanthine dehydrogenase/oxidase,Humans,cofactor,yes
DB16629,Serdexmethylphenidate,small molecule,approved,[H][C@@]1(CCCCN1C(=O)OC[N+]1=CC=CC(=C1)C(=O)N[C@@H](CO)C([O-])=O)[C@H](C(=O)OC)C1=CC=CC=C1,UBZPNQRBUOBBLN-PWRODBHTSA-N,499.52,Q01959,BE0000647,Sodium-dependent dopamine transporter,Humans,inhibitor,yes
DB16629,Serdexmethylphenidate,small molecule,approved,[H][C@@]1(CCCCN1C(=O)OC[N+]1=CC=CC(=C1)C(=O)N[C@@H](CO)C([O-])=O)[C@H](C(=O)OC)C1=CC=CC=C1,UBZPNQRBUOBBLN-PWRODBHTSA-N,499.52,P23975,BE0000486,Sodium-dependent noradrenaline transporter,Humans,inhibitor,yes
DB16640,Almonertinib,small molecule,investigational,COC1=CC(N(C)CCN(C)C)=C(NC(=O)C=C)C=C1NC1=NC(=CC=N1)C1=CN(C2CC2)C2=C1C=CC=C2,DOEOECWDNSEFDN-UHFFFAOYSA-N,525.657,P00533,BE0000767,Epidermal growth factor receptor,Humans,inhibitor,yes
DB16640,Almonertinib,small molecule,investigational,COC1=CC(N(C)CCN(C)C)=C(NC(=O)C=C)C=C1NC1=NC(=CC=N1)C1=CN(C2CC2)C2=C1C=CC=C2,DOEOECWDNSEFDN-UHFFFAOYSA-N,525.657,Q504U8,BE0010047,Receptor protein-tyrosine kinase,Humans,inhibitor,yes
DB16650,Deucravacitinib,small molecule,approved;investigational,[2H]C([2H])([2H])NC(=O)C1=C(NC2=CC=CC(C3=NN(C)C=N3)=C2OC)C=C(NC(=O)C2CC2)N=N1,BZZKEPGENYLQSC-FIBGUPNXSA-N,425.467,P29597,BE0004146,Non-receptor tyrosine-protein kinase TYK2,Humans,inhibitor,yes
DB16656,Zotiraciclib,small molecule,investigational,CN1C\C=C\CCOC2=CC(=CC=C2)C2=CC=NC(NC3=CC=CC(C1)=C3)=N2,VXBAJLGYBMTJCY-NSCUHMNNSA-N,372.472,P24941,BE0001072,Cyclin-dependent kinase 2,Humans,modulator,yes
DB16657,Vecabrutinib,small molecule,investigational,NC(=O)[C@H]1CCN(C[C@@H]1N1CCC[C@@H](NC2=CC(=CC(Cl)=C2)C(F)(F)F)C1=O)C1=NC=NC(N)=C1F,QLRRJMOBVVGXEJ-XHSDSOJGSA-N,529.92,Q06187,BE0001284,Tyrosine-protein kinase BTK,Humans,inhibitor,yes
DB16690,Tegoprazan,small molecule,investigational,CN(C)C(=O)C1=CC(O[C@H]2CCOC3=CC(F)=CC(F)=C23)=C2NC(C)=NC2=C1,CLIQCDHNPDMGSL-HNNXBMFYSA-N,387.387,P05023,BE0010055,Sodium/Potassium Transporting ATPase,Humans,inhibitor,yes
DB16691,Nirmatrelvir,small molecule,approved;investigational,[H][C@]12CN([C@H](C(=O)N[C@@H](C[C@]3([H])CCNC3=O)C#N)[C@@]1([H])C2(C)C)C(=O)[C@@H](NC(=O)C(F)(F)F)C(C)(C)C,LIENCHBZNNMNKG-OJFNHCPVSA-N,499.535,P0DTD1,BE0010016,Replicase polyprotein 1ab,SARS-CoV-2,inhibitor,yes
DB16700,Runcaciguat,small molecule,investigational,C[C@H]([C@H](C(=O)NC1=C(Cl)C=CC(=C1)[C@@H](CC(O)=O)C1CC1)C1=CC=C(Cl)C=C1)C(F)(F)F,NCRMKIWHFXSBGZ-CNBXIYLPSA-N,488.33,Q02108,BE0010061,Guanylate cyclase soluble subunit alpha-1,Humans,activator,yes
DB16700,Runcaciguat,small molecule,investigational,C[C@H]([C@H](C(=O)NC1=C(Cl)C=CC(=C1)[C@@H](CC(O)=O)C1CC1)C1=CC=C(Cl)C=C1)C(F)(F)F,NCRMKIWHFXSBGZ-CNBXIYLPSA-N,488.33,Q02153,BE0010029,Guanylate cyclase soluble subunit beta-1,Humans,activator,yes
DB16703,Belumosudil,small molecule,approved;investigational,CC(C)NC(=O)COC1=CC=CC(=C1)C1=NC2=C(C=CC=C2)C(NC2=CC=C3NN=CC3=C2)=N1,GKHIVNAUVKXIIY-UHFFFAOYSA-N,452.518,O75116,BE0004191,Rho-associated protein kinase 2,Humans,inhibitor,yes
DB16703,Belumosudil,small molecule,approved;investigational,CC(C)NC(=O)COC1=CC=CC(=C1)C1=NC2=C(C=CC=C2)C(NC2=CC=C3NN=CC3=C2)=N1,GKHIVNAUVKXIIY-UHFFFAOYSA-N,452.518,Q13464,BE0001016,Rho-associated protein kinase 1,Humans,inhibitor,yes
DB16704,Durlobactam,small molecule,approved;investigational,CC1=C[C@@H]2C[N@]([C@@H]1C(N)=O)C(=O)N2OS(O)(=O)=O,BISPBXFUKNXOQY-RITPCOANSA-N,277.25,Q939N4,BE0002831,Beta-lactamase CTX-M,Escherichia coli,inhibitor,yes
DB16733,Rimtuzalcap,small molecule,investigational,CC1=NN(C=C1)C1=NC(NC2CCC(F)(F)CC2)=CC(=N1)N1CCOCC1,OVLIDRAJVMUEMC-UHFFFAOYSA-N,378.428,Q92952,BE0004425,Small conductance calcium-activated potassium channel protein 1,Humans,positive allosteric modulator,yes
DB16733,Rimtuzalcap,small molecule,investigational,CC1=NN(C=C1)C1=NC(NC2CCC(F)(F)CC2)=CC(=N1)N1CCOCC1,OVLIDRAJVMUEMC-UHFFFAOYSA-N,378.428,Q9H2S1,BE0004426,Small conductance calcium-activated potassium channel protein 2,Humans,positive allosteric modulator,yes
DB16739,MK-886,small molecule,experimental,CC(C)C1=CC=C2N(CC3=CC=C(Cl)C=C3)C(CC(C)(C)C(O)=O)=C(SC(C)(C)C)C2=C1,QAOAOVKBIIKRNL-UHFFFAOYSA-N,472.08,P09917,BE0000248,Polyunsaturated fatty acid 5-lipoxygenase,Humans,modulator,yes
DB16756,Ivarmacitinib,small molecule,experimental;investigational,[H][C@@]12C[C@H](C[C@]1([H])CN(C2)C(=O)NC1=NC(OC)=NS1)N(C)C1=NC=NC2=C1C=CN2,DNBCBAXDWNDRNO-GDNZZTSVSA-N,414.49,P23458,BE0004145,Tyrosine-protein kinase JAK1,Humans,inhibitor,yes
DB16767,Isorhamnetin,small molecule,experimental,COC1=C(O)C=CC(=C1)C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1,IZQSVPBOUDKVDZ-UHFFFAOYSA-N,316.265,Q16678,BE0001111,Cytochrome P450 1B1,Humans,inhibitor,yes
DB16768,Lavendustin A,small molecule,experimental,OC(=O)C1=C(O)C=CC(=C1)N(CC1=CC=CC=C1O)CC1=CC(O)=CC=C1O,ULTTYPMRMMDONC-UHFFFAOYSA-N,381.384,P00533,BE0000767,Epidermal growth factor receptor,Humans,inhibitor,yes
DB16768,Lavendustin A,small molecule,experimental,OC(=O)C1=C(O)C=CC(=C1)N(CC1=CC=CC=C1O)CC1=CC(O)=CC=C1O,ULTTYPMRMMDONC-UHFFFAOYSA-N,381.384,P06239,BE0000842,Tyrosine-protein kinase Lck,Humans,inhibitor,yes
DB16770,Morin,small molecule,experimental,OC1=CC=C(C(O)=C1)C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1,YXOLAZRVSSWPPT-UHFFFAOYSA-N,302.238,Q92731,BE0000792,Estrogen receptor beta,Humans,inhibitor,yes
DB16770,Morin,small molecule,experimental,OC1=CC=C(C(O)=C1)C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1,YXOLAZRVSSWPPT-UHFFFAOYSA-N,302.238,Q96S37,BE0004782,Solute carrier family 22 member 12,Humans,inhibitor,yes
DB16770,Morin,small molecule,experimental,OC1=CC=C(C(O)=C1)C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1,YXOLAZRVSSWPPT-UHFFFAOYSA-N,302.238,P49327,BE0000959,Fatty acid synthase,Humans,inhibitor,yes
DB16770,Morin,small molecule,experimental,OC1=CC=C(C(O)=C1)C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1,YXOLAZRVSSWPPT-UHFFFAOYSA-N,302.238,Q07820,BE0003511,Induced myeloid leukemia cell differentiation protein Mcl-1,Humans,inhibitor,yes
DB16771,Phlorizin,small molecule,experimental,OC[C@H]1O[C@@H](OC2=C(C(=O)CCC3=CC=C(O)C=C3)C(O)=CC(O)=C2)[C@H](O)[C@@H](O)[C@@H]1O,IOUVKUPGCMBWBT-QNDFHXLGSA-N,436.413,P13866,BE0004754,Sodium/glucose cotransporter 1,Humans,inhibitor,yes
DB16822,AZD-5069,small molecule,investigational,C[C@@H](OC1=CC(NS(=O)(=O)N2CCC2)=NC(SCC2=CC=CC(F)=C2F)=N1)[C@@H](O)CO,QZECRCLSIGFCIO-RISCZKNCSA-N,476.51,P25025,BE0010516,C-X-C chemokine receptor type 2,Humans,inhibitor,yes
DB16823,Vebreltinib,small molecule,investigational,CN1C=C2C=C(C(F)=CC2=N1)C(F)(F)C1=NN=C2C=CC(=NN12)C1=CN(N=C1)C1CC1,QHXLXUIZUCJRKV-UHFFFAOYSA-N,424.391,P08581,BE0000915,Hepatocyte growth factor receptor,Humans,inhibitor,yes
DB16825,Itanapraced,small molecule,investigational,OC(=O)C1(CC1)C1=CC(F)=C(C=C1)C1=CC=C(Cl)C(Cl)=C1,LIYLTQQDABRNRX-UHFFFAOYSA-N,325.16,Q8WW43,BE0017533,Gamma-secretase subunit APH-1B,Humans,modulator,yes
DB16825,Itanapraced,small molecule,investigational,OC(=O)C1(CC1)C1=CC(F)=C(C=C1)C1=CC=C(Cl)C(Cl)=C1,LIYLTQQDABRNRX-UHFFFAOYSA-N,325.16,Q92542,BE0017775,Nicastrin,Humans,modulator,yes
DB16825,Itanapraced,small molecule,investigational,OC(=O)C1(CC1)C1=CC(F)=C(C=C1)C1=CC=C(Cl)C(Cl)=C1,LIYLTQQDABRNRX-UHFFFAOYSA-N,325.16,Q96BI3,BE0003409,Gamma-secretase subunit APH-1A,Humans,modulator,yes
DB16825,Itanapraced,small molecule,investigational,OC(=O)C1(CC1)C1=CC(F)=C(C=C1)C1=CC=C(Cl)C(Cl)=C1,LIYLTQQDABRNRX-UHFFFAOYSA-N,325.16,Q9NZ42,BE0003410,Gamma-secretase subunit PEN-2,Humans,modulator,yes
DB16825,Itanapraced,small molecule,investigational,OC(=O)C1(CC1)C1=CC(F)=C(C=C1)C1=CC=C(Cl)C(Cl)=C1,LIYLTQQDABRNRX-UHFFFAOYSA-N,325.16,P49768,BE0010960,Presenilin-1,Humans,modulator,yes
DB16826,Repotrectinib,small molecule,approved;investigational,C[C@H]1CNC(=O)C2=C3N=C(N[C@H](C)C4=CC(F)=CC=C4O1)C=CN3N=C2,FIKPXCOQUIZNHB-WDEREUQCSA-N,355.373,P08922,BE0009534,Proto-oncogene tyrosine-protein kinase ROS,Humans,inhibitor,yes
DB16826,Repotrectinib,small molecule,approved;investigational,C[C@H]1CNC(=O)C2=C3N=C(N[C@H](C)C4=CC(F)=CC=C4O1)C=CN3N=C2,FIKPXCOQUIZNHB-WDEREUQCSA-N,355.373,P04629,BE0001039,High affinity nerve growth factor receptor,Humans,inhibitor,yes
DB16826,Repotrectinib,small molecule,approved;investigational,C[C@H]1CNC(=O)C2=C3N=C(N[C@H](C)C4=CC(F)=CC=C4O1)C=CN3N=C2,FIKPXCOQUIZNHB-WDEREUQCSA-N,355.373,Q16620,BE0003605,BDNF/NT-3 growth factors receptor,Humans,inhibitor,yes
DB16826,Repotrectinib,small molecule,approved;investigational,C[C@H]1CNC(=O)C2=C3N=C(N[C@H](C)C4=CC(F)=CC=C4O1)C=CN3N=C2,FIKPXCOQUIZNHB-WDEREUQCSA-N,355.373,Q16288,BE0009501,NT-3 growth factor receptor,Humans,inhibitor,yes
DB16828,MK-2206,small molecule,investigational,NC1(CCC1)C1=CC=C(C=C1)C1=NC2=C(C=C1C1=CC=CC=C1)C1=NNC(=O)N1C=C2,ULDXWLCXEDXJGE-UHFFFAOYSA-N,407.477,Q9NPD8,BE0019778,Ubiquitin-conjugating enzyme E2 T,Humans,inhibitor,yes
DB16828,MK-2206,small molecule,investigational,NC1(CCC1)C1=CC=C(C=C1)C1=NC2=C(C=C1C1=CC=CC=C1)C1=NNC(=O)N1C=C2,ULDXWLCXEDXJGE-UHFFFAOYSA-N,407.477,Q9Y243,BE0010514,RAC-gamma serine/threonine-protein kinase,Humans,modulator,yes
DB16832,Fadrozole,small molecule,investigational,N#CC1=CC=C(C=C1)C1CCCC2=CN=CN12,CLPFFLWZZBQMAO-UHFFFAOYSA-N,223.279,P11511,BE0002090,Aromatase,Humans,inhibitor,yes
DB16832,Fadrozole,small molecule,investigational,N#CC1=CC=C(C=C1)C1CCCC2=CN=CN12,CLPFFLWZZBQMAO-UHFFFAOYSA-N,223.279,P15538,BE0000731,"Cytochrome P450 11B1, mitochondrial",Humans,inhibitor,yes
DB16833,Adenosine disphosphate,small molecule,investigational,NC1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1,XTWYTFMLZFPYCI-KQYNXXCUSA-N,427.203,Q15077,BE0014552,P2Y purinoceptor 6,Humans,agonist,yes
DB16833,Adenosine disphosphate,small molecule,investigational,NC1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1,XTWYTFMLZFPYCI-KQYNXXCUSA-N,427.203,Q8TD43,BE0009748,Transient receptor potential cation channel subfamily M member 4,Humans,inhibitor,yes
DB16833,Adenosine disphosphate,small molecule,investigational,NC1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1,XTWYTFMLZFPYCI-KQYNXXCUSA-N,427.203,Q9H244,BE0000110,P2Y purinoceptor 12,Humans,agonist,yes
DB16834,AZD-7648,small molecule,investigational,CN1C(=O)N(C2CCOCC2)C2=NC(NC3=CN4N=CN=C4C=C3C)=NC=C12,XISVSTPEXYIKJL-UHFFFAOYSA-N,380.412,P78527,BE0002385,DNA-dependent protein kinase catalytic subunit,Humans,inhibitor,yes
DB16838,BLZ-945,small molecule,investigational,CNC(=O)C1=NC=CC(OC2=CC=C3N=C(N[C@@H]4CCCC[C@H]4O)SC3=C2)=C1,ADZBMFGQQWPHMJ-RHSMWYFYSA-N,398.48,Q99062,BE0000793,Granulocyte colony-stimulating factor receptor,Humans,inhibitor,yes
DB16838,BLZ-945,small molecule,investigational,CNC(=O)C1=NC=CC(OC2=CC=C3N=C(N[C@@H]4CCCC[C@H]4O)SC3=C2)=C1,ADZBMFGQQWPHMJ-RHSMWYFYSA-N,398.48,P07333,BE0000853,Macrophage colony-stimulating factor 1 receptor,Humans,antagonist,yes
DB16844,BMS-833923,small molecule,investigational,CNCC1=CC(NC(=O)C2=CC=C(NC3=NC4=CC=CC=C4C(=N3)C3=CC=CC=C3)C=C2)=C(C)C=C1,KLRRGBHZCJLIEL-UHFFFAOYSA-N,473.58,Q99835,BE0004659,Protein smoothened,Humans,inhibitor,yes
DB16845,Roblitinib,small molecule,investigational,COCCNC1=CC(NC(=O)N2CCCC3=CC(CN4CCN(C)CC4=O)=C(C=O)N=C23)=NC=C1C#N,BHKDKKZMPODMIQ-UHFFFAOYSA-N,506.567,P22455,BE0001203,Fibroblast growth factor receptor 4,Humans,antagonist,yes
DB16849,Mivavotinib,small molecule,investigational,CN1C=C(C=N1)C1=C2C(=O)NCC2=C(F)C(N[C@@H]2CCCC[C@@H]2N)=N1,MJHOMTRKVMKCNE-NWDGAFQWSA-N,344.394,P36888,BE0000147,Receptor-type tyrosine-protein kinase FLT3,Humans,inhibitor,yes
DB16849,Mivavotinib,small molecule,investigational,CN1C=C(C=N1)C1=C2C(=O)NCC2=C(F)C(N[C@@H]2CCCC[C@@H]2N)=N1,MJHOMTRKVMKCNE-NWDGAFQWSA-N,344.394,P43405,BE0001316,Tyrosine-protein kinase SYK,Humans,inhibitor,yes
DB16854,Caryophyllene,small molecule,investigational,[H][C@]12CC(C)(C)[C@]1([H])CC\C(C)=C/CCC2=C,NPNUFJAVOOONJE-FLFDDASRSA-N,204.357,P34972,BE0000095,Cannabinoid receptor 2,Humans,agonist,yes
DB16857,Undecanoic acid,small molecule,investigational,CCCCCCCCCCC(O)=O,ZDPHROOEEOARMN-UHFFFAOYSA-N,186.295,Q9NQS5,BE0020007,G-protein coupled receptor 84,Humans,agonist,yes
DB16863,Butylated hydroxytoluene,small molecule,investigational,CC1=CC(=C(O)C(=C1)C(C)(C)C)C(C)(C)C,NLZUEZXRPGMBCV-UHFFFAOYSA-N,220.356,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB16865,Rosmarinic acid,small molecule,investigational,OC(=O)[C@@H](CC1=CC=C(O)C(O)=C1)OC(=O)\C=C\C1=CC=C(O)C(O)=C1,DOUMFZQKYFQNTF-WUTVXBCWSA-N,360.318,P14679,BE0000252,Tyrosinase,Humans,inhibitor,yes
DB16865,Rosmarinic acid,small molecule,investigational,OC(=O)[C@@H](CC1=CC=C(O)C(O)=C1)OC(=O)\C=C\C1=CC=C(O)C(O)=C1,DOUMFZQKYFQNTF-WUTVXBCWSA-N,360.318,Q07820,BE0003511,Induced myeloid leukemia cell differentiation protein Mcl-1,Humans,inhibitor,yes
DB16869,Setanaxib,small molecule,investigational,CN(C)C1=CC(=CC=C1)C1=C2C(NN(C2=O)C2=CC=CC=C2Cl)=CC(=O)N1C,RGYQPQARIQKJKH-UHFFFAOYSA-N,394.86,Q9NPH5,BE0019855,NADPH oxidase 4,Humans,modulator,yes
DB16874,CB-5083,small molecule,investigational,CC1=CC2=C(C=CC=C2N1C1=NC(NCC2=CC=CC=C2)=C2COCCC2=N1)C(N)=O,RDALZZCKQFLGJP-UHFFFAOYSA-N,413.481,P55072,BE0004572,Transitional endoplasmic reticulum ATPase,Humans,inhibitor,yes
DB16875,GSK-2982772,small molecule,investigational,CN1C2=CC=CC=C2OC[C@H](NC(=O)C2=NNC(CC3=CC=CC=C3)=N2)C1=O,LYPAFUINURXJSG-AWEZNQCLSA-N,377.404,Q13546,BE0009531,Receptor-interacting serine/threonine-protein kinase 1,Humans,inhibitor,yes
DB16877,Ampiroxicam,small molecule,investigational,CCOC(=O)OC(C)OC1=C(N(C)S(=O)(=O)C2=CC=CC=C12)C(=O)NC1=NC=CC=C1,LSNWBKACGXCGAJ-UHFFFAOYSA-N,447.46,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,modulator,yes
DB16877,Ampiroxicam,small molecule,investigational,CCOC(=O)OC(C)OC1=C(N(C)S(=O)(=O)C2=CC=CC=C12)C(=O)NC1=NC=CC=C1,LSNWBKACGXCGAJ-UHFFFAOYSA-N,447.46,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,modulator,yes
DB16879,AMG-319,small molecule,investigational,C[C@H](NC1=C2N=CNC2=NC=N1)C1=CC2=C(C=C(F)C=C2)N=C1C1=NC=CC=C1,KWRYMZHCQIOOEB-LBPRGKRZSA-N,385.406,O00329,BE0002406,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",Humans,inhibitor,yes
DB16884,Isonicotinic acid,small molecule,investigational,OC(=O)C1=CC=NC=C1,TWBYWOBDOCUKOW-UHFFFAOYSA-N,123.111,Q8TDS4,BE0000635,Hydroxycarboxylic acid receptor 2,Humans,inhibitor,yes
DB16890,Betulin,small molecule,investigational,[H][C@]12[C@@H](CC[C@]1(CO)CC[C@]1(C)[C@]2([H])CC[C@]2([H])[C@@]3(C)CC[C@H](O)C(C)(C)[C@]3([H])CC[C@@]12C)C(C)=C,FVWJYYTZTCVBKE-ROUWMTJPSA-N,442.728,P11217,BE0000916,"Glycogen phosphorylase, muscle form",Humans,inhibitor,yes
DB16891,ENMD-981693,small molecule,investigational,CN1CCN(CC1)C1=CC(NC2=NNC(C)=C2)=NC(\C=C\C2=CC=CC=C2)=N1,BLQYVHBZHAISJM-CMDGGOBGSA-N,375.48,O14965,BE0000991,Aurora kinase A,Humans,inhibitor,yes
DB16893,S-38093,small molecule,investigational,NC(=O)C1=CC=C(OCCCN2CC3CCCC3C2)C=C1,MRNMYWNBLVJWKG-UHFFFAOYSA-N,288.391,Q9Y5N1,BE0000968,Histamine H3 receptor,Humans,antagonist,yes
DB16895,GSK-2879552,small molecule,investigational,OC(=O)C1=CC=C(CN2CCC(CN[C@@H]3C[C@H]3C3=CC=CC=C3)CC2)C=C1,LRULVYSBRWUVGR-FCHUYYIVSA-N,364.489,O60341,BE0010091,Lysine-specific histone demethylase 1A,Humans,inhibitor,yes
DB16909,TIK-301,small molecule,investigational,COC1=CC2=C(NC=C2[C@@H](C)CNC(C)=O)C=C1Cl,RKHCTAKUYDTFHE-QMMMGPOBSA-N,280.75,P48039,BE0000515,Melatonin receptor type 1A,Humans,agonist,yes
DB16911,AF-710B,small molecule,investigational,CC1SC2(CN1C(=O)CCC1=CNC3=C1C=CC=C3)CCN(C)CC2,XWMHYQATSBWUNT-UHFFFAOYSA-N,357.52,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,agonist,yes
DB16911,AF-710B,small molecule,investigational,CC1SC2(CN1C(=O)CCC1=CNC3=C1C=CC=C3)CCN(C)CC2,XWMHYQATSBWUNT-UHFFFAOYSA-N,357.52,Q99720,BE0000156,Sigma non-opioid intracellular receptor 1,Humans,agonist,yes
DB16927,S-Apomorphine,small molecule,investigational,[H][C@]12CC3=C(C(O)=C(O)C=C3)C3=C1C(CCN2C)=CC=C3,VMWNQDUVQKEIOC-ZDUSSCGKSA-N,267.328,P21728,BE0000020,D(1A) dopamine receptor,Humans,inhibitor,yes
DB16927,S-Apomorphine,small molecule,investigational,[H][C@]12CC3=C(C(O)=C(O)C=C3)C3=C1C(CCN2C)=CC=C3,VMWNQDUVQKEIOC-ZDUSSCGKSA-N,267.328,P14416,BE0000756,D(2) dopamine receptor,Humans,inhibitor,yes
DB16936,F-15599,small molecule,investigational,CC1=CN=C(CNCC2(F)CCN(CC2)C(=O)C2=CC=C(F)C(Cl)=C2)N=C1,WAAXKNFGOFTGLP-UHFFFAOYSA-N,394.85,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,modulator,yes
DB16938,D-157495,small molecule,investigational,NC1=NC2=C(C(N)=N1)C(OCC1CCN(CC3=C(Cl)C=CC=C3Cl)CC1)=CC=C2,MNLHFGXIUJNDAF-UHFFFAOYSA-N,432.35,Q96C86,BE0001215,m7GpppX diphosphatase,Humans,inhibitor,yes
DB16943,STX-107,small molecule,investigational,CC1=NC(=CS1)C#CC1=CC=C(N=C1)C1=CC(=CC(F)=C1)C#N,SYOSUEIMOYEGKU-UHFFFAOYSA-N,319.36,P41594,BE0001192,Metabotropic glutamate receptor 5,Humans,antagonist,yes
DB16955,RG-2833,small molecule,investigational,CC1=CC=C(C=C1)C(=O)NCCCCCC(=O)NC1=CC=CC=C1N,VOPDXHFYDJAYNS-UHFFFAOYSA-N,339.439,Q13547,BE0002365,Histone deacetylase 1,Humans,modulator,yes
DB16961,Leupeptin,small molecule,investigational,CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C=O,GDBQQVLCIARPGH-ULQDDVLXSA-N,426.562,P46925,BE0001694,Plasmepsin-2,Plasmodium falciparum,inhibitor,yes
DB16967,Enadoline,small molecule,investigational,CN([C@H]1CC[C@@]2(CCCO2)C[C@@H]1N1CCCC1)C(=O)CC1=CC=CC2=C1C=CO2,JMBYBVLCYODBJQ-HFMPRLQTSA-N,396.531,P41145,BE0000632,Kappa-type opioid receptor,Humans,agonist,yes
DB16968,SRX-246,small molecule,investigational,C[C@@H](NC(=O)[C@@H](CC(=O)N1CCC(CC1)N1CCCCC1)N1[C@H](\C=C\C2=CC=CC=C2)[C@H](N2[C@H](COC2=O)C2=CC=CC=C2)C1=O)C1=CC=CC=C1,FJUKOXWSIGULLE-JVOQCOEYSA-N,703.884,P37288,BE0000165,Vasopressin V1a receptor,Humans,antagonist,yes
DB16987,Soticlestat,small molecule,investigational,OC1(CC2=CC=CC=C2)CCN(CC1)C(=O)C1=CC=CN=C1C1=CC=NC=C1,XKUZMIUSBMCVPP-UHFFFAOYSA-N,373.456,Q9Y6A2,BE0010886,Cholesterol 24-hydroxylase,Humans,inhibitor,yes
DB16995,NP-51,small molecule,investigational,OC(CONC(=N)C1=CC=CN=C1)CN1CCCCC1,MVLOQULXIYSERZ-UHFFFAOYSA-N,278.356,P45983,BE0003790,Mitogen-activated protein kinase 8,Humans,inhibitor,yes
DB16995,NP-51,small molecule,investigational,OC(CONC(=N)C1=CC=CN=C1)CN1CCCCC1,MVLOQULXIYSERZ-UHFFFAOYSA-N,278.356,P45984,BE0003772,Mitogen-activated protein kinase 9,Humans,inhibitor,yes
DB16995,NP-51,small molecule,investigational,OC(CONC(=N)C1=CC=CN=C1)CN1CCCCC1,MVLOQULXIYSERZ-UHFFFAOYSA-N,278.356,P53779,BE0001097,Mitogen-activated protein kinase 10,Humans,inhibitor,yes
DB17018,AZD-5153,small molecule,investigational,COC1=NN=C2C=CC(=NN12)N1CCC(CC1)C1=CC=C(OCCN2CCN(C)C(=O)[C@H]2C)C=C1,RSMYFSPOTCDHHJ-GOSISDBHSA-N,479.585,O60885,BE0010747,Bromodomain-containing protein 4,Humans,inhibitor,yes
DB17021,JQ1,small molecule,investigational,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)OC(C)(C)C)N=C2C1=CC=C(Cl)C=C1,DNVXATUJJDPFDM-KRWDZBQOSA-N,456.99,O60885,BE0010747,Bromodomain-containing protein 4,Humans,inhibitor,yes
DB17021,JQ1,small molecule,investigational,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)OC(C)(C)C)N=C2C1=CC=C(Cl)C=C1,DNVXATUJJDPFDM-KRWDZBQOSA-N,456.99,Q58F21,BE0015062,Bromodomain testis-specific protein,Humans,inhibitor,yes
DB17022,Arachidonyltrifluoromethane,small molecule,investigational,CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)C(F)(F)F,PLWROONZUDKYKG-DOFZRALJSA-N,356.473,P47712,BE0000657,Cytosolic phospholipase A2,Humans,inhibitor,yes
DB17023,ABT-737,small molecule,investigational,CN(C)CC[C@H](CSC1=CC=CC=C1)NC1=CC=C(C=C1[N+]([O-])=O)S(=O)(=O)NC(=O)C1=CC=C(C=C1)N1CCN(CC2=CC=CC=C2C2=CC=C(Cl)C=C2)CC1,HPLNQCPCUACXLM-PGUFJCEWSA-N,813.43,P10415,BE0000246,Apoptosis regulator Bcl-2,Humans,inhibitor,yes
DB17024,Chelerythrine,small molecule,investigational,COC1=CC=C2C(C=[N+](C)C3=C2C=CC2=CC4=C(OCO4)C=C32)=C1OC,LLEJIEBFSOEYIV-UHFFFAOYSA-N,348.377,Q99572,BE0009814,P2X purinoceptor 7,Humans,allosteric modulator,yes
DB17026,Ellipticine,small molecule,investigational,CC1=C2C=CN=CC2=C(C)C2=C1NC1=C2C=CC=C1,CTSPAMFJBXKSOY-UHFFFAOYSA-N,246.313,P11388,BE0000742,DNA topoisomerase 2-alpha,Humans,inhibitor,yes
DB17026,Ellipticine,small molecule,investigational,CC1=C2C=CN=CC2=C(C)C2=C1NC1=C2C=CC=C1,CTSPAMFJBXKSOY-UHFFFAOYSA-N,246.313,Q02880,BE0002425,DNA topoisomerase 2-beta,Humans,inhibitor,yes
DB17029,Go-6976,small molecule,investigational,CN1C2=C(C=CC=C2)C2=C1C1=C(C3=C2C(=O)NC3)C2=CC=CC=C2N1CCC#N,VWVYILCFSYNJHF-UHFFFAOYSA-N,378.435,Q01201,BE0013795,Transcription factor RelB,Humans,inhibitor,yes
DB17029,Go-6976,small molecule,investigational,CN1C2=C(C=CC=C2)C2=C1C1=C(C3=C2C(=O)NC3)C2=CC=CC=C2N1CCC#N,VWVYILCFSYNJHF-UHFFFAOYSA-N,378.435,P19838,BE0001086,Nuclear factor NF-kappa-B p105 subunit,Humans,inhibitor,yes
DB17029,Go-6976,small molecule,investigational,CN1C2=C(C=CC=C2)C2=C1C1=C(C3=C2C(=O)NC3)C2=CC=CC=C2N1CCC#N,VWVYILCFSYNJHF-UHFFFAOYSA-N,378.435,Q00653,BE0002387,Nuclear factor NF-kappa-B p100 subunit,Humans,inhibitor,yes
DB17029,Go-6976,small molecule,investigational,CN1C2=C(C=CC=C2)C2=C1C1=C(C3=C2C(=O)NC3)C2=CC=CC=C2N1CCC#N,VWVYILCFSYNJHF-UHFFFAOYSA-N,378.435,Q04206,BE0005551,Transcription factor p65,Humans,inhibitor,yes
DB17029,Go-6976,small molecule,investigational,CN1C2=C(C=CC=C2)C2=C1C1=C(C3=C2C(=O)NC3)C2=CC=CC=C2N1CCC#N,VWVYILCFSYNJHF-UHFFFAOYSA-N,378.435,Q04864,BE0010782,Proto-oncogene c-Rel,Humans,inhibitor,yes
DB17029,Go-6976,small molecule,investigational,CN1C2=C(C=CC=C2)C2=C1C1=C(C3=C2C(=O)NC3)C2=CC=CC=C2N1CCC#N,VWVYILCFSYNJHF-UHFFFAOYSA-N,378.435,Q05513,BE0009589,Protein kinase C zeta type,Humans,inhibitor,yes
DB17032,Indatraline,small molecule,investigational,CN[C@@H]1C[C@H](C2=CC=CC=C12)C1=CC=C(Cl)C(Cl)=C1,SVFXPTLYMIXFRX-XJKSGUPXSA-N,292.2,Q01959,BE0000647,Sodium-dependent dopamine transporter,Humans,inhibitor,yes
DB17033,JTC-801 free base,small molecule,investigational,CCC1=CC=C(OCC2=CC=CC=C2C(=O)NC2=CC=C3N=C(C)C=C(N)C3=C2)C=C1,VTGBZWHPJFMTKS-UHFFFAOYSA-N,411.505,P41146,BE0002378,Nociceptin receptor,Humans,antagonist,yes
DB17034,Dacinostat,small molecule,investigational,OCCN(CCC1=CNC2=CC=CC=C12)CC1=CC=C(\C=C\C(=O)NO)C=C1,BWDQBBCUWLSASG-MDZDMXLPSA-N,379.46,Q13547,BE0002365,Histone deacetylase 1,Humans,inhibitor,yes
DB17036,N-oleoyldopamine,small molecule,investigational,CCCCCCCC\C=C/CCCCCCCC(=O)NCCC1=CC=C(O)C(O)=C1,QQBPLXNESPTPNU-KTKRTIGZSA-N,417.634,P15917,BE0001363,Lethal factor,Bacillus anthracis,inhibitor,yes
DB17039,Nutlin-3,small molecule,investigational,COC1=CC(OC(C)C)=C(C=C1)C1=N[C@H]([C@H](N1C(=O)N1CCNC(=O)C1)C1=CC=C(Cl)C=C1)C1=CC=C(Cl)C=C1,BDUHCSBCVGXTJM-WUFINQPMSA-N,581.49,P04637,BE0003380,Cellular tumor antigen p53,Humans,inhibitor,yes
DB17040,PD-169316,small molecule,investigational,[O-][N+](=O)C1=CC=C(C=C1)C1=NC(=C(N1)C1=CC=NC=C1)C1=CC=C(F)C=C1,BGIYKDUASORTBB-UHFFFAOYSA-N,360.348,P09917,BE0000248,Polyunsaturated fatty acid 5-lipoxygenase,Humans,inhibitor,yes
DB17041,PD-173952,small molecule,investigational,CN1C(=O)C(=CC2=CNC(=NC3=CC=C(C=C3)N3CCOCC3)N=C12)C1=C(Cl)C=CC=C1Cl,XZEJMVDCQZRHLN-UHFFFAOYSA-N,482.37,P16234,BE0000852,Platelet-derived growth factor receptor alpha,Humans,inhibitor,yes
DB17041,PD-173952,small molecule,investigational,CN1C(=O)C(=CC2=CNC(=NC3=CC=C(C=C3)N3CCOCC3)N=C12)C1=C(Cl)C=CC=C1Cl,XZEJMVDCQZRHLN-UHFFFAOYSA-N,482.37,P12931,BE0000838,Proto-oncogene tyrosine-protein kinase Src,Humans,inhibitor,yes
DB17041,PD-173952,small molecule,investigational,CN1C(=O)C(=CC2=CNC(=NC3=CC=C(C=C3)N3CCOCC3)N=C12)C1=C(Cl)C=CC=C1Cl,XZEJMVDCQZRHLN-UHFFFAOYSA-N,482.37,P06239,BE0000842,Tyrosine-protein kinase Lck,Humans,inhibitor,yes
DB17041,PD-173952,small molecule,investigational,CN1C(=O)C(=CC2=CNC(=NC3=CC=C(C=C3)N3CCOCC3)N=C12)C1=C(Cl)C=CC=C1Cl,XZEJMVDCQZRHLN-UHFFFAOYSA-N,482.37,P09619,BE0000205,Platelet-derived growth factor receptor beta,Humans,inhibitor,yes
DB17041,PD-173952,small molecule,investigational,CN1C(=O)C(=CC2=CNC(=NC3=CC=C(C=C3)N3CCOCC3)N=C12)C1=C(Cl)C=CC=C1Cl,XZEJMVDCQZRHLN-UHFFFAOYSA-N,482.37,P11362,BE0002131,Fibroblast growth factor receptor 1,Humans,inhibitor,yes
DB17042,PD-98059,small molecule,investigational,COC1=CC=CC(=C1N)C1=CC(=O)C2=CC=CC=C2O1,QFWCYNPOPKQOKV-UHFFFAOYSA-N,267.284,Q02750,BE0000870,Dual specificity mitogen-activated protein kinase kinase 1,Humans,inhibitor,yes
DB17042,PD-98059,small molecule,investigational,COC1=CC=CC(=C1N)C1=CC(=O)C2=CC=CC=C2O1,QFWCYNPOPKQOKV-UHFFFAOYSA-N,267.284,P36507,BE0004744,Dual specificity mitogen-activated protein kinase kinase 2,Humans,inhibitor,yes
DB17043,PHA-767491,small molecule,investigational,OC1=NCCC2=C1C=C(N2)C1=CC=NC=C1,DKXHSOUZPMHNIZ-UHFFFAOYSA-N,213.24,O00311,BE0010851,Cell division cycle 7-related protein kinase,Humans,modulator,yes
DB17045,Phorbol 12-myristate 13-acetate diester,small molecule,investigational,[H][C@]12[C@]3([H])C=C(CO)C[C@]4(O)C(=O)C(C)=C[C@@]4([H])[C@@]3(O)[C@H](C)[C@@H](OC(=O)CCCCCCCCCCCCC)[C@@]1(OC(C)=O)C2(C)C,PHEDXBVPIONUQT-RGYGYFBISA-N,616.836,Q9HBA0,BE0009159,Transient receptor potential cation channel subfamily V member 4,Humans,activator,yes
DB17045,Phorbol 12-myristate 13-acetate diester,small molecule,investigational,[H][C@]12[C@]3([H])C=C(CO)C[C@]4(O)C(=O)C(C)=C[C@@]4([H])[C@@]3(O)[C@H](C)[C@@H](OC(=O)CCCCCCCCCCCCC)[C@@]1(OC(C)=O)C2(C)C,PHEDXBVPIONUQT-RGYGYFBISA-N,616.836,Q5JUK3,BE0015369,Potassium channel subfamily T member 1,Humans,activator,yes
DB17045,Phorbol 12-myristate 13-acetate diester,small molecule,investigational,[H][C@]12[C@]3([H])C=C(CO)C[C@]4(O)C(=O)C(C)=C[C@@]4([H])[C@@]3(O)[C@H](C)[C@@H](OC(=O)CCCCCCCCCCCCC)[C@@]1(OC(C)=O)C2(C)C,PHEDXBVPIONUQT-RGYGYFBISA-N,616.836,Q6UVM3,BE0015626,Potassium channel subfamily T member 2,Humans,inhibitor,yes
DB17045,Phorbol 12-myristate 13-acetate diester,small molecule,investigational,[H][C@]12[C@]3([H])C=C(CO)C[C@]4(O)C(=O)C(C)=C[C@@]4([H])[C@@]3(O)[C@H](C)[C@@H](OC(=O)CCCCCCCCCCCCC)[C@@]1(OC(C)=O)C2(C)C,PHEDXBVPIONUQT-RGYGYFBISA-N,616.836,P48544,BE0002218,G protein-activated inward rectifier potassium channel 4,Humans,inhibitor,yes
DB17046,PI-103,small molecule,investigational,OC1=CC=CC(=C1)C1=NC(N2CCOCC2)=C2OC3=NC=CC=C3C2=N1,TUVCWJQQGGETHL-UHFFFAOYSA-N,348.362,P48736,BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",Humans,inhibitor,yes
DB17047,PIK-75,small molecule,investigational,CN(\N=C\C1=CN=C2C=CC(Br)=CN12)S(=O)(=O)C1=CC(=CC=C1C)[N+]([O-])=O,QTHCAAFKVUWAFI-DJKKODMXSA-N,452.28,P78527,BE0002385,DNA-dependent protein kinase catalytic subunit,Humans,inhibitor,yes
DB17047,PIK-75,small molecule,investigational,CN(\N=C\C1=CN=C2C=CC(Br)=CN12)S(=O)(=O)C1=CC(=CC=C1C)[N+]([O-])=O,QTHCAAFKVUWAFI-DJKKODMXSA-N,452.28,P48736,BE0001315,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",Humans,inhibitor,yes
DB17047,PIK-75,small molecule,investigational,CN(\N=C\C1=CN=C2C=CC(Br)=CN12)S(=O)(=O)C1=CC(=CC=C1C)[N+]([O-])=O,QTHCAAFKVUWAFI-DJKKODMXSA-N,452.28,P42338,BE0002407,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",Humans,inhibitor,yes
DB17048,Plumbagin,small molecule,investigational,CC1=CC(=O)C2=C(O)C=CC=C2C1=O,VCMMXZQDRFWYSE-UHFFFAOYSA-N,188.182,Q08210,BE0000612,"Dihydroorotate dehydrogenase (quinone), mitochondrial",Plasmodium falciparum (isolate 3D7),inhibitor,yes
DB17051,SB-218078,small molecule,investigational,O=C1NC(=O)C2=C1C1=C3N(C4CCC(O4)N4C5=C(C=CC=C5)C2=C34)C2=C1C=CC=C2,OTPNDVKVEAIXTI-UHFFFAOYSA-N,393.402,O14757,BE0003382,Serine/threonine-protein kinase Chk1,Humans,inhibitor,yes
DB17052,SB 224289,small molecule,investigational,CN1CCC2(COC3=CC4=C(C=C23)N(CC4)C(=O)C2=CC=C(C=C2)C2=C(C)C=C(C=C2)C2=NOC(C)=N2)CC1,ATQMRMGXINTJHV-UHFFFAOYSA-N,520.633,P28222,BE0000797,5-hydroxytryptamine receptor 1B,Humans,antagonist,yes
DB17053,Scriptaid,small molecule,investigational,ONC(=O)CCCCCN1C(=O)C2=CC=CC3=C2C(=CC=C3)C1=O,JTDYUFSDZATMKU-UHFFFAOYSA-N,326.352,Q13547,BE0002365,Histone deacetylase 1,Humans,inhibitor,yes
DB17055,SNX-2112,small molecule,investigational,CC1(C)CC2=C(C(=NN2C2=CC=C(C(N)=O)C(N[C@H]3CC[C@H](O)CC3)=C2)C(F)(F)F)C(=O)C1,ZFVRYNYOPQZKDG-MQMHXKEQSA-N,464.489,P07900,BE0001120,Heat shock protein HSP 90-alpha,Humans,inhibitor,yes
DB17056,Spiperone,small molecule,investigational,FC1=CC=C(C=C1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1,DKGZKTPJOSAWFA-UHFFFAOYSA-N,395.478,P35348,BE0000501,Alpha-1A adrenergic receptor,Humans,inhibitor,yes
DB17056,Spiperone,small molecule,investigational,FC1=CC=C(C=C1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1,DKGZKTPJOSAWFA-UHFFFAOYSA-N,395.478,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,inhibitor,yes
DB17056,Spiperone,small molecule,investigational,FC1=CC=C(C=C1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1,DKGZKTPJOSAWFA-UHFFFAOYSA-N,395.478,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,inhibitor,yes
DB17056,Spiperone,small molecule,investigational,FC1=CC=C(C=C1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1,DKGZKTPJOSAWFA-UHFFFAOYSA-N,395.478,P50406,BE0000945,5-hydroxytryptamine receptor 6,Humans,inhibitor,yes
DB17056,Spiperone,small molecule,investigational,FC1=CC=C(C=C1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1,DKGZKTPJOSAWFA-UHFFFAOYSA-N,395.478,P35462,BE0000581,D(3) dopamine receptor,Humans,antagonist,yes
DB17056,Spiperone,small molecule,investigational,FC1=CC=C(C=C1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1,DKGZKTPJOSAWFA-UHFFFAOYSA-N,395.478,P21917,BE0000389,D(4) dopamine receptor,Humans,antagonist,yes
DB17056,Spiperone,small molecule,investigational,FC1=CC=C(C=C1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1,DKGZKTPJOSAWFA-UHFFFAOYSA-N,395.478,P14416,BE0000756,D(2) dopamine receptor,Humans,antagonist,yes
DB17056,Spiperone,small molecule,investigational,FC1=CC=C(C=C1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1,DKGZKTPJOSAWFA-UHFFFAOYSA-N,395.478,P34969,BE0000650,5-hydroxytryptamine receptor 7,Humans,inhibitor,yes
DB17059,TW-37,small molecule,investigational,CC(C)C1=CC=CC=C1CC1=C(O)C(O)=C(O)C(=C1)C(=O)NC1=CC=C(C=C1)S(=O)(=O)C1=CC=CC=C1C(C)(C)C,PQAPVTKIEGUPRN-UHFFFAOYSA-N,573.7,P10415,BE0000246,Apoptosis regulator Bcl-2,Humans,inhibitor,yes
DB17059,TW-37,small molecule,investigational,CC(C)C1=CC=CC=C1CC1=C(O)C(O)=C(O)C(=C1)C(=O)NC1=CC=C(C=C1)S(=O)(=O)C1=CC=CC=C1C(C)(C)C,PQAPVTKIEGUPRN-UHFFFAOYSA-N,573.7,Q07820,BE0003511,Induced myeloid leukemia cell differentiation protein Mcl-1,Humans,inhibitor,yes
DB17060,U-0126,small molecule,investigational,N\C(SC1=CC=CC=C1N)=C(\C#N)/C(/C#N)=C(\N)SC1=C(N)C=CC=C1,DVEXZJFMOKTQEZ-JYFOCSDGSA-N,380.49,Q9Y2U5,BE0004745,Mitogen-activated protein kinase kinase kinase 2,Humans,inhibitor,yes
DB17060,U-0126,small molecule,investigational,N\C(SC1=CC=CC=C1N)=C(\C#N)/C(/C#N)=C(\N)SC1=C(N)C=CC=C1,DVEXZJFMOKTQEZ-JYFOCSDGSA-N,380.49,Q13233,BE0003430,Mitogen-activated protein kinase kinase kinase 1,Humans,inhibitor,yes
DB17061,VEGFR 2 Kinase inhibitor I,small molecule,investigational,CCOC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=CC=C3)=C1C,PMUJUSJUVIXDQC-LCYFTJDESA-N,310.353,P35968,BE0000369,Vascular endothelial growth factor receptor 2,Humans,inhibitor,yes
DB17063,ZK-93423,small molecule,investigational,CCOC(=O)C1=NC=C2NC3=C(C=C(OCC4=CC=CC=C4)C=C3)C2=C1COC,ALBKMJDFBZVHAK-UHFFFAOYSA-N,390.439,P14867,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,Humans,inhibitor,yes
DB17063,ZK-93423,small molecule,investigational,CCOC(=O)C1=NC=C2NC3=C(C=C(OCC4=CC=CC=C4)C=C3)C2=C1COC,ALBKMJDFBZVHAK-UHFFFAOYSA-N,390.439,P47870,BE0002346,Gamma-aminobutyric acid receptor subunit beta-2,Humans,inhibitor,yes
DB17063,ZK-93423,small molecule,investigational,CCOC(=O)C1=NC=C2NC3=C(C=C(OCC4=CC=CC=C4)C=C3)C2=C1COC,ALBKMJDFBZVHAK-UHFFFAOYSA-N,390.439,P18507,BE0003592,Gamma-aminobutyric acid receptor subunit gamma-2,Humans,inhibitor,yes
DB17064,ZM-39923,small molecule,investigational,CC(C)N(CCC(=O)C1=CC2=C(C=CC=C2)C=C1)CC1=CC=CC=C1,JSASWRWALCMOQP-UHFFFAOYSA-N,331.459,P23458,BE0004145,Tyrosine-protein kinase JAK1,Humans,inhibitor,yes
DB17064,ZM-39923,small molecule,investigational,CC(C)N(CCC(=O)C1=CC2=C(C=CC=C2)C=C1)CC1=CC=CC=C1,JSASWRWALCMOQP-UHFFFAOYSA-N,331.459,P52333,BE0003493,Tyrosine-protein kinase JAK3,Humans,inhibitor,yes
DB17074,Amiselimod,small molecule,experimental,CCCCCCCOC1=CC=C(CCC(N)(CO)CO)C=C1C(F)(F)F,JVCPIJKPAKAIIP-UHFFFAOYSA-N,377.448,O95136,BE0012208,Sphingosine 1-phosphate receptor 2,Humans,modulator,yes
DB17083,Linzagolix,small molecule,approved,COC1=C(COC2=C(OC)C=C(F)C(=C2)N2C(=O)NC3=CSC(C(O)=O)=C3C2=O)C(F)=C(F)C=C1,BMAAMIIYNNPHAB-UHFFFAOYSA-N,508.42,P30968,BE0000203,Gonadotropin-releasing hormone receptor,Humans,antagonist,yes
DB17096,UCB7362,small molecule,investigational,C[C@H]1C[C@H](CCO1)N1C(=O)C[C@](C)(NC1=N)C1=C(Cl)C(NC(=O)C2=CC=CC(=C2)C#N)=CC=C1,AWSRDDSRQUJMAJ-LCAJTWGOSA-N,479.97,Q8IAS0,BE0010203,Plasmepsin X,Plasmodium falciparum (isolate 3D7),inhibitor;binder,yes
DB17096,UCB7362,small molecule,investigational,C[C@H]1C[C@H](CCO1)N1C(=O)C[C@](C)(NC1=N)C1=C(Cl)C(NC(=O)C2=CC=CC(=C2)C#N)=CC=C1,AWSRDDSRQUJMAJ-LCAJTWGOSA-N,479.97,W7JWW5,BE0010204,Plasmepsin X,Plasmodium falciparum (isolate NF54),inhibitor;binder,yes
DB17097,Vorasidenib,small molecule,approved;investigational,C[C@@H](NC1=NC(=NC(N[C@H](C)C(F)(F)F)=N1)C1=CC=CC(Cl)=N1)C(F)(F)F,QCZAWDGAVJMPTA-RNFRBKRXSA-N,414.74,P50213,BE0000011,"Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial",Humans,inhibitor,yes
DB17097,Vorasidenib,small molecule,approved;investigational,C[C@@H](NC1=NC(=NC(N[C@H](C)C(F)(F)F)=N1)C1=CC=CC(Cl)=N1)C(F)(F)F,QCZAWDGAVJMPTA-RNFRBKRXSA-N,414.74,O43837,BE0000559,"Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial",Humans,inhibitor,yes
DB17097,Vorasidenib,small molecule,approved;investigational,C[C@@H](NC1=NC(=NC(N[C@H](C)C(F)(F)F)=N1)C1=CC=CC(Cl)=N1)C(F)(F)F,QCZAWDGAVJMPTA-RNFRBKRXSA-N,414.74,P51553,BE0000771,"Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial",Humans,inhibitor,yes
DB17097,Vorasidenib,small molecule,approved;investigational,C[C@@H](NC1=NC(=NC(N[C@H](C)C(F)(F)F)=N1)C1=CC=CC(Cl)=N1)C(F)(F)F,QCZAWDGAVJMPTA-RNFRBKRXSA-N,414.74,O75874,BE0001251,Isocitrate dehydrogenase [NADP] cytoplasmic,Humans,inhibitor,yes
DB17097,Vorasidenib,small molecule,approved;investigational,C[C@@H](NC1=NC(=NC(N[C@H](C)C(F)(F)F)=N1)C1=CC=CC(Cl)=N1)C(F)(F)F,QCZAWDGAVJMPTA-RNFRBKRXSA-N,414.74,P48735,BE0004527,"Isocitrate dehydrogenase [NADP], mitochondrial",Humans,inhibitor,yes
DB17101,SC 41930,small molecule,investigational,CCCC1=C(OC)C(=CC=C1OCCCOC1=CC=C2CCC(OC2=C1CCC)C(O)=O)C(C)=O,ZVVCSBSDFGYRCB-UHFFFAOYSA-N,484.589,Q15722,BE0003490,Leukotriene B4 receptor 1,Humans,binder,yes
DB17101,SC 41930,small molecule,investigational,CCCC1=C(OC)C(=CC=C1OCCCOC1=CC=C2CCC(OC2=C1CCC)C(O)=O)C(C)=O,ZVVCSBSDFGYRCB-UHFFFAOYSA-N,484.589,Q9NPC1,BE0003489,Leukotriene B4 receptor 2,Humans,inhibitor,yes
DB17117,Seclidemstat,small molecule,investigational,CN1CCN(CC1)S(=O)(=O)C1=CC=CC(=C1)C(=O)N\N=C(/C)C1=C(O)C=CC(Cl)=C1,MVSQDUZRRVBYLA-HYARGMPZSA-N,450.94,O60341,BE0010091,Lysine-specific histone demethylase 1A,Humans,inhibitor,yes
DB17129,Pelabresib anhydrous,small molecule,investigational,CC1=NOC2=C1C1=C(C=CC=C1)C(=N[C@H]2CC(N)=O)C1=CC=C(Cl)C=C1,GCWIQUVXWZWCLE-INIZCTEOSA-N,365.82,O60885,BE0010747,Bromodomain-containing protein 4,Humans,modulator,yes
DB17131,JAB-3068,small molecule,investigational,CC(=O)N1CC(F)(F)C2=C(SC3=NC=C(N=C3N)N3CCC4(COC[C@H]4N)CC3)C=CC=C12,HGYTYZKWKUXRKA-MRXNPFEDSA-N,476.55,Q06124,BE0001071,Tyrosine-protein phosphatase non-receptor type 11,Humans,inhibitor,yes
DB17140,JNJ-28312141,small molecule,investigational,CN(C)CC(=O)N1CCC(CC1)C1=CC=C(NC(=O)C2=NC(=CN2)C#N)C(=C1)C1=CCCCC1,GUBJNPWVIUFSTR-UHFFFAOYSA-N,460.582,Q16288,BE0009501,NT-3 growth factor receptor,Humans,inhibitor,yes
DB17140,JNJ-28312141,small molecule,investigational,CN(C)CC(=O)N1CCC(CC1)C1=CC=C(NC(=O)C2=NC(=CN2)C#N)C(=C1)C1=CCCCC1,GUBJNPWVIUFSTR-UHFFFAOYSA-N,460.582,P10721,BE0000453,Mast/stem cell growth factor receptor Kit,Humans,inhibitor,yes
DB17140,JNJ-28312141,small molecule,investigational,CN(C)CC(=O)N1CCC(CC1)C1=CC=C(NC(=O)C2=NC(=CN2)C#N)C(=C1)C1=CCCCC1,GUBJNPWVIUFSTR-UHFFFAOYSA-N,460.582,P06239,BE0000842,Tyrosine-protein kinase Lck,Humans,inhibitor,yes
DB17140,JNJ-28312141,small molecule,investigational,CN(C)CC(=O)N1CCC(CC1)C1=CC=C(NC(=O)C2=NC(=CN2)C#N)C(=C1)C1=CCCCC1,GUBJNPWVIUFSTR-UHFFFAOYSA-N,460.582,P36888,BE0000147,Receptor-type tyrosine-protein kinase FLT3,Humans,inhibitor,yes
DB17143,APTO-253,small molecule,investigational,CC1=C(C2=NC3=C(N2)C2=CC=CN=C2C2=C3C=CC=N2)C2=C(N1)C=CC(F)=C2,NIRXBXIPHUTNNI-UHFFFAOYSA-N,367.387,O43474,BE0011713,Krueppel-like factor 4,Humans,inhibitor,yes
DB17149,Berubicin,small molecule,investigational,[H][C@@]1(C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(C=CC=C1OC)C3=O)C(=O)CO)O[C@H]1C[C@H](N)[C@H](OCC2=CC=CC=C2)[C@H](C)O1,FIGNGSHKNAHTSH-JJMFXPFOSA-N,633.65,P11388,BE0000742,DNA topoisomerase 2-alpha,Humans,modulator,yes
DB17149,Berubicin,small molecule,investigational,[H][C@@]1(C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(C=CC=C1OC)C3=O)C(=O)CO)O[C@H]1C[C@H](N)[C@H](OCC2=CC=CC=C2)[C@H](C)O1,FIGNGSHKNAHTSH-JJMFXPFOSA-N,633.65,Q02880,BE0002425,DNA topoisomerase 2-beta,Humans,modulator,yes
DB17152,DRF-1042,small molecule,investigational,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(C(OCCO)C3=CC4=CC=CC=C4N=C13)C2=O,XAKLYHGHEFMDAP-IAXKEJLGSA-N,408.41,P11387,BE0000971,DNA topoisomerase 1,Humans,inhibitor,yes
DB17159,Denfivontinib,small molecule,investigational,CN1CCC(CC1)NC1=NC(NC2=CC=C(OC3=CC=CC=C3)C=C2)=C2C(=O)NC=C(Br)C2=N1,SXWMIXPJPNCXQQ-UHFFFAOYSA-N,521.419,Q12866,BE0004271,Tyrosine-protein kinase Mer,Humans,inhibitor,yes
DB17159,Denfivontinib,small molecule,investigational,CN1CCC(CC1)NC1=NC(NC2=CC=C(OC3=CC=CC=C3)C=C2)=C2C(=O)NC=C(Br)C2=N1,SXWMIXPJPNCXQQ-UHFFFAOYSA-N,521.419,P36888,BE0000147,Receptor-type tyrosine-protein kinase FLT3,Humans,inhibitor,yes
DB17166,Tapotoclax,small molecule,investigational,CO[C@H]1\C=C\C[C@H](C)[C@@H](C)S(=O)(=O)NC(=O)C2=CC3=C(OC[C@]4(CCCC5=C4C=CC(Cl)=C5)CN3C[C@@H]3CC[C@@H]13)C=C2,JQNINBDKGLWYMU-GEAQBIRJSA-N,613.21,Q07820,BE0003511,Induced myeloid leukemia cell differentiation protein Mcl-1,Humans,inhibitor,yes
DB17180,KX-2361,small molecule,investigational,FC1=CC=CC(CNC(=O)CC2=NC=C(C=C2)C2=CC=C(C=C2)N2CCOCC2)=C1,CMKKPJNMYLOUCE-UHFFFAOYSA-N,405.473,P12931,BE0000838,Proto-oncogene tyrosine-protein kinase Src,Humans,inhibitor,yes
DB17191,Altiratinib,small molecule,investigational,FC1=CC=C(NC(=O)C2(CC2)C(=O)NC2=C(F)C=C(OC3=CC=NC(NC(=O)C4CC4)=C3)C(F)=C2)C=C1,GNNDEPIMDAZHRQ-UHFFFAOYSA-N,510.473,P04629,BE0001039,High affinity nerve growth factor receptor,Humans,inhibitor,yes
DB17191,Altiratinib,small molecule,investigational,FC1=CC=C(NC(=O)C2(CC2)C(=O)NC2=C(F)C=C(OC3=CC=NC(NC(=O)C4CC4)=C3)C(F)=C2)C=C1,GNNDEPIMDAZHRQ-UHFFFAOYSA-N,510.473,Q16288,BE0009501,NT-3 growth factor receptor,Humans,inhibitor,yes
DB17191,Altiratinib,small molecule,investigational,FC1=CC=C(NC(=O)C2(CC2)C(=O)NC2=C(F)C=C(OC3=CC=NC(NC(=O)C4CC4)=C3)C(F)=C2)C=C1,GNNDEPIMDAZHRQ-UHFFFAOYSA-N,510.473,P35968,BE0000369,Vascular endothelial growth factor receptor 2,Humans,antagonist,yes
DB17191,Altiratinib,small molecule,investigational,FC1=CC=C(NC(=O)C2(CC2)C(=O)NC2=C(F)C=C(OC3=CC=NC(NC(=O)C4CC4)=C3)C(F)=C2)C=C1,GNNDEPIMDAZHRQ-UHFFFAOYSA-N,510.473,Q02763,BE0003379,Angiopoietin-1 receptor,Humans,inhibitor,yes
DB17191,Altiratinib,small molecule,investigational,FC1=CC=C(NC(=O)C2(CC2)C(=O)NC2=C(F)C=C(OC3=CC=NC(NC(=O)C4CC4)=C3)C(F)=C2)C=C1,GNNDEPIMDAZHRQ-UHFFFAOYSA-N,510.473,P08581,BE0000915,Hepatocyte growth factor receptor,Humans,inhibitor,yes
DB17197,AMG-900,small molecule,investigational,CC1=CSC(=C1)C1=NN=C(NC2=CC=C(OC3=NC=CC=C3C3=NC(N)=NC=C3)C=C2)C2=C1C=CC=C2,IVUGFMLRJOCGAS-UHFFFAOYSA-N,503.58,Q9UQB9,BE0004601,Aurora kinase C,Humans,modulator,yes
DB17197,AMG-900,small molecule,investigational,CC1=CSC(=C1)C1=NN=C(NC2=CC=C(OC3=NC=CC=C3C3=NC(N)=NC=C3)C=C2)C2=C1C=CC=C2,IVUGFMLRJOCGAS-UHFFFAOYSA-N,503.58,Q96GD4,BE0003404,Aurora kinase B,Humans,modulator,yes
DB17197,AMG-900,small molecule,investigational,CC1=CSC(=C1)C1=NN=C(NC2=CC=C(OC3=NC=CC=C3C3=NC(N)=NC=C3)C=C2)C2=C1C=CC=C2,IVUGFMLRJOCGAS-UHFFFAOYSA-N,503.58,O14965,BE0000991,Aurora kinase A,Humans,modulator,yes
DB17277,CBP-501,small molecule,investigational,N[C@H](CC1=CC=C(C=C1)C(=O)C1=CC=CC=C1)C(=O)N[C@H](CO)C(=O)N[C@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@H](CO)C(=O)N[C@H](CC1=C(F)C(F)=C(F)C(F)=C1F)C(=O)N[C@H](CC1CCCCC1)C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H](CCCNC(N)=N)C(O)=O,DEZJGRPRBZSAKI-KMGSDFBDSA-N,1929.1,P27448,BE0009481,MAP/microtubule affinity-regulating kinase 3,Humans,inhibitor,yes
DB17277,CBP-501,small molecule,investigational,N[C@H](CC1=CC=C(C=C1)C(=O)C1=CC=CC=C1)C(=O)N[C@H](CO)C(=O)N[C@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@H](CO)C(=O)N[C@H](CC1=C(F)C(F)=C(F)C(F)=C1F)C(=O)N[C@H](CC1CCCCC1)C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@H](CCCNC(N)=N)C(O)=O,DEZJGRPRBZSAKI-KMGSDFBDSA-N,1929.1,P49137,BE0001373,MAP kinase-activated protein kinase 2,Humans,inhibitor,yes
DB17283,Chrysoeriol,small molecule,investigational,COC1=CC(=CC=C1O)C1=CC(=O)C2=C(O)C=C(O)C=C2O1,SCZVLDHREVKTSH-UHFFFAOYSA-N,300.266,P47989,BE0002204,Xanthine dehydrogenase/oxidase,Humans,inhibitor,yes
DB17283,Chrysoeriol,small molecule,investigational,COC1=CC(=CC=C1O)C1=CC(=O)C2=C(O)C=C(O)C=C2O1,SCZVLDHREVKTSH-UHFFFAOYSA-N,300.266,Q16678,BE0001111,Cytochrome P450 1B1,Humans,inhibitor,yes
DB17298,Disufenton,small molecule,investigational,CC(C)(C)[N+](\[O-])=C\C1=C(C=C(C=C1)S(O)(=O)=O)S(O)(=O)=O,OVTCHWSLKGENKP-GHXNOFRVSA-N,337.36,Q8IWU5,BE0016611,Extracellular sulfatase Sulf-2,Humans,inhibitor,yes
DB17299,p-Toluenesulfonamide,small molecule,investigational,CC1=CC=C(C=C1)S(N)(=O)=O,LMYRWZFENFIFIT-UHFFFAOYSA-N,171.21,P00918,BE0000322,Carbonic anhydrase 2,Humans,inhibitor,yes
DB17299,p-Toluenesulfonamide,small molecule,investigational,CC1=CC=C(C=C1)S(N)(=O)=O,LMYRWZFENFIFIT-UHFFFAOYSA-N,171.21,O43570,BE0001653,Carbonic anhydrase 12,Humans,inhibitor,yes
DB17299,p-Toluenesulfonamide,small molecule,investigational,CC1=CC=C(C=C1)S(N)(=O)=O,LMYRWZFENFIFIT-UHFFFAOYSA-N,171.21,P23280,BE0003628,Carbonic anhydrase 6,Humans,inhibitor,yes
DB17299,p-Toluenesulfonamide,small molecule,investigational,CC1=CC=C(C=C1)S(N)(=O)=O,LMYRWZFENFIFIT-UHFFFAOYSA-N,171.21,Q16790,BE0002437,Carbonic anhydrase 9,Humans,inhibitor,yes
DB17309,Minnelide,small molecule,investigational,[Na+].[Na+].[H][C@@]12C[C@@H]3O[C@@]33[C@H](OCOP([O-])([O-])=O)[C@]4(O[C@H]4[C@@H]4O[C@]34[C@@]1(C)CCC1=C2COC1=O)C(C)C,ZHBJMVNZRZUQEP-KIKMAQITSA-L,514.374,P0DMV9,BE0012549,Heat shock 70 kDa protein 1B,Humans,inhibitor,yes
DB17309,Minnelide,small molecule,investigational,[Na+].[Na+].[H][C@@]12C[C@@H]3O[C@@]33[C@H](OCOP([O-])([O-])=O)[C@]4(O[C@H]4[C@@H]4O[C@]34[C@@]1(C)CCC1=C2COC1=O)C(C)C,ZHBJMVNZRZUQEP-KIKMAQITSA-L,514.374,P0DMV8,BE0010433,Heat shock 70 kDa protein 1A,Humans,inhibitor,yes
DB17383,FN-1501,small molecule,investigational,CN1CCN(CC2=CC=C(NC(=O)C3=NNC=C3NC3=C4C=CNC4=NC=N3)C=C2)CC1,VXLAKHWYGRKCGI-UHFFFAOYSA-N,431.504,P24941,BE0001072,Cyclin-dependent kinase 2,Humans,inhibitor,yes
DB17383,FN-1501,small molecule,investigational,CN1CCN(CC2=CC=C(NC(=O)C3=NNC=C3NC3=C4C=CNC4=NC=N3)C=C2)CC1,VXLAKHWYGRKCGI-UHFFFAOYSA-N,431.504,P36888,BE0000147,Receptor-type tyrosine-protein kinase FLT3,Humans,inhibitor,yes
DB17383,FN-1501,small molecule,investigational,CN1CCN(CC2=CC=C(NC(=O)C3=NNC=C3NC3=C4C=CNC4=NC=N3)C=C2)CC1,VXLAKHWYGRKCGI-UHFFFAOYSA-N,431.504,P11802,BE0002216,Cyclin-dependent kinase 4,Humans,inhibitor,yes
DB17383,FN-1501,small molecule,investigational,CN1CCN(CC2=CC=C(NC(=O)C3=NNC=C3NC3=C4C=CNC4=NC=N3)C=C2)CC1,VXLAKHWYGRKCGI-UHFFFAOYSA-N,431.504,Q00534,BE0002212,Cyclin-dependent kinase 6,Humans,inhibitor,yes
DB17385,Lipotecan,small molecule,investigational,CC[C@@]1(OC(=O)C(C)ON=C2C3=C(C4=C2C=C(C=C4[N+]([O-])=O)[N+]([O-])=O)C(=CC(=C3)[N+]([O-])=O)[N+]([O-])=O)C(=O)OCC2=C1C=C1N(CC3=C1N=C1C=CC(O)=C(CN(C)C)C1=C3)C2=O,JCCCLGDYMMTBPM-HXDHBHDHSA-N,850.71,P11387,BE0000971,DNA topoisomerase 1,Humans,inhibitor,yes
DB17472,Pirtobrutinib,small molecule,approved;investigational,COC1=C(C=C(F)C=C1)C(=O)NCC1=CC=C(C=C1)C1=NN([C@@H](C)C(F)(F)F)C(N)=C1C(N)=O,FWZAWAUZXYCBKZ-NSHDSACASA-N,479.436,Q06187,BE0001284,Tyrosine-protein kinase BTK,Humans,inhibitor,yes
DB17490,NT-219,small molecule,investigational,OC1=CC(CNC(=S)\C=C\C2=C(Br)C(O)=C(O)C=C2)=CC(O)=C1O,XDDQKKXXQHUUHJ-DUXPYHPUSA-N,412.25,Q9Y4H2,BE0021286,Insulin receptor substrate 2,Humans,inhibitor,yes
DB17490,NT-219,small molecule,investigational,OC1=CC(CNC(=S)\C=C\C2=C(Br)C(O)=C(O)C=C2)=CC(O)=C1O,XDDQKKXXQHUUHJ-DUXPYHPUSA-N,412.25,P35568,BE0000977,Insulin receptor substrate 1,Humans,inhibitor,yes
DB17490,NT-219,small molecule,investigational,OC1=CC(CNC(=S)\C=C\C2=C(Br)C(O)=C(O)C=C2)=CC(O)=C1O,XDDQKKXXQHUUHJ-DUXPYHPUSA-N,412.25,P40763,BE0003462,Signal transducer and activator of transcription 3,Humans,inhibitor,yes
DB17506,Etrumadenant,small molecule,investigational,CC1=C(C=CC=C1C#N)C1=NC(N)=NC(=C1)C1=CN(CC2=NC(=CC=C2)C(C)(C)O)N=N1,BUXIAWLTBSXYSW-UHFFFAOYSA-N,426.484,P29274,BE0000924,Adenosine receptor A2a,Humans,antagonist,yes
DB17506,Etrumadenant,small molecule,investigational,CC1=C(C=CC=C1C#N)C1=NC(N)=NC(=C1)C1=CN(CC2=NC(=CC=C2)C(C)(C)O)N=N1,BUXIAWLTBSXYSW-UHFFFAOYSA-N,426.484,P29275,BE0000241,Adenosine receptor A2b,Humans,antagonist,yes
DB17507,COTI-2,small molecule,investigational,S=C(N\N=C1/CCCC2=C1N=CC=C2)N1CCN(CC1)C1=CC=CC=N1,UTDAKQMBNSHJJB-CJLVFECKSA-N,366.49,P04637,BE0003380,Cellular tumor antigen p53,Humans,modulator,yes
DB17520,Vimseltinib,small molecule,investigational,CC(C)NC1=NC=C(C(=O)N1C)C1=CC=C(OC2=CC=NC(=C2)C2=CN(C)N=C2)C(C)=N1,TVGAHWWPABTBCX-UHFFFAOYSA-N,431.5,P07333,BE0000853,Macrophage colony-stimulating factor 1 receptor,Humans,inhibitor,yes
DB17525,Zanzalintinib,small molecule,investigational,CNC(=O)C1=CC2=C(OC3=CC=C(NC(=O)C4(CC4)C(=O)NC4=CC=C(F)C=C4)C=C3)C=CN=C2C=C1OC,JSPCKALGNNVYOO-UHFFFAOYSA-N,528.54,P08581,BE0000915,Hepatocyte growth factor receptor,Humans,inhibitor,yes
DB17549,Alrizomadlin,small molecule,investigational,CCN1[C@H]([C@H](C2=CC=CC(Cl)=C2F)[C@]2(C(=O)NC3=CC(Cl)=CC=C23)C11CCCCC1)C(=O)NC12CCC(CC1)(CC2)C(O)=O,YJCZPJQGFSSFOL-MNZPCBJKSA-N,642.59,Q00987,BE0001003,E3 ubiquitin-protein ligase Mdm2,Humans,inhibitor,yes
DB17549,Alrizomadlin,small molecule,investigational,CCN1[C@H]([C@H](C2=CC=CC(Cl)=C2F)[C@]2(C(=O)NC3=CC(Cl)=CC=C23)C11CCCCC1)C(=O)NC12CCC(CC1)(CC2)C(O)=O,YJCZPJQGFSSFOL-MNZPCBJKSA-N,642.59,P04637,BE0003380,Cellular tumor antigen p53,Humans,inhibitor,yes
DB17568,Belvarafenib,small molecule,investigational,CC1=C(NC(=O)C2=CSC3=C(N)N=CN=C23)C2=CC=NC(NC3=CC=CC(Cl)=C3F)=C2C=C1,KVCQTKNUUQOELD-UHFFFAOYSA-N,478.93,P04049,BE0000036,RAF proto-oncogene serine/threonine-protein kinase,Humans,inhibitor,yes
DB17578,TTI-101,small molecule,investigational,COC1=CC=C(C=C1)S(=O)(=O)NC1=CC(=C(O)C2=CC=CC=C12)C1=C(O)C=CC2=CC=CC=C12,QDCJDYWGYVPBDO-UHFFFAOYSA-N,471.53,P40763,BE0003462,Signal transducer and activator of transcription 3,Humans,inhibitor,yes
DB17589,Loxoribine,small molecule,experimental;investigational,NC1=NC2=C(N(CC=C)C(=O)N2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(=O)N1,VDCRFBBZFHHYGT-IOSLPCCCSA-N,339.308,Q9NYK1,BE0000155,Toll-like receptor 7,Humans,agonist,yes
DB17602,Acecainide,small molecule,investigational,CCN(CC)CCNC(=O)C1=CC=C(NC(C)=O)C=C1,KEECCEWTUVWFCV-UHFFFAOYSA-N,277.368,Q14524,BE0000197,Sodium channel protein type 5 subunit alpha,Humans,blocker,yes
DB17670,VK-0214,small molecule,investigational,CC1=CC(OCP(O)(O)=O)=CC(C)=C1CC1=CC=C(O)C(CC2=CC=CC=C2)=C1,GFJCILQBXUTOGN-UHFFFAOYSA-N,412.422,P10828,BE0000315,Thyroid hormone receptor beta,Humans,agonist,yes
DB17742,Aphidicolin,small molecule,investigational,[H][C@]12C[C@@H]3C[C@]1(CC[C@]3(O)CO)[C@@]1(C)CC[C@@H](O)[C@@](C)(CO)[C@]1([H])CC2,NOFOAYPPHIUXJR-APNQCZIXSA-N,338.488,P04293,BE0000308,DNA polymerase catalytic subunit,HHV-1,inhibitor,yes
DB17749,AQ-13,small molecule,investigational,Cl.Cl.CCN(CC)CCCNC1=CC=NC2=CC(Cl)=CC=C12,ZNHBPWZRWNFJPN-UHFFFAOYSA-N,364.74,Q16570,BE0015068,Atypical chemokine receptor 1,Humans,modulator,yes
DB17757,VT-1598,small molecule,investigational,O[C@@](CN1C=NN=N1)(C1=CC=C(F)C=C1F)C(F)(F)C1=CC=C(C=N1)C#CC1=CC=C(OCC2=CC=C(C=C2)C#N)C=C1,UDGASIIGNCBLSI-PMERELPUSA-N,584.535,P10613,BE0000233,Lanosterol 14-alpha demethylase,Yeast,inhibitor,yes
DB17758,Quilseconazole,small molecule,investigational,O[C@@](CN1C=NN=N1)(C1=CC=C(F)C=C1F)C(F)(F)C1=CC=C(C=N1)C1=CC=C(OC(F)(F)F)C=C1,NCEHACHJIXJSPD-FQEVSTJZSA-N,513.376,Q16850,BE0000875,Lanosterol 14-alpha demethylase,Humans,inhibitor,yes
DB17759,Navuridine,small molecule,investigational,OC[C@H]1O[C@H](C[C@@H]1N=[N+]=[N-])N1C=CC(=O)NC1=O,ZSNNBSPEFVIUDS-SHYZEUOFSA-N,253.218,P03366,BE0002050,Gag-Pol polyprotein,,inhibitor,yes
DB17760,K-777,small molecule,investigational,CN1CCN(CC1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC1=CC=CC=C1)\C=C\S(=O)(=O)C1=CC=CC=C1,RHJLQMVZXQKJKB-FPHSVDBKSA-N,574.74,P25779,BE0001292,Cruzipain,Trypanosoma cruzi,inhibitor,yes
DB17832,Tinlarebant,small molecule,investigational,CC(=O)N1CCC2=C(C1)NN=C2C(=O)N1CCC(CC1)C1=CC=C(F)C(F)=C1C(F)(F)F,HAGSLCBZFRRBLS-UHFFFAOYSA-N,456.417,P02753,BE0000314,Retinol-binding protein 4,Humans,antagonist,yes
DB17837,DS-1211,small molecule,investigational,CC(C)C[C@@H](NC(C)=O)C(O)=O,WXNXCEHXYPACJF-SSDOTTSWSA-N,173.212,P05186,BE0003546,"Alkaline phosphatase, tissue-nonspecific isozyme",Humans,inhibitor,yes
DB17851,Flotufolastat F-18,small molecule,approved;investigational,CC(C)(C)[Si]([18F])(C1=CC=C(C=C1)C(=O)NC[C@@H](NC(=O)CC[C@H](N1CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC1)C(O)=O)C(=O)N[C@H](CCCCNC(=O)CCC(=O)NCCC[C@@H](NC(=O)CC[C@H](NC(=O)N[C@@H](CCC(O)=O)C(O)=O)C(O)=O)C(O)=O)C(O)=O)C(C)(C)C,QMGJNAVROCDAIW-MQNQVPOESA-N,1470.63,Q04609,BE0000568,Glutamate carboxypeptidase 2,Humans,binder,yes
DB17856,Soraprazan,small molecule,investigational,COCCO[C@H]1[C@H](O)[C@H](NC2=C1C=CN1C(C)=C(C)N=C21)C1=CC=CC=C1,PWILYDZRJORZDR-MISYRCLQSA-N,367.449,P20648,BE0000349,Potassium-transporting ATPase alpha chain 1,Humans,modulator,yes
DB17856,Soraprazan,small molecule,investigational,COCCO[C@H]1[C@H](O)[C@H](NC2=C1C=CN1C(C)=C(C)N=C21)C1=CC=CC=C1,PWILYDZRJORZDR-MISYRCLQSA-N,367.449,P51164,BE0000619,Potassium-transporting ATPase subunit beta,Humans,modulator,yes
DB17882,Epitalon,small molecule,investigational,C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O,HGHOBRRUMWJWCU-FXQIFTODSA-N,390.349,O14746,BE0002449,Telomerase reverse transcriptase,Humans,modulator,yes
DB17892,TAK-603,small molecule,investigational,CCOC(=O)C1=C(C2=CC=C(OC)C(OC)=C2)C2=CC(OC)=C(OC)C=C2N=C1CN1C=NC=N1,CLQRMSBSMHXMMC-UHFFFAOYSA-N,478.505,P01579,BE0000944,Interferon gamma,Humans,modulator,yes
DB17919,CPP-115 free base,small molecule,investigational,N[C@H]1C[C@H](CC1=C(F)F)C(O)=O,CBSRETZPFOBWNG-UCORVYFPSA-N,177.151,P80404,BE0000253,"4-aminobutyrate aminotransferase, mitochondrial",Humans,inhibitor,yes
DB17977,Murizatoclax,small molecule,investigational,CO[C@]1(CN2CCN3CCCC[C@@H]3C2)\C=C\C[C@H](C)[C@@H](C)S(=O)(=O)NC(=O)C2=CC=C3OC[C@]4(CCCC5=CC(Cl)=CC=C45)CN(C[C@@H]4CC[C@@H]14)C3=C2,BJTFTQIBRVBSBH-VCQPVEJUSA-N,765.45,Q07820,BE0003511,Induced myeloid leukemia cell differentiation protein Mcl-1,Humans,inhibitor,yes
DB17984,BQ-788,small molecule,investigational,[Na+].CCCC[C@@H](NC(=O)[C@@H](CC1=CN(C(=O)OC)C2=CC=CC=C12)NC(=O)[C@H](CC(C)(C)C)NC(=O)N1[C@@H](C)CCC[C@H]1C)C([O-])=O,QCVIFBRTTLMEOV-FUKQNADPSA-M,663.792,P24530,BE0000043,Endothelin receptor type B,Humans,antagonist,yes
DB17992,Lotilaner,small molecule,approved;vet_approved,CC1=C(SC(=C1)C1=NO[C@@](C1)(C1=CC(Cl)=C(Cl)C(Cl)=C1)C(F)(F)F)C(=O)NCC(=O)NCC(F)(F)F,HDKWFBCPLKNOCK-SFHVURJKSA-N,596.75,E0W492,BE0010256,"Gaba-gated chloride channel, putative",Pediculus humanus subsp. corporis,antagonist,yes
DB17999,Acoramidis,small molecule,investigational,CC1=C(CCCOC2=CC(=CC=C2F)C(O)=O)C(C)=NN1,WBFUHHBPNXWNCC-UHFFFAOYSA-N,292.31,P02766,BE0000337,Transthyretin,Humans,modulator,yes
DB18007,Dersimelagon,small molecule,investigational,COC[C@H]1CN(C[C@@H]1C1=CC=C(C=C1N1CCC(CC1)C(O)=O)C(F)(F)F)C(=O)[C@]1(F)CN(C[C@H]1C1=CC=C(OC)C=C1)C1CCCC1,MUNWOYRHJPWQNE-GMFUQMJFSA-N,675.766,Q01726,BE0002447,Melanocyte-stimulating hormone receptor,Humans,agonist,yes
DB18011,BMS-986278,small molecule,investigational,CCCN(C)C(=O)OCC1=C(N=NN1C)C1=CC=C(O[C@H]2CCC[C@@H](C2)C(O)=O)C(C)=N1,UEUNDURNLYLSNB-HOTGVXAUSA-N,445.52,Q92633,BE0017535,Lysophosphatidic acid receptor 1,Humans,antagonist,yes
DB18012,Vemircopan,small molecule,investigational,CC(=O)C1=NN(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)NC2=NC(Br)=CC=C2C)C2=CC=C(C=C12)C1=CN=C(C)N=C1,OCXAGXCMZACNEC-CTWZREHQSA-N,602.493,P00746,BE0001840,Complement factor D,Humans,inhibitor,yes
DB18019,Erbumine,small molecule,investigational,C[C@@H]1C[C@@](CC2=NC(NC3=NNC(C)=C3)=CC=C2F)(CCN1CC1=CC=CC(Cl)=C1F)C(O)=O,YQQZZYYQTCPEAS-OYLFLEFRSA-N,489.95,O14965,BE0000991,Aurora kinase A,Humans,inhibitor,yes
DB18038,Buloxibutid,small molecule,investigational,CCCCOC(=O)NS(=O)(=O)C1=C(C=C(CC(C)C)S1)C1=CC=C(CN2C=CN=C2)C=C1,XTEOJPUYZWEXFI-UHFFFAOYSA-N,475.62,P50052,BE0003426,Type-2 angiotensin II receptor,Humans,agonist,yes
DB18041,Bezuclastinib,small molecule,investigational,CC1=C(C)C(=NN1)C(=O)NC1=CN=C2NC(=CC2=C1)C1=CC=CC=C1,NVSHVYGIYPBTEZ-UHFFFAOYSA-N,331.379,P10721,BE0000453,Mast/stem cell growth factor receptor Kit,Humans,inhibitor,yes
DB18046,Docarpamine,small molecule,investigational,CCOC(=O)OC1=CC=C(CCNC(=O)[C@H](CCSC)NC(C)=O)C=C1OC(=O)OCC,ZLVMAMIPILWYHQ-INIZCTEOSA-N,470.54,P14416,BE0000756,D(2) dopamine receptor,Humans,modulator,yes
DB18054,Lisaftoclax,small molecule,investigational,[O-][N+](=O)C1=CC(=CC=C1NC[C@H]1COCCO1)S(=O)(=O)NC(=O)C1=CC=C(C=C1OC1=CN=C2NC=CC2=C1)N1CCN(CC2=C(CC3(CCC3)CC2)C2=CC=C(Cl)C=C2)CC1,FNBXDBIYRAPDPI-BHVANESWSA-N,882.43,P10415,BE0000246,Apoptosis regulator Bcl-2,Humans,inhibitor,yes
DB18080,Unesbulin,small molecule,investigational,CC1=NC2=CC=C(F)C=C2N1C1=NC(N)=C(F)C(NC2=CC=C(C=C2)C(F)(F)F)=N1,TWLWOOPCEXYVBE-UHFFFAOYSA-N,420.347,P35226,BE0013109,Polycomb complex protein BMI-1,Humans,inhibitor,yes
DB18091,LNS-8801,small molecule,investigational,[H][C@]12CC=C[C@@]1([H])C1=CC(=CC=C1N[C@H]2C1=CC2=C(OCO2)C=C1Br)C(C)=O,VHSVKVWHYFBIFJ-HKZYLEAXSA-N,412.283,Q99527,BE0003446,G-protein coupled estrogen receptor 1,Humans,agonist,yes
DB18096,Encaleret,small molecule,investigational,C[C@@H](OC[C@H](O)CNC(C)(C)CC1=CC=C(Cl)C(F)=C1)C1=CC=CC=C1C1=CC=C(C(O)=O)C(C)=C1,UNFHDRVFEQPUEL-DENIHFKCSA-N,514.03,P41180,BE0000509,Extracellular calcium-sensing receptor,Humans,modulator,yes
DB18104,TP-1287,small molecule,investigational,CN1CC[C@@H]([C@H](O)C1)C1=C2OC(=CC(=O)C2=C(O)C=C1OP(O)(O)=O)C1=CC=CC=C1Cl,YRNFLVUMZIRYKY-BLLLJJGKSA-N,481.82,P50750,BE0002207,Cyclin-dependent kinase 9,Humans,inhibitor,yes
DB18107,SEL120-34A free base,small molecule,investigational,CC1=C2N=C(N3CCCC(=C23)C(Br)=C1Br)N1CCNCC1,FSBMCTDYWXIBLM-UHFFFAOYSA-N,414.145,Q9BWU1,BE0018995,Cyclin-dependent kinase 19,Humans,inhibitor,yes
DB18107,SEL120-34A free base,small molecule,investigational,CC1=C2N=C(N3CCCC(=C23)C(Br)=C1Br)N1CCNCC1,FSBMCTDYWXIBLM-UHFFFAOYSA-N,414.145,P49336,BE0002224,Cyclin-dependent kinase 8,Humans,inhibitor,yes
DB18122,PF-07059013,small molecule,investigational,C[C@H](OC1=CC2=CC(F)=CC=C2N=C1N)C1=C(C=CC(=O)N1)N1C=CC=N1,CLEFVPILGAPOTG-NSHDSACASA-N,365.368,P68871,BE0000629,Hemoglobin subunit beta,Humans,modulator,yes
DB18124,Fipaxalparant,small molecule,investigational,COC1=CC=C(C=C1OCCC1=CC=CC(C)=C1)C(=O)NC1(CC2=CC=CC=C2C1)C(O)=O,SOJDTNUCCXWTMG-UHFFFAOYSA-N,445.515,Q92633,BE0017535,Lysophosphatidic acid receptor 1,Humans,modulator,yes
DB18124,Fipaxalparant,small molecule,investigational,COC1=CC=C(C=C1OCCC1=CC=CC(C)=C1)C(=O)NC1(CC2=CC=CC=C2C1)C(O)=O,SOJDTNUCCXWTMG-UHFFFAOYSA-N,445.515,Q9UBY5,BE0020529,Lysophosphatidic acid receptor 3,Humans,modulator,yes
DB18125,PTX-100,small molecule,investigational,CC(C)C[C@H](NC(=O)N1CCN(CC2=C(C)N=CN2)C(=O)[C@@H]1CC1=CC=CC=C1)C(O)=O,COLCNDRDBCLVOC-ICSRJNTNSA-N,441.532,P49354,BE0002373,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,Humans,modulator,yes
DB18125,PTX-100,small molecule,investigational,CC(C)C[C@H](NC(=O)N1CCN(CC2=C(C)N=CN2)C(=O)[C@@H]1CC1=CC=CC=C1)C(O)=O,COLCNDRDBCLVOC-ICSRJNTNSA-N,441.532,P49356,BE0002372,Protein farnesyltransferase subunit beta,Humans,modulator,yes
DB18145,Aloxistatin,small molecule,investigational,CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C,SRVFFFJZQVENJC-IHRRRGAJSA-N,342.436,P17655,BE0012693,Calpain-2 catalytic subunit,Humans,inhibitor,yes
DB18145,Aloxistatin,small molecule,investigational,CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C,SRVFFFJZQVENJC-IHRRRGAJSA-N,342.436,P08311,BE0001010,Cathepsin G,Humans,inhibitor,yes
DB18203,Cudetaxestat,small molecule,investigational,CCCN1C=C(C=N1)N1C(Cl)=C(SC2=CC=CC(C(O)=O)=C2F)C2=CC=C(Cl)C(F)=C12,NMDFAQXLJQRHMS-UHFFFAOYSA-N,482.33,Q13822,BE0010333,Autotaxin,Humans,inhibitor,yes
DB18213,Idroxioleic acid,small molecule,investigational,CCCCCCCC\C=C/CCCCCCC(O)C(O)=O,JBSOOFITVPOOSY-KTKRTIGZSA-N,298.467,Q86VZ5,BE0016391,Phosphatidylcholine:ceramide cholinephosphotransferase 1,Humans,modulator,yes
DB18213,Idroxioleic acid,small molecule,investigational,CCCCCCCC\C=C/CCCCCCC(O)C(O)=O,JBSOOFITVPOOSY-KTKRTIGZSA-N,298.467,Q8NHU3,BE0017188,Phosphatidylcholine:ceramide cholinephosphotransferase 2,Humans,modulator,yes
DB18214,Ibutamoren,small molecule,investigational,CC(C)(N)C(=O)N[C@H](COCC1=CC=CC=C1)C(=O)N1CCC2(CN(C3=CC=CC=C23)S(C)(=O)=O)CC1,UMUPQWIGCOZEOY-JOCHJYFZSA-N,528.67,Q92847,BE0003383,Growth hormone secretagogue receptor type 1,Humans,modulator,yes
DB18252,Pralmorelin,small molecule,investigational,C[C@@H](N)C(=O)N[C@H](CC1=CC2=CC=CC=C2C=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(N)=O,HRNLPPBUBKMZMT-RDRUQFPZSA-N,817.992,Q92847,BE0003383,Growth hormone secretagogue receptor type 1,Humans,agonist,yes
DB18252,Pralmorelin,small molecule,investigational,C[C@@H](N)C(=O)N[C@H](CC1=CC2=CC=CC=C2C=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(N)=O,HRNLPPBUBKMZMT-RDRUQFPZSA-N,817.992,P52209,BE0003559,"6-phosphogluconate dehydrogenase, decarboxylating",Humans,inhibitor,yes
DB18267,Ferroheme,small molecule,investigational,[Fe++].CC1=C(CCC(O)=O)/C2=C/C3=N/C(=C\C4=C(C)C(C=C)=C([N-]4)/C=C4\N=C(\C=C\1/[N-]\2)C(C=C)=C4C)/C(C)=C3CCC(O)=O,KABFMIBPWCXCRK-RGGAHWMASA-L,616.499,P09601,BE0000735,Heme oxygenase 1,Humans,inhibitor,yes
DB18267,Ferroheme,small molecule,investigational,[Fe++].CC1=C(CCC(O)=O)/C2=C/C3=N/C(=C\C4=C(C)C(C=C)=C([N-]4)/C=C4\N=C(\C=C\1/[N-]\2)C(C=C)=C4C)/C(C)=C3CCC(O)=O,KABFMIBPWCXCRK-RGGAHWMASA-L,616.499,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB18267,Ferroheme,small molecule,investigational,[Fe++].CC1=C(CCC(O)=O)/C2=C/C3=N/C(=C\C4=C(C)C(C=C)=C([N-]4)/C=C4\N=C(\C=C\1/[N-]\2)C(C=C)=C4C)/C(C)=C3CCC(O)=O,KABFMIBPWCXCRK-RGGAHWMASA-L,616.499,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB18267,Ferroheme,small molecule,investigational,[Fe++].CC1=C(CCC(O)=O)/C2=C/C3=N/C(=C\C4=C(C)C(C=C)=C([N-]4)/C=C4\N=C(\C=C\1/[N-]\2)C(C=C)=C4C)/C(C)=C3CCC(O)=O,KABFMIBPWCXCRK-RGGAHWMASA-L,616.499,P35520,BE0000323,Cystathionine beta-synthase,Humans,inhibitor,yes
DB18267,Ferroheme,small molecule,investigational,[Fe++].CC1=C(CCC(O)=O)/C2=C/C3=N/C(=C\C4=C(C)C(C=C)=C([N-]4)/C=C4\N=C(\C=C\1/[N-]\2)C(C=C)=C4C)/C(C)=C3CCC(O)=O,KABFMIBPWCXCRK-RGGAHWMASA-L,616.499,P09917,BE0000248,Polyunsaturated fatty acid 5-lipoxygenase,Humans,inhibitor,yes
DB18267,Ferroheme,small molecule,investigational,[Fe++].CC1=C(CCC(O)=O)/C2=C/C3=N/C(=C\C4=C(C)C(C=C)=C([N-]4)/C=C4\N=C(\C=C\1/[N-]\2)C(C=C)=C4C)/C(C)=C3CCC(O)=O,KABFMIBPWCXCRK-RGGAHWMASA-L,616.499,P29474,BE0000263,Nitric oxide synthase 3,Humans,inhibitor,yes
DB18267,Ferroheme,small molecule,investigational,[Fe++].CC1=C(CCC(O)=O)/C2=C/C3=N/C(=C\C4=C(C)C(C=C)=C([N-]4)/C=C4\N=C(\C=C\1/[N-]\2)C(C=C)=C4C)/C(C)=C3CCC(O)=O,KABFMIBPWCXCRK-RGGAHWMASA-L,616.499,P69905,BE0000130,Hemoglobin subunit alpha,Humans,inhibitor,yes
DB18267,Ferroheme,small molecule,investigational,[Fe++].CC1=C(CCC(O)=O)/C2=C/C3=N/C(=C\C4=C(C)C(C=C)=C([N-]4)/C=C4\N=C(\C=C\1/[N-]\2)C(C=C)=C4C)/C(C)=C3CCC(O)=O,KABFMIBPWCXCRK-RGGAHWMASA-L,616.499,P29475,BE0000067,Nitric oxide synthase 1,Humans,inhibitor,yes
DB18267,Ferroheme,small molecule,investigational,[Fe++].CC1=C(CCC(O)=O)/C2=C/C3=N/C(=C\C4=C(C)C(C=C)=C([N-]4)/C=C4\N=C(\C=C\1/[N-]\2)C(C=C)=C4C)/C(C)=C3CCC(O)=O,KABFMIBPWCXCRK-RGGAHWMASA-L,616.499,P08684,BE0002638,Cytochrome P450 3A4,Humans,inhibitor,yes
DB18267,Ferroheme,small molecule,investigational,[Fe++].CC1=C(CCC(O)=O)/C2=C/C3=N/C(=C\C4=C(C)C(C=C)=C([N-]4)/C=C4\N=C(\C=C\1/[N-]\2)C(C=C)=C4C)/C(C)=C3CCC(O)=O,KABFMIBPWCXCRK-RGGAHWMASA-L,616.499,P35228,BE0000005,"Nitric oxide synthase, inducible",Humans,inhibitor,yes
DB18268,TAK-075 Free base,small molecule,investigational,CCC1=CC=C(C=C1)C(CC)(CC)NC(=O)C1=C2N[C@H](CC(C)(C)N2N=C1C)C1=CC=CC=C1,UEEHORXWFOHMHK-XMMPIXPASA-N,458.65,P41180,BE0000509,Extracellular calcium-sensing receptor,Humans,antagonist,yes
DB18296,AB-22,small molecule,investigational,CCCOC1=CC(NC(=O)NN(CCO)C2=CC(C(C)C)=C3C(C)=NN(C)C3=N2)=CC(Cl)=N1,GOQBSVFOBGVWTA-UHFFFAOYSA-N,475.98,O95136,BE0012208,Sphingosine 1-phosphate receptor 2,Humans,inhibitor,yes
DB18298,PTI-110,small molecule,investigational,OC1=CC=C(NC(=O)C2=CC=C(O)C(O)=C2)C=C1O,XIKSEDLKDYKPTO-UHFFFAOYSA-N,261.233,P05067,BE0003392,Amyloid-beta precursor protein,Humans,inhibitor,yes
DB18307,VLX-1005,small molecule,investigational,COC1=CC=CC(CNC2=CC=C(C=C2)S(=O)(=O)NC2=NC3=CC=CC=C3S2)=C1O,OWHBVKBNNRYMIN-UHFFFAOYSA-N,441.52,O75342,BE0012120,"Arachidonate 12-lipoxygenase, 12R-type",Humans,inhibitor,yes
DB18313,Cinnamic acid,small molecule,investigational,OC(=O)\C=C\C1=CC=CC=C1,WBYWAXJHAXSJNI-VOTSOKGWSA-N,148.161,Q8TDS4,BE0000635,Hydroxycarboxylic acid receptor 2,Humans,agonist,yes
DB18315,Zagociguat,small molecule,investigational,FC1=CC=CC=C1CC1=NC(=CN2C=CN=C12)C1=NC(=NN1)C(F)(F)F,GTKNNCQKFKGSHR-UHFFFAOYSA-N,362.292,Q02108,BE0010061,Guanylate cyclase soluble subunit alpha-1,Humans,stimulator,yes
DB18315,Zagociguat,small molecule,investigational,FC1=CC=CC=C1CC1=NC(=CN2C=CN=C12)C1=NC(=NN1)C(F)(F)F,GTKNNCQKFKGSHR-UHFFFAOYSA-N,362.292,Q02153,BE0010029,Guanylate cyclase soluble subunit beta-1,Humans,stimulator,yes
DB18393,EP-217609,small molecule,investigational,[H][C@]12CS[C@@H](CCCCC(=O)NCCCC[C@H](NC(=O)CCCNC(=O)C[C@H](NS(=O)(=O)C3=C(C)C=C(OC)C(C)=C3C)C(=O)N[C@H](CC3=CC=C(C=C3)C(N)=N)C(=O)N3CCCCC3)C(=O)NCCOCCOCCOCCO[C@@H]3[C@@H](COS(O)(=O)=O)O[C@H](O[C@@]4([H])[C@H](OC)[C@@H](OC)[C@H](O[C@]5([H])[C@@H](COS(O)(=O)=O)O[C@H](O[C@@]6([H])[C@H](OC)[C@@H](OC)[C@H](O[C@]7([H])[C@@H](COS(O)(=O)=O)O[C@H](OC)[C@H](OS(O)(=O)=O)[C@H]7OC)O[C@H]6C(O)=O)[C@H](OS(O)(=O)=O)[C@H]5OS(O)(=O)=O)O[C@@H]4C(O)=O)[C@H](OC)[C@H]3OC)[C@@]1([H])NC(=O)N2,QIBHGITUGYXJDF-UDLCEBFESA-N,2647.75,P00742,BE0000216,Coagulation factor X,Humans,modulator,yes
DB18393,EP-217609,small molecule,investigational,[H][C@]12CS[C@@H](CCCCC(=O)NCCCC[C@H](NC(=O)CCCNC(=O)C[C@H](NS(=O)(=O)C3=C(C)C=C(OC)C(C)=C3C)C(=O)N[C@H](CC3=CC=C(C=C3)C(N)=N)C(=O)N3CCCCC3)C(=O)NCCOCCOCCOCCO[C@@H]3[C@@H](COS(O)(=O)=O)O[C@H](O[C@@]4([H])[C@H](OC)[C@@H](OC)[C@H](O[C@]5([H])[C@@H](COS(O)(=O)=O)O[C@H](O[C@@]6([H])[C@H](OC)[C@@H](OC)[C@H](O[C@]7([H])[C@@H](COS(O)(=O)=O)O[C@H](OC)[C@H](OS(O)(=O)=O)[C@H]7OC)O[C@H]6C(O)=O)[C@H](OS(O)(=O)=O)[C@H]5OS(O)(=O)=O)O[C@@H]4C(O)=O)[C@H](OC)[C@H]3OC)[C@@]1([H])NC(=O)N2,QIBHGITUGYXJDF-UDLCEBFESA-N,2647.75,P00734,BE0000048,Prothrombin,Humans,modulator,yes
DB18405,Crisdesalazine,small molecule,investigational,OC(=O)C1=CC(NCCC2=CC=C(C=C2)C(F)(F)F)=CC=C1O,UTMVACIBQLDZLP-UHFFFAOYSA-N,325.287,O14684,BE0011075,Prostaglandin E synthase,Humans,inhibitor,yes
DB18409,Fobrepodacin,small molecule,investigational,[H][C@@]1(CCCO1)C1=C2NC(NC(=O)NCC)=NC2=CC(=C1F)C1=CN=C(N=C1)C(C)(C)OP(O)(O)=O,COTQDURISRILOR-CQSZACIVSA-N,508.447,P0AES6,BE0000799,DNA gyrase subunit B,Escherichia coli (strain K12),inhibitor,yes
DB18464,Esuberaprost,small molecule,investigational,[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)[C@@H](C)CC#CC)[C@@]1([H])C1=CC=CC(CCCC(O)=O)=C1O2,CTPOHARTNNSRSR-NOQAJONNSA-N,398.499,P43119,BE0000475,Prostacyclin receptor,Humans,agonist,yes
DB18488,DMP-777,small molecule,investigational,CCC[C@@H](NC(=O)N1[C@@H](OC2=CC=C(C=C2)C(=O)N2CCN(C)CC2)C(CC)(CC)C1=O)C1=CC=C2OCOC2=C1,ZSDCIRYNTCVTMF-GIGWZHCTSA-N,564.683,P08246,BE0000394,Neutrophil elastase,Humans,inhibitor,yes
DB18490,Aficamten,small molecule,investigational,CCC1=NC(=NO1)C1=CC=C2[C@@H](CCC2=C1)NC(=O)C1=CN(C)N=C1,IOVAZWDIRCRMTM-OAHLLOKOSA-N,337.383,Q14896,BE0014590,"Myosin-binding protein C, cardiac-type",Humans,inhibitor,yes
DB18515,Revumenib,small molecule,approved;investigational,CCN(C(C)C)C(=O)C1=CC(F)=CC=C1OC1=CN=CN=C1N1CC2(C1)CCN(C[C@H]1CC[C@@H](CC1)NS(=O)(=O)CC)CC2,FRVSRBKUQZKTOW-YOCNBXQISA-N,630.82,O00255,BE0010442,Menin,Humans,inhibitor,yes
DB18518,Crinecerfont,small molecule,investigational,COC1=CC(Cl)=C(C=C1C)C1=C(C)SC(=N1)N(CC#C)[C@@H](CC1CC1)C1=CC=C(C)C(F)=C1,IEAKXXNRGSLYTQ-DEOSSOPVSA-N,483.04,P34998,BE0008658,Corticotropin-releasing factor receptor 1,Humans,antagonist,yes
DB18632,"1-(3-fluoro-4-(7-(5-methyl-1H-imidazol-2-yl)-1-oxo-2,3-dihydro-1H-isoindo-1-4-yl)-phenyl)-3-(3-trifluoromethyl-phenyl)-urea",small molecule,investigational,CC1=CNC(=N1)C1=CC=C(C2=C1C(=O)NC2)C1=CC=C(NC(=O)NC2=CC=CC(=C2)C(F)(F)F)C=C1F,BOLRZWTVMUHQQU-UHFFFAOYSA-N,509.465,Q06187,BE0001284,Tyrosine-protein kinase BTK,Humans,inhibitor,yes
DB18634,Vasoactive intestinal peptide,small molecule,investigational,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CNC=N1)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O,VBUWHHLIZKOSMS-RIWXPGAOSA-N,3326.83,P32241,BE0013137,Vasoactive intestinal polypeptide receptor 1,Humans,antagonist,yes
DB18665,Psoralen,small molecule,investigational,O=C1OC2=CC3=C(C=CO3)C=C2C=C1,ZCCUUQDIBDJBTK-UHFFFAOYSA-N,186.166,P27338,BE0002196,Amine oxidase [flavin-containing] B,Humans,inhibitor,yes
DB18665,Psoralen,small molecule,investigational,O=C1OC2=CC3=C(C=CO3)C=C2C=C1,ZCCUUQDIBDJBTK-UHFFFAOYSA-N,186.166,P21397,BE0002198,Amine oxidase [flavin-containing] A,Humans,inhibitor,yes
DB18707,AVL-3288,small molecule,investigational,CC1=NOC(=C1)C(=C\NC1=CC=C(Cl)C=C1)\C(=O)NC1=CC=C(Cl)C=C1,VMAKIACTLSBBIY-BOPFTXTBSA-N,388.25,P36544,BE0002341,Neuronal acetylcholine receptor subunit alpha-7,Humans,modulator,yes
DB18715,Tolebrutinib,small molecule,investigational,NC1=C2N(C(=O)N([C@@H]3CCCN(C3)C(=O)C=C)C2=CC=N1)C1=CC=C(OC2=CC=CC=C2)C=C1,KOEUOFPEZFUWRF-LJQANCHMSA-N,455.518,Q06187,BE0001284,Tyrosine-protein kinase BTK,Humans,inhibitor,yes
DB18716,Enmetazobactam,small molecule,approved,[H][C@@]12CC(=O)N1[C@@H](C([O-])=O)[C@](C)(CN1C=C[N+](C)=N1)S2(=O)=O,HFZITXBUTWITPT-YWVKMMECSA-N,314.32,P37321,BE0008647,Extended-spectrum beta-lactamase PER-1,Pseudomonas aeruginosa,inhibitor,yes
DB18716,Enmetazobactam,small molecule,approved,[H][C@@]12CC(=O)N1[C@@H](C([O-])=O)[C@](C)(CN1C=C[N+](C)=N1)S2(=O)=O,HFZITXBUTWITPT-YWVKMMECSA-N,314.32,P00807,BE0000302,Beta-lactamase,Staphylococcus aureus,inhibitor,yes
DB18725,Cevidoplenib,small molecule,investigational,CN1C=C(C(=O)C2CC2)C2=CC(NC3=NC(=CC=N3)N3C=C(CN4C[C@H](O)CO4)C(C)=N3)=CC=C12,YCZUBLQESBVOSH-IBGZPJMESA-N,473.537,P43405,BE0001316,Tyrosine-protein kinase SYK,Humans,inhibitor,yes
DB18736,Celastrol,small molecule,investigational,[H][C@@]12C[C@@](C)(CC[C@]1(C)CC[C@]1(C)C3=CC=C4C(C)=C(O)C(=O)C=C4[C@]3(C)CC[C@@]21C)C(O)=O,KQJSQWZMSAGSHN-JJWQIEBTSA-N,450.619,P01584,BE0001051,Interleukin-1 beta,Humans,suppressor,yes
DB18736,Celastrol,small molecule,investigational,[H][C@@]12C[C@@](C)(CC[C@]1(C)CC[C@]1(C)C3=CC=C4C(C)=C(O)C(=O)C=C4[C@]3(C)CC[C@@]21C)C(O)=O,KQJSQWZMSAGSHN-JJWQIEBTSA-N,450.619,P01375,BE0000704,Tumor necrosis factor,Humans,suppressor,yes
DB18752,Indotecan,small molecule,investigational,COC1=C(OC)C=C2C(=O)N(CCCN3CCOCC3)C3=C(C(=O)C4=CC5=C(OCO5)C=C34)C2=C1,FMFIFGLHVOZDEL-UHFFFAOYSA-N,478.501,P11387,BE0000971,DNA topoisomerase 1,Humans,inhibitor,yes
DB18759,APD-209,small molecule,investigational,[H][C@]1(O[C@@](C[C@H](O)[C@H]1NC(C)=O)(OCCCCCNC(=O)CCOCCOCCOCCOCCOCCNC(=O)CCCCCCCCC#CC#CCCCCCCCCCCCC)C(O)=O)[C@H](O)[C@H](O)CO,VRJMVFQLUBTBKF-HBJHFNNESA-N,1042.359,P07550,BE0000694,Beta-2 adrenergic receptor,Humans,agonist,yes
DB18761,Zotarolimus,small molecule,investigational,[H][C@@]12CC[C@@H](C)[C@@](O)(O1)C(=O)C(=O)N1CCCC[C@@]1([H])C(=O)O[C@@]([H])(CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C2)OC)[C@H](C)C[C@@H]1CC[C@@H]([C@@H](C1)OC)N1C=NN=N1,CGTADGCBEXYWNE-JUKNQOCSSA-N,966.227,P42345,BE0002386,Serine/threonine-protein kinase mTOR,Humans,modulator,yes
DB18767,Zabedosertib,small molecule,investigational,CC(C)(O)C1=CC2=NN(CCS(C)(=O)=O)C=C2C=C1NC(=O)C1=CC=CC(=N1)C(F)(F)F,OQAMEEFUUFJZRS-UHFFFAOYSA-N,470.47,Q9NWZ3,BE0004344,Interleukin-1 receptor-associated kinase 4,Humans,inhibitor,yes
DB18773,Flurpiridaz F-18,small molecule,investigational,CC(C)(C)N1N=CC(OCC2=CC=C(COCC[18F])C=C2)=C(Cl)C1=O,RMXZKEPDYBTFOS-LRFGSCOBSA-N,367.84,Q9P0J0,BE0000525,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13,Humans,inhibitor,yes
DB18782,Vonafexor,small molecule,investigational,OC(=O)C1=CC2=C(Cl)C(=CC=C2O1)N1CCN(CC1)S(=O)(=O)C1=C(Cl)C=CC=C1Cl,XLGQSYUNOIJBNR-UHFFFAOYSA-N,489.75,Q96RI1,BE0001777,Bile acid receptor,Humans,agonist,yes
DB18785,Varoglutamstat,small molecule,investigational,CCCOC1=CC=C(C=C1)[C@H]1CNC(=O)N1C1=CC=C2NC=NC2=C1,XHIKZWOEFZENIX-GOSISDBHSA-N,336.395,Q16769,BE0003330,Glutaminyl-peptide cyclotransferase,Humans,inhibitor,yes
DB18786,APX-3330,small molecule,investigational,CCCCCCCCC\C(=C/C1=C(C)C(=O)C(OC)=C(OC)C1=O)C(O)=O,AALSSIXXBDPENJ-FYWRMAATSA-N,378.465,P27695,BE0002414,DNA repair nuclease/redox regulator APEX1,Humans,inhibitor,yes
DB18788,Ulixacaltamide,small molecule,investigational,CC(C)(C)NC(=O)CN1CCC(CNC(=O)C2=CC(F)=CC(Cl)=C2)CC1,JOCLITFYIMJMNK-UHFFFAOYSA-N,383.89,O95180,BE0000864,Voltage-dependent T-type calcium channel subunit alpha-1H,Humans,modulator,yes
DB18793,Trelanserin,small molecule,investigational,NC(=O)CN1C(=O)C=C(CCN2CCN(CC2)C2=C3C=CSC3=CC=N2)C2=CC=C(F)C=C12,JDLYOFUDIKMYBL-UHFFFAOYSA-N,465.55,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,modulator,yes
DB18794,Trazpiroben,small molecule,investigational,OC(=O)C1=CC=CC(CN2CN(C3CCCCC3)C3(CCN(CCCC(=O)C4=CC=CC=C4)CC3)C2=O)=C1,BDXJYAAYLZTLEK-UHFFFAOYSA-N,517.67,P35462,BE0000581,D(3) dopamine receptor,Humans,inhibitor,yes
DB18794,Trazpiroben,small molecule,investigational,OC(=O)C1=CC=CC(CN2CN(C3CCCCC3)C3(CCN(CCCC(=O)C4=CC=CC=C4)CC3)C2=O)=C1,BDXJYAAYLZTLEK-UHFFFAOYSA-N,517.67,P14416,BE0000756,D(2) dopamine receptor,Humans,inhibitor,yes
DB18795,Traxoprodil,small molecule,investigational,C[C@@H]([C@@H](O)C1=CC=C(O)C=C1)N1CCC(O)(CC1)C1=CC=CC=C1,QEMSVZNTSXPFJA-HNAYVOBHSA-N,327.424,Q13224,BE0000417,"Glutamate receptor ionotropic, NMDA 2B",Humans,antagonist,yes
DB18804,Tepilamide fumarate,small molecule,investigational,CCN(CC)C(=O)COC(=O)\C=C\C(=O)OC,AKUGRXRLHCCENI-VOTSOKGWSA-N,243.259,P19838,BE0001086,Nuclear factor NF-kappa-B p105 subunit,Humans,inhibitor,yes
DB18804,Tepilamide fumarate,small molecule,investigational,CCN(CC)C(=O)COC(=O)\C=C\C(=O)OC,AKUGRXRLHCCENI-VOTSOKGWSA-N,243.259,Q01201,BE0013795,Transcription factor RelB,Humans,inhibitor,yes
DB18804,Tepilamide fumarate,small molecule,investigational,CCN(CC)C(=O)COC(=O)\C=C\C(=O)OC,AKUGRXRLHCCENI-VOTSOKGWSA-N,243.259,Q00653,BE0002387,Nuclear factor NF-kappa-B p100 subunit,Humans,inhibitor,yes
DB18804,Tepilamide fumarate,small molecule,investigational,CCN(CC)C(=O)COC(=O)\C=C\C(=O)OC,AKUGRXRLHCCENI-VOTSOKGWSA-N,243.259,Q04206,BE0005551,Transcription factor p65,Humans,inhibitor,yes
DB18804,Tepilamide fumarate,small molecule,investigational,CCN(CC)C(=O)COC(=O)\C=C\C(=O)OC,AKUGRXRLHCCENI-VOTSOKGWSA-N,243.259,Q04864,BE0010782,Proto-oncogene c-Rel,Humans,inhibitor,yes
DB18806,Temuterkib,small molecule,investigational,CN1N=CC=C1NC1=NC=CC(=N1)C1=CC2=C(S1)C(C)(C)N(CCN1CCOCC1)C2=O,JNPRPMBJODOFEC-UHFFFAOYSA-N,453.57,P28482,BE0000923,Mitogen-activated protein kinase 1,Humans,inhibitor,yes
DB18810,Tarafenacin,small molecule,investigational,FC1=CC=CC(=C1)N(CC1=CC(F)=C(F)C(F)=C1)C(=O)O[C@H]1CN2CCC1CC2,UXZDMXYRRQJIBJ-IBGZPJMESA-N,408.397,P20309,BE0000045,Muscarinic acetylcholine receptor M3,Humans,antagonist,yes
DB18811,Taminadenant,small molecule,investigational,NC1=NC(=NC(N2C=CC=N2)=C1Br)N1C=CC=N1,ATFXVNUWQOXRRU-UHFFFAOYSA-N,306.127,P29274,BE0000924,Adenosine receptor A2a,Humans,antagonist,yes
DB18817,Simufilam,small molecule,investigational,CN1CCC2(CC1)NCC(=O)N2CC1=CC=CC=C1,BSQPTZYKCAULBH-UHFFFAOYSA-N,259.353,P21333,BE0009099,Filamin-A,Humans,inhibitor,yes
DB18823,Zemirciclib,small molecule,investigational,CC(=O)N[C@@H]1CCC[C@@H](C1)C(=O)NC1=CC(C2=C3CC(C)(C)CN3N=C2)=C(Cl)C=N1,AVIWDYSJSPOOAR-LSDHHAIUSA-N,429.95,P50750,BE0002207,Cyclin-dependent kinase 9,Humans,inhibitor,yes
DB18840,Allitinib,small molecule,investigational,FC1=CC=CC(COC2=CC=C(NC3=NC=NC4=CC=C(NC(=O)C=C)C=C34)C=C2Cl)=C1,MVZGYPSXNDCANY-UHFFFAOYSA-N,448.88,P00533,BE0000767,Epidermal growth factor receptor,Humans,modulator,yes
DB18847,Deuruxolitinib,small molecule,investigational,[2H]C1([2H])C([C@@H](CC#N)N2C=C(C=N2)C2=C3C=CNC3=NC=N2)C([2H])([2H])C([2H])([2H])C1([2H])[2H],HFNKQEVNSGCOJV-FBXGHSCESA-N,314.422,O60674,BE0002408,Tyrosine-protein kinase JAK2,Humans,inhibitor,yes
DB18847,Deuruxolitinib,small molecule,investigational,[2H]C1([2H])C([C@@H](CC#N)N2C=C(C=N2)C2=C3C=CNC3=NC=N2)C([2H])([2H])C([2H])([2H])C1([2H])[2H],HFNKQEVNSGCOJV-FBXGHSCESA-N,314.422,P23458,BE0004145,Tyrosine-protein kinase JAK1,Humans,inhibitor,yes
DB18865,Naporafenib,small molecule,investigational,CC1=CC=C(NC(=O)C2=CC=NC(=C2)C(F)(F)F)C=C1C1=CC(OCCO)=NC(=C1)N1CCOCC1,UEPXBTCUIIGYCY-UHFFFAOYSA-N,502.494,P04049,BE0000036,RAF proto-oncogene serine/threonine-protein kinase,Humans,inhibitor,yes
DB18866,Nemtabrutinib,small molecule,investigational,OC[C@@H]1CC[C@H](CO1)NC1=C2C(NC=C2C(=O)C2=CC=C(OC3=CC=CC=C3)C=C2Cl)=NC=N1,JSFCZQSJQXFJDS-QAPCUYQASA-N,478.93,Q06187,BE0001284,Tyrosine-protein kinase BTK,Humans,inhibitor,yes
DB18950,Caricotamide,small molecule,investigational,NC(=O)CN1C=CCC(=C1)C(N)=O,WEJRSYKFMCUCRQ-UHFFFAOYSA-N,181.195,P16083,BE0000220,Ribosyldihydronicotinamide dehydrogenase [quinone],Humans,inhibitor,yes
DB18954,TAK-071,small molecule,investigational,CC1=C(CC2=CC=C(C=C2)N2C=CC=N2)C=C2C(=O)N(CC2=C1F)[C@H]1COCC[C@@H]1O,WFSARWQASFQZMG-VXKWHMMOSA-N,421.472,P11229,BE0000092,Muscarinic acetylcholine receptor M1,Humans,modulator,yes
DB18963,Mitiperstat,small molecule,investigational,C[C@@H](N)C1=CC(Cl)=CC=C1CN1C2=C(NC=C2)C(=O)NC1=S,BHKKSKOHRFHHIN-MRVPVSSYSA-N,334.82,P05164,BE0001075,Myeloperoxidase,Humans,inhibitor,yes
DB18964,Orforglipron,small molecule,investigational,[H][C@@]1(CCOC(C)(C)C1)C1=CC=C2N(C(=CC2=C1)C(=O)N1CCC2=NN(C(N3C=CN(C3=O)C3=CC=C4N(C)N=CC4=C3F)=C2[C@@H]1C)C1=CC(C)=C(F)C(C)=C1)[C@]1(C[C@@H]1C)C1=NOC(=O)N1,USUWIEBBBWHKNI-KHIFEHGGSA-N,882.974,P43220,BE0000857,Glucagon-like peptide 1 receptor,Humans,agonist,yes
DB18968,Elinzanetant,small molecule,investigational,[H][C@]12COCCN1C[C@@H](CO)N(C2)C1=CC(=C(C=N1)N(C)C(=O)C(C)(C)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)C1=CC=C(F)C=C1C,DWRIJNIPBUFCQS-DQEYMECFSA-N,668.657,P29371,BE0002371,Neuromedin-K receptor,Humans,antagonist,yes
DB18968,Elinzanetant,small molecule,investigational,[H][C@]12COCCN1C[C@@H](CO)N(C2)C1=CC(=C(C=N1)N(C)C(=O)C(C)(C)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)C1=CC=C(F)C=C1C,DWRIJNIPBUFCQS-DQEYMECFSA-N,668.657,P25103,BE0000384,Substance-P receptor,Humans,antagonist,yes
DB19010,Supinoxin,small molecule,investigational,COC1=CC(=CC(OC)=C1)N1CCN(CC1)C(=O)NC1=NC2=CC(F)=CC=C2N=C1OC,KAKPGJJRYRYSTP-UHFFFAOYSA-N,441.463,P17844,BE0009162,Probable ATP-dependent RNA helicase DDX5,Humans,modulator,yes
DB19023,Chiglitazar,small molecule,investigational,OC(=O)[C@H](CC1=CC=C(OCCN2C3=C(C=CC=C3)C3=C2C=CC=C3)C=C1)NC1=CC=CC=C1C(=O)C1=CC=C(F)C=C1,QNLWMPLUWMWDMQ-YTTGMZPUSA-N,572.636,P37231,BE0000215,Peroxisome proliferator-activated receptor gamma,Humans,modulator,yes
DB19023,Chiglitazar,small molecule,investigational,OC(=O)[C@H](CC1=CC=C(OCCN2C3=C(C=CC=C3)C3=C2C=CC=C3)C=C1)NC1=CC=CC=C1C(=O)C1=CC=C(F)C=C1,QNLWMPLUWMWDMQ-YTTGMZPUSA-N,572.636,Q07869,BE0000071,Peroxisome proliferator-activated receptor alpha,Humans,modulator,yes
DB19028,Atamparib,small molecule,investigational,C[C@@H](COCCC(=O)N1CCN(CC1)C1=NC=C(C=N1)C(F)(F)F)NC1=C(C(=O)NN=C1)C(F)(F)F,UQZCQKXJAXKZQH-LBPRGKRZSA-N,523.44,Q7Z3E1,BE0016431,Protein mono-ADP-ribosyltransferase TIPARP,Humans,inhibitor,yes
DB19033,Befiradol,small molecule,investigational,CC1=CC=C(CNCC2(F)CCN(CC2)C(=O)C2=CC=C(F)C(Cl)=C2)N=C1,PKZXLMVXBZICTF-UHFFFAOYSA-N,393.86,P08908,BE0000291,5-hydroxytryptamine receptor 1A,Humans,agonist,yes
DB19041,Elimusertib,small molecule,investigational,C[C@@H]1COCCN1C1=NC2=C(N=CC=C2C(=C1)C1=CC=NN1C)C1=CC=NN1,YBXRSCXGRPSTMW-CYBMUJFWSA-N,375.436,Q13535,BE0010060,Serine/threonine-protein kinase ATR,Humans,inhibitor,yes
DB19043,Imlunestrant,small molecule,investigational,[H][C@@]1(OC2=CC(=CC=C2C2=C1C1=CC=C(O)C=C1N=C2)C(F)(F)F)C1=CC=C(OCCN2CC(CF)C2)C=C1,UVBQMXOKKDCBJN-MUUNZHRXSA-N,524.516,P03372,BE0000123,Estrogen receptor,Humans,degradation,yes
DB19054,Deudextromethorphan,small molecule,investigational,[H][C@]12CCCC[C@]11CCN([C@H]2CC2=CC=C(OC([2H])([2H])[2H])C=C12)C([2H])([2H])[2H],MKXZASYAUGDDCJ-QNNIAVNKSA-N,277.441,P31645,BE0000749,Sodium-dependent serotonin transporter,Humans,modulator,yes
DB19054,Deudextromethorphan,small molecule,investigational,[H][C@]12CCCC[C@]11CCN([C@H]2CC2=CC=C(OC([2H])([2H])[2H])C=C12)C([2H])([2H])[2H],MKXZASYAUGDDCJ-QNNIAVNKSA-N,277.441,Q99720,BE0000156,Sigma non-opioid intracellular receptor 1,Humans,modulator,yes
DB19058,Iclepertin,small molecule,investigational,[H][C@@]12C[C@@]1(CN(C2)C(=O)C1=CC(=CC=C1O[C@H](C)C(F)(F)F)S(C)(=O)=O)C1=NOC(=C1)C(F)(F)F,MYHDQTVHHMSLEF-DDBGAENHSA-N,512.42,P48067,BE0000940,Sodium- and chloride-dependent glycine transporter 1,Humans,inhibitor,yes
DB19083,Mescaline,small molecule,investigational,COC1=CC(CCN)=CC(OC)=C1OC,RHCSKNNOAZULRK-UHFFFAOYSA-N,211.261,P28223,BE0000451,5-hydroxytryptamine receptor 2A,Humans,inhibitor,yes
DB19085,Novolimus,small molecule,investigational,[H][C@@]12CC[C@@H](C)[C@@](O)(O1)C(=O)C(=O)N1CCCC[C@@]1([H])C(=O)O[C@@]([H])(CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@@H](O)C2)[C@H](C)C[C@@H]1CC[C@@H](O)[C@@H](C1)OC,ZHYGVVKSAGDVDY-QQQXYHJWSA-N,900.16,P42345,BE0002386,Serine/threonine-protein kinase mTOR,Humans,inhibitor,yes
DB19088,Asundexian,small molecule,investigational,CC[C@H](N1C=C(OC)C(=CC1=O)C1=CC(Cl)=CC=C1N1C=C(N=N1)C(F)(F)F)C(=O)NC1=CC=C(C(N)=O)C(F)=C1,XYWIPYBIIRTJMM-IBGZPJMESA-N,592.94,P03951,BE0001021,Coagulation factor XI,Humans,inhibitor,yes
DB19090,Baxdrostat,small molecule,investigational,CCC(=O)N[C@@H]1CCCC2=C1C=NC=C2C1=CC=C2N(C)C(=O)CCC2=C1,VDEUDSRUMNAXJG-LJQANCHMSA-N,363.461,P19099,BE0003542,"Cytochrome P450 11B2, mitochondrial",Humans,inhibitor,yes
DB19094,Dimepheptanol,small molecule,investigational,CCC(O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,QIRAYNIFEOXSPW-UHFFFAOYSA-N,311.469,P35372,BE0000770,Mu-type opioid receptor,Humans,inhibitor,yes
DB19094,Dimepheptanol,small molecule,investigational,CCC(O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,QIRAYNIFEOXSPW-UHFFFAOYSA-N,311.469,P41143,BE0000420,Delta-type opioid receptor,Humans,inhibitor,yes
DB19094,Dimepheptanol,small molecule,investigational,CCC(O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,QIRAYNIFEOXSPW-UHFFFAOYSA-N,311.469,P41145,BE0000632,Kappa-type opioid receptor,Humans,inhibitor,yes
DB19123,Enzalutamide d3,small molecule,investigational,[2H]C([2H])([2H])NC(=O)C1=CC=C(C=C1F)N1C(=S)N(C(=O)C1(C)C)C1=CC=C(C#N)C(=C1)C(F)(F)F,WXCXUHSOUPDCQV-HPRDVNIFSA-N,467.46,P10275,BE0000132,Androgen receptor,Humans,inhibitor,yes
DB19125,Giredestrant,small molecule,investigational,C[C@@H]1CC2=C(NC3=CC=CC=C23)[C@H](N1CC(F)(F)CO)C1=C(F)C=C(NC2CN(CCCF)C2)C=C1F,GQCXHIKRWBIQMD-AKJBCIBTSA-N,522.564,P03372,BE0000123,Estrogen receptor,Humans,degradation,yes
DB19129,Inupadenant,small molecule,investigational,C[S@+]([O-])CCOC1=CC(N2CCN(CCN3C(=O)SC4=C3N=C(N)N3N=C(N=C43)C3=CC=CO3)CC2)=C(F)C=C1F,QYCCLUSYHJXDEX-RWYGWLOXSA-N,604.65,P29274,BE0000924,Adenosine receptor A2a,Humans,antagonist,yes
DB19130,Relmapirazin,small molecule,investigational,NC1=NC(C(=O)N[C@H](CO)C(O)=O)=C(N)N=C1C(=O)N[C@H](CO)C(O)=O,XHNJXRDGTITISI-QWWZWVQMSA-N,372.294,P26951,BE0001036,Interleukin-3 receptor subunit alpha,Humans,car t-cell therapy,yes
DB19160,Quemliclustat,small molecule,investigational,C[C@H](NC1=C2C=NN([C@@H]3O[C@H](COP(O)(=O)CP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC(Cl)=C1)C1=CC=CC=C1F,MFYLCAMJNGIULC-KCVUFLITSA-N,580.83,P21589,BE0001096,5'-nucleotidase,Humans,inhibitor,yes
DB19168,Dexamethasone palmitate,small molecule,investigational,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)COC(=O)CCCCCCCCCCCCCCC)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,WDPYZTKOEFDTCU-WDJQFAPHSA-N,630.882,P11474,BE0003722,Steroid hormone receptor ERR1,Humans,agonist,yes
DB19169,Pamapimod,small molecule,investigational,CN1C(=O)C(OC2=CC=C(F)C=C2F)=CC2=CN=C(NC(CCO)CCO)N=C12,JYYLVUFNAHSSFE-UHFFFAOYSA-N,406.39,Q16539,BE0001019,Mitogen-activated protein kinase 14,Humans,inhibitor,yes
DB19170,Pemrametostat,small molecule,investigational,CC(=O)N1CCC(CC1)NC1=CC(=NC=N1)C(=O)NC[C@H](O)CN1CCC2=CC=CC=C2C1,JLCCNYVTIWRPIZ-NRFANRHFSA-N,452.559,O14744,BE0011121,Protein arginine N-methyltransferase 5,Humans,inhibitor,yes
DB19177,PXS-4728A free base,small molecule,investigational,CC(C)(C)NC(=O)C1=CC=C(OC\C(CN)=C\F)C=C1,OWNSXNXYELKDSO-DHZHZOJOSA-N,280.343,Q16853,BE0001002,Amine oxidase [copper-containing] 3,Humans,inhibitor,yes
DB19191,Valiltramiprosate,small molecule,investigational,CC(C)[C@H](N)C(=O)NCCCS(O)(=O)=O,NRZRFNYKMSAZBI-ZETCQYMHSA-N,238.3,P05067,BE0003392,Amyloid-beta precursor protein,Humans,inhibitor,yes
DB19193,CFG-920,small molecule,investigational,CC1=CC=NC=C1N1CCN(C1=O)C1=CC=NC(Cl)=C1,ZVIFCOOHWGNPHJ-UHFFFAOYSA-N,288.74,P05093,BE0000344,"Steroid 17-alpha-hydroxylase/17,20 lyase",Humans,inhibitor,yes
DB19199,ABBV-744,small molecule,investigational,CCNC(=O)C1=CC2=C(N1)C(=O)N(C)C=C2C1=CC(=CC=C1OC1=C(C)C=C(F)C=C1C)C(C)(C)O,OEDSFMUSNZDJFD-UHFFFAOYSA-N,491.563,Q15059,BE0014531,Bromodomain-containing protein 3,Humans,inhibitor,yes
DB19199,ABBV-744,small molecule,investigational,CCNC(=O)C1=CC2=C(N1)C(=O)N(C)C=C2C1=CC(=CC=C1OC1=C(C)C=C(F)C=C1C)C(C)(C)O,OEDSFMUSNZDJFD-UHFFFAOYSA-N,491.563,P25440,BE0012869,Bromodomain-containing protein 2,Humans,inhibitor,yes
DB19199,ABBV-744,small molecule,investigational,CCNC(=O)C1=CC2=C(N1)C(=O)N(C)C=C2C1=CC(=CC=C1OC1=C(C)C=C(F)C=C1C)C(C)(C)O,OEDSFMUSNZDJFD-UHFFFAOYSA-N,491.563,O60885,BE0010747,Bromodomain-containing protein 4,Humans,inhibitor,yes
DB19201,Tamnorzatinib,small molecule,investigational,COC1=CC2=NC=CC(OC3=CC=C(NC(=O)C4=CC5=C(CCCC5=O)N(C5=CC=CC=C5)C4=O)N=C3)=C2C=C1OC,WHMMKPWGWNYYFE-UHFFFAOYSA-N,562.582,Q12866,BE0004271,Tyrosine-protein kinase Mer,Humans,inhibitor,yes
DB19201,Tamnorzatinib,small molecule,investigational,COC1=CC2=NC=CC(OC3=CC=C(NC(=O)C4=CC5=C(CCCC5=O)N(C5=CC=CC=C5)C4=O)N=C3)=C2C=C1OC,WHMMKPWGWNYYFE-UHFFFAOYSA-N,562.582,P30530,BE0009412,Tyrosine-protein kinase receptor UFO,Humans,inhibitor,yes
DB19202,Acoltremon,small molecule,investigational,COC1=CC=C(NC(=O)[C@@H]2C[C@H](C)CC[C@H]2C(C)C)C=C1,HNSGVPAAXJJOPQ-XOKHGSTOSA-N,289.419,Q7Z2W7,BE0001186,Transient receptor potential cation channel subfamily M member 8,Humans,activator,yes
DB19205,MAK-683,small molecule,investigational,CC1=NC=CC=C1C1=CN=C(NCC2=C3CCOC3=CC=C2F)N2C=NN=C12,XLIBABIFOBYHSV-UHFFFAOYSA-N,376.395,O75530,BE0012001,Polycomb protein EED,Humans,inhibitor,yes
DB19206,ONO-5334,small molecule,investigational,C[C@@H]1CS\C(=N/NC(=O)C(=O)[C@@H](NC(=O)C2CCCCCC2)C2CCOCC2)N1C,BTZCSXIUAFVRTE-CHGLIHOBSA-N,438.59,P43235,BE0003417,Cathepsin K,Humans,inhibitor,yes
DB19209,Ruzinurad,small molecule,investigational,OC(=O)C1(CCC1)SC1=CC=NC2=CC=C(Br)C=C12,QGBWIYLNOBYNDL-UHFFFAOYSA-N,338.22,Q96S37,BE0004782,Solute carrier family 22 member 12,Humans,inhibitor,yes
DB19210,SX-682,small molecule,investigational,OB(O)C1=CC=C(OC(F)(F)F)C=C1CSC1=NC=C(C=N1)C(=O)NC1=CC=C(F)C=C1,SDUDZBCEHIZMFZ-UHFFFAOYSA-N,467.2,P25025,BE0010516,C-X-C chemokine receptor type 2,Humans,inhibitor,yes
DB19210,SX-682,small molecule,investigational,OB(O)C1=CC=C(OC(F)(F)F)C=C1CSC1=NC=C(C=N1)C(=O)NC1=CC=C(F)C=C1,SDUDZBCEHIZMFZ-UHFFFAOYSA-N,467.2,P25024,BE0003552,C-X-C chemokine receptor type 1,Humans,inhibitor,yes
DB19218,Camizestrant,small molecule,investigational,C[C@@H]1CC2=C3C=NNC3=CC=C2[C@H](N1CC(F)(F)F)C1=CC=C(NC2CN(CCCF)C2)C=N1,WDHOIABIERMLGY-CMJOXMDJSA-N,476.524,P03372,BE0000123,Estrogen receptor,Humans,degradation,yes
DB19243,Padnarsertib,small molecule,investigational,NC1=CC=C(\C=C\C(=O)NCC2=CC3=CC(=CC(=C3O2)C2=CC=C(F)C=C2)C2=CC=C(C=C2)C(=O)N2CCC(F)(F)CC2)C=N1,MRFOPLWJZULAQD-SWGQDTFXSA-N,610.637,O96013,BE0009508,Serine/threonine-protein kinase PAK 4,Humans,inhibitor,yes
DB19255,Gingerol,small molecule,investigational,CCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1,NLDDIKRKFXEWBK-AWEZNQCLSA-N,294.391,O75762,BE0001122,Transient receptor potential cation channel subfamily A member 1,Humans,activator,yes
DB19257,Ginsenoside Rg3,small molecule,investigational,[H][C@@]1(CC[C@]2(C)[C@]1([H])[C@H](O)C[C@]1([H])[C@@]3(C)CC[C@H](O[C@]4([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@]4([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@]3([H])CC[C@@]21C)[C@@](C)(O)CCC=C(C)C,RWXIFXNRCLMQCD-JBVRGBGGSA-N,785.025,Q12809,BE0000090,Voltage-gated inwardly rectifying potassium channel KCNH2,Humans,activator,yes
DB19277,Omilancor,small molecule,investigational,O=C(N1CCN(CC1)C(=O)C1=CC=CC(=N1)C1=NC2=CC=CC=C2N1)C1=CC=CC(=N1)C1=NC2=CC=CC=C2N1,MVHWZNBAQIGPOQ-UHFFFAOYSA-N,528.576,Q9NS86,BE0020245,LanC-like protein 2,Humans,agonist,yes
DB19281,Licochalcone A,small molecule,investigational,COC1=CC(O)=C(C=C1\C=C\C(=O)C1=CC=C(O)C=C1)C(C)(C)C=C,KAZSKMJFUPEHHW-DHZHZOJOSA-N,338.403,P18031,BE0000623,Tyrosine-protein phosphatase non-receptor type 1,Humans,inhibitor,yes
DB19283,Honokiol,small molecule,investigational,OC1=CC=C(C=C1CC=C)C1=CC(CC=C)=CC=C1O,FVYXIJYOAGAUQK-UHFFFAOYSA-N,266.34,P09917,BE0000248,Polyunsaturated fatty acid 5-lipoxygenase,Humans,inhibitor,yes
DB19283,Honokiol,small molecule,investigational,OC1=CC=C(C=C1CC=C)C1=CC(CC=C)=CC=C1O,FVYXIJYOAGAUQK-UHFFFAOYSA-N,266.34,P23219,BE0000017,Prostaglandin G/H synthase 1,Humans,inhibitor,yes
DB19283,Honokiol,small molecule,investigational,OC1=CC=C(C=C1CC=C)C1=CC(CC=C)=CC=C1O,FVYXIJYOAGAUQK-UHFFFAOYSA-N,266.34,P35354,BE0000262,Prostaglandin G/H synthase 2,Humans,inhibitor,yes
DB19306,XK-469 free acid,small molecule,investigational,CC(OC1=CC=C(OC2=NC3=CC(Cl)=CC=C3N=C2)C=C1)C(O)=O,NUQZXROIVGBRGR-UHFFFAOYSA-N,344.75,Q02880,BE0002425,DNA topoisomerase 2-beta,Humans,modulator,yes
DB19311,Farglitazar,small molecule,investigational,CC1=C(CCOC2=CC=C(C[C@H](NC3=CC=CC=C3C(=O)C3=CC=CC=C3)C(O)=O)C=C2)N=C(O1)C1=CC=CC=C1,ZZCHHVUQYRMYLW-HKBQPEDESA-N,546.623,P37231,BE0000215,Peroxisome proliferator-activated receptor gamma,Humans,modulator,yes
DB19312,Sipoglitazar,small molecule,investigational,CCOC1=NN(CC2=CC=C(OCC3=CSC(=N3)C3=CC=CC=C3)C=C2)C=C1CCC(O)=O,SRFCAWATPLCLMG-UHFFFAOYSA-N,463.55,P37231,BE0000215,Peroxisome proliferator-activated receptor gamma,Humans,modulator,yes
DB19312,Sipoglitazar,small molecule,investigational,CCOC1=NN(CC2=CC=C(OCC3=CSC(=N3)C3=CC=CC=C3)C=C2)C=C1CCC(O)=O,SRFCAWATPLCLMG-UHFFFAOYSA-N,463.55,Q07869,BE0000071,Peroxisome proliferator-activated receptor alpha,Humans,modulator,yes
DB19314,Nemonapride,small molecule,investigational,CNC1=CC(OC)=C(C=C1Cl)C(=O)N[C@@H]1CCN(CC2=CC=CC=C2)[C@@H]1C,KRVOJOCLBAAKSJ-RDTXWAMCSA-N,387.91,P14416,BE0000756,D(2) dopamine receptor,Humans,agonist,yes
DB19325,Sofpironium,small molecule,approved;investigational,CCOC(=O)C[N+]1(C)CC[C@H](C1)OC(=O)[C@@](O)(C1CCCC1)C1=CC=CC=C1,SEVCTUCCZYBJER-BSJAROSPSA-N,390.499,P20309,BE0000045,Muscarinic acetylcholine receptor M3,Humans,inhibitor,yes
DB19325,Sofpironium,small molecule,approved;investigational,CCOC(=O)C[N+]1(C)CC[C@H](C1)OC(=O)[C@@](O)(C1CCCC1)C1=CC=CC=C1,SEVCTUCCZYBJER-BSJAROSPSA-N,390.499,P11229,BE0004890,Muscarinic acetylcholine receptor,Humans,inhibitor,yes
DB19329,Azelaprag,small molecule,investigational,COC1=CC=CC(OC)=C1N1C(NS(=O)(=O)[C@@H](C)[C@H](C)C2=NC=C(C)C=N2)=NN=C1C1=CN=CC(C)=C1,DOMQFIFVDIAOOT-ROUUACIJSA-N,523.61,P35414,BE0013166,Apelin receptor,Humans,agonist,yes
DB19353,Benzgalantamine,small molecule,approved,[H][C@]12C[C@@H](OC(=O)C3=CC=CC=C3)C=C[C@]11CCN(C)CC3=CC=C(OC)C(O2)=C13,JKVNJTYHRABHIY-WXVUKLJWSA-N,391.467,P22303,BE0000426,Acetylcholinesterase,Humans,inhibitor,yes
DB19353,Benzgalantamine,small molecule,approved,[H][C@]12C[C@@H](OC(=O)C3=CC=CC=C3)C=C[C@]11CCN(C)CC3=CC=C(OC)C(O2)=C13,JKVNJTYHRABHIY-WXVUKLJWSA-N,391.467,P36544,BE0002341,Neuronal acetylcholine receptor subunit alpha-7,Humans,allosteric modulator,yes
DB19372,Zoxazolamine,small molecule,withdrawn,NC1=NC2=CC(Cl)=CC=C2O1,YGCODSQDUUUKIV-UHFFFAOYSA-N,168.58,Q9H2S1,BE0004426,Small conductance calcium-activated potassium channel protein 2,Humans,activator,yes
DB19378,Megestrol,small molecule,approved,[H][C@@]12CC[C@](O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C=C(C)C2=CC(=O)CC[C@]12C,VXIMPSPISRVBPZ-NWUMPJBXSA-N,342.479,P06401,BE0000557,Progesterone receptor,Humans,binder,yes
